PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Astudillo-Reyes, C; Fernandez, AC; Cichy, KA				Astudillo-Reyes, Carolina; Fernandez, Andrea C.; Cichy, Karen A.			Transcriptome Characterization of Developing Bean (Phaseolus vulgaris L.) Pods from Two Genotypes with Contrasting Seed Zinc Concentrations	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; GENETIC DIVERSITY; IRON-DEFICIENCY; RNA-SEQ; PROTEIN; FAMILY; NICOTIANAMINE; EXPRESSION; GROWTH	Dry bean (Phaseolus vulgaris L.) seeds are a rich source of dietary zinc, especially for people consuming plant-based diets. Within P. vulgaris there is at least two-fold variation in seed Zn concentration. Genetic studies have revealed seed Zn differences to be controlled by a single gene in two closely related navy bean genotypes, Albion and Voyager. In this study, these two genotypes were grown under controlled fertilization conditions and the Zn concentration of various plant parts was determined. The two genotypes had similar levels of Zn in their leaves and pods but Voyager had 52% more Zn in its seeds than Albion. RNA was sequenced from developing pods of both genotypes. Transcriptome analysis of these genotypes identified 27,198 genes in the developing bean pods, representing 86% of the genes in the P. vulgaris genome (v 1.0 DOE-JGI and USDA- NIFA). Expression was detected in 18,438 genes. A relatively small number of genes (381) were differentially expressed between Albion and Voyager. Differentially expressed genes included three genes potentially involved in Zn transport, including zinc-regulated transporter, iron regulated transporter like (ZIP), zinc-induced facilitator (ZIF) and heavy metal associated (HMA) family genes. In addition 12,118 SNPs were identified between the two genotypes. Of the gene families related to Zn and/or Fe transport, eleven genes were found to contain SNPs between Albion and Voyager.	[Astudillo-Reyes, Carolina; Fernandez, Andrea C.; Cichy, Karen A.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Cichy, Karen A.] USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI 48823 USA	Michigan State University; United States Department of Agriculture (USDA)	Cichy, KA (corresponding author), USDA ARS, Sugarbeet & Bean Res Unit, 1066 Bogue St, E Lansing, MI 48823 USA.	Karen.Cichy@ars.usda.gov		Cichy, Karen/0000-0002-4311-0774	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors received USDA-ARS funding for this work.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Assuncao AG, 2010, P NATL ACAD SCI USA; Astudillo C, 2013, FRONT PLANT SCI, P4; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Bhakta MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116822; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; BOBB AJ, 1995, PLANT J, V8, P331, DOI 10.1046/j.1365-313X.1995.08030331.x; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; CHAPPELL J, 1986, PLANT PHYSIOL, V81, P50, DOI 10.1104/pp.81.1.50; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Cichy KA, 2005, CROP SCI, V45, P864, DOI 10.2135/cropsci2004.0104; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DEBOUCK DG, 1993, ECON BOT, V47, P408, DOI 10.1007/BF02907356; Gelin JP, 2007, CROP SCI, V47, P1361, DOI 10.2135/cropsci2006.08.0510; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam FMA, 2002, GENET RESOUR CROP EV, V49, P285, DOI 10.1023/A:1015510428026; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SZ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-114; Migocka M, 2014, J EXPT BOT, P459; Moraghan JT, 1999, SOIL SCI SOC AM J, V63, P918, DOI 10.2136/sssaj1999.634918x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; OLIKER M, 1978, AM J BOT, V65, P366, DOI 10.2307/2442279; Olsen LI, 2014, FRONT PLANT SCI, P5; Pinheiro C, 2010, J FOOD COMPOS ANAL, V23, P319, DOI 10.1016/j.jfca.2010.01.005; Rashid A, 2013, PLANT MOL BIOL REP, V31, P464, DOI 10.1007/s11105-012-0498-3; Ren YJ, 2012, PLANT CELL ENVIRON, V35, P770, DOI 10.1111/j.1365-3040.2011.02450.x; Ricachenevsky FK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-20; Ricachenevsky FK, 2013, FRONT PLANT SCI, P4; Samardjieva KA, 2015, PROTOPLASMA, V252, P345, DOI 10.1007/s00709-014-0683-3; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; SANKARAN RP, 2014, FRONT PLANT SCI, P5, DOI DOI 10.3389/fpls.2014.00149; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schuler M, 2012, PLANT CELL, V24, P2380, DOI 10.1105/tpc.112.099077; Sheokand S, 2005, PLANT SCI, V169, P966, DOI 10.1016/j.plantsci.2005.07.003; STEPHAN UW, 1993, PHYSIOL PLANTARUM, V88, P522, DOI 10.1111/j.1399-3054.1993.tb01367.x; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	60	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137157	10.1371/journal.pone.0137157	http://dx.doi.org/10.1371/journal.pone.0137157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367119	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100052
J	Diezmann, S; Leach, MD; Cowen, LE				Diezmann, Stephanie; Leach, Michelle D.; Cowen, Leah E.			Functional Divergence of Hsp90 Genetic Interactions in Biofilm and Planktonic Cellular States	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; CANDIDA-ALBICANS BIOFILMS; DRUG-RESISTANCE; PROTEIN; VIRULENCE; CHAPERONE; REVEALS; STRESS; FORMS; YEAST	Candida albicans is among the most prevalent opportunistic fungal pathogens. Its capacity to cause life-threatening bloodstream infections is associated with the ability to form biofilms, which are intrinsically drug resistant reservoirs for dispersal. A key regulator of biofilm drug resistance and dispersal is the molecular chaperone Hsp90, which stabilizes many signal transducers. We previously identified 226 C. albicans Hsp90 genetic interactors under planktonic conditions, of which 56 are involved in transcriptional regulation. Six of these transcriptional regulators have previously been implicated in biofilm formation, suggesting that Hsp90 genetic interactions identified in planktonic conditions may have functional significance in biofilms. Here, we explored the relationship between Hsp90 and five of these transcription factor genetic interactors: BCR1, MIG1, TEC1, TUP1, and UPC2. We deleted each transcription factor gene in an Hsp90 conditional expression strain, and assessed biofilm formation and morphogenesis. Strikingly, depletion of Hsp90 conferred no additional biofilm defect in the mutants. An interaction was observed in which deletion of BCR1 enhanced filamentation upon reduction of Hsp90 levels. Further, although Hsp90 modulates expression of TEC1, TUP1, and UPC2 in planktonic conditions, it has no impact in biofilms. Lastly, we probed for physical interactions between Hsp90 and Tup1, whose WD40 domain suggests that it might interact with Hsp90 directly. Hsp90 and Tup1 formed a stable complex, independent of temperature or developmental state. Our results illuminate a physical interaction between Hsp90 and a key transcriptional regulator of filamentation and biofilm formation, and suggest that Hsp90 has distinct genetic interactions in planktonic and biofilm cellular states.	[Diezmann, Stephanie; Leach, Michelle D.; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Diezmann, S (corresponding author), Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England.	s.diezmann@bath.ac.uk; leah.cowen@utoronto.ca		Leach, Michelle/0000-0002-1631-8959; Diezmann, Stephanie/0000-0002-9528-1495	University of Bath; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust) [096072]; Canada Research Chair in Microbial Genomics and Infectious Disease [303712]; Canadian Institutes of Heath Research Operating Grant [MOP-86452]; Natural Sciences & Engineering Research Council (NSERC) Discovery Grant [355965]; NSERC E.W.R. Steacie Memorial Fellowship [468732]; BBSRC [BB/L007886/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L007886/1] Funding Source: researchfish	University of Bath; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); Canadian Institutes of Heath Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC E.W.R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Prize Fellowship from the University of Bath to SD, a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust 096072) to MDL, a Canada Research Chair in Microbial Genomics and Infectious Disease (303712) to LEC, a Canadian Institutes of Heath Research Operating Grant (MOP-86452) to LEC, a Natural Sciences & Engineering Research Council (NSERC) Discovery Grant (355965) to LEC, and a NSERC E.W.R. Steacie Memorial Fellowship (468732) to LEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becherelli M, 2013, J MOL MICROB BIOTECH, V23, P396, DOI 10.1159/000351619; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Burt ET, 2003, ANN CLIN LAB SCI, V33, P86; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Cho T, 2012, BIOL PHARM BULL, V35, P1371, DOI 10.1248/bpb.b12-00228; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Daniels KJ, 2015, EUKARYOT CELL, V14, P228, DOI 10.1128/EC.00224-14; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Finkel JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002525; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Guan GB, 2013, MOL MICROBIOL, V89, P732, DOI 10.1111/mmi.12310; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Khurana N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00100; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Leach MD, 2014, EUKARYOT CELL, V13, P1077, DOI 10.1128/EC.00138-14; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leach MD, 2012, NAT REV MICROBIOL, V10, P693, DOI 10.1038/nrmicro2875; Lin CH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003305; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin R, 2011, INT J MED MICROBIOL, V301, P417, DOI 10.1016/j.ijmm.2011.04.009; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Niklas KJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00008; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; O'Meara TR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7741; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Senn H, 2012, MOL BIOL CELL, V23, P268, DOI 10.1091/mbc.E11-08-0729; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Si HY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003210; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Talibi D, 1999, J BACTERIOL, V181, P231, DOI 10.1128/JB.181.1.231-240.1999; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wisplinghoff H, CLIN INFECT DIS, V004, P309; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	67	10	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137947	10.1371/journal.pone.0137947	http://dx.doi.org/10.1371/journal.pone.0137947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367740	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100181
J	Krivokrysenko, VI; Toshkov, IA; Gleiberman, AS; Krasnov, P; Shyshynova, I; Bespalov, I; Maitra, RK; Narizhneva, NV; Singh, VK; Whitnall, MH; Purmal, AA; Shakhov, AN; Gudkov, AV; Feinstein, E				Krivokrysenko, Vadim I.; Toshkov, Ilia A.; Gleiberman, Anatoli S.; Krasnov, Peter; Shyshynova, Inna; Bespalov, Ivan; Maitra, Ratan K.; Narizhneva, Natalya V.; Singh, Vijay K.; Whitnall, Mark H.; Purmal, Andrei A.; Shakhov, Alexander N.; Gudkov, Andrei V.; Feinstein, Elena			The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; TOTAL-BODY IRRADIATION; TUMOR-NECROSIS-FACTOR; PROTECTS MICE; BACTERIAL FLAGELLIN; IMPROVES SURVIVAL; INDUCED APOPTOSIS; CELL-DEATH	There are currently no approved medical radiation countermeasures (MRC) to reduce the lethality of high-dose total body ionizing irradiation expected in nuclear emergencies. An ideal MRC would be effective even when administered well after radiation exposure and would counteract the effects of irradiation on the hematopoietic system and gastrointestinal tract that contribute to its lethality. Entolimod is a Toll-like receptor 5 agonist with demonstrated radioprotective/mitigative activity in rodents and radioprotective activity in nonhuman primates. Here, we report data from several exploratory studies conducted in lethally irradiated non-human primates (rhesus macaques) treated with a single intramuscular injection of entolimod (in the absence of intensive individualized supportive care) administered in a mitigative regimen, 1-48 hours after irradiation. Following exposure to LD50-70/40 of radiation, injection of efficacious doses of entolimod administered as late as 25 hours thereafter reduced the risk of mortality 2-3-fold, providing a statistically significant (P < 0.01) absolute survival advantage of 40-60% compared to vehicle treatment. Similar magnitude of survival improvement was also achieved with drug delivered 48 hours after irradiation. Improved survival was accompanied by predominantly significant (P < 0.05) effects of entolimod administration on accelerated morphological recovery of hematopoietic and immune system organs, decreased severity and duration of thrombocytopenia, anemia and neutropenia, and increased clonogenic potential of the bone marrow compared to control irradiated animals. Entolimod treatment also led to reduced apoptosis and accelerated crypt regeneration in the gastrointestinal tract. Together, these data indicate that entolimod is a highly promising potential life-saving treatment for victims of radiation disasters.	[Krivokrysenko, Vadim I.; Toshkov, Ilia A.; Gleiberman, Anatoli S.; Krasnov, Peter; Shyshynova, Inna; Bespalov, Ivan; Maitra, Ratan K.; Narizhneva, Natalya V.; Purmal, Andrei A.; Shakhov, Alexander N.; Gudkov, Andrei V.; Feinstein, Elena] Cleveland BioLabs Inc CBLI, Buffalo, NY 14203 USA; [Singh, Vijay K.; Whitnall, Mark H.] Armed Forces Radiobiol Res Inst, Bethesda, MD USA; [Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	United States Department of Defense; Roswell Park Cancer Institute	Gudkov, AV (corresponding author), Cleveland BioLabs Inc CBLI, Buffalo, NY 14203 USA.	andrei.gudkov@roswellpark.org; efeinstein@cbiolabs.com	Singh, Vijay/GWZ-8972-2022	Singh, Vijay/0000-0002-6631-3849; gleiberman, anatoli/0000-0001-8491-0826; Gudkov, Andrei/0000-0003-2548-0154	US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS) [W9113M08C0151, W9113M10C0088]; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH) [RC1AI080306, RC2AI087616]; US DoD Defense Threat Reduction Agency (DTRA) [HDTRA1-07-C-0021, HDTRA1-11-C-0008]; US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA) [HHSO100200800059C]; Cleveland BioLabs, Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080306, RC2AI087616] Funding Source: NIH RePORTER	US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS); National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US DoD Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA); Cleveland BioLabs, Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS), http://www.jpeocbd.osd.mil/packs/Default.aspx?pg=180 [Grants W9113M08C0151 and W9113M10C0088 to Cleveland BioLabs, Inc.]); the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH), http://www.niaid.nih.gov/Pages/default.aspx [Grants RC1AI080306 and RC2AI087616 to A.V.G.]; the US DoD Defense Threat Reduction Agency (DTRA), http://www.dtra.mil/ [Grant HDTRA1-07-C-0021 to E.F.], and [Grant HDTRA1-11-C-0008 to V.I.K.]; the US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA), http://www.phe.gov/about/barda/Pages/default.aspx [Grant HHSO100200800059C to A.V.G.]. Cleveland BioLabs, Inc. (CBLI), provided support in the form of salaries for authors VIK, IAT, ASG, PK, IS, IB, RKM, NVN, AAP, ANS, AVG and EF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Anderson RF, 2001, REDOX REP, V6, P197, DOI 10.1179/135100001101536201; Basile LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030434; Benjamin GC, 2009, ASSESSING MED PREPAR; Bensadoun RJ, 2006, SUPPORT CARE CANCER, V14, P566, DOI 10.1007/s00520-006-0047-4; Bertho JM, 2005, INT J RADIAT ONCOL, V63, P911, DOI 10.1016/j.ijrobp.2005.03.045; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dainiak N, 2010, HEALTH PHYS, V98, P838, DOI 10.1097/HP.0b013e3181b3fce5; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; DHONDT V, 1995, BLOOD, V85, P2347, DOI 10.1182/blood.V85.9.2347.bloodjournal8592347; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Dorr H, 2014, HEALTH PHYS, V106, P129, DOI 10.1097/HP.0b013e3182a12de0; Dorr H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-126; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Epperly MW, 2002, RADIAT RES, V157, P568, DOI 10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;2; Farese AM, 2014, HEALTH PHYS, V106, P39, DOI 10.1097/HP.0b013e3182a4dd2c; Farese AM, 2013, RADIAT RES, V179, P89, DOI 10.1667/RR3049.1; Farrell CL, 1998, CANCER RES, V58, P933; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Gao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009351; Garcia-Castro J, 2008, J CELL MOL MED, V12, P2552, DOI 10.1111/j.1582-4934.2008.00516.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gluzman-Poltorak Z, 2014, AM J HEMATOL, V89, P868, DOI 10.1002/ajh.23770; Gluzman-Poltorak Z, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-31; Gratwohl A, 1998, BLOOD, V92, P765; Hasan UA, 2005, J BIOL CHEM, V280, P20620, DOI 10.1074/jbc.M500877200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayon Y, 2012, CNS NEUROL DISORD-DR, V11, P921, DOI 10.2174/1871527311201070921; He Xiao-Xia, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P695; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; Hendry JH, 1997, INT J RADIAT BIOL, V71, P709, DOI 10.1080/095530097143716; HOLDRINET RSG, 1980, EXP HEMATOL, V8, P103; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Jones RM, 2011, GUT, V60, P648, DOI 10.1136/gut.2010.223891; Kojouharov BM, 2014, ONCOTARGET, V5, P802, DOI 10.18632/oncotarget.1773; Koller B, 2008, J IMMUNOL, V181, P2753, DOI 10.4049/jimmunol.181.4.2753; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Komarova EA, 2001, BIOCHEM PHARMACOL, V62, P657, DOI 10.1016/S0006-2952(01)00733-X; Krivokrysenko VI, 2012, J PHARMACOL EXP THER, V343, P497, DOI 10.1124/jpet.112.196071; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lee JH, 2004, FREE RADICAL BIO MED, V37, P272, DOI 10.1016/j.freeradbiomed.2004.04.029; Leigh ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085587; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Luo JL, 2005, J CLIN IMMUNOL, V25, P541, DOI 10.1007/s10875-005-8217-6; MACVITTIE TJ, 1994, BLOOD, V84, P2515; MacVittie TJ, 2000, BLOOD, V95, P837, DOI 10.1182/blood.V95.3.837.003k08_837_845; Maj JG, 2003, CANCER RES, V63, P4338; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; Miller LS, 1996, INT J MICROCIRC, V16, P147, DOI 10.1159/000179165; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; NETA R, 1992, J EXP MED, V175, P689, DOI 10.1084/jem.175.3.689; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; PATCHEN ML, 1993, EXP HEMATOL, V21, P338; PATCHEN ML, 1991, BLOOD, V77, P472; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Rabbani ZN, 2007, INT J RADIAT ONCOL, V67, P573, DOI 10.1016/j.ijrobp.2006.09.053; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; ROWE AW, 1994, J MED PRIMATOL, V23, P415, DOI 10.1111/j.1600-0684.1994.tb00130.x; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Sasi N, 2009, MOL CANCER THER, V8, P1421, DOI 10.1158/1535-7163.MCT-08-0895; Sergio D, 2008, USING ANIMAL MODELS; Shakhov AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033044; Maia GAS, 2014, ANN HEMATOL, V93, P753, DOI 10.1007/s00277-013-1944-5; Silva SC, 2014, BRAZ J MED BIOL RES, V47, P384, DOI 10.1590/1414-431X20143190; Singh PK, 2011, CYTOKINE, V56, P411, DOI 10.1016/j.cyto.2011.08.016; Singh VK, 2015, EXPERT OPIN BIOL TH, V15, P465, DOI 10.1517/14712598.2015.986453; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Singh VK, 2012, RADIAT RES, V177, P628, DOI 10.1667/RR2657.1; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SRINIVASAN V, 1992, INT J RADIAT ONCOL, V23, P841, DOI 10.1016/0360-3016(92)90657-4; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; THOMAS J, 1982, CLIN EXP IMMUNOL, V47, P457; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; US Department of Health and Human Services, APPR BIOL PROD HUM E, V21, P601; Van Eeden SF, 2000, LEUKEMIA LYMPHOMA, V37, P259, DOI 10.3109/10428190009089427; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; VANDENBERK LC, 2009, J CELL MOL MED; Vigneulle RM, 2002, DIGEST DIS SCI, V47, P1480, DOI 10.1023/A:1015846514471; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Welters ID, 2010, ANESTH ANALG, V110, P934, DOI 10.1213/ANE.0b013e3181c95cfa; Whitnall MH, 2002, IMMUNOPHARM IMMUNOT, V24, P595, DOI 10.1081/IPH-120016038; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yamazaki R, 2006, BONE MARROW TRANSPL, V38, P377, DOI 10.1038/sj.bmt.1705444; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; ZEIDLER C, 1992, BLOOD, V80, P2740; Zgair AK, 2012, J MICROBIOL BIOTECHN, V22, P907, DOI 10.4014/jmb.1112.11079; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	110	35	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135388	10.1371/journal.pone.0135388	http://dx.doi.org/10.1371/journal.pone.0135388			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367124	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100010
J	Li, YK; Carrillo, JA; Ding, Y; He, YH; Zhao, CP; Liu, JN; Liu, GE; Zan, LS; Song, JZ				Li, Yaokun; Carrillo, Jose A.; Ding, Yi; He, Yanghua; Zhao, Chunping; Liu, Jianan; Liu, George E.; Zan, Linsen; Song, Jiuzhou			Transcriptomic Profiling of Spleen in Grass-Fed and Grain-Fed Angus Cattle	PLOS ONE			English	Article							DAIRY BEEF STEERS; HYPERCHOLESTEROLEMIC MEN; ANTIOXIDANT STATUS; IMMUNE-RESPONSE; VITAMIN-E; PASTURE; DIET; MEAT; IDENTIFICATION; CHOLESTEROL	The grass-fed cattle obtain nutrients directly from pastures containing limited assimilable energy but abundant amount of fiber; by contrast, grain-fed steers receive a diet that is comprised mainly of grains and serves as an efficient source of high-digestible energy. Besides energy, these two types of diet differ in a large number of nutritional components. Additionally, animals maintained on rich-energy regimen are more likely to develop metabolic disorders and infectious diseases than pasture raised individuals. Thus, we hypothesize that spleen-a relevant immune organ-may function differently under disparate regimes. The objective of this study was to find the differentially expressed genes in the spleen of grass-fed and grain-fed steers, and furtherly explore the potential involved biopathways. Through RNA sequencing (RNA-Seq), we detected 123 differentially expressed genes. Based on these genes, we performed an Ingenuity Pathway Analysis (IPA) and identified 9 significant molecular networks and 13 enriched biological pathways. Two of the pathways, Nur77 signaling in T lymphocytes and calcium-induced T lymphocyte apoptosis which are immune related, contain a pair of genes HLA-DRA and NR4A1 with dramatically altered expression level. Collectively, our results provided valuable insights into understanding the molecular mechanism of spleen under varied feeding regimens.	[Li, Yaokun; Zhao, Chunping; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Carrillo, Jose A.; Ding, Yi; He, Yanghua; Liu, Jianan; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Liu, George E.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com; songj88@umd.edu	Ding, Yi/U-3314-2019; Liu, George/K-3371-2019; Song, Jiuzhou/AAD-6440-2020	Liu, George/0000-0003-0192-6705; 	China Scholarship Council (CSC); Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds	China Scholarship Council (CSC)(China Scholarship Council); Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds	The work was supported by China Scholarship Council (CSC), Maryland Agricultural Experiment Station (MAES) and Jorgensen Endowment Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; ALTMANN DM, 1993, HUM IMMUNOL, V37, P149, DOI 10.1016/0198-8859(93)90180-9; Andrews S., 2010, FASTQC QUALITY CONTR; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Beauchesne-Rondeau E, 2003, AM J CLIN NUTR, V77, P587, DOI 10.1093/ajcn/77.3.587; Bjorklund EA, 2014, J DAIRY SCI, V97, P1828, DOI 10.3168/jds.2013-6984; Bjorklund EA, 2014, J DAIRY SCI, V97, P1817, DOI 10.3168/jds.2013-6983; Blanco-Ulate B, 2013, FRONT PLANT SCI, P4; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Brunner FS, 2014, P R SOC B, P281; Cross ML, 1999, IMMUNOL CELL BIOL, V77, P345, DOI 10.1046/j.1440-1711.1999.00834.x; De la Fuente J, 2009, MEAT SCI, V82, P331, DOI 10.1016/j.meatsci.2009.02.002; Descalzo AM, 2007, MEAT SCI, V75, P299, DOI 10.1016/j.meatsci.2006.07.015; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Garcia PT, 2008, MEAT SCI, V79, P500, DOI 10.1016/j.meatsci.2007.10.019; Gatellier P, 2004, MEAT SCI, V67, P385, DOI 10.1016/j.meatsci.2003.11.009; Hoffman BG, 2006, GENES IMMUN, V7, P101, DOI 10.1038/sj.gene.6364270; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA204, DOI 10.1289/ehp.120-a204a; Hunninghake DB, 2000, J AM COLL NUTR, V19, P351, DOI 10.1080/07315724.2000.10718931; Insani EM, 2008, MEAT SCI, V79, P444, DOI 10.1016/j.meatsci.2007.10.017; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Ma X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-168; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Melanson K, 2003, NUTRITION, V19, P409, DOI 10.1016/S0899-9007(02)01080-8; Mitra A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-557; Morita T, 2014, PLOS ONE, P9; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Naeem A, 2014, FUNCT INTEGR GENOMIC, V14, P261, DOI 10.1007/s10142-013-0351-2; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Rocha-Perugini V, 2014, EUR J IMMUNOL, V44, P1967, DOI 10.1002/eji.201344235; Smith DR, 2002, EXP BIOL MED, V227, P266, DOI 10.1177/153537020222700407; Smith RA, 1998, J ANIM SCI, V76, P272; Wu F, 2012, J FISH BIOL, V81, P1147, DOI 10.1111/j.1095-8649.2012.03299.x; Yang A, 2002, MEAT SCI, V60, P35, DOI 10.1016/S0309-1740(01)00102-4; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	40	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135670	10.1371/journal.pone.0135670	http://dx.doi.org/10.1371/journal.pone.0135670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367387	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100012
J	Beyer, HM; Gonschorek, P; Samodelov, SL; Meier, M; Weber, W; Zurbriggen, MD				Beyer, Hannes M.; Gonschorek, Patrick; Samodelov, Sophia L.; Meier, Matthias; Weber, Wilfried; Zurbriggen, Matias D.			AQUA Cloning: A Versatile and Simple Enzyme-Free Cloning Approach	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; EXPRESSION	Assembly cloning is increasingly replacing conventional restriction enzyme and DNA-ligase-dependent cloning methods for reasons of efficiency and performance. Here, we describe AQUA (advanced quick assembly), a simple and versatile seamless assembly cloning approach. We demonstrate the applicability and versatility of AQUA Cloning in selected proof-of-principle applications including targeted insertion-, deletion-and site-directed point-mutagenesis, and combinatorial cloning. Furthermore, we show the one pot de novo assembly of multiple DNA fragments into a single circular plasmid encoding a complex light-and chemically-regulated Boolean A NIMPLY B logic operation. AQUA Cloning harnesses intrinsic in vivo processing of linear DNA fragments with short regions of homology of 16 to 32 bp mediated by Escherichia coli. It does not require any kits, enzymes or preparations of reagents and is the simplest assembly cloning protocol to date.	[Beyer, Hannes M.; Gonschorek, Patrick; Samodelov, Sophia L.; Weber, Wilfried; Zurbriggen, Matias D.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Beyer, Hannes M.; Samodelov, Sophia L.; Weber, Wilfried] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Meier, Matthias; Weber, Wilfried; Zurbriggen, Matias D.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Meier, Matthias] Univ Freiburg, Dept Microsyst Engn, IMTEK, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Zurbriggen, MD (corresponding author), Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	matias.zurbriggen@biologie.uni-freiburg.de	Zurbriggen, Matias/L-1778-2013	Zurbriggen, Matias/0000-0002-3523-2907; Samodelov, Sophia/0000-0003-1955-6060; Weber, Wilfried/0000-0003-4340-4446; Beyer, Hannes/0000-0002-6882-006X; Gonschorek, Patrick/0000-0001-9636-3903	Initiating and Networking Fund (IVF) of the Helmholtz Association within the Helmholtz Initiative on Synthetic Biology [SO-078]; European Research Council under the European Community [259043]; excellence initiative of the German Federal Government [EXC 294-BIOSS, GSC 4-SGBM]; excellence initiative of the State Government [EXC 294-BIOSS, GSC 4-SGBM]; Alexander von Humboldt Foundation [1141629]; German Research Foundation [ME3823/1-1]	Initiating and Networking Fund (IVF) of the Helmholtz Association within the Helmholtz Initiative on Synthetic Biology; European Research Council under the European Community(European Research Council (ERC)); excellence initiative of the German Federal Government; excellence initiative of the State Government; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Initiating and Networking Fund (IVF) of the Helmholtz Association within the Helmholtz Initiative on Synthetic Biology [SO-078], the European Research Council under the European Community's Seventh Framework Programme [FP7/2007-2013]/ERC [259043]-CompBioMat, the excellence initiative of the German Federal and State Governments [EXC 294-BIOSS, GSC 4-SGBM], the Alexander von Humboldt Foundation Research Grant No. 1141629, and the German Research Foundation (Emmy-Noether Grant ME3823/1-1).	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Chen SB, 2012, ACS SYNTH BIOL, V1, P284, DOI 10.1021/sb300027y; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; Engler C, 2013, ACS SYNTH BIOL; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; Munteanu B, 2012, J ZHEJIANG UNIV-SC B, V13, P244, DOI 10.1631/jzus.B1100180; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Torella JP, 2014, NAT PROTOC, V9, P2075, DOI 10.1038/nprot.2014.145; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wend S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02052; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Yang RB, 2013, MOL BIOTECHNOL, V55, P10, DOI 10.1007/s12033-012-9597-5; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	33	90	94	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137652	10.1371/journal.pone.0137652	http://dx.doi.org/10.1371/journal.pone.0137652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360249	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100066
J	Cheng, H; Cai, HB; Fu, HT; An, ZW; Fang, JL; Hu, YS; Guo, DJ; Huang, HS				Cheng, Han; Cai, Haibin; Fu, Haitian; An, Zewei; Fang, Jialin; Hu, Yanshi; Guo, Dianjing; Huang, Huasun			Functional Characterization of Hevea brasiliensis CRT/DRE Binding Factor 1 Gene Revealed Regulation Potential in the CBF Pathway of Tropical Perennial Tree	PLOS ONE			English	Article							COLD-ACCLIMATION; LOW-TEMPERATURE; FREEZING TOLERANCE; TRANSCRIPTIONAL ACTIVATORS; SIGNAL-TRANSDUCTION; EXPRESSION; DROUGHT; PLANT; ELEMENT; FAMILY	Rubber trees (Hevea brasiliensis) are susceptible to low temperature and therefore are only planted in the tropical regions. In the past few decades, although rubber trees have been successfully planted in the northern margin of tropical area in China, they suffered from cold injury during the winter. To understand the physiological response under cold stress, we isolated a C-repeat binding factor 1 (CBF1) gene from the rubber tree. This gene (HbCBF1) was found to respond to cold stress but not drought or ABA stress. The corresponding HbCBF1 protein showed CRT/DRE binding activity in gel shift experiment. To further characterize its molecular function, the HbCBF1 gene was overexpressed in Arabidopsis. The HbCBF1 over expression (OE) line showed enhanced cold resistance and relatively slow dehydration, and the expression of Arabidopsis CBF pathway downstream target genes, e.g. AtCOR15a and AtRD29a, were significantly activated under non-acclimation condition. These data suggest HbCBF1 gene is a functional member of the CBF gene family, and may play important regulation function in rubber tree.	[Cheng, Han; Cai, Haibin; An, Zewei; Fang, Jialin; Hu, Yanshi; Huang, Huasun] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China; [Fu, Haitian] Guangxi Subtrop Crops Res Inst, Nanning, Guangxi, Peoples R China; [Guo, Dianjing] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Guo, Dianjing] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese University of Hong Kong; Chinese University of Hong Kong	Huang, HS (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China.	forcheng@gmail.com		, Han/0000-0002-1327-8509; , Zewei/0000-0001-8462-4571	National Natural Science Foundation of China [31301072]; Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China	H. Cheng received the funding of the National Natural Science Foundation of China (grant No.: 31301072); H. Cheng received the funding of Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China (2014-2015).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; An ZeWei, 2012, African Journal of Biotechnology, V11, P9308; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Champ KI, 2007, PHYSIOL PLANTARUM, V129, P529, DOI 10.1111/j.1399-3054.2006.00826.x; Cheng H, 2013, PLANT OMICS, V6, P240; Cheng Han, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P423; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gray GR, 1997, PLANT PHYSIOL, V114, P467, DOI 10.1104/pp.114.2.467; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; He K., 1987, RUBBER CULTURE NO PA; Hua J, 2009, CURR OPIN PLANT BIOL, V12, P568, DOI 10.1016/j.pbi.2009.07.012; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kang Liyan, 2009, CHIN AGR SCI B, P251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Pennycooke JC, 2008, PLANT PHYSIOL, V146, P1242, DOI 10.1104/pp.107.108779; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang Shuming, 2008, TROP AGR SCI TECHNOL, P4; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Xiong YW, 2006, PLANTA, V224, P878, DOI 10.1007/s00425-006-0273-5; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; Zhili Zhao, 2012, IEIT Journal of Adaptive & Dynamic Computing, P12, DOI 10.5813/www.ieit-web.org/IJADC/2012.1.3	50	16	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137634	10.1371/journal.pone.0137634	http://dx.doi.org/10.1371/journal.pone.0137634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361044	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100059
J	Marti, J; Sindelar, J				Marti, Joachim; Sindelar, Jody			Smaller Cigarette Pack as a Commitment to Smoke Less? Insights from Behavioral Economics	PLOS ONE			English	Article							WARNING LABELS; SELF-CONTROL; IMPACT; DEMAND; CESSATION; SIZE; INITIATION; DESIGN; CHOICE; TAXES	Cigarettes are commonly sold in packs of 20 units and therefore little is known about the potential impact of pack size on consumption. Using insights from behavioral economics, we suggest that cigarette packs smaller than the standard size may help some smokers cut back and/or quit, consistent with their long-term goals. Results from an online hypothetical purchase experiment conducted in a sample of US smokers reveal that over a third of smokers are willing to pay a price premium to purchase in smaller quantities. Further, a desire to quit smoking and high self-control is associated with preference for a smaller pack. While we provide some preliminary evidence that smaller packs may be beneficial to certain types of smokers, further research should be conducted to assess whether the smaller pack size should be considered in the arsenal of tobacco control policies to help current smokers quit (JEL: I18; I12; D12)	[Marti, Joachim] Univ Leeds, Acad Unit Hlth Econ, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Sindelar, Jody] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	University of Leeds; Yale University	Marti, J (corresponding author), Univ Leeds, Acad Unit Hlth Econ, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.	J.E.Marti@leeds.ac.uk	Marti, Joachim/C-5141-2016	Marti, Joachim/0000-0001-5763-3704	National Institute on Drug Abuse [R21DA032905]; HSC [1107008837, 0705002660]; National Institute on Alcohol Abuse and Alcoholism [RL1AA17542]; Swiss National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032905] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); HSC; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Grant # R21DA032905 from the National Institute on Drug Abuse (Jody Sindelar - PI), HSC Protocol # 1107008837 (http://www.drugabuse.gov), Grant # RL1AA17542 from the National Institute on Alcohol Abuse and Alcoholism (Jody Sindelar - PI), HIC Protocol # 0705002660 (http://www.niaaa.nih.gov). JM is grateful to the Swiss National Science Foundation (http://www.snf.ch/fr/Pages/default.aspx) for its financial support through the Young Researcher Postdoctoral Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Ashraf N, 2006, Q J ECON, V121, P635, DOI 10.1162/qjec.2006.121.2.635; Bansal-Travers M, 2011, AM J PREV MED, V40, P674, DOI 10.1016/j.amepre.2011.01.021; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Busch SH, 2004, NICOTINE TOB RES, V6, P631, DOI 10.1080/14622200410001727885; CDC, 2011, MMWR-MORBID MORTAL W, V60, P1207; Chapman S, 1992, TOBACCO CONTROL S, V1, P206; DeCicca P, 2008, J HEALTH ECON, V27, P904, DOI 10.1016/j.jhealeco.2008.02.008; DeCicca P, 2013, REV ECON STAT, V95, P516, DOI 10.1162/REST_a_00303; Farrell L, 2011, APPL ECON, V43, P2833, DOI 10.1080/00036840903389838; Few LR, 2012, NICOTINE TOB RES, V14, P761, DOI 10.1093/ntr/ntr222; Goto R, 2007, TOB CONTROL, V16, P336, DOI 10.1136/tc.2006.019281; Green L, 1996, J EXP ANAL BEHAV, V65, P593, DOI 10.1901/jeab.1996.65-593; Gruber J, 2001, Q J EC, V116; Gruber J.H., 2005, BE J EC ANALY POLICY, V5; Gul F, 2007, REV ECON STUD, V74, P147, DOI 10.1111/j.1467-937X.2007.00417.x; Hammar H, 2005, HEALTH ECON, V14, P257, DOI 10.1002/hec.923; Hammond D, 2011, TOBACCO CONTROL; Hammond D, 2009, J PUBLIC HEALTH-UK, V31, P345, DOI 10.1093/pubmed/fdp066; Hersch J, 2005, J RISK UNCERTAINTY, V31, P5, DOI 10.1007/s11166-005-2927-2; Johnston LD, 2004, AM J PREV MED, V27, P267, DOI 10.1016/j.amepre.2004.07.008; Kahneman D., 2011, THINKING FAST SLOW; Kotnowski K, 2013, ADDICTION, V108, P1658, DOI 10.1111/add.12183; KOZLOWSKI LT, 1986, AM J PUBLIC HEALTH, V76, P1337, DOI 10.2105/AJPH.76.11.1337; Ladouceur R, 2012, INT GAMBL STUD, V12, P215, DOI 10.1080/14459795.2012.658078; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Laibson D, 2001, Q J ECON, V116, P81, DOI 10.1162/003355301556356; Lillard DR, 2013, J HEALTH ECON, V32, P114, DOI 10.1016/j.jhealeco.2012.08.006; Loewenstein G., 1999, GETTING HOOKED RATIO, P235, DOI DOI 10.1017/CBO9781139173223.010; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; MacKillop J, 2012, NICOTINE TOB RES; MacKillop J, 2007, DRUG ALCOHOL DEPEN, V89, P227, DOI 10.1016/j.drugalcdep.2007.01.002; Marti J, 2012, EUR J HEALTH ECON, V13, P533, DOI 10.1007/s10198-011-0333-z; O'Connor RJ, 2014, AM J HEALTH BEHAV, V38, P103, DOI 10.5993/AJHB.38.1.11; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; O'Donoghue T, 2001, Q J ECON, V116, P121, DOI 10.1162/003355301556365; Paterson RW, 2008, HEALTH ECON, V17, P1363, DOI 10.1002/hec.1336; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Rousu MC, 2014, J ECON BEHAV ORGAN, V108, P123, DOI 10.1016/j.jebo.2014.09.003; Rousu MC, 2013, APPL ECON PERSPECT P, V35, P171, DOI 10.1093/aepp/pps049; Slade J, 1997, Tob Control, V6, P169; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tauras JA, 2003, NICOTINE TOB RES, V5, P237, DOI 10.1080/1462220031000073306; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thrasher JF, 2009, TOB CONTROL, V18, P431, DOI 10.1136/tc.2008.029132; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; Wansink B, 2005, JAMA-J AM MED ASSOC, V293, P1727, DOI 10.1001/jama.293.14.1727; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Wertenbroch K, 1998, MARKET SCI, V17, P317, DOI 10.1287/mksc.17.4.317; Wilson AG, 2015, NICOTINE TOB RES; Yong HH, 2011, ADDICTION, V106, P2204, DOI 10.1111/j.1360-0443.2011.03533.x	54	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137520	10.1371/journal.pone.0137520	http://dx.doi.org/10.1371/journal.pone.0137520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356844	gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800054
J	Wang, T; Hurwitz, O; Shimada, SG; Qu, LT; Fu, K; Zhang, P; Ma, C; LaMotte, RH				Wang, Tao; Hurwitz, Olivia; Shimada, Steven G.; Qu, Lintao; Fu, Kai; Zhang, Pu; Ma, Chao; LaMotte, Robert H.			Chronic Compression of the Dorsal Root Ganglion Enhances Mechanically Evoked Pain Behavior and the Activity of Cutaneous Nociceptors in Mice	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIC PAIN; C-FIBER NOCICEPTORS; SPARED NERVE INJURY; ELECTROPHYSIOLOGICAL CHANGES; THERMAL HYPERALGESIA; TACTILE ALLODYNIA; SPINAL NERVE; NEURONS; RAT; MODEL	Radicular pain in humans is usually caused by intraforaminal stenosis and other diseases affecting the spinal nerve, root, or dorsal root ganglion (DRG). Previous studies discovered that a chronic compression of the DRG (CCD) induced mechanical allodynia in rats and mice, with enhanced excitability of DRG neurons. We investigated whether CCD altered the pain-like behavior and also the responses of cutaneous nociceptors with unmyelinated axons (C-fibers) to a normally aversive punctate mechanical stimulus delivered to the hairy skin of the hind limb of the mouse. The incidence of a foot shaking evoked by indentation of the dorsum of foot with an aversive von Frey filament (tip diameter 200 mu m, bending force 20 mN) was significantly higher in the foot ipsilateral to the CCD surgery as compared to the contralateral side on post-operative days 2 to 8. Mechanically-evoked action potentials were electrophysiologically recorded from the L3 DRG, in vivo, from cell bodies visually identified as expressing a transgenically labeled fluorescent marker (neurons expressing either the receptor MrgprA3 or MrgprD). After CCD, 26.7% of MrgprA3(+) and 32.1% MrgprD(+) neurons exhibited spontaneous activity (SA), while none of the unoperated control neurons had SA. MrgprA3(+) and MrgprD(+) neurons in the compressed DRG exhibited, in comparison with neurons from unoperated control mice, an increased response to the punctate mechanical stimuli for each force applied (6, 20, 40, and 80 mN). We conclude that CCD produced both a behavioral hyperalgesia and an enhanced response of cutaneous C-nociceptors to aversive punctate mechanical stimuli.	[Wang, Tao; Ma, Chao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Anat Histol & Embryol, Sch Basic Med,Peking Union Med Coll,Neurosci Ctr, Beijing 100730, Peoples R China; [Wang, Tao; Hurwitz, Olivia; Shimada, Steven G.; Qu, Lintao; Fu, Kai; Zhang, Pu; Ma, Chao; LaMotte, Robert H.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Qu, Lintao] Johns Hopkins Univ, Dept Neurosurg, Neurosurg Pain Res Inst, Baltimore, MD USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yale University; Johns Hopkins University	LaMotte, RH (corresponding author), Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA.	robert.lamotte@yale.edu	Wang, Tao/GYU-4584-2022; Ma, Chao/A-7803-2012	Ma, Chao/0000-0003-1346-6961	National Institutes of Health [NS047399, NS014624]; National Natural Science Foundation of China (NSFC) [81271239]; Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund [2011RC01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014624, P01NS047399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants to RHL from the National Institutes of Health (NS047399 and NS014624), and to CM from the National Natural Science Foundation of China (NSFC #81271239) and the Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund (2011RC01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs C A, 1995, Clin Anat, V8, P339, DOI 10.1002/ca.980080506; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RG, 2011, NEUROSCI BULL, V27, P233, DOI 10.1007/s12264-011-1006-8; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Djouhri L, 2012, PAIN, V153, P1824, DOI 10.1016/j.pain.2012.04.019; Fan N, 2011, J NEUROPHYSIOL, V106, P3067, DOI 10.1152/jn.00752.2011; Fan N, 2011, J NEUROPHYSIOL, V106, P211, DOI 10.1152/jn.00065.2011; Gu XP, 2008, ANESTHESIOLOGY, V108, P113, DOI 10.1097/01.anes.0000296073.16972.13; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hu SJ, 1998, PAIN, V77, P15, DOI 10.1016/S0304-3959(98)00067-0; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Kawakami M, 1996, SPINE, V21, P2101, DOI 10.1097/00007632-199609150-00009; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Ma C, 2012, J NEUROPHYSIOL, V107, P357, DOI 10.1152/jn.00801.2011; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; Ma C, 2007, J NEUROSCI, V27, P14059, DOI 10.1523/JNEUROSCI.3699-07.2007; Ma C, 2010, J NEUROSCI METH, V191, P60, DOI 10.1016/j.jneumeth.2010.06.010; Marziniak M, 2011, J AM ACAD DERMATOL, V65, P756, DOI 10.1016/j.jaad.2010.07.036; Misery L, 2014, NAT REV NEUROL, V10, P408, DOI 10.1038/nrneurol.2014.99; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; OLMARKER K, 1993, SPINE, V18, P1425; Qu LT, 2014, BRAIN, V137, P1039, DOI 10.1093/brain/awu007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Ringkamp M, 1999, PAIN, V79, P143, DOI 10.1016/S0304-3959(98)00186-9; Ritter AM, 2001, EUR J NEUROSCI, V14, P411, DOI 10.1046/j.0953-816x.2001.01654.x; Shim B, 2005, NEUROSCIENCE, V132, P193, DOI 10.1016/j.neuroscience.2004.12.036; Sikand P, 2011, PAIN, V152, P2485, DOI 10.1016/j.pain.2011.06.001; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Song Ying, 2013, Shengli Xuebao, V65, P533; TAKAHASHI Y, 1994, NEUROSCI LETT, V168, P85, DOI 10.1016/0304-3940(94)90422-7; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359; Zhang JM, 2008, ANESTHESIOLOGY, V108, P5, DOI 10.1097/01.anes.0000296148.09016.d5; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	41	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137512	10.1371/journal.pone.0137512	http://dx.doi.org/10.1371/journal.pone.0137512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356638	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800052
J	Yepes, S; Torres, MM; Andrade, RE				Yepes, Sally; Mercedes Torres, Maria; Andrade, Rafael E.			Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions	PLOS ONE			English	Article							GENOMIC ABERRATIONS; ENRICHMENT ANALYSIS; MUTATION STATUS; TCL1; RECEPTOR; PATTERN; GENES; MICROENVIRONMENT; PROLIFERATION; BIOMARKERS	Although the identification of inherent structure in chronic lymphocytic leukemia (CLL) gene expression data using class discovery approaches has not been extensively explored, the natural clustering of patient samples can reveal molecular subdivisions that have biological and clinical implications. To explore this, we preprocessed raw gene expression data from two published studies, combined the data to increase the statistical power, and performed unsupervised clustering analysis. The clustering analysis was replicated in 4 independent cohorts. To assess the biological significance of the resultant clusters, we evaluated their prognostic value and identified cluster-specific markers. The clustering analysis revealed two robust and stable subgroups of CLL patients in the pooled dataset. The subgroups were confirmed by different methodological approaches (non-negative matrix factorization NMF clustering and hierarchical clustering) and validated in different cohorts. The subdivisions were related with differential clinical outcomes and markers associated with the microenvironment and the MAPK and BCR signaling pathways. It was also found that the cluster markers were independent of the immunoglobulin heavy chain variable (IGVH) genes mutational status. These findings suggest that the microenvironment can influence the clinical behavior of CLL, contributing to prognostic differences. The workflow followed here provides a new perspective on differences in prognosis and highlights new markers that should be explored in this context.	[Yepes, Sally; Mercedes Torres, Maria] Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Bogota, Colombia; [Andrade, Rafael E.] Univ Los Andes, Fdn Santa Fe Bogota, Univ Hosp, Fac Med,Dept Patol, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Yepes, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Bogota, Colombia.	sl.yepes233@uniandes.edu.co		Torres, Maria/0000-0001-7033-0097	Vicerectoria de Investigaciones; Facultad de Ciencias, Universidad de los Andes	Vicerectoria de Investigaciones; Facultad de Ciencias, Universidad de los Andes	Vicerectoria de Investigaciones and Facultad de Ciencias, Universidad de los Andes supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andritsos LA, 2010, HAEMATOLOGICA S2, V95; [Anonymous], 2014, R LANG ENV STAT COMP; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chuang HY, 2012, BLOOD, V120, P2639, DOI 10.1182/blood-2012-03-416461; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fabris S, 2013, AM J HEMATOL, V88, P24, DOI 10.1002/ajh.23340; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R., ANNOTATE ANNOTATION; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hastie T., 2014, PAMR PAM PREDICTION; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Herling M, 2007, AM J SURG PATHOL, V31, P1123, DOI 10.1097/PAS.0b013e31802e2201; Herling M, 2009, BLOOD, V114, P4675, DOI 10.1182/blood-2009-03-208256; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoyer KK, 2005, J IMMUNOL, V175, P864, DOI 10.4049/jimmunol.175.2.864; Li FJ, 2008, BLOOD, V112, P179, DOI 10.1182/blood-2008-01-131359; Maechler M, 2014, CLUSTER CLUSTER 2NAL; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; Nahi H, 2008, BRIT J HAEMATOL, V141, P445, DOI 10.1111/j.1365-2141.2008.07046.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Parman C, AFFYQCREPORT QC REPO; Pede V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060275; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Popal W, 2010, LEUKEMIA LYMPHOMA, V51, P1375, DOI 10.3109/10428194.2010.505064; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ronchetti D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-27; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwender H, 2012, SIGGENES MULTIPLE TE; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sivina M, 2012, LEUKEMIA, V26, P1812, DOI 10.1038/leu.2012.63; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Villamor N, 2009, HAEMATOL-HEMATOL J, V94, P366; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang X, METADE MICROARRAY ME; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137132	10.1371/journal.pone.0137132	http://dx.doi.org/10.1371/journal.pone.0137132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355846	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800030
J	Bremser, A; Brack, M; Izcue, A				Bremser, Anna; Brack, Maria; Izcue, Ana			Higher Sensitivity of Foxp3(+) Treg Compared to Foxp3(-) Conventional T Cells to TCR-Independent Signals for CD69 Induction	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOLOGICAL SELF-TOLERANCE; AUTOIMMUNE-DISEASE; FACTOR RECEPTOR; ACTIVATION; REQUIREMENT; RECOGNITION; STRENGTH; S1P(1)	T lymphocytes elicit specific responses after recognizing cognate antigen. However, antigen-experienced T cells can also respond to non-cognate stimuli, such as cytokines. CD4(+) Foxp3(+) regulatory T cells (Treg) exhibit an antigen-experienced-like phenotype. Treg can regulate T cell responses in an antigen-specific or bystander way, and it is still unclear as to which extent they rely on T cell receptor (TCR) signals. The study of the antigen response of Treg has been hampered by the lack of downstream readouts for TCR stimuli. Here we assess the effects of TCR signals on the expression of a classical marker of early T cell activation, CD69. Although it can be induced following cytokine exposure, CD69 is commonly used as a readout for antigen response on T cells. We established that upon in vitro TCR stimulation CD69 induction on Foxp3+ Treg cells was more dependent on signaling via soluble factors than on TCR activation. By contrast, expression of the activation marker Nur77 was only induced after TCR stimulation. Our data suggest that Treg are more sensitive to TCR-independent signals than Foxp3(-) cells, which could contribute to their bystander activity.	[Bremser, Anna; Brack, Maria; Izcue, Ana] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Bremser, Anna; Brack, Maria; Izcue, Ana] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency CCI, D-79106 Freiburg, Germany; [Bremser, Anna] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg	Izcue, A (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	izcue@ie-freiburg.mpg.de		Izcue, Ana/0000-0002-7974-7451	Bundesministerium fur Bildung und Forschung [BMBF 01EO1303]; Max Planck Society	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	This study was supported by the Bundesministerium fur Bildung und Forschung (BMBF 01EO1303) (www.bmbf.de) and the Max Planck Society (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alari-Pahissa E, 2012, J LEUKOCYTE BIOL, V92, P145, DOI 10.1189/jlb.1011499; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Cortes JR, 2014, J AUTOIMMUN, V55, P51, DOI 10.1016/j.jaut.2014.05.007; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Larkin J, 2007, EUR J IMMUNOL, V37, P139, DOI 10.1002/eji.200636577; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Lieberman SM, 2012, EUR J IMMUNOL, V42, P1429, DOI 10.1002/eji.201142286; Liu G, 2009, NATURE IMMUNOLOGY, DOI [10.1038/ni.1835, DOI 10.1038/NI.1835]; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Mac Sharry J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098648; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Oh S, 2012, J IMMUNOL, V188, P4171, DOI 10.4049/jimmunol.1103598; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Sekar D, 2012, EUR J IMMUNOL, V42, P1585, DOI 10.1002/eji.201142093; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137393	10.1371/journal.pone.0137393	http://dx.doi.org/10.1371/journal.pone.0137393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352149	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800081
J	Di Ciano, P; Pushparaj, A; Kim, A; Hatch, J; Masood, T; Ramzi, A; Khaled, MATM; Boileau, I; Winstanley, CA; Le Foll, B				Di Ciano, Patricia; Pushparaj, Abhiram; Kim, Aaron; Hatch, Jessica; Masood, Talal; Ramzi, Abby; Khaled, Maram A. T. M.; Boileau, Isabelle; Winstanley, Catherine A.; Le Foll, Bernard			The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task	PLOS ONE			English	Article							IMPROVES COGNITIVE PERFORMANCE; RECEPTOR MESSENGER-RNA; DRUG-ADDICTION; D-3 RECEPTORS; DECISION-MAKING; HIGH-AFFINITY; ANTAGONIST; BEHAVIOR; REWARD; EXPRESSION	Gambling is an addictive disorder with serious societal and personal costs. To-date, there are no approved pharmacological treatments for gambling disorder. Evidence suggests a role for dopamine in gambling disorder and thus may provide a therapeutic target. The present study therefore aimed to investigate the effects of selective antagonists and agonists of D2, D3 and D4 receptors in a rodent analogue of the Iowa gambling task used clinically. In this rat gambling task (rGT), animals are trained to associate different response holes with different magnitudes and probabilities of food pellet rewards and punishing time-out periods. As in the Iowa gambling task, the optimal strategy is to avoid the tempting high-risk high-reward options, and instead favor those linked to smaller per-trial rewards but also lower punishments, thereby maximizing the amount of reward earned over time. Administration of those selective ligands did not affect decision making under the rGT. Only the D4 drug had modest effects on latency measures suggesting that D4 may contribute in some ways to decision making under this task.	[Di Ciano, Patricia; Pushparaj, Abhiram; Kim, Aaron; Masood, Talal; Ramzi, Abby; Khaled, Maram A. T. M.; Le Foll, Bernard] Univ Toronto, Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON M5S 2S1, Canada; [Le Foll, Bernard] Ctr Addict & Mental Hlth, Ambulatory Care & Struct Treatments, Addict Med Serv, Alcohol Res & Treatment Clin, Toronto, ON, Canada; [Le Foll, Bernard] CAMH, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Le Foll, Bernard] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 2S1, Canada; [Hatch, Jessica; Le Foll, Bernard] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 2S1, Canada; [Le Foll, Bernard] Univ Toronto, Dept Psychiat, Div Brain & Therapeut, Toronto, ON M5S 2S1, Canada; [Le Foll, Bernard] Univ Toronto, Inst Med Sci, Toronto, ON M5S 2S1, Canada; [Khaled, Maram A. T. M.] Univ Alexandria, Med Res Inst, Dept Anaesthesia, Pain Management Unit, Alexandria, Egypt; [Boileau, Isabelle] Ctr Addict & Mental Hlth, Addict Imaging Res Grp, Toronto, ON M5T 1R, Canada; [Winstanley, Catherine A.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Egyptian Knowledge Bank (EKB); Alexandria University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of British Columbia	Le Foll, B (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Translat Addict Res Lab, 33 Russell St, Toronto, ON M5S 2S1, Canada.	Bernard.lefoll@camh.ca	Le Foll, Bernard/K-2952-2014	Le Foll, Bernard/0000-0002-6406-4973	Ontario Problem Gambling Research Council	Ontario Problem Gambling Research Council	The current study was funded through a mid-level grant provided by the Ontario Problem Gambling Research Council to CAW and BLF.	Achat-Mendes C, 2010, J PHARMACOL EXP THER, V334, P556, DOI 10.1124/jpet.110.167619; Association AP, 2013, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baarendse PJJ, 2013, PSYCHOPHARMACOLOGY, V225, P719, DOI 10.1007/s00213-012-2857-z; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bernaerts P, 2003, BEHAV BRAIN RES, V142, P41, DOI 10.1016/S0166-4328(02)00371-6; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Browman KE, 2005, PHARMACOL BIOCHEM BE, V82, P148, DOI 10.1016/j.pbb.2005.08.002; Cocker PJ, 2014, BIOL PSYCHIAT, V75, P817, DOI 10.1016/j.biopsych.2013.08.026; Cocker PJ, 2012, J NEUROSCI, V32, P15450, DOI 10.1523/JNEUROSCI.0626-12.2012; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; Diaz J, 2000, J NEUROSCI, V20, P8677; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Heidbreder C, 2005, EUR J PHARMACOL, V526, P101, DOI 10.1016/j.ejphar.2005.09.038; Heidbreder CA, 2005, BRAIN RES REV, V49, P77, DOI 10.1016/j.brainresrev.2004.12.033; Khaled M, 2014, NEUROPSYCHO IN PRESS; Kulagowski JJ, 1996, J MED CHEM, V39, P1941, DOI 10.1021/jm9600712; Le Foll B, 2005, NEUROPHARMACOLOGY, V49, P525, DOI 10.1016/j.neuropharm.2005.04.022; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Linnet J, 2011, SCAND J PSYCHOL, V52, P28, DOI 10.1111/j.1467-9450.2010.00837.x; Lobo DSS, 2015, MOL PSYCHIATR, V20, P1002, DOI 10.1038/mp.2014.113; MeadorWoodruff JH, 1997, ARCH GEN PSYCHIAT, V54, P1089; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; Millan MJ, 2008, J PHARMACOL EXP THER, V324, P600, DOI 10.1124/jpet.107.132563; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Nakajima S, 2013, EUR NEUROPSYCHOPHARM, V23, P799, DOI 10.1016/j.euroneuro.2013.05.006; OMALLEY KL, 1992, NEW BIOL, V4, P137; Paine TA, 2013, BEHAV BRAIN RES, V243, P247, DOI 10.1016/j.bbr.2013.01.018; Payer D, 2014, PROG NEURO-PSYCHOPH, V52, P4, DOI 10.1016/j.pnpbp.2013.08.012; Reavill C, 2000, J PHARMACOL EXP THER, V294, P1154; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Seedat S, 2000, DEPRESS ANXIETY, V11, P185, DOI 10.1002/1520-6394(2000)11:4<185::AID-DA8>3.0.CO;2-H; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; VALERIO A, 1994, NEUROBIOL AGING, V15, P713, DOI 10.1016/0197-4580(94)90053-1; Watson DJG, 2012, NEUROPSYCHOPHARMACOL, V37, P770, DOI 10.1038/npp.2011.254; Winstanley CA, 2011, NEUROPSYCHOPHARMACOL, V36, P913, DOI 10.1038/npp.2010.230; Woolley ML, 2008, BEHAV PHARMACOL, V19, P765, DOI 10.1097/FBP.0b013e32831c3b06; Yan YJ, 2012, NEUROPSYCHOPHARMACOL, V37, P685, DOI 10.1038/npp.2011.245; Young JW, 2011, BEHAV BRAIN RES, V222, P183, DOI 10.1016/j.bbr.2011.03.054; Zack M, 2007, NEUROPSYCHOPHARMACOL, V32, P1678, DOI 10.1038/sj.npp.1301295; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62	43	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136267	10.1371/journal.pone.0136267	http://dx.doi.org/10.1371/journal.pone.0136267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352802	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800032
J	McCullough, LE; Miller, EE; Wang, Q; Li, JY; Liu, L; Li, H; Zhang, J; Smith, JS				McCullough, Lauren E.; Miller, Erline E.; Wang, Qiong; Li, Jia-yuan; Liu, Li; Li, Hui; Zhang, Jing; Smith, Jennifer S.			Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women	PLOS ONE			English	Article							BREAST-CANCER RISK; GROWTH-FACTOR (IGF)-I; PROGESTERONE-RECEPTOR STATUS; PREMENOPAUSAL WOMEN; BINDING PROTEIN-3; MASS INDEX; ENERGY-BALANCE; INSULIN-RESISTANCE; POOLED ANALYSIS; FACTOR-I	The incidence of breast cancer has increased in Asian countries and rates of hormone receptor (HR) negative breast cancer exceed those of Western countries. Epidemiologic data suggest that the association between body size and BC risk may vary by HR status, and could differ geographically. While body size may influence BC risk by moderating the synthesis and metabolism of circulating sex-steroid hormones, insulin-like growth factor (IGF)-1 and related binding proteins, there is a dearth of literature among Asian women. We aimed to examine these specific associations in a sample of Chinese women. In Sichuan Province 143 women aged >= 40 years were recruited through outpatient services (20112012). Questionnaires, anthropometric measurements, and blood samples were utilized for data collection and linear regression was applied in data analyses. Among women <50 years we observed a non-monotonic positive association between body mass index (BMI) and 17 beta-estradiol, and a reversed J-shaped association between BMI and IGF-1 (p <= 0.05). We observed similar associations between waist-to-hip ratio and these markers. Our finding of augmented IGF-1 among women with low body mass may have implications for understanding breast tumor heterogeneity in diverse populations and should be evaluated in larger prospective studies with cancer outcomes.	[McCullough, Lauren E.; Miller, Erline E.; Li, Jia-yuan; Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Wang, Qiong; Li, Jia-yuan; Li, Hui] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu 610041, Peoples R China; [Liu, Li; Zhang, Jing] Chengdu Womens & Childrens Cent Hosp, Comprehens Guidance Ctr Womens Hlth, Chengdu 610015, Peoples R China; [McCullough, Lauren E.; Smith, Jennifer S.] Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; Sichuan University	Li, JY (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, 135 Dauer Dr, Chapel Hill, NC 27599 USA.	lijiayuan@scu.edu.cn	li, jia/GVT-7587-2022		Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China [2010SCU21001]; National Cancer Institute [R25CA057726]	Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was funded by the Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html; Grant no. 2010SCU21001); National Cancer Institute (http://www.cancer.gov/researchandfunding; Grant no. R25CA057726). Funders had no role in the study.	Allen NE, 2003, CANCER CAUSE CONTROL, V14, P65, DOI 10.1023/A:1022518321634; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barnett JB, 2001, NUTR CANCER, V41, P47, DOI 10.1207/S15327914NC41-1&amp;2_6; Beckmann MW, 1997, J MOL MED, V75, P429, DOI 10.1007/s001090050128; Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Blackmore KM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-15; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; COLDITZ GA, 1993, CANCER-AM CANCER SOC, V71, P1480, DOI 10.1002/cncr.2820710413; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Diorio C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2093; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Fair AM, 2007, CANCER DETECT PREV, V31, P214, DOI 10.1016/j.cdp.2007.04.003; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; Freeman EW, 2010, MENOPAUSE, V17, P718, DOI [10.1097/gme.0b013e3181db9f8b, 10.1097/gme.0b013e3181cec85d]; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Green M, 2008, ASIA-PAC J CLIN ONCO, V4, pS5, DOI 10.1111/j.1743-7563.2008.00191.x; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Harris Neil S, 2004, MLO Med Lab Obs, V36, P22; Harris NS, 2004, MLO MED LAB OBS, V36, P2; Henderson KD, 2006, CANCER EPIDEM BIOMAR, V15, P2298, DOI 10.1158/1055-9965.EPI-06-0344; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Iwasaki M, 2007, ANN EPIDEMIOL, V17, P304, DOI 10.1016/j.annepidem.2006.09.003; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 1996, CANCER CAUSE CONTROL, V7, P605, DOI 10.1007/BF00051703; Kalme T, 2003, J STEROID BIOCHEM, V86, P197, DOI 10.1016/S0960-0760(03)00268-1; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Key TJ, 2001, P NUTR SOC, V60, P81, DOI 10.1079/PNS200068; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukanova A, 2004, EUR J ENDOCRINOL, V150, P161, DOI 10.1530/eje.0.1500161; Lukanova A, 2002, CANCER CAUSE CONTROL, V13, P509, DOI 10.1023/A:1016392129279; Maiti B, 2010, BREAST CANCER RES TR, V121, P479, DOI 10.1007/s10549-009-0591-y; Missmer SA, 2006, CANCER EPIDEM BIOMAR, V15, P972, DOI 10.1158/1055-9965.EPI-05-0848; Muti P, 2004, ANN NY ACAD SCI, V1028, P273, DOI 10.1196/annals.1322.031; Nagata C, 2011, CANCER CAUSE CONTROL, V22, P581, DOI 10.1007/s10552-011-9731-x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Panzer C, 2006, J SEX MED, V3, P104, DOI 10.1111/j.1743-6109.2005.00198.x; Paxton RJ, 2013, J CLIN ENDOCR METAB, V98, pE485, DOI 10.1210/jc.2012-2782; Peacock SL, 1999, AM J EPIDEMIOL, V149, P339, DOI 10.1093/oxfordjournals.aje.a009818; Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Song QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072175; Suzuki R, 2006, INT J CANCER, V119, P1683, DOI 10.1002/ijc.22034; Tehard B, 2006, INT J OBESITY, V30, P156, DOI 10.1038/sj.ijo.0803133; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Vongpatanasin W, 2003, J AM COLL CARDIOL, V41, P1358, DOI 10.1016/S0735-1097(03)00156-6; Voskuil DW, 2001, CANCER CAUSE CONTROL, V12, P951, DOI 10.1023/A:1013708627664; Wang Q, 2011, DNA CELL BIOL, V30, P585, DOI 10.1089/dna.2010.1195; Wei SY, 2009, OBESITY, V17, P1070, DOI 10.1038/oby.2008.641; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yasui Y, 1999, CANCER CAUSE CONTROL, V10, P431, DOI 10.1023/A:1008970121595	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137686	10.1371/journal.pone.0137686	http://dx.doi.org/10.1371/journal.pone.0137686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352264	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800109
J	Meier, T; Senftleben, K; Deumelandt, P; Christen, O; Riedel, K; Langer, M				Meier, Toni; Senftleben, Karolin; Deumelandt, Peter; Christen, Olaf; Riedel, Katja; Langer, Martin			Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis	PLOS ONE			English	Article							SODIUM CONSUMPTION; ECONOMIC BURDEN; GLOBAL BURDEN; RISK-FACTORS; CANCER RISK; DIETARY; OBESITY; SENSITIVITY; DISEASE; ADULTS	Non-communicable diseases (NCDs) represent not only the major driver for quality-restricted and lost life years; NCDs and their related medical treatment costs also pose a substantial economic burden on healthcare and intra-generational tax distribution systems. The main objective of this study was therefore to quantify the economic burden of unbalanced nutrition in Germany-in particular the effects of an excessive consumption of fat, salt and sugar-and to examine different reduction scenarios on this basis. In this study, the avoidable direct cost savings in the German healthcare system attributable to an adequate intake of saturated fatty acids (SFA), salt and sugar (mono- & disaccharides, MDS) were calculated. To this end, disease-specific healthcare cost data from the official Federal Health Monitoring for the years 2002-2008 and disease-related risk factors, obtained by thoroughly searching the literature, were used. A total of 22 clinical endpoints with 48 risk-outcome pairs were considered. Direct healthcare costs attributable to an unbalanced intake of fat, salt and sugar are calculated to be 16.8 billion EUR (CI95%: 6.3-24.1 billion EUR) in the year 2008, which represents 7% (CI95% 2%-10%) of the total treatment costs in Germany (254 billion EUR). This is equal to 205 EUR per person annually. The excessive consumption of sugar poses the highest burden, at 8.6 billion EUR (CI95%: 3.0-12.1); salt ranks 2nd at 5.3 billion EUR (CI95%: 3.2-7.3) and saturated fat ranks 3rd at 2.9 billion EUR (CI95%: 32 million-4.7 billion). Predicted direct healthcare cost savings by means of a balanced intake of sugars, salt and saturated fat are substantial. However, as this study solely considered direct medical treatment costs regarding an adequate consumption of fat, salt and sugars, the actual societal and economic gains, resulting both from direct and indirect cost savings, may easily exceed 16.8 billion EUR.	[Meier, Toni; Senftleben, Karolin; Deumelandt, Peter; Christen, Olaf] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Riedel, Katja; Langer, Martin] BRAIN Biotechnol Res & Informat Network AG, Zwingenberg, Germany	Martin Luther University Halle Wittenberg	Meier, T (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	toni.meier@landw.uni-halle.de	MUÑOZ, ROSA ANA/H-3964-2018; Christen, Olaf/C-1093-2012; Meier, Toni/AAB-1704-2021	MUÑOZ, ROSA ANA/0000-0002-7504-2163; Meier, Toni/0000-0001-6056-0665	German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE [FKZ 031A206-B]; Biotechnology Research And Information Network AG (BRAIN AG)	German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE(Federal Ministry of Education & Research (BMBF)); Biotechnology Research And Information Network AG (BRAIN AG)	This study was partially funded by the German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE 2020 (grant no. FKZ 031A206-B) as well as by Biotechnology Research And Information Network AG (BRAIN AG). KR and ML are paid employees of BRAIN AG and they were involved in designing the study, data discussion, the decision to publish and the internal review of the manuscript.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; [Anonymous], GES KRANK DIAGN KRAN; [Anonymous], VERBR DEUTSCHL JAHR; [Anonymous], GES GES RECH KRANKH; [Anonymous], GES GES RECH GES VOL; Arab-Kohlmeier L, 1993, ERNAHRUNGSABHANGIGE, V27; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; BARNARD ND, 1995, PREV MED, V24, P646, DOI 10.1006/pmed.1995.1100; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Behrens G, 2014, CAN MED ASSOC J, V186, pE457, DOI 10.1503/cmaj.140025; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Bonner G., 2003, J HYPERTONIE AUSTRIA, V7, P16; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Caudarella R, 2009, J Endocrinol Invest, V32, P15; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Deutsche Gesellschaft fur Ernahrung, 2012, 12 ERN 2012 DTSCH GE; Deutsche Gesellschaft fur Ernahrung, 2006, EV LEITL FETTK PRAV; Deutsche Gesellschaft fur Ernahrung, 2015, EV LEITL FETTZ PRAV; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Gallus S, 2011, CANCER CAUSE CONTROL, V22, P33, DOI 10.1007/s10552-010-9665-8; Grant RL., 2014, BMJ, V348, pf7450, DOI [DOI 10.1136/BMJ.F7450, 10.1136/bmj.f7450]; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hauner H, 2012, DEUT MED WOCHENSCHR, V137, P389, DOI 10.1055/s-0031-1298916; He F. J., 2013, BMJ, V346; Hjerpsted J, 2011, AM J CLIN NUTR, V94, P1479, DOI 10.3945/ajcn.111.022426; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS STUD 2; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Lamarche B, 2014, APPL PHYSIOL NUTR ME, V39, P1409, DOI 10.1139/apnm-2014-0141; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Marshall TA, 2014, J EVID-BASED DENT PR, V14, P56, DOI 10.1016/j.jebdp.2014.04.018; Max Rubner-Institut, 2008, NAT VERZ 2 ERG 2; Meier T, 2015, ERNAHRUNGS UMSCHAU, V62, pM80, DOI 10.4455/eu.2015.005; Meier T, 2014, APPETITE, V74, P20, DOI 10.1016/j.appet.2013.11.006; Melander O, 2006, J HYPERTENS, V24, P1475, DOI 10.1097/01.hjh.0000239280.89819.bc; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nestel PJ, 2008, J AM COLL NUTR, V27, p735S, DOI 10.1080/07315724.2008.10719751; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rocchini AP, 2000, NUTR METAB CARDIOVAS, V10, P287; Saldana TM, 2007, EPIDEMIOLOGY, V18, P501, DOI 10.1097/EDE.0b013e3180646338; Scheidt-Nave C, 2013, BUNDESGESUNDHEITSBLA, V56, P661, DOI 10.1007/s00103-013-1670-0; Schmid A, 2005, SOZ PRAVENTIV MED, V50, P87, DOI 10.1007/s00038-004-4067-x; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Sieri S, 2008, AM J CLIN NUTR, V88, P1304, DOI 10.3945/ajcn.2008.26090; SIGN, 1999, SIGN PUBL, V39; SIGN, 2014, GUID DEV HDB SIGN 50; Soerensen KV, 2014, AM J CLIN NUTR, V99, P984, DOI 10.3945/ajcn.113.077735; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511; UnitedHealth Group, 2010, 5 UNITEDHEALTH CTR H; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Welte R, 2000, EUR J PUBLIC HEALTH, V10, P31, DOI 10.1093/eurpub/10.1.31; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Woo J, 2009, J HUM HYPERTENS, V23, P451, DOI 10.1038/jhh.2008.156; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2013, 66 WORLD HL IN PRESS	70	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135990	10.1371/journal.pone.0135990	http://dx.doi.org/10.1371/journal.pone.0135990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352606	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800021
J	Micheletti, D; Dettori, MT; Micali, S; Aramini, V; Pacheco, I; Linge, CD; Foschi, S; Banchi, E; Barreneche, T; Quilot-Turion, B; Lambert, P; Pascal, T; Iglesias, I; Carbo, J; Wang, LR; Ma, RJ; Li, XW; Gao, ZS; Nazzicari, N; Troggio, M; Bassi, D; Rossini, L; Verde, I; Laurens, F; Arus, P; Aranzana, MJ				Micheletti, Diego; Dettori, Maria Teresa; Micali, Sabrina; Aramini, Valeria; Pacheco, Igor; Linge, Cassia Da Silva; Foschi, Stefano; Banchi, Elisa; Barreneche, Teresa; Quilot-Turion, Benedicte; Lambert, Patrick; Pascal, Thierry; Iglesias, Ignasi; Carbo, Joaquim; Wang, Li-rong; Ma, Rui-juan; Li, Xiong-wei; Gao, Zhong-shan; Nazzicari, Nelson; Troggio, Michela; Bassi, Daniele; Rossini, Laura; Verde, Ignazio; Laurens, Francois; Arus, Pere; Jose Aranzana, Maria			Whole-Genome Analysis of Diversity and SNP-Major Gene Association in Peach Germplasm	PLOS ONE			English	Article							PRUNUS-PERSICA L.; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; GENOTYPE DATA; FRUIT CROPS; BATSCH; MAP; SELECTION; VARIABILITY; MARKERS	Peach was domesticated in China more than four millennia ago and from there it spread world-wide. Since the middle of the last century, peach breeding programs have been very dynamic generating hundreds of new commercial varieties, however, in most cases such varieties derive from a limited collection of parental lines (founders). This is one reason for the observed low levels of variability of the commercial gene pool, implying that knowledge of the extent and distribution of genetic variability in peach is critical to allow the choice of adequate parents to confer enhanced productivity, adaptation and quality to improved varieties. With this aim we genotyped 1,580 peach accessions (including a few closely related Prunus species) maintained and phenotyped in five germplasm collections (four European and one Chinese) with the International Peach SNP Consortium 9K SNP peach array. The study of population structure revealed the subdivision of the panel in three main populations, one mainly made up of Occidental varieties from breeding programs (POP1OCB), one of Occidental landraces (POP2OCT) and the third of Oriental accessions (POP3OR). Analysis of linkage disequilibrium (LD) identified differential patterns of genome-wide LD blocks in each of the populations. Phenotypic data for seven monogenic traits were integrated in a genome-wide association study (GWAS). The significantly associated SNPs were always in the regions predicted by linkage analysis, forming haplotypes of markers. These diagnostic haplotypes could be used for marker-assisted selection (MAS) in modern breeding programs.	[Micheletti, Diego; Arus, Pere; Jose Aranzana, Maria] IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Campus UAB, Barcelona, Spain; [Dettori, Maria Teresa; Micali, Sabrina; Aramini, Valeria; Verde, Ignazio] IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Campus UAB, Barcelona, Spain; [Pacheco, Igor; Linge, Cassia Da Silva; Rossini, Laura] Ctr Ric Frutticoltura, Consiglio Ric Agr Analisi Econ Agr CRA, Rome, Italy; [Foschi, Stefano] Univ Milan, DiSAA, Milan, Italy; [Banchi, Elisa; Troggio, Michela] Ctr Ric Prod Vegetali, Cesena, FC, Italy; [Barreneche, Teresa] FEM, Res & Innovat Ctr, San Michele All Adige, Italy; [Barreneche, Teresa] INRA, Biol Fruit & Pathol, UMR 1332, Villenave Dornon, France; [Quilot-Turion, Benedicte; Lambert, Patrick; Pascal, Thierry] Univ Bordeaux, Biol Fruit & Pathol, UMR 1332, Villenave Dornon, France; [Iglesias, Ignasi] INRA, Domaine St Maurice, GAFL UR1052, F-84143 Montfavet, France; [Carbo, Joaquim] IRTA, Estacio Expt Lleida, Lleida, Spain; [Wang, Li-rong] IRTA, Estacio Expt Mas Badia, Girona, Spain; [Ma, Rui-juan] CAAS, Zhenzhou Fruit Res Inst, Zhengzhou, Peoples R China; [Li, Xiong-wei; Gao, Zhong-shan] Jiangsu Acad Agr Sci, Inst Hort, Nanjing, Jiangsu, Peoples R China; [Nazzicari, Nelson; Rossini, Laura] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Laurens, Francois] Parco Tecnol Padano, Lodi, Italy; [Laurens, Francois] INRA, Inst Rech Hort & Semences, UMR 1345, Beaucouze, France; [Laurens, Francois] Univ Angers, Inst Rech Hort & Semences, QUASAV, PRES LUNAM,UMR 1345,SFR 4207, Angers, France; Inst Rech Hort & Semences, UMR 1345, Agrocampus Ouest, Angers, France; [Pacheco, Igor] Univ Chile, INTA, Santiago, Chile; [Micheletti, Diego] Fondazione Edmund Mach FEM, Res & Innovat Ctr, TN San Michele All Adige, Italy	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Fondazione Edmund Mach; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE; IRTA; IRTA; Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences; Zhejiang University; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universidad de Chile; Fondazione Edmund Mach	Aranzana, MJ (corresponding author), IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Barcelona, Spain.	mariajose.aranzana@irta.cat	micali, sabrina/ABU-4540-2022; Gao, zhongshan/C-2582-2008; Aranzana, Maria Jose/H-7799-2015; Bassi, Daniele/C-2952-2012; Cruz, Igor Pacheco/A-8507-2015; Cruz, Igor Pacheco/J-1193-2019; da Silva Linge, Cassia/C-9538-2019; Verde, Ignazio/K-6348-2019; Carbo, Joaquim/AAB-3350-2019; Rossini, Laura/J-7873-2012; nazzicari, nelson/ABE-1344-2021; Arús, Pere/F-6443-2015; Quilot-Turion, Bénédicte/AAT-2958-2020; Quilot-Turion, Bénédicte/H-9106-2016	Aranzana, Maria Jose/0000-0002-0240-8021; Cruz, Igor Pacheco/0000-0001-5057-0464; Cruz, Igor Pacheco/0000-0001-5057-0464; da Silva Linge, Cassia/0000-0003-4760-1359; Rossini, Laura/0000-0001-6509-9177; nazzicari, nelson/0000-0003-2710-9885; Arús, Pere/0000-0003-0939-8038; Quilot-Turion, Bénédicte/0000-0003-4095-1399; Quilot-Turion, Bénédicte/0000-0003-4095-1399; BARRENECHE, Teresa/0000-0002-7852-1418; Micheletti, Diego/0000-0001-9175-9853; Micali, Sabrina/0000-0002-2086-7467; Bassi, Daniele/0000-0002-8966-3534; Gao, zhongshan/0000-0001-6944-9955; Banchi, Elisa/0000-0002-6598-0447	EU [FP7-265582]; Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF) [DM14999/7303/08, DM 14658/7303/10]; Spanish Ministry of Science and Innovation [AGL2012-40228-C02-01]; INIA [RF2012-00024-C04-04]	EU(European Commission); Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INIA(Instituto de Investigacion Agropecuaria (INIA))	This work has been funded by the EU seventh Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) through the project "FruitBreedomics: Integrated Approach for increasing breeding efficiency in fruit tree crops" (Grant #FP7-265582; http://fruitbreedomics.com/); by the Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF, http://www.politicheagricole.it) through the project "DRUPOMICS: Sequenziamento del genoma del pesco ed utilizzo della sequenza in programmi di miglioramento della qualita del frutto del pesco e della resistenza alle malattie" (Grant # DM14999/7303/08) and "ESPLORA: Esplorazione della biodiversita vegetale ed animale alla ricerca di alleli superiori da inserire nei programmi avanzati di miglioramento genetico a sostegno dell'agricoltura nazionale" (Grant #DM 14658/7303/10); by the Spanish Ministry of Science and Innovation (http://www.micinn.es/) through the project AGL2012-40228-C02-01 (uso de la secuencia genomica para la caracterizacion de la variabilidad intraclonal e interespecifica en Melocotonero y almendro) and by the INIA (http://www.inia.es/) through the Project RF2012-00024-C04-04 ("conservacion y caracterizacion de germoplasma introducido"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, ACTA HORTIC, P145, DOI 10.17660/ActaHortic.2002.575.14; Abbott A. G., 2008, The peach: botany, production and uses, P85, DOI 10.1079/9781845933869.0085; Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Aranzana MJ, 2003, THEOR APPL GENET, V106, P1341, DOI 10.1007/s00122-002-1128-5; Arus P, 2005, PLANT BREEDING REV, P175; Benjamini Y, 2001, ANN STAT, V29, P1165; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BYRNE DH, 1990, J HERED, V81, P68, DOI 10.1093/oxfordjournals.jhered.a110927; Cao K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0415-1; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; Dettori MT, 2001, GENOME, V44, P783, DOI 10.1139/g01-065; Dirlewanger E, 2007, TREE GENET GENOMES, V3, P1, DOI 10.1007/s11295-006-0053-1; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 1998, THEOR APPL GENET, V97, P888, DOI 10.1007/s001220050969; Eduardo I, 2014, TREE GENET GENOMES, V10, P1695, DOI 10.1007/s11295-014-0789-y; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Faust M., 1995, Horticultural Reviews, V17, P331, DOI 10.1002/9780470650585.ch10; Frett TJ, 2014, TREE GENET GENOMES, V10, P367, DOI 10.1007/s11295-013-0692-y; Hesse C. O., 1975, Advances in fruit breeding. Temperate fruits., P285; Jauregui B, 2001, THEOR APPL GENET, V102, P1169, DOI 10.1007/s001220000511; Aranzana MJ, 2012, TREE GENET GENOMES, V8, P1359, DOI 10.1007/s11295-012-0523-6; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Lambert P, 2011, TREE GENET GENOMES, V7, P1057, DOI 10.1007/s11295-011-0394-2; Li XW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-84; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Monet R, 1996, AGRONOMIE, V16, P321, DOI 10.1051/agro:19960505; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; Pacheco I, 2014, TREE GENET GENOMES, V10, P1223, DOI 10.1007/s11295-014-0756-7; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeu JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-52; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCORZA R, 1985, J AM SOC HORTIC SCI, V110, P547; Soto-Cerda BJ, 2012, GENETIC DIVERSITY IN PLANTS, P29; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vendramin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090574; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Xie RJ, 2010, SCI HORTIC-AMSTERDAM, V125, P622, DOI 10.1016/j.scienta.2010.05.015; Yamamoto T, 2005, J JPN SOC HORTIC SCI, V74, P204, DOI 10.2503/jjshs.74.204; Yang NN, 2013, TREE GENET GENOMES, V9, P573, DOI 10.1007/s11295-012-0580-x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	49	67	74	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136803	10.1371/journal.pone.0136803	http://dx.doi.org/10.1371/journal.pone.0136803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352671	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800049
J	Behr, J; Gaskin, B; Fu, CL; Dong, C; Kunz, R				Behr, Julie; Gaskin, Byron; Fu, Changliang; Dong, Cheng; Kunz, Robert			Localized Modeling of Biochemical and Flow Interactions during Cancer Cell Adhesion	PLOS ONE			English	Article							DYNAMICS; FORCE; DEFORMATION; SIMULATION; MECHANICS; MOLECULES; CONSTANT; SURFACES; KINETICS	This work focuses on one component of a larger research effort to develop a simulation tool to model populations of flowing cells. Specifically, in this study a local model of the biochemical interactions between circulating melanoma tumor cells (TC) and substrate adherent polymorphonuclear neutrophils (PMN) is developed. This model provides realistic three-dimensional distributions of bond formation and attendant attraction and repulsion forces that are consistent with the time dependent Computational Fluid Dynamics (CFD) framework of the full system model which accounts local pressure, shear and repulsion forces. The resulting full dynamics model enables exploration of TC adhesion to adherent PMNs, which is a known participating mechanism in melanoma cell metastasis. The model defines the adhesion molecules present on the TC and PMN cell surfaces, and calculates their interactions as the melanoma cell flows past the PMN. Biochemical rates of reactions between individual molecules are determined based on their local properties. The melanoma cell in the model expresses ICAM-1 molecules on its surface, and the PMN expresses the beta-2 integrins LFA-1 and Mac-1. In this work the PMN is fixed to the substrate and is assumed fully rigid and of a prescribed shear-rate dependent shape obtained from micro-PIV experiments. The melanoma cell is transported with full six-degrees-of-freedom dynamics. Adhesion models, which represent the ability of molecules to bond and adhere the cells to each other, and repulsion models, which represent the various physical mechanisms of cellular repulsion, are incorporated with the CFD solver. All models are general enough to allow for future extensions, including arbitrary adhesion molecule types, and the ability to redefine the values of parameters to represent various cell types. The model presented in this study will be part of a clinical tool for development of personalized medical treatment programs.	[Behr, Julie; Gaskin, Byron; Fu, Changliang; Dong, Cheng; Kunz, Robert] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Behr, Julie; Gaskin, Byron; Kunz, Robert] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kunz, R (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	rfk102@arl.psu.edu	Kunz, Robert/GOV-3020-2022		National Institute of Health [CA-125707]; National Science Foundation [CBET-0729091]; National Natural Science Foundation of China [31170887]; Chinese Scholarship Council; Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory	This work was supported by grants from National Institute of Health Grants (CA-125707, to C.D.), National Science Foundation Grant (CBET-0729091, to C.D.), National Natural Science Foundation of China (31170887, to J.W.), and the Fellowship from Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The second author was supported by an Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory.	Alberts B, 1998, ESSENTIAL BIOL INTRO, V1; Behr J, 2013, THESIS PENNSYLVANIA; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bongrand P., 1984, CELL SURFACE DYNAMIC, P459; Bongrand P, 1988, PHYS BASIS CELL ADHE, P29; Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y; Chtcheglova LA, 2004, BIOPHYS J, V86, P1177, DOI 10.1016/S0006-3495(04)74192-2; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Gaskin BJ, 2014, THESIS; Greenshields CJ, 2005, INT J NUMER METH ENG, V64, P1575, DOI 10.1002/nme.1409; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hammer DA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026402; Hinterdorfer P, 2011, NANOTRIBOLOGY AND NANOMECHANICS: MEASUREMENT TECHNIQUES AND NANOMECHANICS, VOL 1, P355, DOI 10.1007/978-3-642-15283-2_8; Hoskins M, 2008, THESIS PENNSYLVANIA; Hoskins MH, 2009, J FLUID STRUCT, V25, P936, DOI 10.1016/j.jfluidstructs.2009.02.002; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Kan HC, 1998, PHYS FLUIDS, V10, P760, DOI 10.1063/1.869601; Khismatullin DB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1862635; King MR, 2001, BIOPHYS J, V81, P799, DOI 10.1016/S0006-3495(01)75742-6; Kunz R, 2001, AIAA COMP FLUID DYN, V2672; Leyton-Mange J, 2006, J BIOMECH ENG-T ASME, V128, P271, DOI 10.1115/1.2165689; Migliorini C, 2002, BIOPHYS J, V83, P1834, DOI 10.1016/S0006-3495(02)73948-9; Orsello CE, 2001, TRENDS BIOTECHNOL, V19, P310, DOI 10.1016/S0167-7799(01)01692-4; Pawar P, 2008, AM J PHYSIOL-HEART C, V295, pH1439, DOI 10.1152/ajpheart.91536.2007; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814, DOI 10.1152/ajpcell.2001.280.4.C814; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604	33	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136926	10.1371/journal.pone.0136926	http://dx.doi.org/10.1371/journal.pone.0136926			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366568	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100034
J	Jarde, T; Kass, L; Staples, M; Lescesen, H; Carne, P; Oliva, K; McMurrick, PJ; Abud, HE				Jarde, Thierry; Kass, Lisa; Staples, Margaret; Lescesen, Helen; Carne, Peter; Oliva, Karen; McMurrick, Paul J.; Abud, Helen E.			ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer	PLOS ONE			English	Article							TYROSINE KINASE; EXPRESSION; COLON; PROTEIN; LINES; CD44; APC	Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if cancer stem cells within tumours are marked by expression of ERBB3. Expression of ERBB3 and intestinal stem cell markers (LGR5, EPHB2, CD44s and CD44v6) was assessed by qRT-PCR in primary colorectal tumours (stages 0 to IV) and matched normal tissues from 53 patients. The localisation of ERBB3, EPHB2 and KI-67 within tumours was investigated using co-immunofluorescence. Expression of ERBB3 and intestinal stem cell markers were significantly elevated in adenomas and colorectal tumours compared to normal tissue. Positive correlations were found between ERBB3 and intestinal stem cell markers. However, co-immunofluorescence analysis showed that ERBB3 and EPHB2 marked specific cell populations that were mutually exclusive within tumours with distinct proliferative potentials, the majority of ERBB3+ve cells being non-proliferative. This pattern resembles cellular organisation within normal colonic epithelium where EPHB2 labelled proliferative cells reside at the crypt base and ERBB3+ve cells mark differentiated cells at the top of crypts. Our results show that ERBB3 and intestinal stem cell markers correlate in colorectal cancers. ERBB3 localises to differentiated cell populations within tumours that are non-proliferative and distinct from cancer stem cells. These data support the concept that tumours contain discrete stem, proliferative and differentiation compartments similar to that present in normal crypts.	[Jarde, Thierry; Kass, Lisa; Lescesen, Helen; Abud, Helen E.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Jarde, Thierry] Hudson Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Staples, Margaret] Cabrini Hlth, Cabrini Inst, Malvern, Vic, Australia; [Carne, Peter; Oliva, Karen; McMurrick, Paul J.] Cabrini Monash Univ, Dept Surg, Malvern, Vic, Australia	Monash University; Hudson Institute of Medical Research; Cabrini Health; Monash University	Abud, HE (corresponding author), Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic, Australia.	Helen.abud@monash.edu	Jarde, Thierry/H-6781-2019	Jarde, Thierry/0000-0001-7483-8672; Abud, Helen/0000-0003-3792-4023	National Health and Medical Research Council (Australia) [1010429, 1011187]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support for this work from the National Health and Medical Research Council (Australia) project grants 1010429 to HA and PJM, and 1011187 to HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurisicchio L, 2012, ONCOTARGET, V3, P744, DOI 10.18632/oncotarget.550; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brunschwig EB, 2003, CANCER RES, V63, P1568; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Ledel F, 2014, EUR J CANCER, V50, P656, DOI 10.1016/j.ejca.2013.11.008; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Ljuslinder I, 2009, ANTICANCER RES, V29, P1489; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; RAJKUMAR T, 1993, J PATHOL, V170, P271, DOI 10.1002/path.1711700309; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; WHITEHEAD RH, 1992, IMMUNOL CELL BIOL, V70, P227, DOI 10.1038/icb.1992.30; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	34	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138336	10.1371/journal.pone.0138336	http://dx.doi.org/10.1371/journal.pone.0138336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367378	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100250
J	Dettin, M; Zamuner, A; Roso, M; Gloria, A; Iucci, G; Messina, GML; D'Amora, U; Marletta, G; Modesti, M; Castagliuolo, I; Brun, P				Dettin, Monica; Zamuner, Annj; Roso, Martina; Gloria, Antonio; Iucci, Giovanna; Messina, Grazia M. L.; D'Amora, Ugo; Marletta, Giovanni; Modesti, Michele; Castagliuolo, Ignazio; Brun, Paola			Electrospun Scaffolds for Osteoblast Cells: Peptide-Induced Concentration-Dependent Improvements of Polycaprolactone	PLOS ONE			English	Article							SELF-ASSEMBLING PEPTIDE; SURFACE; DIFFERENTIATION; NANOFIBERS; GELATIN; NEXAFS; TIO2; XPS; AU	The design of hybrid poly-e-caprolactone (PCL)-self-assembling peptides (SAPs) matrices represents a simple method for the surface functionalization of synthetic scaffolds, which is essential for cell compatibility. This study investigates the influence of increasing concentrations (2.5%, 5%, 10% and 15% w/w SAP compared to PCL) of three different SAPs on the physico-chemical/mechanical and biological properties of PCL fibers. We demonstrated that physico-chemical surface characteristics were slightly improved at increasing SAP concentrations: the fiber diameter increased; surface wettability increased with the first SAP addition (2.5%) and slightly less for the following ones; SAP-surface density increased but no change in the conformation was registered. These results could allow engineering matrices with structural characteristics and desired wettability according to the needs and the cell system used. The biological and mechanical characteristics of these scaffolds showed a particular trend at increasing SAP concentrations suggesting a prevailing correlation between cell behavior and mechanical features of the matrices. As compared with bare PCL, SAP enrichment increased the number of metabolic active h-osteoblast cells, fostered the expression of specific osteoblast-related mRNA transcripts, and guided calcium deposition, revealing the potential application of PCL-SAP scaffolds for the maintenance of osteoblast phenotype.	[Dettin, Monica; Zamuner, Annj; Roso, Martina; Modesti, Michele] Univ Padua, Dept Ind Engn, Padua, Italy; [Gloria, Antonio; D'Amora, Ugo] Natl Res Council Italy, Inst Polymers Composites & Biomat, Naples, Italy; [Iucci, Giovanna] Univ Roma Tre, Dept Phys, Rome, Italy; [Messina, Grazia M. L.; Marletta, Giovanni] Univ Catania, Dept Chem, Catania, Italy; [Castagliuolo, Ignazio; Brun, Paola] Univ Padua, Dept Mol Med, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Roma Tre University; University of Catania; University of Padua	Dettin, M (corresponding author), Univ Padua, Dept Ind Engn, Padua, Italy.	monica.dettin@unipd.it	castagliuolo, ignazio/K-9963-2016; Marletta, Giovanni/F-3154-2012; D'Amora, Ugo/P-6304-2019	castagliuolo, ignazio/0000-0001-9888-7030; Marletta, Giovanni/0000-0002-6929-9499; D'Amora, Ugo/0000-0002-6142-059X; Modesti, Michele/0000-0002-5805-5587; Zamuner, Annj/0000-0002-8113-0346; Gloria, Antonio/0000-0001-5233-5687; IUCCI, Giovanna/0000-0002-6478-3759; roso, martina/0000-0001-6430-2751	Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Rilevante iInteresse Nazionale [SH3K]; University of Padova Progetto di Ateneo [CPDA128452]	Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Rilevante iInteresse Nazionale; University of Padova Progetto di Ateneo	This work has been supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it/) Progetti di Rilevante iInteresse Nazionale 2010 (SH3K) (MD, MM, GI) and by University of Padova (http://www.unipd.it/) Progetto di Ateneo 2012 (CPDA128452) (MD, PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, HDB XRAY PHOTOELECTR; Barbieri L, 2007, LANGMUIR, V23, P1723, DOI 10.1021/la0617964; Battocchio C, 2012, MAT SCI ENG C, V169, P36; Brun P, 2013, ACTA BIOMATER, V9, P6105, DOI 10.1016/j.actbio.2012.12.018; Brun P, 2011, ACTA BIOMATER, V7, P2526, DOI 10.1016/j.actbio.2011.02.025; Danesin R, 2012, BONE, V51, P851, DOI 10.1016/j.bone.2012.08.119; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Dettin M, 1998, J PEPT SCI, V4, P436, DOI 10.1002/(SICI)1099-1387(199811)4:7<436::AID-PSC163>3.0.CO;2-C; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; He LN, 2011, APPL SURF SCI, V257, P3547, DOI 10.1016/j.apsusc.2010.11.072; Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034; Iucci G, 2007, SURF SCI, V601, P3843, DOI 10.1016/j.susc.2007.04.024; LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J; Li MY, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833; Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Mahmoud ZN, 2011, BIOMATERIALS, V32, P3712, DOI 10.1016/j.biomaterials.2010.12.002; Marmur A, 2009, LANGMUIR, V25, P1277, DOI 10.1021/la802667b; Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t; Mit-uppatham C, 2004, MACROMOL CHEM PHYS, V205, P2327, DOI 10.1002/macp.200400225; Moraes C, 2014, LAB CHIP, V14, P2191, DOI 10.1039/c4lc00122b; Ortiz J, 2012, J BIOMED MATER RES A, V100A, P1770, DOI 10.1002/jbm.a.34103; Ozeki M, 2011, J BIOMATER APPL, V25, P663, DOI 10.1177/0885328209356328; Pathak JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131041; Polzonetti G, 2006, MAT SCI ENG C-BIO S, V26, P929, DOI 10.1016/j.msec.2005.09.062; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Son WK, 2004, POLYMER, V45, P2959, DOI [10.1016/j.polymer.2004.03.006, 10.1016/j.polymer.2004.02.006]; Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Watts J. F., 1992, HIGH RESOLUTION XPS; Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z; Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k	38	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137505	10.1371/journal.pone.0137505	http://dx.doi.org/10.1371/journal.pone.0137505			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361004	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100047
J	Hao, PY; Wang, L; Niu, Z				Hao, Pengyu; Wang, Li; Niu, Zheng			Comparison of Hybrid Classifiers for Crop Classification Using Normalized Difference Vegetation Index Time Series: A Case Study for Major Crops in North Xinjiang, China	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; REMOTE-SENSING DATA; RANDOM FORESTS; IMAGE-ANALYSIS; MODIS; UNCERTAINTY; ALGORITHMS; TM; REQUIREMENTS; ACCURACY	A range of single classifiers have been proposed to classify crop types using time series vegetation indices, and hybrid classifiers are used to improve discriminatory power. Traditional fusion rules use the product of multi-single classifiers, but that strategy cannot integrate the classification output of machine learning classifiers. In this research, the performance of two hybrid strategies, multiple voting (M-voting) and probabilistic fusion (P-fusion), for crop classification using NDVI time series were tested with different training sample sizes at both pixel and object levels, and two representative counties in north Xinjiang were selected as study area. The single classifiers employed in this research included Random Forest (RF), Support Vector Machine (SVM), and See 5 (C 5.0). The results indicated that classification performance improved (increased the mean overall accuracy by 5%similar to 10%, and reduced standard deviation of overall accuracy by around 1%) substantially with the training sample number, and when the training sample size was small (50 or 100 training samples), hybrid classifiers substantially outperformed single classifiers with higher mean overall accuracy (1%similar to 2%). However, when abundant training samples (4,000) were employed, single classifiers could achieve good classification accuracy, and all classifiers obtained similar performances. Additionally, although object-based classification did not improve accuracy, it resulted in greater visual appeal, especially in study areas with a heterogeneous cropping pattern.	[Hao, Pengyu; Wang, Li; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing 100101, Peoples R China; [Hao, Pengyu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing 100101, Peoples R China.	wangli@radi.ac.cn	niu, zheng/M-9923-2017; Wang, Li/P-9811-2018; HAO, Pengyu/P-1175-2014	Wang, Li/0000-0002-2929-4255; HAO, Pengyu/0000-0003-3711-6157	National Natural Science Foundation of China [41371358, 41301498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by the National Natural Science Foundation of China (41371358) and (41301498).	Agapiou A, 2014, INT J DIGIT EARTH, V7, P351, DOI 10.1080/17538947.2012.674159; Araya YH, GEO ENVIRONMENT AND, P233; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, BREIMAN CUTLERS RAND; Camps-Valls G, 2008, IEEE T GEOSCI REMOTE, V46, P1822, DOI 10.1109/TGRS.2008.916201; CCRSDA, TECHNICAL SPECIFICAT; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Conrad C, 2013, GLOBAL PLANET CHANGE, V110, P88, DOI 10.1016/j.gloplacha.2013.08.002; De Rainville FM, 2014, PATTERN ANAL APPL, V17, P401, DOI 10.1007/s10044-012-0307-5; Dorren LKA, 2003, FOREST ECOL MANAG, V183, P31, DOI 10.1016/S0378-1127(03)00113-0; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; Exelis, ENV VIS IM 2015; Exelis, FAST LIN OF SIGHT AT; Foody GM, 2004, REMOTE SENS ENVIRON, V93, P107, DOI 10.1016/j.rse.2004.06.017; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fry J.A., 2009, COMPLETION NATL LAND; Gallego J., 2008, BEST PRACTICES CROP; Gao Y, 2006, INT J REMOTE SENS, V27, P4039, DOI 10.1080/01431160600702632; Ghiyamat A, 2010, INT J REMOTE SENS, V31, P1837, DOI 10.1080/01431160902926681; Ghosh A, 2014, INT J APPL EARTH OBS, V26, P298, DOI 10.1016/j.jag.2013.08.011; Hao PY, 2014, REMOTE SENS-BASEL, V6, P7610, DOI 10.3390/rs6087610; Howard DM, 2014, PHOTOGRAMM ENG REM S, V80, P537, DOI 10.14358/PERS.80.6.537-549; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang WJ, 2013, SENSORS-BASEL, V13, P16023, DOI 10.3390/s131216023; Huang X, 2013, IEEE T GEOSCI REMOTE, V51, P257, DOI 10.1109/TGRS.2012.2202912; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ju JC, 2008, REMOTE SENS ENVIRON, V112, P1196, DOI 10.1016/j.rse.2007.08.011; Kuhn M, 2014, C5 0 DECISION TREES; Low F, 2013, ISPRS J PHOTOGRAMM, V85, P102, DOI 10.1016/j.isprsjprs.2013.08.007; Low F, 2014, REMOTE SENS-BASEL, V6, P9034, DOI 10.3390/rs6099034; Long JA, 2013, GISCI REMOTE SENS, V50, P418, DOI 10.1080/15481603.2013.817150; Loosvelt L, 2012, IEEE T GEOSCI REMOTE, V50, P4185, DOI 10.1109/TGRS.2012.2189012; Loosvelt L, 2012, INT J APPL EARTH OBS, V19, P173, DOI 10.1016/j.jag.2012.05.011; Los SO, 2005, REMOTE SENS ENVIRON, V99, P400, DOI 10.1016/j.rse.2005.08.017; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Meyer D., MISC FUNCTIONS DEP S; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; NASS, 2014, CROPSPACE CROPL DAT; Ouyang ZT, 2011, ECOL INFORM, V6, P136, DOI 10.1016/j.ecoinf.2011.01.002; PAL NR, 1994, IEEE T FUZZY SYST, V2, P107, DOI 10.1109/91.277960; [庞素琳 PANG Su-lin], 2009, [系统工程理论与实践, Systems Engineering-Theory & Practice], V29, P94, DOI 10.1016/S1874-8651(10)60092-0; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Petitjean F, 2012, IEEE T GEOSCI REMOTE, V50, P3081, DOI 10.1109/TGRS.2011.2179050; Potgieter AB, 2013, INT J APPL EARTH OBS, V23, P254, DOI 10.1016/j.jag.2012.09.009; Robertson LD, 2011, INT J REMOTE SENS, V32, P1505, DOI 10.1080/01431160903571791; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; RuleQuest, 2013, DAT MIN TOOLS SEE5 C; Shao Y, 2010, PHOTOGRAMM ENG REM S, V76, P73, DOI 10.14358/PERS.76.1.73; Space ADa, 2015, DMC CONST; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tong A, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073599; Vanonckelen S, 2013, INT J APPL EARTH OBS, V24, P9, DOI 10.1016/j.jag.2013.02.003; Vieira MA, 2012, REMOTE SENS ENVIRON, V123, P553, DOI 10.1016/j.rse.2012.04.011; Vintrou E, 2013, IEEE J-STARS, V6, P2132, DOI 10.1109/JSTARS.2013.2238507; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Zheng BJ, 2015, INT J APPL EARTH OBS, V34, P103, DOI 10.1016/j.jag.2014.07.002; Zhong LH, 2014, REMOTE SENS ENVIRON, V140, P1, DOI 10.1016/j.rse.2013.08.023; Zhou FQ, 2013, ISPRS J PHOTOGRAMM, V84, P114, DOI 10.1016/j.isprsjprs.2013.07.008; Zhu S, 2012, INT CONF AGRO-GEOINF, P603	65	23	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137748	10.1371/journal.pone.0137748	http://dx.doi.org/10.1371/journal.pone.0137748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360597	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100080
J	Meier, D; Lopez, M; Franken, P; Fontana, A				Meier, Daniel; Lopez, Martin; Franken, Paul; Fontana, Adriano			Twist1 Is a TNF-Inducible Inhibitor of Clock Mediated Activation of Period Genes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCADIAN CLOCK; E-BOX; TRANSCRIPTION FACTOR; EXPRESSION; BINDING; ALPHA; PROTEINS; MORPHOGENESIS; INFLAMMATION	Background Activation of the immune system affects the circadian clock. Tumor necrosis factor (TNF) and Interleukin (IL)-1 beta inhibit the expression of clock genes including Period (Per) genes and the PAR-bZip clock-controlled gene D-site albumin promoter-binding protein (Dbp). These effects are due to cytokine-induced interference of E-box mediated transcription of clock genes. In the present study we have assessed the two E-box binding transcriptional regulators Twist1 and Twist2 for their role in cytokine induced inhibition of clock genes. Methods The expression of the clock genes Per1, Per2, Per3 and of Dbp was assessed in NIH-3T3 mouse fibroblasts and the mouse hippocampal neuronal cell line HT22. Cells were treated for 4h with TNF and IL-1 beta. The functional role of Twist1 and Twist2 was assessed by siR-NAs against the Twist genes and by overexpression of TWIST proteins. In luciferase (luc) assays NIH-3T3 cells were transfected with reporter gene constructs, which contain a 3xPer1 E-box or a Dbp E-box. Quantitative chromatin immunoprecipitation (ChIP) was performed using antibodies to TWIST1 and CLOCK, and the E-box consensus sequences of Dbp (CATGTG) and Per1 E-box (CACGTG). Results We report here that siRNA against Twist1 protects NIH-3T3 cells and HT22 cells from down-regulation of Period and Dbp by TNF and IL-1 beta. Overexpression of Twist1, but not of Twist2, mimics the effect of the cytokines. TNF down-regulates the activation of Per1-3xE-box-luc, the effect being prevented by siRNA against Twist1. Overexpression of Twist1, but not of Twist2, inhibits Per1-3xE-box-luc or Dbp-E-Box-luc activity. ChIP experiments show TWIST1 induction by TNF to compete with CLOCK binding to the E-box of Period genes and Dbp. Conclusion Twist1 plays a pivotal role in the TNF mediated suppression of E-box dependent transactivation of Period genes and Dbp. Thereby Twist1 may provide a link between the immune system and the circadian timing system.	[Meier, Daniel; Lopez, Martin; Fontana, Adriano] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Zurich; University of Lausanne	Fontana, A (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	fontana.adriano7@gmail.com	Franken, Paul/A-9633-2018	Franken, Paul/0000-0002-2500-2921; Lopez, Martin/0000-0002-6254-8915	Swiss National Science Foundation [141055]; Baugarten Stiftung; Lotex Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baugarten Stiftung; Lotex Foundation	The work was supported to A.F. by the Swiss National Science Foundation (Project 141055), the Baugarten Stiftung and the Lotex Foundation. Adriano Fontana is Hertie Senior Research Professor for Neuroscience of the Gemeinnutzige Hertie-Stiftung.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chang AT, 2015, GENE DEV, V29, P603, DOI 10.1101/gad.242842.114; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Franken P, 2013, CURR OPIN NEUROBIOL, V23, P864, DOI 10.1016/j.conb.2013.05.002; Gast H, 2012, ANN NY ACAD SCI, V1261, P79, DOI 10.1111/j.1749-6632.2012.06640.x; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez M, 2014, J BIOL CHEM, V289, P2736, DOI 10.1074/jbc.M113.508200; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Naidoo N, 2014, AGING CELL, V13, P131, DOI 10.1111/acel.12158; Ohdo S, 2001, NAT MED, V7, P356, DOI 10.1038/85507; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Suzuki T, 2008, BIOMED RES-TOKYO, V29, P99, DOI 10.2220/biomedres.29.99; Taraborrelli C, 2011, BRAIN BEHAV IMMUN, V25, P434, DOI 10.1016/j.bbi.2010.11.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	39	4	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137229	10.1371/journal.pone.0137229	http://dx.doi.org/10.1371/journal.pone.0137229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361389	Green Submitted, gold, Green Published			2022-12-27	WOS:000361043100026
J	Movahed, E; Munusamy, K; Tan, GMY; Looi, CY; Tay, ST; Wong, WF				Movahed, Elaheh; Munusamy, Komathy; Tan, Grace Min Yi; Looi, Chung Yeng; Tay, Sun Tee; Wong, Won Fen			Genome-Wide Transcription Study of Cryptococcus neoformans H99 Clinical Strain versus Environmental Strains	PLOS ONE			English	Article							SIDEROPHORE BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; ASPERGILLUS-FUMIGATUS; CELL INTEGRITY; IRON UPTAKE; VIRULENCE; SEC2P; GENE; IDENTIFICATION; DEHYDROGENASE	The infection of Cryptococcus neoformans is acquired through the inhalation of desiccated yeast cells and basidiospores originated from the environment, particularly from bird's droppings and decaying wood. Three environmental strains of C. neoformans originated from bird droppings (H4, S48B and S68B) and C. neoformans reference clinical strain (H99) were used for intranasal infection in C57BL/6 mice. We showed that the H99 strain demonstrated higher virulence compared to H4, S48B and S68B strains. To examine if gene expression contributed to the different degree of virulence among these strains, a genome-wide microarray study was performed to inspect the transcriptomic profiles of all four strains. Our results revealed that out of 7,419 genes (22,257 probes) examined, 65 genes were significantly up-or down-regulated in H99 versus H4, S48B and S68B strains. The up-regulated genes in H99 strain include Hydroxymethylglutaryl-CoA synthase (MVA1), Mitochondrial matrix factor 1 (MMF1), Bud-site-selection protein 8 (BUD8), High affinity glucose transporter 3 (SNF3) and Rho GTPase-activating protein 2 (RGA2). Pathway annotation using DAVID bioinformatics resource showed that metal ion binding and sugar transmembrane transporter activity pathways were highly expressed in the H99 strain. We suggest that the genes and pathways identified may possibly play crucial roles in the fungal pathogenesis.	[Movahed, Elaheh; Munusamy, Komathy; Tan, Grace Min Yi; Tay, Sun Tee; Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Wong, WF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	wonfen@um.edu.my	Tay, Sun Tee/N-2295-2019; Wong, Won Fen/D-3087-2012	Tay, Sun Tee/0000-0002-3120-6998; Wong, Won Fen/0000-0003-1082-1956	Malaysian Ministry of Higher Education [E000013-20001]; University of Malaya [RG525-13HTM]	Malaysian Ministry of Higher Education; University of Malaya(Universiti Malaya)	This work was supported by Malaysian Ministry of Higher Education (E000013-20001) and University of Malaya (RG525-13HTM). EM was supported by a postgraduate research fund (PPP) from University of Malaya.	Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Ardon O, 2001, J BIOL CHEM, V276, P43049, DOI 10.1074/jbc.M108701200; BISSON LF, 1987, J BACTERIOL, V169, P1656, DOI 10.1128/jb.169.4.1656-1662.1987; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Broad Institute of Harvard and MIT, CRYPT NEOF VAR GRUB; Caballero-Lima D, 2014, MOL MICROBIOL, V94, P828, DOI 10.1111/mmi.12799; CELENZA JL, 1988, P NATL ACAD SCI USA, V85, P2130, DOI 10.1073/pnas.85.7.2130; Chan MY, 2010, MYCOSES, V53, P26, DOI 10.1111/j.1439-0507.2008.01654.x; Choi KM, 2015, FEBS LETT, V589, P349, DOI 10.1016/j.febslet.2014.12.020; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Elkind NB, 2000, J CELL BIOL, V149, P95, DOI 10.1083/jcb.149.1.95; Ellerbroek PM, 2004, J IMMUNOL, V173, P7513, DOI 10.4049/jimmunol.173.12.7513; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Enache-Angoulvant A, 2007, J CLIN MICROBIOL, V45, P1261, DOI 10.1128/JCM.01839-06; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Fraser JA, 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00408-13; GarciaHermoso D, 1997, J CLIN MICROBIOL, V35, P2683, DOI 10.1128/JCM.35.10.2683-2685.1997; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Herrero AB, 2002, EUKARYOT CELL, V1, P420, DOI 10.1128/EC.1.3.420-431.2002; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; Jain N, 2013, MOL MICROBIOL, V88, P713, DOI 10.1111/mmi.12216; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim SY, 2010, FUNGAL GENET BIOL, V47, P782, DOI 10.1016/j.fgb.2010.06.005; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Krappmann AB, 2007, MOL BIOL CELL, V18, P3323, DOI 10.1091/mbc.E06-10-0899; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Kronstad J, 2008, CELL HOST MICROBE, V4, P308, DOI 10.1016/j.chom.2008.09.003; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lazera MS, 1996, J MED VET MYCOL, V34, P127; Lee YJ, 2012, J BIOL CHEM, V287, P44221, DOI 10.1074/jbc.M112.375360; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x; Litvintseva AP, 2009, INFECT IMMUN, V77, P3188, DOI 10.1128/IAI.00296-09; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Price MS, 2011, MBIO, V2, DOI 10.1128/mBio.00103-11; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Stalder D, 2013, P NATL ACAD SCI USA, V110, P19995, DOI 10.1073/pnas.1320029110; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Tan GMY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11046; Tangen KL, 2007, MICROBIOL-SGM, V153, P29, DOI 10.1099/mic.0.2006/000927-0; Tay ST, 2006, MED MYCOL, V44, P617, DOI 10.1080/13693780600857330; Tay ST, 2005, MYCOPATHOLOGIA, V159, P509, DOI 10.1007/s11046-005-3091-6; Theodoris G, 2001, FEMS MICROBIOL LETT, V197, P73, DOI 10.1016/S0378-1097(01)00088-X; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Warringer J, 2006, YEAST, V23, P389, DOI 10.1002/yea.1363; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wong WF, 2014, EUR J IMMUNOL, V44, P894, DOI 10.1002/eji.201343496; Wright LC, 2004, BIOCHEM J, V384, P377, DOI 10.1042/BJ20041079; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; Zhu XD, 2003, MOL MICROBIOL, V47, P1007, DOI 10.1046/j.1365-2958.2003.03340.x	77	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137457	10.1371/journal.pone.0137457	http://dx.doi.org/10.1371/journal.pone.0137457			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360021	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100041
J	Yashiro, T; Kubo, M; Ogawa, H; Okumura, K; Nishiyama, C				Yashiro, Takuya; Kubo, Masato; Ogawa, Hideoki; Okumura, Ko; Nishiyama, Chiharu			PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells	PLOS ONE			English	Article							IL-4 GENE-EXPRESSION; RESPONSE ELEMENT; MAST-CELLS; DIFFERENTIATION; IDENTIFICATION; REPRESSION; COMPLEX; MOUSE; INVOLVEMENT; PROGENITORS	The transcription factor PU.1 is predominantly expressed in dendritic cells (DCs) and is essential for DC differentiation. Although there are several reports that PU.1 positively regulates the expression of DC-specific genes, whether PU.1 also has a suppressive effect on DCs is largely unknown. Here we demonstrate that PU.1 suppresses the expression of Th2 cytokines including IL-13 and IL-5 in bone marrow-derived DCs (BMDCs), through repression of the expression of GATA3, which is a master regulator of Th2 differentiations. When PU.1 siRNA was introduced into BMDCs, LPS-induced expression of IL-13 and IL-5 was increased along with upregulation of the constitutive expression of GATA2 and GATA3. The additional introduction of GATA3 siRNA but not of GATA2 siRNA abrogated PU.1 siRNAmediated upregulation of IL-13 and IL-5. A chromatin immunoprecipitation assay showed that PU.1 bound to Gata3 proximal promoter region, which is more dominant than the distal promoter in driving GATA3 transcription in DCs. The degree of histone acetylation at the Gata3 promoter was decreased in PU.1 siRNA-introduced DCs, suggesting the involvement of PU.1 in chromatin modification of the Gata3 promoter. Treatment with a histone deacetylase (HDAC) inhibitor, trichostatin A, increased the degree of histone H3 acetylation at the Gata3 promoter and induced the subsequent expression of GATA3. Experiments using HDAC inhibitors and siRNAs showed that HDAC3 suppressed GATA3 expression. The recruitment of HDAC3 to the Gata3 promoter was decreased by PU.1 knockdown. LPSinduced IL-13 expression was dramatically reduced in BMDCs generated from mice lacking the conserved GATA3 response element, termed CGRE, which is an essential site for the binding of GATA3 on the Il-13 promoter. The degree of H3K4me3 at CGRE was significantly increased in PU.1 siRNA-transfected stimulated DCs. Our results indicate that PU.1 plays pivotal roles in DC development and function, serving not only as a transcriptional activator but also as a repressor.	[Yashiro, Takuya; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, Tokyo 1258585, Japan; [Yashiro, Takuya; Ogawa, Hideoki; Okumura, Ko; Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Kubo, Masato] RIKEN Yokohama Inst, Integrat Med Sci, Lab Cytokine Regulat, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba 2780022, Japan	Tokyo University of Science; Juntendo University; RIKEN; Tokyo University of Science	Nishiyama, C (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	chinishi@rs.tus.ac.jp	yashiro, takuya/Y-1543-2019; Kubo, Masato/A-5918-2016; Nishiyama, Chiharu/GPW-9372-2022		Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan [LS111]; MEXT-Supported Program for the Strategic Research Foundation at Private University (Atopy (Allergy) Research Center, Juntendo University School of Medicine); MEXT-Supported Program for the Strategic Research Foundation at Private University (Translational Research Center, Tokyo University of Science); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [10792]; Grants-in-Aid for Scientific Research [15H01267] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan; MEXT-Supported Program for the Strategic Research Foundation at Private University (Atopy (Allergy) Research Center, Juntendo University School of Medicine); MEXT-Supported Program for the Strategic Research Foundation at Private University (Translational Research Center, Tokyo University of Science); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to CN #LS111), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine; Translational Research Center, Tokyo University of Science). TY has been supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792).	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Gobel F, 2009, BLOOD, V114, P3813, DOI 10.1182/blood-2009-03-210484; Goswami R, 2012, J IMMUNOL, V189, P3026, DOI 10.4049/jimmunol.1201496; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Henkel GW, 1999, BLOOD, V93, P2849; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Kwan M, 2005, EUR J IMMUNOL, V35, P1267, DOI 10.1002/eji.200425619; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Matsumura I, 2000, BLOOD, V96, P2440; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nakano N, 2007, BLOOD, V109, P4846, DOI 10.1182/blood-2006-09-045641; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tone Y, 1996, EUR J IMMUNOL, V26, P1222, DOI 10.1002/eji.1830260606; Yamada T, 1998, EXP CELL RES, V245, P186, DOI 10.1006/excr.1998.4251; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	46	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137699	10.1371/journal.pone.0137699	http://dx.doi.org/10.1371/journal.pone.0137699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361334	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100073
J	Logvinova, DS; Markov, DI; Nikolaeva, OP; Sluchanko, NN; Ushakov, DS; Levitsky, DI				Logvinova, Daria S.; Markov, Denis I.; Nikolaeva, Olga P.; Sluchanko, Nikolai N.; Ushakov, Dmitry S.; Levitsky, Dmitrii I.			Does Interaction between the Motor and Regulatory Domains of the Myosin Head Occur during ATPase Cycle? Evidence from Thermal Unfolding Studies on Myosin Subfragment 1	PLOS ONE			English	Article							ESSENTIAL LIGHT-CHAIN; SKELETAL-MUSCLE MYOSIN; BERYLLIUM FLUORIDE; MOLECULAR MOTOR; ENERGY-TRANSFER; SCALLOP MYOSIN; ALKALI LIGHT; FLUORESCENCE; ACTIN; COMPLEX	Myosin head (myosin subfragment 1, S1) consists of two major structural domains, the motor (or catalytic) domain and the regulatory domain. Functioning of the myosin head as a molecular motor is believed to involve a rotation of the regulatory domain (lever arm) relative to the motor domain during the ATPase cycle. According to predictions, this rotation can be accompanied by an interaction between the motor domain and the C-terminus of the essential light chain (ELC) associated with the regulatory domain. To check this assumption, we applied differential scanning calorimetry (DSC) combined with temperature dependences of fluorescence to study changes in thermal unfolding and the domain structure of S1, which occur upon formation of the ternary complexes S1-ADP-AlF(4)(-)and S1-ADP-BeFx that mimic S1 ATPase intermediate states S1**-ADP-P-i and S1*-ATP, respectively. To identify the thermal transitions on the DSC profiles (i.e. to assign them to the structural domains of S1), we compared the DSC data with temperature-induced changes in fluorescence of either tryptophan residues, located only in the motor domain, or recombinant ELC mutants (light chain 1 isoform), which were first fluorescently labeled at different positions in their C-terminal half and then introduced into the S1 regulatory domain. We show that formation of the ternary complexes S1-ADP-AlF4-and S1-ADP-BeFx significantly stabilizes not only the motor domain, but also the regulatory domain of the S1 molecule implying inter-domain interaction via ELC. This is consistent with the previously proposed concepts and also adds some new interesting details to the molecular mechanism of the myosin ATPase cycle.	[Logvinova, Daria S.; Markov, Denis I.; Sluchanko, Nikolai N.; Levitsky, Dmitrii I.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Logvinova, Daria S.] Moscow MV Lomonosov State Univ, Dept Biochem, Sch Biol, Moscow, Russia; [Logvinova, Daria S.] Vyatka State Univ, Dept Biotechnol, Sch Biol, Kirov, Russia; [Nikolaeva, Olga P.; Levitsky, Dmitrii I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Ushakov, Dmitry S.] Kings Coll London, London WC2R 2LS, England	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Vyatka State University; Lomonosov Moscow State University; University of London; King's College London	Levitsky, DI (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	Levitsky@inbi.ras.ru	Sluchanko, Nikolai/R-4110-2016; Ushakov, Dmitry/AAF-7914-2020	Sluchanko, Nikolai/0000-0002-8608-1416; Ushakov, Dmitry/0000-0001-7109-4217	Russian Foundation for Basic Research [15-04-03037]; Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This investigation was supported by the Russian Foundation for Basic Research (grant 15-04-03037 to DIL) and the Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences (DIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington N, 2014, J MOL BIOL, V426, P894, DOI 10.1016/j.jmb.2013.11.028; BOBKOV AA, 1995, BIOCHEMISTRY-US, V34, P9708, DOI 10.1021/bi00030a008; BOBKOV AA, 1993, FEBS LETT, V332, P64, DOI 10.1016/0014-5793(93)80485-D; Borejdo J, 2001, BIOCHEMISTRY-US, V40, P3796, DOI 10.1021/bi002527u; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; GOLITSINA NL, 1992, FEBS LETT, V303, P255, DOI 10.1016/0014-5793(92)80532-L; Golitsina NL, 1996, J MUSCLE RES CELL M, V17, P475, DOI 10.1007/BF00123363; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; HOLT JC, 1975, BIOCHEMISTRY-US, V14, P4609, DOI 10.1021/bi00692a008; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levitsky D. I., 2004, The nature of biological systems as revealed by thermal methods, P127; LEVITSKY DI, 1992, EUR J BIOCHEM, V209, P829, DOI 10.1111/j.1432-1033.1992.tb17354.x; Levitsky DI, 1998, EUR J BIOCHEM, V251, P275, DOI 10.1046/j.1432-1327.1998.2510275.x; Levitsky DI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P322; LEVITSKY DI, 1990, FEBS LETT, V264, P176, DOI 10.1016/0014-5793(90)80242-B; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Markov DI, 2010, ACTA NATURAE, V2, P77, DOI 10.32607/20758251-2010-2-2-77-81; Markov DI, 2008, FEBS LETT, V582, P1407, DOI 10.1016/j.febslet.2008.03.035; Markov DI, 2010, INT J MOL SCI, V11, P4194, DOI 10.3390/ijms11114194; MARSH DJ, 1980, BIOCHEMISTRY-US, V19, P774, DOI 10.1021/bi00545a025; MARSH DJ, 1982, BIOCHEMISTRY-US, V21, P1925, DOI 10.1021/bi00537a035; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Nelson MR, 1998, PROTEIN SCI, V7, P270; Nikolaeva OP, 2002, EUR J BIOCHEM, V269, P5678, DOI 10.1046/j.1432-1033.2002.03279.x; PHAN B, 1992, BIOCHEMISTRY-US, V31, P4787, DOI 10.1021/bi00135a007; Ponomarev MA, 2000, BIOCHEMISTRY-US, V39, P4527, DOI 10.1021/bi992420a; Privalov P L, 1986, Methods Enzymol, V131, P4; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Shakirova L, 2007, J MUSCLE RES CELL M, V28, P67, DOI 10.1007/s10974-007-9108-7; TRAYER HR, 1988, BIOCHEMISTRY-US, V27, P5718, DOI 10.1021/bi00415a049; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8; Ushakov DS, 2011, J BIOL CHEM, V286, P842, DOI 10.1074/jbc.M110.149526; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; VANBUREN P, 1994, P NATL ACAD SCI USA, V91, P12403, DOI 10.1073/pnas.91.26.12403; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; ZAAGER S, 1988, J BIOL CHEM, V263, P13891	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137517	10.1371/journal.pone.0137517	http://dx.doi.org/10.1371/journal.pone.0137517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356744	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800053
J	Smith, CAM; Toupin-April, K; Jutai, JW; Duffy, CM; Rahman, P; Cavallo, S; Brosseau, L				Smith, Christine A. M.; Toupin-April, Karine; Jutai, Jeffrey W.; Duffy, Ciaran M.; Rahman, Prinon; Cavallo, Sabrina; Brosseau, Lucie			A Systematic Critical Appraisal of Clinical Practice Guidelines in Juvenile Idiopathic Arthritis Using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument	PLOS ONE			English	Article							OF-RHEUMATOLOGY RECOMMENDATIONS; QUALITY; PAIN; MANAGEMENT; CHILDREN; SYMPTOMS; VALIDITY; THERAPY; CARE	Objectives The objectives of this review are to: 1) appraise the methodological quality of clinical practice guidelines (CPGs) in juvenile idiopathic arthritis (JIA) providing pharmacological and/or non-pharmacological intervention recommendations, and 2) summarize the recommendations provided by the included CPGs and compare them where possible. Methods A systematic search was performed. Three trained appraisers independently evaluated the methodological quality of the CPGs using a validated and reliable instrument, the Appraisal of Guidelines in Research and Evaluation II. Six domains were considered: 1) score and purpose; 2) stakeholder involvement; 3) rigor of development; 4) clarity of presentation; 5) applicability; and 6) editorial independence. The domains consist of a total of 23 items each scored on a 7-point scale. High quality CPGs were identified if they had a domain score above 60% in rigor of development, and two other domains. Results Of the three included CPGs, the Royal Australian College of General Practitioners (RACGP) and American College of Rheumatology (ACR) CPGs were considered to be of high quality, but the German Society for Pediatric Rheumatology was of lower quality. Domains one to four had high domain scores across the guidelines (mean (standard deviation)): 72.76 (13.80); 66.67 (9.81); 64.67 (7.77); and 87.00 (9.64), respectively. Lower scores were obtained for applicability (14.00 (5.57)) and editorial independence (43.44 (7.02)). Recommendations varied across CPGs due to differences in context, target audience (general practitioners, rheumatologists, and other multidisciplinary healthcare professionals) and patients' disease presentations. Despite this variability, progression of pharmacological treatment did not conflict between CPGs. Recommendations for non-pharmacological interventions were vague and the interventions considered varied between CPGs. Conclusions Overall, recommendations were based on a paucity of evidence and weak study designs. Further research is needed on interventions in JIA, as well as higher quality CPGs to facilitate implementation of the best evidence-based recommendations in clinical practice.	[Smith, Christine A. M.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Toupin-April, Karine] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Toupin-April, Karine; Duffy, Ciaran M.] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON K1N 6N5, Canada; [Jutai, Jeffrey W.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Duffy, Ciaran M.] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Rahman, Prinon] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Cavallo, Sabrina] Univ Montreal, Ecole Santa Publ, Montreal, PQ, Canada; [Brosseau, Lucie] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Dalhousie University; Universite de Montreal; University of Ottawa	Brosseau, L (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada.	Lucie.Brosseau@uottawa.ca	Cavallo, Sabrina/AAN-9872-2021; Cavallo, Sabrina/AAX-8970-2020	Jutai, Jeffrey/0000-0002-7294-1323	University of Ottawa Research Chair	University of Ottawa Research Chair	The authors are thankful for the financial support of the University of Ottawa Research Chair for the salary support of graduate students (CAMS, PR, SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funding source did not influence the content of this review.	Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Bloom BJ, 2002, J RHEUMATOL, V29, P169; Boros C, 2010, AUST FAM PHYSICIAN, V39, P630; Bromberg MH, 2014, ARTHRITIS RHEUMATOL, V66, P462, DOI 10.1002/art.38223; Brosseau L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095369; Brosseau L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082986; Brouwers MC, 2010, PREV MED, V51, P421, DOI 10.1016/j.ypmed.2010.08.005; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Cavallo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104642; Davies K, 2010, RHEUMATOLOGY, V49, P1406, DOI 10.1093/rheumatology/kep460; Dueckers G, 2012, CLIN IMMUNOL, V142, P176, DOI 10.1016/j.clim.2011.10.003; Field MJ, 1990, CLIN PRACTICE GUIDEL; Hashkes PJ, 2011, NAT REV RHEUMATOL, V7, P377, DOI 10.1038/nrrheum.2011.67; Hayward K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2619; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hurkmans EJ, 2011, RHEUMATOLOGY, V50, P1879, DOI 10.1093/rheumatology/ker195; Johnson CJ, 2001, ANN PHARMACOTHER, V35, P464; Larmer PJ, 2014, ARCH PHYS MED REHAB, V95, P375, DOI 10.1016/j.apmr.2013.10.011; Levinson AJ, AGREE 2 OVERVIEW TUT; Manners PJ, 2002, J RHEUMATOL, V29, P1520; McMaster University, 2008, AGREE 2 RAT CONC CAL; Munro J, 2009, EVIDENCE CONSENSUS B; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty RE, 2016, TXB PEDIAT RHEUMATOL, P188; Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339; Ringold S, 2013, ARTHRITIS RHEUM-US, V65, P2499, DOI 10.1002/art.38092; Sabharwal S, 2014, CLIN ORTHOP RELAT R, V472, P1982, DOI 10.1007/s11999-014-3530-0; Schanberg LE, 2003, ARTHRITIS RHEUM-US, V48, P1390, DOI 10.1002/art.10986; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Stanley LC, 2011, J PEDIATR HEALTH CAR, V25, P191, DOI 10.1016/j.pedhc.2010.12.003; Takken T, 2008, EUR J PHYS REHAB MED, V44, P287; Tupper SM, 2013, ARTHRIT CARE RES, V65, P563, DOI 10.1002/acr.21850; Wallen M, 2006, COCHRANE DB SYST REV, V1; Weiss JE, 2014, PEDIATR DRUGS, V16, P473, DOI 10.1007/s40272-014-0094-0; Yan JP, 2013, J EVAL CLIN PRACT, V19, P626, DOI 10.1111/j.1365-2753.2012.01873.x	36	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137180	10.1371/journal.pone.0137180	http://dx.doi.org/10.1371/journal.pone.0137180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356098	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800032
J	Shafiek, H; Fiorentino, F; Merino, JL; Lopez, C; Oliver, A; Segura, J; de Paul, I; Sibila, O; Agust, A; Cosio, BG				Shafiek, Hanaa; Fiorentino, Federico; Merino, Jose Luis; Lopez, Carla; Oliver, Antonio; Segura, Jaume; de Paul, Ivan; Sibila, Oriol; Agust, Alvar; Cosio, Borja G.			Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EXHALED BREATH; BRONCHIAL INFLAMMATION; LUNG-CANCER; PNEUMONIA; DIAGNOSIS; DISCRIMINATION; IDENTIFICATION; RECOGNITION; BACTERIA	Background The electronic nose (e-nose) detects volatile organic compounds (VOCs) in exhaled air. We hypothesized that the exhaled VOCs print is different in stable vs. exacerbated patients with chronic obstructive pulmonary disease (COPD), particularly if the latter is associated with airway bacterial infection, and that the e-nose can distinguish them. Methods Smell-prints of the bacteria most commonly involved in exacerbations of COPD (ECOPD) were identified in vitro. Subsequently, we tested our hypothesis in 93 patients with ECOPD, 19 of them with pneumonia, 50 with stable COPD and 30 healthy controls in a cross-sectional case-controlled study. Secondly, ECOPD patients were re-studied after 2 months if clinically stable. Exhaled air was collected within a Tedlar bag and processed by a Cynarose 320 e-nose. Breath-prints were analyzed by Linear Discriminant Analysis (LDA) with "One Out" technique and Sensor logic Relations (SLR). Sputum samples were collected for culture. Results ECOPD with evidence of infection were significantly distinguishable from non-infected ECOPD (p = 0.018), with better accuracy when ECOPD was associated to pneumonia. The same patients with ECOPD were significantly distinguishable from stable COPD during follow-up (p = 0.018), unless the patient was colonized. Additionally, breath-prints from COPD patients were significantly distinguished from healthy controls. Various bacteria species were identified in culture but the e-nose was unable to identify accurately the bacteria smell-print in infected patients. Conclusion E-nose can identify ECOPD, especially if associated with airway bacterial infection or pneumonia.	[Shafiek, Hanaa; Fiorentino, Federico; Cosio, Borja G.] Hosp Univ Son Espases IdISPa, Dept Resp Med, Palma De Mallorca, Spain; [Shafiek, Hanaa] Univ Alexandria, Fac Med, Dept Chest Dis, Alexandria, Egypt; [Merino, Jose Luis; Segura, Jaume; de Paul, Ivan] UIB, GSE, Palma De Mallorca, Spain; [Lopez, Carla; Oliver, Antonio] Hosp Univ Son Espases IdISPa, Dept Microbiol, Palma De Mallorca, Spain; [Sibila, Oriol] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Resp Med, Barcelona, Spain; [Agust, Alvar] Univ Barcelona, IDIBAPS, Hosp Clin, Thorax Inst, Barcelona, Spain; [Agust, Alvar; Cosio, Borja G.] CIBERES, Madrid, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Egyptian Knowledge Bank (EKB); Alexandria University; Barcelona School of Economics; Universitat de les Illes Balears; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cosio, BG (corresponding author), Hosp Univ Son Espases IdISPa, Dept Resp Med, Palma De Mallorca, Spain.	borja.cosio@ssib.es	Sibila, Oriol/T-4366-2017; G.Cosio, Borja/P-4963-2017; López-Causapé, Carla/AAG-5231-2019; Shafiek, Hanaa/HGC-3311-2022; Oliver, Antonio/V-5541-2019; Shafiek, Hanaa/AAM-7161-2021; Oliver, Antonio/E-4048-2012; López-Causapé, Carla/F-5414-2019	Sibila, Oriol/0000-0002-4833-6713; G.Cosio, Borja/0000-0002-6388-8209; López-Causapé, Carla/0000-0003-2228-2005; Oliver, Antonio/0000-0001-9327-1894; Shafiek, Hanaa/0000-0002-4716-4809; Oliver, Antonio/0000-0001-9327-1894; López-Causapé, Carla/0000-0003-2228-2005; Segura, Jaume/0000-0001-9742-2936; de Paul Bernal, Ivan/0000-0001-9526-3492	Instituto de Salud Carlos III [FIS PI12/02628]; Spanish Respiratory Society	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Respiratory Society	This project was supported by the Instituto de Salud Carlos III (FIS PI12/02628) and the Spanish Respiratory Society. The funding sources were used to cover fungible expenses and had no influence on the results.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bathoorn E., 2009, INT J CHRONIC OBSTR, V4, P101; Boixeda R, 2012, INT J CHRONIC OBSTR, V7, P327, DOI 10.2147/COPD.S30568; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Corhay JL, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0115-0; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dutta R, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-4; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; Fens N, 2013, CLIN EXP ALLERGY, V43, P705, DOI 10.1111/cea.12052; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gompertz S, 2001, EUR RESPIR J, V17, P1112, DOI 10.1183/09031936.01.99114901; Hanson CW, 2005, ANESTHESIOLOGY, V102, P63, DOI 10.1097/00000542-200501000-00013; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Joensen O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115584; Lai SY, 2002, LARYNGOSCOPE, V112, P975, DOI 10.1097/00005537-200206000-00007; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McWilliams A, 2015, IEEE T BIOMED ENG; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Moser B, 2005, RESP PHYSIOL NEUROBI, V145, P295, DOI 10.1016/j.resp.2004.02.002; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pavlou A, 2002, LETT APPL MICROBIOL, V35, P366, DOI 10.1046/j.1472-765X.2002.01197.x; Ram FSF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004403.pub2; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Shykhon ME, 2004, J LARYNGOL OTOL, V118, P706, DOI 10.1258/0022215042244660; Sibila O, 2014, RESP MED; SMITH CB, 1976, J INFECT DIS, V134, P552, DOI 10.1093/infdis/134.6.552; Spencer S, 2003, THORAX, V58, P589, DOI 10.1136/thorax.58.7.589; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Thaler ER, 2006, AM J RHINOL, V20, P170, DOI 10.1177/194589240602000209; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Voelkel NF, 2000, CHEST, V117, p376S, DOI 10.1378/chest.117.5_suppl_2.376S; White AJ, 2003, THORAX, V58, P680, DOI 10.1136/thorax.58.8.680; Zhang HX, 2003, SENSOR ACTUAT B-CHEM, V96, P385, DOI 10.1016/S0925-4005(03)00574-4	44	47	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135199	10.1371/journal.pone.0135199	http://dx.doi.org/10.1371/journal.pone.0135199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353114	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800007
J	Wang, L; Wu, LF; Lu, X; Mo, XB; Tang, ZX; Lei, SF; Deng, FY				Wang, Lan; Wu, Long-Fei; Lu, Xin; Mo, Xing-Bo; Tang, Zai-Xiang; Lei, Shu-Feng; Deng, Fei-Yan			Integrated Analyses of Gene Expression Profiles Digs out Common Markers for Rheumatic Diseases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANKYLOSING-SPONDYLITIS; CANDIDATE GENES; FACTOR-ALPHA; ARTHRITIS; CELLS; PATHOGENESIS; METAANALYSIS; APOPTOSIS; IMMUNITY	Objective Rheumatic diseases have some common symptoms. Extensive gene expression studies, accumulated thus far, have successfully identified signature molecules for each rheumatic disease, individually. However, whether there exist shared factors across rheumatic diseases has yet to be tested. Methods We collected and utilized 6 public microarray datasets covering 4 types of representative rheumatic diseases including rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and osteoarthritis. Then we detected overlaps of differentially expressed genes across datasets and performed a meta-analysis aiming at identifying common differentially expressed genes that discriminate between pathological cases and normal controls. To further gain insights into the functions of the identified common differentially expressed genes, we conducted gene ontology enrichment analysis and protein-protein interaction analysis. Results We identified a total of eight differentially expressed genes (TNFSF10, CX3CR1, LY96, TLR5, TXN, TIA1, PRKCH, PRF1), each associated with at least 3 of the 4 studied rheumatic diseases. Meta-analysis warranted the significance of the eight genes and highlighted the general significance of four genes (CX3CR1, LY96, TLR5, and PRF1). Protein-protein interaction and gene ontology enrichment analyses indicated that the eight genes interact with each other to exert functions related to immune response and immune regulation. Conclusion The findings support that there exist common factors underlying rheumatic diseases. For rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and osteoarthritis diseases, those common factors include TNFSF10, CX3CR1, LY96, TLR5, TXN, TIA1, PRKCH, and PRF1. In-depth studies on these common factors may provide keys to understanding the pathogenesis and developing intervention strategies for rheumatic diseases.	[Wang, Lan; Wu, Long-Fei; Lu, Xin; Mo, Xing-Bo; Tang, Zai-Xiang; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Lan; Wu, Long-Fei; Lu, Xin; Mo, Xing-Bo; Tang, Zai-Xiang; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China.	fdeng@suda.edu.cn	Mo, Xingbo/I-7112-2013	Mo, Xingbo/0000-0001-8956-4918	national Natural Science Foundation of China [81373010, 81473046, 31401079, 81401343, 31271336, 31071097]; Natural Science Foundation of Jiangsu Province [BK20130300]; Soochow University [Q413900112, Q413900712]	national Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Soochow University	Funding: The study was supported by the national Natural Science Foundation of China http://www.nsfc.gov.cn/ (81373010, 81473046, 31401079, 81401343, 31271336, and 31071097), the Natural Science Foundation of Jiangsu Province http://www.jstd.gov.cn/ (BK20130300), the Startup Fund from Soochow University http://www.suda.edu.cn/ (Q413900112, Q413900712). SFL received the funding. The funders had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Astorri E, 2014, RHEUMATOLOGY, V53, P611, DOI 10.1093/rheumatology/ket401; Audo R, 2011, ARTHRITIS RHEUM-US, V63, P904, DOI 10.1002/art.30181; Balada E, 2014, CLIN EXP RHEUMATOL, V32, P113; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bellan Mattia, 2010, ARTHRITIS RHEUM S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Broux B, 2012, J AUTOIMMUN, V38, P10, DOI 10.1016/j.jaut.2011.11.006; Chamberlain ND, 2012, J IMMUNOL, V189, P475, DOI 10.4049/jimmunol.1102977; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Goris A, 2012, COLD SPRING HARB PER, V4; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Han KH, 2014, BONE, V61, P91, DOI 10.1016/j.bone.2013.12.032; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; He W, 2002, J RHEUMATOL, V29, P546; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lee HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2584; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; Li HL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/953462; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Pimentel-Santos FM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3309; Pingiotti E, 2007, ANN NY ACAD SCI, V1107, P32, DOI 10.1196/annals.1381.004; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Raffeiner B, 2005, ARTHRITIS RES THER, V7, pR1412, DOI 10.1186/ar1840; Ramos YFM, 2014, ANN RHEUM DIS, V73, P1844, DOI 10.1136/annrheumdis-2013-203405; Romero V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006869; Sanchez E, 2009, CLIN EXP RHEUMATOL, V27, P267; Shi XJ, 2014, BRIEF BIOINFORM, V15, P671, DOI 10.1093/bib/bbt044; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sugihara M, 2007, ARTHRITIS RHEUM, V56, P2160, DOI 10.1002/art.22724; Takata Y, 2007, ARTHRITIS RHEUM-US, V56, P30, DOI 10.1002/art.22262; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Tsui FWL, 2014, APPL CLIN GENET, V7, P105, DOI 10.2147/TACG.S37325; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; Zai-Xing Y, 2008, J CLIN LAB ANAL, V22, P138, DOI 10.1002/jcla.20231; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	43	13	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137522	10.1371/journal.pone.0137522	http://dx.doi.org/10.1371/journal.pone.0137522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352601	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800093
J	Zhang, C; Phang, CW; Zeng, XH; Wang, XM; Xu, YJ; Huang, Y; Contractor, N				Zhang, Cheng; Phang, Chee Wei; Zeng, Xiaohua; Wang, Ximeng; Xu, Yunjie; Huang, Yun; Contractor, Noshir			Circadian Rhythms in Socializing Propensity	PLOS ONE			English	Article								Using large-scale interaction data from a virtual world, we show that people's propensity to socialize (forming new social connections) varies by hour of the day. We arrive at our results by longitudinally tracking people's friend-adding activities in a virtual world. Specifically, we find that people are most likely to socialize during the evening, at approximately 8 p.m. and 12 a.m., and are least likely to do so in the morning, at approximately 8 a.m. Such patterns prevail on weekdays and weekends and are robust to variations in individual characteristics and geographical conditions.	[Zhang, Cheng; Phang, Chee Wei; Wang, Ximeng; Xu, Yunjie] Fudan Univ, Dept Informat Management & Informat Syst, Shanghai 200433, Peoples R China; [Zeng, Xiaohua] City Univ Hong Kong, Coll Business, Hong Kong, Hong Kong, Peoples R China; [Huang, Yun; Contractor, Noshir] Northwestern Univ, Sch Commun, Evanston, IL USA	Fudan University; City University of Hong Kong; Northwestern University	Phang, CW (corresponding author), Fudan Univ, Dept Informat Management & Informat Syst, Shanghai 200433, Peoples R China.	phangcw@fudan.edu.cn	Contractor, Noshir/AAJ-8371-2020; Zhang, Cheng/P-6145-2019; Contractor, Noshir/B-7456-2009; Xu, Yunjie/E-9466-2011; Zhang, Cheng/A-1230-2009	Contractor, Noshir/0000-0002-9989-3018; Zhang, Cheng/0000-0002-8277-5138; Zeng, Xiaohua/0000-0003-2488-8203	Research Grants Council of the Hong Kong Special Administrative Region [CityU 11507514]; National Science Foundation of China [71372112, 71232008, 71102018]; Shanghai Social Science Fund [2013BGL003]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Social Science Fund	This work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (Grant CityU 11507514), the National Science Foundation of China (71372112, 71232008, 71102018) and the Shanghai Social Science Fund (2013BGL003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burt R.S., 1992, STRUCTURAL HOLES; Clary EG, 2002, J SOCIAL ISSUES, V58; Dodds PS, 2010, J HAPPINESS STUDIES, V11; Dy Jr Manuel B., 1994, CONT SOCIAL PHILOS; Forsling ML, 1998, EXP PHYSL, V83; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; Golder A, 2011, SCIENCE, V333; Golder S, P IEEE C SOC COMP 20; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jaques E, 1982, THE FORM OF TIME; Jiang ZQ, 2010, PHYSICA A, V389, P807, DOI 10.1016/j.physa.2009.10.028; Jiang ZQ, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/48007; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McPherson  M., 2001, ANN REV SOCIOLOGY, V27; Mislove A., P 5 INT AAAI C WEBL; MONK TH, 1991, PSYCHIAT RES, V36, P195, DOI 10.1016/0165-1781(91)90131-8; Nonaka I., 1995, KNOWLEDGE CREATION C; O'Connor B, P INT AAAI C WEBL SO; Ohta H, 1993, ESSAYS ML GREENHUT; Reisberg B, 2002, AM J ALZHEIMERS DIS, V17; Shen GH, 2008, BIPOLAR DISORDERS, V10; Tauber M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-47; van Wingen GA, 2011, NEUROSCIENCE, V191, P38, DOI 10.1016/j.neuroscience.2011.04.042; Wellman B, 1996, SOCIAL NETWORKS, V18; West J. H., 2012, OPEN J PREVENTIVE ME, V2; Whelan DC, 2012, SOCIAL PSYCHOL PERSO, V3; Xie WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05244	27	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136325	10.1371/journal.pone.0136325	http://dx.doi.org/10.1371/journal.pone.0136325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26353080	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800034
J	de Andrade, ED; Hennington, EA; de Siqueira, HR; Rolla, VC; Mannarino, C				de Andrade, Elizabeth da Trindade; Hennington, Elida Azevedo; de Siqueira, Helio Ribeiro; Rolla, Valeria Cavalcanti; Mannarino, Celina			Perspectives of Patients, Doctors and Medical Students at a Public University Hospital in Rio de Janeiro Regarding Tuberculosis and Therapeutic Adherence	PLOS ONE			English	Article							BARRIERS	Introduction The World Health Organization (WHO) identifies 8.7 million new cases of tuberculosis (TB) annually around the world. The unfavorable outcomes of TB treatment prevent the achievement of the WHO's cure target. Goal To evaluate existing intersections in the conceptions relative to the knowledge of TB, the experience of the illness and the treatment. Methods Doctors, medical students and patients were selected from a public university in Rio de Janeiro, Brazil, from 2011 to 2013. The data were obtained by semi-structured individual and focus group interviews, participant observation and a field journal. The inclusion of patients was interrupted due to saturation, and the inclusion of doctors and medical students stopped due to exhaustion. The theoretical background included symbolic Interactionism, and the analysis used rounded Theory. The analysis prioritized the actions/interactions axis. Results Twenty-three patients with pulmonary TB, seven doctors and 15 medical students were included. In the interviews, themes such as stigma, self-segregation, and difficulties in assistance emerged, in addition to defense mechanisms such as denial, rationalization, isolation and other mental mechanisms, including guilt, accountability and concealment of the disease. Aspects related to the assistance strategy, the social support network, bonding with the healthcare staff and the doctor-patient relationship were highlighted as adherence enablers. Doctors and students recommended an expansion of the theoretical and practical instruction on TB during medical students' education. The existence of health programs and policies was mentioned as a potential enabler of adherence. Conclusion The main concepts identified were the stigma, self-segregation, guilt, responsibility, concealment and emotional repercussions. In relation to the facilitation of therapeutic adherence, the concepts identified were the bonds with healthcare staff, the doctor-patient relationship, assistance and educational health strategies.	[de Andrade, Elizabeth da Trindade; Hennington, Elida Azevedo; Rolla, Valeria Cavalcanti; Mannarino, Celina] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Rio De Janeiro, Brazil; [Hennington, Elida Azevedo; Mannarino, Celina] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Educ, Rio De Janeiro, Brazil; [de Siqueira, Helio Ribeiro] State Univ Rio de Janeiro UERJ, Fac Med Sci, Rio De Janeiro, Brazil; [Rolla, Valeria Cavalcanti] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Clin Res Lab Mycobacteria, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	de Andrade, ED (corresponding author), Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Rio De Janeiro, Brazil.	bethtrind@gmail.com	Hennington, Elida Azevedo/AAK-3354-2020; Rolla, Valeria Cavalcanti/AAI-6078-2021	Hennington, Elida Azevedo/0000-0001-5280-8827; Rolla, Valeria Cavalcanti/0000-0002-0841-1408				Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Abrão Carolina Borges, 2008, Rev. bras. educ. med., V32, P315, DOI 10.1590/S0100-55022008000300006; Abreu Neto Iron Pires de, 2006, Rev. bras. educ. med., V30, P154, DOI 10.1590/S0100-55022006000300006; [Anonymous], 2013, GLOB TUB CONTR; Backes MTS, 2011, ESC A NERY, V15; Fontanella BJ, 2008, CAD SAUDE PUBLICA, V24, P17, DOI 10.1590/S0102-311X2008000100003; Fontanella BJB, 2011, CAD SAUDE PUBLICA, V27, P389, DOI 10.1590/S0102-311X2011000200020; Bertazone Érika do Carmo, 2005, Rev. Latino-Am. Enfermagem, V13, P374; Blumer H., 1969, SYMB INTERACT; Brasil. Ministerio da Saude, 2013, B EPIDEMIOLOGICO, V44; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2010, MAN REC CONTR TUB BR; Chirinos NEC, 2011, TEXTO CONTEXTO ENFER, V20, P399, DOI 10.1590/S0104-07072011000300023; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Clementino FS, 2011, REV ENFERM UERJ, V19, P638; Corbin J, 2009, PESQUISA QUALITATIVA; Costa A, 2009, REV BRASILEIRA TERAP, V11, P329; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; DENZIN N., 2006, PLANEJAMENTO PESQUIS, V2; Ferreira-Santos E, 2010, ESTUDANTE MED PSICOL, P61; Goffman E., 2004, ESTIGMA NOTAS MANIPU, V4, DOI [10.4324/9781315182131-8, DOI 10.4324/9781315182131-8]; Hane F, 2007, INT J TUBERC LUNG D, V11, P539; Koifman L., 2001, Historia Ciencias, Saude - Manguinhos, V8, P49, DOI 10.1590/S0104-59702001000200003; Konradsen H, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23644; Kuznetsov VN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-712; Lakatos EM, 2009, METODOLOGIA CIENTIFI; Laperriere A, 2010, PESQUI QUAL ENFOQUES; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Mala G, 2013, J EVAL CLIN PRACT, V20, P88; Marra Carlo A, 2004, Health Qual Life Outcomes, V2, P58, DOI 10.1186/1477-7525-2-58; *MIN SAUD, 2012, B EP ESP TUB, P43; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Neves SC, 2010, ENSINO SAUDE AMBIENT, V3; Nico Lucélia Silva, 2007, Ciênc. saúde coletiva, V12, P789; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Singh V, 2002, TROP MED INT HEALTH, V7, P693, DOI 10.1046/j.1365-3156.2002.00909.x; SOUZA SF, 2006, THESIS U FEDERAL SAN; Spitz L, 1997, CAD IPUB SAUDE MENTA, P85; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Valadares G, 2011, REV ENFERM UERJ, V19, P473; Watkins RE, 2004, INT J TUBERC LUNG D, V8, P218; WHO, 2012, GLOB TUB CONTR	44	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137572	10.1371/journal.pone.0137572	http://dx.doi.org/10.1371/journal.pone.0137572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360291	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100054
J	Keogh, SC; Kimaro, G; Muganyizi, P; Philbin, J; Kahwa, A; Ngadaya, E; Bankole, A				Keogh, Sarah C.; Kimaro, Godfather; Muganyizi, Projestine; Philbin, Jesse; Kahwa, Amos; Ngadaya, Esther; Bankole, Akinrinola			Incidence of Induced Abortion and Post-Abortion Care in Tanzania	PLOS ONE			English	Article							UNSAFE ABORTION; WORLDWIDE; DISTRICT; TRENDS; LEVEL; WOMEN; URBAN	Background Tanzania has one of the highest maternal mortality ratios in the world, and unsafe abortion is one of its leading causes. Yet little is known about its incidence. Objectives To provide the first ever estimates of the incidence of unsafe abortion in Tanzania, at the national level and for each of the 8 geopolitical zones (7 in Mainland plus Zanzibar). Methods A nationally representative survey of health facilities was conducted to determine the number of induced abortion complications treated in facilities. A survey of experts on abortion was conducted to estimate the likelihood of women experiencing complications and obtaining treatment. These surveys were complemented with population and fertility data to obtain abortion numbers, rates and ratios, using the Abortion Incidence Complications Methodology. Results In Tanzania, women obtained just over 405,000 induced abortions in 2013, for a national rate of 36 abortions per 1,000 women age 15-49 and a ratio of 21 abortions per 100 live births. For each woman treated in a facility for induced abortion complications, 6 times as many women had an abortion but did not receive care. Abortion rates vary widely by zone, from 10.7 in Zanzibar to 50.7 in the Lake zone. Conclusions The abortion rate is similar to that of other countries in the region. Variations by zone are explained mainly by differences in fertility and contraceptive prevalence. Measures to reduce the incidence of unsafe abortion and associated maternal mortality include expanding access to post-abortion care and contraceptive services to prevent unintended pregnancies.	[Keogh, Sarah C.; Philbin, Jesse; Bankole, Akinrinola] Guttmacher Inst, New York, NY 10038 USA; [Kimaro, Godfather; Kahwa, Amos; Ngadaya, Esther] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Muganyizi, Projestine] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania	National Institute of Medical Research; Muhimbili University of Health & Allied Sciences	Keogh, SC (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	skeogh@guttmacher.org		Ngadaya, Esther/0000-0003-4540-5637	Netherlands Ministry of Foreign Affairs [24590]; Department for International Development of the UK Government [203177-101]; Norwegian Agency for Development Cooperation [1300340]	Netherlands Ministry of Foreign Affairs; Department for International Development of the UK Government; Norwegian Agency for Development Cooperation	This study was funded by the Netherlands Ministry of Foreign Affairs (http://www.government.nl/ministries/bz), grant number 24590; the Department for International Development of the UK Government (https://www.gov.uk/government/organisations/department-for-international-development), grant number 203177-101; and the Norwegian Agency for Development Cooperation (http://www.norad.no/en/front/), grant number 1300340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2nd African Union Assembly, 2007, PROT AFR CHART HUM P; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Beckmann N, 2010, CULT HEALTH SEX, V12, P619, DOI 10.1080/13691051003663713; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Center for Reproductive Rights, 2012, TECHN GUID UND LEG P; European Union (EU), 2012, POPULATION HOUSING C; Guttmacher Institute, 2012, COSTS BEN INV COTRA; Harlap S, 1980, HUMAN EMBRYONIC FETA, P145; Izugbara C., 2013, INCIDENCE COMPLICATI; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Levandowski BA, 2013, INT PERSPECT SEX R H, V39, P88, DOI 10.1363/3908813; Ministry of Health and Social Welfare, 2014, NAT ROAD MAP STRAT P; Mswia R, 2003, B WORLD HEALTH ORGAN, V81, P87; National Bureau of Statistics & MACRO, 2010, TANZ DEM HLTH SURV 2; Nielsen Karoline Kragelund, 2009, Afr J Reprod Health, V13, P129; Pembe AB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-326; Price N., 2003, ADDRESSING REPROD HL; Rasch V, 2000, TROP MED INT HEALTH, V5, P495, DOI 10.1046/j.1365-3156.2000.00584.x; Rasch V, 2005, STUD FAMILY PLANN, V36, P301, DOI 10.1111/j.1728-4465.2005.00072.x; Rasch V, 2005, CONTRACEPTION, V72, P377, DOI 10.1016/j.contraception.2005.04.015; Rasch V, 2004, ACTA OBSTET GYN SCAN, V83, P570, DOI 10.1111/j.0001-6349.2004.0529.x; Rasch V, 2004, TROP MED INT HEALTH, V9, P399, DOI 10.1111/j.1365-3156.2004.01197.x; Rasch Vibeke, 2008, BMC Pregnancy Childbirth, V8, P32, DOI 10.1186/1471-2393-8-32; Rasch V, 2009, TROP MED INT HEALTH, V14, P1128, DOI 10.1111/j.1365-3156.2009.02327.x; Remez Alyssa., 2010, METHODOLOGIES ESTIMA, P71; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2015, INT PERSPECT SEX R H, V41, P11, DOI 10.1363/4101115; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Sedgh G, 2011, STUD FAMILY PLANN, V42, P147, DOI 10.1111/j.1728-4465.2011.00275.x; Shwekerel B, 2007, BJOG-INT J OBSTET GY, V114, P1363, DOI 10.1111/j.1471-0528.2007.01469.x; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S., 2014, ADDING IT COSTS BENE; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Singh S, 2010, INT PERSPECT SEX R H, V36, P16, DOI 10.1363/ipsrh.36.016.10; Sorensen BL, 2010, TROP MED INT HEALTH, V15, P894, DOI 10.1111/j.1365-3156.2010.02554.x; UN Department of Economic and Social Affairs, 2015, AB POL UN REP TANZ; Venture Strategies Innovations, 2011, TANZ FIGHTS MAT MORT; Venture Strategies Innovations, 2012, ASS AV UT TANZ UNPUB; Wanjiru M, 2007, ASSESSING FEASIBILIT; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2013, UNS AB GLOB REG EST	42	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0133933	10.1371/journal.pone.0133933	http://dx.doi.org/10.1371/journal.pone.0133933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26361246	Green Submitted, gold, Green Published			2022-12-27	WOS:000361043100001
J	Lee, SY; Lee, SH; Yang, EJ; Kim, EK; Kim, JK; Shin, DY; Cho, ML				Lee, Seon-Yeong; Lee, Seung Hoon; Yang, Eun-Ji; Kim, Eun-Kyung; Kim, Jae-Kyung; Shin, Dong-Yun; Cho, Mi-La			Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance	PLOS ONE			English	Article								Objective Metformin is used to treat type 2 diabetes. We sought to determine whether metformin reduces inflammation, by regulating p-signal transducer and activator of transcription 3 (STAT3) expression and T-helper 17 (Th17) cell proliferation, in a mouse model of inflammatory bowel disease (IBD). Methods IBD mice were administered metformin for 16 days and their tissues were analyzed. AMP-activated protein kinase (AMPK), the mammalian target of rapamycin (mTOR), p-STAT3 and p-STAT5 in the spleen and lymph nodes were detected using immunohistochemistry and confocal microscopy. Gene expression was determined using quantitative PCR assays, and protein expression levels were measured using western blotting and enzyme-linked immunosorbent assays. Human HT-29 cell proliferation was evaluated using MTT assays. Results Metformin reduced disease activity index scores and inhibited weight loss. Metformin also decreased the colonic histological score and inflammatory mediators and increased colon lengths increased. Treatment with metformin inhibited the expression of interleukin (IL)-17, p-STAT3, and p-mTOR. In contrast, metformin treatment increased expression levels of p-AMPK and Foxp3. In addition, expression of inflammatory cytokines decreased in a dose-dependent manner in inflamed human HT-29 cells cultured with metformin at various concentrations. Conclusions Metformin attenuates IBD severity and reduces inflammation through the inhibition of p-STAT3 and IL-17 expression. Our results have increased our understanding of this chronic inflammatory disease, and support the strategy of using p-STAT3 inhibitors to treat IBD.	[Lee, Seon-Yeong; Lee, Seung Hoon; Yang, Eun-Ji; Kim, Eun-Kyung; Kim, Jae-Kyung; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, Seon-Yeong; Cho, Mi-La] Catholic Univ, CRCID, Lab Immune Network, Seoul, South Korea; [Shin, Dong-Yun] Gachon Univ Med & Sci, Coll Pharm, 191 Hambakmoe Ro, Inchon 406799, South Korea	Catholic University of Korea; Catholic University of Korea; Gachon University	Shin, DY (corresponding author), Gachon Univ Med & Sci, Coll Pharm, 191 Hambakmoe Ro, Inchon 406799, South Korea.	dyshin21@naver.com; iammila@catholic.ac.kr			Korean Health Technology RAMP;D Project, Ministry for Health AMP; Welfare, Republic of Korea [HI14C3417]; Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute [HI14C1549]	Korean Health Technology RAMP;D Project, Ministry for Health AMP; Welfare, Republic of Korea; Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute	Funding for this work was provided by The Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417), the Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, and The Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI14C1549).	Capiralla H, 2012, FEBS J, V279, P3791, DOI 10.1111/j.1742-4658.2012.08739.x; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Dignass A, 2012, J CROHNS COLITIS, V6, DOI [10.1016/j.crohns.2012.09.003, DOI 10.1016/J.CR0HNS.2012.09.003]; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Galvez Julio, 2014, ISRN Inflamm, V2014, P928461, DOI 10.1155/2014/928461; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gu FM, 2011, MOL CANCER, P10; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Isoda K, 2006, ARTERIOSCLER THROMB, V26; Izutani R, 1995, INFLAMM BOWEL DIS, V1; Jhun J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/351856; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; Koh SJ, 2014, J GASTROENTEROL HEPA, V29; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Marafini I, 2013, CURR DRUG TARGETS, V14, P1400, DOI 10.2174/13894501113149990157; Micic D, 2011, HORMONES ATHENS, V10; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Park CS, 2012, BIOCH PHARM, V84; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rudensky AY, 2007, NAT IMMUNOL, V8; Sandborn WJ, LANCET, V369; Scaldaferri F, 2009, GASTROENTEROLOGY, V136; Selmi C, 2011, AUTOIMMUN REV, V10, P725, DOI 10.1016/j.autrev.2011.06.004; Shaw RJ, 2009, NAT REV CANC, V9; Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Wruck CJ, ANN RHEUM DIS, V70; Yang EJ, 2014, PLOS ONE, V9; Yang XO, 2007, J BIOL CHEM, V282; Yu H, 2009, NAT REV CANC, V9; Zhou J, 2007, P NATL ACAD SCI US, V104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	36	76	86	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135858	10.1371/journal.pone.0135858	http://dx.doi.org/10.1371/journal.pone.0135858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360050	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100005
J	Pallister, KB; Mason, S; Nygaard, TK; Liu, B; Griffith, S; Jones, J; Linderman, S; Hughes, M; Erickson, D; Voyich, JM; Davis, MF; Wilson, E				Pallister, Kyler B.; Mason, Sara; Nygaard, Tyler K.; Liu, Bin; Griffith, Shannon; Jones, Jennifer; Linderman, Susanne; Hughes, Melissa; Erickson, David; Voyich, Jovanka M.; Davis, Mary F.; Wilson, Eric			Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; MAMMARY-GLAND; CHEMOKINE RECEPTORS; MUCOSAL TISSUES; CXC CHEMOKINES; CUTTING EDGE; IDENTIFICATION; ACCUMULATION; INVOLVEMENT; EXPRESSION	In addition to the well characterized function of chemokines in mediating the homing and accumulation of leukocytes to tissues, some chemokines also exhibit potent antimicrobial activity. Little is known of the potential role of chemokines in bovine mammary gland health and disease. The chemokine CCL28 has previously been shown to play a key role in the homing and accumulation of IgA antibody secreting cells to the lactating murine mammary gland. CCL28 has also been shown to act as an antimicrobial peptide with activity demonstrated against a wide range of pathogens including bacteria, fungi and protozoans. Here we describe the cloning and function of bovine CCL28 and document the concentration of this chemokine in bovine milk. Bovine CCL28 was shown to mediate cellular chemotaxis via the CCR10 chemokine receptor and exhibited antimicrobial activity against a variety of bovine mastitis causing organisms. The concentration of bovine CCL28 in milk was found to be highly correlated with the lactation cycle. Highest concentrations of CCL28 were observed soon after parturition, with levels decreasing over time. These results suggest a potential role for CCL28 in the prevention/resolution of bovine mastitis.	[Pallister, Kyler B.; Nygaard, Tyler K.; Griffith, Shannon; Jones, Jennifer; Voyich, Jovanka M.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Mason, Sara; Liu, Bin; Linderman, Susanne; Hughes, Melissa; Erickson, David; Davis, Mary F.; Wilson, Eric] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Montana State University System; Montana State University Bozeman; Brigham Young University	Wilson, E (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	ericwilson@byu.edu		Erickson, David/0000-0001-6149-273X; Nygaard, Tyler/0000-0002-4736-0156; Mason, Sara/0000-0002-0684-2714; Linderman, Susanne/0000-0003-3297-3774	United States Department of Agriculture [2008-35204-04623]; National Center for Research Resources [NIH-RR020185]; National Institute of Allergy And Infectious Diseases [2R15AI072769-02A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072769] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the United States Department of Agriculture grant number 2008-35204-04623 to JMV; the National Center for Research Resources grant NIH-RR020185 to JMV; and the National Institute of Allergy And Infectious Diseases grant number 2R15AI072769-02A1 to EW.	Berri M, 2008, MOL IMMUNOL, V45, P271, DOI 10.1016/j.molimm.2007.04.026; Berri M, 2014, DEV COMP IMMUNOL, V44, P286, DOI 10.1016/j.dci.2014.01.005; Bourges D, 2004, SCAND J IMMUNOL, V60, P338, DOI 10.1111/j.0300-9475.2004.01479.x; Bourges D, 2008, MOL IMMUNOL, V45, P3354, DOI 10.1016/j.molimm.2008.04.017; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Distelhorst K, 2010, VET IMMUNOL IMMUNOP, V138, P134, DOI 10.1016/j.vetimm.2010.07.008; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Karlsson C, 2013, BLOOD, V121, P3838, DOI 10.1182/blood-2013-02-481192; Kerr DE, 2003, J ANIM SCI, V81, P38; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; Ott TR, 2004, BIOCHEMISTRY-US, V43, P3670, DOI 10.1021/bi035895h; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Watkins HR, 2007, J PERIODONTOL, V78, P2356, DOI 10.1902/jop.2007.060504; Widdison S, 2011, ANIM GENET, V42, P341, DOI 10.1111/j.1365-2052.2011.02200.x; Widdison S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-439; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138084	10.1371/journal.pone.0138084	http://dx.doi.org/10.1371/journal.pone.0138084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359669	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100111
J	Zhang, Y; Liang, Q; Gao, RT; Hou, HB; Tan, WB; He, XS; Zhang, H; Yu, MD; Ma, LN; Xi, BD; Wang, XW				Zhang, Yuan; Liang, Qiong; Gao, Rutai; Hou, Haobo; Tan, Wenbing; He, Xiaosong; Zhang, Hui; Yu, Minda; Ma, Lina; Xi, Beidou; Wang, Xiaowei			Contamination of Phthalate Esters (PAEs) in Typical Wastewater-Irrigated Agricultural Soils in Hebei, North China	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; ORGANIC-CARBON; YELLOW-RIVER; FATE; RESIDUES; SAMPLES; AREAS	The Wangyang River (WYR) basin is a typical wastewater irrigation area in Hebei Province, North China. This study investigated the concentration and distribution of six priority phthalate esters (PAEs) in the agricultural soils in this area. Thirty-nine soil samples (0-20 cm) were collected along the WYR to assess the PAE residues in soils. Results showed that PAEs are ubiquitous environmental contaminants in the topsoil obtained from the irrigation area. The concentrations of Sigma(6)PAEs range from 0.191 mu g g(-1) dw to 0.457 mu g g(-1) dw with an average value of 0.294 mu g g(-1) dw. Di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DnBP) are the dominant PAE species in the agricultural soils. Among the DEHP concentrations, the highest DEHP concentration was found at the sites close to the villages; this result suggested that dense anthropogenic activities and random garbage disposal in the rural area are possible sources of PAEs. The PAE concentrations were weakly and positively correlated with soil organic carbon and soil enzyme activities; thus, these factors can affect the distribution of PAEs. This study further showed that only dimethyl phthalate (DMP) concentrations exceeded the recommended allowable concentrations; no remediation measures are necessary to control the PAEs in the WYR area. However, the PAEs in the topsoil may pose a potential risk to the ecosystem and human health in this area. Therefore, the exacerbating PAE pollution should be addressed.	[Zhang, Yuan; Hou, Haobo] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430079, Peoples R China; [Liang, Qiong] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab New Tech Agr Applicat, Beijing 102206, Peoples R China; [Gao, Rutai; Tan, Wenbing; He, Xiaosong; Zhang, Hui; Yu, Minda; Ma, Lina; Xi, Beidou; Wang, Xiaowei] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China	Wuhan University; Beijing University of Agriculture; Chinese Research Academy of Environmental Sciences	Xi, BD (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China.	xibeidou@263.net	Wang, Xiaowei/AAJ-6512-2020		Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07203-003]; National Natural Science Funds [51325804]; Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture [14ZK001]; Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences [2014-GOT-019-N-26]	Major Science and Technology Program for Water Pollution Control and Treatment of China; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture; Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences	This work was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (No. 2012ZX07203-003) of China, National Natural Science Funds for Distinguished Young Scholar (No. 51325804), Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture (No. 14ZK001), and Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences (No. 2014-GOT-019-N-26).	[Anonymous], 1994, 4046 TAGM DEP ENV CO; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Cai QY, 2008, SCI TOTAL ENVIRON, V389, P209, DOI 10.1016/j.scitotenv.2007.08.026; Chai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095701; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chen Y, 2005, ENVIRON INT, V31, P778, DOI 10.1016/j.envint.2005.05.024; Chi J, 2009, CHEMOSPHERE, V77, P48, DOI 10.1016/j.chemosphere.2009.05.043; China National Environmental Protection Agency, 2008, ENV QUAL STAND SOILS; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Fatoki OS, 2002, WATER AIR SOIL POLL, V140, P85, DOI 10.1023/A:1020134707450; Gao DW, 2014, CHEMOSPHERE, V95, P24, DOI 10.1016/j.chemosphere.2013.08.009; He W, 2013, SCI TOTAL ENVIRON, V461, P672, DOI [10.1016/j.scitotenv2013.05.049, 10.1016/j.scitotenv.2013.05.049]; Hu Xiongxing, 2007, ENV SCI MANAGEMENT, V32, P37; Jiang YH, 2014, CHEMOSPHERE, V112, P267, DOI 10.1016/j.chemosphere.2014.04.075; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Kong SF, 2012, ENVIRON POLLUT, V170, P161, DOI 10.1016/j.envpol.2012.06.017; Liang Q, 2014, AGR WATER MANAGE, V135, P100, DOI 10.1016/j.agwat.2014.01.003; Mackintosh CE, 2006, ENVIRON SCI TECHNOL, V40, P3481, DOI 10.1021/es0519637; Mapanda F, 2005, AGR ECOSYST ENVIRON, V107, P151, DOI 10.1016/j.agee.2004.11.005; Meng XZ, 2014, SCI TOTAL ENVIRON, V476, P242, DOI 10.1016/j.scitotenv.2014.01.007; Niu LL, 2014, ENVIRON POLLUT, V195, P16, DOI 10.1016/j.envpol.2014.08.014; Penalver A, 2000, J CHROMATOGR A, V872, P191, DOI 10.1016/S0021-9673(99)01284-4; Schinner F., 1996, METHODS SOIL BIOL; Seth R, 1999, ENVIRON SCI TECHNOL, V33, P2390, DOI 10.1021/es980893j; Sha YJ, 2007, ENVIRON MONIT ASSESS, V124, P277, DOI 10.1007/s10661-006-9225-6; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; TAN GH, 1995, B ENVIRON CONTAM TOX, V54, P171, DOI 10.1007/BF00197427; Teil MJ, 2006, SCI TOTAL ENVIRON, V354, P212, DOI 10.1016/j.scitotenv.2004.12.083; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vethaak AD, 2005, CHEMOSPHERE, V59, P511, DOI 10.1016/j.chemosphere.2004.12.053; Vieira FCB, 2007, SOIL TILL RES, V96, P195, DOI 10.1016/j.still.2007.06.007; Vitali M, 1997, ENVIRON INT, V23, P337, DOI 10.1016/S0160-4120(97)00035-4; Wang J, 2014, SCI TOTAL ENVIRON, V500, P113, DOI 10.1016/j.scitotenv.2014.08.092; Wang M, 2015, J SEP SCI, V38, P445, DOI 10.1002/jssc.201400991; Wang XL, 2013, ECOL ENG, V51, P10, DOI 10.1016/j.ecoleng.2012.12.079; Wang XJ, 2006, CHEMOSPHERE, V64, P1514, DOI 10.1016/j.chemosphere.2005.12.052; Xu N, 2007, CHEMOSPHERE, V69, P1419, DOI 10.1016/j.chemosphere.2007.04.070; Yang HJ, 2013, ENVIRON MONIT ASSESS, V185, P8489, DOI 10.1007/s10661-013-3190-7; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045; Zhang Y, 2015, SCI TOTAL ENVIRON, V506, P118, DOI 10.1016/j.scitotenv.2014.10.075; Zhou QH, 2005, SOIL BIOL BIOCHEM, V37, P1454, DOI 10.1016/j.soilbio.2005.01.003	42	34	49	8	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137998	10.1371/journal.pone.0137998	http://dx.doi.org/10.1371/journal.pone.0137998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360905	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100106
J	D'Souza, K; Epureanu, BI; Pascual, M				D'Souza, Kiran; Epureanu, Bogdan I.; Pascual, Mercedes			Forecasting Bifurcations from Large Perturbation Recoveries in Feedback Ecosystems	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING INDICATOR; ECOLOGY; SYSTEMS; SHIFTS; TIME	Forecasting bifurcations such as critical transitions is an active research area of relevance to the management and preservation of ecological systems. In particular, anticipating the distance to critical transitions remains a challenge, together with predicting the state of the system after these transitions are breached. In this work, a new model-less method is presented that addresses both these issues based on monitoring recoveries from large perturbations. The approach uses data from recoveries of the system from at least two separate parameter values before the critical point, to predict both the bifurcation and the post-bifurcation dynamics. The proposed method is demonstrated, and its performance evaluated under different levels of measurement noise, with two ecological models that have been used extensively in previous studies of tipping points and alternative steady states. The first one considers the dynamics of vegetation under grazing; the second, those of macrophyte and phytoplankton in shallow lakes. Applications of the method to more complex situations are discussed together with the kinds of empirical data needed for its implementation.	[D'Souza, Kiran] Ohio State Univ, Mech & Aerosp Engn Dept, Columbus, OH 43210 USA; [Epureanu, Bogdan I.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Chicago; The Santa Fe Institute	D'Souza, K (corresponding author), Ohio State Univ, Mech & Aerosp Engn Dept, Columbus, OH 43210 USA.	dsouza.60@osu.edu	D'Souza, Kiran Xavier/J-6120-2014	D'Souza, Kiran Xavier/0000-0002-1144-2432	National Science Foundation [1334908]; Div Of Civil, Mechanical, & Manufact Inn [1334908] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation, grant #1334908, http://www.nsf.gov/; BIE, KD, MP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Berglund N., 2002, STOCH DYNAM, V2, P327, DOI DOI 10.1142/S0219493702000455; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Chung KW, 2009, J SOUND VIB, V320, P163, DOI 10.1016/j.jsv.2008.07.019; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Gamarra JGP, 2000, ECOL LETT, V3, P114; Golomb D, 2001, PHYS REV LETT, V86, P4179, DOI 10.1103/PhysRevLett.86.4179; Grillo S, 2008, 2008 PROCEEDINGS OF THE 43RD INTERNATIONAL UNIVERSITIES POWER ENGINEERING CONFERENCE, VOLS 1-3, P356; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Horsthemke W., 1984, NOISE INDUCED TRANSI; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Lee E, 2011, J MATH ANAL APPL, V381, P732, DOI 10.1016/j.jmaa.2011.03.048; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lim J, 2012, NONLINEAR DYNAM, V67, P2291, DOI 10.1007/s11071-011-0146-8; Lim J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016203; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 1998, POPULATION COMMUNITY, V22, P1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2002, AQUAT BOT, V72, P275, DOI 10.1016/S0304-3770(01)00206-6; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Yang HL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.154101; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025	37	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137779	10.1371/journal.pone.0137779	http://dx.doi.org/10.1371/journal.pone.0137779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356503	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800081
J	Ho, CT; Chang, YJ; Yang, LX; Wei, PL; Liu, TZ; Liu, JJ				Ho, Chun-Te; Chang, Yu-Jia; Yang, Li-Xi; Wei, Po-Li; Liu, Tsan-Zon; Liu, Jun-Jen			A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; COLCHICINE; APOPTOSIS; MECHANISMS; INHIBITION; THIOCOLCHICINE; DERIVATIVES; PACLITAXEL; BINDING; PROTEIN	Here, we present evidence of a novel microtubule-disrupting agent, N-deacetyl-N-(chromone-2-carbonyl)-thiocolchicine (TCD), exhibiting potent antitumor activity (with IC50 values in the nanomolar range) against hepatocellular carcinoma cell lines. Cell cycle analysis revealed that TCD induced G2/M cell-cycle arrest in a dose-and time-dependent manner in both Hep-J5 and Mahlavu HCC cell lines. TCD also induced a decrease in mitochondrial membrane potential (Delta psi m) and caused DNA damage. Mechanistically, TCD activated protein kinase RNA-like endoplasmic reticular kinase and several transcription factors, including activating transcription factor (ATF) 6, ATF4, ATF3, and the CCAAT-enhancer binding protein homologous protein. These data clearly demonstrate that the antitumor activity of TCD is mechanistically linked to its capacity to trigger both intrinsic and extrinsic apoptotic cell death via endoplasmic reticular stress pathway. The potent antitumor activity of TCD was similarly demonstrated in a hepatocellular carcinoma xenograft model, where 5 and 10 mg/kg doses of TCD significantly arrested Hep-J5 and Mahlavu tumor growth. Our finding suggests that TCD is a promising therapeutic agent against hepatocellular carcinoma; further translational assessment of its clinical usage is warranted.	[Ho, Chun-Te; Liu, Jun-Jen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ho, Chun-Te; Liu, Jun-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li; Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li] Taipei Med Univ & Hosp, Dept Surg, Taipei, Taiwan; [Yang, Li-Xi] Calif Pacific Med Ctr, Res Inst, Radiobiol Lab, San Francisco, CA USA; [Yang, Li-Xi] St Marys Hosp, San Francisco, CA USA	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; California Pacific Medical Center; California Pacific Medical Center Research Institute	Liu, JJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jjliu_96@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021	Chang, Yu-Jia/0000-0003-3978-3244	National Science Council [NSC 98-2320-B-038-008-MY3]; Ministry of Health and Welfare [DOH102-TD-N-111-006, MOHW103-TDU-N-211-133003]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	JJL received the funding for this work from a National Science Council grant (NSC 98-2320-B-038-008-MY3); URL: http://statistics.most.gov.tw/was2/award/AsAwardMultiQuery.aspx?year=98&code=QS01&organ=&name=%E5%8A%89%E4%BF%8A%E4%BB%81; and a Ministry of Health and Welfare grant (DOH102-TD-N-111-006, MOHW103-TDU-N-211-133003); URL: https://rdsys.tmu.edu.tw/applyadmin/myview.aspx?hea=jjliu_96. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	BROSSI A, 1990, J MED CHEM, V33, P2311, DOI 10.1021/jm00171a001; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Craig DH, 2008, J CLIN INVEST, V118, P3170, DOI 10.1172/JCI34279; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gangjee A, 2007, J MED CHEM, V50, P3290, DOI 10.1021/jm070194u; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; GRIMM J, 1976, EUR J BIOCHEM, V64, P249, DOI 10.1111/j.1432-1033.1976.tb10294.x; Guan J, 1998, BIOORGAN MED CHEM, V6, P2127, DOI 10.1016/S0968-0896(98)00165-5; Hamed EA, 2010, J PEDIAT HEMATOL ONC, V32, P267, DOI 10.1097/MPH.0b013e3181d419d6; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; Heald R, 2002, J CELL SCI, V115, P3; HSU ML, 1995, CANCER LETT, V94, P41, DOI 10.1016/0304-3835(95)03820-M; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Huang YH, 2012, PLOS ONE, V5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joyce Margaret, 2009, Oncology (Williston Park), V23, P25; Karantanis E, 1994, Eur J Surg Oncol, V20, P653; Kim Sung-Kuk, 2013, Exp Mol Med, V45, pe19, DOI 10.1038/emm.2013.38; Knockaert L, 2011, FEBS J, V278, P4252, DOI 10.1111/j.1742-4658.2011.08357.x; Latiff ZA, 2010, J PEDIAT HEMATOL ONC, V32, P407, DOI 10.1097/MPH.0b013e3181e01584; Lee SH, 2005, ARCH PHARM, V338, P582, DOI 10.1002/ardp.200500148; Lim YS, 2014, GASTROENTEROLOGY, V147, P152, DOI 10.1053/j.gastro.2014.02.033; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mane JY, 2008, J CHEM INF MODEL, V48, P1824, DOI 10.1021/ci800054n; Marzo I, 2013, BIOCHEM PHARMACOL, V86, P703, DOI 10.1016/j.bcp.2013.07.010; Nakajima Y, 2013, INT J MOL SCI, V14, P7771, DOI 10.3390/ijms14047771; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nimeiri HS, 2010, INVEST NEW DRUG, V28, P854, DOI 10.1007/s10637-009-9297-6; Oh JM, 2010, LIFE SCI, V87, P286, DOI 10.1016/j.lfs.2010.07.002; Okano JI, 2007, ONCOL REP, V17, P1195; Park EC, 2014, GASTROENTEROLOGY, V147, P860, DOI 10.1053/j.gastro.2014.06.039; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Passarella D, 2008, BIOORGAN MED CHEM, V16, P6269, DOI 10.1016/j.bmc.2008.04.025; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; ROWINSKY EK, 1988, CANCER RES, V48, P4093; Saha MN, 2014, BRIT J CANCER, V110, P2224, DOI 10.1038/bjc.2014.164; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Sha SK, 2007, MOL CANCER THER, V6, P147, DOI 10.1158/1535-7163.MCT-06-0371; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spratt JS, 1996, J SURG ONCOL, V61, P68, DOI 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E; Tabrizian P, 2014, WORLD J GASTROENTERO, V20, P10223, DOI 10.3748/wjg.v20.i30.10223; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tung CY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-26; Uchida T, 1996, INT J CANCER, V67, P892	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136340	10.1371/journal.pone.0136340	http://dx.doi.org/10.1371/journal.pone.0136340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355599	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800012
J	Mall, R; Langone, R; Suykens, JAK				Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.			Netgram: Visualizing Communities in Evolving Networks	PLOS ONE			English	Article								Real-world complex networks are dynamic in nature and change over time. The change is usually observed in the interactions within the network over time. Complex networks exhibit community like structures. A key feature of the dynamics of complex networks is the evolution of communities over time. Several methods have been proposed to detect and track the evolution of these groups over time. However, there is no generic tool which visualizes all the aspects of group evolution in dynamic networks including birth, death, splitting, merging, expansion, shrinkage and continuation of groups. In this paper, we propose Netgram: a tool for visualizing evolution of communities in time-evolving graphs. Netgram maintains evolution of communities over 2 consecutive time-stamps in tables which are used to create a query database using the sql outer-join operation. It uses a line-based visualization technique which adheres to certain design principles and aesthetic guidelines. Netgram uses a greedy solution to order the initial community information provided by the evolutionary clustering technique such that we have fewer line cross-overs in the visualization. This makes it easier to track the progress of individual communities in time evolving graphs. Netgram is a generic toolkit which can be used with any evolutionary community detection algorithm as illustrated in our experiments. We use Netgram for visualization of topic evolution in the NIPS conference over a period of 11 years and observe the emergence and merging of several disciplines in the field of information processing systems.	[Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.] Katholieke Univ Leuven, ESAT STADIUS, B-3001 Leuven, Belgium	KU Leuven	Mall, R (corresponding author), Katholieke Univ Leuven, ESAT STADIUS, Kasteelpk Arenberg 10, B-3001 Leuven, Belgium.	raghvendra.mall@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Mall, Raghvendra/I-9470-2019	Suykens, Johan A.K./0000-0002-8846-6352; Mall, Raghvendra/0000-0003-1779-3150; Langone, Rocco/0000-0002-7583-7003	EU: ERC AdG A-DATADRIVE-B [290923]; Research Council KUL [GOA/10/-/09 MaNet]; CoE [PFV/10/002, BIL12/11T]; Flemish Government; FWO [G.0377.12, G.088114N]; IWT [100031]; iMinds Medical Information Technologies SBO Belgian Federal Science Policy Office [IUAP P7/19]; ERC (European Research Council); KU Leuven; BELSPO	EU: ERC AdG A-DATADRIVE-B; Research Council KUL(KU Leuven); CoE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Flemish Government(European Commission); FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); iMinds Medical Information Technologies SBO Belgian Federal Science Policy Office; ERC (European Research Council)(European Research Council (ERC)); KU Leuven(KU Leuven); BELSPO(Belgian Federal Science Policy Office)	This work was supported by EU: ERC AdG A-DATADRIVE-B (290923), Research Council KUL: GOA/10/-/09 MaNet, CoE PFV/10/002 (OPTEC), BIL12/11T; PhD/Postdoc grants-Flemish Government; FWO: projects: G.0377.12 (Structured systems), G.088114N (Tensor based data similarity); PhD/Postdoc grants; IWT: projects: SBO POM (100031); PhD/Postdoc grants; iMinds Medical Information Technologies SBO 2014-Belgian Federal Science Policy Office: IUAP P7/19 (DYSCO, Dynamical systems, control and optimization, 2012-2017). Johan Suykens received the funding. ERC (European Research Council): http://erc.europa.eu/. FWO (Fonds Wetenschappelijk Onderzoek): http://www.fwo.be/en/. KU Leuven: http://www.kuleuven.be/English. BELSPO (Belgian Federal Science Policy): https://www.belspo.be/belspo/index_en.stm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate C, 2010, IEEE T PATTERN ANAL, V32, P335, DOI 10.1109/TPAMI.2008.292; [Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; Bache Kevin, 2013, UCI MACHINE LEARNING; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chi Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P153; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greene D, 2010, P INT C ADV SOC NETW; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lamirel JC, 2011, PAKDD WORKSH, P209; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Langone R, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P1, DOI 10.1109/CIDM.2014.7008141; Langone R, 2013, PHYSICA A, V392, P2588, DOI 10.1016/j.physa.2013.01.058; Lin YR, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1514888.1514891; Mall Raghvendra, 2013, 2013 IEEE International Conference on Big Data, P385, DOI 10.1109/BigData.2013.6691599; Mall Raghvendra, 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference, PAKDD 2013. Proceedings, P161, DOI 10.1007/978-3-642-37453-1_14; Mall R, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P9, DOI 10.1109/CIDM.2014.7008142; Mall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099966; Mall R, 2013, ENTROPY-SWITZ, V15, P1567, DOI 10.3390/e15051567; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; MURTAGH F, 1984, DISCRETE APPL MATH, V7, P191, DOI 10.1016/0166-218X(84)90066-0; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pratt PJ, 2005, A GUIDE TO SQL; Robertson S, 2004, J DOC, V60, P503, DOI 10.1108/00220410410560582; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Selcuk A. A., 2008, J NETWORK SECURITY, V6, P227; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Tanahashi Y, 2015, IEEE T VIS COMPUT GR, V21, P730, DOI 10.1109/TVCG.2015.2392771; Tanahashi Y, 2012, IEEE T VIS COMPUT GR, V18, P2679, DOI 10.1109/TVCG.2012.212; Wang Q, 2013, DYNAMICS COMPLEX NET, V2, P159, DOI DOI 10.1007/978-1-4614-6729-8_9; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Xu KS, 2014, DATA MIN KNOWL DISC, V28, P304, DOI 10.1007/s10618-012-0302-x; Yu Clement, 1998, PRINCIPLES DATABASE	40	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137502	10.1371/journal.pone.0137502	http://dx.doi.org/10.1371/journal.pone.0137502			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356538	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800051
J	Moutardier, G; Gereva, S; Mills, SC; Adjeroud, M; Beldade, R; Ham, J; Kaku, R; Dumas, P				Moutardier, Gregoire; Gereva, Sompert; Mills, Suzanne C.; Adjeroud, Mehdi; Beldade, Ricardo; Ham, Jayven; Kaku, Rocky; Dumas, Pascal			Lime Juice and Vinegar Injections as a Cheap and Natural Alternative to Control COTS Outbreaks	PLOS ONE			English	Article							OF-THORNS STARFISH; GREAT-BARRIER-REEF; LYSOSOMAL MEMBRANE DAMAGE; RED RETENTION ASSAY; ACANTHASTER-PLANCI; CORAL-REEFS; SEA STAR; MYTILUS-GALLOPROVINCIALIS; POPULATION OUTBREAKS; EXTRACELLULAR PH	Outbreaks of the corallivorous crown-of-thorns seastar Acanthaster planci (COTS) represent one of the greatest disturbances to coral reef ecosystems in the Indo-Pacific, affecting not only coral reefs but also the coastal communities which rely on their resources. While injection approaches are increasingly used in an attempt to control COTS densities, most of them display severe drawbacks including logistical challenges, high residual environmental impacts or low cost-effectiveness. We tested a new alternative control method based upon acidic injections of cheap, 100% natural products. We investigated the lethal doses, intra- and inter-specific disease transmission and immune responses of COTS when injected with fresh lime juice (extracted from local Citrus arantifolia) and white spirit vinegar. High COTS mortality was achieved with small volumes: 10-20 ml per seastar induced death in 89%/97% of injected specimens after an average 34.3 h/29.8 h for lime juice and vinegar respectively. Highest efficiency was reached for both solutions with double shots of (2 x 10 ml) in two different areas on the body: 100% mortality occurred within 12-24 h, which is similar or faster compared with other current injection methods. Multiple immune measures suggested that death was very likely caused by pH stress from the acidic solutions rather than a bacterial infection. Contagion to either conspecifics or a variety of other reef species was not observed, even at COTS densities 15 times higher than the highest naturally reported. 10 to 20 I lime juice/vinegar could kill up to a thousand COTS at a cost of less than 0.05 USD per specimen; no permits or special handling procedures are required. We conclude that injections of lime juice and vinegar offer great advantages when compared to current best practises and constitute a cheap and natural option for all reefs affected by COTS.	[Moutardier, Gregoire; Dumas, Pascal] IRD, UMR ENTROPIE 9220, Noumea, New Caledonia; [Moutardier, Gregoire; Gereva, Sompert; Ham, Jayven; Kaku, Rocky; Dumas, Pascal] Fisheries Dept Vanuatu, Port Vila, Vanuatu; [Mills, Suzanne C.; Adjeroud, Mehdi; Beldade, Ricardo; Dumas, Pascal] Lab Excellence Corail, F-66860 Perpignan, France; [Mills, Suzanne C.; Beldade, Ricardo] UPVD, CRIOBE, USR 3278, CNRS,EPHE, F-66860 Perpignan, France; [Beldade, Ricardo] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, P-1749016 Lisbon, Portugal; [Adjeroud, Mehdi] Univ Perpignan, IRD, UMR ENTROPIE 9220, F-66860 Perpignan, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia	Dumas, P (corresponding author), IRD, UMR ENTROPIE 9220, BP A5, Noumea, New Caledonia.	pascal-paul.dumas@ird.fr	Beldade, Ricardo/B-3724-2012; Mills, Suzanne/K-5538-2012; Adjeroud, Mehdi/J-6411-2016	Beldade, Ricardo/0000-0003-1911-0122; Mills, Suzanne/0000-0001-8948-3384; Adjeroud, Mehdi/0000-0002-6825-8759; Dumas, Pascal/0000-0001-7369-8989	Fisheries Department of Vanuatu [COT012]; Government of New Caledonia; LabEx Corail; Agence Nationale de la Recherche [ANR-11-JSV7-012-01]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/26901/2006]	Fisheries Department of Vanuatu; Government of New Caledonia; LabEx Corail; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This project was funded by grants from the Fisheries Department of Vanuatu (www.fisheries.gov.vu), grant #COT012. This was the main grant for this work, which covered fieldwork (Vanuatu) and functioning costs (hatchery and aquaculture facilities, technical staff, laboratory materials) of the study. Support was also provided by grants from the Government of New Caledonia (www.gouv.nc/portal/page/portal/gouv/), grant for project MANAO_2015, covered the hosting of Gregoire Moutardier at the Fisheries Department of Vanuatu during his MSc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by grants from the LabEx Corail (www.labex-corail.fr/), grant for project DYNACANTH-2015, covered the field trip of Dr. Suzanne Mills in Vanuatu during the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by grants from the Agence Nationale de la Recherche (ANR-11-JSV7-012-01 "Live and Let Die", Suzanne C. Mills) and the Fundacao para a Ciencia e Tecnologia (SFRH/BPD/26901/2006, Ricardo Beldade) provided additional support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Antonova OA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P605, DOI 10.1134/S0006297909060030; BAINTON DF, 1973, J CELL BIOL, V58, P249, DOI 10.1083/jcb.58.2.249; BARHAM EG, 1973, FISH B-NOAA, V71, P927; Bekri K, 2004, AQUAT TOXICOL, V66, P39, DOI 10.1016/j.aquatox.2003.07.001; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bos AR, 2013, OCEAN COAST MANAGE, V71, P116, DOI 10.1016/j.ocecoaman.2012.09.011; BRANHAM JM, 1971, SCIENCE, V172, P1155, DOI 10.1126/science.172.3988.1155; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CAMERON AM, 1991, MAR ECOL PROG SER, V75, P251, DOI 10.3354/meps075251; Celliers Louis, 2006, Western Indian Ocean Journal of Marine Science, V5, P105; CHENEY D P, 1973, Micronesica, V9, P171; Chesher RH., 1969, ACANTHASTER PLANCI I; Ciacci C, 2009, COMP BIOCHEM PHYS B, V153, P365, DOI 10.1016/j.cbpb.2009.04.007; Coteur G, 2002, FISH SHELLFISH IMMUN, V12, P187, DOI 10.1006/fsim.2001.0366; De Dios Homer Hermes Y., 2015, Galaxea - Tokyo, V17, P23; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dumas P, 2015, SPC FISHERIES NEWSLE, V146, P47; Dumas P, 2014, COMMUNITY BASED MANA; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fraser N, 2000, BEST PRACTICES GUIDE; Friedman KJ, 2008, VANUATU COUNTRY REPO; GLYNN PW, 1984, B MAR SCI, V35, P54; Glynn PW., 1981, INT COR REEF S MAN P; Great Barrier Reef Marine Park Authority, 2004, CROWN OF THORNS STAR; Greenberg SS, 1989, IMMUNITY SURVIVAL; Hauton C, 1998, COMP BIOCHEM PHYS B, V119, P619, DOI 10.1016/S0305-0491(98)00036-4; Hoey J, 2004, STATE GREAT BARRIER; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; JOHNSON DB, 1990, CORAL REEFS, V9, P167, DOI 10.1007/BF00258231; Kanayama RK, 1970, ALOHA AINA DEP LAND, V1, P16; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kayal M, 2011, CORAL REEFS, V30, P827, DOI 10.1007/s00338-011-0763-1; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koonjul MS, 2003, MAUR ANN M AGR SCI, P333; Kuroshio Biological Research Foundation, 2012, CROWN OF THORNS SEAS; Leray M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035456; LOWE DM, 1994, AQUAT TOXICOL, V30, P357, DOI 10.1016/0166-445X(94)00045-X; LOWE DM, 1992, MAR ECOL PROG SER, V91, P135, DOI 10.3354/meps091135; LOWE DM, 1995, AQUAT TOXICOL, V33, P105, DOI 10.1016/0166-445X(95)00015-V; Lowe DM, 1995, MAR ECOL PROG SER, V129, P189, DOI 10.3354/meps129189; MCCALL CE, 1969, J EXP MED, V129, P267, DOI 10.1084/jem.129.2.267; Mendonca VM, 2010, ZOOL STUD, V49, P108; Mills S, 2012, CORAL REEFS, V31, P603, DOI 10.1007/s00338-012-0883-2; Naviti W, 2000, REG S COR REEF PAC S; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Ormond R.F.G., 1974, Proceedings int Coral Reef Symp, V2, P595; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Phillips RM, 2001, ANTICANCER RES, V21, P1795; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 1999, CORAL REEFS, V18, P272, DOI 10.1007/s003380050192; Rivera-Posada JA, 2011, DIS AQUAT ORGAN, V97, P85, DOI 10.3354/dao02401; Rivera-Posada J, 2013, MAR POLLUT BULL, V75, P133, DOI 10.1016/j.marpolbul.2013.07.053; Rivera-Posada J, 2012, J EXP MAR BIOL ECOL, V429, P1, DOI 10.1016/j.jembe.2012.06.008; ROMAN MR, 1993, LIMNOL OCEANOGR, V38, P1603, DOI 10.4319/lo.1993.38.8.1603; Sano M, 2000, MAR ECOL PROG SER, V198, P121, DOI 10.3354/meps198121; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; Song L, 2007, J SHELLFISH RES, V26, P493, DOI 10.2983/0730-8000(2007)26[493:TAONRR]2.0.CO;2; SONG YL, 1994, DEV COMP IMMUNOL, V18, P201, DOI 10.1016/0145-305X(94)90012-4; Wang WN, 2009, COMP BIOCHEM PHYS C, V150, P428, DOI 10.1016/j.cbpc.2009.06.010; Wang WN, 2002, AQUAT TOXICOL, V60, P75, DOI 10.1016/S0166-445X(01)00271-5; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Yamamoto T., 2013, NATURALISTAE, V17, P63; Yanong RP, 2010, USE COPPER MARINE AQ; Zhou J, 2008, AQUACULTURE, V275, P356, DOI 10.1016/j.aquaculture.2007.12.005	67	12	13	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137605	10.1371/journal.pone.0137605	http://dx.doi.org/10.1371/journal.pone.0137605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356840	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800069
J	Farnsworth, ML; Dickson, BG; Zachmann, LJ; Hegeman, EE; Cangelosi, AR; Jackson, TG; Scheib, AF				Farnsworth, Matthew L.; Dickson, Brett G.; Zachmann, Luke J.; Hegeman, Ericka E.; Cangelosi, Amanda R.; Jackson, Thomas G., Jr.; Scheib, Amanda F.			Short-Term Space-Use Patterns of Translocated Mojave Desert Tortoise in Southern California	PLOS ONE			English	Article							GOPHERUS-AGASSIZII; ENERGY DEVELOPMENT; HOME-RANGE; CONSERVATION; POPULATION; WILDLIFE; VARIABILITY; ECOSYSTEM; MOVEMENT; IMPACTS	Increasingly, renewable energy comprises a larger share of global energy production. Across the western United States, public lands are being developed to support renewable energy production. Where there are conflicts with threatened or endangered species, translocation can be used in an attempt to mitigate negative effects. For the threatened Mojave desert tortoise (Gopherus agassizii), we sought to compare habitat-and space-use patterns between short-distance translocated, resident, and control groups. We tested for differences in home range size based on utilization distributions and used linear mixed-effects models to compare space-use intensity, while controlling for demographic and environmental variables. In addition, we examined mean movement distances as well as home range overlap between years and for male and female tortoises in each study group. During the first active season post-translocation, home range size was greater and space-use intensity was lower for translocated tortoises than resident and control groups. These patterns were not present in the second season. In both years, there was no difference in home range size or space-use intensity between control and resident groups. Translocation typically resulted in one active season of questing followed by a second active season characterized by space-use patterns that were indistinguishable from control tortoises. Across both years, the number of times a tortoise was found in a burrow was positively related to greater space-use intensity. Minimizing the time required for translocated tortoises to exhibit patterns similar to non-translocated individuals may have strong implications for conservation by reducing exposure to adverse environmental conditions and predation. With ongoing development, our results can be used to guide future efforts aimed at understanding how translocation strategies influence patterns of animal space use.	[Farnsworth, Matthew L.; Dickson, Brett G.; Zachmann, Luke J.; Hegeman, Ericka E.; Cangelosi, Amanda R.] Conservat Sci Partners, Ft Collins, CO 80524 USA; [Jackson, Thomas G., Jr.] Kaweah Biol Consulting Inc, Three Rivers, CA USA; [Scheib, Amanda F.] Scheib Biol, Las Vegas, NV USA		Farnsworth, ML (corresponding author), Conservat Sci Partners, 5 Old Town Sq,Suite 205, Ft Collins, CO 80524 USA.	matt@csp-inc.org			NRG Energy Services; Google Inc.; BrightSource Energy	NRG Energy Services; Google Inc.(Google Incorporated); BrightSource Energy	Field data collection and analysis was funded by NRG Energy Services (www.nrg.com), Google Inc. (www.google.com), and BrightSource Energy (www.brightsourceenergy.com) through three limited liability companies: Solar Partners I, Solar Partners II, and Solar Partners VIII. The ISEGS is operated by NRG Energy Services. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SA, 2000, APPL ENERG, V65, P121, DOI 10.1016/S0306-2619(99)00077-X; Aiello CM, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12147; Andersen MC, 2000, ECOL APPL, V10, P890, DOI 10.1890/1051-0761(2000)010[0890:RTMODT]2.0.CO;2; Anderson D. R., 2008, MODEL BASED INFERENC; Averill-Murray RC, 2012, BIOSCIENCE, V62, P893, DOI 10.1525/bio.2012.62.10.9; BAILEY SJ, 1995, J HERPETOL, V29, P361, DOI 10.2307/1564985; BERRY KH, 1986, HERPETOLOGICA, V42, P113; Beyer H. L, 2012, GEOSPATIAL MODELLING; Boarman William I., 1998, Herpetological Review, V29, P26; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Duda JJ, 1999, J WILDLIFE MANAGE, V63, P1181, DOI 10.2307/3802836; Esque Todd C., 2010, Endangered Species Research, V12, P167, DOI 10.3354/esr00298; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flather CH, 1998, BIOSCIENCE, V48, P365, DOI 10.2307/1313375; Franks Bryan R., 2011, Endangered Species Research, V13, P191, DOI 10.3354/esr00313; Freilich JE, 2000, CONSERV BIOL, V14, P1479, DOI 10.1046/j.1523-1739.2000.98360.x; Germano JM, 2015, FRONT ECOL ENVIRON, V13, P100, DOI 10.1890/140137; Grandmaison DD, 2010, J HERPETOL, V44, P581, DOI 10.1670/08-291.1; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Harless ML, 2009, COPEIA, P378, DOI 10.1643/CE-07-226; Hereford R, 2006, J ARID ENVIRON, V67, P13, DOI 10.1016/j.jaridenv.2006.09.019; Hinderle D, 2015, J WILDLIFE MANAGE, V79, P137, DOI 10.1002/jwmg.823; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Miller KA, 2014, CONSERV BIOL, V28, P1045, DOI 10.1111/cobi.12254; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Nussear KE, 2012, J WILDLIFE MANAGE, V76, P1341, DOI 10.1002/jwmg.390; O'Connor Michael P., 1994, Herpetological Monographs, V8, P60, DOI 10.2307/1467070; PETERSON CC, 1994, BIOL CONSERV, V70, P101, DOI 10.1016/0006-3207(94)90277-1; Pinhiero J, 2014, LINEAR NONLINEAR MIX; REN21, 2013, REN GLOB FUT REP; REN21, 2014, REN 2014 GLOB STAT R; Riedle JD, 2008, COPEIA, P414, DOI 10.1643/CH-06-010; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zimmerman Linda C., 1994, Herpetological Monographs, V0, P45, DOI 10.2307/1467069	49	15	15	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0134250	10.1371/journal.pone.0134250	http://dx.doi.org/10.1371/journal.pone.0134250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352691	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800004
J	Maranhao, B; Biswas, P; Gottsch, ADH; Navani, M; Naeem, MA; Suk, J; Chu, J; Khan, SN; Poleman, R; Akram, J; Riazuddin, S; Lee, P; Riazuddin, SA; Hejtmancik, JF; Ayyagari, R				Maranhao, Bruno; Biswas, Pooja; Gottsch, Alexander D. H.; Navani, Mili; Naeem, Muhammad Asif; Suk, John; Chu, Justin; Khan, Sheen N.; Poleman, Rachel; Akram, Javed; Riazuddin, Sheikh; Lee, Pauline; Riazuddin, S. Amer; Hejtmancik, J. Fielding; Ayyagari, Radha			Investigating the Molecular Basis of Retinal Degeneration in a Familial Cohort of Pakistani Decent by Exome Sequencing	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; RETINITIS-PIGMENTOSA; CONGENITAL AMAUROSIS; MUTATIONS; DYSTROPHY; GENE; IDENTIFICATION; REVEALS; ALMS1	Purpose To define the molecular basis of retinal degeneration in consanguineous Pakistani pedigrees with early onset retinal degeneration. Methods A cohort of 277 individuals representing 26 pedigrees from the Punjab province of Pakistan was analyzed. Exomes were captured with commercial kits and sequenced on an Illumina HiSeq 2500. Candidate variants were identified using standard tools and analyzed using exomeSuite to detect all potentially pathogenic changes in genes implicated in retinal degeneration. Segregation analysis was performed by dideoxy sequencing and novel variants were additionally investigated for their presence in ethnicity-matched controls. Results We identified a total of nine causal mutations, including six novel variants in RPE65, LCA5, USH2A, CNGB1, FAM161A, CERKL and GUCY2D as the underlying cause of inherited retinal degenerations in 13 of 26 pedigrees. In addition to the causal variants, a total of 200 variants each observed in five or more unrelated pedigrees investigated in this study that were absent from the dbSNP, HapMap, 1000 Genomes, NHLBI ESP6500, and ExAC databases were identified, suggesting that they are common in, and unique to the Pakistani population. Conclusions We identified causal mutations associated with retinal degeneration in nearly half of the pedigrees investigated in this study through next generation whole exome sequencing. All novel variants detected in this study through exome sequencing have been cataloged providing a reference database of variants common in, and unique to the Pakistani population.	[Maranhao, Bruno; Biswas, Pooja; Navani, Mili; Suk, John; Chu, Justin; Poleman, Rachel; Lee, Pauline; Ayyagari, Radha] Univ Calif La Jolla, Dept Ophthalmol, La Jolla, CA USA; [Gottsch, Alexander D. H.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Naeem, Muhammad Asif; Khan, Sheen N.; Riazuddin, Sheikh; Riazuddin, S. Amer] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan; [Hejtmancik, J. Fielding] NEI, OGVF Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University of Health Science - Pakistan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hejtmancik, JF (corresponding author), NEI, OGVF Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov; rayyagari@ucsd.edu		Maranhao, Bruno/0000-0002-0224-5488; Naeem, Muhammad Asif/0000-0001-8547-6419	Foundation Fighting Blindness, Research to Prevent Blindness [NIH-EY21237, P30-EY22589]; NATIONAL EYE INSTITUTE [P30EY022589, R01EY021237, ZIAEY000272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Foundation Fighting Blindness, Research to Prevent Blindness (to Department of Ophthalmology at UCSD, La Jolla, and Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD), NIH-EY21237, P30-EY22589.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali S, 2015, OPHTHALMOLOGY, V122, P429, DOI 10.1016/j.ophtha.2014.07.057; Ali S, 2011, MOL VIS, V17, P1373; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, EX; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; Chassine T, 2015, BRIT J OPHTHALMOL, V99, P1360, DOI 10.1136/bjophthalmol-2014-306224; Chen YB, 2013, INVEST OPHTH VIS SCI, V54, P4351, DOI 10.1167/iovs.13-11606; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Duncan JL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1301, DOI 10.1001/archophthalmol.2012.1906; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Iqbal M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1351, DOI 10.1001/archophthalmol.2011.267; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan MI, 2014, GENES-BASEL, V5, P176, DOI 10.3390/genes5010176; Khan Sadia Javed, 2007, J Pak Med Assoc, V57, P334; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Li D, 2014, MOL VIS, V20, P1; Li L, 2010, AM J HUM GENET, V87, P400, DOI 10.1016/j.ajhg.2010.08.003; Maranhao B, 2014, GENOMICS, V103, P169, DOI 10.1016/j.ygeno.2014.02.006; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033	42	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136561	10.1371/journal.pone.0136561	http://dx.doi.org/10.1371/journal.pone.0136561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352687	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800040
J	Adhikari, RP; Kort, T; Shulenin, S; Kanipakala, T; Ganjbaksh, N; Roghmann, MC; Holtsberg, FW; Aman, MJ				Adhikari, Rajan P.; Kort, Thomas; Shulenin, Sergey; Kanipakala, Tulasikumari; Ganjbaksh, Nader; Roghmann, Mary-Claire; Holtsberg, Frederick W.; Aman, M. Javad			Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT STAPHYLOCOCCUS-AUREUS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; GAMMA-HEMOLYSIN; VIRULENCE DETERMINANTS; COMMUNITY; TOXINS; PORE; INFECTIONS; LEUCOCIDIN	S. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organism should target extracellular toxins which are responsible for host tissue destruction and immunosuppression. Major staphylococcal toxins are alpha toxin (a single subunit hemolysin) along with a group of bicomponent pore-forming toxins (BCPFT), namely Panton-Valentine leukocidin (PVL), gamma hemolysins (HlgCB and AB), LukAB and LukED. In our previous report, an attenuated mutant of LukS-PV (PVL-S subunit) named as "LukS-mut9" elicited high immunogenic response as well as provided a significant protection in a mouse sepsis model. Recent discovery of PVL receptors shows that mice lack receptors for this toxin, thus the reported protection of mice with the PVL vaccine may relate to cross protective responses against other homologous toxins. This manuscript addresses this issue by demonstrating that polyclonal antibody generated by LukS-mut9 can neutralize other canonical and non-canonical leukotoxin pairs. In this report, we also demonstrated that several potent toxins can be created by non-canonical pairing of subunits. Out of 5 pairs of canonical and 8 pairs of non-canonical toxins tested, anti-LukS-mut9 polyclonal antibodies neutralized all except for LukAB. We also studied the potential hemolytic activities of canonical and noncanonical pairs among biocomponent toxins and discovered that a novel non-canonical pair consisting of HlgA and LukD is a highly toxic combination. This pair can lyse RBC from different species including human blood far better than alpha hemolysin. Moreover, to follow-up our last report, we explored the correlation between the levels of pre-existing antibodies to new sets of leukotoxins subunits and clinical outcomes in adult patients with S. aureus bacteremia. We found that there is an inversed correlation between the antibody titer to sepsis for leukotoxins LukS-mut9, LukF-PV, HlgC, LukE and LukAB, suggesting the risk of sepsis was significantly lower in the patients with higher antibody titer against those toxins.	[Adhikari, Rajan P.; Kort, Thomas; Shulenin, Sergey; Kanipakala, Tulasikumari; Ganjbaksh, Nader; Holtsberg, Frederick W.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA; [Roghmann, Mary-Claire] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Roghmann, Mary-Claire] VA Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Adhikari, RP (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA.	rajan@integratedbiotherapeutics.com	Adhikari, Rajan/J-7396-2019		National Institute of Allergy and Infectious Diseases (NIAID) [AI106162, AI098232]; Integrated BioTherapeutics, Inc. (IBT) internal RD research fund; Integrated BioTherapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106162, R56AI111205, R43AI098232, R01AI111205] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrated BioTherapeutics, Inc. (IBT) internal RD research fund; Integrated BioTherapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by grants (AI106162 to R.P.A. and AI098232 to M.J.A.) from the National Institute of Allergy and Infectious Diseases (NIAID) and partially from Integrated BioTherapeutics, Inc. (IBT) internal R&D research fund. Integrated BioTherapeutics, Inc. provided support in the form of salaries for authors RPA, TK, SS, FWH and MJA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adhikari RP, 2012, J INFECT DIS, V206, P915, DOI 10.1093/infdis/jis462; Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Aman MJ, 2014, TOXINS, V6, P950, DOI 10.3390/toxins6030950; Arciola CR, 2007, INT J ARTIF ORGANS, V30, P792, DOI 10.1177/039139880703000908; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Karauzum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065384; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lattar SM, 2014, INFECT IMMUN, V82, P83, DOI 10.1128/IAI.01050-13; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Malachowa N, 2012, J INFECT DIS, V206, P1185, DOI 10.1093/infdis/jis495; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Merck, 2012, EFF IMM SAF SINGL DO; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; OZAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1181, DOI 10.1271/bbb.59.1181; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Salgado-Pabon W, 2014, NAT REV MICROBIOL, V12, P585, DOI 10.1038/nrmicro3308; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Skurnik D, 2012, CLIN INFECT DIS, V55, P1188, DOI 10.1093/cid/cis624; Spaan AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6438; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Sugawara N, 1999, BIOSCI BIOTECH BIOCH, V63, P884, DOI 10.1271/bbb.63.884; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Varshney AK, 2010, J INFECT DIS, V201, P92, DOI 10.1086/648613; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286, DOI 10.1128/JCM.27.6.1286-1291.1989	50	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137874	10.1371/journal.pone.0137874	http://dx.doi.org/10.1371/journal.pone.0137874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367030	Green Published, gold			2022-12-27	WOS:000361601100163
J	Branecky, KL; Niswender, KD; Pendergast, JS				Branecky, Katrina L.; Niswender, Kevin D.; Pendergast, Julie S.			Disruption of Daily Rhythms by High-Fat Diet Is Reversible	PLOS ONE			English	Article							INDUCED OBESITY; LEPTIN RESISTANCE; CIRCADIAN CLOCK; MICE; METABOLISM; WORK	In mammals a network of circadian clocks coordinates behavior and physiology with 24-h environmental cycles. Consumption of high-fat diet disrupts this temporal coordination by advancing the phase of the liver molecular clock and altering daily rhythms of eating behavior and locomotor activity. In this study we sought to determine whether these effects of high-fat diet on circadian rhythms were reversible. We chronically fed mice high-fat diet and then returned them to low-fat chow diet. We found that the phase of the liver PERIOD2:: LUCIFERASE rhythm was advanced (by 4h) and the daily rhythms of eating behavior and locomotor activity were altered for the duration of chronic high-fat diet feeding. Upon diet reversal, the eating behavior rhythm was rapidly reversed (within 2 days) and the phase of the liver clock was restored by 7 days of diet reversal. In contrast, the daily pattern of locomotor activity was not restored even after 2 weeks of diet reversal. Thus, while the circadian system is sensitive to changes in the macronutrient composition of food, the eating behavior rhythm and liver circadian clock are specifically tuned to respond to changes in diet.	[Branecky, Katrina L.; Niswender, Kevin D.; Pendergast, Julie S.] Vanderbilt Univ, Sch Med, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Niswender, Kevin D.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Pendergast, JS (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	julie.pendergast@uky.edu			National Institutes of Health [DK098321, DK058404, DK085712, DK064857]; Vanderbilt University Digestive Disease Research Center (National Institutes of Health) [P30 DK058404]; resources of the VA Tennessee Valley Healthcare System; Diabetes Research and Training Center [DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, K08DK064857, R01DK085712, P60DK020593, K01DK098321, P30DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center (National Institutes of Health); resources of the VA Tennessee Valley Healthcare System; Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (www.nih.gov) grants DK098321 (to J.S.P.) and DK058404 (Pilot Award to J.S.P.). J.S.P. was supported by a Young Investigator Award from the Vanderbilt University Digestive Disease Research Center (National Institutes of Health grant P30 DK058404). K.D.N. was supported by resources of the VA Tennessee Valley Healthcare System and National Institutes of Health grants (DK085712 and DK064857) and the Diabetes Research and Training Center (DK20593). The authors declare no competing financial or non-financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Eberly R., 2010, IJAHSP, V8, P1; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Suwazono Y, 2009, CHRONOBIOL INT, V26, P926, DOI 10.1080/07420520903044422; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	48	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137970	10.1371/journal.pone.0137970	http://dx.doi.org/10.1371/journal.pone.0137970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366733	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100189
J	Lin, LZ; Chen, HB; Zhang, YX; Lin, W; Liu, Y; Li, T; Zeng, YP; Chen, JH; Du, HW; Chen, RH; Tan, Y; Liu, N				Lin, Longzai; Chen, Hongbin; Zhang, Yixian; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Tan, Yi; Liu, Nan			IL-10 Protects Neurites in Oxygen-Glucose-Deprived Cortical Neurons through the PI3K/Akt Pathway	PLOS ONE			English	Article							NF-KAPPA-B; GAP-43 NEUROMODULIN; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; PYRAMIDAL NEURONS; BRAIN-INJURY; RAT-BRAIN; IN-VITRO; CELLS; EXPRESSION	IL-10, as a cytokine, has an anti-inflammatory cascade following various injuries, but it remains blurred whether IL-10 protects neurites of cortical neurons after oxygen-glucose deprivation injury. Here, we reported that IL-10, in a concentration-dependent manner, reduced neuronal apoptosis and increased neuronal survival in oxygen-glucose-deprived primary cortical neurons, producing an optimal protective effect at 20ng/ml. After staining NF-H and GAP-43, we found that IL-10 significantly protected neurites in terms of axon length and dendrite number by confocal microscopy. Furthermore, it induced the phosphorylation of AKT, suppressed the activation of caspase-3, and up-regulated the protein expression of GAP-43. In contrast, LY294002, a specific inhibitor of PI3K/AKT, reduced the level of AKT phosphorylation and GAP-43 expression, increased active caspase-3 expression and thus significantly weakened IL-10-mediated protective effect in the OGD-induced injury model. IL-10NA, the IL-10 neutralizing antibody, reduced the level of p-PI3K phosphorylation and increased the expression of active caspase-3. These findings suggest that IL-10 provides neuroprotective effects by protecting neurites through PI3K/AKT signaling pathway in oxygen-glucose-deprived primary cortical neurons.	[Lin, Longzai; Chen, Hongbin; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Liu, Nan] Fujian Med Univ, Affiliated Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Lin, Longzai; Chen, Hongbin; Zhang, Yixian; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Tan, Yi; Liu, Nan] Inst Cerebral Vasc Dis Fujian Prov, Fuzhou, Fujian, Peoples R China; [Zhang, Yixian; Liu, Nan] Fujian Med Univ, Affiliated Union Hosp, Dept Rehabil, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Liu, N (corresponding author), Fujian Med Univ, Affiliated Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China.	xieheliunan1984@sina.com			National Natural Science Foundation of China [81171867, 81472161]; Fujian Provincial Department of Science and Technology [2011Y0027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science and Technology	This research was supported by National Natural Science Foundation of China (No. 81171867 and No. 81472161) and Fujian Provincial Department of Science and Technology (No. 2011Y0027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Albrecht J, 2005, EUR J NEUROSCI, V22, P2295, DOI 10.1111/j.1460-9568.2005.04398.x; Avwenagha O, 2003, J NEUROCYTOL, V32, P1077, DOI 10.1023/B:NEUR.0000021903.24849.6c; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chakravarthy B, 2008, BIOCHEM BIOPH RES CO, V371, P679, DOI 10.1016/j.bbrc.2008.04.119; Cianciulli A, 2015, INT IMMUNOPHARMACOL, V24, P369, DOI 10.1016/j.intimp.2014.12.035; Dent EW, 1998, J NEUROBIOL, V35, P287, DOI 10.1002/(SICI)1097-4695(19980605)35:3<287::AID-NEU6>3.0.CO;2-V; Forgie ML, 2003, BEHAV NEUROSCI, V117, P257, DOI 10.1037/0735-7044.117.2.257; Furutani R, 2012, J NEUROTRAUM, V29, P1266, DOI 10.1089/neu.2010.1630; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Hendrickson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046918; Hong-Qi Y, 2012, TRANSL NEURODEGENER, V1, DOI [10.1186/2047-9158-1-7, 10.1186/2047-9158-1-21]; Ikeda-Matsuo Y, 2011, J NEUROIMMUNOL, V238, P34, DOI 10.1016/j.jneuroim.2011.06.014; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1186/2045-9912-3-3, 10.1063/2.1306201]; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Liu Z, 2012, CELL MOL NEUROBIOL, V32, P191, DOI 10.1007/s10571-011-9746-6; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Song JQ, 2009, APOPTOSIS, V14, P1061, DOI 10.1007/s10495-009-0382-2; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; Wang XH, 2005, NEUROSCI RES, V51, P129, DOI 10.1016/j.neures.2004.10.001; Wu XM, 2012, NEUROSCI BULL, V28, P509, DOI 10.1007/s12264-012-1273-z; Xiang J, 2010, CAN J PHYSIOL PHARM, V88, P907, DOI [10.1139/Y10-069, 10.1139/y10-069]; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023	40	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136959	10.1371/journal.pone.0136959	http://dx.doi.org/10.1371/journal.pone.0136959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366999	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100037
J	Sun, YL; Vedsted, P; Fenger-Gron, M; Sen Wu, C; Bech, BH; Olsen, J; Benros, ME; Vestergaard, M				Sun, Yuelian; Vedsted, Peter; Fenger-Gron, Morten; Sen Wu, Chun; Bech, Bodil Hammer; Olsen, Jorn; Benros, Michael Eriksen; Vestergaard, Mogens			Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: A Population Based Cohort Study	PLOS ONE			English	Article							BREAST-CANCER; COLLABORATIVE CARE; SOCIAL-INEQUALITY; DEPRESSION; SURVIVAL; STRESS; CARCINOMA; DENMARK; ANXIETY; HISTORY	Background Depression is common after a cancer diagnosis and is associated with an increased mortality, but it is unclear whether depression occurring before the cancer diagnosis affects cancer mortality. We aimed to study cancer mortality of people treated with antidepressants before cancer diagnosis. Methods and Findings We conducted a population based cohort study of all adults diagnosed with cancer between January 2003 and December 2010 in Denmark (N = 201,662). We obtained information on cancer from the Danish Cancer Registry, on the day of death fromthe Danish Civil Registry, and on redeemed antidepressants from the Danish National Prescription Registry. Current users of antidepressants were defined as those who redeemed the latest prescription of antidepressant 0-4 months before cancer diagnosis (irrespective of earlier prescriptions), and former users as those who redeemed the latest prescription five or more months before cancer diagnosis. We estimated an all-cause one-year mortality rate ratio (MRR) and a conditional five-year MRR for patients who survived the first year after cancer diagnosis and confidence interval (CI) using a Cox proportional hazards regressionmodel. Overall, 33,111 (16.4%) patients redeemed at least one antidepressant prescription in the three years before cancer diagnosis of whom 21,851 (10.8%) were current users at the time of cancer diagnosis. Current antidepressant users had a 32% higher one-year mortality (MRR = 1.32, 95% CI: 1.29-1.35) and a 22% higher conditional five-year mortality (MRR = 1.22, 95% CI: 1.17-1.26) if patients survived the first year after the cancer diagnosis than patients not redeeming antidepressants. The one-year mortality was particularly high for patients who initiated antidepressant treatment within fourmonths before cancer diagnosis (MRR = 1.54, 95% CI: 1.47-1.61). Former users had no increased cancermortality. Conclusions Initiation of antidepressive treatment prior to cancer diagnosis is common and is associated with an increased mortality.	[Sun, Yuelian; Vedsted, Peter; Fenger-Gron, Morten; Bech, Bodil Hammer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Sun, Yuelian; Sen Wu, Chun; Bech, Bodil Hammer; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Benros, Michael Eriksen] Copenhagen Univ Hosp, Psychiat Res Unit, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Sun, YL (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	ys@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Vedsted, Peter/C-2583-2008; Vestergaard, Mogens/M-9333-2014; Sun, Yuelian/AFF-2622-2022; Benros, Michael Eriksen/N-5868-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Vedsted, Peter/0000-0003-2113-5599; Vestergaard, Mogens/0000-0001-8830-2174; Sun, Yuelian/0000-0002-6905-0503; Benros, Michael Eriksen/0000-0003-4939-9465; Fenger-Gron, Morten/0000-0002-6354-5871	Lundbeck Foundation; Novo Nordisk Foundation; Danish Cancer Society [R20-A1028-10-52]; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish; The Danish Cancer Society [R142-A9081] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); The Danish Cancer Society(Danish Cancer Society)	This study was supported by an unrestricted grant from the Lundbeck Foundation (http://www.lundbeckfoundation.com/) (MV), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en) (PV), and the Danish Cancer Society (http://www.cancer.dk/) (JO PV) (for project R20-A1028-10-52 and project on 'From symptom to treatment-Research Centre for Cancer Diagnosis in Primary Care'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall-Barbry G, 2012, PSYCHOSOMATICS, V53, P356, DOI 10.1016/j.psym.2012.01.001; Ancoli-Israel S, 2014, SUPPORT CARE CANCER, V22, P2535, DOI 10.1007/s00520-014-2204-5; Andersen TF, 1999, DAN MED BULL, V46, P263; Batty GD, 2012, BRIT J CANCER, V106, P1842, DOI 10.1038/bjc.2012.150; Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Boyd CA, 2012, SURGERY, V152, P403, DOI 10.1016/j.surg.2012.06.010; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen S, 1998, J NATL CANCER I, V90, P3, DOI 10.1093/jnci/90.1.3; Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018; Dalton SO, 2008, EUR J CANCER, V44, P1938, DOI [10.1016/j.ejca.2008.06.010, 10.1016/j.ejca.2008.06.034]; Deleuran Thomas, 2012, Clin Epidemiol, V4 Suppl 2, P39, DOI 10.2147/CLEP.S33315; Forbes LJL, 2014, BRIT J CANCER, V111, P581, DOI 10.1038/bjc.2014.304; FRAS I, 1967, AM J PSYCHIAT, V123, P1553, DOI 10.1176/ajp.123.12.1553; Froslev Trine, 2012, Clin Epidemiol, V4 Suppl 2, P5, DOI 10.2147/CLEP.S32064; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; Graber MA, 2000, J GEN INTERN MED, V15, P204, DOI 10.1046/j.1525-1497.2000.04399.x; Hinz A, 2010, EUR J CANCER CARE, V19, P522, DOI 10.1111/j.1365-2354.2009.01088.x; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Holland-Bill Louise, 2012, Clin Epidemiol, V4 Suppl 2, P25, DOI 10.2147/CLEP.S31542; Howard LM, 2010, LANCET ONCOL, V11, P797, DOI 10.1016/S1470-2045(10)70085-1; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; JOFFE RT, 1986, GEN HOSP PSYCHIAT, V8, P241, DOI 10.1016/0163-8343(86)90004-6; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278; Kotwal AA, 2012, MED CARE, V50, P1037, DOI 10.1097/MLR.0b013e318269e096; Ludman EJ, 2010, AM J PREV MED, V38, P303, DOI 10.1016/j.amepre.2009.10.039; Moreno-Smith M, 2010, FUTURE ONCOL, V6, P1863, DOI [10.2217/fon.10.142, 10.2217/FON.10.142]; Nguyen-Nielsen Mary, 2012, Clin Epidemiol, V4 Suppl 2, P17, DOI 10.2147/CLEP.S32004; Ording Anne Gulbech, 2012, Clin Epidemiol, V4 Suppl 2, P11, DOI 10.2147/CLEP.S31574; Ostenfeld Eva Bjerre, 2012, Clin Epidemiol, V4 Suppl 2, P33; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Prasad SM, 2014, J CLIN ONCOL, V32, P2471, DOI 10.1200/JCO.2013.51.1048; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Sogaard Mette, 2012, Clin Epidemiol, V4 Suppl 2, P1; Storm HH, 1997, DAN MED BULL, V44, P535; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2	40	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138134	10.1371/journal.pone.0138134	http://dx.doi.org/10.1371/journal.pone.0138134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367120	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100234
J	Jiang, N; Zhao, GQ; Lin, J; Hu, LT; Che, CY; Li, C; Wang, Q; Xu, Q; Peng, XD				Jiang, Nan; Zhao, Guiqiu; Lin, Jing; Hu, Liting; Che, Chengye; Li, Cui; Wang, Qian; Xu, Qiang; Peng, Xudong			Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections	PLOS ONE			English	Article							TRYPTOPHAN CATABOLISM; IMMUNE RECOGNITION; RECEPTOR DECTIN-1; FUNGAL KERATITIS; DENDRITIC CELLS; INNATE; TOLERANCE; EXPRESSION; MACROPHAGES; INDUCTION	Indoleamine 2,3-dioxygenase (IDO), which is mainly expressed in activated dendritic cells, is known as a regulator of immune responses. However, the role of IDO in immune responses against fungal corneal infection has not been investigated. To evaluate the regulatory mechanisms of IDO in fungal inflammation, we resorted to human corneal epithelial cells (HCECs), known as the first barrier of cornea against pathogenic microorganisms. We found that IDO was significantly up-regulated in corneal epithelium infected with Aspergillus fumigatus (A. fumigatus) and HCECs incubated with spores of A. fumigatus. Furthermore, IDO inhibitor (1-methyltryptophan, 1-MT) enhanced inflammatory cytokines IL-1 beta and IL-6 expression which were up-regulated by A. fumigatus spores infection. Dectin-1, as one of the important C-type lectin receptors, can identify beta-glucan, and mediate fungal innate immune responses. In the present study, pre-treatment with curdlan, a Dectin-1 agonist, further enhanced IDO expression compared with A. fumigatus stimulation. While laminarin, the Dectin-1 specific inhibitor, partially inhibited IDO expression stimulated by A. fumigatus. Further studies demonstrated inhibition of IDO activity amplified the expressions of inflammatory cytokines IL-1 beta and IL-6 induced by activation of Dectin-1. These results suggested that IDO was involved in the immune responses of fungal keratitis. The activation of Dectin-1 may contribute to A. fumigatus spores-induced up-regulation of IDO.	[Jiang, Nan; Zhao, Guiqiu; Lin, Jing; Hu, Liting; Che, Chengye; Li, Cui; Wang, Qian; Xu, Qiang; Peng, Xudong] Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266003, Shandong, Peoples R China	Qingdao University	Zhao, GQ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266003, Shandong, Peoples R China.	zhaoguiqiu_good@126.com			National Natural Science Foundation of China [81170825, 81470609]; Specialized Research Fund for the Doctoral Program of Higher Education [20123706110003]; Youth Natural Science Foundation of Shandong Province [ZR2013HQ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Youth Natural Science Foundation of Shandong Province	This work was supported by grants from National Natural Science Foundation of China (81170825, 81470609), Specialized Research Fund for the Doctoral Program of Higher Education (20123706110003) and grant from the Youth Natural Science Foundation of Shandong Province (ZR2013HQ007).	Agrawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013418; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bozza S, 2005, J IMMUNOL, V174, P2910, DOI 10.4049/jimmunol.174.5.2910; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carvalho A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00156; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; de Luca A, 2010, CELL MOL IMMUNOL, V7, P459, DOI 10.1038/cmi.2010.43; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fujikawa T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002882; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Guo H, 2009, FEMS IMMUNOL MED MIC, V56, P88, DOI 10.1111/j.1574-695X.2009.00551.x; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jain S, 2014, J CLIN DIAGN RES, V8, pDD01; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Karumuthil-Melethil S, 2014, J IMMUNOL, V193, P3308, DOI 10.4049/jimmunol.1400186; Kredics L, 2015, MYCOSES, V58, P243, DOI 10.1111/myc.12306; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Min L, 2012, J IMMUNOL, V188, P1789, DOI 10.4049/jimmunol.1101755; Montagnoli Claudia, 2006, Novartis Found Symp, V279, P66; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Ryu YH, 2007, INVEST OPHTH VIS SCI, V48, P4148, DOI 10.1167/iovs.05-1336; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sukhithasri V, 2013, MICROBIOL RES, V168, P396, DOI 10.1016/j.micres.2013.02.005; Sun XG, 2007, AM J OPHTHALMOL, V143, P131, DOI 10.1016/j.ajo.2006.09.042; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Tarabishy AB, 2008, J IMMUNOL, V181, P593, DOI 10.4049/jimmunol.181.1.593; Taylor PR, 2014, J IMMUNOL, V192, P3319, DOI 10.4049/jimmunol.1302235; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; Wang LY, 2009, CLIN EXP OPHTHALMOL, V37, P763, DOI 10.1111/j.1442-9071.2009.02155.x; Weindl G, 2010, J DENT RES, V89, P666, DOI 10.1177/0022034510368784; Wu TG, 2003, INVEST OPHTH VIS SCI, V44, P210, DOI 10.1167/iovs.02-0446; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; Yeung AWS, 2012, J LEUKOCYTE BIOL, V91, P657, DOI 10.1189/jlb.1011532; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zelante T, 2009, EUR J IMMUNOL, V39, P645, DOI 10.1002/eji.200839102; Zhong WX, 2009, MOL VIS, V15, P1303	48	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137423	10.1371/journal.pone.0137423	http://dx.doi.org/10.1371/journal.pone.0137423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361229	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100036
J	Krumhuber, EG; Swiderska, A; Tsankova, E; Kamble, SV; Kappas, A				Krumhuber, Eva G.; Swiderska, Aleksandra; Tsankova, Elena; Kamble, Shanmukh V.; Kappas, Arvid			Real or Artificial? Intergroup Biases in Mind Perception in a Cross-Cultural Perspective	PLOS ONE			English	Article							SOCIAL CATEGORIZATION; INGROUP; EMPATHY; INFRAHUMANIZATION; DEHUMANIZATION; NEUROSCIENCE; ATTRIBUTION; PREJUDICE; RESPONSES; EMOTIONS	Recent research suggests that attributions of aliveness and mental capacities to faces are influenced by social group membership. In this article, we investigated group related biases in mind perception in participants from a Western and Eastern culture, employing faces of varying ethnic groups. In Experiment 1, Caucasian faces that ranged on a continuum from real to artificial were evaluated by participants in the UK (in-group) and in India (out-group) on animacy, abilities to plan and to feel pain, and having a mind. Human features were found to be assigned to a greater extent to faces when these belonged to in-group members, whereas out-group faces had to appear more realistic in order to be perceived as human. When participants in India evaluated South Asian (in-group) and Caucasian (out-group) faces in Experiment 2, the results closely mirrored those of the first experiment. For both studies, ratings of out-group faces were significantly predicted by participants' levels of ethnocultural empathy. The findings highlight the role of intergroup processes (i.e., in-group favoritism, out-group dehumanization) in the perception of human and mental qualities and point to ethnocultural empathy as an important factor in responses to out-groups.	[Krumhuber, Eva G.] UCL, Dept Expt Psychol, London, England; [Swiderska, Aleksandra; Tsankova, Elena; Kappas, Arvid] Jacobs Univ Bremen, Dept Psychol & Methods, D-28759 Bremen, Germany; [Kamble, Shanmukh V.] Karnatak Univ, Dept Psychol, Dharwad, Karnataka, India	University of London; University College London; Jacobs University; Karnatak University	Krumhuber, EG (corresponding author), UCL, Dept Expt Psychol, London, England.	e.krumhuber@ucl.ac.uk	Kappas, Arvid/F-8224-2013; Kamble, Shanmukh Vasant/ABE-6993-2021; Świderska, Aleksandra/AAP-2333-2020; Tsankova, Elena/AAE-7687-2022	Kappas, Arvid/0000-0002-7715-8709; Tsankova, Elena/0000-0002-5008-8894; Krumhuber, Eva/0000-0003-1894-2517; Swiderska, Aleksandra/0000-0001-7252-4581; kamble, shanmukh/0000-0002-2185-8052	EU FP7 project eCUTE [ICT-5-4.2 257666]	EU FP7 project eCUTE	This research was supported by a grant from the EU FP7 project eCUTE (ICT-5-4.2 257666) to Arvid Kappas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander O, 2010, IEEE COMPUT GRAPH, V30, P20, DOI 10.1109/MCG.2010.65; [Anonymous], 1998, HDB SOCIAL PSYCHOL, DOI DOI 10.1037/0021-9010.92.5.1414; Appel J, 2012, ADV HUM-COMPUT INTER, V2012, DOI 10.1155/2012/324694; Bain P, 2009, GROUP PROCESS INTERG, V12, P789, DOI 10.1177/1368430209340415; Bastian B, 2011, BASIC APPL SOC PSYCH, V33, P295, DOI 10.1080/01973533.2011.614132; Batson CD, 2009, SOC ISS POLICY REV, V3, P141, DOI 10.1111/j.1751-2409.2009.01013.x; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Boccato G, 2007, EUR J SOC PSYCHOL, V37, P987, DOI 10.1002/ejsp.412; Capozza D, 2009, GROUP PROCESS INTERG, V12, P777, DOI 10.1177/1368430209344868; Cheetham M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00126; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Cortes BP, 2005, PERS SOC PSYCHOL B, V31, P243, DOI 10.1177/0146167204271421; Demoulin S, 2004, COGNITION EMOTION, V18, P71, DOI 10.1080/02699930244000444; Dovidio JF, 2004, PERS SOC PSYCHOL B, V30, P1537, DOI 10.1177/0146167204271177; Epley N., 2010, HDB SOCIAL PSYCHOL, P498, DOI [10.1002/9780470561119.socpsy001014, DOI 10.1002/9780470561119.SOCPSY001014]; Farid H, 2012, DIGIT INVEST, V8, P226, DOI 10.1016/j.diin.2011.06.003; Freeman JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025107; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gong L, 2008, COMPUT HUM BEHAV, V24, P1494, DOI 10.1016/j.chb.2007.05.007; Gray K, 2012, COGNITION, V125, P125, DOI 10.1016/j.cognition.2012.06.007; Hackel LM, 2014, J EXP SOC PSYCHOL, V52, P15, DOI 10.1016/j.jesp.2013.12.001; Harris LT, 2009, EUR REV SOC PSYCHOL, V20, P192, DOI 10.1080/10463280902954988; Haslam N, 2005, J PERS SOC PSYCHOL, V89, P937, DOI 10.1037/0022-3514.89.6.937; Haslam N, 2007, PERS SOC PSYCHOL B, V33, P57, DOI 10.1177/0146167206293191; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Ishiguro H, 2007, J ARTIF ORGANS, V10, P133, DOI 10.1007/s10047-007-0381-4; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kubota JT, 2012, NAT NEUROSCI, V15, P940, DOI 10.1038/nn.3136; LEYENS JP, 1992, EUR J SOC PSYCHOL, V22, P549, DOI 10.1002/ejsp.2420220604; Looser CE, 2012, SCAN, V2012, P1; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Maister L, 2013, COGNITION, V128, P170, DOI 10.1016/j.cognition.2013.04.002; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Moser E, 2007, J NEUROSCI METH, V161, P126, DOI 10.1016/j.jneumeth.2006.10.016; OPOTOW S, 1990, J SOC ISSUES, V46, P1, DOI 10.1111/j.1540-4560.1990.tb00268.x; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Pizarro DA, 2006, CREATIVITY AND REASON IN COGNITIVE DEVELOPMENT, P81, DOI 10.1017/CBO9780511606915.006; Powers A., 2006, P 1 ACM SIGCHI SIGAR, DOI [10.1145/1121241.1121280, DOI 10.1145/1121241.1121280]; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rakison DH, 2001, PSYCHOL BULL, V127, P209, DOI 10.1037//0033-2909.127.2.209; Saminaden A, 2010, BRIT J SOC PSYCHOL, V49, P91, DOI 10.1348/014466609X415293; Stephan WG, 1999, J SOC ISSUES, V55, P729, DOI 10.1111/0022-4537.00144; Tarrant M, 2009, BRIT J SOC PSYCHOL, V48, P427, DOI 10.1348/014466608X373589; Todd AR, 2011, J PERS SOC PSYCHOL, V100, P1027, DOI 10.1037/a0022308; Trawalter S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048546; Viki GT, 2006, SOC COGNITION, V24, P753, DOI 10.1521/soco.2006.24.6.753; Wang YW, 2003, J COUNS PSYCHOL, V50, P221, DOI 10.1037/0022-0167.50.2.221; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; Wheatley T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017960; YZERBYT VY, 1995, EUR J SOC PSYCHOL, V25, P1, DOI 10.1002/ejsp.2420250102; Zimmerman J, 2005, DES PLEAS PROD INT 2, P233, DOI [10.1184/R1/6470366.v1, DOI 10.1184/R1/6470366.V1]	54	14	15	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137840	10.1371/journal.pone.0137840	http://dx.doi.org/10.1371/journal.pone.0137840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26360588	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100092
J	Lin, KY; Liao, SH; Liu, WC; Cheng, A; Lin, SW; Chang, SY; Tsai, MS; Kuo, CH; Wu, MR; Wang, HP; Hung, CC; Chang, SC				Lin, Kuan-Yin; Liao, Sih-Han; Liu, Wen-Chun; Cheng, Aristine; Lin, Shu-Wen; Chang, Sui-Yuan; Tsai, Mao-Song; Kuo, Ching-Hua; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen			Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RITONAVIR-BOOSTED ATAZANAVIR; C VIRUS-INFECTION; STONE DISEASE; UDP-GLUCURONOSYLTRANSFERASE; GALLSTONE DISEASE; POPULATION; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT	Objectives This study aimed to describe the epidemiology and risk factors of cholelithiasis and nephrolithiasis among HIV-positive patients in the era of combination antiretroviral therapy. Methods We retrospectively reviewed the medical records of HIV-positive patients who underwent routine abdominal sonography for chronic viral hepatitis, fatty liver, or elevated aminotransferases between January 2004 and January 2015. Therapeutic drug monitoring of plasma concentrations of atazanavir was performed and genetic polymorphisms, including UDP-glucuronosyltransferase (UGT) 1A1*28 and multidrug resistance gene 1 (MDR1) G2677T/A, were determined in a subgroup of patients who received ritonavir-boosted or unboosted atazanavir-containing combination antiretroviral therapy. Information on demographics, clinical characteristics, and laboratory testing were collected and analyzed. Results During the 11-year study period, 910 patients who underwent routine abdominal sonography were included for analysis. The patients were mostly male (96.9%) with a mean age of 42.2 years and mean body-mass index of 22.9 kg/m(2) and 85.8% being on antiretroviral therapy. The anchor antiretroviral agents included non-nucleoside reverse-transcriptase inhibitors (49.3%), unboosted atazanavir (34.4%), ritonavir-boosted lopinavir (20.4%), and ritonavir-boosted atazanavir (5.5%). The overall prevalence of cholelithiasis and nephrolithiasis was 12.5% and 8.2%, respectively. Among 680 antiretroviral-experienced patients with both baseline and follow-up sonography, the crude incidence of cholelithiasis and nephrolithiasis was 4.3% and 3.7%, respectively. In multivariate analysis, the independent factors associated with incident cholelithiasis were exposure to ritonavir-boosted atazanavir for >2 years (adjusted odds ratio [AOR], 6.29; 95% confidence interval [CI], 1.12-35.16) and older age (AOR, 1.04; 95% CI, 1.00-1.09). The positive association between duration of exposure to ritonavir-boosted atazanavir and incident cholelithiasis was also found (AOR, per 1-year exposure, 1.49; 95% CI, 1.05-2.10). The associated factors with incident nephrolithiasis were hyperlipidemia (AOR, 3.97; 95% CI, 1.32-11.93), hepatitis B or C coinfection (AOR, 3.41; 95% CI, 1.09-10.62), and exposure to abacavir (AOR, 12.01; 95% CI, 1.54-93.54). Of 180 patients who underwent therapeutic drug monitoring of plasma atazanavir concentrations and pharmacogenetic investigations, we found that the atazanavir concentrations and UGT 1A1*28 and MDR1 G2677T/A polymorphisms were not statistically significantly associated with incident cholelithiasis and nephrolithiasis. Conclusions In HIV-positive patients in the era of combination antiretroviral therapy, a high prevalence of cholelithiasis and nephrolithiasis was observed, and exposure to ritonavir-boosted atazanavir for >2 years was associated with incident cholelithiasis.	[Lin, Kuan-Yin] Taipei City Hosp, Dept Internal Med, Div Infect Dis, Kun Ming Branch, Taipei, Taiwan; [Liao, Sih-Han; Cheng, Aristine] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Liu, Wen-Chun; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Wen-Chun; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Kuo, Ching-Hua] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, HP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wanghp@ntu.edu.tw; hcc0401@ntu.edu.tw		LIAO, SIH-HAN/0000-0002-7339-2768; KUO, CHING-HUA/0000-0001-5722-0360; Cheng, Aristine/0000-0002-1182-7375; Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SHAN-CHWEN/0000-0001-6505-4139; Lin, Kuan-Yin/0000-0001-6877-5345; CHANG, SUI-YUAN/0000-0002-6009-6724; LIN, SHU-WEN/0000-0002-9940-0850	Centers for Disease Control, Taiwan [DOH102-DC-1401, MOHW103-CDC-C-114-000405]; National Taiwan University Hospital [NTUH101S-1917]	Centers for Disease Control, Taiwan; National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 and MOHW103-CDC-C-114-000405 to C.-C. H.) and National Taiwan University Hospital (grant number NTUH101S-1917 to C.-C. H.). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication.	Acalovschi M, 2009, J VIRAL HEPATITIS, V16, P860, DOI 10.1111/j.1365-2893.2009.01141.x; Ahmed MH, 2014, RENAL FAILURE, V36, P957, DOI 10.3109/0886022X.2014.900424; [Anonymous], 2012, FULL PRESCRIPTION IN; AONO S, 1995, LANCET, V345, P958, DOI 10.1016/S0140-6736(95)90702-5; Boyd MA, 2006, J ANTIMICROB CHEMOTH, V57, P1161, DOI 10.1093/jac/dkl112; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chen JY, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-83; Collin F, 2007, THER DRUG MONIT, V29, P164, DOI 10.1097/ftd.0b013e318030839e; Colombo S, 2006, ANTIMICROB AGENTS CH, V50, P3801, DOI 10.1128/AAC.00098-06; Crixivan (Indinavir Sulfate), 2013, CRIX IND SULF FULL P; Foca E, 2012, DRUGS, V72, P1161, DOI 10.2165/11631070-000000000-00000; Hamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069845; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Huang WY, 2013, J UROLOGY, V189, P2158, DOI 10.1016/j.juro.2012.12.105; Lafaurie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112836; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Malavaud B, 2000, ANTIVIR THER, V5, P3; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nishijima T, 2014, J ANTIMICROB CHEMOTH, V69, P3320, DOI 10.1093/jac/dku304; Nishijima T, 2014, J ANTIMICROB CHEMOTH, V69, P1385, DOI 10.1093/jac/dkt514; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Nkhoma E, 2014, J INT AIDS SOC, V17, P48, DOI 10.7448/IAS.17.4.19560; Park WB, 2010, CLIN INFECT DIS, V51, P101, DOI 10.1086/653427; [R. O. C.(Taiwan) Centers for Disease Control], 2013, GUIDELINES FOR DIAGN; Raheem OA, 2012, J ENDOUROL, V26, P1095, DOI 10.1089/end.2011.0639; Rakotondravelo S, 2012, CLIN INFECT DIS, V55, P1270, DOI 10.1093/cid/cis620; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Romero Victoriano, 2010, Rev Urol, V12, pe86; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; SHEA JA, 1994, ARCH INTERN MED, V154, P2573, DOI 10.1001/archinte.154.22.2573; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447	34	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137660	10.1371/journal.pone.0137660	http://dx.doi.org/10.1371/journal.pone.0137660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360703	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100069
J	Ukaji, T; Lin, YZ; Banno, K; Okada, S; Umezawa, K				Ukaji, Tamami; Lin, Yinzhi; Banno, Kouji; Okada, Shoshiro; Umezawa, Kazuo			Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells	PLOS ONE			English	Article							CAPILLARY-TUBE FORMATION; PROTEIN-PROTEIN INTERACTION; STREPTOMYCES SP; ANGIOGENESIS INHIBITOR; COLORECTAL-CANCER; VASOHIBIN; GROWTH; METASTASIS; UCS15A; LUMINACINS	Previously we isolated migracin A from a Streptomyces culture filtrate as an inhibitor of cancer cell migration. In the present research, we found that migracin A inhibited migration and invasion of ovarian clear cell carcinoma ES-2 cells. In the course of our mechanistic study, migracin A was shown to enhance vasohibin-1 expression in an angiogenesis array. We also confirmed that it increased the mRNA expression of this protein. Moreover, overexpression of vasohibin-1 lowered the migration but not the invasion of ES-2 cells. Then, we looked for another target protein employing a motility array, and found that migracin A lowered the IGF-1 expression. Knockdown of IGF-1 by siRNA decreased the migration and invasion of ES-2 cells. Migracin A also decreased Akt phosphorylation involved in the downstream signaling. Crosstalk analysis indicated that overexpression of vasohibin-1 decreased the IGF-1 expression. On the other hand, it showed no direct anticancer activity in terms of the ES-2 growth in agar. Migracin A inhibited the migration and IGF-1 expression in not only ES-2 but also another ovarian clear cell carcinoma JHOC-5 cells. In addition, it also inhibited capillary tube formation of human umbilical vein endothelial cells. Since its cytotoxicity is very low, migracin A may be a candidate for an anti-metastasis agent not exhibiting prominent toxicity.	[Ukaji, Tamami; Lin, Yinzhi; Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, Nagakute, Aichi 4801195, Japan; [Banno, Kouji] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 4801195, Japan	Aichi Medical University; Keio University; Aichi Medical University	Umezawa, K (corresponding author), Aichi Med Univ, Sch Med, Dept Mol Target Med, 1-1 Yazako Karimata, Nagakute, Aichi 4801195, Japan.	umezawa@aichi-med-u.ac.jp			MEXT, KU [C 26350975]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, KU	MEXT, KU; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, KU	This work was supported by Grants-in-Aid for Scientific Research programs (C 26350975) from MEXT, (https://www.jsps.go.jp/j-grantsinaid), KU, and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, (http://amu-strategy.org/), KU.	Andre F, 2004, ONCOGENE, V23, P1177, DOI 10.1038/sj.onc.1207238; Arai Y, 2013, J ANTIBIOT, V66, P225, DOI 10.1038/ja.2012.112; Bauer TW, 2005, ANN SURG, V241, P748, DOI 10.1097/01.sla.0000160699.59061.92; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jiang H, 2012, MOL MED, V18, P1197, DOI 10.2119/molmed.2012.00075; Kern J, 2008, ARTERIOSCL THROM VAS, V28, P478, DOI 10.1161/ATVBAHA.107.160432; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; King ER, 2011, GYNECOL ONCOL, V123, P13, DOI 10.1016/j.ygyno.2011.06.016; Li ZJ, 2013, WORLD J GASTROENTERO, V19, P7788, DOI 10.3748/wjg.v19.i43.7788; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Naruse N, 2000, J ANTIBIOT, V53, P579, DOI 10.7164/antibiotics.53.579; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; Oneyama C, 2002, ONCOGENE, V21, P2037, DOI 10.1038/sj.onc.1205271; Serin IS, 2008, GYNECOL ENDOCRINOL, V24, P117, DOI 10.1080/09513590801895559; Sharma SV, 2001, ONCOGENE, V20, P2068, DOI 10.1038/sj.onc.1204296; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; Wakabayashi T, 2000, J ANTIBIOT, V53, P591, DOI 10.7164/antibiotics.53.591; Wang XS, 2010, PATHOLOGY, V42, P457, DOI 10.3109/00313025.2010.493864; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003	25	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137663	10.1371/journal.pone.0137663	http://dx.doi.org/10.1371/journal.pone.0137663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360832	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100070
J	Willaschek, C; Meint, S; Rager, K; Buchhorn, R				Willaschek, Christian; Meint, Sebastian; Rager, Klaus; Buchhorn, Reiner			Modified Clonidine Testing for Growth Hormone Stimulation Reveals alpha(2)-Adrenoreceptor Sub Sensitivity in Children with Idiopathic Growth Hormone Deficiency	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SHORT STATURE; BIRTH-WEIGHT; ADULTS; BORN; REPLACEMENT; MODULATION; MORTALITY; PROFILE; LIFE	Introduction The association between short stature and increased risk of ischemic heart disease has been subject to studies for decades. The recent discussion of cardiovascular risk during growth hormone therapy has given new importance to this question. We have hypothesized that the autonomic system is a crucial element relating to this subject. Methods Heart rate variability calculated from 24-hour electrocardiogram data is providing insight into the regulatory state of the autonomous nervous system and is an approved surrogate parameter for estimating cardiovascular risk. We have calculated heart rate variability during clonidine testing for growth hormone stimulation of 56 children. As clonidine is a well-known effector of the autonomous system, stimulating vagal tone and decreasing sympathetic activity, we compared the autonomous reactions of children with constitutional growth delay (CGD), growth hormone deficiency (GHD) and former small for gestational age (SGA). Results During clonidine testing children with CGD showed the expected alpha(2)-adrenoreceptor mediated autonomous response of vagal stimulation for several hours. This vagal reaction was significantly reduced in the SGA group and nearly non-existent in the GHD group. Discussion Children with GHD show a reduced autonomous response to clonidine indicating alpha(2)-adrenoreceptor sub sensitivity. This can be found prior to the start of growth hormone treatment. Since reduction of HRV is an approved surrogate parameter, increased cardiovascular risk has to be assumed for patients with GHD. In the SGA group a similar but less severe reduction of the autonomous response to clonidine was found. These findings may enrich the interpretation of the data on growth hormone therapy, which are being collected by the SAGhE study group.	[Willaschek, Christian; Meint, Sebastian; Rager, Klaus; Buchhorn, Reiner] Caritas Krankenhaus, Dept Pediat, Bad Mergentheim, Germany	Caritas Hospital Bad Mergentheim	Willaschek, C (corresponding author), Caritas Krankenhaus, Dept Pediat, Bad Mergentheim, Germany.	christian.willaschek@ckbm.de		Willaschek, Christian/0000-0003-1980-9638				Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; AULAKH CS, 1994, NEUROENDOCRINOLOGY, V59, P35, DOI 10.1159/000126635; Aziz W, 2012, CLIN AUTON RES, V22, P91, DOI 10.1007/s10286-011-0149-z; Binder G, 2014, GUIDELINE DTSCH GESE; Boguszewski M, 1997, ACTA PAEDIATR, V86, P189; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Capalbo D, 2013, CLIN ENDOCRINOL OXF; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; De Bock F, 2013, INT J CARDIOL, V170, pE30, DOI 10.1016/j.ijcard.2013.10.067; Dippacher S, 2014, EUR J CLIN NUTR, V68, P1271, DOI 10.1038/ejcn.2014.198; FRASER NC, 1983, ARCH DIS CHILD, V58, P355, DOI 10.1136/adc.58.5.355; Jelinek HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00186; Khadilkar V, 2014, ENDOCR RES, V39, P74, DOI 10.3109/07435800.2013.828742; Kunze D, 2001, MONATSSCHR KINDERH, V149, P807; Leong KS, 2001, CLIN ENDOCRINOL, V54, P819, DOI 10.1046/j.1365-2265.2001.01267.x; Leong KS, 2000, J CLIN ENDOCR METAB, V85, P628, DOI 10.1210/jc.85.2.628; Muller A, 2011, CLIN CHEM LAB MED, V49, P1135, DOI 10.1515/CCLM.2011.201; Nyberg CH, 2012, AM J HUM BIOL, V24, P730, DOI 10.1002/ajhb.22304; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Petryk A, 2013, PEDIATR BLOOD CANCER, V60, P467, DOI 10.1002/pbc.24308; Rakow A, 2013, PEDIATR RES, V74, P339, DOI 10.1038/pr.2013.97; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1843, DOI 10.1016/j.psyneuen.2013.05.018; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rodriguez-Colon SM, 2015, METABOLISM, V64, P626, DOI 10.1016/j.metabol.2015.01.018; Singh JP, 1998, HYPERTENSION, V32, P293, DOI 10.1161/01.HYP.32.2.293; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Tanriverdi F, 2005, CLIN ENDOCRINOL, V62, P706, DOI 10.1111/j.1365-2265.2005.02283.x; Tenenbaum-Rakover Yardena, 2008, Pediatr Endocrinol Rev, V5, P880; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Weitz G, 2013, AM J CARDIOVASC DIS, V3, P239; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748; Zhou Y, 2012, CAN J CARDIOL, V28, P477, DOI 10.1016/j.cjca.2012.02.003	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137643	10.1371/journal.pone.0137643	http://dx.doi.org/10.1371/journal.pone.0137643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361394	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100062
J	Kabir, ME; Singh, H; Lu, R; Olde, B; Leeb-Lundberg, LMF; Bopassa, JC				Kabir, Mohammad E.; Singh, Harpreet; Lu, Rong; Olde, Bjorn; Leeb-Lundberg, L. M. Fredrik; Bopassa, Jean Chrisostome			G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3 beta Pathway after Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PERMEABILITY TRANSITION PORE; RAT-HEART; IN-VIVO; MOUSE HEART; BETA; KINASE; ALPHA; ACTIVATION; EXPRESSION	Three types of estrogen receptors (ER) exist in the heart, Esr1, Esr2 and the G protein-coupled estrogen receptor 1, Gper1. However, their relative importance in mediating estrogen protective action is unknown. We found that, in the male mouse ventricle, Gper1 transcripts are three-and seventeen-fold more abundant than Esr1 and Esr2 mRNAs, respectively. Analysis of the three ER knockouts (Esr1(-/-), Esr2(-/-) and Gper1(-/-)) showed that only the Gper1(-/-)hearts lost their ability to be protected by 40 nM estrogen as measured by heart function, infarct size and mitochondrial Ca2+ overload, an index of mitochondrial permeability transition pore (mPTP) activity. Analysis of Akt, ERK1/2 and GSK-3 beta salvage kinases uncovered Akt and ERK1/2 transient activation by estrogen whose phosphorylation increased during the first 5 min of non-ischemic perfusion. All these increase in phosphorylation effects were abrogated in Gper1(-/-). Inhibition of MEK1/2/ERK1/2 (1 mu M U0126) and PI3K/Akt (10 mu M LY294002) signaling showed that the MEK1/2/ERK1/2 pathway via GSK-3 beta exclusively was responsible for cardioprotection as an addition of U0126 prevented estrogen-induced GSK-3 beta increased phosphorylation, resistance to mitochondrial Ca2+-overload, functional recovery and protection against infarction. Further, inhibiting PKC translocation (1 mu M chelerythrin-chloride) abolished estrogen-induced cardioprotection. These data indicate that estrogen-Gper1 acute coupling plays a key role in cardioprotection against ischemia/reperfusion injury in male mouse via a cascade involving PKC translocation, ERK1/2/GSK-3 beta phosphorylation leading to the inhibition of the mPTP opening.	[Kabir, Mohammad E.; Bopassa, Jean Chrisostome] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Physiol, San Antonio, TX 78229 USA; [Singh, Harpreet] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Lu, Rong] Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Olde, Bjorn; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden	University of Texas System; University of Texas Health San Antonio; Drexel University; University of California System; University of California Los Angeles; Lund University	Bopassa, JC (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Physiol, San Antonio, TX 78229 USA.	Bopassa@uthscsa.edu	Singh, Harpreet/M-9822-2019	Singh, Harpreet/0000-0002-6135-1897	American Heart Association (AHA) [09POST2190008]; Max and Minnie Tomerlin Voelcker fund; AHA National Scientist Development Grant [11SDG7230059]; Swedish Research Council	American Heart Association (AHA)(American Heart Association); Max and Minnie Tomerlin Voelcker fund; AHA National Scientist Development Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the American Heart Association (AHA) Fellowship 09POST2190008 (JCB); Max and Minnie Tomerlin Voelcker fund (JCB); AHA National Scientist Development Grant 11SDG7230059 (HS); and a Swedish Research Council grant (LMFL-L).	Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Bopassa JC, 2006, CARDIOVASC RES, V69, P178, DOI 10.1016/j.cardiores.2005.07.014; Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Deschamps AM, 2009, AM J PHYSL HEART CIR; Deschamps AM, 2010, TRENDS CARDIOVAS MED, V20, P73, DOI 10.1016/j.tcm.2010.05.001; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Dupont S, 2000, DEVELOPMENT, V127, P4277; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Holm A, 2012, MOL CELL BIOCHEM, V366, P239, DOI 10.1007/s11010-012-1301-3; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Hunter JC, 2007, AM J PHYSIOL-REG I, V292, pR800, DOI 10.1152/ajpregu.00374.2006; Hutchens MP, 2010, ANESTHESIOLOGY, V112, P395, DOI 10.1097/ALN.0b013e3181c98da9; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kuno A, 2007, J MOL CELL CARDIOL, V43, P262, DOI 10.1016/j.yjmcc.2007.05.016; Kurt AH, 2013, EUR J PHARMACOL, V702, P71, DOI 10.1016/j.ejphar.2013.01.020; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; MARTENSSON UE, 2008, ENDOCRINOLOGY; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; Node K, 1997, CIRCULATION, V96, P1953, DOI 10.1161/01.CIR.96.6.1953; Patel VH, 2010, INT J MOL MED, V26, P193, DOI 10.3892/ijmm_00000452; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; Siomboing X, 2001, FARMACO, V56, P859, DOI 10.1016/S0014-827X(01)01165-X; Solenkova NV, 2006, AM J PHYSIOL-HEART C, V290, pH441, DOI 10.1152/ajpheart.00589.2005; Sovershaev MA, 2006, AM J PHYSIOL-HEART C, V291, pH1554, DOI 10.1152/ajpheart.01171.2005; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vornehm ND, 2009, SURGERY, V146, P145, DOI 10.1016/j.surg.2009.04.026; Wang MJ, 2006, CIRCULATION, V114, pI282, DOI 10.1161/CIRCULATIONAHA.105.001164; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101	40	53	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135988	10.1371/journal.pone.0135988	http://dx.doi.org/10.1371/journal.pone.0135988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356837	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800009
J	Emanuele, AA; Garcia, GA				Emanuele, Anthony A.; Garcia, George A.			Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; III SECRETION SYSTEM; H-NS; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; LARGE PLASMID; ICSA; PATHOGENESIS; INVASION	Shigella spp. are among the main causative agents of acute diarrheal illness and claim more than 1 million lives per year worldwide. There are multiple bacterial genes that control the pathogenesis of Shigella, but the virF gene may be the most important. This gene, located on the primary pathogenicity island of Shigella, encodes VirF, an AraC-family transcriptional activator that is responsible for initiating the pathogenesis cycle in Shigella. We have previously shown that it is possible to attenuate the virulence of Shigella flexneri via small molecule inhibition of VirF. In this study, we probed the mechanism of action of our small molecule inhibitors of VirF. To enable these studies, we have developed a homologous and efficient expression and purification system for VirF and have optimized two different in vitro VirF-DNA binding assays. We have determined that one of our HTS hit compounds inhibits VirF binding to DNA with a calculated K-i similar to the effective doses seen in our transcriptional activation and virulence screens. This is consistent with inhibition of DNA binding as the mechanism of action of this hit compound. We have also screened 15 commercially sourced analogs of this compound and deduced an initial SAR from the approximately 100-fold range in activities. Our four other HTS hit compounds do not inhibit DNA binding and yet they do block VirF activity. This suggests that multiple agents with different molecular mechanisms of inhibition of VirF could be developed. Pursuing hits with different mechanisms of action could be a powerful approach to enhance activity and to circumvent resistance that could develop to any one of these agents.	[Emanuele, Anthony A.; Garcia, George A.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Garcia, GA (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA.	gagarcia@umich.edu			National Institutes of Health [AI085179, GM007767]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the National Institutes of Health (AI085179 to GAG and GM007767, AAE trainee) for funding.	ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bowser TE, 2007, BIOORG MED CHEM LETT, V17, P5652, DOI 10.1016/j.bmcl.2007.07.072; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; COLONNA B, 1995, J BACTERIOL, V177, P4703, DOI 10.1128/jb.177.16.4703-4712.1995; Emanuele AA, 2014, J ANTIBIOT, V67, P379, DOI 10.1038/ja.2014.10; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Glass LS, 2010, BIOORG MED CHEM LETT, V20, P1685, DOI 10.1016/j.bmcl.2010.01.033; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Hurt JK, 2010, J BIOMOL SCREEN, V15, P379, DOI 10.1177/1087057110362101; Jullien N, 2011, BIOTECHNIQUES, V51, P267, DOI 10.2144/000113751; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Koppolu V, 2013, INFECT IMMUN, V81, P4220, DOI 10.1128/IAI.00919-13; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MAURELLI AT, 1984, INFECT IMMUN, V43, P397, DOI 10.1128/IAI.43.1.397-401.1984; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; MILLS JA, 1992, INFECT IMMUN, V60, P175, DOI 10.1128/IAI.60.1.175-182.1992; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Nguyen B, 2004, BIOPHYS J, V86, P1028, DOI 10.1016/S0006-3495(04)74178-8; Porter ME, 1997, MOL GEN GENET, V256, P93, DOI 10.1007/s004380050550; Porter ME, 2002, J BACTERIOL, V184, P531, DOI 10.1128/JB.184.2.531-539.2002; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; SAKAI T, 1988, MOL MICROBIOL, V2, P589, DOI 10.1111/j.1365-2958.1988.tb00067.x; SANSONETTI PJ, 1991, VACCINE, V9, P416, DOI 10.1016/0264-410X(91)90128-S; SASAKAWA C, 1988, J BACTERIOL, V170, P2480, DOI 10.1128/jb.170.6.2480-2484.1988; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Skredenske JM, 2013, J BIOMOL SCREEN, V18, P588, DOI 10.1177/1087057112474690; TOBE T, 1995, J BACTERIOL, V177, P1094, DOI 10.1128/jb.177.4.1094-1097.1995; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Tse WC, 2004, ACCOUNTS CHEM RES, V37, P61, DOI 10.1021/ar030113y; Tse Winston C, 2005, Curr Protoc Nucleic Acid Chem, VChapter 8, DOI 10.1002/0471142700.nc0805s20; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; Zumsteg AB, 2014, CELL HOST MICROBE, V15, P435, DOI 10.1016/j.chom.2014.03.001	40	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137410	10.1371/journal.pone.0137410	http://dx.doi.org/10.1371/journal.pone.0137410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352269	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800082
J	Korhonova, M; Doricakova, A; Dvorak, Z				Korhonova, Martina; Doricakova, Aneta; Dvorak, Zdenek			Optical Isomers of Atorvastatin, Rosuvastatin and Fluvastatin Enantiospecifically Activate Pregnane X Receptor PXR and Induce CYP2A6, CYP2B6 and CYP3A4 in Human Hepatocytes	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; DRUG-INTERACTIONS; HEALTHY-VOLUNTEERS; NUCLEAR RECEPTORS; CELL-LINE; PHARMACOKINETICS; EXPRESSION; CONSTRUCTION; ENZYMES; ASSAY	Atorvastatin, fluvastatin and rosuvastatin are drugs used for treatment of hypercholesterolemia. They cause numerous drug-drug interactions by inhibiting and inducing drug-metabolizing cytochromes P450. These three statins exist in four optical forms, but they are currently used as enantiopure drugs, i.e., only one single enantiomer. There are numerous evidences that efficacy, adverse effects and toxicity of drugs may be enantiospecific. Therefore, we investigated the effects of optical isomers of atorvastatin, fluvastatin and rosuvastatin on the expression of drug-metabolizing P450s in primary human hepatocytes, using western blots and RT-PCR for measurement of proteins and mRNAs, respectively. The activity of P450 transcriptional regulators, including pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR) and glucocorticoid receptor (GR), was assessed by gene reporter assays and EMSA. Transcriptional activity of AhR was not influenced by any statin tested. Basal transcriptional activity of GR was not affected by tested statins, but dexamethasoneinducible activity of GR was dose-dependently and enantioselectively inhibited by fluvastatin. Basal and ligand-inducible transcriptional activity of PXR was dose-dependently influenced by all tested statins, and the potency and efficacy between individual optical isomers varied depending on statin and optical isomer. The expression of CYP1A1 and CYP1A2 in human hepatocytes was not influenced by tested statins. All statins induced CYP2A6, CYP2B6 and CYP3A4, and the effects on CYP2C9 were rather modulatory. The effects varied between statins and enantiomers and induction potency decreased in order: atorvastatin (RR>RS = SR>SS) > fluvastatin (SR>RS = SS>RR) >> rosuvastatin (only RS active). The data presented here might be of toxicological and clinical importance.	[Korhonova, Martina; Doricakova, Aneta; Dvorak, Zdenek] Palacky Univ, Dept Cell Biol & Genet, Fac Sci, Olomouc 78371, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Dept Cell Biol & Genet, Fac Sci, Slechtitelu 27, Olomouc 78371, Czech Republic.	moulin@email.cz	Vrzalová, Aneta/AAL-3571-2021	Vrzalova, Aneta/0000-0002-7923-5851; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Czech Ministry of Health [IGA NT/13591]; Palacky University [PrF-2015-003]	Czech Science Agency; Czech Ministry of Health(Ministry of Health, Czech Republic); Palacky University	This work was supported by a grant from Czech Science Agency (www.gacr.cz) GACR 13-01809S, a grant from Czech Ministry of Health (www.mzcr.cz) IGA NT/13591, and a student grant from Palacky University PrF-2015-003 (www.upol.cz).	Bellosta S, 2012, EXPERT OPIN DRUG SAF, V11, P933, DOI 10.1517/14740338.2012.712959; Boralli VB, 2009, J CLIN PHARMACOL, V49, P205, DOI 10.1177/0091270008327536; Choi DH, 2008, EUR J CLIN PHARMACOL, V64, P445, DOI 10.1007/s00228-007-0447-5; Cohen LH, 2000, BIOPHARM DRUG DISPOS, V21, P353, DOI 10.1002/bdd.249; Cooper KJ, 2003, CLIN PHARMACOL THER, V73, P322, DOI 10.1016/S0009-9236(02)17633-8; Cooper KJ, 2003, BRIT J CLIN PHARMACO, V55, P94, DOI 10.1046/j.1365-2125.2003.01720.x; Di Pietro G, 2006, J CHROMATOGR B, V832, P256, DOI 10.1016/j.jchromb.2006.01.007; Doricakova A, 2013, ARCH TOXICOL, V87, P291, DOI 10.1007/s00204-012-0937-9; Fischer V, 1999, DRUG METAB DISPOS, V27, P410; Garcia I, 2012, CURR TOP MED CHEM, V12, P895, DOI 10.2174/156802612800166729; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hoffart E, 2012, BRIT J PHARMACOL, V165, P1595, DOI 10.1111/j.1476-5381.2011.01665.x; Howe K, 2011, XENOBIOTICA, V41, P519, DOI 10.3109/00498254.2011.569773; Hsyu PH, 2001, ANTIMICROB AGENTS CH, V45, P3445, DOI 10.1128/AAC.45.12.3445-3450.2001; Kobayashi K, 2005, DRUG METAB DISPOS, V33, P924, DOI 10.1124/dmd.104.002741; Kocarek TA, 2002, DRUG METAB DISPOS, V30, P1400, DOI 10.1124/dmd.30.12.1400; Lee CK, 2015, PHARMACOL REP, V67, P44, DOI 10.1016/j.pharep.2014.08.005; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Meadowcroft AM, 1999, J CLIN PHARMACOL, V39, P418, DOI 10.1177/00912709922007886; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Novotna A, 2014, PLOS ONE, P9; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; Olsson AG, 2002, CARDIOVASC DRUG REV, V20, P303; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Plee-Gautier E, 2012, BIOCHEM PHARMACOL, V84, P571, DOI 10.1016/j.bcp.2012.05.012; Prueksaritanont T, 1999, BRIT J CLIN PHARMACO, V47, P291, DOI 10.1046/j.1365-2125.1999.00903.x; Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x; Scripture CD, 2001, CLIN PHARMACOKINET, V40, P263, DOI 10.2165/00003088-200140040-00003; Sekhar MC, 2012, MOL CELL BIOCHEM, V364, P159, DOI 10.1007/s11010-011-1214-6; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Transon C, 1996, EUR J CLIN PHARMACOL, V50, P209, DOI 10.1007/s002280050094; Vavrova A, 2013, ELECTROPHORESIS, V34, P1863, DOI 10.1002/elps.201300079; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Yamasaki D, 2009, EUR J PHARM SCI, V37, P126, DOI 10.1016/j.ejps.2009.01.009	35	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137720	10.1371/journal.pone.0137720	http://dx.doi.org/10.1371/journal.pone.0137720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366873	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100120
J	Kuo, YH; Chen, CW; Chu, Y; Lin, P; Chiang, HM				Kuo, Yueh-Hsiung; Chen, Chien-Wen; Chu, Yin; Lin, Ping; Chiang, Hsiu-Mei			In Vitro and In Vivo Studies on Protective Action of N-Phenethyl Caffeamide against Photodamage of Skin	PLOS ONE			English	Article							FACTOR-KAPPA-B; MATRIX METALLOPROTEINASE-1 EXPRESSION; OXIDATIVE STRESS; INFLAMMATION; PATHWAY; ACTIVATION; RADIATION; DAMAGE; MODEL; AP-1	In our previous study, N-phenethyl caffeamide (K36) was proved to act as an antioxidant and an antiphotoaging agent by inhibiting type I procollagen degradation and stimulating collagen synthesis in human skin fibroblasts. In the present study, in vitro and in vivo experiments were conducted to investigate the mechanism of action and the antiinflammatory and antiphotoaging activity of K36. K36 reduced UVB-induced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthases (iNOS) expression by regulating I kappa B and p-I kappa B expression. K36 also inhibited the nuclear translocation of NF-kappa B. Furthermore, the inhibition of mitogen-activated protein (MAP) kinases by K36 was attributed to the downregulation of COX-2. Topically applying K36 led to efficient antiwrinkle formation and reduced UVB-induced erythema and thickness of epidermis in hairless mice. In addition, K36 penetrated into the skin of hairless mice. Our findings show that K36 has significant beneficial effects on antioxidant, antiinflammatory, and antiphotoaging activity and suggest that K36 can be developed as an antiaging agent for cosmetic and skin care products.	[Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung 404, Taiwan; [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Chen, Chien-Wen; Chu, Yin; Lin, Ping; Chiang, Hsiu-Mei] China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Chiang, HM (corresponding author), China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan.	hmchiang@mail.cmu.edu.tw	Chiang, Hsiu-Mei/L-8150-2013		National Science Council [NSC100-2320-B-039-002-MY3, 99-2622-B-039-001-CC3]; Taipei; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence, Taiwan [MOHW103-TDU-B-212-113002]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence, Taiwan	This study was sponsored by the National Science Council (NSC100-2320-B-039-002-MY3 and 99-2622-B-039-001-CC3), Taipei, and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan, and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Taiwan.	Afaq F, 2011, MINI-REV MED CHEM, V11, P1200; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Chiang H-M, 2013, EVIDENCE COMPLEM ALT, V2013, P12, DOI DOI 10.1155/2013/696879; CHIANG HM, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/324864; Chiang HM, 2015, J AGR FOOD CHEM, V63, P4551, DOI 10.1021/jf502500t; Chiang HM, 2014, FOOD CHEM TOXICOL, V72, P154, DOI 10.1016/j.fct.2014.07.007; Chiang HM, 2012, FOOD CHEM TOXICOL, V50, P4260, DOI 10.1016/j.fct.2012.08.018; Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Filip GA, 2012, J PHYSIOL PHARMACOL, V63, P423; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hong MJ, 2013, J PHARM PHARMACOL, V65, P142, DOI 10.1111/j.2042-7158.2012.01570.x; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035922; Hung CF, 2012, J DERMATOL SCI, V68, P135, DOI 10.1016/j.jdermsci.2012.09.005; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P3374, DOI 10.1016/j.fct.2011.10.002; Kim MS, 2013, PHOTOCHEM PHOTOBIOL, V89, P911, DOI 10.1111/php.12061; Kim YG, 2009, EUR J PHARMACOL, V602, P148, DOI 10.1016/j.ejphar.2008.11.021; Kuo Y-H, 2014, CURRENT PHA IN PRESS; Lee CW, 2012, APPL BIOCHEM BIOTECH, V166, P1137, DOI 10.1007/s12010-011-9500-z; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Nicolaou A, 2011, CHEM PHYS LIPIDS, V164, P535, DOI 10.1016/j.chemphyslip.2011.04.005; Portugal-Cohen M, 2011, EXP DERMATOL, V20, P749, DOI 10.1111/j.1600-0625.2011.01317.x; Serarslan G, 2007, CLIN EXP DERMATOL, V32, P709, DOI 10.1111/j.1365-2230.2007.02470.x; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Wen KC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/417346; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhang JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099703	31	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136777	10.1371/journal.pone.0136777	http://dx.doi.org/10.1371/journal.pone.0136777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367260	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100025
J	Nakagawa, H; Koizumi, N; Okumura, N; Suganami, H; Kinoshita, S				Nakagawa, Hiroko; Koizumi, Noriko; Okumura, Naoki; Suganami, Hideki; Kinoshita, Shigeru			Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study	PLOS ONE			English	Article							ROCK INHIBITOR; Y-27632; ENHANCEMENT; DYSTROPHY	Purpose To investigate the effect and safety of a selective Rho kinase inhibitor, ripasudil 0.4% eye drops, on corneal endothelial cells of healthy subjects. Design Prospective, interventional case series. Methods In this study, 6 healthy subjects were administered ripasudil 0.4% in the right eye twice daily for 1 week. Morphological changes and corneal endothelial cell density were examined by noncontact and contact specular microscopy. Central corneal thickness and corneal volume of 5 mm-diameter area of center cornea were analyzed by Pentacam Scheimpflug topography. All the above measurements were conducted in both eyes before administration, 1.5 and 6 hours after the initial administration on day 0; and in the same manner after the final administration on day 7. Results By noncontact specular microscopy, indistinct cell borders with pseudo guttae were observed, but by contact specular microscopy, morphological changes of corneal endothelial cells were mild and pseudo guttae was not observed after single and repeated administration of ripasudil in all subjects. These changes resolved prior to the next administration, and corneal endothelial cell density, central corneal thickness and corneal volume were not changed throughout the study period. Conclusion Transient morphological changes of corneal endothelial cells such as indistinct cell borders with pseudo guttae were observed by noncontact specular microscopy in healthy subjects after ripasudil administration. Corneal edema was not observed and corneal endothelial cell density did not decrease after 1 week repetitive administration. These morphological changes were reversible and corneal endothelial cell morphology returned to normal prior to the next administration.	[Nakagawa, Hiroko; Koizumi, Noriko; Okumura, Naoki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Kyoto, Japan; [Koizumi, Noriko; Okumura, Naoki] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Kyoto, Japan; [Suganami, Hideki] Kowa Co Ltd, Nagoya, Aichi, Japan	Kyoto Prefectural University of Medicine; Doshisha University; Kowa Company, Ltd.	Koizumi, N (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Kyoto, Japan.	nkoizumi@mail.doshisha.ac.jp			Kowa Company, Ltd, Nagoya, Japan	Kowa Company, Ltd, Nagoya, Japan	This study was sponsored by Kowa Company, Ltd, Nagoya, Japan. The sponsor participated in design, study conduct, data collection, data management, data analysis, interpretation of the data of the study, and preparation, review, and approval of the manuscript.	Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1354; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Isobe T, 2014, CURR EYE RES, V39, P813, DOI 10.3109/02713683.2013.874444; Jhanji V, 2012, CURR OPIN OPHTHALMOL, V23, P324, DOI 10.1097/ICU.0b013e32835484a1; Jhanji V, 2010, CURR OPIN OPHTHALMOL, V21, P301, DOI 10.1097/ICU.0b013e32833a8dd3; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Koizumi N, 2014, CORNEA, V33, pS25, DOI 10.1097/ICO.0000000000000240; Koizumi N, 2013, CORNEA, V32, P1167, DOI 10.1097/ICO.0b013e318285475d; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Tanihara H, 2015, ACTA OPHTHA IN PRESS; Tian B, 2001, CURR EYE RES, V22, P109, DOI 10.1076/ceyr.22.2.109.5529; Wato E, 2014, FUNDAM TOXICOL SCI, V1, P39, DOI DOI 10.2131/fts.1.39; ZANTOS SG, 1977, AM J OPTOM PHYS OPT, V54, P856	23	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136802	10.1371/journal.pone.0136802	http://dx.doi.org/10.1371/journal.pone.0136802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367375	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100026
J	Niu, ZM; Wang, JC; Zou, HJ; Yang, CD; Huang, W; Jin, L				Niu, Zhenmin; Wang, Jiucun; Zou, Hejian; Yang, Chengde; Huang, Wei; Jin, Li			Common MIR146A Polymorphisms in Chinese Ankylosing Spondylitis Subjects and Controls	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; MIR-146A EXPRESSION; MONONUCLEAR-CELLS; ASSOCIATION; SUSCEPTIBILITY; IRAK1; GENE; MICRORNA-146A	Common polymorphisms of microRNA gene MIR146A were reported as associated with different autoimmune diseases, include systemic lupus erythematosus, psoriatic arthritis, asthma and ankylosing spondylitis. In this study we investigated MIR146A SNPs in Chinese people with ankylosing spondylitis. Three common SNPs: rs2910164, rs2431697 and rs57095329 were selected and genotyped in 611 patients and 617 controls. We found no association between these SNPs and ankylosing spondylitis in our samples.	[Niu, Zhenmin; Wang, Jiucun; Jin, Li] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Niu, Zhenmin; Wang, Jiucun; Jin, Li] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Niu, Zhenmin; Huang, Wei] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Niu, Zhenmin; Huang, Wei] SITI, Shanghai 201203, Peoples R China; [Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200040, Peoples R China; [Yang, Chengde] Shanghai Jiao Tong Univ, Renji Hosp, Div Rheumatol, Shanghai 200001, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	Huang, W (corresponding author), Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, 250 Bibo Rd, Shanghai 201203, Peoples R China.	huangwei@chgc.sh.cn; lijin.fudan@gmail.com	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	Chinese National Natural Science Fund for Young Scholars [81101341]; National Basic Research Program [2014CB541801]; Science and Technology Committee of Shanghai Municipality [12DZ1942500]; National Health and Family Planning Commission [201202008]	Chinese National Natural Science Fund for Young Scholars; National Basic Research Program(National Basic Research Program of China); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); National Health and Family Planning Commission	This work was supported by grants from the Chinese National Natural Science Fund for Young Scholars (81101341), the National Basic Research Program (2014CB541801), the Science and Technology Committee of Shanghai Municipality (12DZ1942500), and National Health and Family Planning Commission (201202008).	Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chen HF, 2013, GENE, V521, P259, DOI 10.1016/j.gene.2013.03.073; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jimenez-Morales S, 2012, TISSUE ANTIGENS, V80, P317, DOI 10.1111/j.1399-0039.2012.01929.x; Lofgren SE, 2012, GENES IMMUN, V13, P268, DOI 10.1038/gene.2011.84; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Sakoguchi A, 2013, CLIN EXP DERMATOL, V38, P99, DOI 10.1111/j.1365-2230.2012.04453.x; Singh S, 2014, RHEUMATOL INT, V34, P1395, DOI 10.1007/s00296-014-3001-7; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Xu H, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122055, 10.1371/journal.pone.0138683]; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yang Q, 2013, BRIT J DERMATOL, V168, P1060, DOI 10.1111/bjd.12142; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340; Zilahi E, 2012, IMMUNOL LETT, V141, P165, DOI 10.1016/j.imlet.2011.09.006	18	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137770	10.1371/journal.pone.0137770	http://dx.doi.org/10.1371/journal.pone.0137770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366721	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100133
J	Batabyal, S; Cervenka, G; Ha, JH; Kim, YT; Mohanty, S				Batabyal, Subrata; Cervenka, Gregory; Ha, Ji Hee; Kim, Young-tae; Mohanty, Samarendra			Broad-Band Activatable White-Opsin	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; EXCITABLE CELLS; OPTICAL CONTROL; LIGHT; CHANNELRHODOPSIN-2; MICE	Currently, the use of optogenetic sensitization of retinal cells combined with activation/inhibition has the potential to be an alternative to retinal implants that would require electrodes inside every single neuron for high visual resolution. However, clinical translation of optogenetic activation for restoration of vision suffers from the drawback that the narrow spectral sensitivity of an opsin requires active stimulation by a blue laser or a light emitting diode with much higher intensities than ambient light. In order to allow an ambient light-based stimulation paradigm, we report the development of a 'white-opsin' that has broad spectral excitability in the visible spectrum. The cells sensitized with white-opsin showed excitability at an order of magnitude higher with white light compared to using only narrow-band light components. Further, cells sensitized with white-opsin produced a photocurrent that was five times higher than Channelrhodopsin-2 under similar photo-excitation conditions. The use of fast white-opsin may allow opsin-sensitized neurons in a degenerated retina to exhibit a higher sensitivity to ambient white light. This property, therefore, significantly lowers the activation threshold in contrast to conventional approaches that use intense narrow-band opsins and light to activate cellular stimulation.	[Batabyal, Subrata; Cervenka, Gregory; Mohanty, Samarendra] Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA; [Ha, Ji Hee] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Kim, Young-tae] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Arlington	Mohanty, S (corresponding author), Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA.	smohanty@uta.edu			National Institutes of Health [NS084311]; National Science Foundation [1148541]; Office of President and Provost, The University of Texas at Arlington; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Office of President and Provost, The University of Texas at Arlington; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SM would like to acknowledge support from the National Institutes of Health (NS084311), National Science Foundation (1148541), and Office of President and Provost, The University of Texas at Arlington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buj R, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-18; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cao H, 2013, IEEE T BIO-MED ENG, V60, P225, DOI 10.1109/TBME.2012.2217395; Castonguay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094633; Chow AY, 2002, J REHABIL RES DEV, V39, P313; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gu L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662887; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Mezer E, 2007, OPHTHALMIC GENET, V28, P9, DOI 10.1080/13816810701199423; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Sugawara T, 2010, EYE, V24, P535, DOI 10.1038/eye.2009.176; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136958	10.1371/journal.pone.0136958	http://dx.doi.org/10.1371/journal.pone.0136958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360377	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100019
J	Bekelis, K; Missios, S; Coy, S; Rahmani, R; Singer, RJ; MacKenzie, TA				Bekelis, Kimon; Missios, Symeon; Coy, Shannon; Rahmani, Redi; Singer, Robert J.; MacKenzie, Todd A.			Surgical Clipping versus Endovascular Intervention for the Treatment of Subarachnoid Hemorrhage Patients in New York State	PLOS ONE			English	Article							ANEURYSM TRIAL; STROKE; MORTALITY; ISAT	Object Randomized trials have demonstrated a survival benefit for endovascular treatment of ruptured cerebral aneurysms. We investigated the association of surgical clipping and endovascular coiling with outcomes in subarachnoid hemorrhage (SAH) patients in a real-world regional cohort. Methods We performed a cohort study involving patients with ruptured cerebral aneurysms, who underwent surgical clipping, or endovascular coiling from 2009-2013 and were registered in the Statewide Planning and Research Cooperative System (SPARCS) database. An instrumental variable analysis was used to investigate the association of treatment technique with outcomes. Results Of the 4,098 patients undergoing treatment, 2,585 (63.1%) underwent coiling, and 1,513 (36.9%) underwent clipping. Using an instrumental variable analysis, we did not identify a difference in inpatient mortality [marginal effect (ME), -0.56; 95% CI, -1.03 to 0.02], length of stay (LOS) (ME, 1.72; 95% CI, -3.39 to 6.84), or the rate of 30-day readmissions (ME, -0.30; 95% CI, -0.82 to 0.22) between the two treatment techniques for patients with SAH. Clipping was associated with a higher rate of discharge to rehabilitation (ME, 0.63; 95% CI, 0.24 to 1.01). In sensitivity analysis, mixed effect regression, and propensity score adjusted regression models demonstrated identical results. Conclusions Using a comprehensive all-payer cohort of patients in New York State presenting with aneurysmal SAH we did not identify an association of treatment method with mortality, LOS or 30-day readmission. Clipping was associated with a higher rate of discharge to rehabilitation.	[Bekelis, Kimon; Singer, Robert J.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA; [Missios, Symeon] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Coy, Shannon; Rahmani, Redi] Geisel Sch Med Dartmouth, Hanover, NH USA; [MacKenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [MacKenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Lebanon, NH 03766 USA; [MacKenzie, Todd A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Rahmani, Redi/AAD-1811-2021; Bekelis, Kimon/Y-3402-2019	Rahmani, Redi/0000-0003-3161-2125; 	NIH (Dartmouth Clinical and Translational Science Institute) [UL1TR001086]	NIH (Dartmouth Clinical and Translational Science Institute)	Funding provided by NIH (Dartmouth Clinical and Translational Science Institute-UL1TR001086).	Bekelis K, 2014, VARIATION CARE SURG; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Feasby TE, 2007, ARCH NEUROL-CHICAGO, V64, P1496, DOI 10.1001/archneur.64.10.1496; Foster EM, 1997, SOC SCI RES, V26, P287; Garabedian LF, 2014, ANN INTERN MED, V161, P131, DOI 10.7326/M13-1887; Harbaugh RE, 2003, LANCET, V361, P783, DOI 10.1016/S0140-6736(03)12641-4; Health NYSDo, 2015, STAT PLANN RES COOP; Jalbert JJ, 2015, JAMA NEUROL; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Neuman MD, 2014, JAMA-J AM MED ASSOC, V311, P2508, DOI 10.1001/jama.2014.6499; NeuroPoint Alliance, 2015, NAT NEUR QUAL OUTC D; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Xian Y, 2011, JAMA-J AM MED ASSOC, V305, P373, DOI 10.1001/jama.2011.22; Zacharia BE, 2014, STROKE, V45, P1447, DOI 10.1161/STROKEAHA.113.004412; Zacharia BE, 2011, STROKE, V42, P2844, DOI 10.1161/STROKEAHA.111.619767	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137946	10.1371/journal.pone.0137946	http://dx.doi.org/10.1371/journal.pone.0137946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360422	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100103
J	Hassan, SS; Akram, M; King, EC; Dockrell, HM; Cliff, JM				Hassan, Syeda S.; Akram, Muhammad; King, Elizabeth C.; Dockrell, Hazel M.; Cliff, Jacqueline M.			PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment	PLOS ONE			English	Article							PROGRAMMED DEATH 1; B7 FAMILY; EXHAUSTION; PATHWAY; TOLERANCE; LIGANDS	Background The PD-1 axis is a cell intrinsic immunoregulatory pathway that mediates T cell exhaustion in chronic infection particularly in some viral infections. We hypothesized that PD-1, PD-L1 and PD-L2 would be highly expressed in untreated tuberculosis patients compared to controls due to their chronic infection and would decrease with successful TB treatment. Materials and Methods Untreated tuberculosis patients (n = 26) were recruited at diagnosis and followed up during treatment. Household contacts (n = 24) were recruited to establish baseline differences. Blood gene expression ex vivo was investigated using qRT-PCR. Flow cytometry was performed to establish protein expression patterns. Results PD-L1 gene expression was found to be elevated in active TB disease; however, this was not observed for PD-1 or PD-L2. The intensive phase of TB treatment was associated with a significant decline in PD-1, PD-L1 and PD-L2 gene expression. PD-1 protein expression on the surface of NK cells, CD8(+) and CD4(+) T cells was similar in patients with active TB disease compared to controls but declined with successful TB treatment, with the greatest decline occurring on the NK cells followed by CD8(+) T cells and then CD4(+) T cells. Granzyme B/PD-1 co-expression declined with successful intensive phase treatment. Conclusion Modulation of PD-1/PD-L1 pathway through TB treatment indicates changes in the peripheral T cell response caused by live Mycobacterium tuberculosis (Mtb) followed by the response to dead bacilli, antigen-release and immuno-pathology resolution. The PD-1 axis could be a host drug target for immunomodulatory treatments in the future.	[Hassan, Syeda S.; King, Elizabeth C.; Dockrell, Hazel M.; Cliff, Jacqueline M.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1E 7HT, England; [Akram, Muhammad] Gulab Devi Chest Hosp, Lahore, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Hassan, SS (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	syeda.hassan@lshtm.ac.uk		Cliff, Jackie/0000-0002-5653-1818; Dockrell, Hazel/0000-0003-1869-9107	University of London Central Research Fund [AR/CRF/B]; EDCTP [IP.2009.32040.011]	University of London Central Research Fund; EDCTP	This work was supported by the University of London Central Research Fund (Grant # AR/CRF/B), http://www.london.ac.uk/awards_pg.html. Salary support for JMC was provided by the EDCTP (Grant: IP.2009.32040.011), http://www.edctp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Bandaru A, 2014, EUR J IMMUNOL, V44, P2013, DOI 10.1002/eji.201343680; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Dong HD, 1999, NAT MED, V5, P1365; Elliott TOJP, 2015, J INFECT DIS, V212, P1469, DOI 10.1093/infdis/jiv238; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Hassan SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070063; Henao-Tamayo M, 2011, TUBERCULOSIS, V91, P308, DOI 10.1016/j.tube.2011.04.001; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kulpa DA, 2013, SEMIN IMMUNOL, V25, P219, DOI 10.1016/j.smim.2013.02.002; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111098; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Jurado JO, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17428; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh A, 2014, TUBERCULOSIS, V94, P197, DOI 10.1016/j.tube.2014.01.005; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; World Health Organization, 2014, GLOB TUB REP; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	35	41	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137646	10.1371/journal.pone.0137646	http://dx.doi.org/10.1371/journal.pone.0137646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359860	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100064
J	Zandona, E; Auer, SK; Kilham, SS; Reznick, DN				Zandona, Eugenia; Auer, Sonya K.; Kilham, Susan S.; Reznick, David N.			Contrasting Population and Diet Influences on Gut Length of an Omnivorous Tropical Fish, the Trinidadian Guppy (Poecilia reticulata)	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; PHENOTYPIC FLEXIBILITY; INTESTINE LENGTH; DIGESTIVE-SYSTEM; ORGAN SIZE; PLASTICITY; PREDATION; STREAM; FOOD; DIVERSITY	Phenotypic plasticity is advantageous for organisms that live in variable environments. The digestive system is particularly plastic, responding to changes in diet. Gut length is the result of a trade-off between maximum nutrient absorption and minimum cost for its maintenance and it can be influenced by diet and by evolutionary history. We assessed variation in gut length of Trinidadian guppies (Poecilia reticulata) as a function of diet, season, ontogeny, and local adaptation. Populations of guppies adapted to different predation levels have evolved different life history traits and have different diets. We sampled guppies from sites with low (LP) and high predation (HP) pressure in the Aripo and Guanapo Rivers in Trinidad. We collected fish during both the dry and wet season and assessed their diet and gut length. During the dry season, guppies from HP sites fed mostly on invertebrates, while guppies in the LP sites fed mainly on detritus. During the wet season, the diet of LP and HP populations became very similar. We did not find strong evidence of an ontogenetic diet shift. Gut length was negatively correlated with the proportion of invertebrates in diet across fish from all sites, supporting the hypothesis that guppy digestive systems adapt in length to changes in diet. Population of origin also had an effect on gut length, as HP and LP fish maintained different gut lengths even in the wet season, when their diets were very similar and individuals in both types of populations fed mostly on detritus. Thus, both environment and population of origin influenced guppies gut length, but population of origin seemed to have a stronger effect. Our study also showed that, even in omnivorous fish, gut length adapted to different diets, being more evident when the magnitude of difference between animal and plant material in the diet was very large.	[Zandona, Eugenia; Kilham, Susan S.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Auer, Sonya K.; Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Drexel University; University of California System; University of California Riverside	Zandona, E (corresponding author), Univ Estado Rio de Janeiro, Dept Ecol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, RJ, Brazil.	eugenia.zandona@gmail.com	Zandona, Eugenia/B-3449-2013; Zandona, Eugenia/ABG-8207-2020; Zandona, Eugenia/GQH-9518-2022	Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; reznick, david/0000-0002-1144-0568	National Science Foundations Frontiers in Integrative Biological Research program [EF-0623632]; Betz Chair of Environmental Science at Drexel University; Joseph Mozino scholarship	National Science Foundations Frontiers in Integrative Biological Research program; Betz Chair of Environmental Science at Drexel University; Joseph Mozino scholarship	This research was funded by the National Science Foundations Frontiers in Integrative Biological Research program, grant no. EF-0623632 to DNR, the Betz Chair of Environmental Science at Drexel University and the Joseph Mozino scholarship awarded to EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer SK, 2012, J ANIM ECOL, V81, P818, DOI 10.1111/j.1365-2656.2012.01964.x; Barboza PS, 2010, PHYSIOL BIOCHEM ZOOL, V83, P764, DOI 10.1086/650472; Bassar RD, 2013, AM NAT, V181, P25, DOI 10.1086/668590; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Cant JP, 1996, J ANIM SCI, V74, P2541; Davis AM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-53; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DUSSAULT GV, 1981, CAN J ZOOL, V59, P684, DOI 10.1139/z81-098; German DP, 2014, COMP BIOCHEM PHYS B, V168, P12, DOI 10.1016/j.cbpb.2013.11.006; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Heatherly T, 2012, FLOW REGIME GUPPY IN; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kohler TJ, 2012, FRESHW SCI, V31, P1019, DOI 10.1899/11-141.1; Kotrschal A, 2014, FUNCT ECOL, V28, P878, DOI 10.1111/1365-2435.12230; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P129, DOI 10.1007/BF00001991; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P115, DOI 10.1007/BF00001990; Leung ASL, 2011, FRESHWATER BIOL, V56, P1193, DOI 10.1111/j.1365-2427.2010.02556.x; Levin SA, 2009, PRINCETON GUIDE ECOL; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; Maharaj LD, 1994, ECOLOGY SELECTED AQU; Merritt RW, 2007, INTRO AQUATIC INSECT; Naya DE, 2007, EVOL ECOL RES, V9, P1363; Naya DE, 2009, J EXP ZOOL PART A, V311A, P270, DOI 10.1002/jez.525; Olsson J, 2007, BIOL J LINN SOC, V90, P517, DOI 10.1111/j.1095-8312.2007.00742.x; Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879; Perez G. R, 1996, GUIA ESTUDIO MACROIN; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pringle CM, 1997, ECOLOGY, V78, P2432; Ramirez A, 2006, J N AM BENTHOL SOC, V25, P108, DOI 10.1899/0887-3593(2006)25[108:TASPIS]2.0.CO;2; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2012, EVOLUTION, V66, P2903, DOI 10.1111/j.1558-5646.2012.01650.x; REZNICK DN, 1987, EVOLUTION, V41, P1370, DOI 10.1111/j.1558-5646.1987.tb02474.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; REZNICK DN, 1989, EVOLUTION, V43, P1285, DOI 10.1111/j.1558-5646.1989.tb02575.x; Sibly R.M., 1981, P109; Starck JM, 2003, ANIM BIOL, V53, P245, DOI 10.1163/157075603322539444; Starck JM, 2003, J EXP BIOL, V206, P1887, DOI 10.1242/jeb.00372; Starck JM, 1999, J EXP BIOL, V202, P3171; Sullam KE, 2015, OECOLOGIA, V177, P245, DOI 10.1007/s00442-014-3158-5; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; WHITE TCR, 1985, OECOLOGIA, V67, P596, DOI 10.1007/BF00790034; Winemiller KO, 1998, J FISH BIOL, V53, P267, DOI 10.1111/j.1095-8649.1998.tb01032.x; Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x	53	37	38	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136079	10.1371/journal.pone.0136079	http://dx.doi.org/10.1371/journal.pone.0136079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360601	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100008
J	Kirksey, MA; Haskins, SC; Cheng, J; Liu, SS				Kirksey, Meghan A.; Haskins, Stephen C.; Cheng, Jennifer; Liu, Spencer S.			Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review	PLOS ONE			English	Review							BRACHIAL-PLEXUS BLOCK; CLONIDINE-BUPRENORPHINE-DEXAMETHASONE; ELIMINATING POSTOPERATIVE NAUSEA; MULTIMODAL PERINEURAL ANALGESIA; ACTIVATED CATION CURRENT; SHOT INTERSCALENE BLOCK; OFF-PATENT ANTIEMETICS; REGIONAL ANESTHESIA; SHOULDER SURGERY; DOUBLE-BLIND	Background The use of peripheral nerve blocks for anesthesia and postoperative analgesia has increased significantly in recent years. Adjuvants are frequently added to local anesthetics to prolong analgesia following peripheral nerve blockade. Numerous randomized controlled trials and meta-analyses have examined the pros and cons of the use of various individual adjuvants. Objectives To systematically review adjuvant-related randomized controlled trials and meta-analyses and provide clinical recommendations for the use of adjuvants in peripheral nerve blocks. Methods Randomized controlled trials and meta-analyses that were published between 1990 and 2014 were included in the initial bibliographic search, which was conducted using Medline/PubMed, Cochrane Central Register of Controlled Trials, and EMBASE. Only studies that were published in English and listed block analgesic duration as an outcome were included. Trials that had already been published in the identified meta-analyses and included adjuvants not in widespread use and published without an Investigational New Drug application or equivalent status were excluded. Results Sixty one novel clinical trials and meta-analyses were identified and included in this review. The clinical trials reported analgesic duration data for the following adjuvants: buprenorphine (6), morphine (6), fentanyl (10), epinephrine (3), clonidine (7), dexmedetomidine (7), dexamethasone (7), tramadol (8), and magnesium (4). Studies of perineural buprenorphine, clonidine, dexamethasone, dexmedetomidine, and magnesium most consistently demonstrated prolongation of peripheral nerve blocks. Conclusions Buprenorphine, clonidine, dexamethasone, magnesium, and dexmedetomidine are promising agents for use in prolongation of local anesthetic peripheral nerve blocks, and further studies of safety and efficacy are merited. However, caution is recommended with use of any perineural adjuvant, as none have Food and Drug Administration approval, and concerns for side effects and potential toxicity persist.	[Kirksey, Meghan A.; Haskins, Stephen C.; Cheng, Jennifer; Liu, Spencer S.] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; [Kirksey, Meghan A.; Haskins, Stephen C.; Liu, Spencer S.] Cornell Univ, Dept Anesthesiol, Weill Coll Med, New York, NY 10021 USA	Cornell University	Liu, SS (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.	LiuSp@hss.edu						Abdallah FW, 2013, BRIT J ANAESTH, V110, P915, DOI 10.1093/bja/aet066; Agarwal Sandhya, 2014, J Anaesthesiol Clin Pharmacol, V30, P36, DOI 10.4103/0970-9185.125701; Albrecht E, 2013, ANAESTHESIA, V68, P190, DOI 10.1111/j.1365-2044.2012.07337.x; Alemanno F, 2012, MINERVA ANESTESIOL, V78, P291; Ammar AS, 2012, SAUDI J ANAESTH, V6, P229, DOI 10.4103/1658-354X.101213; An K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123459; Bailard NS, 2014, AM J HEALTH-SYST PH, V71, P373, DOI 10.2146/ajhp130336; Bazin JE, 1997, ANAESTHESIA, V52, P858, DOI 10.1111/j.1365-2044.1997.174-az0311.x; Behr A, 2012, J ANESTH, V26, P746, DOI 10.1007/s00540-012-1416-4; Bhuvaneswari V, 2012, INDIAN J ANAESTH, V56, P34, DOI 10.4103/0019-5049.93341; Biradar PA, 2013, INDIAN J ANAESTH, V57, P180, DOI 10.4103/0019-5049.111850; BORGBJERG FM, 1994, ANESTH ANALG, V79, P105; BOURKE DL, 1993, J CLIN ANESTH, V5, P114, DOI 10.1016/0952-8180(93)90137-4; Braun H, 1903, MUNCH MED WSCHR, V50, P352; Brummett CM, 2011, ANESTHESIOLOGY, V115, P836, DOI 10.1097/ALN.0b013e318221fcc9; Candido KD, 2002, REGION ANESTH PAIN M, V27, P162, DOI 10.1053/rapm.2002.30671; Candido KD, 2001, REGION ANESTH PAIN M, V26, P352, DOI 10.1053/rapm.2001.23931; Candido KD, 2010, ANESTHESIOLOGY, V113, P1419, DOI 10.1097/ALN.0b013e3181f90ce8; Canduz B, 2007, J CLIN NEUROSCI, V14, P968, DOI 10.1016/j.jocn.2006.10.006; Chakraborty S, 2010, INDIAN J PHARMACOL, V42, P74, DOI 10.4103/0253-7613.64498; Choi S, 2014, BRIT J ANAESTH, V112, P427, DOI 10.1093/bja/aet417; Dani C, 2007, J MATERN-FETAL NEO M, V20, P325, DOI 10.1080/14767050701227992; Demirel E, 2006, ANAESTH INTENS CARE, V34, P218, DOI 10.1177/0310057X0603400204; Desmet M, 2013, BRIT J ANAESTH, V111, P445, DOI 10.1093/bja/aet109; Dogru K, 2012, BRATISL MED J, V113, P607, DOI 10.4149/BLL_2012_136; Dogru K, 2003, REGION ANESTH PAIN M, V28, P401, DOI 10.1016/S1098-7339(03)00225-6; ELEDJAM JJ, 1991, CAN J ANAESTH, V38, P870, DOI 10.1007/BF03036962; Elshamaa HA, 2014, EGYPT J ANAESTH, V30, P169, DOI 10.1016/j.egja.2013.10.005; Erdine S, 1999, PAIN, V80, P419, DOI 10.1016/S0304-3959(98)00240-1; Fanelli G, 2001, ACTA ANAESTH SCAND, V45, P590, DOI 10.1034/j.1399-6576.2001.045005590.x; FLETCHER D, 1994, REGION ANESTH, V19, P183; FLORY N, 1995, BRIT J ANAESTH, V75, P23, DOI 10.1093/bja/75.1.23; Fournier R, 2012, REGION ANESTH PAIN M, V37, P521, DOI 10.1097/AAP.0b013e3182606168; Fredrickson MJ, 2013, REGION ANESTH PAIN M, V38, P300, DOI 10.1097/AAP.0b013e318292c121; Fritsch G, 2014, REGION ANESTH PAIN M, V39, P37, DOI 10.1097/AAP.0000000000000033; Gunduz A, 2006, REGION ANESTH PAIN M, V31, P233, DOI 10.1016/j.rapm.2006.03.001; Guven M, 2005, INT J NEUROSCI, V115, P339, DOI 10.1080/00207450590520948; Henao JP, 2014, EUR J ANAESTH, V31, P231, DOI 10.1097/EJA.0000000000000048; Ilfeld BM, 2011, ANESTH ANALG, V113, P904, DOI 10.1213/ANE.0b013e3182285e01; Jadon A, 2009, J ANAESTHESIOL CLIN, V25, P207; Jaiswal R, 2013, ASIAN J PHARM CLI S3, V6, P165, DOI DOI 10.1007/BF03024866; Kaabachi O, 2009, ANESTH ANALG, V108, P367, DOI 10.1213/ane.0b013e31818e0c6b; Kamibayashi T, 2000, ANESTHESIOLOGY, V93, P1345, DOI 10.1097/00000542-200011000-00030; Kapral S, 1999, ANESTH ANALG, V88, P853, DOI 10.1097/00000539-199904000-00032; Karakaya D, 2001, REGION ANESTH PAIN M, V26, P434, DOI 10.1053/rapm.2001.24675; KARDASH K, 1995, REGION ANESTH, V20, P311; Kesimci E, 2007, ACTA ANAESTH SCAND, V51, P736, DOI 10.1111/j.1399-6576.2007.01308.x; Keskinbora K, 2009, J ANESTH, V23, P11, DOI 10.1007/s00540-008-0700-9; Kim YH, 2011, NEUROTOXICOLOGY, V32, P864, DOI 10.1016/j.neuro.2011.05.011; Kohli Santvana, 2013, J Anaesthesiol Clin Pharmacol, V29, P491, DOI 10.4103/0970-9185.119147; Koppert W, 2005, PAIN, V118, P15, DOI 10.1016/j.pain.2005.06.030; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; Kroin JS, 2004, ANESTHESIOLOGY, V101, P488, DOI 10.1097/00000542-200408000-00031; Lee AR, 2012, CAN J ANESTH, V59, P21, DOI 10.1007/s12630-011-9604-5; Lee IO, 2002, ACTA ANAESTH SCAND, V46, P821, DOI 10.1034/j.1399-6576.2002.460711.x; Leffler A, 2012, ANESTHESIOLOGY, V116, P1335, DOI 10.1097/ALN.0b013e3182557917; Lin Yu-Nan, 2013, Acta Anaesthesiol Taiwan, V51, P63, DOI 10.1016/j.aat.2013.06.001; Liu JB, 2015, J CLIN ANESTH, V27, P237, DOI 10.1016/j.jclinane.2014.12.004; Ma R, 2010, NEUROSCIENCE, V167, P329, DOI 10.1016/j.neuroscience.2009.12.049; Magistris L, 2000, EUR J ANAESTH, V17, P348, DOI 10.1046/j.1365-2346.2000.00685.x; MALINOVSKY JM, 1991, ANESTHESIOLOGY, V75, P91, DOI 10.1097/00000542-199107000-00015; Mannion S, 2005, BRIT J ANAESTH, V94, P352, DOI 10.1093/bja/aei057; Marhofer D, 2013, BRIT J ANAESTH, V110, P438, DOI 10.1093/bja/aes400; McCartney CIL, 2007, REGION ANESTH PAIN M, V32, P330, DOI 10.1016/j.rapm.2007.02.010; Memis D, 2004, ANESTH ANALG, V98, P835; Moharari RS, 2010, DARU, V18, P298; Molnar RR, 1997, REGION ANESTH, V22, P137, DOI 10.1016/S1098-7339(06)80032-5; MYERS RR, 1989, ANESTHESIOLOGY, V71, P757, DOI 10.1097/00000542-198911000-00021; Neal JM, 2003, REGION ANESTH PAIN M, V28, P124, DOI 10.1053/rapm.2003.50024; Neal JM, 2010, REGION ANESTH PAIN M, V35, pS1, DOI 10.1097/AAP.0b013e3181d22fe0; Nishikawa K, 2000, ANESTH ANALG, V91, P384, DOI 10.1097/00000539-200008000-00028; Nishiyama T, 1999, ACTA ANAESTH SCAND, V43, P568, DOI 10.1034/j.1399-6576.1999.430514.x; Omar AM, 2011, EGYPT J ANAESTH, V27, P101, DOI 10.1016/j.egja.2011.04.002; Picard PR, 1997, PAIN, V72, P309, DOI 10.1016/S0304-3959(97)00040-7; Popping DM, 2009, ANESTHESIOLOGY, V111, P406, DOI 10.1097/ALN.0b013e3181aae897; RACZ H, 1991, ANESTH ANALG, V72, P769; Rahangdale R, 2014, ANESTH ANALG, V118, P1113, DOI 10.1213/ANE.0000000000000137; Rancourt MPM, 2012, ANESTH ANALG, V115, P958, DOI 10.1213/ANE.0b013e318265bab7; Rasmussen SB, 2013, PAIN MED, V14, P1239, DOI 10.1111/pme.12150; Robaux S, 2004, ANESTH ANALG, V98, P1172, DOI 10.1213/01.ANE.0000108966.84797.72; SABBE MB, 1994, ANESTHESIOLOGY, V81, P899, DOI 10.1097/00000542-199410000-00017; Saeki H, 2004, ANESTH ANALG, V99, P1805, DOI 10.1213/01.ANE.0000138039.04548.3D; Saritas A, 2014, J PAK MED ASSOC, V64, P433; Sarsu S, 2011, J SURG RES, V165, pE23, DOI 10.1016/j.jss.2010.09.032; Sert H, 2011, RENAL FAILURE, V33, P280, DOI 10.3109/0886022X.2011.560502; Sindjelic RP, 2010, ANESTH ANALG, V111, P234, DOI 10.1213/ANE.0b013e3181e1e9ab; Skledar SJ, 2007, THESCIENTIFICWORLDJO, V7, P959, DOI 10.1100/tsw.2007.131; Sondekoppam RV, 2014, BRIT J ANAESTH, V112, P175, DOI 10.1093/bja/aet454; Song JH, 2014, KOREAN J ANESTHESIOL, V66, P283, DOI 10.4097/kjae.2014.66.4.283; Sousa AM, 2012, BRAZ J MED BIOL RES, V45, P147, DOI 10.1590/S0100-879X2011007500164; STERNLO JE, 1992, ANAESTHESIA, V47, P613, DOI 10.1111/j.1365-2044.1992.tb02338.x; Swami SS, 2012, INDIAN J ANAESTH, V56, P243, DOI 10.4103/0019-5049.98767; TAMSEN A, 1984, LANCET, V2, P231; Trivedi Vandana, 2010, J Indian Med Assoc, V108, P563; Troster A, 2012, CLIN J PAIN, V28, P705, DOI 10.1097/AJP.0b013e318241d948; Tufek A, 2013, CLIN INVEST MED, V36, pE95; Vastani N, 2013, EUR J ANAESTH, V30, P21, DOI 10.1097/EJA.0b013e32835949ab; Weber A, 2001, ANESTH ANALG, V93, P1327, DOI 10.1097/00000539-200111000-00060; WEBER WV, 1975, NEUROSCI LETT, V1, P115, DOI 10.1016/0304-3940(75)90055-5; Werdehausen R, 2011, REGION ANESTH PAIN M, V36, P436, DOI 10.1097/AAP.0b013e318226ba62; West S.L., 2002, SYSTEMS RATE STRENGT; Williams BA, 2007, THESCIENTIFICWORLDJO, V7, P978, DOI 10.1100/tsw.2007.132; Williams BA, 2015, PAIN MED, V16, P1, DOI 10.1111/pme.12599; Williams BA, 2015, PAIN MED, V16, P7, DOI 10.1111/pme.12609; Williams BA, 2015, PAIN MED, V16, P186, DOI 10.1111/pme.12592; Williams BA, 2014, ANESTH ANALG, V118, P912, DOI 10.1213/ANE.0000000000000203; Williams BA, 2011, REGION ANESTH PAIN M, V36, P225, DOI 10.1097/AAP.0b013e3182176f70; Williams BA, 2009, REGION ANESTH PAIN M, V34, P445, DOI 10.1097/AAP.0b013e3181ac9e42; YaDeau JT, 2008, ANESTH ANALG, V106, P1916, DOI 10.1213/ane.0b013e318172fe44; Zhang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055556	110	107	115	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137312	10.1371/journal.pone.0137312	http://dx.doi.org/10.1371/journal.pone.0137312			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355598	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800042
J	Ypsilantis, PP; Siddique, M; Sohn, HM; Davies, A; Cook, G; Goh, V; Montana, G				Ypsilantis, Petros-Pavlos; Siddique, Musib; Sohn, Hyon-Mok; Davies, Andrew; Cook, Gary; Goh, Vicky; Montana, Giovanni			Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; TEXTURAL FEATURES; PREOPERATIVE CHEMORADIOTHERAPY; ESOPHAGOGASTRIC JUNCTION; FRACTAL ANALYSIS; TUMOR RESPONSE; FDG-PET; ESOPHAGEAL; HETEROGENEITY	Imaging of cancer with F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) has become a standard component of diagnosis and staging in oncology, and is becoming more important as a quantitative monitor of individual response to therapy. In this article we investigate the challenging problem of predicting a patient's response to neoadjuvant chemotherapy from a single F-18-FDG PET scan taken prior to treatment. We take a "radiomics" approach whereby a large amount of quantitative features is automatically extracted from pretherapy PET images in order to build a comprehensive quantification of the tumor phenotype. While the dominant methodology relies on hand-crafted texture features, we explore the potential of automatically learning low-to high-level features directly from PET scans. We report on a study that compares the performance of two competing radiomics strategies: an approach based on state-of-the-art statistical classifiers using over 100 quantitative imaging descriptors, including texture features as well as standardized uptake values, and a convolutional neural network, 3S-CNN, trained directly from PET scans by taking sets of adjacent intra-tumor slices. Our experimental results, based on a sample of 107 patients with esophageal cancer, provide initial evidence that convolutional neural networks have the potential to extract PET imaging representations that are highly predictive of response to therapy. On this dataset, 3S-CNN achieves an average 80.7% sensitivity and 81.6% specificity in predicting non-responders, and outperforms other competing predictive models.	[Ypsilantis, Petros-Pavlos; Montana, Giovanni] Kings Coll London, Dept Biomed Engn, London SE1 7EH, England; [Siddique, Musib; Sohn, Hyon-Mok; Davies, Andrew; Cook, Gary; Goh, Vicky] Kings Coll London, Dept Canc Imaging, London SE1 7EH, England	University of London; King's College London; University of London; King's College London	Montana, G (corresponding author), Kings Coll London, Dept Biomed Engn, London SE1 7EH, England.	giovanni.montana@kcl.ac.uk	Goh, Vicky/AAG-2708-2020	Cook, Gary/0000-0002-8732-8134; Goh, Vicky/0000-0002-2321-8091	NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust; CRUK; EPSRC; Cancer Research UK [16463] Funding Source: researchfish	NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust; CRUK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	Support was received from the NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust in partnership with Kings College London, and King's College London and UCL Comprehensive Cancer Imaging Centre funded by the CRUK and EPSRC in association with the MRC and DoH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bergstra J., 2010, P 9 PYTH SCI C, P3, DOI DOI 10.25080/MAJORA-92BF1922-003; Bottou L., 2008, ADV NEURAL INFORM PR, V20, P161, DOI DOI 10.7751/mitpress/8996.003.0015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brun E, 2002, HEAD NECK-J SCI SPEC, V24, P127, DOI 10.1002/hed.10037.abs; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chen CH, 2011, HDB PATTERN RECOGNIT; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; CONNERS RW, 1980, IEEE T PATTERN ANAL, V2, P204, DOI 10.1109/TPAMI.1980.4767008; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Glorot X., 2011, P 14 INT C ART INT S, P315; Ha S, 2014, J NUCL MED, V55; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; Hicks RJ, 2004, INT J RADIAT ONCOL, V60, P412, DOI 10.1016/j.ijrobp.2004.03.036; Hofstetter W, 2002, ANN SURG, V236, P376, DOI 10.1097/00000658-200209000-00014; Javeri H, 2009, CANCER-AM CANCER SOC, V115, P624, DOI 10.1002/cncr.24056; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kalff V, 2006, J NUCL MED, V47, P14; Kalliokoski KK, 2001, EUR J NUCL MED, V28, P450, DOI 10.1007/s002590000458; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1989, GEN NETWORK DESIGN S; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; Miller TR, 2003, J NUCL MED, V44, P192; Miwa K, 2014, EUR J RADIOL, V83, P715, DOI 10.1016/j.ejrad.2013.12.020; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Ranzato MA, 1995, COMPUTER VISION PATT, P1; Rizk NP, 2009, J THORAC ONCOL, V4, P875, DOI 10.1097/JTO.0b013e3181a8cebf; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; SARKAR N, 1994, IEEE T SYST MAN CYB, V24, P115, DOI 10.1109/21.259692; Schollaert P, 2014, J GASTROINTEST SURG, V18, P894, DOI 10.1007/s11605-014-2488-2; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vesselle H, 2000, CLIN CANCER RES, V6, P3837; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Willaime J, 2012, J NUCL MED, V53; Yan Xu, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1626, DOI 10.1109/ICASSP.2014.6853873; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Zhu W, 2012, BRIT J RADIOL, V85, pE694, DOI 10.1259/bjr/29946900	58	111	118	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137036	10.1371/journal.pone.0137036	http://dx.doi.org/10.1371/journal.pone.0137036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355298	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800025
J	Hassani, S; Lindman, AS; Kristoffersen, DT; Tomic, O; Helgeland, J				Hassani, Sahar; Lindman, Anja Schou; Kristoffersen, Doris Tove; Tomic, Oliver; Helgeland, Jon			30-Day Survival Probabilities as a Quality Indicator for Norwegian Hospitals: Data Management and Analysis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY-CARE; HEALTH-CARE; MORTALITY; OUTCOMES; STROKE	Background The Norwegian Knowledge Centre for the Health Services (NOKC) reports 30-day survival as a quality indicator for Norwegian hospitals. The indicators have been published annually since 2011 on the website of the Norwegian Directorate of Health (www.helsenorge.no), as part of the Norwegian Quality Indicator System authorized by the Ministry of Health. Openness regarding calculation of quality indicators is important, as it provides the opportunity to critically review and discuss the method. The purpose of this article is to describe the data collection, data pre-processing, and data analyses, as carried out by NOKC, for the calculation of 30-day risk-adjusted survival probability as a quality indicator. Methods and Findings Three diagnosis-specific 30-day survival indicators (first time acute myocardial infarction (AMI), stroke and hip fracture) are estimated based on all-cause deaths, occurring in-hospital or out-of-hospital, within 30 days counting from the first day of hospitalization. Furthermore, a hospital-wide (i.e. overall) 30-day survival indicator is calculated. Patient administrative data from all Norwegian hospitals and information from the Norwegian Population Register are retrieved annually, and linked to datasets for previous years. The outcome (alive/death within 30 days) is attributed to every hospital by the fraction of time spent in each hospital. A logistic regression followed by a hierarchical Bayesian analysis is used for the estimation of risk-adjusted survival probabilities. A multiple testing procedure with a false discovery rate of 5% is used to identify hospitals, hospital trusts and regional health authorities with significantly higher/lower survival than the reference. In addition, estimated risk-adjusted survival probabilities are published per hospital, hospital trust and regional health authority. The variation in risk-adjusted survival probabilities across hospitals for AMI shows a decreasing trend over time: estimated survival probabilities for AMI in 2011 varied from 80.6% (in the hospital with lowest estimated survival) to 91.7%(in the hospital with highest estimated survival), whereas it ranged from 83.8% to 91.2% in 2013. Conclusions Since 2011, several hospitals and hospital trusts have initiated quality improvement projects, and some of the hospitals have improved the survival over these years. Public reporting of survival/mortality indicators are increasingly being used as quality measures of health care systems. Openness regarding the methods used to calculate the indicators are important, as it provides the opportunity of critically reviewing and discussing the methods in the literature. In this way, the methods employed for establishing the indicators may be improved.	[Hassani, Sahar; Lindman, Anja Schou; Kristoffersen, Doris Tove; Tomic, Oliver; Helgeland, Jon] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Hassani, Sahar] Univ Oslo, Dept Med Genet, Oslo, Norway; [Hassani, Sahar] Oslo Univ Hosp, Oslo, Norway; [Hassani, Sahar] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway	Norwegian Knowledge Centre for Health Services; University of Oslo; University of Oslo; University of Oslo	Lindman, AS (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway.	anja.lindman@gmail.com	Tomic, Oliver/L-9455-2019; Kristoffersen, Doris Tove/GWQ-3158-2022	Tomic, Oliver/0000-0003-1595-9962; 				Borzecki AM, 2010, MED CARE, V48, P1117, DOI 10.1097/MLR.0b013e3181ef9d53; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Clench-Aas J, 2005, METHODOLOGICAL DEVEL; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Department of Health, 2014, HLTH CAR QUAL IND IR; Hastie T. J., 1991, STAT MODELS S; Helgeland J, 2013, OVERLEVELSE REINNLEG; Helgeland J, 2013, 30 DAGERS OVERLEVELS; Helgeland J, 2011, 30 DAGERS OVERLEVELS; Helsedirektoratet, 2014, ICD 10 INT STAT KLAS; Hosmer DW, 2005, INTERPRETATION FITTE, P47; Kristoffersen DT, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-364; Kristoffersen DT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006741; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Lindman AS, 2014, 30 DAGERS OVERLEVELS; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001004; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Paul Aylin AB, 2009, HSMR MORTALITY INDIC; Quality AfHRa, 2003, CLIN CLASS SOFTW ICD; Quality AfHRa, CLIN CLASS SOFTW CCS; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Shield T, 2003, QUAL SAF HEALTH CARE, V12, P100, DOI 10.1136/qhc.12.2.100; THOMAS N, 1994, STAT MED, V13, P889, DOI 10.1002/sim.4780130902; World Health Organization, INT CLASS DIS ICD; Yoav B, 1995, J ROY STAT SOC, V57, P289; Zimmerman D R, 1995, Health Care Financ Rev, V16, P107	30	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136547	10.1371/journal.pone.0136547	http://dx.doi.org/10.1371/journal.pone.0136547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352600	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800039
J	Kuuliala, K; Kuuliala, A; Koivuniemi, R; Oksanen, S; Hamalainen, M; Moilanen, E; Kautiainen, H; Leirisalo-Repo, M; Repo, H				Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Oksanen, Suvi; Hamalainen, Mari; Moilanen, Eeva; Kautiainen, Hannu; Leirisalo-Repo, Marjatta; Repo, Heikki			Constitutive STAT3 Phosphorylation in Circulating CD4(+) T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis	PLOS ONE			English	Article							SIGNALING PROFILES; ACUTE-PANCREATITIS; UP-REGULATION; ACTIVATION; INFLAMMATION; LEUKOCYTES; CANCER; ADHESION; CELLS; IL-6	The aim of the present study was to examine constitutive signal transducer and activator of transcription 3 (STAT3) phosphorylation in circulating leukocytes as a candidate biomarker in rheumatoid arthritis (RA). 25 patients with recent-onset, untreated RA provided samples for whole blood flow cytometric determination of intracellular STAT3 phosphorylation, expressed as relative fluorescence units. The occurrence of constitutive STAT3 phosphorylation was evaluated by determining proportion of STAT3-phosphorylated cells among different leukocyte subtypes. Plasma levels of interleukin (IL)-6, IL-17 and IL-21 were measured by immunoassay, radiographs of hands and feet were examined and disease activity score (DAS28) was determined. Biomarkers were restudied and treatment response (according to European League Against Rheumatism) was determined after 12 months of treatment with disease-modifying antirheumatic drugs. At baseline, constitutive phosphorylation of STAT3 occurred in CD4(+) T cells of 14 (56%) patients, CD8(+) T cells of 13 (52%) patients, in CD19+ B cells of 7 (28%) patients, and in CD14(+) monocytes of 12 (48%) patients. STAT3 phosphorylation levels of CD4(+) T cells associated with DAS28, and those of all leukocyte subtypes studied associated with erosive disease. The presence of constitutive STAT3 phosphorylation in CD4(+) T lymphocytes, pSTAT3 fluorescence intensity of CD4(+) and CD8(+) T cells and C-reactive protein (CRP) levels at baseline associated with good treatment response. In conclusion, constitutive STAT3 phosphorylation in circulating CD4(+) T cells is common in recent-onset untreated RA and associates with good treatment response in patients characterized by high disease activity and the presence of systemic inflammation.	[Kuuliala, Krista; Kuuliala, Antti; Oksanen, Suvi; Leirisalo-Repo, Marjatta; Repo, Heikki] Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland; [Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Oksanen, Suvi; Kautiainen, Hannu; Leirisalo-Repo, Marjatta; Repo, Heikki] Univ Helsinki, Helsinki, Finland; [Koivuniemi, Riitta; Leirisalo-Repo, Marjatta] Helsinki Univ Hosp, Rheumatol, Helsinki, Finland; [Hamalainen, Mari; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Hamalainen, Mari; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Gen Practice, Helsinki, Finland; [Kautiainen, Hannu] Kuopio Univ Hosp, Unit Primary Hlth Care, SF-70210 Kuopio, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Kuuliala, K (corresponding author), Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland.	krista.kuuliala@helsinki.fi		Hamalainen, Mari/0000-0002-6409-3758; Kuuliala, Antti/0000-0002-3190-207X	Paulo Foundation; Finnish Cultural Foundation; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	This work was supported by Paulo Foundation and Finnish Cultural Foundation (to KK); Helsinki University Central Hospital Research Funds (to MLR and HR); and Finska Lakaresallskapet (to MLR and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Alanara T, 2012, SCAND J RHEUMATOL, V41, P267, DOI 10.3109/03009742.2012.664649; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Anderson AE, 2016, ANN RHEUM DIS, V75, P466, DOI 10.1136/annrheumdis-2014-205850; Attridge K, 2014, J IMMUNOL, V192, P2195, DOI 10.4049/jimmunol.1302082; Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Baillet A, 2015, ARTHRIT CARE RES, V67, P905, DOI 10.1002/acr.22513; BARRERA P, 1995, BRIT J RHEUMATOL, V34, P747; BD Biosciences, PERM BUFFER III; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Caiello I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107886; CALAFAT J, 1993, BLOOD, V81, P3122; Caldwell CC, 2011, CRIT CARE, V15, DOI 10.1186/cc9397; Cho JY, 2008, BIOL PHARM BULL, V31, P726, DOI 10.1248/bpb.31.726; da Silva JC, 2013, CLINICS, V68, P766, DOI 10.6061/clinics/2013(06)07; de Hooge ASK, 2004, ARTHRITIS RHEUM-US, V50, P2014, DOI 10.1002/art.20302; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Engstad CS, 1997, THROMB HAEMOSTASIS, V77, P690; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; GREENFIELD SM, 1993, GUT, V34, P252, DOI 10.1136/gut.34.2.252; Hakala Markku, 2009, Duodecim, V125, P2131; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Isomaki P, 2015, RHEUMATOLOGY, V54, P1103, DOI 10.1093/rheumatology/keu430; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Knudsen LS, 2008, J RHEUMATOL, V35, P1277; Kuuliala K, 2013, SCAND J CLIN LAB INV, V73, P494, DOI 10.3109/00365513.2013.811612; Kuuliala K, 2011, ARTHRITIS RHEUM-US, V63, pS1008; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Liu Y, 2011, IMMUNOLOGY, V132, P540, DOI 10.1111/j.1365-2567.2010.03399.x; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Newhall KJ, 2010, CLIN CHEM, V56, P1483, DOI 10.1373/clinchem.2006.144618; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; Nupponen I, 2013, SCAND J IMMUNOL, V78, P426, DOI 10.1111/sji.12094; Oiva J, 2013, PANCREATOLOGY, V13, P118, DOI 10.1016/j.pan.2013.01.010; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Ortiz MA, 2015, CLIN IMMUNOL, V158, P174, DOI 10.1016/j.clim.2015.03.025; Pratt AG, 2012, ANN RHEUM DIS, V71, P1374, DOI 10.1136/annrheumdis-2011-200968; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; SENGUPTA TK, 1995, J EXP MED, V181, P1015, DOI 10.1084/jem.181.3.1015; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Stjernberg-Salmela S, 2010, RHEUMATOLOGY, V49, P382, DOI 10.1093/rheumatology/kep327; Sun M, 2012, PROSTATE, V72, P82, DOI 10.1002/pros.21409; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Ye H, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0590-9; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	58	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137385	10.1371/journal.pone.0137385	http://dx.doi.org/10.1371/journal.pone.0137385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353115	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800079
J	Wellard, R; Erbe, C; Fouda, L; Blewitt, M				Wellard, Rebecca; Erbe, Christine; Fouda, Leila; Blewitt, Michelle			Vocalisations of Killer Whales (Orcinus orca) in the Bremer Canyon, Western Australia	PLOS ONE			English	Article							BRITISH-COLUMBIA; ACOUSTIC BEHAVIOR; CULTURAL TRANSMISSION; VANCOUVER-ISLAND; NORTH PACIFIC; ECHOLOCATION; WHISTLES; CALLS; WATERS; POPULATIONS	To date, there has been no dedicated study in Australian waters on the acoustics of killer whales. Hence no information has been published on the sounds produced by killer whales from this region. Here we present the first acoustical analysis of recordings collected off the Western Australian coast. Underwater sounds produced by Australian killer whales were recorded during the months of February and March 2014 and 2015 in the Bremer Canyon in Western Australia. Vocalisations recorded included echolocation clicks, burst-pulse sounds and whistles. A total of 28 hours and 29 minutes were recorded and analysed, with 2376 killer whale calls (whistles and burst-pulse sounds) detected. Recordings of poor quality or signal-to-noise ratio were excluded from analysis, resulting in 142 whistles and burst-pulse vocalisations suitable for analysis and categorisation. These were grouped based on their spectrographic features into nine Bremer Canyon (BC) "call types". The frequency of the fundamental contours of all call types ranged from 600 Hz to 29 kHz. Calls ranged from 0.05 to 11.3 seconds in duration. Biosonar clicks were also recorded, but not studied further. Surface behaviours noted during acoustic recordings were categorised as either travelling or social behaviour. A detailed description of the acoustic characteristics is necessary for species acoustic identification and for the development of passive acoustic tools for population monitoring, including assessments of population status, habitat usage, migration patterns, behaviour and acoustic ecology. This study provides the first quantitative assessment and report on the acoustic features of killer whales vocalisations in Australian waters, and presents an opportunity to further investigate this little-known population.	[Wellard, Rebecca; Erbe, Christine; Fouda, Leila] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; [Blewitt, Michelle] Marine Environm Res Consultants, Sydney, NSW 2099, Australia; [Blewitt, Michelle] Univ Sydney, Inst Marine Sci, Sydney, NSW 2006, Australia	Curtin University; University of Sydney	Wellard, R (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia.	becwellard@gmail.com	Erbe, Christine/H-4777-2012; Wellard, Rebecca/AAW-7310-2020; Erbe, Christine/AAA-3801-2021	Erbe, Christine/0000-0002-7884-9907; Wellard, Rebecca/0000-0001-8427-564X; Fouda, Leila/0000-0002-0723-3697	Busch Gardens Conservation Fund	Busch Gardens Conservation Fund	The 2015 data collection was supported by the Busch Gardens Conservation Fund (http://swbgconservationfund.org/). Authors who received the funding were CE and LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2004, J ACOUST SOC AM, V115, P901, DOI 10.1121/1.1642628; Au WWL, 2000, SPR HDB AUD, V12, P364; Bannister J, 1996, ACTION PLAN AUSTR CE; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Bigg M., 1982, ASSESSMENT KILLER WH; Bigg M.A., 1987, KILLER WHALES STUDY; Bioacoustics Research Program, RAV PRO INT SOUND AN; Chatto Ray, 2000, Beagle, V16, P163; Deecke VB, 2005, ANIM BEHAV, V69, P395, DOI 10.1016/j.anbehav.2004.04.014; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Ding Wang, 1995, P299; Erbe C, 2013, ACOUST AUST, V41, P113; Evans W, 1973, J ACOUST SOC AM, P191; Filatova OA, 2009, ACTA ETHOL, V12, P37, DOI 10.1007/s10211-009-0056-7; Filatova OA, 2012, J ACOUST SOC AM, V132, P3618, DOI 10.1121/1.4764874; Fllatova OA, 2007, BIOACOUSTICS, V16, P261; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K. B., 1987, CANADIAN DATA REPORT; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Ford JKB, 2002, ENCY MARINE MAMMALS; Gassmann M, 2013, J ACOUST SOC AM, V134, P3513, DOI 10.1121/1.4824162; Holt MM, 2011, J ACOUST SOC AM, V130, P3100, DOI 10.1121/1.3641446; KASAMATSU F, 1995, ANTARCT SCI, V7, P365, DOI 10.1017/S0954102095000514; LING J K, 1991, Transactions of the Royal Society of South Australia, V115, P95; MathWorks Inc, 2014, MATLAB; Miller PJO, 2006, J COMP PHYSIOL A, V192, P449, DOI 10.1007/s00359-005-0085-2; Miller PJO, 2004, ANIM BEHAV, V67, P1099, DOI 10.1016/j.anbehav.2003.06.017; MOORE S E, 1988, Rit Fiskideildar, V11, P225; Morrice M.G., 2004, KILLER WHALES ORCINU; Morrice MG, 2008, MAMMALS AUSTR, P860; Morrice MG, 2007, IWC SCI COMM ANCH US; Mustoe S, 2008, VICTORIAN NAT, V125, P76, DOI DOI 10.1371/J0URNAL.P0NE.0136535; Parker D, 1978, AUSTR WILDLIFE RES, P25; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Richlen Michael F., 2008, Aquatic Mammals, V34, P448, DOI 10.1578/AM.34.4.2008.448; Riesch R, 2006, ANIM BEHAV, V71, P79, DOI 10.1016/j.anbehav.2005.03.026; Riesch R, 2011, BEHAV ECOL SOCIOBIOL, V65, P1377, DOI 10.1007/s00265-011-1148-8; Ross G.J., 2006, REV CONSERVATION STA; Samarra FIP, 2010, J ACOUST SOC AM, V128, pEL205, DOI 10.1121/1.3462235; Simon M, 2007, J ACOUST SOC AM, V121, P749, DOI 10.1121/1.2404922; Simonis AE, 2012, J ACOUST SOC AM, V131, pEL295, DOI 10.1121/1.3690963; STRAGER H, 1995, CAN J ZOOL, V73, P1037, DOI 10.1139/z95-124; Thiele D, 2000, DEEP-SEA RES PT II, V47, P2543, DOI 10.1016/S0967-0645(00)00035-7; Thiele D, 1999, ANTARCT SCI, V11, P48, DOI 10.1017/S0954102099000073; Thomsen F, 2002, NATURWISSENSCHAFTEN, V89, P404, DOI 10.1007/s00114-002-0351-x; Thomsen F, 2001, J ACOUST SOC AM, V109, P1240, DOI 10.1121/1.1349537; Tyack PL, 2000, SPR HDB AUD, V12, P156; Van Waerebeek Koen, 2010, Journal of Cetacean Research and Management, V11, P315; Weib BM, 2007, J ACOUST SOC AM, V122, P3710, DOI 10.1121/1.2799907; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Yurk H, 2002, ANIM BEHAV, V63, P1103, DOI 10.1006/anbe.2002.3012; [No title captured]	55	16	17	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136535	10.1371/journal.pone.0136535	http://dx.doi.org/10.1371/journal.pone.0136535			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352429	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800038
J	Xie, Z; Duan, XJ; Ouyang, ZZ; Zhang, PY				Xie, Zheng; Duan, Xiaojun; Ouyang, Zhenzheng; Zhang, Pengyuan			Quantitative Analysis of the Interdisciplinarity of Applied Mathematics	PLOS ONE			English	Article								The increasing use of mathematical techniques in scientific research leads to the interdisciplinarity of applied mathematics. This viewpoint is validated quantitatively here by statistical and network analysis on the corpus PNAS 1999-2013. A network describing the interdisciplinary relationships between disciplines in a panoramic view is built based on the corpus. Specific network indicators show the hub role of applied mathematics in interdisciplinary research. The statistical analysis on the corpus content finds that algorithms, a primary topic of applied mathematics, positively correlates, increasingly co-occurs, and has an equilibrium relationship in the long-run with certain typical research paradigms and methodologies. The finding can be understood as an intrinsic cause of the interdisciplinarity of applied mathematics.	[Xie, Zheng; Duan, Xiaojun; Ouyang, Zhenzheng; Zhang, Pengyuan] Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Xie, Z (corresponding author), Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China.	xiezheng81@nudt.edu.cn; xjduan@nudt.edu.cn			program for new century excellent talents in university, state education ministry in China [10-0893]; key laboratory of high performance computing [201403-01]; national university of defense technology graduate teaching reform project [201406-01]	program for new century excellent talents in university, state education ministry in China; key laboratory of high performance computing; national university of defense technology graduate teaching reform project	This work is funded by the program for new century excellent talents in university, state education ministry in China (No. 10-0893), key laboratory of high performance computing (No. 201403-01), and the national university of defense technology graduate teaching reform project (No. 201406-01).	[Anonymous], 2009, INTRO STAT TIME SERI; Ausburg T, 2006, BECOMING INTERDISCIP; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Brier S, 2013, INTEGR REV, V9, P222; Christopher K, 2005, MODERN CONTROL TECHN; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cojocaru M, 2015, INTERDISCIPLINARY TO; Erciyes K., 2014, COMPLEX NETWORKS ALG; Hey T., 2009, 4 PARADIGM DATA INTE; Johannes L, 2006, SIMULATION PRAGMATIC; JOHANSEN S, 1991, ECONOMETRICA, V59, P1551, DOI 10.2307/2938278; Klein T. J., 1990, INTERDISCIPLINARITY, DOI DOI 10.2307/1772875; Krioukov D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00793; Li ZN, 2010, ECONOMETRICS; Majumder SR, 2009, P NATL ACAD SCI USA, V106, P679, DOI 10.1073/pnas.0805037106; Mane KK, 2004, P NATL ACAD SCI USA, V101, P5287, DOI 10.1073/pnas.0307626100; National Research Council, 2013, MATH SCI 2025; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nicolescu B, 2010, TRANSDISCIPLNARY J E, V1, P17, DOI [10.22545/2010/0009, DOI 10.22545/2010/0009]; Pearson K., 1895, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, DOI 10.1098/RSPL.1895.0041]; Quarteroni A., 2009, SIMULATION, V56, P10; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; Sokolowski JA, 2009, PRINCIPLES MODELLING; Sontag E.D., 1998, MATH CONTROL THEORY; Xie Z, 2015, ARXIV150501332; Xie Z, 2015, PHYSICA A, V436, P492, DOI 10.1016/j.physa.2015.05.076; Xie Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120687; Xie Z, 2014, PHYSICA A, V406, P244, DOI 10.1016/j.physa.2014.03.061; Yi L, 2012, SYSTEMS SCI METHODOL	30	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137424	10.1371/journal.pone.0137424	http://dx.doi.org/10.1371/journal.pone.0137424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352604	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800084
J	Doucet, CM; Esmery, N; de Saint-Jean, M; Antonny, B				Doucet, Christine M.; Esmery, Nina; de Saint-Jean, Maud; Antonny, Bruno			Membrane Curvature Sensing by Amphipathic Helices Is Modulated by the Surrounding Protein Backbone	PLOS ONE			English	Article							LIPID-PACKING; GOLGI LOCALIZATION; ARFGAP1; MOTIFS; MECHANISMS; SEQUENCES; REQUIRES; DOMAINS; COMPLEX; SENSORS	Membrane curvature is involved in numerous biological pathways like vesicle trafficking, endocytosis or nuclear pore complex assembly. In addition to its topological role, membrane curvature is sensed by specific proteins, enabling the coordination of biological processes in space and time. Amongst membrane curvature sensors are the ALPS (Amphipathic Lipid Packing Sensors). ALPS motifs are short peptides with peculiar amphipathic properties. They are found in proteins targeted to distinct curved membranes, mostly in the early secretory pathway. For instance, the ALPS motif of the golgin GMAP210 binds trafficking vesicles, while the ALPS motif of Nup133 targets nuclear pores. It is not clear if, besides curvature sensitivity, ALPS motifs also provide target specificity, or if other domains in the surrounding protein backbone are involved. To elucidate this aspect, we studied the subcellular localization of ALPS motifs outside their natural protein context. The ALPS motifs of GMAP210 or Nup133 were grafted on artificial fluorescent probes. Importantly, ALPS motifs are held in different positions and these contrasting architectures were mimicked by the fluorescent probes. The resulting chimeras recapitulated the original proteins localization, indicating that ALPS motifs are sufficient to specifically localize proteins. Modulating the electrostatic or hydrophobic content of Nup133 ALPS motif modified its avidity for cellular membranes but did not change its organelle targeting properties. In contrast, the structure of the backbone surrounding the helix strongly influenced targeting. In particular, introducing an artificial coiled-coil between ALPS and the fluorescent protein increased membrane curvature sensitivity. This coiled-coil domain also provided membrane curvature sensitivity to the amphipathic helix of Sar1. The degree of curvature sensitivity within the coiled-coil context remains correlated to the natural curvature sensitivity of the helices. This suggests that the chemistry of ALPS motifs is a key parameter for membrane curvature sensitivity, which can be further modulated by the surrounding protein backbone.	[Doucet, Christine M.; Esmery, Nina; de Saint-Jean, Maud; Antonny, Bruno] CNRS UMR 7275, IPMC, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Doucet, CM (corresponding author), CNRS UMR 5048, CBS, 29 Rue Navacelles, F-34090 Montpellier, France.	christine.doucet@cbs.cnrs.fr	Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Doucet, Christine/0000-0002-1611-8279	Centre National de la Recherche Scientifique; Marie Curie grant from the 7th Framework Programme for Research [IRG 277018]; European Research Council (ERC) [268888]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Marie Curie grant from the 7th Framework Programme for Research; European Research Council (ERC)(European Research Council (ERC))	CMD is supported by the Centre National de la Recherche Scientifique and by a Marie Curie grant (IRG 277018) from the 7th Framework Programme for Research. BA is supported by an advanced grant from the European Research Council (ERC 268888). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Antonny B, 2012, DEV CELL; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Cardenas J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-56; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Krabben L, 2011, J NEUROSCI, V31, P18149, DOI 10.1523/JNEUROSCI.4345-11.2011; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Levi S, 2008, J BIOL CHEM, V283, P8564, DOI 10.1074/jbc.M709738200; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Parnis A, 2006, J BIOL CHEM, V281, P3785, DOI 10.1074/jbc.M508959200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Sato K, 2015, MOL BIOL CELL, V26, P537, DOI 10.1091/mbc.E14-10-1450; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; SIMPSON RJ, 2002, PROTEINS PROTEOMICS; Stachowiak JC, 2013, NAT CELL BIOL, V15, P1019, DOI 10.1038/ncb2832; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Woolfson BDN, INTRO PROTEIN DESIGN, V70, P79, DOI [10.1016/S0065-3233(04)70004-2, DOI 10.1016/S0065-3233(04)70004-2]	51	19	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137965	10.1371/journal.pone.0137965	http://dx.doi.org/10.1371/journal.pone.0137965			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366573	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100188
J	Panero, J; Stella, F; Schutz, N; Fantl, DB; Slavutsky, I				Panero, Julieta; Stella, Flavia; Schutz, Natalia; Beatriz Fantl, Dorotea; Slavutsky, Irma			Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders	PLOS ONE			English	Article							MONOCLONAL GAMMOPATHY; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; CLINICAL-SIGNIFICANCE; DYSKERIN EXPRESSION; STAGING SYSTEM; MESSENGER-RNA; HUMAN-DISEASE; COMPLEX; PROFILE	Telomerase, shelterin proteins and various interacting factors, named non-shelterin proteins, are involved in the regulation of telomere length (TL). Altered expression of any of these telomere-associated genes can lead to telomere dysfunction, causing genomic instability and disease development. In this study, we investigated the expression profile of a set of non-shelterin genes involved in essential processes such as replication (RPA1), DNA damage repair pathways (MRE11-RAD50-NBS1) and stabilization of telomerase complex (DKC1), in 35 patients with monoclonal gammopathy of undetermined significance (MGUS) and 40 cases with multiple myeloma (MM). Results were correlated with hTERT expression, TL and clinical parameters. Overall, a significant increase in DKC1, RAD50, MRE11, NBS1 and RPA1 expression along with an upregulation of hTERT in MM compared with MGUS was observed (p <= 0.032). Interestingly, in both entities high mRNA levels of non-shelterin genes were associated with short TLs and increased hTERT expression. Significant differences were observed for DKC1 in MM (p <= 0.026), suggesting an important role for this gene in the maintenance of short telomeres by telomerase in myeloma plasma cells. With regard to clinical associations, we observed a significant increase in DKC1, RAD50, MRE11 and RPA1 expression in MM cases with high bone marrow infiltration (p <= 0.03) and a tendency towards cases with advanced ISS stage, providing the first evidence of non-shelterin genes associated to risk factors in MM. Taken together, our findings bring new insights into the intricate mechanisms by which telomere-associated proteins collaborate in the maintenance of plasma cells immortalization and suggest a role for the upregulation of these genes in the progression of the disease.	[Panero, Julieta; Stella, Flavia; Slavutsky, Irma] CONICET Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina; [Schutz, Natalia; Beatriz Fantl, Dorotea] Hosp Italiano Buenos Aires, Secc Hematol, Dept Clin Med, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Hospital Italiano de Buenos Aires; University of Buenos Aires	Panero, J (corresponding author), CONICET Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina.	julieta.panero@gmail.com			National Research Council [517]; National Agency of Scientific and Technical Promotion [2008-0465]; "Alberto J Roemmers" Foundation	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); National Agency of Scientific and Technical Promotion; "Alberto J Roemmers" Foundation	IS received grants to support this work from the National Research Council (Grant number: 517; www.conicet.gov.ar) and the National Agency of Scientific and Technical Promotion (Grant number: 2008-0465; www.agencia.mincyt.gob.ar). JP and IS received funds from "Alberto J Roemmers" Foundation (no grant number; www.roemmers.com.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Bianchi G, 2014, CA-CANCER J CLIN, V64, P422, DOI 10.3322/caac.21252; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Chai WH, 2006, EMBO REP, V7, P225, DOI 10.1038/sj.embor.7400600; Chang JTC, 2002, EUR J BIOCHEM, V269, P3442, DOI 10.1046/j.1432-1033.2002.03025.x; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cottliar A, 2003, EUR J HAEMATOL, V71, P334, DOI 10.1034/j.1600-0609.2003.00157.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de la Guardia RD, 2012, J CELL MOL MED, V16, P3009, DOI 10.1111/j.1582-4934.2012.01628.x; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hajek R, 2011, Klin Onkol, V24 Suppl, pS10; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hoxha M, 2014, GENE CHROMOSOME CANC, V53, P612, DOI 10.1002/gcc.22171; Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043147; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Merlini G, 2012, HEMATOL-AM SOC HEMAT, P595, DOI 10.1182/asheducation-2012.1.595; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Panero J, 2014, BLOOD CELL MOL DIS, V52, P134, DOI 10.1016/j.bcmd.2013.10.002; Panero J, 2010, MOL MED, V16, P471, DOI 10.2119/molmed.2010.00057; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Robles-Espinoza CD, 2015, MOL CANCER RES, V13, P211, DOI 10.1158/1541-7786.MCR-14-0305; Rujkijyanont P, 2007, BRIT J HAEMATOL, V137, P537, DOI 10.1111/j.1365-2141.2007.06608.x; Safa L, 2014, BIOCHIMIE, V103, P80, DOI 10.1016/j.biochi.2014.04.006; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shay JW, 1997, J CLIN PATHOL, V50, P799, DOI 10.1136/jcp.50.10.799; Shiratsuchi M, 2002, CANCER, V94, P2232, DOI 10.1002/cncr.10472; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Witkowska A, 2010, INT J MOL MED, V25, P321, DOI 10.3892/ijmm_00000348; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wu KD, 2003, BLOOD, V101, P4982, DOI 10.1182/blood-2002-11-3451; Wu Y, 2007, NAT STRUCT MOL BIOL, V14, P832, DOI 10.1038/nsmb1286; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Xu D, 2001, BRIT J CANCER, V84, P621, DOI 10.1054/bjoc.2000.1655; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yuan SSF, 2012, JNCI-J NATL CANCER I, V104, P1485, DOI 10.1093/jnci/djs355	51	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137972	10.1371/journal.pone.0137972	http://dx.doi.org/10.1371/journal.pone.0137972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366868	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100190
J	Ryu, JA; Yang, JH; Lee, D; Park, CM; Suh, GY; Jeon, K; Cho, J; Baek, SY; Carriere, KC; Chung, CR				Ryu, Jeong-Am; Yang, Jeong Hoon; Lee, Daesang; Park, Chi-Min; Suh, Gee Young; Jeon, Kyeongman; Cho, Joongbum; Baek, Sun Young; Carriere, Keumhee C.; Chung, Chi Ryang			Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock	PLOS ONE			English	Article							INTENSIVE-CARE; PROGNOSTIC MARKER; MALIGNANCIES; INDICATOR; SURVIVAL; THERAPY	Sepsis is a major cause of mortality and morbidity in critically ill patients. Procalcitonin (PCT) and C-reactive protein (CRP) are the most frequently used biomarkers in sepsis. We investigated changes in PCT and CRP concentrations in critically ill patients with sepsis to determine which biochemical marker better predicts outcome. We retrospectively analyzed 171 episodes in 157 patients with severe sepsis and septic shock who were admitted to the Samsung Medical Center intensive care unit from March 2013 to February 2014. The primary endpoint was patient outcome within 7 days from ICU admission (treatment failure). The secondary endpoint was 28-day mortality. Severe sepsis was observed in 42 (25%) episodes from 41 patients, and septic shock was observed in 129 (75%) episodes from 120 patients. Fifty-five (32%) episodes from 42 patients had clinically-documented infection, and 116 (68%) episodes from 99 patients had microbiologically-documented infection. Initial peak PCT and CRP levels were not associated with treatment failure and 28-day mortality. However, PCT clearance (PCTc) and CRP (CRPc) clearance were significantly associated with treatment failure (p = 0.027 and p = 0.030, respectively) and marginally significant with 28-day mortality (p = 0.064 and p = 0.062, respectively). The AUC for prediction of treatment success was 0.71 (95% CI, 0.61-0.82) for PCTc and 0.71 (95% CI, 0.61-0.81) for CRPc. The AUC for survival prediction was 0.77 (95% CI, 0.66-0.88) for PCTc and 0.77 (95% CI, 0.67-0.88) for CRPc. Changes in PCT and CRP concentrations were associated with outcomes of critically ill septic patients. CRP may not be inferior to PCT in predicting outcome in these patients.	[Ryu, Jeong-Am; Yang, Jeong Hoon; Lee, Daesang; Park, Chi-Min; Suh, Gee Young; Jeon, Kyeongman; Cho, Joongbum; Chung, Chi Ryang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea; [Park, Chi-Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Baek, Sun Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Carriere, Keumhee C.] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Alberta	Chung, CR (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	ccrzzang@gmail.com	Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Ryu, Jeong-Am/0000-0003-1705-848X	KHIDI [H I14C 0743]	KHIDI	This work was funded by grant number H I14C 0743 (funder's website: www.khidi.or.kr/kps) (KHIDI). CRC received the funding. The funders supported the cost for the English correction of manuscript.	Benoit DD, 2006, INTENS CARE MED, V32, P93, DOI 10.1007/s00134-005-2836-5; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Darmon M, 2005, CRIT CARE MED, V33, P2488, DOI 10.1097/01.CCM.0000181728.13354.0A; Debiane L, 2014, CRIT CARE MED, V42, P2500, DOI 10.1097/CCM.0000000000000526; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devran O, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-47; Freifeld AG, 2011, CLIN INFECT DIS, V52, P56, DOI [10.1093/cid/cir073, DOI 10.1093/CID/CIR073]; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; Hoeboer SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065564; Jain Saransh, 2014, BMC Res Notes, V7, P458, DOI 10.1186/1756-0500-7-458; Jensen JU, 2006, CRIT CARE MED, V34, P2596, DOI 10.1097/01.CCM.0000239116.01855.61; Jimeno A, 2004, CANCER-AM CANCER SOC, V100, P2462, DOI 10.1002/cncr.20275; Karlsson S, 2010, CRIT CARE, V14, DOI 10.1186/cc9327; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu X, 2015, LEUKEMIA LYMPHOMA, V56, P85, DOI 10.3109/10428194.2014.911864; Navi BB, 2010, NEUROLOGY, V74, P494, DOI 10.1212/WNL.0b013e3181cef837; Nor MBM, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/819034; Oliveira CF, 2013, CRIT CARE MED, V41, P2336, DOI 10.1097/CCM.0b013e31828e969f; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; Robinson JO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018886; Ruiz-Alvarez M J, 2009, J Intensive Care Med, V24, P63, DOI 10.1177/0885066608327095; Ruiz-Rodriguez JC, 2012, MED INTENSIVA, V36, P475, DOI [10.1016/j.medin.2011.11.024, 10.1016/j.medine.2012.10.003]; Seligman R, 2006, CRIT CARE, V10, DOI 10.1186/cc5036; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Song JU, 2011, SUPPORT CARE CANCER, V19, P491, DOI 10.1007/s00520-010-0841-x; YENTIS SM, 1995, INTENS CARE MED, V21, P602, DOI 10.1007/BF01700168; Yoo H, 2013, CRIT CARE, V17, DOI 10.1186/cc12829	31	56	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138150	10.1371/journal.pone.0138150	http://dx.doi.org/10.1371/journal.pone.0138150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367532	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100237
J	Smith, SG; Smits, K; Joosten, SA; van Meijgaarden, KE; Satti, I; Fletcher, HA; Caccamo, N; Dieli, F; Mascart, F; McShane, H; Dockrell, HM; Ottenhoff, THM				Smith, Steven G.; Smits, Kaatje; Joosten, Simone A.; van Meijgaarden, Krista E.; Satti, Iman; Fletcher, Helen A.; Caccamo, Nadia; Dieli, Francesco; Mascart, Francoise; McShane, Helen; Dockrell, Hazel M.; Ottenhoff, Tom H. M.		TBVI TB Biomarker Working Grp	Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; WHOLE-CELL; PROTECTION; MEMORY; SAFETY; ASSAYS; GAMMA	Intracellular cytokine staining combined with flow cytometry is one of a number of assays designed to assess T-cell immune responses. It has the specific advantage of enabling the simultaneous assessment of multiple phenotypic, differentiation and functional parameters pertaining to responding T-cells, most notably, the expression of multiple effector cytokines. These attributes make the technique particularly suitable for the assessment of T-cell immune responses induced by novel tuberculosis vaccines in clinical trials. However, depending upon the particular nature of a given vaccine and trial setting, there are approaches that may be taken at different stages of the assay that are more suitable than other alternatives. In this paper, the Tuberculosis Vaccine Initiative (TBVI) TB Biomarker Working group reports on efforts to assess the conditions that will determine when particular assay approaches should be employed. We have found that choices relating to the use of fresh whole blood or peripheral blood mononuclear cells (PBMC) and frozen PBMC; use of serum-containing or serum-free medium; length of stimulation period and use of co-stimulatory antibodies can all affect the sensitivity of intracellular cytokine assays. In the case of sample material, frozen PBMC, despite some loss of sensitivity, may be more advantageous for batch analysis. We also recommend that for multi-site studies, common antibody panels, gating strategies and analysis approaches should be employed for better comparability.	[Smith, Steven G.; Fletcher, Helen A.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [Smits, Kaatje; Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Joosten, Simone A.; van Meijgaarden, Krista E.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Satti, Iman; Fletcher, Helen A.; McShane, Helen] Jenner Inst, Oxford, England; [Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Biomed Res Ctr, Palermo, Italy; [Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy; [Mascart, Francoise] Univ Libre Bruxelles, Immunobiol Clin, Hop Erasme, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; Universite Libre de Bruxelles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Jenner Institute; University of Palermo; University of Palermo; Universite Libre de Bruxelles	Smith, SG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1, England.	steven.smith@lshtm.ac.uk	Joosten, Simone/E-4731-2011; Caccamo, Nadia/J-6808-2018; Joosten, Simone A/F-1357-2011	Joosten, Simone A/0000-0002-9878-0863; McShane, Helen/0000-0002-2126-5142; Dockrell, Hazel/0000-0003-1869-9107; Satti, Iman/0000-0003-4760-4664; Fletcher, Helen/0000-0002-0435-1006; Smith, Steven/0000-0001-5623-7806; Tailleux, Ludovic/0000-0003-3931-1052; Dieli, Francesco/0000-0002-6685-352X	European Commission (EC) [HEALTH-F3-2009-241745]; Tuberculosis Vaccine Initiative [TBVI-12 NORAD]; EC FP7 EURIPRED [INFRASTRUCTURES. 2012.1 312661]; EC H2020 TBVAC2020 [H2020-PHC-643381]; INNOV IRIS from the Region de Bruxelles-Capitale the Fonds de la Recherche Scientifique Medicale (FRSM) [T.0147.13]	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Tuberculosis Vaccine Initiative; EC FP7 EURIPRED; EC H2020 TBVAC2020; INNOV IRIS from the Region de Bruxelles-Capitale the Fonds de la Recherche Scientifique Medicale (FRSM)	The authors acknowledge funding from: European Commission (EC) FP7 NEWTBVAC contract number HEALTH-F3-2009-241745; Tuberculosis Vaccine Initiative contract number TBVI-12 NORAD; EC FP7 EURIPRED contract number INFRASTRUCTURES. 2012.1 312661; EC H2020 TBVAC2020 contract number H2020-PHC-643381; INNOV IRIS from the Region de Bruxelles-Capitale the Fonds de la Recherche Scientifique Medicale (FRSM, grant noT.0147.13). HMcS is a Wellcome Senior Clinical Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Britten CM, 2012, IMMUNITY, V37, P1, DOI 10.1016/j.immuni.2012.07.010; Cardona PJ, 2009, VACCINE, V27, P2499, DOI 10.1016/j.vaccine.2009.02.060; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Dockrell HM, 2000, LEPROSY REV, V71, pS60; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Katoch K, 2008, VACCINE, V26, P1228, DOI 10.1016/j.vaccine.2007.12.025; Korsholm KS, 2014, VACCINE, V32, P3927, DOI 10.1016/j.vaccine.2014.05.050; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; McNeil LK, 2013, CYTOM PART A, V83A, P728, DOI [10.1002/cyto.22319, 10.1002/cyto.a.22319]; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Smits K, 2013, VACCINE, V32, P111, DOI 10.1016/j.vaccine.2013.10.056; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Vilaplana C, 2010, VACCINE, V28, P1106, DOI 10.1016/j.vaccine.2009.09.134; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08	42	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138042	10.1371/journal.pone.0138042	http://dx.doi.org/10.1371/journal.pone.0138042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367374	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361601100208
J	Aguilera, MA; Valdivia, N; Broitman, BR				Aguilera, Moises A.; Valdivia, Nelson; Broitman, Bernardo R.			Herbivore-Alga Interaction Strength Influences Spatial Heterogeneity in a Kelp-Dominated Intertidal Community	PLOS ONE			English	Article							ROCKY SHORES; NORTHERN CHILE; DURVILLAEA-ANTARCTICA; FUNCTIONAL REDUNDANCY; GEOGRAPHIC-VARIATION; POPULATION BIOLOGY; LIFE-HISTORIES; BOTTOM-UP; PATTERNS; MARINE	There is a general consensus that marine herbivores can affect algal species composition and abundance, but little empirical work exists on the role of herbivores as modifiers of the spatial structure of resource assemblages. Here, we test the consumption/bulldozing effects of the molluscan grazer Enoplochiton niger and its influence on the spatial structure of a low intertidal community dominated by the bull kelp Durvillaea antarctica and the kelp Lessonia spicata. Through field experiments conducted at a rocky intertidal shore in north-central Chile (similar to 30 degrees-32 degrees S), the edge of the grazer and algae geographic distributions, we estimated the strength and variability of consumptive effects of the grazer on different functional group of algae. We also used data from abundance field surveys to evaluate spatial co-occurrence patterns of the study species. Exclusion-enclosure experiments showed that E. niger maintained primary space available by preventing algal colonization, even of large brown algae species. The grazing activity of E. niger also reduced spatial heterogeneity of the ephemeral algal species, increasing bare space availability and variability through time in similar ways to those observed for the collective effect with other grazers. Overall, our result suggests that E. niger can be considered an important modifier of the spatial structure of the large brown algae-dominated community. Effects of E. niger on resource variability seem to be directly related to its foraging patterns, large body size, and population densities, which are all relevant factors for management and conservation of the large brown algae community. Our study thus highlights the importance of considering functional roles and identity of generalist consumers on spatial structure of the entire landscape.	[Aguilera, Moises A.; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Larrondo 1281, Coquimbo, Chile; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, CEAZA, Larrondo 1281, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Broitman, Bernardo R/D-6007-2013; Valdivia, Nelson/C-3613-2009	Aguilera, Moisés/0000-0002-3517-6255; Broitman, Bernardo R/0000-0001-6582-3188; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [11121360, 1090488, 1120988, 3100014, 1141037]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) [AUS0805]; UACH [S-2013-03]; CEAZA; Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project [NC120086]; Center for Marine Conservation [RC130024]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP); UACH; CEAZA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAZA); Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project; Center for Marine Conservation	Research was supported by grants from the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) to MAA (grant #11121360), BRB (grants #1090488 and 1120988) and NV (grants #3100014 and 1141037), and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) and UACH to NV (grants #AUS0805 and S-2013-03, respectively). Funds from CEAZA to MAA and BRB greatly appreciated. Finally, the Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project NC120086 and the Center for Marine Conservation RC130024 also supported the final stages of this project.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, REV CHIL HIST NAT, V84, P241, DOI 10.4067/S0716-078X2011000200009; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Benedetti-Cecchi L, 2000, NATURE, V407, P370, DOI 10.1038/35030089; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V209, P171, DOI 10.1016/S0022-0981(96)02686-X; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Botsford LW, 2007, MANAGEMENT FISHERIES, V277, P509; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Burrows MT, 1998, MAR ECOL PROG SER, V167, P1, DOI 10.3354/meps167001; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; CAMUS PA, 1994, J EXP MAR BIOL ECOL, V184, P171, DOI 10.1016/0022-0981(94)90003-5; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Chapman MG, 2008, MAR ECOL PROG SER, V354, P147, DOI 10.3354/meps07205; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; DELLASANTINA P, 1995, MAR BIOL, V122, P265; Diaz ER, 2011, J ECOL, V99, P416, DOI 10.1111/j.1365-2745.2010.01779.x; Duffy JE, 2001, ECOLOGY, V82, P2417; DUGGINS DO, 1985, OECOLOGIA, V67, P183, DOI 10.1007/BF00384282; Elahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078969; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fox RJ, 2009, MAR ECOL PROG SER, V385, P261, DOI 10.3354/meps08059; Fraser CI, 2009, J PHYCOL, V45, P436, DOI 10.1111/j.1529-8817.2009.00658.x; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Jenkins SR, 2005, MAR ECOL PROG SER, V287, P77, DOI 10.3354/meps287077; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; Johansson CL, 2013, CORAL REEFS, V32, P963, DOI 10.1007/s00338-013-1044-y; Johnson MP, 2008, J EXP MAR BIOL ECOL, V365, P136, DOI 10.1016/j.jembe.2008.08.006; Johnson MP, 1997, MAR ECOL PROG SER, V160, P209, DOI 10.3354/meps160209; Jonsson PR, 2006, ECOLOGY, V87, P1169, DOI 10.1890/0012-9658(2006)87[1169:IBWAAG]2.0.CO;2; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; LUBCHENCO J, 1980, ECOLOGY, V61, P676, DOI 10.2307/1937433; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; Navarrete SA, 2003, OIKOS, V100, P251, DOI 10.1034/j.1600-0706.2003.11996.x; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olff H, 1999, NATURE, P400; Orostica MH, 2014, MAR ECOL PROG SER, V511, P71, DOI 10.3354/meps10931; Osenberg Craig W., 1996, P134; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; Owen-Smith N, 2014, ECOGRAPHY, V37, P416, DOI 10.1111/j.1600-0587.2013.00613.x; Paine RT, 2010, AM NAT, V176, P385, DOI 10.1086/656273; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Price TD, 2009, P ROY SOC B-BIOL SCI, V276, P1429, DOI 10.1098/rspb.2008.1199; R Core Team, 2016, R FDN STAT COMP; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Sala E, 2002, P NATL ACAD SCI USA, V99, P3678, DOI 10.1073/pnas.052028499; Sala E, 2011, MAR ECOL-EVOL PERSP, V32, P300, DOI 10.1111/j.1439-0485.2011.00471.x; Sanhueza AG, 2008, REV CHIL HIST NAT, V81, P533; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Silliman BR, 2013, ANNU REV ECOL EVOL S, V44, P503, DOI 10.1146/annurev-ecolsys-110512-135753; Stafford R, 2007, MAR ECOL PROG SER, V342, P151, DOI 10.3354/meps342151; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; STIMSON J, 1973, ECOLOGY, V54, P1020, DOI 10.2307/1935568; Tapia FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110841; Taylor DI, 2010, ECOLOGY, V91, P201, DOI 10.1890/08-1512.1; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Thiel M, 2000, HYDROBIOLOGIA, V440, P45, DOI 10.1023/A:1004188826443; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; Underwood AJ, 1998, J EXP MAR BIOL ECOL, V231, P291, DOI 10.1016/S0022-0981(98)00091-4; Vasquez JA, 1997, REV CHIL HIST NAT, V70, P41; Vasquez JA, 2012, J APPL PHYCOL, V24, P417, DOI 10.1007/s10811-012-9794-4; Von Ende C, 1993, DESIGN ANAL ECOLOGIC, P445; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; WESTERMEIER R, 1994, MAR ECOL PROG SER, V110, P187, DOI 10.3354/meps110187; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	87	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137287	10.1371/journal.pone.0137287	http://dx.doi.org/10.1371/journal.pone.0137287			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360294	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100030
J	Lengyel, B; Varga, A; Sagvari, B; Jakobi, A; Kertesz, J				Lengyel, Balazs; Varga, Attila; Sagvari, Bence; Jakobi, Akos; Kertesz, Janos			Geographies of an Online Social Network	PLOS ONE			English	Article							DISTANCE; FEATHER; BIRDS	How is online social media activity structured in the geographical space? Recent studies have shown that in spite of earlier visions about the "death of distance", physical proximity is still a major factor in social tie formation and maintenance in virtual social networks. Yet, it is unclear, what are the characteristics of the distance dependence in online social networks. In order to explore this issue the complete network of the former major Hungarian online social network is analyzed. We find that the distance dependence is weaker for the online social network ties than what was found earlier for phone communication networks. For a further analysis we introduced a coarser granularity: We identified the settlements with the nodes of a network and assigned two kinds of weights to the links between them. When the weights are proportional to the number of contacts we observed weakly formed, but spatially based modules resemble to the borders of macro-regions, the highest level of regional administration in the country. If the weights are defined relative to an uncorrelated null model, the next level of administrative regions, counties are reflected.	[Lengyel, Balazs; Sagvari, Bence] Int Business Sch Budapest, OSON Res Lab, Budapest, Hungary; [Lengyel, Balazs] Hungarian Acad Sci, Ctr Econ & Reg Studies, Budapest, Hungary; [Varga, Attila] Univ Arizona, Sch Sociol, Tucson, AZ USA; [Sagvari, Bence] Hungarian Acad Sci, Ctr Social Sci, Budapest, Hungary; [Jakobi, Akos] Eotvos Lorand Univ, Dept Reg Sci, Budapest, Hungary; [Kertesz, Janos] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Kertesz, Janos] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; University of Arizona; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences; Eotvos Lorand University; Central European University; Budapest University of Technology & Economics	Lengyel, B (corresponding author), Int Business Sch Budapest, OSON Res Lab, Budapest, Hungary.	blengyel@ibs-b.hu	Jakobi, Akos/L-5223-2018; Sagvari, Bence/L-7317-2019	Jakobi, Akos/0000-0001-9624-7785; Sagvari, Bence/0000-0001-5862-4789; Lengyel, Balazs/0000-0001-5196-5599	International Business School; Hungarian Scientific Research Fund (OTKA) [K112713]; Hungarian Academy of Sciences; EU grant MULTIPLEX [317532]; U.S. Air Force Office of Scientific Research (MURI Award) [FA9550-10-1-0569]	International Business School; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); EU grant MULTIPLEX; U.S. Air Force Office of Scientific Research (MURI Award)	Financial support from International Business School and the Hungarian Scientific Research Fund (OTKA, K112713) is gratefully acknowledged. Research work of AJ was supported by the Janos Bolyai Fellowship of the Hungarian Academy of Sciences. JK acknowledges partial support from EU grant MULTIPLEX (Grant No. 317532). AV was supported by the U.S. Air Force Office of Scientific Research (MURI Award FA9550-10-1-0569).	Acar Adam, 2014, CULTURE SOCIAL MEDIA; Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; [Anonymous], 2011, PREPRINT; Backstrom L, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P33; Blau P. M., 1984, CROSSCUTTING SOCIAL; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Cairncross Frances, 1997, DEATH DISTANCE COMMU; Csanyi G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036131; Dunbar RIM, 2012, PHILOS T R SOC B, V367, P2192, DOI 10.1098/rstb.2012.0121; Dunbar RIM, 2011, J I ECON, V7, P345, DOI 10.1017/S1744137410000366; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Ellin N., 2006, INTEGRAL URBANISM, P1; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Goldenberg J., 2009, PREPRINT; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hecht B, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P237; Helminen V, 2007, J TRANSP GEOGR, V15, P331, DOI 10.1016/j.jtrangeo.2006.12.004; Hipp JR, 2009, CITY COMMUNITY, V8, P5, DOI 10.1111/j.1540-6040.2009.01267.x; Jakobi A, 2015, LECT NOTES GEOINFORM, P227, DOI [10.1007/978-3-319-07926-4_18, DOI 10.1007/978-3-319-07926-4_18]; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Leskovec J, 2014, IEEE TRANS COMPUT SO, V1, P156, DOI 10.1109/TCSS.2014.2377789; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mok D, 2010, URBAN STUD, V47, P2747, DOI 10.1177/0042098010377363; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Scellato Salvatore, 2010, WOSN; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	34	43	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137248	10.1371/journal.pone.0137248	http://dx.doi.org/10.1371/journal.pone.0137248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26359668	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000361043100027
J	Odahara, S; Uchiyama, K; Kubota, T; Ito, Z; Takami, S; Kobayashi, H; Saito, K; Koido, S; Ohkusa, T				Odahara, Shunichi; Uchiyama, Kan; Kubota, Takahiro; Ito, Zensho; Takami, Shinichiro; Kobayashi, Hiroko; Saito, Keisuke; Koido, Shigeo; Ohkusa, Toshifumi			A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD)	PLOS ONE			English	Article							S-METHYLTRANSFERASE; 6-THIOGUANINE NUCLEOTIDE; CROHNS-DISEASE; DRUG-REACTIONS; GENETIC-BASIS; AZATHIOPRINE; 6-MERCAPTOPURINE; THERAPY; POLYMORPHISM; MAINTENANCE	Azathioprine (AZA) is frequently used in patients with inflammatory bowel disease (IBD). However, toxic adverse reactions frequently develop and limit the clinical benefits. Currently, the precise mechanisms underlying thiopurine-related toxicity are not well understood. To investigate the relationship between the extent of thiopurine metabolism and adverse reactions in Japanese IBD patients, we prospectively observed 48 IBD patients who received AZA. We analyzed the thiopurine S-methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) gene mutations and measured the concentrations of 6-thioguanine nucleotide (6-TGN) continuously for 52 weeks. All patients possessed wild-type TPMT gene sequences. The ITPA 94C>A mutation was detected in 19 patients (39.6%). Adverse reactions developed in 14 of the 48 patients (29.2%), including leukopenia in 10 patients (20.8%). In the leukopenia group, the percentages of patients with 94C>A were higher than those in the without-leukopenia group (70.0% vs. 31.6%, P < 0.05). The average concentrations of 6-TGN in the patients with 94C>A were generally higher than those in the patients without 94C>A, however, there were no significant differences. Only 3 out of 10 patients with leukopenia exhibited high 6-TGN levels (30.0%). No negative correlations between white blood cell (WBC) counts and 6-TGN concentrations were observed. The cumulative incidence of leukopenia were higher for patients with 94C>A. Seven out of 19 patients (36.8%) with the ITPA 94C>A mutation developed leukopenia; however, this mutation may not unequivocally increase the risk of developing leukopenia. In addition, there are factors other than increased 6-TGN levels that are involved in the onset of leukopenia.	[Odahara, Shunichi; Uchiyama, Kan; Ito, Zensho; Takami, Shinichiro; Kobayashi, Hiroko; Saito, Keisuke; Koido, Shigeo; Ohkusa, Toshifumi] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Kashiwa Hosp, Chiba, Japan; [Kubota, Takahiro] Niigata Univ Pharm & Appl Life Sci, Dept Biopharmaceut, Fac Pharmaceut Sci, Niigata, Japan	Jikei University; Niigata University	Uchiyama, K (corresponding author), Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Kashiwa Hosp, Chiba, Japan.	uchikan@jikei.ac.jp	大草, 敏史/HGD-2376-2022		JSPS KAKENHI [24590204]; Grants-in-Aid for Scientific Research [24590204] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number 24590204. There was no additional external funding received for this study.	Ansari A, 2002, ALIMENT PHARM THER, V16, P1743, DOI 10.1046/j.1365-2036.2002.01353.x; Appell ML, 2013, PHARMACOGENET GENOM, V23, P242, DOI 10.1097/FPC.0b013e32835f1cc0; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; Ban H, 2008, INTERNAL MED, V47, P1645, DOI 10.2169/internalmedicine.47.1268; Blaker PA, 2013, BIOCHEM PHARMACOL, V86, P539, DOI 10.1016/j.bcp.2013.06.002; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Cuffari C, 1996, GUT, V39, P401, DOI 10.1136/gut.39.3.401; de Boer NKH, 2007, AM J GASTROENTEROL, V102, P2747, DOI 10.1111/j.1572-0241.2007.01511.x; Derijks LJJ, 2006, ALIMENT PHARM THER, V24, P715, DOI 10.1111/j.1365-2036.2006.02980.x; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Hanai H, 2010, INFLAMM BOWEL DIS, V16, P1376, DOI 10.1002/ibd.21190; Hande S, 2006, INFLAMM BOWEL DIS, V12, P251, DOI 10.1097/01.MIB.0000206544.05661.9f; Hibi T, 2003, J GASTROENTEROL, V38, P740, DOI 10.1007/s00535-003-1139-2; Hiratsuka M, 2000, MUTAT RES-FUND MOL M, V448, P91, DOI 10.1016/S0027-5107(00)00004-X; Kubota T, 2004, THER DRUG MONIT, V26, P319, DOI 10.1097/00007691-200406000-00017; Kubota T, 2001, BRIT J CLIN PHARMACO, V51, P475, DOI 10.1046/j.1365-2125.2001.01371.x; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; LENNARD L, 1983, J PHARM PHARMACOL, V35, P15, DOI 10.1111/j.2042-7158.1983.tb04255.x; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Lowenthal A, 2001, EUR J CLIN PHARMACOL, V57, P43, DOI 10.1007/s002280100267; Maeda T, 2005, MOL GENET METAB, V85, P271, DOI 10.1016/j.ymgme.2005.03.011; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; MCLEOD HL, 1994, CLIN PHARMACOL THER, V55, P15, DOI 10.1038/clpt.1994.4; Ohtsuka Y, 2010, J GASTROEN HEPATOL, V25, P1626, DOI 10.1111/j.1440-1746.2010.06364.x; Ooi CY, 2007, ALIMENT PHARM THER, V25, P941, DOI 10.1111/j.1365-2036.2007.03278.x; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Pike MG, 2001, J CHROMATOGR B, V757, P1, DOI 10.1016/S0378-4347(00)00513-2; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; Zelinkova Z, 2006, CLIN GASTROENTEROL H, V4, P44, DOI 10.1016/j.cgh.2005.10.019	33	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137798	10.1371/journal.pone.0137798	http://dx.doi.org/10.1371/journal.pone.0137798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360046	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100089
J	Selinus, EN; Molero, Y; Lichtenstein, P; Larson, T; Lundstrom, S; Anckarsater, H; Gumpert, CH				Selinus, Eva Noren; Molero, Yasmina; Lichtenstein, Paul; Larson, Tomas; Lundstrom, Sebastian; Anckarsater, Henrik; Gumpert, Clara Hellner			Childhood Symptoms of ADHD Overrule Comorbidity in Relation to Psychosocial Outcome at Age 15: A Longitudinal Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DEVELOPMENTAL COORDINATION DISORDER; HUMAN-CAPITAL ACCUMULATION; AUTISM SPECTRUM DISORDERS; ADOLESCENT SUBSTANCE USE; A-TAC; TELEPHONE INTERVIEW; TOURETTE-SYNDROME; CONDUCT DISORDER	Objective Neurodevelopmental problems (NDPs) may influence the transition from childhood to adolescence. Our aim was to study long-term psychosocial outcomes of NDPs, focusing on ADHD. Method Data was collected through a telephone interview with parents of twins at ages 9 or 12 years. NDP screen-positive children were clinically assessed at age 15; N = 450. Psychosocial outcome concerning peers, school, internalizing problems, antisocial behavior, alcohol misuse, drug misuse, and impaired daily functioning was examined. Results Even after controlling for other NDP comorbidity, screen-positivity for ADHD doubled or tripled the odds of later psychosocial problems. When controlling for parental education level, the significant effect of ADHD remained only for antisocial behavior and impaired daily functioning. Conclusions Signs of NDPs as well as other psychiatric diagnoses at ages 9 or 12 years are associated with a more problematic adolescence. However, despite the presence of comorbidity, early ADHD symptoms stand out as the most important risk factor for later antisocial development and impaired daily functioning.	[Selinus, Eva Noren; Gumpert, Clara Hellner] Karolinska Inst, Ctr Psychiat Res & Educ, Dept Clin Neurosci, Stockholm, Sweden; [Selinus, Eva Noren; Gumpert, Clara Hellner] Stockholm Cty Council, Stockholm, Sweden; [Molero, Yasmina; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Larson, Tomas; Lundstrom, Sebastian; Anckarsater, Henrik] Univ Gothenburg, Ctr Eth Law & Mental Hlth CELAM, Gothenburg, Sweden; [Lundstrom, Sebastian] Univ Gothenburg, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden	Karolinska Institutet; Stockholm County Council; Karolinska Institutet; University of Gothenburg; University of Gothenburg	Selinus, EN (corresponding author), Karolinska Inst, Ctr Psychiat Res & Educ, Dept Clin Neurosci, Stockholm, Sweden.	eva.noren@ki.se	Lundström, Sebastian/N-2303-2015	Selinus, Eva Noren/0000-0002-6104-7836; Molero, Yasmina/0000-0002-5663-2010	Swedish Council for Research; Hedlund Foundation	Swedish Council for Research; Hedlund Foundation	This work was supported by grants from the Swedish Council for Research and the Hedlund Foundation. The study funders had no role in the design, collection, analysis, or interpretation of the data, or in the writing or decision to submit the manuscript.	Anckarsater H, 2011, TWIN RES HUM GENET, V14, P495, DOI 10.1375/twin.14.6.495; Anckarsater H, 2010, INT J LAW PSYCHIAT, V33, P59, DOI 10.1016/j.ijlp.2009.12.001; [Anonymous], 2000, STOLD VALD DROG BLAN; [Anonymous], 2012, KRIM 2011; Antshel KM, 2013, EXPERT REV NEUROTHER, V13, P1117, DOI 10.1586/14737175.2013.840417; Ayton A, 2009, EUR EAT DISORD REV, V17, P14, DOI 10.1002/erv.887; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P265, DOI 10.1097/DBP.0b013e31811ff87d; Bella T, 2011, J AFFECT DISORDERS, V133, P204, DOI 10.1016/j.jad.2011.03.022; Biederman J, 2006, J CLIN PSYCHIAT, V67, P524, DOI 10.4088/JCP.v67n0403; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Biederman J, 2008, J DEV BEHAV PEDIATR, V29, P501, DOI 10.1097/DBP.0b013e318190b290; BIRD HR, 1990, J AM ACAD CHILD PSY, V29, P796, DOI 10.1097/00004583-199009000-00020; Bitsko RH, 2013, J CHILD NEUROL, V28, P1626, DOI 10.1177/0883073812465121; Canino G, 2004, ARCH GEN PSYCHIAT, V61, P85, DOI 10.1001/archpsyc.61.1.85; Canitano R, 2007, AUTISM, V11, P19, DOI 10.1177/1362361307070992; Cubo Esther, 2012, Tremor Other Hyperkinet Mov (N Y), V2, DOI 10.7916/D8445K68; Cubo E, 2011, MOVEMENT DISORD, V26, P520, DOI 10.1002/mds.23460; Currie J, 2006, J HEALTH ECON, V25, P1094, DOI 10.1016/j.jhealeco.2006.03.001; De Alwis D, 2014, J STUD ALCOHOL DRUGS, V75, P211, DOI 10.15288/jsad.2014.75.211; Einarsson E, 2009, NORD J PSYCHIAT, V63, P361, DOI 10.1080/08039480902759184; Elkins IJ, 2007, ARCH GEN PSYCHIAT, V64, P1145, DOI 10.1001/archpsyc.64.10.1145; Elliot DS, 1985, EXPLAINING DELINQUEN; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Faraone SV, 2013, BRIT J PSYCHIAT, V203, P81, DOI 10.1192/bjp.bp.113.126524; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Fletcher J, 2008, J HEALTH ECON, V27, P794, DOI 10.1016/j.jhealeco.2007.10.010; Frazier TW, 2007, J LEARN DISABIL-US, V40, P49, DOI 10.1177/00222194070400010401; Fredriksen M, 2014, ADHD-ATTEND DEFICIT, V6, P87, DOI 10.1007/s12402-014-0126-1; Fried R, 2013, J ATTEN DISORD, DOI 10.1177/1087054712473180; Galera C, 2009, PSYCHOL MED, V39, P1895, DOI 10.1017/S0033291709005510; Galera C, 2013, J PEDIATR-US, V163, P1677, DOI 10.1016/j.jpeds.2013.07.008; Geluk CAML, 2012, J CHILD PSYCHOL PSYC, V53, P160, DOI 10.1111/j.1469-7610.2011.02456.x; Gillberg C, 2003, LANCET, V362, P811, DOI 10.1016/S0140-6736(03)14275-4; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Gilmour J, 2004, J CHILD PSYCHOL PSYC, V45, P967, DOI 10.1111/j.1469-7610.2004.t01-1-00289.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hallerod SLH, 2010, NORD J PSYCHIAT, V64, P218, DOI 10.3109/08039480903514443; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; Helles A., 2014, J CHILD PSYCHOL PSYC; Hurtig T, 2007, EUR CHILD ADOLES PSY, V16, P362, DOI 10.1007/s00787-007-0607-2; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Junger-Tas J., 1994, DELINQUENT BEHAV YOU; Kadesjo B, 1999, J AM ACAD CHILD PSY, V38, P820, DOI 10.1097/00004583-199907000-00011; Kanne SM, 2009, J AUTISM DEV DISORD, V39, P827, DOI 10.1007/s10803-008-0688-x; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Khalifa N, 2003, DEV MED CHILD NEUROL, V45, P315, DOI 10.1017/S0012162203000598; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Kirby A, 2014, ARCH DIS CHILD, V99, P292, DOI 10.1136/archdischild-2012-303569; Kotte A, 2013, PEDIATRICS, V132, pE612, DOI 10.1542/peds.2012-3947; Kuja-Halkola R., 2014, J CHILD PSYCHOL PSYC; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; Larson T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-233; Larson T, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-1; Larsson H, 2014, J CHILD PSYCHOL PSYC, V55, P428, DOI 10.1111/jcpp.12140; Leaf PJ, 1996, J AM ACAD CHILD PSY, V35, P889, DOI 10.1097/00004583-199607000-00014; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Lundh A., 2012, CHILDRENS GLOBAL ASS; Lundh A, 2012, ADM POLICY MENT HLTH, V39, P458, DOI 10.1007/s10488-011-0369-5; Lundh A, 2010, PSYCHIAT RES, V177, P206, DOI 10.1016/j.psychres.2010.02.006; Lundstrom S, 2014, J AUTISM DEV DISORD, V44, P2707, DOI 10.1007/s10803-013-1873-0; Marshall I.H., 1999, SELF REPORT METHODOL; Matson JL, 2014, RES DEV DISABIL, V35, P952, DOI 10.1016/j.ridd.2014.02.012; MILNE JM, 1995, J AM ACAD CHILD PSY, V34, P1202, DOI 10.1097/00004583-199509000-00018; Missiuna C, 2014, RES DEV DISABIL, V35, P1198, DOI 10.1016/j.ridd.2014.01.007; Molina BSG, 2003, J ABNORM PSYCHOL, V112, P497, DOI 10.1037/0021-843X.112.3.497; Moruzzi S, 2011, J AUTISM DEV DISORD, V41, P1665, DOI 10.1007/s10803-011-1199-8; Petersen DJ, 2006, EUR CHILD ADOLES PSY, V15, P71, DOI 10.1007/s00787-006-0488-9; Piek JP, 2010, HUM MOVEMENT SCI, V29, P777, DOI 10.1016/j.humov.2010.03.006; Pingault JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062594; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polatajko Helene J, 2005, Semin Pediatr Neurol, V12, P250; Reiersen AM, 2008, J AM ACAD CHILD PSY, V47, P662, DOI 10.1097/CHI.0b013e31816bff88; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Reiersen AM, 2011, J AM ACAD CHILD PSY, V50, P857, DOI 10.1016/j.jaac.2011.06.012; Ringman JM, 2000, J CHILD NEUROL, V15, P394, DOI 10.1177/088307380001500608; Rizzo R, 2014, J CHILD NEUROL, V29, P1383, DOI 10.1177/0883073814534317; Ronald A, 2010, J ABNORM CHILD PSYCH, V38, P185, DOI 10.1007/s10802-009-9366-5; Sayal K, 2010, ARCH PEDIAT ADOL MED, V164, P462, DOI 10.1001/archpediatrics.2010.40; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Simonoff E, 2013, J CHILD PSYCHOL PSYC, V54, P186, DOI 10.1111/j.1469-7610.2012.02606.x; Siponmaa L, 2001, J AM ACAD PSYCHIATRY, V29, P420; Solberg ME, 2003, AGGRESSIVE BEHAV, V29, P239, DOI 10.1002/ab.10047; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; Steinhausen HC, 2001, AUST NZ J PSYCHIAT, V35, P282, DOI 10.1046/j.1440-1614.2001.00901.x; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Sturm H, 2004, DEV MED CHILD NEUROL, V46, P444, DOI 10.1017/S0012162204000738; Tseng MH, 2007, INT J REHABIL RES, V30, P327, DOI 10.1097/MRR.0b013e3282f144c7; Twyman KA, 2010, J DEV BEHAV PEDIATR, V31, P1, DOI 10.1097/DBP.0b013e3181c828c8; Walkup JT, 2010, DEPRESS ANXIETY, V27, P600, DOI 10.1002/da.20711; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.032; Zulauf CA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-013-0436-6	93	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137475	10.1371/journal.pone.0137475	http://dx.doi.org/10.1371/journal.pone.0137475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26360378	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100043
J	Tehrani, FR; Montazeri, SA; Hosseinpanah, F; Cheraghi, L; Erfani, H; Tohidi, M; Azizi, F				Tehrani, Fahimeh Ramezani; Montazeri, Seyed Ali; Hosseinpanah, Farhad; Cheraghi, Leila; Erfani, Hadi; Tohidi, Maryam; Azizi, Fereidoun			Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study	PLOS ONE			English	Article							OLIGOMENORRHEA AND/OR HIRSUTISM; SELF-REPORTED SYMPTOMS; CARDIOVASCULAR-DISEASE RISK; INSULIN-RESISTANCE; FOLLOW-UP; POSTMENOPAUSAL WOMEN; WAIST CIRCUMFERENCE; YOUNG-WOMEN; PREVALENCE; PCOS	Objective To see the changes of cardio-metabolic risk factors overtime in polycystic ovary syndrome vs. control women. Methods This study was conducted on 637 participants (85 PCOS and 552 control reproductive aged, 18-45 years) of Tehran Lipid and Glucose Study (TLGS), an ongoing population-based cohort study with 12 years of follow-up. The cardiovascular risk factors of these groups were assessed in three-year intervals using standard questionnaires, history taking, anthropometric measures, and metabolic/endocrine evaluation. Generalized estimating equation was used to analyze the data. Results Overall mean of insulin (3.55, CI: 0.66-6.45), HOMA-IR (0.63, CI: 0.08-1.18), and HOMA-beta (45.90, CI: 0.86-90.93) were significantly higher in PCOS than in healthy women after adjustment for age, BMI, and baseline levels. However, the negative interaction (follow-up years x PCOS status) of PCOS and normal women converged overtime. Comparing third follow-up with first, insulin and HOMA-IR decreased 10.6% and 5%, respectively in PCOS women; and increased 6.7% and 14.6%, respectively in controls (P<0.05). The results did not show any significant result for other cardio-metabolic variables including WC, lipid profile, FPG, 2-h PG, SBP, and DBP. Conclusion While the insulin level and insulin resistance rate were higher in reproductive aged PCOS than in healthy women, the difference of these risk factors decreased overtime. Thus, the metabolic consequences of PCOS women in later life may be lower than those initially anticipated.	[Tehrani, Fahimeh Ramezani; Montazeri, Seyed Ali; Cheraghi, Leila; Erfani, Hadi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Tohidi, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Montazeri, Seyed Ali; Erfani, Hadi] Shahid Beheshti Univ Med Sci, Publ Hlth, Sch Publ Hlth, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Res Inst Endocrine Sci 24 Parvaneh, Yaman St,POB 19395-4763, Tehran, Iran.	ramezani@endocrine.ac.ir	Tohidi, Maryam/V-2261-2019; Tehrani, Fahimeh Ramezani/H-6133-2017; Erfani, Hadi/R-1463-2017; Azizi, Fereidoun/ABD-4136-2021; hosseinpanah, farhad/AAM-7277-2020	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Erfani, Hadi/0000-0002-1655-6877; Azizi, Fereidoun/0000-0002-6470-2517; hosseinpanah, farhad/0000-0001-5235-9451	National Council of Scientific Research of the Islamic Republic of Iran	National Council of Scientific Research of the Islamic Republic of Iran	The National Council of Scientific Research of the Islamic Republic of Iran has approved and funded the TLGS as a national research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2004, THE SEVENTH REPORT O; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Baillargeon JP, 2007, FERTIL STERIL, V88, P886, DOI 10.1016/j.fertnstert.2006.12.055; Brown ZA, 2011, FERTIL STERIL, V96, P1259, DOI 10.1016/j.fertnstert.2011.09.002; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Fauser BCJM, 2011, J CLIN ENDOCR METAB, V96, P3675, DOI 10.1210/jc.2011-2935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gambineri A, 2012, DIABETES, V61, P2369, DOI 10.2337/db11-1360; Giles LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-341; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Huang J, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-142; Hudecova M, 2012, CURR DIABETES REV, V8, P444, DOI 10.2174/157339912803529913; Hudecova M, 2011, FERTIL STERIL, V96, P1271, DOI 10.1016/j.fertnstert.2011.08.006; Lawson MA, 2008, J CLIN ENDOCR METAB, V93, P2089, DOI 10.1210/jc.2007-2656; Lunde O, 2007, GYNECOL ENDOCRINOL, V23, P704, DOI 10.1080/09513590701705189; Mani H, 2013, CLIN ENDOCRINOL, V78, P926, DOI 10.1111/cen.12068; Mason JB, 2011, AGING CELL, V10, P448, DOI 10.1111/j.1474-9726.2011.00691.x; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Moran LJ, 2015, TRENDS ENDOCRINOL ME; Morgan CL, 2012, J CLIN ENDOCR METAB, V97, P3251, DOI 10.1210/jc.2012-1690; Morin-Papunen LC, 2000, HUM REPROD, V15, P1266, DOI 10.1093/humrep/15.6.1266; Perls TT, 1997, NATURE, V389, P133, DOI 10.1038/38148; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Schmidt J, 2011, J CLIN ENDOCR METAB, V96, P3794, DOI 10.1210/jc.2011-1677; Schmidt J, 2011, J CLIN ENDOCR METAB, V96, P2178, DOI 10.1210/jc.2010-2959; Shaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425; Skrha J, 2004, J CLIN ENDOCR METAB, V89, P135, DOI 10.1210/jc.2002-030024; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Talbott E, 1998, J CLIN EPIDEMIOL, V51, P415, DOI 10.1016/S0895-4356(98)00010-9; TALBOTT E, 1995, ARTERIOSCL THROM VAS, V15, P821, DOI 10.1161/01.ATV.15.7.821; Taponen S, 2003, J CLIN ENDOCR METAB, V88, P141, DOI 10.1210/jc.2002-020982; Taponen S, 2004, HUM REPROD, V19, P1083, DOI 10.1093/humrep/deh214; Taponen S, 2004, J CLIN ENDOCR METAB, V89, P2114, DOI 10.1210/jc.2003-031720; Teede HJ, 2006, ENDOCRINE, V30, P45, DOI 10.1385/ENDO:30:1:45; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-144; Tehrani FR, 2010, HUM REPROD, V25, P1775, DOI 10.1093/humrep/deq088; Tosi F, 2009, EUR J ENDOCRINOL, V161, P737, DOI 10.1530/EJE-09-0379; Twisk JWR, 2003, APPL LONGITUDINAL DA, Vxvi; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang ET, 2011, J CLIN ENDOCR METAB, V96, pE114, DOI 10.1210/jc.2010-1709; Wang ET, 2011, OBSTET GYNECOL, V117, P6, DOI 10.1097/AOG.0b013e31820209bb; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; World Health Organization, 1996, RES MEN 1990S REP WH; Zadeh-Vakili A, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-18; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	52	42	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137609	10.1371/journal.pone.0137609	http://dx.doi.org/10.1371/journal.pone.0137609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360602	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100056
J	Giannini, TC; Garibaldi, LA; Acosta, AL; Silva, JS; Maia, KP; Saraiva, AM; Guimaraes, PR; Kleinert, AMP				Giannini, Tereza C.; Garibaldi, Lucas A.; Acosta, Andre L.; Silva, Juliana S.; Maia, Kate P.; Saraiva, Antonio M.; Guimaraes, Paulo R., Jr.; Kleinert, Astrid M. P.			Native and Non-Native Supergeneralist Bee Species Have Different Effects on Plant-Bee Networks	PLOS ONE			English	Article							POLLINATION NETWORKS; CLIMATE-CHANGE; COEVOLUTIONARY NETWORKS; MUTUALISTIC NETWORKS; BIOLOGICAL INVASIONS; HABITAT LOSS; ARCHITECTURE; DIVERSITY; COMMUNITIES; NESTEDNESS	Supergeneralists, defined as species that interact with multiple groups of species in ecological networks, can act as important connectors of otherwise disconnected species subsets. In Brazil, there are two supergeneralist bees: the honeybee Apis mellifera, a non-native species, and Trigona spinipes, a native stingless bee. We compared the role of both species and the effect of geographic and local factors on networks by addressing three questions: 1) Do both species have similar abundance and interaction patterns (degree and strength) in plant-bee networks? 2) Are both species equally influential to the network structure (nestedness, connectance, and plant and bee niche overlap)? 3) How are these species affected by geographic (altitude, temperature, precipitation) and local (natural vs. disturbed habitat) factors? We analyzed 21 plant-bee weighted interaction networks, encompassing most of the main biomes in Brazil. We found no significant difference between both species in abundance, in the number of plant species with which each bee species interacts (degree), and in the sum of their dependencies (strength). Structural equation models revealed the effect of A. mellifera and T. spinipes, respectively, on the interaction network pattern (nestedness) and in the similarity in bee's interactive partners (bee niche overlap). It is most likely that the recent invasion of A. mellifera resulted in its rapid settlement inside the core of species that retain the largest number of interactions, resulting in a strong influence on nestedness. However, the long-term interaction between native T. spinipes and other bees most likely has a more direct effect on their interactive behavior. Moreover, temperature negatively affected A. mellifera bees, whereas disturbed habitats positively affected T. spinipes. Conversely, precipitation showed no effect. Being positively (T. spinipes) or indifferently (A. mellifera) affected by disturbed habitats makes these species prone to pollinate plant species in these areas, which are potentially poor in pollinators.	[Giannini, Tereza C.; Acosta, Andre L.; Maia, Kate P.; Guimaraes, Paulo R., Jr.; Kleinert, Astrid M. P.] Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil; [Giannini, Tereza C.] Inst Tecnol Vale Desenvolvimento Sustentado, Belem, Para, Brazil; [Garibaldi, Lucas A.] UNRN, Sede Andina, San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Silva, Juliana S.] Inst Fed Educ Ciencia Tecnol Mato Grosso, Cuiaba, Mato Grosso, Brazil; [Saraiva, Antonio M.] Univ Sao Paulo, Escola Politecn, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Federal de Mato Grosso (IFMT); Universidade de Sao Paulo	Giannini, TC (corresponding author), Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil.	giannini@usp.br	Saraiva, Antonio M/B-6350-2011; Acosta, Andre Luis/H-2036-2012; Giannini, Tereza Cristina/AAA-2958-2019; Guimarães-Junior, Paulo R/M-1298-2016; Garibaldi, Lucas A/D-7302-2013; Giannini, Tereza C/F-2676-2012; Maia, Kate P./B-1122-2013; Kleinert, Astrid M.P./A-1486-2008; Saraiva, Antonio/ABC-5330-2021; Guimaraes, Paulo R./E-1915-2016; Silva, Juliana Saragiotto/A-8182-2010	Saraiva, Antonio M/0000-0003-2283-1123; Acosta, Andre Luis/0000-0002-4244-9637; Giannini, Tereza Cristina/0000-0001-9830-1204; Maia, Kate P./0000-0002-2095-5731; Kleinert, Astrid M.P./0000-0003-0550-7452; Saraiva, Antonio/0000-0003-2283-1123; Guimaraes, Paulo R./0000-0001-9161-8305; Silva, Juliana Saragiotto/0000-0002-3711-6432; Garibaldi, Lucas Alejandro/0000-0003-0725-4049	National Counsel of Technological and Scientific Development [CNPq 472702/2013-0]; Sao Paulo Research Foundation [FAPESP 2004/15801-0, 2008/06704-1, 2011/12779-7, 2009/54422-8]; Mato Grosso (FAPEMAT) Research Foundation; Coordination for the Improvement of Higher Level Personnel (CAPES); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp)	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Mato Grosso (FAPEMAT) Research Foundation; Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp)	The authors thank the National Counsel of Technological and Scientific Development (CNPq 472702/2013-0), Sao Paulo (FAPESP 2004/15801-0, 2008/06704-1, 2011/12779-7, 2009/54422-8) and Mato Grosso (FAPEMAT) Research Foundations; Coordination for the Improvement of Higher Level Personnel (CAPES); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); and Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida GF, 2008, THESIS U SAO PAULO; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Biesmeijer Jacobus C., 2005, Biota Neotropica, V5, P1; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Canard EF, 2014, AM NAT, V183, P468, DOI 10.1086/675363; Canard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038295; Carneiro LT, 2012, APIDOLOGIE, V43, P474, DOI 10.1007/s13592-011-0116-7; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; CORTOPASSILAURINO M, 1988, APIDOLOGIE, V19, P1, DOI 10.1051/apido:19880101; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Davey CM, 2013, J ANIM ECOL, V82, P551, DOI 10.1111/1365-2656.12035; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Fox J, 2012, SEM STRUCTURAL EQUAT; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gianquitto T, 2014, AMERICA'S DARWIN: DARWINIAN THEORY AND U.S. LITERARY CULTURE, P1, DOI 10.1007/s13592-014-0316-z; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 2009, ECOLOGIA EVOLUCI ON, P17; Kleinert AMP, 2012, POLINIZADORES BRASIL, P175; Kleinert Astrid de Matos Peixoto, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/291519; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Legendre P., 2012, DEV ENV MODELLING, V24, P265, DOI [10.1016/B978-0-444-42386-3.50001-0, DOI 10.1016/B978-0-444-42386-3.50001-0, 10.1016/B978-0-444-53868-0.50007-1, DOI 10.1016/B978-0-444-53868-0.50007-1]; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Lurgi M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00036; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Gonzalez AMM, 2010, ECOL COMPLEX, V7, P36, DOI 10.1016/j.ecocom.2009.03.008; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Nieh JC, 2005, INSECT SOC, V52, P147, DOI 10.1007/s00040-004-0785-6; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, R LANG ENV STAT COMP; Romanuk TN, 2009, PHILOS T R SOC B, V364, P1743, DOI 10.1098/rstb.2008.0286; ROUBIK DAVID W, 2009, Acta biol.Colomb., V14, P115; Sakagami S. F., 1967, Journal of the Faculty of Science Hokkaido University Zoology, V16, P253; Santos GMD, 2012, BIOL INVASIONS, V14, P2369, DOI 10.1007/s10530-012-0235-8; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Traveset A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3040; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vidal MM, 2014, ECOLOGY, V95, P3440, DOI 10.1890/13-1584.1; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Villanueva R, 2004, APIDOLOGIE, V35, P481, DOI 10.1051/apido:2004041; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002	77	52	53	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137198	10.1371/journal.pone.0137198	http://dx.doi.org/10.1371/journal.pone.0137198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356234	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800033
J	Nyakatura, JA; Allen, VR; Laustroer, J; Andikfar, A; Danczak, M; Ullrich, HJ; Hufenbach, W; Martens, T; Fischer, MS				Nyakatura, John A.; Allen, Vivian R.; Laustroeer, Jonas; Andikfar, Amir; Danczak, Marek; Ullrich, Hans-Juergen; Hufenbach, Werner; Martens, Thomas; Fischer, Martin S.			A Three-Dimensional Skeletal Reconstruction of the Stem Amniote Orobates pabsti (Diadectidae): Analyses of Body Mass, Centre of Mass Position, and Joint Mobility	PLOS ONE			English	Article							ATLAS-AXIS COMPLEX; TERRESTRIAL LOCOMOTION; KINEMATICS; ARCHOSAURS; DINOSAURS; TETRAPODS; ORIGIN; MOTION; PANDERICHTHYS; PERSPECTIVES	Orobates pabsti, a basal diadectid from the lower Permian, is a key fossil for the understanding of early amniote evolution. Quantitative analysis of anatomical information suffers from fragmentation of fossil bones, plastic deformation due to diagenetic processes and fragile preservation within surrounding rock matrix, preventing further biomechanical investigation. Here we describe the steps taken to digitally reconstruct MNG 10181, the holotype specimen of Orobates pabsti, and subsequently use the digital reconstruction to assess body mass, position of the centre of mass in individual segments as well as the whole animal, and study joint mobility in the shoulder and hip joints. The shape of most fossil bone fragments could be recovered from micro-focus computed tomography scans. This also revealed structures that were hitherto hidden within the rock matrix. However, parts of the axial skeleton had to be modelled using relevant isolated bones from the same locality as templates. Based on the digital fossil, mass of MNG 10181 was estimated using a model of body shape that was varied within a plausible range to account for uncertainties of the dimension. In the mean estimate model the specimen had an estimated mass of circa 4 kg. Varying of the mass distribution amongst body segments further revealed that Orobates carried most of its weight on the hind limbs. Mostly unrestricted joint morphology further suggested that MNG 10181 was able to effectively generate propulsion with the pelvic limbs. The digital reconstruction is made available for future biomechanical studies.	[Nyakatura, John A.] Humboldt Univ, Bild Wissen Gestaltung Ein Interdisziplinares Lab, AG Morphol & Formengeschichte, D-10099 Berlin, Germany; [Nyakatura, John A.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Nyakatura, John A.; Allen, Vivian R.; Fischer, Martin S.] Univ Jena, Phyletischem Museum, Inst Spezielle Zool & Evolutionsbiol, Jena, Germany; [Allen, Vivian R.] Royal Vet Coll, Struct & Mot Lab, N Mymms, England; [Laustroeer, Jonas; Andikfar, Amir] Hsch Angew Wissensch, Dept Design, Hamburg, Germany; [Danczak, Marek; Ullrich, Hans-Juergen; Hufenbach, Werner] Tech Univ Dresden, Inst Leichtbau & Kunststofftech, D-01062 Dresden, Germany; [Martens, Thomas] Stiftung Schloss Friedenstein, Museum Nat, Gotha, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Friedrich Schiller University of Jena; University of London; University of London Royal Veterinary College; Hochschule Angewandte Wissenschaft Hamburg; Technische Universitat Dresden	Nyakatura, JA (corresponding author), Humboldt Univ, Bild Wissen Gestaltung Ein Interdisziplinares Lab, AG Morphol & Formengeschichte, D-10099 Berlin, Germany.	john.nyakatura@hu-berlin.de	Nyakatura, John A./AAC-9807-2019	Nyakatura, John A./0000-0001-8088-8684; Hufenbach, Werner/0000-0002-5131-3483	Volkswagen Foundation [858587]	Volkswagen Foundation(Volkswagen)	This study was funded by the Volkswagen Foundation (http://www.volkswagenstiftung.de/; grant number: 858587 to MSF, TM, and JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arnold P, 2014, J ANAT, V225, P31, DOI 10.1111/joa.12187; ASHLEYROSS MA, 1994, J EXP BIOL, V193, P255; Baier DB, 2013, J ANAT, V223, P462, DOI 10.1111/joa.12102; BARCLAY OR, 1946, J EXP BIOL, V23, P177; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Berman David S., 2004, Bulletin of Carnegie Museum of Natural History, V35, P1, DOI 10.2992/0145-9058(2004)35[1:ANDDOP]2.0.CO;2; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Carroll Robert L., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P389; Clack JA, 2002, GAINING GROUND THE O; Clemente CJ, 2013, J EXP BIOL, V216, P3854, DOI 10.1242/jeb.089060; Eberth DA, 2000, PALAIOS, V15, P293, DOI 10.2307/3515538; Edwards JL, 1977, EVOLUTION TERRESTRIA, P553; GAUTHIER JA, 1988, PHYLOGENY CLASSIFICA, V1, P103; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutson JD, 2013, J EXP BIOL, V216, P275, DOI 10.1242/jeb.074229; Hutson JD, 2012, J EXP BIOL, V215, P2030, DOI 10.1242/jeb.069567; Karakasiliotis K, 2013, BIOL CYBERN, V107, P529, DOI 10.1007/s00422-012-0540-4; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; Krause TM, 2006, ABHANDLUNGEN BERICHT, V24, P199; Laurin Michel, 1997, P9, DOI 10.1016/B978-012676460-4/50003-2; Lutzner H, 2012, SCHRIFTENREIHE DTSCH, V61, P418, DOI 10.1127/sdgg/61/2012/418.(InGerman); Mallison H., 2010, PALAEONTOLOGIA ELECT, V13; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Martens T, 2005, 65 ANN M SOC VERT PA, P89; Martens Thomas, 2001, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V23, P45; Martens Thomas, 2009, Zeitschrift fuer Geologische Wissenschaften, V37, P81; Modesto S, 1992, J VERTEBR PALEONTOL, V11, p49A; Molnar J.L., 2012, PALAEONTOL ELECTRON, V15, P18; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; Nyakatura JA, 2014, EVOL BIOL, V41, P175, DOI 10.1007/s11692-013-9266-z; Ogihara N, 2006, AM J PHYS ANTHROPOL, V130, P1, DOI 10.1002/ajpa.20332; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2013, NATURE, V494, P226, DOI 10.1038/nature11825; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Schmidt-Nielsen K., SCALING WHY IS ANIMA; Sellers WI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078733; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; SUMIDA SS, 1992, PHILOS T ROY SOC B, V336, P259, DOI 10.1098/rstb.1992.0060; SUMIDA SS, 1991, J PALEONTOL, V65, P973, DOI 10.1017/S002233600003328X; Sumida Stuart S., 1997, P353, DOI 10.1016/B978-012676460-4/50012-3; TAYLOR CR, 1980, J EXP BIOL, V86, P9; Voigt S, 2007, J VERTEBR PALEONTOL, V27, P553, DOI 10.1671/0272-4634(2007)27[553:FWTAOP]2.0.CO;2; Voigt S, 2011, PALAIOS, V26, P555, DOI 10.2110/palo.2011.p11-014r; Zaaf A, 2001, J EXP BIOL, V204, P1233	52	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137284	10.1371/journal.pone.0137284	http://dx.doi.org/10.1371/journal.pone.0137284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355297	gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800040
J	Bertucci, F; Parmentier, E; Berten, L; Brooker, RM; Lecchini, D				Bertucci, Frederic; Parmentier, Eric; Berten, Laetitia; Brooker, Rohan M.; Lecchini, David			Temporal and Spatial Comparisons of Underwater Sound Signatures of Different Reef Habitats in Moorea Island, French Polynesia	PLOS ONE			English	Article							PELAGIC LARVAE; AMBIENT NOISE; DEEP-OCEAN; FISH; ORIENTATION; BEHAVIOR; CUE	As environmental sounds are used by larval fish and crustaceans to locate and orientate towards habitat during settlement, variations in the acoustic signature produced by habitats could provide valuable information about habitat quality, helping larvae to differentiate between potential settlement sites. However, very little is known about how acoustic signatures differ between proximate habitats. This study described within-and between-site differences in the sound spectra of five contiguous habitats at Moorea Island, French Polynesia: the inner reef crest, the barrier reef, the fringing reef, a pass and a coastal mangrove forest. Habitats with coral (inner, barrier and fringing reefs) were characterized by a similar sound spectrum with average intensities ranging from 70 to 78 dB re 1 mu Pa. Hz(-1). The mangrove forest had a lower sound intensity of 70 dB re 1 mu Pa. Hz-1 while the pass was characterized by a higher sound level with an average intensity of 91 dB re 1 mu Pa. Hz(-1). Habitats showed significantly different intensities for most frequencies, and a decreasing intensity gradient was observed from the reef to the shore. While habitats close to the shore showed no significant diel variation in sound intensities, sound levels increased at the pass during the night and barrier reef during the day. These two habitats also appeared to be louder in the North than in the West. These findings suggest that daily variations in sound intensity and across-reef sound gradients could be a valuable source of information for settling larvae. They also provide further evidence that closely related habitats, separated by less than 1 km, can differ significantly in their spectral composition and that these signatures might be typical and conserved along the coast of Moorea.	[Bertucci, Frederic; Berten, Laetitia; Lecchini, David] CRIOBE, USR CNRS EPHE UPVD 3278, Moorea, France; [Bertucci, Frederic; Parmentier, Eric; Berten, Laetitia] Univ Liege, Lab Morphol Fonct & Evolut, Liege, Belgium; [Brooker, Rohan M.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Lecchini, David] Lab Excellence CORAIL, Moorea, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Liege; University of Delaware	Bertucci, F (corresponding author), CRIOBE, USR CNRS EPHE UPVD 3278, Moorea, France.	fred.bertucci@gmail.com	Brooker, Rohan/AAB-6248-2021; Parmentier, Eric/P-9733-2018	Brooker, Rohan/0000-0001-8739-6914; Bertucci, Frederic/0000-0002-2425-9362	Fond de la Recherche Scientifique (FNRS)	Fond de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Fond de la Recherche Scientifique (FNRS) grant to LB.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; AXELROD EH, 1965, J ACOUST SOC AM, V37, P77, DOI 10.1121/1.1909312; Bacchet P., 2006, GUIDE POISSONS TAHIT; Cato D, 1992, ACOUST AUST, V20, P76; Cato D. H., 2002, Acoustics Australia, V30, P13; CATO DH, 1976, J ACOUST SOC AM, V60, P320, DOI 10.1121/1.381109; Chapman NR, 2011, J ACOUST SOC AM, V129, pE161, DOI 10.1121/1.3567084; Deane GB, 2010, J ACOUST SOC AM, V127, P3394, DOI 10.1121/1.3419774; Galzin R., 1985, P 5 INT COR REEF C T, V1, P73; Gerhardt HC, 2007, SPR HDB AUD, V28, P113; Heenan A, 2008, P INT COR REEF S FT, P554; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; KERMAN BR, 1984, J ACOUST SOC AM, V75, P149, DOI 10.1121/1.390409; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Lecchini D, 2006, ICHTHYOL RES, V53, P298, DOI 10.1007/s10228-006-0340-8; Leis JM, 2005, B MAR SCI, V76, P715; Lenhardt X, 1991, THESIS; Lobel PS, 2010, REPRODUCTION AND SEXUALITY IN MARINE FISHES: PATTERNS AND PROCESSES, P307; Locascio JV, 2005, BIOL LETTERS, V1, P362, DOI 10.1098/rsbl.2005.0309; McCauley R, 2011, WOODSIDE KIMBERLEY S; McCauley RD, 2010, J ACOUST SOC AM, V109, P2391; McCauley RD, 2010, PHILOS T R SOC B, V355, P1289; McCauley RD, 2001, BIOL SEA NOISE NO AU; McCauley RD, 2012, C P AC 2012 FREM NOV; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; Parmentier E, 2015, J FISH BIOL, V86, P1507, DOI 10.1111/jfb.12651; Parmentier E, 2010, MAR BIOL, V157, P2317, DOI 10.1007/s00227-010-1498-1; Parsons M, 2013, ACOUST AUST, V41, P58; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Popper Arthur N., 2003, P3, DOI 10.1007/978-0-387-22628-6_1; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2007, B MAR SCI, V80, P369; SCHWARZ AL, 1985, ENVIRON BIOL FISH, V13, P3, DOI 10.1007/BF00004851; Simpson S, 2011, PLOS ONE, V6, P1; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Tolimieri N, 2004, CORAL REEFS, V23, P184, DOI 10.1007/s00338-004-0383-0; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Tonolla D, 2009, AQUAT SCI, V71, P449, DOI 10.1007/s00027-009-0111-5; Urick RJ, 1972, DEPTH PROFILE AMBIEN; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660	45	33	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135733	10.1371/journal.pone.0135733	http://dx.doi.org/10.1371/journal.pone.0135733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352701	Green Published, gold			2022-12-27	WOS:000360932800013
J	Kriangkum, J; Motz, SN; Mack, T; Beiggi, S; Baigorri, E; Kuppusamy, H; Belch, AR; Johnston, JB; Pilarski, LM				Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Beiggi, Sara; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Johnston, James B.; Pilarski, Linda M.			Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; IDENTIFICATION; EVOLUTION; CLL	The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Single-cell PCR analysis and next-generation immuno-sequencing identified IGH-defined clones. In 23% (18/79) of cases whose clones carried unmutated immunoglobulin heavy chain variable (IGHV) genes (U-CLL), IGH rearrangements were bialleic with one productive (P) and one non-productive (NP) allele. Two U-CLL were biclonal, each clone being monoallelic (P). In 119 IGHV-mutated (M-CLL) cases, one had biallelic rearrangements in their CLL (P/NP) and five had 2-4 distinct clones. Allelic exclusion was maintained in all B-clones analyzed. Based on single-cell PCR analysis, 5/11 partner clones (45%) reached levels of >5x10(9) cells/L, suggesting second CLL clones. Partner clones persisted over years. Conventional IGH characterization and next-generation sequencing of 13 CLL, 3 multiple myeloma, 2 Waldenstrom's macroglobulinemia and 3 age-matched healthy donors consistently identified the same rearranged IGH sequences. Most multiple clones occurred in M-CLL, perhaps indicative of weak clonal dominance, thereby associating with a good prognosis. In contrast, biallelic CLL occurred primarily in U-CLL thus being associated with poor prognosis. Extending beyond intraclonal diversity, molecular analysis of clonal evolution and apparent subclones in CLL may also reflect inter-clonal diversity.	[Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Beiggi, Sara; Johnston, James B.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Alberta; University of Alberta	Pilarski, LM (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	lpilarsk@ualberta.ca						BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chang H, 2006, AM J CLIN PATHOL, V126, P23, DOI 10.1309/0YYF17GFKFJFNP5G; CROSSEN PE, 1993, GENE CHROMOSOME CANC, V8, P49, DOI 10.1002/gcc.2870080109; Gonzalez-Campos J, 1997, ANN HEMATOL, V74, P243, DOI 10.1007/s002770050292; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Henriques A, 2014, HAEMATOLOGICA, V99, P897, DOI 10.3324/haematol.2013.098913; Henriques A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067751; Hsi ED, 2000, AM J CLIN PATHOL, V113, P798, DOI 10.1309/V8AN-A2XP-7TDV-HR0T; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kern W, 2014, BRIT J HAEMATOL, V164, P565, DOI 10.1111/bjh.12652; Kriangkum J, 2007, CLIN CANCER RES, V13, P2005, DOI 10.1158/1078-0432.CCR-06-2788; Kriangkum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064927; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Plevova K, 2014, HAEMATOLOGICA, V99, P329, DOI 10.3324/haematol.2013.087593; Rassenti LZ, 1997, J EXP MED, V185, P1435, DOI 10.1084/jem.185.8.1435; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Sanchez ML, 2003, BLOOD, V102, P2994, DOI 10.1182/blood-2003-01-0045; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Souto-Carneiro MM, 2005, J IMMUNOL, V175, P7425, DOI 10.4049/jimmunol.175.11.7425; Stamatopoulos K, 1996, LEUKEMIA, V10, P1551; Taylor Brian J., 2005, V113, P121, DOI 10.1385/1-59259-916-8:121; Villamor N, 2013, SEMIN HEMATOL, V50, P286, DOI 10.1053/j.seminhematol.2013.09.005	31	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137232	10.1371/journal.pone.0137232	http://dx.doi.org/10.1371/journal.pone.0137232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353109	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800070
J	Bedre, R; Rajasekaran, K; Mangu, VR; Timm, LES; Bhatnagar, D; Baisakh, N				Bedre, Renesh; Rajasekaran, Kanniah; Mangu, Venkata Ramanarao; Timm, Luis Eduardo Sanchez; Bhatnagar, Deepak; Baisakh, Niranjan			Genome-Wide Transcriptome Analysis of Cotton (Gossypium hirsutum L.) Identifies Candidate Gene Signatures in Response to Aflatoxin Producing Fungus Aspergillus flavus	PLOS ONE			English	Article							PLANT DEFENSE GENES; BIOLOGICAL-CONTROL; CHITINASE GENE; ABIOTIC STRESS; NITRIC-OXIDE; RESISTANCE; BIOSYNTHESIS; EXPRESSION; PATHOGEN; CONTAMINATION	Aflatoxins are toxic and potent carcinogenic metabolites produced from the fungi Aspergillus flavus and A. parasiticus. Aflatoxins can contaminate cottonseed under conducive pre-harvest and postharvest conditions. United States federal regulations restrict the use of aflatoxin contaminated cottonseed at >20 ppb for animal feed. Several strategies have been proposed for controlling aflatoxin contamination, and much success has been achieved by the application of an atoxigenic strain of A. flavus in cotton, peanut and maize fields. Development of cultivars resistant to aflatoxin through overexpression of resistance associated genes and/ or knocking down aflatoxin biosynthesis of A. flavus will be an effective strategy for controlling aflatoxin contamination in cotton. In this study, genome-wide transcriptome profiling was performed to identify differentially expressed genes in response to infection with both toxigenic and atoxigenic strains of A. flavus on cotton (Gossypium hirsutum L.) pericarp and seed. The genes involved in antifungal response, oxidative burst, transcription factors, defense signaling pathways and stress response were highly differentially expressed in pericarp and seed tissues in response to A. flavus infection. The cell-wall modifying genes and genes involved in the production of antimicrobial substances were more active in pericarp as compared to seed. The genes involved in auxin and cytokinin signaling were also induced. Most of the genes involved in defense response in cotton were highly induced in pericarp than in seed. The global gene expression analysis in response to fungal invasion in cotton will serve as a source for identifying biomarkers for breeding, potential candidate genes for transgenic manipulation, and will help in understanding complex plant-fungal interaction for future downstream research.	[Bedre, Renesh; Mangu, Venkata Ramanarao; Timm, Luis Eduardo Sanchez; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Rajasekaran, Kanniah; Bhatnagar, Deepak] USDA ARS, So Reg Res Ctr, New Orleans, LA 70124 USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA)	Baisakh, N (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu	Sanchez, Eduardo/AAE-8651-2019; Bedre, Renesh/Q-9617-2018	Sanchez, Eduardo/0000-0001-7712-3605; Bedre, Renesh/0000-0001-8874-5100	United States Department of Agriculture-National Institute of Food and Agriculture (SCA) [58-6435-0-529]	United States Department of Agriculture-National Institute of Food and Agriculture (SCA)	Funded by United States Department of Agriculture-National Institute of Food and Agriculture (SCA# 58-6435-0-529).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asano T, 2012, PLANT SIGNAL BEHAV, V7, P817, DOI 10.4161/psb.20351; Baisakh N, 2001, PLANT BIOTECHNOL-NAR, V18, P101, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.101; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BEARDMORE J, 1983, PHYSIOL PLANT PATHOL, V22, P209; Birkenbihl RP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00076; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; CARDOSOSILVA CB, 2014, PLOS ONE, V9; CHAPPELL J, 1984, NATURE, V311, P76, DOI 10.1038/311076a0; Chen ZY, 1999, PHYTOPATHOLOGY, V89, P902, DOI 10.1094/PHYTO.1999.89.10.902; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cleveland TE, 2004, J TOXICOL-TOXIN REV, V23, P345, DOI 10.1081/TXR-200027892; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; COLLINGE DB, 1987, PLANT MOL BIOL, V9, P389, DOI 10.1007/BF00014913; COTTY PJ, 1994, PHYTOPATHOLOGY, V84, P1270, DOI 10.1094/Phyto-84-1270; Coumans JVF, 2009, PROTEOMICS, V9, P335, DOI 10.1002/pmic.200800251; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dolezal AL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00384; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Dorner JW, 2008, FOOD ADDIT CONTAM A, V25, P203, DOI 10.1080/02652030701658357; Dorner JW, 2004, J TOXICOL-TOXIN REV, V23, P425, DOI 10.1081/TXR-200027877; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Goffard N, 2007, NUCLEIC ACIDS RES, V35, pW176, DOI 10.1093/nar/gkm261; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan X, 2011, PROTOPLASMA, V248, P415, DOI 10.1007/s00709-010-0162-4; Guo BZ, 2011, TOXINS, V3, P737, DOI 10.3390/toxins3070737; Guo RY, 2011, MOL BIOL REP, V38, P49, DOI 10.1007/s11033-010-0076-4; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kelley RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036892; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAWTON MA, 1987, MOL CELL BIOL, V7, P335, DOI 10.1128/MCB.7.1.335; Lee S, 2012, PHYSIOL MOL PLANT P, V80, P35, DOI 10.1016/j.pmpp.2012.08.001; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Lillehoj EB, 1987, P US U CIMMYT MAIZ A; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Luo M, 2011, TOXINS, V3, P766, DOI 10.3390/toxins3070766; Pitt JI, 2006, MYCOPATHOLOGIA, V162, P233, DOI 10.1007/s11046-006-0059-0; Prasad K, 2013, J PLANT BIOCHEM BIOT, V22, P222, DOI 10.1007/s13562-012-0155-9; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Richard J. L., 2003, MYCOTOXINS RISKS PLA; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rohini VK, 2001, PLANT SCI, V160, P889, DOI 10.1016/S0168-9452(00)00462-3; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sanchez-Vallet A, 2012, PLANT PHYSIOL, V160, P2109, DOI 10.1104/pp.112.200154; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Siemens J, 2006, MOL PLANT MICROBE IN, V19, P480, DOI 10.1094/MPMI-19-0480; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; van Egmond HP, 2005, FOOD SCI, V151, P77; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Wang SY, 2012, FOOD RES INT, V45, P116, DOI 10.1016/j.foodres.2011.10.010; Wasternack C, 2014, BIOTECHNOL ADV, V32, P31, DOI 10.1016/j.biotechadv.2013.09.009; Wogan GN, 2000, SEMIN CANCER BIOL, V10, P201, DOI 10.1006/scbi.2000.0320; Wright MS, 2000, TOXICON, V38, P1215, DOI 10.1016/S0041-0101(99)00221-4; Yin YN, 2008, J ZHEJIANG UNIV-SC B, V9, P787, DOI 10.1631/jzus.B0860003; Yoshioka H, 2011, NITRIC OXIDE-BIOL CH, V25, P216, DOI 10.1016/j.niox.2010.12.008; Yu JJ, 2012, OMICS TECHNOLOGIES: TOOLS FOR FOOD SCIENCE, P367; Yu JJ, 2012, TOXINS, V4, P1024, DOI 10.3390/toxins4111024	75	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138025	10.1371/journal.pone.0138025	http://dx.doi.org/10.1371/journal.pone.0138025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366857	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100204
J	Le Bloc'h, J; Leray, V; Nazih, H; Gauthier, O; Serisier, S; Magot, T; Krempf, M; Nguyen, P; Ouguerram, K				Le Bloc'h, Jerom; Leray, Veronique; Nazih, Hassan; Gauthier, Olivier; Serisier, Samuel; Magot, Thierry; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija			Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; EXTENDED-RELEASE NIACIN; PPAR-GAMMA EXPRESSION; APOLIPOPROTEIN-A-I; TRANSFER PROTEIN; SELECTIVE UPTAKE; PLASMA-LIPOPROTEINS; METABOLISM; BINDING; RECEPTOR	Aim Nicotinic acid (NA) treatment decreases plasma triglycerides and increases HDL cholesterol, but the mechanisms involved in these change are not fully understood. A reduction in cholesteryl ester transfer protein (CETP) activity has been advanced to explain most lipid-modulating effects of NA. However, due to the central role of CETP in reverse cholesterol transport in humans, other effects of NA may have been hidden. As dogs have no CETP activity, we conducted this study to examine the specific effects of extended-release niacin (NA) on lipids and high-density lipoprotein (HDL) cholesteryl ester (CE) turnover in obese Insulin-Resistant dogs with increase plasma triglycerides. Methods HDL kinetics were assessed in fasting dogs before and four weeks after NA treatment through endogenous labeling of cholesterol and apolipoprotein AI by simultaneous infusion of [1,2 C-13(2)] acetate and [5,5,5 H-2(3)] leucine for 8 h. Kinetic data were analyzed by compartmental modeling. In vitro cell cholesterol efflux of serum from NA-treated dogs was also measured. Results NA reduced plasma total cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, triglycerides (TG), and very-low-density lipoprotein TG concentrations (p < 0.05). The kinetic study also showed a higher cholesterol esterification rate (p < 0.05). HDL-CE turnover was accelerated (p < 0.05) via HDL removal through endocytosis and selective CE uptake (p < 0.05). We measured an elevated in vitro cell cholesterol efflux (p < 0.05) with NA treatment in accordance with a higher cholesterol esterification. Conclusion NA decreased HDL cholesterol but promoted cholesterol efflux and esterification, leading to improved reverse cholesterol transport. These results highlight the CETP-independent effects of NA in changes of plasma lipid profile.	[Le Bloc'h, Jerom; Krempf, Michel; Ouguerram, Khadija] INRA, UMR 1280, Physiol Adaptat Nutr, F-44093 Nantes, France; [Le Bloc'h, Jerom; Leray, Veronique; Serisier, Samuel; Nguyen, Patrick] LUNAM Univ, Natl Coll Vet Med Food Sci & Engn, Endocrinol & Nutr Unit, Oniris, F-44307 Nantes, France; [Le Bloc'h, Jerom; Leray, Veronique; Nazih, Hassan; Serisier, Samuel; Magot, Thierry; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija] CHU, CRNH, West Human Nutr Res Ctr Nantes, F-44093 Nantes, France; [Nazih, Hassan] IUML Inst Univ Mer & Littoral, CNRS, FR3473, MMS,Mer Mol Sante,EA 2160, Nantes, France; [Gauthier, Olivier] LUNAM Univ, Natl Coll Vet Med Food Sci & Engn, Small Anim Surg Dept, Oniris,Nantes Atlantic, F-44307 Nantes, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Ouguerram, K (corresponding author), INRA, UMR 1280, Physiol Adaptat Nutr, F-44093 Nantes, France.	Khadija.Ouguerram@univ-nantes.fr	Serisier, Samuel/AAI-4608-2020	Nazih, Hassan/0000-0002-3607-295X; Serisier, Samuel/0000-0002-5702-1350; Krempf, Michel/0000-0002-4353-9511				ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Bailhache E, 2003, J ANIM PHYSIOL AN N, V87, P86, DOI 10.1046/j.1439-0396.2003.00419.x; Bailhache E, 2003, METABOLISM, V52, P559, DOI 10.1053/meta.2003.50110; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; BOBERG J, 1966, CLIN CHIM ACTA, V14, P325, DOI 10.1016/0009-8981(66)90109-4; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Czarnecka H, 1996, J BIOL CHEM, V271, P2023, DOI 10.1074/jbc.271.4.2023; DELALLERAMOYA M, 1994, ARTERIOSCLER THROMB, V14, P1056, DOI 10.1161/01.ATV.14.7.1056; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; Frenais R, 1997, DIABETOLOGIA, V40, P578, DOI 10.1007/s001250050718; Goldberg A, 2000, AM J CARDIOL, V85, P1100, DOI 10.1016/S0002-9149(00)00703-7; HA YC, 1982, COMP BIOCHEM PHYS B, V71, P265, DOI 10.1016/0305-0491(82)90252-8; HANEDA K, 1986, TOHOKU J EXP MED, V148, P49, DOI 10.1620/tjem.148.49; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; KHOO JC, 1995, J LIPID RES, V36, P593; KIEFT KA, 1991, J LIPID RES, V32, P859; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Koh Y, 2014, INT J WOMENS HEALTH, V6, P913, DOI 10.2147/IJWH.S69908; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Le DSNT, 2009, METABOLISM, V58, P304, DOI 10.1016/j.metabol.2008.09.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Nieland TJF, 2007, J LIPID RES, V48, P1832, DOI 10.1194/jlr.M700209-JLR200; Ouguerram K, 1996, METABOLISM, V45, P4, DOI 10.1016/S0026-0495(96)90193-6; Ouguerram K, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.29006; Ouguerram K, 2004, COMP BIOCHEM PHYS B, V138, P339, DOI 10.1016/j.cbpc.2004.04.011; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Poynten AM, 2003, METABOLISM, V52, P699, DOI 10.1016/S0026-0495(03)00030-1; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; Siripurkpong P, 2009, J NUTR BIOCHEM, V20, P261, DOI 10.1016/j.jnutbio.2008.02.010; Thacker SG, 2015, J LIPID RES, V56, P1282, DOI 10.1194/jlr.M048629; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Verdoia M, 2015, NUTR METAB CARDIOVAS, V25, P9, DOI 10.1016/j.numecd.2014.09.003; Watts GF, 2008, ARTERIOSCL THROM VAS, V28, P1892, DOI 10.1161/ATVBAHA.108.175224; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Zhang LH, 2012, J LIPID RES, V53, P941, DOI 10.1194/jlr.M020917; Zhao SP, 2008, INT J CARDIOL, V124, P172, DOI 10.1016/j.ijcard.2006.12.032	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136934	10.1371/journal.pone.0136934	http://dx.doi.org/10.1371/journal.pone.0136934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366727	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100035
J	Nwosu, BU; Maranda, L; Cullen, K; Greenman, L; Fleshman, J; McShea, N; Barton, BA; Lee, MM				Nwosu, Benjamin Udoka; Maranda, Louise; Cullen, Karen; Greenman, Lisa; Fleshman, Jody; McShea, Nancy; Barton, Bruce A.; Lee, Mary M.			A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; GLYCEMIC CONTROL; INSULIN; MELLITUS; ADOLESCENTS; CHILDREN	Context Insulin resistance has been proposed as one of the causes of poor glycemic control in overweight/obese youth with type 1 diabetes (T1D). However, the role of adjunctive metformin, an insulin sensitizer, on glycemic control in these patients is unclear. Objective To compare the effect of metformin vs. placebo on hemoglobin A1c (HbA1c), total daily dose (TDD) of insulin, and other parameters in overweight/obese youth with T1D. Hypothesis Adjunctive metformin therapy will improve glycemic control in overweight/obese youth with T1D. Design, Setting, and Participants A 9-mo randomized, double-blind, placebo controlled trial of metformin and placebo in 28 subjects (13m/15f) of ages 10-20years (y), with HbA1c >8% (64 mmol/mol), BMI >85%, and T1D > 12 months was conducted at a university outpatient facility. The metformin group consisted of 15 subjects (8 m/7f), of age 15.0 +/- 2.5 y; while the control group was made up of 13 subjects (5m/8f), of age 14.5 +/- 3.1y. All participants employed a self-directed treat-to-target insulin regimen based on a titration algorithm of (-2)-0-(+2) units to adjust their long-acting insulin dose every 3rd day from -3 mo through +9 mo to maintain fasting plasma glucose (FPG) between 90-120 mg/dL (5.0-6.7 mmol/L). Pubertal maturation was determined by Tanner stage. Results Over the course of the 9 months of observation, the between-treatment differences in HbA1c of 0.4% (9.85% [8.82 to 10.88] for placebo versus 9.46% [8.47 to 10.46] for metformin) was not significant (p = 0.903). There were non-significant reduction in fasting plasma glucose (189.4 mg/dL [133.2 to 245.6] for placebo versus 170.5 mg/dL [114.3 to 226.7] for metformin), (p = 0.927); total daily dose (TDD) of short-acting insulin per kg body weight/day (p = 0.936); and the TDD of long-acting insulin per kg body weight per day (1.15 units/kg/day [0.89 to 1.41] for placebo versus 0.90 units/kg/day [0.64 to 1.16] for metformin) (p = 0.221). There was no difference in the occurrence of hypoglycemia between the groups. Conclusions This 9-month RCT of adjunctive metformin therapy in overweight and obese youth with T1D resulted in a 0.4% lower HbA1c value in the metformin group compared to the placebo group.	[Nwosu, Benjamin Udoka; Cullen, Karen; Greenman, Lisa; Fleshman, Jody; McShea, Nancy; Lee, Mary M.] Univ Massachusetts, Sch Med, Dept Pediat, Div Pediat Endocrinol, Worcester, MA 01655 USA; [Maranda, Louise; Barton, Bruce A.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Pediat Endocrinol, 55 Lake Ave N, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Barton, Bruce/0000-0001-7878-8895; Lee, Mary Min-chin/0000-0003-1985-4594	 [H-13938]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161, UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by grant number: H-13938. http://www.novonordisk.com/science/; http://www.novonordisk-us.com/Images/innovation/terms_final_07032011.pdf. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelghaffar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006691.pub2; Blonde L, 2009, DIABETES OBES METAB, V11, P623, DOI 10.1111/j.1463-1326.2009.01060.x; Chalew SA, 2000, J DIABETES COMPLICAT, V14, P71, DOI 10.1016/S1056-8727(00)00072-6; Codner E, 2013, HORM RES PAEDIAT, V80, P343, DOI 10.1159/000355513; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; DESMANGLES J, 2000, END SOC M; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; Gomez R, 2002, J PEDIATR ENDOCR MET, V15, P1147; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Jacobsen IB, 2009, BASIC CLIN PHARMACOL, V105, P145, DOI 10.1111/j.1742-7843.2009.00380.x; Jones KL, 2002, DIABETES CARE, V25, P89, DOI 10.2337/diacare.25.1.89; Lund SS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003363; Meyer L, 2002, DIABETES CARE, V25, P2153, DOI 10.2337/diacare.25.12.2153; Nadeau KJ, 2015, PEDIATR DIABETES, V16, P196, DOI 10.1111/pedi.12140; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Sacks DB, 2014, JAMA-J AM MED ASSOC, V311, P2271, DOI 10.1001/jama.2014.6342; Sarnblad S, 2003, EUR J ENDOCRINOL, V149, P323, DOI 10.1530/eje.0.1490323; Smith Karen E, 2004, Diabetes Technol Ther, V6, P828, DOI 10.1089/dia.2004.6.828; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Ucar F, 2013, CLIN BIOCHEM, V46, P1548, DOI 10.1016/j.clinbiochem.2013.05.055; Urakami T, 2005, PEDIATR INT, V47, P430, DOI 10.1111/j.1442-200x.2005.02075.x; Vella S, 2011, DIABETOLOGIA, V54, P203, DOI 10.1007/s00125-010-1953-z; Vella S, 2010, DIABETOLOGIA, V53, P809, DOI 10.1007/s00125-009-1636-9; Walravens PA CP, 2000, AM DIAB ASS 60 SCI S; Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774	25	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137525	10.1371/journal.pone.0137525	http://dx.doi.org/10.1371/journal.pone.0137525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367281	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100081
J	Yamamoto, K; Ito, S; Hanafusa, H; Shimizu, K; Ouchida, M				Yamamoto, Kumiko; Ito, Sachio; Hanafusa, Hiroko; Shimizu, Kenji; Ouchida, Mamoru			Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression	PLOS ONE			English	Article							CELL; EXPRESSION; CLUSTER; A20; RNA; MICRORNAS; GENES; FOXP1; IDENTIFICATION; PATHOGENESIS	Micro RNAs (miRNAs) regulate the expression of target genes posttranscriptionally by pairing incompletely with mRNA in a sequence-specific manner. About 30% of human genes are regulated by miRNAs, and a single miRNA is capable of reducing the production of hundreds of proteins by means of incomplete pairing upon miRNA-mRNA binding. Lately, evidence implicating miRNAs in the development of lung cancers has been emerging. In particular, miR-19a, which is highly expressed in malignant lung cancer cells, is considered the key miRNA for tumorigenesis. However, its direct targets remain underreported. In the present study, we focused on six potential miR-19a target genes selected by miRNA target prediction software. To evaluate these genes as direct miR-19a target genes, we performed luciferase, pull-down, and western blot assays. The luciferase activity of plasmids with each miR-19a-binding site was observed to decrease, while increased luciferase activity was observed in the presence of anti-miR-19a locked nucleic acid (LNA). The pull-down assay showed biotinylated miR-19a to bind to AGO2 protein and to four of six potential target mRNAs. Western blot analysis showed that the expression levels of the four genes changed depending on treatment with miR-19a mimic or anti-miR-19a-LNA. Finally, FOXP1, TP53INP1, TNFAIP3, and TUSC2 were identified as miR-19a targets. To examine the function of these four target genes in lung cancer cells, LK79 (which has high miR-19a expression) and A549 (which has low miR-19a expression) were used. The expression of the four target proteins was higher in A549 than in LK79 cells. The four miR-19a target cDNA expression vectors suppressed cell viability, colony formation, migration, and invasion of A549 and LK79 cells, but LK79 cells transfected with FOXP1 and TP53INP1 cDNAs showed no difference compared to the control cells in the invasion assay.	[Yamamoto, Kumiko; Ito, Sachio; Hanafusa, Hiroko; Shimizu, Kenji; Ouchida, Mamoru] Okayama Univ, Dept Mol Genet, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan	Okayama University	Ouchida, M (corresponding author), Okayama Univ, Dept Mol Genet, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591905]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 24591905 to M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-840; Asai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056820; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hao M, 2015, INT J CANCER, V136, P1835, DOI 10.1002/ijc.29199; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lerman MI, 2000, CANCER RES, V60, P6116; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin J, 2011, BIOCHEM BIOPH RES CO, V410, P235, DOI 10.1016/j.bbrc.2011.05.122; Liu FC, 2015, FEBS LETT, V589, P500, DOI 10.1016/j.febslet.2015.01.009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Lu WD, 2014, INT J CLIN EXP PATHO, V7, P7286; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meng JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077067; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Qin J, 2014, GENE, V538, P342, DOI 10.1016/j.gene.2013.12.043; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takayama K, 2014, MOL ENDOCRINOL, V28, P2012, DOI 10.1210/me.2014-1171; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zhang J, 2014, INT J CLIN EXP PATHO, V7, P602; Zhong JF, 2014, INT J MOL SCI, V15, P20355, DOI 10.3390/ijms151120355	49	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137887	10.1371/journal.pone.0137887	http://dx.doi.org/10.1371/journal.pone.0137887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367773	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100167
J	Zingerman, B; Herman-Edelstein, M; Erman, A; Itach, SBS; Ori, Y; Rozen-Zvi, B; Gafter, U; Chagnac, A				Zingerman, Boris; Herman-Edelstein, Michal; Erman, Arie; Itach, Sarit Bar Sheshet; Ori, Yaacov; Rozen-Zvi, Benaya; Gafter, Uzi; Chagnac, Avry			Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial	PLOS ONE			English	Article							BODY-MASS INDEX; FEEDBACK-MEDIATED REDUCTION; TYPE-1 DIABETES-MELLITUS; INDEPENDENT RISK FACTOR; RENAL BLOOD FLOW; LITHIUM CLEARANCE; FILTRATION-RATE; TUBULOGLOMERULAR FEEDBACK; TUBULAR REABSORPTION; METABOLIC SYNDROME	Aims Obesity is an important risk factor for the development of chronic kidney disease. One of the major factors involved in the pathogenesis of obesity-associated kidney disease is glomerular hyperfiltration. Increasing salt-delivery to the macula densa is expected to decrease glomerular filtration rate (GFR) by activating tubuloglomerular feedback. Acetazolamide, a carbonic anhydrase inhibitor which inhibits salt reabsorption in the proximal tubule, increases distal salt delivery. Its effects on obesity-related glomerular hyperfiltration have not previously been studied. The aim of this investigation was to evaluate whether administration of acetazolamide to obese non diabetic subjects reduces glomerular hyperfiltration. Materials and Methods The study was performed using a randomized double-blind crossover design. Obese nondiabetic men with glomerular hyperfiltration were randomized to receive intravenously either acetazolamide or furosemide at equipotent doses. Twelve subjects received the allocated medications. Two weeks later, the same subjects received the drug which they had not received during the first study. Inulin clearance, p-aminohippuric acid clearance and fractional lithium excretion were measured before and after medications administration. The primary end point was a decrease in GFR, measured as inulin clearance. Results GFR decreased by 21% following acetazolamide and did not decrease following furosemide. Renal vascular resistance increased by 12% following acetazolamide, while it remained unchanged following furosemide administration. Natriuresis increased similarly following acetazolamide and furosemide administration. Sodium balance was similar in both groups. Conclusions Intravenous acetazolamide decreased GFR in obese non-diabetic men with glomerular hyperfiltration. Furosemide, administered at equipotent dose, did not affect GFR, suggesting that acetazolamide reduced glomerular hyperfiltration by activating tubuloglomerular feedback.	[Zingerman, Boris; Herman-Edelstein, Michal; Erman, Arie; Itach, Sarit Bar Sheshet; Ori, Yaacov; Rozen-Zvi, Benaya; Gafter, Uzi; Chagnac, Avry] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Zingerman, Boris; Herman-Edelstein, Michal; Erman, Arie; Ori, Yaacov; Rozen-Zvi, Benaya; Gafter, Uzi; Chagnac, Avry] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Chagnac, A (corresponding author), Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel.	chagnac@post.tau.ac.il	rozen-zvi, benaya/AAR-4812-2021					ANDREASEN F, 1989, J PHARMACOL EXP THER, V248, P1182; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; BIRTCH AG, 1967, CIRC RES, V21, P869, DOI 10.1161/01.RES.21.6.869; BOER WH, 1989, KIDNEY INT, V35, P1183, DOI 10.1038/ki.1989.108; BOER WH, 1995, KIDNEY INT, V47, P1023, DOI 10.1038/ki.1995.148; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; BROCHNERMORTENSEN J, 1980, SCAND J CLIN LAB INV, V40, P695, DOI 10.3109/00365518009095584; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; COGAN MG, 1982, AM J PHYSIOL, V242, pF274, DOI 10.1152/ajprenal.1982.242.3.F274; COLUSSI G, 1989, NEPHROL DIAL TRANSPL, V4, P707, DOI 10.1093/ndt/4.8.707; D'Agati VD, 2008, KIDNEY INT, V73, P909, DOI 10.1038/ki.2008.42; GERBER JG, 1983, FED PROC, V42, P1707; GERBER JG, 1980, KIDNEY INT, V18, P454, DOI 10.1038/ki.1980.158; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; GUIDI E, 1995, EXP NEPHROL, V3, P61; Guidi E, 2001, AM J HYPERTENS, V14, P121, DOI 10.1016/S0895-7061(00)01238-3; GUTSCHE HU, 1984, CAN J PHYSIOL PHARM, V62, P412, DOI 10.1139/y84-065; HANNEDOUCHE T, 1991, CLIN SCI, V81, P457, DOI 10.1042/cs0810457; HANNEDOUCHE TP, 1990, KIDNEY INT, V37, P1126, DOI 10.1038/ki.1990.95; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; JOHNSTON PA, 1992, METHOD FIND EXP CLIN, V14, P523; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; KOOMANS HA, 1989, KIDNEY INT, V36, P2, DOI 10.1038/ki.1989.153; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kwakernaak AJ, 2013, J AM SOC NEPHROL, V24, P987, DOI 10.1681/ASN.2012050460; LEYSSAC PP, 1991, AM J PHYSIOL, V261, pF169, DOI 10.1152/ajprenal.1991.261.1.F169; Lorenz JN, 1999, AM J PHYSIOL-RENAL, V277, pF447, DOI 10.1152/ajprenal.1999.277.3.F447; LUDENS JH, 1968, J PHARMACOL EXP THER, V163, P456; Masud T, 2002, KIDNEY INT, V62, P1750, DOI 10.1046/j.1523-1755.2002.00606.x; MATHISEN O, 1976, SCAND J CLIN LAB INV, V36, P617, DOI 10.3109/00365517609054486; MEES EJD, 1990, AM J PHYSIOL, V258, pF1100, DOI 10.1152/ajprenal.1990.258.4.F1100; Meier-Kriesche HU, 2002, TRANSPLANTATION, V73, P70, DOI 10.1097/00007890-200201150-00013; Munger KA, 2012, BRENNER RECTORS KIDN, DOI DOI 10.1016/B978-1-4160-6193-9.10003-X; Ogna A, 2015, EUR J NUTR; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Pecly IMD, 2006, INT J CLIN PRACT, V60, P1198, DOI 10.1111/j.1742-1241.2006.01037.x; PERSSON AEG, 1982, ACTA PHYSIOL SCAND, V114, P1, DOI 10.1111/j.1748-1716.1982.tb06945.x; Porter LE, 1998, HYPERTENSION, V32, P144, DOI 10.1161/01.HYP.32.1.144; Praga M, 2005, NEPHROL DIAL TRANSPL, V20, P2594, DOI 10.1093/ndt/gfi201; PUSCHETT JB, 1968, J LAB CLIN MED, V71, P666; PUSCHETT JB, 1969, J LAB CLIN MED, V73, P956; RADTKE HW, 1972, KIDNEY INT, V1, P100, DOI 10.1038/ki.1972.13; REISIN E, 1987, J HYPERTENS, V5, P397; Reiss WG, 1996, ANN PHARMACOTHER, V30, P514, DOI 10.1177/106002809603000515; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Ritz E, 2011, CURR OPIN NEPHROL HY, V20, P44, DOI 10.1097/MNH.0b013e3283414ca1; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; SEELY JF, 1977, KIDNEY INT, V11, P1, DOI 10.1038/ki.1977.1; SKOTT P, 1988, DIABETOLOGIA, V31, P806; SKOTT P, 1989, SCAND J CLIN LAB INV, V49, P583, DOI 10.3109/00365518909089139; Slomowitz LA, 1996, AM J NEPHROL, V16, P315, DOI 10.1159/000169016; STEELE TH, 1975, NEPHRON, V14, P48, DOI 10.1159/000180435; Strazzullo P, 2001, J HYPERTENS, V19, P2157, DOI 10.1097/00004872-200112000-00007; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; TUCKER BJ, 1978, J CLIN INVEST, V62, P993, DOI 10.1172/JCI109229; Vallon V, 1999, J AM SOC NEPHROL, V10, P2569; Vallon V, 2003, J AM SOC NEPHROL, V14, P530, DOI 10.1097/01.ASN.0000051700.07403.27; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; WRIGHT FS, 1974, J CLIN INVEST, V53, P1695, DOI 10.1172/JCI107721; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; YEYATI NL, 1992, RENAL PHYSIOL BIOCH, V15, P99	69	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137163	10.1371/journal.pone.0137163	http://dx.doi.org/10.1371/journal.pone.0137163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367377	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100054
J	Amano, C; Minematsu, H; Fujita, K; Iwashita, S; Adachi, M; Igarashi, K; Hinuma, S				Amano, Chie; Minematsu, Hideki; Fujita, Kazuyo; Iwashita, Shinki; Adachi, Masaki; Igarashi, Koichi; Hinuma, Shuji			Nanoparticles Containing Curcumin Useful for Suppressing Macrophages In Vivo in Mice	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; LIPOSOME; CELLS; TUMOR; PROLIFERATION; ACCUMULATION; INFLAMMATION; REGION; DRUGS	To explore a novel method using liposomes to suppress macrophages, we screened food constituents through cell culture assays. Curcumin was one of the strongest compounds exhibiting suppressive effects on macrophages. We subsequently tried various methods to prepare liposomal curcumin, and eventually succeeded in preparing liposomes with sufficient amounts of curcumin to suppress macrophages by incorporating a complex of curcumin and bovine serum albumin. The diameter of the resultant nanoparticles, the liposomes containing curcumin, ranged from 60 to 100 nm. Flow cytometric analyses revealed that after intraperitoneal administration of the liposomes containing curcumin into mice, these were incorporated mainly by macrophages positive for F4/80, CD36, and CD11b antigens. Peritoneal cells prepared from mice injected in vivo with the liposomes containing curcumin apparently decreased interleukin-6-producing activities. Major changes in body weight and survival rates in the mice were not observed after administrating the liposomes containing curcumin. These results indicate that the liposomes containing curcumin are safe and useful for the selective suppression of macrophages in vivo in mice.	[Amano, Chie; Minematsu, Hideki; Iwashita, Shinki; Adachi, Masaki; Igarashi, Koichi] Katayama Chem Ind Co Ltd, R&D Div, Minoh City, Osaka, Japan; [Fujita, Kazuyo; Hinuma, Shuji] Senri Kinran Univ, Fac Human Life Sci, Dept Food & Nutr, Suita, Osaka, Japan		Hinuma, S (corresponding author), Katayama Chem Ind Co Ltd, R&D Div, Minoh City, Osaka, Japan.	s-hinuma@cs.kinran.ac.jp			Senri Kinran University; Katayama Chemical Industries, Co., Ltd.; JSPS KAKENHI Grant [23500941]	Senri Kinran University; Katayama Chemical Industries, Co., Ltd.; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Senri Kinran University, Katayama Chemical Industries, Co., Ltd., and JSPS KAKENHI Grant Number 23500941 (http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors CA, HM, SI and MA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Ben-Efraim S, 1992, Mediators Inflamm, V1, P295, DOI 10.1155/S0962935192000449; Biskobing DM, 1997, ENDOCRINOLOGY, V138, P4852, DOI 10.1210/en.138.11.4852; Capini C, 2009, J IMMUNOL, V182, P3556, DOI 10.4049/jimmunol.0802972; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; HARRIGAN PR, 1993, BIOCHIM BIOPHYS ACTA, V1149, P329, DOI 10.1016/0005-2736(93)90218-O; HINUMA S, 1989, MICROBIOL IMMUNOL, V33, P761, DOI 10.1111/j.1348-0421.1989.tb00962.x; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Inokuchi C, 2009, EXP ANIM TOKYO, V58, P383, DOI 10.1538/expanim.58.383; Iwasa S, 2011, YAKUGAKU ZASSHI, V131, P1111, DOI 10.1248/yakushi.131.1111; KUMAGAI K, 1979, J IMMUNOL METHODS, V29, P17, DOI 10.1016/0022-1759(79)90121-2; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Licinska I, 2002, J NUCL MED, V5, P145; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V857, P123, DOI 10.1016/0005-2736(86)90105-7; Naksuriya O, 2014, BIOMATERIALS, V35, P3365, DOI 10.1016/j.biomaterials.2013.12.090; Nicaise P, 1999, EUR CYTOKINE NETW, V10, P365; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Sanders A, 1994, J IMMUNOL METHODS, V174, P83; SCHOOK LB, 1983, J IMMUNOL, V130, P661; Ushio Y, 1996, MICROBIOL IMMUNOL, V40, P489, DOI 10.1111/j.1348-0421.1996.tb01099.x; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Wang FP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/737264; Yachi K, 1996, BIOPHARM DRUG DISPOS, V17, P589, DOI 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.3.CO;2-4; YAMAZAKI N, 1994, METHOD ENZYMOL, V242, P56; YAMAZAKI N, 1989, J MEMBRANE SCI, V41, P249, DOI 10.1016/S0376-7388(00)82406-0; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	30	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137207	10.1371/journal.pone.0137207	http://dx.doi.org/10.1371/journal.pone.0137207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361331	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100025
J	Buss, LW; Anderson, CP; Perry, EK; Buss, ED; Bolton, EW				Buss, Leo W.; Anderson, Christopher P.; Perry, Elena K.; Buss, Evan D.; Bolton, Edward W.			Nutrient Distribution and Absorption in the Colonial Hydroid Podocoryna carnea Is Sequentially Diffusive and Directional	PLOS ONE			English	Article							HYDRACTINIA-SYMBIOLONGICARPUS CNIDARIA; STEADY STATE GROWTH; TISSUE DYNAMICS; CELL MOVEMENTS; CAMPANULARIA FLEXUOSA; NUTRITIVE ENDOCYTOSIS; DIGESTIVE CELLS; STOLON; LITTORALIS; PHYSIOLOGY	The distribution and absorption of ingested protein was characterized within a colony of Podocoryna carnea when a single polyp was fed. Observations were conducted at multiple spatial and temporal scales at three different stages of colony ontogeny with an artificial food item containing Texas Red conjugated albumin. Food pellets were digested and all tracer absorbed by digestive cells within the first 2-3 hours post-feeding. The preponderance of the label was located in the fed polyp and in a transport-induced diffusion pattern surrounding the fed polyp. After 6 hours post-feeding particulates re-appeared in the gastrovascular system and their absorption increased the area over which the nutrients were distributed, albeit still in a pattern that was centered on the fed polyp. At later intervals, tracer became concentrated in some stolon tips, but not in others, despite the proximity of these stolons either to the fed polyp or to adjacent stolons receiving nutrients. Distribution and absorption of nutrients is sequentially diffusive and directional.	[Buss, Leo W.; Anderson, Christopher P.; Perry, Elena K.; Buss, Evan D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Buss, Leo W.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Bolton, Edward W.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; Yale University	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	leo.buss@yale.edu		Perry, Elena/0000-0002-7151-1479				AFZELIUS BA, 1965, Z ZELLFORSCH MIK ANA, V67, P24, DOI 10.1007/BF00339274; Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; BERRILL NJ, 1949, Q J MICROSC SCI, V90, P235; BERRILL NJ, 1949, J MORPHOL, V84, P1, DOI 10.1002/jmor.1050840102; Beutler R, 1924, J COMP PHYSL, V1, P1; Bird R. B., 2002, INTERPHASE TRANSPORT; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BOARDMAN RS, 1973, ANIMAL COLONIES; BRAVERMAN M, 1971, J MORPHOL, V135, P131, DOI 10.1002/jmor.1051350202; BRAVERMAN M, 1968, J MORPHOL, V126, P95, DOI 10.1002/jmor.1051260106; Braverman M, 1966, CNIDARIA THEIR EVOLU, P169; Braverman M, 1974, ANN REV OCEANOGRAPHY, V12, P129; Brien P., 1951, Bulletin de la Societe Zoologique de France, V76, P277; Brien P., 1949, Bulletin Biologique de la France et de la Belgique, V83, P293; Bumann D, 2008, INVERTEBR BIOL, V127, P368, DOI 10.1111/j.1744-7410.2008.00135.x; BURNETT AL, 1961, J EXP ZOOL, V146, P21, DOI 10.1002/jez.1401460105; Buss LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072221; Buss LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048914; Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3; Cadavid LF, 2004, GENETICS, V167, P357, DOI 10.1534/genetics.167.1.357; CAMPBELL RD, 1967, J EMBRYOL EXP MORPH, V17, P607; CAMPBELL RD, 1967, J EXP ZOOL, V164, P379, DOI 10.1002/jez.1401640308; CAMPBELL RD, 1967, DEV BIOL, V15, P487, DOI 10.1016/0012-1606(67)90039-5; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; CARTWRIGHT P, 2006, J EXP ZOOL PART B, V306, P1; Cook CB, 1979, CYTOBIOS, V89, P17; CROWELL S, 1957, J EXP ZOOL, V134, P63, DOI 10.1002/jez.1401340104; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; GAUTHIER GF, 1963, J EXP ZOOL, V152, P13, DOI 10.1002/jez.1401520104; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; Hale LJ, 1960, Q J MICROSC SCI, V101, P39; Hamann O, 1882, JENA Z NATURISS, V15, P473; HUNDGEN M, 1978, MAR BIOL, V45, P79, DOI 10.1007/BF00388979; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kosevich I. A., 2006, Russian Journal of Developmental Biology, V37, P90, DOI 10.1134/S1062360406020056; Kuhn A., 1914, ERG FORTSCHR ZOOL, P1; LARWOOD G, 1979, BIOL SYSTEMATICS COL; LENHOFF HM, 1961, EXP CELL RES, V23, P335, DOI 10.1016/0014-4827(61)90043-X; LENTZ T, 1966, CELL BIOL HYDRA; LENTZ TL, 1965, J ULTRA MOL STRUCT R, V13, P192, DOI 10.1016/S0022-5320(65)80096-X; LUNGER PD, 1963, J ULTRA MOL STRUCT R, V9, P362, DOI 10.1016/S0022-5320(63)80012-X; McConnell CH, 1931, J MORPHOL, V52, P249, DOI 10.1002/jmor.1050520112; MCNEIL PL, 1981, J CELL SCI, V49, P311; MCNEIL PL, 1984, TISSUE CELL, V16, P519, DOI 10.1016/0040-8166(84)90028-4; Metschnikoff E, 1880, ZOOL ANZ, V3, P261; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; OVERTON J, 1963, J CELL BIOL, V17, P661, DOI 10.1083/jcb.17.3.661; Parker J, 1879, P ROY SOC LONDON, V30, P61; Powell AE, 2007, GENETICS, V177, P2101, DOI 10.1534/genetics.107.075689; Powell AE, 2011, G3-GENES GENOM GENET, V1, P499, DOI 10.1534/g3.111.001149; Rees J, 1970, COMP BIOCH PHYSL, V1970, P309; SHOSTAK S, 1967, DEV BIOL, V15, P451, DOI 10.1016/0012-1606(67)90037-1; SHOSTAK S, 1967, SCIENCE, V155, P1567, DOI 10.1126/science.155.3769.1567; SLAUTTERBACK DB, 1967, J CELL SCI, V2, P563; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; STREHLER BL, 1961, GERONTOLOGY, V5, P1; TRIPP KARL, 1928, ZEITSCHR WISS ZOOL [KORSCHELT FESTBAND], V132, P476; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1973, J MORPHOL, V139, P363, DOI 10.1002/jmor.1051390306; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699	66	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136814	10.1371/journal.pone.0136814	http://dx.doi.org/10.1371/journal.pone.0136814			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359660	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100015
J	Geraedts, HAE; Zijlstra, W; Van Keeken, HG; Zhang, W; Stevens, M				Geraedts, Hilde A. E.; Zijlstra, Wiebren; Van Keeken, Helco G.; Zhang, Wei; Stevens, Martin			Validation and User Evaluation of a Sensor-Based Method for Detecting Mobility-Related Activities in Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; AMBULATORY SYSTEM; GAIT; CLASSIFICATION; ACCELEROMETER; POSTURES; FRAIL; RELIABILITY; ACCURACY; BALANCE	Regular physical activity is essential for older adults to stay healthy and independent. However, daily physical activity is generally low among older adults and mainly consists of activities such as standing and shuffling around indoors. Accurate measurement of this low-energy expenditure daily physical activity is crucial for stimulation of activity. The objective of this study was to assess the validity of a necklace-worn sensor-based method for detecting time-on-legs and daily life mobility related postures in older adults. In addition user opinion about the practical use of the sensor was evaluated. Twenty frail and non-frail older adults performed a standardized and free movement protocol in their own home. Results of the sensor-based method were compared to video observation. Sensitivity, specificity and overall agreement of sensor outcomes compared to video observation were calculated. Mobility was assessed based on time-on-legs. Further assessment included the categories standing, sitting, walking and lying. Time-on-legs based sensitivity, specificity and percentage agreement were good to excellent and comparable to laboratory outcomes in other studies. Category-based sensitivity, specificity and overall agreement were moderate to excellent. The necklace-worn sensor is considered an acceptable valid instrument for assessing home-based physical activity based upon time-on-legs in frail and non-frail older adults, but category-based assessment of gait and postures could be further developed.	[Geraedts, Hilde A. E.; Zijlstra, Wiebren; Van Keeken, Helco G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Zijlstra, Wiebren] German Sport Univ Cologne, Inst Movement & Sport Gerontol, Cologne, Germany; [Zhang, Wei] Philips Res Europe, Eindhoven, Netherlands; [Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands	University of Groningen; German Sport University Cologne; Philips; Philips Research; University of Groningen	Geraedts, HAE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	H.A.E.Geraedts@med.umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; Zhang, Wei/0000-0002-6022-6832	Netherlands Organisation for Health Research and Development (ZonMw) [40-00812-98-09014]; Philips Research Europe	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Philips Research Europe	This study is funded by The Netherlands Organisation for Health Research and Development (ZonMw; website URL http://www.zonmw.nl/en/), funder approval number 40-00812-98-09014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was performed using technology and expertise provided by Philips Research Europe. Philips Research Europe provided support in the form of a salary for author W. Zhang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Aminian K, 2004, GAIT POSTURE, V20, P102, DOI 10.1016/S0966-6362(03)00093-6; Annegarn J, 2011, ARCH PHYS MED REHAB, V92, P1852, DOI 10.1016/j.apmr.2011.06.021; Bagala F, 2013, IEEE T NEUR SYS REH, V21, P624, DOI 10.1109/TNSRE.2012.2230189; Bergmann JHM, 2011, ANN BIOMED ENG, V39, P2299, DOI 10.1007/s10439-011-0339-9; Bergmann JHM, 2012, SENSORS-BASEL, V12, P16695, DOI 10.3390/s121216695; Blikman T, 2013, J ORTHOP SPORT PHYS, V43, P650, DOI 10.2519/jospt.2013.4422; Bussmann JBJ, 1998, PAIN, V74, P153, DOI 10.1016/S0304-3959(97)00161-9; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Fleiss JL, 1981, STAT METHODS; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Ganea R, 2012, IEEE T NEUR SYS REH, V20, P688, DOI 10.1109/TNSRE.2012.2202691; Godfrey A, 2011, MED ENG PHYS, V33, P1127, DOI 10.1016/j.medengphy.2011.05.002; Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587; Laufer Y, 2002, CLIN REHABIL, V16, P141, DOI 10.1191/0269215502cr481oa; Lindemann U, 2014, SENSORS-BASEL, V14, P1267, DOI 10.3390/s140101267; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Paraschiv-Ionescu A, 2004, GAIT POSTURE, V20, P113, DOI 10.1016/j.gaitpost.2003.07.005; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rydwik E, 2008, AGING CLIN EXP RES, V20, P159; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Steverink N, 2001, GERONTOLOGIST, V41, P236; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Taylor LM, 2014, ARCH PHYS MED REHAB, V95, P930, DOI 10.1016/j.apmr.2014.01.013; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tung JY, 2014, GAIT POSTURE, V39, P991, DOI 10.1016/j.gaitpost.2013.11.015; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; World Health Organization, PHYSICAL ACTIVITY AN; Zeng HS, 2011, SENSORS-BASEL, V11, P638, DOI 10.3390/s110100638; Zhang W, 2014, IEEE ENG MED BIO, P1830, DOI 10.1109/EMBC.2014.6943965	36	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137668	10.1371/journal.pone.0137668	http://dx.doi.org/10.1371/journal.pone.0137668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361009	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100071
J	Nelson, BS; Donovan, JM; Takahashi, TT				Nelson, Brian S.; Donovan, Jeff M.; Takahashi, Terry T.			A Neural Model of Auditory Space Compatible with Human Perception under Simulated Echoic Conditions	PLOS ONE			English	Article							INTERAURAL TIME; SOUND LOCALIZATION; INFERIOR COLLICULUS; LOW-FREQUENCY; PRECEDENCE; SENSITIVITY; ENVELOPE; CUES; DOMINANCE; LATERALIZATION	In a typical auditory scene, sounds from different sources and reflective surfaces summate in the ears, causing spatial cues to fluctuate. Prevailing hypotheses of how spatial locations may be encoded and represented across auditory neurons generally disregard these fluctuations and must therefore invoke additional mechanisms for detecting and representing them. Here, we consider a different hypothesis in which spatial perception corresponds to an intermediate or sub-maximal firing probability across spatially selective neurons within each hemisphere. The precedence or Haas effect presents an ideal opportunity for examining this hypothesis, since the temporal superposition of an acoustical reflection with sounds arriving directly from a source can cause otherwise stable cues to fluctuate. Our findings suggest that subjects' experiences may simply reflect the spatial cues that momentarily arise under various acoustical conditions and how these cues are represented. We further suggest that auditory objects may acquire "edges" under conditions when interaural time differences are broadly distributed.	[Nelson, Brian S.; Donovan, Jeff M.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nelson, BS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	bsnelson@uoregon.edu			University of Oregon Academic Support Account; NIDCD [R01-DC003925]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003925] Funding Source: NIH RePORTER	University of Oregon Academic Support Account; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported in part by the University of Oregon Academic Support Account; the present experiments are also based on prior work in the owl supported by a grant from the NIDCD: Grant No. R01-DC003925.	Akeroyd MA, 2001, J ACOUST SOC AM, V110, P2516, DOI 10.1121/1.1412442; Baxter CS, 2013, J NEUROPHYSIOL, V109, P924, DOI 10.1152/jn.00755.2012; Best V, 2004, J ACOUST SOC AM, V115, P324, DOI 10.1121/1.1632484; Bianchi F, 2013, JARO-J ASSOC RES OTO, V14, P767, DOI 10.1007/s10162-013-0406-z; BLAUERT J, 1988, ACUSTICA, V66, P267; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Blauert J., 1997, SPATIAL HEARING PSYC; Braasch J., 2003, Acoustical Science and Technology, V24, P293, DOI 10.1250/ast.24.293; Braasch J, 2013, J ACOUST SOC AM, V134, P420, DOI 10.1121/1.4807829; Brown AD, 2015, JARO-J ASSOC RES OTO, V16, P1, DOI 10.1007/s10162-014-0496-2; Brown AD, 2013, J ACOUST SOC AM, V133, P2883, DOI 10.1121/1.4796113; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Cazettes F, 2014, ELIFE, V3, DOI 10.7554/eLife.04854; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; Dietz M, 2015, J ACOUST SOC AM, V137, pEL137, DOI 10.1121/1.4905891; Dietz M, 2014, J NEUROPHYSIOL, V111, P1973, DOI 10.1152/jn.00681.2013; Dizon RM, 2006, J ACOUST SOC AM, V119, P2947, DOI 10.1121/1.2189451; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; Donovan JM, 2012, J ACOUST SOC AM, V132, P3912, DOI 10.1121/1.4764877; Faller C, 2004, J ACOUST SOC AM, V116, P3075, DOI 10.1121/1.1791872; GABRIEL KJ, 1981, J ACOUST SOC AM, V69, P1394, DOI 10.1121/1.385821; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAAS H, 1951, ACUSTICA, V1, P49; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hartung K, 2001, J ACOUST SOC AM, V110, P1505, DOI 10.1121/1.1390339; HOUTGAST T, 1994, HEARING RES, V72, P29, DOI 10.1016/0378-5955(94)90202-X; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Joris PX, 2003, J NEUROSCI, V23, P6345; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 2001, J ACOUST SOC AM, V109, P346, DOI 10.1121/1.1328792; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Meffin H, 2009, J ACOUST SOC AM, V126, P2437, DOI 10.1121/1.3238239; Nelson BS, 2010, NEURON, V67, P643, DOI 10.1016/j.neuron.2010.07.014; Nelson BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003598; PERROTT D R, 1987, Journal of Auditory Research, V27, P59; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; RAJAN R, 1990, J NEUROPHYSIOL, V64, P872, DOI 10.1152/jn.1990.64.3.872; SHINNCUNNINGHAM BG, 1995, J ACOUST SOC AM, V98, P164, DOI 10.1121/1.413752; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Stecker GC, 2014, J ACOUST SOC AM, V135, P3541, DOI 10.1121/1.4876179; Tollin DJ, 1998, J ACOUST SOC AM, V104, P3030, DOI 10.1121/1.423884; Tollin DJ, 1999, J ACOUST SOC AM, V105, P838, DOI 10.1121/1.426273; Tollin DJ., 1998, P NATO ADV STUD I CO, P77; Trahiotis C, 2002, HEARING RES, V168, P55, DOI 10.1016/S0378-5955(02)00357-X; von Bekesy G, 1930, PHYS Z, V31, P824; Wagner H, 2007, J NEUROSCI, V27, P4191, DOI 10.1523/JNEUROSCI.5250-06.2007; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; WENSTRUP JJ, 1986, J NEUROSCI, V6, P962; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; Yost WA, 2013, J ACOUST SOC AM, V133, P2301, DOI 10.1121/1.4792155; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974	56	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137900	10.1371/journal.pone.0137900	http://dx.doi.org/10.1371/journal.pone.0137900			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355676	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800088
J	Okolicsanyi, RK; Camilleri, ET; Oikari, LE; Yu, C; Cool, SM; van Wijnen, AJ; Griffiths, LR; Haupt, LM				Okolicsanyi, Rachel K.; Camilleri, Emily T.; Oikari, Lotta E.; Yu, Chieh; Cool, Simon M.; van Wijnen, Andre J.; Griffiths, Lyn R.; Haupt, Larisa M.			Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion	PLOS ONE			English	Article							HUMAN-BONE-MARROW; III BETA-TUBULIN; CD44 VARIANT ISOFORMS; STROMAL CELLS; PROGENITOR CELLS; PERIPHERAL-BLOOD; SELF-RENEWAL; ADULT; CULTURES; NESTIN	The suitability of human mesenchymal stem cells (hMSCs) in regenerative medicine relies on retention of their proliferative expansion potential in conjunction with the ability to differentiate toward multiple lineages. Successful utilisation of these cells in clinical applications linked to tissue regeneration requires consideration of biomarker expression, time in culture and donor age, as well as their ability to differentiate towards mesenchymal (bone, cartilage, fat) or non-mesenchymal (e. g., neural) lineages. To identify potential therapeutic suitability we examined hMSCs after extended expansion including morphological changes, potency (stemness) and multilineage potential. Commercially available hMSC populations were expanded in vitro for > 20 passages, equating to > 60 days and > 50 population doublings. Distinct growth phases (A-C) were observed during serial passaging and cells were characterised for stemness and lineage markers at representative stages (Phase A: P+ 5, approximately 13 days in culture; Phase B: P+ 7, approximately 20 days in culture; and Phase C: P+ 13, approximately 43 days in culture). Cell surface markers, stem cell markers and lineage-specific markers were characterised by FACS, ICC and Q-PCR revealing MSCs maintained their multilineage potential, including neural lineages throughout expansion. Co-expression of multiple lineage markers along with continued CD45 expression in MSCs did not affect completion of osteogenic and adipogenic specification or the formation of neurospheres. Improved standardised isolation and characterisation of MSCs may facilitate the identification of biomarkers to improve therapeutic efficacy to ensure increased reproducibility and routine production of MSCs for therapeutic applications including neural repair.	[Okolicsanyi, Rachel K.; Oikari, Lotta E.; Yu, Chieh; Griffiths, Lyn R.; Haupt, Larisa M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld 4001, Australia; [Camilleri, Emily T.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg & Biochem & Mol Biol, Rochester, MN USA; [Cool, Simon M.] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore, Singapore	Queensland University of Technology (QUT); Mayo Clinic; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Haupt, LM (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld 4001, Australia.	larisa.haupt@qut.edu.au	Haupt, Larisa M/C-6066-2017; Cool, Simon/W-1257-2018; van Wijnen, Andre J./AAG-3578-2019; Oikari, Lotta/AAZ-2508-2020; Cool, Simon McKenzie/AAG-4346-2021	Haupt, Larisa M/0000-0002-7735-8110; Cool, Simon/0000-0001-8543-3056; van Wijnen, Andre J./0000-0002-4458-0946; Oikari, Lotta/0000-0001-7821-8622; Okolicsanyi, Rachel/0000-0002-3488-4559; Yu, Chieh/0000-0003-3712-5491; Camilleri, Emily/0000-0001-8982-6770	Australian Postgraduate Award; Estate of the late Clem Jones, AO; National Institutes of Health [R01 AR049069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	Australian Postgraduate Award(Australian Government); Estate of the late Clem Jones, AO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by an Australian Postgraduate Award stipend (RKO), and the support of the Estate of the late Clem Jones, AO (LMH and LRG). In addition, we appreciate the philanthropic support of William and Karen Eby (AJvW and ETC), as well as a grant from the National Institutes of Health (R01 AR049069 to AJvW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, INT J MOL MED, V18, P233; Ahmed S, 2009, CELL ADHES MIGR, V3, P412, DOI 10.4161/cam.3.4.8803; Alexanian AR, 2005, EXP CELL RES, V310, P383, DOI 10.1016/j.yexcr.2005.08.015; ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bieback Karen, 2007, Curr Stem Cell Res Ther, V2, P310, DOI 10.2174/157488807782793763; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Cai N, 2012, CEREBELLUM, V11, P181, DOI 10.1007/s12311-011-0294-x; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Choi MR, 2012, EXP MOL MED, V44, P503, DOI 10.3858/emm.2012.44.8.057; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; Deschaseaux F, 2003, BRIT J HAEMATOL, V122, P506, DOI 10.1046/j.1365-2141.2003.04469.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Foudah D, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987678; Foudah D, 2013, CELL MOL BIOL LETT, V18, P163, DOI 10.2478/s11658-013-0083-2; Foudah D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/820821; FOX SB, 1994, CANCER RES, V54, P4539; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Haupt LM, 2009, CURR CANCER THER REV, V5, P256, DOI 10.2174/157339409789712672; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Ichikawa H, 1999, BRAIN RES, V838, P205, DOI 10.1016/S0006-8993(99)01710-2; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kishaba Y, 2010, PATHOL INT, V60, P378, DOI 10.1111/j.1440-1827.2010.02532.x; KOOPMAN G, 1993, J EXP MED, V177, P897, DOI 10.1084/jem.177.4.897; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Lee S, 2005, EUR J CELL BIOL, V84, P453, DOI 10.1016/j.ejcb.2004.11.001; Lei T, 2013, DOMEST ANIM ENDOCRIN, V45, P28, DOI 10.1016/j.domaniend.2013.03.003; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; Maslova O. O., 2012, Biopolymers and Cell, V28, P190; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Okolicsanyi RK, 2014, DEV BIOL; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Parte S, 2011, STEM CELLS DEV, V20, P1451, DOI 10.1089/scd.2010.0461; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Piras F, 2010, ONCOL REP, V23, P17, DOI 10.3892/or_00000601; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Ragni E, 2013, INT J BIOCHEM CELL B, V45, P2456, DOI 10.1016/j.biocel.2013.07.024; Reading L, 2000, BONE SUPPL, V26; Rogers I, 2004, BEST PRACT RES CL OB, V18, P893, DOI 10.1016/j.bpobgyn.2004.06.004; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Samsonraj RM, 2015, STEM CELLS, V33, P1878, DOI 10.1002/stem.1982; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Schipani E., 2008, ADULT MESENCHYMAL ST; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shields LE, 1998, AM J OBSTET GYNECOL, V178, P931, DOI 10.1016/S0002-9378(98)70526-5; SIENA S, 1989, BLOOD, V74, P1905; SINGER JW, 1987, BLOOD, V70, P464; TAVASSOLI M, 1991, P SOC EXP BIOL MED, V196, P367; Tondreau T, 2001, BLOOD, V98, p125B; Verdi J, 2014, NEURAL REGEN RES, V9, P845, DOI 10.4103/1673-5374.131601; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137; Wetzig A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-54; Wu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090883; Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528	81	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137255	10.1371/journal.pone.0137255	http://dx.doi.org/10.1371/journal.pone.0137255			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356539	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800036
J	Uchida, T; Miftahussurur, M; Pittayanon, R; Vilaichone, R; Wisedopas, N; Ratanachu-ek, T; Kishida, T; Moriyama, M; Yamaoka, Y; Mahachai, V				Uchida, Tomohisa; Miftahussurur, Muhammad; Pittayanon, Rapat; Vilaichone, Rathakorn; Wisedopas, Naruemon; Ratanachu-ek, Thawee; Kishida, Tetsuko; Moriyama, Masatsugu; Yamaoka, Yoshio; Mahachai, Varocha			Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype	PLOS ONE			English	Article							GASTRIC-MUCOSAL ATROPHY; HIGH PREVALENCE; GENE; IMMUNOHISTOCHEMISTRY; MECHANISMS; DIVERSITY; GENOTYPE; DISEASE; CANCER	Background The risk to develop gastric cancer in Thailand is relatively low among Asian countries. In addition, the age-standardized incidence rate (ASR) of gastric cancer in Thailand varies with geographical distribution; the ASR in the North region is 3.5 times higher than that in the South region. We hypothesized that the prevalence of H. pylori infection and diversity of CagA phenotype contributes to the variety of gastric cancer risk in various regions of Thailand. Methods We conducted a nationwide survey within Thailand. We determined H. pylori infection prevalence by detecting H. pylori, using histochemical and immunohistochemical methods. The anti-CagA antibody and anti-East-Asian type CagA antibody (alpha-EAS Ab), which showed high accuracy in several East Asian countries, were used to determine CagA phenotype. Results Among 1,546 patients from four regions, including 17 provinces, the overall prevalence of H. pylori infection was 45.9% (710/1,546). Mirroring the prevalence of H. pylori infection, histological scores were the lowest in the South region. Of the 710 H. pylori-positive patients, 93.2%(662) were immunoreactive with the anti-CagA antibody. CagA-negative strain prevalence in the South region was significantly higher than that in other regions (17.9%; 5/28; p < 0.05). Overall, only 77 patients (11.6%) were immunoreactive with the alpha-EAS Ab. There were no differences in the alpha-EAS Ab immunoreactive rate across geographical regions. Conclusions This is the first study using immunohistochemistry to confirm H. pylori infections across different regions in Thailand. The prevalence of East-Asian type CagA H. pylori in Thailand was low. The low incidence of gastric cancer in Thailand may be attributed to the low prevalence of precancerous lesions. The low incidence of gastric cancer in the South region might be associated with the lower prevalence of H. pylori infection, precancerous lesions, and CagA-positive H. pylori strains, compared with that in the other regions.	[Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita, Japan; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu City, Oita, Japan; [Miftahussurur, Muhammad] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Pittayanon, Rapat] Chulalongkorn Univ, Div Gastroenterol, Bangkok, Thailand; [Vilaichone, Rathakorn] Thammasat Univ Hosp, Gastroenterol Unit, Pathum Thani, Thailand; [Wisedopas, Naruemon] Chulalongkorn Univ Hosp, Dept Pathol, Bangkok, Thailand; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Kishida, Tetsuko] Oita Univ, Fac Med, Dept Forens Med, Yufu City, Oita, Japan; [Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Mahachai, Varocha] Bangkok Med Ctr, Gastrointestinal & Liver Ctr, Bangkok, Thailand	Oita University; Oita University; Airlangga University; Chulalongkorn University; Thammasat University; Chulalongkorn University; Rajavithi Hospital; Oita University; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Hasama Machi, Yufu City, Oita, Japan.	yyamaoka@oita-u.ac.jp; vmahachai@gmail.com	Miftahussurur, Muhammad/AAB-6151-2021; Vilaichone, Ratha-korn/ABA-1118-2020	Yamaoka, Yoshio/0000-0002-1222-5819; Miftahussurur, Muhammad/0000-0003-1415-6033	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 24590418]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24406015, 24659200, 25293104, and 26640114) (YY), and (24590418) (TU). This work was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY), and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY).	Atisook K, 2003, HELICOBACTER, V8, P132, DOI 10.1046/j.1523-5378.2003.00134.x; Bodger K, 2001, HELICOBACTER, V6, P216, DOI 10.1046/j.1523-5378.2001.00031.x; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Bui XT, 2009, J CLIN MICROBIOL, V47, P4021, DOI 10.1128/JCM.00504-09; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Duncan SS, 2012, J BACTERIOL, V194, P1593, DOI 10.1128/JB.06340-11; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 2001, EUR J GASTROEN HEPAT, V13, P177, DOI 10.1097/00042737-200102000-00014; Graham DY, 2007, T ROY SOC TROP MED H, V101, P849, DOI 10.1016/j.trstmh.2007.06.006; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Hirai I, 2010, MICROBES INFECT, V12, P227, DOI 10.1016/j.micinf.2009.12.007; Jonkers D, 1997, J INFECTION, V35, P149, DOI 10.1016/S0163-4453(97)91611-X; Kanada R, 2008, PATHOL INT, V58, P218, DOI 10.1111/j.1440-1827.2008.02214.x; Lam TN, 2009, CLIN VACCINE IMMUNOL, V16, P1687, DOI 10.1128/CVI.00200-09; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Mitacek EJ, 2008, NUTR CANCER, V60, P196, DOI 10.1080/01635580701649636; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Myint T, 2015, WORLD J GASTROENTERO, V21, P629, DOI 10.3748/wjg.v21.i2.629; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Shiota S, 2013, J MED MICROBIOL, V62, P1571, DOI 10.1099/jmm.0.060905-0; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Trang VT, 2009, J AGR FOOD CHEM, V57, P11343, DOI 10.1021/jf9026876; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	36	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136775	10.1371/journal.pone.0136775	http://dx.doi.org/10.1371/journal.pone.0136775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355839	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000360965800015
J	Carter, G; Schoeppler, D; Manthey, M; Knornschild, M; Denzinger, A				Carter, Gerald; Schoeppler, Diana; Manthey, Marie; Knoernschild, Mirjam; Denzinger, Annette			Distress Calls of a Fast-Flying Bat (Molossus molossus) Provoke Inspection Flights but Not Cooperative Mobbing	PLOS ONE			English	Article							ALARM CALLS; PREDATOR; CHIROPTERA; BEHAVIOR; RESPONSES; CONSPECIFICS; VESPERTILIONIDAE; NONLINEARITIES; RESPONSIVENESS; SCREAMS	Many birds and mammals produce distress calls when captured. Bats often approach speakers playing conspecific distress calls, which has led to the hypothesis that bat distress calls promote cooperative mobbing. An alternative explanation is that approaching bats are selfishly assessing predation risk. Previous playback studies on bat distress calls involved species with highly maneuverable flight, capable of making close passes and tight circles around speakers, which can look like mobbing. We broadcast distress calls recorded from the velvety free-tailed bat, Molossus molossus, a fast-flying aerial-hawker with relatively poor maneuverability. Based on their flight behavior, we predicted that, in response to distress call playbacks, M. molossus would make individual passing inspection flights but would not approach in groups or approach within a meter of the distress call source. By recording responses via ultrasonic recording and infrared video, we found that M. molossus, and to a lesser extent Saccopteryx bilineata, made more flight passes during distress call playbacks compared to noise. However, only the more maneuverable S. bilineata made close approaches to the speaker, and we found no evidence of mobbing in groups. Instead, our findings are consistent with the hypothesis that single bats approached distress calls simply to investigate the situation. These results suggest that approaches by bats to distress calls should not suffice as clear evidence for mobbing.	[Carter, Gerald] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Schoeppler, Diana; Manthey, Marie; Denzinger, Annette] Univ Tubingen, Inst Neurobiol, Anim Physiol, Tubingen, Germany; [Knoernschild, Mirjam] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	University System of Maryland; University of Maryland College Park; Eberhard Karls University of Tubingen; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Carter, G (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gcarter@umd.edu		Knornschild, Mirjam/0000-0003-0448-9600	UMD-UT collaboration program of the University of Maryland; University of Tuebingen	UMD-UT collaboration program of the University of Maryland; University of Tuebingen	This project was funded by the UMD-UT collaboration program of the University of Maryland and the University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, JMP VERS 12; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; August P.V., 1979, P151; AUGUST PV, 1985, SOUTHWEST NAT, V30, P371, DOI 10.2307/3671269; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Branch CL, 2012, BEHAV ECOL, V23, P854, DOI 10.1093/beheco/ars041; Breviglieri CPB, 2013, OECOLOGIA, V173, P905, DOI 10.1007/s00442-013-2677-9; Caro Tim, 2005, pXIII; Carter Gerald G., 2013, P225; CONOVER MR, 1994, BEHAVIOUR, V131, P19, DOI 10.1163/156853994X00190; de Toledo Luis Felipe, 2009, South American Journal of Herpetology, V4, P25, DOI 10.2994/057.004.0104; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; FENTON MB, 1976, CAN J ZOOL, V54, P1443, DOI 10.1139/z76-167; FITZGIBBON CD, 1994, BEHAV ECOL SOCIOBIOL, V34, P139; FRANKENBERG E, 1975, ISRAEL J ZOOL, V24, P43; Frommolt Karl-Heinz, 1999, Bioacoustics, V10, P219; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Griesser M, 2009, P R SOC B, V276, P2887, DOI 10.1098/rspb.2009.0551; HAUSER MD, 1986, BEHAV ECOL SOCIOBIOL, V19, P65, DOI 10.1007/BF00303844; HILL GE, 1986, ANIM BEHAV, V34, P590, DOI 10.1016/S0003-3472(86)80128-2; HOGSTEDT G, 1983, AM NAT, V121, P562, DOI 10.1086/284083; Holland RA, 2011, ACTA CHIROPTEROL, V13, P399, DOI 10.3161/150811011X624875; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085279; Karp D, 2014, ETHOLOGY, V120, P189, DOI 10.1111/eth.12195; Knoernschild M, 2010, CAN J ZOOL, V88, P589, DOI 10.1139/Z10-028; Knoernschild Mirjam, 2012, Chiroptera Neotropical, V18, P1132; Laiolo P, 2004, P ROY SOC B-BIOL SCI, V271, pS513, DOI 10.1098/rsbl.2004.0239; Lemasson A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1027, DOI 10.1007/s00265-007-0530-z; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Lucan RK, 2013, MAMMALIA, V77, P235, DOI 10.1515/mammalia-2012-0067; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Mora EC, 2004, J COMP PHYSIOL A, V190, P561, DOI 10.1007/s00359-004-0519-2; Nagel J, 2006, THESIS U W ONTARIO; Naguib M, 1999, BEHAV ECOL, V10, P636, DOI 10.1093/beheco/10.6.636; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; PERRONE M, 1980, WILSON BULL, V92, P404; PITCHER TJ, 1986, J FISH BIOL, V28, P439, DOI 10.1111/j.1095-8649.1986.tb05181.x; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Russ JM, 2005, ANIM BEHAV, V70, P397, DOI 10.1016/j.anbehav.2004.11.006; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; RYAN JM, 1985, J MAMMAL, V66, P179, DOI 10.2307/1380980; Slaughter EI, 2013, ETHOLOGY, V119, P309, DOI 10.1111/eth.12066; STATON MA, 1978, AM NAT, V112, P327, DOI 10.1086/283275; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Townsend SW, 2011, BIOL LETTERS, V7, P47, DOI 10.1098/rsbl.2010.0537; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Wise KK, 1999, BEHAVIOUR, V136, P935, DOI 10.1163/156853999501658; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383	51	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136146	10.1371/journal.pone.0136146	http://dx.doi.org/10.1371/journal.pone.0136146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353118	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800025
J	Moreno-Ramos, OA; Olivares, AM; Haider, NB; de Autismo, LC; Lattig, MC				Moreno-Ramos, Oscar A.; Maria Olivares, Ana; Haider, Neena B.; Colombiana de Autismo, Liga; Claudia Lattig, Maria			Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SYNONYMOUS VARIANTS; GENE-EXPRESSION; GENOME; DNA; IDENTIFICATION; INDIVIDUALS; FRAMEWORK; PATTERNS; RISK	Autism spectrum disorders (ASDs) are a range of complex neurodevelopmental conditions principally characterized by dysfunctions linked to mental development. Previous studies have shown that there are more than 1000 genes likely involved in ASD, expressed mainly in brain and highly interconnected among them. We applied whole exome sequencing in Colombian-South American trios. Two missense novel SNVs were found in the same child: ALDH1A3 (RefSeq NM_000693: c.1514T>C (p.I505T)) and FOXN1 (RefSeq NM_003593: c. 146C>T (p.S49L)). Gene expression studies reveal that Aldh1a3 and Foxn1 are expressed in similar to E13.5 mouse embryonic brain, as well as in adult piriform cortex (PC; similar to P30). Conserved Retinoic Acid Response Elements (RAREs) upstream of human ALDH1A3 and FOXN1 and in mouse Aldh1a3 and Foxn1 genes were revealed using bioinformatic approximation. Chromatin immunoprecipitation (ChIP) assay using Retinoid Acid Receptor B (Rarb) as the immunoprecipitation target suggests RA regulation of Aldh1a3 and Foxn1 in mice. Our results frame a possible link of RA regulation in brain to ASD etiology, and a feasible non-additive effect of two apparently unrelated variants in ALDH1A3 and FOXN1 recognizing that every result given by next generation sequencing should be cautiously analyzed, as it might be an incidental finding.	[Moreno-Ramos, Oscar A.; Claudia Lattig, Maria] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Bogota, Colombia; [Maria Olivares, Ana; Haider, Neena B.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA; [Colombiana de Autismo, Liga] Liga Colombiana Autismo LICA, Bogota, Colombia	Universidad de los Andes (Colombia); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Lattig, MC (corresponding author), Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Bogota, Colombia.	mlattig@uniandes.edu.co		lattig, claudia/0000-0003-2113-9266				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2013, CLIN GENET, V84, P128, DOI 10.1111/cge.12184; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Amorosi S, 2010, J NEUROL SCI, V298, P121, DOI 10.1016/j.jns.2010.08.066; Moreno-Ramos OA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-59; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bonhomme D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00006; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Buske OJ, 2013, BIOINFORMATICS, V29, P1843, DOI 10.1093/bioinformatics/btt308; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chatzi C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000609; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao WL, 2005, EUR J NEUROSCI, V21, P3262, DOI 10.1111/j.1460-9568.2005.04178.x; Liao WL, 2005, DEV DYNAM, V232, P887, DOI 10.1002/dvdy.20281; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035; Mory A, 2014, EUR J HUM GENET, V22, P419, DOI 10.1038/ejhg.2013.157; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Roos L, 2013, CLIN GENET; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Semerci CN, 2014, BRIT J OPHTHALMOL, V98, P832, DOI 10.1136/bjophthalmol-2013-304058; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Zaroff CM, 2012, SOC PSYCH PSYCH EPID, V47, P395, DOI 10.1007/s00127-011-0350-3	64	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135927	10.1371/journal.pone.0135927	http://dx.doi.org/10.1371/journal.pone.0135927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352270	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800019
J	Hryckowian, AJ; Baisa, GA; Schwartz, KJ; Welch, RA				Hryckowian, Andrew J.; Baisa, Gary A.; Schwartz, Kevin J.; Welch, Rodney A.			dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073	PLOS ONE			English	Article							D-SERINE-DEAMINASE; STAPHYLOCOCCUS-SAPROPHYTICUS; PYRIDOXAL 5-PHOSPHATE; POSITIVE CONTROL; MUTANTS; GENES; DEHYDRATASE; ACTIVATOR; STRAINS; TRANSPORTER	The urinary tract environment provides many conditions that deter colonization by microorganisms. D-serine is thought to be one of these stressors and is present at high concentrations in urine. D-serine interferes with L-serine and pantothenate metabolism and is bacteriostatic to many species. Uropathogenic Escherichia coli commonly possess the dsdCXA genetic locus, which allows them to use D-serine as a sole carbon, nitrogen, and energy source. It was previously reported that in the model UPEC strain CFT073, a dsdA mutant outcompetes wild type in the murine model of urinary tract infection. This "hypercolonization" was used to propose a model whereby UPEC strains sense D-serine in the urinary tract and subsequently up-regulate genes necessary for pathogenesis. Here, we show that inactivation of dsdA does not lead to hypercolonization. We suggest that this previously observed effect is due to an unrecognized secondary mutation in rpoS and that some D-serine specific effects described in other studies may be affected by the rpoS status of the strains used. Inactivation of dsdA in the original clinical isolate of CFT073 gives CFT073 Delta dsdA a growth defect in human urine and renders it unable to grow on minimal medium containing D-serine as the sole carbon source. However, CFT073 Delta dsdA is able to colonize the urinary tracts of CBA/J mice indistinguishably from wild type. These findings indicate that D-serine catabolism, though it may play role(s) during urinary tract infection, does not affect the ability of uropathogenic E. coli to colonize the murine urinary tract.	[Hryckowian, Andrew J.; Baisa, Gary A.; Schwartz, Kevin J.; Welch, Rodney A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Welch, RA (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	rawelch@wisc.edu			National Institutes of Health [R01DK063250]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (http://www.nih.gov/) Grant R01DK063250, awarded to RAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; Anfora AT, 2006, J BACTERIOL, V188, P6622, DOI 10.1128/JB.00634-06; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; BLOOM FR, 1975, J BACTERIOL, V121, P1078, DOI 10.1128/JB.121.3.1078-1084.1975; BLOOM FR, 1975, J BACTERIOL, V121, P1092, DOI 10.1128/JB.121.3.1092-1101.1975; COSLOY SD, 1973, J BACTERIOL, V114, P679, DOI 10.1128/JB.114.2.679-684.1973; COSLOY SD, 1973, J BACTERIOL, V114, P685, DOI 10.1128/JB.114.2.685-694.1973; Danysz W, 1998, PHARMACOL REV, V50, P597; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; DUPOURQUE D, 1966, J BIOL CHEM, V241, P1233; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5379; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5372; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gunther NW, 2002, INFECT IMMUN, V70, P3344, DOI 10.1128/IAI.70.7.3344-3354.2002; Haugen BJ, 2007, INFECT IMMUN, V75, P278, DOI 10.1128/IAI.01319-06; HEINCZ MC, 1978, P NATL ACAD SCI USA, V75, P1695, DOI 10.1073/pnas.75.4.1695; HEINCZ MC, 1978, J BACTERIOL, V136, P96, DOI 10.1128/JB.136.1.96-103.1978; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Hryckowian AJ, 2014, MBIO, V5, DOI [10.1128/mBio.01043-14, DOI 10.1128/MBI0.01043-14]; Hryckowian AJ, 2013, MBIO, V4, DOI 10.1128/mBio.00023-13; Huang Y, 1998, BIOL PHARM BULL, V21, P156, DOI 10.1248/bpb.21.156; Korte-Berwanger M, 2013, INFECT IMMUN, V81, P4525, DOI 10.1128/IAI.00599-13; Kucheria R, 2005, POSTGRAD MED J, V81, P83, DOI 10.1136/pgmj.2004.023036; KUMASHIRO S, 1995, BRAIN RES, V681, P117, DOI 10.1016/0006-8993(95)00307-C; LABOW R, 1966, J BIOL CHEM, V241, P1239; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; MCFALL E, 1983, J BACTERIOL, V153, P872, DOI 10.1128/JB.153.2.872-877.1983; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; O'Hanley P., 1996, URINARY TRACT INFECT; Patzold R, 2005, BIOMED CHROMATOGR, V19, P466, DOI 10.1002/bmc.515; Peekhaus N, 1997, FEMS MICROBIOL LETT, V147, P233, DOI 10.1111/j.1574-6968.1997.tb10247.x; Putnam D. F., 1971, COMPOSITION CONCENTR; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; Roesch PL, 2003, MOL MICROBIOL, V49, P54, DOI 10.1046/j.1365-2958.2003.03543.x; Sakinc T, 2005, INFECT IMMUN, V73, P6419, DOI 10.1128/IAI.73.10.6419-6428.2005; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Snyder E, 2012, G3-GENES GENOM GENET, V2, P1341, DOI 10.1534/g3.112.003855; Spira B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-248; SU HS, 1991, J BACTERIOL, V173, P2473, DOI 10.1128/jb.173.8.2473-2480.1991; WARGEL RJ, 1970, J BACTERIOL, V103, P778, DOI 10.1128/JB.103.3.778-788.1970; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138121	10.1371/journal.pone.0138121	http://dx.doi.org/10.1371/journal.pone.0138121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366567	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100230
J	Hui, S; Levy, AS; Slack, DL; Burnstein, MJ; Errett, L; Bonneau, D; Latter, D; Rotstein, OD; Bolz, SS; Lidington, D; Voigtlaender-Bolz, J				Hui, Sonya; Levy, Andrew S.; Slack, Daniel L.; Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia			Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries	PLOS ONE			English	Article							RECEPTOR-NULL MICE; HEART-FAILURE; BLOOD-FLOW; SPHINGOSINE 1-PHOSPHATE; CEREBRAL-ARTERIES; CORONARY-ARTERIES; EXERCISE; MODEL; TONE; VASOCONSTRICTION	We recently identified sphingosine-1-phosphate (S1P) signaling and the cystic fibrosis transmembrane conductance regulator (CFTR) as prominent regulators of myogenic responsiveness in rodent resistance arteries. However, since rodent models frequently exhibit limitations with respect to human applicability, translation is necessary to validate the relevance of this signaling network for clinical application. We therefore investigated the significance of these regulatory elements in human mesenteric and skeletal muscle resistance arteries. Mesenteric and skeletal muscle resistance arteries were isolated from patient tissue specimens collected during colonic or cardiac bypass surgery. Pressure myography assessments confirmed endothelial integrity, as well as stable phenylephrine and myogenic responses. Both human mesenteric and skeletal muscle resistance arteries (i) express critical S1P signaling elements, (ii) constrict in response to S1P and (iii) lose myogenic responsiveness following S1P receptor antagonism (JTE013). However, while human mesenteric arteries express CFTR, human skeletal muscle resistance arteries do not express detectable levels of CFTR protein. Consequently, modulating CFTR activity enhances myogenic responsiveness only in human mesenteric resistance arteries. We conclude that human mesenteric and skeletal muscle resistance arteries are a reliable and consistent model for translational studies. We demonstrate that the core elements of an S1P-dependent signaling network translate to human mesenteric resistance arteries. Clear species and vascular bed variations are evident, reinforcing the critical need for further translational study.	[Hui, Sonya; Levy, Andrew S.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON, Canada; [Hui, Sonya; Levy, Andrew S.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Hui, Sonya; Levy, Andrew S.; Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Hui, Sonya; Levy, Andrew S.; Slack, Daniel L.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.] St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Voigtlaender-Bolz, Julia] Univ Toronto, Toronto, ON, Canada; [Bolz, Steffen-Sebastian] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Voigtlaender-Bolz, Julia] St Michaels Hosp, Dept Anaesthesia, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bolz, SS (corresponding author), Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON, Canada.	sts.bolz@utoronto.ca		Lidington, Darcy/0000-0001-7582-7924	Canadian Institutes of Health Research [FRN-119345, FRN-37779]; Heart and Stoke Foundation of Canada [NI6581, CI7432]; Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; St. Michael's Hospital; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research in association with Hypertension Canada [DHY-121263]; University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stoke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; St. Michael's Hospital(University of Toronto); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research in association with Hypertension Canada; University of Toronto(University of Toronto)	Operating Funding: Canadian Institutes of Health Research (FRN-119345 to SSB; FRN-37779 to ODR), Heart and Stoke Foundation of Canada (NI6581 and CI7432 to SSB), seed funding for the Toronto Centre for Microvascular Medicine from the Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research and St. Michael's Hospital (SSB and JVB), Ontario Ministry of Research and Innovation Postdoctoral Fellow Scholarship Program (AL), a Doctoral Research Award from the Canadian Institutes of Health Research in association with Hypertension Canada (DHY-121263 to SH) and Start-Up funding from the University of Toronto (SSB). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the publication.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Braun OO, 2009, J AM COLL CARDIOL, V54, P1146, DOI 10.1016/j.jacc.2009.06.019; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Jensen BC, 2009, J AM COLL CARDIOL, V54, P1137, DOI 10.1016/j.jacc.2009.05.056; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Lidington D, 2013, CARDIOVASC RES, V97, P404, DOI 10.1093/cvr/cvs345; Lidington D, 2009, ARTERIOSCL THROM VAS, V29, P1916, DOI 10.1161/ATVBAHA.109.194803; Magosso E, 2002, MED BIOL ENG COMPUT, V40, P660, DOI 10.1007/BF02345305; Malik FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130313; Mann DL, 2012, CIRCULATION, V125, P2692, DOI 10.1161/CIRCULATIONAHA.112.107797; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; METTING PJ, 1989, AM J PHYSIOL, V256, pR98, DOI 10.1152/ajpregu.1989.256.1.R98; METTING PJ, 1989, J CLIN INVEST, V84, P1900, DOI 10.1172/JCI114377; Moien-Afshari F, 2004, CAN J PHYSIOL PHARM, V82, P840, DOI 10.1139/Y04-100; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; PAWELCZYK JA, 1992, J APPL PHYSIOL, V73, P1838, DOI 10.1152/jappl.1992.73.5.1838; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Scherer EQ, 2010, STROKE, V41, P2618, DOI 10.1161/STROKEAHA.110.593327; SULLIVAN MJ, 1989, CIRCULATION, V80, P769, DOI 10.1161/01.CIR.80.4.769; The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DIAGN DIS H; Yagi K, 2015, STROKE, V46, P2260, DOI 10.1161/STROKEAHA.114.006365; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yang JL, 2012, CIRCULATION, V126, P196, DOI 10.1161/CIRCULATIONAHA.111.039644	30	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138142	10.1371/journal.pone.0138142	http://dx.doi.org/10.1371/journal.pone.0138142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367262	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100235
J	Marchal, PO; Kavvadas, P; Abed, A; Kazazian, C; Authier, F; Koseki, H; Hiraoka, S; Boffa, JJ; Martinerie, C; Chadjichristos, CE				Marchal, Pierre-Olivier; Kavvadas, Panagiotis; Abed, Ahmed; Kazazian, Chantal; Authier, Florence; Koseki, Haruhiko; Hiraoka, Shuichi; Boffa, Jean-Jacques; Martinerie, Cecile; Chadjichristos, Christos E.			Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice	PLOS ONE			English	Article							DOMAIN RECEPTOR 1; HUMAN NOV; URETERAL OBSTRUCTION; WILMS-TUMORS; CCN3 NOV; MODEL; GENE; GLOMERULONEPHRITIS; QUANTIFICATION; REGULATOR	The main hallmark of chronic kidney disease (CKD) is excessive inflammation leading to interstitial tissue fibrosis. It has been recently reported that NOV/CCN3 could be involved in kidney damage but its role in the progression of nephropathies is poorly known. NOV/CCN3 is a secreted multifunctional protein belonging to the CCN family involved in different physiological and pathological processes such as angiogenesis, inflammation and cancers. The purpose of our study was to determine the role of NOV/CCN3 in renal inflammation and fibrosis related to primitive tubulointerstitial injury. After unilateral ureteral obstruction (UUO), renal histology and real-time PCR were performed in NOV/CCN3-/- and wild type mice. NOV/CCN3 mRNA expression was increased in the obstructed kidneys in the early stages of the obstructive nephropathy. Interestingly, plasmatic levels of NOV/CCN3 were strongly induced after 7 days of UUO and the injection of recombinant NOV/CCN3 protein in healthy mice significantly increased CCL2 mRNA levels. Furthermore, after 7 days of UUO NOV/CCN3-/- mice displayed reduced proinflammatory cytokines and adhesion markers expression leading to restricted accumulation of interstitial monocytes, in comparison with their wild type littermates. Consequently, in NOV/CCN3-/- mice interstitial renal fibrosis was blunted after 15 days of UUO. In agreement with our experimental data, NOV/CCN3 expression was highly increased in biopsies of patients with tubulointerstitial nephritis. Thus, the inhibition of NOV/CCN3 may represent a novel target for the progression of renal diseases.	[Marchal, Pierre-Olivier; Kazazian, Chantal; Martinerie, Cecile] Hop St Antoine, INSERM, UMR S938, Ctr Rech St Antoine, F-75571 Paris, France; [Marchal, Pierre-Olivier; Kavvadas, Panagiotis; Abed, Ahmed; Authier, Florence; Boffa, Jean-Jacques; Chadjichristos, Christos E.] Tenon Hosp, INSERM, UMR S1155, Paris, France; [Marchal, Pierre-Olivier; Abed, Ahmed; Martinerie, Cecile; Chadjichristos, Christos E.] Univ Paris 06, Sorbonne Univ, Paris, France; [Koseki, Haruhiko] RIKEN, Yokohama Inst, RCAI, Yokohama, Kanagawa, Japan; [Hiraoka, Shuichi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 658, Japan; [Boffa, Jean-Jacques] Tenon Hosp, Dept Nephrol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; RIKEN; Kobe Pharmaceutical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Chadjichristos, CE (corresponding author), Tenon Hosp, INSERM, UMR S1155, Paris, France.	christos.chadjichristos@upmc.fr	Koseki, Haruhiko/I-3825-2014; Chadjichristos, Christos E/J-4871-2016	Koseki, Haruhiko/0000-0001-8424-5854; Chadjichristos, Christos E/0000-0001-6657-7900	INSERM and the University Paris VI	INSERM and the University Paris VI	Support for this study was provided by the INSERM and the University Paris VI (CM, CEC). POM is a doctoral fellow of the French Ministry of Education. AA is a doctoral fellow of a UPMC Univ Paris 6- Palestinian Universities cooperation program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2014, KIDNEY INT, V86, P768, DOI 10.1038/ki.2014.108; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Borkham-Kamphorst E, 2012, LIVER INT, V32, P1342, DOI 10.1111/j.1478-3231.2012.02837.x; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chevalier G, 1998, AM J PATHOL, V152, P1563; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; DIAMOND JR, 1994, AM J PHYSIOL, V266, pF926, DOI 10.1152/ajprenal.1994.266.6.F926; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x; Guerrot D, 2011, AM J PATHOL, V179, P83, DOI 10.1016/j.ajpath.2011.03.023; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kerroch M, 2012, FASEB J, V26, P4079, DOI 10.1096/fj.11-194902; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Lafont J, 2005, CELL COMMUN ADHES, V12, P41, DOI 10.1080/15419060500383069; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Le Dreau G, 2010, MOL CELL NEUROSCI, V43, P60, DOI 10.1016/j.mcn.2009.02.011; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; MARTINERIE C, 1994, ONCOGENE, V9, P2729; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Niu ZH, 2005, J UROLOGY, V174, P1460, DOI 10.1097/01.ju.0000173008.73741.80; Pakradouni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066788; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; van Roeyen CRC, 2012, AM J PATHOL, V180, P1979, DOI 10.1016/j.ajpath.2012.01.031	33	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137876	10.1371/journal.pone.0137876	http://dx.doi.org/10.1371/journal.pone.0137876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367310	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100165
J	Zhang, Y; Ma, XJ; Shi, DZ				Zhang, Ying; Ma, Xiao-juan; Shi, Da-zhuo			Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; MYOCARDIAL-INFARCTION; INJURY	Optimizing the metabolism of the myocardium is a new strategy for patients with ischemic heart disease. Many studies have reported beneficial effects of trimetazidine (TMZ) on the clinical prognosis of patients with ischemic heart disease, but whether these beneficial effects are extended to patients undergoing percutaneous coronary intervention (PCI) remains uncertain. A meta-analysis was performed to evaluate the effect of TMZ on patients undergoing PCI. We conducted an electronic search of PubMed, Cochrane databases, the China National Knowledge Infrastructure, and Chinese Biological Medicine Database to identify randomized controlled trials. Methodological quality was assessed according to the Jadad scale score, and the meta-analysis was performed using Cochrane Collaboration RevMan 5.2 and Comprehensive Meta-Analysis. Dichotomous data were analyzed using relative risk (RR) or odds ratio (OR) with effect size indicated by the 95% confidence interval (CI), and continuous variables were analyzed using weighted mean differences (WMD) with effect size indicated by the 95% CI. Sensitivity analysis was performed by changing the statistical methods and effect model. Nine studies involving a total of 778 patients were included in this meta-analysis. Additional use of TMZ significantly improved the left ventricular ejection fraction (WMD: 3.11, 95% CI: [2.26, 3.96]) and reduced elevated cardiac troponin Ic level (RR: 0.69, 95% CI: [0.48, 0.99]), angina attacks during PCI (OR: 0.16, 95% CI: [0.07, 0.38]), and ischemic ST-T changes on the echocardiogram during PCI (RR: 0.76, 95% CI: [0.59, 0.98]). However, no significant difference was observed in serum BNP level 30 days after PCI between the experimental and control group. Additional use of TMZ for patients undergoing PCI may reduce myocardial injury during the procedure and improve cardiac function.	[Zhang, Ying] Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China; [Zhang, Ying; Ma, Xiao-juan; Shi, Da-zhuo] China Acad Chinese Med Sci, China Heart Inst Chinese Med, Beijing, Peoples R China; [Zhang, Ying; Ma, Xiao-juan; Shi, Da-zhuo] China Acad Chinese Med Sci, Xiyuan Hosp, Cardiovasc Dis Ctr, Beijing, Peoples R China	Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS	Shi, DZ (corresponding author), China Acad Chinese Med Sci, China Heart Inst Chinese Med, Beijing, Peoples R China.	dz_shi@126.com			National Natural Science Foundation of China [81030063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by the grants from the National Natural Science Foundation of China (No. 81030063).	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Birand A, 1997, ANGIOLOGY, V48, P413, DOI 10.1177/000331979704800505; Bonello L, 2007, HEART, V93, P703, DOI 10.1136/hrt.2006.107524; Chen Yun-dai, 2010, Zhonghua Nei Ke Za Zhi, V49, P473; D'Ascenzo F, 2014, EUROINTERVENTION, V9, P1463, DOI 10.4244/EIJV9I12A244; Demirelli S, 2013, KOREAN CIRC J, V43, P462, DOI 10.4070/kcj.2013.43.7.462; Di Napoli P, 2005, HEART, V91, P161, DOI 10.1136/hrt.2003.031310; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Fragasso G, 2006, EUR HEART J, V27, P942, DOI 10.1093/eurheartj/ehi816; Gao DF, 2011, HEART, V97, P278, DOI 10.1136/hrt.2010.208751; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Labrou A, 2007, AM J CARDIOVASC DRUG, V7, P143, DOI 10.2165/00129784-200707020-00006; [马琦琳 Ma Qili], 2010, [中国现代医学杂志, China Journal of Modern Medicine], V20, P2643; Polonski L, 2002, CURR MED RES OPIN, V18, P389, DOI 10.1185/030079902125001146; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Xu Xiao-han, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P205; Yu Q., 2012, CHIN J CLIN HLTH, V15, P360; Zhang L, 2012, J AM COLL CARDIOL, V59, P913, DOI 10.1016/j.jacc.2011.11.027; Zhang N, 2015, CARDIOLOGY, V131, P86, DOI 10.1159/000375289; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094660	23	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137775	10.1371/journal.pone.0137775	http://dx.doi.org/10.1371/journal.pone.0137775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367001	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100135
J	Rosas-Aguirre, A; Speybroeck, N; Llanos-Cuentas, A; Rosanas-Urgell, A; Carrasco-Escobar, G; Rodriguez, H; Gamboa, D; Contreras-Mancilla, J; Alava, F; Soares, IS; Remarque, E; D'Alessandro, U; Erhart, A				Rosas-Aguirre, Angel; Speybroeck, Niko; Llanos-Cuentas, Alejandro; Rosanas-Urgell, Anna; Carrasco-Escobar, Gabriel; Rodriguez, Hugo; Gamboa, Dionicia; Contreras-Mancilla, Juan; Alava, Freddy; Soares, Irene S.; Remarque, Edmond; D'Alessandro, Umberto; Erhart, Annette			Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey	PLOS ONE			English	Article							PLASMODIUM-VIVAX-MALARIA; FALCIPARUM; COMMUNITIES; PREVALENCE; ENDEMICITY; PATTERNS; VECTOR; REGION; AREAS	Background With low and markedly seasonal malaria transmission, increasingly sensitive tools for better stratifying the risk of infection and targeting control interventions are needed. A cross-sectional survey to characterize the current malaria transmission patterns, identify hotspots, and detect recent changes using parasitological and serological measures was conducted in three sites of the Peruvian Amazon. Material and Methods After full census of the study population, 651 participants were interviewed, clinically examined and had a blood sample taken for the detection of malaria parasites (microscopy and PCR) and antibodies against P. vivax (PvMSP1(19), PvAMA1) and P. falciparum (PfGLURP, PfAMA1) antigens by ELISA. Risk factors for malaria infection (positive PCR) and malaria exposure (seropositivity) were assessed by multivariate survey logistic regression models. Age-specific seroprevalence was analyzed using a reversible catalytic conversion model based on maximum likelihood for generating seroconversion rates (SCR, lambda). SaTScan was used to detect spatial clusters of serology-positive individuals within each site. Results The overall parasite prevalence by PCR was low, i.e. 3.9% for P. vivax and 6.7% for P. falciparum, while the seroprevalence was substantially higher, 33.6% for P. vivax and 22.0% for P. falciparum, with major differences between study sites. Age and location (site) were significantly associated with P. vivax exposure; while location, age and outdoor occupation were associated with P. falciparum exposure. P. falciparum seroprevalence curves showed a stable transmission throughout time, while for P. vivax transmission was better described by a model with two SCRs. The spatial analysis identified well-defined clusters of P. falciparum seropositive individuals in two sites, while it detected only a very small cluster of P. vivax exposure. Conclusion The use of a single parasitological and serological malaria survey has proven to be an efficient and accurate method to characterize the species specific heterogeneity in malaria transmission at micro-geographical level as well as to identify recent changes in transmission.	[Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro; Carrasco-Escobar, Gabriel; Gamboa, Dionicia; Contreras-Mancilla, Juan] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Rosas-Aguirre, Angel; Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Rodriguez, Hugo; Alava, Freddy] Iquitos, Reg Salud Loreto, Loreto 160, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru; [Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil; [Remarque, Edmond] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; [D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Universidad Peruana Cayetano Heredia; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Rosas-Aguirre, A (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.	angelrosasa@gmail.com	Rosanas-Urgell, Anna/D-3193-2015; Remarque, Ed/AAE-8643-2020; Aguirre, Angel Rosas/A-5054-2016; Soares, Irene Silva/C-5974-2012; Gamboa, Dionicia/CAF-2097-2022; Soares, Irene/GQF-1984-2022	Rosanas-Urgell, Anna/0000-0002-0432-5203; Aguirre, Angel Rosas/0000-0002-3271-7028; Soares, Irene Silva/0000-0002-3336-6856; Gamboa, Dionicia/0000-0002-1420-7729; Carrasco-Escobar, Gabriel/0000-0002-6945-0419; ALAVA AREVALO, FREDDY FRANCO/0000-0002-1402-2556; Speybroeck, Niko/0000-0003-3322-3502; Contreras Mancilla, Juan Jose/0000-0003-0447-0926; Llanos-Cuentas, Alejandro/0000-0002-7567-5534	Directorate General for Development Cooperation (DGCD) of the Belgian Government	Directorate General for Development Cooperation (DGCD) of the Belgian Government	The study was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government within the Third Framework Agreement of the Institutional Collaboration between the Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima and the Institute of Tropical Medicine in Antwerp, Belgium (FA3-II project, 2011-2013)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Cunha MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113357; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Elliott SR, 2014, F1000PRIME REP, V6, DOI 10.12703/P6-100; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Instituto Nacional de Estadistica e Informatica, 2014, AN EST AMB 2013; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 2011, SATSCAN USER GUIDE V; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Maki S, 2001, ENVIRON CONSERV, V28, P199, DOI 10.1017/S0376892901000212; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Ministerio de Salud del Peru, 2013, B EPIDEMIOL, V22, P1088; Muench H., CATALYTIC MODELS EPI, P8928; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Organismo Andino de Salud-PAMAFRO, 2009, COMP LECC APR; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; QGIS developer team, 2014, QGIS US GUID REL 2 6; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Rosas-Aguirre Ángel, 2010, Rev. perú. med. exp. salud publica, V27, P540, DOI 10.1590/s1726-46342010000400008; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137458	10.1371/journal.pone.0137458	http://dx.doi.org/10.1371/journal.pone.0137458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356311	Green Published, Green Accepted, gold			2022-12-27	WOS:000360965800049
J	Sa, L; Costa-Santos, C; Teixeira, A; Couto, L; Costa-Pereira, A; Hespanhol, A; Santos, P; Martins, C				Sa, Luisa; Costa-Santos, Cristina; Teixeira, Andreia; Couto, Luciana; Costa-Pereira, Altamiro; Hespanhol, Alberto; Santos, Paulo; Martins, Carlos			Portuguese Family Physicians' Awareness of Diagnostic and Laboratory Test Costs: A Cross-Sectional Study	PLOS ONE			English	Article							CARE; CHARGES; INFORMATION; PRICE	Background Physicians' ability to make cost-effective decisions has been shown to be affected by their knowledge of health care costs. This study assessed whether Portuguese family physicians are aware of the costs of the most frequently prescribed diagnostic and laboratory tests. Methods A cross-sectional study was conducted in a representative sample of Portuguese family physicians, using computer-assisted telephone interviews for data collection. A Likert scale was used to assess physician's level of agreement with four statements about health care costs. Family physicians were also asked to estimate the costs of diagnostic and laboratory tests. Each physician's cost estimate was compared with the true cost and the absolute error was calculated. Results One-quarter (24%; 95% confidence interval: 23%-25%) of all cost estimates were accurate to within 25% of the true cost, with 55% (95% IC: 53-56) overestimating and 21% (95% IC: 20-22) underestimating the true actual cost. The majority (76%) of family physicians thought they did not have or were uncertain as to whether they had adequate knowledge of diagnostic and laboratory test costs, and only 7% reported receiving adequate education. The majority of the family physicians (82%) said that they had adequate access to information about the diagnostic and laboratory test costs. Thirty-three percent thought that costs did not influence their decision to order tests, while 27% were uncertain. Conclusions Portuguese family physicians have limited awareness of diagnostic and laboratory test costs, and our results demonstrate a need for improved education in this area. Further research should focus on identifying whether interventions in cost knowledge actually change ordering behavior, in identifying optimal methods to disseminate cost information, and on improving the cost-effectiveness of care.	[Sa, Luisa; Couto, Luciana; Hespanhol, Alberto; Santos, Paulo; Martins, Carlos] Fac Med Porto, Social Sci & Hlth Dept, Family Med Unit, Oporto, Portugal; [Sa, Luisa] Family Hlth Unit Nova Via, Oporto, Portugal; [Costa-Santos, Cristina; Teixeira, Andreia; Costa-Pereira, Altamiro; Santos, Paulo; Martins, Carlos] Univ Porto, Ctr Res Hlth Technol & Informat Syst CINTESIS, Fac Med, P-4200319 Oporto, Portugal; [Costa-Santos, Cristina; Teixeira, Andreia; Costa-Pereira, Altamiro; Santos, Paulo; Martins, Carlos] Univ Porto, Informat Sci & Decis Hlth Dept CIDES, Fac Med, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Martins, C (corresponding author), Fac Med Porto, Social Sci & Hlth Dept, Family Med Unit, Oporto, Portugal.	carlosmartins20@gmail.com	Costa-Pereira, Altamiro/I-5987-2012; Santos, Cristina/J-3255-2013; Teixeira, Andreia/D-3646-2011; Santos, Paulo/C-5923-2013; Martins, Carlos/C-3924-2013; , Cristina/S-7443-2019	Costa-Pereira, Altamiro/0000-0001-8467-6398; Santos, Cristina/0000-0002-7109-1101; Teixeira, Andreia/0000-0003-1199-2220; Santos, Paulo/0000-0002-2362-5527; Martins, Carlos/0000-0001-8561-5167; , Cristina/0000-0002-7109-1101	AstraZeneca Portugal Foundation; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/86383/2012]	AstraZeneca Portugal Foundation(AstraZeneca); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors have received a financial support of (sic)15 000 from the AstraZeneca Portugal Foundation 2010 programme for support of research. A Teixeira acknowledges the Fundacao para a Ciencia e a Tecnologia postdocs grant SFRH/BPD/86383/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2008, INT J TECHNOL ASSESS, V24, P158, DOI 10.1017/S0266462308080227; Allan GM, 2004, CAN FAM PHYSICIAN, V50, P263; BAREFORD D, 1990, BRIT MED J, V301, P1305, DOI 10.1136/bmj.301.6764.1305; Bates DW, 1997, ARCH INTERN MED, V157, P2501, DOI 10.1001/archinte.157.21.2501; Beilby JJ, 1997, MED J AUSTRALIA, V167, P89, DOI 10.5694/j.1326-5377.1997.tb138787.x; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bovier PA, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-72; Central Administration of the Health Service, PER PUBL NUMB US ENR; Central Administration of the Health Service, ID CARD CONTR IND PR; Central Administration of the Health Service, 2011, ACT REP 2009 2010; Central Administration of the Health Services, 2012, TABL DIAGN THER COMP; Court of Auditors, AUD PERF FUNCT UN PR; CUMMINGS KM, 1982, MED CARE, V20, P293, DOI 10.1097/00005650-198203000-00006; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; LEURQUIN P, 1995, BRIT J GEN PRACT, V45, P21; LONG MJ, 1983, MED CARE, V21, P243, DOI 10.1097/00005650-198302000-00011; Lorh S, 1999, DESIGN ANAL; Mannion R, 2008, BMJ-BRIT MED J, V336, P306, DOI 10.1136/bmj.39463.454815.94; Martins C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081256; Moynihan R, BMJ; Portugal-OECD, 2014, DOES PORT COMP; PUGH JA, 1989, ARCH INTERN MED, V149, P426, DOI 10.1001/archinte.149.2.426; Ryan rew M, HARVARD BUSINESS REV; Shye D, 1998, INT J QUAL HEALTH C, V10, P83, DOI 10.1093/intqhc/10.2.83; Sood R, 2007, NETH J MED, V65, P167; SULLIVAN F, 1995, BMJ-BRIT MED J, V311, P848, DOI 10.1136/bmj.311.7009.848; Tek Sehgal Raj, 2011, J Grad Med Educ, V3, P182, DOI 10.4300/JGME-D-10-00186.1; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; Varkey P, 2010, J EVAL CLIN PRACT, V16, P1055, DOI 10.1111/j.1365-2753.2009.01249.x; Verstappen WHJM, 2004, INT J QUAL HEALTH C, V16, P391, DOI 10.1093/intqhc/mzh070	31	4	4	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137025	10.1371/journal.pone.0137025	http://dx.doi.org/10.1371/journal.pone.0137025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356625	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800022
J	Sips, FLP; Nyman, E; Adiels, M; Hilbers, PAJ; Stralfors, P; van Riel, NAW; Cedersund, G				Sips, Fianne L. P.; Nyman, Elin; Adiels, Martin; Hilbers, Peter A. J.; Stralfors, Peter; van Riel, Natal A. W.; Cedersund, Gunnar			Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; NUCLEAR-MAGNETIC-RESONANCE; DIACYLGLYCEROL ACTIVATION; OBESE-PATIENTS; METABOLISM; LIVER; MEAL; TRIGLYCERIDE; MECHANISMS; CYCLE	In metabolic diseases such as Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, the systemic regulation of postprandial metabolite concentrations is disturbed. To understand this dysregulation, a quantitative and temporal understanding of systemic postprandial metabolite handling is needed. Of particular interest is the intertwined regulation of glucose and non-esterified fatty acids (NEFA), due to the association between disturbed NEFA metabolism and insulin resistance. However, postprandial glucose metabolism is characterized by a dynamic interplay of simultaneously responding regulatory mechanisms, which have proven difficult to measure directly. Therefore, we propose a mathematical modelling approach to untangle the systemic interplay between glucose and NEFA in the postprandial period. The developed model integrates data of both the perturbation of glucose metabolism by NEFA as measured under clamp conditions, and postprandial time-series of glucose, insulin, and NEFA. The model can describe independent data not used for fitting, and perturbations of NEFA metabolism result in an increased insulin, but not glucose, response, demonstrating that glucose homeostasis is maintained. Finally, the model is used to show that NEFA may mediate up to 30-45% of the postprandial increase in insulin-dependent glucose uptake at two hours after a glucose meal. In conclusion, the presented model can quantify the systemic interactions of glucose and NEFA in the postprandial state, and may therefore provide a new method to evaluate the disturbance of this interplay in metabolic disease.	[Sips, Fianne L. P.; Hilbers, Peter A. J.; van Riel, Natal A. W.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] CVMD iMED DMPK AstraZeneca R&D, S-43183 Molndal, Sweden; [Adiels, Martin] Univ Gothenburg, Hlth Metr Sahlgrenska Acad, Gothenburg, Sweden; [Stralfors, Peter; Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Eindhoven University of Technology; Linkoping University; AstraZeneca; University of Gothenburg; Linkoping University	Sips, FLP (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Postbus 513, NL-5600 MB Eindhoven, Netherlands.	f.l.p.sips@tue.nl	van Riel, Natal/J-5319-2013; Nyman, Elin/I-3363-2019	van Riel, Natal/0000-0001-9375-4730; Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806	European Union [305707]; Linkoping Initiative within Life Science Technologies; Ostergotland County Council; Swedish Research Council; AstraZeneca	European Union(European Commission); Linkoping Initiative within Life Science Technologies; Ostergotland County Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca)	This study was supported by the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No 305707, the Linkoping Initiative within Life Science Technologies, the Ostergotland County Council, and the Swedish Research Council. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salary for author EN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adiels M, 2012, ATHEROSCLEROSIS, V222, P222, DOI 10.1016/j.atherosclerosis.2012.02.001; Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Aryangat AV, 2010, VASC HEALTH RISK MAN, V6, P145; Basu R, 2003, AM J PHYSIOL-ENDOC M, V284, pE55, DOI 10.1152/ajpendo.00190.2001; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BEVILACQUA S, 1987, METABOLISM, V36, P502, DOI 10.1016/0026-0495(87)90051-5; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Boren J, 2012, J INTERN MED, V271, P166, DOI 10.1111/j.1365-2796.2011.02497.x; Boston RC, 2008, AM J PHYSIOL-REG I, V294, pR1140, DOI 10.1152/ajpregu.00749.2007; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Campbell PJ, 2006, AM J PHYSIOL 1, V263, pE1063; Cassader M, 2001, LIPIDS, V36, P1117, DOI 10.1007/s11745-001-0822-5; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cobelli C, 2014, IEEE T BIO-MED ENG, V61, P1577, DOI 10.1109/TBME.2014.2310514; Dalla Man C, 2006, IEEE T BIO-MED ENG, V53, P2472, DOI 10.1109/TBME.2006.883792; Farmer TG, 2008, J DRUG DELIV SCI TEC, V18, P387, DOI 10.1016/S1773-2247(08)50076-1; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Fielding B, 2011, P NUTR SOC, V70, P342, DOI 10.1017/S002966511100084X; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Galbo T, 2013, AGING-US, V5, P582, DOI 10.18632/aging.100585; Heath RB, 2007, AM J PHYSIOL-ENDOC M, V292, pE732, DOI 10.1152/ajpendo.00409.2006; Hijmans BS, 2015, FASEB J, V29, P1153, DOI 10.1096/fj.14-254656; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jacome-Sosa MM, 2014, CURR OPIN LIPIDOL, V25, P213, DOI 10.1097/MOL.0000000000000080; Jelic K, 2009, ANN BIOMED ENG, V37, P1897, DOI 10.1007/s10439-009-9738-6; Johanson EH, 2004, J INTERN MED, V255, P273, DOI 10.1046/j.1365-2796.2003.01281.x; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kirkman MS, 2006, DIABETES CARE, V29, P2095, DOI 10.2337/dc06-0061; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kruszynska YT, 1997, DIABETES, V46, P1586, DOI 10.2337/diabetes.46.10.1586; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lambert JE, 2012, BBA-MOL CELL BIOL L, V1821, P721, DOI 10.1016/j.bbalip.2012.01.006; Lefebvre P, 1998, DIABETIC MED, V15, pS63, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S63::AID-DIA737>3.3.CO;2-Z; Lewis GF, 1997, DIABETES, V46, P1111, DOI 10.2337/diabetes.46.7.1111; Lewis GF, 1998, AM J PHYSIOL-ENDOC M, V275, pE177, DOI 10.1152/ajpendo.1998.275.1.E177; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marmarelis V, 2014, LECT N BIOENG, pV; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2001, METABOLISM, V50, P598, DOI 10.1053/meta.2001.22561; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; RANDLE PJ, 1963, LANCET, V1, P785; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Robertson MD, 2002, AM J CLIN NUTR, V75, P505, DOI 10.1093/ajcn/75.3.505; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Roy A, 2006, DIABETES TECHNOL THE, V8, P617, DOI 10.1089/dia.2006.8.617; Salinari S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1890, DOI 10.1152/ajpendo.00563.2006; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shah P, 2002, DIABETES, V51, P301, DOI 10.2337/diabetes.51.2.301; Smith JMD, 2009, OBESITY, V17, P632, DOI 10.1038/oby.2008.604; Staehr P, 2003, DIABETES, V52, P260, DOI 10.2337/diabetes.52.2.260; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Tiemann CA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003166; van Oostrom AJ, 2004, AM J CLIN NUTR, V79, P510	65	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135665	10.1371/journal.pone.0135665	http://dx.doi.org/10.1371/journal.pone.0135665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356502	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800006
J	Bender, J; Engeholm, M; Ederer, MS; Breu, J; Moller, TC; Michalakis, S; Rasko, T; Wanker, EE; Biel, M; Martinez, KL; Wurst, W; Deussing, JM				Bender, Julia; Engeholm, Maik; Ederer, Marion S.; Breu, Johannes; Moller, Thor C.; Michalakis, Stylianos; Rasko, Tamas; Wanker, Erich E.; Biel, Martin; Martinez, Karen L.; Wurst, Wolfgang; Deussing, Jan M.			Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Clustering with MAGUKs Is Mediated via Its C-Terminal PDZ Binding Motif	PLOS ONE			English	Article							5-HT2A SEROTONIN RECEPTORS; D-ASPARTATE RECEPTORS; PROTEIN-KINASE-A; INTRACELLULAR LOOP; DENDRITIC SPINES; PSD-95 FAMILY; DOMAIN; COMPLEX; ANXIETY; STRESS	The corticotropin-releasing hormone receptor type 1 (CRHR1) plays an important role in orchestrating neuroendocrine, behavioral, and autonomic responses to stress. To identify molecules capable of directly modulating CRHR1 signaling, we performed a yeast-two-hybrid screen using the C-terminal intracellular tail of the receptor as bait. We identified several members of the membrane-associated guanylate kinase (MAGUK) family: postsynaptic density protein 95 (PSD95), synapse-associated protein 97 (SAP97), SAP102 and membrane associated guanylate kinase, WWand PDZ domain containing 2 (MAGI2). CRHR1 is co-expressed with the identified MAGUKs and with the additionally investigated PSD93 in neurons of the adult mouse brain and in primary hippocampal neurons, supporting the probability of a physiological interaction in vivo. The C-terminal PDZ (PSD-95, discs large, zona occludens 1) binding motif of CRHR1 is essential for its physical interaction with MAGUKs, as revealed by the CRHR1-STAVA mutant, which harbors a functionally impaired PDZ binding motif. The imitation of a phosphorylation at Thr413 within the PDZ binding motif also disrupted the interaction with MAGUKs. In contrast, distinct PDZ domains within the identified MAGUKs are involved in the interactions. Expression of CRHR1 in primary neurons demonstrated its localization throughout the neuronal plasma membrane, including the excitatory post synapse, where the receptor co-localized with PSD95 and SAP97. The co-expression of CRHR1 and respective interacting MAGUKs in HEK293 cells resulted in a clustered subcellular co-localization which required an intact PDZ binding motif. In conclusion, our study characterized the PDZ binding motif-mediated interaction of CRHR1 with multiple MAGUKs, which directly affects receptor function.	[Bender, Julia; Ederer, Marion S.; Deussing, Jan M.] Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, Mol Neurogenet, Munich, Germany; [Engeholm, Maik; Breu, Johannes] Max Planck Inst Psychiat, Munich, Germany; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Michalakis, Stylianos; Biel, Martin] Univ Munich, CIPSM, Munich, Germany; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Rasko, Tamas; Wanker, Erich E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wurst, Wolfgang] German Res Ctr Environm Hlth, Inst Dev Genet, Helmholtz Ctr Munich, Neuherberg, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis Helmholtz Assoc, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet Helmholtz Zentram M, Neuherberg, Germany	Max Planck Society; Max Planck Society; University of Copenhagen; University of Copenhagen; University of Munich; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Deussing, JM (corresponding author), Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, Mol Neurogenet, Munich, Germany.	deussing@psych.mpg.de	Michalakis, Stylianos/M-4677-2019; Martinez, Karen/W-3709-2019; Michalakis, Stylianos/W-2094-2018; martinez, karen L/J-5933-2013; Deussing, Jan M/ABB-5993-2021; Biel, Martin/G-1175-2014; Møller, Thor C/T-9452-2018	Michalakis, Stylianos/0000-0001-5092-9238; Martinez, Karen/0000-0003-0932-8080; Michalakis, Stylianos/0000-0001-5092-9238; martinez, karen L/0000-0003-0932-8080; Biel, Martin/0000-0002-9974-3052; Møller, Thor C/0000-0002-2256-577X; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252; Wanker, Erich/0000-0001-8072-1630	German Federal Ministry of Education and Research [01ZX1314H]; program for medical genome research within the framework of the NGFN-Plus [FKZ: 01GS08151]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); program for medical genome research within the framework of the NGFN-Plus; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was partially supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/), within the framework of the e:Med research and funding concept (IntegraMent: Integrated Understanding of Causes and Mechanisms in Mental Disorders; FKZ 01ZX1314H), by the program for medical genome research within the framework of the NGFN-Plus (FKZ: 01GS08151) and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Chen Y, 2004, NEUROSCIENCE, V126, P533, DOI 10.1016/j.neuroscience.2004.03.036; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dunn HA, 2014, MOL PHARMACOL, V86, P275, DOI 10.1124/mol.114.093476; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Fiorentini M, 2013, ACTA CRYSTALLOGR D, V69, P587, DOI 10.1107/S0907444912051839; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardiol D, 2002, J GEN VIROL, V83, P283, DOI 10.1099/0022-1317-83-2-283; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Graf C, 2012, MOL CELL ENDOCRINOL, V362, P29, DOI 10.1016/j.mce.2012.05.007; Grammatopoulos D, 1996, J CLIN ENDOCR METAB, V81, P745, DOI 10.1210/jc.81.2.745; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Justice NJ, 2008, J COMP NEUROL, V511, P479, DOI 10.1002/cne.21848; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kristiansen LV, 2005, SCHIZOPHR RES, V78, P87, DOI 10.1016/j.schres.2005.06.012; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lauks J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039420; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Moller TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063352; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oakley RH, 2007, AM J PHYSIOL-REG I, V293, pR209, DOI 10.1152/ajpregu.00099.2006; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Papadopoulou N, 2004, MOL ENDOCRINOL, V18, P624, DOI 10.1210/me.2003-0365; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Punn A, 2012, J BIOL CHEM, V287, P8974, DOI 10.1074/jbc.M111.272161; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reul Johannes M H M, 2002, Dialogues Clin Neurosci, V4, P31; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Xia Z, 2003, NEUROSCIENCE, V122, P907, DOI 10.1016/S0306-4522(03)00589-X; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200	64	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136768	10.1371/journal.pone.0136768	http://dx.doi.org/10.1371/journal.pone.0136768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352593	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360932800048
J	Nassal, MMJ; Wan, XP; Laurita, KR; Cutler, MJ				Nassal, Michelle M. J.; Wan, Xiaoping; Laurita, Kenneth R.; Cutler, Michael J.			Atrial SERCA2a Overexpression Has No Affect on Cardiac Alternans but Promotes Arrhythmogenic SR Ca2+ Triggers	PLOS ONE			English	Article							REPOLARIZATION ALTERNANS; INTRACELLULAR CALCIUM; ACTION-POTENTIALS; FIBRILLATION; MYOCYTES; MECHANISM; REFRACTORINESS; DYSFUNCTION; SIMULATION; INSIGHTS	Background Atrial fibrillation (AF) is the most common arrhythmia in humans, yet; treatment has remained sub-optimal due to poor understanding of the underlying mechanisms. Cardiac alternans precede AF episodes, suggesting an important arrhythmia substrate. Recently, we demonstrated ventricular SERCA2a overexpression suppresses cardiac alternans and arrhythmias. Therefore, we hypothesized that atrial SERCA2a overexpression will decrease cardiac alternans and arrhythmias. Methods Adult rat isolated atrial myocytes where divided into three treatment groups 1) Control, 2) SERCA2a overexpression (Ad. SERCA2a) and 3) SERCA2a inhibition (Thapsigargin, 1 mu m). Intracellular Ca2+ was measured using Indo-1AM and Ca2+ alternans (Ca-ALT) was induced with a standard ramp pacing protocol. Results As predicted, SR Ca2+ reuptake was enhanced with SERCA2a overexpression (p < 0.05) and reduced with SERCA2a inhibition (p < 0.05). Surprisingly, there was no difference in susceptibility to Ca-ALT with either SERCA2a overexpression or inhibition when compared to controls (p = 0.73). In contrast, SERCA2a overexpression resulted in increased premature SR Ca2+ (SCR) release compared to control myocytes (28% and 0%, p < 0.05) and concomitant increase in SR Ca2+ load (p < 0.05). Based on these observations we tested in-vivo atrial arrhythmia inducibility in control and Ad. SERCA2a animals using an esophageal atrial burst pacing protocol. There were no inducible atrial arrhythmias in Ad. GFP (n = 4) animals though 20% of Ad. SERCA2a (n = 5) animals had inducible atrial arrhythmias (p = 0.20). Conclusions Our findings suggest that unlike the ventricle, SERCA2a is not a key regulator of cardiac alternans in the atrium. Importantly, SERCA2a overexpression in atrial myocytes can increase SCR, which may be arrhythmogenic.	[Nassal, Michelle M. J.; Wan, Xiaoping; Laurita, Kenneth R.; Cutler, Michael J.] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA; [Nassal, Michelle M. J.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cutler, Michael J.] Intermt Heart Inst, Salt Lake City, UT USA	Case Western Reserve University; Case Western Reserve University	Cutler, MJ (corresponding author), Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA.	Michael.Cutler@imail.org			National Institutes of Health [T32CM007250, T32HL105338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants T32CM007250 and T32HL105338.	Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cutler MJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P686, DOI 10.1161/CIRCEP.109.863118; De Jong AM, 2013, J CELL MOL MED, V17, P743, DOI 10.1111/jcmm.12064; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Heijman J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00030; Hiromoto K, 2005, CIRC J, V69, P1368, DOI 10.1253/circj.69.1368; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Li QC, 2012, BIOPHYS J, V102, P1471, DOI 10.1016/j.bpj.2012.03.007; Liang X, 2008, CARDIOLOGY, V111, P102, DOI 10.1159/000119697; Lugo CA, 2014, AM J PHYSIOL-HEART C, V306, pH1540, DOI 10.1152/ajpheart.00515.2013; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Narayan SM, 2002, CIRCULATION, V106, P1968, DOI 10.1161/01.CIR.0000037062.35762.B4; Pastore JM, 2000, CIRC RES, V87, P1157, DOI 10.1161/01.RES.87.12.1157; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Tsai CT, 2011, J AM COLL CARDIOL, V58, P2106, DOI 10.1016/j.jacc.2011.07.039; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Wan XP, 2005, J MOL CELL CARDIOL, V39, P419, DOI 10.1016/j.yjmcc.2005.06.004; Xie WJ, 2013, J MOL CELL CARDIOL, V64, P120, DOI 10.1016/j.yjmcc.2013.09.003; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	30	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137359	10.1371/journal.pone.0137359	http://dx.doi.org/10.1371/journal.pone.0137359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352986	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800078
J	No, YR; Lee, SJ; Kumar, A; Yun, CC				No, Yi Ran; Lee, Sei-Jung; Kumar, Ajay; Yun, C. Chris			HIF1 alpha-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; HYPOXIA-INDUCIBLE FACTOR; FACTOR GENE; CANCER; EXPRESSION; SURVIVAL; COLITIS; PROTEIN; MICE; P53	Macrophage migration inhibitory factor (MIF) is a cytokine that has broad effects on immune system and inflammatory response. A growing body of evidence implicates the role of MIF in tumor growth and metastasis. Lysophosphatidic acid (LPA), a bioactive lipid mediator, regulates colon cancer cell proliferation, invasion, and survival through LPA(2) receptor. Loss of LPA(2) results in decreased expression of MIF in a rodent model of colon cancer, but the mechanism of MIF regulation by LPA is yet to be determined. In this study, we show that LPA transcriptionally regulates MIF expression in colon cancer cells. MIF knockdown decreased LPA-mediated proliferation of HCT116 human adenocarcinoma cells without altering the basal proliferation rates. Conversely, extracellular recombinant MIF stimulated cell proliferation, suggesting that the effect of MIF may in part be mediated through activation of surface receptor. We have shown recently that LPA increases hypoxia-inducible factor 1 alpha (HIF1 alpha) expression. We found that MIF regulation by LPA was ablated by knockdown of HIF1 alpha, indicating that MIF is a transcriptional target of HIF1 alpha. Conversely, knockdown of MIF ablated an increase in HIF1 alpha expression in LPA-treated cells, suggesting a reciprocal relationship between HIF1 alpha and MIF. LPA stimulated co-immunoprecipitation of HIF1 alpha and MIF, indicating that their association is necessary for stabilization of HIF1 alpha. It has been shown previously that CSN9 signalosome subunit 5 (CSN5) interacts with HIF1 alpha to stabilize HIF1 alpha under aerobic conditions. We found that LPA did not alter expression of CSN5, but stimulated its interaction with HIF1 alpha and MIF. Depletion of CSN5 mitigated the association between HIF1 alpha and MIF, indicating that CSN5 acts as a physical link. We suggest that HIF1 alpha, MIF, and CSN5 form a ternary complex whose formation is necessary to prevent degradation of HIF1 alpha under aerobic conditions.	[No, Yi Ran; Lee, Sei-Jung; Kumar, Ajay; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	ccyun@emory.edu	Kumar, Ajay/AER-0947-2022; Lee, Sei-Jung/V-8772-2019		National Institutions of Health [R01DK071597]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597] Funding Source: NIH RePORTER	National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by National Institutions of Health grant R01DK071597 and a Senior Research Award from the Crohn's and Colitis Foundation of America to C.C.Y.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bai FW, 2012, J BIOL CHEM, V287, P30653, DOI 10.1074/jbc.M112.385583; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Han I, 2008, CLIN ORTHOP RELAT R, V466, P2107, DOI 10.1007/s11999-008-0333-1; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koong AC, 2000, CANCER RES, V60, P883; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Larsen M, 2008, CANCER LETT, V265, P239, DOI 10.1016/j.canlet.2008.02.012; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Maaser C, 2002, GASTROENTEROLOGY, V122, P667, DOI 10.1053/gast.2002.31891; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nishihira J, 2012, ANN NY ACAD SCI, V1271, P53, DOI 10.1111/j.1749-6632.2012.06735.x; Nohara H, 2004, J GASTROENTEROL, V39, P242, DOI 10.1007/s00535-003-1284-7; Oda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002215; Ohkawara T, 2005, CLIN EXP IMMUNOL, V140, P241, DOI 10.1111/j.1365-2249.2005.02771.x; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; Ren Y, 2005, ANN SURG, V242, P55, DOI 10.1097/01.sla.0000168555.97710.bb; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Sun B, 2005, CLIN CANCER RES, V11, P1050; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Yun CC, 2015, EXP CELL RES, V333, P201, DOI 10.1016/j.yexcr.2014.11.013; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137513	10.1371/journal.pone.0137513	http://dx.doi.org/10.1371/journal.pone.0137513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352431	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800092
J	Pertesi, M; Galia, P; Nazaret, N; Vallee, M; Garderet, L; Leleu, X; Avet-Loiseau, H; Foll, M; Byrnes, G; Lachuer, J; Mckay, JD; Dumontet, C				Pertesi, Maroulio; Galia, Perrine; Nazaret, Nicolas; Vallee, Maxime; Garderet, Laurent; Leleu, Xavier; Avet-Loiseau, Herve; Foll, Matthieu; Byrnes, Graham; Lachuer, Joel; Mckay, James D.; Dumontet, Charles			Rare Circulating Cells in Familial Waldenstrom Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; M MONOCLONAL GAMMOPATHY; DNA-SEQUENCING DATA; LYMPHOPROLIFERATIVE DISORDERS; READ ALIGNMENT; LYMPHOCYTES-B; EXPRESSION; FRAMEWORK; VARIANTS; LINES	The MYD88 L265P is a recurrent somatic mutation in neoplastic cells from patients with Waldenstrom Macroglobulinemia (WM). We identified the MYD88 L265P mutation in three individuals from unrelated families, but its presence did not explain the disease segregation within these WM pedigrees. We observed the mutation in these three individuals at high allele fractions in DNA extracted from EBV-immortalized Lymphoblastoid cell lines established from peripheral blood (LCL), but at much lower allele fractions in DNA extracted directly from peripheral blood, suggesting that this mutation is present in a clonal cell sub-population rather than of germ-line origin. Furthermore, we observed that the MYD88 L265P mutation is enriched in WM families, detected in 40.5% of patients with familial WM or MGUS (10/22 WM, 5/15 MGUS), compared to 3.5% of patients with familial MM or MGUS (0/72 MM, 4/41 MGUS) (p = 10(-7)). The mutant allele frequency increased with passages in vitro after immortalization with Epstein-Barr virus (EBV) consistent with the MYD88 L265P described gain-of-function proposed for this mutation. The MYD88 L265P mutation appears to be frequently present in circulating cells in patients with WM, and MGUS, and these cells are amenable to immortalization by EBV.	[Pertesi, Maroulio; Vallee, Maxime; Foll, Matthieu; Mckay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil, F-69372 Lyon, France; [Galia, Perrine; Dumontet, Charles] Hosp Civils Lyon, Pierre Benite, France; [Galia, Perrine; Dumontet, Charles] CRCL, CNRS 5286, INSERM 1052, Lyon, France; [Galia, Perrine; Dumontet, Charles] Univ Lyon, Lyon, France; [Galia, Perrine; Nazaret, Nicolas; Lachuer, Joel; Dumontet, Charles] ProfilExpert, Lyon, France; [Garderet, Laurent] INSERM, UMR S Proliferat & Differentiat Stem Cells 938, Paris, France; [Garderet, Laurent] Hop St Antoine, AP HP, Dept Hematol & Therapie Cellulaire, F-75571 Paris, France; [Garderet, Laurent] Univ Paris 06, Sorbonne Univ, Paris, France; [Leleu, Xavier] CHRU Lille, Hop Huriez, Serv Malad Sang, F-59037 Lille, France; [Leleu, Xavier] Inst Rech Canc IRCL, Facteurs Persistance Cellules Leucem, Ctr Rech, INSERM,U837, Lille, France; [Avet-Loiseau, Herve] CRCT INSERM U1037, Inst Univ Canc Toulouse Oncopole, Unite Genom Myelome, Toulouse, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization; International Agency for Research on Cancer (IARC)	Dumontet, C (corresponding author), Hosp Civils Lyon, Pierre Benite, France.	charles.dumontet@chu-lyon.fr	Foll, Matthieu/A-8561-2014; Avet-Loiseau, Herve/P-8872-2014	Foll, Matthieu/0000-0001-9006-8436; Avet-Loiseau, Herve/0000-0002-3050-0140; Byrnes, Graham/0000-0003-3893-7539; lachuer, joel/0000-0002-5209-5094; Vallee, Maxime/0000-0002-3616-9508; Dumontet, Charles/0000-0003-1875-134X	Institut National du Cancer (INCA) [2010-077]; Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG)	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG)	The work was funded from the Institut National du Cancer (INCA, Projet Transla 2010-077, CD) and the Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DOYLE MG, 1993, LEUKEMIA, V7, P1858; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jimenez C, 2014, APPL IMMUNOHISTO M M, V22, P768, DOI 10.1097/PAI.0000000000000020; Kriangkum J, 2004, BLOOD, V104, P2134, DOI 10.1182/blood-2003-11-4024; Kristinsson SY, 2008, BLOOD, V112, P3052, DOI 10.1182/blood-2008-06-162768; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kyle RA, 2013, CL LYMPH MYELOM LEUK, V13, P184, DOI 10.1016/j.clml.2013.02.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080088; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; SMITH BR, 1983, BLOOD, V61, P911; Steingrimsson V, 2015, BLOOD, V125, P2174, DOI 10.1182/blood-2015-01-622068; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; SZEKELY L, 1995, ONCOGENE, V10, P1869; Toffart AC, 2014, LUNG CANCER, V83, P182, DOI 10.1016/j.lungcan.2013.12.003; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136505	10.1371/journal.pone.0136505	http://dx.doi.org/10.1371/journal.pone.0136505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352266	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800037
J	Seibert, AM; Koblitz, JC; Denzinger, A; Schnitzler, HU				Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich			Bidirectional Echolocation in the Bat Barbastella barbastellus: Different Signals of Low Source Level Are Emitted Upward through the Nose and Downward through the Mouth	PLOS ONE			English	Article							DIRECTIONALITY; TACTICS; DETECT; RANGE; MOTHS	The Barbastelle bat (Barbastella barbastellus) preys almost exclusively on tympanate moths. While foraging, this species alternates between two different signal types. We investigated whether these signals differ in emission direction or source level (SL) as assumed from earlier single microphone recordings. We used two different settings of a 16-microphone array to determine SL and sonar beam direction at various locations in the field. Both types of search signals had low SLs (81 and 82 dB SPL rms re 1 m) as compared to other aerial-hawking bats. These two signal types were emitted in different directions; type 1 signals were directed downward and type 2 signals upward. The angle between beam directions was approximately 70 degrees. Barbastelle bats are able to emit signals through both the mouth and the nostrils. As mouth and nostrils are roughly perpendicular to each other, we conclude that type 1 signals are emitted through the mouth while type 2 signals and approach signals are emitted through the nose. We hypothesize that the "stealth" echolocation system of B. barbastellus is bifunctional. The more upward directed nose signals may be mainly used for search and localization of prey. Their low SL prevents an early detection by eared moths but comes at the expense of a strongly reduced detection range for the environment below the bat. The more downward directed mouth signals may have evolved to compensate for this disadvantage and may be mainly used for spatial orientation. We suggest that the possibly bifunctional echolocation system of B. barbastellus has been adapted to the selective foraging of eared moths and is an excellent example of a sophisticated sensory arms race between predator and prey.	[Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich] Univ Tubingen, Inst Neurobiol, Anim Physiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Seibert, AM (corresponding author), Univ Tubingen, Inst Neurobiol, Anim Physiol, Morgenstelle 28, D-72076 Tubingen, Germany.	anni.seibert@googlemail.com			Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen [S.51.40001.2]; Deutsche Forschungsgemeinschaft (DFG) [SFB 550, Schn 138/27-1, EXC 307]	Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen (S.51.40001.2). The CIN is an Excellence Cluster funded by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the Excellence Initiative (EXC 307). This study was also funded by the Deutsche Forschungsgemeinschaft (SFB 550 and Schn 138/27-1). Furthermore we acknowledge support by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I., 1981, Sveriges Lantbruksuniversitet Institutionen for Viltekologi Rapport, P1; Ahlen I., 1990, IDENTIFICATION BATS; Barataud M, 2001, VESPERE, V2, P95; Barataud M, 2004, RHINOLOPHE, V17, P87; Denzinger A, 2001, J COMP PHYSIOL A, V187, P521, DOI 10.1007/s003590100223; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dietz C., 2007, HDB FLEDERMAUSE EURO; FENTON MB, 1979, J COMP PHYSIOL, V132, P77, DOI 10.1007/BF00617734; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; GRINNELL AD, 1977, J COMP PHYSIOL, V116, P63, DOI 10.1007/BF00605517; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jakobsen L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00089; Koblitz JC, 2009, 5 AN SON S KYOT JAP; KOLB ANTON, 1965, Z VERGLEICHENDE PHYSIOL, V49, P412, DOI 10.1007/BF00298111; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Parsons S, 2000, J EXP BIOL, V203, P2641; Plank M, 2012, J ZOOL, V286, P154, DOI 10.1111/j.1469-7998.2011.00859.x; Pye J. D., 1960, Journal of Laryngology and Otology, V74, P718, DOI 10.1017/S0022215100057170; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; Rydell J., 2012, FAUNA FLORA STOCKHOL, V197, P38; Rydell Jens, 1997, Mammalian Species, V557, P1; Schnitzler Hans-Ulrich, 1998, P183; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Sierro A, 1997, ACTA OECOL, V18, P91, DOI 10.1016/S1146-609X(97)80067-7; Sierro A, 1999, J ZOOL, V248, P429, DOI 10.1111/j.1469-7998.1999.tb01042.x; Stilz P, 2006, J ACOUST SOC AM, V120, P3324; Stilz WP, 2012, J ACOUST SOC AM, V132, P1765, DOI 10.1121/1.4733537; Surlykke A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P551; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Vaughan Nancy, 1997, Bioacoustics, V7, P189; VOLLETH M, 1985, GENETICA, V66, P231, DOI 10.1007/BF00128044; Waters DA, 2003, PHYSIOL ENTOMOL, V28, P237, DOI 10.1111/j.1365-3032.2003.00355.x	34	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135590	10.1371/journal.pone.0135590	http://dx.doi.org/10.1371/journal.pone.0135590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352271	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800010
J	Wei, YC; Hu, XD; Gao, YS; Fu, Z; Zhao, W; Yu, QX; Wang, SZ; Zhu, SH; Li, J; Yu, JM; Yuan, SH				Wei, Yu-Chun; Hu, Xudong; Gao, Yongsheng; Fu, Zheng; Zhao, Wei; Yu, Qingxi; Wang, Suzhen; Zhu, Shouhui; Li, Jun; Yu, Jinming; Yuan, Shuanghu			Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers F-18-Alfatide and F-18-FDG: A Comparative Analysis	PLOS ONE			English	Article							FDG-PET; INTEROBSERVER VARIABILITY; CANCER; DELINEATION; RADIOTHERAPY; DEFINITION; INTEGRINS; THERAPY; IMPACT	Purpose To explore the value of a new simple lyophilized kit for labeling PRGD(2) peptide (F-18-ALF-NOTA-PRGD(2), denoted as F-18-alfatide) in the determination of metabolic tumor volume (MTV) with micro-PET in lewis lung carcinoma (LLC) tumor-bearing C57BL/6 mice verified by pathologic examination and compared with those using F-18-fluorodeoxyglucose (FDG) PET. Methods All LLC tumor-bearing C57BL/6 mice underwent two attenuation-corrected whole-body micro-PET scans with the radiotracers F-18-alfatide and F-18-FDG within two days. F-18-alfatide metabolic tumor volume (V-RGD) and F-18-FDG metabolic tumor volume (V-FDG) were manually delineated slice by slice on PET images. Pathologic tumor volume (V-Path) was measured in vitro after the xenografts were removed. Results A total of 37 mice with NSCLC xenografts were enrolled and 33 of them underwent F-18-alfatide PET, and 35 of them underwent F-18-FDG PET and all underwent pathological examination. The mean +/- standard deviation of V-Path, V-RGD, and V-FDG were 0.59 +/- 0.32 cm(3) (range, 0.13 +/- 1.64 cm(3)), 0.61 +/- 0.37 cm(3) (range, 0.15 +/- 1.86 cm(3)), and 1.24 +/- 0.53 cm(3) (range, 0.17 +/- 2.20 cm(3)), respectively. V-Path vs. V-RGD, V-Path vs. V-FDG, and V-RGD vs. V-FDG comparisons were t = -0.145, P = 0.885, t = -6.239, P<0.001, and t = -5.661, P<0.001, respectively. No significant difference was found between V-Path and V-RGD. V-FDG was much larger than V-RGD and V-Path. V-RGD seemed more approximate to the pathologic gross tumor volume. Furthermore, V-Path was more strongly correlated with V-RGD (R = 0.964, P<0.001) than with VFDG (R = 0.584, P<0.001). Conclusions F-18-alfatide PET provided a better estimation of gross tumor volume than F-18-FDG PET in LLC tumor-bearing C57BL/6 mice.	[Wei, Yu-Chun; Hu, Xudong; Zhao, Wei; Yu, Qingxi; Wang, Suzhen; Zhu, Shouhui; Yu, Jinming; Yuan, Shuanghu] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China; [Wei, Yu-Chun] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Peoples R China; [Gao, Yongsheng] Shandong Canc Hosp & Inst, Dept Pathol, Jinan, Peoples R China; [Fu, Zheng] Shandong Canc Hosp & Inst, Dept Nucl Med, Jinan, Peoples R China; [Li, Jun] Shandong Prov Hosp, Dept Thorac Surg, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Yuan, SH (corresponding author), Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China.	yuanshuanghu@sina.com						Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Buijsen J, 2012, RADIOTHER ONCOL, V102, P371, DOI 10.1016/j.radonc.2011.12.016; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Diederichs CG, 1998, J NUCL MED, V39, P1030; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Guo JF, 2006, J NUCL MED, V47, P419; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; MacManus M, 2009, RADIOTHER ONCOL, V91, P85, DOI 10.1016/j.radonc.2008.11.008; Mochizuki TA, 2001, J NUCL MED, V42, P1551; Nakamoto Y, 2005, RADIOLOGY, V234, P879, DOI 10.1148/radiol.2343030301; Nestle U, 2005, J NUCL MED, V46, P1342; Ormsby AWWE, 2013, AM J NUCL MED MOLEC, V3, P32; Paulino AC, 2004, INT J RADIAT ONCOL, V59, P4, DOI 10.1016/j.ijrobp.2003.10.045; Steenbakkers RJHM, 2006, INT J RADIAT ONCOL, V64, P435, DOI 10.1016/j.ijrobp.2005.06.034; van Baardwijk A, 2007, EUR J CANCER, V43, P1392, DOI 10.1016/j.ejca.2007.03.027; Van de Steene J, 2002, RADIOTHER ONCOL, V62, P37, DOI 10.1016/S0167-8140(01)00453-4; Wu CX, 2014, THERANOSTICS, V4, P546, DOI 10.7150/thno.8159	22	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136195	10.1371/journal.pone.0136195	http://dx.doi.org/10.1371/journal.pone.0136195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352404	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800029
J	Babitha, KC; Vemanna, RS; Nataraja, KN; Udayakumar, M				Babitha, K. C.; Vemanna, Ramu S.; Nataraja, Karaba N.; Udayakumar, M.			Overexpression of EcbHLH57 Transcription Factor from Eleusine coracana L. in Tobacco Confers Tolerance to Salt, Oxidative and Drought Stress	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; ATYPICAL BHLH PROTEIN; LOOP-HELIX PROTEINS; ABSCISIC-ACID; FUNCTIONAL-ANALYSIS; ABIOTIC STRESS; DESICCATION TOLERANCE; LIPID-PEROXIDATION; FACTOR FAMILY; GENOME-WIDE	Basic helix-loop-helix (bHLH) transcription factors constitute one of the largest families in plants and are known to be involved in various developmental processes and stress tolerance. We report the characterization of a stress responsive bHLH transcription factor from stress adapted species finger millet which is homologous to OsbHLH57 and designated as EcbHLH57. The full length sequence of EcbHLH57 consisted of 256 amino acids with a conserved bHLH domain followed by leucine repeats. In finger millet, EcbHLH57 transcripts were induced by ABA, NaCl, PEG, methyl viologen (MV) treatments and drought stress. Overexpression of EcbHLH57 in tobacco significantly increased the tolerance to salinity and drought stress with improved root growth. Transgenic plants showed higher photosynthetic rate and stomatal conductance under drought stress that resulted in higher biomass. Under long-term salinity stress, the transgenic plants accumulated higher seed weight/pod and pod number. The transgenic plants were also tolerant to oxidative stress and showed less accumulation of H(2)0(2) and MDA levels. The overexpression of EcbHLH57 enhanced the expression of stress responsive genes such as LEA14, rd29A, rd29B, SOD, APX, ADH1, HSP70 and also PP2C and hence improved tolerance to diverse stresses.	[Babitha, K. C.; Vemanna, Ramu S.; Nataraja, Karaba N.; Udayakumar, M.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India	University of Agricultural Sciences Bangalore	Udayakumar, M (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	udayakumar_m@yahoo.com		Nataraja, Karaba N./0000-0002-9766-3622; Vemanna, Ramu/0000-0002-9729-8768	Department of Biotechnology, Centre of Excellence programme [BT/01/COE/05/03]; Indian Council of Agricultural Research Niche area of Excellence programme [10-(6)/2005 EPD]; Department of Biotechnology-University of Agricultural Sciences Biotech HUB [BT/INF/UAS Bangalore/2011]	Department of Biotechnology, Centre of Excellence programme; Indian Council of Agricultural Research Niche area of Excellence programme; Department of Biotechnology-University of Agricultural Sciences Biotech HUB	This work was supported by the Department of Biotechnology, Centre of Excellence programme support (BT/01/COE/05/03), the Indian Council of Agricultural Research Niche area of Excellence programme (F.No. 10-(6)/2005 EP&D), and the Department of Biotechnology-University of Agricultural Sciences Biotech HUB (Ref No. BT/INF/UAS Bangalore/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca D, 2001, J EXP BOT, V52, P1417, DOI 10.1093/jexbot/52.360.1417; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Anjum F., 2003, Pakistan Journal of Agricultural Sciences, V40, P45; Aroca R, 2008, MICROB ECOL, V56, P704, DOI 10.1007/s00248-008-9390-y; Ashraf M, 1996, INT J PLANT SCI, V157, P729, DOI 10.1086/297395; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Badawi M, 2008, PLANT CELL PHYSIOL, V49, P1237, DOI 10.1093/pcp/pcn100; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Casaretto J, 2003, PLANT CELL, V15, P271, DOI 10.1105/tpc.007096; Chandler JW, 2009, PLANT MOL BIOL, V69, P57, DOI 10.1007/s11103-008-9405-6; CHAZEN O, 1995, PLANT CELL ENVIRON, V18, P727, DOI 10.1111/j.1365-3040.1995.tb00575.x; Chen J., 1994, MAIZE SCI, V2, P36; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Du YL, 2013, FUNCT PLANT BIOL, V40, P494, DOI 10.1071/FP12250; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Fairchild CD, 2000, GENE DEV, V14, P2377; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fisher R.A., 1960, DESIGN EXPT, V7th; Fu XZ, 2011, ENVIRON EXP BOT, V74, P106, DOI 10.1016/j.envexpbot.2011.05.006; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Goding CR, 2000, GENE DEV, V14, P1712; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Heang D, 2012, BREEDING SCI, V62, P133, DOI 10.1270/jsbbs.62.133; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Huang XS, 2013, PLANT PHYSIOL, V162, P1178, DOI 10.1104/pp.112.210740; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kirschbaum MUF, 2011, PLANT PHYSIOL, V155, P117, DOI 10.1104/pp.110.166819; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li CY, 2004, ENVIRON EXP BOT, V51, P237, DOI 10.1016/j.envexpbot.2003.11.001; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; MARCHETTI A, 1995, J MOL BIOL, V248, P541, DOI 10.1006/jmbi.1995.0241; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meng L, 2010, MOL PLANT, V3, P760, DOI 10.1093/mp/ssq021; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nazarbeygi E., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P70; Negi NP, 2015, PLANT CELL REP, V34, P1109, DOI 10.1007/s00299-015-1770-4; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Noreen Z, 2009, ENVIRON EXP BOT, V67, P395, DOI 10.1016/j.envexpbot.2009.05.011; Payne CT, 2000, GENETICS, V156, P1349; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Ramegowda HV, 2009, THESIS U AGR SCI BAN; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rao RCN, 2001, J AGRON CROP SCI, V186, P175, DOI 10.1046/j.1439-037X.2001.00472.x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakamoto W, 2001, PLANT CELL PHYSIOL, V42, P982, DOI 10.1093/pcp/pce128; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; SHEN QX, 1993, J BIOL CHEM, V268, P23652; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Wang W, 2004, TRENDS PLANT SCI, V9, P1360; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Whittaker A, 2001, J EXP BOT, V52, P961, DOI 10.1093/jexbot/52.358.961; Ye NH, 2012, RICE, V5, DOI 10.1186/1939-8433-5-1; Zhou J, 2009, J PLANT PHYSIOL, V166, P1296, DOI 10.1016/j.jplph.2009.02.007	78	58	64	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137098	10.1371/journal.pone.0137098	http://dx.doi.org/10.1371/journal.pone.0137098			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366726	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100049
J	Cutler, T; Sarkar, A; Moran, M; Steffensmeier, A; Puli, OR; Mancini, G; Tare, M; Gogia, N; Singh, A				Cutler, Timothy; Sarkar, Ankita; Moran, Michael; Steffensmeier, Andrew; Puli, Oorvashi Roy; Mancini, Greg; Tare, Meghana; Gogia, Neha; Singh, Amit			Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease	PLOS ONE			English	Article							PHOTORECEPTOR AXON GUIDANCE; RUBINSTEIN-TAYBI-SYNDROME; TRANSCRIPTIONAL COACTIVATOR; BETA OLIGOMERS; CELL; P300; ACETYLATION; CHROMATIN; TOXICITY; RETINA	Background The progressive neurodegenerative disorder Alzheimer's disease (AD) manifests as loss of cognitive functions, and finally leads to death of the affected individual. AD may result from accumulation of amyloid plaques. These amyloid plaques comprising of amyloid-beta 42 (A beta 42) polypeptides results from the improper cleavage of amyloid precursor protein (APP) in the brain. The A beta 42 plaques have been shown to disrupt the normal cellular processes and thereby trigger abnormal signaling which results in the death of neurons. However, the molecular-genetic mechanism(s) responsible for A beta 42 mediated neurodegeneration is yet to be fully understood. Methodology/Principal Findings We have utilized Gal4/UAS system to develop a transgenic fruit fly model for A beta 42 mediated neurodegeneration. Targeted misexpression of human A beta 42 in the differentiating photoreceptor neurons of the developing eye of transgenic fly triggers neurodegeneration. This progressive neurodegenerative phenotype resembles Alzheimer's like neuropathology. We identified a histone acetylase, CREB Binding Protein (CBP), as a genetic modifier of A beta 42 mediated neurodegeneration. Targeted misexpression of CBP along with A beta 42 in the differentiating retina can significantly rescue neurodegeneration. We found that gain-of-function of CBP rescues A beta 42 mediated neurodegeneration by blocking cell death. Misexpression of A beta 42 affects the targeting of axons from retina to the brain but misexpression of full length CBP along with A beta 42 can restore this defect. The CBP protein has multiple domains and is known to interact with many different proteins. Our structure function analysis using truncated constructs lacking one or more domains of CBP protein, in transgenic flies revealed that Bromo, HAT and polyglutamine (BHQ) domains together are required for the neuroprotective function of CBP. This BHQ domain of CBP has not been attributed to promote survival in any other neurodegenerative disorders. Conclusions/Significance We have identified CBP as a genetic modifier of A beta 42 mediated neurodegeneration. Furthermore, we have identified BHQ domain of CBP is responsible for its neuroprotective function. These studies may have significant bearing on our understanding of genetic basis of AD.	[Cutler, Timothy; Steffensmeier, Andrew; Mancini, Greg; Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Sarkar, Ankita; Moran, Michael; Puli, Oorvashi Roy; Tare, Meghana; Gogia, Neha; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton	Singh, A (corresponding author), Univ Dayton, Premed Program, Dayton, OH 45469 USA.	asingh1@udayton.edu	Puli, Oorvashi G./N-7671-2017; Sarkar, Ankita/AAC-8549-2020; Singh, Amit/T-5619-2019; Gogia, Neha/S-4777-2019	Puli, Oorvashi G./0000-0003-0358-7428; Singh, Amit/0000-0002-2962-2255; Gogia, Neha/0000-0002-0544-1265	University of Dayton	University of Dayton	This work was supported by University of Dayton startup Support; University of Dayton Honors Program; and University of Dayton Graduate Program.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Anderson J, 2005, GENETICS, V171, P1655, DOI 10.1534/genetics.105.045450; [Anonymous], [No title captured]; Arensman MD, 2014, MOL CANCER THER, V13, P2303, DOI 10.1158/1535-7163.MCT-13-1005; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2011, ARCH NEUROL-CHICAGO, V68, P268, DOI 10.1001/archneurol.2011.4; Beduer A, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/024001; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Chan HM, 2001, J CELL SCI, V114, P2363; Chan KC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09979; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Cowan CM, 2010, BIOCHEM SOC T, V38, P988, DOI 10.1042/BST0380988; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Goodman RH, 2000, GENE DEV, V14, P1553; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Kumar JP, 2011, DEV NEUROBIOL, V71, P1133, DOI 10.1002/dneu.20921; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; League GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021218; Lee JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122628; Lilja T, 2003, DEV BIOL, V262, P294, DOI 10.1016/S0012-1606(03)00392-0; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Mallik M, 2010, GENETICS, V184, P927, DOI 10.1534/genetics.109.113696; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Meinertzhagen Ian A., 1993, P1363; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Moran MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080829; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Newsome TP, 2000, DEVELOPMENT, V127, P851; NORDHEIM A, 1994, NATURE, V370, P177, DOI 10.1038/370177a0; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pena-Ortega F, 2015, PROTEIN AND PEPTIDE; Petrij F, 2000, AM J MED GENET, V92, P47, DOI 10.1002/(SICI)1096-8628(20000501)92:1<47::AID-AJMG8>3.0.CO;2-H; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; RINCONLIMAS DE, 2012, CURR PHARM DES; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh A, 2005, AD DEV BIOL, V14, P59, DOI 10.1016/S1574-3349(04)14004-0; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Singh A, 2012, DEV DYNAM, V241, P1, DOI 10.1002/dvdy.23712; Steffensmeier AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078717; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Tare M., 2013, **DROPPED REF**, P37; Tare M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024361; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; van Genderen MM, 2000, BRIT J OPHTHALMOL, V84, P1177, DOI 10.1136/bjo.84.10.1177; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wolff Tanya, 1993, P1277; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	88	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137691	10.1371/journal.pone.0137691	http://dx.doi.org/10.1371/journal.pone.0137691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367392	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100110
J	Gomez-Laich, A; Yoda, K; Zavalaga, C; Quintana, F				Gomez-Laich, Agustina; Yoda, Ken; Zavalaga, Carlos; Quintana, Flavio			Selfies of Imperial Cormorants (Phalacrocorax atriceps): What Is Happening Underwater?	PLOS ONE			English	Article							FORAGING BEHAVIOR; GREAT CORMORANTS; DIVING PATTERNS; VISUAL-FIELDS; TOP PREDATOR; SHAGS; EYE; ATTACHMENT; STRATEGIES; MOVEMENTS	During the last few years, the development of animal-borne still cameras and video recorders has enabled researchers to observe what a wild animal sees in the field. In the present study, we deployed miniaturized video recorders to investigate the underwater foraging behavior of Imperial cormorants (Phalacrocorax atriceps). Video footage was obtained from 12 animals and 49 dives comprising a total of 8.1 h of foraging data. Video information revealed that Imperial cormorants are almost exclusively benthic feeders. While foraging along the seafloor, animals did not necessarily keep their body horizontal but inclined it downwards. The head of the instrumented animal was always visible in the videos and in the majority of the dives it was moved constantly forward and backward by extending and contracting the neck while travelling on the seafloor. Animals detected prey at very short distances, performed quick capture attempts and spent the majority of their time on the seafloor searching for prey. Cormorants foraged at three different sea bottom habitats and the way in which they searched for food differed between habitats. Dives were frequently performed under low luminosity levels suggesting that cormorants would locate prey with other sensory systems in addition to sight. Our video data support the idea that Imperial cormorants' efficient hunting involves the use of specialized foraging techniques to compensate for their poor underwater vision.	[Gomez-Laich, Agustina; Quintana, Flavio] Consejo Nacl Invest Cient & Tecn, Inst Biol Organismos Marinos IBIOMAR CENPAT, Puerto Madryn, Chubut, Argentina; [Yoda, Ken; Zavalaga, Carlos] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Zavalaga, Carlos] Univ Cient Sur, Fac Ciencias Ambientales, Lima 42, Peru; [Quintana, Flavio] Wildlife Conservat Soc, Buenos Aires, DF, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Nagoya University; Universidad Cientifica del Sur (CIENTIFICA)	Gomez-Laich, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol Organismos Marinos IBIOMAR CENPAT, Blvd Brown 2915,U9120ACD, Puerto Madryn, Chubut, Argentina.	agomezlaich@cenpat-conicet.gob.ar		Quintana, Flavio/0000-0003-0696-2545	Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica; Japan Society for Promotion of Science	Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by grants from the Wildlife Conservation Society, Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica to F. Quintana, and by the Japan Society for Promotion of Science to C. Zavalaga and K. Yoda.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Bannasch R, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P141; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Cronin TW, 2007, J ORNITHOL, V148, pS563, DOI 10.1007/s10336-007-0199-0; CROXALL JP, 1991, J ZOOL, V225, P177, DOI 10.1111/j.1469-7998.1991.tb03810.x; Davis RW, 2001, COMP BIOCHEM PHYS A, V129, P759, DOI 10.1016/S1095-6433(01)00345-2; Davis RW, 2004, POLAR RES E, V58, P148; Dmytryk R, 2012, WILDLIFE SEARCH RESC; FRIEDMAN MB, 1975, NATURE, V255, P67, DOI 10.1038/255067a0; FROST BJ, 1978, J EXP BIOL, V74, P187; Fujita M, 2006, J COMP PHYSIOL A, V192, P481, DOI 10.1007/s00359-005-0083-4; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Gomez-Laich A, 2013, MAR BIOL, V160, P1697, DOI 10.1007/s00227-013-2222-8; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Gremillet D, 2012, AQUAT BIOL, V15, P187, DOI 10.3354/ab00430; Gunji M, 2013, J COMP PHYSIOL A, V199, P703, DOI 10.1007/s00359-013-0828-4; Harris S, 2014, EMU, V114, P222, DOI 10.1071/MU13059; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; Irigoyen AJ, 2011, BIOL INVASIONS, V13, P17, DOI 10.1007/s10530-010-9780-1; Johnson C, 2007, PRACTICAL ZONE SYSTE; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kokubun N, 2010, AQUAT BIOL, V8, P289, DOI 10.3354/ab00243; Malacalza Viviana E., 1995, Ornitologia Neotropical, V5, P91; MARTIN GR, 1991, BRAIN BEHAV EVOLUT, V37, P65, DOI 10.1159/000114347; MARTIN GR, 1984, PROC R SOC SER B-BIO, V223, P197, DOI 10.1098/rspb.1984.0090; Martin GR, 2008, IBIS, V150, P485, DOI 10.1111/j.1474-919X.2008.00808.x; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Moll RJ, 2009, COMPUT ELECTRON AGR, V66, P133, DOI 10.1016/j.compag.2009.01.001; Parker G., 1997, MAR ARGENTINO SUS RE, V1, P65; Pelletier D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031768, DOI 10.1371/J0URNAL.P0NE.0031768]; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Shepard ELC, 2010, AQUAT BIOL, V8, P259, DOI 10.3354/ab00232; Strod T, 2004, CURR BIOL, V14, pR376, DOI 10.1016/j.cub.2004.05.009; Svagelj WS, 2007, WATERBIRDS, V30, P97, DOI 10.1675/1524-4695(2007)030[0097:SSDASD]2.0.CO;2; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Troje NF, 2000, J EXP BIOL, V203, P935; VOSLAMBER B, 1995, ARDEA, V83, P213; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanuki Y, 2004, MAR BIOL, V145, P427, DOI 10.1007/s00227-004-1345-3; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; White CR, 2008, IBIS, V150, P231, DOI 10.1111/j.1474-919X.2008.00837.x; White CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000639; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Wilson RP, 1986, J WILDLIFE MANAGE, V54, P447; Yoda K, 2012, MAR ECOL PROG SER, V466, P249, DOI 10.3354/meps09939; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602	59	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136980	10.1371/journal.pone.0136980	http://dx.doi.org/10.1371/journal.pone.0136980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367384	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100040
J	Huang, SL; Li, RH; Huang, FY; Tang, FC				Huang, Shu-Ling; Li, Ren-Hau; Huang, Feng-Ying; Tang, Feng-Cheng			The Potential for Mindfulness-Based Intervention in Workplace Mental Health Promotion: Results of a Randomized Controlled Trial	PLOS ONE			English	Article							STRESS REDUCTION; PILOT; WORK; QUESTIONNAIRE; DISORDERS; FATIGUE; PROGRAM; LIFE; BENEFITS; VALIDITY	Objectives This study aims to intensively evaluate the effectiveness of mindfulness-based intervention (MBI) on mental illness risks (including psychological distress, prolonged fatigue, and perceived stress) and job strain (job control and job demands) for employees with poor mental health. Methods A longitudinal research design was adopted. In total, 144 participants were randomized to the intervention group or the control group. The intervention group participated in MBI for eight weeks. Measurements were collected for both groups at five time points: at pre-intervention (T1), at mid-intervention (T2), at the completion of intervention (T3), four weeks after intervention (T4), and eight weeks after intervention (T5). Data were analyzed according to the intention-to-treat principle. A linear mixed model with two levels was employed to analyze the repeated measurement data. Results Compared with the control group, the intercepts (means at T3) for the intervention group were significantly lower on psychological distress, prolonged fatigue, and perceived stress when MBI was completed. Even with the demographic variables controlled, the positive effects remained. For growth rates of prolonged fatigue and perceived stress, participants in the intervention group showed a steeper decrease than did the participants in the control group. Regarding job strain, although the intercept (mean at T3) of job demands showed a significant decline when BMI was completed, the significance disappeared when the demographic variables were controlled. Moreover, the other results for job control and job demands did not show promising findings. Conclusion As a workplace health promotion program, the MBI seems to have potential in improving mental illness risks for employees with poor mental health. However, there was insufficient evidence to support its effect on mitigating job strain. Further research on maintaining the positive effects on mental health for the long term and on developing innovative MBI to suit job strain are recommended.	[Huang, Shu-Ling; Li, Ren-Hau] Chung Shan Med Univ, Dept Psychol, Taichung, Taiwan; [Huang, Shu-Ling] Chung Shan Med Univ Hosp, Room Clin Psychol, Taichung, Taiwan; [Huang, Feng-Ying] Natl Taipei Univ Educ, Dept Educ, Taipei, Taiwan; [Tang, Feng-Cheng] Changhua Christian Hosp, Dept Occupat Med, Changhua, Taiwan; [Tang, Feng-Cheng] Chaoyang Univ Technol, Dept Leisure Serv Management, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taipei University of Education; Changhua Christian Hospital; Chaoyang University of Technology	Tang, FC (corresponding author), Changhua Christian Hosp, Dept Occupat Med, Changhua, Taiwan.	106159@cch.org.tw	Li, Ren-Hau/HGU-8191-2022		Health Promotion Administration, Ministry of Health and Welfare, Taiwan [HPA 100-Soc-4]	Health Promotion Administration, Ministry of Health and Welfare, Taiwan	This study was funded by the Health Promotion Administration, Ministry of Health and Welfare, Taiwan(HPA 100-Soc-4). (http://www.hpa.gov.tw/BHPNet/Web/Index/Index.aspx.) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385; Agnes PT, 2005, 4 EUROPEAN WORKING C; Aikens KA, 2014, J OCCUP ENVIRON MED, V56, P721, DOI 10.1097/JOM.0000000000000209; Bazarko D, 2013, J WORKPLACE BEHAV HE, V28, P107, DOI 10.1080/15555240.2013.779518; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Blacker M., 2009, STRESS REDUCTION CLI; Bush HE, 2014, AM J HEALTH PROMOT, V28, P380, DOI 10.4278/ajhp.120404-QUAN-186; CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247; Cheng YW, 2003, INT J BEHAV MED, V10, P15, DOI 10.1207/S15327558IJBM1001_02; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cohen-Katz Joanne, 2005, Holist Nurs Pract, V19, P78; Cohen-Katz Joanne, 2005, Holist Nurs Pract, V19, P26; Czabala C, 2011, HEALTH PROMOT INT, V26, pI70, DOI 10.1093/heapro/dar050; Dobkin PL, 2014, MINDFULNESS, V5, P710, DOI 10.1007/s12671-013-0225-7; DOHRENWEND BP, 1990, SOC PSYCH PSYCH EPID, V25, P41; Duchemin AM, 2015, J OCCUP ENVIRON MED, V57, P393, DOI 10.1097/JOM.0000000000000371; Flaxman PE, 2010, J OCCUP HEALTH PSYCH, V15, P347, DOI 10.1037/a0020522; Fortney L, 2013, ANN FAM MED, V11, P412, DOI 10.1370/afm.1511; Foureur M, 2013, CONTEMP NURSE, V45, P114, DOI 10.5172/conu.2013.45.1.114; [GCP ICH], 2014, GLOSSARY; Goetzel RZ, 2012, HEALTH AFFAIR, V31, P2474, DOI 10.1377/hlthaff.2011.0819; Goldberg D, 1978, MANUAL GEN HLTH QUES; Goodwin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078693; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Guo Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-100; Horner JK, 2014, APPL NURS RES, V27, P198, DOI 10.1016/j.apnr.2014.01.003; Huang SL, 2012, J OCCUP HEALTH, V54, P241, DOI 10.1539/joh.11-0171-FS; Hulsheger UR, 2013, J APPL PSYCHOL, V98, P310, DOI 10.1037/a0031313; International Labour Office, 2000, MENT HLTH WORKPL; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Karasek R., 1985, JOB CONTENT QUESTION; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Klatt MD, 2009, HEALTH EDUC BEHAV, V36, P601, DOI 10.1177/1090198108317627; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; Lakhan SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071834; Leone SS, 2007, QJM-INT J MED, V100, P617, DOI 10.1093/qjmed/hcm073; LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92; Malarkey WB, 2013, BRAIN BEHAV IMMUN, V27, P145, DOI 10.1016/j.bbi.2012.10.009; Marchand A, 2005, SOCIOL HEALTH ILL, V27, P602, DOI 10.1111/j.1467-9566.2005.00458.x; Meyer JD, 2014, AM J IND MED, V57, P587, DOI 10.1002/ajim.22255; Meyer JD, 2011, J OCCUP ENVIRON MED, V53, P139, DOI 10.1097/JOM.0b013e318203f220; Michalsen A, 2002, DEUT MED WOCHENSCHR, V127, P1742; Moody K, 2013, J PEDIATR ONCOL NURS, V30, P275, DOI 10.1177/1043454213504497; Pipe TB, 2009, J NURS ADMIN, V39, P130, DOI 10.1097/NNA.0b013e31819894a0; Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010; Siegrist J., 2001, INT ENCY SOCIAL BEHA, V22, P15175; van Berkel J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-9; van Berkel J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084118; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; WHO Regional Office for Europe, 2014, MENT HLTH DAT STAT; Wolever RQ, 2012, J OCCUP HEALTH PSYCH, V17, P246, DOI 10.1037/a0027278; World Health Organization, 1986, OTT CHART GES; Wu YS, 2011, SURVEY PERCEPTIONS S	56	40	41	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138089	10.1371/journal.pone.0138089	http://dx.doi.org/10.1371/journal.pone.0138089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367270	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100221
J	Martins, VT; Chavez-Fumagalli, MA; Lage, DP; Duarte, MC; Garde, E; Costa, LE; da Silva, VG; Oliveira, JS; de Magalhaes-Soares, DF; Teixeira, SMR; Fernandes, AP; Soto, M; Tavares, CAP; Coelho, EAF				Martins, Vivian Tamietti; Chavez-Fumagalli, Miguel Angel; Lage, Daniela Pagliara; Duarte, Mariana Costa; Garde, Esther; Costa, Lourena Emanuele; da Silva, Viviane Gomes; Oliveira, Jamil Silvano; de Magalhaes-Soares, Danielle Ferreira; Ribeiro Teixeira, Santuza Maria; Fernandes, Ana Paula; Soto, Manuel; Pereira Tavares, Carlos Alberto; Ferraz Coelho, Eduardo Antonio			Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL RESPONSE; IMMUNE-RESPONSES; CUTANEOUS LEISHMANIASIS; BALB/C MICE; CANINE LEISHMANIASIS; BRAZILIAN DOGS; VACCINE; INFECTION; CHAGASI	In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be evaluated against L. infantum infection. Also, the antigenicity of the three proteins was analyzed, and their use for the serodiagnosis of canine visceral leishmaniasis (CVL) was evaluated. The LiHyp1, LiHyp6, and HRF DNA coding sequences were cloned in prokaryotic expression vectors and the recombinant proteins were purified. When employed in ELISA assays, all proteins were recognized by sera from visceral leishmaniasis (VL) dogs, and presented no cross-reactivity with either sera from dogs vaccinated with a Brazilian commercial vaccine, or sera of Trypanosoma cruzi-infected or Ehrlichia canis-infected animals. In addition, the antigens were not recognized by antibodies from non-infected animals living in endemic or non-endemic areas for leishmaniasis. The immunogenicity and protective efficacy of the three proteins administered in the presence of saponin, individually or in combination (composing a polyproteins vaccine), were evaluated in a VL murine model: BALB/c mice infected with L. infantum. Spleen cells from mice inoculated with the individual proteins or with the polyproteins vaccine plus saponin showed a protein-specific production of IFN-gamma, IL-12, and GM-CSF after an in vitro stimulation, which was maintained after infection. These animals presented significant reductions in the parasite burden in different evaluated organs, when compared to mice inoculated with saline or saponin. The decrease in parasite burden was associated with an IL-12-dependent production of IFN-gamma against parasite total extracts (produced mainly by CD4(+) T cells), correlated to the induction of parasite proteins-driven NO production. Mice inoculated with the recombinant protein-based vaccines showed also high levels of parasite-specific IgG2a antibodies. The polyproteins vaccine administration induced a more pronounced Th1 response before and after challenge infection than individual vaccines, which was correlated to a higher control of parasite dissemination to internal organs.	[Martins, Vivian Tamietti; da Silva, Viviane Gomes; Oliveira, Jamil Silvano; Ribeiro Teixeira, Santuza Maria; Pereira Tavares, Carlos Alberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Chavez-Fumagalli, Miguel Angel; Duarte, Mariana Costa; Costa, Lourena Emanuele; Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Lage, Daniela Pagliara; Duarte, Mariana Costa; Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil; [Garde, Esther; Soto, Manuel] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [de Magalhaes-Soares, Danielle Ferreira] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Coelho, EAF (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.	eduardoferrazcoelho@yahoo.com.br	COELHO, EA/V-7926-2017; Fumagalli, Miguel Angel Chávez/AAI-9413-2020; Chávez Fumagalli, Miguel Angel/I-6756-2016; Álvarez, Manuel Soto/Q-5234-2018	COELHO, EA/0000-0002-6681-9014; Fumagalli, Miguel Angel Chávez/0000-0002-8394-4802; Chávez Fumagalli, Miguel Angel/0000-0002-8394-4802; Álvarez, Manuel Soto/0000-0001-6825-841X	Pro-Reitoria de Pesquisa from UFMG [Edital 01/2014]; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG [CBB-APQ-00819-12]; CNPq [APQ-472090/2011-9, APQ-482976/2012-8, APQ-488237/2013-0]; FAPEMIG/CAPES; CNPq; Ministerio de Ciencia e Innovacion [FIS PI14/00366]	Pro-Reitoria de Pesquisa from UFMG; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from Pro-Reitoria de Pesquisa from UFMG (Edital 01/2014), Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar), FAPEMIG (CBB-APQ-00819-12), and CNPq (APQ-472090/2011-9, APQ-482976/2012-8, APQ-488237/2013-0). MACF is a grant recipient of FAPEMIG/CAPES. EAFC, APF and SMRT are grant recipient of CNPq. This study was also, in part, supported in Spain by grants from Ministerio de Ciencia e Innovacion (FIS PI14/00366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Agallou M, 2012, VACCINE, V30, P5086, DOI 10.1016/j.vaccine.2012.05.075; Alves Waneska Alexandre, 2004, Cad. Saúde Pública, V20, P259, DOI 10.1590/S0102-311X2004000100043; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Baharia RK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003557; Balaraman S, 2004, BIOCHEM BIOPH RES CO, V317, P639, DOI 10.1016/j.bbrc.2004.03.097; Barbieri CL, 2006, PARASITE IMMUNOL, V28, P329, DOI 10.1111/j.1365-3024.2006.00840.x; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrion J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-150; Cerpa-Cruz SS, 2013, IMMUNOL RES, V56, P299, DOI 10.1007/s12026-013-8400-4; Chavez-Fumagalli MA, 2010, MICROBES INFECT, V12, P967, DOI 10.1016/j.micinf.2010.06.008; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Coelho EAF, 2003, INFECT IMMUN, V71, P3988, DOI 10.1128/IAI.71.7.3988-3994.2003; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110014; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Das A, 2012, EXPERT REV VACCINES, V11, P783, DOI [10.1586/ERV.12.50, 10.1586/erv.12.50]; Pereira NCD, 2015, EXP PARASITOL, V153, P180, DOI 10.1016/j.exppara.2015.03.027; Dumas C, 2003, INFECT IMMUN, V71, P6499, DOI 10.1128/IAI.71.11.6499-6509.2003; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Figueiredo FB, 2010, REV INST MED TROP SP, V52, P193, DOI 10.1590/S0036-46652010000400005; Follador I, 2002, VACCINE, V20, P1365, DOI 10.1016/S0264-410X(01)00469-8; Galli V, 2013, CLIN VACCINE IMMUNOL, V20, P1370, DOI 10.1128/CVI.00140-13; GarciaAlonso M, 1996, PARASITE IMMUNOL, V18, P539, DOI 10.1046/j.1365-3024.1996.d01-28.x; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREEN SJ, 1990, IMMUNOL LETT, V25, P15, DOI 10.1016/0165-2478(90)90083-3; Iborra S, 2008, MICROBES INFECT, V10, P1133, DOI 10.1016/j.micinf.2008.06.002; Joshi J, 2014, PARASITOLOGY, V141, P554, DOI 10.1017/S0031182013001959; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kang JA, 2014, IMMUNOLOGY, V143, P550, DOI 10.1111/imm.12333; Kaur S, 2008, PARASITOL RES, V103, P1413, DOI 10.1007/s00436-008-1150-x; Kharazmi A, 1999, IMMUNOL LETT, V65, P105, DOI 10.1016/S0165-2478(98)00132-1; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002148, 10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f]; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; Minodier Philippe, 2007, Travel Med Infect Dis, V5, P150, DOI 10.1016/j.tmaid.2006.09.004; Miro G, 2007, PARASITOL RES, V101, P253, DOI 10.1007/s00436-007-0497-8; Miro G, 2008, TRENDS PARASITOL, V24, P371, DOI 10.1016/j.pt.2008.05.003; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1995, J CLIN INVEST, V95, P1183, DOI 10.1172/JCI117767; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Mutiso JM, 2013, J BIOMED RES, V27, P85, DOI [10.7555/BR.27.20120064, 10.7555/JBR.27.20120064]; Oliveira DM, 2012, PARASITOL RES, V110, P1277, DOI 10.1007/s00436-011-2628-5; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Palatnik-de-Sousa CB, 2008, EXPERT REV VACCINES, V7, P833, DOI 10.1586/14760584.7.6.833; RACHAMIM N, 1993, J IMMUNOL, V150, P2322; Ramirez L, 2013, VACCINE, V31, P1312, DOI 10.1016/j.vaccine.2012.12.071; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Resende DM, 2008, VACCINE, V26, P4585, DOI 10.1016/j.vaccine.2008.05.091; Saljoughian N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002174; Pereira BAS, 2008, VET PARASITOL, V158, P239, DOI 10.1016/j.vetpar.2008.09.015; Soudi S, 2011, PARASITE IMMUNOL, V33, P561, DOI 10.1111/j.1365-3024.2011.01318.x; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Strauss-Ayali D, 2004, J INFECT DIS, V189, P1729, DOI 10.1086/383281; Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; Weiss WR, 1998, J IMMUNOL, V161, P2325; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895; WHO, 2010, WHO TECH REP SER, V949, P1; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zahedifard F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002751; Zanin FHC, 2007, MICROBES INFECT, V9, P1070, DOI 10.1016/j.micinf.2007.05.012	70	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137683	10.1371/journal.pone.0137683	http://dx.doi.org/10.1371/journal.pone.0137683			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367128	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100108
J	Tomioka, K; Okamoto, N; Kurumatani, N; Hosoi, H				Tomioka, Kimiko; Okamoto, Nozomi; Kurumatani, Norio; Hosoi, Hiroshi			Association of Psychosocial Conditions, Oral Health, and Dietary Variety with Intellectual Activity in Older Community-Dwelling Japanese Adults	PLOS ONE			English	Article							LEVEL FUNCTIONAL-CAPACITY; LIFE SOCIAL ACTIVITY; PERIODONTAL-DISEASE; INFLAMMATORY MARKERS; PHYSICAL PERFORMANCE; LONGITUDINAL CHANGES; RISK INDICATORS; ELDERLY ADULTS; RELATIVE RISK; MORTALITY	Background This study examined the factors related to intellectual activity in community-dwelling elderly persons. Methods Self-administered questionnaires mailed to all people aged >= 65 years in a dormitory suburb in Japan (n = 15,210). The response rate was 72.2%. Analytical subjects (n = 8,910) were those who lived independently and completely answered questions about independent and dependent variables and covariates. Independent variables included psychosocial conditions (i.e., social activities, hobbies, and a sense that life is worth living (ikigai)), oral health (i.e., dental health behaviors and oral function evaluated by chewing difficulties, swallowing difficulties, and oral dryness), and dietary variety measured using the dietary variety score (DVS). A dependent variable was intellectual activity measured using the Tokyo Metropolitan Institute of Gerontology Index of Competence. Covariates included age, gender, family structure, pensions, body mass index, alcohol, smoking, medical history, self-rated health, medications, cognitive function, depression, and falling. Logistic regression was used to estimate the odds ratio (OR) for poor intellectual activity. Results Poor intellectual activity was reported by 28.9% of the study population. After adjustment for covariates and independent variables, poor intellectual activity was significantly associated with nonparticipation in social activities (OR = 1.90, 95% CI = 1.61-2.24), having neither hobbies nor ikigai (3.13, 2.55-3.84), having neither regular dental visits nor daily brushing (1.70, 1.35-2.14), the poorest oral function (1.61, 1.31-1.98), and the lowest DVS quartile (1.96, 1.70-2.26). Conclusion These results indicate that psychosocial conditions, oral health, and dietary variety are independently associated with intellectual activity in elderly persons. The factors identified in this study may be used in community health programs for maintaining the intellectual activity ability of the elderly.	[Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi] Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan; [Okamoto, Nozomi; Kurumatani, Norio] Nara Med Univ, Dept Community Hlth & Epidemiol, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Tomioka, K (corresponding author), Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan.	tkimiko@naramed-u.ac.jp			center administrative expense from Nara Medical University	center administrative expense from Nara Medical University	This work was supported by center administrative expense from Nara Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Amano H, 2005, J AM GERIATR SOC, V53, P2128, DOI 10.1111/j.1532-5415.2005.00536.x; American Academy of Periodontology, 1992, GLOSSARY OF PERIODON; [Anonymous], 2003, GERIATR GERONTOL INT; Attin T, 2005, Oral Health Prev Dent, V3, P135; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1096, DOI 10.1016/S0002-8223(02)90246-4; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Campbell WW, 2007, J AM COLL NUTR, V26, p696S, DOI 10.1080/07315724.2007.10719650; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Drewnowski A, 1997, J AM DIET ASSOC, V97, P266, DOI 10.1016/S0002-8223(97)00070-9; Ekuni D, 2011, NEUROMOL MED, V13, P197, DOI 10.1007/s12017-011-8151-0; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57; Fujiwara Y, 2009, INT J GERIATR PSYCH, V24, P547, DOI 10.1002/gps.2148; Fushiki Y, 2012, J EPIDEMIOL, V22, P340, DOI 10.2188/jea.JE20110057; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; Haga H, 1997, FACT RES INTERV GER, P53; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; Imai E, 2014, J AM GERIATR SOC, V62, P426, DOI 10.1111/jgs.12690; Ishida R, 2006, STRESS HEALTH, V22, P275, DOI 10.1002/smi.1095; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Iwasa H, 2009, INT J GERIATR PSYCH, V24, P1192, DOI 10.1002/gps.2245; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kajikawa M, 2014, CIRC J, V78, P950, DOI 10.1253/circj.CJ-13-1330; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Kondo N, 2008, PREV MED, V46, P457, DOI 10.1016/j.ypmed.2007.12.007; Kono A, 2004, J GERONTOL A-BIOL, V59, P275; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Koyano W., 1987, JPN J PUBLIC HLTH, V34, P109; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lawton MP, 1972, RES PLANNING ACTION, P122; Lee L, 2001, PUBLIC HEALTH, V115, P133, DOI 10.1016/S0033-3506(01)00432-2; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Listl S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-70; Liu L, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0053-3; LOCKER D, 1993, J DENT RES, V72, P9, DOI 10.1177/00220345930720011501; Marshall TA, 2001, J NUTR, V131, P2192, DOI 10.1093/jn/131.8.2192; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Miura H, 2007, J ORAL REHABIL, V34, P422, DOI 10.1111/j.1365-2842.2007.01741.x; Moriya S, 2013, GERODONTOLOGY, V30, P133, DOI 10.1111/j.1741-2358.2012.00654.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mortazavi H, 2014, ANN MED HEALTH SCI R, V4, P503, DOI 10.4103/2141-9248.139284; Murata C, 2006, ARCH GERONTOL GERIAT, V43, P369, DOI 10.1016/j.archger.2006.01.002; Nakanishi N, 1998, SCAND J SOC MED, V26, P198, DOI 10.1177/14034948980260031001; Nakanishi N, 2005, J AM GERIATR SOC, V53, P54, DOI 10.1111/j.1532-5415.2005.53010.x; Nakanishi N, 1999, AGE AGEING, V28, P323, DOI 10.1093/ageing/28.3.323; Ohara Y, 2015, GERIATR GERONTOL INT, V15, P755, DOI 10.1111/ggi.12345; Osterberg T, 2002, Gerodontology, V19, P95, DOI 10.1111/j.1741-2358.2002.00095.x; Rudberg MA, 1996, J GERONTOL A-BIOL, V51, pM189, DOI 10.1093/gerona/51A.5.M189; Saito E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-93; Sbaraglia M, 2002, J PUBLIC HEALTH DENT, V62, P51, DOI 10.1111/j.1752-7325.2002.tb03421.x; Shinkai S., 2003, GERIATR GERONTOL INT, V3, pS31, DOI [10.1111/j.1444-0594.2003.00094.x, DOI 10.1111/J.1444-0594.2003.00094.X]; Sone T, 2008, PSYCHOSOM MED, V70, P709, DOI 10.1097/PSY.0b013e31817e7e64; Takata Y, 2008, GERODONTOLOGY, V25, P147, DOI 10.1111/j.1741-2358.2007.00203.x; Takata Y, 2007, GERONTOLOGY, V53, P46, DOI 10.1159/000095934; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Teixeira FB, 2014, INT J MED SCI, V11, P209, DOI 10.7150/ijms.6801; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Worthington HV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub4; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	69	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137656	10.1371/journal.pone.0137656	http://dx.doi.org/10.1371/journal.pone.0137656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26360380	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100067
J	Zhang, PF				Zhang, Peifeng			Spatiotemporal Features of the Three-Dimensional Architectural Landscape in Qingdao, China	PLOS ONE			English	Article							URBAN LAND EXPANSION; LIDAR DATA; DYNAMICS; IMAGERY; EXTRACTION; FUSION; SCENES; SAR; GIS	The evolution and development of the three-dimensional (3D) architectural landscape is the basis of proper urban planning, eco-environment construction and the improvement of environmental quality. This paper presents the spatiotemporal characteristics of the 3D architectural landscape of the Shinan and Shibei districts in Qingdao, China, based on buildings' 3D information extracted from Quickbird images from 2003 to 2012, supported by Barista, landscape metrics and GIS. The results demonstrated that: (1) Shinan and Shibei districts expanded vertically and urban land use intensity increased noticeably from year to year. (2) Significant differences in the 3D architectural landscape existed among the western, central and eastern regions, and among the 26 sub-districts over the study period. The differentiation was consistent with the diverse development history, function and planning of the two districts. Finally, we found that population correlates positively with the variation in the 3D architectural landscape. This research provides an important reference for related studies, urban planning and eco-city construction.	China Univ Petr, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhang, PF (corresponding author), China Univ Petr, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China.	windzpf@163.com			Projects of National Natural Science Foundation of China [41301198]; Fundamental Research Funds for the Central Universities [14CX02081A]	Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the Projects of National Natural Science Foundation of China (41301198) and the Fundamental Research Funds for the Central Universities (14CX02081A).	Aguilera F, 2011, LANDSCAPE URBAN PLAN, V99, P226, DOI 10.1016/j.landurbplan.2010.10.004; Awrangjeb M, 2010, ISPRS J PHOTOGRAMM, V65, P457, DOI 10.1016/j.isprsjprs.2010.06.001; Baillard C, 1999, COMPUT VIS IMAGE UND, V76, P244, DOI 10.1006/cviu.1999.0793; Chen JF, 2014, HABITAT INT, V43, P61, DOI 10.1016/j.habitatint.2014.01.004; Cici A, 2009, COMPUTERS ENV URBAN, V33, P285; Dell'Acqua F, 2009, ISPRS J PHOTOGRAMM, V64, P482, DOI 10.1016/j.isprsjprs.2008.09.006; Giilch E., 1999, INT ARCH PHOTOGRAMME, V32, P177, DOI 10.1.1.115.8061; Hanley H., 2004, PROC 20 ISPRS C, P24; Haregeweyn N, 2012, LANDSCAPE URBAN PLAN, V106, P149, DOI 10.1016/j.landurbplan.2012.02.016; Jiang L, 2012, LANDSCAPE URBAN PLAN, V108, P131, DOI 10.1016/j.landurbplan.2012.08.008; Kim J, 2011, INT J REMOTE SENS, V32, P2245, DOI 10.1080/01431161003698237; Li L, 2003, LANDSCAPE URBAN PLAN, V64, P67, DOI 10.1016/S0169-2046(02)00201-3; Li XW, 2010, PROCEDIA ENVIRON SCI, V2, P1139, DOI 10.1016/j.proenv.2010.10.123; Li YF, 2014, REG ENVIRON CHANGE, V14, P1175, DOI 10.1007/s10113-013-0552-1; Li YF, 2010, LANDSCAPE URBAN PLAN, V94, P218, DOI 10.1016/j.landurbplan.2009.10.006; Liu ZF, 2012, LANDSCAPE URBAN PLAN, V106, P62, DOI 10.1016/j.landurbplan.2012.02.013; Ma YL, 2010, HABITAT INT, V34, P228, DOI 10.1016/j.habitatint.2009.09.007; Nassar AK, 2014, COMPUT ENVIRON URBAN, V45, P50, DOI 10.1016/j.compenvurbsys.2014.02.005; Rottensteiner F, 2002, INT ARCH PHOTOGRAMM, DOI DOI 10.3390/S120506347; Soergel U, 2009, ISPRS J PHOTOGRAMM, V64, P490, DOI 10.1016/j.isprsjprs.2008.10.007; Sohn G, 2007, ISPRS J PHOTOGRAMM, V62, P43, DOI 10.1016/j.isprsjprs.2007.01.001; Suveg I, 2002, P SPIE INT SOC OPTIC; Trisirisatayawong I, 2004, ISPRS 20 C 12 23 JUL; Tupin F, 2003, ISPRS J PHOTOGRAMM, V58, P71, DOI 10.1016/S0924-2716(03)00018-2; VOSSELMAN G, 2001, INT ARCH PHOTOGRAMME, V34, P37; Vozikis G, 2003, PUBLIKATIONEN DTSCH, V12, P179; Willneff J., 2006, 13 AUSTR REM SENS PH; WILLNEFF J., INT ARCH PHOTOGRAMME, V36; Xiao JY, 2006, LANDSCAPE URBAN PLAN, V75, P69, DOI 10.1016/j.landurbplan.2004.12.005; Xu XL, 2013, CITIES, V35, P104, DOI 10.1016/j.cities.2013.05.002; Yang XM, 2006, DYNAM CONT DIS SER A, V13, P1418; Yu BL, 2010, LANDSCAPE URBAN PLAN, V98, P210, DOI 10.1016/j.landurbplan.2010.08.004; Zhang PF, 2014, J INDIAN SOC REMOTE, V42, P409, DOI 10.1007/s12524-013-0315-y	33	10	12	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137853	10.1371/journal.pone.0137853	http://dx.doi.org/10.1371/journal.pone.0137853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361016	gold, Green Published			2022-12-27	WOS:000361043100095
J	Boone, D; Mallett, S; McQuillan, J; Taylor, SA; Altman, DG; Halligan, S				Boone, Darren; Mallett, Susan; McQuillan, Justine; Taylor, Stuart A.; Altman, Douglas G.; Halligan, Steve			Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers	PLOS ONE			English	Article							MULTICENTER RANDOMIZED-TRIAL; 2ND READER; TOMOGRAPHIC COLONOGRAPHY; COLORECTAL-CANCER; COLONOSCOPY; POLYPS; RADIOLOGISTS; PERFORMANCE; POPULATION; ACCURACY	Objectives To quantify the incremental benefit of computer-assisted-detection (CAD) for polyps, for inexperienced readers versus experienced readers of CT colonography. Methods 10 inexperienced and 16 experienced radiologists interpreted 102 colonography studies unassisted and with CAD utilised in a concurrent paradigm. They indicated any polyps detected on a study sheet. Readers' interpretations were compared against a ground-truth reference standard: 46 studies were normal and 56 had at least one polyp (132 polyps in total). The primary study outcome was the difference in CAD net benefit (a combination of change in sensitivity and change in specificity with CAD, weighted towards sensitivity) for detection of patients with polyps. Results Inexperienced readers' per-patient sensitivity rose from 39.1% to 53.2% with CAD and specificity fell from 94.1% to 88.0%, both statistically significant. Experienced readers' sensitivity rose from 57.5% to 62.1% and specificity fell from 91.0% to 88.3%, both non-significant. Net benefit with CAD assistance was significant for inexperienced readers but not for experienced readers: 11.2%(95% CI 3.1% to 18.9%) versus 3.2% (95% CI -1.9% to 8.3%) respectively. Conclusions Concurrent CAD resulted in a significant net benefit when used by inexperienced readers to identify patients with polyps by CT colonography. The net benefit was nearly four times the magnitude of that observed for experienced readers. Experienced readers did not benefit significantly from concurrent CAD.	[Boone, Darren; McQuillan, Justine; Taylor, Stuart A.; Halligan, Steve] UCL, Ctr Med Imaging, London, England; [Mallett, Susan] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of London; University College London; University of Birmingham; University of Oxford	Halligan, S (corresponding author), UCL, Ctr Med Imaging, London, England.	s.halligan@ucl.ac.uk	Halligan, Steve/C-5875-2009; Mallett, Sue/GPS-9933-2022	Halligan, Steve/0000-0003-0632-5108; Taylor, Stuart/0000-0002-6765-8806; Mallett, Sue/0000-0002-0596-8200	UK Department of Health via a National Institute for Health Research Programme [RP-PG-0407-10338]; NIHR Biomedical Research Centre; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10338, NF-SI-0513-10019] Funding Source: researchfish	UK Department of Health via a National Institute for Health Research Programme; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded partly by the UK Department of Health via a National Institute for Health Research Programme Grant (RP-PG-0407-10338). This work was undertaken at UCLH and UCL, which receives a proportion of funding from the NIHR Biomedical Research Centre funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin W, 2013, LANCET, V381, P1194, DOI 10.1016/S0140-6736(12)62186-2; Boone D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080767; Dachman AH, 2010, RADIOLOGY, V256, P827, DOI 10.1148/radiol.10091890; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Halligan S, 2006, GASTROENTEROLOGY, V131, P1690, DOI 10.1053/j.gastro.2006.09.051; Halligan S, 2015, EUR RADIOL, V25, P932, DOI 10.1007/s00330-014-3487-0; Halligan S, 2013, LANCET, V381, P1185, DOI 10.1016/S0140-6736(12)62124-2; Halligan S, 2011, RADIOLOGY, V258, P469, DOI 10.1148/radiol.10100354; Iussich G, 2014, INVEST RADIOL, V49, P173, DOI 10.1097/RLI.0000000000000009; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Lieberman David, 2010, Gastrointest Endosc Clin N Am, V20, P239, DOI 10.1016/j.giec.2010.02.012; Liedenbaum MH, 2011, RADIOLOGY, V258, P477, DOI 10.1148/radiol.10100019; Mallett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107633; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Mang T, 2007, EUR RADIOL, V17, P2598, DOI 10.1007/s00330-007-0608-z; Mang T, 2014, EUR RADIOL, V24, P1466, DOI 10.1007/s00330-014-3158-1; Neri E, 2011, EUR J RADIOL, V80, P303, DOI 10.1016/j.ejrad.2010.07.014; Obuchowski NA, 2011, AM J ROENTGENOL, V197, pW821, DOI 10.2214/AJR.11.6764; Petrick N, 2008, RADIOLOGY, V246, P148, DOI 10.1148/radiol.2453062161; Regge D, 2013, RADIOLOGY, V266, P168, DOI 10.1148/radiol.12120376; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Summers RM, 2005, GASTROENTEROLOGY, V129, P1832, DOI 10.1053/j.gastro.2005.08.054; Taylor SA, 2008, BRIT J RADIOL, V81, P180, DOI 10.1259/bjr/93375459; Taylor SA, 2008, RADIOLOGY, V246, P463, DOI 10.1148/radiol.2461070190; Taylor SA, 2007, EUR RADIOL, V17, P575, DOI 10.1007/s00330-006-0407-y; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136624	10.1371/journal.pone.0136624	http://dx.doi.org/10.1371/journal.pone.0136624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355745	Green Submitted, gold, Green Published			2022-12-27	WOS:000360965800014
J	Cui, HY; Wang, YB; Jiang, Q; Chen, SP; Ma, JY; Sun, W				Cui, Haiying; Wang, Yunbo; Jiang, Qi; Chen, Shiping; Ma, Jian-Ying; Sun, Wei			Carbon Isotope Composition of Nighttime Leaf-Respired CO2 in the Agricultural-Pastoral Zone of the Songnen Plain, Northeast China	PLOS ONE			English	Article							DIURNAL-VARIATION; NICOTIANA-SYLVESTRIS; DARK RESPIRATION; METABOLIC ORIGIN; LEAVES; DELTA-C-13; DISCRIMINATION; FRACTIONATION; DYNAMICS; C-13	Variations in the carbon isotope signature of leaf dark-respired CO2 (delta C-13(R)) within a single night is a widely observed phenomenon. However, it is unclear whether there are plant functional type differences with regard to the amplitude of the nighttime variation in delta C-13(R). These differences, if present, would be important for interpreting the short-term variations in the stable carbon signature of ecosystem respiration and the partitioning of carbon fluxes. To assess the plant functional type differences relating to the magnitude of the nighttime variation in delta C-13(R) and the respiratory apparent fractionation, we measured the delta C-13(R), the leaf gas exchange, and the delta C-13 of the respiratory substrates of 22 species present in the agricultural-pastoral zone of the Songnen Plain, northeast China. The species studied were grouped into C-3 and C-4 plants, trees, grasses, and herbs. A significant nocturnal shift in delta C-13(R) was detected in 20 of the studied species, with the magnitude of the shift ranging from 1 parts per thousand to 5.8 parts per thousand. The magnitude of the nighttime variation in delta C-13(R) was strongly correlated with the daytime cumulative carbon assimilation, which suggests that variation in delta C-13(R) were influenced, to some extent, by changes in the contribution of malate decarboxylation to total respiratory CO2 flux. There were no differences in the magnitude of the nighttime variation in delta C-13(R) between the C-3 and C-4 plants, as well as among the woody plants, herbs and graminoids. Leaf respired CO2 was enriched in C-13 compared to biomass, soluble carbohydrates and lipids; however the magnitude of enrichment differed between 8 pm and 4 am, which were mainly caused by the changes in delta C-13(R). We also detected the plant functional type differences in respiratory apparent fractionation relative to biomass at 4 am, which suggests that caution should be exercised when using the delta C-13 of bulk leaf material as a proxy for the delta C-13 of leaf-respired CO2.	[Cui, Haiying; Wang, Yunbo; Jiang, Qi; Sun, Wei] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China; [Chen, Shiping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Ma, Jian-Ying] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830011, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Sun, W (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China.	sunwei@nenu.edu.cn	Chen, Shiping/AAH-9751-2019	Cui, Haiying/0000-0003-4993-2231	National Natural Science Foundation of China [31270445]; State Key Laboratory of Vegetation and Environmental Change [LVEC2012kf01]; Program for New Century Excellent Talents in University [NCET-12-0814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by National Natural Science Foundation of China (31270445), the State Key Laboratory of Vegetation and Environmental Change (LVEC2012kf01), and Program for New Century Excellent Talents in University (NCET-12-0814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Barbour MM, 2007, PLANT CELL ENVIRON, V30, P469, DOI 10.1111/j.1365-3040.2007.01634.x; Barbour MM, 2011, NEW PHYTOL, V190, P990, DOI 10.1111/j.1469-8137.2010.03635.x; Bowling DR, 2008, NEW PHYTOL, V178, P24, DOI 10.1111/j.1469-8137.2007.02342.x; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Duranceau M, 1999, PLANT CELL ENVIRON, V22, P515, DOI 10.1046/j.1365-3040.1999.00420.x; Duranceau M, 2001, AUST J PLANT PHYSIOL, V28, P65, DOI 10.1071/PP00068; Gessler A, 2009, NEW PHYTOL, V181, P374, DOI 10.1111/j.1469-8137.2008.02672.x; Ghashghaie J, 2001, PLANT CELL ENVIRON, V24, P505, DOI 10.1046/j.1365-3040.2001.00699.x; Ghashghaie J, 2014, NEW PHYTOL, V201, P751, DOI 10.1111/nph.12563; Ghashghaie Jaleh, 2003, Phytochemistry Reviews, V2, P145, DOI 10.1023/B:PHYT.0000004326.00711.ca; Gottlicher S, 2006, RAPID COMMUN MASS SP, V20, P653, DOI 10.1002/rcm.2352; Griffis TJ, 2005, AGR FOREST METEOROL, V132, P1, DOI 10.1016/j.agrformet.2005.06.005; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hymus GJ, 2005, NEW PHYTOL, V167, P377, DOI 10.1111/j.1469-8137.2005.01475.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Knohl A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002301; Lloyd J, 1996, AUST J PLANT PHYSIOL, V23, P371, DOI 10.1071/PP9960371; MELZER E, 1987, PLANT PHYSIOL, V84, P58, DOI 10.1104/pp.84.1.58; MELZER E, 1987, J BIOL CHEM, V262, P8159; Ocheltree TW, 2004, J EXP BOT, V55, P2599, DOI 10.1093/jxb/erh263; PARK R, 1961, PLANT PHYSIOL, V36, P133, DOI 10.1104/pp.36.2.133; Prater JL, 2006, PLANT CELL ENVIRON, V29, P202, DOI 10.1111/j.1365-3040.2005.01413.x; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; ROSSMANN A, 1991, PLANT PHYSIOL, V96, P609, DOI 10.1104/pp.96.2.609; Scartazza A, 2004, OECOLOGIA, V140, P340, DOI 10.1007/s00442-004-1588-1; Schnyder H, 2005, PLANT BIOLOGY, V7, P592, DOI 10.1055/s-2005-872872; Shimoda S, 2009, AGR FOREST METEOROL, V149, P603, DOI 10.1016/j.agrformet.2008.10.007; Sun W, 2012, PLANT CELL ENVIRON, V35, P567, DOI 10.1111/j.1365-3040.2011.02436.x; Sun W, 2010, OECOLOGIA, V164, P297, DOI 10.1007/s00442-010-1643-z; Sun W, 2009, PLANT CELL ENVIRON, V32, P1390, DOI 10.1111/j.1365-3040.2009.02006.x; Tcherkez G, 2003, PLANT PHYSIOL, V131, P237, DOI 10.1104/pp.013078; Wanek W, 2001, RAPID COMMUN MASS SP, V15, P1136, DOI 10.1002/rcm.353; Wang YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127695; Wegener F, 2010, FUNCT PLANT BIOL, V37, P849, DOI 10.1071/FP09224; Werner C, 2012, BIOGEOSCIENCES, V9, P3083, DOI 10.5194/bg-9-3083-2012; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner C, 2007, RAPID COMMUN MASS SP, V21, P1352, DOI 10.1002/rcm.2970; Werner C, 2009, RAPID COMMUN MASS SP, V23, P2428, DOI 10.1002/rcm.4036; Werner RA, 2011, NEW PHYTOL, V191, P10, DOI 10.1111/j.1469-8137.2011.03741.x; Wingate L, 2010, NEW PHYTOL, V188, P576, DOI 10.1111/j.1469-8137.2010.03384.x; Xu CY, 2004, NEW PHYTOL, V163, P499, DOI 10.1111/j.1469-8137.2004.01153.x	42	13	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137575	10.1371/journal.pone.0137575	http://dx.doi.org/10.1371/journal.pone.0137575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356083	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800062
J	Xu, L; Jiang, CQ; Cheng, KK; Yeung, SLRA; Sen Zhang, W; Lam, TH; Schooling, CM				Xu, Lin; Jiang, Chao Qiang; Cheng, Kar Keung; Yeung, Shiu Lun Ryan Au; Sen Zhang, Wei; Lam, Tai Hing; Schooling, Catherine Mary			Alcohol Use and Gamma-Glutamyltransferase Using a Mendelian Randomization Design in the Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; CONSUMPTION; ENZYMES; POPULATION; DEPENDENCE; DISEASE; MARKERS; RISK; MEN	Background Observational studies and small intervention studies suggest alcohol raises gamma-glutamyltransferase (GGT). We used Mendelian randomization to assess the causal effect of alcohol use on GGT in older Chinese people. Methods An instrumental variable (IV) analysis in 2,321 men and 2,757 women aged 50+ years from phase 3 of the Guangzhou Biobank Cohort Study with ALDH2 (rs671) genotyped, alcohol use and GGT available was used to assess the causal effect of alcohol use on GGT. Rs671 was used as an IV and F-statistics was used to test for weak instrument hypothesis. An F-statistic of >= 10 indicates the IV is not weak. Results In men, the F-statistic for rs671 on alcohol use was 70. Using IV analysis alcohol use increased GGT by 10.60 U/L per alcohol unit (10 gram ethanol) per day (95% confidence interval (CI) 6.58 to 14.62). The estimate was lower in observational multivariate regression: 3.48 U/L GGT per alcohol unit per day (95% CI 2.84 to 4.11) adjusted for age, education, physical activity and smoking. In women, rs671 was not associated with alcohol or GGT and the F-statistic was 7 precluding IV analysis. Conclusion In Mendelian randomization, we found confirmative evidence that alcohol use increases GGT among Southern Chinese men. Moreover, we found that the ALDH2 variant rs671 was not associated with GGT among Southern Chinese women who generally consume very low levels of alcohol. Taken together our findings strongly suggest that alcohol increases GGT, although we cannot rule out the possibility that other unknown factors may cause a different relation between alcohol and GGT in other populations.	[Xu, Lin; Yeung, Shiu Lun Ryan Au; Lam, Tai Hing; Schooling, Catherine Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chao Qiang; Sen Zhang, Wei] Guangzhou 12 Hosp, Guangzhou 510620, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Schooling, Catherine Mary] CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System; Hunter College (CUNY)	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; SL, Au Yeung/ABD-3938-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; SL, Au Yeung/0000-0001-6136-1836; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971	University of Hong Kong Foundation for Development and Research, Hong Kong; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, Guangzhou, China; Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, UK; Hong Kong Health and Health Services Research Fund [06070981]; Bureau of Guangzhou Science and Technology [2013J4100031]; Key technology collaboration project - Bureau of Guangzhou Science and Technology [2012J5100041]; Natural Science Foundation of Guangdong Province, China	University of Hong Kong Foundation for Development and Research, Hong Kong(University of Hong Kong); University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, Guangzhou, China; Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, UK; Hong Kong Health and Health Services Research Fund; Bureau of Guangzhou Science and Technology; Key technology collaboration project - Bureau of Guangzhou Science and Technology; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the University of Hong Kong Foundation for Development and Research, Hong Kong; The University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; and The University of Birmingham, Birmingham, UK. This sub-study was supported by the Hong Kong Health and Health Services Research Fund (Grant 06070981), the Bureau of Guangzhou Science and Technology (Grant 2013J4100031), the Key technology collaboration project funded by the Bureau of Guangzhou Science and Technology (Grant number: 2012J5100041) and Natural Science Foundation of Guangdong Province, China. The authors have indicated no financial conflicts of interest.	Belfrage P, 1972, ACTA MED SCAND, V552, P1; Bouchard C., 1996, GENETIC EPIDEMIOLOGY, P470; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P587, DOI 10.1093/alcalc/35.6.587; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; FREER DE, 1977, CLIN CHEM, V23, P830; FRIMPONG NA, 1989, AM J CLIN NUTR, V50, P987, DOI 10.1093/ajcn/50.5.987; GJERDE H, 1987, BRIT J ADDICT, V82, P1027; GLUUD C, 1981, EUR J CLIN INVEST, V11, P171, DOI 10.1111/j.1365-2362.1981.tb01837.x; Hao W, 1999, ADDICTION, V94, P1467, DOI 10.1046/j.1360-0443.1999.941014673.x; Jiang CQ, 2013, INT J CARDIOL, V164, P349, DOI 10.1016/j.ijcard.2011.07.046; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Lawlor DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114294; Lee DH, 2002, ANN EPIDEMIOL, V12, P90, DOI 10.1016/S1047-2797(01)00252-6; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; NAKAJIMA T, 1994, AM J CLIN NUTR, V60, P87, DOI 10.1093/ajcn/60.1.87; NISHIMURA M, 1982, BIOCHEM PHARMACOL, V31, P377; PAPOZ L, 1981, JAMA-J AM MED ASSOC, V245, P1748; PERSSON J, 1989, ALCOHOL, V6, P403, DOI 10.1016/0741-8329(89)90011-6; Randell E, 1998, J CLIN LAB ANAL, V12, P92, DOI 10.1002/(SICI)1098-2825(1998)12:2<92::AID-JCLA4>3.3.CO;2-D; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Salujha S K, 2014, Ind Psychiatry J, V23, P44, DOI 10.4103/0972-6748.144956; Schooling CM, 2009, J EPIDEMIOL COMMUN H, V63, P121, DOI 10.1136/jech.2008.077602; Schooling CM, 2013, J AM COLL CARDIOL, V61, P1931, DOI 10.1016/j.jacc.2012.12.049; Silva ISS, 2004, J GASTROEN HEPATOL, V19, P314, DOI 10.1111/j.1440-1746.2003.03256.x; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Steenland K, 1996, AM J EPIDEMIOL, V143, P202; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Yeung SLA, 2013, J EPIDEMIOL COMMUN H, V67, P1054, DOI 10.1136/jech-2013-202807; Yeung SLA, 2012, AM J EPIDEMIOL, V175, P1021, DOI 10.1093/aje/kwr462; Yeung SLA, 2014, ANN EPIDEMIOL, V24, P606, DOI 10.1016/j.annepidem.2014.05.015; Yeung SLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068054; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	34	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137790	10.1371/journal.pone.0137790	http://dx.doi.org/10.1371/journal.pone.0137790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356841	Green Published, gold			2022-12-27	WOS:000360965800084
J	Zhang, P; Tang, J; Sun, WJ; Yu, YQ; Zhang, W				Zhang, Ping; Tang, Jie; Sun, Wenjuan; Yu, Yongqiang; Zhang, Wen			Differential Effects of Conservational Management on SOC Accumulation in the Grasslands of China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; LAND-USE CHANGE; VERTICAL-DISTRIBUTION; TERRESTRIAL ECOSYSTEMS; NITROGEN DYNAMICS; CLIMATE-CHANGE; SEQUESTRATION; STORAGE; IMPACTS; TURNOVER	Conservational management practices in grasslands have been considered one of the efficient options to enhance the soil organic carbon (SOC) accumulation. However, the SOC changes after the conservational management practices vary significantly under different grassland vegetation types and the environmental conditions. At present, it is not clear how the SOC accumulation changes along the soil profile if conservational management practice was adopted. In this study, we collected 663 paired observational data of SOC changes with and without conservational management practices in grasslands of China from 176 published literatures that has both the surface (0. 20 cm) and subsurface (to 40 cm depth) SOC measurements. The differences of SOC density (SOCD) between pre. management and post. management in the vertical soil layers were analyzed in order to establish a quantitative relationship of the SOC changes between the subsurface and the surface. The results revealed that in all grasslands, conservational management practices benefits the SOC accumulation by enhancing 0.43. 1.14 Mg C ha(-1) yr(-1). But the SOC increment weakened downwards along the soil profile. While the surface SOC was enhanced by 17% after conservational management, the subsurface SOC was enhanced by only 7%. The SOC accumulation was closely correlated with restoration duration, pre-management SOCD and the environmental factors and differed greatly among different grasslands and the practices adopted. The alpine and mountain grassland showed a higher annual SOC increment than the temperate grassland with the annual rate of 1.62 and 0.72 Mg C ha(-1) yr(-1), respectively. The SOC increment caused by the artificial plantation and the grazing exclusion conservational management was more than 2-fold that of the cropland abandonment and the extensive utilization. With the quantitative relationship of the SOC changes between soil layers, we provide a methodological option to estimate SOC changes to layers deeper than the recommendation of IPCC when only the surface layer SOC increment is available.	[Zhang, Ping; Tang, Jie] Jilin Univ, Minist Educ, Key Lab Groundwater Resources & Environm, Changchun 130021, Peoples R China; [Zhang, Ping; Yu, Yongqiang; Zhang, Wen] Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China; [Sun, Wenjuan] Chinese Acad Sci, Inst Bot, LVEC, Beijing 100093, Peoples R China	Jilin University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, W (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China.	zhw@mail.iap.ac.cn	Zhang, Wen/AAH-6060-2020; LAPC, IAP/AAI-6991-2020; IAP, LAPC/AAI-6390-2020; Yu, Yongqiang/C-9661-2011	Zhang, Wen/0000-0001-6670-3057; LAPC, IAP/0000-0002-0025-3484; IAP, LAPC/0000-0002-6195-7362; Yu, Yongqiang/0000-0002-9345-2211; sun, wenjuan/0000-0002-9667-1882	National Basic Research Program of China [2010CB950604]; National Science Foundation of China [41471444, 41471152]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Basic Research Program of China (2010CB950604) and National Science Foundation of China (41471444, 41471152).	An SS, 2009, APPL SOIL ECOL, V41, P286, DOI 10.1016/j.apsoil.2008.12.001; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Batjes NH, 2004, DEV SUSTAINABILITY, V6, P133, DOI DOI 10.1023/B:ENVI.0000003633.14591.fd; Batlle-Bayer L, 2010, AGR ECOSYST ENVIRON, V137, P47, DOI 10.1016/j.agee.2010.02.003; Beier C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003381; Bell MJ, 2009, GEODERMA, V152, P74, DOI 10.1016/j.geoderma.2009.05.020; Blanco H, 2008, PRINCIPLES SOIL CONS, P449; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Conant RT, 2011, FRONT ECOL ENVIRON, V9, P169, DOI 10.1890/090153; Conant RT, 2003, BIOL FERT SOILS, V38, P386, DOI 10.1007/s00374-003-0652-z; Conant RT, 2004, ENVIRON MANAGE, V33, P467, DOI 10.1007/s00267-003-9104-7; Conant RT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001661; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Covaleda S, 2006, ORG GEOCHEM, V37, P1943, DOI 10.1016/j.orggeochem.2006.09.001; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Don A, 2009, J PLANT NUTR SOIL SC, V172, P53, DOI 10.1002/jpln.200700158; Dubeux JCB, 2006, SOIL BIOL BIOCHEM, V38, P2705, DOI 10.1016/j.soilbio.2006.04.021; Foote RL, 2010, ECOSYSTEMS, V13, P795, DOI 10.1007/s10021-010-9355-0; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Garcia-Pausas J, 2007, BIOGEOCHEMISTRY, V82, P279, DOI 10.1007/s10533-007-9071-9; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; He NP, 2009, GEODERMA, V150, P302, DOI 10.1016/j.geoderma.2009.02.004; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Homann PS, 2007, BIOGEOCHEMISTRY, V85, P303, DOI 10.1007/s10533-007-9139-6; Huang Y, 2010, SCI CHINA LIFE SCI, V53, P766, DOI 10.1007/s11427-010-4022-4; IPCC, 2014, 2013 SUPPLEMENT 2006; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Knops JMH, 2009, SOIL SCI SOC AM J, V73, P2096, DOI 10.2136/sssaj2009.0058; Krishnan P, 2007, CURR SCI INDIA, V93, P706; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lal R, 2001, ADV AGRON, V71, P145, DOI 10.1016/S0065-2113(01)71014-0; Lal R., 1998, POTENTIAL US CROPLAN, P128; Lal R, 1999, GLOBALGLOBAL CHANGEN, V37, P4; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Ma W, 2006, CARBON STORAGE TEMPE, P34; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Matamala R, 2008, ECOL APPL, V18, P1470, DOI 10.1890/07-1609.1; McLauchlan KK, 2006, GEODERMA, V136, P289, DOI 10.1016/j.geoderma.2006.03.053; Ogle SM, 2003, GLOBAL CHANGE BIOL, V9, P1521, DOI 10.1046/j.1365-2486.2003.00683.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Reeder JD, 1998, SOIL TILL RES, V47, P339, DOI 10.1016/S0167-1987(98)00122-6; Ren Hai, 2007, Landscape and Ecological Engineering, V3, P1, DOI 10.1007/s11355-006-0018-4; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Silver WL, 2010, RANGELAND ECOL MANAG, V63, P128, DOI 10.2111/REM-D-09-00106.1; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith P, 2000, SOIL USE MANAGE, V16, P1, DOI 10.1111/j.1475-2743.2000.tb00162.x; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Sommer R, 2000, PLANT SOIL, V219, P231, DOI 10.1023/A:1004772301158; Song GH, 2005, BIOGEOCHEMISTRY, V74, P47, DOI 10.1007/s10533-004-2222-3; Soussana JF, 2004, SOIL USE MANAGE, V20, P219, DOI 10.1079/SUM2003234; State Environmental Protection Administration, 2008, REP STAT ENV CHIN, P54; Sun WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2009GB003484, 10.1029/2009GB003727]; Tan ZX, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002536; Torok P, 2012, J NAT CONSERV, V20, P41, DOI 10.1016/j.jnc.2011.07.006; Wang CT, 2009, LAND DEGRAD DEV, V20, P187, DOI 10.1002/ldr.879; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wiesmeier M, 2009, SOIL TILL RES, V104, P299, DOI 10.1016/j.still.2009.04.005; Wright AL, 2004, SOIL BIOL BIOCHEM, V36, P1809, DOI 10.1016/j.soilbio.2004.05.004; Wu GL, 2010, PLANT SOIL, V333, P469, DOI 10.1007/s11104-010-0363-9; Wu HB, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001844; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Yang Y, 2008, CARBON NITROGEN STOR, P74; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2009, GLOBAL CHANGE BIOL, V15, P2723, DOI 10.1111/j.1365-2486.2009.01924.x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	79	3	3	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137280	10.1371/journal.pone.0137280	http://dx.doi.org/10.1371/journal.pone.0137280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356845	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800039
J	Burns, M; Shultz, JW				Burns, Mercedes; Shultz, Jeffrey W.			Biomechanical Diversity of Mating Structures among Harvestmen Species Is Consistent with a Spectrum of Precopulatory Strategies	PLOS ONE			English	Article							SEXUAL SELECTION; MATE CHOICE; OPILIONES; EVOLUTION; CONFLICT; PHYLOGENY; ARACHNIDA	Diversity in reproductive structures is frequently explained by selection acting at individual to generational timescales, but interspecific differences predicted by such models (e.g., female choice or sexual conflict) are often untestable in a phylogenetic framework. An alternative approach focuses on clade-or function-specific hypotheses that predict evolutionary patterns in terms neutral to specific modes of sexual selection. Here we test a hypothesis that diversity of reproductive structures in leiobunine harvestmen (daddy longlegs) of eastern North America reflects two sexually coevolved but non-overlapping precopulatory strategies, a primitive solicitous strategy (females enticed by penis-associated nuptial gifts), and a multiply derived antagonistic strategy (penis exerts mechanical force against armature of the female pregenital opening). Predictions of sexual coevolution and fidelity to precopulatory categories were tested using 10 continuously varying functional traits from 28 species. Multivariate analyses corroborated sexual coevolution but failed to partition species by precopulatory strategy, with multiple methods placing species along a spectrum of mechanical antagonistic potential. These findings suggest that precopulatory features within species reflect different co-occurring levels of solicitation and antagonism, and that gradualistic evolutionary pathways exist between extreme strategies. The ability to quantify antagonistic potential of precopulatory structures invites comparison with ecological variables that may promote evolutionary shifts in precopulatory strategies.	Univ Maryland, BEES Program, College Pk, MD 20742 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Burns, M (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	mercedes.burns@gmail.com			University of Maryland; National Science Foundation GRF grant; National Science Foundation DDIG grant; National Science Foundation PRFB grant; Maryland Agricultural Experiment Station; Div Of Biological Infrastructure [1401110] Funding Source: National Science Foundation	University of Maryland; National Science Foundation GRF grant; National Science Foundation DDIG grant; National Science Foundation PRFB grant; Maryland Agricultural Experiment Station; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	MB was funded by the University of Maryland and National Science Foundation GRF, DDIG, and PRFB grants. JWS was supported by the Maryland Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Arnqvist G, 2004, EVOLUTION, V58, P1383; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist Goran, 2005, pUnpaginated; Bergsten J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000522; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Bishop S. C., 1949, Proceedings of the Rochester Academy of Science, V9, P159; Boettiger C, 2012, EVOLUTION, V66, P2240, DOI 10.1111/j.1558-5646.2011.01574.x; Brennan PLR, 2012, PHILOS T R SOC B, V367, P2324, DOI 10.1098/rstb.2011.0284; Brinckmann P., 2002, MUSCULOSKELETAL BIOM; Burns M, 2012, MOL PHYLOGENET EVOL, V63, P291, DOI 10.1016/j.ympev.2011.12.025; Burns MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066767; Cianciolo Cosentino Chiara, 2010, J Vis Exp, DOI 10.3791/2079; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Darwin C., 1871, P423; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Edgar A. L., 1971, Miscellaneous Publs Mus Zool Univ Mich, VNo. 144, P1; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fisher RA, 1930, GENETICAL THEORY NAT; Fowler-Finn KD, 2014, BEHAVIOUR, V151, P1663, DOI 10.1163/1568539X-00003209; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hedin M, 2012, MOL PHYLOGENET EVOL, V62, P224, DOI 10.1016/j.ympev.2011.09.017; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Kokko H, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017517; Macias-Ordo~~nez R, 1997, THESIS LEHIGH U BETH; Macias-Ordonez R, 2000, NAT HIST, V109, P58; Macias-Ordonez Rogelio, 2010, P285; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; Oneal E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2236; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Prum RO, 1997, AM NAT, V149, P668, DOI 10.1086/286014; R Core Team, 2018, R LANG ENV STAT COMP; Rasband WS, 1997, IMAGEJ; Revell LJ, 2008, BIOINFORMATICS, V24, P1018, DOI 10.1093/bioinformatics/btn065; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ruff C, MOMENTMACROJ V 1 14; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Shultz J.W., 2005, AM ARACHNOL, V72, P11; Shultz JW, 2000, ZOOL J LINN SOC-LOND, V128, P401, DOI 10.1111/j.1096-3642.2000.tb01522.x; Simmons LW, 2014, AUSTRAL ENTOMOL, V53, P1, DOI 10.1111/aen.12053; Tatarnic NJ, 2010, J EVOLUTION BIOL, V23, P1321, DOI 10.1111/j.1420-9101.2010.01991.x; Venables WN., 2002, MODERN APPL STAT S 4	50	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137181	10.1371/journal.pone.0137181	http://dx.doi.org/10.1371/journal.pone.0137181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352413	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800065
J	Iannitti, T; Graham, A; Dolan, S				Iannitti, Tommaso; Graham, Annette; Dolan, Sharron			Adiponectin-Mediated Analgesia and AntiInflammatory Effects in Rat	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PARAVENTRICULAR NUCLEUS; NEUROPATHIC PAIN; SPINAL-CORD; EXPRESSION; INFLAMMATION; NEURONS; MODULATION; MECHANISMS; OBESITY	The adipose tissue-derived protein, adiponectin, has significant anti-inflammatory properties in a variety of disease conditions. Recent evidence that adiponectin and its receptors (AdipoR1 and AdipoR2) are expressed in central nervous system, suggests that it may also have a central modulatory role in pain and inflammation. This study set out to investigate the effects of exogenously applied recombinant adiponectin (via intrathecal and intraplantar routes; 10-5000 ng) on the development of peripheral inflammation (paw oedema) and pain hypersensitivity in the rat carrageenan model of inflammation. Expression of adiponectin, AdipoR1 and AdipoR2 mRNA and protein was characterised in dorsal spinal cord using real-time polymerase chain reaction (PCR) and Western blotting. AdipoR1 and AdipoR2 mRNA and protein were found to be constitutively expressed in dorsal spinal cord, but no change in mRNA expression levels was detected in response to carrageenan-induced inflammation. Adiponectin mRNA, but not protein, was detected in dorsal spinal cord, although levels were very low. Intrathecal administration of adiponectin, both pre-and 3 hours post-carrageenan, significantly attenuated thermal hyperalgesia and mechanical hypersensitivity. Intrathecal administration of adiponectin post-carrageenan also reduced peripheral inflammation. Intraplantar administration of adiponectin pre-carrageenan dose-dependently reduced thermal hyperalgesia but had no effect on mechanical hypersensitivity and peripheral inflammation. These results show that adiponectin functions both peripherally and centrally at the spinal cord level, likely through activation of AdipoRs to modulate pain and peripheral inflammation. These data suggest that adiponectin receptors may be a novel therapeutic target for pain modulation.	[Iannitti, Tommaso; Graham, Annette; Dolan, Sharron] Glasgow Caledonian Univ, Dept Life Sci, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Iannitti, T (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England.	tommaso.iannitti@gmail.com		Dolan, Sharron/0000-0001-9053-6105	Glasgow Caledonian University	Glasgow Caledonian University	This study was funded by a Glasgow Caledonian University PhD Scholarship.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Beloeil H, 2006, ANESTHESIOLOGY, V105, P139, DOI 10.1097/00000542-200607000-00023; Biddlestone L, 2007, BRIT J PHARMACOL, V151, P285, DOI 10.1038/sj.bjp.0707220; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Coope A, 2008, FEBS LETT, V582, P1471, DOI 10.1016/j.febslet.2008.03.037; Cui J, 2011, CLIN NEPHROL, V75, P26, DOI 10.2379/CNP75026; Dolan S, 2003, PAIN, V106, P501, DOI 10.1016/j.pain.2003.09.017; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Fry M, 2006, J NEUROSCI, V26, P9695, DOI 10.1523/JNEUROSCI.2014-06.2006; Hong SJ, 2006, CIRC J, V70, P414, DOI 10.1253/circj.70.414; Hoyda TD, 2007, J PHYSIOL-LONDON, V585, P805, DOI 10.1113/jphysiol.2007.144519; Hoyda TD, 2010, ENDOCRINOLOGY, V151, P3154, DOI 10.1210/en.2009-1390; Hoyda TD, 2009, BRAIN RES, V1256, P76, DOI 10.1016/j.brainres.2008.12.012; Huber JD, 2006, AM J PHYSIOL-HEART C, V290, pH732, DOI 10.1152/ajpheart.00747.2005; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Iannitti T, 2012, EXP PHYSIOL, V97, P1236, DOI 10.1113/expphysiol.2011.064220; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Klein I, 2011, BRAIN RES, V1423, P1, DOI 10.1016/j.brainres.2011.09.019; Kudriashova E Iu, 2002, Tsitologiia, V44, P285; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Lee SW, 2008, SCAND J RHEUMATOL, V37, P260, DOI 10.1080/03009740801910346; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; Maruyoshi H, 2005, CIRC J, V69, P1154, DOI 10.1253/circj.69.1154; Morgenweck J, 2010, NEUROPHARMACOLOGY, V58, P337, DOI 10.1016/j.neuropharm.2009.10.008; Morinigo R, 2006, OBES SURG, V16, P745, DOI 10.1381/096089206777346736; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Peterlin BL, 2008, NEUROLOGY, V70, P1905, DOI 10.1212/01.wnl.0000312278.40250.6e; Phillips SA, 2010, CURR OPIN PHARMACOL, V10, P676, DOI 10.1016/j.coph.2010.08.002; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; Rodriguez-Pacheco F, 2007, ENDOCRINOLOGY, V148, P401, DOI 10.1210/en.2006-1019; Roza C, 2008, PAIN, V138, P537, DOI 10.1016/j.pain.2008.01.031; SEKUT L, 1994, J LAB CLIN MED, V124, P813; Takahashi Y, 2011, ANESTH ANALG, V113, P398, DOI 10.1213/ANE.0b013e31821b220c; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Thundyil J, 2012, BRIT J PHARMACOL, V165, P313, DOI 10.1111/j.1476-5381.2011.01560.x; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xu W, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-49; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	46	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136819	10.1371/journal.pone.0136819	http://dx.doi.org/10.1371/journal.pone.0136819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352808	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000360932800050
J	Peet, ED; McCoy, DC; Danaei, G; Ezzati, M; Fawzi, W; Jarvelin, MR; Pillas, D; Fink, G				Peet, Evan D.; McCoy, Dana C.; Danaei, Goodarz; Ezzati, Majid; Fawzi, Wafaie; Jarvelin, Marjo-Riitta; Pillas, Demetris; Fink, Gunther			Early Childhood Development and Schooling Attainment: Longitudinal Evidence from British, Finnish and Philippine Birth Cohorts	PLOS ONE			English	Article							CHILDREN; NUTRITION; HEIGHT; GROWTH; INTERVENTIONS; INFLAMMATION; INTELLIGENCE; EXPERIENCE; EDUCATION; HEALTH	Background While recent literature has highlighted the importance of early childhood development for later life outcomes, comparatively little is known regarding the relative importance of early physical and cognitive development in predicting educational attainment cross-culturally. Methods We used prospective data from three birth cohorts: the Northern Finland Birth Cohort of 1986 (NFBC1986), the 1970 British Cohort Study (BCS1970), and the Cebu Longitudinal Health and Nutrition Survey of 1983 (CLHNS) to assess the association of height-for-age z-score (HAZ) and cognitive development measured prior to age 8 with schooling attainment. Multivariate linear regression models were used to estimate baseline and adjusted associations. Results Both physical and cognitive development were highly predictive of adult educational attainment conditional on parental characteristics. The largest positive associations between physical development and schooling were found in the CLHNS (beta = 0.53, 95%-CI: [0.32, 0.74]) with substantially smaller associations in the BCS1970 (beta = 0.10, 95% CI [0.04, 0.16]) and the NFBC1986 (beta = 0.06, 95% CI [-0.05, 0.16]). Strong associations between cognitive development and educational attainment were found for all three cohorts (NFBC1986: beta = 0.22, 95%-CI: [0.12, 0.31], BCS1970: beta = 0.58, 95%-CI: [0.52, 0.64], CLHNS: beta = 1.08, 95%-CI: [0.88, 1.27]). Models jointly estimating educational associations of physical and cognitive development demonstrated weaker associations for physical development and minimal changes for cognitive development. Conclusion The results indicate that although physical and cognitive early development are both important predictors of educational attainment, cognitive development appears to play a particularly important role. The large degree of heterogeneity in the observed effect sizes suggest that the importance of early life physical growth and cognitive development is highly dependent on socioeconomic and institutional contexts.	[Peet, Evan D.; Danaei, Goodarz; Fawzi, Wafaie; Fink, Gunther] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Peet, Evan D.] RAND Corp, Pittsburgh, PA USA; [McCoy, Dana C.] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA; [Ezzati, Majid; Jarvelin, Marjo-Riitta; Pillas, Demetris] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland	Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation; Harvard University; Imperial College London; University of Oulu; University of Oulu; University of Oulu	Peet, ED (corresponding author), Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	epeet@rand.org		Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Saving Brains Program; Grand Challenges Canada; Aga Khan Foundation; Bernard van Leer Foundation; Bill and Melinda Gates Foundation; Maria Cecilia Souto Vidigal Foundation; Norlien Foundation; World Vision Canada	Saving Brains Program; Grand Challenges Canada(CGIAR); Aga Khan Foundation; Bernard van Leer Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Maria Cecilia Souto Vidigal Foundation; Norlien Foundation; World Vision Canada	This work was supported by the Saving Brains Program in partnership with Grand Challenges Canada, Aga Khan Foundation, Bernard van Leer Foundation, Bill and Melinda Gates Foundation, Maria Cecilia Souto Vidigal Foundation, Norlien Foundation, and World Vision Canada.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Anderson LM, 2003, AM J PREV MED, V24, P32, DOI 10.1016/S0749-3797(02)00655-4; Banerjee AV, 2006, UNDERSTANDING POVERT, DOI [10.1093/0195305191.003.0006, DOI 10.1093/0195305191.003.0006]; Card D, 2001, ECONOMETRICA, V69, P1127, DOI 10.1111/1468-0262.00237; Case Anne, 2006, J POLITICAL EC, V16, P499; Centre for Longitudinal Studies (CLS), 2014, 1970 BRITISH COHORT; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; Davie R, 1972, FROM BIRTH TO SEVEN; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Feranil AB., 2008, ASIA PACIFIC POPULAT, V23, P39; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GUTHRIE GM, 1977, J SOC PSYCHOL, V102, P3, DOI 10.1080/00224545.1977.9713233; Harris, 1963, CHILDRENS DRAWINGS M; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Komlos J, 1994, LIVING STANDARDS EC; Leroy JL, 2013, AM J CLIN NUTR, V98, P854, DOI 10.3945/ajcn.113.066647; Leung Janet T Y, 2011, Int J Adolesc Med Health, V23, P109; Lochner L, 2004, AM ECON REV, V94, P155, DOI 10.1257/000282804322970751; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; LYNN R, 1989, BRIT J EDUC PSYCHOL, V59, P372, DOI 10.1111/j.2044-8279.1989.tb03112.x; MOOCK PR, 1986, J DEV ECON, V20, P33, DOI 10.1016/0304-3878(86)90004-0; Moretti E, 2004, J ECONOMETRICS, V121, P175, DOI 10.1016/j.jeconom.2003.10.015; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Pirkola J, 2010, DIABETES CARE, V33, P1115, DOI 10.2337/dc09-1871; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Stein AD, 2005, FOOD NUTR BULL, V26, P46; Strauss J, 1998, J ECON LIT, V36, P766; Vulliamy G, 1997, S COMP AN CURR CHANG; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Wiggins D., 2014, HANDLING ATTRITION N	39	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137219	10.1371/journal.pone.0137219	http://dx.doi.org/10.1371/journal.pone.0137219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352937	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800069
J	Pickett, EJ; Thomson, DL; Li, TA; Xing, S				Pickett, Evan J.; Thomson, David L.; Li, Teng A.; Xing, Shuang			Jensen's Inequality and the Impact of Short-Term Environmental Variability on Long-Term Population Growth Rates	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; EXTINCTION; STOCHASTICITY; DEMOGRAPHY; TRENDS; WINTER	It is well established in theory that short-term environmental fluctuations could affect the long-term growth rates of wildlife populations, but this theory has rarely been tested and there remains little empirical evidence that the effect is actually important in practice. Here we develop models to quantify the effects of daily, seasonal, and yearly temperature fluctuations on the average population growth rates, and we apply them to long-term data on the endangered Black-faced Spoonbill (Platalea minor); an endothermic species whose population growth rates follow a concave relationship with temperature. We demonstrate for the first time that the current levels of temperature variability, particularly seasonal variability, are already large enough to substantially reduce long-term population growth rates. As the climate changes, our results highlight the importance of considering the ecological effects of climate variability and not just average conditions.	[Pickett, Evan J.; Thomson, David L.; Li, Teng A.; Xing, Shuang] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Thomson, David L.] UAE Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates	University of Hong Kong; United Arab Emirates University	Thomson, DL (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	dthomson@hku.hk	Xing, Shuang/AAL-7991-2020		RGC-GRF from the Hong Kong Research Grants Council [HKU778512]	RGC-GRF from the Hong Kong Research Grants Council	This work has been supported financially with RGC-GRF grant HKU778512 to DLT from the Hong Kong Research Grants Council (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; BOYCE MS, 1977, THEOR POPUL BIOL, V12, P366, DOI 10.1016/0040-5809(77)90050-8; Carey G., 2002, WATERBIRD COUNT HDB; CAWTHORNE RA, 1980, BIRD STUDY, V27, P163, DOI 10.1080/00063658009476675; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doak DF, 2005, AM NAT, V166, pE14, DOI 10.1086/430642; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Giorgi F, 2004, CLIM DYNAM, V23, P839, DOI 10.1007/s00382-004-0467-0; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Lundberg P, 2000, TRENDS ECOL EVOL, V15, P460, DOI 10.1016/S0169-5347(00)01981-9; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Preston KL, 2012, BIOL CONSERV, V152, P280, DOI 10.1016/j.biocon.2012.03.011; R Core Team, 2021, R LANGUAGE ENV STAT; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schneider SH, 2002, WILDLIFE RESPONSES C; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Ueng YT, 2006, WATERBIRDS, V29, P185, DOI 10.1675/1524-4695(2006)29[185:DOTBSW]2.0.CO;2; Ueta M, 2002, IBIS, V144, P340, DOI 10.1046/j.1474-919X.2002.00037.x; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	34	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136072	10.1371/journal.pone.0136072	http://dx.doi.org/10.1371/journal.pone.0136072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352857	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800023
J	Bernegger, A; Kienesberger, K; Carlberg, L; Swoboda, P; Ludwig, B; Koller, R; Kapusta, ND; Aigner, M; Haslacher, H; Schmoger, M; Kasper, S; Schosser, A				Bernegger, Alexandra; Kienesberger, Klemens; Carlberg, Laura; Swoboda, Patrick; Ludwig, Birgit; Koller, Romina; Kapusta, Nestor D.; Aigner, Martin; Haslacher, Helmuth; Schmoeger, Michaela; Kasper, Siegfried; Schosser, Alexandra			Influence of Sex on Suicidal Phenotypes in Affective Disorder Patients with Traumatic Childhood Experiences	PLOS ONE			English	Article							MENTAL-HEALTH; SELF-INJURY; ABUSE; DEPRESSION; IMPACT; MALTREATMENT; BEHAVIOR	Objectives In the current study, we aimed to investigate the impact of childhood trauma on suicidal behaviour phenotypes in a group of patients with diagnosed affective disorder (unipolar or bipolar affective disorder). Patients and Methods Patients with and without a history of childhood abuse, measured by Childhood Trauma Questionnaire (CTQ), were assessed to explore risks for suicidal behaviour (including suicide attempt, self-harm and non-suicidal self-injury). The tested sample consisted of 258 patients (111 males and 147 females, in-patients and out-patients at the Department of Psychiatry and Psychotherapy, Medical University of Vienna and University Hospital Tulln, Lower Austria). Psychiatric diagnoses were derived from the SCAN (Schedules for Clinical Assessment in Neuropsychiatry) interview. In addition, patients were administered the Lifetime Parasuicidal Count (LPC), Suicidal Behaviour Questionnaire (SBQ-R), and Viennese Suicide Risk Assessment Scale (VISURIAS) questionnaires. Results In contrast to male suicide attempters, female suicide attempters showed both significantly higher total CTQ scores (p<0.001), and higher CTQ subscores (emotional, physical and sexual abuse, as well as emotional and physical neglect) in comparison to the non-suicidal control group. Besides, females with a history of self-harming behaviour (including suicidal intention) and Non-Suicidal-Self Injury (NSSI) had significantly higher CTQ total scores (p<0.001) than the control group. Conclusion These findings suggest gender differences in suicidal behaviour after being exposed to childhood trauma.	[Bernegger, Alexandra; Kienesberger, Klemens; Carlberg, Laura; Swoboda, Patrick; Ludwig, Birgit; Koller, Romina; Kasper, Siegfried; Schosser, Alexandra] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Kapusta, Nestor D.] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Aigner, Martin] Univ Hosp Tulln, Dept Psychiat, Tulln, Austria; [Haslacher, Helmuth] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Schmoeger, Michaela] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Schosser, Alexandra] BBRZ Med, Zentrum Seel Gesundheit LEOpoldau, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schosser, A (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria.	alexandra.schosser@meduniwien.ac.at	Ludwig, Birgit/B-2925-2018; Haslacher, Helmuth/D-4233-2013; Kapusta, Nestor D/C-9368-2009	Ludwig, Birgit/0000-0002-5119-8665; Haslacher, Helmuth/0000-0003-4605-2503; Kapusta, Nestor D/0000-0002-0970-4341; Kasper, Siegfried/0000-0001-8278-191X	Austrian Science Fund (FWF) [KLI220]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF)-Grant Number KLI degrees 220 (by AS), www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2015, WORLD J BIOL PSYCHIA, V16, P76, DOI 10.3109/15622975.2014.1001786; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brewer-Smyth K, 2015, J FORENSIC NURS, V11, P4, DOI 10.1097/JFN.0000000000000062; BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; Davies S, 2001, BRIT MED J, V322, P1500, DOI 10.1136/bmj.322.7301.1500; Devries KM, 2014, PEDIATRICS, V133, pE1331, DOI 10.1542/peds.2013-2166; DiLillo D, 2006, ASSESSMENT, V13, P297, DOI 10.1177/1073191106288391; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernando SC, 2014, J TRAUMA DISSOCIATIO, V15, P384, DOI 10.1080/15299732.2013.863262; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hausmann A, 2008, NEUROPSYCHIATRIE, V22, P43; Hawton K, 1996, BRIT J PSYCHIAT, V169, P202, DOI 10.1192/bjp.169.2.202; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hofer P, 2013, EUR NEUROPSYCHOPHARM, V23, P79, DOI 10.1016/j.euroneuro.2012.04.013; Iffland B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-980; Janiri D, 2015, J AFFECT DISORDERS, V175, P92, DOI 10.1016/j.jad.2014.12.055; Jeon HJ, 2009, J AFFECT DISORDERS, V119, P210, DOI 10.1016/j.jad.2009.03.002; Kapusta N, 2011, EUR PSYCHIAT, V32, P1621, DOI DOI 10.1016/S0924-9338(11)73325-9; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Kranz GS, 2015, BIOL PSYCHIAT, V78, P525, DOI 10.1016/j.biopsych.2014.09.010; Lab DD, 2000, CHILD ABUSE NEGLECT, V24, P391, DOI 10.1016/S0145-2134(99)00152-0; Linehann MC, 1994, LIFETIME PARASUICIDE; Maikovich-Fong AK, 2010, CHILD ABUSE NEGLECT, V34, P429, DOI 10.1016/j.chiabu.2009.10.006; Mandelli L, 2011, J PSYCHIATR RES, V45, P742, DOI 10.1016/j.jpsychires.2010.11.005; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Moller-Leimkuhler AM, 2004, J AFFECT DISORDERS, V80, P87, DOI 10.1016/S0165-0327(03)00051-X; Moscicki E K, 1995, Int Psychogeriatr, V7, P137; MOSCICKI EK, 1995, SUICIDE LIFE-THREAT, V25, P22; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Perez-Fuentes G, 2013, COMPR PSYCHIAT, V54, P16, DOI 10.1016/j.comppsych.2012.05.010; Roy A, 2005, SUICIDE LIFE-THREAT, V35, P690, DOI 10.1521/suli.2005.35.6.690; Roy A, 2007, NEUROPSYCHOPHARMACOL, V32, P2046, DOI 10.1038/sj.npp.1301331; Roy A, 2006, SUICIDE LIFE-THREAT, V36, P329, DOI 10.1521/suli.2006.36.3.329; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Rutz W, 1995, Lakartidningen, V92, P3893; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Sarchiapone M, 2007, DEPRESS ANXIETY, V24, P268, DOI 10.1002/da.20243; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Swannell S, 2012, CHILD ABUSE NEGLECT, V36, P572, DOI 10.1016/j.chiabu.2012.05.005; Weismoore JT, 2010, J YOUTH ADOLESCENCE, V39, P281, DOI 10.1007/s10964-009-9452-6; WHO, 2014, SUIC 2014; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wingenfeld K., 2010, PSYCHOTHER PSYCHOSOM, V60, pe13, DOI [DOI 10.1055/S-0030-1253494, 10.1055/s-0030-1253494]; Winkler D, 2005, PSYCHOTHER PSYCHOSOM, V74, P303, DOI 10.1159/000086321	45	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137763	10.1371/journal.pone.0137763	http://dx.doi.org/10.1371/journal.pone.0137763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366559	gold, Green Published			2022-12-27	WOS:000361601100132
J	Da Silva, S; Robbe-Masselot, C; Raymond, A; Mercade-Loubiere, M; Salvador-Cartier, C; Ringot, B; Leonard, R; Fourquaux, I; Ait-Belgnaoui, A; Loubiere, P; Theodorou, V; Mercier-Bonin, M				Da Silva, Stephanie; Robbe-Masselot, Catherine; Raymond, Arthur; Mercade-Loubiere, Myriam; Salvador-Cartier, Christel; Ringot, Belinda; Leonard, Renaud; Fourquaux, Isabelle; Ait-Belgnaoui, Afifa; Loubiere, Pascal; Theodorou, Vassilia; Mercier-Bonin, Muriel			Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; LACTIC-ACID BACTERIA; GASTROINTESTINAL-TRACT; RHAMNOSUS GG; PHYLOGENETIC ANALYSIS; HELICOBACTER-PYLORI; FUNCTIONAL-ANALYSIS; ULCERATIVE-COLITIS; REUTERI ATCC-55730; MICROBIAL ECOLOGY	The present study aimed at detecting the exogenously applied probiotic Lactobacillus farciminis in rats, after exposure to IBS-like chronic stress, based on 4-day Water Avoidance Stress (WAS). The presence of L. farciminis in both ileal and colonic mucosal tissues was demonstrated by FISH and qPCR, with ileum as the preferential niche, as for the SFB population. A different spatial distribution of the probiotic was observed: in the ileum, bacteria were organized in micro-colonies more or less close to the epithelium whereas, in the colon, they were mainly visualized far away from the epithelium. When rats were submitted to WAS, the L. farciminis population substantially decreased in both intestinal regions, due to a stress-induced increase in colonic motility and defecation, rather than a modification of bacterial binding to the intestinal mucin Muc2.	[Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] Univ Toulouse, LISBP, INP, INSA,UPS, F-31077 Toulouse, France; [Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] CNRS, UMR5504, F-31400 Toulouse, France; [Da Silva, Stephanie; Salvador-Cartier, Christel; Ait-Belgnaoui, Afifa; Theodorou, Vassilia; Mercier-Bonin, Muriel] UPS, INRA, INPT, Equipe NeuroGastroenterol & Nutr,TOXALIM,UMR 1331, F-31027 Toulouse 9, France; [Robbe-Masselot, Catherine; Ringot, Belinda; Leonard, Renaud] Univ Lille Nord France, USTL, Unite Glycobiol Struct & Fonct, IFR 147, F-59650 Villeneuve Dascq, France; [Robbe-Masselot, Catherine; Ringot, Belinda; Leonard, Renaud] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Fourquaux, Isabelle] CMEAB, Fac Med Rangueil, F-31062 Toulouse, France; [Ait-Belgnaoui, Afifa] Lallemand SA, F-31702 Blagnac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Lallemand - France	Theodorou, V (corresponding author), UPS, INRA, INPT, Equipe NeuroGastroenterol & Nutr,TOXALIM,UMR 1331, 180 Chemin Tournefeuille, F-31027 Toulouse 9, France.	vtheodor@toulouse.inra.fr	MERCIER-BONIN, Muriel/AAO-5286-2021	DA SILVA-HEIL, Stephanie/0000-0001-8817-6403; Robbe Masselot, Catherine/0000-0001-6266-6033; Leonard, Renaud/0000-0001-5023-1032	INRA (CEPIA Division); CNRS (INSIS Institute); Lallemand SA	INRA (CEPIA Division); CNRS (INSIS Institute); Lallemand SA	This work was supported by INRA (CEPIA Division; http://www.inra.fr) and CNRS (INSIS Institute; www.cnrs.fr) through the doctoral grant of Stephanie Da Silva (2010-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Lallemand SA provided support in the form of salary for author (Afifa Ait-Belgnaoui), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. No additional external funding was received for this study.	Agostini S, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01865.x; Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Ait-Belgnaoui A, 2006, GUT, V55, P1090, DOI 10.1136/gut.2005.084194; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; Blasco L, 2003, FEMS MICROBIOL LETT, V225, P115, DOI 10.1016/S0378-1097(03)00501-9; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Da Silva S, 2014, AM J PHYSIOL-GASTR L, V307, pG420, DOI 10.1152/ajpgi.00290.2013; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Del Piano M, 2010, J CLIN GASTROENTEROL, V44, pS42, DOI 10.1097/MCG.0b013e3181ed0e71; Distrutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063893; Le DTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079850; Doan TLL, 2011, BIOPHYS J, V101, P2843, DOI 10.1016/j.bpj.2011.10.034; Ducrotte P, 2012, WORLD J GASTROENTERO, V18, P4012, DOI 10.3748/wjg.v18.i30.4012; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Greenwood-Van Meerveld B, 2015, AM J PHYSIOL-GASTR L, V308, pG885, DOI 10.1152/ajpgi.00463.2014; Guyonnet D, 2007, ALIMENT PHARM THER, V26, P475, DOI 10.1111/j.1365-2036.2007.03362.x; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kerckhoffs APM, 2009, WORLD J GASTROENTERO, V15, P2887, DOI 10.3748/wjg.15.2887; Kim HJ, 2005, NEUROGASTROENT MOTIL, V17, P687, DOI 10.1111/j.1365-2982.2005.00695.x; King TS, 1998, LANCET, V352, P1187, DOI 10.1016/S0140-6736(98)02146-1; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KOOPMAN JP, 1987, LAB ANIM-UK, V21, P48, DOI 10.1258/002367787780740743; Lamine F, 2004, SCAND J GASTROENTERO, V39, P1250, DOI 10.1080/00365520410007953; Lamine F, 2004, SCAND J GASTROENTERO, V39, P37, DOI 10.1080/00365520310007152; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Lebeer S, 2011, LETT APPL MICROBIOL, V52, P220, DOI 10.1111/j.1472-765X.2010.02994.x; Lebeer S, 2010, BENEF MICROBES, V1, P335, DOI 10.3920/BM2010.0032; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Mare L, 2006, J APPL MICROBIOL, V100, P838, DOI 10.1111/j.1365-2672.2006.02835.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Niv E, 2005, CLIN NUTR, V24, P925, DOI 10.1016/j.clnu.2005.06.001; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Quigley EMM, 2011, GASTROENTEROL CLIN N, V40, P207, DOI 10.1016/j.gtc.2010.12.009; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Saxami G, 2012, ANAEROBE, V18, P417, DOI 10.1016/j.anaerobe.2012.04.002; Schmulson M, 2011, ALIMENT PHARM THER, V33, P1071, DOI 10.1111/j.1365-2036.2011.04637.x; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; Tobin Jacinta M, 2013, BMC Res Notes, V6, P252, DOI 10.1186/1756-0500-6-252; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wang B, 2009, INT J FOOD MICROBIOL, V132, P59, DOI 10.1016/j.ijfoodmicro.2009.03.016; Yoon JS, 2014, J GASTROEN HEPATOL, V29, P52, DOI 10.1111/jgh.12322; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739	66	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136048	10.1371/journal.pone.0136048	http://dx.doi.org/10.1371/journal.pone.0136048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367538	Green Published, gold			2022-12-27	WOS:000361601100013
J	Gomez, H; Kautza, B; Escobar, D; Nassour, I; Luciano, J; Botero, AM; Gordon, L; Martinez, S; Holder, A; Ogundele, O; Loughran, P; Rosengart, MR; Pinsky, M; Shiva, S; Zuckerbraun, BS				Gomez, Hernando; Kautza, Benjamin; Escobar, Daniel; Nassour, Ibrahim; Luciano, Jason; Botero, Ana Maria; Gordon, Lisa; Martinez, Silvia; Holder, Andre; Ogundele, Olufunmilayo; Loughran, Patricia; Rosengart, Matthew R.; Pinsky, Michael; Shiva, Sruti; Zuckerbraun, Brian S.			Inhaled Carbon Monoxide Protects against the Development of Shock and Mitochondrial Injury following Hemorrhage and Resuscitation	PLOS ONE			English	Article							HEME OXYGENASE-1; TRANSCRIPTIONAL CONTROL; CELLULAR RESPIRATION; LUNG INJURY; BIOGENESIS; LIVER; INHALATION; MODEL; INHIBITION; MECHANISM	Aims Currently, there is no effective resuscitative adjunct to fluid and blood products to limit tissue injury for traumatic hemorrhagic shock. The objective of this study was to investigate the role of inhaled carbon monoxide (CO) to limit inflammation and tissue injury, and specifically mitochondrial damage, in experimental models of hemorrhage and resuscitation. Results Inhaled CO (250 ppm for 30 minutes) protected against mortality in severe murine hemorrhagic shock and resuscitation (HS/R) (20% vs. 80%; P < 0.01). Additionally, CO limited the development of shock as determined by arterial blood pH (7.25 +/- 0.06 vs. 7.05 +/- 0.05; P < 0.05), lactate levels (7.2 +/- 5.1 vs 13.3 +/- 6.0; P < 0.05), and base deficit (13 +/- 3.0 vs 24 +/- 3.1; P < 0.05). A dose response of CO (25-500 ppm) demonstrated protection against HS/R lung and liver injury as determined by MPO activity and serum ALT, respectively. CO limited HS/R-induced increases in serum tumor necrosis factor-alpha and interleukin-6 levels as determined by ELISA (P < 0.05 for doses of 100-500ppm). Furthermore, inhaled CO limited HS/R induced oxidative stress as determined by hepatic oxidized glutathione: reduced glutathione levels and lipid peroxidation. In porcine HS/R, CO did not influence hemodynamics. However, CO limited HS/R-induced skeletal muscle and platelet mitochondrial injury as determined by respiratory control ratio (muscle) and ATP-linked respiration and mitochondrial reserve capacity (platelets). Conclusion These preclinical studies suggest that inhaled CO can be a protective therapy in HS/R; however, further clinical studies are warranted.	[Gomez, Hernando; Gordon, Lisa; Holder, Andre; Ogundele, Olufunmilayo; Rosengart, Matthew R.; Pinsky, Michael] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Gomez, Hernando; Rosengart, Matthew R.; Zuckerbraun, Brian S.] Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA; [Kautza, Benjamin; Escobar, Daniel; Nassour, Ibrahim; Luciano, Jason; Botero, Ana Maria; Martinez, Silvia; Loughran, Patricia; Zuckerbraun, Brian S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Shiva, Sruti; Zuckerbraun, Brian S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Zuckerbraun, Brian S.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zuckerbraun, BS (corresponding author), Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA.	zuckerbraunbs@upmc.edu	Nassour, Ibrahim/J-5807-2019; Gomez, Hernando/ABB-4589-2020; Loughran, Patricia/AAB-1184-2021	Nassour, Ibrahim/0000-0002-9845-1074; 	National Institutes of Health [R01GM082830, UM1 HL120877-01, 1K12HL109068-02]; Veterans Affairs Merit Award [1I01BX000566]; Department of Defense [DM102439]; Hemophilia Center of Western Pennsylvania; UPMC Military Medicine Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820, UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082830] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); Hemophilia Center of Western Pennsylvania; UPMC Military Medicine Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by National Institutes of Health grants R01GM082830 (BSZ), UM1 HL120877-01 (BSZ), 1K12HL109068-02 (HG), Veterans Affairs Merit Award 1I01BX000566 (BSZ), Department of Defense DM102439 (BSZ), Hemophilia Center of Western Pennsylvania (SS) and UPMC Military Medicine Center (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BO, 1991, J APPL PHYSIOL, V71, P1862, DOI 10.1152/jappl.1991.71.5.1862; Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327; Bauer M, 1996, AM J PHYSIOL-GASTR L, V271, pG929, DOI 10.1152/ajpgi.1996.271.5.G929; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Carrico CJ, 2002, SHOCK, V17, P165, DOI 10.1097/00024382-200203000-00001; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; ECKSTEIN RW, 1946, AM J PHYSIOL, V147, P685, DOI 10.1152/ajplegacy.1946.147.4.685; Kaczorowski DJ, 2007, CURR MED CHEM, V14, P2720, DOI 10.2174/092986707782023181; Kanagawa F, 2010, J TRAUMA, V69, P185, DOI 10.1097/TA.0b013e3181bbd516; Kawanishi S, 2013, MOL MED REP, V7, P3, DOI 10.3892/mmr.2012.1173; Kubulus D, 2008, SHOCK, V29, P583, DOI 10.1097/SHK.0b013e318157e526; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pannen BHJ, 1998, J CLIN INVEST, V102, P1220, DOI 10.1172/JCI3428; Paxian M, 2001, SHOCK, V15, P438, DOI 10.1097/00024382-200115060-00005; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Sakai H, 2009, SHOCK, V31, P507, DOI 10.1097/SHK.0b013e318188f83d; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Shah NS, 1998, SHOCK, V10, P343, DOI 10.1097/00024382-199811000-00006; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Vallabhaneni R, 2010, SHOCK, V33, P274, DOI 10.1097/SHK.0b013e3181b0f566; WEST MA, 1985, INFECT IMMUN, V49, P563, DOI 10.1128/IAI.49.3.563-570.1985; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003; Zuckerbraun BS, 2005, SHOCK, V23, P527, DOI 10.1097/01.shk.0000163206.22032.a1	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135032	10.1371/journal.pone.0135032	http://dx.doi.org/10.1371/journal.pone.0135032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366865	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000361601100008
J	Hoevenaren, IA; Meulstee, J; Krikken, E; Berge, SJ; Ulrich, DJO; Maal, TJJ				Hoevenaren, Inge A.; Meulstee, J.; Krikken, E.; Berge, S. J.; Ulrich, D. J. O.; Maal, Thomas J. J.			Development of a Three-Dimensional Hand Model Using Three-Dimensional Stereophotogrammetry: Assessment of Image Reproducibility	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RECONSTRUCTION; PRECISION; SYSTEM; PHOTOGRAMMETRY; SIMULATIONS; RELIABILITY; DISSECTION; ACCURACY; FLAP	Purpose Using three-dimensional (3D) stereophotogrammetry precise images and reconstructions of the human body can be produced. Over the last few years, this technique is mainly being developed in the field of maxillofacial reconstructive surgery, creating fusion images with computed tomography (CT) data for precise planning and prediction of treatment outcome. Though, in hand surgery 3D stereophotogrammetry is not yet being used in clinical settings. Methods A total of 34 three-dimensional hand photographs were analyzed to investigate the reproducibility. For every individual, 3D photographs were captured at two different time points (baseline T0 and one week later T1). Using two different registration methods, the reproducibility of the methods was analyzed. Furthermore, the differences between 3D photos of men and women were compared in a distance map as a first clinical pilot testing our registration method. Results The absolute mean registration error for the complete hand was 1.46 mm. This reduced to an error of 0.56 mm isolating the region to the palm of the hand. When comparing hands of both sexes, it was seen that the male hand was larger (broader base and longer fingers) than the female hand. Conclusions This study shows that 3D stereophotogrammetry can produce reproducible images of the hand without harmful side effects for the patient, so proving to be a reliablemethod for soft tissue analysis. Its potential use in everyday practice of hand surgery needs to be further explored.	[Hoevenaren, Inge A.; Ulrich, D. J. O.] Radboud Univ Nijmegen, Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-6525 ED Nijmegen, Netherlands; [Meulstee, J.; Krikken, E.; Berge, S. J.; Maal, Thomas J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Krikken, E.] Univ Twente, Tech Med, NL-7500 AE Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Twente	Hoevenaren, IA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-6525 ED Nijmegen, Netherlands.	inge.hoevenaren@radboudumc.nl	Bergé, S.J./H-8011-2014; Berge, Stefaan/AAP-3708-2020; Ulrich, D.J.O./H-8099-2014; Meulstee, Jene/F-3723-2016; Meulstee, Jene/AAE-1903-2019; Maal, Thomas JJ/L-4497-2015	Meulstee, Jene/0000-0002-1285-6602; Maal, Thomas JJ/0000-0002-1702-4733				Adamczyk C, 2009, ANN ANAT, V191, P339, DOI 10.1016/j.aanat.2009.03.003; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Ayoub AF, 1998, BRIT J ORAL MAX SURG, V36, P353, DOI 10.1016/S0266-4356(98)90646-5; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bugaighis I, 2012, EUR J ORTHODONT, P8, DOI [10.1093/ejo/cjs060, DOI 10.1093/EJ0/CJS060]; COOMBES AM, 1991, EUR J ORTHODONT, V13, P95, DOI 10.1093/ejo/13.2.95; Crossingham JL, 2009, HPB, V11, P523, DOI 10.1111/j.1477-2574.2009.00097.x; Gacto-Sanchez P, 2010, J SURG RES, V162, P140, DOI 10.1016/j.jss.2009.01.025; Gacto-Sanchez P, 2010, PLAST RECONSTR SURG, V125, P24, DOI 10.1097/PRS.0b013e3181c4948b; Gerlach NL, 2010, J ORAL MAXIL SURG, V68, P811, DOI 10.1016/j.joms.2009.09.059; Giunta RE, 2010, HANDCHIR MIKROCHIR P, V42, P143, DOI 10.1055/s-0030-1249039; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; Henseler H, 2012, J PLAST RECONSTR AES, V65, P1209, DOI 10.1016/j.bjps.2012.03.043; Hoehnke C, 2007, J PLAST RECONSTR AES, V60, P1138, DOI 10.1016/j.bjps.2007.01.068; Hoevenaren IA, 2015, J PLAST RECONSTR AES, V68, P709, DOI 10.1016/j.bjps.2014.12.025; Ibrahim AE, 2012, EUR J PLAST SURG, V35, P571, DOI 10.1007/s00238-012-0737-8; Jastrow H, 2003, CLIN ANAT, V16, P44, DOI 10.1002/ca.10062; Johnston DJ, 2003, CLEFT PALATE-CRAN J, V40, P291, DOI 10.1597/1545-1569(2003)040<0291:AFER>2.0.CO;2; Jones DG, 1997, CLIN ANAT, V10, P123, DOI 10.1002/(SICI)1098-2353(1997)10:2<123::AID-CA9>3.0.CO;2-W; Kau CH, 2005, AM J ORTHOD DENTOFAC, V128, P424, DOI 10.1016/j.ajodo.2004.06.037; Kimoto K, 2007, J ORAL REHABIL, V34, P201, DOI 10.1111/j.1365-2842.2006.01663.x; Kovacs L, 2005, BURNS, V31, P85, DOI 10.1016/j.burns.2004.07.010; Kovacs L, 2007, BREAST, V16, P137, DOI 10.1016/j.breast.2006.08.001; Kovacs L, 2012, AESTHET PLAST SURG, V36, P879, DOI 10.1007/s00266-012-9892-3; Kowalczuk J, 2012, SURG ENDOSC, V26, P3413, DOI 10.1007/s00464-012-2355-8; Krimmel M, 2005, BIOMED TECH, V50, P45, DOI 10.1515/BMT.2005.008; Lane C, 2008, AM J ORTHOD DENTOFAC, V133, P612, DOI 10.1016/j.ajodo.2007.03.023; Lee Samson, 2004, Arch Facial Plast Surg, V6, P410, DOI 10.1001/archfaci.6.6.410; Lefevre P, 2007, INT J LEGAL MED, V121, P511, DOI 10.1007/s00414-007-0204-4; Levine MG, 1999, CLIN ANAT, V12, P191, DOI 10.1002/(SICI)1098-2353(1999)12:3<191::AID-CA8>3.0.CO;2-5; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Littlefield TR, 2004, J CRANIOFAC SURG, V15, P175, DOI 10.1097/00001665-200401000-00042; Ma LL, 2009, COMPUT METH PROG BIO, V94, P290, DOI 10.1016/j.cmpb.2009.01.010; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Okada E, 2001, J CRANIOFAC SURG, V12, P167, DOI 10.1097/00001665-200103000-00014; Plooij JM, 2009, INT J ORAL MAX SURG, V38, P267, DOI 10.1016/j.ijom.2008.12.009; Pommert A, 2001, MED IMAGE ANAL, V5, P221, DOI 10.1016/S1361-8415(01)00044-5; Reeves RE, 2004, CLIN ANAT, V17, P337, DOI 10.1002/ca.10245; Schittek M, 2001, Eur J Dent Educ, V5, P93, DOI 10.1034/j.1600-0579.2001.050301.x; Sierra R, 2006, MED IMAGE ANAL, V10, P275, DOI 10.1016/j.media.2005.11.003; Silen C, 2008, MED TEACH, V30, pE115, DOI 10.1080/01421590801932228; Small KH, 2010, J PLAST RECONSTR AES, V63, P346, DOI 10.1016/j.bjps.2008.11.023; Smith-Bindman R, 2013, JAMA; Trunk P, 2007, COMPUT BIOL MED, V37, P1398, DOI 10.1016/j.compbiomed.2006.11.003; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Weinberg SM, 2005, J CRANIOFAC SURG, V16, P847, DOI 10.1097/01.SCS.0000164330.96675.0C; Zhang YZ, 2007, MICROSURG, V27, P553, DOI 10.1002/micr.20410	49	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136710	10.1371/journal.pone.0136710	http://dx.doi.org/10.1371/journal.pone.0136710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366860	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100022
J	Hynson, NA; Allison, SD; Treseder, KK				Hynson, Nicole A.; Allison, Steven D.; Treseder, Kathleen K.			Quantum Dots Reveal Shifts in Organic Nitrogen Uptake by Fungi Exposed to Long-Term Nitrogen Enrichment	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; HOME-FIELD ADVANTAGE; FUNCTIONAL-SIGNIFICANCE; MYCORRHIZAL FUNGI; DECOMPOSITION; LITTER; CARBON; NANOCRYSTALS; DIVERSITY; STOICHIOMETRY	Anthropogenic nitrogen (N) enrichment can alter N dynamics associated with decomposing plant litter. However, it is unclear to what extent these alterations occur via microbial effects (e.g., changes in gene regulation, physiology, or community composition) versus plant litter effects (e.g., changes in composition of N and C compounds). To isolate microbial effects from plant litter effects, we collected plant litter from long-term N fertilized and control plots, reciprocally inoculated it with microbes from the two treatments, and incubated it in a common field setting for three months. We used quantum dots (QDs) to track fungal uptake of glycine and chitosan. Glycine is a relatively simple organic N compound; chitosan is more complex. We found that microbial and litter origins each contributed to a shift in fungal uptake capacities under N fertilization. Specifically, N fungi preferred glycine over chitosan, but control fungi did not. In comparison, litter effects were more subtle, and manifested as a three-way interaction between litter origin, microbial origin, and type of organic N (glycine versus chitosan). In particular, control fungi tended to target chitosan only when incubated with control litter, while N fungi targeted glycine regardless of litter type. Overall, microbial effects may mediate how N dynamics respond to anthropogenic N enrichment in ecosystems.	[Hynson, Nicole A.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Allison, Steven D.; Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Irvine	Hynson, NA (corresponding author), Univ Hawaii Manoa, Dept Bot, 3190 Maile Way, Honolulu, HI 96822 USA.	nhynson@hawaii.edu	Allison, Steven D./E-2978-2010; Treseder, Kathleen K/E-5148-2011	Allison, Steven D./0000-0003-4629-7842; Treseder, Kathleen K/0000-0003-2847-6935; Hynson, Nicole/0000-0001-7098-9641	Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling); NSF [DEB-1256896, EAR-1411942]; Direct For Biological Sciences [1457160] Funding Source: National Science Foundation; Directorate For Geosciences [1411942] Funding Source: National Science Foundation; Division Of Environmental Biology [1256896] Funding Source: National Science Foundation	Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling), NSF DEB-1256896, and NSF EAR-1411942.	Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Allison SD, 2010, SOIL ENZYMOLOGY, P245; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cleveland CC, 2014, OECOLOGIA, V174, P283, DOI 10.1007/s00442-013-2758-9; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Dighton J, 2016, FUNGI ECOSYSTEM PROC, DOI DOI 10.1201/9781315371528; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Egerton-Warburton LM, 2000, ECOL APPL, V10, P484, DOI 10.1890/1051-0761(2000)010[0484:SIAMCA]2.0.CO;2; Entwistle EM, 2013, SOIL SCI SOC AM J, V77, P1648, DOI 10.2136/sssaj2013.05.0179; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Freschet GT, 2012, J ECOL, V100, P619, DOI 10.1111/j.1365-2745.2011.01943.x; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gooday Graham W., 1994, P279; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Gustafsson FS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06971; Hanson CA, 2008, ECOSYSTEMS, V11, P1157, DOI 10.1007/s10021-008-9186-4; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kagata H, 2013, POPUL ECOL, V55, P69, DOI 10.1007/s10144-012-0342-5; Kivlin SN, 2015, MICROB ECOL, V69, P748, DOI 10.1007/s00248-014-0509-z; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LeBauer DS, 2010, CAN J FOREST RES, V40, P1076, DOI 10.1139/X10-054; Lin Z, 2004, RUSS CHEM B+, V53, P2690, DOI 10.1007/s11172-005-0176-9; Madigan MT, 2009, BROCK BIOL MICROORGA; Matulich KL, 2015, ISME J; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Mohan JE, 2014, FUNGAL ECOL, V10, P3, DOI 10.1016/j.funeco.2014.01.005; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Potts DL, 2012, J ARID ENVIRON, V81, P59, DOI 10.1016/j.jaridenv.2012.01.007; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; ROSSWALL T, 1982, PLANT SOIL, V67, P15, DOI 10.1007/BF02182752; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; SPSS, 2009, SYST 13 VERS 13 00 0; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wardle D., 2002, COMMUNITIES ECOSYSTE; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Whiteside MD, 2009, ECOLOGY, V90, P100, DOI 10.1890/07-2115.1	64	7	7	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138158	10.1371/journal.pone.0138158	http://dx.doi.org/10.1371/journal.pone.0138158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367868	Green Published, gold			2022-12-27	WOS:000361601100238
J	Nalluri, S; Ghoshal-Gupta, S; Kutiyanawalla, A; Gayatri, S; Lee, BR; Jiwani, S; Rojiani, AM; Rojiani, MV				Nalluri, Srilatha; Ghoshal-Gupta, Sampa; Kutiyanawalla, Ammar; Gayatri, Sitaram; Lee, Byung Rho; Jiwani, Shahanawaz; Rojiani, Amyn M.; Rojiani, Mumtaz V.			TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; TISSUE INHIBITOR; METALLOPROTEINASES-1 TIMP-1; SIGNALING PATHWAY; CARCINOMA CELLS; CANCER; PHOSPHORYLATION; ANGIOGENESIS; PROGNOSIS; SURVIVAL	Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.	[Nalluri, Srilatha; Ghoshal-Gupta, Sampa; Kutiyanawalla, Ammar; Gayatri, Sitaram; Lee, Byung Rho; Jiwani, Shahanawaz; Rojiani, Amyn M.; Rojiani, Mumtaz V.] Georgia Regents Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA	University System of Georgia; Augusta University	Rojiani, MV (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912 USA.	mrojiani@GRU.edu	Gayatri, Sitaram/GLT-7340-2022	Lee, Byung Rho/0000-0002-2729-1616; Rojiani, Amyn/0000-0001-5621-3724; nalluri, srilatha/0000-0002-7265-8165; Gayatri, Sitaram/0000-0002-0773-6278	Georgia Research Alliance [GCC0059]; Georgia Regents University	Georgia Research Alliance; Georgia Regents University	This study was funded by Research Award GCC0059 from the Georgia Research Alliance to AMR and intramural research funds from the Georgia Regents University to MVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. C. S, 2014, CANC FACTS FIG; Aljada IS, 2004, J CLIN ONCOL, V22, P3218, DOI 10.1200/JCO.2004.02.110; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Davidsen ML, 2006, BRIT J CANCER, V95, P1114, DOI 10.1038/sj.bjc.6603378; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fong KM, 1996, CLIN CANCER RES, V2, P1369; Gao M, 2012, ONCOL REP, V27, P585, DOI 10.3892/or.2011.1527; Gonzalez-Puertos VY, 2010, J GASTROEN HEPATOL, V25, P1306, DOI 10.1111/j.1440-1746.2009.06175.x; Gouyer V, 2005, CANCER-AM CANCER SOC, V103, P1676, DOI 10.1002/cncr.20965; Grunnet M, 2013, SCAND J GASTROENTERO, V48, P899, DOI 10.3109/00365521.2013.812235; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Guo YH, 2004, LIFE SCI, V75, P2483, DOI 10.1016/j.lfs.2004.07.007; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Ikenaka Y, 2003, INT J CANCER, V105, P340, DOI 10.1002/ijc.11094; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Jin ZH, 2004, J BIOL CHEM, V279, P40209, DOI 10.1074/jbc.M404056200; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Lee JH, 2011, J GASTROINTEST LIVER, V20, P287; Lee SJ, 2003, BIOCHEM BIOPH RES CO, V312, P1196, DOI 10.1016/j.bbrc.2003.11.050; Li GY, 1999, CANCER RES, V59, P6267; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Park JS, 2012, INT J ONCOL, V40, P1210, DOI 10.3892/ijo.2011.1310; Pesta M, 2011, ANTICANCER RES, V31, P4031; Phelps RM, 1996, J CELL BIOCHEM, P32; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Ritter LM, 1999, BIOCHEM BIOPH RES CO, V257, P494, DOI 10.1006/bbrc.1999.0408; Rojiani MV, 2015, J NEUROPATH EXP NEUR, V74, P293, DOI 10.1097/NEN.0000000000000175; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Stilley JAW, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094680; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Tsagaraki I, 2010, CELL TISSUE RES, V342, P87, DOI 10.1007/s00441-010-1025-1; Van Geest RJ, 2013, J CELL COMMUN SIGNAL, V7, P1, DOI 10.1007/s12079-012-0178-y; Wang T, 2002, BIOCHEM BIOPH RES CO, V296, P201, DOI 10.1016/S0006-291X(02)00741-6; Wu TY, 2014, INT J CLIN EXP PATHO, V7, P56; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719; Yamada E, 2001, HISTOL HISTOPATHOL, V16, P87, DOI 10.14670/HH-16.87; Ye DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027637; Zhao WQ, 1998, J CELL SCI, V111, P1147	53	26	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137673	10.1371/journal.pone.0137673	http://dx.doi.org/10.1371/journal.pone.0137673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366732	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100105
J	Jin, DH; Park, SE; Lee, J; Kim, KM; Kim, S; Kim, DH; Park, J				Jin, Dong-Hao; Park, Seong-Eun; Lee, Jeeyun; Kim, Kyung-Mi; Kim, Sung; Kim, Duk-Hwan; Park, Joobae			Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HER2 GENE AMPLIFICATION; C-MYC; PROTEIN EXPRESSION; TRANSCRIPTION FACTOR; IDENTIFICATION; CARCINOMA; FHIT; ADENOCARCINOMA; PROGRESSION	The present study was aimed at discovering DNA copy number alterations (CNAs) involved in the carcinogenesis of stomach and at understanding their clinicopathological significances in the Korean population. DNA copy numbers were analyzed using Agilent 244K or 400K array comparative genomic hybridization (aCGH) in fresh-frozen tumor and matched normal tissues from 40 gastric cancer patients. Some of the detected CNA regions were validated using multiplex ligation-dependent probe amplification (MLPA) in six of the 40 patients and customized Agilent 60K aCGH in an independent set of 48 gastric cancers. The mRNA levels of genes at common CNA regions were analyzed using quantitative real-time PCR. Copy number gains were more common than losses across the entire genome in tumor tissues compared to matched normal tissues. The mean number of alterations per case was 64 for gains and 40 for losses, and the median aberration length was 44016 bp for gains and 4732 bp for losses. Copy number gains were frequently detected at 7p22.1 (20%), 8q24.21 (27%-30%), 8q24.3 (22%-48%), 13q34 (20%-31%), and 20q11-q13 (25%-30%), and losses at 3p14.2 (43%), 4q35.2 (27%), 6q26 (23%), and 17p13.3 (20%-23%). CNAs at 7p22.1, 13q34, and 17p13.3 have not been reported in other populations. Most of the copy number losses were associated with down-regulation of mRNA levels, but the correlation between copy number gains and mRNA expression levels varied in a gene-dependent manner. In addition, copy number gains tended to occur more commonly in intestinal-type cancers than in diffuse-type cancers. In conclusion, the present study suggests that copy number gains at 8q24 and 20q11-q13 and losses at 3p14.2 may be common events in gastric cancer but CNAs at 7p22.1, 13q34, and 17p13.3 may be Korean-specific.	[Jin, Dong-Hao; Park, Seong-Eun; Kim, Duk-Hwan; Park, Joobae] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 135710, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul 135710, South Korea; [Kim, Kyung-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea; [Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 135710, South Korea.	dukhwan.kim@samsung.com; jb.park@skku.edu	Lee, Jee Yun/C-9646-2011; Kim, Sung/G-4114-2014		National R&D Program for Cancer Control, Ministry for Health and Welfare [1120270]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1979]	National R&D Program for Cancer Control, Ministry for Health and Welfare; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants from the National R&D Program for Cancer Control, Ministry for Health and Welfare (# 1120270) and from the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (HI14C1979), Republic of Korea.	Baffa R, 1998, CANCER RES, V58, P4708; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boussioutas A, 2001, INTERN MED J, V31, P296, DOI 10.1046/j.1445-5994.2001.00057.x; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Cheng L, 2012, CANCER LETT, V326, P105, DOI 10.1016/j.canlet.2012.07.031; Cheng L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-14; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Souza CR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064420, DOI 10.1371/J0URNAL.P0NE.0064420]; Diosdado B, 2010, CLIN CANCER RES, V16, P1391, DOI 10.1158/1078-0432.CCR-09-1773; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gemma A, 1997, CANCER RES, V57, P1435; Gogusev J, 1999, HUM GENET, V105, P444, DOI 10.1007/s004390051129; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koizumi Y, 1997, CLIN CANCER RES, V3, P1067; Kokkola A, 1998, CANCER GENET CYTOGEN, V107, P32, DOI 10.1016/S0165-4608(98)00092-2; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Lips EH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-314; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Oh EK, 2012, INT J ONCOL, V41, P2038, DOI 10.3892/ijo.2012.1644; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Park CH, 2010, J SURG ONCOL, V102, P454, DOI 10.1002/jso.21585; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Roa JC, 2005, REV MED CHILE, V133, P874; Rocco A, 2003, J CANCER RES CLIN, V129, P84, DOI 10.1007/s00432-002-0409-3; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rossi E, 2011, HUM PATHOL, V42, P1937, DOI 10.1016/j.humpath.2011.02.016; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Sonoda A, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-25; Sung CO, 2013, CANCER GENET-NY, V206, P145, DOI 10.1016/j.cancergen.2013.04.002; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Varis A, 2002, CANCER RES, V62, P2625; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; Xu AG, 2001, WORLD J GASTROENTERO, V7, P403; Yan B, 2010, J CLIN PATHOL, V63, P839, DOI 10.1136/jcp.2010.076570; Yano T, 2006, ONCOL REP, V15, P65; Yun SH, 2014, PLOS ONE, V3, P1, DOI DOI 10.1038/0NC.2013.472; Zhang L, 2010, MOL CELL BIOCHEM, V344, P125, DOI 10.1007/s11010-010-0536-0	51	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137657	10.1371/journal.pone.0137657	http://dx.doi.org/10.1371/journal.pone.0137657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360582	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100068
J	Sarkar, A; Brenk, R				Sarkar, Aurijit; Brenk, Ruth			To Hit or Not to Hit, That Is the Question - Genome-wide Structure-Based Druggability Predictions for Pseudomonas aeruginosa Proteins	PLOS ONE			English	Article							LIGAND-BINDING-SITES; DRUG DISCOVERY; TARGETS; IDENTIFICATION; CAVITIES; POCKETS; DESIGN; INFORMATION; INHIBITORS; LIBRARY	Pseudomonas aeruginosa is a Gram-negative bacterium known to cause opportunistic infections in immune-compromised or immunosuppressed individuals that often prove fatal. New drugs to combat this organism are therefore sought after. To this end, we subjected the gene products of predicted perturbative genes to structure-based druggability predictions using DrugPred. Making this approach suitable for large-scale predictions required the introduction of new methods for calculation of descriptors, development of a workflow to identify suitable pockets in homologous proteins and establishment of criteria to obtain valid druggability predictions based on homologs. We were able to identify 29 perturbative proteins of P. aeruginosa that may contain druggable pockets, including some of them with no or no drug-like inhibitors deposited in ChEMBL. These proteins form promising novel targets for drug discovery against P. aeruginosa.	[Sarkar, Aurijit; Brenk, Ruth] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Brenk, Ruth] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Brenk, Ruth] Univ Bergen, Dept Biomed, Bergen, Norway	University of Dundee; Johannes Gutenberg University of Mainz; University of Bergen	Brenk, R (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dow St, Dundee, Scotland.	ruth.brenk@uib.no	Sarkar, Aurijit/AAW-3417-2020	Brenk, Ruth/0000-0002-6204-5488; Sarkar, Aurijit/0000-0003-3735-6345	European Commission; Aeropath	European Commission(European CommissionEuropean Commission Joint Research Centre); Aeropath	This work was funded by the European Commission Seventh Framework Programme (FP7/2007-2013; Aeropath, http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Alphey MS, 2013, ACS CHEM BIOL, V8, P387, DOI 10.1021/cb300426u; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; de Jonge BLM, 2013, ANTIMICROB AGENTS CH, V57, P6005, DOI 10.1128/AAC.01661-13; Desaphy J, 2012, J CHEM INF MODEL, V52, P2287, DOI 10.1021/ci300184x; Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hopkins AL, 2011, CURR TOP MED CHEM, V11, P1292; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010109; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Krasowski A, 2011, J CHEM INF MODEL, V51, P2829, DOI 10.1021/ci200266d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perola E, 2012, J CHEM INF MODEL, V52, P1027, DOI 10.1021/ci200613b; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Shanmugham B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059126; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Sheridan RP, 2010, J CHEM INF MODEL, V50, P2029, DOI 10.1021/ci100312t; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; Uddin R, 2014, COMPUT BIOL CHEM, V48, P55, DOI 10.1016/j.compbiolchem.2013.11.005; Volkamer A, 2014, FUTURE MED CHEM, V6, P319, DOI 10.4155/fmc.14.3; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wang CY, 2006, CLIN MICROBIOL INFEC, V12, P63, DOI 10.1111/j.1469-0691.2005.01305.x; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Zhang J, 2012, CURR MED CHEM, V19, P2038, DOI 10.2174/092986712800167374	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137279	10.1371/journal.pone.0137279	http://dx.doi.org/10.1371/journal.pone.0137279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360059	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100029
J	Dosemeci, A; Toy, D; Reese, TS; Tao-Cheng, JH				Dosemeci, Ayse; Toy, Dana; Reese, Thomas S.; Tao-Cheng, Jung-Hwa			AIDA-1 Moves out of the Postsynaptic Density Core under Excitatory Conditions	PLOS ONE			English	Article							DOMAIN-ASSOCIATED PROTEIN-1; NEURONS; SYNGAP; MANNER	AIDA-1 is highly enriched in postsynaptic density (PSD) fractions and is considered a major component of the PSD complex. In the present study, immunogold electron microscopy was applied to determine localization as well as the activity-induced redistribution of AIDA-1 at the PSD using two antibodies that recognize two different epitopes. In cultured rat hippocampal neurons under basal conditions, immunogold label for AIDA-1 is mostly located within the dense core of the PSD, with a median distance of similar to 30 nm from the postsynaptic membrane. Under excitatory conditions, such as depolarization with high K+ (90 mM, 2 min) or application of NMDA (50 mu M, 2 min), AIDA-1 label density at the PSD core is reduced to 40% of controls and the median distance of label from the postsynaptic membrane increases to similar to 55 nm. The effect of excitatory conditions on the postsynaptic distribution of AIDA-1 is reversed within 30 minutes after returning to control conditions. The reversible removal of AIDA-1 from the PSD core under excitatory conditions is similar to the redistribution of another abundant PSD protein, SynGAP. Both SynGAP-alpha1 and AIDA-1 are known to bind PSD-95. Activity-induced transient translocation of these abundant proteins from the PSD core could promote structural flexibility, vacate sites on PSD-95 for the insertion of other components and thus may create a window for synaptic modification.	[Dosemeci, Ayse; Toy, Dana; Reese, Thomas S.] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Dosemeci, A (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dosemeca@mail.nih.gov			Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2001, P NATL ACAD SCI USA, V98, P10428, DOI 10.1073/pnas.181336998; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Dosemeci A, 2013, BIOCHEM BIOPH RES CO, V430, P245, DOI 10.1016/j.bbrc.2012.10.131; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Jacob AL, 2010, J COMP NEUROL, V518, P3221, DOI 10.1002/cne.22394; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; Mulholland PJ, 2012, ALCOHOL, V46, P569, DOI 10.1016/j.alcohol.2012.04.004; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; Tao-Cheng JH, 2010, NEUROSCIENCE, V168, P11, DOI 10.1016/j.neuroscience.2010.03.041; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Tindi JO, 2015, J NEUROSCI, V35, P8986, DOI 10.1523/JNEUROSCI.4029-14.2015; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137216	10.1371/journal.pone.0137216	http://dx.doi.org/10.1371/journal.pone.0137216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356309	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800034
J	Logvinenko, AD; Funt, B; Mirzaei, H; Tokunaga, R				Logvinenko, Alexander D.; Funt, Brian; Mirzaei, Hamidreza; Tokunaga, Rumi			Rethinking Colour Constancy	PLOS ONE			English	Article							OBJECT-COLOR; MANIFOLD; SCENES	Colour constancy needs to be reconsidered in light of the limits imposed by metamer mismatching. Metamer mismatching refers to the fact that two objects reflecting metameric light under one illumination may reflect non-metameric light under a second; so two objects appearing as having the same colour under one illuminant can appear as having different colours under a second. Yet since Helmholtz, object colour has generally been believed to remain relatively constant. The deviations from colour constancy registered in experiments are usually thought to be small enough that they do not contradict the notion of colour constancy. However, it is important to determine how the deviations from colour constancy relate to the limits metamer mismatching imposes on constancy. Hence, we calculated metamer mismatching's effect for the 20 Munsell papers and 8 pairs of illuminants employed in the colour constancy study by Logvinenko and Tokunaga and found it to be so extensive that the two notions-metamer mismatching and colour constancy-must be mutually exclusive. In particular, the notion of colour constancy leads to some paradoxical phenomena such as the possibility of 20 objects having the same colour under chromatic light dispersing into a hue circle of colours under neutral light. Thus, colour constancy refers to a phenomenon, which because of metamer mismatching, simply cannot exist. Moreover, it obscures the really important visual phenomenon; namely, the alteration of object colours induced by illumination change. We show that colour is not an independent, intrinsic attribute of an object, but rather an attribute of an object/light pair, and then define a concept of material colour in terms of equivalence classes of such object/light pairs. We suggest that studying the shift in material colour under a change in illuminant will be more fruitful than pursuing colour constancy's false premise that colour is an intrinsic attribute of an object.	[Logvinenko, Alexander D.] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Funt, Brian; Mirzaei, Hamidreza] Simon Fraser Univ, Sch Comp Sci, Vancouver, BC, Canada; [Tokunaga, Rumi] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kyoto, Japan	Glasgow Caledonian University; Simon Fraser University; Ritsumeikan University	Funt, B (corresponding author), Simon Fraser Univ, Sch Comp Sci, Vancouver, BC, Canada.	funt@sfu.ca	Mirzaee, Hamidreza/AAU-8999-2021		Natural Sciences and Engineering Research Council of Canada [RGPIN4322]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by funds from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) under grant number RGPIN4322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard K, 2002, IEEE T IMAGE PROCESS, V11, P972, DOI 10.1109/TIP.2002.802531; Brainard D. H, 2009, SAGE ENCY PERCEPTION, P253; Brainard DH, 2004, VISUAL NEUROSCIENCES, P948; Brill MH, 2008, COLOR RES APPL, V33, P320, DOI 10.1002/col.20420; Buchsbaum G, 1980, FRANKLIN INSTITUTE, V310, P1, DOI [10.1016/0016-0032(80)90058-7, DOI 10.1016/0016-0032(80)90058-7]; Cardei VC, 2002, J OPT SOC AM A, V19, P2374, DOI 10.1364/JOSAA.19.002374; CHICHILNISKY EJ, 1995, VISION RES, V35, P239, DOI 10.1016/0042-6989(94)00122-3; DZMURA M, 1986, J OPT SOC AM A, V3, P1662, DOI 10.1364/JOSAA.3.001662; Ebner M., 2007, COMPUTER VISION; Evans Ralph M., 1948, INTRO COLOR; Fairchild M. D., 2005, COLOR APPEARANCE MOD, V2nd, P26; Finayson GD, 2001, IEEE T PATTERN ANAL, V23, P1209, DOI 10.1109/34.969113; Finlayson GD, 1996, COLOR RES APPL, V21, P87, DOI 10.1002/(SICI)1520-6378(199604)21:2<87::AID-COL2>3.0.CO;2-0; FINLAYSON GD, 1994, J OPT SOC AM A, V11, P1553, DOI 10.1364/JOSAA.11.001553; FINLAYSON GD, 1994, J OPT SOC AM A, V11, P3011, DOI 10.1364/JOSAA.11.003011; Foster DH, 2006, J OPT SOC AM A, V23, P2359, DOI 10.1364/JOSAA.23.002359; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Foster DH, 2003, TRENDS COGN SCI, V7, P439, DOI 10.1016/j.tics.2003.08.002; Fox C.W, 1999, THE WORLD OF COLOUR; Funt B, 2012, J IMAGING SCI TECHN, V56; Gijsenij A, 2011, IEEE T IMAGE PROCESS, V20, P2475, DOI 10.1109/TIP.2011.2118224; Hordley SD, 2006, COLOR RES APPL, V31, P303, DOI 10.1002/col.20226; HUNT RWG, 1985, COLOR RES APPL, V10, P165, DOI 10.1002/col.5080100306; Hunt RWG, 2004, REPROD COLOUR; Hurlbert A, 2007, CURR BIOL, V17, pR906, DOI 10.1016/j.cub.2007.08.022; JAMESON D, 1989, ANNU REV PSYCHOL, V40, P1, DOI 10.1146/annurev.ps.40.020189.000245; LAND EH, 1977, SCI AM, V237, P108, DOI 10.1038/scientificamerican1277-108; LOGVINENKO A, 1994, PERCEPTION, V23, P1007, DOI 10.1068/p231007; Logvinenko A. D., 2009, P 11 C INT COL ASS A; Logvinenko AD, 2005, SPATIAL VISION, V18, P337, DOI 10.1163/1568568054089357; Logvinenko AD, 2015, FDN COLOUR IN PRESS; Logvinenko AD, 2014, IEEE T IMAGE PROCESS, V23, P34, DOI 10.1109/TIP.2013.2283148; Logvinenko AD, 2013, INT J COMPUT VISION, V101, P143, DOI 10.1007/s11263-012-0555-2; Logvinenko AD, 2012, J VISION, V12, DOI 10.1167/12.4.17; Logvinenko AD, 2011, SEEING PERCEIVING, V24, P407, DOI 10.1163/187847511X588746; Logvinenko AD, 2009, J VISION, V9, DOI 10.1167/9.11.5; MacLeod DIA, 2003, TRENDS COGN SCI, V7, P97, DOI 10.1016/S1364-6613(03)00022-6; Maloney L., 2003, COLOUR PERCEPTION MI, P279, DOI 10.1093/acprof:oso/9780198505006.003.0009; Maloney LT, 1999, PERCEPTION, V28, P19; MALONEY LT, 1986, J OPT SOC AM A, V3, P29, DOI 10.1364/JOSAA.3.000029; Munsell A., MUNSELL BOOK COLOR G; Shepard R.N., 1992, ADAPTED MIND EVOLUTI, P495; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Tokunaga R, 2010, J OPT SOC AM A, V27, P2551, DOI 10.1364/JOSAA.27.002551; Tokunaga R, 2010, OPHTHAL PHYSL OPT, V30, P611, DOI 10.1111/j.1475-1313.2010.00733.x; Tokunaga R, 2010, VISION RES, V50, P1740, DOI 10.1016/j.visres.2010.05.030; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Von Kries J., 1970, SOURCES COLOR SCI, P120; WEINBERG JW, 1976, GEN RELAT GRAVIT, V7, P135, DOI 10.1007/BF00762021; WEST G, 1982, J MATH BIOL, V15, P249, DOI 10.1007/BF00275077; Whittle P., 2003, COLOUR PERCEPTION MI, P115, DOI DOI 10.1093/ACPROF:OSO/9780198505006.003.0003; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; [No title captured]	54	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135029	10.1371/journal.pone.0135029	http://dx.doi.org/10.1371/journal.pone.0135029			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356217	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800003
J	Ray, A; Vasudevan, S; Sengupta, S				Ray, Anasuya; Vasudevan, Smreti; Sengupta, Suparna			6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death	PLOS ONE			English	Article							MAMMARY STEM/PROGENITOR CELLS; GINGER; IDENTIFICATION; PROLIFERATION; ACTIVATION; MECHANISMS; CARCINOMA; GROWTH; TUMORS	Cancer stem cells (CSCs) pose a serious obstacle to cancer therapy as they can be responsible for poor prognosis and tumour relapse. In this study, we have investigated inhibitory activity of the ginger-derived compound 6-shogaol against breast cancer cells both in monolayer and in cancer-stem cell-like spheroid culture. The spheroids were generated from adherent breast cancer cells. 6-shogaol was effective in killing both breast cancer monolayer cells and spheroids at doses that were not toxic to noncancerous cells. The percentages of CD44(+) CD24(-)/(low) cells and the secondary sphere content were reduced drastically upon treatment with 6-shogaol confirming its action on CSCs. Treatment with 6-shogaol caused cytoplasmic vacuole formation and cleavage of microtubule associated protein Light Chain3 (LC3) in both monolayer and spheroid culture indicating that it induced autophagy. Kinetic analysis of the LC3 expression and a combination treatment with chloroquine revealed that the autophagic flux instigated cell death in 6-shogaol treated breast cancer cells in contrast to the autophagy inhibitor chloroquine. Furthermore, 6-shogaol-induced cell death got suppressed in the presence of chloroquine and a very low level of apoptosis was exhibited even after prolonged treatment of the compound, suggesting that autophagy is the major mode of cell death induced by 6-shogaol in breast cancer cells. 6-shogaol reduced the expression levels of Cleaved Notch1 and its target proteins Hes1 and Cyclin D1 in spheroids, and the reduction was further pronounced in the presence of a gamma-secretase inhibitor. Secondary sphere formation in the presence of the inhibitor was also further reduced by 6-shogaol. Together, these results indicate that the inhibitory action of 6-shogaol on spheroid growth and sustainability is conferred through gamma-secretase mediated down-regulation of Notch signaling. The efficacy of 6-shogaol in monolayer and cancer stem cell-like spheroids raise hope for its therapeutic benefit in breast cancer treatment.	[Ray, Anasuya; Vasudevan, Smreti; Sengupta, Suparna] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram 695014, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sengupta, S (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram 695014, Kerala, India.	sengupta_suparna@hotmail.com		Sengupta, Suparna/0000-0003-3639-4630	Woman Scientist Scheme, Department of Science and Technology, Govt. of India [SR/WOS-A/LS-326/2009]; Rajiv Gandhi Centre for Biotechnology	Woman Scientist Scheme, Department of Science and Technology, Govt. of India; Rajiv Gandhi Centre for Biotechnology	The work was supported by the following: grant no. SR/WOS-A/LS-326/2009; Woman Scientist Scheme, Department of Science and Technology, Govt. of India (http://dst.gov.in/scientific-programme/women-scientists.htm) to AR; and Rajiv Gandhi Centre for Biotechnology (http://rgcb.res.in/) core funding to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bak MJ, 2012, MOLECULES, V17, P8037, DOI 10.3390/molecules17078037; Banerjee SK, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-4; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gan FF, 2011, APOPTOSIS, V16, P856, DOI 10.1007/s10495-011-0611-3; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Ishiguro K, 2008, FEBS LETT, V582, P3531, DOI 10.1016/j.febslet.2008.09.027; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Ling H, 2010, BRIT J PHARMACOL, V161, P1763, DOI 10.1111/j.1476-5381.2010.00991.x; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ray A, 2011, INT J ONCOL, V39, P797, DOI 10.3892/ijo.2011.1093; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Subramaniam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030590; Tan BS, 2013, CANCER LETT, V336, P127, DOI 10.1016/j.canlet.2013.04.014; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	42	56	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137614	10.1371/journal.pone.0137614	http://dx.doi.org/10.1371/journal.pone.0137614			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355461	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800071
J	Gargiulo, F; Bindi, J; Apolloni, A				Gargiulo, Floriana; Bindi, Jacopo; Apolloni, Andrea			The Topology of a Discussion: The #Occupy Case	PLOS ONE			English	Article							NETWORKS	Introduction We analyse a large sample of the Twitter activity that developed around the social movement 'Occupy Wall Street', to study the complex interactions between the human communication activity and the semantic content of a debate. Methods We use a network approach based on the analysis of the bipartite graph @Users-#Hashtags and of its projections: the 'semantic network', whose nodes are hashtags, and the 'users interest network', whose nodes are users. In the first instance, we find out that discussion topics (#hashtags) present a high structural heterogeneity, with a relevant role played by the semantic hubs that are responsible to guarantee the continuity of the debate. In the users'case, the self-organisation process of users'activity, leads to the emergence of two classes of communicators: the 'professionals'and the 'amateurs'. Results Both the networks present a strong community structure, based on the differentiation of the semantic topics, and a high level of structural robustness when certain sets of topics are censored and/or accounts are removed. Conclusions By analysing the characteristics of the dynamical networks we can distinguish three phases of the discussion about the movement. Each phase corresponds to a specific moment of the movement: from declaration of intent, organisation and development and the final phase of political reactions. Each phase is characterised by the presence of prototypical #hashtags in the discussion.	[Gargiulo, Floriana] Univ Namur, NaxYs, Namur, Belgium; [Bindi, Jacopo] Politecn Torino, DISAT, Turin, Italy; [Bindi, Jacopo] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Apolloni, Andrea] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of Namur; Polytechnic University of Turin; Polytechnic University of Turin; University of London; London School of Hygiene & Tropical Medicine	Gargiulo, F (corresponding author), Univ Namur, NaxYs, Namur, Belgium.	floriana.gargiulo@gmail.com	Gargiulo, Floriana/GYJ-8061-2022	Bindi, Jacopo/0000-0002-2337-7412	Interuniversity Attraction Poles Programme; Belgian Science Policy Office; WHO [EPIDZB44]	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); WHO(World Health Organization)	This paper presents research results of the Belgian Network DYSCO (Dynamical Systems, Control, and Optimization), funded by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. Andrea Apolloni is funded by the WHO project EPIDZB44, mathematical modelling on the impact of Hepatitis B vaccination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903; Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; [Anonymous], 2011, OPENING CLOSED REGIM; Apolloni A, 2011, ADV COMPLEX SYST, V14, P151, DOI 10.1142/S0219525911003037; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Beguerisse-Diaz M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0940; Berlingerio M, 2013, INTELL DATA ANAL, V17, P27, DOI 10.3233/IDA-120566; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borge-Holthoefer J, 2011, STRUCTURAL DYNAMICAL, V6; Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066123; Borondo J, 2012, CHAOS, V22; Brooks B., 2014, USING TWITTER DATA I; Bryden J, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds15; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Daniel C, 2011, OCCUPY WALL STREET 1; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Guillaume JL, 2004, INFORM PROCESS LETT, V90, P215, DOI 10.1016/j.ipl.2004.03.007; Hirsch R. M., 2002, STAT METHODS WATER R; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman ME, 2001, PHYS REV E, V64; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Rivers C., 2014, ETHICAL RES STANDARD, V3, P38, DOI [DOI 10.12688/F1000RESEARCH.3-38.V2, 10.12688/f1000research.3-38.v2]; Roth C, 2010, SOC NETWORKS, V32, P16, DOI 10.1016/j.socnet.2009.04.005; Salathe M, 2012, PLOS COMPUT BIOL, V8; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200	31	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137191	10.1371/journal.pone.0137191	http://dx.doi.org/10.1371/journal.pone.0137191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352596	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800066
J	Loos, CMJ; Klarenbeek, P; van Oostenbrugge, RJ; Staals, J				Loos, Caroline M. J.; Klarenbeek, Pim; van Oostenbrugge, Robert J.; Staals, Julie			Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; AMBULATORY BLOOD-PRESSURE; VIRCHOW-ROBIN SPACES; SILENT BRAIN INFARCTS; MRI; LESIONS; BARRIER; ADULTS	Objectives Perivascular spaces are associated with MRI markers of cerebral small vessel disease, including white matter hyperintensities. Although perivascular spaces are considered to be an early MRI marker of cerebral small vessel disease, it is unknown whether they are associated with further progression of MRI markers, especially white matter hyperintensities. We determined the association between perivascular spaces and progression of white matter hyperintensities after 2-year follow-up in lacunar stroke patients. Methods In 118 lacunar stroke patients we obtained brain MRI and 24-hour ambulatory blood pressure measurements at baseline, and a follow-up brain MRI 2 years later. We visually graded perivascular spaces and white matter hyperintensities at baseline. Progression of white matter hyperintensities was assessed using a visual white matter hyperintensity change scale. Associations with white matter hyperintensity progression were tested with binary logistic regression analysis. Results Extensive basal ganglia perivascular spaces were associated with progression of white matter hyperintensities (OR 4.29; 95% CI: 1.28-14.32; p < 0.05), after adjustment for age, gender, 24-hour blood pressure and vascular risk factors. This association lost significance after additional adjustment for baseline white matter hyperintensities. Centrum semiovale perivascular spaces were not associated with progression of white matter hyperintensities. Conclusions Our study shows that extensive basal ganglia perivascular spaces are associated with progression of white matter hyperintensities in cerebral small vessel disease. However, this association was not independent of baseline white matter hyperintensities. Therefore, presence of white matter hyperintensities at baseline remains an important determinant of further progression of white matter hyperintensities in cerebral small vessel disease.	[Loos, Caroline M. J.; van Oostenbrugge, Robert J.; Staals, Julie] Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands; [Loos, Caroline M. J.; van Oostenbrugge, Robert J.; Staals, Julie] Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Klarenbeek, Pim] Zuyderland Hosp, Dept Neurol, Heerlen, Netherlands	Maastricht University; Maastricht University	Loos, CMJ (corresponding author), Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands.	c.loos@mumc.nl	Loos, Caroline M.J./AAC-9952-2022		Dutch Pearl String Initiative	Dutch Pearl String Initiative	This project was supported by the Dutch Pearl String Initiative (C.M.J. Loos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham HMA, 2016, J CEREBR BLOOD F MET, V36, P132, DOI 10.1038/jcbfm.2015.121; Charidimou A, 2015, STROKE, V46, P1707, DOI 10.1161/STROKEAHA.115.009090; de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Donnan G, 2002, SUBCORTICAL STROKE, P27; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Firbank MJ, 2007, J NEUROL, V254, P713, DOI 10.1007/s00415-006-0238-4; Gottesman RF, 2010, STROKE, V41, P3, DOI 10.1161/STROKEAHA.109.566992; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Guo XX, 2009, HYPERTENSION, V54, P57, DOI 10.1161/HYPERTENSIONAHA.109.129700; Klarenbeek P, 2013, STROKE, V44, P2995, DOI 10.1161/STROKEAHA.113.002545; Klarenbeek P, 2013, J NEUROL, V260, P115, DOI 10.1007/s00415-012-6598-z; Marcus J, 2011, STROKE, V42, P2639, DOI 10.1161/STROKEAHA.111.617571; Prins ND, 2004, NEUROLOGY, V62, P1533, DOI 10.1212/01.WNL.0000123264.40498.B6; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; Schwartz GL, 2007, HYPERTENSION, V49, P1228, DOI 10.1161/HYPERTENSIONAHA.106.078691; Staals J, 2009, STROKE, V40, P3264, DOI 10.1161/STROKEAHA.109.558049; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299; Yao M, 2014, CEREBROVASC DIS, V37, P155, DOI 10.1159/000356982; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	31	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137323	10.1371/journal.pone.0137323	http://dx.doi.org/10.1371/journal.pone.0137323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352265	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800073
J	Lu, J; Yoshimura, K; Goto, K; Lee, C; Hamura, K; Kwon, O; Tamanoi, F				Lu, Jie; Yoshimura, Kohei; Goto, Koichi; Lee, Craig; Hamura, Ken; Kwon, Ohyun; Tamanoi, Fuyuhiko			Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells	PLOS ONE			English	Article							MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; FARNESYLTRANSFERASE INHIBITORS; TRANSFERASE INHIBITORS; PROTEIN TRANSFERASE; POLYMERIC MICELLES; LUNG-CANCER; H-RAS; K-RAS; N-RAS	Small molecule inhibitors against protein geranylgeranyltransferase-I such as P61A6 have been shown to inhibit proliferation of a variety of human cancer cells and exhibit antitumor activity in mouse models. Development of these inhibitors could be dramatically accelerated by conferring tumor targeting and controlled release capability. As a first step towards this goal, we have encapsulated P61A6 into a new type of liposomes that open and release cargos only under low pH condition. These low pH-release type liposomes were prepared by adjusting the ratio of two types of phospholipid derivatives. Loading of geranylgeranyltransferase-I inhibitor (GGTI) generated liposomes with average diameter of 50-100 nm. GGTI release in solution was sharply dependent on pH values, only showing release at pH lower than 6. Release of cargos in a pH-dependent manner inside the cell was demonstrated by the use of a proton pump inhibitor Bafilomycin A1 that Increased lysosomal pH and inhibited the release of a dye carried in the pH-liposome. Delivery of GGTI to human pancreatic cancer cells was demonstrated by the inhibition of protein geranylgeranylation inside the cell and this effect was blocked by Bafilomycin A1. In addition, GGTI delivered by pH-liposomes induced proliferation inhibition, G1 cell cycle arrest that is associated with the expression of cell cycle regulator p21(CIP1/WAF1). Proliferation inhibition was also observed with various lung cancer cell lines. Availability of nanoformulated GGTI opens up the possibility to combine with other types of inhibitors. To demonstrate this point, we combined the liposomal-GGTI with farnesyltransferase inhibitor (FTI) to inhibit K-Ras signaling in pancreatic cancer cells. Our results show that the activated K-Ras signaling in these cells can be effectively inhibited and that synergistic effect of the two drugs is observed. Our results suggest a new direction in the use of GGTI for cancer therapy.	[Lu, Jie; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yoshimura, Kohei; Hamura, Ken] NOF CORP, DDS Res Lab, Kawasaki, Kanagawa 2100865, Japan; [Goto, Koichi] Sojo Univ, Grad Sch Engn, Div Appl Life Sci, Kumamoto, Japan; [Lee, Craig; Kwon, Ohyun] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Sojo University; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			NIH [CA41996, R01GM071779, P41GM081282]; NOF, Inc; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071779, P41GM081282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOF, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by NIH grant CA41996 (to FT) and R01GM071779 and P41GM081282 (to OK), https://grants.nih.gov/grants/giwelcome.htm. A part of the work carried out in this paper was supported by a sponsored research agreement with NOF, Inc (to FT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Barar J, 2013, BIOIMPACTS, V3, P149, DOI 10.5681/bi.2013.036; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BOS JL, 1989, CANCER RES, V49, P4682; Bozzuto G, 2015, INT J NANOMED, V10, P975, DOI 10.2147/IJN.S68861; Braude E. A., 1955, DETERMINATION ORGANI; Cabral H, 2014, J CONTROL RELEASE, V190, P465, DOI 10.1016/j.jconrel.2014.06.042; Castellano S, 2007, J AM CHEM SOC, V129, P5843, DOI 10.1021/ja070274n; Chan LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026135; Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209; Dai WM, 2005, CURR MED CHEM, V12, P1947, DOI 10.2174/0929867054546591; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; DeSolms SJ, 2003, J MED CHEM, V46, P2973, DOI 10.1021/jm020587n; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Douroumis D, 2013, CRIT REV BIOTECHNOL, V33, P229, DOI 10.3109/07388551.2012.685860; Eloy JO, 2014, COLLOID SURFACE B, V123, P345, DOI 10.1016/j.colsurfb.2014.09.029; Galdiero S, 2014, J PEPT SCI, V20, P468, DOI 10.1002/psc.2649; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gurudevan S, 2013, CURR GENE THER, V13, P322, DOI 10.2174/156652321305131212123558; Head Julia E, 2003, Expert Opin Emerg Drugs, V8, P163, DOI 10.1517/eoed.8.1.163.21041; Hwang AA, 2014, SMALL; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Kohli AG, 2014, J CONTROL RELEASE, V190, P274, DOI 10.1016/j.jconrel.2014.04.047; Kraft JC, 2014, J PHARM SCI-US, V103, P29, DOI 10.1002/jps.23773; Kusama T, 2006, INT J ONCOL, V29, P217; Kuthati Y, 2013, J NANOSCI NANOTECHNO, V13, P2399, DOI 10.1166/jnn.2013.7363; Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lobell RB, 2001, CANCER RES, V61, P8758; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Maeda H., 2015, ADV DRUG DELIV REV; Matsumura Y, 2014, JPN J CLIN ONCOL, V44, P515, DOI 10.1093/jjco/hyu046; Mazet JL, 1999, FEBS LETT, V460, P235, DOI 10.1016/S0014-5793(99)01355-1; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Perez-Herrero E, 2015, EUR J PHARM BIOPHARM; Prabhu RH, 2015, INT J NANOMED, V10, P1001, DOI 10.2147/IJN.S56932; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1040, DOI 10.1021/bc7004736; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Tetlow AL, 2013, ENZYMES, V33, P1, DOI [10.1016/B978-0-12-416749-0.00001-4, 10.1016/B978-0-12-420146-0.00008-1]; Unzueta U, 2015, TRENDS BIOTECHNOL; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yachi K, 1996, BIOPHARM DRUG DISPOS, V17, P589, DOI 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.3.CO;2-4; Yanes RE, 2012, THER DELIV, V3, P389, DOI [10.4155/tde.12.9, 10.4155/TDE.12.9]; Yokoyama M, 2014, J DRUG TARGET, V22, P576, DOI 10.3109/1061186X.2014.934688; Yuba E, 2014, BIOMATERIALS, V35, P3091, DOI 10.1016/j.biomaterials.2013.12.024; Yuba E, 2013, BIOMATERIALS, V34, P5711, DOI 10.1016/j.biomaterials.2013.04.007; Zimonjic DB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-198	55	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137595	10.1371/journal.pone.0137595	http://dx.doi.org/10.1371/journal.pone.0137595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352258	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800100
J	Hong, W; Cheng, Q; Zhu, XY; Zhu, HM; Li, HL; Zhang, XM; Zheng, SB; Du, YP; Tang, WJ; Xue, SH; Ye, ZB				Hong, Wei; Cheng, Qun; Zhu, Xiaoying; Zhu, Hanmin; Li, Huilin; Zhang, Xuemei; Zheng, Songbai; Du, Yanping; Tang, Wenjing; Xue, Sihong; Ye, Zhibin			Prevalence of Sarcopenia and Its Relationship with Sites of Fragility Fractures in Elderly Chinese Men and Women	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; BONE-MINERAL DENSITY; HIP FRACTURE; POSTMENOPAUSAL WOMEN; OLDER-ADULTS; OBESITY; EPIDEMIOLOGY; FAT; OSTEOPOROSIS; ASSOCIATION	Objective Sarcopenia might be associated with bone fragility in elderly individuals. This study aimed to investigate the prevalence of sarcopenia and its association with fragility fracture sites in elderly Chinese patients. Methods Patients (322 men and 435 women) aged 65-94 years and with a history of fragility fractures in the ankle, wrist, vertebrae or hip, and healthy men (n = 1263) and women (n = 1057) aged 65-92 years without a history of fractures were enrolled. Whole-body dual energy Xray absorptiometry was used to analyze skeletal muscle mass index (SMI), fat mass and bone mineral density. Sarcopenia was defined as SMI less than two standard deviations below the mean of a young reference group. Results Sarcopenia occurrence varied with fracture location. Sarcopenia was more common in females with vertebral and hip fractures and in men with hip and ankle fractures than in the non-fracture group). Sarcopenia was significantly more prevalent in men with wrist, hip and ankle fractures than in women. SMI was correlated with BMD in different fracture groups. Logistic regression analyses revealed that lower SMI was associated with an increased risk of hip fracture both in men and women and ankle fracture in men. Discussion Sarcopenia may be an independent risk factor for hip and ankle fractures in men, and for hip fractures in women.	[Hong, Wei; Cheng, Qun; Zhu, Xiaoying; Zhu, Hanmin; Li, Huilin; Zhang, Xuemei; Du, Yanping; Tang, Wenjing; Xue, Sihong] Fudan Univ, Dept Osteoporosis, Res Sect Geriatr Metab Bone Dis, Huadong Hosp, Shanghai 200433, Peoples R China; [Zheng, Songbai; Ye, Zhibin] Fudan Univ, Dept Nephrol, Huadong Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhu, HM (corresponding author), Fudan Univ, Dept Osteoporosis, Res Sect Geriatr Metab Bone Dis, Huadong Hosp, Shanghai 200433, Peoples R China.	zhuhanmin@yeah.net; yezb2013@163.com			Research project of the Shanghai Municipal Health Bureau [2013ZXY0801]	Research project of the Shanghai Municipal Health Bureau	This work was supported by the Research project of the Shanghai Municipal Health Bureau (2013ZXY0801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson K, 2013, OSTEOPOROSIS INT, V24, P2135, DOI 10.1007/s00198-013-2348-z; American Society of Bariatric Physicians, 2005, OB ALG; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cederholm T, 2013, EUR J PHYS REHAB MED, V49, P111; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cheng Q, 2014, J BONE MINER METAB, V32, P78, DOI 10.1007/s00774-013-0468-3; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Demontiero O, 2014, CLIN GERIATR MED, V30, P333, DOI 10.1016/j.cger.2014.01.018; Dhanwal DK, 2011, INDIAN J ORTHOP, V45, P15, DOI 10.4103/0019-5413.73656; Di Monaco M, 2007, J BONE MINER METAB, V25, P237, DOI 10.1007/s00774-007-0752-1; Di Monaco M, 2012, ARCH GERONTOL GERIAT, V55, pE48, DOI 10.1016/j.archger.2012.05.002; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; Edwards MH, 2015, BONE; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hida T, 2015, EUR SPINE J; Hida T, 2013, GERIATR GERONTOL INT, V13, P413, DOI 10.1111/j.1447-0594.2012.00918.x; Hita-Contreras F, 2015, MATURITAS, V80, P126, DOI 10.1016/j.maturitas.2014.11.009; Ilich JZ, 2014, AGEING RES REV, V15, P51, DOI 10.1016/j.arr.2014.02.007; Ilich JZ, 2015, OSTEOPOROS INT; Iolascon G, 2013, AGING CLIN EXP RES, V25, pS129, DOI 10.1007/s40520-013-0102-1; Kaji H, 2013, CURR OPIN CLIN NUTR, V16, P272, DOI 10.1097/MCO.0b013e32835fe6a5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Karasik D, 2008, J BONE MINER RES, V23, P788, DOI 10.1359/JBMR.080218; Kim W, 2014, J BONE MINER METAB, V32, P709, DOI 10.1007/s00774-013-0545-7; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Li ZP, 2012, NUTR REV, V70, P57, DOI 10.1111/j.1753-4887.2011.00453.x; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; Malkov S, 2015, J BONE MINER RES; Organization W.H., 1998, GUID PRECL EV CLIN T; Ormsbee MJ, 2014, J CACHEXIA SARCOPENI, V5, P183, DOI 10.1007/s13539-014-0146-x; Oros S, 2012, ACTA ENDOCRINOL-BUCH, V8, P67, DOI 10.4183/aeb.2012.67; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Singh MAF, 2009, J GERONTOL A-BIOL, V64, P568, DOI 10.1093/gerona/glp002; Tarantino U, 2015, J BONE JOINT SURG AM, V97A, P429, DOI 10.2106/JBJS.N.00648; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; Wang ZM, 1996, J APPL PHYSIOL, V80, P824, DOI 10.1152/jappl.1996.80.3.824	41	52	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138102	10.1371/journal.pone.0138102	http://dx.doi.org/10.1371/journal.pone.0138102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367872	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100224
J	Hursel, R; Martens, EAP; Gonnissen, HKJ; Hamer, HM; Senden, JMG; van Loon, LJC; Westerterp-Plantenga, MS				Hursel, Rick; Martens, Eveline A. P.; Gonnissen, Hanne K. J.; Hamer, Henrike M.; Senden, Joan M. G.; van Loon, Luc J. C.; Westerterp-Plantenga, Margriet S.			Prolonged Adaptation to a Low or High Protein Diet Does Not Modulate Basal Muscle Protein Synthesis Rates - A Substudy	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; AMINO-ACIDS; BODY-WEIGHT; ENERGY-EXPENDITURE; MEN; MAINTENANCE; METABOLISM; KINETICS; LEUCINE	Background Based on controlled 36 h experiments a higher dietary protein intake causes a positive protein balance and a negative fat balance. A positive net protein balance may support fat free mass accrual. However, few data are available on the impact of more prolonged changes in habitual protein intake on whole-body protein metabolism and basal muscle protein synthesis rates. Objective To assess changes in whole-body protein turnover and basal muscle protein synthesis rates following 12 weeks of adaptation to a low versus high dietary protein intake. Methods A randomized parallel study was performed in 40 subjects who followed either a high protein (2.4 g protein/kg/d) or low protein (0.4 g protein/kg/d) energy-balanced diet (30/35/35% or 5/60/35% energy from protein/carbohydrate/fat) for a period of 12 weeks. A subgroup of 7 men and 8 women (body mass index: 22.8 +/- 2.3 kg/m(2), age: 24.3 +/- 4.9 y) were selected to evaluate the impact of prolonged adaptation to either a high or low protein intake on whole body protein metabolism and basal muscle protein synthesis rates. After the diet, subjects received continuous infusions with L-[ring-H-2(5)]phenylalanine and L-[ring-H-2(2)]tyrosine in an overnight fasted state, with blood samples and muscle biopsies being collected to assess post-absorptive whole-body protein turnover and muscle protein synthesis rates in vivo in humans. Results After 12 weeks of intervention, whole-body protein balance in the fasted state was more negative in the high protein treatment when compared with the low protein treatment (-4.1 +/- 0.5 vs -2.7 +/- 0.6 mu mol phenylalanine/kg/h; P<0.001). Whole-body protein breakdown (43.0 +/- 4.4 vs 37.8 +/- 3.8 mu mol phenylalanine/kg/h; P<0.03), synthesis (38.9 +/- 4.2 vs 35.1 +/- 3.6 mu mol phenylalanine/kg/h; P<0.01) and phenylalanine hydroxylation rates (4.1 +/- 0.6 vs 2.7 +/- 0.6 mu mol phenylalanine/kg/h; P<0.001) were significantly higher in the high vs low protein group. Basal muscle protein synthesis rates were maintained on a low vs high protein diet (0.042 +/- 0.01 vs 0.045 +/- 0.01%/h; P = 0.620). Conclusions In the overnight fasted state, adaptation to a low-protein intake (0.4 g/kg/d) does not result in a more negative whole-body protein balance and does not lower basal muscle protein synthesis rates when compared to a high-protein intake.	[Hursel, Rick; Martens, Eveline A. P.; Gonnissen, Hanne K. J.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands; [Hamer, Henrike M.; Senden, Joan M. G.; van Loon, Luc J. C.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Movement Sci, Maastricht, Netherlands	Maastricht University; Maastricht University	Hursel, R (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	rick.hursel@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; van Loon, Luc J C/G-5920-2010	van Loon, Luc J.C./0000-0002-6768-9231; van Loon, Luc J C/0000-0002-6768-9231	European Union Seventh Framework Programme (FP7) [266408]	European Union Seventh Framework Programme (FP7)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 266408. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NN, 1981, METABOLISM, V30, P936, DOI 10.1016/0026-0495(81)90074-3; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Boirie Y, 1996, AM J PHYSIOL-ENDOC M, V271, pE1083, DOI 10.1152/ajpendo.1996.271.6.E1083; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dideriksen K, 2013, NUTRIENTS, V5, P852, DOI 10.3390/nu5030852; Fujita S, 2007, AM J PHYSIOL-ENDOC M, V292, pE77, DOI 10.1152/ajpendo.00173.2006; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; HEGSTED DM, 1976, J NUTR, V106, P307; Henderson GC, 2009, FASEB J, V23, P631, DOI 10.1096/fj.08-117200; HUSEK P, 1991, FEBS LETT, V280, P354, DOI 10.1016/0014-5793(91)80330-6; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; Koopman R, 2006, AM J CLIN NUTR, V84, P623, DOI 10.1093/ajcn/84.3.623; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; Martens EA, 2015, CLIN NUTR, V34, P968, DOI 10.1016/j.clnu.2014.10.007; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; MILLWARD DJ, 1991, P NUTR SOC, V50, P197, DOI 10.1079/PNS19910030; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Smith GI, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-11; Smith GI, 2009, J APPL PHYSIOL, V107, P1308, DOI 10.1152/japplphysiol.00348.2009; Soenen S, 2013, J NUTR, V143, P591, DOI 10.3945/jn.112.167593; Soenen S, 2010, PHYSIOL BEHAV, V101, P635, DOI 10.1016/j.physbeh.2010.09.014; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; van Loon LJC, 2011, NESTLE NUTR WORKS SE, V69, P79, DOI 10.1159/000329287; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wolfe R.R., 2005, ISOTOPE TRACERMETA, Vsecond; Wolfe RR, 2002, J NUTR, V132, p3219S, DOI 10.1093/jn/131.10.3219S; YOUNG V R, 1986, Journal of Nutrition, V116, P700; YOUNG VR, 1987, HUM NUTR-CLIN NUTR, V41C, P1	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137183	10.1371/journal.pone.0137183	http://dx.doi.org/10.1371/journal.pone.0137183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367529	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100055
J	Meier, ER; Byrnes, C; Weissman, M; Lee, YT; Miller, JL				Meier, Emily Riehm; Byrnes, Colleen; Weissman, Maxine; Lee, Y. Terry; Miller, Jeffery L.			Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia	PLOS ONE			English	Article							RED-BLOOD-CELLS; F-CELLS; ERYTHROPOIESIS; ERYTHROCYTES; EXPRESSION; SURVIVAL; DISEASE; RISK	Hemoglobin switching is largely complete in humans by six months of age. Among infants with sickle cell anemia (HbSS, SCA), reticulocytosis begins early in life as fetal hemoglobin (HbF) is replaced by sickle hemoglobin (HbS). The objective of this study was to determine if absolute reticulocyte count (ARC) is related to HbF levels in a cohort of pediatric SCA patients. A convenience sample of 106 children with SCA between the ages of 1 month and 20 years who were not receiving hydroxyurea or monthly blood transfusions were enrolled in this observational study. Hematologic data, including ARC and HbF levels, were measured at steady state. F-cells were enumerated by flow cytometry. Initial studies compared infants with ARC greater than or equal to 200 K/mu L (ARC >= 200) based upon the previously reported utility of this threshold as a predictive marker for SCA severity. Mean HbF and F-cell levels were significantly lower in the ARC >= 200 group when compared to the ARC < 200 group. Both HbF and F-cell percentages were negatively correlated to ARC in infants and in children between the ages of 1 and 9 years. However, the inverse relationship was lost after the age of 10 years. Overall, decreased expression and distribution of HbF during childhood SCA is well-correlated with increased reticulocyte production and release into the peripheral blood. As such, these data further support the clinical use of reticulocyte enumeration as a disease severity biomarker for childhood sickle cell anemia.	[Meier, Emily Riehm; Byrnes, Colleen; Lee, Y. Terry; Miller, Jeffery L.] NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Meier, Emily Riehm] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Weissman, Maxine] NIH, Dept Lab Med, Hematol Serv, Bethesda, MD 20892 USA; [Meier, Emily Riehm] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; National Institutes of Health (NIH) - USA; George Washington University	Miller, JL (corresponding author), NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NIH National Center for Advancing Translational Sciences [UL1TR000075, KL2TR000076]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075, KL2TR000076] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work. Dr. Meier is supported by Award Numbers UL1TR000075 and KL2TR000076 from the NIH National Center for Advancing Translational Sciences. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The authors have no conflicts of interest to disclose.	ALTER BP, 1976, BLOOD, V48, P843; Bhanu NV, 2004, BLOOD, V103, P1929, DOI 10.1182/blood-2003-05-1624; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CROUCH JY, 1985, ARCH PATHOL LAB MED, V109, P325; DOVER GJ, 1978, NEW ENGL J MED, V299, P1428, DOI 10.1056/NEJM197812282992603; Franco RS, 2006, BLOOD, V108, P1073, DOI 10.1182/blood-2005-09-008318; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Marcus SJ, 1997, AM J HEMATOL, V54, P40, DOI 10.1002/(SICI)1096-8652(199701)54:1<40::AID-AJH6>3.0.CO;2-4; Meier ER, 2014, AM J HEMATOL, V89, P904, DOI 10.1002/ajh.23777; Meier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070794; Meier ER, 2011, PEDIATR BLOOD CANCER, V56, P103, DOI 10.1002/pbc.22643; NAGEL RL, 1993, BLOOD, V81, P9; Navenot JM, 1998, CYTOMETRY, V32, P186, DOI 10.1002/(SICI)1097-0320(19980701)32:3<186::AID-CYTO4>3.3.CO;2-D; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Oneal PA, 2006, BLOOD, V108, P2081, DOI 10.1182/blood-2006-04-015859; PAPAYANNOPOULOU T, 1980, BRIT J HAEMATOL, V44, P535, DOI 10.1111/j.1365-2141.1980.tb08707.x; Perrine SP, 2008, PEDIATR ANN, V37, P339, DOI 10.3928/00904481-20080501-10; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; STAMATOYANNOPOULOS G, 1985, ANN NY ACAD SCI, V445, P188, DOI 10.1111/j.1749-6632.1985.tb17188.x	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136672	10.1371/journal.pone.0136672	http://dx.doi.org/10.1371/journal.pone.0136672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366562	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100020
J	Unlu, ES; Gordon, DM; Telli, M				Unlu, Ercan Selcuk; Gordon, Donna M.; Telli, Murat			Small RNA Sequencing Based Identification of MiRNAs in Daphnia magna	PLOS ONE			English	Article							GASTRIC-CANCER; PREDICTION; DISCOVERY; MICRORNA; GROWTH	Small RNA molecules are short, non-coding RNAs identified for their crucial role in post-transcriptional regulation. A well-studied example includes miRNAs (microRNAs) which have been identified in several model organisms including the freshwater flea and planktonic crustacean Daphnia. A model for epigenetic-based studies with an available genome database, the identification of miRNAs and their potential role in regulating Daphnia gene expression has only recently garnered interest. Computational-based work using Daphnia pulex, has indicated the existence of 45 miRNAs, 14 of which have been experimentally verified. To extend this study, we took a sequencing approach towards identifying miRNAs present in a small RNA library isolated from Daphnia magna. Using Perl codes designed for comparative genomic analysis, 815,699 reads were obtained from 4 million raw reads and run against a database file of known miRNA sequences. Using this approach, we have identified 205 putative mature miRNA sequences belonging to 188 distinct miRNA families. Data from this study provides critical information necessary to begin an investigation into a role for these transcripts in the epigenetic regulation of Daphnia magna.	[Unlu, Ercan Selcuk] Abant Izzet Baysal Univ, Fac Art & Sci, Dept Chem, Bolu, Turkey; [Gordon, Donna M.] Mississippi State Univ, Dept Biol Sci, Starkville, MS USA; [Telli, Murat] Abant Izzet Baysal Univ, Fac Art & Sci, Dept Biol, Bolu, Turkey	Abant Izzet Baysal University; Mississippi State University; Abant Izzet Baysal University	Telli, M (corresponding author), Abant Izzet Baysal Univ, Fac Art & Sci, Dept Biol, Bolu, Turkey.	tellim@ibu.edu.tr	Telli, Murat/U-3821-2019; Ünlü, Ercan Selçuk/AAG-8127-2019	Telli, Murat/0000-0001-5546-0379; Ünlü, Ercan Selçuk/0000-0003-0097-1125	Council of Higher Education of Turkey	Council of Higher Education of Turkey(Ministry of National Education - Turkey)	This work was supported by the Council of Higher Education of Turkey (http://www.yok.gov.tr/en/web/uluslararasi-iliskiler/anasayfa) to MT.	Alon S, 2015, BIOINFORMATICS, V31, P2568, DOI 10.1093/bioinformatics/btv187; Bai J, 2015, PROTEIN CELL, V6, P397, DOI 10.1007/s13238-015-0159-z; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Griffiths-Jones S, NUCLEIC ACIDS RES, V36, pD154, DOI [10.1093/nar/gkm952.2008, DOI 10.1093/NAR/GKM952.2008]; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kou YW, 2015, TUMOR BIOL, V36, P2249, DOI 10.1007/s13277-014-2832-x; Lampert W, 2006, POL J ECOL, V54, P607; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meester L, 1999, ECOLOGY EVOLUTION IN; Niu SY, 2016, MOL GENET GENOMICS, V291, P181, DOI 10.1007/s00438-015-1102-y; Orellana EA, 2015, CANCERS, V7, P1388, DOI 10.3390/cancers7030842; Price C, 2014, GENES DIS, V1, P53, DOI 10.1016/j.gendis.2014.06.004; Reynolds C., 2011, FRESHW REV, V4, P85, DOI [10.1608/FRJ-4.1.425, DOI 10.1608/FRJ-4.1.425]; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134899; Wang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133491; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Xiao L., 2014, ABSTR APPL ANAL, V1-8, DOI DOI 10.1371/J0URNAL.P0NE.0083708; Yoo JK, 2012, STEM CELLS DEV, V21, P2049, DOI 10.1089/scd.2011.0500; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137617	10.1371/journal.pone.0137617	http://dx.doi.org/10.1371/journal.pone.0137617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367422	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100096
J	Wei, K; Wang, LY; Zhang, CC; Wu, LY; Li, HL; Zhang, F; Cheng, H				Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao			Transcriptome Analysis Reveals Key Flavonoid 3 '-Hydroxylase and Flavonoid 3 ',5 '-Hydroxylase Genes in Affecting the Ratio of Dihydroxylated to Trihydroxylated Catechins in Camellia sinensis	PLOS ONE			English	Article							L. O.-KUNTZE; GREEN TEA; BIOSYNTHESIS; EXPRESSION; COLOR; DELPHINIDIN; CULTIVAR; PLANTS; SHADE	The ratio of dihydroxylated to trihydroxylated catechins (RDTC) is an important indicator of tea quality and biochemical marker for the study of genetic diversity. It is reported to be under genetic control but the underlying mechanism is not well understood. Flavonoid 3'-hydroxylase (F3'H) and flavonoid 3',5'-hydroxylase (F3'5'H) are key enzymes involved in the formation of dihydroxylated and trihydroxylated catechins. The transcriptome and HPLC analysis of tea samples from Longjing43 and Zhonghuang2 under control and shading treatment were performed to assess the F3'H and F3'5'H genes that might affect RDTC. A total of 74.7 million reads of mRNA seq (2x101bp) data were generated. After de novo assembly, 109,909 unigenes were obtained, and 39,982 of them were annotated using 7 public databases. Four key F3'H and F3'5'H genes (including CsF3'5'H1, CsF3'H1, CsF3'H2 and CsF3'H3) were identified to be closely correlated with RDTC. Shading treatment had little effect on RDTC, which was attributed to the stable expression of these key F3'H and F3'5'H genes. The correlation of the coexpression of four key genes and RDTC was further confirmed among 13 tea varieties by real time PCR and HPLC analysis. The coexpression of three F3'H genes and a F3'5'H gene may play a key role in affecting RDTC in Camellia sinensis. The current results may establish valuable foundation for further research about the mechanism controlling catechin composition in tea.	[Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao] Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou 310008, Zhejiang, Peoples R China; [Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao] Minist Agr, Key Lab Tea Plant Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Cheng, H (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, 9 Meiling South Rd, Hangzhou 310008, Zhejiang, Peoples R China.	chenghao@mail.tricaas.com			National Natural Science Foundation of China [31470396]; Natural Science Foundation of Zhejiang Province [LY14C020001]; Earmarked Fund for China Agriculture Research System [CARS-23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Earmarked Fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31470396), the Natural Science Foundation of Zhejiang Province (LY14C020001) and the Earmarked Fund for China Agriculture Research System (CARS-23). The Natural Science Foundation of Zhejiang Province (LY14C020001) and the Earmarked Fund for China Agriculture Research System (CARS-23) had roles in study design, data collection and analysis. The National Natural Science Foundation of China (31470396) had a role in preparation of the manuscript and publication.	Ashihara H, 2010, PHYTOCHEMISTRY, V71, P559, DOI 10.1016/j.phytochem.2010.01.010; Boase MR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-107; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chen L, 2012, PREP BIOCHEM BIOTECH, V42, P87, DOI 10.1080/10826068.2011.566297; Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; GERATS AM, 1992, PHENOLIC METABOLISM, P167; Guo Q, 1999, BBA-GEN SUBJECTS, V1427, P13, DOI 10.1016/S0304-4165(98)00168-8; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Jin JQ, 2014, J AGR FOOD CHEM, V62, P9436, DOI 10.1021/jf5024559; Katiyar SK, 1996, INT J ONCOL, V8, P221; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2; Nanjo F, 1999, BIOSCI BIOTECH BIOCH, V63, P1621, DOI 10.1271/bbb.63.1621; Owuor PO, 2007, FOOD CHEM, V100, P873, DOI 10.1016/j.foodchem.2005.10.030; Rani A, 2012, GENE, V495, P205, DOI 10.1016/j.gene.2011.12.029; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; SAIJO R, 1980, PLANT CELL PHYSIOL, V21, P989; Saravanan M, 2005, PHYTOCHEMISTRY, V66, P561, DOI 10.1016/j.phytochem.2004.06.024; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Tijburg LBM, 1997, CRIT REV FOOD SCI, V37, P771, DOI 10.1080/10408399709527802; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Wang YS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0347-7; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wei K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107201; Wei K, 2011, FOOD CHEM, V125, P44, DOI 10.1016/j.foodchem.2010.08.029; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Xiong LG, 2013, PLANT PHYSIOL BIOCH, V71, P132, DOI 10.1016/j.plaphy.2013.06.019; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515	39	34	36	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137925	10.1371/journal.pone.0137925	http://dx.doi.org/10.1371/journal.pone.0137925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367395	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100180
J	Yousefi, M; Ahmadi, M; Nourani, E; Behrooz, R; Rajabizadeh, M; Geniez, P; Kaboli, M				Yousefi, Masoud; Ahmadi, Mohsen; Nourani, Elham; Behrooz, Roozbeh; Rajabizadeh, Mehdi; Geniez, Philippe; Kaboli, Mohammad			Upward Altitudinal Shifts in Habitat Suitability of Mountain Vipers since the Last Glacial Maximum	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; CONSERVATION; DISTRIBUTIONS; VERTEBRATES; PREDICTION; AUSTRALIA; IMPACT; AREAS	We determined the effects of past and future climate changes on the distribution of the Montivipera raddei species complex (MRC) that contains rare and endangered viper species limited to Iran, Turkey and Armenia. We also investigated the current distribution of MRC to locate unidentified isolated populations as well as to evaluate the effectiveness of the current network of protected areas for their conservation. Present distribution of MRC was modeled based on ecological variables and model performance was evaluated by field visits. Some individuals at the newly identified populations showed uncommon morphological characteristics. The distribution map of MRC derived through modeling was then compared with the distribution of protected areas in the region. We estimated the effectiveness of the current protected area network to be 10%, which would be sufficient for conserving this group of species, provided adequate management policies and practices are employed. We further modeled the distribution of MRC in the past (21,000 years ago) and under two scenarios in the future (to 2070). These models indicated that climatic changes probably have been responsible for an upward shift in suitable habitats of MRC since the Last Glacial Maximum, leading to isolation of allopatric populations. Distribution will probably become much more restricted in the future as a result of the current rate of global warming. We conclude that climate change most likely played a major role in determining the distribution pattern of MRC, restricting allopatric populations to mountaintops due to habitat alterations. This long-term isolation has facilitated unique local adaptations among MRC populations, which requires further investigation. The suitable habitat patches identified through modeling constitute optimized solutions for inclusion in the network of protected areas in the region.	[Yousefi, Masoud; Ahmadi, Mohsen; Nourani, Elham; Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Environm Sci, Tehran, Iran; [Ahmadi, Mohsen] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran; [Nourani, Elham] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan; [Behrooz, Roozbeh; Geniez, Philippe] Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175,EPHE,Lab Biogeog & Ecol Vertebres, F-34293 Montpellier 5, France; [Rajabizadeh, Mehdi] Univ Ghent, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Rajabizadeh, Mehdi] Grad Univ Adv Technol, Inst Sci & High Technol & Environm Sci, Dept Biodivers, Kerman, Iran; [Rajabizadeh, Mehdi] Razi Univ, Fac Sci, Iranian Plateau Herpetol Res Grp IPHRG, Kermanshah, Iran	University of Tehran; Isfahan University of Technology; Nagasaki University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; Ghent University; Graduate University of Advanced Technology; Razi University	Kaboli, M (corresponding author), Univ Tehran, Fac Nat Resources, Dept Environm Sci, Tehran, Iran.	mkaboli@ut.ac.ir	Ahmadi, Mohsen/AAW-7357-2021; Yousefi, Masoud/L-4131-2019; Nourani, Elham/E-2623-2016; Ahmadi, Mohsen/J-7360-2017; Yousefi, Masoud/R-2895-2016	Ahmadi, Mohsen/0000-0002-9657-699X; Nourani, Elham/0000-0003-4420-3902; Ahmadi, Mohsen/0000-0002-9657-699X; Yousefi, Masoud/0000-0002-1465-4027				Ahmadi H., 2006, QUATERNARY FORMATION; Ahmadzadeh F, 2013, ZOOL ANZ, V252, P141, DOI 10.1016/j.jcz.2012.05.002; [Anonymous], 2004, K 1 COUPLED GCM MIRO; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Behruz R, 2009, 15 EUR C HERP KUS TU; Bergl RA, 2007, BIOL CONSERV, V134, P195, DOI 10.1016/j.biocon.2006.08.013; Boettger O, 1890, P ZOOL SOC LOND, V314, P424; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Chunco AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059853; Ehlers J, 2004, QUATERNARY GLACIAT 3; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gaston K.J., 1994, RARITY POPULATION CO, V13; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IONIA, 2009, GLOBC LAND COV; IUCN, 2013, IUCN RED LIST THREAT; Kian Najmeh, 2011, Herpetological Review, V42, P535; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Latifi M, 2000, SNAKES IRAN, V3rd; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lesbarreres D, 2009, HEREDITY, V102, P213, DOI 10.1038/hdy.2008.121; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Martinez-Freiria F, 2013, NATURWISSENSCHAFTEN, V100, P877, DOI 10.1007/s00114-013-1088-4; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; MERTENS ROBERT, 1967, SENCKENBERG BIOL, V48, P161; Meyneeke JO, 2004, ECOL MODEL, V174, P347, DOI 10.1016/j.ecolmodel.2003.07.012; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nagelkerke Kees, 2003, Levende Natuur, V104, P114; NILSON G, 1985, Amphibia-Reptilia, V6, P207, DOI 10.1163/156853885X00119; Nilson G., 2009, IUCN RED LIST THREAT; Nilson Goran, 1996, Symposia of the Zoological Society of London, V70, P31; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parra-Quijano M, 2012, BIODIVERS CONSERV, V21, P79, DOI 10.1007/s10531-011-0167-0; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rajabizadeh M, 2013, THESIS GHENT U GHENT; Rajabizadeh M, 2007, THESIS SHAHID BEHESH; Rajabizadeh Mehdi, 2011, Russian Journal of Herpetology, V18, P235; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rodder D, 2010, BIODIVERS CONSERV, V19, P2651, DOI 10.1007/s10531-010-9865-2; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ruddiman W.F., 2000, EARTHS CLIMATE FUTUR; Santos X, 2006, BIOL CONSERV, V130, P416, DOI 10.1016/j.biocon.2006.01.003; SCHNEIDER SH, 1998, STATUS TRENDS NATION, P89; Teixeira J, 2002, BIODIVERS CONSERV, V11, P2167, DOI 10.1023/A:1021342611769; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x	60	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138087	10.1371/journal.pone.0138087	http://dx.doi.org/10.1371/journal.pone.0138087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367126	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100220
J	Parente-Rocha, JA; Parente, AFA; Baeza, LC; Bonfim, SMRC; Hernandez, O; McEwen, JG; Bailao, AM; Taborda, CP; Borges, CL; Soares, CMD				Parente-Rocha, Juliana Alves; Alves Parente, Ana Flavia; Baeza, Lilian Cristiane; Rondon Caixeta Bonfim, Sheyla Maria; Hernandez, Orville; McEwen, Juan G.; Bailao, Alexandre Melo; Taborda, Carlos Pelleschi; Borges, Clayton Luiz; de Almeida Soares, Celia Maria			Macrophage Interaction with Paracoccidioides brasiliensis Yeast Cells Modulates Fungal Metabolism and Generates a Response to Oxidative Stress	PLOS ONE			English	Article							NITROSATIVE STRESS; NANOUPLC-MSE; GENE; MULTIPLICATION; ANTIOXIDANT; ACTIVATION; MECHANISMS; PHAGOCYTES; EXPRESSION; AUTOPHAGY	Macrophages are key players during Paracoccidioides brasiliensis infection. However, the relative contribution of the fungal response to counteracting macrophage activity remains poorly understood. In this work, we evaluated the P. brasiliensis proteomic response to macrophage internalization. A total of 308 differentially expressed proteins were detected in P. brasiliensis during infection. The positively regulated proteins included those involved in alternative carbon metabolism, such as enzymes involved in gluconeogenesis, beta-oxidation of fatty acids and amino acids catabolism. The down-regulated proteins during P. brasiliensis internalization in macrophages included those related to glycolysis and protein synthesis. Proteins involved in the oxidative stress response in P. brasiliensis yeast cells were also up-regulated during macrophage infection, including superoxide dismutases (SOD), thioredoxins (THX) and cytochrome c peroxidase (CCP). Antisense knockdown mutants evaluated the importance of CCP during macrophage infection. The results suggested that CCP is involved in a complex system of protection against oxidative stress and that gene silencing of this component of the antioxidant system diminished the survival of P. brasiliensis in macrophages and in a murine model of infection.	[Parente-Rocha, Juliana Alves; Alves Parente, Ana Flavia; Baeza, Lilian Cristiane; Rondon Caixeta Bonfim, Sheyla Maria; Bailao, Alexandre Melo; Borges, Clayton Luiz; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil; [Hernandez, Orville; McEwen, Juan G.] CIB, Unidad Biol Celular & Mol, Medellin, Colombia; [Hernandez, Orville] Univ Antioquia, Escuela Microbiol, Grp Invest MICROBA, Medellin, Colombia; [McEwen, Juan G.] Univ Antioquia, Fac Med, Medellin, Colombia; [Taborda, Carlos Pelleschi] Univ Sao Paulo, Lab Micol, Dept Microbiol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Alves Parente, Ana Flavia] Univ Fed Amazonas, Dept Ciencias Fisiol, Manaus, Amazonas, Brazil	Universidade Federal de Goias; Universidad de Antioquia; Universidad de Antioquia; Universidade de Sao Paulo; Universidade Federal de Amazonas	Soares, CMD (corresponding author), Lab Biol Mol, Campus Samambaia,S-N ICB2,Sala 206, BR-74690900 Goiania, Go, Brazil.		Taborda, Carlos Pelleschi/AAH-7031-2020; Parente-Rocha, Juliana/GNP-7393-2022; McEwen, Juan/AAG-6621-2021; Bailao, Alexandre Melo/H-1272-2013; Taborda, Carlos P/K-1660-2016; Baeza, Lilian Cristiane/F-2916-2018; BORGES, CLAYTON LUIZ/GQB-5595-2022	Bailao, Alexandre Melo/0000-0001-7754-4047; Taborda, Carlos P/0000-0001-9928-9809; Baeza, Lilian Cristiane/0000-0003-4119-9573; McEwen, Juan Guillermo/0000-0001-8594-9087	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa de Goias (FAPEG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work at Universidade Federal de Goias was funded by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa de Goias (FAPEG). LCB is a post-doctoral fellow from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; BRUMMER E, 1988, J IMMUNOL, V140, P2786; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1989, INFECT IMMUN, V57, P2289, DOI 10.1128/IAI.57.8.2289-2294.1989; BRUMMER E, 1988, INT J IMMUNOPHARMACO, V10, P945, DOI 10.1016/0192-0561(88)90041-0; Campos EG, 2005, GENET MOL RES, V4, P409; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrari CKB, 2011, ARCH IMMUNOL THER EX, V59, P441, DOI 10.1007/s00005-011-0144-z; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Khalfan WA, 2002, CURR OPIN CELL BIOL, V14, P468, DOI 10.1016/S0955-0674(02)00343-5; Lacaz C, 1994, PARACOCCIDIOIDOMYCOS, P1; Lima PD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002855; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; Martin DW, 2012, MICROBIOL-SGM, V158, P1767, DOI 10.1099/mic.0.059584-0; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matute DR, 2006, J CLIN MICROBIOL, V44, P2153, DOI 10.1128/JCM.02540-05; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, AM J TROP MED HYG, V36, P603, DOI 10.4269/ajtmh.1987.36.603; Menino Joao F, 2012, Methods Mol Biol, V845, P187, DOI 10.1007/978-1-61779-539-8_12; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Murad AM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-82; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Parente AFA, 2015, MICROBES INFECT, V17, P575, DOI 10.1016/j.micinf.2015.03.012; Sambrook J., 2001, MOL CLONING LAB MANU; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Schmidt M, 2013, MICROBIOL-SGM, V159, P2364, DOI 10.1099/mic.0.070516-0; Shi YY, 2013, J MED MICROBIOL, V62, P1226, DOI 10.1099/jmm.0.056903-0; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Xu LS, 2013, MOL PLANT MICROBE IN, V26, P431, DOI 10.1094/MPMI-07-12-0177-R	38	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137619	10.1371/journal.pone.0137619	http://dx.doi.org/10.1371/journal.pone.0137619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360774	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100057
J	Zhou, YY; Dong, HY; Zhong, YJ; Huang, J; Lv, JL; Li, JX				Zhou, Yanyan; Dong, Haiyun; Zhong, Yanjun; Huang, Jia; Lv, Jianlei; Li, Jinxiu			The Cold-Inducible RNA-Binding Protein (CIRP) Level in Peripheral Blood Predicts Sepsis Outcome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENE-EXPRESSION; APACHE-II; PROCALCITONIN; HYPOTHERMIA; LIVER	Objectives Sepsis is a lethal and complex clinical syndrome caused by infection or suspected infection. Cold-inducible RNA-binding protein (CIRP) is a widely distributed cold-shock protein that plays a proinflammatory role in sepsis and that may induce organ damage. However, clinical studies regarding the use of CIRP for the prognostic evaluation of sepsis are lacking. The purpose of this research was to investigate the prognostic significance of peripheral blood concentrations of CIRP in sepsis. Sepsis was assessed using several common measures, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) score; the Sepsis-related Organ Failure Assessment (SOFA) score; the lactate, serum creatinine, and procalcitonin (PCT) levels; the white blood cell (WBC) count; and the neutrophil ratio (N%). Design Sixty-nine adult patients with sepsis were enrolled in this study. According to the mortality data from the hospital, 38 patients were survivors, and 31 were nonsurvivors. The plasma levels of the biomarkers were measured and the APACHE II and SOFA scores were calculated within 24 hours of patient enrollment into our study. The CIRP level was measured via ELISA. Results The plasma level of CIRP was significantly higher in the nonsurvivors than in the survivors (median (IQR) 4.99 (2.37-30.17) ng/mL and 1.68 (1.41-13.90) ng/mL, respectively; p = 0.013). The correlations of the CIRP level with the APACHE II score (r = 0.248, p = 0.040, n = 69), the SOFA score (r = 0.323, p = 0.007, n = 69), the serum creatinine level (r = 0.316, p = 0.008, n = 69), and the PCT level (r = 0.282, p = 0.019, n = 69) were significant. Receiver operator characteristic (ROC) curve analysis showed that the area under the ROC curve (AUC) for the CIRP level was 0.674 (p = 0.013). According to Cox proportional hazards models, the CIRP level independently predicts sepsis mortality. When the CIRP level in the peripheral blood increased by 10 ng/mL, the mortality risk increased by 1.05-fold (p = 0.012). Thus, the CIRP level reflects the degree of renal injury but does not predict the severity of sepsis or organ damage. Conclusion An elevated plasma concentration of CIRP was significantly associated with poor prognosis among patients with sepsis. Therefore, CIRP is a potential predictor of sepsis prognosis.	[Zhou, Yanyan; Dong, Haiyun; Zhong, Yanjun; Huang, Jia; Lv, Jianlei; Li, Jinxiu] Cent South Univ, Xiangya Hosp 2, Intens Care Unit, Changsha, Hunan, Peoples R China	Central South University	Li, JX (corresponding author), Cent South Univ, Xiangya Hosp 2, Intens Care Unit, Changsha, Hunan, Peoples R China.	LJX669025@163.com						Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; Brochu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057426; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cheng B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846935; Das U, 2014, ARCH MED SCI, V10, P325, DOI 10.5114/aoms.2014.42586; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Godwin A, 2015, SHOCK, V43, P24, DOI 10.1097/SHK.0000000000000251; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Jiang D, 2014, MOL BIOL REP, V41, P1015, DOI 10.1007/s11033-013-2946-z; Jiang L, 2015, J INT MED RES, V43, P188, DOI 10.1177/0300060514561136; Kim H, 2014, CLIN LAB, V60, P2015, DOI 10.7754/Clin.Lab.2014.140528; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Na YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118203; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pop-Began V, 2014, J Med Life, V7 Spec No. 2, P38; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Sakurai T, 2015, CANCER SCI, V106, P352, DOI 10.1111/cas.12611; Sakurai T, 2014, CANCER RES, V74, P6119, DOI 10.1158/0008-5472.CAN-14-0471; Sakurai T, 2013, DIGEST DIS, V31, P440, DOI 10.1159/000355242; Tang C, 2015, CELL BIOL INT, V39, P678, DOI 10.1002/cbin.10438; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Umberger R, 2015, DIMENS CRIT CARE NUR, V34, P100, DOI 10.1097/DCC.0000000000000098; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Xia ZP, 2012, ASIAN J ANDROL, V14, P884, DOI 10.1038/aja.2012.71; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	32	47	49	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137721	10.1371/journal.pone.0137721	http://dx.doi.org/10.1371/journal.pone.0137721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361390	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100074
J	Gutierrez-Exposito, C; Ramirez, F; Afan, I; Forero, MG; Hobson, KA				Gutierrez-Exposito, Carlos; Ramirez, Francisco; Afan, Isabel; Forero, Manuela G.; Hobson, Keith A.			Toward a Deuterium Feather Isoscape for Sub-Saharan Africa: Progress, Challenges and the Path Ahead	PLOS ONE			English	Article							STABLE HYDROGEN; MIGRATORY CONNECTIVITY; ISOTOPES; PRECIPITATION; TECHNOLOGY; ORIGINS; BIRDS	A key challenge to the application of continent-wide feather isoscapes for geographic assignment of migrant birds is the lack of ground-truthed samples. This is especially true for long-distance Palearctic-Afrotropical migrants. We used spatially-explicit information on the delta H-2 composition of archived feathers from Green-backed/Grey-backed Camaroptera, to create a feather delta H-2 isoscape for sub-Saharan Africa. We sampled from 34 out of 41 sub-Saharan countries, totaling 205 sampling localities. Feather samples were obtained from museum collections (n = 224, from 1950 to 2014) for delta H-2 assay. Region, altitude, annual rainfall and seasonal patterns in precipitation were revealed as relevant explanatory variables for spatial patterns in feather delta H-2. Predicted feather delta H-2 values ranged from -4.0% to -63.3%, with higher values observed in the Great Rift Valley and South Africa, and lower values in central Africa. Our feather isoscape differed fromthat modelled previously using a precipitation delta H-2 isoscape and an assumed feather-to-precipitation calibration, but the relatively low model goodness fit (F-10,F-213 = 5.98, p< 0.001, R-2 = 0.18) suggests that other, non-controlled variables might be driving observed geographic patterns in feather delta H-2 values. Additional ground-truthing studies are therefore recommended to improve the accuracy of the African feather delta H-2 isoscape.	[Gutierrez-Exposito, Carlos; Ramirez, Francisco; Forero, Manuela G.] Estac Biol Donana CSIC, Dept Biol Conservac, Seville, Spain; [Afan, Isabel] Estac Biol Donana CSIC, Lab SIG & Teledetecc LAST EBD, Seville, Spain; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Environment & Climate Change Canada	Gutierrez-Exposito, C (corresponding author), Estac Biol Donana CSIC, Dept Biol Conservac, Seville, Spain.	carlines@ebd.csic.es	Hobson, Keith/Q-9306-2019; Gutiérrez-Expósito, Carlos/H-3478-2016; Afán, Isabel/F-4783-2015; Ramírez, Francisco/I-3553-2014	Gutiérrez-Expósito, Carlos/0000-0002-2907-7998; Afán, Isabel/0000-0003-3874-0461; Ramírez, Francisco/0000-0001-9670-486X	National Science and Engineering Council of Canada (NSERC) [103367]; Environment Canada; Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RDI [SEV-2012-0262]	National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RDI	Support was provided by a National Science and Engineering Council of Canada (NSERC) grant 103367 to CGE and an Environment Canada operating grant to KAH. Sampling costs were supported by the Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in R&D&I (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DA, 1939, BIRDS TROPICAL W AFR; Barton K., 2014, MUMIN MULTIMODEL INF; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bridge ES, 2014, ECOL INDIC, V45, P266, DOI 10.1016/j.ecolind.2014.04.027; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Clark I., 1997, ENV ISOTOPES HYDROGE; CRAIG AJFK, 1983, OSTRICH, V54, P220, DOI 10.1080/00306525.1983.9634475; del Hoyo J, 2006, HDB BIRDS WORLD VOL, V11; FOGDEN MPL, 1979, J ZOOL, V189, P233; Gelman A., 2014, ARM DATA ANAL USING; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hallworth MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep11069; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson Keith A., 2013, Animal Migration, V1, P8, DOI 10.2478/ami-2012-0002; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045005; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P167, DOI 10.1016/j.gexplo.2009.02.007; IAEA/WMO, 2014, GNIP DAT; International Atomic Energy Agency (IAEA), 1992, IAEA TECHN REP SER, V331; Lobo JM, 2007, EUROPEAN DISTRIBUTED; Mackworth-Praed CW, 1960, AFRICA HDB BIRDS 1, V2; Mazerolle DF, 2005, OECOLOGIA, V144, P541, DOI 10.1007/s00442-005-0031-6; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; PAYNE RB, 1969, CONDOR, V71, P140, DOI 10.2307/1366075; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Prochazka P, 2013, J AVIAN BIOL, V44, P541, DOI 10.1111/j.1600-048X.2013.00185.x; Reichlin TS, 2013, OECOLOGIA, V171, P591, DOI 10.1007/s00442-012-2418-5; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P1; Urban EK, 1997, BIRDS AFRICA, V5; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Walsh R. P. D., 1981, Weather, V36, P201, DOI 10.1002/j.1477-8696.1981.tb05400.x; Wassenaar L. I., 2003, ISOT ENVIRON HEALT S, V39, P1; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12	47	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135938	10.1371/journal.pone.0135938	http://dx.doi.org/10.1371/journal.pone.0135938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356677	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800008
J	Hauquier, F; Suja, LD; Gutt, J; Veit-Kohler, G; Vanreusel, A				Hauquier, Freija; Suja, Laura Duran; Gutt, Julian; Veit-Koehler, Gritta; Vanreusel, Ann			Different Oceanographic Regimes in the Vicinity of the Antarctic Peninsula Reflected in Benthic Nematode Communities	PLOS ONE			English	Article							NATIONAL-PARK BERCHTESGADEN; OLIGOTROPHIC LAKE KONIGSSEE; SOUTH SHETLAND ISLANDS; DEEP-SEA NEMATODES; CLIMATE-CHANGE; MEIOFAUNA DISTRIBUTION; MARINE NEMATODES; ABYSSAL-PLAIN; DRAKE PASSAGE; SHELF WATERS	Marine free-living nematode communities were studied at similar depths (similar to 500 m) at two sides of the Antarctic Peninsula, characterised by different environmental and oceanographic conditions. At the Weddell Sea side, benthic communities are influenced by cold deep-water formation and seasonal sea-ice conditions, whereas the Drake Passage side experiences milder oceanic conditions and strong dynamics of the Antarctic Circumpolar Current. This resulted in different surface primary productivity, which contrasted with observed benthic pigment patterns and varied according to the area studied: chlorophyll a concentrations (as a proxy for primary production) were high in the Weddell Sea sediments, but low in the surface waters above; this pattern was reversed in the Drake Passage. Differences between areas were largely mirrored by the nematode communities: nematode densities peaked in Weddell stations and showed deeper vertical occurrence in the sediment, associated with deeper penetration of chlorophyll a and indicative of a strong benthopelagic coupling. Generic composition showed some similarities across both areas, though differences in the relative contribution of certain genera were noted, together with distinct community shifts with depth in the sediment at all locations.	[Hauquier, Freija; Suja, Laura Duran; Vanreusel, Ann] Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Gutt, Julian] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Veit-Koehler, Gritta] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany	Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Hauquier, F (corresponding author), Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium.	freija.hauquier@ugent.be		Hauquier, Freija/0000-0002-6606-2162; Gutt, Julian/0000-0003-3773-9370	Research Foundation of Flanders [FWO11/ASP/256]; Belgian Science Policy (BELSPO/BRAIN) [BR/132/A1/vERSO]	Research Foundation of Flanders(FWO); Belgian Science Policy (BELSPO/BRAIN)	FH is a fellow with the Research Foundation of Flanders (no.FWO11/ASP/256; http://www.fwo.be/en/). The presented work contributes to project no. BR/132/A1/vERSO of the Belgian Science Policy (BELSPO/BRAIN; http://www.belspo.be/belspo/index_en.stm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan EL, 2013, ECOL EVOL, V3, P2994, DOI 10.1002/ece3.678; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arntz WE, 2005, SCI MAR, V69, P237, DOI 10.3989/scimar.2005.69s2237; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Bain O, 2014, HDB ZOOLOGY; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Barker PF, 2001, EARTH-SCI REV, V55, P1, DOI 10.1016/S0012-8252(01)00055-1; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; BATHMANN UV, 1991, DEEP-SEA RES, V38, P1341, DOI 10.1016/0198-0149(91)90031-A; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; Mendes CRB, 2013, POLAR BIOL, V36, P537, DOI 10.1007/s00300-012-1282-4; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; BRANDT A, 1993, POLAR BIOL, V13, P565; BRANDT A, 1995, MAR ECOL PROG SER, V121, P39, DOI 10.3354/meps121039; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Crame JA, 1999, SCI MAR, V63, P1; Damerau M, 2012, POLAR BIOL, V35, P1073, DOI 10.1007/s00300-012-1155-x; Danovaro R, 2013, DEEP-SEA RES PT II, V92, P97, DOI 10.1016/j.dsr2.2013.03.035; Dayton P.K., 1990, P631; De Grisse A.T., 1969, MEDEDELINGEN RIJKSFA, V34, P351, DOI DOI 10.1163/156854199508559; de Skowronski RSP, 2002, POLAR BIOL, V25, P126, DOI 10.1007/s003000100320; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Fabiano M, 1999, POLAR BIOL, V22, P115, DOI 10.1007/s003000050398; Figuerola B, 2014, J SEA RES, V85, P1, DOI 10.1016/j.seares.2013.09.003; Galeron J, 2001, PROG OCEANOGR, V50, P303, DOI 10.1016/S0079-6611(01)00059-3; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Glover AG, 2008, DEEP-SEA RES PT II, V55, P2491, DOI 10.1016/j.dsr2.2008.06.008; Gordon AL, 2001, J GEOPHYS RES-OCEANS, V106, P9005, DOI 10.1029/2000JC000281; Gorley C.K., 2006, GETTING STARTED PRIM; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Guilini K, 2013, PROG OCEANOGR, V110, P80, DOI 10.1016/j.pocean.2013.01.002; Guilini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018912; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Gutt Julian, 2013, Berichte zur Polar- und Meeresforschung, V665, P3; Hauquier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022240; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip C., 1982, Helminthologia (Bratislava), V51, P1; Heip Carlo H. R., 1998, Oceanis, V24, P61; HERMAN RL, 1992, POLAR BIOL, V12, P313; Higgins R.P., 1988, P1; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; Ingels J, 2012, ECOL EVOL, V2, P453, DOI 10.1002/ece3.96; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JENSEN P, 1988, DEEP-SEA RES, V35, P1173, DOI 10.1016/0198-0149(88)90008-8; JENSEN P, 1987, MAR ECOL PROG SER, V35, P187, DOI 10.3354/meps035187; Jiang MS, 2013, DEEP-SEA RES PT II, V90, P15, DOI 10.1016/j.dsr2.2013.02.029; JUMARS PA, 1984, AM ZOOL, V24, P45; Kang SH, 2001, J PLANKTON RES, V23, P333, DOI 10.1093/plankt/23.4.333; Knefelkamp B, 2007, J EXP MAR BIOL ECOL, V345, P61, DOI 10.1016/j.jembe.2007.01.008; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lins L, 2014, DEEP-SEA RES PT II, V108, P60, DOI 10.1016/j.dsr2.2014.05.003; Lins L, 2015, PROG OCEANOGR, V134, P356, DOI 10.1016/j.pocean.2015.03.006; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Lochte K, 1997, DEEP-SEA RES PT II, V44, P321, DOI 10.1016/S0967-0645(96)00081-1; Lockhart SJ, 2008, CCAMLR SCI, V15, P167; Maar M, 2011, J MARINE SYST, V85, P57, DOI 10.1016/j.jmarsys.2010.11.006; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Moens T, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P105, DOI 10.1079/9780851990095.0105; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Pennak RW, 1988, ECOLOGY FRESHWATER M, P39; Piepenburg D, 2002, POLAR BIOL, V25, P146, DOI 10.1007/s003000100322; Platt H.M., 1980, Systematics Association Special Volume Series, P729; Platt HM, 1983, NEW SERIES SYNOPSES, V28, P307; Platt HM, 1998, SYNOPSES BRIT FAUNA, V38; Portnova D, 2011, MAR ECOL-EVOL PERSP, V32, P24, DOI 10.1111/j.1439-0485.2010.00403.x; Prezelin BB, 2004, J MAR RES, V62, P419, DOI 10.1357/0022240041446173; R Core Team, 2021, R LANGUAGE ENV STAT; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; Sane E, 2011, J SEA RES, V65, P94, DOI 10.1016/j.seares.2010.07.005; SanVicente CS, 1997, POLAR BIOL, V18, P415; Schratzberger M, 2006, J SEA RES, V55, P113, DOI 10.1016/j.seares.2005.07.002; Schroder M, 2002, DEEP-SEA RES PT II, V49, P4767, DOI 10.1016/S0967-0645(02)00158-3; Sebastian S, 2007, DEEP-SEA RES PT II, V54, P1727, DOI 10.1016/j.dsr2.2007.07.004; Sharma J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014491, DOI 10.1371/journal.pone.0014491]; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith WO, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004251; SMITH WO, 1986, BIOSCIENCE, V36, P251, DOI 10.2307/1310215; Suzuki H, 2001, POLAR BIOL, V24, P697, DOI 10.1007/s003000100271; Thomson MRA, 2004, DEEP-SEA RES PT II, V51, P1467, DOI 10.1016/j.dsr2.2004.06.021; Traunspurger W, 1996, ARCH HYDROBIOL, V135, P393; Traunspurger W, 1996, ARCH HYDROBIOL, V135, P557; Traunspurger Walter, 1992, Spixiana, V15, P233; Van Gaever S, 2004, J MAR BIOL ASSOC UK, V84, P547, DOI 10.1017/S0025315404009555h; Vanaverbeke J, 2014, NEMYS WORLD DATABASE; Vanhove S, 1999, MAR ECOL PROG SER, V181, P237, DOI 10.3354/meps181237; Vanhove S, 2004, DEEP-SEA RES PT II, V51, P1665, DOI 10.1016/j.dsr2.2004.06.029; VANHOVE S, 1995, MAR ECOL PROG SER, V127, P65, DOI 10.3354/meps127065; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Veit-Kohler G, 2011, DEEP-SEA RES PT II, V58, P1983, DOI 10.1016/j.dsr2.2011.05.008; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; VIDEAU C, 1994, J MARINE SYST, V5, P235, DOI 10.1016/0924-7963(94)90049-3; Vincx Magda, 1996, P187; VITIELLO P, 1974, ANN I OCEANOGR PARIS, V50, P145; Watson AJ, 2013, NATURE, V501, P408, DOI 10.1038/nature12432; WEBB DG, 1993, J EXP MAR BIOL ECOL, V166, P151, DOI 10.1016/0022-0981(93)90215-A; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wing SR, 2012, ECOLOGY, V93, P314, DOI 10.1890/11-0996.1; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7; Zhou M, 2010, DEEP-SEA RES PT I, V57, P1039, DOI 10.1016/j.dsr.2010.05.012	124	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137527	10.1371/journal.pone.0137527	http://dx.doi.org/10.1371/journal.pone.0137527			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355457	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800056
J	Kelly, H; Downing, T; Tuite, NL; Smith, TJ; Kerin, MJ; Dwyer, RM; Clancy, E; Barry, T; Reddington, K				Kelly, Helena; Downing, Tim; Tuite, Nina L.; Smith, Terry J.; Kerin, Michael J.; Dwyer, Rolsin M.; Clancy, Eoin; Barry, Thomas; Reddington, Kate			Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs	PLOS ONE			English	Article							GENE-EXPRESSION; NORMALIZATION METHODS; MICRORNA EXPRESSION; QUANTITATIVE PCR; DOWN-REGULATION; QUALITY-CONTROL; RNA; CANCER; BIOMARKERS; BLOOD	Introduction Micro RNAs (miRNAs) are a class of highly conserved small non-coding RNAs that play an important part in the post-transcriptional regulation of gene expression. A substantial number of miRNAs have been proposed as biomarkers for diseases. While reverse transcriptase Real-time PCR (RT-qPCR) is considered the gold standard for the evaluation and validation of miRNA biomarkers, small RNA sequencing is now routinely being adopted for the identification of dysregulated miRNAs. However, in many cases where putative miRNA biomarkers are identified using small RNA sequencing, they are not substantiated when RT-qPCR is used for validation. To date, there is a lack of consensus regarding optimal methodologies for miRNA detection, quantification and standardisation when different platform technologies are used. Materials and Methods In this study we present an experimental pipeline that takes into consideration sample collection, processing, enrichment, and the subsequent comparative analysis of circulating small ribonucleic acids using small RNA sequencing and RT-qPCR. Results, Discussion, Conclusions Initially, a panel of miRNAs dysregulated in circulating blood from breast cancer patients compared to healthy women were identified using small RNA sequencing. MiR-320a was identified as the most dysregulated miRNA between the two female cohorts. Total RNA and enriched small RNA populations (<30 bp) isolated from peripheral blood from the same female cohort samples were then tested for using a miR-320a RT-qPCR assay. When total RNA was analysed with this miR-320a RT-qPCR assay, a 2.3-fold decrease in expression levels was observed between blood samples from healthy controls and breast cancer patients. However, upon enrichment for the small RNA population and subsequent analysis of miR-320a using RT-qPCR, its dysregulation in breast cancer patients was more pronounced with an 8.89-fold decrease in miR-320a expression. We propose that the experimental pipeline outlined could serve as a robust approach for the identification and validation of small RNA biomarkers for disease.	[Kelly, Helena; Tuite, Nina L.; Barry, Thomas; Reddington, Kate] Natl Univ Ireland, NADRL, Microbiol, Sch Nat Sci, Galway, Ireland; [Downing, Tim] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Smith, Terry J.; Clancy, Eoin] Natl Univ Ireland, Sch Nat Sci, MDRG, Galway, Ireland; [Smith, Terry J.; Clancy, Eoin] Natl Univ Ireland, Biomed Diagnost Inst BDI Programme, Galway, Ireland; [Kerin, Michael J.; Dwyer, Rolsin M.] Natl Univ Ireland Galway, Discipline Surg, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Dublin City University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Barry, T (corresponding author), Natl Univ Ireland, NADRL, Microbiol, Sch Nat Sci, Galway, Ireland.	Thomas.barry@nuigalway.ie	Dwyer, Roisin M/C-6654-2013; Reddington, Kate/J-7868-2015	Dwyer, Roisin M/0000-0002-5854-0339; Downing, Tim/0000-0002-8385-6730; Smith, Terry/0000-0002-4956-3299; Kerin, Michael/0000-0003-4164-5561; Reddington, Kate/0000-0002-9559-5638	Science Foundation Ireland [10/CE/B1821]; Breast Cancer Research; European Union's Seventh Programme for research, technological development and demonstration	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Breast Cancer Research; European Union's Seventh Programme for research, technological development and demonstration	EC and TS have been supported during the time this work was carried out by Science Foundation Ireland under Grant No. 10/CE/B1821. MJK and RMD are supported by Breast Cancer Research. NLT, TB, and KR are supported under European Union's Seventh Programme for research, technological development and demonstration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng C, 2014, TUMOR BIOL, V35, P4177, DOI 10.1007/s13277-013-1546-9; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Chevillet JR, 2014, MOLECULES, V19, P6080, DOI 10.3390/molecules19056080; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hicks S. C., 2014, USE QUANTILE NORMALI, P12203; Huang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085201; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Kim JH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-76; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kratz A, 2014, NAT BIOTECHNOL, V32, P882, DOI 10.1038/nbt.3015; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Q, 2014, ONCOGENE, V33, P2589, DOI 10.1038/onc.2013.226; Li W, 2009, ANAL BIOANAL CHEM, V394, P1117, DOI 10.1007/s00216-008-2570-2; Lopez JP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0109-x; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Luo HE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0527-7; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Meyer M., 2010, COLD SPRING HARB PRO; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pieter M, 2014, NATURE METHODS; Redshaw N, 2013, BIOTECHNIQUES, V54, P155, DOI 10.2144/000114002; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth C, 2011, MOL ONCOL, V5, P281, DOI 10.1016/j.molonc.2011.02.002; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shang C, 2014, MOL BIOL REP, V41, P2521, DOI 10.1007/s11033-014-3110-0; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Silahtaroglu A, 2010, ESSAYS BIOCHEM, V48, P165, DOI [10.1042/BSE0480165, 10.1042/bse0480165]; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Svec D, 2015, BIOMOLECULAR DETECTI; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Yang HP, 2014, ONCOL LETT, V8, P1043, DOI 10.3892/ol.2014.2298; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Yuan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073604; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1; Zhao H, 2013, CARCINOGENESIS; Zhou XB, 2013, RNA, V19, P733, DOI 10.1261/rna.037895.112	79	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137389	10.1371/journal.pone.0137389	http://dx.doi.org/10.1371/journal.pone.0137389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355751	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000360965800044
J	Konrath, S; Falk, E; Fuhrel-Forbis, A; Liu, M; Swain, J; Tolman, R; Cunningham, R; Walton, M				Konrath, Sara; Falk, Emily; Fuhrel-Forbis, Andrea; Liu, Mary; Swain, James; Tolman, Richard; Cunningham, Rebecca; Walton, Maureen			Can Text Messages Increase Empathy and Prosocial Behavior? The Development and Initial Validation of Text to Connect	PLOS ONE			English	Article							SOCIAL DESIRABILITY BIAS; PERSPECTIVE-TAKING; GENDER-DIFFERENCES; CHILDRENS EMPATHY; THERAPIST EMPATHY; COLLEGE-STUDENTS; SELF-ESTEEM; MEDIA USE; INTERVENTIONS; COMMUNICATION	To what extent can simple mental exercises cause shifts in empathic habits? Can we use mobile technology to make people more empathic? It may depend on how empathy is measured. Scholars have identified a number of different facets and correlates of empathy. This study is among the first to take a comprehensive, multidimensional approach to empathy to determine how empathy training could affect these different facets and correlates. In doing so, we can learn more about empathy and its multifaceted nature. Participants (N = 90) were randomly assigned to receive either an empathy-building text message program (Text to Connect) or one of two control conditions (active versus passive). Respondents completed measures of dispositional empathy (i.e. self-perceptions of being an empathic person), affective empathy (i.e. motivations to help, immediate feelings of empathic concern), and prosocial behavior (i.e. self-reports and observer-reports) at baseline, and then again after the 14 day intervention period. We found that empathy-building messages increased affective indicators of empathy and prosocial behaviors, but actually decreased self-perceptions of empathy, relative to control messages. Although the brief text messaging intervention did not consistently impact empathy-related personality traits, it holds promise for the use of mobile technology for changing empathic motivations and behaviors.	[Konrath, Sara] Indiana Univ, Lilly Family Sch Philanthropy, Indianapolis, IN 46204 USA; [Konrath, Sara; Fuhrel-Forbis, Andrea; Liu, Mary] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Konrath, Sara] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Falk, Emily] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA; [Swain, James; Walton, Maureen] Univ Michigan, Dept Psychiat, Psychol, Ann Arbor, MI 48109 USA; [Swain, James; Walton, Maureen] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Tolman, Richard] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA; [Cunningham, Rebecca] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Cunningham, Rebecca; Walton, Maureen] Univ Michigan, Injury Ctr, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; University of Rochester; University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Konrath, S (corresponding author), Indiana Univ, Lilly Family Sch Philanthropy, Indianapolis, IN 46204 USA.	skonrath@iupui.edu	Tolman, Richard/AAD-6395-2020; Swain, James/S-2468-2019	Swain, James/0000-0001-8440-0658; Konrath, Sara/0000-0001-9182-0095	Psychology of Character at Wake Forest University; John Templeton Foundation [47993, 57942]; Office of the Vice-President for Research at the University of Michigan; National Institutes of Health [NIH-1 DP2 DA035156-01]; Open Access Publishing Fund at Indiana University-Purdue University, Indianapolis	Psychology of Character at Wake Forest University; John Templeton Foundation; Office of the Vice-President for Research at the University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Publishing Fund at Indiana University-Purdue University, Indianapolis	This project was supported by grants from the Psychology of Character at Wake Forest University (to SK and AFF: http://www.thecharacterproject.com), from the John Templeton Foundation (to SK and RT: http://www.templeton.org), via grants #47993 and 57942, from the Office of the Vice-President for Research at the University of Michigan (to SK: http://research.umich.edu/ovpr), and from the National Institutes of Health (to EF: grant#NIH-1 DP2 DA035156-01). We also thank the Open Access Publishing Fund at Indiana University-Purdue University, Indianapolis, for support with publication charges (to SK: http://www2.ulib.iupui.edu/digitalscholarship/oafund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2012, EFFECT MOBILE UNPUB; BARAK A, 1987, SIMULAT GAMING, V18, P458, DOI 10.1177/0037550087184002; Barkai J.L., 1983, SW U LAW REV, V13, P505; BARNETT MA, 1984, J GENET PSYCHOL, V145, P241; BARNETT MA, 1982, CHILD DEV, V53, P920, DOI 10.2307/1129128; BARTAL D, 1979, CHILD DEV, V50, P1235, DOI 10.2307/1129357; Batson C.D., 2011, ALTRUISM HUMANS; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; Batson CD, 1999, EUR J SOC PSYCHOL, V29, P909, DOI 10.1002/(SICI)1099-0992(199911)29:7<909::AID-EJSP965>3.0.CO;2-L; BATSON CD, 1989, J PERS SOC PSYCHOL, V56, P922, DOI 10.1037/0022-3514.56.6.922; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borman WC, 2001, INT J SELECT ASSESS, V9, P52, DOI 10.1111/1468-2389.00163; Brehm SS, 1981, CHILD STUDY J; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.1111/j.1467-8624.1982.tb01331.x; Campbell SW, 2008, SOCIOL COMPASS, V2, P371, DOI 10.1111/j.1751-9020.2007.00080.x; Clary EG, 1998, J PERS SOC PSYCHOL, V74, P1516, DOI 10.1037/0022-3514.74.6.1516; Clary EG, 1999, CURR DIR PSYCHOL SCI, V8, P156, DOI 10.1111/1467-8721.00037; Cocotas A, 2013, BUSINESS INSIDER; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Coyne SM, 2011, FAM RELAT, V60, P150, DOI 10.1111/j.1741-3729.2010.00639.x; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; Davis M, 1997, EMPATHIC ACCURACY; DAVIS MH, 1994, J PERS, V62, P369, DOI 10.1111/j.1467-6494.1994.tb00302.x; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1991, J RES PERS, V25, P70, DOI 10.1016/0092-6566(91)90006-C; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2015, CURR OPIN BEHAV SCI, V3, P1, DOI 10.1016/j.cobeha.2014.12.001; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Dey AK, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P163; Dutton JE, 2014, ANN REV ORG IN PRESS; EISENBERG N, 1995, CHILD DEV, V66, P1179, DOI 10.1111/j.1467-8624.1995.tb00930.x; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; EISENBERG N, 1987, DEV PSYCHOL, V23, P712, DOI 10.1037/0012-1649.23.5.712; Eisenberg N, 1999, CHILD DEV, V70, P1360, DOI 10.1111/1467-8624.00100; Ellison N, 2011, NEW MEDIA SOC; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Empathy Feshbach N., 1984, EMPATHY EMPATHY TRAI, P192; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P683; Faulkner X, 2005, INTERACT COMPUT, V17, P167, DOI 10.1016/j.intcom.2004.11.002; Feshbach ND, 2001, PREVENTION AND CONTROL OF AGGRESSION AND THE IMPACT ON ITS VICTIMS, P355; Fiordelli M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2430; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Goldstein TR, 2012, J COGN DEV, V13, P19, DOI 10.1080/15248372.2011.573514; Grossmann K, 2002, SOC DEV, V11, P307; Gruhn D, 2008, EMOTION, V8, P753, DOI 10.1037/a0014123; Hatcher SL, 1994, ADOLESCENCE; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Hepper EG, 2014, PERS SOC PSYCHOL B, V40, P1079, DOI 10.1177/0146167214535812; Herbert L, 2013, DIABETES TECHNOL THE, V15, P362, DOI 10.1089/dia.2012.0291; Ho SS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00152; Hodges S. D., 1997, EMPATHIC ACCURACY, P311; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huesmann LR, 1997, J PERS SOC PSYCHOL, V72, P408, DOI 10.1037/0022-3514.72.2.408; Ickes W, 2007, BLACKWELL HDB SOCIAL, P229, DOI [10.1002/9780470998557.ch9, DOI 10.1002/9780470998557.CH9]; Ickes W.J., 1997, EMPATHIC ACCURACY; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Jolliffe D, 2004, AGGRESS VIOLENT BEH, V9, P441, DOI 10.1016/j.avb.2003.03.001; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; Klein KJK, 2001, PERS SOC PSYCHOL B, V27, P720, DOI 10.1177/0146167201276007; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; KOESTNER R, 1990, J PERS SOC PSYCHOL, V58, P709, DOI 10.1037/0022-3514.58.4.709; Kohn A, 1991, CARING KIDS ROLE SCH; Konrath S., 2012, HDB RES TECHNOSELF I, P30, DOI DOI 10.4018/978-1-4666-2211-1.CH012; Konrath S, 2014, PERSONALITY IN PRESS; Konrath S., 2014, ENCY MOBILE IN PRESS; Konrath S, 2012, HEALTH PSYCHOL, V31, P87, DOI 10.1037/a0025226; Konrath SH, 2011, PERS SOC PSYCHOL REV, V15, P180, DOI 10.1177/1088868310377395; Konrath Sara H., 2012, HDB HLTH SOCIAL RELA; Kremer JF, 1991, J COLL STUDENT DEV; Krevans J, 1996, CHILD DEV, V67, P3263, DOI 10.1111/j.1467-8624.1996.tb01913.x; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; KURTZ RR, 1972, J CONSULT CLIN PSYCH, V39, P106, DOI 10.1037/h0033190; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Leplatte Dayna, 2012, Ment Health Fam Med, V9, P39; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; Lilius JM, 2011, ANN ARBOR, V1001, P48109, DOI DOI 10.1093/0XF0RDHB/9780199734610.013.0021; Ling R, 2010, COMMUNICATION; MATTHEWS KA, 1981, J PERS, V49, P237, DOI 10.1111/j.1467-6494.1981.tb00933.x; Militello LK, 2012, WORLDV EVID-BASED NU, V9, P66, DOI 10.1111/j.1741-6787.2011.00239.x; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Milton JG, 2004, J CLIN NEUROPHYSIOL, V21, P134, DOI 10.1097/00004691-200405000-00002; Moses-Kolko EL, 2014, J NEUROENDO IN PRESS; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Nelson LD, 2005, J EXP SOC PSYCHOL, V41, P423, DOI 10.1016/j.jesp.2004.08.003; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; O'Brien E, 2013, J GERONTOL B-PSYCHOL, V68, P168, DOI 10.1093/geronb/gbs055; Padilla-Walker LM, 2012, FAM RELAT, V61, P426, DOI 10.1111/j.1741-3729.2012.00710.x; Park LG, 2014, J ADV NURSING; PERRY MA, 1975, J COUNS PSYCHOL, V22, P173, DOI 10.1037/h0076713; Pettigrew J, 2009, MARRIAGE FAM REV, V45, P697, DOI 10.1080/01494920903224269; Piff PK, 2014, PERS SOC PSYCHOL B, V40, P34, DOI 10.1177/0146167213501699; Przybylski AK, 2013, J SOC PERS RELAT, V30, P237, DOI 10.1177/0265407512453827; Putnam RD., 2000, BOWLING ALONE COLLAP; Ramsauer B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-24; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; RUSHTON JP, 1986, J PERS SOC PSYCHOL, V50, P1192, DOI 10.1037/0022-3514.50.6.1192; Rynes SL, 2012, ACAD MANAGE REV, V37, P503, DOI 10.5465/amr.2012.0124; SCHMIT MJ, 1995, J APPL PSYCHOL, V80, P607, DOI 10.1037/0021-9010.80.5.607; Schreiter S, 2013, J AFFECT DISORDERS, V150, P1, DOI 10.1016/j.jad.2013.03.009; SCHWARZ N, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P217; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; SCHWARZ N, 1992, ADV CONSUM RES, V19, P72; Shaw R, 2012, HEALTH INFORM J, V18, P235, DOI 10.1177/1460458212442422; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Stellar JE, 2012, EMOTION, V12, P449, DOI 10.1037/a0026508; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Strayer J, 2004, SOC DEV, V13, P1, DOI 10.1111/j.1467-9507.2004.00254.x; Swain JE, 2014, BRAIN RES, V1580, P78, DOI 10.1016/j.brainres.2014.03.007; Swain J. E., 2014, 34 ANN M CAN AC CHIL; THORNTON B, 1993, PERS SOC PSYCHOL B, V19, P474, DOI 10.1177/0146167293194012; Truax C.B., 1971, HDB PSYCHOTHERAPY BE, P299; TRUAX CB, 1966, J CONSULT PSYCHOL, V30, P395, DOI 10.1037/h0023827; Turkle S., 2012, ALONE TOGETHER WHY W; Twenge JM, 2008, J PERS, V76, P875, DOI 10.1111/j.1467-6494.2008.00507.x; Twenge JM, 2008, J RES PERS, V42, P1619, DOI 10.1016/j.jrp.2008.06.014; UNDERWOOD B, 1982, PSYCHOL BULL, V91, P143, DOI 10.1037/0033-2909.91.1.143; van der Mark IL, 2002, SOC DEV, V11, P451, DOI 10.1111/1467-9507.00210; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Volbrecht MM, 2007, J GENET PSYCHOL, V168, P105, DOI 10.3200/GNTP.168.2.105-130; Waller R, 2013, CLIN PSYCHOL REV, V33, P593, DOI 10.1016/j.cpr.2013.03.001; WARNER RE, 1984, J EDUC RES, V77, P366, DOI 10.1080/00220671.1984.10885558; Whittaker R, 2009, COCHRANE DATABASE SY, V4; Wilhelm M. O., 2012, PRINCIPLE CARE UNPUB; Wilhelm MO, 2010, SOC PSYCHOL QUART, V73, P11, DOI 10.1177/0190272510361435; Wood AM, 2012, J PERS, V80, P1275, DOI 10.1111/j.1467-6494.2012.00763.x; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038; Zhou Q, 2002, CHILD DEV, V73, P893, DOI 10.1111/1467-8624.00446	139	19	19	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137585	10.1371/journal.pone.0137585	http://dx.doi.org/10.1371/journal.pone.0137585			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356504	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800066
J	Taktikos, J; Lin, YT; Stark, H; Biais, N; Zaburdaev, V				Taktikos, Johannes; Lin, Yen Ting; Stark, Holger; Biais, Nicolas; Zaburdaev, Vasily			Pili-Induced Clustering of N-gonorrhoeae Bacteria	PLOS ONE			English	Article							CORTICAL PLAQUE-FORMATION; TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; IV PILI; EPITHELIAL-CELLS; BIOFILMS; CYTOPROTECTION; MICROSCOPY; RETRACTION; MECHANISM	Type IV pili (Tfp) are prokaryotic retractable appendages known to mediate surface attachment, motility, and subsequent clustering of cells. Tfp are the main means of motility for Neisseria gonorrhoeae, the causative agent of gonorrhea. Tfp are also involved in formation of the microcolonies, which play a crucial role in the progression of the disease. While motility of individual cells is relatively well understood, little is known about the dynamics of N. gonorrhoeae aggregation. We investigate how individual N. gonorrhoeae cells, initially uniformly dispersed on flat plastic or glass surfaces, agglomerate into spherical microcolonies within hours. We quantify the clustering process by measuring the area fraction covered by the cells, number of cell aggregates, and their average size as a function of time. We observe that the microcolonies are also able to move but their mobility rapidly vanishes as the size of the colony increases. After a certain critical size they become immobile. We propose a simple theoretical model which assumes a pili-pili interaction of cells as the main clustering mechanism. Numerical simulations of the model quantitatively reproduce the experimental data on clustering and thus suggest that the agglomeration process can be entirely explained by the Tfp-mediated interactions. In agreement with this hypothesis mutants lacking pili are not able to form colonies. Moreover, cells with deficient quorum sensing mechanism show similar aggregation as the wild-type bacteria. Therefore, our results demonstrate that pili provide an essential mechanism for colony formation, while additional chemical cues, for example quorum sensing, might be of secondary importance.	[Taktikos, Johannes; Zaburdaev, Vasily] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Taktikos, Johannes; Stark, Holger] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Taktikos, Johannes; Lin, Yen Ting; Zaburdaev, Vasily] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Biais, Nicolas] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA	Harvard University; Technical University of Berlin; Max Planck Society; City University of New York (CUNY) System; Brooklyn College (CUNY)	Biais, N (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	nicolas@mechano-micro-biology.org; vzaburd@pks.mpg.de	Lin, Yen Ting/ABB-8491-2020; Zaburdaev, Vasily/B-8194-2017	Lin, Yen Ting/0000-0001-6893-8423; Zaburdaev, Vasily/0000-0001-8234-3442	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems"; NIH [AI116566]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC2AI116566] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JT, HS, and VZ acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems." NB would like to acknowledge support from grant AI116566 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dewenter L, 2015, INTEGR BIOL-UK, V7, P1161, DOI 10.1039/c5ib00018a; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; Holz C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178104; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Lee SW, 2005, CELL MICROBIOL, V7, P1271, DOI 10.1111/j.1462-5822.2005.00551.x; Lushnikov PM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061904; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Marathe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4759; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Morikawa R, 2014, JPS C P, V1; MORSE SA, 1978, INFECT IMMUN, V21, P87, DOI 10.1128/IAI.21.1.87-95.1978; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Park HSM, 2001, MOL MICROBIOL, V42, P293, DOI 10.1046/j.1365-2958.2001.02629.x; Peruani F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098102; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Taktikos J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051901; Ulrich LE, 2009, NUCLEIC ACIDS RES, V38; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Weber C, 2014, KINETIC DESCRI UNPUB; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253; Zaburdaev V, 2014, BIOPHYS J, V107, P1523, DOI 10.1016/j.bpj.2014.07.061	35	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137661	10.1371/journal.pone.0137661	http://dx.doi.org/10.1371/journal.pone.0137661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355966	Green Published, gold			2022-12-27	WOS:000360965800076
J	Rifkin, RF; Dayet, L; Queffelec, A; Summers, B; Lategan, M; d'Errico, F				Rifkin, Riaan F.; Dayet, Laure; Queffelec, Alain; Summers, Beverley; Lategan, Marlize; d'Errico, Francesco			Evaluating the Photoprotective Effects of Ochre on Human Skin by In Vivo SPF Assessment: Implications for Human Evolution, Adaptation and Dispersal	PLOS ONE			English	Article							MIDDLE-STONE-AGE; BLAKE GEOMAGNETIC EXCURSION; MITOCHONDRIAL-DNA DELETION; SUN PROTECTION FACTOR; SOLAR UV-RADIATION; WESTERN-CAPE; BLOMBOS CAVE; SHELL BEADS; VITAMIN-D; ULTRAVIOLET-RADIATION	Archaeological indicators of cognitively modern behaviour become increasingly prevalent during the African Middle Stone Age (MSA). Although the exploitation of ochre is viewed as a key feature of the emergence of modern human behaviour, the uses to which ochre and ochre-based mixtures were put remain ambiguous. Here we present the results of an experimental study exploring the efficacy of ochre as a topical photoprotective compound. This is achieved through the in vivo calculation of the sun protection factor (SPF) values of ochre samples obtained from Ovahimba women (Kunene Region, Northern Namibia) and the Palaeozoic Bokkeveld Group deposits of the Cape Supergroup (Western Cape Province, South Africa). We employ visible spectroscopy, energy-dispersive X-ray fluorescence (EDXRF), X-ray diffraction (XRD) and granulometric analyses to characterise ochre samples. The capacity of ochre to inhibit the susceptibility of humans to the harmful effects of exposure to ultraviolet radiation (UVR) is confirmed and the mechanisms implicated in the efficacy of ochre as a sunscreen identified. It is posited that the habitual application of ochre may have represented a crucial innovation for MSA humans by limiting the adverse effects of ultraviolet exposure. This may have facilitated the colonisation of geographic regions largely unfavourable to the constitutive skin colour of newly arriving populations.	[Rifkin, Riaan F.] Univ Bergen, Inst Archaeol Hist Culture & Relig, Bergen, Norway; [Rifkin, Riaan F.; d'Errico, Francesco] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Dayet, Laure; Queffelec, Alain; d'Errico, Francesco] Univ Bordeaux, Unite Mixte Rech, CNRS, Pessac, France; [Summers, Beverley; Lategan, Marlize] Univ Limpopo, Dept Pharm, Photobiol Lab, Medunsa, South Africa	University of Bergen; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Sefako Makgatho Health Sciences University; University of Limpopo	Rifkin, RF (corresponding author), Univ Bergen, Inst Archaeol Hist Culture & Relig, Bergen, Norway.	riaanrifkin@gmail.com	Queffelec, Alain/AAD-9531-2019	DAYET, Laure/0000-0003-0408-6035; Queffelec, Alain/0000-0002-9763-7600; Summers, Beverley/0000-0001-7852-8858	PROTEA French-South Africa exchange programme; AHKR (Department of Archaeology, History, Cultural Studies and Religion, University of Bergen); European Research Council; TRACSYMBOLS [249587]; Photobiology Laboratory of Medunsa Campus, Sefako Makgatho University of Health Sciences	PROTEA French-South Africa exchange programme; AHKR (Department of Archaeology, History, Cultural Studies and Religion, University of Bergen); European Research Council(European Research Council (ERC)European Commission); TRACSYMBOLS; Photobiology Laboratory of Medunsa Campus, Sefako Makgatho University of Health Sciences	The authors acknowledge financial support provided by the PROTEA French-South Africa exchange programme, the AHKR (Department of Archaeology, History, Cultural Studies and Religion, University of Bergen), the European Research Council Advanced Grant, TRACSYMBOLS no. 249587, awarded under the FP7 programme and the Photobiology Laboratory of Medunsa Campus, Sefako Makgatho University of Health Sciences. The authors also acknowledge assistance provided by the Namibian Ministry of Culture and the National Museum of Namibia.	ALEXANDER JE, 1838, EXPEDITION DISCOVERY; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Barham L, 2002, J HUM EVOL, V43, P585, DOI 10.1006/jhev.2002.0597; Barham LS, 1998, CURR ANTHROPOL, V39, P703, DOI 10.1086/204793; Beaumont PB, 2006, S AFR J SCI, V102, P217; Beleza S, 2012, PLOS GENET, V9, P1; Bernerd F, 2003, EUR J DERMATOL, V13, P242; Biniek K, 2012, P NATL ACAD SCI USA, V109, P17111, DOI 10.1073/pnas.1206851109; Bleek W. H. I., 1911, SPECIMENS BUSHMAN FO; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Bourne M, 2012, EARTH PLANET SC LETT, V333, P21, DOI 10.1016/j.epsl.2012.04.017; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Burchell W.J., 1822, TRAVELS INTERIOR SO; Campbell J, 1816, TRAVELS S AFRICA UND; Cerqueira CCS, 2012, AM J HUM BIOL, V24, P705, DOI 10.1002/ajhb.22263; Chen TC, 2010, PHOTOBIOLOGY VITAMIN; Condamine FL, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12062; CRIPPS DJ, 1981, J INVEST DERMATOL, V77, P154, DOI 10.1111/1523-1747.ep12479359; Cruz-Uribe K, 2003, J ARCHAEOL SCI, V30, P559, DOI 10.1016/S0305-4403(02)00202-9; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2009, ORIGIN LANGUAGE DIVE; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; Dayer L, 2014, J ARCHAEOL SCI, V44, P180, DOI 10.1016/j.jas.2014.01.032; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Discamps E, 2014, QUATERN INT, V337, P64, DOI 10.1016/j.quaint.2013.07.046; Dusseldorp GL, 2011, QUATERN INT, V270, P7079; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elias M, 2006, MAT SCI ENG B-SOLID, V127, P70, DOI 10.1016/j.mseb.2005.09.061; Elias PM, 2013, J HUM EVOL, V64, P687, DOI 10.1016/j.jhevol.2013.02.003; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fluhr JW, 2008, DIS MECH, V5, P249; Galton Francis, 1891, NARRATIVE EXPLORER T; Gasparro FP, 2000, ENVIRON HEALTH PERSP, V108, P71, DOI 10.2307/3454633; Gear S, 2002, VIOL TRANSIT, V8, P1; Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071; Gewald JB, 2010, P NATL ACAD SCI USA, V107, pE75, DOI 10.1073/pnas.1001284107; Gilaberte Y, 2010, ACTAS DERMO-SIFILOGR, V101, P659, DOI 10.1016/S1578-2190(10)70696-X; Gilchrest BA, 2008, AM J CLIN NUTR, V88, p570S, DOI 10.1093/ajcn/88.2.570S; Gilligan I, 2007, WORLD ARCHAEOL, V39, P499, DOI 10.1080/00438240701680492; Gordon JR, 1786, CAPE TRAVELS; Grove M, 2012, J ARCHAEOL SCI, V39, P3085, DOI 10.1016/j.jas.2012.04.023; Guerreiro MV., 1968, BOCHIMANES KHU ANGOL; Guillou H, 2004, EARTH PLANET SC LETT, V227, P331, DOI 10.1016/j.epsl.2004.09.018; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Herrling T, 2008, SPECTROCHIM ACTA A, V69, P1429, DOI 10.1016/j.saa.2007.09.030; Hoang-Minh T, 2010, APPL CLAY SCI, V48, P349, DOI 10.1016/j.clay.2010.01.005; Hoang-Minh T., 2011, APPL CLAY SCI, V53, P66; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Hodgson DA, 2005, EARTH PLANET SC LETT, V236, P765, DOI 10.1016/j.epsl.2005.05.023; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; JAYACHANDRAN T. N., 1965, REPORT GOVT BECHUANA; Johnston HH, 1884, J ANTHR I GREAT BRIT, V13, P461; Juzeniene A, 2009, J PHOTOCH PHOTOBIO B, V96, P93, DOI 10.1016/j.jphotobiol.2009.04.009; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kanazawa S, 2008, INTELLIGENCE, V36, P99, DOI 10.1016/j.intell.2007.04.001; Kanazawa S, 2011, INTELLIGENCE, V39, P7, DOI 10.1016/j.intell.2010.11.003; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Knudsen MF, 2008, EARTH PLANET SC LETT, V272, P319, DOI 10.1016/j.epsl.2008.04.048; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Kummu M, 2011, APPL GEOGR, V31, P495, DOI 10.1016/j.apgeog.2010.10.009; Kuntz J, 1912, PETERMANNS MITTEILUN, V25, P206; Laj C, 2008, GEOMAGNETIC EXCURSIO; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Lautenschlager S, 2007, LANCET, V370, P528, DOI 10.1016/S0140-6736(07)60638-2; LaViolette PA, 2011, RADIOCARBON, V53, P303, DOI 10.1017/S0033822200056575; Light JE, 2009, MOL PHYLOGENET EVOL, V50, P376, DOI 10.1016/j.ympev.2008.10.023; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; Lydell J., 1979, HAMAR SO ETHIOPIA; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackintosh JA, 2001, J THEOR BIOL, V211, P101, DOI 10.1006/jtbi.2001.2331; MARSHALL L, 1961, AFRICA, V31, P231, DOI 10.2307/1157263; Marshall Lorna., 1976, KUNG NYAE NYAE; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Menabreaz L, 2011, EARTH PLANET SC LETT, V312, P305, DOI 10.1016/j.epsl.2011.10.037; Methuen H. H., 1846, LIFE WILDERNESS; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Moan J, 2008, P NATL ACAD SCI USA, V105, P668, DOI 10.1073/pnas.0710615105; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; Nicoll K, 2010, QUATERNARY SCI REV, V29, P1419, DOI 10.1016/j.quascirev.2009.02.026; Nowaczyk NR, 2012, EARTH PLANET SC LETT, V351, P54, DOI 10.1016/j.epsl.2012.06.050; Nyman T., 2012, ECOL LETT, V14, P1; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Osete ML, 2012, EARTH PLANET SC LETT, V353, P173, DOI 10.1016/j.epsl.2012.07.041; Parra EJ, 2007, YEARB PHYS ANTHROPOL, V50, P85, DOI 10.1002/ajpa.20727; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Plenier G, 2007, EARTH PLANET SC LETT, V259, P414, DOI 10.1016/j.epsl.2007.04.039; Power C, 1997, FEMALE PROTO SYMBOLI; Reichrath J, 2007, EXP DERMATOL, V16, P618, DOI 10.1111/j.1600-0625.2007.00570.x; Reichrath J, 2006, PROG BIOPHYS MOL BIO, V92, P9, DOI 10.1016/j.pbiomolbio.2006.02.010; RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558; Rifkin RF, 2015, S AFR J SCI, V111, P65; Rifkin RF, 2012, J ANTHROPOL ARCHAEOL, V31, P174, DOI 10.1016/j.jaa.2011.11.004; Rifkin RF, 2011, J AFR ARCHAEOL, V9, P131, DOI 10.3213/2191-5784-10199; Rindermann H, 2012, INTELLIGENCE, V40, P362, DOI 10.1016/j.intell.2012.04.002; Robinson KC, 2009, SEMIN CELL DEV BIOL, V20, P111, DOI 10.1016/j.semcdb.2008.11.016; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Salomon H, 2012, ARCHAEOMETRY, V54, P698, DOI 10.1111/j.1475-4754.2011.00649.x; Shoenfeld N, 2009, NAT CLIN PRACT RHEUM, V5, P99, DOI 10.1038/ncprheum0989; Sorensen B, 2011, J ANTHROPOL ARCHAEOL, V30, P17, DOI 10.1016/j.jaa.2010.12.003; Soressi M., 2007, PIGMENTS GRAVURES PA; Stow George W., 1905, NATIVE RACES S AFRIC; Strecker IA, 1976, TRADITIONAL LIFE PRO; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Summers B, 2012, SAMJ S AFR MED J, V102, P897, DOI 10.7196/SAMJ.6484; Swiatoniowski AK, 2013, AM J PHYS ANTHROPOL, V151, P325, DOI 10.1002/ajpa.22274; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Tam TTT, 2009, J PHOTOCH PHOTOBIO B, V94, P201, DOI 10.1016/j.jphotobiol.2008.12.003; Thouveny N, 2004, EARTH PLANET SC LETT, V219, P377, DOI 10.1016/S0012-821X(03)00701-5; Thouveny N, 2008, EARTH PLANET SC LETT, V275, P269, DOI 10.1016/j.epsl.2008.08.020; Thunberg C.P, 1986, TRAVELS CAPE GOOD HO, P1793; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tonjes H., 1911, OVAMBOLAND COUNTRY P; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Tryon CA, 2002, J HUM EVOL, V42, P211, DOI 10.1006/jhev.2001.0513; Ullrich SE, 2002, EXP DERMATOL, V11, P13, DOI 10.1034/j.1600-0625.11.s.1.4.x; Valet JP, 2010, QUATERNARY SCI REV, V29, P3887, DOI 10.1016/j.quascirev.2010.09.010; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Vedder H, 1928, CAPE TIMES; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Vorster CJ, 2002, SIMPLIFIED GEOLOGY I; Wadley L., 2005, FARMING, V3, P1, DOI DOI 10.3828/BFARM.2005.3.1; Wadley L, 2006, REVISITING CULTURAL; Wagner JK, 2002, PIGM CELL RES, V15, P385, DOI 10.1034/j.1600-0749.2002.02046.x; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102; Watts I, 2009, RED OCHRE BODY PAINT; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Winkler H, 2008, J GEOPHYS RES, V113, P1; WITZEL RF, 1973, J OPT SOC AM, V63, P615, DOI 10.1364/JOSA.63.000615; World Health Organization, 2002, GLOBAL SOLAR UV INDE; Wright CY, 2012, S AFR J SCI, V108, P23, DOI 10.4102/sajs.v108i11/12.1245; Young Antony R, 2006, Prog Biophys Mol Biol, V92, P80, DOI 10.1016/j.pbiomolbio.2006.02.005; Yuen AWC, 2010, MED HYPOTHESES, V74, P39, DOI 10.1016/j.mehy.2009.08.007; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897; Zihlman A.L., 1988, HUM EVOL, V3, P397, DOI [10.1007/BF02447222, DOI 10.1007/BF02447222]; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	163	53	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136090	10.1371/journal.pone.0136090	http://dx.doi.org/10.1371/journal.pone.0136090			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ9KG	26353012	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800024
J	Russell, KA; Gibson, TWG; Chong, A; Co, C; Koch, TG				Russell, Keith A.; Gibson, Thomas W. G.; Chong, Andrew; Co, Carmon; Koch, Thomas G.			Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; STEM-CELLS; IN-VITRO; EXPANSION; THERAPY; DIFFERENTIATION; SUBSTITUTE; EXPRESSION; CULTURE	Background Mesenchymal stromal cells (MSC) are increasingly investigated for their clinical utility in dogs. Fetal bovine serum (FBS) is a common culture supplement used for canine MSC expansion. However, FBS content is variable, its clinical use carries risk of an immune response, and its cost is increasing due to global demand. Platelet lysate (PL) has proven to be a suitable alternative to FBS for expansion of human MSC. Hypothesis and Objectives We hypothesized that canine adipose tissue (AT) and bone marrow (BM) MSC could be isolated and expanded equally in PL and FBS at conventionally-used concentrations with differentiation of these MSC unaffected by choice of supplement. Our objectives were to evaluate the use of canine PL in comparison with FBS at four stages: 1) isolation, 2) proliferation, 3) spontaneous differentiation, and 4) directed differentiation. Results 1) Medium with 10% PL was unable to isolate MSC. 2) MSC, initially isolated in FBS-supplemented media, followed a dose-dependent response with no significant difference between PL and FBS cultures at up to 20% (AT) or 30% (BM) enrichment. Beyond these respective peaks, proliferation fell in PL cultures only, while a continued dose-dependent proliferation response was noted in FBS cultures. 3) Further investigation indicated PL expansion culture was inducing spontaneous adipogenesis in concentrations as low as 10% and as early as 4 days in culture. 4) MSC isolated in FBS, but expanded in either FBS or PL, maintained ability to undergo directed adipogenesis and osteogenesis, but not chondrogenesis. Conclusions/Significance Canine PL did not support establishment of MSC colonies from AT and BM, nor expansion of MSC, which appear to undergo spontaneous adipogenesis in response to PL exposure. In vivo studies are warranted to determine if concurrent use of MSC with any plateletderived products such as platelet- rich plasma are associated with synergistic, neutral or antagonistic effects.	[Russell, Keith A.; Chong, Andrew; Co, Carmon; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada; [Gibson, Thomas W. G.] Univ Guelph, Clin Studies, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; Aarhus University	Russell, KA (corresponding author), Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	karussell.edu@gmail.com	Russell, Keith/HHS-2364-2022	Russell, Keith/0000-0002-1704-2966	Morris Animal Foundation [D12CA-313]; Pet-Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	Morris Animal Foundation; Pet-Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Morris Animal Foundation, grant ID# D12CA-313; Pet-Trust Research Foundation, Ontario Veterinary College; The Dean's Office, Ontario Veterinary College and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSOGG ACG, 1993, AM J VET RES, V54, P635; Allan D, 2012, REGENERATIVE THERAPY, P217, DOI [10.1007/978-1-61779-471-1, DOI 10.1007/978-1-61779-471-1]; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bieback K, 2008, TRANSFUS MED HEMOTH, V35, P286, DOI 10.1159/000141567; Bieback K, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/193519; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Brindley DA, 2012, REGEN MED, V7, P7, DOI [10.2217/rme.11.112, 10.2217/RME.11.112]; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Buechli ME, 2013, STEM CELLS DEV, V22, P1288, DOI 10.1089/scd.2012.0411; Capelli C, 2007, BONE MARROW TRANSPL, V40, P785, DOI 10.1038/sj.bmt.1705798; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Co C, 2014, OSTEOARTHR CARTILAGE, V22, P472, DOI 10.1016/j.joca.2013.12.021; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Russell KA, 2016, EQUINE VET J, V48, P261, DOI 10.1111/evj.12440; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schallmoser Katharina, 2013, Methods Mol Biol, V946, P349, DOI 10.1007/978-1-62703-128-8_22; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012	29	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136621	10.1371/journal.pone.0136621	http://dx.doi.org/10.1371/journal.pone.0136621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353112	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800043
J	Gao, YJ; Zhang, M; Li, J; Yang, M; Liu, Y; Guo, XD; Li, HW; Liu, ZW; Zhao, JM				Gao, Yinjie; Zhang, Min; Li, Jin; Yang, Mei; Liu, Yuan; Guo, Xiaodong; Li, Hanwei; Liu, Zhenwen; Zhao, Jingmin			Circulating FoxP3+Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation	PLOS ONE			English	Article							IMMUNE-RESPONSE; CORE ANTIGEN; ANTIBODY; INTERLEUKIN-17; CONTRIBUTE; SEVERITY; T(H)17	Objective To longitudinally investigate the role of FoxP3+ Regulatory T cells (Treg) and interleukin17-producing T helper 17 cells (Th17) in De Novo Hepatitis B Virus infection after orthotopic Liver Transplantation (DNHB-OLT), and analyze the possible correlation between these cells and HBV clearance of the disease. Methods We enrolled 12 control cases after orthotopic Liver Transplantation (OLT) and 24 patients, including 12 diagnosed with DNHB-OLT and 12 diagnosed with Acute Hepatitis B Virus infection (AHB), into the study from the liver transplantation and research center at Beijing 302 Hospital. Flow cytometry was used to detect the frequencies of Treg and Th17, and ELISA was applied to detect the concentration of IL6, IL22, TGF-beta and IL2 in peripheral blood. We also measured the gene expression level by real time-quantitative PCR and protein expression using immunohistochemistry and western-blot. Furthermore, we divided DNHB-OLT patients into the clearance and non-clearance groups and examined longitudinally Th17, Treg cells at different times. Results The percentage of Treg cells, expression of FoxP3 mRNA and related anti-inflammatory cytokines such as IL2 and TGF-beta 1 in the DNHB-OLT group were significantly higher than that in the AHB and OLT groups. The percentage of Th17 cells, expression of ROR gamma t mRNA and related pro-inflammatory cytokines such as IL17 and IL22 in the DNHB-OLT group were significantly lower than that in the AHB group, but the levels of these cytokines are very similar to the OLT group. The ratios of Treg to Th17 in the DNHB-OLT group were significantly higher than that in the OLT and AHB groups. Treg frequencies significantly correlated with HBV DNA, whereas IL17 frequencies didn't significantly correlate with ALT. In DNHB-OLT patients, the clearance group was accompanied by a rapid increase in the Th17 cells during the first 4th week and afterwards continuously decrease to the control group, together with a continuously decrease in Treg cells from the onset time point, which lead to a significant reduction in the ratios of Treg to Th17. The non-clearance group was accompanied by an increase in the Treg cells during the first 4th week and afterwards sharply decrease, together with a relatively stable and unchanged Th17 cells, which lead to a significant change in the ratios. In addition, compared to clearance group, the ratios of Treg to Th17 in non-clearance group were significantly higher at the onset point, 4th and 12th week, but no difference at 24th week. Conclusion DNHB-OLT patients possessed a favorable Treg differentiation environment, accompanied by a sustained higher preferentially Treg frequencies and up-regulation of related anti-inflammatory cytokines. The immune imbalance of the ratios between Treg and Th17 existed in DNHB-OLT patients. The changes of the ratios during the DNHB-OLT events were associated with HBV clearance, which suppressed immune inflammation reaction as well as inhibited ability of specific HBV clearance and led to immune escape and chronicity.	[Gao, Yinjie; Zhang, Min; Li, Jin; Liu, Zhenwen] 302 Mil Hosp, Liver Transplantat & Res Ctr, Beijing, Peoples R China; [Gao, Yinjie] Chinese PLA, Sch Med, Dept Infect Dis, Beijing, Peoples R China; [Yang, Mei; Liu, Yuan; Guo, Xiaodong] 302 Mil Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China; [Li, Hanwei] 302 Mil Hosp, Liver Cirrhosis & Res Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Liu, ZW (corresponding author), 302 Mil Hosp, Liver Transplantat & Res Ctr, Beijing, Peoples R China.	jmzhao302@126.com; liuzhw302@126.com						Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bohorquez HE, 2013, LIVER TRANSPLANT, V19, P611, DOI 10.1002/lt.23644; Boni C, 2003, J HEPATOL, V39, P595, DOI 10.1016/S0168-8278(03)00292-7; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Gao YJ, 2014, J GASTROEN HEPATOL, V29, P554, DOI 10.1111/jgh.12404; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lenci I, 2011, J HEPATOL, V55, P587, DOI 10.1016/j.jhep.2010.12.036; Leonhard Stross, 2012, HEPATOLOGY, V56, P253; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li J, 2014, DIGEST DIS SCI, V59, P1475, DOI 10.1007/s10620-013-3022-1; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Liang XS, 2014, WORLD J GASTROENTERO, V20, P8558, DOI 10.3748/wjg.v20.i26.8558; Liang XS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-43; Lohse Ansgar W, 2010, J Hepatol, V52, P136, DOI 10.1016/j.jhep.2009.10.016; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Prieto M, 2009, LIVER TRANSPLANT, V15, P1164, DOI 10.1002/lt.21814; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Skagen CL, 2011, CLIN TRANSPLANT, V25, pE243, DOI 10.1111/j.1399-0012.2011.01409.x; Stoop JN, 2007, VIROLOGY, V361, P141, DOI 10.1016/j.virol.2006.11.018; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Su WJ, 2010, LIVER TRANSPLANT, V16, P215, DOI 10.1002/lt.21980; Sun HQ, 2012, J VIRAL HEPATITIS, V19, P396, DOI 10.1111/j.1365-2893.2011.01561.x; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; Ueda Y, 2011, ANTIVIR THER, V16, P479, DOI 10.3851/IMP1771; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang FS, 2007, HEPATOL RES, V37, pS339, DOI 10.1111/j.1872-034X.2007.00222.x; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x; Ye YF, 2010, J CLIN IMMUNOL, V30, P546, DOI 10.1007/s10875-010-9416-3; Yu L, 2009, LIVER TRANSPLANT, V15, P1343, DOI 10.1002/lt.21788; Yu XP, 2014, J GASTROEN HEPATOL, V29, P1065, DOI 10.1111/jgh.12459; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JG, 2010, EBM 2010: INTERNATIONAL CONFERENCE ON ENGINEERING AND BUSINESS MANAGEMENT, VOLS 1-8, P5; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137881	10.1371/journal.pone.0137881	http://dx.doi.org/10.1371/journal.pone.0137881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367459	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100166
J	Gooding, S; Lau, IJ; Sheikh, M; Roberts, P; Wong, JL; Dickens, E; Bullement, A; Elvidge, J; Lee, D; Ramasamy, K				Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Roberts, Pamela; Wong, Julia; Dickens, Emmy; Bullement, Ash; Elvidge, Jamie; Lee, Dawn; Ramasamy, Karthik			Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs	PLOS ONE			English	Article							THERAPIES; SURVIVAL; ERA	Double relapsed and/or refractory multiple myeloma (DRMM), MM that is relapsed and/or refractory to bortezomib and lenalidomide, carries a poor prognosis. The healthcare costs of DRMM have not previously been reported. We analyzed detailed medical resource utilization (MRU) costs, drug costs and outcomes for 39 UK patients receiving standard DRMM therapy. Median OS in this cohort was 5.6 months. The mean cost of DRMM treatment plus MRU until death was 23,472 pound [range: 1,411- pound 90,262] pound, split between drug costs 11,191 pound and other resource use costs 12,281 pound. The cost per assumed quality-adjusted life year (QALY) during DRMM was 66,983 pound. These data provide a standard of care comparison when evaluating the cost-effectiveness of new drugs in DRMM.	[Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Roberts, Pamela; Wong, Julia; Dickens, Emmy; Ramasamy, Karthik] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Oxford OX3 7LE, England; [Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Dickens, Emmy; Ramasamy, Karthik] Oxford Univ Hosp NHS Trust, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Gooding, Sarah] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; [Sheikh, Mimi] Univ Oxford, Dept Oncol, Oxford OX3 7LH, England; [Bullement, Ash; Elvidge, Jamie; Lee, Dawn] BresMed Hlth Solut, Sheffield S1 2DW, S Yorkshire, England; [Ramasamy, Karthik] Royal Berkshire Hosp NHS Trust, Reading RG1 5AN, Berks, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; Royal Berkshire Hospital	Ramasamy, K (corresponding author), Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Old Rd, Oxford OX3 7LE, England.	karthik.ramasamy@ouh.nhs.uk	lee, dawn/GRJ-7459-2022; Bullement, Ash/AEO-3423-2022	Bullement, Ash/0000-0001-7091-0972; Ramasamy, Karthik/0000-0003-3385-3707; Lau, I-Jun/0000-0003-1727-3243	Wellcome Trust [102341/Z/13/Z]; Medical Research Council Clinical Research Training Fellowship [MR/M003221/1]; Oxford Cancer Research Centre Clinical Research Training Fellowship [OCRC-CRF14-MW]; MRC [MR/M003221/1] Funding Source: UKRI; Medical Research Council [MR/M003221/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Cancer Research Centre Clinical Research Training Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SG was supported by Wellcome Trust Research Training Fellowship 2013-2016. Grant code 102341/Z/13/Z (http://www.wellcome.ac.uk/Funding/Biomedical-science/Fundingschemes/Fellowships/Clinical-fellowships/wtd004435.htm). IL was supported by Medical Research Council Clinical Research Training Fellowship 2014-2017. Grant code MR/M003221/1 (http://www.mrc.ac.uk/skillscareers/fellowships/clinical-fellowships/clinical-research-training-fellowship-crtf/). MS was supported by Oxford Cancer Research Centre Clinical Research Training Fellowship 2014-2017. Grant code OCRC-CRF14-MW (http://www.cancercentre.ox.ac.uk/graduate-studies/clinical-research-trainingfellowships/). BresMed Health Solutions provided support in the form of salaries for authors AB, JE and DL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brown RE, 2013, EUR J HEALTH ECON, V14, P507, DOI 10.1007/s10198-012-0395-6; Durie Brian, 2013, J Med Econ, V16, P614, DOI 10.3111/13696998.2012.760159; Gaultney JG, 2013, J CLIN PHARM THER, V38, P41, DOI 10.1111/jcpt.12020; Gaultney JG, 2013, ONCOLOGIST, V18, P5, DOI 10.1634/theoncologist.2012-0484; Jordan K, 2014, SUPPORT CARE CANCER, V22, P417, DOI 10.1007/s00520-013-1991-4; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Lau IJ, 2014, ANN HEMATOLOGY; Lee Hans C, 2013, Am Soc Clin Oncol Educ Book, DOI 10.1200/EdBook_AM.2013.33.e302; Meadows JP, 2013, CURR HEMATOL MALIG R, V8, P253, DOI 10.1007/s11899-013-0173-2; National Institute for Health and Care Excellence, 2013, GUIDE TO THE METHODS; Palumbo A, 2013, LYMPH MYEL 2013 INT; Pozzi S, 2013, BRIT J HAEMATOL, V163, P40, DOI 10.1111/bjh.12465; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Teitelbaum A, 2013, ONCOLOGIST, V18, P37, DOI 10.1634/theoncologist.2012-0113	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136207	10.1371/journal.pone.0136207	http://dx.doi.org/10.1371/journal.pone.0136207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367874	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000361601100014
J	Hartley, SW; Coon, SL; Savastano, LE; Mullikin, JC; Fu, C; Klein, DC				Hartley, Stephen W.; Coon, Steven L.; Savastano, Luis E.; Mullikin, James C.; Fu, Cong; Klein, David C.		NISC Comparative Sequencing	Neurotranscriptomics: The Effects of Neonatal Stimulus Deprivation on the Rat Pineal Transcriptome	PLOS ONE			English	Article							SEROTONIN N-ACETYLTRANSFERASE; PARAVENTRICULAR NUCLEUS AREA; CYCLIC-AMP MECHANISM; RNA-SEQ; MELATONIN SYNTHESIS; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; CIRCADIAN EXPRESSION; NEUROPEPTIDE-Y; GLAND	The term neurotranscriptomics is used here to describe genome-wide analysis of neural control of transcriptomes. In this report, next-generation RNA sequencing was using to analyze the effects of neonatal (5-days-of-age) surgical stimulus deprivation on the adult rat pineal transcriptome. In intact animals, more than 3000 coding genes were found to exhibit differential expression (adjusted-p < 0.001) on a night/day basis in the pineal gland (70% of these increased at night, 376 genes changed more than 4-fold in either direction). Of these, more than two thousand genes were not previously known to be differentially expressed on a night/day basis. The night/day changes in expression were almost completely eliminated by neonatal removal (SCGX) or decentralization (DCN) of the superior cervical ganglia (SCG), which innervate the pineal gland. Other than the loss of rhythmic variation, surgical stimulus deprivation had little impact on the abundance of most genes; of particular interest, expression levels of the melatonin-synthesis-related genes Tph1, Gch1, and Asmt displayed little change (less than 35%) following DCN or SCGX. However, strong and consistent changes were observed in the expression of a small number of genes including the gene encoding Serpina1, a secreted protease inhibitor that might influence extracellular architecture. Many of the genes that exhibited night/day differential expression in intact animals also exhibited similar changes following in vitro treatment with norepinephrine, a superior cervical ganglia transmitter, or with an analog of cyclic AMP, a norepinephrine second messenger in this tissue. These findings are of significance in that they establish that the pineal-defining transcriptome is established prior to the neonatal period. Further, this work expands our knowledge of the biological process under neural control in this tissue and underlines the value of RNA sequencing in revealing how neurotransmission influences cell biology.	[Hartley, Stephen W.; Mullikin, James C.] NHGRI, Comparat Genom Anal Unit, Canc Genet & Comparat Genom Branch, NIH, Bethesda, MD 20892 USA; [Coon, Steven L.; Fu, Cong; Klein, David C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Savastano, Luis E.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [NISC Comparative Sequencing] NHGRI, NIH, Intramural Sequencing Ctr, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Klein, DC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Off Sci Director, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Klein, David/0000-0002-1792-5806	Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008958] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER	Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892; and, the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; BERG GR, 1972, J NEUROCHEM, V19, P2519, DOI 10.1111/j.1471-4159.1972.tb01311.x; BOWERS CW, 1982, J PHYSIOL-LONDON, V330, P279, DOI 10.1113/jphysiol.1982.sp014341; BOWERS CW, 1984, NEUROSCIENCE, V13, P87, DOI 10.1016/0306-4522(84)90261-6; Bustos DM, 2011, CELL TISSUE RES, V344, P1, DOI 10.1007/s00441-010-1094-1; Coon SL, 2012, P NATL ACAD SCI USA, V109, P13319, DOI 10.1073/pnas.1207748109; DeMeo DL, 2004, THORAX, V59, P259, DOI 10.1136/thx.2003.006502; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Savastano LE, 2010, J NEUROSCI METH, V192, P22, DOI 10.1016/j.jneumeth.2010.07.007; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fukuhara C, 2008, NEUROSCI RES, V60, P192, DOI 10.1016/j.neures.2007.10.011; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hartley SW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0670-5; Hernandez SC, 2004, MOL PHARMACOL, V66, P978, DOI 10.1124/mol.104.002345; HO AK, 1990, PROG CLIN BIOL RES, V342, P139; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Humphries A, 2004, J NEUROCHEM, V91, P946, DOI 10.1111/j.1471-4159.2004.02777.x; Humphries A, 2002, J NEUROENDOCRINOL, V14, P101, DOI 10.1046/j.0007-1331.2001.00738.x; Karolczak M, 2005, ENDOCRINE, V27, P89, DOI 10.1385/ENDO:27:2:089; Kim JS, 2010, MOL CELL ENDOCRINOL, V314, P128, DOI 10.1016/j.mce.2009.05.013; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1971, P NATL ACAD SCI USA, V68, P3107, DOI 10.1073/pnas.68.12.3107; KLEIN DC, 1985, CIBA F SYMP, V117, P38; KLEIN DC, 1983, BRAIN RES BULL, V10, P647, DOI 10.1016/0361-9230(83)90033-3; KLEIN DC, 1979, BRAIN RES, V174, P245, DOI 10.1016/0006-8993(79)90848-5; KLEIN DC, 1983, P NATL ACAD SCI-BIOL, V80, P599, DOI 10.1073/pnas.80.2.599; KLEIN DC, 1991, SUPRACHIASMATIC NUCL, V16; LINGAPPA JR, 1987, NEUROSCIENCE, V21, P893, DOI 10.1016/0306-4522(87)90045-5; Maronde E, 1999, ADV EXP MED BIOL, V460, P109; Maronde E, 1997, BIOL CELL, V89, P505, DOI 10.1016/S0248-4900(98)80006-3; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; Mikkelsen JD, 1999, ADV EXP MED BIOL, V460, P95; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; MOORE RY, 1974, BRAIN RES, V71, P17, DOI 10.1016/0006-8993(74)90188-7; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; PARFITT AG, 1976, ENDOCRINOLOGY, V99, P840, DOI 10.1210/endo-99-3-840; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; SUGDEN D, 1985, NATURE, V314, P359, DOI 10.1038/314359a0; SUGDEN LA, 1987, J BIOL CHEM, V262, P741; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; VACAS MI, 1987, CELL MOL NEUROBIOL, V7, P309, DOI 10.1007/BF00711307; VANECEK J, 1985, ENDOCRINOLOGY, V116, P2167, DOI 10.1210/endo-116-6-2167; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; YANOVSKI J, 1987, BRAIN RES BULL, V19, P129, DOI 10.1016/0361-9230(87)90175-4; ZATZ M, 1985, J NEUROCHEM, V45, P95, DOI 10.1111/j.1471-4159.1985.tb05479.x	56	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137548	10.1371/journal.pone.0137548	http://dx.doi.org/10.1371/journal.pone.0137548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367423	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100082
J	Moreau, CS; Hugall, AF; McDonald, KR; Jamieson, BGM; Moritz, C				Moreau, Corrie S.; Hugall, Andrew F.; McDonald, Keith R.; Jamieson, Barrie G. M.; Moritz, Craig			An Ancient Divide in a Contiguous Rainforest: Endemic Earthworms in the Australian Wet Tropics	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENY; GEOGRAPHIC RANGE; CLIMATE-CHANGE; DIVERSITY; EVOLUTION; SPECIATION; DYNAMICS; DIVERSIFICATION	Understanding the factors that shape current species diversity is a fundamental aim of ecology and evolutionary biology. The Australian Wet Tropics (AWT) are a system in which much is known about how the rainforests and the rainforest-dependent organisms reacted to late Pleistocene climate changes, but less is known about how events deeper in time shaped speciation and extinction in this highly endemic biota. We estimate the phylogeny of a species-rich endemic genus of earthworms (Terrisswalkerius) from the region. Using DEC and DIVA historical biogeography methods we find a strong signal of vicariance among known biogeographical sub-regions across the whole phylogeny, congruent with the phylogeography of less diverse vertebrate groups. Absolute dating estimates, in conjunction with relative ages of major biogeographic disjunctions across Australia, indicate that diversification in Terrisswalkerius dates back before the mid-Miocene shift towards aridification, into the Paleogene era of isolation of mesothermal Gondwanan Australia. For the Queensland endemic Terrisswalkerius earthworms, the AWT have acted as both a museum of biological diversity and as the setting for continuing geographically structured diversification. These results suggest that past events affecting organismal diversification can be concordant across phylogeographic to phylogenetic levels and emphasize the value of multi-scale analysis, from intra-to interspecies, for understanding the broad-scale processes that have shaped geographic diversity.	[Moreau, Corrie S.] Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA; [Hugall, Andrew F.] Museum Victoria, Melbourne, Vic 3001, Australia; [McDonald, Keith R.] Queensland Parks & Wildlife Serv, Atherton, Qld 4883, Australia; [Jamieson, Barrie G. M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Moritz, Craig] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal, Canberra, ACT 2601, Australia	Field Museum of Natural History (Chicago); Museum Victoria; University of Queensland; Australian National University; Australian National University	Moreau, CS (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA.	cmoreau@fieldmuseum.org		Moreau, Corrie/0000-0003-1139-5792	Australian Research Council; Department of Science and Education; Field Museum of Natural History; Miller Institute for Basic Research in Science, University of California Berkeley	Australian Research Council(Australian Research Council); Department of Science and Education; Field Museum of Natural History; Miller Institute for Basic Research in Science, University of California Berkeley(University of California System)	B.G.M.J. thanks the Australian Research Council for grants supporting collection of Wet Tropics earthworms and K.R.M. for making this possible. C.S.M. would like to thank the Department of Science and Education, Field Museum of Natural History and the Miller Institute for Basic Research in Science, University of California Berkeley for support during the analyzing and writing of this research.	[Anonymous], 1878, TROPICAL NATURE OTHE; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Beaulieu JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-80; Bell KL, 2007, MOL ECOL, V16, P4984, DOI 10.1111/j.1365-294X.2007.03533.x; Bell KL, 2004, MOL PHYLOGENET EVOL, V31, P741, DOI 10.1016/j.ympev.2003.09.010; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; BERMINGHAM E, 2005, TROPICAL RAINFORESTS; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; Buckley TR, 2011, MOL PHYLOGENET EVOL, V58, P85, DOI 10.1016/j.ympev.2010.09.024; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Chacon J, 2014, J BIOGEOGR, V41, P1414, DOI 10.1111/jbi.12301; Chang CH, 2008, MOL PHYLOGENET EVOL, V49, P958, DOI 10.1016/j.ympev.2008.08.025; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyne Geoffrey R., 1994, Memoirs of the Queensland Museum, V36, P59; ENDLER JA, 1982, AM ZOOL, V22, P441; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fernandez R, 2012, MOL PHYLOGENET EVOL, V64, P368, DOI 10.1016/j.ympev.2012.04.011; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hocknull SA, 2007, EARTH PLANET SC LETT, V264, P317, DOI 10.1016/j.epsl.2007.10.004; Hoskin CJ, 2003, AUST J ZOOL, V51, P153, DOI 10.1071/ZO02072; Hoskin CJ, 2004, AUST J ZOOL, V52, P237, DOI 10.1071/ZO03056; Hoskin CJ, 2011, AM NAT, V178, P561, DOI 10.1086/662164; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall A, 2003, SM S COMP E, P270; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; James SW, 2012, INVERTEBR SYST, V26, P213, DOI 10.1071/IS11012; Jamieson B. G. M., 1994, Memoirs of the Queensland Museum, V37, P157; Jamieson B. G. M., 1981, ECOLOGICAL BIOGEOGRA, P885; Jamieson Barrie G.M., 2006, P235; Jamieson Barrie G. M., 2013, Memoirs of the Queensland Museum, V58, P15; Jamieson Barrie G. M., 2002, Zoosystema, V24, P707; Jamieson BGM, 2000, NATIVE EARTHWORMS AU; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kershaw A. P., 2005, Tropical rainforests: past, present and future, P374; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; MAYR E, 1986, EVOLUTION, V40, P55, DOI 10.1111/j.1558-5646.1986.tb05717.x; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; Minamiya Y, 2009, EUR J SOIL BIOL, V45, P423, DOI 10.1016/j.ejsobi.2009.06.004; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Moritz C, 2005, CONSERV BIOL SER, V8, P243; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Nix HA, 1991, RAINFOREST ANIMALS A, P11; Novo M, 2011, MOL PHYLOGENET EVOL, V61, P125, DOI 10.1016/j.ympev.2011.05.018; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028153; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Ponniah M, 2004, EVOLUTION, V58, P1073; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ricklefs Robert E., 2005, P16; Ricklefs Robert E., 1993, P215; Rossetto M, 2007, AUST J BOT, V55, P416, DOI 10.1071/BT06195; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Sharma A, 2011, ZOOL SCI, V28, P25, DOI 10.2108/zsj.28.25; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shull HC, 2005, MOL PHYLOGENET EVOL, V37, P249, DOI 10.1016/j.ympev.2005.04.034; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Sturzenbaum SR, 2009, P ROY SOC B-BIOL SCI, V276, P789, DOI 10.1098/rspb.2008.1510; Swofford DL, 2001, PAUP STAR VER 4 0B10; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Voelker G, 2010, GLOBAL ECOL BIOGEOGR, V19, P111, DOI 10.1111/j.1466-8238.2009.00500.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Williams S. E., 1996, Pacific Conservation Biology, V2, P327; Williams SE, 1997, P ROY SOC B-BIOL SCI, V264, P709, DOI 10.1098/rspb.1997.0101; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zwickl DJ., 2006, THESIS	85	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136943	10.1371/journal.pone.0136943	http://dx.doi.org/10.1371/journal.pone.0136943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366862	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100036
J	Yang, XS; Wang, L; Hao, C; Gu, Y; Song, W; Wang, J; Chang, MM; Zhao, Q				Yang, Xiaoshi; Wang, Lie; Hao, Chun; Gu, Yuan; Song, Wei; Wang, Jian; Chang, Margaret M.; Zhao, Qun			Sex Partnership and Self-Efficacy Influence Depression in Chinese Transgender Women: A Cross-Sectional Study	PLOS ONE			English	Article							HIV-RISK BEHAVIORS; SOCIAL SUPPORT; FUNCTIONAL HEALTH; HORMONE USE; DISCRIMINATION; INDIVIDUALS; PREVALENCE; QUALITY; STRESS; SCALE	Background Transgender women often suffer from transition-related discrimination and loss of social support due to their gender transition, which may pose considerable psychological challenges and may lead to a high prevalence of depression in this population. Increased self-efficacy may combat the adverse effects of gender transition on depression. However, few available studies have investigated the protective effect of self-efficacy on depression among transgender women, and there is a scarcity of research describing the mental health of Chinese transgender women. This study aims to describe the prevalence of depression among Chinese transgender women and to explore the associated factors. Methods A cross-sectional study was conducted in Shenyang, Liaoning Province of China by convenience sampling from January 2014 to July 2014. Two hundred and nine Chinese transgender women were interviewed face-to-face with questionnaires that covered topics including the Zung Self-Rating Depression Scale (SDS), demographic characteristics, transition status, sex partnership, perceived transgender-related discrimination, the Multidimensional Scale of Perceived Social Support (MSPSS) and the adapted General Self-efficacy Scale (GSES). A hierarchical multiple regression analysis was performed to explore the factors associated with SDS scores. Results The prevalence of depression among transgender women was 45.35%. Transgender women with regular partners or casual partners exhibited higher SDS scores than those without regular partners or casual partners. Regression analyses showed that sex partnership explained most (16.6%) of the total variance in depression scores. Self-efficacy was negatively associated with depression. Conclusions Chinese transgender women experienced high levels of depression. Depression was best predicted by whether transgender women had a regular partner or a casual partner rather than transgender-related discrimination and transition status. Moreover, self-efficacy had positive effects on attenuating depression due to gender transition. Therefore, interventions should focus on improving the sense of self-efficacy among these women to enable them to cope with depression and to determine risky sex partnership characteristics, especially for regular and casual partners.	[Yang, Xiaoshi; Wang, Lie; Zhao, Qun] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning Provin, Peoples R China; [Hao, Chun] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Gu, Yuan; Song, Wei] Shenyang Ctr Dis Control & Prevent, Dept AIDS & STD Control, Shenyang, Liaoning Provin, Peoples R China; [Wang, Jian] Chinese Armed Police Force, Liaoning Prov Hosp, Dept Clin Lab, Shenyang, Liaoning Provin, Peoples R China; [Chang, Margaret M.] China Med Univ, Dept Clin Med, Shenyang, Liaoning Provin, Peoples R China; [Hao, Chun] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA	China Medical University; Sun Yat Sen University; China Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Zhao, Q (corresponding author), China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning Provin, Peoples R China.	zhaoqun2014cmu@163.com			National Natural Science of Foundation of China [81302475]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science of Foundation of China, # 81302475, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, to Xiaoshi Yang, for the research on AIDS high risky sexual behavior and risk prediction among Male-to-Female Transgenders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Arnett JJ, 2005, J DRUG ISSUES, V35, P235, DOI 10.1177/002204260503500202; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Barlow JH, 1996, ARTHRIT CARE RES, V9, P189, DOI 10.1002/1529-0131(199606)9:3<189::AID-ANR1790090307>3.0.CO;2-#; Barrientos J, 2010, J HOMOSEXUAL, V57, P760, DOI 10.1080/00918369.2010.485880; Bazargan M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-663; Budge SL, 2013, COUNS PSYCHOL, V41, P601, DOI 10.1177/0011000011432753; Budge SL, 2013, J CONSULT CLIN PSYCH, V81, P545, DOI 10.1037/a0031774; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Clements-Nolle K, 2006, J HOMOSEXUAL, V51, P53, DOI 10.1300/J082v51n03_04; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Curtis R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05569; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Fletcher JB, 2014, ARCH SEX BEHAV, V43, P1651, DOI 10.1007/s10508-014-0368-1; Gooren LJ, 2015, CULT HEALTH SEX, V17, P92, DOI 10.1080/13691058.2014.950982; Gooren LJ, 2013, ASIAN J ANDROL, V15, P280, DOI 10.1038/aja.2012.139; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hoffman B, 2014, DEPRESSION RES TREAT, V2014, DOI [10.1155/2014/394283, DOI 10.1155/2014/394283]; Jefferson Kevin, 2013, Ethn Inequal Health Soc Care, V6, P121; Jiang Q., 2001, CHIN J BEHAV MED SCI, V10, P41, DOI 10.3760/cma.j.issn.1674-6554.2001.01.018; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Kreitler S, 2007, PSYCHO-ONCOLOGY, V16, P329, DOI 10.1002/pon.1063; Lazarus RS, 1984, STRESS APPRAISAL COP, P163; Liu Jun, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P483; [刘泽文 Liu Zewen], 2006, [心理科学进展, ADVANCES IN PSYCHOLOGICAL SCIENCE], V14, P631; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597; Nuttbrock L, 2002, INT J TRANSGENDERISM, V6, P4; Nuttbrock L, 2010, J SEX RES, V47, P12, DOI 10.1080/00224490903062258; Otis MD, 2006, J SOC PERS RELAT, V23, P81, DOI 10.1177/0265407506060179; Pinto RM, 2008, J GAY LESBIAN SOC SE, V20, P203, DOI 10.1080/10538720802235179; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reisner SL, 2009, J ASSOC NURSE AIDS C, V20, P373, DOI 10.1016/j.jana.2009.06.003; Sandfort T, 2013, AIDS BEHAV, V17, pS23, DOI 10.1007/s10461-012-0294-y; Wang Y, 2010, J PREV MED INFORM, V26, P597; Wong CF, 2013, AM J COMMUN PSYCHOL, V51, P439, DOI 10.1007/s10464-012-9562-2; Wu Q-Q., 2005, CHIN J CLIN REHABIL, V9, P4, DOI [10.3321/j.issn:1673-8225.2005.16.002, DOI 10.3321/J.ISSN:1673-8225.2005.16.002]; Yadegarfard M, 2013, CULT HEALTH SEX, V15, P726, DOI 10.1080/13691058.2013.784362; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	42	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136975	10.1371/journal.pone.0136975	http://dx.doi.org/10.1371/journal.pone.0136975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367265	Green Published, gold			2022-12-27	WOS:000361601100039
J	Baldauf, C; Jeschke, A; Kanbach, V; Catala-Lehnen, P; Baumhoer, D; Gerull, H; Buhs, S; Amling, M; Nollau, P; Harroch, S; Schinke, T				Baldauf, Christina; Jeschke, Anke; Kanbach, Vincent; Catala-Lehnen, Philip; Baumhoer, Daniel; Gerull, Helwe; Buhs, Sophia; Amling, Michael; Nollau, Peter; Harroch, Sheila; Schinke, Thorsten			The Protein Tyrosine Phosphatase Rptp zeta Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice	PLOS ONE			English	Article							GRADE CENTRAL OSTEOSARCOMA; GROWTH-FACTOR MIDKINE; GENE-EXPRESSION; DIFFERENTIATED OSTEOBLASTS; P53 MUTATIONS; COPY-NUMBER; IN-VITRO; BETA; CANCER; INACTIVATION	Osteosarcoma (OS), a highly aggressive primary bone tumor, belongs to the most common solid tumors in growing children. Since specific molecular targets for OS treatment remain to be identified, surgical resection combined with multimodal (neo-) adjuvant chemotherapy is still the only way to help respective individuals. We have previously identified the protein tyrosine phosphatase Rptp zeta as a marker of terminally differentiated osteoblasts, which negatively regulates their proliferation in vitro. Here we have addressed the question if Rptp zeta can function as a tumor suppressor protein inhibiting OS development in vivo. We therefore analyzed the skeletal phenotype of mice lacking Ptprz1, the gene encoding Rptp zeta on a tumor-prone genetic background, i.e. Trp53-heterozygosity. By screening a large number of 52 week old Trp53-heterozygous mice by contact radiography we found that Ptprz1-deficiency significantly enhanced OS development with 19% of the mice being affected. The tumors in Ptprz1-deficient Trp53-heterozygous mice were present in different locations (spine, long bones, ribs), and their OS nature was confirmed by undecalcified histology. Likewise, cell lines derived from the tumors were able to undergo osteogenic differentiation ex vivo. A comparison between Ptprz1-heterozygous and Ptprz1-deficient cultures further revealed that the latter ones displayed increased proliferation, a higher abundance of tyrosine-phosphorylated proteins and resistance towards the influence of the growth factor Midkine. Our findings underscore the relevance of Rptp zeta as an attenuator of proliferation in differentiated osteoblasts and raise the possibility that activating Rptp zeta-dependent signaling could specifically target osteoblastic tumor cells.	[Baldauf, Christina; Jeschke, Anke; Kanbach, Vincent; Catala-Lehnen, Philip; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Baumhoer, Daniel] Univ Basel Hosp, Bone Tumor Reference Ctr, CH-4031 Basel, Switzerland; [Baumhoer, Daniel] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Gerull, Helwe; Buhs, Sophia; Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Res Inst Childrens Canc Ctr, D-20246 Hamburg, Germany; [Gerull, Helwe; Buhs, Sophia; Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Harroch, Sheila] Inst Pasteur, Dept Neurosci, F-75624 Paris, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schinke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany.	schinke@uke.de		Catala-Lehnen, Philip/0000-0001-5475-6741	Deutsche Forschungsgemeinschaft [AM103/10-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by a grant from the Deutsche Forschungsgemeinschaft (AM103/10-3; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; BARNEA G, 1994, CELL, V76, P205, DOI 10.1016/0092-8674(94)90328-X; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Diamantopoulou Z, 2012, J BIOL CHEM, V287, P40339, DOI 10.1074/jbc.M112.405852; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gokgoz N, 2001, CANCER, V92, P2181, DOI 10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Kleihues P, 1997, AM J PATHOL, V150, P1; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lietman Steven A, 2010, Cleve Clin J Med, V77 Suppl 1, pS8, DOI 10.3949/ccjm.77.s1.02; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; Machida Kazuya, 2012, Genes Cancer, V3, P353, DOI 10.1177/1947601912459048; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maehara H, 2007, BIOCHEM BIOPH RES CO, V358, P757, DOI 10.1016/j.bbrc.2007.04.183; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mirabello L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv101; Musselman JRB, 2012, INT J MOL EPIDEMIOL, V3, P286; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; Pariser H, 2005, BIOCHEM BIOPH RES CO, V335, P232, DOI 10.1016/j.bbrc.2005.07.060; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Savage SA, 2013, NAT GENET, V45, P799, DOI 10.1038/ng.2645; Savage Sharon A., 2011, Sarcoma, V2011, P548151, DOI 10.1155/2011/548151; Schinke T, 2008, BONE, V42, P524, DOI 10.1016/j.bone.2007.11.009; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Schweigel H, 2013, PROTEOMICS, V13, P1016, DOI 10.1002/pmic.201200353; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sueyoshi T, 2012, CANCER LETT, V316, P23, DOI 10.1016/j.canlet.2011.10.013; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116	63	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137745	10.1371/journal.pone.0137745	http://dx.doi.org/10.1371/journal.pone.0137745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360410	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100079
J	Christensen, AW; Tarp, S; Furst, DE; Dossing, A; Amris, K; Bliddal, H; Taylor, PC; Christensen, R				Christensen, Anton Wulf; Tarp, Simon; Furst, Daniel E.; Dossing, Anna; Amris, Kirstine; Bliddal, Henning; Taylor, Peter C.; Christensen, Robin			Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study	PLOS ONE			English	Article							AMERICAN-COLLEGE; CLINICAL-TRIALS; METAANALYSIS; METHOTREXATE; BIOLOGICS; EFFICACY; REGRESSION	Objective To determine if variations in trial eligibility criteria and patient baseline characteristics could be considered effect modifiers of the treatment response when testing targeted therapies (biological agents and targeted synthetic disease modifying antirheumatic drugs (DMARDs)) for rheumatoid arthritis (RA). Methods We conducted a meta-epidemiological study of all trials evaluating a targeted therapy approved by regulatory authorities for treating RA. The database search was completed on December 11th 2013. Eligible trials reported ACR20 data at months 3-6 and used an addon design. Odds ratios (ORs) were calculated from the response rates and compared among the trial eligibility criteria/patient baseline characteristics of interest. Comparisons are presented as the Ratio of Odds Ratios (ROR). Results Sixty-two trials (19,923 RA patients) were included in the primary analyses using ACR20 response. Overall, targeted therapies constituted an effective treatment (OR 3.96 95% confidence interval (CI) 3.41 to 4.60). The majority of the trial eligibility criteria and patient baseline characteristics did not modify treatment effect. The added benefit of targeted therapies was lower in trials including "DMARD-naive" patients compared with trials including "DMARD inadequate responders" (ROR = 0.45, 95% CI 0.31 to 0.66) and trials including "targeted therapy inadequate responders" (0.50, 95% CI 0.29 to 0.87), test for interaction: p = 0.0002. Longer mean disease duration was associated with a higher likelihood of responding to treatment (beta = 1.05, 95% CI 1.00 to 1.11 OR's per year; p = 0.03). Analyses conducted using DAS28-remission as the outcome supported the above-mentioned findings. Conclusion Our results suggest that a highly selective inclusion is not associated with greater treatment effect, as might otherwise be expected. The added benefit of a targeted therapy was lower in trials including patients who were DMARD-naive and trials including patients with shorter disease durations.	[Christensen, Anton Wulf; Tarp, Simon; Dossing, Anna; Amris, Kirstine; Bliddal, Henning; Christensen, Robin] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark; [Furst, Daniel E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Taylor, Peter C.] Univ Oxford, Botnar Res Ctr, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX1 2JD, England	University of Copenhagen; Bispebjerg Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford	Christensen, R (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark.	robin.christensen@regionh.dk	amris, kirstine/AAZ-2007-2020; Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668; Dossing, Anna/0000-0002-8388-9735; Christensen, Robin/0000-0002-6600-0631	Oak Foundation; Selsbjerg Holding; Region Hovedstadens Forskningsfond	Oak Foundation; Selsbjerg Holding; Region Hovedstadens Forskningsfond	This study is supported financially by The Oak Foundation, Selsbjerg Holding and Region Hovedstadens Forskningsfond. The Oak Foundation, Selsbjerg Holding and Region Hovedstadens Forskningsfond are non-profit funding sources and had no role in the design and conduct of the study or in the collection, analysis, and interpretation of the data or in the preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dossing Anna, 2014, BMJ Open, V4, pe005297, DOI 10.1136/bmjopen-2014-005297; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fox DA, 2012, NEW ENGL J MED, V367, P565, DOI 10.1056/NEJMe1206315; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hwang YG, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0417-8; Kanters S, 2014, RHEUMATOLOGY, V53, P1264, DOI 10.1093/rheumatology/ket492; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Mandema JW, 2011, CLIN PHARMACOL THER, V90, P828, DOI 10.1038/clpt.2011.256; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Portnov BA, 2007, J EXPO SCI ENV EPID, V17, P106, DOI 10.1038/sj.jes.7500533; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rahman MU, 2011, ANN RHEUM DIS, V70, P1631, DOI 10.1136/ard.2010.146043; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2003, ARTHRITIS RHEUM-US, V48, P313, DOI 10.1002/art.10817; Romanelli PRS, 2010, SAO PAULO MED J, V128, P309, DOI 10.1590/S1516-31802010000500013; Tugwell P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4027; Turkstra E, 2011, CURR MED RES OPIN, V27, P1885, DOI 10.1185/03007995.2011.608655; van Vollenhoven RF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-25	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136982	10.1371/journal.pone.0136982	http://dx.doi.org/10.1371/journal.pone.0136982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360583	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100020
J	Grams, ST; Kimoto, KYM; Azevedo, EMD; Lanca, M; de Albuquerque, ALP; de Brito, CMM; Yamaguti, WP				Grams, Samantha Torres; Mota Kimoto, Karen Yumi; de Oliveira Azevedo, Elen Moda; Lanca, Marina; Pereira de Albuquerque, Andre Luis; Moran de Brito, Christina May; Yamaguti, Wellington Pereira			Unidirectional Expiratory Valve Method to Assess Maximal Inspiratory Pressure in Individuals without Artificial Airway	PLOS ONE			English	Article							RESPIRATORY PRESSURES; REFERENCE VALUES; MANEUVERS; TESTS; AGE	Introduction Maximal Inspiratory Pressure (MIP) is considered an effective method to estimate strength of inspiratory muscles, but still leads to false positive diagnosis. Although MIP assessment with unidirectional expiratory valve method has been used in patients undergoing mechanical ventilation, no previous studies investigated the application of this method in subjects without artificial airway. Objectives This study aimed to compare the MIP values assessed by standard method (MIPsta) and by unidirectional expiratory valve method (MIPuni) in subjects with spontaneous breathing without artificial airway. MIPuni reproducibility was also evaluated. Methods This was a crossover design study, and 31 subjects performed MIPsta and MIPuni in a random order. MIPsta measured MIP maintaining negative pressure for at least one second after forceful expiration. MIPuni evaluated MIP using a unidirectional expiratory valve attached to a face mask and was conducted by two evaluators (A and B) at two moments (Tests 1 and 2) to determine interobserver and intraobserver reproducibility of MIP values. Intraclass correlation coefficient (ICC[2,1]) was used to determine intraobserver and interobserver reproducibility. Results The mean values for MIPuni were 14.3% higher (-117.3 +/- 24.8 cmH(2)O) than the mean values for MIPsta (-102.5 +/- 23.9 cmH(2)O) (p<0.001). Interobserver reproducibility assessment showed very high correlation for Test 1 (ICC[2,1] = 0.91), and high correlation for Test 2 (ICC[2,1] = 0.88). The assessment of the intraobserver reproducibility showed high correlation for evaluator A (ICC[2,1] = 0.86) and evaluator B (ICC[2,1] = 0.77). Conclusions MIPuni presented higher values when compared with MIPsta and proved to be reproducible in subjects with spontaneous breathing without artificial airway.	[Grams, Samantha Torres; Mota Kimoto, Karen Yumi; de Oliveira Azevedo, Elen Moda; Lanca, Marina; Pereira de Albuquerque, Andre Luis; Moran de Brito, Christina May; Yamaguti, Wellington Pereira] HSL, Dept Rehabil, Sao Paulo, SP, Brazil; [Pereira de Albuquerque, Andre Luis] HSL, NAT, Dept Pulm Funct, Sao Paulo, SP, Brazil		Yamaguti, WP (corresponding author), HSL, Dept Rehabil, Sao Paulo, SP, Brazil.	wellington.psyamaguti@hsl.org.br	Brito, Christina M/I-7269-2012; Albuquerque, Andre L P/C-8835-2012	Albuquerque, Andre L P/0000-0003-3486-5240				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caruso P, 1999, CHEST, V115, P1096, DOI 10.1378/chest.115.4.1096; Costa D, 2010, J BRAS PNEUMOL, V36, P306, DOI 10.1590/S1806-37132010000300007; FEELEY TW, 1975, NEW ENGL J MED, V292, P903, DOI 10.1056/NEJM197504242921707; Fiore Junior Julio Flavio, 2004, J. bras. pneumol., V30, P515, DOI 10.1590/S1806-37132004000600005; FIZ JA, 1989, THORAX, V44, P419, DOI 10.1136/thx.44.5.419; Fregonezi GAD, 2005, CHEST, V128, P1524, DOI 10.1378/chest.128.3.1524; Gayraud J, 2010, PEDIATR PULM, V45, P552, DOI 10.1002/ppul.21204; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Lin Suh-Jen, 2012, Cardiopulm Phys Ther J, V23, P29; MARINI J J, 1986, Journal of Critical Care, V1, P32, DOI 10.1016/S0883-9441(86)80114-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Munro, 1997, STAT METHODS HLTH CA; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Parreira VF, 2007, BRAZ J PHYS THER, V11, P361, DOI 10.1590/S1413-35552007000500006; Parreira VF, 2012, BRAZ J PHYS THER, V16, P225, DOI 10.1590/S1413-35552012000300008; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; SAHN SA, 1973, CHEST, V63, P1002, DOI 10.1378/chest.63.6.1002; SMYTH RJ, 1984, CHEST, V86, P568, DOI 10.1378/chest.86.4.568; Souza RB, 2002, J PNEUMOL S3, V28, P155; Steier J, 2007, THORAX, V62, P975, DOI 10.1136/thx.2006.072884; Terzano C, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-8; TRUWIT JD, 1992, CHEST, V102, P1216, DOI 10.1378/chest.102.4.1216; Tzanis G, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-14; Wen AS, 1997, CHEST, V111, P802, DOI 10.1378/chest.111.3.802; Wohlgemuth M, 2003, EUR RESPIR J, V22, P1001, DOI 10.1183/09031936.03.00028103; Yamaguti WPS, 2004, REV BRAS TER INTENSI, V16, P142	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137825	10.1371/journal.pone.0137825	http://dx.doi.org/10.1371/journal.pone.0137825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360255	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100090
J	Kreisinger, J; Cizkova, D; Kropackova, L; Albrecht, T				Kreisinger, Jakub; Cizkova, Dagmar; Kropackova, Lucie; Albrecht, Tomas			Cloacal Microbiome Structure in a Long-Distance Migratory Bird Assessed Using Deep 16sRNA Pyrosequencing	PLOS ONE			English	Article							GUT MICROBIOME; GASTROINTESTINAL MICROBIOTA; EVOLUTION; BACTERIA; DIVERSITY; DIET; WILD; ASSEMBLAGES; COMMUNITIES; POPULATIONS	Effects of vertebrate-associated microbiota on physiology and health are of significant interest in current biological research. Most previous studies have focused on host-microbiota interactions in captive-bred mammalian models. These interactions and their outcomes are still relatively understudied, however, in wild populations and non-mammalian taxa. Using deep pyrosequencing, we described the cloacal microbiome (CM) composition in free living barn swallows Hirundo rustica, a long-distance migratory passerine bird. Barn swallow CM was dominated by bacteria of the Actinobacteria, Proteobacteria and Firmicutes phyla. Bacteroidetes, which represent an important proportion of the digestive tract microbiome in many vertebrate species, was relatively rare in barn swallow CM (< 5%). CM composition did not differ between males and females. A significant correlation of CM within breeding pair members is consistent with the hypothesis that cloacal contact during within-pair copulation may promote transfer of bacterial assemblages. This effect on CM composition had a relatively low effect size, however, possibly due to the species' high level of sexual promiscuity.	[Kreisinger, Jakub; Cizkova, Dagmar; Albrecht, Tomas] Acad Sci Czech Republ, Inst Vertebrate Biol, Studenec Res Facil, CS-60365 Brno, Czech Republic; [Kreisinger, Jakub; Kropackova, Lucie; Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, CR-12844 Prague 2, Czech Republic; [Kreisinger, Jakub] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, TN, Italy	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; Fondazione Edmund Mach	Kreisinger, J (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Studenec Res Facil, Kvetna 8, CS-60365 Brno, Czech Republic.	jakubkreisinger@seznam.cz	Kreisinger, Jakub/H-4020-2011; Schmiedová, Lucie/S-3351-2017; Albrecht, Tomas/A-1130-2011	Schmiedová, Lucie/0000-0003-2180-5281; Albrecht, Tomas/0000-0002-9213-0034; Cizkova, Dagmar/0000-0001-5031-7792	Czech Science foundation [P506/12/2472, 14-16596P]; OPVK [CZ.1.07/2.3.00/20.0303]; Czech Academy of Sciences ("Operacni Program pro Vzdelavani a Konkurenceschopnost") [RVO:68081766]; SVV ("Specificky Vysokoskolsky Vyzkum") [260 087/2014]	Czech Science foundation(Grant Agency of the Czech Republic); OPVK; Czech Academy of Sciences ("Operacni Program pro Vzdelavani a Konkurenceschopnost"); SVV ("Specificky Vysokoskolsky Vyzkum")	Field works were funded by Czech Science foundation project P506/12/2472 (http://www.gacr.cz/). Wet-lab procedures and data analyses were funded by Czech Science foundation project 14-16596P. Jakub Kreisinger and Dagmar Cizkova were partially supported by OPVK CZ.1.07/2.3.00/20.0303 and by institutional funding of the Czech Academy of Sciences RVO:68081766 ("Operacni Program pro Vzdelavani a Konkurenceschopnost", http://www.ivb.cz/projekty-nextgenproject-technologie-nove-generace-v-evolucni-genetice.html). Lucie Kropackova was supported by SVV 260 087/2014 ("Specificky Vysokoskolsky Vyzkum", http://www.cuni.cz/UK-3362.html). All these funders are non-commercial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Benskin CMH, 2010, MOL ECOL, V19, P5531, DOI 10.1111/j.1365-294X.2010.04892.x; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bunge J, 2012, BIOINFORMATICS, V28, P1045, DOI 10.1093/bioinformatics/bts075; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cepak J, 2008, ATLAS MIGRACE PTAKU; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; Cho EJ, 2013, ANN LAB MED, V33, P145, DOI 10.3343/alm.2013.33.2.145; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cunningham EJA, 2003, BEHAV ECOL, V14, P326, DOI 10.1093/beheco/14.3.326; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Godoy-Vitorino F, 2012, RES MICROBIOL, V163, P211, DOI 10.1016/j.resmic.2012.01.001; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Hannigan GD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015362; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kokko H, 2002, EVOLUTION, V56, P1091; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Lombardo MP, 1999, BEHAV ECOL, V10, P333, DOI 10.1093/beheco/10.3.333; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mathis D, 2011, CELL HOST MICROBE, V10, P297, DOI 10.1016/j.chom.2011.09.007; May A, 2014, BIOINFORMATICS, V30, P1530, DOI 10.1093/bioinformatics/btu085; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moller AP., 1994, SEXUAL SELECTION BAR; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Poiani A, 2000, AUK, V117, P1061, DOI 10.1642/0004-8038(2000)117[1061:STDAPC]2.0.CO;2; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2021, R LANGUAGE ENV STAT; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Rubolini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048955; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Saino N, 1997, FUNCT ECOL, V11, P604, DOI 10.1046/j.1365-2435.1997.00131.x; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Skraban J, 2013, VET MICROBIOL, V165, P416, DOI 10.1016/j.vetmic.2013.04.014; SMITH HG, 1992, CONDOR, V94, P750, DOI 10.2307/1369260; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Toth EM, 2008, INT J SYST EVOL MICR, V58, P976, DOI 10.1099/ijs.0.65324-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056565; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	78	53	53	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137401	10.1371/journal.pone.0137401	http://dx.doi.org/10.1371/journal.pone.0137401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360776	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100033
J	Louise, C; Vidal, PO; Suesdek, L				Louise, Caroline; Vidal, Paloma Oliveira; Suesdek, Lincoln			Microevolution of Aedes aegypti	PLOS ONE			English	Article							DIPTERA-CULICIDAE POPULATIONS; GENETIC-STRUCTURE; MOSQUITO VECTOR; WING GEOMETRY; DENGUE; PHYLOGEOGRAPHY; ANOPHELES; SOFTWARE; NUMBER; SHAPE	Scientific research into the epidemiology of dengue frequently focuses on the microevolution and dispersion of the mosquito Aedes aegypti. One of the world's largest urban agglomerations infested by Ae. aegypti is the Brazilian megalopolis of Sao Paulo, where >26,900 cases of dengue were reported until June 2015. Unfortunately, the dynamics of the genetic variability of Ae. aegypti in the Sao Paulo area have not been well studied. To reduce this knowledge gap, we assessed the morphogenetic variability of a population of Ae. aegypti from a densely urbanised neighbourhood of Sao Paulo. We tested if allelic patterns could vary over a short term and if wing shape could be a predictor of the genetic variation. Over a period of 14 months, we examined the variation of genetic (microsatellites loci) and morphological (wing geometry) markers in Ae. aegypti. Polymorphisms were detected, as revealed by the variability of 20 microsatellite loci (115 alleles combined; overall F-st = 0.0358) and 18 wing landmarks (quantitative estimator Q(st) = 0.4732). These levels of polymorphism are higher than typically expected to an exotic species. Allelic frequencies of the loci changed over time and temporal variation in the wing shape was even more pronounced, permitting high reclassification levels of chronological samples. In spite of the fact that both markers underwent temporal variation, no correlation was detected between their dynamics. We concluded that microevolution was detected despite the short observational period, but the intensities of change of the markers were discrepant. Wing shape failed from predicting allelic temporal variation. Possibly, natural selection (Q(st)>F-st) or variance of expressivity of wing phenotype are involved in this discrepancy. Other possibly influential factors on microevolution of Ae. aegypti are worth searching. Additionally, the implications of the rapid evolution and high polymorphism of this mosquito vector on the efficacy of control methods have yet to be investigated.	[Louise, Caroline; Vidal, Paloma Oliveira; Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil; [Louise, Caroline; Suesdek, Lincoln] Univ Sao Paulo, Inst Med Trop, Programa Posgrad Med Trop, Sao Paulo, SP, Brazil; [Vidal, Paloma Oliveira] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Biol Relacao Patogenohosp, BR-05508 Sao Paulo, SP, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Suesdek, L (corresponding author), Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil.	lincoln.suesdek@butantan.gov.br	Suesdek, Lincoln/C-7943-2013	Suesdek, Lincoln/0000-0001-6829-738X	FAPESP [2011/18962-8, 2010/15039-1]; CAPES [23038.005274/2011-24, 1275/2011]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by FAPESP Grants 2011/18962-8 (CL) and 2010/15039-1 (POV) and CAPES Grants #23038.005274/2011-24 and #1275/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendonca BAA, 2014, ACTA TROP, V134, P80, DOI 10.1016/j.actatropica.2014.02.014; Belkhir K, 1996, 5171 CNRS UMR U MONT; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2013, J MED ENTOMOL, V50, P294, DOI 10.1603/ME12173; Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8; Calle DA, 2002, MEM I OSWALDO CRUZ, V97, P1191, DOI 10.1590/S0074-02762002000800021; Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Demari-Silva B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-174; Dujardin JP, 2008, INFECT GENET EVOL, V8, P875, DOI 10.1016/j.meegid.2008.07.011; Dujardin JP, 2006, THE CLICK PACKAGE; Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Forattini OP, 2002, CULICIDOLOGIA MED; Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; Huber K, 2001, MOL ECOL NOTES, V1, P219, DOI 10.1046/j.1471-8278.2001.00077.x; Jirakanjanakit N, 2007, TROP MED INT HEALTH, V12, P1354, DOI 10.1111/j.1365-3156.2007.01919.x; Jirakanjanakit N, 2008, INFECT GENET EVOL, V8, P414, DOI 10.1016/j.meegid.2007.05.004; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KLACZKO LB, 1990, NATURE, V346, P321, DOI 10.1038/346321a0; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002; NEI M, 1974, GENETICS, V76, P379; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, FIGTREE V1 4 0 TREE; Rasheed SB, 2013, MED VET ENTOMOL, V27, P430, DOI 10.1111/mve.12001; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROHLF F, 2005, TPSREGR; Rohlf F.J., 2010, TPSUTIL; Rohlf FJ, 2018, TPSDIG; Rohlf FJ, 2010, TPSRELW; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas REM, 2013, INFECT GENET EVOL, V13, P242, DOI 10.1016/j.meegid.2012.08.008; Vidal PO, 2012, INFECT GENET EVOL, V12, P591, DOI 10.1016/j.meegid.2011.11.013; Vidal PO, 2012, MEM I OSWALDO CRUZ, V107, P1030, DOI 10.1590/S0074-02762012000800011; da Costa-Ribeiro MCV, 2006, MEM I OSWALDO CRUZ, V101, P917, DOI 10.1590/S0074-02762006000800015; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, GENET RES, V74, P215, DOI 10.1017/S0016672399004127	53	35	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137851	10.1371/journal.pone.0137851	http://dx.doi.org/10.1371/journal.pone.0137851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360876	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100094
J	Alsharari, SD; King, JR; Nordman, JC; Muldoon, PP; Jackson, A; Zhu, AZX; Tyndale, RF; Kabbani, N; Damaj, MI				Alsharari, Shakir D.; King, Justin R.; Nordman, Jacob C.; Muldoon, Pretal P.; Jackson, Asti; Zhu, Andy Z. X.; Tyndale, Rachel F.; Kabbani, Nadine; Damaj, M. Imad			Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; CIGARETTE SMOKERS; SMOKING-CESSATION; AFRICAN-AMERICAN; UP-REGULATION; INHIBITION; ABSTINENCE	Although menthol, a common flavoring additive to cigarettes, has been found to impact the addictive properties of nicotine cigarettes in smokers little is known about its pharmacological and molecular actions in the brain. Studies were undertaken to examine whether the systemic administration of menthol would modulate nicotine pharmacokinetics, acute pharmacological effects (antinociception and hypothermia) and withdrawal in male ICR mice. In addition, we examined changes in the brain levels of nicotinic receptors of rodents exposed to nicotine and menthol. Administration of i. p. menthol significantly decreased nicotine's clearance (2-fold decrease) and increased its AUC compared to i. p. vehicle treatment. In addition, menthol pretreatment prolonged the duration of nicotine-induced antinociception and hypothermia (2.5 mg/kg, s. c.) for periods up to 180 min post-nicotine administration. Repeated administration of menthol with nicotine increased the intensity of mecamylamine-precipitated withdrawal signs in mice exposed chronically to nicotine. The potentiation of withdrawal intensity by menthol was accompanied by a significant increase in nicotine plasma levels in these mice. Western blot analyses of alpha 4 and beta 2 nAChR subunit expression suggests that chronic menthol impacts the levels and distribution of these nicotinic subunits in various brain regions. In particular, co-administration of menthol and nicotine appears to promote significant increase in beta 2 and alpha 4 nAChR subunit expression in the hippocampus, prefrontal cortex and striatum of mice. Surprisingly, chronic injections of menthol alone to mice caused an upregulation of beta 2 and alpha 4 nAChR subunit levels in these brain regions. Because the addition of menthol to tobacco products has been suggested to augment their addictive potential, the current findings reveal several new pharmacological molecular adaptations that may contribute to its unique addictive profile.	[Alsharari, Shakir D.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Alsharari, Shakir D.; Muldoon, Pretal P.; Jackson, Asti; Damaj, M. Imad] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [King, Justin R.; Nordman, Jacob C.; Kabbani, Nadine] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Zhu, Andy Z. X.; Tyndale, Rachel F.] Univ Toronto, Dept Pharmacol & Toxicol & Psychiat, Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada	King Saud University; Virginia Commonwealth University; George Mason University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Kabbani, N (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA.	nkabbani@gmu.edu	AlSharari, Shakir/AAC-9103-2020	Nordman, Jacob/0000-0003-2513-7831; Tyndale, Rachel/0000-0003-1297-2053	National Institute on Drug Abuse [DA-05274, DA020830]; Endowed Chair in Addiction for the Department of Psychiatry; Canadian Institutes of Health Research [MOP86471, TMH109787]; Centre for Addiction and Mental Health (CAMH) foundation; Canada Foundation for Innovation [20289, 16014]; Ontario Ministry of Research and Innovation; Virginia Foundation for Healthy Youth; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830, P30DA033934, T32DA007027] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Endowed Chair in Addiction for the Department of Psychiatry; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Addiction and Mental Health (CAMH) foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Virginia Foundation for Healthy Youth; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse grant # DA-05274 (MID), DA020830 (RFT), http://www.drugabuse.gov/; the Endowed Chair in Addiction for the Department of Psychiatry (RFT), http://www.psychiatry.utoronto.ca/endowed-chairs/; Canadian Institutes of Health Research (MOP86471 and TMH109787) (RFT), http://www.cihr-irsc.gc.ca/e/193.html; Centre for Addiction and Mental Health (CAMH) foundation (RFT), www.camh.ca; the Canada Foundation for Innovation (#20289 and #16014) (RFT), http://www.innovation.ca/; the Ontario Ministry of Research and Innovation (RFT), https://www.ontario.ca/ministry-research-innovation; and Virginia Foundation for Healthy Youth (NK), http://www.vfhy.org/.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Ashoor A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067674; Bagdas D, 2014, NEUROPHARMACOLOGY, V85, P67, DOI 10.1016/j.neuropharm.2014.05.006; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Brody AL, 2013, INT J NEUROPSYCHOPH, V16, P957, DOI 10.1017/S1461145712001022; Cosgrove KP, 2009, ARCH GEN PSYCHIAT, V66, P666, DOI 10.1001/archgenpsychiatry.2009.41; Dessirier JM, 2001, PHYSIOL BEHAV, V73, P25, DOI 10.1016/S0031-9384(01)00431-0; Gandhi KK, 2009, INT J CLIN PRACT, V63, P360, DOI 10.1111/j.1742-1241.2008.01969.x; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Isola R, 1999, BRAIN RES, V850, P189, DOI 10.1016/S0006-8993(99)02131-9; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kramlinger VM, 2012, CHEM-BIOL INTERACT, V197, P87, DOI 10.1016/j.cbi.2012.03.009; MacDougall JM, 2003, CHEM RES TOXICOL, V16, P988, DOI 10.1021/tx0340551; Okuyemi KS, 2007, ADDICTION, V102, P1979, DOI 10.1111/j.1360-0443.2007.02010.x; Pan R, 2012, J PHARMACOL EXP THER, V343, P661, DOI 10.1124/jpet.112.196717; Pletcher MJ, 2006, ARCH INTERN MED, V166, P1915, DOI 10.1001/archinte.166.17.1915; Ruskin D, 2008, NICOTINE TOB RES, V10, P1753, DOI 10.1080/14622200802443734; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Williams JM, 2007, NICOTINE TOB RES, V9, P873, DOI 10.1080/14622200701484995; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383	24	59	59	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137070	10.1371/journal.pone.0137070	http://dx.doi.org/10.1371/journal.pone.0137070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355604	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800027
J	Beernaert, K; Deliens, L; Pardon, K; Van den Block, L; Devroey, D; Chambaere, K; Cohen, J				Beernaert, Kim; Deliens, Luc; Pardon, Koen; Van den Block, Lieve; Devroey, Dirk; Chambaere, Kenneth; Cohen, Joachim			What Are Physicians' Reasons for Not Referring People with Life-Limiting Illnesses to Specialist Palliative Care Services? A Nationwide Survey	PLOS ONE			English	Article							DEATH CERTIFICATES; CANCER-PATIENTS; OLDER-PEOPLE; DEMENTIA; END; POPULATION; BARRIERS; BELGIUM; FLANDERS; FACILITATORS	Background Many people who might benefit from specialist palliative care services are not using them. Aim We examined the use of these services and the reasons for not using them in a population in potential need of palliative care. Methods We conducted a population-based survey regarding end-of-life care among physicians certifying a large representative sample (n = 6188) of deaths in Flanders, Belgium. Results Palliative care services were not used in 79% of cases of people with organ failure, 64% of dementia and 44% of cancer. The most frequently indicated reasons were that 1) existing care already sufficiently addressed palliative and supportive needs (56%), 2) palliative care was not deemed meaningful (26%) and 3) there was insufficient time to initiate palliative care (24%). The reasons differed according to patient characteristics: in people with dementia the consideration of palliative care as not meaningful was more likely to be a reason for not using it; in older people their care needs already being sufficiently addressed was more likely to be a reason. For those patients who were referred the timing of referral varied from a median of six days before death (organ failure) to 16 days (cancer). Conclusions Specialist palliative care is not initiated in almost half of the people for whom it could be beneficial, most frequently because physicians deem regular caregivers to be sufficiently skilled in addressing palliative care needs. This would imply that the safeguarding of palliative care skills in this regular 'general' care is an essential health policy priority.	[Beernaert, Kim; Deliens, Luc; Pardon, Koen; Van den Block, Lieve; Chambaere, Kenneth; Cohen, Joachim] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Beernaert, Kim; Deliens, Luc; Pardon, Koen; Van den Block, Lieve; Chambaere, Kenneth; Cohen, Joachim] Univ Ghent, Brussels, Belgium; [Van den Block, Lieve; Devroey, Dirk] Vrije Univ Brussel, Dept Family Med & Chron Care, Brussels, Belgium; [Deliens, Luc] Univ Hosp Ghent, Dept Med Oncol, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Beernaert, K (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.	kim.beernaert@vub.ac.be	Chambaere, Kenneth/ACV-2311-2022; Cohen, Joachim/B-6803-2008; Van den Block, Lieve/D-1247-2011	Cohen, Joachim/0000-0002-7224-9476; Van den Block, Lieve/0000-0002-7770-348X; Devroey, Dirk/0000-0002-6083-2998; Deliens, Luc/0000-0002-8158-2422; Beernaert, Kim/0000-0002-2520-3977; Pardon, Koen/0000-0002-0571-709X	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT) [100036]	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT)	This study is part of the 'Flanders Study to Improve End-of-Life Care and Evaluation Tools (FLIECE-project)', a collaboration between the Vrije Universiteit Brussel, Ghent University, the Katholieke Universiteit Leuven, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. This study is supported by a grant from the Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT nr. 100036).	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Albinsson L, 2003, PALLIATIVE MED, V17, P359, DOI 10.1191/0269216303pm669oa; Arber A, 2010, INT J PALLIAT NURS, V16, P24, DOI 10.12968/ijpn.2010.16.1.46180; Barnato AE, 2005, JAMA-J AM MED ASSOC, V293, P1591, DOI 10.1001/jama.293.13.1591-b; Beernaert K, 2014, PALLIATIVE MED, V28, P480, DOI 10.1177/0269216314522318; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Brickner Leslea, 2004, J Palliat Med, V7, P411, DOI 10.1089/1096621041349518; Catt S, 2005, PALLIATIVE MED, V19, P402, DOI 10.1191/0269216305pm1037oa; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Claessen SJJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625184; Cohen J, 2011, J PAIN SYMPTOM MANAG, V42, P839, DOI 10.1016/j.jpainsymman.2011.02.017; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Currow DC, 2008, PALLIATIVE MED, V22, P43, DOI 10.1177/0269216307085182; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Gibbins J, 2009, CLIN MED, V9, P116, DOI 10.7861/clinmedicine.9-2-116; Hearn J, 1998, PALLIATIVE MED, V12, P317, DOI 10.1191/026921698676226729; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Higginson IJ, 2002, J PAIN SYMPTOM MANAG, V23, P96, DOI 10.1016/S0885-3924(01)00406-7; Hughes JC, 2005, BRIT MED J, V330, P57, DOI 10.1136/bmj.330.7482.57; Hui D, 2012, ONCOLOGIST, V17, P1574, DOI 10.1634/theoncologist.2012-0192; Johnson C, 2011, J PALLIAT MED, V14, P429, DOI 10.1089/jpm.2010.0259; Meeussen K, 2012, INT PSYCHOGERIATR, V24, P1581, DOI 10.1017/S1041610212000865; Miyashita M, 2007, J PALLIAT MED, V10, P390, DOI 10.1089/jpm.2006.0154; Pivodic L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084440; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Rosenwax LK, 2005, PALLIATIVE MED, V19, P556, DOI 10.1191/0269216305pm1067oa; Ryan T, 2012, PALLIATIVE MED, V26, P879, DOI 10.1177/0269216311423443; Sachs GA, 2004, J GEN INTERN MED, V19, P1057, DOI 10.1111/j.1525-1497.2004.30329.x; Sampson EL, 2006, AGE AGEING, V35, P187, DOI 10.1093/ageing/afj025; Teno JM, 2005, JAMA-J AM MED ASSOC, V293, P1591, DOI 10.1001/jama.293.13.1591-a; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Vandervoort A, 2013, J AM MED DIR ASSOC, V14, P485, DOI 10.1016/j.jamda.2013.01.016; Vig EK, 2010, J GEN INTERN MED, V25, P1009, DOI 10.1007/s11606-010-1423-9; Walshe C, 2008, SOC SCI MED, V67, P137, DOI 10.1016/j.socscimed.2008.03.027; World Health Organization, STRENGTH PALL CAR CO	37	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137251	10.1371/journal.pone.0137251	http://dx.doi.org/10.1371/journal.pone.0137251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356477	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800035
J	Zong, JW; Zhao, TT; Ma, QH; Liang, LS; Wang, GX				Zong, Jian-Wei; Zhao, Tian-Tian; Ma, Qing-Hua; Liang, Li-Song; Wang, Gui-Xi			Assessment of Genetic Diversity and Population Genetic Structure of Corylus mandshurica in China Using SSR Markers	PLOS ONE			English	Article							AVELLANA L. CULTIVARS; MICROSATELLITE MARKERS; LINKAGE MAP; HAZELNUT; SOFTWARE; TRANSFERABILITY; GERMPLASM; ALLELES; SHANXI; NUMBER	Corylus mandshurica, also known as pilose hazelnut, is an economically and ecologically important species in China. In this study, ten polymorphic simple sequence repeat (SSR) markers were applied to evaluate the genetic diversity and population structure of 348 C. mandshurica individuals among 12 populations in China. The SSR markers expressed a relatively high level of genetic diversity (Na = 15.3, Ne = 5.6604, I = 1.8853, Ho = 0.6668, and He = 0.7777). According to the coefficient of genetic differentiation (F-st = 0.1215), genetic variation within the populations (87.85%) were remarkably higher than among populations (12.15%). The average gene flow (Nm = 1.8080) significantly impacts the genetic structure of C. mandshurica populations. The relatively high gene flow (Nm = 1.8080) among wild C. mandshurica may be caused by wind-pollinated flowers, highly nutritious seeds and self-incompatible mating system. The UPGMA (unweighted pair group method of arithmetic averages) dendrogram was divided into two main clusters. Moreover, the results of STRUCTURE analysis suggested that C. mandshurica populations fell into two main clusters. Comparison of the UPGMA dendrogram and the Bayesian STRUCTURE analysis showed general agreement between the population subdivisions and the genetic relationships among populations of C. mandshurica. Group I accessions were located in Northeast China, while Group II accessions were in North China. It is worth noting that a number of genetically similar populations were located in the same geographic region. The results further showed that there was obvious genetic differentiation among populations from Northeast China to North China. Results from the Mantel test showed a weak but still significant positive correlation between Nei's genetic distance and geographic distance (km) among populations (r = 0.419, P = 0.005), suggesting that genetic differentiation in the 12 C. mandshurica populations might be related to geographic distance. These data provide comprehensive information for the development of conservation strategies of these valuable hazelnut resources.	[Zong, Jian-Wei; Zhao, Tian-Tian; Ma, Qing-Hua; Liang, Li-Song; Wang, Gui-Xi] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Zong, Jian-Wei] Pingdingshan Univ, Coll Resource & Environm Sci, Pingdingshan, Henan Province, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Pingdingshan University	Zhao, TT (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	Zhaotian1984@163.com; Wanggx0114@126.com		Zhao, Tiantian/0000-0003-2700-5314	Beijing Municipal Natural Science Foundation [6144030]; Special Fund from State Forestry Administration in the Public Interest [201304710]; Special Fund for Basic Scientific Research Business of Central Public Research Institutes [RIF2013-10]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Special Fund from State Forestry Administration in the Public Interest; Special Fund for Basic Scientific Research Business of Central Public Research Institutes	This work was supported by Beijing Municipal Natural Science Foundation (Grant No. 6144030, http://www.bjnsf.org/), the Special Fund from State Forestry Administration in the Public Interest (Grant No. 201304710, http://www.forestry.gov.cn/), and Special Fund for Basic Scientific Research Business of Central Public Research Institutes (Grant No. RIF2013-10, http://rif.caf.ac.cn/).	Bacchetta L, 2015, GENET RESOUR CROP EV, V62, P649, DOI 10.1007/s10722-014-0173-7; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Bassil NV, 2005, J AM SOC HORTIC SCI, V130, P543, DOI 10.21273/JASHS.130.4.543; Bassil NV, 2005, ACTA HORTIC, V686, P105, DOI DOI 10.17660/ACTAHORTIC.2005.686.13; Boccacci P, 2006, GENOME, V49, P598, DOI 10.1139/G06-017; Boccacci P, 2005, MOL ECOL NOTES, V5, P934, DOI 10.1111/j.1471-8286.2005.01121.x; Boccacci P, 2008, HORTSCIENCE, V43, P667, DOI 10.21273/HORTSCI.43.3.667; Boccacci P, 2010, SCI HORTIC-AMSTERDAM, V124, P128, DOI 10.1016/j.scienta.2009.12.015; Cheng Lili, 2009, Scientia Silvae Sinicae, V45, P22; Di XiaoiaoYao, 2014, Plant Omics, V7, P213; Doyle J. J., 1987, PHYTOCHEM B, P11; Editorial Board of flora of China, 1979, FLORA CHINA; Erfatpour M, 2011, AUST J CROP SCI, V5, P1286; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fritsch Peter, 1996, P54; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gerber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085130; Gokirmak T, 2005, ACTA HORTIC, P141; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Gurcan K, 2010, PLANT BREEDING, V129, P422, DOI 10.1111/j.1439-0523.2009.01753.x; Hamrick J. L., 1990, PLANT POPULATION GEN; KIMURA M, 1964, GENETICS, V49, P725; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; Li Shiming, 2010, MODERN MANAGEMENT SC, V12, P1; Liu HJ, 2013, J CHIN CERE OILS ASS, V28, P41; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Mayr Ernst, 1997, EVOLUTION DIVERSITY; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Mohammadzedeh M, 2014, SCI HORTIC-AMSTERDAM, V167, P17, DOI 10.1016/j.scienta.2013.12.025; Muehlbauer MF, 2014, J AM SOC HORTIC SCI, V139, P399, DOI 10.21273/JASHS.139.4.399; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rowland LJ, 2014, MOL BREEDING, V34, P2033, DOI 10.1007/s11032-014-0161-9; Sathuvalli VR, 2011, TREE GENET GENOMES, V7, P337, DOI 10.1007/s11295-010-0335-5; Sathuvalli VR, 2012, GENET RESOUR CROP EV, V59, P1055, DOI 10.1007/s10722-011-9743-0; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valentini N, 2014, SCI HORTIC-AMSTERDAM, V165, P303, DOI 10.1016/j.scienta.2013.11.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang GX, 1992, SHANXI FOREST; Wang Y., 2008, THESIS BEIJING FORES; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wu Z, 1995, VEGETATION IN CHINA; Zhang Peng-Fei, 2014, Plant Science Journal, V32, P131, DOI 10.3724/SP.J.1142.2014.20131; [张艳波 ZHANG Yanbo], 2007, [吉林农业科学, Journal of Jilin Agricultural Sciences], V32, P56; [赵娣 Zhao Di], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P87	50	27	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137528	10.1371/journal.pone.0137528	http://dx.doi.org/10.1371/journal.pone.0137528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355595	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800057
J	Bennabi, M; Delorme, R; Oliveira, J; Fortier, C; Lajnef, M; Boukouaci, W; Feugeas, JP; Marzais, F; Gaman, A; Charron, D; Ghaleh, B; Krishnamoorthy, R; Leboyer, M; Tamouza, R				Bennabi, Meriem; Delorme, Richard; Oliveira, Jose; Fortier, Catherine; Lajnef, Mohamed; Boukouaci, Wahid; Feugeas, Jean-Paul; Marzais, Francois; Gaman, Alexandru; Charron, Dominique; Ghaleh, Bijan; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad			Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; INNATE IMMUNITY; FAMILY-HISTORY; CHILDREN; RECEPTOR; SYMPTOMS; RISK; HOSPITALIZATION; ABNORMALITIES; ASSOCIATION	Introduction In autism spectrum disorders (ASD), complex gene-environment interactions contribute to disease onset and progress. Given that gastro-intestinal dysfunctions are common in ASD, we postulated involvement of microbial dysbiosis in ASD and investigated, under a case-control design, the influence of DNA polymorphisms in the CLEC7A gene that encodes a pivotal fungal sensor, Dectin-1. Material and methods DNAs from 478 ASD patients and 351 healthy controls (HC) were analyzed for the CLEC7A rs16910631G/A and rs2078178 A/G single nucleotide polymorphisms (SNPs). Differences in the distribution of allele, genotype and haplotype by Chi-square testing and nonparametric analysis by Kruskal-Wallis/Mann-Whitney tests, where appropriate, were performed. The free statistical package R. 2.13 software was used for the statistical analysis. Results We found that the CLEC7A rs2078178 G allele and GG genotype were more prevalent in HC as compared to ASD but failed to reach statistical significance for the latter (pc = 0.01, 0.06 respectively). However, after phenotype-based stratification, the CLEC7A rs2078178 G allele and GG genotype were found to be significantly more frequent in the Asperger group as compared to other ASD subsets (pc = 0.02, 0.01), a finding reinforced by haplotype analysis (rs2078178/rs16910631 G-G/G-G) (pc = 0.002). Further, intellectual quotient (IQ)-based stratification of ASD patients revealed that IQ values increase linearly along the CLEC7A rs2078178 AA, AG and GG genotypes (p = 0.05) and in a recessive manner (GG vs. AA+AG p = 0.02), further confirmed by haplotype distribution (CLEC7A rs2078178-16910631; A-G/A-G, A-G/G-G and G-G/G-G, p = 0.02, G-G/G-G vs. others, p = 0.01). Conclusion Our data suggest that the genetic diversity of CLEC7A gene influences the ASD phenotype by behaving as a disease specifier and imply that the genetic control of innate immune response could determine the ASD phenotype.	[Bennabi, Meriem; Oliveira, Jose; Boukouaci, Wahid; Krishnamoorthy, Rajagopal; Tamouza, Ryad] Hop St Louis, INSERM, U1160, Paris, France; [Bennabi, Meriem; Oliveira, Jose; Lajnef, Mohamed; Gaman, Alexandru; Leboyer, Marion] Hop Henri Mondor, INSERM, U955, Psychiat Genet, F-94010 Creteil, France; [Bennabi, Meriem; Oliveira, Jose; Lajnef, Mohamed; Gaman, Alexandru; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad] Fdn FondaMental, Creteil, France; [Delorme, Richard] Hop Robert Debre, DHU Protect, Serv Psychiat Enfant & Adolescent, F-75019 Paris, France; [Delorme, Richard] Inst Pasteur, Dept Genet Humaine & Fonct Cognit, Paris, France; [Fortier, Catherine; Marzais, Francois; Charron, Dominique; Tamouza, Ryad] Hop St Louis, Lab Jean Dausset, Paris, France; [Fortier, Catherine; Marzais, Francois; Charron, Dominique; Tamouza, Ryad] Hop St Louis, LabEx Transplantex, Paris, France; [Feugeas, Jean-Paul] Hop Bichat Claude Bernard, INSERM, U1137, F-75877 Paris, France; [Feugeas, Jean-Paul; Charron, Dominique; Tamouza, Ryad] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ghaleh, Bijan] Hop Univ Henri Mondor, Ctr Ressources Biol, Creteil, France; [Leboyer, Marion] Hop Univ Henri Mondor, AP HP, Pole Psychiat, DHU PePSY, Creteil, France; [Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Tamouza, R (corresponding author), Hop St Louis, INSERM, U1160, Paris, France.	tamouza.ryad@gmail.com	Oliveira, José/P-8459-2019; Leboyer, Marion/AAW-3648-2021; Tamouza, Ryad/AGQ-6644-2022	Oliveira, José/0000-0003-3475-4794; Leboyer, Marion/0000-0001-5473-3697; Delorme, Richard/0000-0002-5614-3663; Charron, Dominique/0000-0001-7689-8038; Ghaleh, Bijan/0000-0003-0061-5462				Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Cao Xinyi, 2013, Shanghai Arch Psychiatry, V25, P342, DOI 10.3969/j.issn.1002-0829.2013.06.003; Centers for disease and prevention, 2014, 63 MMWR SURV SUMM CE, P1; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Guerini FR, 2015, BRAIN BEHAV IMMUN, V44, P207, DOI 10.1016/j.bbi.2014.10.002; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jyonouchi H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0187-2; Jyonouchi H, 2011, J NEUROIMMUNOL, V238, P73, DOI 10.1016/j.jneuroim.2011.07.001; Jyonouchi H, 2010, EXPERT REV CLIN IMMU, V6, P397, DOI [10.1586/eci.10.18, 10.1586/ECI.10.18]; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Krigsman A., 2010, AUTISM INSIGHTS, V2, P1; Lauritsen MB, 2013, EUR CHILD ADOLES PSY, V22, pS37, DOI 10.1007/s00787-012-0359-5; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McLean MH, 2015, GUT, V64, P332, DOI [10.1136/gutjnl-2014-308514, 10.1136/gutjnl-2013-306499]; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; Oliveira J, 2014, J AFFECT DISORDERS, V165, P135, DOI 10.1016/j.jad.2014.04.059; Oliveira J, 2014, J AFFECT DISORDERS, V152, P395, DOI 10.1016/j.jad.2013.09.043; Pagan C, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.120; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schippa S, 2014, NUTRIENTS, V6, P5786, DOI 10.3390/nu6125786; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Wang Harold Z., 2013, Frontiers in Genetics, V4, P195, DOI 10.3389/fgene.2013.00195; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V55, P322, DOI 10.1016/j.neubiorev.2015.05.004; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Zerbo O, 2013, J AUTISM DEV DISORD	43	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137339	10.1371/journal.pone.0137339	http://dx.doi.org/10.1371/journal.pone.0137339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352598	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800075
J	Edwards, HM; Canavati, SE; Rang, C; Ly, P; Sovannaroth, S; Canier, L; Khim, N; Menard, D; Ashton, RA; Meek, SR; Roca-Feltrer, A				Edwards, Hannah M.; Canavati, Sara E.; Rang, Chandary; Ly, Po; Sovannaroth, Siv; Canier, Lydie; Khim, Nimol; Menard, Didier; Ashton, Ruth A.; Meek, Sylvia R.; Roca-Feltrer, Arantxa			Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; NEW-GUINEAN CHILDREN; FALCIPARUM POPULATIONS; MALARIA TRANSMISSION; CHALLENGES; PARASITE; DISEASE; MOVEMENT; SPREAD; THREAT	Background Human population movement across country borders presents a real challenge for malaria control and elimination efforts in Cambodia and its neighbouring countries. To quantify Plasmodium infection among the border-crossing population, including asymptomatic and artemisinin resistant (AR) parasites, three official border crossing points, one from each of Cambodia's borders with Thailand, Laos and Vietnam, were selected for sampling. Methods and Findings A total of 3206 participants (of 4110 approached) were recruited as they crossed the border, tested for malaria and interviewed. By real-time polymerase chain reaction (RT-PCR), 5.4% of all screened individuals were found to harbour Plasmodium parasites. The proportion was highest at the Laos border (11.5%). Overall there were 97 P. vivax (55.7%), 55 P. falciparum (31.6%), two P. malariae (1.1%) and 20 mixed infections (11.5%). Of identified infections, only 20% were febrile at the time of screening. Of the 24 P. falciparum samples where a further PCR was possible to assess AR, 15 (62.5%) had mutations in the K13 propeller domain gene, all from participants at the Laos border point. Malaria rapid diagnostic test (RDT) pLDH/HRP-2 identified a positivity rate of 3.2% overall and sensitivity compared to RT-PCR was very low (43.1%). Main individual risk factors for infection included sex, fever, being a forest-goer, poor knowledge of malaria prevention methods and previous malaria infection. Occupation, day of the week and time of crossing (morning vs. afternoon) also appeared to play an important role in predicting positive cases. Conclusions This study offers a novel approach to identify asymptomatic infections and monitor AR parasite flow among mobile and migrant populations crossing the borders. Similar screening activities are recommended to identify other hot borders and characterise potential hot spots of AR. Targeted "customised" interventions and surveillance activities should be implemented in these sites to accelerate elimination efforts in the region.	[Edwards, Hannah M.; Canavati, Sara E.; Rang, Chandary; Ashton, Ruth A.; Meek, Sylvia R.; Roca-Feltrer, Arantxa] Malaria Consortium, Phnom Penh, Cambodia; [Ly, Po; Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control CNM, Phnom Penh, Cambodia; [Canier, Lydie; Khim, Nimol; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia	National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Roca-Feltrer, A (corresponding author), Malaria Consortium, Phnom Penh, Cambodia.	a.roca@malariaconsortium.org	Menard, Didier/O-3294-2013; Roca-Feltrer, Arantxa/AAW-6986-2020; Ashton, Ruth/GPS-9349-2022; Ashton, Ruth/S-7822-2019	Menard, Didier/0000-0003-1357-4495; Ashton, Ruth/0000-0002-7248-7730	UKaid from the UK Government	UKaid from the UK Government	This study was funded by UKaid from the UK Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PAR CONF MAL DIAGN R; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; ASEAN, 2008, ASEAN EC COMM BLUEPR; Bhumiratana A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/363417; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Cambodian National Institute of Statistics, 2008, GEN POP CENS 2008 AG; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; CNM, 2011, NAT STRAT PLAN EL MA; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dysoley L, 2010, CAMBODIA MALARIA SUR; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kitvatanachai Sirima, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P48; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Mharakurwa S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-89; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; PROTHERO RM, 1961, B WORLD HEALTH ORGAN, V24, P405; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P166; StataCorp, 2011, STAT STAT SOFTW REL; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; WHO F CDC TDR, 2012, MAL RAP DIAGN TEST P	34	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0124300	10.1371/journal.pone.0124300	http://dx.doi.org/10.1371/journal.pone.0124300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352262	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800001
J	Heu, CC; Kurtti, TJ; Nelson, CM; Munderloh, UG				Heu, Chan C.; Kurtti, Timothy J.; Nelson, Curtis M.; Munderloh, Ulrike G.			Transcriptional Analysis of the Conjugal Transfer Genes of Rickettsia bellii RML 369-C	PLOS ONE			English	Article							HOST CELL-INTERACTIONS; TIME QUANTITATIVE PCR; MESSENGER-RNA DECAY; CHICKEN-EMBRYO; IN-VITRO; PLASMID; PROTEIN; EVOLUTION; QUANTIFICATION; IDENTIFICATION	Rickettsia bellii is an obligate intracellular bacterium that is one of the few rickettsiae that encode a complete set of conjugative transfer (tra) genes involved in bacterial conjugation and has been shown to exhibit pili-like structures. The reductive genomes of rickettsiae beg the question whether the tra genes are nonfunctional or functioning to enhance the genetic plasticity and biology of rickettsiae. We characterized the transcriptional dynamics of R. bellii tra genes in comparison to genes transcribed stably and above the background level to understand when and at what levels the tra genes are active or whether the tra genes are degenerative. We determined that the best reference genes, out of 10 tested, were methionyl tRNA ligase (metG) or a combination of metG and ribonucleoside diphosphate reductase 2 subunit beta (nrdF), using statistical algorithms from two different programs: Normfinder and BestKeeper. To validate the use of metG with other rickettsial genes exhibiting variable transcriptional patterns we examined its use with sca2 and rickA, genes involved in actin based motility. Both were shown to be up-regulated at different times of replication in Vero cells, showing variable and stable transcription levels of rickA and sca2, respectively. traATi was up-regulated at 72 hours post inoculation in the tick cell line ISE6, but showed no apparent changes in the monkey cell line Vero and mouse cell line L929. The transcription of tra genes was positively correlated with one another and up-regulated from 12 to 72 hours post inoculation (HPI) when compared to RBE_0422 (an inactivated transposase-derivative found within the tra cluster). Thus, the up-regulation of the tra genes indicated that the integrity and activity of each gene were intact and may facilitate the search for the optimal conditions necessary to demonstrate conjugation in rickettsiae.	[Heu, Chan C.; Kurtti, Timothy J.; Nelson, Curtis M.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Heu, CC (corresponding author), Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA.	heuxx012@umn.edu		Heu, Chan/0000-0002-5235-288X	UGM, National Institutes of Health [5RO1AI081690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081690] Funding Source: NIH RePORTER	UGM, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by UGM, National Institutes of Health, funding number 5RO1AI081690.	AltMorbe J, 1996, J BACTERIOL, V178, P4248, DOI 10.1128/jb.178.14.4248-4257.1996; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anthony KG, 1999, J BACTERIOL, V181, P5149, DOI 10.1128/JB.181.17.5149-5159.1999; Audette GF, 2007, MICROBIOL-SGM, V153, P442, DOI 10.1099/mic.0.2006/001917-0; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Bellanger X, 2014, FEMS MICROBIOL REV, V38, P720, DOI 10.1111/1574-6976.12058; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; FIRTH N, 1992, MOL GEN GENET, V232, P145, DOI 10.1007/BF00299147; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Frost LS, 1998, MICROBIOL-SGM, V144, P2579, DOI 10.1099/00221287-144-9-2579; Galletti MFBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077388; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gaywee J, 2002, INFECT IMMUN, V70, P6346, DOI 10.1128/IAI.70.11.6346-6354.2002; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2015, GENOME BIOL EVOL, V7, P35, DOI 10.1093/gbe/evu262; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Haglund CM, 2011, RICKETTSIA SCA2 IS B; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez-Lopez A, 2013, GENOME BIOL EVOL, V5, P2305, DOI 10.1093/gbe/evt178; HOPPS HE, 1959, J IMMUNOL, V82, P161; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; Koraimann G, 1996, MOL GEN GENET, V250, P466; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kurtti TJ, 2015, INT J SYST EVOL MICR; Lang S, 2011, MOL MICROBIOL, V82, P1071, DOI 10.1111/j.1365-2958.2011.07872.x; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANNING PA, 1981, P NATL ACAD SCI-BIOL, V78, P7487, DOI 10.1073/pnas.78.12.7487; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marrero J, 2005, DEV CELL, V8, P963, DOI 10.1016/j.devcel.2005.05.004; Matson SW, 2005, J BACTERIOL, V187, P697, DOI 10.1128/JB.187.2.697-706.2005; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; NELSON WC, 1995, J BIOL CHEM, V270, P28374; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver JD, 2013, APPL ENVIRON MICROB; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ragonese H, 2007, MOL MICROBIOL, V63, P1173, DOI 10.1111/j.1365-2958.2006.05576.x; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; SILVERMAN DJ, 1980, INFECT IMMUN, V29, P778; Weinert LA, 2009, P R SOC B, V276, P3619, DOI 10.1098/rspb.2009.0875; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; WISSEMAN CL, 1976, INFECT IMMUN, V14, P1052, DOI 10.1128/IAI.14.4.1052-1064.1976; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137214	10.1371/journal.pone.0137214	http://dx.doi.org/10.1371/journal.pone.0137214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352829	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800068
J	Kyeong, S; Park, S; Cheon, KA; Kim, JJ; Song, DH; Kim, E				Kyeong, Sunghyon; Park, Seonjeong; Cheon, Keun-Ah; Kim, Jae-Jin; Song, Dong-Ho; Kim, Eunjoo			A New Approach to Investigate the Association between Brain Functional Connectivity and Disease Characteristics of Attention-Deficit/Hyperactivity Disorder: Topological Neuroimaging Data Analysis	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; ADHD; CHILDREN; VALIDITY; DISABILITIES; NEUROSCIENCE; PREDICTION; SUBTYPES; FUTURE	Background Attention-deficit/hyperactivity disorder (ADHD) is currently diagnosed by a diagnostic interview, mainly based on subjective reports from parents or teachers. It is necessary to develop methods that rely on objectively measureable neurobiological data to assess brainbehavior relationship in patients with ADHD. We investigated the application of a topological data analysis tool, Mapper, to analyze the brain functional connectivity data from ADHD patients. Methods To quantify the disease severity using the neuroimaging data, the decomposition of individual functional networks into normal and disease components by the healthy state model (HSM) was performed, and the magnitude of the disease component (MDC) was computed. Topological data analysis using Mapper was performed to distinguish children with ADHD (n = 196) from typically developing controls (TDC) (n = 214). Results In the topological data analysis, the partial clustering results of patients with ADHD and normal subjects were shown in a chain-like graph. In the correlation analysis, the MDC showed a significant increase with lower intelligence scores in TDC. We also found that the rates of comorbidity in ADHD significantly increased when the deviation of the functional connectivity from HSM was large. In addition, a significant correlation between ADHD symptom severity and MDC was found in part of the dataset. Conclusions The application of HSM and topological data analysis methods in assessing the brain functional connectivity seem to be promising tools to quantify ADHD symptom severity and to reveal the hidden relationship between clinical phenotypic variables and brain connectivity.	[Kyeong, Sunghyon; Cheon, Keun-Ah; Kim, Jae-Jin; Song, Dong-Ho; Kim, Eunjoo] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kyeong, Sunghyon; Cheon, Keun-Ah; Kim, Jae-Jin; Song, Dong-Ho; Kim, Eunjoo] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Kyeong, Sunghyon; Kim, Jae-Jin] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Kyeong, Sunghyon; Park, Seonjeong] Natl Inst Math Sci, Div Math Models, Taejon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; National Institute for Mathematical Sciences (NIMS), Republic of Korea	Kim, E (corresponding author), Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	ejkim96@yuhs.ac	Kim, Eunjoo/GLN-2706-2022	Kyeong, Sunghyon/0000-0002-9095-5219; Kim, Eunjoo/0000-0003-3061-2051; Cheon, Keun-Ah/0000-0001-7113-9286; Kim, Jae-Jin/0000-0002-1395-4562; Song, Dong Ho/0000-0002-9647-3130				Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Balazs J, 2014, EUR CHILD ADOLES PSY, V23, P393, DOI 10.1007/s00787-013-0514-7; Biederman J, 2006, J CLIN PSYCHIAT, V67, P524, DOI 10.4088/JCP.v67n0403; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Bullmore ET, 2012, NEUROIMAGE, V62, P1267, DOI 10.1016/j.neuroimage.2012.01.026; Bullmore ET, 2009, BRIT J PSYCHIAT, V194, P293, DOI 10.1192/bjp.bp.108.058479; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; de Zeeuw P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035770; Dey S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00075; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Eloyan Ani, 2012, Front Syst Neurosci, V6, P61, DOI 10.3389/fnsys.2012.00061; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Getahun D, 2013, JAMA PEDIATR, V167, P282, DOI 10.1001/2013.jamapediatrics.401; Hyman SE, 2002, PSYCHOPATHOLOGY, V35, P139, DOI 10.1159/000065134; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Johnson BD, 1999, DEV NEUROPSYCHOL, V15, P213, DOI 10.1080/87565649909540746; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Klorman R, 1999, J AM ACAD CHILD PSY, V38, P1148, DOI 10.1097/00004583-199909000-00020; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; KORKMAN M, 1994, J LEARN DISABIL, V27, P383, DOI 10.1177/002221949402700605; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Lahey BB, 2010, J CLIN CHILD ADOLESC, V39, P761, DOI 10.1080/15374416.2010.517173; Lum PY, 2013, SCI REP, P3; Mayes SD, 2000, J LEARN DISABIL-US, V33, P417, DOI 10.1177/002221940003300502; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Nesse RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-5; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nicolau M, 2007, BIOINFORMATICS, V23, P957, DOI 10.1093/bioinformatics/btm033; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Seidman LJ, 2006, BIOL PSYCHIAT, V60, P1071, DOI 10.1016/j.biopsych.2006.04.031; SEIDMAN LJ, 1995, J AM ACAD CHILD PSY, V34, P1015, DOI 10.1097/00004583-199508000-00011; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Singh G, 2007, EUR S POINT BAS GRAP, P1; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; van Praag HM, 2008, EUR ARCH PSY CLIN N, V258, P29, DOI 10.1007/s00406-008-2006-1; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Weiler MD, 2000, CHILD NEUROPSYCHOL, V6, P3, DOI 10.1076/0929-7049(200003)6:1;1-B;FT003; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Woo BSC, 2005, AUST NZ J PSYCHIAT, V39, P344, DOI 10.1080/j.1440-1614.2005.01580.x; Yao Y, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3103496; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	49	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137296	10.1371/journal.pone.0137296	http://dx.doi.org/10.1371/journal.pone.0137296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352147	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800072
J	Wu, YX; Kang, XJ; Zheng, HY; Liu, HY; Liu, JQ				Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Liu, Jianqiao			Effect of Paternal Age on Reproductive Outcomes of In Vitro Fertilization	PLOS ONE			English	Article							OLDER; FATHERS; COUPLES; MEN	Although the adverse effects of maternal aging on reproductive outcomes have been investigated widely, there is no consensus on the impact of paternal age. Therefore, we investigated the effect of paternal age on reproductive outcomes in a retrospective analysis of 9,991 in vitro fertilization (IVF) cycles performed at the Reproductive Medicine Center of the Third Affiliated Hospital of Guangzhou Medical University (China) between January 2007 and October 2013. Samples were grouped according to maternal age [<30 (3,327 cycles), 30-34 (4,587 cycles), and 35-38 (2,077 cycles)] and then subgrouped according to paternal age (<30, 30-32, 33-35, 36-38, 39-41, and >= 42). The groups did not differ in terms of fertilization rate, numbers of viable and high-quality embryos and miscarriage rate when controlling maternal age (P > 0.05). Chi-squared analysis revealed that there were no differences in implantation and pregnancy rates among the different paternal age groups when maternal age was <30 and 35-38 years (P > 0.05). However, implantation and pregnancy rates decreased with paternal age in the 31-34 y maternal age group (P <0.05). Our study indicates that paternal age has no impact on fertilization rate, embryo quality at the cleavage stage and miscarriage rate. For the 30-34 y maternal age group, the implantation rate decreased with increased paternal age, with the pregnancy rate in this group being significantly higher in the paternal <30 y and 30-32 y age groups, compared with those in the 3638 y and 39-41 y groups.	[Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, JQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China.	ljq88gz@163.com			National Natural Science Foundation of China [81401254]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant: the National Natural Science Foundation of China (No. 81401254), grant recipient XJK, http://www.nsfc.gov.cn/. Role of funder: data collection, decision to publish.	Aboulghar M, 2007, REPROD BIOMED ONLINE, V14, P588, DOI 10.1016/S1472-6483(10)61050-4; Begueria R, 2014, HUM REPROD, V29, P2114, DOI 10.1093/humrep/deu189; Bellver J, 2008, REPROD BIOMED ONLINE, V17, P595, DOI 10.1016/S1472-6483(10)60305-7; de La Rochebrochard E, 2003, AM J OBSTET GYNECOL, V189, P901, DOI 10.1067/S0002-9378(03)00753-1; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; de la Rochebrochard E, 2006, FERTIL STERIL, V85, P1420, DOI 10.1016/j.fertnstert.2005.11.040; Ferreira RC, 2010, FERTIL STERIL, V93, P1870, DOI 10.1016/j.fertnstert.2008.12.043; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Frattarelli JL, 2008, FERTIL STERIL, V90, P97, DOI 10.1016/j.fertnstert.2007.06.009; Gu LJ, 2012, J ASSIST REPROD GEN, V29, P331, DOI 10.1007/s10815-012-9719-9; Hellstrom WJG, 2006, J ANDROL, V27, P421, DOI 10.2164/jandrol.05156; Klonoff-Cohen HS, 2004, AM J OBSTET GYNECOL, V191, P507, DOI 10.1016/j.ajog.2004.01.035; Luna M, 2009, FERTIL STERIL, V92, P1772, DOI 10.1016/j.fertnstert.2009.05.036; Paulson RJ, 2001, AM J OBSTET GYNECOL, V184, P818, DOI 10.1067/mob.2001.113852; Robertshaw I, 2014, REPROD SCI, V21, P590, DOI 10.1177/1933719113506497; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Tsai YR, 2013, TAIWAN J OBSTET GYNE, V52, P351, DOI 10.1016/j.tjog.2013.06.001; Whitcomb BW, 2011, FERTIL STERIL, V95, P147, DOI 10.1016/j.fertnstert.2010.06.039	18	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135734	10.1371/journal.pone.0135734	http://dx.doi.org/10.1371/journal.pone.0135734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352861	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800014
J	Addabbo, M; Longhi, E; Bolognini, N; Senna, I; Tagliabue, P; Cassia, VM; Turati, C				Addabbo, Margaret; Longhi, Elena; Bolognini, Nadia; Senna, Irene; Tagliabue, Paolo; Cassia, Viola Macchi; Turati, Chiara			Seeing Touches Early in Life	PLOS ONE			English	Article							HAND-MOUTH COORDINATION; SOMATOSENSORY ACTIVATIONS; FACE PREFERENCE; BODY PERCEPTION; SENSE; FETAL; SELF	The sense of touch provides fundamental information about the surrounding world, and feedback about our own actions. Although touch is very important during the earliest stages of life, to date no study has investigated infants' abilities to process visual stimuli implying touch. This study explores the developmental origins of the ability to visually recognize touching gestures involving others. Looking times and orienting responses were measured in a visual preference task, in which participants were simultaneously presented with two videos depicting a touching and a no-touching gesture involving human body parts (face, hand) and/or an object (spoon). In Experiment 1, 2-day-old newborns and 3-month-old infants viewed two videos: in one video a moving hand touched a static face, in the other the moving hand stopped before touching it. Results showed that only 3-month-olds, but not newborns, differentiated the touching from the no-touching gesture, displaying a preference for the former over the latter. To test whether newborns could manifest a preferential visual response when the touched body part is different from the face, in Experiment 2 newborns were presented with touching/no-touching gestures in which a hand or an inanimate object -i.e., a spoon-moved towards a static hand. Newborns were able to discriminate a hand-to-hand touching gesture, but they did not manifest any preference for the object-to-hand touch. The present findings speak in favour of an early ability to visually recognize touching gestures involving the interaction between human body parts.	[Addabbo, Margaret; Longhi, Elena; Bolognini, Nadia; Senna, Irene; Cassia, Viola Macchi; Turati, Chiara] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Addabbo, Margaret; Bolognini, Nadia; Cassia, Viola Macchi; Turati, Chiara] Milan Ctr Neurosci, NeuroMi, Milan, Italy; [Longhi, Elena] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Bolognini, Nadia] Ist Auxol Italiano, Neuropsychol Lab, Milan, Italy; [Senna, Irene] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Senna, Irene] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Tagliabue, Paolo] San Gerardo Hosp, MBBM Fdn, Neonatol & Intens Care Unit, I-20900 Monza, Italy	University of Milano-Bicocca; University of London; University College London; IRCCS Istituto Auxologico Italiano; University of Bielefeld; University of Bielefeld; San Gerardo Hospital	Addabbo, M (corresponding author), Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1 U6, I-20126 Milan, Italy.	m.addabbo2@campus.unimib.it	BOLOGNINI, NADIA/J-5746-2016; addabbo, margaret/ABD-5240-2020; Macchi Cassia, Viola/HCI-2058-2022	BOLOGNINI, NADIA/0000-0002-2921-8658; addabbo, margaret/0000-0002-8414-6853; Senna, Irene/0000-0002-3237-8193; macchi cassia, viola/0000-0002-9983-8254	ERC-Starting Grant [241176]	ERC-Starting Grant	Research was supported by an ERC-Starting Grant to CT ODMIR No. 241176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrick LE, 2013, CURR BIOL, V23, pR1039, DOI 10.1016/j.cub.2013.10.060; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bolognini N, 2014, CURR BIOL, V24, P1513, DOI 10.1016/j.cub.2014.05.025; Bolognini N, 2013, CURR BIOL, V23, pR436, DOI 10.1016/j.cub.2013.03.036; Bolognini N, 2013, J NEUROSCI, V33, P4201, DOI 10.1523/JNEUROSCI.4498-12.2013; Bolognini N, 2012, CEREB CORTEX, V22, P2055, DOI 10.1093/cercor/bhr283; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; BUTTERWORTH G, 1988, BRIT J DEV PSYCHOL, V6, P303, DOI 10.1111/j.2044-835X.1988.tb01103.x; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Cassia VM, 2001, DEVELOPMENTAL SCI, V4, P101; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013199; COHEN LB, 1972, CHILD DEV, V43, P869, DOI 10.2307/1127638; COHEN LB, 1973, MERRILL PALMER QUART, V19, P157; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Field T, 2001, TOUCH; Filippetti ML, 2013, CURR BIOL, V23, P2413, DOI 10.1016/j.cub.2013.10.017; Hertenstein MJ, 2002, HUM DEV, V45, P70, DOI 10.1159/000048154; Johnson MH, 1991, BIOL COGNITIVE DEV C; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kuehn E, 2014, BRAIN STRUCT FUNCT, V219, P119, DOI 10.1007/s00429-012-0489-z; Kurjak A, 2005, CROAT MED J, V46, P772; LEW AR, 1995, DEV PSYCHOL, V31, P456, DOI 10.1037/0012-1649.31.3.456; Longhi E, 2015, CHILD DEV, V86, P632, DOI 10.1111/cdev.12329; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meyer K, 2011, CEREB CORTEX, V21, P2113, DOI 10.1093/cercor/bhq289; Montagu A., 1971, TOUCHING HUMAN SIGNI; Myowa-Yamakoshi M, 2006, INFANCY, V10, P289, DOI 10.1207/s15327078in1003_5; Nagy E, 2014, DEVELOPMENTAL SCI, V17, P841, DOI 10.1111/desc.12163; Reissland N, 2014, DEV PSYCHOBIOL, V56, P955, DOI 10.1002/dev.21172; Rochat P, 1997, EARLY DEV PARENTING, V6, P105; Rossetti A, 2012, EUR J NEUROSCI, V36, P2317, DOI 10.1111/j.1460-9568.2012.08137.x; Saxe R, 2007, DEV PSYCHOL, V43, P149, DOI 10.1037/0012-1649.43.1.149; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Sparling Joyce W., 1993, Physical and Occupational Therapy in Pediatrics, V12, P97, DOI 10.1300/J006v12n02_06; Sparling JW, 1999, PHYS THER, V79, P24, DOI 10.1093/ptj/79.1.24; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Zmyj N, 2011, COGNITION, V120, P82, DOI 10.1016/j.cognition.2011.03.001; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3	44	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0134549	10.1371/journal.pone.0134549	http://dx.doi.org/10.1371/journal.pone.0134549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366563	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100006
J	Hu, XY; Li, JX; Hong, YL; Wang, L				Hu, Xiaoyue; Li, Jing Xian; Hong, Youlian; Wang, Lin			Characteristics of Plantar Loads in Maximum Forward Lunge Tasks in Badminton	PLOS ONE			English	Article							PLAYERS	Background Badminton players often perform powerful and long-distance lunges during such competitive matches. The objective of this study is to compare the plantar loads of three one-step maximum forward lunges in badminton. Methods Fifteen right-handed male badminton players participated in the study. Each participant performed five successful maximum lunges at three directions. For each direction, the participant wore three different shoe brands. Plantar loading, including peak pressure, maximum force, and contact area, was measured by using an insole pressure measurement system. Two-way ANOVA with repeated measures was employed to determine the effects of the different lunge directions and different shoes, as well as the interaction of these two variables, on the measurements. Results The maximum force (MF) on the lateral midfoot was lower when performing left-forward lunges than when performing front-forward lunges (p = 0.006, 95% CI = -2.88 to -0.04% BW). The MF and peak pressures (PP) on the great toe region were lower for the front-forward lunge than for the right-forward lunge (MF, p = 0.047, 95% CI = -3.62 to -0.02% BW; PP, p = 0.048, 95% CI = -37.63 to -0.16 KPa) and left-forward lunge (MF, p = 0.015, 95% CI = -4.39 to -0.38% BW; PP, p = 0.008, 95% CI = -47.76 to -5.91 KPa). Conclusions These findings indicate that compared with the front-forward lunge, left and right maximum forward lunges induce greater plantar loads on the great toe region of the dominant leg of badminton players. The differences in the plantar loads of the different lunge directions may be potential risks for injuries to the lower extremities of badminton players.	[Hu, Xiaoyue; Hong, Youlian; Wang, Lin] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Li, Jing Xian] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Shanghai University of Sport; University of Ottawa	Wang, L (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	wanglin@sus.edu.cn	WANG, LIN/AAD-6960-2021	Wang, Lin/0000-0003-3057-3742	Shanghai Municipal Education Commission [14ZZ149]; National Natural Science Fund of China [11572202]	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Shanghai Municipal Education Commission (14ZZ149) and the National Natural Science Fund of China (11572202).	Abian-Vicen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037821; Castanedo JAVA, 2014, INT J SPORT PHYSIOL, V9, P689, DOI [10.1123/ijspp.2013-0269, 10.1123/IJSPP.2013-0269]; Badminton Grice T., 1992, BADMINTON STEPS SUCC; Boesen MI, 2006, AM J SPORT MED, V34, P2013, DOI 10.1177/0363546506290188; Dowling AV, 2010, AM J SPORT MED, V38, P478, DOI 10.1177/0363546509348374; Hong Y., 2013, ROUTLEDGE HDB ERGONO, P376; Hong YL, 2014, J APPL BIOMECH, V30, P113, DOI 10.1123/jab.2012-0151; Hong YL, 2012, J SCI MED SPORT, V15, P554, DOI 10.1016/j.jsams.2012.01.004; Kroner K, 1990, Br J Sports Med, V24, P169; Kuntze G, 2010, J SPORT SCI, V28, P183, DOI 10.1080/02640410903428533; Phomsoupha M, 2015, SPORTS MED, V45, P473, DOI 10.1007/s40279-014-0287-2; RAMANATHAN AK, 2010, FOOT ANKLE SURG, V16, P70, DOI DOI 10.1016/J.FAS.2009.05.006; Robinson G., 2008, INT J PERF ANAL SPOR, V8, P127; Singh R, 2012, FOOTWEAR SCI, V1, P166, DOI DOI 10.1080/19424280903063630; Wang L, 2012, RES SPORTS MED, V20, P75, DOI 10.1080/15438627.2012.660816; Wei Y, 2009, J MED BIOL ENG, V29, P172; Wiegerinck JI, 2009, GAIT POSTURE, V29, P514, DOI 10.1016/j.gaitpost.2008.12.001; Winge S, 1990, SPORTS MED, V10, P169	18	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137558	10.1371/journal.pone.0137558	http://dx.doi.org/10.1371/journal.pone.0137558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367741	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100083
J	Lee, JE; Walsh, MC; Hoehn, KL; James, DE; Wherry, EJ; Choi, Y				Lee, Jang Eun; Walsh, Matthew C.; Hoehn, Kyle L.; James, David E.; Wherry, E. John; Choi, Yongwon			Acetyl CoA Carboxylase 2 Is Dispensable for CD8(+) T Cell Responses	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; MEMORY; COENZYME; REGULATOR; OXIDATION	Differentiation of T cells is closely associated with dynamic changes in nutrient and energy metabolism. However, the extent to which specific metabolic pathways and molecular components are determinative of CD8(+) T cell fate remains unclear. It has been previously established in various tissues that acetyl CoA carboxylase 2 (ACC2) regulates fatty acid oxidation (FAO) by inhibiting carnitine palmitoyltransferase 1 (CPT1), a rate-limiting enzyme of FAO in mitochondria. Here, we explore the cell-intrinsic role of ACC2 in T cell immunity in response to infections. We report here that ACC2 deficiency results in a marginal increase of cellular FAO in CD8(+) T cells, but does not appear to influence antigen-specific effector and memory CD8(+) T cell responses during infection with listeria or lymphocytic choriomeningitis virus. These results suggest that ACC2 is dispensable for CD8(+) T cell responses.	[Lee, Jang Eun; Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Lee, Jang Eun; Walsh, Matthew C.; Wherry, E. John; Choi, Yongwon] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Hoehn, Kyle L.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [James, David E.] Univ Sydney, Charles Perkins Ctr Res & Educ Hub, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Virginia; University of Sydney	Choi, Y (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	James, David/0000-0001-5946-5257; Hoehn, Kyle/0000-0002-0214-3238	National Institutes of Health [AI064909, AI105343, AI112521, AI082630, AI095608, HHSN266200500030C]; Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea [K13050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105343, P01AI112521, U01AI095608, U19AI082630, R21AI108627, R01AI064909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI064909 to YC, the National Institutes of Health AI105343, AI112521, AI082630, AI095608, and HHSN266200500030C to EJW, and the Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea Grant K13050 to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Lee JE, 2008, J IMMUNOL, V181, P6201, DOI 10.4049/jimmunol.181.9.6201; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137776	10.1371/journal.pone.0137776	http://dx.doi.org/10.1371/journal.pone.0137776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367121	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100136
J	Liao, KW; Tsai, MS; Chang, CH; Chien, LC; Mao, IF; Tsai, YA; Chen, ML				Liao, Kai-Wei; Tsai, Ming-Song; Chang, Chia-Huang; Chien, Ling-Chu; Mao, I-Fang; Tsai, Yen-An; Chen, Mei-Lien			Do the Levels of Maternal Plasma Trace Elements Affect Fetal Nuchal Translucency Thickness?	PLOS ONE			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; CHROMOSOMALLY NORMAL FETUSES; DOWNS-SYNDROME; CONTROLLED-TRIAL; PREGNANT-WOMEN; HUMAN PLACENTA; 1ST TRIMESTER; BIRTH-WEIGHT; DOUBLE-BLIND; POTASSIUM	Objective Fetal nuchal translucency (NT) thickness is an important marker for prenatal screening; however, studies focusing on the correlation between maternal trace element levels and NT thickness are limited. The aim of this study was to evaluate maternal trace element levels during the first trimester and to investigate the association between maternal trace element levels and fetal NT thickness. Methods In total, 113 samples were obtained from singleton pregnant women. Maternal plasma samples were collected in the first trimester of gestation. Plasma trace element levels were measured using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Nuchal translucency thickness was measured using ultrasonography at 10-14 weeks of gestation. Results We found that maternal plasma potassium (K) levels had a significant negative correlation with both NT (r = -0.230, p < 0.05) and NT Multiples of the Median (NT MoM) (r = -0.206, p < 0.05). After adjustment for potential confounders, log-transformed maternal plasma potassium levels in the first trimester were significantly associated with fetal NT (NT MoM: beta = -0.68, p < 0.05; NT: beta = -1.20, p < 0.01). Although not statistically significant, the As, Hg and Pb levels in maternal plasma were positively correlated with NT, and the Mg, Cu, Zn, Na and Ca levels were negatively correlated with NT. Conclusion Maternal plasma K levels during the first trimester appeared to be associated with NT thickness. The essential elements tended to decrease NT thickness, and non-essential elements tended to increase it.	[Liao, Kai-Wei; Chang, Chia-Huang; Tsai, Yen-An; Chen, Mei-Lien] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Tsai, Ming-Song] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tsai, Ming-Song] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Tsai, Ming-Song] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Chien, Ling-Chu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Mao, I-Fang] Chung Shan Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan	National Yang Ming Chiao Tung University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University; Chung Shan Medical University	Chen, ML (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan.	mlchen@ym.edu.tw	Liao, Kai-Wei/AAW-5992-2020	Liao, Kai-Wei/0000-0003-3842-416X; Chien, Ling-Chu/0000-0001-5539-8974	National Science Council of the Republic of China, Taiwan [NSC 99-2314-B-010-018-MY3, NSC 100-2314-B-281-001-MY3]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by the National Science Council of the Republic of China, Taiwan (NSC 99-2314-B-010-018-MY3 and NSC 100-2314-B-281-001-MY3).	ANASTASIADIS P, 1984, ZBL GYNAKOL, V106, P101; Axt-Fliedner R, 2010, ULTRASCHALL MED, V31, P144, DOI 10.1055/s-0028-1109702; Bakker M, 2013, BEST PRACT RES CLIN, DOI [10.1016/j.bpobgyn.2013.10.004, DOI 10.1016/J.BP0BGYN.2013.10.004]; Bilardo CM, 2001, ULTRASOUND OBST GYN, V17, P288, DOI 10.1046/j.1469-0705.2001.00387.x; BLACKBURN S, 2003, MATERNAL FETAL NEONA; BOBROWSKI RA, 1995, AM J OBSTET GYNECOL, V172, P1764, DOI 10.1016/0002-9378(95)91409-9; Braithwaite JM, 1996, BRIT J OBSTET GYNAEC, V103, P82, DOI 10.1111/j.1471-0528.1996.tb09520.x; Braithwaite JM, 1996, BRIT J OBSTET GYNAEC, V103, P1201, DOI 10.1111/j.1471-0528.1996.tb09629.x; Carter AM, 2009, PLACENTA, V30, pS19, DOI 10.1016/j.placenta.2008.11.006; Chen CP, 2010, TAIWAN J OBSTET GYNE, V49, P133, DOI 10.1016/S1028-4559(10)60029-0; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Clur SAB, 2011, ULTRASOUND OBST GYN, V37, P48, DOI 10.1002/uog.8807; COHEN P, 1991, J CLIN ENDOCR METAB, V73, P564, DOI 10.1210/jcem-73-3-564; Cowans NJ, 2011, PRENATAL DIAG, V31, P446, DOI 10.1002/pd.2713; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; DANCIS J, 1970, PEDIATR RES, V4, P345, DOI 10.1203/00006450-197007000-00005; Davis M, 2004, J PERINAT NEONAT NUR, V18, P312, DOI 10.1097/00005237-200410000-00002; De Biasio P, 2002, PRENATAL DIAG, V22, P492, DOI 10.1002/pd.338; DEFRONZO RA, 1980, AM J PHYSIOL, V238, pE421, DOI 10.1152/ajpendo.1980.238.5.E421; Deruelle P, 2004, EUR J OBSTET GYN R B, V115, P106, DOI 10.1016/j.ejogrb.2004.01.030; DUFFUS GM, 1971, J OBSTET GYN BR COMM, V78, P97; EDGE V, 1993, AM J OBSTET GYNECOL, V168, P1881, DOI 10.1016/0002-9378(93)90706-O; Gardella C, 2001, OBSTET GYNECOL SURV, V56, P231, DOI 10.1097/00006254-200104000-00024; Haak MC, 2003, HUM REPROD UPDATE, V9, P175, DOI 10.1093/humupd/dmg008; Hall S, 2000, BMJ-BRIT MED J, V320, P407, DOI 10.1136/bmj.320.7232.407; Harding R, 1994, TXB FETAL PHYSL; Hasegawa J, 2013, J OBSTET GYNAECOL RE, V39, P766, DOI 10.1111/j.1447-0756.2012.02037.x; Hendrick V, 2003, AM J OBSTET GYNECOL, V188, P812, DOI 10.1067/mob.2003.172; Holmes P, 2009, SCI TOTAL ENVIRON, V408, P171, DOI 10.1016/j.scitotenv.2009.09.043; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hyett J, 1996, ULTRASOUND OBST GYN, V7, P245, DOI 10.1046/j.1469-0705.1996.07040245.x; Hyett JA, 1997, ULTRASOUND OBST GYN, V10, P242, DOI 10.1046/j.1469-0705.1997.10040242.x; IOM, 2002, DIET REF INT VIT A V; Iyengar GV, 2001, SCI TOTAL ENVIRON, V280, P221, DOI 10.1016/S0048-9697(01)00827-0; JARA L, 1991, Archivos de Biologia y Medicina Experimentales, V24, P57; JAUNIAUX E, 1991, PLACENTA, V12, P269, DOI 10.1016/0143-4004(91)90008-4; Jewell D, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.cd000145, DOI 10.1002/14651858.CD000145]; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P618, DOI 10.1002/uog.5331; Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8; LINDHEIMER MD, 1987, J REPROD MED, V32, P517; LITTLE B, 1965, ANESTHESIOLOGY, V26, P400, DOI 10.1097/00000542-196507000-00005; Liu SSA, 2004, ACTA OBSTET GYN SCAN, V83, P1130, DOI 10.1111/j.0001-6349.2004.00425.x; Loncar D, 2011, MED GLAS, V8, P19; Marttala J, 2012, AM J PERINAT, V29, P211, DOI 10.1055/s-0031-1285095; MCCOY EE, 1974, NEW ENGL J MED, V291, P950, DOI 10.1056/NEJM197410312911807; Miron P, 2009, J OBSTET GYNAECOL CA, V31, P227, DOI 10.1016/S1701-2163(16)34121-4; Mogra R, 2012, EARLY HUM DEV, V88, P261, DOI 10.1016/j.earlhumdev.2012.02.009; Mol BWJ, 1999, BMJ-BRIT MED J, V318, P70, DOI 10.1136/bmj.318.7176.70; MOSCOSO G, 1995, ULTRASOUND OBST GYN, V5, P6, DOI 10.1046/j.1469-0705.1995.05010006.x; Nguyen TQ, 2011, CLIN J AM SOC NEPHRO, V6, P1533, DOI 10.2215/CJN.00750111; Nicolaides KH, 2004, AM J OBSTET GYNECOL, V191, P45, DOI 10.1016/j.ajog.2004.03.090; Nicolaides KH, 2002, PRENATAL DIAG, V22, P308, DOI 10.1002/pd.308; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; PAGE IJ, 1995, BRIT J OBSTET GYNAEC, V102, P758, DOI 10.1111/j.1471-0528.1995.tb11444.x; Pajkrt E, 1998, OBSTET GYNECOL, V91, P208, DOI 10.1016/S0029-7844(97)00658-3; PAJKRT E, 1995, OBSTET GYNECOL, V86, P994, DOI 10.1016/0029-7844(95)00310-N; Palomaki GE, 2008, GENET MED, V10, P131, DOI 10.1097/GIM.0b013e3181616bf8; PANDYA PP, 1995, ULTRASOUND OBST GYN, V5, P381, DOI 10.1046/j.1469-0705.1995.05060381.x; Peregrine E., 2009, FETAL MED BASIC SCI, V2nd ed.; Polin R.A., 2004, FETAL NEONATAL PHYSL, Vthird, pi; POOLEWILSON PA, 1984, CLIN ENDOCRINOL META, V13, P249, DOI 10.1016/S0300-595X(84)80021-3; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Saucedo MD, 2009, OBSTET GYNECOL, V114, P829, DOI 10.1097/AOG.0b013e3181b6f251; Schoeters G, 2006, ACTA PAEDIATR, V95, P50, DOI 10.1080/08035320600886232; SERRANO CV, 1964, J CLIN INVEST, V43, P27, DOI 10.1172/JCI104890; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Sotiriadis A, 2012, ULTRASOUND OBST GYN, V39, P10, DOI 10.1002/uog.10143; Souka AP, 2001, ULTRASOUND OBST GYN, V18, P9, DOI 10.1046/j.1469-0705.2001.00454.x; Steinlauf AF, 1999, MED COMPLICATIONS PR; Strah DM, 2008, J PERINAT MED, V36, P145, DOI 10.1515/JPM.2008.015; Sun Qian, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P514; SZABO J, 1990, LANCET, V336, P1133, DOI 10.1016/0140-6736(90)92614-N; Tahmasebpour A, 2012, IRAN J PUBLIC HEALTH, V41, P92; Tomala J, 1994, Zentralbl Gynakol, V116, P285; Tsui B, 2001, AM J OBSTET GYNECOL, V185, P433, DOI 10.1067/mob.2001.116688; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; Yagel S, 1998, ULTRASOUND OBST GYN, V11, P262, DOI 10.1046/j.1469-0705.1998.11040262.x; Zadeh N, 2011, PRENATAL DIAG, V31, P327, DOI 10.1002/pd.2646	81	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138145	10.1371/journal.pone.0138145	http://dx.doi.org/10.1371/journal.pone.0138145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367380	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100236
J	Nowacki, A; Fiechter, M; Fichtner, J; Debove, I; Lachenmayer, L; Schupbach, M; Oertel, MF; Wiest, R; Pollo, C				Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael; Oertel, Markus Florian; Wiest, Roland; Pollo, Claudio			Using MDEFT MRI Sequences to Target the GPi in DBS Surgery	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; INVERSION-RECOVERY SEQUENCE; GLOBUS-PALLIDUS-INTERNUS; HIGH-RESOLUTION; SUBTHALAMIC STIMULATION; PARKINSON-DISEASE; DYSTONIA; LOCALIZATION; ELECTRODES; LOCATION	Objective Recent advances in different MRI sequences have enabled direct visualization and targeting of the Globus pallidus internus (GPi) for DBS surgery. Modified Driven Equilibrium Fourier Transform (MDEFT) MRI sequences provide high spatial resolution and an excellent contrast of the basal ganglia with low distortion. In this study, we investigate if MDEFT sequences yield accurate and reliable targeting of the GPi and compare direct targeting based on MDEFT sequences with atlas-based targeting. Methods 13 consecutive patients considered for bilateral GPi-DBS for dystonia or PD were included in this study. Preoperative targeting of the GPi was performed visually based on MDEFT sequences as well as by using standard atlas coordinates. Postoperative CT imaging was performed to calculate the location of the implanted leads as well as the active electrode(s). The coordinates of both visual and atlas based targets were compared. The stereotactic coordinates of the lead and active electrode(s) were calculated and projected on the segmented GPi. Results On MDEFT sequences the GPi was well demarcated in most patients. Compared to atlas-based planning the mean target coordinates were located significantly more posterior. Subgroup analysis showed a significant difference in the lateral coordinate between dystonia (LAT = 19.33 +/- 0.90) and PD patients (LAT = 20.67 +/- 1.69). Projected on the segmented preoperative GPi the active contacts of the DBS electrode in both dystonia and PD patients were located in the inferior and posterior part of the structure corresponding to the motor part of the GPi. Conclusions MDEFT MRI sequences provide high spatial resolution and an excellent contrast enabling precise identification and direct visual targeting of the GPi. Compared to atlas-based targeting, it resulted in a significantly different mean location of our target. Furthermore, we observed a significant variability of the target among the PD and dystonia subpopulation suggesting accurate targeting for each individual patient.	[Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Oertel, Markus Florian; Pollo, Claudio] Univ Hosp Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland; [Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael; Oertel, Markus Florian; Wiest, Roland; Pollo, Claudio] Univ Bern, Bern, Switzerland; [Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Nowacki, A (corresponding author), Univ Hosp Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland.	neuro.nowacki@gmail.com						Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Elias WJ, 2007, J NEUROSURG, V107, P983, DOI 10.3171/JNS-07/11/0983; Hamani C, 2008, NEUROSURGERY, V63, P217, DOI [10.1227/01.NEU.0000297026.98243.68, 10.1227/01.neu.0000317396.16089.bc]; Hemm S, 2009, ACTA NEUROCHIR, V151, P823, DOI 10.1007/s00701-009-0393-3; Karas PJ, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.9.FOCUS13383; Kern DS, 2007, NEUROLOGIST, V13, P237, DOI 10.1097/NRL.0b013e3181492c48; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Menuel C, 2005, J NEUROSURG, V103, P256, DOI 10.3171/jns.2005.103.2.0256; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Norris DG, 1999, MAGN RESON MATER PHY, V9, P92; O'Gorman RL, 2009, STEREOT FUNCT NEUROS, V87, P205, DOI 10.1159/000225973; Petersen EA, 2010, NEUROSURGERY, V67, P213, DOI 10.1227/01.NEU.0000380991.23444.08; Pinsker MO, 2008, ZBL NEUROCHIR, V69, P144, DOI 10.1055/s-2008-1077075; Pinsker MO, 2008, ZBL NEUROCHIR, V69, P71, DOI 10.1055/s-2007-1004583; Pinsker MO, 2009, ACTA NEUROCHIR, V151, P751, DOI 10.1007/s00701-009-0375-5; Reich CA, 2000, AM J NEURORADIOL, V21, P928; Sako W, 2014, J NEUROL NEUROSURG P; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Tisch S, 2007, J NEUROL NEUROSUR PS, V78, P1314, DOI 10.1136/jnnp.2006.109694; Vayssiere N, 2004, J NEUROSURG, V101, P181, DOI 10.3171/jns.2004.101.2.0181; Vayssiere N, 2002, J NEUROSURG, V96, P673, DOI 10.3171/jns.2002.96.4.0673; Welter ML, 2014, NEUROLOGY, V82, P1352, DOI 10.1212/WNL.0000000000000315	26	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137868	10.1371/journal.pone.0137868	http://dx.doi.org/10.1371/journal.pone.0137868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366574	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100160
J	Shi, JR; Yang, W; Zheng, XY				Shi, Jiarong; Yang, Wei; Zheng, Xiuyun			Robust Generalized Low Rank Approximations of Matrices	PLOS ONE			English	Article								In recent years, the intrinsic low rank structure of some datasets has been extensively exploited to reduce dimensionality, remove noise and complete the missing entries. As a well-known technique for dimensionality reduction and data compression, Generalized Low Rank Approximations of Matrices (GLRAM) claims its superiority on computation time and compression ratio over the SVD. However, GLRAM is very sensitive to sparse large noise or outliers and its robust version does not have been explored or solved yet. To address this problem, this paper proposes a robust method for GLRAM, named Robust GLRAM (RGLRAM). We first formulate RGLRAM as an l(1)-norm optimization problem which minimizes the l(1)-norm of the approximation errors. Secondly, we apply the technique of Augmented Lagrange Multipliers (ALM) to solve this l(1)-norm minimization problem and derive a corresponding iterative scheme. Then the weak convergence of the proposed algorithm is discussed under mild conditions. Next, we investigate a special case of RGLRAM and extend RGLRAM to a general tensor case. Finally, the extensive experiments on synthetic data show that it is possible for RGLRAM to exactly recover both the low rank and the sparse components while it may be difficult for previous state-of-the-art algorithms. We also discuss three issues on RGLRAM: the sensitivity to initialization, the generalization ability and the relationship between the running time and the size/number of matrices. Moreover, the experimental results on images of faces with large corruptions illustrate that RGLRAM obtains the best denoising and compression performance than other methods.	[Shi, Jiarong; Yang, Wei; Zheng, Xiuyun] Xian Univ Architecture & Technol, Sch Sci, Xian, Peoples R China	Xi'an University of Architecture & Technology	Shi, JR (corresponding author), Xian Univ Architecture & Technol, Sch Sci, Xian, Peoples R China.	jiarongs3@163.com		Shi, Jiarong/0000-0002-4315-8655	National Natural Science Foundation of China [61403298, 11401457]; Natural Science Basic Research Plan In Shaanxi Province of China [2014JQ8323, 2014JQ1019]; Shaanxi Provincial Education Department [2013JK0587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan In Shaanxi Province of China; Shaanxi Provincial Education Department	This work is partially supported by National Natural Science Foundation of China under Grant No. 61403298 and No. 11401457, the Natural Science Basic Research Plan In Shaanxi Province of China under Grant No. 2014JQ8323 and No. 2014JQ1019, and by Shaanxi Provincial Education Department under Grant No. 2013JK0587.	[Anonymous], P VLSM; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Ding C, 2005, SIAM PROC S, P32; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Golub G. H., 2012, MATRIX COMPUTATIONS; Jiarong Shi, 2014, ICIC Express Letters, Part B: Applications, V5, P1619; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Ke Q., 2005, P IEEE C COMP VIS PA; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kwak N, 2008, IEEE T PATTERN ANAL, V30, P1672, DOI 10.1109/TPAMI.2008.114; Li, 2004, P ADV NEUR INF PROC, P1569; Lin Z., 2009, UILUENG092215; Liu G., 2010, P INT C MACH LEARN, P663, DOI DOI 10.1109/ICDMW.2010.64; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Liu J, 2010, IEEE T NEURAL NETWOR, V21, P621, DOI 10.1109/TNN.2010.2040290; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shen Y., 2012, OPTIMIZATION METHODS, V29, P1; Wright J., 2009, P ADV NEURAL INFORM, V22, DOI DOI 10.5555/2984093.2984326; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Ye JP, 2005, MACH LEARN, V61, P167, DOI 10.1007/s10994-005-3561-6; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004	25	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138028	10.1371/journal.pone.0138028	http://dx.doi.org/10.1371/journal.pone.0138028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367116	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100206
J	Valenza, E; Otsuka, Y; Bulf, H; Ichikawa, H; Kanazawa, S; Yamaguchi, MK				Valenza, Eloisa; Otsuka, Yumiko; Bulf, Hermann; Ichikawa, Hiroko; Kanazawa, So; Yamaguchi, Masami K.			Face Orientation and Motion Differently Affect the Deployment of Visual Attention in Newborns and 4-Month-Old Infants	PLOS ONE			English	Article							RECOGNITION; PREFERENCE; PERCEPTION; EXPERIENCE; SPECIALIZATION; STIMULI; LOOKING; SYSTEM; DISENGAGEMENT; 3-MONTH-OLDS	Orienting visual attention allows us to properly select relevant visual information from a noisy environment. Despite extensive investigation of the orienting of visual attention in infancy, it is unknown whether and how stimulus characteristics modulate the deployment of attention from birth to 4 months of age, a period in which the efficiency in orienting of attention improves dramatically. The aim of the present study was to compare 4-month-old infants' and newborns' ability to orient attention from central to peripheral stimuli that have the same or different attributes. In Experiment 1, all the stimuli were dynamic and the only attribute of the central and peripheral stimuli to be manipulated was face orientation. In Experiment 2, both face orientation and motion of the central and peripheral stimuli were contrasted. The number of valid trials and saccadic latency were measured at both ages. Our results demonstrated that the deployment of attention is mainly influenced by motion at birth, while it is also influenced by face orientation at 4-month of age. These findings provide insight into the development of the orienting visual attention in the first few months of life and suggest that maturation may be not the only factor that determines the developmental change in orienting visual attention from birth to 4 months.	[Valenza, Eloisa] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, I-35131 Padua, Italy; [Valenza, Eloisa] Univ Padua, Interdept Ctr Cognit Sci CISC, I-35131 Padua, Italy; [Otsuka, Yumiko] UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia; [Bulf, Hermann] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Bulf, Hermann] Milan Ctr Neurosci NeuroMI, Milan, Italy; [Ichikawa, Hiroko; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo 1920393, Japan; [Ichikawa, Hiroko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa 2148565, Japan	University of Padua; University of Padua; University of New South Wales Sydney; University of Milano-Bicocca; Chuo University; Japan Society for the Promotion of Science; Japan Womens University	Otsuka, Y (corresponding author), Ehime Univ, Fac Law & Letters, Bunkyo Cho 3, Matsuyama, Ehime 7908577, Japan.	otsuka.yumiko.wf@ehime-u.ac.jp			Progetti di Eccellenza CARIPARO [1873/2012]; JSPS [26285167, 196068]; MEXT [20119002]	Progetti di Eccellenza CARIPARO(Fondazione Cariparo); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present research was supported by a grant from 'Progetti di Eccellenza CARIPARO' (rep. no. 1873/2012). The research was also supported by a Grant-in-Aid for Scientific Research (B) (26285167 to M.K.Y) and by Excellent Young Researcher Overseas Visit Program (196068 to Y.O.) from JSPS, and by a Grant-in-Aid for Scientific Research on Innovative Areas, 'Face perception and recognition' from MEXT KAKENHI (20119002 to M. K. Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON J, 1988, PERCEPTION, V17, P367; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bertin E, 2004, DEVELOPMENTAL SCI, V7, P431, DOI 10.1111/j.1467-7687.2004.00363.x; Bhatt RS, 2005, CHILD DEV, V76, P169, DOI 10.1111/j.1467-8624.2005.00837.x; Blaga OA, 2006, DEV PSYCHOL, V42, P1069, DOI 10.1037/0012-1649.42.6.1069; Bulf H, 2010, VIS COGN, V18, P504, DOI 10.1080/13506280903272037; Butcher PR, 2000, INFANT BEHAV DEV, V23, P3, DOI 10.1016/S0163-6383(00)00031-X; Cassia VM, 2008, CHILD DEV, V79, P807, DOI 10.1111/j.1467-8624.2008.01160.x; Cassia VM, 2011, BRIT J PSYCHOL, V102, P816, DOI 10.1111/j.2044-8295.2011.02046.x; Cassia VM, 2009, PSYCHOL SCI, V20, P853, DOI 10.1111/j.1467-9280.2009.02376.x; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Cassia VM, 2001, DEVELOPMENTAL SCI, V4, P101; Cohen LB, 2001, INFANT CHILD DEV, V10, P83, DOI 10.1002/icd.250; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; de Schonen S, 2002, PSYCHOL TURN MILLENN; Easterbrook MA, 1999, CAN J EXP PSYCHOL, V53, P231, DOI 10.1037/h0087312; Elman JL, 1996, RETHINKING INNATENES; Farroni T, 1999, DEVELOPMENTAL SCI, V2, P174, DOI 10.1111/1467-7687.00066; FINLAY D, 1984, DEV PSYCHOL, V20, P29, DOI 10.1037/0012-1649.20.1.29; Frick JE, 1999, CHILD DEV, V70, P537, DOI 10.1111/1467-8624.00039; Gallay M, 2006, CHILD DEV, V77, P984, DOI 10.1111/j.1467-8624.2006.00914.x; GOREN CC, 1975, PEDIATRICS, V56, P544; Guellai B, 2011, VIS COGN, V19, P1212, DOI 10.1080/13506285.2011.620578; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; HOOD B, 1990, DEV MED CHILD NEUROL, V32, P1067; Hood B. M., 1995, ADV INFANCY RES, V10, P163; HOOD BM, 1993, INFANT BEHAV DEV, V16, P405, DOI 10.1016/0163-6383(93)80001-O; Hunnius S, 2004, INFANT BEHAV DEV, V27, P397, DOI 10.1016/j.infbeh.2004.02.003; Ichikawa H, 2013, JPN PSYCHOL RES, V55, P254, DOI 10.1111/j.1468-5884.2012.00540.x; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Johnson MH, 1991, BIOL COGNITIVE DEV C; JOHNSON MH, 1993, BRAIN DEV COGNITION; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; KLEINER KA, 1993, NATO ADV SCI INST SE, V69, P103; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lee K, 2013, J VIS, V13, P985; Leo I, 2009, DEVELOPMENTAL SCI, V12, P492, DOI 10.1111/j.1467-7687.2008.00791.x; Lewis TL, 1996, INVEST OPHTH VIS SCI, V37, pS1067; Libertus K, 2014, INT J BEHAV DEV, V38, P529, DOI 10.1177/0165025414535122; Libertus K, 2011, DEVELOPMENTAL SCI, V14, P1355, DOI 10.1111/j.1467-7687.2011.01084.x; MACFARLANE A, 1976, J EXP CHILD PSYCHOL, V21, P532, DOI 10.1016/0022-0965(76)90080-1; Matsuzawa M, 1997, INFANT BEHAV DEV, V20, P449, DOI 10.1016/S0163-6383(97)90035-7; MAURER D, 1981, CHILD DEV, V52, P196, DOI 10.2307/1129230; MICHEL GF, 1995, DEV PSYCHOBIOLOGY IN; Nelson C.A., 2001, HDB DEV COGNITIVE NE; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Otsuka Y, 2012, J EXP CHILD PSYCHOL, V111, P164, DOI 10.1016/j.jecp.2010.10.014; Otsuka Y, 2009, CHILD DEV, V80, P1259, DOI 10.1111/j.1467-8624.2009.01330.x; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Peltola MJ, 2008, DEVELOPMENTAL SCI, V11, P60, DOI 10.1111/j.1467-7687.2007.00659.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rafal Robert, 1995, P625; REGAL DM, 1981, VISION RES, V21, P549, DOI 10.1016/0042-6989(81)90100-0; ROTHBART MK, 1994, DEV PSYCHOPATHOL, V6, P635, DOI 10.1017/S0954579400004715; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Shirai N, 2010, JPN PSYCHOL RES, V52, P78, DOI 10.1111/j.1468-5884.2010.00426.x; Simion F, 2002, DEVELOPMENTAL SCI, V5, P427, DOI 10.1111/1467-7687.00237; Simion F, 2001, INFANT CHILD DEV, V10, P59, DOI 10.1002/icd.247; Simion F, 2007, PROG BRAIN RES, V164, P169, DOI 10.1016/S0079-6123(07)64009-6; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; TRONICK E, 1972, PERCEPT PSYCHOPHYS, V11, P373, DOI 10.3758/BF03206270; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2005, J EXP CHILD PSYCHOL, V90, P255, DOI 10.1016/j.jecp.2004.11.001; Turati C, 2004, CURR DIR PSYCHOL SCI, V13, P5, DOI 10.1111/j.0963-7214.2004.01301002.x; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Valenza E, 2007, DEVELOPMENTAL SCI, V10, P492, DOI 10.1111/j.1467-7687.2007.00602.x; Valenza E, 2006, CHILD DEV, V77, P1810, DOI 10.1111/j.1467-8624.2006.00975.x; Valenza E, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00027; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; [No title captured]	77	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136965	10.1371/journal.pone.0136965	http://dx.doi.org/10.1371/journal.pone.0136965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367122	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100038
J	Buchholz, S; Tietze, H; Kowarik, I; Schirmel, J				Buchholz, Sascha; Tietze, Hedwig; Kowarik, Ingo; Schirmel, Jens			Effects of a Major Tree Invader on Urban Woodland Arthropods	PLOS ONE			English	Article							ROBINIA-PSEUDOACACIA; SPECIES-DIVERSITY; INVASIVE PLANTS; ALIEN; COMMUNITIES; ASSEMBLAGES; IMPACTS; URBANIZATION; BIODIVERSITY; VEGETATION	Biological invasions are a major threat to biodiversity; however, the degree of impact can vary depending on the ecosystem and taxa. Here, we test whether a top invader at a global scale, the tree Robinia pseudoacacia (black locust or false acacia), which is known to profoundly change site conditions, significantly affects urban animal diversity. As a first multitaxon study of this kind, we analyzed the effects of Robinia dominance on 18 arthropod taxa by pairwise comparisons of woodlands in Berlin, Germany, that were dominated by R. pseudoacacia or the native pioneer tree Betula pendula. As a negative effect, abundances of five arthropod taxa decreased (Chilopoda, Formicidae, Diptera, Heteroptera, Hymenoptera); 13 others were not affected. Woodland type affected species composition of carabids and functional groups in spiders, but surprisingly did not decrease alpha and beta diversity of carabid and spider assemblages or the number of endangered species. Tree invasion thus did not induce biotic homogenization at the habitat scale. We detected no positive effects of alien dominance. Our results illustrate that invasions by a major tree invader can induce species turnover in ground-dwelling arthropods, but do not necessarily reduce arthropod species abundances or diversity and might thus contribute to the conservation of epigeal invertebrates in urban settings. Considering the context of invasion impacts thus helps to set priorities in managing biological invasions and can illustrate the potential of novel ecosystems to maintain urban biodiversity.	[Buchholz, Sascha; Tietze, Hedwig; Kowarik, Ingo] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Buchholz, Sascha; Kowarik, Ingo] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Schirmel, Jens] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	Technical University of Berlin; University of Koblenz & Landau	Buchholz, S (corresponding author), Tech Univ Berlin, Dept Ecol, Berlin, Germany.	sascha.buchholz@tu-berlin.de	Schirmel, Jens/I-3467-2012	Schirmel, Jens/0000-0003-0330-3376				Agosti D, 2000, BIOL DIVERSITY HDB S; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1996, SPIDERS BRITAIN NO E; Bartz R, 2010, CONSERV BIOL, V24, P675, DOI 10.1111/j.1523-1739.2009.01385.x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Briggs J. C., 2013, ENV SKEPTICS CRITICS, V2, P73; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; Buchholz S, 2013, INSECT SCI, V20, P662, DOI 10.1111/j.1744-7917.2012.01556.x; Bultman TL, 2008, BIOL INVASIONS, V10, P749, DOI 10.1007/s10530-007-9168-z; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Castro-Diez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100254; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; DAISIE (Delivering Alien Invasive Species Inventories for Europe), 2013, HDB ALIEN SPECIES EU; de Groot M, 2007, BIOL CONSERV, V136, P612, DOI 10.1016/j.biocon.2007.01.005; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fischer LK, 2009, J BIOGEOGR, V36, P2251, DOI 10.1111/j.1365-2699.2009.02173.x; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Irmler Ulrich, 2004, Faunistisch-Oekologische Mitteilungen Supplement, V32, P1; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jeschke JM, 2014, CONSERV BIOL, V28, P1188, DOI 10.1111/cobi.12299; Jones EL, 2012, EUR J ENTOMOL, V109, P463, DOI 10.14411/eje.2012.060; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; Kielhorn K-H., 2005, LANDESBEAUFTRAGTE NA; Kleinbauer I, 2010, BIOL CONSERV, V143, P382, DOI 10.1016/j.biocon.2009.10.024; Kowarik I, 2005, WILD URBAN WOODLANDS: NEW PERSPECTIVES FOR URBAN FORESTRY, P287, DOI 10.1007/3-540-26859-6_18; Kowarik I, 2013, PRESLIA, V85, P113; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; Lambdon PW, 2008, PRESLIA, V80, P101; Liu Jian, 2012, NeoBiota, P27; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Masaka K, 2013, FOREST SCI, V59, P589, DOI 10.5849/forsci.11-106; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; MULLER-MOTZFELD G., 2006, KALER MITTELEUROPAS, V2; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pataki D. E., 2006, CLIMATIC CHANGE, V12, P1, DOI DOI 10.1111/J.1365-2486.2006.01242.X; Pearce JL, 2004, BIODIVERS CONSERV, V13, P1305, DOI 10.1023/B:BIOC.0000019403.26948.55; Platen R, 2005, LANDESBEAUFTRAGTE NA; Platen Ralph, 1995, Verhandlungen der Gesellschaft fuer Oekologie, V24, P431; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Roberts M. J., 1987, SPIDERGREAT BRITAI, VII; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sattler T, 2011, LANDSCAPE URBAN PLAN, V103, P347, DOI 10.1016/j.landurbplan.2011.08.008; Sax DF, 2002, GLOBAL ECOL BIOGEOGR, V11, P49, DOI 10.1046/j.1466-822X.2001.00262.x; Schirmel J, 2013, BIOL INVASIONS, V15, P1089, DOI 10.1007/s10530-012-0352-4; Schirmel J, 2011, BIOL INVASIONS, V13, P605, DOI 10.1007/s10530-010-9852-2; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schlick-Steiner BC, 2006, INSECT SOC, V53, P274, DOI 10.1007/s00040-006-0869-6; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sitzia T, 2012, FOREST ECOL MANAG, V285, P85, DOI 10.1016/j.foreco.2012.08.016; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Thomas CD, 2013, NATURE, V502, P7, DOI 10.1038/502007a; Topp W, 2008, BIOL INVASIONS, V10, P381, DOI 10.1007/s10530-007-9137-6; Trentanovi G, 2013, DIVERS DISTRIB, V19, P738, DOI 10.1111/ddi.12028; Venables WN., 2002, MODERN APPL STAT S 4; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitkova M, 2015, SCI TOTAL ENVIRON, V505, P315, DOI 10.1016/j.scitotenv.2014.09.104; Von Holle B, 2006, BIODIVERS CONSERV, V15, P2197, DOI 10.1007/s10531-004-6906-8; Von Holle B, 2013, OECOLOGIA, V172, P915, DOI 10.1007/s00442-012-2543-1; Wei XR, 2009, AFR J BIOTECHNOL, V8, P2984; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; 조광진, 2005, Journal of Ecology and Environment, V28, P15; [No title captured]	75	23	23	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137723	10.1371/journal.pone.0137723	http://dx.doi.org/10.1371/journal.pone.0137723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359665	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100075
J	Castillo, V; Onate, M; Woehlbier, U; Rozas, P; Andreu, C; Medinas, D; Valdes, P; Osorio, F; Mercado, G; Vidal, RL; Kerr, B; Court, FA; Hetz, C				Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Osorio, Fabiola; Mercado, Gabriela; Vidal, Rene L.; Kerr, Bredford; Court, Felipe A.; Hetz, Claudio			Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; PARKINSONS-DISEASE; SCHWANN-CELLS; NEURODEGENERATIVE DISEASES; MISFOLDED PROTEINS; NERVE REGENERATION; SENSOR IRE1-ALPHA; PERIPHERAL-NERVE	ERp57 (also known as grp58 and PDIA3) is a protein disulfide isomerase that catalyzes disulfide bonds formation of glycoproteins as part of the calnexin and calreticulin cycle. ERp57 is markedly upregulated in most common neurodegenerative diseases downstream of the endoplasmic reticulum (ER) stress response. Despite accumulating correlative evidence supporting a neuroprotective role of ERp57, the contribution of this foldase to the physiology of the nervous system remains unknown. Here we developed a transgenic mouse model that overexpresses ERp57 in the nervous system under the control of the prion promoter. We analyzed the susceptibility of ERp57 transgenic mice to undergo neuro-degeneration. Unexpectedly, ERp57 overexpression did not affect dopaminergic neuron loss and striatal denervation after injection of a Parkinson's disease-inducing neurotoxin. In sharp contrast, ERp57 transgenic animals presented enhanced locomotor recovery after mechanical injury to the sciatic nerve. These protective effects were associated with enhanced myelin removal, macrophage infiltration and axonal regeneration. Our results suggest that ERp57 specifically contributes to peripheral nerve regeneration, whereas its activity is dispensable for the survival of a specific neuronal population of the central nervous system. These results demonstrate for the first time a functional role of a component of the ER proteostasis network in peripheral nerve regeneration.	[Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Mercado, Gabriela; Vidal, Rene L.; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile; [Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Mercado, Gabriela; Hetz, Claudio] Univ Chile, Inst Biomed Sci, Ctr Mol Studies Cell, Program Cellular & Mol Biol, Santiago, Chile; [Onate, Maritza; Court, Felipe A.] Pontificia Univ Catolica Chile, Fac Biol, Millenium Nucl Regenerat Biol, Santiago, Chile; [Osorio, Fabiola] Univ Chile, Inst Biomed Sci, Program Immunol, Santiago, Chile; [Vidal, Rene L.] Neuroun Biomed Fdn, CENPAR, Santiago, Chile; [Kerr, Bredford] Ctr Estudios Cient, Valdivia, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Hetz, C (corresponding author), Univ Chile, Inst Biomed Sci, Independencia 1027, Santiago, Chile.	chetz@med.uchile.cl	Andreu, Catherine/AAV-6825-2021; Hetz, Claudio/ABD-7514-2021; Medinas, Danilo/ABA-1182-2021; Vidal, Rene Luis/S-7154-2019; Osorio, Fabiola/H-4529-2014	Andreu, Catherine/0000-0003-2402-0252; Bilches Medinas, Danilo/0000-0002-1822-1974; Osorio, Fabiola/0000-0001-5306-7856; Court, Felipe/0000-0002-9394-7601; Kerr, Bredford/0000-0001-8714-8726; vidal, rene/0000-0002-4305-7387; Woehlbier, Ute/0000-0003-3114-9708; Mercado, Gabriela/0000-0002-3346-5758	FONDEF [D11I1007]; Millennium Institute [P09-015-F]; Frick Foundation; FONDECYT [1140549]; Michael J Fox Foundation for Parkinson Research; Alzheimer's Association; Muscular Dystrophy Association; COPEC-UC Foundation; CONICYT [USA2013-0003]; ECOS-CONICYT [C13S02]; ALS Therapy Alliance; Millennium Nucleus [P-07-011-F]; CONICYT PAI [82130031];  [ACT1109]	FONDEF; Millennium Institute(Takeda Pharmaceutical Company Ltd); Frick Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Michael J Fox Foundation for Parkinson Research; Alzheimer's Association(Alzheimer's Association); Muscular Dystrophy Association(Muscular Dystrophy Association); COPEC-UC Foundation; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ALS Therapy Alliance; Millennium Nucleus; CONICYT PAI; 	This work was funded by Ring Initiative ACT1109 (FC and CH), FONDEF D11I1007, Millennium Institute No. P09-015-F, the Frick Foundation, FONDECYT no. 1140549, Michael J Fox Foundation for Parkinson Research, the Alzheimer's Association, the Muscular Dystrophy Association, COPEC-UC Foundation, CONICYT grant USA2013-0003, ECOS-CONICYT C13S02, and ALS Therapy Alliance (CH). Millennium Nucleus P-07-011-F, FONDECYT no. 1110987 (FC), FONDECYT no. 1150608 (RV). FONDECYT no. 3130351 (DM), FONDECYT no. 3120146 (GM), CONICYT PAI No 82130031. VC, PR and MO are postgraduate fellows supported by a CONICYT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bernard-Marissal N, 2015, NEUROBIOL DIS, V73, P130, DOI 10.1016/j.nbd.2014.09.009; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Bradford BM, 2009, J NEUROSCI, V29, P15445, DOI 10.1523/JNEUROSCI.4195-09.2009; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Coleman M, 2011, ADV GENET, V73, P185, DOI 10.1016/B978-0-12-380860-8.00005-7; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; Court F, 2000, BRAIN RES, V867, P1, DOI 10.1016/S0006-8993(00)02140-5; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Filezac de LEtang A, 2015, NATURE NEUROSCIENCE; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Gonzalez-Perez P, 2015, GENE, V566, P158, DOI 10.1016/j.gene.2015.04.035; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Hashida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047950; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hirsch I, 2014, APOPTOSIS, V19, P801, DOI 10.1007/s10495-013-0961-0; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Jin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112837; Jung J, 2011, FASEB J, V25, P3929, DOI 10.1096/fj.11-184911; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Lu X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-17; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mantuano E, 2011, J NEUROSCI, V31, P13376, DOI 10.1523/JNEUROSCI.2850-11.2011; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Nemere I, 2010, J BIOL CHEM, V285, P31859, DOI 10.1074/jbc.M110.116954; Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017; NOEL F, 1995, J NEUROSCI, V15, P6926; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Penas C, 2011, NEUROSCIENCE, V178, P33, DOI 10.1016/j.neuroscience.2011.01.012; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu XF, 2014, TOXICOL LETT, V230, P19, DOI 10.1016/j.toxlet.2014.07.026; Yang Qi-rui, 2015, Instrument Technique and Sensor, P1; Yao M, 1998, LARYNGOSCOPE, V108, P1141, DOI 10.1097/00005537-199808000-00007; Ying ZX, 2014, P NATL ACAD SCI USA, V111, P16142, DOI 10.1073/pnas.1407462111; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	84	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136620	10.1371/journal.pone.0136620	http://dx.doi.org/10.1371/journal.pone.0136620			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361352	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100013
J	Hedna, K; Hakkarainen, KM; Gyllensten, H; Jonsson, AK; Sundell, KA; Petzold, M; Hagg, S				Hedna, Khedidja; Hakkarainen, Katja M.; Gyllensten, Hanna; Jonsson, Anna K.; Sundell, Karolina Andersson; Petzold, Max; Hagg, Staffan			Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?	PLOS ONE			English	Article							HYPERTENSION TREATMENT; DRUG ADHERENCE; PERSISTENCE; NONADHERENCE; OUTCOMES	Background Although a majority of patients with hypertension require a multidrug therapy, this is rarely considered when measuring adherence from refill data. Moreover, investigating the association between refill non-adherence to antihypertensive therapy (AHT) and elevated blood pressure (BP) has been advocated. Objective Identify factors associated with non-adherence to AHT, considering the multidrug therapy, and investigate the association between non-adherence to AHT and elevated BP. Methods A retrospective cohort study including patients with hypertension, identified from a random sample of 5025 Swedish adults. Two measures of adherence were estimated by the proportion of days covered method (PDC >= 80%): (1) Adherence to any antihypertensive medication and, (2) adherence to the full AHT regimen. Multiple logistic regressions were performed to investigate the association between sociodemographic factors (age, sex, education, income), clinical factors (user profile, number of antihypertensive medications, healthcare use, cardiovascular comorbidities) and non-adherence. Moreover, the association between non-adherence (long-term and a month prior to BP measurement) and elevated BP was investigated. Results Non-adherence to any antihypertensive medication was higher among persons < 65 years (Odds Ratio, OR 2.75 [95% CI, 1.18-6.43]) and with the lowest income (OR 2.05 [95% CI, 1.01-4.16]). Non-adherence to the full AHT regimen was higher among new users (OR 2.04 [95% CI, 1.32-3.15]), persons using specialized healthcare (OR 1.63, [95% CI, 1.14-2.32]), and having multiple antihypertensive medications (OR 1.85 [95% CI, 1.25-2.75] and OR 5.22 [95% CI, 3.48-7.83], for 2 and >= 3 antihypertensive medications, respectively). Non-adherence to any antihypertensive medication a month prior to healthcare visit was associated with elevated BP. Conclusion Sociodemographic factors were associated with non-adherence to any antihypertensive medication while clinical factors with non-adherence to the full AHT regimen. These differing findings support considering the use of multiple antihypertensive medications when measuring refill adherence. Monitoring patients' refill adherence prior to healthcare visit may facilitate interpreting elevated BP.	[Hedna, Khedidja; Hagg, Staffan] Linkoping Univ, Dept Drug Res Clin Pharmacol, Linkoping, Sweden; [Hedna, Khedidja; Hakkarainen, Katja M.; Gyllensten, Hanna] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Hakkarainen, Katja M.] EPID Res, Espoo, Finland; [Gyllensten, Hanna] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Jonsson, Anna K.] Linkoping Univ, Dept Clin Pharmacol, Linkoping, Sweden; [Jonsson, Anna K.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundell, Karolina Andersson] Univ Gothenburg, Sect Social Med, Gothenburg, Sweden; [Petzold, Max] Univ Gothenburg, Ctr Appl Biostat, Gothenburg, Sweden; [Hagg, Staffan] Futurum, Jonkoping Cty Council, Jonkoping, Sweden	Linkoping University; Karolinska Institutet; Linkoping University; Linkoping University; University of Gothenburg; University of Gothenburg; Futurum	Hedna, K (corresponding author), Linkoping Univ, Dept Drug Res Clin Pharmacol, Linkoping, Sweden.	khedidja.hedna@liu.se	Hägg, Staffan/G-5612-2013; Gyllensten, Hanna/H-7378-2016	Hägg, Staffan/0000-0002-5137-8420; Gyllensten, Hanna/0000-0001-6890-5162; fuchs, flavio/0000-0002-1191-0523	National Corporation of Swedish Pharmacies; Linkoping University; Ostergotland County Council	National Corporation of Swedish Pharmacies; Linkoping University; Ostergotland County Council	The project was funded through unrestricted grants from The National Corporation of Swedish Pharmacies, Linkoping University and Ostergotland County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak R, 2014, J MANAG CARE SPEC PH, V20, P815, DOI 10.18553/jmcp.2014.20.8.815; Bramley TJ, 2006, J MANAGE CARE PHARM, V12, P239, DOI 10.18553/jmcp.2006.12.3.239; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Choudhry NK, 2014, AM HEART J, V167, P51, DOI 10.1016/j.ahj.2013.09.014; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; De Smet PAGM, 2004, DRUGS, V64, P1779, DOI 10.2165/00003495-200464160-00005; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Fung V, 2007, CLIN THER, V29, P972, DOI 10.1016/j.clinthera.2007.05.010; Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150; Hansen RA, 2009, ANN PHARMACOTHER, V43, P413, DOI 10.1345/aph.1L496; Hasford J, 2007, EUR J CLIN PHARMACOL, V63, P1055, DOI 10.1007/s00228-007-0340-2; Ishisaka DY, 2012, J AM SOC HYPERTENS, V6, P201, DOI 10.1016/j.jash.2012.02.004; Jones I, 1998, BRIT J GEN PRACT, V48, P903; Kirkman MS, 2015, DIABETES CARE, V38, P604, DOI 10.2337/dc14-2098; Krueger KP, 2005, ADV THER, V22, P313, DOI 10.1007/BF02850081; Lagu T, 2009, AM J MANAG CARE, V15, P24; Lim Gregory B, 2013, Nat Rev Cardiol, V10, P59, DOI 10.1038/nrcardio.2012.194; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vinker S, 2008, EXPERT OPIN PHARMACO, V9, P1271, DOI 10.1517/14656566.9.8.1271 ; Wamala S, 2007, INT J QUAL HEALTH C, V19, P134, DOI 10.1093/intqhc/mzm011; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; World Health Organization, 2003, ADH LONG TERM THER	34	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137451	10.1371/journal.pone.0137451	http://dx.doi.org/10.1371/journal.pone.0137451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359861	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100040
J	Liu, PF; Xiao, L; Zhang, J				Liu, Pengfei; Xiao, Liang; Zhang, Jun			Fast Second Degree Total Variation Method for Image Compressive Sensing	PLOS ONE			English	Article							SIGNAL RECOVERY; MINIMIZATION; ALGORITHMS	This paper presents a computationally efficient algorithm for image compressive sensing reconstruction using a second degree total variation (HDTV2) regularization. Firstly, a preferably equivalent formulation of the HDTV2 functional is derived, which can be formulated as a weighted L-1-L-2 mixed norm of second degree image derivatives under the spectral decomposition framework. Secondly, using the equivalent formulation of HDTV2, we introduce an efficient forward-backward splitting (FBS) scheme to solve the HDTV2-based image reconstruction model. Furthermore, from the averaged non-expansive operator point of view, we make a detailed analysis on the convergence of the proposed FBS algorithm. Experiments on medical images demonstrate that the proposed method outperforms several fast algorithms of the TV and HDTV2 reconstruction models in terms of peak signal to noise ratio (PSNR), structural similarity index (SSIM) and convergence speed.	[Liu, Pengfei; Xiao, Liang] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Jun] Nanjing Univ Sci & Technol, Sch Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Nanjing University of Science & Technology	Xiao, L (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xiaoliang@mail.njust.edu.cn	xiao, liang/G-2968-2010; xiao, liang/V-2280-2019	xiao, liang/0000-0003-0178-9384; xiao, liang/0000-0003-0178-9384	Fundamental Research Funds for the Central Universities [30915012204]; National Nature Science Foundation of China [61171165, 11431015, 61101198]; Nature Science Foundation of Jiangsu Province [BK2012800]; National Scientific Equipment Developing Project of China [2012YQ050250]; Six Top Talents Project of Jiangsu Province [2012DZXX-036]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Scientific Equipment Developing Project of China; Six Top Talents Project of Jiangsu Province	This research is supported by the Fundamental Research Funds for the Central Universities (30915012204), the National Nature Science Foundation of China (61171165, 11431015, 61101198), Nature Science Foundation of Jiangsu Province (BK2012800), National Scientific Equipment Developing Project of China (2012YQ050250) and Six Top Talents Project of Jiangsu Province (2012DZXX-036).	Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bredies K, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/1/015005; Byrne C, 2004, INVERSE PROBL, V20, P103, DOI 10.1088/0266-5611/20/1/006; Byrne C., 2007, APPL ITERATIVE METHO; Candes E, 2005, PROC SPIE, V5674, P76, DOI 10.1117/12.600722; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Combettes PL, 2011, SPRINGER SER OPTIM A, V49, P185, DOI 10.1007/978-1-4419-9569-8_10; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Hu Y, 2012, IEEE T IMAGE PROCESS, V21, P2559, DOI 10.1109/TIP.2012.2183143; Lefkimmiatis S, 2012, IEEE T IMAGE PROCESS, V21, P983, DOI 10.1109/TIP.2011.2168232; Li F, 2007, J VIS COMMUN IMAGE R, V18, P322, DOI 10.1016/j.jvcir.2007.04.005; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Nesterov Y., 1983, SOV MATH DOKL, V27, P372; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Schnabel RB, 1983, NUMERICAL METHODS UN; Sluder G, 2007, METHOD CELL BIOL, V81, P1; Sra S, 2011, LECT NOTES ARTIF INT, V6913, P305, DOI 10.1007/978-3-642-23808-6_20; Vogel C. R., 2002, FRONT APPL MATH, DOI DOI 10.1137/1.9780898717570; Wen YW, 2008, SIAM J SCI COMPUT, V30, P2655, DOI 10.1137/070683374; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; You YL, 2000, IEEE T IMAGE PROCESS, V9, P1723, DOI 10.1109/83.869184	24	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137115	10.1371/journal.pone.0137115	http://dx.doi.org/10.1371/journal.pone.0137115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361008	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100023
J	Cascalheira, J; Bicho, N				Cascalheira, Joao; Bicho, Nuno			On the Chronological Structure of the Solutrean in Southern Iberia	PLOS ONE			English	Article							RADIOCARBON CHRONOLOGY; WESTERN-EUROPE; AGE; ECOLOGY	The Solutrean techno-complex has gained particular significance over time for representing a clear demographic and techno-typological deviation from the developments occurred during the course of the Upper Paleolithic in Western Europe. Some of Solutrean's most relevant features are the diversity and techno-typological characteristics of the lithic armatures. These have been recurrently used as pivotal elements in numerous Solutrean-related debates, including the chronological organization of the techno-complex across Iberia and Southwestern France. In Southern Iberia, patterns of presence and/or absence of specific point types in stratified sequences tend to validate the classical ordering of the techno-complex into Lower, Middle and Upper phases, although some evidence, namely radiocarbon determinations, have not always been corroborative. Here we present the first comprehensive analysis of the currently available radiocarbon data for the Solutrean in Southern Iberia. We use a Bayesian statistical approach from 13 stratified sequences to compare the duration, and the start and end moments of each classic Solutrean phase across sites. We conclude that, based on the current data, the traditional organization of the Solutrean cannot be unquestionably confirmed for Southern Iberia, calling into doubt the status of the classically defined type-fossils as precise temporal markers.	[Cascalheira, Joao; Bicho, Nuno] Univ Algarve, FCHS, ICArEHB, P-8005139 Faro, Portugal	Universidade do Algarve	Cascalheira, J (corresponding author), Univ Algarve, FCHS, ICArEHB, Campus Gambelas, P-8005139 Faro, Portugal.	jmcascalheira@ualg.pt	Cascalheira, João/B-8343-2014; Bicho, Nuno/J-2841-2012	Cascalheira, João/0000-0003-0321-8892; Bicho, Nuno/0000-0001-9655-0549	Fundacao para a Ciencia e Tecnologia [PTDC/HAH/64184/2006, PTDC/HIS-ARQ/117540/2010, SFRH/BD/65527/2009, SFRH/BPD/96277/2013]; National Geographic Society [8045-06]; Wenner-Gren Foundation for Anthropological Research [8290]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Geographic Society(National Geographic Society); Wenner-Gren Foundation for Anthropological Research	This work was supported by Fundacao para a Ciencia e Tecnologia (PT) (PTDC/HAH/64184/2006 and PTDC/HIS-ARQ/117540/2010), National Geographic Society (8045-06); Wenner-Gren Foundation for Anthropological Research (8290) funded radiocarbon dates from the site of Vale Boi, Algarve, Portugal. Fundacao para a Ciencia e Tecnologia (PT) awarded doctoral (SFRH/BD/65527/2009) and post-doctoral (SFRH/BPD/96277/2013) grants to Joao Cascalheira.	ALLARD M, 1993, PALEO, V5, P179; Aubry T., 2001, REV PORT ARQUEOL, V4, P19; Aubry T., 1995, B SOC PREHISTORIQUE, V92, P296, DOI [10.3406/bspf.1995.10030, DOI 10.3406/BSPF.1995.10030]; Aubry T., 2013, REV ARCHEOLOGIQUE S, P37; Aubry T, 2011, QUATERNARY RES, V75, P66, DOI 10.1016/j.yqres.2010.11.002; Aura JE., 1988, THESIS U VALENCIA VA; Aura JE, 2009, TRABAJOS PREHIST, V59, P69; Aura JE, 2012, ESPACIO TIEMPO FORMA, V5, P149, DOI DOI 10.5944/ETFI.5.2012.10851; Aura JE., 1995, 9 REUN NAC CUAT REC, P32; Aura JE., 1986, ZEPHYRUS, VXXXVII-XXXVIII, P99; Aura Tortosa J. E., 1989, SAGUNTUM, V22, P35; Banks WE, 2009, J ARCHAEOL SCI, V36, P2853, DOI 10.1016/j.jas.2009.09.014; Bicho N., 2009, BAR INT SERIES, P243; Bicho N, 2013, QUATERN INT, V308, P130, DOI 10.1016/j.quaint.2012.10.049; Bicho Nuno, 2012, Quartaer, V59, P153; Bicho N, 2012, QUATERN INT, V272, P6, DOI 10.1016/j.quaint.2012.02.055; BOFINGER E, 1977, J ARCHAEOL SCI, V4, P231, DOI 10.1016/0305-4403(77)90091-7; Bouzouggar A, 2002, ANTHROPOLOGIE, V106, P207; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Bradley B, 2006, WORLD ARCHAEOL, V38, P704, DOI 10.1080/00438240601022001; Calvo A, 2012, ESPACIO TIEMPO FORMA, V5, P131, DOI 10.5944/etfi.5.2012.5377; Cascalheira J, 2012, ESPACIO TIEMPO FORMA, V5, P455, DOI [10.5944/etfi.5.5376, DOI 10.5944/ETF\%0020I.5.5376, DOI 10.5944/ETFI.5.2012.5376]; Cascalheira J, 2010, TECNOLOGIA LITICA AB; Cascalheira J., 2013, ARQUEOLOGIA PORTUGAL, P269; Cascalheira J., 2013, THESIS U ALGARVE FAR; Cascalheira J, 2013, QUATERN INT, V318, P117, DOI 10.1016/j.quaint.2013.05.039; Cerda J., 1990, GEOGACETA, V8, P102; Corchon Rodriguez M., 2005, ZEPHYRUS, P89; Corchon Rodriguez M.S., 1999, ZEPHYRUS, V52, P3; Cortes Sanchez M, 2007, PALEOTLITICO MEDIO S; de la Rasilla M, 1995, SOLUTRENSE PENISNULA, P57; Domenech Faus E, 2012, RECERQUES MUSEU DALC, V21, P7; Douka K, 2014, J HUM EVOL, V68, P1, DOI 10.1016/j.jhevol.2013.12.007; Aura JE, 2012, QUATERN INT, V272, P75, DOI 10.1016/j.quaint.2012.05.020; Eren MI, 2013, J ARCHAEOL SCI, V40, P2934, DOI 10.1016/j.jas.2013.02.031; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Fortea J., 1976, ZEPHYRUS, V26, P167; Fullola J. M., 1978, ZEPHYRUS, VXXVIII-XXIX, P125; Fullola JM., 1979, IND LITICAS PALEOLIT; Fullola JM, 1985, BAR INT SERIES, V239, P222; Fusson H., 1990, FEUILLES PIERRE IND, P293; Gibaja JF, 2013, REV ARCHEOLOGIQUE S, P185; Higham T, 2011, J HUM EVOL, V61, P549, DOI 10.1016/j.jhevol.2011.06.005; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Iturbe G, 1987, TRABAJOS PREHIST, V44, P267; Jochim M., 1987, PLEISTOCENE OLD WORL, P317, DOI DOI 10.1007/978-1-4613-1817-020; Jorda F, 1955, EOLUTRENSE ESPANA PR; Jorda JF, 2008, ESPACIO TIEMPO FOR 1, P239, DOI DOI 10.5944/ETFI.1.2008.1922; Jorda Pardo JF, 2012, ESPACIO TIEMPO FORMA, V5, P63, DOI [10.5944/etfi.5.9212, DOI 10.5944/ETFI.5.9212]; Lucena A, 2012, ETF ARQUEOL, V5, P447, DOI [doi: 10. 5944/ etf i. 5.8290, DOI 10.5944/ETF, 10.5944/etfi.5.2012.8290]; Munoz Ibanez FJ, 2000, PUNTAS LIGERAS PROYE; O'Brien MJ, 2014, ANTIQUITY, V88, P606, DOI 10.1017/S0003598X0010122X; Otte M., 2002, ZEPHYRUS, V55, P77; Pereira T., 2010, THESIS U ALGARVE FAR; Pericot L., 1942, CUEVA PARPALLO GANDI; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasilla Vives M. de la, 1989, TRABAJOS PREHIST, V46, DOI [10.3989/tp.1989.v46.i0.585, DOI 10.3989/TP.1989.V46.I0.585]; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renard C., 2010, BAR INT SERIES, V2070; Renard C, 2011, WORLD ARCHAEOL, V43, P726, DOI 10.1080/00438243.2011.624789; Ripoll S., 1988, BAR INT SERIES, V462; Roche J., 1974, ZEPHYRUS, V25, P81; Rodrigo M, 1987, THESIS U VALENCIA VA; Roque C., 2001, DATATION, P217; SIMON MD, 2012, TRABAJOS PREHIST, V69, P7, DOI DOI 10.3989/TP.2012.12076; Smith P.E.L., 1966, SOLUTREEN FRANCE; Straus L.G., 1986, MUNIBE ANTROPOLOGIA, V38, P35; Straus L.G., 1986, ANTHR RES PAPERS, V36; Straus LG, 2000, ANTIQUITY, V74, P553; Straus LG, 2005, WORLD ARCHAEOL, V37, P507, DOI 10.1080/00438240500395797; Straus LG, 2000, J ANTHROPOL RES, V56, P39, DOI 10.1086/jar.56.1.3630967; STRAUS LG, 1991, CURR ANTHROPOL, V32, P189, DOI 10.1086/203940; Straus LG., 1983, SOLUTRENSE VASCO CAN; Straus LG., 1975, THESIS U CHICAGO; Straus LG, 1976, CURR ANTHROPOL, V17, P342; Talamo S, 2012, J ARCHAEOL SCI, V39, P175, DOI 10.1016/j.jas.2011.09.019; Tiffagom M, 2006, PIERRE HOMME ESSAI P; Utrilla P., 1994, FERVEDES, V1, P89; Villaverde V, 1994, ARTE PALEOLTICO COV; Villaverde V, 1999, ARCH PREHISTORIA LEV, VXXIII, P6; Villaverde V, 1981, PIEZAS ESCOTADURA PA; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Zilh~ao J., 2010, PALEOLITICO SUPERIOR, V8; ZILHAO J, 1995, ANTHROPOLOGIE, V99, P125; Zilhao J., 1994, FERVEDES, V1, P119; Zilhao J., 2002, PORTRAIT ARTIST CHIL; Zilhao J, 1984, ARQUEOLOGO PORTUGUES, VIV, P15; Zilhao J., 2013, PLEISTOCENE FORAGERS, P201; Zilhao J., 1997, PALEOLITICO SUPERIOR; Zilhao J., 2002, PORTRAIT ARTIST CHIL, P20	91	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137308	10.1371/journal.pone.0137308	http://dx.doi.org/10.1371/journal.pone.0137308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355459	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800041
J	Chiu, TY; Chiang, HJK; Huang, RY; Jiang, JHR; Fages, F				Chiu, Tai-Yin; Chiang, Hui-Ju K.; Huang, Ruei-Yang; Jiang, Jie-Hong R.; Fages, Francois			Synthesizing Configurable Biochemical Implementation of Linear Systems from Their Transfer Function Specifications	PLOS ONE			English	Article							DNA STRAND DISPLACEMENT; BRANCH MIGRATION; DESIGN; COMPUTATION; CIRCUITS; KINETICS; CONSTRUCTION; CASCADES; NETWORK; DEVICES	The ability to engineer synthetic systems in the biochemical context is constantly being improved and has a profound societal impact. Linear system design is one of the most pervasive methods applied in control tasks, and its biochemical realization has been proposed by Oishi and Klavins and advanced further in recent years. However, several technical issues remain unsolved. Specifically, the design process is not fully automated from specification at the transfer function level, systems once designed often lack dynamic adaptivity to environmental changes, matching rate constants of reactions is not always possible, and implementation may be approximative and greatly deviate from the specifications. Building upon the work of Oishi and Klavins, this paper overcomes these issues by introducing a design flow that transforms a transfer-function specification of a linear system into a set of chemical reactions, whose input-output response precisely conforms to the specification. This system is implementable using the DNA strand displacement technique. The underlying configurability is embedded into primitive components and template modules, and thus the entire system is adaptive. Simulation of DNA strand displacement implementation confirmed the feasibility and superiority of the proposed synthesis flow.	[Chiu, Tai-Yin] Natl Taiwan Univ, Dept Phys, Taipei 10764, Taiwan; [Chiu, Tai-Yin; Chiang, Hui-Ju K.; Huang, Ruei-Yang; Jiang, Jie-Hong R.] Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10764, Taiwan; [Chiang, Hui-Ju K.; Fages, Francois] Inria Paris Rocquencourt, EPI Lifeware, Rocquencourt, France; [Jiang, Jie-Hong R.] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Jiang, JHR (corresponding author), Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10764, Taiwan.	jhjiang@ntu.edu.tw	Fages, Francois/F-7137-2015; Jiang, Jie-Hong R./P-1759-2014		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: The Ministry of Science and Technology, Taiwan, provided support in the form of salaries for authors Tai-Yin Chiu, Hui-Ju Chiang, Ruei-Yang Huang, and Jie-Hong R. Jiang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Cardelli L, 2013, MATH STRUCT COMP SCI, V23, P247, DOI 10.1017/S0960129512000102; Cardelli L, 2009, LECT NOTES COMPUT SC, V5877, P12, DOI 10.1007/978-3-642-10604-0_2; Chandran H, 2011, LECT NOTES COMPUT SC, V6937, P64, DOI 10.1007/978-3-642-23638-9_8; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Densmore D, 2012, IEEE DES TEST COMPUT, V29, P7, DOI 10.1109/MDT.2012.2193370; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gopalkrishnan N, 2011, FDN NAN M FNANO; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Gyorgy A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003486; HOLLOMAN WK, 1975, P NATL ACAD SCI USA, V72, P2394, DOI 10.1073/pnas.72.6.2394; KLONOWSKI W, 1983, BIOPHYS CHEM, V18, P73, DOI 10.1016/0301-4622(83)85001-7; Lakin MR, 2012, J R SOC INTERFACE, V9, P1470, DOI 10.1098/rsif.2011.0800; Lakin MR, 2012, J R SOC INTERFACE, V9, P470, DOI 10.1098/rsif.2011.0343; Lakin MR, 2011, BIOINFORMATICS, V27, P3211, DOI 10.1093/bioinformatics/btr543; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Oishi K, 2011, IET SYST BIOL, V5, P252, DOI 10.1049/iet-syb.2010.0056; Padirac A, 2013, CURR OPIN BIOTECH, V24, P575, DOI 10.1016/j.copbio.2012.11.011; Padirac A, 2012, P NATL ACAD SCI USA, V109, pE3212, DOI 10.1073/pnas.1212069109; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PHILLIPS A, 2009, J R SOC INTERFACE S4, V6, DOI DOI 10.1098/RSIF.2009.0072.FOCUS; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; ROBINSON BH, 1987, BIOPHYS J, V51, P611, DOI 10.1016/S0006-3495(87)83386-6; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; WEINSTOCK PH, 1990, NUCLEIC ACIDS RES, V18, P4207, DOI 10.1093/nar/18.14.4207; Yordanov B, 2014, ACS SYNTH BIOL, V3, P600, DOI 10.1021/sb400169s; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137442	10.1371/journal.pone.0137442	http://dx.doi.org/10.1371/journal.pone.0137442			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352855	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800086
J	Kalderstam, J; Eden, P; Ohlsson, M				Kalderstam, Jonas; Eden, Patrik; Ohlsson, Mattias			Finding Risk Groups by Optimizing Artificial Neural Networks on the Area under the Survival Curve Using Genetic Algorithms	PLOS ONE			English	Article								We investigate a new method to place patients into risk groups in censored survival data. Properties such as median survival time, and end survival rate, are implicitly improved by optimizing the area under the survival curve. Artificial neural networks (ANN) are trained to either maximize or minimize this area using a genetic algorithm, and combined into an ensemble to predict one of low, intermediate, or high risk groups. Estimated patient risk can influence treatment choices, and is important for study stratification. A common approach is to sort the patients according to a prognostic index and then group them along the quartile limits. The Cox proportional hazards model (Cox) is one example of this approach. Another method of doing risk grouping is recursive partitioning (Rpart), which constructs a decision tree where each branch point maximizes the statistical separation between the groups. ANN, Cox, and Rpart are compared on five publicly available data sets with varying properties. Cross-validation, as well as separate test sets, are used to validate the models. Results on the test sets show comparable performance, except for the smallest data set where Rpart's predicted risk groups turn out to be inverted, an example of crossing survival curves. Cross-validation shows that all three models exhibit crossing of some survival curves on this small data set but that the ANN model manages the best separation of groups in terms of median survival time before such crossings. The conclusion is that optimizing the area under the survival curve is a viable approach to identify risk groups. Training ANNs to optimize this area combines two key strengths from both prognostic indices and Rpart. First, a desired minimum group size can be specified, as for a prognostic index. Second, the ability to utilize non-linear effects among the covariates, which Rpart is also able to do.	[Kalderstam, Jonas; Eden, Patrik; Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden	Lund University	Kalderstam, J (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	jonask@thep.lu.se		Ohlsson, Mattias/0000-0003-1145-4297	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	Funding: Funding provided by the Swedish Foundation for Strategic Research (http://www.createhealth.lth.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-29; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; [Anonymous], 2014, R LANG ENV STAT COMP; Banerjee M, 2000, CANCER, V89, P404, DOI 10.1002/1097-0142(20000715)89:2<404::AID-CNCR28>3.0.CO;2-M; Bishop C. M, 2006, PATTERN RECOGNITION; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breslow NE, 1999, J R STAT SOC C-APPL, V48, P457, DOI 10.1111/1467-9876.00165; COX DR, 1972, J R STAT SOC B, V34, P187; Dispenzieri A, 2012, MAYO CLIN PROC, V87, P517, DOI 10.1016/j.mayocp.2012.03.009; Goldberg D.E., 1989, GENETIC ALGORITHMS S; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Kalderstam J, 2013, ARTIF INTELL MED, V58, P125, DOI 10.1016/j.artmed.2013.03.001; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; Montana D. J., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P762; SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894; Therneau T, 2015, RPART RECURSIVE PART; Therneau T. M., 2014, PACKAGE SURVIVAL; Therneau T.M., 2000, MODELING SURVIVAL DA; Van Belle V, 2007, P 3 INT C COMP INT M, P1; Van Belle V, 2013, NEUROCOMPUTING, V112, P200, DOI 10.1016/j.neucom.2012.12.049	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137597	10.1371/journal.pone.0137597	http://dx.doi.org/10.1371/journal.pone.0137597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352405	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800101
J	Maeder, EM; Yamamoto, S				Maeder, Evelyn M.; Yamamoto, Susan			Culture in the Courtroom: Ethnocentrism and Juror Decision-Making	PLOS ONE			English	Article							GENDER; RACE; ATTRACTIVENESS; DEFENDANTS; JUDGMENTS; BIAS	The purpose of this study was to investigate whether a culturally-based argument in a non-insane automatism defense would be detrimental or beneficial to the defendant. We also examined how juror ethnocentrism might affect perceptions of such a defense. Participants read a fictional filicide homicide case in which the defendant claimed to have blacked out during the crime; we manipulated whether culture was used as an explanation for what precipitated the defendant's blackout. We conducted path analyses to assess the role of ethnocentrism in predicting lower defendant credibility, and harsher verdict decisions. Results revealed an interaction between ethnocentrism and defense type, such that ethnocentrism related to lower perceived defendant credibility in the cultural condition, but not in the standard automatism condition. This study marks a starting point for empirically investigating the role of culture in the courtroom, which may aid scholars in discussing the merits of a standalone cultural defense.	[Maeder, Evelyn M.] Carleton Univ, Inst Criminol & Criminal Justice, Ottawa, ON K1S 5B6, Canada; [Yamamoto, Susan] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Maeder, EM (corresponding author), Carleton Univ, Inst Criminol & Criminal Justice, Ottawa, ON K1S 5B6, Canada.	evelyn.maeder@carleton.ca	Yamamoto, Susan/CHD-4148-2022	Yamamoto, Susan/0000-0001-9368-0348	Social Sciences and Humanities Research Council [430]	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	Funding: This research was supported by a Social Sciences and Humanities Research Council (http://www.sshrccrsh.gc.ca/home-accueil-eng.aspx) Insight Development Grant (#430) provided to the first author (EMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; [Anonymous], 1986, HARVARD LAW REV, V99, P1293; Arboleda-Florez K, 2002, CURR OPIN PSYCHIATR, V15, P569; Bizumic B., 2014, J SOC POLIT PSYCHOL, V2, P3, DOI [DOI 10.HTTPS://D0I.0RG/10.5964/JSPP.V2I1.264, 10.5964/jspp.v2i1.264, DOI 10.5964/JSPP.V2I1.264]; CORTES DE, 1994, AM J COMMUN PSYCHOL, V22, P707, DOI 10.1007/BF02506900; Devine DJ, 2014, PSYCHOL PUBLIC POL L, V20, P109, DOI 10.1037/law0000006; Dick C, 2011, CAN J WOMEN LAW, V23, P519, DOI 10.3138/cjwl.23.2.519; ERBER R, 1984, J PERS SOC PSYCHOL, V47, P709, DOI 10.1037/0022-3514.47.4.709; Gudykunst WB., 1994, BRIDGING JAPANESE N, DOI [10.4135/9781452243184, DOI 10.4135/9781452243184]; HASTIE R, 1991, PERSPECTIVES ON SOCIALLY SHARED COGNITION, P308, DOI 10.1037/10096-013; Huckerby J., 2003, DUKE J GENDER LAW PO, V10, P149; Hunt JS, 2004, J APPL PSYCHOL, V89, P347, DOI 10.1037/0021-9010.89.2.347; Iga M, 1996, ARCH SUICIDE RES, V2, P87, DOI 10.1080/13811119608251959; KASIAN M, 1993, LAW HUMAN BEHAV, V17, P289, DOI 10.1007/BF01044510; KERR NL, 1995, LAW HUMAN BEHAV, V19, P545, DOI 10.1007/BF01499374; MAZZELLA R, 1994, J APPL SOC PSYCHOL, V24, P1315, DOI 10.1111/j.1559-1816.1994.tb01552.x; McCroskey J, 2015, SPEECH MONOGR, V33, P456; Mitchell T, 2005, LAW HUMAN BEHAV, V29, P621, DOI 10.1007/s10979-005-8122-9; Muthen L.K., MPLUS USERS GUIDE, V8th; Negy Charles, 2003, Cultur Divers Ethnic Minor Psychol, V9, P333, DOI 10.1037/1099-9809.9.4.333; Neuliep J., 2001, COMMUNICATION RES RE, V18, P137, DOI [10.1080/08824090109384791, DOI 10.1080/08824090109384791]; Neuliep J.W., COMMUN RES REP, V14, P145, DOI [10.1080/08824099709388656, DOI 10.1080/08824099709388656]; Neuliep JW, 2005, COMMUN Q, V53, P41, DOI 10.1080/01463370500055954; Phillips A., 2003, MOD LAW REV, V66, P510, DOI DOI 10.1111/1468-2230.6604002; RENTELN AlisonDundes, 2004, CULTURAL DEFENSE; Sommers SR, 2007, LAW HUMAN BEHAV, V31, P261, DOI 10.1007/s10979-006-9048-6; Sommers SR, 2001, PSYCHOL PUBLIC POL L, V7, P201, DOI 10.1037/1076-8971.7.1.201; STEPHAN CW, 1986, J APPL SOC PSYCHOL, V16, P577, DOI 10.1111/j.1559-1816.1986.tb01160.x; Sumner W. G., 1906, FOLKWAYS; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; TAYLOR DM, 1974, J CROSS CULT PSYCHOL, V5, P162, DOI 10.1177/002202217400500202; The Asian Population, 2010, C2010BR11 US CEN BUR; Van Broeck J., 2001, EUROPEAN J CRIME CRI, V9, P1, DOI DOI 10.1163/15718170120519282; Volpp L, 1996, COLUMBIA LAW REV, V96, P1573, DOI 10.2307/1123327; Volpp Leti, 1994, HARVARD WOMENS LAW J, V17, P57; Vrij A., 2001, INT REV VICTIMOLOGY, V8, P245, DOI DOI 10.1177/026975800100800301; Weiner B., 2006, SOCIAL MOTIVATION JU; Wilczynski A, 1997, BRIT J CRIMINOL, V37, P419	38	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137799	10.1371/journal.pone.0137799	http://dx.doi.org/10.1371/journal.pone.0137799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26353122	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800115
J	Mwilambwe-Tshilobo, L; Davis, AJO; Aizenberg, M; Geffen, MN				Mwilambwe-Tshilobo, Laetitia; Davis, Andrew J. O.; Aizenberg, Mark; Geffen, Maria N.			Selective Impairment in Frequency Discrimination in a Mouse Model of Tinnitus	PLOS ONE			English	Article							PURE-TONE TRAUMA; ACOUSTIC TRAUMA; PERCEPTION; MECHANISMS; PLASTICITY; RATS; EPIDEMIOLOGY; NEUROSCIENCE; HEARING; CORTEX	Tinnitus is an auditory disorder, which affects millions of Americans, including active duty service members and veterans. It is manifested by a phantom sound that is commonly restricted to a specific frequency range. Because tinnitus is associated with hearing deficits, understanding how tinnitus affects hearing perception is important for guiding therapies to improve the quality of life in this vast group of patients. In a rodent model of tinnitus, prolonged exposure to a tone leads to a selective decrease in gap detection in specific frequency bands. However, whether and how hearing acuity is affected for sounds within and outside those frequency bands is not well understood. We induced tinnitus in mice by prolonged exposure to a loud mid-range tone, and behaviorally assayed whether mice exhibited a change in frequency discrimination acuity for tones embedded within the mid-frequency range and high-frequency range at 1, 4, and 8 weeks post-exposure. A subset of tone-exposed mice exhibited tinnitus-like symptoms, as demonstrated by selective deficits in gap detection, which were restricted to the high frequency range. These mice exhibited impaired frequency discrimination both for tones in the mid-frequency range and high-frequency range. The remaining tone exposed mice, which did not demonstrate behavioral evidence of tinnitus, showed temporary deficits in frequency discrimination for tones in the mid-frequency range, while control mice remained unimpaired. Our findings reveal that the high frequency-specific deficits in gap detection, indicative of tinnitus, are associated with impairments in frequency discrimination at the frequency of the presumed tinnitus.	[Mwilambwe-Tshilobo, Laetitia; Davis, Andrew J. O.; Aizenberg, Mark; Geffen, Maria N.] Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA	University of Pennsylvania	Geffen, MN (corresponding author), Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA.	mgeffen@med.upenn.edu		Aizenberg, Mark/0000-0002-0010-0453	Klingenstein Award in Neuroscience; Burroughs Wellcome Career Award at the Scientific Interface; NIDCD NIH [R03DC013660]; PA Lions Hearing Research Fellowship; NIH [R01DC014700]; Human Frontiers in Science Foundation; NARSAD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014479, R03DC013660] Funding Source: NIH RePORTER	Klingenstein Award in Neuroscience(Klingenstein Philanthropies); Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NIDCD NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PA Lions Hearing Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: Klingenstein Award in Neuroscience to MNG (http://www.klingfund.org). Burroughs Wellcome Career Award at the Scientific Interface to MNG: (http://www.bwfund.org/). NIDCD NIH R03DC013660 to MNG. PA Lions Hearing Research Fellowship to MNG. NIH R01DC014700 to MNG. Human Frontiers in Science Foundation Young Investigator Award to MNG. NARSAD Young Investigator Award to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Ahmad N, 2004, DRUG AGING, V21, P297, DOI 10.2165/00002512-200421050-00002; Aizenberg M, 2013, NAT NEUROSCI, V16, P994, DOI 10.1038/nn.3443; Araneda R, 2015, RESTOR NEUROL NEUROS, V33, P67, DOI 10.3233/RNN-140433; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Komiya H, 2000, ACTA OTO-LARYNGOL, V120, P750; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Saunders JC, 2007, J COMMUN DISORD, V40, P313, DOI 10.1016/j.jcomdis.2007.03.006; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Thai-Van H, 2003, BRAIN, V126, P2235, DOI 10.1093/brain/awg228; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137749	10.1371/journal.pone.0137749	http://dx.doi.org/10.1371/journal.pone.0137749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352864	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800113
J	Su, HH; Cheng, YM; Wang, ZY; Li, Z; Stanley, D; Yang, YZ				Su, Honghua; Cheng, Yuming; Wang, Zhongyang; Li, Zhong; Stanley, David; Yang, Yizhong			Silk Gland Gene Expression during Larval-Pupal Transition in the Cotton Leaf Roller Sylepta derogata (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; CLONING	The cotton leaf roller, Sylepta derogata, is a silk-producing insect pest. While young larvae feed on the underside of leaves, the older ones roll cotton leaves and feed on the leaf edges, which defoliates cotton plants. The larvae produce silk to stabilize the rolled leaf and to balloon from used to new leaves. Despite the significance of silk in the biology of pest insect species, there is virtually no information on the genes involved in their silk production. This is a substantial knowledge gap because some of these genes may be valuable targets for developing molecular pest management technologies. We addressed the gap by posing the hypothesis that silk gland gene expression changes during the transition from larvae to pupae. We tested our hypothesis using RNA-seq to investigate changes in silk gland gene expression at three developmental stages, 5th instar larvae (silk producing; 15,445,926 clean reads), prepupae (reduced silk producing; 13,758,154) and pupae (beyond silk producing; 16,787,792). We recorded 60,298 unigenes and mapped 50,158 (larvae), 48,415 (prepupae) and 46,623 (pupae) of them to the NCBI database. Most differentially expressed genes in the 5th instar larvae/prepupae libraries were relevant to nucleotide synthesis and maintenance of silk gland function. We identified down-regulated transcriptional factors and several genes involved in silk formation in the three libraries and verified the expression pattern of eight genes by qPCR. The developmental-and tissue-specific expression patterns of the fibroin light chain gene showed it was highly expressed during the larval silk-producing stage. We recorded highest expression of this gene in the larval silk gland, compared to other tissues, including midgut, hindgut, epidermis, Malpighian tubes, hemolymph and fat body. These data are a genetic resource to guide selection of key genes that may be targeted for in planta and other gene-silencing technologies for sustainable cotton agriculture.	[Su, Honghua; Cheng, Yuming; Li, Zhong; Yang, Yizhong] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Zhongyang] Yangzhou Termite Control Ctr, Yangzhou 225001, Jiangsu, Peoples R China; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65203 USA	Yangzhou University; United States Department of Agriculture (USDA)	Yang, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.	yzyang@yzu.edu.cn			major science and technology project - Ministry of Agriculture of the People's Republic of China [2014ZX08012004-007]; Yangzhou Termite Control Center	major science and technology project - Ministry of Agriculture of the People's Republic of China; Yangzhou Termite Control Center	This research was supported by a major science and technology project to create new crop varieties using gene transfer technology (Biosafety Monitoring Technique of Genetically Modified Organisms: 2014ZX08012004-007) funded by Ministry of Agriculture of the People's Republic of China. Co-author Zhongyang Wang is employed by Yangzhou Termite Control Center. Yangzhou Termite Control Center provided support in the form of salary for author Zhongyang Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Chaitanya RK, 2010, GEN COMP ENDOCR, V167, P113, DOI 10.1016/j.ygcen.2010.02.007; Chen CX, 2015, J ENV ENTOM IN PRESS; Di JX, 2007, JIANGSU AGR SCI, V5, P82; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Kamimura M, 2007, ARCH INSECT BIOCHEM, V65, P143, DOI 10.1002/arch.20186; Klapwijk MJ, 2013, ECOL EVOL, V3, P4183, DOI 10.1002/ece3.717; Kontogiannatos D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073834; Li H, 2014, ONCOGENE, V33, P4589, DOI 10.1038/onc.2013.408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105717; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Qiao HL, 2013, J INSECT PHYSIOL, V59, P667, DOI 10.1016/j.jinsphys.2013.04.004; Reumer A, 2009, DEV COMP IMMUNOL, V33, P1186, DOI 10.1016/j.dci.2009.06.010; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; Shimizu K, 2007, INSECT BIOCHEM MOLEC, V37, P713, DOI 10.1016/j.ibmb.2007.03.016; Statzner B, 1999, WATER RESOUR RES, V35, P3495, DOI 10.1029/1999WR900196; Sun W, 2012, INT J BIOL SCI, V8, P125, DOI 10.7150/ijbs.8.125; Takiya S, 2009, J BIOCHEM, V146, P103, DOI 10.1093/jb/mvp053; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Tootle TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019943; Wang Meng-Qing, 2004, Entomological Knowledge, V41, P90; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Xu J, 2010, J ECON ENTOMOL, V103, P1166, DOI 10.1603/EC09265; Yang HJ, 2011, ARCH INSECT BIOCHEM, V78, P17, DOI 10.1002/arch.20436; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhao XQ, 2014, J BIOL CHEM; Zheng YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111369	28	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136868	10.1371/journal.pone.0136868	http://dx.doi.org/10.1371/journal.pone.0136868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352931	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800051
J	Beretta, VS; Gobbi, LTB; Lirani-Silva, E; Simieli, L; Orcioli-Silva, D; Barbieri, FA				Beretta, Victor Spiandor; Bucken Gobbi, Lilian Teresa; Lirani-Silva, Ellen; Simieli, Lucas; Orcioli-Silva, Diego; Barbieri, Fabio Augusto			Challenging Postural Tasks Increase Asymmetry in Patients with Parkinson's Disease	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; BALANCE CONTROL; STANCE; BRAZIL; GAIT; INSTABILITY; PREVALENCE; PEOPLE; MOTOR; SWAY	The unilateral predominance of Parkinson's disease (PD) symptoms suggests that balance control could be asymmetrical during static tasks. Although studies have shown that balance control asymmetries exist in patients with PD, these analyses were performed using only simple bipedal standing tasks. Challenging postural tasks, such as unipedal or tandem standing, could exacerbate balance control asymmetries. To address this, we studied the impact of challenging standing tasks on postural control asymmetry in patients with PD. Twenty patients with PD and twenty neurologically healthy individuals (control group) participated in this study. Participants performed three 30s trials for each postural task: bipedal, tandem adapted and unipedal standing. The center of pressure parameter was calculated for both limbs in each of these conditions, and the asymmetry between limbs was assessed using the symmetric index. A significant effect of condition was observed, with unipedal standing and tandem standing showing greater asymmetry than bipedal standing for the mediolateral root mean square (RMS) and area of sway parameters, respectively. In addition, a group* condition interaction indicated that, only for patients with PD, the unipedal condition showed greater asymmetry in the mediolateral RMS and area of sway than the bipedal condition and the tandem condition showed greater asymmetry in the area of sway than the bipedal condition. Patients with PD exhibited greater asymmetry while performing tasks requiring postural control when compared to neurologically healthy individuals, especially for challenging tasks such as tandem and unipedal standing.	[Beretta, Victor Spiandor; Bucken Gobbi, Lilian Teresa; Lirani-Silva, Ellen; Simieli, Lucas; Orcioli-Silva, Diego; Barbieri, Fabio Augusto] Univ Estadual Paulista, UNESP, Posture & Gait Studies Lab, Dept Phys Educ,Biosci Inst, Sao Paulo, Brazil; [Barbieri, Fabio Augusto] Univ Estadual Paulista, UNESP, Lab Informat Vis & Act, Dept Phys Educ,Fac Sci, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Barbieri, FA (corresponding author), Univ Estadual Paulista, UNESP, Posture & Gait Studies Lab, Dept Phys Educ,Biosci Inst, Sao Paulo, Brazil.	barbieri_rc@hotmail.com	Barbieri, Fabio A./G-8721-2013; Gobbi, Lilian T B/C-9879-2010; Orcioli-Silva, Diego/I-4108-2016; SIMIELI, L./M-6087-2014; Beretta, Victor S/D-4511-2017	Barbieri, Fabio A./0000-0002-3678-8456; Gobbi, Lilian T B/0000-0003-3984-3403; Orcioli-Silva, Diego/0000-0002-2278-8092; SIMIELI, L./0000-0001-5025-4613; Beretta, Victor S/0000-0002-4640-7733	FAPESP [2012-24040-9, 2013/00925-4]; FUNDUNESP; Pro Reitoria de Pesquisa da UNESP [0716/011 - PROPE]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FUNDUNESP; Pro Reitoria de Pesquisa da UNESP	The authors thank FAPESP (# 2012-24040-9; # 2013/00925-4), FUNDUNESP and Pro Reitoria de Pesquisa da UNESP (#0716/011 - PROPE) for financial support.	Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barbosa MT, 2006, MOVEMENT DISORD, V21, P800, DOI 10.1002/mds.20806; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Boonstra TA, 2014, J NEUROPHYSIOL, V112, P3227, DOI 10.1152/jn.00813.2013; Boonstra TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102493; Brown LA, 1997, GAIT POSTURE, V6, P89, DOI 10.1016/S0966-6362(96)01106-X; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Geurts ACH, 2011, GAIT POSTURE, V33, P143, DOI 10.1016/j.gaitpost.2010.09.018; GEURTS ACH, 1992, SCAND J REHABIL MED, V24, P83; GOLBE LI, 1991, NEUROLOGY, V41, P168, DOI 10.1212/WNL.41.2_Part_1.168; Haddad JM, 2013, EXERC SPORT SCI REV, V41, P123, DOI 10.1097/JES.0b013e3182877cc8; Henry SM, 2001, J NEUROPHYSIOL, V85, P559, DOI 10.1152/jn.2001.85.2.559; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Horak FB, 2010, APPROACH FALLING PAT; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kim JW, 2014, BIO-MED MATER ENG, V24, P2681, DOI 10.3233/BME-141085; KNABLE MB, 1995, J NUCL MED, V36, P1216; Morris ME, 2000, PHYS THER, V80, P578, DOI 10.1093/ptj/80.6.578; Potgieser ARE, 2011, HUM MOVEMENT SCI, V30, P1072, DOI 10.1016/j.humov.2011.02.005; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Sadeghi H, 2003, GAIT POSTURE, V17, P197, DOI 10.1016/S0966-6362(02)00089-9; Schenkman M, 2001, PARKINSONISM RELAT D, V8, P41, DOI 10.1016/S1353-8020(00)00079-1; Shumway-Cook A, 2010, MOTOR CONTROL THEORY; Stewart KC, 2009, PARKINSONISM RELAT D, V15, P781, DOI 10.1016/j.parkreldis.2009.02.001; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Tatsch K, 1997, EUR J NUCL MED, V24, P415, DOI 10.1007/BF00881814; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van der Burg JCE, 2006, PARKINSONISM RELAT D, V12, P492, DOI 10.1016/j.parkreldis.2006.06.007; van der Hoorn A, 2011, PARKINSONISM RELAT D, V17, P58, DOI 10.1016/j.parkreldis.2010.10.002; van der Kooij H, 2007, J NEURAL TRANSM, V114, P1333, DOI 10.1007/s00702-007-0801-x; Visser Jasper E., 2005, Neural Plasticity, V12, P161, DOI 10.1155/NP.2005.161; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	42	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137722	10.1371/journal.pone.0137722	http://dx.doi.org/10.1371/journal.pone.0137722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367032	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100121
J	Chen, LD; Liu, JN; Lin, L; Wu, Z; Li, H; Ye, YM; Xu, QZ; Lin, QC				Chen, Li-Da; Liu, Jian-Nan; Lin, Li; Wu, Zhi; Li, Hao; Ye, Yu-Ming; Xu, Qiao-Zhen; Lin, Qi-Chang			Effect of Continuous Positive Airway Pressure on Adiponectin in Patients with Obstructive Sleep Apnea: A Meta-Analysis	PLOS ONE			English	Article							INSULIN-RESISTANCE; HYPOPNEA SYNDROME; OXIDATIVE STRESS; PLASMA-LEVELS; CPAP; OBESITY; DISEASE; MEN	Objective Obstructive sleep apnea (OSA) has been suggested to be associated with low levels of adiponectin. Continuous positive airway pressure (CPAP) is the gold standard treatment for OSA; however, previous studies assessing the effect of CPAP on adiponectin in patients with OSA yielded conflicting results. The present meta-analysis was performed to determine whether CPAP therapy could increase adiponectin levels. Methods Two reviewers independently searched PubMed, Cochrane library, Embase and Web of Science before February 2015. Information on characteristics of subjects, study design and pre-and post-CPAP treatment of serum adiponectin was extracted for analysis. Standardized mean difference (SMD) was used to analyze the summary estimates for CPAP therapy. Results Eleven studies involving 240 patients were included in this meta-analysis, including ten observational studies and one randomized controlled study. The meta-analysis showed that there was no change of adiponectin levels before and after CPAP treatment in OSA patients (SMD = 0.059, 95% confidence interval (CI) = -0.250 to 0.368, z = 0.37, p = 0.710). Subgroup analyses indicated that the results were not affected by age, baseline body mass index, severity of OSA, CPAP therapy duration, sample size and racial differences. Conclusions This meta-analysis suggested that CPAP therapy has no impact on adiponectin in OSA patients, without significant changes in body weight. Further large-scale, well-designed long-term interventional investigations are needed to clarify this issue.	[Chen, Li-Da; Liu, Jian-Nan; Lin, Li; Wu, Zhi; Li, Hao; Ye, Yu-Ming; Xu, Qiao-Zhen] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Resp Med, Zhangzhou 363000, Fujian Province, Peoples R China; [Lin, Qi-Chang] Fujian Med Univ, Affiliated Hosp 1, Fujian Prov Sleep Disordered Breathing Clin Ctr, Lab Resp Dis,Dept Resp Med, Fuzhou 350005, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University	Lin, QC (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Fujian Prov Sleep Disordered Breathing Clin Ctr, Lab Resp Dis,Dept Resp Med, 20 Chazhong Rd, Fuzhou 350005, Fujian Province, Peoples R China.	chang4e@126.com	LIN, QI/HDO-8145-2022	Li, Hao/0000-0003-0868-9925				Carneiro G, 2009, METAB SYNDR RELAT D, V7, P537, DOI 10.1089/met.2009.0019; Chami HA, 2011, CIRCULATION, V123, P1280, DOI 10.1161/CIRCULATIONAHA.110.974022; Delporte ML, 2002, BIOCHEM J, V367, P677, DOI 10.1042/BJ20020610; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Garcia JM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-80; Harsch IA, 2004, RESPIRATION, V71, P580, DOI 10.1159/000081758; Higgins JP, 2005, COCHRANE HANDBOOK FO; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; de Lima AMJ, 2010, RESPIRATION, V79, P370, DOI 10.1159/000227800; Kim J, 2010, ARCH OTOLARYNGOL, V136, P896, DOI 10.1001/archoto.2010.142; Kohler M, 2009, THORAX, V64, P67, DOI 10.1136/thx.2008.097931; Kritikou I, 2014, EUR RESPIR J, V43, P145, DOI 10.1183/09031936.00126712; Li AM, 2010, CHEST, V137, P529, DOI 10.1378/chest.09-2153; Lindberg E, 2000, SLEEP MED REV, V4, P411, DOI 10.1053/smrv.2000.0118; Malhotra A, 2000, Curr Opin Pulm Med, V6, P490, DOI 10.1097/00063198-200011000-00005; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martinez D, 2012, SLEEP BREATH, V16, P695, DOI 10.1007/s11325-011-0559-0; Masserini B, 2006, J ENDOCRINOL INVEST, V29, P700, DOI 10.1007/BF03344179; Nakagawa Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE778, DOI 10.1152/ajpendo.00709.2007; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Salord N, 2013, RESPIROLOGY, V18, P1135, DOI 10.1111/resp.12131; Sanchez-de-la-Torre M, 2012, SLEEP BREATH, V16, P649, DOI 10.1007/s11325-011-0552-7; Simon S, 2012, CHEST, V142, P1645, DOI 10.1378/chest.12-2391; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sumi K, 2006, QJM-INT J MED, V99, P545, DOI 10.1093/qjmed/hcl074; Takahashi KI, 2008, ANTIOXID REDOX SIGN, V10, P715, DOI 10.1089/ars.2007.1949; Vgontzas AN, 2008, EUR J CLIN INVEST, V38, P585, DOI 10.1111/j.1365-2362.2008.01984.x; West SD, 2007, THORAX, V62, P969, DOI 10.1136/thx.2006.074351; Wolk R, 2005, OBES RES, V13, P186, DOI 10.1038/oby.2005.24; Yoshikawa M, 2014, LUNG, V192, P289, DOI 10.1007/s00408-013-9550-9; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhang XL, 2007, CHINESE MED J-PEKING, V120, P1477, DOI 10.1097/00029330-200709010-00002; Zhang XL, 2006, RESPIRATION, V73, P73, DOI 10.1159/000088690	35	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136837	10.1371/journal.pone.0136837	http://dx.doi.org/10.1371/journal.pone.0136837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367527	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100027
J	Oberoi, R; Bogalle, EP; Matthes, LA; Schuett, H; Koch, AK; Grote, K; Schieffer, B; Schuett, J; Luchtefeld, M				Oberoi, Raghav; Bogalle, Eskindir P.; Matthes, Lukas A.; Schuett, Harald; Koch, Ann-Kathrin; Grote, Karsten; Schieffer, Bernhard; Schuett, Jutta; Luchtefeld, Maren			Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; SCAVENGER RECEPTOR; EXPRESSION; MACROPHAGES; PROTEIN; POLARIZATION; MORTALITY; CYTOKINES	Background Lipocalin (LCN) 2 is associated with multiple acute and chronic inflammatory diseases but the underlying molecular and cellular mechanisms remain unclear. Here, we investigated whether LCN2 is released from macrophages and contributes to pro-atherosclerotic processes and whether LCN2 plasma levels are associated with the severity of coronary artery disease progression in humans. Methods and Results In an autocrine-paracrine loop, tumor necrosis factor (TNF)-alpha promoted the release of LCN2 from murine bone-marrow derived macrophages (BMDM) and vice versa. Moreover, LCN2 stimulation of BMDM led to up-regulation of M1 macrophage markers. In addition, enhanced migration of monocytic J774A. 1 cells towards LCN2 was observed. Furthermore, LCN2 increased the expression of the scavenger receptors Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) as well as scavenger receptor class A-1 (SRA-1) and induced the conversion of macrophages to foam cells. In atherosclerotic lesions of low density lipoprotein receptor-deficient (ldlr(-/-)) mice fed a high fat, high cholesterol diet, LCN2 was found to be co-localized with macrophages in the shoulder region of the atherosclerotic plaque. In addition, LCN2 plasma levels were significantly increased in plasma samples of these mice. Finally, LCN2 plasma levels correlated with the severity of coronary artery disease (CAD) in patients as determined by coronary angiography. Conclusions Here we demonstrated that LCN2 plays a pivotal role in processes involved in atherogenesis by promoting polarization and migration of monocytic cells and development of macrophages towards foam cells. Moreover, LCN2 may be used as a prognostic marker to determine the status of CAD progression.	[Oberoi, Raghav; Schuett, Harald; Koch, Ann-Kathrin; Grote, Karsten; Schieffer, Bernhard; Schuett, Jutta; Luchtefeld, Maren] Univ Marburg, Dept Cardiol & Angiol, Marburg, Germany; [Bogalle, Eskindir P.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Philipps University Marburg; Hannover Medical School	Luchtefeld, M (corresponding author), Univ Marburg, Dept Cardiol & Angiol, Marburg, Germany.	Maren.Luchtefeld@gmx.de		Grote, Karsten/0000-0001-7914-3159; Vlacil, Ann-Kathrin/0000-0001-9743-0290	Ellen-Schmidt foundation (Hannover Medical School, M.L.)	Ellen-Schmidt foundation (Hannover Medical School, M.L.)	This work was supported by the Ellen-Schmidt foundation (Hannover Medical School, M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; BLANK RS, 1988, J CELL BIOL, V107, P299, DOI 10.1083/jcb.107.1.299; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V121, P255, DOI 10.1046/j.1365-2249.2000.01281.x; Cervellin G, 2012, CLIN CHEM LAB MED, V50, P1489, DOI 10.1515/cclm-2012-0433; Cheng L, 2015, SCAND J IMMUNOL, V81, P31, DOI 10.1111/sji.12245; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Devarajan P, 2008, NEPHROL DIAL TRANSPL, V23, P3737, DOI 10.1093/ndt/gfn531; Dittrich AM, 2010, CLIN EXP ALLERGY, V40, P1689, DOI 10.1111/j.1365-2222.2010.03508.x; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Guo H, 2014, MOL ENDOCRINOL, V28, P1616, DOI 10.1210/me.2014-1092; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hofnagel O, 2004, ARTERIOSCL THROM VAS, V24, P1789, DOI 10.1161/01.ATV.0000140061.89096.2b; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kafkas N, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/189797; KJELDSEN L, 1994, BLOOD, V83, P799; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luchtefeld M, 2011, PLOS ONE, V6, P1, DOI [10.1371/journal.pone.0019427, DOI 10.1371/J0URNAL.P0NE.0019427]; Mao SS, 2011, INT J MOL MED, V27, P555, DOI 10.3892/ijmm.2011.613; Martin-Fuentes P, 2007, J IMMUNOL, V179, P3242, DOI 10.4049/jimmunol.179.5.3242; Mori K, 2010, CLIN EXP NEPHROL, V14, P523, DOI 10.1007/s10157-010-0320-1; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; Prasad H, 2012, POSTGRAD MED, V124, P21, DOI 10.3810/pgm.2012.01.2514; RAJMAN I, 1994, LANCET, V344, P1363, DOI 10.1016/S0140-6736(94)90721-8; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Sahinarslan A, 2011, CORONARY ARTERY DIS, V22, P333, DOI 10.1097/MCA.0b013e3283472a71; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Silverstein RL, 2009, CLEVE CLIN J MED S2, V76, pS27, DOI DOI 10.3949/CCJM.76.S2.06; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997; Zhao P, 2014, J BIOL CHEM, V289, P5960, DOI 10.1074/jbc.M113.532234; Zografos T, 2009, AM J CARDIOL, V104, P917, DOI 10.1016/j.amjcard.2009.05.023	38	19	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137924	10.1371/journal.pone.0137924	http://dx.doi.org/10.1371/journal.pone.0137924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367277	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100179
J	Relja, B; Weber, R; Maraslioglu, M; Wagner, N; Borsello, T; Jobin, C; Marzi, I; Lehnert, M				Relja, Borna; Weber, Roxane; Maraslioglu, Miriam; Wagner, Nils; Borsello, Tiziana; Jobin, Christian; Marzi, Ingo; Lehnert, Mark			Differential Relevance of NF-kappa B and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol Feeding	PLOS ONE			English	Article							TERMINAL KINASE PROTECTS; C-JUN; PEPTIDE INHIBITOR; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; HEPATIC-INJURY; CASPASE-3 ACTIVATION; SIGNAL-TRANSDUCTION; REPERFUSION INJURY; CEREBRAL-ISCHEMIA	Background Chronic ethanol (EtOH) abuse worsens pathophysiological derangements after hemorrhagic shock and resuscitation (H/R) that induce hepatic injury and strong inflammatory changes via JNK and NF-kappa B activation. Inhibiting JNK with a cell-penetrating, proteaseresistant peptide D-JNKI-1 after H/R in mice with healthy livers ameliorated these effects. Here, we studied if JNK inhibition by D-JNKI-1 in chronically EtOH-fed mice after hemorrhagic shock prior to the onset of resuscitation also confers protection. Methods Male mice were fed a Lieber-DeCarli diet containing EtOH or an isocaloric control (ctrl) diet for 4 weeks. Animals were hemorrhaged for 90 min (32 +/- 2 mm Hg) and randomly received either D-JNKI-1 (11 mg/kg, intraperitoneally, i.p.) or sterile saline as vehicle (veh) immediately before the onset of resuscitation. Sham animals underwent surgical procedures without H/R and were either D-JNKI-1 or veh treated. Two hours after resuscitation, blood samples and liver tissue were harvested. Results H/R induced hepatic injury with increased systemic interleukin (IL)-6 levels, and enhanced local gene expression of NF-kappa B-controlled genes such as intercellular adhesion molecule (ICAM)-1 and matrix metallopeptidase (MMP) 9. c-Jun and NF-kappa B phosphorylation were increased after H/R. These effects were further increased in EtOH-fed mice after H/R. D-JNKI-1 application inhibited the proinflammatory changes and reduced significantly hepatic injury after H/R in ctrl-fed mice. Moreover, D-JNKI-1 reduces in ctrl-fed mice the H/R-induced c-Jun and NF-kappa B phosphorylation. However, in chronically EtOH-fed mice, JNK inhibition did not prevent the H/R-induced hepatic damage and proinflammatory changes nor c-Jun and NF-kappa B phosphorylation after H/R. Conclusions These results indicate, that JNK inhibition is protective only in not pre-harmed liver after H/R. In contrast, the pronounced H/R-induced liver damage in mice being chronically fed with ethanol cannot be prevented by JNK inhibition after H/R and seems to be under the control of NF-kappa B.	[Relja, Borna; Weber, Roxane; Maraslioglu, Miriam; Wagner, Nils; Marzi, Ingo; Lehnert, Mark] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60054 Frankfurt, Germany; [Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Neuronal Death & Neuroprotect Unit, Milan, Italy; [Jobin, Christian] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; State University System of Florida; University of Florida	Relja, B (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60054 Frankfurt, Germany.	info@bornarelja.com	Borsello, Tiziana/ABG-7759-2020; Maraslioglu, M./I-8306-2019; Relja, Borna/B-6642-2016; Borsello, Tiziana/J-8232-2016	Maraslioglu, M./0000-0002-2071-2801; Relja, Borna/0000-0002-5625-8823; Borsello, Tiziana/0000-0002-9729-7642	Deutsche Forschungsgemeinschaft (DE) [LE 1346/2-1]	Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DE) grant nr. LE 1346/2-1.	Aroor AR, 2011, ALCOHOL CLIN EXP RES, V35, P2128, DOI 10.1111/j.1530-0277.2011.01577.x; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Benakis C, 2010, BRAIN BEHAV IMMUN, V24, P800, DOI 10.1016/j.bbi.2009.11.001; Bertelsen M, 2005, ASSAY DRUG DEV TECHN, V3, P261, DOI 10.1089/adt.2005.3.261; Bogner V, 2009, EUR J MED RES, V14, P284, DOI 10.1186/2047-783X-14-7-284; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bradford BU, 2008, TOXICOL APPL PHARM, V232, P236, DOI 10.1016/j.taap.2008.06.022; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Davoli E, 2014, J PHARMACOL TOX MET, V70, P55, DOI 10.1016/j.vascn.2014.04.001; DECARLI LM, 1967, J NUTR, V91, P331, DOI 10.1093/jn/91.3_Suppl.331; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Eshraghi AA, 2007, HEARING RES, V226, P168, DOI 10.1016/j.heares.2006.09.008; Fan CG, 2004, J CLIN INVEST, V113, P746, DOI 10.1172/JCI200417337; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Koteish A, 2002, J BIOL CHEM, V277, P13037, DOI 10.1074/jbc.M101632200; Lehnert M, 2008, SHOCK, V30, P159, DOI 10.1097/SHK.0b013e31815dd623; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Maraslioglu M, 2013, BRIT J PHARMACOL, V170, P506, DOI 10.1111/bph.12224; Maraslioglu M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/808695; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Nau C, 2012, INJURY; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Peden M, 2002, BRIT MED J, V324, P1153, DOI 10.1136/bmj.324.7346.1153; Reinecke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030985; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Relja B, 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/781519; Relja B, 2010, PLANT POLYPHENOLS AT; Relja B, 2013, SCAND J GASTROENTERO, V48, P448, DOI 10.3109/00365521.2013.772228; Relja B, 2011, BRIT J NUTR, V105, P1791, DOI 10.1017/S000711451000560X; Relja B, 2010, SHOCK, V34, P46, DOI 10.1097/SHK.0b013e3181cd8d05; Relja B, 2009, SHOCK, V32, P509, DOI 10.1097/SHK.0b013e3181a2530d; Rensing H, 2001, CRIT CARE MED, V29, P1962, DOI 10.1097/00003246-200110000-00019; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; Shimizu T, 2007, J HEPATOL, V46, P1047, DOI 10.1016/j.jhep.2007.01.019; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; van Meurs M, 2008, SHOCK, V29, P291, DOI 10.1097/shk.0b013e318145a7c1; Wang J, 2003, J NEUROSCI, V23, P8596; Wang XD, 2009, FREE RADICAL BIO MED, V47, P518, DOI 10.1016/j.freeradbiomed.2009.05.021; Wetzel G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930419	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137875	10.1371/journal.pone.0137875	http://dx.doi.org/10.1371/journal.pone.0137875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367181	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100164
J	Wu, P; Wang, LP; Cowling, BJ; Yu, JX; Fang, VJ; Li, F; Zeng, LJ; Wu, JT; Li, ZJ; Leung, GM; Yu, HJ				Wu, Peng; Wang, Liping; Cowling, Benjamin J.; Yu, Jianxing; Fang, Vicky J.; Li, Fu; Zeng, Lingjia; Wu, Joseph T.; Li, Zhongjie; Leung, Gabriel M.; Yu, Hongjie			Live Poultry Exposure and Public Response to Influenza A(H7N9) in Urban and Rural China during Two Epidemic Waves in 2013-2014	PLOS ONE			English	Article							A H7N9 VIRUS; BEHAVIORAL-RESPONSES; HUMAN INFECTIONS; HONG-KONG; MARKETS	Background The novel influenza A(H7N9) virus has caused 2013 spring and 2013-2014 winter waves of human infections since its first emergence in China in March 2013. Exposure to live poultry is a risk factor for H7N9 infection. Public psychobehavioral responses often change during progression of an epidemic. Methods We conducted population-based surveys in southern China to examine human exposure to live poultry, and population psychological response and behavioral changes in the two waves. In Guangzhou, an urban area of Guangdong province, we collected data using telephone surveys with random digit dialing in May-June 2013 and again in December 2013 to January 2014. In Zijin county, a rural area of the same province, we used door-to-door surveys under a stratified sampling design in July 2013 and again in December 2013 to January 2014. All responses were weighted by age and sex to the respective adult populations. Findings Around half of the urban respondents (53.8%) reported having visited LPMs in the previous year in the first survey, around double that reported in the second survey (27.7%). In the rural surveys, around half of the participants reported raising backyard poultry in the past year in the first survey, increasing to 83.2% participants in the second survey. One third of urban subjects supported the permanent closure of LPMs in the first and second surveys, and factors associated with support for closure included female sex, higher level of worry towards H7N9, and worry induced by a hypothetical influenza-like illness. Conclusions Our study indicated high human exposure to live poultry and low support for permanent closure of markets in both urban and rural residents regardless of increased worry during the epidemic.	[Wu, Peng; Cowling, Benjamin J.; Fang, Vicky J.; Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China; [Wang, Liping; Yu, Jianxing; Li, Fu; Zeng, Lingjia; Li, Zhongjie; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China	University of Hong Kong; World Health Organization; Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; Wu, Joseph/ABD-5880-2021; Cowling, Benjamin John/C-4263-2009; Wu, Joseph Tsz Kei/C-4450-2009	Cowling, Benjamin John/0000-0002-6297-7154; YU, Jianxing/0000-0002-9696-2460; Wu, Peng/0000-0003-1157-9401; Leung, Gabriel/0000-0002-2503-6283; Wu, Joseph Tsz Kei/0000-0002-3155-5987	US National Institutes of Health [U19 AI51915)]; China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China [2012 ZX10004-201]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [HKU-13-06-01]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915), the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China (2012 ZX10004-201), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. HKU-13-06-01), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Peng ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095430; Wang LP, 2014, EMERG INFECT DIS, V20, P1296, DOI 10.3201/eid2008.131821; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2	10	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137831	10.1371/journal.pone.0137831	http://dx.doi.org/10.1371/journal.pone.0137831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367002	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100149
J	Yin, L; Bian, XH; Wang, X; Chen, M; Wu, J; Xu, JH; Qian, PD; Guo, WJ; Jiang, XS; Zhu, HF; Gu, JJ; Wu, JF; Zhang, YW; He, X				Yin, Li; Bian, Xiu-Hua; Wang, Xue; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; Zhang, Ye-wei; He, Xia			Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PHASE-II TRIAL; NECK-CANCER; TREATMENT OUTCOMES; RANDOMIZED-TRIALS; RADIATION-THERAPY; CHEMOTHERAPY; NEDAPLATIN; HEAD; METAANALYSIS	Background N-stage is related to distant metastasis in nasopharyngeal carcinoma (NPC) patients. The purpose of this study was to evaluate the efficacy and toxicity of different nedaplatin-based chemotherapy regimens in advanced N2-3 stage NPC patients treated with intensity modulated radiation therapy (IMRT). Patients and Methods Between April 2005 and December 2009, a total of 128 patients with N2-3 advanced NPC were retrospectively analyzed. Patients were treated with IMRT concurrent with 2 cycles of chemotherapy consisting of either nedaplatin plus paclitaxel (NP group, n = 67) or nedaplatin plus fluorouracil and paclitaxel (NFP group, n = 61). Two to four cycles of adjuvant chemotherapy were then administered every 21 days following concurrent chemoradiotherapy. Results With a median follow-up of 60 months, the 5-year overall survival (OS), progression-free survival (PFS), local-regional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) for all patients were 81.4%, 71.5%, 87.8% and 82.0%, respectively. No significant difference in PFS (66.6% vs. 76.7%, P = 0.212) and LRRFS rates (89.0% vs. 86.3%, P = 0.664) was observed between the NP and NFP groups. The 5-year OS (75.4% vs. 88.5%, P = 0.046) and DMFS (75.1% vs. 89.0%, P = 0.042) rate were superior in the NFP group compared with the NP group. The NFP group had a higher incidence of grade 3-4 acute toxicities including bone marrow suppression (leukopenia: chi(2) = 3.935, P = 0.047; anemia: chi(2) = 9.760, P = 0.002; thrombocytopenia: chi(2) = 8.821, P = 0.003), and both liver and renal dysfunction (chi(2) = 5.206, P = 0.023) compared with the NP group. Late toxicities were moderate and no difference was observed between the two groups. Conclusion IMRT concurrent with nedaplatin-based chemotherapy is an advocated regimen for patients with advanced N2-3 stage NPC. Patients with advanced N2-3 stage may be better candidates for the NFP regimen although this regimen was associated with a high acute toxicity rate.	[Yin, Li; Bian, Xiu-Hua; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; He, Xia] Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Li; Bian, Xiu-Hua; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; Zhang, Ye-wei; He, Xia] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Wang, Xue] Jilin Canc Hosp, Dept Radiat Oncol, Changchun, Peoples R China; [Zhang, Ye-wei] Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	He, X (corresponding author), Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China.	hexia200302@tom.com	Qian, Pu/GZM-2400-2022		JiangSu Clinical medicine Science and Technology Special Fund [BL2014091]; JiangSu Provincial Commission of Health and Family Planning Young Scholars Award [Q201501]	JiangSu Clinical medicine Science and Technology Special Fund; JiangSu Provincial Commission of Health and Family Planning Young Scholars Award	This research was supported by grants from the JiangSu Clinical medicine Science and Technology Special Fund (No:BL2014091, http://www.jstd.gov.cn/), the JiangSu Provincial Commission of Health and Family Planning Young Scholars Award (Q201501, http://www.jswst.gov.cn/jsswshjhsywyh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Argiris A, 2011, ANN ONCOL, V22, P773, DOI 10.1093/annonc/mdq426; Bae WK, 2010, CANCER CHEMOTH PHARM, V65, P589, DOI 10.1007/s00280-009-1152-0; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; Kalogera-Fountzila A, 2006, STRAHLENTHER ONKOL, V182, P458, DOI 10.1007/s00066-006-1538-4; Kodaira T, 2006, ANTICANCER RES, V26, P2265; Kong Lin, 2010, Chin J Cancer, V29, P551; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Li XX, 2013, 2013 SEVENTH INTERNATIONAL CONFERENCE ON INTERNET COMPUTING FOR ENGINEERING AND SCIENCE (ICICSE 2013), P48, DOI 10.1109/ICICSE.2013.17; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Ohashi T, 2011, JPN J CLIN ONCOL, V41, P348, DOI 10.1093/jjco/hyq196; Shen ZT, 2013, WORLD J GASTROENTERO, V19, P9447, DOI 10.3748/wjg.v19.i48.9447; Shenouda G, 2015, INT J RADIAT ONCOL, V91, P907, DOI 10.1016/j.ijrobp.2014.12.018; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Sun XM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-265; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Wu F, 2014, RADIOTHER ONCOL, V112, P106, DOI 10.1016/j.radonc.2014.05.005; Xu JH, 2013, CANCER RADIOTHER, V17, P297, DOI 10.1016/j.canrad.2013.03.006; Xu JH, 2014, HEAD NECK-J SCI SPEC, V36, P1474, DOI 10.1002/hed.23487; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	29	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137383	10.1371/journal.pone.0137383	http://dx.doi.org/10.1371/journal.pone.0137383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367317	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100067
J	Lv, J; Liu, DD; Ma, J; Wang, XY; Zhang, J				Lv, Jun; Liu, Dongdong; Ma, Jing; Wang, Xiaoying; Zhang, Jue			Graph Theoretical Analysis of BOLD Functional Connectivity during Human Sleep without EEG Monitoring	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; EYE-MOVEMENT SLEEP; COMPLEX BRAIN NETWORKS; CEREBRAL-CORTEX; ORGANIZATION; CONSCIOUSNESS; STIMULATION; INSIGHTS; SYSTEMS; PET	Background Functional brain networks of human have been revealed to have small-world properties by both analyzing electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) time series. Methods & Results In our study, by using graph theoretical analysis, we attempted to investigate the changes of paralimbic-limbic cortex between wake and sleep states. Ten healthy young people were recruited to our experiment. Data from 2 subjects were excluded for the reason that they had not fallen asleep during the experiment. For each subject, blood oxygen level dependency (BOLD) images were acquired to analyze brain network, and peripheral pulse signals were obtained continuously to identify if the subject was in sleep periods. Results of fMRI showed that brain networks exhibited stronger small-world characteristics during sleep state as compared to wake state, which was in consistent with previous studies using EEG synchronization. Moreover, we observed that compared with wake state, paralimbic-limbic cortex had less connectivity with neocortical system and centrencephalic structure in sleep. Conclusions In conclusion, this is the first study, to our knowledge, has observed that small-world properties of brain functional networks altered when human sleeps without EEG synchronization. Moreover, we speculate that paralimbic-limbic cortex organization owns an efficient defense mechanism responsible for suppressing the external environment interference when humans sleep, which is consistent with the hypothesis that the paralimbic-limbic cortex may be functionally disconnected from brain regions which directly mediate their interactions with the external environment. Our findings also provide a reasonable explanation why stable sleep exhibits homeostasis which is far less susceptible to outside world.	[Lv, Jun; Wang, Xiaoying; Zhang, Jue] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Liu, Dongdong] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Ma, Jing] Peking Univ, Dept Pulm Med, Hosp 1, Beijing 100871, Peoples R China; [Wang, Xiaoying] Peking Univ, Dept Radiol, Hosp 1, Beijing 100871, Peoples R China; [Zhang, Jue] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Peking University	Wang, XY (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	cjr.wangxiaoying@vip.163.com; zhangjue@pku.edu.cn		Lyu, Jun/0000-0003-1989-1360				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; [Anonymous], [No title captured]; AUSTIN MP, 1992, J AFFECT DISORDERS, V26, P31, DOI 10.1016/0165-0327(92)90032-2; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Santana MTCG, 2010, EPILEPSY RES, V89, P327, DOI 10.1016/j.eplepsyres.2010.02.006; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferri R, 2008, CLIN NEUROPHYSIOL, V119, P2026, DOI 10.1016/j.clinph.2008.04.294; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; Grachev ID, 1997, PSYCHIAT CLIN NEUROS, V51, P315, DOI 10.1111/j.1440-1819.1997.tb03205.x; Greene R, 2004, NEUROMOL MED, V5, P59, DOI 10.1385/NMM:5:1:059; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maderwald S, 2010, P INT SOC MAG RES ME, P1299; Malliani, 1995, CRIT CARE MED, V23, P1795; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; Parker DJ, 2002, APPL RADIOL, V14, P65; Reddy CG, 2010, J NEUROSURG, V112, P1301, DOI 10.3171/2009.7.JNS09404; Spoormaker VI, 2011, PHILOS T R SOC A, V369, P3708, DOI 10.1098/rsta.2011.0078; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vafaee MS, 2004, NEUROIMAGE, V22, P966, DOI 10.1016/j.neuroimage.2004.02.019; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1105, DOI 10.1016/j.mri.2013.01.006	39	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137297	10.1371/journal.pone.0137297	http://dx.doi.org/10.1371/journal.pone.0137297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360464	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100031
J	Hagberg, A; Lemons, N				Hagberg, Aric; Lemons, Nathan			Fast Generation of Sparse Random Kernel Graphs	PLOS ONE			English	Article							EFFICIENT GENERATION; MODEL; NETWORKS	The development of kernel-based inhomogeneous random graphs has provided models that are flexible enough to capture many observed characteristics of real networks, and that are also mathematically tractable. We specify a class of inhomogeneous random graph models, called random kernel graphs, that produces sparse graphs with tunable graph properties, and we develop an efficient generation algorithm to sample random instances from this model. As real-world networks are usually large, it is essential that the run-time of generation algorithms scales better than quadratically in the number of vertices n. We show that for many practical kernels our algorithm runs in time at most O(n(logn)(2)). As a practical example we show how to generate samples of power-law degree distribution graphs with tunable assortativity.	[Hagberg, Aric] Los Alamos Natl Lab, Ctr Nonlinear Studies, Div Theoret, Los Alamos, NM 87545 USA; [Lemons, Nathan] Los Alamos Natl Lab, Div Theoret, Appl Math & Plasma Phys, Los Alamos, NM 87544 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Lemons, N (corresponding author), Los Alamos Natl Lab, Div Theoret, Appl Math & Plasma Phys, Los Alamos, NM 87544 USA.	nlemons@lanl.gov			Department of Energy at Los Alamos National Laboratory through the Laboratory Directed Research and Development Program [DE-AC52-06NA25396]	Department of Energy at Los Alamos National Laboratory through the Laboratory Directed Research and Development Program	This work was funded by the Department of Energy at Los Alamos National Laboratory under contract DE-AC52-06NA25396 through the Laboratory Directed Research and Development Program.	Aiello W, 2001, EXP MATH, V10, P53, DOI 10.1080/10586458.2001.10504428; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barrett C, 2006, INTERACTIVE COMPUTAT, P353; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bayati M, 2010, ALGORITHMICA, V58, P860, DOI 10.1007/s00453-009-9340-1; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Blitzstein J, 2011, INTERNET MATH, V6, P489, DOI 10.1080/15427951.2010.557277; Bollobas B., 2001, RANDOM GRAPHS; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Bollobas B, 2007, RANDOM STRUCT ALGOR, V31, P3, DOI 10.1002/rsa.20168; Bollobas B, 2011, RANDOM STRUCT ALGOR, V38, P269, DOI 10.1002/rsa.20322; Chakrabarti D, 2004, SIAM PROC S, P442; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Durrett R, 2010, P NATL ACAD SCI USA, V107, P4491, DOI 10.1073/pnas.0914402107; ERDOS P, 1960, B INT STATIST INST, V38, P343; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hay M, 2010, VLDB J, V19, P797, DOI 10.1007/s00778-010-0210-x; Janson S, 2010, RANDOM STRUCT ALGOR, V36, P26, DOI 10.1002/rsa.20297; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kolda TG, 2014, SIAM J SCI COMPUT, V36, pC424, DOI 10.1137/130914218; Litvak N, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022801; Miller JC, 2011, LECT NOTES COMPUT SC, V6732, P115; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ray Jaideep, 2012, Algorithms and Models for the Web Graph. Proceedings 9th International Workshop, WAW 2012, P153, DOI 10.1007/978-3-642-30541-2_12; Seshadhri C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056109; Soderberg B, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066121; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135177	10.1371/journal.pone.0135177	http://dx.doi.org/10.1371/journal.pone.0135177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356296	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800004
J	Jhunjhunwala, S; Aresta-DaSilva, S; Tang, K; Alvarez, D; Webber, MJ; Tang, BC; Lavin, DM; Veiseh, O; Doloff, JC; Bose, S; Vegas, A; Ma, ML; Sahay, G; Chiu, A; Bader, A; Langan, E; Siebert, S; Li, J; Greiner, DL; Newburger, PE; von Andrian, UH; Langer, R; Anderson, DG				Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Alvarez, David; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Greiner, Dale L.; Newburger, Peter E.; von Andrian, Ulrich H.; Langer, Robert; Anderson, Daniel G.			Neutrophil Responses to Sterile Implant Materials	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSES; EXTRACELLULAR TRAPS; BONE-MARROW; MAST-CELLS; MECHANISMS; RELEASE; PROFILE	In vivo implantation of sterile materials and devices results in a foreign body immune response leading to fibrosis of implanted material. Neutrophils, one of the first immune cells to be recruited to implantation sites, have been suggested to contribute to the establishment of the inflammatory microenvironment that initiates the fibrotic response. However, the precise numbers and roles of neutrophils in response to implanted devices remains unclear. Using a mouse model of peritoneal microcapsule implantation, we show 30-500 fold increased neutrophil presence in the peritoneal exudates in response to implants. We demonstrate that these neutrophils secrete increased amounts of a variety of inflammatory cytokines and chemokines. Further, we observe that they participate in the foreign body response through the formation of neutrophil extracellular traps (NETs) on implant surfaces. Our results provide new insight into neutrophil function during a foreign body response to peritoneal implants which has implications for the development of biologically compatible medical devices.	[Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Alvarez, David; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Dept Mol Med, Worcester, MA 01605 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [von Andrian, Ulrich H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	Webber, Matthew J/D-4847-2011; Veiseh, Omid/GLS-9547-2022; Bose, Suman/A-1794-2009; Jhunjhunwala, Siddharth/K-1526-2013; Veiseh, Omid/N-1137-2019	Veiseh, Omid/0000-0003-1153-8079; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Webber, Matthew/0000-0003-3111-6228; Tang, Benjamin/0000-0002-3807-0480; Doloff, Joshua/0000-0002-4323-3264; Newburger, Peter/0000-0002-8615-673X	Mazumdar-Shaw International Oncology Fellowship; JDRF [17-2007-1063]; Leona M. and Harry B. Helmsley Charitable Trust Foundation [09PG-T1D027]; NIH [EB000244, EB000351, DE013023, CA151884, PO1AI111595, U19AI095261, 5T32 HL066987]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI111595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244, R01EB000351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016516, R01DE013023] Funding Source: NIH RePORTER	Mazumdar-Shaw International Oncology Fellowship; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Mazumdar-Shaw International Oncology Fellowship to SJ; JDRF: Grant 17-2007-1063 to RL and DGA; Leona M. and Harry B. Helmsley Charitable Trust Foundation: Grant 09PG-T1D027 to RL and DGA; NIH: Grants EB000244, EB000351, DE013023, and CA151884 to RL and DGA; NIH: Grants PO1AI111595, U19AI095261 to UHvA. DA was supported by NIH (5T32 HL066987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; KAW JL, 1982, JPN J EXP MED, V52, P261; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lee PY, 2011, J IMMUNOL, V186, P1747, DOI 10.4049/jimmunol.1001328; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Ratner, 2012, BIOMATERIALS SCI; Ratner BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5371; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049; Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	38	59	63	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137550	10.1371/journal.pone.0137550	http://dx.doi.org/10.1371/journal.pone.0137550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355958	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800061
J	Baranowski, DS; Kotkowiak, W; Kierzek, R; Pasternak, A				Baranowski, Daniel Sylwester; Kotkowiak, Weronika; Kierzek, Ryszard; Pasternak, Anna			Hybridization Properties of RNA Containing 8-Methoxyguanosine and 8-Benzyloxyguanosine	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; GLYCOSIDIC CONFORMATION; STRUCTURAL BASIS; CELL; OLIGONUCLEOTIDES; 2-DEOXYADENOSINE; PHOSPHORAMIDITES; INHIBITION; NUCLEOSIDE; GUANOSINE	Modified nucleobase analogues can serve as powerful tools for changing physicochemical and biological properties of DNA or RNA. Guanosine derivatives containing bulky substituents at 8 position are known to adopt syn conformation of N-glycoside bond. On the contrary, in RNA the anti conformation is predominant in Watson-Crick base pairing. In this paper two 8-substituted guanosine derivatives, 8-methoxyguanosine and 8-benzyloxyguanosine, were synthesized and incorporated into oligoribonucleotides to investigate their influence on the thermodynamic stability of RNA duplexes. The methoxy and benzyloxy substituents are electron-donating groups, decreasing the rate of depurination in the monomers, as confirmed by N-glycoside bond stability assessments. Thermodynamic stability studies indicated that substitution of guanosine by 8-methoxy- or 8-benzyloxyguanosine significantly decreased the thermodynamic stability of RNA duplexes. Moreover, the presence of 8-substituted guanosine derivatives decreased mismatch discrimination. Circular dichroism spectra of modified RNA duplexes exhibited patterns typical for A-RNA geometry.	[Baranowski, Daniel Sylwester; Kotkowiak, Weronika; Kierzek, Ryszard; Pasternak, Anna] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Pasternak, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	apa@ibch.poznan.pl	Pasternak, Anna/H-9411-2013	Kotkowiak, Weronika/0000-0002-9776-0924; Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Baranowski, Daniel/0000-0002-4346-4804	National Science Center [2012/05/D/ST5/03599]; Polish Ministry of Science and Higher Education under KNOW program	National Science Center(National Science Centre, Poland); Polish Ministry of Science and Higher Education under KNOW program	Funding: This work was supported by the National Science Center [grant number 2012/05/D/ST5/03599 to AP]. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	Bianco C, 1997, CLIN CANCER RES, V3, P439; Bramsen JB, 2010, NUCLEIC ACIDS RES, V38, P5761, DOI 10.1093/nar/gkq341; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Chang KY, 1997, J MOL BIOL, V269, P52, DOI 10.1006/jmbi.1997.1021; Chen LS, 2002, NUCLEOS NUCLEOT NUCL, V21, P599, DOI 10.1081/NCN-120015071; Childs-Disney JL, 2007, ACS CHEM BIOL, V2, P745, DOI 10.1021/cb700174r; Davis AR, 2011, NUCLEIC ACIDS RES, V39, P1081, DOI 10.1093/nar/gkq793; DIAS E, 1994, J AM CHEM SOC, V116, P4479, DOI 10.1021/ja00089a048; Eason RG, 1996, NUCLEIC ACIDS RES, V24, P890, DOI 10.1093/nar/24.5.890; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fabrega C, 2001, NUCLEOS NUCLEOT NUCL, V20, P251, DOI 10.1081/NCN-100002085; Kim SN, 2000, BIOCHEM BIOPH RES CO, V273, P404, DOI 10.1006/bbrc.2000.2949; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; LAAYOUN A, 1994, TETRAHEDRON LETT, V35, P4989, DOI 10.1016/S0040-4039(00)73300-4; Langkjaer N, 2009, BIOORGAN MED CHEM, V17, P5420, DOI 10.1016/j.bmc.2009.06.045; LIN TS, 1985, J MED CHEM, V28, P1194, DOI 10.1021/jm00147a012; Liu XJ, 2004, J AM CHEM SOC, V126, P9196, DOI 10.1021/ja048936l; Madela K, 2012, FUTURE MED CHEM, V4, P625, DOI [10.4155/FMC.12.10, 10.4155/fmc.12.10]; Marcelo F, 2013, J AM CHEM SOC, V135, P16418, DOI 10.1021/ja405515r; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Messias AC, 2004, ACCOUNTS CHEM RES, V37, P279, DOI 10.1021/ar030034m; MOLLER A, 1984, BIOCHEMISTRY-US, V23, P54, DOI 10.1021/bi00296a009; Pasternak A, 2011, ORG BIOMOL CHEM, V9, P3591, DOI 10.1039/c0ob01085e; Proctor DJ, 2003, J AM CHEM SOC, V125, P2390, DOI 10.1021/ja029176m; Rose SD, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P171; Schaaper R M, 1982, Basic Life Sci, V20, P199; Schaffner-Barbero C, 2010, BIOCHEMISTRY-US, V49, P10458, DOI 10.1021/bi101577p; Scuotto M, 2015, NUCLEIC ACIDS RES, V43, P7702, DOI 10.1093/nar/gkv789; Szombati Z, 2012, CHEMBIOCHEM, V13, P700, DOI 10.1002/cbic.201100573; TAYLOR CW, 1992, ANTI-CANCER DRUG, V3, P485, DOI 10.1097/00001813-199210000-00007; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yajima R, 2007, CHEM BIOL, V14, P23, DOI 10.1016/j.chembiol.2006.11.004	33	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137674	10.1371/journal.pone.0137674	http://dx.doi.org/10.1371/journal.pone.0137674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353054	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800106
J	Greenaway, KH; Frye, M; Cruwys, T				Greenaway, Katharine H.; Frye, Margaret; Cruwys, Tegan			When Aspirations Exceed Expectations: Quixotic Hope Increases Depression among Students	PLOS ONE			English	Article							HIGH SELF-ESTEEM; EDUCATIONAL ASPIRATIONS; LOST TALENT; DARK SIDE; HAPPINESS; OPTIMISM; THINKING; ANXIETY; ALTERNATIVES; DISCREPANCY	A paradox exists in modern schooling: students are simultaneously more positive about the future and more depressed than ever. We suggest that these two phenomena may be linked. Two studies demonstrated that students are more likely to be depressed when educational aspirations exceed expectations. In Study 1 (N = 85) aspiring to a thesis grade higher than one expected predicted greater depression at the beginning and end of the academic year. In Study 2 (N = 2820) aspiring to a level of education (e.g., attending college) higher than one expected to achieve predicted greater depression cross-sectionally and five years later. In both cases the negative effects of aspiring high while expecting low persisted even after controlling for whether or not students achieved their educational aspirations. These findings highlight the danger of teaching students to aspire higher without also investing time and money to ensure that students can reasonably expect to achieve their educational goals.	[Greenaway, Katharine H.; Cruwys, Tegan] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Greenaway, Katharine H.] Canadian Inst Adv Res Social Interact Ident & Wel, Toronto, ON, Canada; [Frye, Margaret] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Frye, Margaret] Canadian Inst Adv Res Successful Soc Program, Toronto, ON, Canada	University of Queensland; Canadian Institute for Advanced Research (CIFAR); Princeton University; Canadian Institute for Advanced Research (CIFAR)	Greenaway, KH (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	k.greenaway@psy.uq.edu.au	Greenaway, Katharine/A-9269-2015; Cruwys, Tegan/G-2956-2014	Greenaway, Katharine/0000-0002-0271-5312; Cruwys, Tegan/0000-0001-5296-3480	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		American College Health Association, 2011, NAT COLL HLTH ASS 2; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Baumeister RF, 1996, PSYCHOL REV, V103, P5, DOI 10.1037/0033-295X.103.1.5; BAUMEISTER RF, 1993, J PERS SOC PSYCHOL, V64, P141, DOI 10.1037/0022-3514.64.1.141; Boxer P., 2001, J ADOLESCENCE, V34, P609; Carnegie Dale, 1936, WIN FRIENDS INFLUENC; Covey S., 1998, 7 HABITS HIGHLY EFFE; COYNE JC, 1981, J ABNORM PSYCHOL, V90, P439, DOI 10.1037/0021-843X.90.5.439; Crocker J, 2002, PERS SOC PSYCHOL B, V28, P1275, DOI 10.1177/01461672022812012; Cruwys T., 2015, AUST P IN PRESS 0208; Ehrenreich Barbara, 2009, SMILE DIE POSITIVE T; Freitas AL, 2002, PSYCHOL SCI, V13, P1, DOI 10.1111/1467-9280.00401; Gillham JE, 1995, PSYCHOL SCI, V6, P343, DOI 10.1111/j.1467-9280.1995.tb00524.x; Greenaway KH, 2016, POLIT PSYCHOL, V37, P89, DOI 10.1111/pops.12225; Gruber J, 2011, PERSPECT PSYCHOL SCI, V6, P222, DOI 10.1177/1745691611406927; HANSON SL, 1994, SOCIOL EDUC, V67, P159, DOI 10.2307/2112789; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; HIGGINS ET, 1985, SOC COGNITION, V3, P51, DOI 10.1521/soco.1985.3.1.51; Hill JP, 2011, J SCI STUD RELIG, V50, P533, DOI 10.1111/j.1468-5906.2011.01587.x; Jorgensen J., 2014, NEW YORK OBSERVER; Kirk CM, 2012, EDUC STUD-UK, V38, P507, DOI 10.1080/03055698.2011.643114; Lerner, 1999, ACTION SELF DEV THEO, P315, DOI DOI 10.4135/; Longest KC, 2007, J MARRIAGE FAM, V69, P703, DOI 10.1111/j.1741-3737.2007.00401.x; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; MacLeod J., 2009, AINT MAKINIT ASPIRAT, V3rd; Mauss IB, 2011, EMOTION, V11, P807, DOI 10.1037/a0022010; Murray SL, 2011, PSYCHOL SCI, V22, P619, DOI 10.1177/0956797611403155; Oettingen G, 2002, J PERS SOC PSYCHOL, V83, P1198, DOI 10.1037//0022-3514.83.5.1198; Oettingen G., 1996, PSYCHOL ACTION LINKI, P236; Oyserman D., SELF IDENTI IN PRESS; Reynolds JR, 2006, SOC PROBL, V53, P186, DOI 10.1525/sp.2006.53.2.186; Reynolds JR, 2010, AM SOCIOL REV, V75, P151, DOI 10.1177/0003122409357064; Sanna LJ, 1996, J PERS SOC PSYCHOL, V71, P1020, DOI 10.1037/0022-3514.71.5.1020; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHNEIDER BL, 1999, AMBITIOUS GENERATION; Sevincer AT, 2014, PSYCHOL SCI, V25, P1010, DOI 10.1177/0956797613518350; Sharot T., 2011, NY TIMES; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stephens NM, 2014, PSYCHOL SCI, V25, P943, DOI 10.1177/0956797613518349; Sweeny K, 2010, EMOTION, V10, P750, DOI 10.1037/a0019016; Trusty J, 2004, CAREER DEV Q, V53, P2, DOI 10.1002/j.2161-0045.2004.tb00651.x; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Vaisey S, 2010, SOC FORCES, V88, P1595; Vaisey S, 2010, ANN AM ACAD POLIT SS, V629, P75, DOI 10.1177/0002716209357146; Whitson JA, 2015, J EXP SOC PSYCHOL, V56, P89, DOI 10.1016/j.jesp.2014.09.002; Young AA, 2004, PRINC STUD CULT, P1; Zhang AR, 2013, SOC PSYCHOL PERS SCI, V4, P159, DOI 10.1177/1948550612452890	49	12	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135477	10.1371/journal.pone.0135477	http://dx.doi.org/10.1371/journal.pone.0135477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352151	Green Published, gold			2022-12-27	WOS:000360932800009
J	Shao, ML; Zhang, X; Rao, ZM; Xu, MJ; Yang, TW; Li, H; Xu, ZH				Shao, Minglong; Zhang, Xian; Rao, Zhiming; Xu, Meijuan; Yang, Taowei; Li, Hui; Xu, Zhenghong			Enhanced Production of Androst-1,4-Diene-3,17-Dione by Mycobacterium neoaurum JC-12 Using Three-Stage Fermentation Strategy	PLOS ONE			English	Article							GENE-ENCODING 3-KETOSTEROID-DELTA(1)-DEHYDROGENASE; MICROBIAL TRANSFORMATION; SOYBEAN PHYTOSTEROLS; BIOTRANSFORMATION; CHOLESTEROL; ANDROSTA-1,4-DIENE-3,17-DIONE; BIOCONVERSION; 4-ANDROSTENE-3,17-DIONE; ANDROSTENEDIONE; STEROLS	To improve the androst-1,4-diene-3,17-dione (ADD) production from phytosterol by Mycobacterium neoaurum JC-12, fructose was firstly found favorable as the initial carbon source to increase the biomass and eliminate the lag phase of M. neoaurum JC-12 in the phytosterol transformation process. Based on this phenomenon, two-stage fermentation by using fructose as the initial carbon source and feeding glucose to maintain strain metabolism was designed. By applying this strategy, the fermentation duration was decreased from 168 h to 120 h with the ADD productivity increased from 0.071 g/(L.h) to 0.108 g/(L.h). Further, three-stage fermentation by adding phytosterol to improve ADD production at the end of the two-stage fermentation was carried out and the final ADD production reached 18.6 g/L, which is the highest reported ADD production using phytosterol as substrate. Thus, this strategy provides a possible way in enhancing the ADD production in pharmaceutical industry.	[Shao, Minglong; Zhang, Xian; Rao, Zhiming; Xu, Meijuan; Yang, Taowei] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Lab Appl Microorganisms & Metab Engn,Sch Biotechn, Wuxi 214122, Jiangsu, Peoples R China; [Li, Hui; Xu, Zhenghong] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn	Xu, Meijuan/C-1790-2012		National Basic Research Program of China (973 Program) [2012CB725202]; High-Tech Research and Development Programs of China [2011AA02A211]; National Natural Science Foundation of China [21276110]; Fundamental Research Funds for the Central Universities [JUSRP51306A]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); High-Tech Research and Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding: This work was supported by the National Basic Research Program of China (973 Program) (2012CB725202), the High-Tech Research and Development Programs of China (2011AA02A211), the National Natural Science Foundation of China (21276110), the Fundamental Research Funds for the Central Universities (JUSRP51306A), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego S, 2000, TISSUE CELL, V32, P494, DOI 10.1016/S0040-8166(00)80005-1; Carvalho F, 2009, BIORESOURCE TECHNOL, V100, P4050, DOI 10.1016/j.biortech.2009.03.044; Chaudhari PN, 2010, BIOTECHNOL LETT, V32, P695, DOI 10.1007/s10529-010-0206-z; Claudino MJC, 2008, BIORESOURCE TECHNOL, V99, P2304, DOI 10.1016/j.biortech.2007.05.007; Dias ACP, 2002, BIORESOURCE TECHNOL, V82, P253, DOI 10.1016/S0960-8524(01)00187-0; Fernandes P, 2007, BIORESOURCE TECHNOL, V98, P2335, DOI 10.1016/j.biortech.2006.10.006; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Gulla V, 2010, J CHEM TECHNOL BIOT, V85, P1135, DOI 10.1002/jctb.2410; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; Huang CL, 2006, ENZYME MICROB TECH, V39, P296, DOI 10.1016/j.enzmictec.2005.10.017; LEE CY, 1993, APPL MICROBIOL BIOT, V38, P447; Li Y, 2007, LETT APPL MICROBIOL, V44, P563, DOI 10.1111/j.1472-765X.2007.02134.x; Lin YL, 2009, BIORESOURCE TECHNOL, V100, P1864, DOI 10.1016/j.biortech.2008.09.040; Liu YC, 2011, WORLD J MICROB BIOT, V27, P759, DOI 10.1007/s11274-010-0513-5; Lo CK, 2002, J IND MICROBIOL BIOT, V28, P280, DOI 10.1038/sj/jim/7000243; Mahato SB, 1997, STEROIDS, V62, P332, DOI 10.1016/S0039-128X(96)00251-6; Malaviya A, 2008, BIORESOURCE TECHNOL, V99, P6725, DOI 10.1016/j.biortech.2008.01.039; Manosroi A, 2008, J STEROID BIOCHEM, V108, P132, DOI 10.1016/j.jsbmb.2007.05.032; Molchanova MA, 2007, RUSS J BIOORG CHEM+, V33, P354, DOI 10.1134/S1068162007030132; Olivares A, 2011, WORLD J MICROB BIOT, V27, P2513, DOI 10.1007/s11274-011-0720-8; Perez C, 2006, J IND MICROBIOL BIOT, V33, P719, DOI 10.1007/s10295-006-0148-6; ROY PK, 1991, INDIAN J BIOCHEM BIO, V28, P150; Saab HB, 2013, J IND MICROBIOL BIOT, V40, P1315, DOI 10.1007/s10295-013-1315-1; Sallam LAR, 2005, PROCESS BIOCHEM, V40, P203, DOI 10.1016/j.procbio.2003.12.006; Sharma P, 2012, ANN MICROBIOL, V62, P1651, DOI 10.1007/s13213-012-0422-y; Shen YB, 2012, J IND MICROBIOL BIOT, V39, P1253, DOI 10.1007/s10295-012-1130-0; Shen YB, 2011, APPL MICROBIOL BIOT, V90, P1995, DOI 10.1007/s00253-011-3214-6; Sripalakit P, 2006, J MOL CATAL B-ENZYM, V41, P49, DOI 10.1016/j.molcatb.2006.04.007; Wang M, 2009, J MOL CATAL B-ENZYM, V59, P58, DOI 10.1016/j.molcatb.2008.12.017; Wang ZF, 2002, J CHEM TECHNOL BIOT, V77, P1349, DOI 10.1002/jctb.728; Wang ZL, 2008, J IND MICROBIOL BIOT, V35, P645, DOI 10.1007/s10295-008-0345-6; Wang ZL, 2006, PROCESS BIOCHEM, V41, P557, DOI 10.1016/j.procbio.2005.09.014; Wei W, 2010, APPL ENVIRON MICROB, V76, P4578, DOI 10.1128/AEM.00448-10; Wu Y, 2014, STEROIDS, V84, P70, DOI 10.1016/j.steroids.2014.03.007; Yao K, 2013, METAB ENG, V15, P75, DOI 10.1016/j.ymben.2012.10.005; Ye Q, 2010, APPL MICROBIOL BIOT, V87, P517, DOI 10.1007/s00253-010-2536-0; Zehentgruber D, 2010, J BIOTECHNOL, V146, P179, DOI 10.1016/j.jbiotec.2010.01.019; Zhang LT, 2009, APPL BIOCHEM BIOTECH, V159, P642, DOI 10.1007/s12010-008-8499-2; Zhang WQ, 2013, J STEROID BIOCHEM, V135, P36, DOI 10.1016/j.jsbmb.2012.12.016; ZURKOWSK.P, 1964, CLIN CHEM, V10, P481	40	25	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137658	10.1371/journal.pone.0137658	http://dx.doi.org/10.1371/journal.pone.0137658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352898	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800105
J	Sobral, G; Sues, HD; Muller, J				Sobral, Gabriela; Sues, Hans-Dieter; Mueller, Johannes			Anatomy of the Enigmatic Reptile Elachistosuchus huenei Janensch, 1949 (Reptilia: Diapsida) from the Upper Triassic of Germany and Its Relevance for the Origin of Sauria	PLOS ONE			English	Article							MISSING DATA; PHYLOGENETIC ANALYSES; INCOMPLETE TAXA; INTERRELATIONSHIPS; DINOSAURIA; BRAINCASE; THEROPODA; ACCURACY; SKELETON; FOSSILS	The holotype and only known specimen of the enigmatic small reptile Elachistosuchus huenei Janensch, 1949 from the Upper Triassic (Norian) Arnstadt Formation of Saxony-Anhalt (Germany) is redescribed using mu CT scans of the material. This re-examination revealed new information on the morphology of this taxon, including previously unknown parts of the skeleton such as the palate, braincase, and shoulder girdle. Elachistosuchus is diagnosed especially by the presence of the posterolateral process of the frontal, the extension of the maxillary tooth row to the posterior margin of the orbit, the free posterior process of the jugal, and the notched anterior margin of the interclavicle. Phylogenetic analyses using two recently published character-taxon matrices recovered conflicting results for the phylogenetic position of Elachistosuchus-either as an archosauromorph, as a lepidosauromorph or as a more basal, non-saurian diapsid. These different placements highlight the need of a thorough revision of critical taxa and new character sets used for inferring neodiapsid relationships.	[Sobral, Gabriela; Mueller, Johannes] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde Berlin, Berlin, Germany; [Sues, Hans-Dieter] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Smithsonian Institution; Smithsonian National Museum of Natural History	Sobral, G (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde Berlin, Berlin, Germany.	Gabriela.Sobral@mfn-berlin.de	Sobral, Gabriela/AAX-4093-2020; Müller, Johannes/A-6293-2017	Sobral, Gabriela/0000-0002-5001-4406; Müller, Johannes/0000-0001-5801-856X; Sues, Hans-Dieter/0000-0002-9911-7254	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Deutscher Akademischer Austauschdienst [BEX 3474/09-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	GS was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) and the Deutscher Akademischer Austauschdienst (www.daad.de): BEX 3474/09-7.	Abel RL, 2012, PALAEONTOL ELECTRON, V15; [Anonymous], [No title captured]; Balanoff AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113559; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P423; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Clark James M., 1993, Journal of Vertebrate Paleontology, V13, P48; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; CURRIE P J, 1981, Palaeontologia Africana, V24, P99; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Evans S.E., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P577; Evans S.E., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1987, P193; Evans S.E., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V173, P181; EVANS SE, 1981, ZOOL J LINN SOC-LOND, V73, P81, DOI 10.1111/j.1096-3642.1981.tb01580.x; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; Evans Susan E., 2009, Palaeontologia Polonica, P145; Evans Susan E., 2009, Palaeontologia Polonica, P179; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086864; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; Gardner NM, 2010, PALAEONTOL ELECTRON, V13; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOW C E, 1975, Palaeontologia Africana, V18, P89; Hahn G., 1973, Palaeontographica Abt A, V142, P1; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Jaekel O, 1913, PALAEONTOL Z, V1, P155; Jalil NE, 1997, J VERTEBR PALEONTOL, V17, P506, DOI 10.1080/02724634.1997.10010998; Janensch W., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, VB 8, P225; Kearney M, 2002, SYST BIOL, V51, P369, DOI 10.1080/10635150252899824; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kodandaramaiah U, 2010, MOL PHYLOGENET EVOL, V54, P386, DOI 10.1016/j.ympev.2009.08.012; Kuhn O., 1939, Palaeontologische Zeitschrift Berlin, V21, P258; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; Maddison WP, 2011, MESQUITE MODULAR SYS; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Modesto SP, 2002, J VERTEBR PALEONTOL, V22, P851, DOI 10.1671/0272-4634(2002)022[0851:AENDRF]2.0.CO;2; Muller J, 2005, CAN J EARTH SCI, V42, P1347, DOI 10.1139/E05-030; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Pardo JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108542; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Reisz R.R., 1981, University of Kansas Publications of the Museum of Natural History, P1; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; Rieppel O., 1989, Journal of Vertebrate Paleontology, V9, P373; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sen K, 2003, J ASIAN EARTH SCI, V21, P663, DOI 10.1016/S1367-9120(02)00110-4; Shavit L, 2007, MOL BIOL EVOL, V24, P2400, DOI 10.1093/molbev/msm178; Sobral G, 2012, J VERTEBR PALEONTOL, V32, P1090, DOI 10.1080/02724634.2012.693554; STORRS GW, 1993, J GEOL SOC LONDON, V150, P1103, DOI 10.1144/gsjgs.150.6.1103; Vaughn PP, 1955, B MUS COMP ZOOL HARV, V114, P36; WALKER AD, 1966, NATURE, V211, P583, DOI 10.1038/211583a0; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; WHITESIDE DI, 1986, PHILOS T ROY SOC B, V312, P379, DOI 10.1098/rstb.1986.0014; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135114	10.1371/journal.pone.0135114	http://dx.doi.org/10.1371/journal.pone.0135114			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352985	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800006
J	Gourand, F; Amini, N; Jia, ZS; Stone-Elander, S; Guilloteau, D; Barre, L; Halldin, C				Gourand, Fabienne; Amini, Nahid; Jia, Zhisheng; Stone-Elander, Sharon; Guilloteau, Denis; Barre, Louisa; Halldin, Christer			[C-11]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; LIVER-MICROSOMES; HUMANS; BRAIN; SPECT; CYTOCHROME-P450; QUANTIFICATION; IDENTIFICATION; I-123-ADAM	In quantitative PET measurements, the analysis of radiometabolites in plasma is essential for determining the exact arterial input function. Diphenyl sulfide compounds are promising PET and SPECT radioligands for in vivo quantification of the serotonin transporter (SERT) and it is therefore important to investigate their radiometabolism. We have chosen to explore the radiometabolic profile of [C-11] MADAM, one of these radioligands widely used for in vivo PET-SERT studies. The metabolism of [C-11]MADAM/MADAM was investigated using rat and human liver microsomes (RLM and HLM) in combination with radio-HPLC or UHPLC/Q-ToF-MS for their identification. The effect of carrier on the radiometabolic rate of the radioligand [C-11]MADAM in vitro and in vivo was examined by radio-HPLC. RLM and HLM incubations were carried out at two different carrier concentrations of 1 and 10 mu M. Urine samples after perfusion of [C-11]MADAM/ MADAM in rats were also analysed by radio-HPLC. Analysis by UHPLC/Q-ToF-MS identified the metabolites produced in vitro to be results of N-demethylation, S-oxidation and benzylic hydroxylation. The presence of carrier greatly affected the radiometabolism rate of [C-11]MADAM in both RLM/HLM experiments and in vivo rat studies. The good concordance between the results predicted by RLM and HLM experiments and the in vivo data obtained in rat studies indicate that the kinetics of the radiometabolism of the radioligand [C-11]MADAM is dose-dependent. This issue needs to be addressed when the diarylsulfide class of compounds are used in PET quantifications of SERT.	[Gourand, Fabienne; Amini, Nahid; Jia, Zhisheng; Halldin, Christer] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, S-17176 Stockholm, Sweden; [Gourand, Fabienne; Barre, Louisa] CEA, DSV I2BM, LDM TEP Grp, GIP Cyceron, F-14074 Caen, France; [Gourand, Fabienne; Barre, Louisa] Univ Caen Basse Normandie, Caen, France; [Gourand, Fabienne; Barre, Louisa] CNRS, UMR ISTCT 6301, LDM TEP Grp, GIP Cyceron, Caen, France; [Stone-Elander, Sharon] Karolinska Inst, Karolinska Univ Hosp, MicroPET & Clin Neurosci, Neuroradiol, S-17176 Stockholm, Sweden; [Guilloteau, Denis] Univ Tours, CHRU Tours, INSERM, U930, F-37044 Tours, France	Karolinska Institutet; CEA; Universite de Caen Normandie; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Karolinska Institutet; Karolinska University Hospital; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Gourand, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, S-17176 Stockholm, Sweden.	gourand@cyceron.fr		Guilloteau, Denis/0000-0002-4545-3068	European programme DiMI: WP3; Commissariat a l'energie atomique et aux energies alternatives (CEA)	European programme DiMI: WP3; Commissariat a l'energie atomique et aux energies alternatives (CEA)(French Atomic Energy Commission)	This project was partially funded by the European programme DiMI: WP3 and the Commissariat a l'energie atomique et aux energies alternatives (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton PD, 2001, J NUCL MED, V42, P1556; Amini N, 2013, ANAL BIOANAL CHEM, V405, P1303, DOI 10.1007/s00216-012-6541-2; Catafau AM, 2005, J NUCL MED, V46, P1301; Frankle WG, 2006, J NUCL MED, V47, P815; Frokjaer VG, 2008, J NUCL MED, V49, P247, DOI 10.2967/jnumed.107.046102; Gourand F, 2014, NUCL MED BIOL, V41, P501, DOI 10.1016/j.nucmedbio.2014.03.022; Halldin C, 2005, SYNAPSE, V58, P173, DOI 10.1002/syn.20189; HALLDIN C, 1995, DEV NUC MED, V26, P55; Lundberg J, 2005, J NUCL MED, V46, P1505; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; Nnane IP, 2003, LIFE SCI, V73, P359, DOI 10.1016/S0024-3205(03)00290-X; Nnane IP, 2002, J PHARMACEUT BIOMED, V27, P315, DOI 10.1016/S0731-7085(01)00551-9; Schou M, 2009, MOL IMAGING BIOL, V11, P23, DOI 10.1007/s11307-008-0175-y; Shetty HU, 2007, EUR J NUCL MED MOL I, V34, P667, DOI 10.1007/s00259-006-0277-1	14	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137160	10.1371/journal.pone.0137160	http://dx.doi.org/10.1371/journal.pone.0137160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367261	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100053
J	Melgar-Rojas, P; Alvarado, JC; Fuentes-Santamaria, V; Gabaldon-Ull, MC; Juiz, JM				Melgar-Rojas, Pedro; Carlos Alvarado, Juan; Fuentes-Santamaria, Veronica; Cruz Gabaldon-Ull, Maria; Juiz, Jose M.			Validation of Reference Genes for RT-qPCR Analysis in Noise-Induced Hearing Loss: A Study in Wistar Rat	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; MESSENGER-RNA EXPRESSION; REAL-TIME PCR; PIG INNER-EAR; IMPULSE NOISE; HAIR-CELLS; INTENSE NOISE; FREE-RADICALS; RESPONSE ABR; GLUTATHIONE-PEROXIDASE	The reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) requires adequate normalization in order to ensure accurate results. The use of reference genes is the most common method to normalize RT-qPCR assays; however, many studies have reported that the expression of frequently used reference genes is more variable than expected, depending on experimental conditions. Consequently, proper validation of the stability of reference genes is an essential step when performing new gene expression studies. Despite the fact that RT-qPCR has been widely used to elucidate molecular correlates of noise-induced hearing loss (NIHL), up to date there are no reports demonstrating validation of reference genes for the evaluation of changes in gene expression after NIHL. Therefore, in this study we evaluated the expression of some commonly used reference genes (Arbp, b-Act, b2m, CyA, Gapdh, Hprt1, Tbp, Tfrc and UbC) and examined their suitability as endogenous control genes for RT-qPCR analysis in the adult Wistar rat in response to NIHL. Four groups of rats were noise-exposed to generate permanent cochlear damage. Cochleae were collected at different time points after noise exposure and the expression level of candidate reference genes was evaluated by RT-qPCR using geNorm, NormFinder and BestKeeper software to determine expression stability. The three independent applications revealed Tbp as the most stably expressed reference gene. We also suggest a group of top-ranked reference genes that can be combined to obtain suitable reference gene pairs for the evaluation of the effects of noise on gene expression in the cochlea. These findings provide essential basis for further RT-qPCR analysis in studies of NIHL using Wistar rats as animal model.	[Melgar-Rojas, Pedro; Carlos Alvarado, Juan; Fuentes-Santamaria, Veronica; Cruz Gabaldon-Ull, Maria; Juiz, Jose M.] Univ Castilla La Mancha, Sch Med, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain	Universidad de Castilla-La Mancha	Melgar-Rojas, P (corresponding author), Univ Castilla La Mancha, Sch Med, Inst Invest Discapacidades Neurol IDINE, Campus Albacete, Albacete, Spain.	pedro.melgar@uclm.es	Alvarado, Juan C./G-3379-2015; juiz, jose m/G-3025-2015; juiz, jose/ABF-8752-2020	Alvarado, Juan C./0000-0002-3623-4090; juiz, jose m/0000-0002-9668-8983; juiz, jose/0000-0002-9668-8983	European Commission [FP7-HEALTH-2012-INNOVATION 304925]; Spain's MINECO [BFU2012-39982-C02-02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spain's MINECO	This work was supported by the European Commission, FP7-HEALTH-2012-INNOVATION 304925 (PROHEARING) (ec.europa.eu/research/fp7) and by Spain's MINECO BFU2012-39982-C02-02 (http://www.idi.mineco.gob.es/portal/site/MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00029; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AXELSSON A, 1987, HEARING RES, V31, P183, DOI 10.1016/0378-5955(87)90125-0; Bas E, 2009, ACTA OTO-LARYNGOL, V129, P385, DOI 10.1080/00016480802566279; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; BOHNE BA, 1976, EFFECTS NOISE HEARIN, P41; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; Alvarado JC, 2012, NEUROSCI RES, V73, P302, DOI 10.1016/j.neures.2012.05.001; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; Chen GD, 2006, HEARING RES, V222, P54, DOI 10.1016/j.heares.2006.08.011; Chen J, 2009, ACTA OTO-LARYNGOL, V129, P644, DOI 10.1080/00016480802311015; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Church MW, 2012, NEUROTOXICOL TERATOL, V34, P196, DOI 10.1016/j.ntt.2011.09.004; Church MW, 2010, NEUROTOXICOL TERATOL, V32, P171, DOI 10.1016/j.ntt.2009.09.006; Church MW, 2013, HEARING RES, V302, P96, DOI 10.1016/j.heares.2013.05.007; Church MW, 2012, ALCOHOL CLIN EXP RES, V36, P83, DOI 10.1111/j.1530-0277.2011.01594.x; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fetoni AR, 2015, FREE RADICAL BIO MED, V85, P269, DOI 10.1016/j.freeradbiomed.2015.04.021; Fetoni AR, 2013, J NEUROSCI, V33, P4011, DOI 10.1523/JNEUROSCI.2282-12.2013; Fetoni AR, 2012, ACTA OTO-LARYNGOL, V132, P391, DOI 10.3109/00016489.2011.652307; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Garcia-Pino E, 2010, J COMP NEUROL, V518, P1301, DOI 10.1002/cne.22276; Gourevitch B, 2009, BRAIN RES, V1304, P66, DOI 10.1016/j.brainres.2009.09.041; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Gurgen O, 2014, ANAL QUANT CYTOPATHO, V36, P213; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Han Y, 2012, GENE, V499, P318, DOI 10.1016/j.gene.2012.02.042; Han Y, 2011, NEUROSCI LETT, V491, P79, DOI 10.1016/j.neulet.2011.01.010; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENDERSON D, 1986, J ACOUST SOC AM, V80, P569, DOI 10.1121/1.394052; HENDERSON D, 1994, HEARING RES, V76, P101, DOI 10.1016/0378-5955(94)90092-2; Henderson Donald, 2008, V31, P195; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu BH, 2006, HEARING RES, V211, P16, DOI 10.1016/j.heares.2005.08.006; Hu BH, 2000, ACTA OTO-LARYNGOL, V120, P19, DOI 10.1080/000164800760370774; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Hu BH, 2012, J NEUROSCI, V32, P14927, DOI 10.1523/JNEUROSCI.1588-12.2012; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; Hu BH, 2012, SPRINGER HANDB AUDIT, V40, P57, DOI 10.1007/978-1-4419-9523-0_5; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishii N, 1996, BRAIN RES, V726, P123, DOI 10.1016/0006-8993(96)00305-8; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kireev RA, 2013, BIOGERONTOLOGY, V14, P431, DOI 10.1007/s10522-013-9443-6; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; Le Prell CG, 2012, SPRINGER HANDB AUDIT, V40, P1, DOI 10.1007/978-1-4419-9523-0_1; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mazurek B, 2007, HEARING RES, V231, P73, DOI 10.1016/j.heares.2007.05.008; Nakao R, 2015, MUSCLE NERVE, V51, P276, DOI 10.1002/mus.24310; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Niu XZ, 2003, NEUROREPORT, V14, P1025, DOI 10.1097/01.wnr.0000070830.57864.32; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; OVERBECK GW, 1992, HEARING RES, V59, P129, DOI 10.1016/0378-5955(92)90110-9; Patel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058471; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pilati N, 2012, P NATL ACAD SCI USA, V109, P8292, DOI 10.1073/pnas.1116981109; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Rarey KE, 1996, ACTA OTO-LARYNGOL, V116, P833, DOI 10.3109/00016489609137935; SAUNDERS JC, 1985, J ACOUST SOC AM, V78, P833, DOI 10.1121/1.392915; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; SLEPECKY N, 1986, HEARING RES, V22, P307, DOI 10.1016/0378-5955(86)90107-3; SUBRAMANIAM M, 1992, HEARING RES, V58, P57, DOI 10.1016/0378-5955(92)90008-B; Tagoe T, 2014, J NEUROSCI, V34, P2684, DOI 10.1523/JNEUROSCI.3977-13.2014; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Usami S, 1996, BRAIN RES, V743, P337, DOI 10.1016/S0006-8993(96)01090-6; Vandesompele J., 2011, GENORM DISCUSSION GR; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vicente-Torres MA, 2006, J NEUROSCI RES, V83, P1564, DOI 10.1002/jnr.20832; Vlajkovic SM, 2013, HEARING RES, V304, P145, DOI 10.1016/j.heares.2013.07.012; Vlajkovic SM, 2010, J NEUROSCI RES, V88, P2598, DOI 10.1002/jnr.22421; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wong ACY, 2010, HEARING RES, V260, P81, DOI 10.1016/j.heares.2009.12.004; Wong CC, 2000, DEV BRAIN RES, V119, P187, DOI 10.1016/S0165-3806(99)00173-X; Wu HP, 2010, HEARING RES, V267, P71, DOI 10.1016/j.heares.2010.03.082; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Yamashita D, 2008, J NEUROSCI RES, V86, P920, DOI 10.1002/jnr.21533; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yang WP, 2004, HEARING RES, V196, P69, DOI 10.1016/j.heares.2004.04.015; Ying YLM, 2009, HEARING RES, V253, P116, DOI 10.1016/j.heares.2009.04.006	94	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138027	10.1371/journal.pone.0138027	http://dx.doi.org/10.1371/journal.pone.0138027			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366995	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100205
J	Chekabab, SM; Silverman, RJ; Lafayette, SL; Luo, YS; Rousseau, S; Nguyen, D				Chekabab, Samuel M.; Silverman, Richard J.; Lafayette, Shantelle L.; Luo, Yishan; Rousseau, Simon; Nguyen, Dao			Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; CYSTIC-FIBROSIS PATIENTS; INTERLEUKIN-8 PRODUCTION; IN-VITRO; INFLAMMATORY RESPONSES; PULMONARY INFECTION; SIGNALING PATHWAYS; KINASE ACTIVATION; VIRULENCE FACTORS; EXPRESSION	Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) are major respiratory pathogens and can concurrently colonize the airways of patients with chronic obstructive diseases, such as cystic fibrosis (CF). Airway epithelial cell signalling is critical to the activation of innate immune responses. In the setting of polymicrobial colonization or infection of the respiratory tract, how epithelial cells integrate different bacterial stimuli remains unknown. Our study examined the inflammatory responses to PA and SA co-stimulations. Immortalised airway epithelial cells (Beas-2B) exposed to bacteria-free filtrates from PA (PAF) induced a robust production of the neutrophil chemoattractant IL-8 while bacteriafree filtrates from SA (SAF) had a minimal effect. Surprisingly, co-stimulation with PAF+SAF demonstrated that SAF strongly inhibited the PAF-driven IL-8 production, showing that SAF has potent anti-inflammatory effects. Similarly SAF decreased IL-8 production induced by the TLR1/TLR2 ligand Pam(3)CysSK(4) but not the TLR4 ligand LPS nor TLR5 ligand flagellin in Beas-2B cells. Moreover, SAF greatly dampened TLR1/TLR2-mediated activation of the NF-kappa B pathway, but not the p38 MAPK pathway. We observed this SAF-dependent antiinflammatory activity in several SA clinical strains, as well as in the CF epithelial cell line CFBE41o-. These findings show a novel direct anti-inflammatory effect of SA on airway epithelial cells, highlighting its potential to modulate inflammatory responses in the setting of polymicrobial infections.	[Chekabab, Samuel M.; Silverman, Richard J.; Lafayette, Shantelle L.; Luo, Yishan; Rousseau, Simon; Nguyen, Dao] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Chekabab, Samuel M.; Lafayette, Shantelle L.; Rousseau, Simon; Nguyen, Dao] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Nguyen, Dao] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Nguyen, D (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	dao.nguyen@mcgill.ca		Rousseau, Simon/0000-0002-8773-575X; Wu, Min/0000-0003-1205-982X; Chekabab, Samuel M/0000-0002-5636-4095	Burroughs Wellcome Fund; Meakins-Christie Laboratories; Cystic Fibrosis Canada [2148]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Meakins-Christie Laboratories; Cystic Fibrosis Canada	The authors acknowledge funding support from the Burroughs Wellcome Fund (to DN), Meakins-Christie Laboratories (to SMC) and Cystic Fibrosis Canada grant #2148 (to DN and SR).	Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Beaudoin T, 2013, J INFECT DIS, V207, P1544, DOI 10.1093/infdis/jit059; Beaudoin T, 2012, J BACTERIOL, V194, P3128, DOI 10.1128/JB.06178-11; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Below S, 2009, AM J PHYSIOL-LUNG C, V296, pL470, DOI 10.1152/ajplung.90498.2008; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Devalaraja MN, 1999, CANCER RES, V59, P1372; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Elewaut D, 1999, J IMMUNOL, V163, P1457; Filkins LM, 2015, J BACTERIOL; Fugere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086705; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Hawdon NA, 2010, FEMS IMMUNOL MED MIC, V59, P207, DOI 10.1111/j.1574-695X.2010.00693.x; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hubert D, 2013, J CYST FIBROS, V12, P497, DOI 10.1016/j.jcf.2012.12.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Martel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059116; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Michelsen CF, 2014, J BACTERIOL, V196, P3903, DOI 10.1128/JB.02006-14; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Ordonez CL, 2001, PEDIATR PULM, V32, P29, DOI 10.1002/ppul.1085; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Parker D, 2011, TRENDS IMMUNOL, V32, P582, DOI 10.1016/j.it.2011.09.003; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rath S, 2013, CELL MICROBIOL, V15, P1253, DOI 10.1111/cmi.12113; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Rudkjobing VB, 2012, FEMS IMMUNOLOGY MED; Sadowska B, 2013, ARCH IMMUNOL THER EX, V61, P413, DOI 10.1007/s00005-013-0240-3; Shah PL, 1999, EUR RESPIR J, V14, P1340, DOI 10.1183/09031936.99.14613409; Tajima A, 2007, CLIN EXP IMMUNOL, V147, P148, DOI 10.1111/j.1365-2249.2006.03254.x; Tajima A, 2009, INFECT IMMUN, V77, P327, DOI 10.1128/IAI.00748-08; Tiedemann RE, 2009, BLOOD, V113, P4027, DOI 10.1182/blood-2008-09-179796; TODER DS, 1994, INFECT IMMUN, V62, P1320, DOI 10.1128/IAI.62.4.1320-1327.1994; Winder AA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-96; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	58	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137753	10.1371/journal.pone.0137753	http://dx.doi.org/10.1371/journal.pone.0137753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360879	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100082
J	Petruccelli, E; Lansdon, P; Kitamoto, T				Petruccelli, Emily; Lansdon, Patrick; Kitamoto, Toshihiro			Exaggerated Nighttime Sleep and Defective Sleep Homeostasis in a Drosophila Knock-In Model of Human Epilepsy	PLOS ONE			English	Article							FEBRILE SEIZURES PLUS; REDUCED SLEEP; MOUSE MODEL; PDF CELLS; DEPRIVATION; NEURONS; SCN1A; AROUSAL; FLIES	Despite an established link between epilepsy and sleep behavior, it remains unclear how specific epileptogenic mutations affect sleep and subsequently influence seizure susceptibility. Recently, Sun et al. (2012) created a fly knock-in model of human generalized epilepsy with febrile seizures plus (GEFS+), a wide-spectrum disorder characterized by fever-associated seizing in childhood and lifelong affliction. GEFS+ flies carry a disease-causing mutation in their voltage-gated sodium channel (VGSC) gene and display semidominant heat-induced seizing, likely due to reduced GABAergic inhibitory activity at high temperature. Here, we show that at room temperature the GEFS+ mutation dominantly modifies sleep, with mutants exhibiting rapid sleep onset at dusk and increased nighttime sleep as compared to controls. These characteristics of GEFS+ sleep were observed regardless of sex, mating status, and genetic background. GEFS+ mutant sleep phenotypes were more resistant to pharmacologic reduction of GABA transmission by carbamazepine (CBZ) than controls, and were mitigated by reducing GABA(A) receptor expression specifically in wake-promoting pigment dispersing factor (PDF) neurons. These findings are consistent with increased GABAergic transmission to PDF neurons being mainly responsible for the enhanced nighttime sleep of GEFS+ mutants. Additionally, analyses under other light conditions suggested that the GEFS+ mutation led to reduced buffering of behavioral responses to light on and off stimuli, which contributed to characteristic GEFS+ sleep phenotypes. We further found that GEFS+ mutants had normal circadian rhythms in free-running dark conditions. Interestingly, the mutants lacked a homeostatic rebound following mechanical sleep deprivation, and whereas deprivation treatment increased heat-induced seizure susceptibility in control flies, it unexpectedly reduced seizure activity in GEFS+ mutants. Our study has revealed the sleep architecture of a Drosophila VGSC mutant that harbors a human GEFS+ mutation, and provided unique insight into the relationship between sleep and epilepsy.	[Petruccelli, Emily; Lansdon, Patrick; Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Kitamoto, Toshihiro] Univ Iowa, Dept Anesthesia, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kitamoto, T (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	toshi-kitamoto@uiowa.edu		Petruccelli, Emily/0000-0002-6911-7157; Kitamoto, Toshihiro/0000-0003-0863-8466	National Institutes of Health; Iowa Center for Research by Undergraduates; NIAAA [F31AA021625]; NINDS [T32NS045549]; NIMH [R01 MH085081]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA021625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Center for Research by Undergraduates; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding provided by National Institutes of Health (http://www.nih.gov/), Iowa Center for Research by Undergraduates (http://www.uiowa.edu/icru/), NIAAA F31AA021625 (EP), NINDS T32NS045549 (PL), NIMH R01 MH085081 (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Derry CP, 2013, EPILEPSY BEHAV, V26, P394, DOI 10.1016/j.yebeh.2012.10.033; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; ELLINGSON RJ, 1984, J CLIN NEUROPHYSIOL, V1, P83, DOI 10.1097/00004691-198401000-00005; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Giorelli Andre S, 2013, Epilepsy Res Treat, V2013, P629469, DOI 10.1155/2013/629469; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jain SV, 2014, EPILEPSIA, V55, P26, DOI 10.1111/epi.12478; Kalume F, 2015, NEUROBIOL DIS, V77, P141, DOI 10.1016/j.nbd.2015.02.016; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Liu S, 2014, NEURON, V82, P151, DOI 10.1016/j.neuron.2014.01.040; Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105678; Lucey BP, 2015, SLEEP, V38, P777, DOI 10.5665/sleep.4674; Malow Beth A, 2004, Epilepsy Curr, V4, P193, DOI 10.1111/j.1535-7597.2004.04509.x; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Matos G, 2011, PROG NEUROBIOL, V95, P396, DOI 10.1016/j.pneurobio.2011.09.006; Neiman ES, 2010, SLEEP MED, V11, P799, DOI 10.1016/j.sleep.2010.04.006; Papale LA, 2010, J BIOL CHEM, V285, P16553, DOI 10.1074/jbc.M109.090084; Papale LA, 2013, EPILEPSIA, V54, P625, DOI 10.1111/epi.12060; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Potdar S, 2013, J NEUROGENET, V27, P23, DOI 10.3109/01677063.2013.791692; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sinha SR, 2011, J CLIN NEUROPHYSIOL, V28, P103, DOI 10.1097/WNP.0b013e3182120d41; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sun L, 2012, J NEUROSCI, V32, P14145, DOI 10.1523/JNEUROSCI.2932-12.2012; Tabuchi M, 2015, CURR BIOL, V25, P702, DOI 10.1016/j.cub.2015.01.016; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Xu Xiao-jing, 2012, Zhonghua Er Ke Za Zhi, V50, P580	48	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137758	10.1371/journal.pone.0137758	http://dx.doi.org/10.1371/journal.pone.0137758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361221	gold, Green Published			2022-12-27	WOS:000361043100084
J	Zahid, MSH; Awasthi, SP; Asakura, M; Chatterjee, S; Hinenoya, A; Faruque, SM; Yamasaki, S				Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Asakura, Masahiro; Chatterjee, Shruti; Hinenoya, Atsushi; Faruque, Shah M.; Yamasaki, Shinji			Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System	PLOS ONE			English	Article							TOXIN-COREGULATED PILUS; EL-TOR VARIANT; GENE-EXPRESSION; INDUCTION; REGULATOR; ACTIVATOR; STRAINS; APHA; DEGRADATION; INHIBITOR	Use of natural compounds as antivirulence drugs could be an alternative therapeutic approach to modify the outcome of bacterial infections, particularly in view of growing resistance to available antimicrobials. Here, we show that sub-bactericidal concentration of anethole, a component of sweet fennel seed, could suppress virulence potential in O1 El Tor biotype strains of toxigenic Vibrio cholerae, the causative agent of the ongoing 7th cholera pandemic. The expression of cholera toxin (CT) and toxin coregulated pilus (TCP), the major virulence factors of V. cholerae, is controlled through a regulatory cascade involving activation of ToxT with synergistic coupling interaction of ToxR/ToxS with TcpP/TcpH. We present evidence that anethole inhibits in vitro expression of CT and TCP in a toxT-dependent but toxR/toxS-independent manner and through repression of tcpP/tcpH, by using bead-ELISA, western blotting and quantitative real-time RT-PCR assays. The cyclic AMP (cAMP)-cAMP receptor protein (CRP) is a well-studied global signaling system in bacterial pathogens, and this complex is known to suppress expression of tcpP/tcpH in V. cholerae. We find that anethole influences the virulence regulatory cascade by over-expressing cyaA and crp genes. Moreover, suppression of toxigenic V. cholerae-mediated fluid accumulation in ligated ileum of rabbit by anethole demonstrates its potentiality as an antivirulence drug candidate against the diseases caused by toxigenic V. cholerae. Taken altogether, these results revealing a mechanism of virulence inhibition in V. cholerae by the natural compound anethole, may have relevance in designing antivirulence compounds, particularly against multiple antibiotic resistant bacterial pathogens.	[Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Asakura, Masahiro; Chatterjee, Shruti; Hinenoya, Atsushi; Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh	Osaka Metropolitan University; International Centre for Diarrhoeal Disease Research (ICDDR)	Yamasaki, S (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan.	shinji@vet.osakafu-u.ac.jp		Awasthi, Sharda Prasad/0000-0003-1606-3543; Faruque, Shah/0000-0002-7006-622X	Yamazaki Spice Promotion Foundation, Osaka Prefecture University	Yamazaki Spice Promotion Foundation, Osaka Prefecture University	Funding provided by Yamazaki Spice Promotion Foundation, Osaka Prefecture University.	Abuaita BH, 2011, MOL MICROBIOL, V81, P1640, DOI 10.1111/j.1365-2958.2011.07798.x; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Beck NA, 2004, J BACTERIOL, V186, P8309, DOI 10.1128/JB.186.24.8309-8316.2004; Behari J, 2001, J BACTERIOL, V183, P178, DOI 10.1128/JB.183.1.178-188.2001; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chatterjee E, 2013, INFECT IMMUN, V81, P3935, DOI 10.1128/IAI.00722-13; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Corrigan D, 2001, NATURAL REMEDIES THE, P124; De M, 2002, PHYTOTHER RES, V16, P94, DOI 10.1002/ptr.989; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; DiRita VJ, 2013, MBIO, V4, DOI [10.1128/mBio.00403-13, DOI 10.1128/MBI0.00403-13]; Dog TL, 2006, EXPLORE-NY, V2, P446, DOI 10.1016/j.explore.2006.06.010; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; Ghosh-Banerjee J, 2010, J CLIN MICROBIOL, V48, P4283, DOI 10.1128/JCM.00799-10; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; HIGGINS DE, 1994, MOL MICROBIOL, V14, P17, DOI 10.1111/j.1365-2958.1994.tb01263.x; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Kubo I, 2008, J SCI FOOD AGR, V88, P242, DOI 10.1002/jsfa.3079; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Matson JS, 2005, P NATL ACAD SCI USA, V102, P16403, DOI 10.1073/pnas.0505818102; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Medrano AI, 1999, INFECT IMMUN, V67, P2178, DOI 10.1128/IAI.67.5.2178-2183.1999; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nye MB, 2000, J BACTERIOL, V182, P4295, DOI 10.1128/JB.182.15.4295-4303.2000; OKU Y, 1988, MICROBIOL IMMUNOL, V32, P807, DOI 10.1111/j.1348-0421.1988.tb01442.x; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Sanmugam D, 2007, NATURALLY SPEAKING I, P79; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yamasaki S, 2011, INDIAN J MED RES, V133, P232; Yu RR, 1999, J BACTERIOL, V181, P2584, DOI 10.1128/JB.181.8.2584-2592.1999; Zahid MSH, 2015, J VET MED SCI, V77, P535, DOI 10.1292/jvms.14-0664	47	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137529	10.1371/journal.pone.0137529	http://dx.doi.org/10.1371/journal.pone.0137529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361388	Green Submitted, gold, Green Published			2022-12-27	WOS:000361043100050
J	Cui, GY; Chen, YM; Cao, Y				Cui, Gaoyang; Chen, Yunming; Cao, Yang			Temporal-Spatial Pattern of Carbon Stocks in Forest Ecosystems in Shaanxi, Northwest China	PLOS ONE			English	Article							EUROPEAN FORESTS; BIOMASS; STORAGE; SEQUESTRATION; AMAZON; SINK; SOIL; DEFORESTATION; EMISSIONS; DIOXIDE	The precise and accurate quantitative evaluation of the temporal and spatial pattern of carbon (C) storage in forest ecosystems is critical for understanding the role of forests in the global terrestrial C cycle and is essential for formulating forest management policies to combat climate change. In this study, we examined the C dynamics of forest ecosystems in Shaanxi, northwest China, based on four forest inventories (1989-1993, 1994-1998, 1999-2003, and 2004-2008) and field-sampling measurements (2012). The results indicate that the total C storage of forest ecosystems in Shaanxi increased by approximately 29.3%, from 611.72 Tg in 1993 to 790.75 Tg in 2008, partially as a result of ecological restoration projects. The spatial pattern of C storage in forest ecosystems mainly exhibited a latitude-zonal distribution across the province, increasing from north (high latitude) to south (low latitude) generally, which signifies the effect of environmental conditions, chiefly water and heat related factors, on forest growth and C sequestration. In addition, different data sources and estimation methods had a significant effect on the results obtained, with the C stocks in 2008 being considerably overestimated (864.55 Tg) and slightly underestimated (778.07 Tg) when measured using the mean C density method and integrated method, respectively. Overall, our results demonstrated that the forest ecosystem in Shaanxi acted as a C sink over the last few decades. However, further studies should be carried out with a focus on adaption of plants to environmental factors along with forest management for vegetation restoration to maximize the C sequestration potential and to better cope with climate change.	[Cui, Gaoyang] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Cui, Gaoyang] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Chen, Yunming; Cao, Yang] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Cao, Y (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	yang.cao@nwsuaf.edu.cn			Chinese Academy of Sciences [XDA05050203-05, K318021304]; National Natural Science Foundation of China [41201088, 41371506]; Ministry of Education of China [2014YB056]; Institute of Soil and Water Conservation [A315021380]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Institute of Soil and Water Conservation	Funding: This study was supported by the Chinese Academy of Sciences (XDA05050203-05, http://www.cas.ac.cn/) (to YMC), the Chinese Academy of Sciences (K318021304, http://www.cas.ac.cn/) (to YC), the National Natural Science Foundation of China (41201088, http://www.nsfc.gov.cn/) (to YC), the National Natural Science Foundation of China (41371506, http://www.nsfc.gov.cn/) (to YMC), the Ministry of Education of China (2014YB056, http://www.moe.edu.cn/) (to YC), and the Institute of Soil and Water Conservation (A315021380, http://www.iswc.ac.cn/) (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, SOIL PHYS CHEM ANAL; [Anonymous], 2005, SOURCEBOOK LAND USE; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Cao Y, 2013, J NW A F U, V41, P114; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Eggleston H.S., 2006, 2019 REF 2006 IPCC G; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fang J., 1996, ACTA ECOL SIN, V16, P497; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Hu HF, 2008, FOREST ECOL MANAG, V255, P1400, DOI 10.1016/j.foreco.2007.10.064; Kauffman J. B, 2012, PROTOCOLS MEASUREMEN; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; LI KR, 2002, LAND USE CHANGE GREE; Liu HX, 2014, J ENVIRON MANAGE, V133, P86, DOI 10.1016/j.jenvman.2013.11.037; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Nabuurs GJ, 2010, FOREST ECOL MANAG, V260, P239, DOI 10.1016/j.foreco.2009.11.024; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Ren H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108163; Ren H, 2013, PLANT SOIL, V363, P123, DOI 10.1007/s11104-012-1302-8; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SEDJO RA, 1993, WATER AIR SOIL POLL, V70, P295, DOI 10.1007/BF01105003; Wang Xin-chuang, 2011, Yingyong Shengtai Xuebao, V22, P2013; WANG XK, 2001, CHINESE J APPL ECOLO, V12, P13; [吴庆标 WU QingBiao], 2008, [生态学报, Acta Ecologica Sinica], V28, P517; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518	38	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137452	10.1371/journal.pone.0137452	http://dx.doi.org/10.1371/journal.pone.0137452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353011	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800087
J	Freeman, BT; Jung, JP; Ogle, BM				Freeman, Brian T.; Jung, Jangwook P.; Ogle, Brenda M.			Single-Cell RNA-Seq of Bone Marrow-Derived Mesenchymal Stem Cells Reveals Unique Profiles of Lineage Priming	PLOS ONE			English	Article							GENE-EXPRESSION; STROMAL CELLS; EXTRACELLULAR VESICLES; MYOCARDIAL-INFARCTION; DIFFERENTIAL GENE; UMBILICAL-CORD; SELF-RENEWAL; MARKERS; ANGIOGENESIS; BIOLOGY	The plasticity and immunomodulatory capacity of mesenchymal stem cells (MSCs) have spurred clinical use in recent years. However, clinical outcomes vary and many ascribe inconsistency to the tissue source of MSCs. Yet unconsidered is the extent of heterogeneity of individual MSCs from a given tissue source with respect to differentiation potential and immune regulatory function. Here we use single-cell RNA-seq to assess the transcriptional diversity of murine mesenchymal stem cells derived from bone marrow. We found genes associated with MSC multipotency were expressed at a high level and with consistency between individual cells. However, genes associated with osteogenic, chondrogenic, adipogenic, neurogenic and vascular smooth muscle differentiation were expressed at widely varying levels between individual cells. Further, certain genes associated with immunomodulation were also inconsistent between individual cells. Differences could not be ascribed to cycles of proliferation, culture bias or other cellular process, which might alter transcript expression in a regular or cyclic pattern. These results support and extend the concept of lineage priming of MSCs and emphasize caution for in vivo or clinical use of MSCs, even when immunomodulation is the goal, since multiple mesodermal (and even perhaps ectodermal) outcomes are a possibility. Purification might enable shifting of the probability of a certain outcome, but is unlikely to remove multilineage potential altogether.	[Freeman, Brian T.; Jung, Jangwook P.; Ogle, Brenda M.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ogle, BM (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	ogle@umn.edu			National Institutes of Health [HL089679]; National Science Foundation Graduate Research Fellowship Program [NSF-GRFP 2010105691]; National Science Foundation (CAREER) [0844537]; University of Minnesota Genomics Center, New Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation (CAREER)(National Science Foundation (NSF)); University of Minnesota Genomics Center, New Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors received funding from the National Institutes of Health (HL089679), National Science Foundation Graduate Research Fellowship Program (NSF-GRFP 2010105691), National Science Foundation (CAREER, award 0844537), University of Minnesota Genomics Center, New Investigator Award.	Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chateauvieux S, 2007, PHYSIOL GENOMICS, V29, P128, DOI 10.1152/physiolgenomics.00197.2006; De Luca A, 2014, ONCOTARGET, V5, P10518; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; DELCARPIO JB, 1991, CIRC RES, V69, P1591, DOI 10.1161/01.RES.69.6.1591; Delorme B, 2009, STEM CELLS, V27, P1142, DOI 10.1002/stem.34; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Foudah D, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987678; Foudah D, 2013, CELL MOL BIOL LETT, V18, P163, DOI 10.2478/s11658-013-0083-2; Foudah D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/820821; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Griffith LM, 2006, BIOL BLOOD MARROW TR, V12, P688, DOI 10.1016/j.bbmt.2006.02.007; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jaager K, 2014, GENE, V533, P173, DOI 10.1016/j.gene.2013.09.094; James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693; Jeong JA, 2005, STEM CELLS, V23, P584, DOI 10.1634/stemcells.2004-0304; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Li JX, 2015, STEM CELLS DEV, V24, P610, DOI 10.1089/scd.2014.0330; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nassiri SM, 2014, STEM CELLS DEV, V23, P319, DOI 10.1089/scd.2013.0419; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09; Pevsner-Fischer M, 2011, STEM CELL REV REP, V7, P560, DOI 10.1007/s12015-011-9229-7; Phinney DG, 2006, STEM CELLS, V24, P186, DOI 10.1634/stemcells.2004-0236; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Roson-Burgo B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-910; Rostovskaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051221; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trivedi P, 2007, EXP HEMATOL, V35, P146, DOI 10.1016/j.exphem.2006.09.003; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304	58	43	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136199	10.1371/journal.pone.0136199	http://dx.doi.org/10.1371/journal.pone.0136199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352588	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800030
J	Barden, HE; Behnsen, J; Bergmann, U; Leng, MJ; Manning, PL; Withers, PJ; Wogelius, RA; van Dongen, BE				Barden, Holly E.; Behnsen, Julia; Bergmann, Uwe; Leng, Melanie J.; Manning, Phillip L.; Withers, Philip J.; Wogelius, Roy A.; van Dongen, Bart E.			Geochemical Evidence of the Seasonality, Affinity and Pigmenation of Solenopora jurassica	PLOS ONE			English	Article							ISOTOPIC DISEQUILIBRIUM; GROWTH BANDS; RED; GLOUCESTERSHIRE	Solenopora jurassica is a fossil calcareous alga that functioned as an important reef-building organism during the Palaeozoic. It is of significant palaeobiological interest due to its distinctive but poorly understood pink and white banding. Though widely accepted as an alga there is still debate over its taxonomic affinity, with recent work arguing that it should be reclassified as a chaetetid sponge. The banding is thought to be seasonal, but there is no conclusive evidence for this. Other recent work has, however demonstrated the presence of a unique organic boron-containing pink/red pigment in the pink bands of S. jurassica. We present new geochemical evidence concerning the seasonality and pigmentation of S. jurassica. Seasonal growth cycles are demonstrated by X-ray radiography, which shows differences in calcite density, and by varying delta C-13 composition of the bands. Temperature variation in the bands is difficult to constrain accurately due to conflicting patterns arising from Mg/Ca molar ratios and delta O-18 data. Fluctuating chlorine levels indicate increased salinity in the white bands, when combined with the isotope data this suggests more suggestive of marine conditions during formation of the white band and a greater freshwater component (lower chlorinity) during pink band precipitation (delta O-18). Increased photosynthesis is inferred within the pink bands in comparison to the white, based on delta C-13. Pyrolysis Gas Chromatography Mass Spectrometry (Py-GCMS) and Fourier Transform Infrared Spectroscopy (FTIR) show the presence of tetramethyl pyrrole, protein moieties and carboxylic acid groups, suggestive of the presence of the red algal pigment phycoerythrin. This is consistent with the pink colour of S. jurassica. As phycoerythrin is only known to occur in algae and cyanobacteria, and no biomarker evidence of bacteria or sponges was detected we conclude S. jurassica is most likely an alga. Pigment analysis may be a reliable classification method for fossil algae.	[Barden, Holly E.; Manning, Phillip L.; Wogelius, Roy A.; van Dongen, Bart E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Behnsen, Julia; Withers, Philip J.] Univ Manchester, Sch Mat Sci, Manchester M13 9PL, Lancs, England; [Bergmann, Uwe] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Leng, Melanie J.] British Geol Survey, NERC Isotope Geosci Facil, Keyworth NG12 5GG, Notts, England; [Leng, Melanie J.] Univ Nottingham, Sch Geog, Ctr Environm Geochem, Nottingham NG7 2RD, England	University of Manchester; University of Manchester; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham	Barden, HE (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England.	holly.barden@manchester.ac.uk	Manning, Phillip/F-9966-2011; Wogelius, Roy/C-4917-2008; Withers, Phil/A-6760-2009	Manning, Phillip/0000-0002-7161-6246; Withers, Phil/0000-0002-1946-5647; van Dongen, Bart/0000-0003-1189-142X; Leng, Melanie/0000-0003-1115-5166	Natural Environment Research Council (NERC); Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility [EP/F007906/1, EP/F028431/1, EP/F001452, EP/I02249X]; Engineering and Physical Sciences Research Council [EP/J021229/1, EP/M010619/1, EP/F007906/1, EP/F028431/1] Funding Source: researchfish; Natural Environment Research Council [nigl010001, NE/J023426/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/M001814/1] Funding Source: researchfish; EPSRC [EP/F028431/1, EP/F007906/1, EP/M010619/1, EP/J021229/1] Funding Source: UKRI; NERC [NE/J023426/1, nigl010001] Funding Source: UKRI; STFC [ST/M001814/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A Natural Environment Research Council (NERC, http://www.nerc.ac.uk/) PhD studentship funded HEB to complete the work as part of her PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge funding from the Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility under EP/F007906/1, EP/F028431/1, EP/F001452 and EP/I02249X (http://www.epsrc.ac.uk/).	Barnes DJ, 1996, GLOBAL CHANGE BIOL, V2, P569, DOI 10.1111/j.1365-2486.1996.tb00068.x; Brown A, 1894, GEOL MAG, V1, P145, DOI 10.1017/S0016756800140762; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; Craig H., 1965, STABLE ISOTOPES OCEA, P161; DODGE RE, 1974, EARTH PLANET SC LETT, V23, P313, DOI 10.1016/0012-821X(74)90121-6; Edwards NP, 2014, METALLOMICS, V6, P774, DOI 10.1039/c3mt00242j; EMRY RJ, 1973, SMITHSONIAN CONTRIBU, V18, P1, DOI DOI 10.5479/SI.00810266.18.1; Faulk H, 1994, MIKROCHIM ACTA, V117, P1, DOI [10.1007/BF01243010, DOI 10.1007/BF01243010]; Ferguson JE, 2008, EARTH PLANET SC LETT, V265, P153, DOI 10.1016/j.epsl.2007.10.011; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; Fujiwara BYT, 1936, J BIOCH, V43, P195; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gornitz V, 2009, ENCY PALEOCLIMATOLOG, P719; Gupta NS, 2007, ORG GEOCHEM, V38, P499, DOI 10.1016/j.orggeochem.2006.06.011; HARLAND TL, 1982, PALAEONTOLOGY, V25, P905; Insalaco E, 1996, PALAEONTOLOGY, V39, P413; KLEIN R, 1990, NATURE, V345, P145, DOI 10.1038/345145a0; KLEIN R, 1992, MAR BIOL, V112, P259, DOI 10.1007/BF00702470; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; KOLESAR PT, 1978, J SEDIMENT PETROL, V48, P815; Lear CH, 2002, GEOCHIM COSMOCHIM AC, V66, P3375, DOI 10.1016/S0016-7037(02)00941-9; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; Peters K.E., 2005, BIOMARKER GUIDE 1, V1; Riding R, 2004, PALAEONTOLOGY, V47, P117, DOI 10.1111/j.0031-0239.2004.00351.x; Russell J.D., 1987, HDB DETERMINATIVE ME, P133; Sharp Z., 2007, PRINCIPLES STABLE IS; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Toole CM, 2003, ADV PHOTO RESPIRAT, V14, P305; WEBER JN, 1975, NATURE, V255, P697, DOI 10.1038/255697a0; Wolkenstein K, 2010, P NATL ACAD SCI USA, V107, P19374, DOI 10.1073/pnas.1007973107; Wray JL, 1977, CALCAREOUS ALGAE, P28; WRIGHT VP, 1985, J PALEONTOL, V59, P721	35	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138305	10.1371/journal.pone.0138305	http://dx.doi.org/10.1371/journal.pone.0138305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367117	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000361601100248
J	Chen, B; Xu, JG; He, XM; Xu, HP; Li, GH; Du, HL; Nie, QH; Zhang, XQ				Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Du, Hongli; Nie, Qinghua; Zhang, Xiquan			A Genome-Wide mRNA Screen and Functional Analysis Reveal FOXO3 as a Candidate Gene for Chicken Growth	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; TRANSCRIPTION FACTOR FOXO3A; SKELETAL-MUSCLE; UBIQUITIN LIGASES; EXPRESSION; MYOD; DIFFERENTIATION; IDENTIFICATION; CELLS; ASSOCIATION	Chicken growth performance provides direct economic benefits to the poultry industry. However, the underlying genetic mechanisms are unclear. The objective of this study was to identify candidate genes associated with chicken growth and investigate their potential mechanisms. We used RNA-Seq to study the breast muscle transcriptome in high and low tails of Recessive White Rock (WRRh, WRRl) and Xinghua chickens (XHh, XHl). A total of 60, 23, 153 and 359 differentially expressed genes were detected in WRRh vs. WRRl, XHh vs. XHl, WRRh vs. XHh and WRRl vs. XHl, respectively. GO, KEGG pathway and gene network analyses showed that CEBPB, FBXO32, FOXO3 and MYOD1 played key roles in growth. The functions of FBXO32 and FOXO3 were validated. FBXO32 was predominantly expressed in leg muscle, heart and breast muscle. After decreased FBXO32 expression, growth-related genes such as PDK4, IGF2R and IGF2BP3 were significantly downregulated (P < 0.05). FBXO32 was significantly (P < 0.05) associated with carcass and meat quality traits, but not growth traits. FOXO3 was predominantly expressed in breast and leg muscle. In both of these tissues, the FOXO3 mRNA level in XH was significantly higher than that in WRR chickens with normal body weight (P < 0.05). In DF-1 cells, siRNA knockdown of FOXO3 significantly (P < 0.01) inhibited the MYOD expression and significantly upregulated (P < 0.01 or P < 0.05) the expression of growth- related genes including CEBPB, FBXO32, GH, GHR, IGF1R, IGF2R, IGF2BP1, IGF2BP3, INSR, PDK1 and PDK4. Moreover, 18 SNPs were identified in FOXO3. G66716193A was significantly (P < 0.05) associated with growth traits. The sites C66716002T, C66716195T and A66716179G were significantly (P < 0.05) associated with growth or carcass traits. These results demonstrated that FOXO3 is a candidate gene influencing chicken growth. Our observations provide new clues to understand the molecular basis of chicken growth.	[Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] South China Agr Univ, Dept Anim Genet Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China; [Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Key Lab Chicken Genet,Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Du, Hongli] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; South China University of Technology	Du, HL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	hldu@scut.edu.cn; nqinghua@scau.edu.cn	Chen, Biao/HGC-3146-2022; xu, haiping/GSJ-1374-2022	Chen, Biao/0000-0003-1852-5289; 	National Natural Science Foundation of China [31172200, 31472090]; Program for New Century Excellent Talents in University [NCET-13-0803]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]; Foundation for High-level Talents in Higher Education of Guangdong, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries; Foundation for High-level Talents in Higher Education of Guangdong, China	This research was supported by the National Natural Science Foundation of China (31172200; 31472090), the Program for New Century Excellent Talents in University (NCET-13-0803), the Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005), and the Foundation for High-level Talents in Higher Education of Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Muhammad, 2013, Frontiers in Genetics, V4, P226, DOI 10.3389/fgene.2013.00226; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blum R, 2014, J CELL BIOCHEM, V115, P1855, DOI 10.1002/jcb.24854; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Flisar T, 2014, POULTRY SCI, V93, P16, DOI 10.3382/ps.2013-03464; Henriksen Tora, 2012, Recent Pat Biotechnol, V6, P167; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Hu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056411; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Jiang CD, 2010, INT J BIOL SCI, V6, P627, DOI 10.7150/ijbs.6.627; Kim JR, 2006, OBESITY, V14, P188, DOI 10.1038/oby.2006.24; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lei MM, 2005, POULTRY SCI, V84, P1191, DOI 10.1093/ps/84.8.1191; Liang SS, 2015, DOMEST ANIM ENDOCRIN, V50, P65, DOI 10.1016/j.domaniend.2014.09.006; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Murphy BA, 2014, VET J, V201, P39, DOI 10.1016/j.tvjl.2014.03.028; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Niarami MD, 2014, ANIM BIOTECHNOL, V25, P13, DOI 10.1080/10495398.2013.803478; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004476; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang Mingfeng, 2013, Evid Based Complement Alternat Med, V2013, P285489, DOI 10.1155/2013/285489; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yin H, 2014, POULTRY SCI, V93, P147, DOI 10.3382/ps.2013-03612; Yu LH, 2013, EUR J HUM GENET, V21, P731, DOI 10.1038/ejhg.2012.239; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	50	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137087	10.1371/journal.pone.0137087	http://dx.doi.org/10.1371/journal.pone.0137087			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366565	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100048
J	D'Haene, N; Le Mercier, M; De Neve, N; Blanchard, O; Delaunoy, M; El Housni, H; Dessars, B; Heimann, P; Remmelink, M; Demetter, P; Tejpar, S; Salmon, I				D'Haene, Nicky; Le Mercier, Marie; De Neve, Nancy; Blanchard, Oriane; Delaunoy, Melanie; El Housni, Hakim; Dessars, Barbara; Heimann, Pierre; Remmelink, Myriam; Demetter, Pieter; Tejpar, Sabine; Salmon, Isabelle			Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers	PLOS ONE			English	Article							DOSE-ESCALATION; PI3K INHIBITOR; MUTATIONS; SPECIMENS; DIAGNOSIS; PANEL; EGFR; PCR	Objective Recently, Next Generation Sequencing (NGS) has begun to supplant other technologies for gene mutation testing that is now required for targeted therapies. However, transfer of NGS technology to clinical daily practice requires validation. Methods We validated the Ion Torrent AmpliSeq Colon and Lung cancer panel interrogating 1850 hotspots in 22 genes using the Ion Torrent Personal Genome Machine. First, we used commercial reference standards that carry mutations at defined allelic frequency (AF). Then, 51 colorectal adenocarcinomas (CRC) and 39 non small cell lung carcinomas (NSCLC) were retrospectively analyzed. Results Sensitivity and accuracy for detecting variants at an AF >4% was 100% for commercial reference standards. Among the 90 cases, 89 (98.9%) were successfully sequenced. Among the 86 samples for which NGS and the reference test were both informative, 83 showed concordant results between NGS and the reference test; i.e. KRAS and BRAF for CRC and EGFR for NSCLC, with the 3 discordant cases each characterized by an AF <10%. Conclusions Overall, the AmpliSeq colon/lung cancer panel was specific and sensitive for mutation analysis of gene panels and can be incorporated into clinical daily practice.	[D'Haene, Nicky; Le Mercier, Marie; De Neve, Nancy; Blanchard, Oriane; Remmelink, Myriam; Demetter, Pieter; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, Brussels, Belgium; [Delaunoy, Melanie; El Housni, Hakim; Dessars, Barbara; Heimann, Pierre] Univ Libre Bruxelles, Erasme Hosp, Dept Genet, Brussels, Belgium; [Tejpar, Sabine] Univ Hosp Leuven, Dept Oncol, Leuven, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven	Salmon, I (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, Brussels, Belgium.	isabelle.salmon@erasme.ulb.ac.be			"Fonds Yvonne Boel" (Brussels, Belgium)	"Fonds Yvonne Boel" (Brussels, Belgium)	This work was supported by funding from the "Fonds Yvonne Boel" (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2012, MODERN PATHOL, V25, P1599, DOI 10.1038/modpathol.2012.121; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Dienstmann R, 2014, MOL ONCOLOGY; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kerr KM, 2014, ANN ONCOL; Le Mercier M, 2015, HISTOPATHOLOGY, V66, P215, DOI 10.1111/his.12461; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Malapelle U, 2015, J CLIN PATHOL, V68, P64, DOI 10.1136/jclinpath-2014-202691; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Marchetti A, 2006, N ENGL J MED, V354; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Metzger GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033520; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Normanno N, 2015, ANN ONCOL; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Scarpa A, 2013, PLOS ONE, V13, P8, DOI DOI 10.1371/J0URNAL.P0NE.0080478; Shi CJ, 2012, AM J CLIN PATHOL, V137, P847, DOI 10.1309/AJCPI83DINULUJNI; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Spoerke JM, 2012, CLIN CANCER RES, V18, P6771, DOI 10.1158/1078-0432.CCR-12-2347; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tops BBJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1015-5; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Walls M, 2014, CLIN CANCER RES, V20, P631, DOI 10.1158/1078-0432.CCR-13-1663; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Zar J., 2010, BIOSTATISCTICAL ANAL	33	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138245	10.1371/journal.pone.0138245	http://dx.doi.org/10.1371/journal.pone.0138245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366557	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100244
J	Dhariwal, J; Kitson, J; Jones, RE; Nicholson, G; Tunstall, T; Walton, RP; Francombe, G; Gilbert, J; Tan, AJ; Murdoch, R; Kon, OM; Openshaw, PJ; Hansel, TT				Dhariwal, Jaideep; Kitson, Jeremy; Jones, Reema E.; Nicholson, Grant; Tunstall, Tanushree; Walton, Ross P.; Francombe, Grace; Gilbert, Jane; Tan, Andrew J.; Murdoch, Robert; Kon, Onn Min; Openshaw, Peter J.; Hansel, Trevor T.			Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; AIRWAY; ENDOTOXIN; ASTHMA; RESPONSES; INFECTION; EXPOSURE; RELEASE; MARKERS; INFLUX	Background Practical methods of monitoring innate immune mucosal responsiveness are lacking. Lipopolysaccharide (LPS) is a component of the cell wall of Gram negative bacteria and a potent activator of Toll-like receptor (TLR)-4. To measure LPS responsiveness of the nasal mucosa, we administered LPS as a nasal spray and quantified chemokine and cytokine levels in mucosal lining fluid (MLF). Methods We performed a 5-way cross-over, single blind, placebo-controlled study in 15 healthy nonatopic subjects (n = 14 per protocol). Doses of ultrapure LPS (1, 10, 30 or 100 mu g/100 mu l) or placebo were administered by a single nasal spray to each nostril. Using the recently developed method of nasosorption with synthetic adsorptive matrices (SAM), a series of samples were taken. A panel of seven cytokines/chemokines were measured by multiplex immunoassay in MLF. mRNA for intercellular cell adhesion molecule-1 (ICAM-1) was quantified from nasal epithelial curettage samples taken before and after challenge. Results Topical nasal LPS was well tolerated, causing no symptoms and no visible changes to the nasal mucosa. LPS induced dose-related increases in MLF levels of IL-1 beta, IL-6, CXCL8 (IL-8) and CCL3 (MIP-1 alpha) (AUC at 0.5 to 10h, compared to placebo, p < 0.05 at 30 and 100 mu g LPS). At 100 mu g LPS, IL-10, IFN-alpha and TNF-alpha were also increased (p < 0.05). Dose-related changes in mucosal ICAM-1 mRNA were also seen after challenge, and neutrophils appeared to peak in MLF at 8h. However, 2 subjects with high baseline cytokine levels showed prominent cytokine and chemokine responses to relatively low LPS doses (10 mu g and 30 mu g LPS). Conclusions Topical nasal LPS causes dose-dependent increases in cytokines, chemokines, mRNA and cells. However, responsiveness can show unpredictable variations, possibly because baseline innate tone is affected by environmental factors. We believe that this new technique will have wide application in the study of the innate immune responses of the respiratory mucosa. Key Messages Ultrapure LPS was used as innate immune stimulus in a human nasal challenge model, with serial sampling of nasal mucosal lining fluid (MLF) by nasosorption using a synthetic absorptive matrix (SAM), and nasal curettage of mucosal cells. A dose response could be demonstrated in terms of levels of IL-1 beta, IL-6, CXCL8 and CCL3 in MLF, as well as ICAM-1 mRNA in nasal curettage specimens, and levels of neutrophils in nasal lavage. Depending on higher baseline levels of inflammation, there were occasional magnified innate inflammatory responses to LPS.	[Dhariwal, Jaideep; Nicholson, Grant; Tunstall, Tanushree; Walton, Ross P.; Tan, Andrew J.; Kon, Onn Min; Openshaw, Peter J.; Hansel, Trevor T.] Univ London Imperial Coll Sci Technol & Med, St Marys Univ, Natl Heart & Lung Inst, Ctr Resp Infect, London W2 1NY, England; [Kitson, Jeremy; Jones, Reema E.; Murdoch, Robert] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Francombe, Grace; Gilbert, Jane] GlaxoSmithKline, Uxbridge UB11 1BT, Middx, England	Imperial College London; St Mary's University Twickenham London; GlaxoSmithKline; GlaxoSmithKline	Hansel, TT (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Univ, Natl Heart & Lung Inst, Ctr Resp Infect, London W2 1NY, England.	t.hansel@imperial.ac.uk	Openshaw, Peter/AAL-9442-2020	Openshaw, Peter/0000-0002-7220-2555; Kon, Onn Min/0000-0003-2647-4688; Nicholson, Grant/0000-0001-8724-6115; Dhariwal, Jaideep/0000-0003-2352-5638; Tunstall, Tanushree/0000-0002-3220-8346	Glaxo SmithKline; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Imperial College NHS Trust; Imperial College, London, United Kingdom; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [CH11SJ] Funding Source: researchfish	Glaxo SmithKline(GlaxoSmithKline); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Imperial College NHS Trust; Imperial College, London, United Kingdom; National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This study was funded by Glaxo SmithKline and supported by National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College NHS Trust and Imperial College, London, United Kingdom. Glaxo SmithKline provided support in the form of salaries for authors JK, REJ, GF, JG and RM, and played a full and active role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bachar O, 2007, CLIN EXP ALLERGY, V37, P1773, DOI 10.1111/j.1365-2222.2007.02842.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V125, P1387, DOI 10.1016/j.jaci.2010.01.039; Danuser B, 2000, EUR ARCH OTO-RHINO-L, V257, P527, DOI 10.1007/s004050000285; Doreswamy V, 2011, INHAL TOXICOL, V23, P142, DOI 10.3109/08958378.2011.553247; Dreskin SC, 2002, J IMMUNOL METHODS, V268, P189, DOI 10.1016/S0022-1759(02)00206-5; Ekman AK, 2012, INT ARCH ALLERGY IMM, V159, P6, DOI 10.1159/000335196; Ekman AK, 2009, INT ARCH ALLERGY IMM, V149, P154, DOI 10.1159/000189199; Erin EM, 2005, CLIN EXP ALLERGY, V35, P1608, DOI 10.1111/j.1365-2222.2005.02381.x; Folsgaard NV, 2011, AM J RESP CRIT CARE; Fransson M, 2007, ACTA OTO-LARYNGOL, V127, P285, DOI 10.1080/00016480600801340; GREIFF L, 1990, CLIN EXP ALLERGY, V20, P253, DOI 10.1111/j.1365-2222.1990.tb02680.x; Habibzay M, 2012, MUCOSAL IMMUNOL, V5, P524, DOI 10.1038/mi.2012.28; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hentschel J, 2014, J IMMUNOL METHODS, V404, P41, DOI 10.1016/j.jim.2013.12.003; Hernandez ML, 2012, J ALLERGY CLIN IMMUN, V130, P869, DOI 10.1016/j.jaci.2012.05.026; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Nicholson GC, 2011, J ALLERGY CLIN IMMUN, V128, P800, DOI 10.1016/j.jaci.2011.05.013; Nita I, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-12; O'Byrne PM, 2009, CLIN EXP ALLERGY, V39, P181, DOI 10.1111/j.1365-2222.2008.03172.x; Peden DB, 1999, J ALLERGY CLIN IMMUN, V104, P388, DOI 10.1016/S0091-6749(99)70383-0; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Pollard AJ, 2012, LANCET INFECT DIS, V12, P903, DOI 10.1016/S1473-3099(12)70292-X; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Riechelmann H, 2003, EUR RESPIR J, V21, P600, DOI 10.1183/09031936.03.00072003; Scadding GW, 2012, J IMMUNOL METHODS, V384, P25, DOI 10.1016/j.jim.2012.06.013; Schaumann F, 2008, AM J RESP CRIT CARE, V177, P1307, DOI 10.1164/rccm.200706-870OC; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Simpson A, 2010, CLIN EXP ALLERGY, V40, P209, DOI 10.1111/j.1365-2222.2009.03391.x; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Virtala R, 2012, CLIN EXP ALLERGY, V42, P590, DOI 10.1111/j.1365-2222.2011.03921.x; Wang SZ, 2013, EUR ARCH OTO-RHINO-L, V270, P1329, DOI 10.1007/s00405-012-2136-y; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229	40	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135363	10.1371/journal.pone.0135363	http://dx.doi.org/10.1371/journal.pone.0135363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367003	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100009
J	Donner, DG; Elliott, GE; Beck, BR; Bulmer, AC; Du Toit, EF				Donner, Daniel G.; Elliott, Grace E.; Beck, Belinda R.; Bulmer, Andrew C.; Du Toit, Eugene F.			Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS)	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; BODY-FAT PERCENTAGE; MIDDLE-AGED MEN; HORMONE-BINDING GLOBULIN; LATE-ONSET HYPOGONADISM; CORONARY-HEART-DISEASE; PROSTATE-CANCER; INSULIN-RESISTANCE; ISCHEMIA-REPERFUSION; RISK-FACTORS	Introduction Currentmodels of obesity utilise normogonadic animals and neglect the strong relationships between obesity-associated metabolic syndrome (MetS) and male testosterone deficiency (TD). The joint presentation of these conditions has complex implications for the cardiovascular system that are not well understood. We have characterised and investigated three models in male rats: one of diet-induced obesity with the MetS; a second using orchiectomised rats mimicking TD; and a third combining MetS with TD which we propose is representative of males with testosterone deficiency and the metabolic syndrome (TDMetS). Methods Male Wistar rats (n = 24) were randomly assigned to two groups and provided ad libitum access to normal rat chow (CTRL) or a high fat/high sugar/low protein "obesogenic" diet (OGD) for 28 weeks (n = 12/group). These groups were further sub-divided into sham-operated or orchiectomised (ORX) animals to mimic hypogonadism, with and without diet-induced obesity (n = 6/group). Serum lipids, glucose, insulin and sex hormone concentrations were determined. Body composition, cardiovascular structure and function; and myocardial tolerance to ischemia-reperfusion were assessed. Results OGD-fed animals had 72% greater fat mass; 2.4-fold greater serum cholesterol; 2.3-fold greater serum triglycerides and 3-fold greater fasting glucose (indicative of diabetes mellitus) compared to CTRLs (all p<0.05). The ORX animals had reduced serum testosterone and left ventricle mass (p<0.05). In addition to the combined differences observed in each of the isolated models, the OGD, ORX and OGD+ORX models each had greater CK-MB levels following in vivo cardiac ischemia-reperfusion insult compared to CTRLs (p<0.05). Conclusion Our findings provide evidence to support that the MetS and TD independently impair myocardial tolerance to ischemia-reperfusion. The combined OGD+ORX phenotype described in this study is a novel animal model with associated cardiovascular risk factors and complex myocardial pathology which may be representative of male patients presenting with TDMetS.	[Donner, Daniel G.; Elliott, Grace E.; Bulmer, Andrew C.; Du Toit, Eugene F.] Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld, Australia; [Beck, Belinda R.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University	Donner, DG (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld, Australia.	d.donner@griffith.edu.au	Beck, Belinda/B-9079-2008	Beck, Belinda/0000-0003-1295-6395; Bulmer, Andrew/0000-0002-2994-7893; Donner, Daniel G./0000-0003-4924-720X	Menzies Health Institute Queensland, Griffith University; EFDT	Menzies Health Institute Queensland, Griffith University; EFDT	Funding for this project was provided by the Menzies Health Institute Queensland, Griffith University and was received by EFDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2002, J CLIN ENDOCR METAB, V87, P4522, DOI 10.1210/jc.2002-020567; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Sanchez-Garrido MA, 2014, ENDOCRINOLOGY, V155, P1067, DOI 10.1210/en.2013-1584; Bell JR, 2011, ENDOCRINOLOGY, V152, P4937, DOI 10.1210/en.2011-1212; Bertelli DF, 2013, J ENDOCRINOL, V217, P131, DOI 10.1530/JOE-12-0562; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bouhidel O, 2008, AM J PHYSIOL-HEART C, V295, pH1580, DOI 10.1152/ajpheart.00379.2008; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Clark C, 2011, PHYSIOL RES, V60, P291, DOI 10.33549/physiolres.931999; Corona G, 2011, J ENDOCRINOL INVEST, V34, P557, DOI 10.3275/7806; Corona G, 2013, ARCH ESP UROL, V66, P711; Dockery F, 2003, CLIN SCI, V104, P195, DOI 10.1042/CS20020209; Donner D, 2013, DIS MODEL MECH, V6, P457, DOI 10.1242/dmm.010959; Donner DG, 2012, MYOCARDIAL INSULIN R, V2012, P12; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; du Toit EF, 2008, AM J PHYSIOL-HEART C, V294, pH2336, DOI 10.1152/ajpheart.00481.2007; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906; ERI LM, 1995, J UROLOGY, V154, P100, DOI 10.1016/S0022-5347(01)67239-2; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Habib SS, 2013, BIOMED ENVIRON SCI, V26, P94, DOI 10.3967/0895-3988.2013.02.003; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall SA, 2008, J CLIN ENDOCR METAB, V93, P3870, DOI 10.1210/jc.2008-0021; Haring R, 2010, AGING MALE, V13, P247, DOI 10.3109/13685538.2010.487553; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Jankowska EA, 2006, CIRCULATION, V114, P1829, DOI 10.1161/CIRCULATIONAHA.106.649426; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kapoor D, 2008, DRUG AGING, V25, P357, DOI 10.2165/00002512-200825050-00001; Katakam PVG, 2007, AM J PHYSIOL-REG I, V292, pR920, DOI 10.1152/ajpregu.00520.2006; Kaushik M, 2010, INT J CARDIOL, V142, P8, DOI 10.1016/j.ijcard.2009.10.033; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; KHAW KT, 1991, ARTERIOSCLER THROMB, V11, P489, DOI 10.1161/01.ATV.11.3.489; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Kramer CK, 2009, J CLIN ENDOCR METAB, V94, P5039, DOI 10.1210/jc.2009-1497; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530/eje.0.1490601; Lam CSP, 2015, EUR J HEART FAIL, V17, P301, DOI 10.1002/ejhf.238; Lekli I, 2008, AM J PHYSIOL-HEART C, V294, pH859, DOI 10.1152/ajpheart.01048.2007; Li L, 2012, CLIN EXP PHARMACOL P, V39, P393, DOI 10.1111/j.1440-1681.2012.05684.x; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Mammi C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/789653; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x; Nettleship JE, 2009, FRONT HORM RES, V37, P91, DOI 10.1159/000176047; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Pavon N, 2012, J STEROID BIOCHEM, V132, P135, DOI 10.1016/j.jsbmb.2012.05.003; Peart JN, 2007, J MOL CELL CARDIOL, V42, P972, DOI 10.1016/j.yjmcc.2007.02.011; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Rubio-Gayosso I, 2013, STEROIDS, V78, P362, DOI 10.1016/j.steroids.2012.12.004; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Salvador C, 2013, UROL INT, V90, P41, DOI 10.1159/000342814; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sivaraman V, 2010, J CELL MOL MED, V14, P1740, DOI 10.1111/j.1582-4934.2009.00796.x; Smith JC, 2001, J CLIN ENDOCR METAB, V86, P4261, DOI 10.1210/jc.86.9.4261; Smith MR, 2008, UROLOGY, V71, P318, DOI 10.1016/j.urology.2007.08.035; Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Svartberg J, 2008, INT J IMPOT RES, V20, P378, DOI 10.1038/ijir.2008.19; Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513; Tchernof A, 1997, ATHEROSCLEROSIS, V133, P235, DOI 10.1016/S0021-9150(97)00125-1; Travison TG, 2008, J AM GERIATR SOC, V56, P831, DOI 10.1111/j.1532-5415.2008.01679.x; Usui C, 2010, J NUTR SCI VITAMINOL, V56, P109, DOI 10.3177/jnsv.56.109; Vermeulen A., 1999, Journal of Endocrinological Investigation, V22, P110; Wagner C, 2008, J CARDIOVASC PHARM, V52, P430, DOI 10.1097/FJC.0b013e31818c12a7; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; Wang C, 2009, EUR UROL, V55, P121, DOI 10.1016/j.eururo.2008.08.033; Webb CM, 1999, CIRCULATION, V100, P1690, DOI 10.1161/01.CIR.100.16.1690; Wensley I, 2013, EXP PHYSIOL, V98, P1552, DOI 10.1113/expphysiol.2013.074948; Ye Ying, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P1235; Zmuda JM, 1997, AM J EPIDEMIOL, V146, P609, DOI 10.1093/oxfordjournals.aje.a009326	92	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138019	10.1371/journal.pone.0138019	http://dx.doi.org/10.1371/journal.pone.0138019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366723	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100203
J	Greenwood, AK; Peichel, CL				Greenwood, Anna K.; Peichel, Catherine L.			Social Regulation of Gene Expression in Threespine Sticklebacks	PLOS ONE			English	Article							AFRICAN CICHLID FISH; SPATIAL EXPRESSION; BEHAVIOR NETWORK; HONEY-BEE; BRAIN; ZEBRAFISH; MOUSE; MICE; LIFE; TELENCEPHALON	Identifying genes that are differentially expressed in response to social interactions is informative for understanding the molecular basis of social behavior. To address this question, we described changes in gene expression as a result of differences in the extent of social interactions. We housed threespine stickleback (Gasterosteus aculeatus) females in either group conditions or individually for one week, then measured levels of gene expression in three brain regions using RNA-sequencing. We found that numerous genes in the hind-brain/cerebellum had altered expression in response to group or individual housing. However, relatively few genes were differentially expressed in either the diencephalon or telencephalon. The list of genes upregulated in fish from social groups included many genes related to neural development and cell adhesion as well as genes with functions in sensory signaling, stress, and social and reproductive behavior. The list of genes expressed at higher levels in individually-housed fish included several genes previously identified as regulated by social interactions in other animals. The identified genes are interesting targets for future research on the molecular mechanisms of normal social interactions.	[Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Peichel, CL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpeichel@fhcrc.org		Peichel, Catherine/0000-0002-7731-8944	National Science Foundation Division of Integrative Organismal Systems [IOS 1145866]; Direct For Biological Sciences [1145866] Funding Source: National Science Foundation	National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation Division of Integrative Organismal Systems grant IOS 1145866 to AKG and CLP (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Deasey S, 2012, AMINO ACIDS, V42, P1065, DOI 10.1007/s00726-011-1021-0; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dunlap KD, 2008, DEV NEUROBIOL, V68, P1420, DOI 10.1002/dneu.20673; Earley RL, 2006, PHYSIOL BEHAV, V88, P353, DOI 10.1016/j.physbeh.2006.04.002; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Feng Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052674; Fernando CA, 2010, DEV DYNAM, V239, P1755, DOI 10.1002/dvdy.22279; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Ganz Julia, 2014, F1000Res, V3, P308, DOI 10.12688/f1000research.5595.2; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goodson JL, 2013, HORM BEHAV, V64, P103, DOI 10.1016/j.yhbeh.2013.05.006; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Hamilton SM, 2011, BEHAV BRAIN RES, V218, P29, DOI 10.1016/j.bbr.2010.11.026; Hitzemann R, 2013, GENES BRAIN BEHAV, V12, P1, DOI 10.1111/gbb.12007; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kidd MR, 2013, BEHAV ECOL SOCIOBIOL, V67, P1307, DOI 10.1007/s00265-013-1559-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MJ, 2007, GLYCOBIOLOGY, V17, P231, DOI 10.1093/glycob/cwl069; Klein SE, 2008, MOL CELL ENDOCRINOL, V286, P148, DOI 10.1016/j.mce.2007.08.010; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Kroes RA, 2006, NEUROSCIENCE, V137, P37, DOI 10.1016/j.neuroscience.2005.08.076; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Levine JB, 2007, NEUROSCIENCE, V145, P42, DOI 10.1016/j.neuroscience.2006.11.063; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Mulder J, 2010, EUR J NEUROSCI, V31, P2166, DOI 10.1111/j.1460-9568.2010.07275.x; O'Connell LA, 2013, J CHEM NEUROANAT, V47, P106, DOI 10.1016/j.jchemneu.2012.12.007; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Reiss D, 2007, BEHAV BRAIN RES, V184, P167, DOI 10.1016/j.bbr.2007.07.010; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Moldes I, 2002, BRAIN RES BULL, V57, P331, DOI 10.1016/S0361-9230(01)00700-6; Sanogo YO, 2012, P ROY SOC B-BIOL SCI, V279, P4929, DOI 10.1098/rspb.2012.2087; Sanogo YO, 2011, BRAIN BEHAV EVOLUT, V77, P270, DOI 10.1159/000328221; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; STACEY NE, 1982, CAN J FISH AQUAT SCI, V39, P92, DOI 10.1139/f82-011; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse B, 2008, THE ZEBRAFISH MODEL; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Trainor BC, 2006, ENDOCRINOLOGY, V147, P5119, DOI 10.1210/en.2006-0511; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P106, DOI 10.1016/j.cbpa.2013.01.025; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Wark AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018316; Wootton R.J., 1976, BIOL STICKLEBACKS; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	63	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137726	10.1371/journal.pone.0137726	http://dx.doi.org/10.1371/journal.pone.0137726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367311	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100123
J	Kong, LL; Wang, XB; Zhang, K; Yuan, WJ; Yang, QW; Fan, JP; Wang, P; Liu, QH				Kong, Lulu; Wang, Xiaobing; Zhang, Kun; Yuan, Wenjuan; Yang, Qiwen; Fan, Jianping; Wang, Pan; Liu, Quanhong			Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation	PLOS ONE			English	Article							MITOCHONDRIA-DEPENDENT PATHWAYS; GYNOSTEMMA-PENTAPHYLLUM MAKINO; MURINE XENOGRAFT MODEL; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; CELLS; RESISTANCE; CHEMOTHERAPY; COMBINATION; PATHOGENESIS	Objective 5-Fluorouracil (5-Fu) has been widely used as a first-line drug for colorectal cancer (CRC) treatment but limited by drug resistance and severe toxicity. The chemo-sensitizers that augment its efficiency and overcome its limitation are urgently needed. Gypenosides (Gyp), the main components from Gynostemma pentaphyllum (Thunb.) Makino, has shown potential anti-tumor property with little side-effect. Here, we carefully explored the chemo-sensitization of Gyp to potentiate the anti-tumor effect of 5-Fu in vitro and in vivo. Methodology / Principal Findings 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltertrazolium bromide tetrazolium assay and colony formation test reveal that Gyp could significantly enhance the 5-Fu-caused SW-480, SW-620 and Caco2 cells viability loss. Calcusyn analysis shows that Gyp acts synergistically with 5-Fu. Annexin V-PE/7-AAD staining indicates 5-Fu + Gyp could induce SW-480 cell apoptosis. The activations of caspase 3, caspase 9 and poly (ADP-ribose) polymerase (PARP) were involved in the process. Gyp was also found to up-regulate 5-Fu-caused phospho-p53 expression and thus augment 5-Fu-induced G0/G1 phase arrest. Gyp elevated intracellular ROS level, significantly enhanced 5-Fu-triggered DNA damage response as evidenced by flow cytometry, comet assay and the expression of Ser139-Histone H2A. X. Inhibition of ROS and p53 respectively reversed the cell death induced by 5-Fu + Gyp, suggesting the key roles of ROS and p53 in the process. Moreover, 5-Fu and Gyp in combination exhibits much superior tumor volume and weight inhibition on CT-26 xenograft mouse model in comparison to 5-Fu or Gyp alone. Immunohistochemistry analysis suggests the combinations greatly suppressed tumor proliferation. Preliminary toxicological results show that 5-Fu + Gyp treatment is relatively safe. Conclusions As a potential chemo-sensitizer, Gyp displays a splendid synergistic effect with 5-Fu to inhibit cancer cell proliferation and tumor growth. By using 5-Fu and Gyp in combination would be a promising therapeutic strategy for CRC treatment.	[Kong, Lulu; Wang, Xiaobing; Zhang, Kun; Yuan, Wenjuan; Yang, Qiwen; Fan, Jianping; Wang, Pan; Liu, Quanhong] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Shaanxi, Peoples R China	Shaanxi Normal University	Wang, P (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Shaanxi, Peoples R China.	wangpan@snnu.edu.cn						Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen JC, 2006, ANTICANCER RES, V26, P4313; Chen JC, 2009, ORAL ONCOL, V45, P273, DOI 10.1016/j.oraloncology.2008.05.012; Chen MH, 2008, J ETHNOPHARMACOL, V117, P309, DOI 10.1016/j.jep.2008.02.009; Chiranthanut N, 2013, J ETHNOPHARMACOL, V149, P228, DOI 10.1016/j.jep.2013.06.027; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Circosta C, 2005, PHYTOMEDICINE, V12, P638, DOI 10.1016/j.phymed.2004.06.023; Colin DJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.486; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Fishbein AB, 2009, ARCH PHARM RES, V32, P505, DOI 10.1007/s12272-009-1405-9; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Hayano S, 2015, DEVELOPMENT, V142, P1357, DOI 10.1242/dev.118802; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Ijichi K, 2014, ANTICANCER RES, V34, P2907; Johnson KR, 1997, CLIN CANCER RES, V3, P1739; Johnston PG, 2001, ANTI-CANCER DRUG, V12, P639, DOI 10.1097/00001813-200109000-00001; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lin JJ, 2011, PHYTOMEDICINE, V18, P1075, DOI 10.1016/j.phymed.2011.03.009; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lu KW, 2012, INTEGR CANCER THER, V11, P129, DOI 10.1177/1534735411403306; Megalli S, 2005, J PHARM PHARM SCI, V8, P507; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Quan Y, 2015, MOL MED REP, V11, P2845, DOI 10.3892/mmr.2014.3095; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Santandreu FM, 2011, CELL PHYSIOL BIOCHEM, V28, P219, DOI 10.1159/000331733; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Su XM, 2014, DRUG CHEM TOXICOL, V37, P348, DOI 10.3109/01480545.2013.866135; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tudek B, 2010, AM J TRANSL RES, V2, P254; Wang QF, 2002, CANCER LETT, V183, P169, DOI 10.1016/S0304-3835(01)00828-X; Wang QF, 2007, PLANTA MED, V73, P535, DOI 10.1055/s-2007-967200; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yan H, 2014, HUM EXP TOXICOL, V33, P522, DOI 10.1177/0960327113497771; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095609; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551	43	43	43	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137888	10.1371/journal.pone.0137888	http://dx.doi.org/10.1371/journal.pone.0137888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368019	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100168
J	Nao, N; Kajihara, M; Manzoor, R; Maruyama, J; Yoshida, R; Muramatsu, M; Miyamoto, H; Igarashi, M; Eguchi, N; Sato, M; Kondoh, T; Okamatsu, M; Sakoda, Y; Kida, H; Takada, A				Nao, Naganori; Kajihara, Masahiro; Manzoor, Rashid; Maruyama, Junki; Yoshida, Reiko; Muramatsu, Mieko; Miyamoto, Hiroko; Igarashi, Manabu; Eguchi, Nao; Sato, Masahiro; Kondoh, Tatsunari; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kida, Hiroshi; Takada, Ayato			A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains	PLOS ONE			English	Article							MATRIX PROTEIN; A VIRUS; NUCLEAR TRANSPORT; HONG-KONG; RNA; EXPRESSION; VIRULENCE; WATERFOWL; RIBONUCLEOPROTEINS; PHOSPHORYLATION	Two highly pathogenic avian influenza virus strains, A/duck/Hokkaido/WZ83/2010 ( H5N1) (WZ83) and A/duck/Hokkaido/WZ101/2010 (H5N1) (WZ101), which were isolated from wild ducks in Japan, were found to be genetically similar, with only two amino acid differences in their M1 and PB1 proteins at positions 43 and 317, respectively. We found that both WZ83 and WZ101 caused lethal infection in chickens but WZ101 killed them more rapidly than WZ83. Interestingly, ducks experimentally infected with WZ83 showed no or only mild clinical symptoms, whereas WZ101 was highly lethal. We then generated reassortants between these viruses and found that exchange of the M gene segment completely switched the pathogenic phenotype in both chickens and ducks, indicating that the difference in the pathogenicity for these avian species between WZ83 and WZ101 was determined by only a single amino acid in the M1 protein. It was also found that WZ101 showed higher pathogenicity than WZ83 in mice and that WZ83, whose M gene was replaced with that of WZ101, showed higher pathogenicity than wild-type WZ83, although this reassortant virus was not fully pathogenic compared to wild-type WZ101. These results suggest that the amino acid at position 43 of the M1 protein is one of the factors contributing to the pathogenicity of H5N1 highly pathogenic avian influenza viruses in both avian and mammalian hosts.	[Nao, Naganori; Kajihara, Masahiro; Manzoor, Rashid; Maruyama, Junki; Yoshida, Reiko; Muramatsu, Mieko; Miyamoto, Hiroko; Igarashi, Manabu; Eguchi, Nao; Sato, Masahiro; Kondoh, Tatsunari; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Okamatsu, Masatoshi; Sakoda, Yoshihiro] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Hokkaido University; Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Kajihara, Masahiro/AAF-5724-2020; Maruyama, Junki/H-7993-2013; Maruyama, Junki/M-4735-2019; Igarashi, Manabu/F-6871-2012; Manzoor, Rashid/ABB-8209-2020; YOSHIDA, Reiko/F-6883-2012	Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; 	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); KAKENHI; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS)	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency (JICA) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS)	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.amed.go.jp/en/), KAKENHI (https://www.jsps.go.jp/english/index.html), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/), and partly by the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/index.html) and Japan International Cooperation Agency (JICA) (http://www.jica.go.jp/english/index.html) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS) (http://www.jst.go.jp/global/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2013, MOL IMMUNOL, V56, P358, DOI 10.1016/j.molimm.2013.05.236; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Campbell PJ, 2014, J VIROL, V88, P7569, DOI 10.1128/JVI.00119-14; Centers for Disease C Prevention., 1997, ISOLATION AVIAN INFL, V46, P1204; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; GREEN IJ, 1962, SCIENCE, V138, P42, DOI 10.1126/science.138.3536.42; Halder UC, 2013, J BIOL CHEM, V288, P14554, DOI 10.1074/jbc.M112.447086; Hatta M, 2001, PHILOS T R SOC B, V356, P1841, DOI 10.1098/rstb.2001.1000; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang XY, 2001, VIROLOGY, V287, P405, DOI 10.1006/viro.2001.1067; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Kajihara M, 2011, JPN J VET RES, V59, P89; KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9; KIDA H, 1980, INFECT IMMUN, V30, P547; Kishida N, 2005, ARCH VIROL, V150, P1383, DOI 10.1007/s00705-004-0473-x; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Donnell CD, 2014, J VIROL, V88, P12374, DOI 10.1128/JVI.01107-14; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; ROTT R, 1982, VIROLOGY, V120, P215, DOI 10.1016/0042-6822(82)90019-8; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P26, DOI 10.1111/irv.12077; WAKEFIELD L, 1989, NUCLEIC ACIDS RES, V17, P8569, DOI 10.1093/nar/17.21.8569; Wang SS, 2013, J VIROL, V87, P6182, DOI 10.1128/JVI.03024-12; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WHITTAKER G, 1995, J VIROL, V69, P439, DOI 10.1128/JVI.69.1.439-445.1995; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; YE ZP, 1989, J VIROL, V63, P3586, DOI 10.1128/JVI.63.9.3586-3594.1989; ZIMMERMANN T, 1960, VIROLOGY, V11, P676, DOI 10.1016/0042-6822(60)90114-8	47	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137989	10.1371/journal.pone.0137989	http://dx.doi.org/10.1371/journal.pone.0137989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368015	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100196
J	Raba, DN; Poiana, MA; Borozan, AB; Stef, M; Radu, F; Popa, MV				Raba, Diana Nicoleta; Poiana, Mariana-Atena; Borozan, Aurica Breica; Stef, Marius; Radu, Florina; Popa, Mirela-Viorica			Investigation on Crude and High-Temperature Heated Coffee Oil by ATR-FTIR Spectroscopy along with Antioxidant and Antimicrobial Properties	PLOS ONE			English	Article							TRANSFORM-INFRARED-SPECTROSCOPY; EDIBLE OILS; OXIDATIVE STABILITY; FATTY-ACIDS; LIPID FRACTION; DITERPENES; ABSORBENCY; DPPH; EXTRACTION; SPECTRA	The coffee oil has a promising potential to be used in food industry, but an efficient use, especially in products that required high-temperature heating, depends on its chemical composition and the changes induced by processing. Since there is little information on this topic, the aim of our study was to investigate the crude green and roasted coffee oil (GCO, RCO) and heated (HGCO, HRCO) for 1 h at 200 degrees C, by Fourier Transform Infrared (FTIR) spectroscopy and in terms of antioxidant and antimicrobial properties. The results of FTIR spectroscopy revealed that no statistically significant differences (one-way ANOVA, p>0.05) in the oxidative status of GCO and RCO were found. The coffee oils heating induced significant spectral changes in the regions 3100-3600 cm(-1), 2800-3050 cm(-1) and 1680-1780 cm(-1) proved by the differences in the absorbance ratios A 3009 cm(-1)/A 2922 cm(-1), A 3009 cm(-1)/A 2853 cm(-1), A 3009 cm(-1)/A 1744 cm(-1), A 1744 cm(-1)/A 2922 cm(-1). These alterations were related to the reduction of the unsaturation degree due to primary and secondary oxidation processes of the lipid fraction. The radical scavenging ability of oils investigated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay revealed that the IC50 value of GCO was significantly lower than of RCO (p<0.05). The IC50 values of crude coffee oils were lower than those of heated samples. The antioxidant activity of oils was attributed to both antioxidant compounds with free-radical scavenging capacity and to lipids oxidation products generated by heating. In the first 6 h of incubation, the inhibitory activity of crude oils against E. coli and E. faecalis was not significantly different to the control (p>0.05). Also, HGCO and HRCO showed significantly different inhibitory potential related to the control (p<0.05). The heating induced statistically significant decreases in the effectiveness of coffee oils against the tested bacteria. GCO proved to be the most effective among investigated coffee oils against the tested bacteria.	[Raba, Diana Nicoleta; Poiana, Mariana-Atena; Radu, Florina; Popa, Mirela-Viorica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Timisoara 300645, Romania; [Borozan, Aurica Breica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Hort & Forestry, Timisoara 300645, Romania; [Stef, Marius] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; West University of Timisoara	Poiana, MA (corresponding author), Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Calea Aradului 119, Timisoara 300645, Romania.	atenapoiana@yahoo.com	poiana, atena mariana/AAJ-9409-2020; radu, florina/AAO-8169-2021; Poiana, Mariana Atena/N-1152-2013; Stef, Marius/D-2170-2014; radu, florina/U-8575-2017; Stef, Marius/J-1623-2019	poiana, atena mariana/0000-0002-4774-4440; Stef, Marius/0000-0002-1750-0082	SUPREMIA GRUP SRL from Romania [2029/2015]	SUPREMIA GRUP SRL from Romania	The authors of this paper gratefully acknowledge the financial support in the performing of this study by SUPREMIA GRUP SRL from Romania, leader in the Romanian food ingredients, on the basis of research project No. 2029/2015, entitled: "Development of some bakery premixes based on dried fruits with high sensory and nutritional properties". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AMR, 2000, GRASAS ACEITES, V51, P74; Amarowicz R, 2009, EUR J LIPID SCI TECH, V111, P109, DOI 10.1002/ejlt.200900011; Ambrosio SR, 2008, Z NATURFORSCH C, V63, P326; American Oil Chemists' Society [AOCS], 2017, OFFICIAL METHODS REC, V7th; Anese M, 2000, ITAL J FOOD SCI, V12, P457; de Oliveira PMA, 2014, J SUPERCRIT FLUID, V95, P137, DOI 10.1016/j.supflu.2014.08.016; Bach D, 2001, BBA-BIOMEMBRANES, V1514, P318, DOI 10.1016/S0005-2736(01)00388-1; Cammerer B, 2006, EUR FOOD RES TECHNOL, V223, P469, DOI 10.1007/s00217-005-0226-4; Calligaris S, 2009, EUR J LIPID SCI TECH, V111, P1270, DOI 10.1002/ejlt.200900042; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; CLSI, 2011, M100S20 CLSI, P172; Czerny M, 2000, J AGR FOOD CHEM, V48, P868, DOI 10.1021/jf990609n; Dias RCE, 2014, EUR FOOD RES TECHNOL, V239, P961, DOI 10.1007/s00217-014-2293-x; Falade Ayodeji Osmund, 2015, Int J Food Sci, V2015, P806524, DOI 10.1155/2015/806524; Ferrari M, 2010, COLLOID SURFACE A, V365, P79, DOI 10.1016/j.colsurfa.2010.02.002; Frascareli EC, 2012, FOOD BIOPROD PROCESS, V90, P413, DOI 10.1016/j.fbp.2011.12.002; Gichimu B. M., 2014, Journal of Food Research, V3, P31; Guillen MD, 2005, J AGR FOOD CHEM, V53, P1093, DOI 10.1021/jf0489062; Guillen MD, 1998, J AGR FOOD CHEM, V46, P1788, DOI 10.1021/jf9705274; Guillen MD, 2002, FOOD CHEM, V77, P503, DOI 10.1016/S0308-8146(01)00371-5; Gutierrez D, 2012, APPL ENVIRON MICROB, V78, P8547, DOI 10.1128/AEM.02045-12; HARTMAN L, 1968, J AM OIL CHEM SOC, V45, P577, DOI 10.1007/BF02667175; Hashim L, 1995, FOOD RES INT, V28, P619, DOI 10.1016/0963-9969(95)00037-2; Herrera FC, 2006, J APPL MICROBIOL, V100, P527, DOI 10.1111/j.1365-2672.2005.02848.x; Jeong MK, 2012, J AM OIL CHEM SOC, V89, P1831, DOI 10.1007/s11746-012-2088-9; Jovic O, 2013, CROAT CHEM ACTA, V86, P335, DOI 10.5562/cca2377; Lago R. C. A., 2001, Boletim do Centro de Pesquisa e Processamento de Alimentos, V19, P319; Lee J, 2007, FOOD CHEM, V103, P662, DOI 10.1016/j.foodchem.2006.07.052; Wagemaker TAL, 2011, IND CROP PROD, V33, P469, DOI 10.1016/j.indcrop.2010.10.026; Martinez-Yusta M, 2014, COMPREHENSIVE REV FO, V13, P38; Moharam MA, 2010, AFR J MICROBIOL RES, V4, P1921; Moreno MCMM, 1999, TALANTA, V50, P269, DOI 10.1016/S0039-9140(99)00034-X; Nicoli MC, 1997, FOOD SCI TECHNOL-LEB, V30, P292, DOI 10.1006/fstl.1996.0181; Oliveira AL, 2011, CIENCIA TECNOLOGIA A, V25, P677; Ramadan MF, 2006, J FOOD COMPOS ANAL, V19, P838, DOI 10.1016/j.jfca.2006.02.013; RAVINDRANATH R, 1972, J SCI FOOD AGR, V23, P307, DOI 10.1002/jsfa.2740230306; Rohman A., 2011, International Food Research Journal, V18, P303; SAS Institute Inc, 2000, SAS WIND; Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014; Toci AT, 2013, LWT-FOOD SCI TECHNOL, V50, P581, DOI 10.1016/j.lwt.2012.08.007; Tsukui A, 2014, FOOD CHEM, V164, P266, DOI 10.1016/j.foodchem.2014.05.039; VANDEVOORT FR, 1994, J AM OIL CHEM SOC, V71, P243, DOI 10.1007/BF02638049; Pereda MDV, 2009, J COSMET DERMATOL-US, V8, P56, DOI 10.1111/j.1473-2165.2009.00425.x; Vila MA, 2005, J AM OIL CHEM SOC, V82, P639, DOI 10.1007/s11746-005-1122-1; Vlachos N, 2006, ANAL CHIM ACTA, V573, P459, DOI 10.1016/j.aca.2006.05.034; Wagemaker T.A.L., 2012, BIOMED BIOPHARM RES, V9, P207; Wang SJ, 2007, FEMS IMMUNOL MED MIC, V51, P8, DOI 10.1111/j.1574-695X.2007.00305.x; Yeo J, 2012, FOOD SCI BIOTECHNOL, V21, P199, DOI 10.1007/s10068-012-0025-1; Yeo J, 2010, FOOD SCI BIOTECHNOL, V19, P253, DOI 10.1007/s10068-010-0036-8; YOSHIDA H, 1992, J AM OIL CHEM SOC, V69, P119, DOI 10.1007/BF02540560	50	26	27	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138080	10.1371/journal.pone.0138080	http://dx.doi.org/10.1371/journal.pone.0138080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366731	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100217
J	Sumner-Rooney, LH; Sigwart, JD				Sumner-Rooney, Lauren H.; Sigwart, Julia D.			Is the Schwabe Organ a Retained Larval Eye? Anatomical and Behavioural Studies of a Novel Sense Organ in Adult Leptochiton asellus (Mollusca, Polyplacophora) Indicate Links to Larval Photoreceptors	PLOS ONE			English	Article							NERVOUS-SYSTEM; NEURONS; LEPIDOPLEURIDA; METAMORPHOSIS; MORPHOLOGY; PATHWAYS	The discovery of a sensory organ, the Schwabe organ, was recently reported as a unifying feature of chitons in the order Lepidopleurida. It is a patch of pigmented tissue located on the roof of the pallial cavity, beneath the velum on either side of the mouth. The epithelium is densely innervated and contains two types of potential sensory cells. As the function of the Schwabe organ remains unknown, we have taken a cross-disciplinary approach, using anatomical, histological and behavioural techniques to understand it. In general, the pigmentation that characterises this sensory structure gradually fades after death; however, one particular concentrated pigment dot persists. This dot is positionally homologous to the larval eye in chiton trochophores, found in the same neuroanatomical location, and furthermore the metamorphic migration of the larval eye is ventral in species known to possess Schwabe organs. Here we report the presence of a discrete subsurface epithelial structure in the region of the Schwabe organ in Leptochiton asellus that histologically resembles the chiton larval eye. Behavioural experiments demonstrate that Leptochiton asellus with intact Schwabe organs actively avoid an upwelling light source, while Leptochiton asellus with surgically ablated Schwabe organs and a control species lacking the organ (members of the other extant order, Chitonida) do not (Kruskal-Wallis, H = 24.82, df = 3, p < 0.0001). We propose that the Schwabe organ represents the adult expression of the chiton larval eye, being retained and elaborated in adult lepidopleurans.	[Sumner-Rooney, Lauren H.; Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Sumner-Rooney, Lauren H.; Sigwart, Julia D.] Queens Univ Belfast, Queens Marine Lab, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Sumner-Rooney, LH (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	lsumnerrooney01@qub.ac.uk	Sigwart, Julia/J-2928-2014	Sigwart, Julia/0000-0002-3005-6246; Sumner-Rooney, Lauren/0000-0003-0196-5069	DEL Northern Ireland	DEL Northern Ireland	The authors received no specific funding for this work. A PhD studentship for LHSR was provided by DEL Northern Ireland (http://www.delni.gov.uk). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1920, AM NAT, V54, P376; Arey LB, 1919, J EXP ZOOL, V29, P157, DOI 10.1002/jez.1400290203; BOYLE P R, 1972, Marine Behaviour and Physiology, V1, P171; Boyle P.R., 1977, Oceanography mar Biol, V15, P461; BOYLE PR, 1974, CELL TISSUE RES, V153, P383; CHRISTIANSEN MARIT ELLEN, 1954, NYTT MAG ZOOL [OSLO], V2, P52; FISCHER F P, 1978, Spixiana, V1, P209; FISCHER F P, 1980, Spixiana, V3, P53; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Giraudoux P., 2013, PGIRMESS DATA ANAL E; HASZPRUNAR G, 1987, PHILOS T R SOC B, V315, P37, DOI 10.1098/rstb.1987.0002; HASZPRUNAR G, 1992, B ZOOL, V59, P1, DOI 10.1080/11250009209386641; Heath H., 1904, Proceedings of the Academy Philadelphia, P257; Kowalevsky MA., 1883, ANN DU MUSEUM DHISTO, pT1; Lord JP, 2011, J MOLLUS STUD, V77, P182, DOI 10.1093/mollus/eyr004; Naef A., 1926, ERGEBNISSE FORTSCHRI, P28; OMELICH PAUL, 1967, VELIGER, V10, P77; Pearse J.S., 1979, P27; R Core Team, 2013, R LANGUAGE ENV STAT; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; ROSEN MD, 1979, VELIGER, V22, P173; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Shepherd D, 1996, DEVELOPMENT, V122, P2375; Sigwart JD, 2015, STRUCTURE EVOLUTION; Sigwart JD, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-7; Sigwart JD, 2010, INVERTEBR SYST, V24, P560, DOI 10.1071/IS10028; Sigwart JD, 2009, J NAT HIST, V43, P447, DOI 10.1080/00222930802604157; Speiser DI, 2011, CURR BIOL, V21, P665, DOI 10.1016/j.cub.2011.03.033; Usui-Ishihara A, 2000, DEV BIOL, V225, P357, DOI 10.1006/dbio.2000.9838; Voronezhskaya EE, 2002, J COMP NEUROL, V444, P25, DOI 10.1002/cne.10130; Williams DW, 1999, J NEUROBIOL, V39, P275, DOI 10.1002/(SICI)1097-4695(199905)39:2<275::AID-NEU11>3.0.CO;2-0	31	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137119	10.1371/journal.pone.0137119	http://dx.doi.org/10.1371/journal.pone.0137119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366861	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100050
J	Sundin, J; Rangel, I; Repsilber, D; Brummer, RJ				Sundin, Johanna; Rangel, Ignacio; Repsilber, Dirk; Brummer, Robert-Jan			Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; DYSFUNCTION; ACTIVATION; BUTYRATE; COLITIS; CELLS; GUT	Background Microbial dysbiosis and prolonged immune activation resulting in low-grade inflammation and intestinal barrier dysfunction have been suggested to be underlying causes of post-infectious irritable bowel syndrome (PI-IBS). The aim of this study was to evaluate the difference in cytokine response between mucosal specimens of PI-IBS patients and healthy controls (HC) after ex vivo stimulation with key anaerobic bacteria. Methods Colonic biopsies from 11 PI-IBS patients and 10 HC were stimulated ex vivo with the commensal bacteria Bacteroides ovatus, Ruminococcus gnavus, Akkermansia muciniphila, Subdoligranulum variabile and Eubacterium limosum, respectively. The cytokine release (IL-1 beta, IL-2, IL-8, IL-10, IL-13, IL-17, TNF-alpha and IFN-gamma) in stimulation supernatants was analyzed using the LUMINEX assay. Comparison of cytokine release between PI-IBS patients and healthy controls was performed taking both unstimulated and bacterially stimulated mucosal specimens into account. Key Results IL-13 release from mucosal specimens without bacterial stimulation was significantly lower in PI-IBS patients compared to HC (p < 0.05). After stimulation with Subdoligranulum variabile, IL-1 beta release from PI-IBS patients was significantly increased compared to HC (p < 0.05). Stimulation with Eubacterium limosum resulted in a significantly decreased IL-10 release in HC compared to PI-IBS patients (p < 0.05) and a tendency to decreased IL-13 release in HC compared to PI-IBS patients (p = 0.07). Conclusions & Inferences PI-IBS patients differ from HC with regard to cytokine release ex vivo after stimulation with selected commensal bacteria. Hence, our results support that the pathogenesis of PI-IBS comprises an altered immune response against commensal gut microbes.	[Sundin, Johanna; Rangel, Ignacio; Repsilber, Dirk; Brummer, Robert-Jan] Univ Orebro, Fac Med & Hlth, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden	Orebro University	Sundin, J (corresponding author), Univ Orebro, Fac Med & Hlth, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.	Johanna.sundin@oru.se			Medical Faculty, Orebro University	Medical Faculty, Orebro University	Johanna Sundin is supported by a grant from the Medical Faculty, Orebro University.	[Anonymous], 2014, COMP FIS; Barbara G, 2012, J CLIN GASTROENTEROL, V46, pS52, DOI 10.1097/MCG.0b013e318264e918; Belmonte L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042777; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Brint EK, 2011, AM J GASTROENTEROL, V106, P329, DOI 10.1038/ajg.2010.438; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Darkoh C, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093144, DOI 10.1371/J0URNAL.P0NE.0093144]; Degnan BA, 1997, CURR MICROBIOL, V34, P290, DOI 10.1007/s002849900184; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; FALK P, 1990, J BIOCHEM-TOKYO, V108, P466, DOI 10.1093/oxfordjournals.jbchem.a123223; Guilarte M, 2007, GUT, V56, P203, DOI 10.1136/gut.2006.100594; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994; Kanauchi O, 2006, WORLD J GASTROENTERO, V12, P1071, DOI 10.3748/wjg.v12.i7.1071; Kanauchi O, 2010, INT J MOL MED, V25, P547, DOI 10.3892/ijmm_00000376; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P389, DOI 10.1111/j.1365-2982.2008.01220.x; Kumawat AK, 2013, J CROHNS COLITIS, V7, P694, DOI [10.1016/j.crohns.2013.04.019, 10.1016/j.crohns.2012.08.014]; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marshall JK, 2004, ALIMENT PHARM THER, V20, P1317, DOI 10.1111/j.1365-2036.2004.02284.x; Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305; Matsuoka K, 2014, SEMIN IMMUNOPATHOL; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Lucas MO, 2010, REV ESP ENFERM DIG, V102, P637; Ouwerkerk JP, 2013, BEST PRACT RES CL GA, V27, P25, DOI 10.1016/j.bpg.2013.03.001; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Rinttila T, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-6; Rodriguez-Fandino O, 2013, NEUROGASTROENT MOTIL, V25, P872, DOI 10.1111/nmo.12204; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Spiller RC, 2004, BEST PRACT RES CL GA, V18, P641, DOI 10.1016/j.bpg.2004.04.002; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Sundin J, 2015, ALIMENT PHARM THER, V41, P342, DOI 10.1111/apt.13055; Sundin J, 2014, SCAND J GASTROENTERO, V49, P1068, DOI 10.3109/00365521.2014.926982	36	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0134836	10.1371/journal.pone.0134836	http://dx.doi.org/10.1371/journal.pone.0134836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366730	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100007
J	Adams, R; Nicke, B; Pohlenz, HD; Sohler, F				Adams, Robert; Nicke, Barbara; Pohlenz, Hans-Dieter; Sohler, Florian			Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin Expression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; GENE-EXPRESSION; ZEB1; EMT; GROWTH; MYB; IDENTIFICATION; TRANSCRIPTS; ACTIVATION	Functional RNAi based screening is affected by large numbers of false positive and negative hits due to prevalent sequence based off-target effects. We performed a druggable genome targeting siRNA screen intended to identify novel regulators of E-cadherin (CDH1) expression, a known key player in epithelial mesenchymal transition (EMT). Analysis of primary screening results indicated a large number of false-positive hits. To address these crucial difficulties we developed an analysis method, SENSORS, which, similar to published methods, is a seed enrichment strategy for analyzing siRNA off-targets in RNAi screens. Using our approach, we were able to demonstrate that accounting for seed based off-target effects stratifies primary screening results and enables the discovery of additional screening hits. While traditional hit detection methods are prone to false positive results which are undetected, we were able to identify false positive hits robustly. Transcription factor MYBL1 was identified as a putative novel target required for CDH1 expression and verified experimentally. No siRNA pool targeting MYBL1 was present in the used siRNA library. Instead, MYBL1 was identified as a putative CDH1 regulating target solely based on the SENSORS off-target score, i.e. as a gene that is a cause for off-target effects down regulating E-cadherin expression.	[Adams, Robert; Nicke, Barbara; Pohlenz, Hans-Dieter; Sohler, Florian] Bayer Pharma AG, BPH GDD GTRG CIPL, D-13353 Berlin, Germany; [Adams, Robert] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Humboldt University of Berlin	Adams, R (corresponding author), Bayer Pharma AG, BPH GDD GTRG CIPL, Muellerstr 178, D-13353 Berlin, Germany.	robert.adams@bayer.com		Sohler, Florian/0000-0003-4276-0238	Bayer Pharma AG	Bayer Pharma AG	Bayer Pharma AG provided support for this work in the form of salaries for authors RA, BN, HDP and FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Ellenrieder V, 2001, CANCER RES, V61, P4222; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson MC, 2011, MOL CANCER RES, V9, P724, DOI 10.1158/1541-7786.MCR-10-0436; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Muta H, 1996, JPN J CANCER RES, V87, P843, DOI 10.1111/j.1349-7006.1996.tb02109.x; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schmidt CR, 2004, SURGERY, V136, P303, DOI 10.1016/j.surg.2004.05.004; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Swanton C, 2007, CELL CYCLE, V6, P2001, DOI 10.4161/cc.6.16.4538; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wickham H., 2009, ELEGANT GRAPHICS FOR	43	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137640	10.1371/journal.pone.0137640	http://dx.doi.org/10.1371/journal.pone.0137640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361354	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100061
J	Levy, DE; Adamkiewicz, G; Rigotti, NA; Fang, SC; Winickoff, JP				Levy, Douglas E.; Adamkiewicz, Gary; Rigotti, Nancy A.; Fang, Shona C.; Winickoff, Jonathan P.			Changes in Tobacco Smoke Exposure following the Institution of a Smoke-Free Policy in the Boston Housing Authority	PLOS ONE			English	Article							SECONDHAND SMOKE; NICOTINE; COTININE; US	Introduction To protect residents from tobacco smoke exposure (TSE), the Boston Housing Authority (BHA) prohibited smoking in BHA-owned apartments beginning in 2012. Our goal was to determine if the smoke-free policy reduced TSE for non-smoking BHA residents. Methods We compared TSE before the smoke-free policy (2012) and one year later among BHA residents as well as residents of the neighboring Cambridge Housing Authority (CHA) where no such policy was in place. Participants were a convenience sample of adult non-smoking BHA and CHA residents cohabitating with only non-smokers. Main outcomes were 7-day airborne nicotine in participants' apartments; residents' saliva cotinine; and residents' self-reported TSE. Results We enrolled 287 confirmed non-smokers (192 BHA, 95 CHA). Seventy-nine percent (229) were assessed at follow-up. At baseline, apartment and resident TSE were high in both housing authorities (detectable airborne nicotine: 46% BHA, 48% CHA; detectable saliva cotinine: 49% BHA, 70% CHA). At follow-up there were significant but similar declines in nicotine in both sites (detectable: -33% BHA, -39% CHA, p = 0.40). Detectable cotinine rose among BHA residents while declining among CHA participants (+17% BHA vs. -13% CHA, p = 0.002). Resident self-reported TSE within and outside of the housing environment decreased similarly for both BHA and CHA residents. Conclusions Apartment air nicotine decreased after the introduction of the smoke-free policy, though the decline may not have resulted from the policy. The BHA policy did not result in reduced individual-level TSE. Unmeasured sources of non-residential TSE may have contributed to BHA residents' cotinine levels.	[Levy, Douglas E.; Rigotti, Nancy A.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Levy, Douglas E.; Rigotti, Nancy A.; Winickoff, Jonathan P.] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Levy, Douglas E.; Rigotti, Nancy A.; Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA USA; [Adamkiewicz, Gary; Fang, Shona C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Fang, Shona C.] New England Res Inst, Watertown, MA 02172 USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp Children, Div Gen Pediat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; HealthCore, Inc	Levy, DE (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA.	dlevy3@mgh.harvard.edu	Levy, Douglas/W-1516-2019	Levy, Douglas/0000-0001-9446-7899	National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL112212]; Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112212] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: Support was provided by the National Institutes of Health/National Heart, Lung, and Blood Institute R01-HL112212 (www.nhlbi.nih.gov) to DEL, GA, NAR, SCF, and JPW; and by the Flight Attendants Medical Research Institute (www.famri.org) to DEL. Neither funder had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Heating Refrigerating and Air- Conditioning Engineers, 2013, ASHRAE POS DOC ENV T; Arku RE, 2015, INDOOR AIR, V25, P13, DOI 10.1111/ina.12121; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Fargen J., 2010, BOSTON HERALD   0131; HAMMOND SK, 1987, ATMOS ENVIRON, V21, P457, DOI 10.1016/0004-6981(87)90027-8; HAMMOND SK, 1987, ENVIRON SCI TECHNOL, V21, P494, DOI 10.1021/es00159a012; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Kraev TA, 2009, TOB CONTROL, V18, P438, DOI 10.1136/tc.2009.029728; Levy D, 2010, COMMUNICATION; Levy DE, 2013, AM J PREV MED, V44, P63, DOI 10.1016/j.amepre.2012.09.048; Matt GE, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037382; Max W, 2009, INT J ENV RES PUB HE, V6, P1633, DOI 10.3390/ijerph6051633; MIESNER EA, 1989, JAPCA J AIR WASTE MA, V39, P1577, DOI 10.1080/08940630.1989.10466652; National Center for Health in Public Housing, DEM FACTS RES LIV PU; [Office on Smoking and Health U. S. Department of Health and Human Services], 2006, HLTH CONS INV EXP TO; Pion M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2003.005447; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Russo ET, 2015, NICOTINE TOB RES, V17, P316, DOI 10.1093/ntr/ntu146; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; U. S. Environmental Protection Agency, 2010, BLOOD COT LEV 2010; US Department of Housing and Urban Development, 2009, NONSM POL PUBL HOUS; US Department of Housing and Urban Development, HUDS PUBL HOUS PROGR; US Surgeon General, 2014, HLTH CONS SMOK 50 YE; Wilson KM, 2011, PEDIATRICS, V127, P85, DOI 10.1542/peds.2010-2046	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137740	10.1371/journal.pone.0137740	http://dx.doi.org/10.1371/journal.pone.0137740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360258	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100078
J	Marco, EM; Rapino, C; Caprioli, A; Borsini, F; Laviola, G; Maccarrone, M				Marco, Eva M.; Rapino, Cinzia; Caprioli, Antonio; Borsini, Franco; Laviola, Giovanni; Maccarrone, Mauro			Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ELEVATED PLUS-MAZE; ENDOCANNABINOID SYSTEM; REVERSIBLE INHIBITORS; ANIMAL-MODELS; BEHAVIOR; CANNABINOIDS; STRESS; URB597; ANANDAMIDE	Anxiety disorders are among the most prevalent psychiatric diseases with high personal costs and a remarkable socio-economic burden. However, current treatment of anxiety is far from satisfactory. Novel pharmacological targets have emerged in the recent years, and attention has focused on the endocannabinoid (eCB) system, given the increasing evidence that supports its central role in emotion, coping with stress and anxiety. In the management of anxiety disorders, drug development strategies have left apart the direct activation of type-1 cannabinoid receptors to indirectly enhance eCB signalling through the inhibition of eCB deactivation, that is, the inhibition of the fatty acid amide hydrolase (FAAH) enzyme. In the present study, we provide evidence for the anxiolytic-like properties of a novel, potent and selective reversible inhibitor of FAAH, ST4070, orally administered to rodents. ST4070 (3 to 30 mg/kg per os) administered to CD1 male mice induced an increase of time spent in the exploration of the open arms of the elevated-plus maze. A partial reduction of anxiety-related behaviour by ST4070 was also obtained in Wistar male rats, which moderately intensified the time spent in the illuminated compartment of the light-dark box. ST4070 clearly inhibited FAAH activity and augmented the levels of two of its substrates, N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine, in anxiety-relevant brain regions. Altogether, ST4070 offers a promising anxiolytic-like profile in preclinical studies, although further studies are warranted to clearly demonstrate its efficacy in the clinic management of anxiety disorders.	[Marco, Eva M.; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Rapino, Cinzia] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Caprioli, Antonio; Borsini, Franco] Sigma Tau R&D, Pomezia, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Rome, Italy; [Maccarrone, Mauro] Fdn Santa Lucia, IRCCS, CERC, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Teramo; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia	Laviola, G (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it; m.maccarrone@unicampus.it	Laviola, Giovanni/K-4392-2016; Laviola, Giovanni/AAA-2391-2022; Maccarrone, Mauro/K-5398-2012; Marco, Eva M./ABH-3257-2020; Marco, Eva M./Q-3870-2019; Lodola, Alessio/H-9078-2013	Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Maccarrone, Mauro/0000-0002-3990-2963; Marco, Eva M./0000-0002-2457-475X; Lodola, Alessio/0000-0002-8675-1002	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This investigation was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2010-2011 grant to MM). EMM was a postdoctoral fellow from the Spanish "Ministerio de Ciencia e Innovacion (MCINN)" - ref. 2008-0489. The authors declare a commercial affiliation with the Drug Company ALFASIGMA (actual name for Sigma-Tau). Further, the authors declare that the funding organization did provide some research material and did play a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Further, at the time the study was performed, the following authors (Dr. Franco Borsini and Dr. Antonio Caprioli) were employed at the Sigma-Tau (IT).	Ahn K, 2009, EXPERT OPIN DRUG DIS, V4, P763, DOI 10.1517/17460440903018857; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Batista LA, 2014, BEHAV PHARMACOL, V25, P425, DOI 10.1097/FBP.0000000000000073; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gattinoni S, 2010, BIOORG MED CHEM LETT, V20, P4406, DOI 10.1016/j.bmcl.2010.06.050; Gattinoni S, 2010, CHEMMEDCHEM, V5, P357, DOI 10.1002/cmdc.200900472; Haller J, 2014, PSYCHOPHARMACOLOGY, V231, P593, DOI 10.1007/s00213-013-3273-8; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Keith JM, 2008, BIOORG MED CHEM LETT, V18, P4838, DOI 10.1016/j.bmcl.2008.07.081; KILFOIL T, 1989, NEUROPHARMACOLOGY, V28, P901, DOI 10.1016/0028-3908(89)90188-3; Kinden R, 2015, BEHAV BRAIN RES, V284, P225, DOI 10.1016/j.bbr.2015.02.025; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Kwilasz AJ, 2014, BEHAV PHARMACOL, V25, P119, DOI 10.1097/FBP.0000000000000023; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Maccarrone M, 2014, NAT REV NEUROSCI, V15, P786, DOI 10.1038/nrn3846; Marco EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00063; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Milian MJ, 2015, EUR NEUROPSYCHOPHARM, V25, P599, DOI 10.1016/j.euroneuro.2015.01.016; Moise AM, 2008, PSYCHOPHARMACOLOGY, V200, P333, DOI 10.1007/s00213-008-1209-5; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Okamoto Y, 2009, VITAM HORM, V81, P1, DOI 10.1016/S0083-6729(09)81001-7; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00098; Rutkowska M, 2006, PHARMACOL REP, V58, P200; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Viveros Maria-Paz, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/52908; Viveros MP, 2005, PHARMACOL BIOCHEM BE, V81, P331, DOI 10.1016/j.pbb.2005.01.029; YOUNG R, 1991, PHARMACOL BIOCHEM BE, V40, P739, DOI 10.1016/0091-3057(91)90078-G	51	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137034	10.1371/journal.pone.0137034	http://dx.doi.org/10.1371/journal.pone.0137034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360704	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000361043100021
J	Resni, N; Repnik, U; Kreft, ME; Sepcic, K; Macek, P; Turk, B; Veranic, P				Resni, Natasa; Repnik, Urska; Kreft, Mateja Erdani; Sepcic, Kristina; Macek, Peter; Turk, Boris; Veranic, Peter			Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-beta-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells	PLOS ONE			English	Article							LIPID RAFTS; MEMBRANE CHOLESTEROL; OYSTER MUSHROOM; PLASMA-MEMBRANE; BLADDER-CANCER; METABOLISM; BINDING; TUMORS; CARCINOGENESIS; THERAPEUTICS	Cholesterol content can vary distinctly between normal and cancer cells, with elevated levels in cancer cells. Here, we investigated cholesterol sequestration with methyl-beta-cyclodextrin (MCD), and pore-formation with the ostreolysin A/pleurotolysin B (OlyA/PlyB) protein complex that binds to cholesterol/sphingomyelin-rich membrane domains. We evaluated the effects on viability of T24 invasive and RT4 noninvasive human urothelial cancer cells and normal porcine urothelial (NPU) cells. Cholesterol content strongly correlated with cancerous transformation, as highest in the T24 high-grade invasive urothelial cancer cells, and lowest in NPU cells. MCD treatment induced prominent cell death of T24 cells, whereas OlyA/PlyB treatment resulted in greatly decreased viability of the RT4 low-grade noninvasive carcinoma cells. Biochemical and transmission electron microscopy analyses revealed that MCD and OlyA/PlyB induce necrotic cell death in these cancer cells, while viability of NPU cells was not significantly affected by either treatment. We conclude that MCD is more toxic for T24 high-grade invasive urothelial cancer cells, and OlyA/PlyB for RT4 low-grade noninvasive urothelial cancer cells, and neither is toxic for NPU cells. The cholesterol and cholesterol/sphingomyelin-rich membrane domains in urothelial cancer cells thus constitute a selective therapeutic target for elimination of urothelial cancer cells.	[Resni, Natasa; Kreft, Mateja Erdani; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Repnik, Urska; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia; [Sepcic, Kristina; Macek, Peter] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Vrazov Trg 2, Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si	Veranic, Peter/I-6276-2015; Maček, Peter/U-4662-2017; Sepcic, Kristina/S-5533-2018; Maček, Peter/Y-9877-2019	Veranic, Peter/0000-0003-1999-9988; Maček, Peter/0000-0001-6470-7759; Sepcic, Kristina/0000-0002-4023-5379; Maček, Peter/0000-0001-6470-7759; Kreft, Mateja Erdani/0000-0001-6486-165X; Turk, Boris/0000-0002-9007-5764	Slovenian Research Agency [P3-0108, P1-0207, P1-0140, J1-4305]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was funded by Slovenian Research Agency (http://www.arrs.gov.si/en/agencija), grants P3-0108, P1-0207, P1-0140, and J1-4305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal G, 2013, PHARM DEV TECHNOL, V18, P916, DOI 10.3109/10837450.2011.609993; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; BENNIS A, 1993, ANN CARDIOL ANGEIOL, V42, P173; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; DEBOER WI, 1993, INT J CANCER, V54, P1022, DOI 10.1002/ijc.2910540627; Fedida-Metula S, 2008, CARCINOGENESIS, V29, P1546, DOI 10.1093/carcin/bgn146; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Funahashi H, 2008, PANCREAS, V36, P353, DOI 10.1097/MPA.0b013e31815ccc44; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hong YM, 2008, UROLOGY, V71, P131, DOI 10.1016/j.urology.2007.08.014; Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]; Kaufman DS, 2006, ANN ONCOL, V17, pV106, DOI 10.1093/annonc/mdj963; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Kreft ME, 2010, BIOL CELL, V102, P593, DOI 10.1042/BC20100024; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lasic E, 2015, REV PHYSL BIOCH PHAR; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lindgren D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-183; Lokar M, 2012, INT J NANOMED, V7, P1891, DOI 10.2147/IJN.S28723; Marco C, 2014, ANTITUMORAL ALKYLPHO; MAY GL, 1988, INT J CANCER, V42, P728, DOI 10.1002/ijc.2910420517; MERCHANT TE, 1995, CANCER, V76, P1715, DOI 10.1002/1097-0142(19951115)76:10<1715::AID-CNCR2820761007>3.0.CO;2-D; Ota K, 2013, BIOCHIMIE; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Rebolj K, 2006, BBA-BIOMEMBRANES, V1758, P1662, DOI 10.1016/j.bbamem.2006.06.003; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Rudling M, 1998, AM J PATHOL, V153, P1923, DOI 10.1016/S0002-9440(10)65706-9; Sandal S, 2009, CELL BIOCHEM FUNCT, V27, P155, DOI 10.1002/cbf.1549; Sauer LA, 2007, J NUTR BIOCHEM, V18, P637, DOI 10.1016/j.jnutbio.2006.12.009; Schlumberger S, 2014, FEBS LETT, V588, P35, DOI 10.1016/j.febslet.2013.10.038; SCHROEDER F, 1984, CANCER RES, V44, P3262; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; See WA, 2009, BJU INT, V103, P1714, DOI 10.1111/j.1464-410X.2008.08274.x; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Silvente-Poirot S, 2012, CURR OPIN PHARMACOL, V12, P673, DOI 10.1016/j.coph.2012.10.004; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; VANBLITTERSWIJK WJ, 1982, BIOCHIM BIOPHYS ACTA, V688, P495, DOI 10.1016/0005-2736(82)90361-3; Veranic P, 2009, HISTOCHEM CELL BIOL, V131, P129, DOI 10.1007/s00418-008-0492-x; Visnjar T, 2015, HISTOCHEM CELL BIOL, V143, P95, DOI 10.1007/s00418-014-1265-3; Visnjar T, 2013, IN VITRO CELL DEV-AN, V49, P196, DOI 10.1007/s11626-013-9585-5; VITOLS S, 1994, BLOOD, V84, P2689; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zupancic D, 2013, RADIOL ONCOL, V47, P338, DOI 10.2478/raon-2013-0052	57	43	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137878	10.1371/journal.pone.0137878	http://dx.doi.org/10.1371/journal.pone.0137878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361392	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100098
J	Singh, SP; Chand, HS; Gundavarapu, S; Saeed, AI; Langley, RJ; Tesfaigzi, Y; Mishra, NC; Sopori, ML				Singh, Shashi P.; Chand, Hitendra S.; Gundavarapu, Sravanthi; Saeed, Ali Imran; Langley, Raymond J.; Tesfaigzi, Yohannes; Mishra, Neerad C.; Sopori, Mohan L.			HIF-1 alpha Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice	PLOS ONE			English	Article							INTUBATED PREMATURE-INFANTS; HYPOXIA-INDUCIBLE FACTORS; FACTOR-KAPPA-B; CANCER-CELLS; RESPIRATORY-DISTRESS; RECEPTOR ANTAGONIST; CHILDRENS HEALTH; LUNG-FUNCTION; P53 ACTIVITY; EXPOSURE	Rationale Smoking during pregnancy increases the risk of bronchopulmonary dysplasia (BPD) and, in mice, gestational exposure to sidestream cigarette smoke (SS) induces BPD-like condition characterized by alveolar simplification, impaired angiogenesis, and suppressed surfactant protein production. Normal fetal development occurs in a hypoxic environment and nicotinic acetylcholine receptors (nAChRs) regulate the hypoxia-inducible factor (HIF)-1 alpha that controls apoptosis and angiogenesis. To understand SS-induced BPD, we hypothesized that gestational SS affected alveolar development through HIF-1 alpha. Methods Pregnant BALB/c mice were exposed to air (control) or SS throughout the gestational period and the 7-day-old lungs of the progeny were examined. Results Gestational SS increased apoptosis of alveolar and airway epithelial cells. This response was associated with increased alveolar volumes, higher levels of proapoptotic factors (FOXO3a, HIPK2, p53, BIM, BIK, and BAX) and the antiangiogenic factor (GAX), and lower levels of antiapoptotic factors (Akt-PI3K, NF-kappa B, HIF-1 alpha, and Bcl-2) in the lung. Although gestational SS increased the cells containing the proangiogenic bombesin-like-peptide, it markedly decreased the expression of its receptor GRPR in the lung. The effects of SS on apoptosis were attenuated by the nAChR antagonist mecamylamine. Conclusions Gestational SS-induced BPD is potentially regulated by nAChRs and associated with downregulation of HIF-1 alpha, increased apoptosis of epithelial cells, and increased alveolar volumes. Thus, in mice, exposure to sidestream tobacco smoke during pregnancy promotes BPD-like condition that is potentially mediated through the nAChR/HIF-1 alpha pathway.	[Singh, Shashi P.; Gundavarapu, Sravanthi; Langley, Raymond J.; Mishra, Neerad C.; Sopori, Mohan L.] Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM 87108 USA; [Chand, Hitendra S.; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, COPD Program, Albuquerque, NM USA; [Saeed, Ali Imran] Univ New Mexico, Pulm & Crit Care Med, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; University of New Mexico	Sopori, ML (corresponding author), Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM 87108 USA.	msopori@lrri.org	Chand, Hitendra/AAE-7975-2020	Chand, Hitendra/0000-0002-0574-9307	NIH [RO1 HL 125000]; US Army Medical Research and Material Command, Fort Detrick, Maryland [GW093005]; Lovelace Respiratory Research Institute, Albuquerque, NM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command, Fort Detrick, Maryland; Lovelace Respiratory Research Institute, Albuquerque, NM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by the funds from a grant from the NIH (RO1 HL 125000), the US Army Medical Research and Material Command (GW093005), Fort Detrick, Maryland and funds from Lovelace Respiratory Research Institute, Albuquerque, NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif ME, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008308.pub2; Ali K, 2012, THER ADV RESPIR DIS, V6, P115, DOI 10.1177/1753465812436803; Ali Z, 2013, ARCH GYNECOL OBSTET, V288, P325, DOI 10.1007/s00404-013-2753-8; Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Antonucci R, 2004, J PERINAT MED, V32, P272, DOI 10.1515/JPM.2004.051; Ashour K, 2006, AM J RESP CRIT CARE, V173, P1377, DOI 10.1164/rccm.200507-1014OC; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Baraldi E, 2009, EARLY HUM DEV, V85, pS1, DOI 10.1016/j.earlhumdev.2009.08.002; Been JV, 2014, LANCET; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bourbia A, 2006, ARCH DIS CHILD-FETAL, V91, pF36, DOI 10.1136/adc.2003.045807; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Brostrom EB, 2010, RESP MED, V104, P362, DOI 10.1016/j.rmed.2009.10.008; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Callaghan WM, 2006, PEDIATRICS, V118, P1566, DOI 10.1542/peds.2006-0860; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chakraborty D, 2012, CELL CYCLE, V11, P2427, DOI 10.4161/cc.20542; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; de Blic J, 2011, REV MAL RESPIR, V28, P187, DOI 10.1016/j.rmr.2010.10.029; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Eriksson L, 2013, PEDIAT PULMONOL; Gall S, 2014, EUR HEART J; Gough A, 2014, EUR RESPIR J, V43, P808, DOI 10.1183/09031936.00039513; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Hohla F, 2010, CELL CYCLE, V9, P1738, DOI 10.4161/cc.9.9.11347; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hylkema Machteld N, 2009, Proc Am Thorac Soc, V6, P660, DOI 10.1513/pats.200907-065DP; Iosef C, 2012, AM J PHYSIOL-LUNG C, V302, pL1023, DOI 10.1152/ajplung.00230.2011; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jeong YJ, 2013, TOXICOL APPL PHARM, V273, P542, DOI 10.1016/j.taap.2013.09.027; KERTESZ NJ, 1992, PROSTAG LEUKOTR ESS, V45, P159, DOI 10.1016/0952-3278(92)90233-9; Koksal N, 2012, EUR CYTOKINE NETW, V23, P29, DOI 10.1684/ecn.2012.0304; Levine CR, 2005, PEDIATR RES, V58, P15, DOI 10.1203/01.PDR.0000156371.89952.35; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Lv YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083312; Mao YB, 2013, ONCOL LETT, V6, P169, DOI 10.3892/ol.2013.1316; Martinez FD, 1997, CIBA F SYMP, V206, P233; Merritt TA, 2009, SEMIN FETAL NEONAT M, V14, P345, DOI 10.1016/j.siny.2009.08.009; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Narang Indra, 2010, Chron Respir Dis, V7, P259, DOI 10.1177/1479972310375454; Nardinocchi L, 2011, AGING-US, V3, P33, DOI 10.18632/aging.100254; Nikrad M, 2005, MOL CANCER THER, V4, P443; PARKER DJP, 1992, J EPIDEMIOL COMMUN H, V46, P8, DOI 10.1136/jech.46.1.8; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Petronilho Fabricia, 2007, Inflammation & Allergy Drug Targets, V6, P197; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Ryan RM, 2014, AM J PHYSL LUNG CELL; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Sandberg K, 2004, PEDIATR RES, V56, P432, DOI 10.1203/01.PDR.0000136276.52104.61; Sayegh AI, 2013, PROG MOL BIOL TRANSL, V114, P343, DOI 10.1016/B978-0-12-386933-3.00010-8; SHAH SS, 2003, COCHRANE DB SYST REV; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Singh SP, 2013, ENVIRON HEALTH PERSP, V121, P957, DOI 10.1289/ehp.1306611; Singh SP, 2011, J IMMUNOL, V187, P4542, DOI 10.4049/jimmunol.1101567; Singh SP, 2009, J IMMUNOL, V183, P2115, DOI 10.4049/jimmunol.0900826; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Subramaniam M, 2007, AM J RESP CRIT CARE, V176, P902, DOI 10.1164/rccm.200611-1734OC; Thomas M, 2013, PRIM CARE RESP J, V22, P101, DOI 10.4104/pcrj.2013.00025; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Wright CJ, 2011, PEDIATRICS, V128, P111, DOI 10.1542/peds.2010-3875; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07; Zambrano CA, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.111; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898	74	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137757	10.1371/journal.pone.0137757	http://dx.doi.org/10.1371/journal.pone.0137757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361040	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100083
J	Yi, J; Xiang, ZY; Deng, XM; Fan, T; Fu, RQ; Geng, WM; Guo, RH; He, N; Li, CH; Li, L; Li, M; Li, TZ; Tian, M; Wang, G; Wang, L; Wang, TL; Wu, AS; Wu, D; Xue, XD; Xu, MJ; Yang, XM; Yang, ZM; Yuan, JH; Zhao, QH; Zhou, GQ; Zuo, MZ; Pan, S; Zhan, LJ; Yao, M; Huang, YG				Yi, Jie; Xiang, Ziyong; Deng, Xiaoming; Fan, Ting; Fu, Runqiao; Geng, Wanming; Guo, Ruihong; He, Nong; Li, Chenghui; Li, Lei; Li, Min; Li, Tianzuo; Tian, Ming; Wang, Geng; Wang, Lei; Wang, Tianlong; Wu, Anshi; Wu, Di; Xue, Xiaodong; Xu, Mingjun; Yang, Xiaoming; Yang, Zhanmin; Yuan, Jianhu; Zhao, Qiuhua; Zhou, Guoqing; Zuo, Mingzhang; Pan, Shuang; Zhan, Lujing; Yao, Min; Huang, Yuguang			Incidence of Inadvertent Intraoperative Hypothermia and Its Risk Factors in Patients Undergoing General Anesthesia in Beijing: A Prospective Regional Survey	PLOS ONE			English	Article							POSTOPERATIVE HYPOTHERMIA; WOUND-INFECTION; BLOOD-LOSS; FLUID; IMPLEMENTATION; NORMOTHERMIA	Background/Objective Inadvertent intraoperative hypothermia (core temperature <36 degrees C) is a recognized risk in surgery and has adverse consequences. However, no data about this complication in China are available. Our study aimed to determine the incidence of inadvertent intraoperative hypothermia and its associated risk factors in a sample of Chinese patients. Methods We conducted a regional cross-sectional survey in Beijing from August through December, 2013. Eight hundred thirty patients who underwent various operations under general anesthesia were randomly selected from 24 hospitals through a multistage probability sampling. Multivariate logistic regression analyses were applied to explore the risk factors of developing hypothermia. Results The overall incidence of intraoperative hypothermia was high, 39.9%. All patients were warmed passively with surgical sheets or cotton blankets, whereas only 10.7% of patients received active warming with space heaters or electric blankets. Pre-warmed intravenous fluid were administered to 16.9% of patients, and 34.6% of patients had irrigation of wounds with pre-warmed fluid. Active warming (OR = 0.46, 95% CI 0.26-0.81), overweight or obesity (OR = 0.39, 95% CI 0.28-0.56), high baseline core temperature before anesthesia (OR = 0.08, 95% CI 0.04-0.13), and high ambient temperature (OR = 0.89, 95% CI 0.79-0.98) were significant protective factors for hypothermia. In contrast, major-plus operations (OR = 2.00, 95% CI 1.32-3.04), duration of anesthesia (1-2 h) (OR = 3.23, 95% CI 2.19-4.78) and >2 h (OR = 3.44, 95% CI 1.90-6.22,), and intravenous un-warmed fluid (OR = 2.45, 95% CI 1.45-4.12) significantly increased the risk of hypothermia. Conclusions The incidence of inadvertent intraoperative hypothermia in Beijing is high, and the rate of active warming of patients during operation is low. Concern for the development of intraoperative hypothermia should be especially high in patients undergoing major operations, requiring long periods of anesthesia, and receiving un-warmed intravenous fluids.	[Yi, Jie; Huang, Yuguang] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Xiang, Ziyong; Pan, Shuang; Zhan, Lujing; Yao, Min] 3M China R&D Ctr, Shanghai, Peoples R China; [Deng, Xiaoming] PUMC, CAMS, Plast Surg Hosp & Inst, Beijing, Peoples R China; [Fan, Ting] Tsinghua Univ, Yuquan Hosp, Beijing 100084, Peoples R China; [Fu, Runqiao] Beijing Chuiyangliu Hosp, Beijing, Peoples R China; [Geng, Wanming] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China; [Guo, Ruihong] Miyunxian Hosp, Beijing, Peoples R China; [He, Nong] Peking Univ, Shougang Hosp, Beijing 100871, Peoples R China; [Li, Chenghui] China Japan Friendship Hosp, Beijing, Peoples R China; [Li, Lei] China Meitan Gen Hosp, Beijing, Peoples R China; [Li, Min] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Li, Tianzuo] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China; [Tian, Ming] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Wang, Geng] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Wang, Lei] Haidian Maternal & Child Hlth Hosp, Beijing, Peoples R China; [Wang, Tianlong] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China; [Wu, Anshi] Beijing Chao Yang Hosp, Beijing, Peoples R China; [Wu, Di] Capital Med Univ, Luhe Teaching Hosp, Beijing, Peoples R China; [Xue, Xiaodong; Yang, Xiaoming] PLA, Air Force Gen Hosp, Beijing, Peoples R China; [Xu, Mingjun] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China; [Yang, Zhanmin] China Aerosp Corp, Cent Hosp, Beijing, Peoples R China; [Yuan, Jianhu] Beijing Rectum Hosp, Beijing, Peoples R China; [Zhao, Qiuhua] Beijing Shi Jing Shan Hosp, Beijing, Peoples R China; [Zhou, Guoqing] Beijing Pinggu Hosp, Beijing, Peoples R China; [Zuo, Mingzhang] Minist Hlth, Beijing Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; 3M; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS; Tsinghua University; Capital Medical University; Peking University; China-Japan Friendship Hospital; Peking University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Air Force General Hospital PLA; Capital Medical University; Beijing Hospital	Huang, YG (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.	huangyg@pumch.cn			China National Health and Planned Parenthood Committee Health Quality Improvement Award [201402017]; China National Nature Science Foundation [31070930]; unrestricted research grant from 3M China [MDI0077]	China National Health and Planned Parenthood Committee Health Quality Improvement Award; China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); unrestricted research grant from 3M China	This study was funded by the China National Health and Planned Parenthood Committee Health Quality Improvement Award (ID# 201402017, principle investigator Yuguang Huang, MD), China National Nature Science Foundation (Grant# 31070930, principle investigator Yuguang Huang, MD), and an unrestricted research grant (MDI0077, principle investigator Yuguang Huang, MD) from 3M China.	Andrzejowski JC, 2010, ANAESTHESIA, V65, P942, DOI 10.1111/j.1365-2044.2010.06473.x; Barclay KL, 2013, ANZ J SURG; Barthel ER, 2012, J TRAUMA ACUTE CARE, V72, P1588, DOI 10.1097/TA.0b013e31824a7943; Burger Leona, 2009, Br J Nurs, V18, P1116; Burns SM, 2010, J PERIANESTH NURS, V25, P286, DOI 10.1016/j.jopan.2010.07.001; BUSH HL, 1995, J VASC SURG, V21, P392, DOI 10.1016/S0741-5214(95)70281-4; Forbes SS, 2008, J AM COLL SURGEONS, V207, P336, DOI 10.1016/j.jamcollsurg.2008.03.014; Forbes SS, 2009, J AM COLL SURGEONS, V209, P492, DOI 10.1016/j.jamcollsurg.2009.07.002; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; Guest James D, 2004, Spine J, V4, P130, DOI 10.1016/j.spinee.2003.08.027; Han SB, 2014, TRANSPL P, V46, P705, DOI 10.1016/j.transproceed.2013.11.091; Hedrick TL, 2007, J AM COLL SURGEONS, V205, P432, DOI 10.1016/j.jamcollsurg.2007.04.042; HEIER T, 1991, ANESTHESIOLOGY, V74, P815, DOI 10.1097/00000542-199105000-00003; Jeyadoss J, 2013, ANAESTH INTENS CARE, V41, P759, DOI 10.1177/0310057X1304100611; JORIS J, 1994, ANESTHESIOLOGY, V80, P268, DOI 10.1097/00000542-199402000-00006; Karalapillai D, 2009, ANAESTHESIA, V64, P968, DOI 10.1111/j.1365-2044.2009.05989.x; Kongsayreepong S, 2003, ANESTH ANALG, V96, P826, DOI 10.1213/01.ANE.0000048822.27698.28; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leijtens B, 2013, J ARTHROPLASTY, V28, P895, DOI 10.1016/j.arth.2012.10.006; Leslie Kate, 2003, Best Pract Res Clin Anaesthesiol, V17, P485, DOI 10.1016/S1521-6896(03)00049-1; Long KC, 2013, GYNECOL ONCOL, V131, P525, DOI 10.1016/j.ygyno.2013.08.034; Moola S, 2011, INT J EVID-BASED HEA, V9, P337, DOI 10.1111/j.1744-1609.2011.00227.x; Ng SF, 2003, ANESTH ANALG, V96, P171, DOI 10.1097/00000539-200301000-00036; NICE, 2003, PREOP TESTS US PREOP; Oshvandi Khodayar, 2014, Iran J Nurs Midwifery Res, V19, P64; Raymond CJ, 2006, ANESTH ANALG, V103, P1605, DOI 10.1213/01.ane.0000246442.83235.dc; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; SLOTMAN GJ, 1985, AM J SURG, V149, P495, DOI 10.1016/S0002-9610(85)80046-5; Smith CE, 1998, J CLIN ANESTH, V10, P380, DOI 10.1016/S0952-8180(98)00049-X; Tander B, 2005, PEDIATR ANESTH, V15, P574, DOI 10.1111/j.1460-9592.2005.01504.x; Tappen R M, 1996, AORN J, V63, P639, DOI 10.1016/S0001-2092(06)63411-X; VAUGHAN MS, 1981, ANESTH ANALG, V60, P746; Weaver MD, 2014, PREHOSP EMERG CARE, V18, P335, DOI 10.3109/10903127.2013.864354; Winkler M, 2000, ANESTH ANALG, V91, P978, DOI 10.1097/00000539-200010000-00039	36	46	56	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136136	10.1371/journal.pone.0136136	http://dx.doi.org/10.1371/journal.pone.0136136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360773	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100009
J	Bachert, BA; Choi, SJ; Snyder, AK; Rio, RVM; Durney, BC; Holland, LA; Amemiya, K; Welkos, SL; Bozue, JA; Cote, CK; Berisio, R; Lukomski, S				Bachert, Beth A.; Choi, Soo J.; Snyder, Anna K.; Rio, Rita V. M.; Durney, Brandon C.; Holland, Lisa A.; Amemiya, Kei; Welkos, Susan L.; Bozue, Joel A.; Cote, Christopher K.; Berisio, Rita; Lukomski, Slawomir			A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; III SECRETION SYSTEM; TIME PCR ASSAY; TRIPLE-HELIX; SURFACE PROTEIN; CELLULAR FIBRONECTIN; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; CAUSATIVE AGENT; SIGNAL PEPTIDES	Burkholderia pseudomallei and Burkholderia mallei, classified as category B priority pathogens, are significant human and animal pathogens that are highly infectious and broad-spectrum antibiotic resistant. Currently, the pathogenicity mechanisms utilized by Burkholderia are not fully understood, and correct diagnosis of B. pseudomallei and B. mallei infection remains a challenge due to limited detection methods. Here, we provide a comprehensive analysis of a set of 13 novel Burkholderia collagen-like proteins (Bucl) that were identified among B. pseudomallei and B. mallei select agents. We infer that several Bucl proteins participate in pathogenesis based on their noncollagenous domains that are associated with the components of a type III secretion apparatus and membrane transport systems. Homology modeling of the outer membrane efflux domain of Bucl8 points to a role in multi-drug resistance. We determined that bucl genes are widespread in B. pseudomallei and B. mallei; Fischer's exact test and Cramer's V-2 values indicate that the majority of bucl genes are highly associated with these pathogenic species versus nonpathogenic B. thai-landensis. We designed a bucl-based quantitative PCR assay which was able to detect B. pseudomallei infection in a mouse with a detection limit of 50 CFU. Finally, chromosomal mapping and phylogenetic analysis of bucl loci revealed considerable genomic plasticity and adaptation of Burkholderia spp. to host and environmental niches. In this study, we identified a large set of phylogenetically unrelated bucl genes commonly found in Burkholderia select agents, encoding predicted pathogenicity factors, detection targets, and vaccine candidates.	[Bachert, Beth A.; Choi, Soo J.; Lukomski, Slawomir] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Snyder, Anna K.; Rio, Rita V. M.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Durney, Brandon C.; Holland, Lisa A.] W Virginia Univ, Dept Chem, Morgantown, WV 26506 USA; [Amemiya, Kei; Welkos, Susan L.; Bozue, Joel A.; Cote, Christopher K.] United States Army Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD USA; [Berisio, Rita] CNR, Inst Biostruct & Bioimaging, Naples, Italy	West Virginia University; West Virginia University; West Virginia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Lukomski, S (corresponding author), W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176	National Science Foundation [EPS-1003907, CHE1212537]; NSF-EPSCoR Graduate Fellowship Program [1003907]	National Science Foundation(National Science Foundation (NSF)); NSF-EPSCoR Graduate Fellowship Program	This work was supported by the National Science Foundation Cooperative Agreement EPS-1003907 (to SL). BAB was supported by the NSF-EPSCoR Graduate Fellowship Program (under Cooperative Agreement 1003907). Amplicon size determination using naonogel separation described in this report is based upon work supported by the National Science Foundation under Grant No. CHE1212537. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Angus AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083779; Anuntagool N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; Berisio R, 2002, PROTEIN PEPTIDE LETT, V9, P107, DOI 10.2174/0929866023408922; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Bowers Jolene R, 2010, PLoS One, V5, pe15413, DOI 10.1371/journal.pone.0015413; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Bozue J, 2007, INFECT IMMUN, V75, P4498, DOI 10.1128/IAI.00434-07; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Castanha ER, 2006, J MICROBIOL METH, V64, P27, DOI 10.1016/j.mimet.2005.04.032; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Choh LC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00005; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190; Doxey AC, 2013, VIRULENCE, V4, P453, DOI 10.4161/viru.25180; Durney BC, 2015, ANAL CHIM ACTA, V880, P136, DOI 10.1016/j.aca.2015.03.009; Durney BC, 2013, ANAL CHEM, V85, P6617, DOI 10.1021/ac303745g; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Hoffmaster Alex R, 2015, Emerg Infect Dis, V21, DOI 10.3201/eid2102.141045; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Ikeda Masami, 2002, In Silico Biology, V2, P19; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Karlstrom A, 2005, VET MICROBIOL; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leski TA, 2009, APPL ENVIRON MICROB, V75, P7163, DOI 10.1128/AEM.01069-09; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Luo RJ, 2010, ANAL CHEM, V82, P1228, DOI 10.1021/ac902052m; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Nylander J.A.A, 2004, MRMODELTEST V2; Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110; Oliver-Kozup H, 2013, MOL MICROBIOL, V87, P672, DOI 10.1111/mmi.12125; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Phan G, 2010, STRUCTURE, V18, P507, DOI 10.1016/j.str.2010.01.018; Pizarro-Guajardo M, 2014, ANAEROBE, V25, P18, DOI 10.1016/j.anaerobe.2013.11.003; Price EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037723; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Sylvestre P, 2003, J BACTERIOL, V185, P1555, DOI 10.1128/JB.185.5.1555-1563.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Tuntevski K, 2013, APPL ENVIRON MICROB, V79, P7882, DOI 10.1128/AEM.02835-13; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vandersmissen L, 2010, FEMS MICROBIOL LETT, V306, P168, DOI 10.1111/j.1574-6968.2010.01951.x; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; White CM, 2007, ELECTROPHORESIS, V28, P3049, DOI 10.1002/elps.200600816; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wongsuvan G, 2009, SE ASIAN J TROP MED, V40, P781; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003	103	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137578	10.1371/journal.pone.0137578	http://dx.doi.org/10.1371/journal.pone.0137578			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356298	Green Published, gold			2022-12-27	WOS:000360965800064
J	Carrillo, M; Migliorati, F; Bruls, R; Han, YY; Heinemans, M; Pruis, I; Gazzola, V; Keysers, C				Carrillo, Maria; Migliorati, Filippo; Bruls, Rune; Han, Yingying; Heinemans, Mirjam; Pruis, Ilanah; Gazzola, Valeria; Keysers, Christian			Repeated Witnessing of Conspecifics in Pain: Effects on Emotional Contagion	PLOS ONE			English	Article							CONDITIONED FEAR; EMPATHY; MICE; RATS; CHIMPANZEES; BEHAVIOR; ANXIETY	Witnessing of conspecifics in pain has been shown to elicit socially triggered freezing in rodents. It is unknown how robust this response is to repeated exposure to a cage-mate experiencing painful stimulation. To address this question, shock-experienced Observer rats repeatedly witnessed familiar Demonstrators receive painful footshocks (six sessions). Results confirm that Observers freeze during the first testing session. The occurrence of this behaviour however gradually diminished as the experimental sessions progressed, reaching minimal freezing levels by the end of the experiments. In contrast, the appearance and continuous increase in the frequency of yawning, a behavior that was inhibited by metyrapone (i. e,. a glucocorticoid synthesis blocker), might represent an alternative coping strategy, suggesting that the observer's reduced freezing does not necessarily indicate a disappearance in the affective response to the Demonstrator's distress.	[Carrillo, Maria; Migliorati, Filippo; Bruls, Rune; Han, Yingying; Heinemans, Mirjam; Pruis, Ilanah; Gazzola, Valeria; Keysers, Christian] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Heinemans, Mirjam; Gazzola, Valeria; Keysers, Christian] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands; [Pruis, Ilanah] Vrije Univ Amsterdam, Earth & Life Sci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Vrije Universiteit Amsterdam	Carrillo, M (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	m.carrillo@nin.knaw.nl; v.gazzola@nin.knaw.nl; c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013; Han, Yingying/AAD-3628-2020	Keysers, Christian/0000-0002-2845-5467; Han, Yingying/0000-0002-2894-5626; Gazzola, Valeria/0000-0003-0324-0619; Heinemans, Mirjam/0000-0002-9321-9727	European Research Council [ERC-StG 312511]	European Research Council(European Research Council (ERC)European Commission)	The research was funded by a European Research Council starting grant (ERC-StG 312511) to CK (http://erc.europa.eu/starting-grants).	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; ARGIOLAS A, 1987, BRAIN RES, V421, P349, DOI 10.1016/0006-8993(87)91305-9; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; BAENNINGER R, 1987, J COMP PSYCHOL, V101, P349, DOI 10.1037/0735-7036.101.4.349; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; EGUfBAR J, 1984, ACTA NEUROBIOL EXP, V44, P179; Gallup AC, 2011, ETHOLOGY, V117, P145, DOI 10.1111/j.1439-0310.2010.01854.x; Gallup AC, 2010, J COMP PSYCHOL, V124, P133, DOI 10.1037/a0018006; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Guzman YF, 2009, BEHAV BRAIN RES, V201, P173, DOI 10.1016/j.bbr.2009.02.024; Hatfield E., 1994, REV PERSONALITY SOCI; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kim S, 2012, P NATL ACAD SCI USA, V109, P15497, DOI 10.1073/pnas.1213903109; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kubota N, 2014, NEUROSCI LETT, V566, P182, DOI 10.1016/j.neulet.2014.02.064; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Leone A, 2014, SCI REP, P4; Liang AC, 2015, PHYSIOL BEHAV, V140, P38, DOI 10.1016/j.physbeh.2014.11.029; Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003; Martin LJ, 2015, CURR BIOL, V25, P326, DOI 10.1016/j.cub.2014.11.028; Miller ML, 2010, ANIM BEHAV, V80, P615, DOI 10.1016/j.anbehav.2010.05.018; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Sanders J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074609; Sauer EF, 1967, AUK, P571; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x	30	18	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136979	10.1371/journal.pone.0136979	http://dx.doi.org/10.1371/journal.pone.0136979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356506	gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800021
J	Hsiou, AS; De Franca, MAG; Ferigolo, J				Hsiou, Annie Schmaltz; Gallo De Franca, Marco Aurelio; Ferigolo, Jorge			New Data on the Clevosaurus (Sphenodontia: Clevosauridae) from the Upper Triassic of Southern Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; DIAPSIDA LEPIDOSAURIA; CATURRITA FORMATION; 1ST RECORD; RHYNCHOCEPHALIA; THERAPSIDA; PHYLOGENY; REPTILIA; CLASSIFICATION; BIOGEOGRAPHY	The sphenodontian fossil record in South America is well known from Mesozoic and Paleogene deposits of Argentinean Patagonia, mainly represented by opisthodontians, or taxa closely related to the modern Sphenodon. In contrast, the Brazilian fossil record is restricted to the Caturrita Formation, Late Triassic of Rio Grande do Sul, represented by several specimens of Clevosauridae, including Clevosaurus brasiliensis Bonaparte and Sues, 2006. Traditionally, Clevosauridae includes several Late Triassic to Early Jurassic taxa, such as Polysphenodon, Brachyrhinodon, and Clevosaurus, the latter well-represented by several species. The detailed description of the specimen MCN-PV 2852 allowed the first systematic revision of most Clevosaurus species. Within Clevosauridae, Polysphenodon is the most basal taxon, and an IterPCR analysis revealed Brachrhynodon as a possible Clevosaurus; C. petilus, C. wangi, and C. mcgilli as possibly distinct taxonomic entities; and the South African Clevosaurus sp. is not closely related to C. brasiliensis. These data indicate the need of a deep phylogenetic review of Clevosauridae, in order to discover synapomorphic characters among the diversity of these Triassic/Jurassic sphenodontians.	[Hsiou, Annie Schmaltz] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Gallo De Franca, Marco Aurelio] Univ Fed Vale Sao Francisco, Colegiado Ciencias Biol, Petr, PE, Brazil; [Ferigolo, Jorge] Fundacao Zoobot Rio Grande Sul, Secao Paleontol, Museu Ciencias Nat, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade Federal do Vale do Sao Francisco	Hsiou, AS (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil.	anniehsiou@ffclrp.usp.br	Hsiou, Annie Schmaltz/B-9061-2012; Ferigolo, Jorge/AAV-2684-2021; França, Marco A G/F-3018-2014	Hsiou, Annie Schmaltz/0000-0003-2392-6191; Ferigolo, Jorge/0000-0001-7985-6466; França, Marco A G/0000-0002-9671-1485	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/14080-0, 2011/23834-9]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [APQ-0165-204/14]; Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS	This work was funded by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant to ASH, FAPESP Process n. 2011/14080-0; and grant to M.A.G.F. Postdoctoral Fellowship FAPESP Process n. 2011/23834-9), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (grant to M.A.G.F., FACEPE process APQ-0165-204/14), and Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS (grant to J.F.).	Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Albino Adriana, 2007, P87; Andreis R.R., 1980, 31 C BRAS GEOL SBG B, P659; Apesteguia S, 2005, CR PALEVOL, V4, P663, DOI 10.1016/j.crpv.2005.06.003; Apesteguia S, 2012, CRETACEOUS RES, V34, P154, DOI 10.1016/j.cretres.2011.10.014; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0811; Apesteguia S, 2014, J VERTEBR PALEONTOL, V34, P303, DOI 10.1080/02724634.2013.803974; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Apesteguia S, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3581[1:ALCSMF]2.0.CO;2; Arantes BA, 2011, THESIS U FEDERAL RIO; Arantes BD, 2009, REV BRAS PALEONTOLOG, V12, P43, DOI 10.4072/rbp.2009.1.04; Barboni R, 2013, AMEGHINIANA, V50, P14, DOI 10.5710/AMGH.28.11.2012.444; BENTON MJ, 1985, ZOOL J LINN SOC-LOND, V84, P97, DOI 10.1111/j.1096-3642.1985.tb01796.x; Bittencourt JS, 2012, ALCHERINGA, V36, P269, DOI 10.1080/03115518.2012.634111; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte JF, 2006, PALAEONTOLOGY, V49, P917, DOI 10.1111/j.1475-4983.2006.00568.x; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Cisneros JC, 2003, NEUES JAHRB GEOL P-A, V227, P365; Conrad JL, 2006, HIST BIOL, V18, P405, DOI 10.1080/08912960600679570; Da Silva RC, 2007, GONDWANA RES, V11, P303, DOI 10.1016/j.gr.2006.05.011; Dias-da-Silva S, 2009, GONDWANA RES, V15, P131, DOI 10.1016/j.gr.2008.07.002; Dumeril AMC, 1839, ERPETOLOGIE GEN HIST, Vviii; EVANS SE, 1983, COPEIA, P845, DOI 10.2307/1444363; Evans SE, 2004, ACTA PALAEONTOL POL, V49, P393; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; EVANS SE, 1984, ZOOL J LINN SOC-LOND, V82, P87, DOI 10.1111/j.1096-3642.1984.tb00537.x; EVANS SE, 1981, COPEIA, P883, DOI 10.2307/1444191; Evans SE, 2001, ZOOL J LINN SOC-LOND, V133, P309, DOI 10.1006/zjls.2000.0266; Evans Susan E., 2009, Palaeontologia Polonica, P179; Faccini U., 1989, THESIS U FEDERAL RIO; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Ferigolo J, PALEONTOLOGIA RIO GR, P236; Ferigolo J, 1999, B INFORM SOC BRASILE, P60; Ferigolo J, 2009, VERTEBRADOS FOSSEIS, P89, DOI [10.1371/journal.pone.0116716, DOI 10.1371/JOURNAL.PONE.0116716]; Ferigolo J, 1999, 7 INT S MES TERR EC, P24; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1989, ZOOL J LINN SOC-LOND, V96, P413, DOI 10.1111/j.1096-3642.1989.tb02521.x; FRASER NC, 1986, PALAEONTOLOGY, V29, P165; Fraser NC, 1993, NEW MEX MUSEUM NAT H, V3, P135; Gauthier J., 1988, P15; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gonzaga, 1980, ACT 2 C ARG PAL BIOE, V2, P159; Gunther A., 1867, PHILOS T ROYAL SOC L, V157, P595, DOI DOI 10.1098/RSTL.1867.0019; Jones Marc E.H., 2006, P55; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones Marc E.H., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P548; Kischlat EE, 2003, J VERTEBR PALEONTOL, V23, P464, DOI 10.1671/0272-4634(2003)023[0464:APFTUT]2.0.CO;2; Langer M. C., 2007, NEW MEXICO MUSEUM NA, V41, P201; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2010, EARTH ENV SCI T R SO, V101, P301, DOI 10.1017/S175569101102007X; Langer MC, 2012, PALEONTOLOGIA DESTAQ, P47; Leal LA, 2004, ZOOTAXA, P1; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinez PRRV, 2013, PALEONTOLOGIA DESTAQ, V66, P67; Martinez PRRV, 2014, THESIS U FEDERAL RIO; Martinez RN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2057; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Rauhut OWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046839; Reynoso V-H, 1996, THESIS MCGILL U MCGI, P297; Reynoso VH, 1998, J VERTEBR PALEONTOL, V18, P333, DOI 10.1080/02724634.1998.10011061; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 1996, J VERTEBR PALEONTOL, V16, P210, DOI 10.1080/02724634.1996.10011309; Reynoso VH, 2000, J PALEONTOL, V74, P133, DOI 10.1666/0022-3360(2000)074<0133:AUASRD>2.0.CO;2; RIEPPEL O, 1992, J HERPETOL, V26, P80, DOI 10.2307/1565028; Robinson P.L., 1973, Journal geol Soc Lond, V129, P457, DOI 10.1144/gsjgs.129.5.0457; Martinez PRRD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119307; RUBERT RR, 2004, PESQUISAS GEOCIENCIA, V31, P71; Saila LK, 2005, PALAEONTOLOGY, V48, P817, DOI 10.1111/j.1475-4983.2005.00486.x; SCHERER C.M.S., 2000, GEOLOGIA RIO GRANDE, P335; Simon Maria Edith, 2003, Boletim do Museu Nacional Nova Serie Geologia, V68, P1; Soares MB, 2011, GEODIVERSITAS, V33, P265, DOI 10.5252/g2011n2a4; SUES HD, 1994, J VERTEBR PALEONTOL, V14, P327, DOI 10.1080/02724634.1994.10011563; SUES HD, 1995, J PALEONTOL, V69, P123, DOI 10.1017/S0022336000026974; Swinton WE, 1939, J NATURAL HIST 11, V4, P37; Whiteside DI, 1986, PHILOS T R SOC B, V312, P597, DOI [10.1098/rstb.1986.0014, DOI 10.1098/RSTB.1986.0014]; Wilkinson M, 1996, PHILOS T ROY SOC B, V351, P1, DOI 10.1098/rstb.1996.0001; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Wu X-C, 1991, THESIS MCGILL U, P229; WU XC, 1994, IN THE SHADOW OF THE DINOSAURS, P38; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	86	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137523	10.1371/journal.pone.0137523	http://dx.doi.org/10.1371/journal.pone.0137523			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355294	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800055
J	Huang, JF; Wei, C; Zhang, Y; Blackburn, GA; Wang, XZ; Wei, CW; Wang, J				Huang, Jingfeng; Wei, Chen; Zhang, Yao; Blackburn, George Alan; Wang, Xiuzhen; Wei, Chuanwen; Wang, Jing			Meta-Analysis of the Detection of Plant Pigment Concentrations Using Hyperspectral Remotely Sensed Data	PLOS ONE			English	Article							CROP CHLOROPHYLL CONTENT; LEAF REFLECTANCE SPECTRA; VEGETATION INDEXES; NONDESTRUCTIVE ESTIMATION; RED-EDGE; ANTHOCYANIN CONTENT; INFRARED REFLECTANCE; DEEPOXIDATION STATE; OPTICAL-PROPERTIES; XANTHOPHYLL CYCLE	Passive optical hyperspectral remote sensing of plant pigments offers potential for understanding plant ecophysiological processes across a range of spatial scales. Following a number of decades of research in this field, this paper undertakes a systematic meta-analysis of 85 articles to determine whether passive optical hyperspectral remote sensing techniques are sufficiently well developed to quantify individual plant pigments, which operational solutions are available for wider plant science and the areas which now require greater focus. The findings indicate that predictive relationships are strong for all pigments at the leaf scale but these decrease and becomemore variable across pigment types at the canopy and landscape scales. At leaf scale it is clear that specific sets of optimal wavelengths can be recommended for operational methodologies: total chlorophyll and chlorophyll a quantification is based on reflectance in the green (550-560nm) and red edge (680-750nm) regions; chlorophyll b on the red, (630-660nm), red edge (670-710nm) and the near-infrared (800-810nm); carotenoids on the 500-580nm region; and anthocyanins on the green (550-560nm), red edge (700-710nm) and near-infrared (780-790nm). For total chlorophyll the optimal wavelengths are valid across canopy and landscape scales and there is some evidence that the same applies for chlorophyll a.	[Huang, Jingfeng; Wei, Chen; Zhang, Yao; Wei, Chuanwen; Wang, Jing] Zhejiang Univ, Inst Agr Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Chen] Zhejiang Meteorol Serv Ctr, Hangzhou, Zhejiang, Peoples R China; [Blackburn, George Alan] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Wang, Xiuzhen] Hangzhou Normal Univ, Inst Remote Sensing & Earth Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Lancaster University; Hangzhou Normal University	Wang, XZ (corresponding author), Hangzhou Normal Univ, Inst Remote Sensing & Earth Sci, Hangzhou, Zhejiang, Peoples R China.	wxz0516@sina.com		Huang, Jingfeng/0000-0003-4627-6021; Albrectsen, Benedicte Riber/0000-0002-9337-4540	National Natural Science Foundation of China [41171276]; National Key Technology R&D Program of China [SQ2012BAJY3429]; Ph.D. Programs Foundation of Ministry of Educational of China [200100101110035]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Ph.D. Programs Foundation of Ministry of Educational of China; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Our work was supported by grants from the National Natural Science Foundation of China (41171276), National Key Technology R&D Program of China (SQ2012BAJY3429), and Ph.D. Programs Foundation of Ministry of Educational of China (200100101110035). The funders had a role in data collection and analysis.	Adams ML, 1999, INT J REMOTE SENS, V20, P3663, DOI 10.1080/014311699211264; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Bannari A, 2006, INT GEOSCI REMOTE SE, P112, DOI 10.1109/IGARSS.2006.34; Blackburn GA, 2002, REMOTE SENS ENVIRON, V82, P311, DOI 10.1016/S0034-4257(02)00049-4; Blackburn GA, 1999, REMOTE SENS ENVIRON, V70, P224, DOI 10.1016/S0034-4257(99)00048-6; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Borenstein M, 2009, INTRO METAANALYSIS, P12; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Chen L, 2005, INT GEOSCI REMOTE SE, P1416; Cheng Qian, 2003, J Zhejiang Univ Sci, V4, P727, DOI 10.1631/jzus.2003.0727; Ciganda V, 2009, J PLANT PHYSIOL, V166, P157, DOI 10.1016/j.jplph.2008.03.004; Clevers JGPW, 2013, INT J APPL EARTH OBS, V23, P344, DOI 10.1016/j.jag.2012.10.008; Clevers JGPW, 2012, IEEE J-STARS, V5, P574, DOI 10.1109/JSTARS.2011.2176468; Coops NC, 2003, TREE PHYSIOL, V23, P23, DOI 10.1093/treephys/23.1.23; CORNELL JA, 1987, PHYTOPATHOLOGY, V77, P63, DOI 10.1094/Phyto-77-63; Croft H, 2014, ECOL COMPLEX, V17, P119, DOI 10.1016/j.ecocom.2013.11.005; CURRAN PJ, 1992, REMOTE SENS ENVIRON, V39, P153, DOI 10.1016/0034-4257(92)90133-5; CURRAN PJ, 1990, TREE PHYSIOL, V7, P33, DOI 10.1093/treephys/7.1-2-3-4.33; CURRAN PJ, 1995, TREE PHYSIOL, V15, P203, DOI 10.1093/treephys/15.3.203; Curtis PS, 2012, NEW PHYTOL, V195, P279, DOI 10.1111/j.1469-8137.2012.04207.x; Darvishzadeh R, 2008, REMOTE SENS ENVIRON, V112, P2592, DOI 10.1016/j.rse.2007.12.003; Darvishzadeh R, 2008, ISPRS J PHOTOGRAMM, V63, P409, DOI 10.1016/j.isprsjprs.2008.01.001; Dash J, 2004, INT J REMOTE SENS, V25, P5403, DOI 10.1080/0143116042000274015; Datt B, 1999, INT J REMOTE SENS, V20, P2741, DOI 10.1080/014311699211778; Delegido J, 2008, INT J REMOTE SENS, V29, P7107, DOI 10.1080/01431160802238401; Delegido J, 2014, ECOL INDIC, V40, P34, DOI 10.1016/j.ecolind.2014.01.002; Delegido J, 2010, INT J APPL EARTH OBS, V12, P165, DOI 10.1016/j.jag.2010.02.003; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; FILELLA I, 1994, INT J REMOTE SENS, V15, P1459, DOI 10.1080/01431169408954177; Filella I, 2009, INT J REMOTE SENS, V30, P4443, DOI 10.1080/01431160802575661; FILELLA I, 1995, CROP SCI, V35, P1400, DOI 10.2135/cropsci1995.0011183X003500050023x; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Garriga M, 2014, J INTEGR PLANT BIOL, V56, P505, DOI 10.1111/jipb.12193; Garrity SR, 2011, REMOTE SENS ENVIRON, V115, P628, DOI 10.1016/j.rse.2010.10.007; GITELSON A, 1994, J PHOTOCH PHOTOBIO B, V22, P247, DOI 10.1016/1011-1344(93)06963-4; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286, DOI 10.1016/S0176-1617(11)81633-0; Gitelson A.A., 2004, REMOTE SENS AGR ENV, P78; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Gitelson AA, 2002, PHOTOCHEM PHOTOBIOL, V75, P272, DOI 10.1562/0031-8655(2002)075<0272:ACCIPL>2.0.CO;2; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gitelson AA, 1996, INT GEOSCI REMOTE SE, P2355, DOI 10.1109/IGARSS.1996.516985; Gitelson AA, 1998, ADV SPACE RES, V22, P689, DOI 10.1016/S0273-1177(97)01133-2; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494, DOI 10.1016/S0176-1617(96)80284-7; Gitelson AA, 2009, AM J BOT, V96, P1861, DOI 10.3732/ajb.0800395; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Guan YN, 2005, LECT NOTES COMPUT SC, V3514, P908; Gurevitch J, 2001, ADV ECOL RES, V32, P199, DOI 10.1016/S0065-2504(01)32013-5; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; Haboudane D, 2007, INT GEOSCI REMOTE SE, P3297, DOI 10.1109/IGARSS.2007.4423549; Haboudane D, 2008, IEEE T GEOSCI REMOTE, V46, P423, DOI 10.1109/TGRS.2007.904836; Hall FG, 2008, REMOTE SENS ENVIRON, V112, P3201, DOI 10.1016/j.rse.2008.03.015; Han JW, 2006, DATA MINING CONCEPTS, P53; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Hedges LV, 1985, STAT METHODS METAANA, P31; HENDRY GAF, 1987, NEW PHYTOL, V107, P255, DOI 10.1111/j.1469-8137.1987.tb00181.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter JE, 2004, METHODS METAANALYSIS, P33; Imanishi J, 2010, LANDSC ECOL ENG, V6, P219, DOI 10.1007/s11355-009-0101-8; Jacquemoud S, 1995, REMOTE SENS ENVIRON, V54, P180, DOI 10.1016/0034-4257(95)00170-0; Ju CH, 2010, PEDOSPHERE, V20, P633, DOI 10.1016/S1002-0160(10)60053-7; Kochubey SM, 2007, J PLANT PHYSIOL, V164, P1648, DOI 10.1016/j.jplph.2006.11.007; Levizou E, 2007, ENVIRON EXP BOT, V59, P293, DOI 10.1016/j.envexpbot.2006.03.002; Li J, 2007, NEW ZEAL J AGR RES, V50, P1031; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lichtenthaler HK, 1996, J PLANT PHYSIOL, V148, P483, DOI 10.1016/S0176-1617(96)80283-5; Lipsey MW, 2000, PRACTICAL METAANALYS, P112; Liu ML, 2010, BIOSYST ENG, V106, P223, DOI 10.1016/j.biosystemseng.2009.12.008; Maccioni A, 2001, J PHOTOCH PHOTOBIO B, V61, P52, DOI 10.1016/S1011-1344(01)00145-2; MERZLYAK MN, 1995, J PLANT PHYSIOL, V145, P315, DOI 10.1016/S0176-1617(11)81896-1; Merzlyak MN, 2003, POSTHARVEST BIOL TEC, V27, P197, DOI 10.1016/S0925-5214(02)00066-2; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; Mosteller F, 1996, ANNU REV PUBL HEALTH, V17, P1, DOI 10.1146/annurev.pu.17.050196.000245; Oppelt N, 2004, INT J REMOTE SENS, V25, P145, DOI 10.1080/0143116031000115300; Pappas CS, 2011, J FOOD COMPOS ANAL, V24, P17, DOI 10.1016/j.jfca.2010.07.001; Peguero-Pina JJ, 2008, OECOLOGIA, V156, P1, DOI 10.1007/s00442-007-0957-y; Pena MA, 2009, INT J PEST MANAGE, V55, P197, DOI 10.1080/09670870902725809; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Qin JL, 2011, IFIP ADV INF COMM TE, V347, P47; Rao NR, 2008, J AGR SCI-CAMBRIDGE, V146, P65, DOI 10.1017/S0021859607007514; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Schlemmer M, 2013, INT J APPL EARTH OBS, V25, P47, DOI 10.1016/j.jag.2013.04.003; Simic A, 2014, IEEE J-STARS, V7, P92, DOI 10.1109/JSTARS.2013.2271583; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Steele MR, 2009, AM J ENOL VITICULT, V60, P87; THOMAS JR, 1977, AGRON J, V69, P799, DOI 10.2134/agronj1977.00021962006900050017x; Thomas V, 2008, INT J REMOTE SENS, V29, P1029, DOI 10.1080/01431160701281023; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; Verschuyl J, 2011, FOREST ECOL MANAG, V261, P221, DOI 10.1016/j.foreco.2010.10.010; Vina A, 2011, IEEE GEOSCI REMOTE S, V8, P464, DOI 10.1109/LGRS.2010.2086430; Vincini M, 2014, IEEE T GEOSCI REMOTE, V52, P3220, DOI 10.1109/TGRS.2013.2271813; Wang Q, 2012, ECOL INDIC, V14, P56, DOI 10.1016/j.ecolind.2011.08.021; Wu CY, 2008, AGR FOREST METEOROL, V148, P1230, DOI 10.1016/j.agrformet.2008.03.005; Wu CY, 2010, INT J REMOTE SENS, V31, P1079, DOI 10.1080/01431160903252335; Xu XG, 2011, IFIP ADV INF COMM TE, V344, P296; Yang F, 2010, COMPUT ELECTRON AGR, V70, P52, DOI 10.1016/j.compag.2009.08.010; Yang XiaoHua, 2006, Journal of Zhejiang University (Science A), V7, P2002, DOI 10.1631/jzus.2006.A2002; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Zarco-Tejada PJ, 2004, REMOTE SENS ENVIRON, V89, P189, DOI 10.1016/j.rse.2002.06.002; ZARCOTEJADA PJ, 2000, THESIS YORK U TORONT; Zhao DH, 2007, ISPRS J PHOTOGRAMM, V62, P25, DOI 10.1016/j.isprsjprs.2007.01.003; Zhao DL, 2005, AGRON J, V97, P89, DOI 10.2134/agronj2005.0089; Zhao X, 2004, INT GEOSCI REMOTE SE, P4504; Zolkos SG, 2013, REMOTE SENS ENVIRON, V128, P289, DOI 10.1016/j.rse.2012.10.017	114	11	11	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137029	10.1371/journal.pone.0137029	http://dx.doi.org/10.1371/journal.pone.0137029			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356842	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800024
J	Kim, ED; Han, SJ; Byun, YH; Yoon, SC; Choi, KS; Seong, BL; Seo, KY				Kim, Eun-Do; Han, Soo Jung; Byun, Young-Ho; Yoon, Sang Chul; Choi, Kyoung Sub; Seong, Baik Lin; Seo, Kyoung Yul			Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly( I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CROSS-PROTECTION; VIRUS INFECTION; MICE; RESPONSES; NANOPARTICLES; PROTEINS; ANTIBODY; HUMANS; ROUTE	The eye route has been evaluated as an efficient vaccine delivery routes. However, in order to induce sufficient antibody production with inactivated vaccine, testing of the safety and efficacy of the use of inactivated antigen plus adjuvant is needed. Here, we assessed various types of adjuvants in eyedrop as an anti-influenza serum and mucosal Ab production-enhancer in BALB/c mice. Among the adjuvants, poly (I:C) showed as much enhancement in antigen-specific serum IgG and mucosal IgA antibody production as cholera toxin (CT) after vaccinations with trivalent hemagglutinin-subunits or split H1N1 vaccine antigen in mice. Vaccination with split H1N1 eyedrop vaccine antigen plus poly(I:C) showed a similar or slightly lower efficacy in inducing antibody production than intranasal vaccination; the eyedrop vaccine-induced immunity was enough to protect mice from lethal homologous influenza A/California/04/09 (H1N1) virus challenge. Additionally, ocular inoculation with poly(I:C) plus vaccine antigen generated no signs of inflammation within 24 hours:no increases in the mRNA expression levels of inflammatory cytokines nor in the infiltration of mononuclear cells to administration sites. In contrast, CT administration induced increased expression of IL-6 cytokine mRNA and mononuclear cell infiltration in the conjunctiva within 24 hours of vaccination. Moreover, inoculated visualizing materials by eyedrop did not contaminate the surface of the olfactory bulb in mice; meanwhile, intranasally administered materials defiled the surface of the brain. On the basis of these findings, we propose that the use of eyedrop inactivated influenza vaccine plus poly(I:C) is a safe and effective mucosal vaccine strategy for inducing protective anti-influenza immunity.	[Kim, Eun-Do; Han, Soo Jung; Yoon, Sang Chul; Seo, Kyoung Yul] Yonsei Univ, Coll Med, Dept Ophthalmol, Eye & Ear Hosp,Severance Hosp,Inst Vis Res, Seoul, South Korea; [Kim, Eun-Do] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Coll Med, Dept Biotechnol, Seoul, South Korea; [Choi, Kyoung Sub] Yonsei Univ, Grad Sch, Seoul 120749, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Vaccine Translat Res Ctr, Seoul 120749, South Korea; [Choi, Kyoung Sub] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Ophthalmol, Gyounggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; NHIS Ilsan Hospital	Seo, KY (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Eye & Ear Hosp,Severance Hosp,Inst Vis Res, Seoul, South Korea.	seoky@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Yoon, Sangchul/0000-0003-0454-9597; Seo, Kyoung Yul/0000-0002-9855-1980	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) [A103001]; Vaccine Translational Research Center by Ministry of Health & Welfare, Republic of Korea [HI13Co826]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Vaccine Translational Research Center by Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) (Grant No.: A103001) and Vaccine Translational Research Center (Grant No: HI13Co826), in part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CDC, INVL VACC LIV ATT VA; Centers for Disease Control and Prevention (CDC), 2012, INFL VACC LIV INTR 2; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; Choi KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100229; Martins RD, 2012, J CONTROL RELEASE, V162, P553, DOI 10.1016/j.jconrel.2012.07.030; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hikono H, 2013, VET IMMUNOL IMMUNOP, V151, P83, DOI 10.1016/j.vetimm.2012.10.005; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jang YH, 2014, VACCINE, V32, P535, DOI 10.1016/j.vaccine.2013.12.002; Jansson B, 2004, THESIS FACULTY PHARM, P305; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V19, P145, DOI 10.1007/BF00688493; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Malik B, 2014, INT IMMUNOPHARMACOL, V19, P17, DOI 10.1016/j.intimp.2013.12.023; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Miyaki C, 2010, VACCINE, V28, P2505, DOI 10.1016/j.vaccine.2010.01.044; Mo JS, 2001, EUR J IMMUNOL, V31, P3806, DOI 10.1002/1521-4141(200112)31:12<3806::AID-IMMU3806>3.0.CO;2-M; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Rosenfeld MR, 2010, NEURO-ONCOLOGY, V12, P1071, DOI 10.1093/neuonc/noq071; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Sircar P, 2013, MUCOSAL IMMUNOL, V6, P93, DOI 10.1038/mi.2012.52; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steven P, 2008, INVEST OPHTH VIS SCI, V49, P1512, DOI 10.1167/iovs.07-0809; Tamura S, 2010, JPN J INFECT DIS, V63, P8; UNDERDOWN BJ, 1986, ANNU REV IMMUNOL, V4, P389, DOI 10.1146/annurev.iy.04.040186.002133; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Veglia F, 2011, INFECT IMMUN, V79, P1300, DOI 10.1128/IAI.01181-10	42	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137608	10.1371/journal.pone.0137608	http://dx.doi.org/10.1371/journal.pone.0137608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355295	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800070
J	Naticchioni, M; Karani, R; Smith, MA; Onusko, E; Robbins, N; Jiang, M; Radzyukevich, T; Fulford, L; Gao, X; Apel, R; Heiny, J; Rubinstein, J; Koch, SE				Naticchioni, Mindi; Karani, Rajiv; Smith, Margaret A.; Onusko, Evan; Robbins, Nathan; Jiang, Min; Radzyukevich, Tatiana; Fulford, Logan; Gao, Xu; Apel, Ryan; Heiny, Judith; Rubinstein, Jack; Koch, Sheryl E.			Transient Receptor Potential Vanilloid 2 Regulates Myocardial Response to Exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; TRPV2; MOUSE; MICE; PHOSPHORYLATION; PERFORMANCE; CHANNELS	The myocardial response to exercise is an adaptive mechanism that permits the heart to maintain cardiac output via improved cardiac function and development of hypertrophy. There are many overlapping mechanisms via which this occurs with calcium handling being a crucial component of this process. Our laboratory has previously found that the stretch sensitive TRPV2 channels are active regulators of calcium handling and cardiac function under baseline conditions based on our observations that TRPV2-KO mice have impaired cardiac function at baseline. The focus of this study was to determine the cardiac function of TRPV2-KO mice under exercise conditions. We measured skeletal muscle at baseline in WT and TRPV2-KO mice and subjected them to various exercise protocols and measured the cardiac response using echocardiography and molecular markers. Our results demonstrate that the TRPV2-KO mouse did not tolerate forced exercise although they became increasingly exercise tolerant with voluntary exercise. This occurs as the cardiac function deteriorates further with exercise. Thus, our conclusion is that TRPV2-KO mice have impaired cardiac functional response to exercise.	[Naticchioni, Mindi; Karani, Rajiv; Smith, Margaret A.; Onusko, Evan; Robbins, Nathan; Jiang, Min; Fulford, Logan; Gao, Xu; Apel, Ryan; Rubinstein, Jack; Koch, Sheryl E.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45220 USA; [Radzyukevich, Tatiana; Heiny, Judith] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Koch, SE (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45220 USA.	sheryl.koch@uc.edu		Robbins, Nathan/0000-0002-9275-0778; Rubinstein, Jack/0000-0002-8811-1551	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [RO1 AM063710]; American Heart Association [13BGIA17140069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063710] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number RO1 AM063710 (JH) and the American Heart Association (Beginning Grant in Aid 13BGIA17140069 to JR). The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Barro-Soria R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049624; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Iwata Y, 2013, CARDIOVASC RES, V99, P760, DOI 10.1093/cvr/cvt163; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; National Research Council, 2011, GUIDE CARE USE LAB A; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2013, J BIOL CHEM, V288, P1226, DOI 10.1074/jbc.M112.424663; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Weiner RB, 2014, EXPERT REV CARDIOVAS, V12, P1243, DOI 10.1586/14779072.2014.970178; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136901	10.1371/journal.pone.0136901	http://dx.doi.org/10.1371/journal.pone.0136901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356305	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800019
J	Punzalan, FR; Kunieda, Y; Amano, A				Punzalan, Florencio Rusty; Kunieda, Yoshitoshi; Amano, Akira			Program Code Generator for Cardiac Electrophysiology Simulation with Automatic PDE Boundary Condition Handling	PLOS ONE			English	Article							MARKUP LANGUAGE; MODEL; REPRESENTATION; CELLML	Clinical and experimental studies involving human hearts can have certain limitations. Methods such as computer simulations can be an important alternative or supplemental tool. Physiological simulation at the tissue or organ level typically involves the handling of partial differential equations (PDEs). Boundary conditions and distributed parameters, such as those used in pharmacokinetics simulation, add to the complexity of the PDE solution. These factors can tailor PDE solutions and their corresponding program code to specific problems. Boundary condition and parameter changes in the customized code are usually prone to errors and time-consuming. We propose a general approach for handling PDEs and boundary conditions in computational models using a replacement scheme for discretization. This study is an extension of a program generator that we introduced in a previous publication. The program generator can generate code for multi-cell simulations of cardiac electrophysiology. Improvements to the system allow it to handle simultaneous equations in the biological function model as well as implicit PDE numerical schemes. The replacement scheme involves substituting all partial differential terms with numerical solution equations. Once the model and boundary equations are discretized with the numerical solution scheme, instances of the equations are generated to undergo dependency analysis. The result of the dependency analysis is then used to generate the program code. The resulting program code are in Java or C programming language. To validate the automatic handling of boundary conditions in the program code generator, we generated simulation code using the FHN, Luo-Rudy 1, and Hund-Rudy cell models and run cell-to-cell coupling and action potential propagation simulations. One of the simulations is based on a published experiment and simulation results are compared with the experimental data. We conclude that the proposed program code generator can be used to generate code for physiological simulations and provides a tool for studying cardiac electrophysiology.	[Punzalan, Florencio Rusty; Amano, Akira] Ritsumeikan Univ, Coll Life Sci, Dept Bioinformat, Kyoto, Shiga, Japan; [Kunieda, Yoshitoshi] Ritsumeikan Univ, Coll Informat Sci & Engn, Dept Comp Sci, Kobe, Shiga, Japan	Ritsumeikan University; Ritsumeikan University	Amano, A (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Bioinformat, Kyoto, Shiga, Japan.	a-amano@fc.ritsumei.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22136001]; Grants-in-Aid for Scientific Research [26350520] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funding for this project came from the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT) for the Grant-in-Aid for Scientific Research (Kakenhi). It is part of a big project described in research grant number 22136001 and the grant information can be seen in: https://kaken.nii.ac.jp/d/p/22136001.ja.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2001, AM J PHYSIOL-HEART C, V281, pH533, DOI 10.1152/ajpheart.2001.281.2.H533; Asai Y, 2008, J PHYSIOL SCI, V58, P447, DOI 10.2170/physiolsci.RP013308; Bradley C, 2011, PROG BIOPHYS MOL BIO, V107, P32, DOI 10.1016/j.pbiomolbio.2011.06.015; Chang D, 2007, P ANN INT IEEE EMBS, P402, DOI 10.1109/IEMBS.2007.4352309; Christie GR, 2009, PHILOS T R SOC A, V367, P1869, DOI 10.1098/rsta.2009.0025; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Cuellar AA, 2003, SIMUL-T SOC MOD SIM, V79, P740, DOI 10.1177/0037549703040939; Diestel R, 2006, GRADUATE TEXTS MATH, P17; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Fritzson P, 2004, PRINCIPLES OBJECT OR, P662; Garny A, 2008, PHILOS T R SOC A, V366, P3017, DOI 10.1098/rsta.2008.0094; Gustafsson B, 2008, HIGH ORDER DIFFERENC, P115; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Hunter P, 2002, PFLUG ARCH EUR J PHY, V445, P1, DOI 10.1007/s00424-002-0890-1; Kawabata M, 2012, P INT WORKSH INN ARC; Keener J, 2009, MATHEMATICAL PHYSIOL, VII, P568; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Linge S, 2009, PHILOS T R SOC A, V367, P1931, DOI 10.1098/rsta.2008.0306; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Muranushi T, 2012, COMPUT SCI DISC, V5, DOI [10.1088/1749-4699/5/1/015003, DOI 10.1088/1749-4699/5/1/015003]; Pitt-Francis J, 2008, PHILOS T R SOC A, V366, P3111, DOI 10.1098/rsta.2008.0096; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Press W, 2007, NUMERICAL RECIPES AR, P1024; Pullan A.J., 2005, MATH MODELLING ELECT; Punzalan FR, 2013, IEEE ENG MED BIO, P1494, DOI 10.1109/EMBC.2013.6609795; Punzalan FR, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-11; Rezzolla L, 2011, NUMERICAL METHODS SO; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tung L, 1978, THESIS MIT	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136821	10.1371/journal.pone.0136821	http://dx.doi.org/10.1371/journal.pone.0136821			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356082	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800017
J	Toyama, T; Furuichi, K; Shimizu, M; Hara, A; Iwata, Y; Sakai, N; Perkovic, V; Kobayashi, M; Mano, T; Kaneko, S; Wada, T				Toyama, Tadashi; Furuichi, Kengo; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Sakai, Norihiko; Perkovic, Vlado; Kobayashi, Makoto; Mano, Toshiki; Kaneko, Shuichi; Wada, Takashi			Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney Function	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; BLOOD-PRESSURE; RENAL-DISEASE; ALLOPURINOL; ASSOCIATION; PROTEINURIA; PROGRESSION; CREATININE	Background Some observational studies have shown the relationships between hyperuricemia and chronic kidney disease (CKD); however, the threshold of serum uric acid (SUA) for deterioration of kidney function and the association between SUA and kidney injury by baseline kidney function remains unclear. This study aimed to clarify the relationships between SUA and reduced kidney function. Methods We analyzed a historical cohort of male Japanese individuals who underwent medical checkup between 1998 and 2007. Participants with baseline data and who were followed up for at least one year were included and stratified according to baseline kidney function. Kidney function was classified as normal [estimated glomerular filtration rate (eGFR) >= 90 ml/min/1.73 m(2)] or mildly reduced (eGFR 60-89 ml/min/1.73 m(2)). The outcome measured was kidney impairment defined as a decrease in eGFR to < 60 ml/min/1.73 m(2). Associations between SUA and risk for outcome and eGFR slopes were assessed. Results A total of 41632 subjects with mean age 45.4 years were included. During a mean follow-up of four years, 3186 (7.6%) subjects developed kidney dysfunction. Subjects with SUA >= 6.0 mg/dL had a significantly increased risk for kidney impairment compared with subjects with SUA of 4-4.9 mg/dL. SUA threshold levels were different according to baseline kidney function; SUA >= 7.0 and >= 6.0 mg/dL for normal and mildly reduced kidney function, respectively. Approximately the same trends were observed for eGFR slopes. Conclusion In the general population, hyperuricemia appears to be a risk factor for kidney impairment in males. For participants with mild kidney dysfunction, even a slight elevation of SUA can be a risk factor.	[Toyama, Tadashi; Furuichi, Kengo; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Sakai, Norihiko; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Toyama, Tadashi; Perkovic, Vlado] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Kobayashi, Makoto; Mano, Toshiki] Tama Grad Sch Management & Informat Sci, Tokyo, Japan; [Kobayashi, Makoto] CRECON Res & Consulting Inc, Tokyo, Japan; [Kaneko, Shuichi] Kanazawa Univ, Dept Dis Control & Homeostasis, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Lab Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; George Institute for Global Health; University of Sydney; Kanazawa University; Kanazawa University	Wada, T (corresponding author), Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	twada@m-kanazawa.jp	Perkovic, Vlado/AAY-1933-2021; Hara, Akinori/W-8522-2019		Ministry of Health, Labour and Welfare of Japan; JSPS [26870218]; Grants-in-Aid for Scientific Research [15K09251] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Diabetic Nephropathy Research, a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research, and a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan. This work was also supported by JSPS KAKENHI Grant Number 26870218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Ishikawa I, 1990, Nihon Jinzo Gakkai Shi, V32, P923; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118031; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707; Levey AS, 1991, ASSESSING PROGRESSIO, P9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Ministry of Health, 1982, NAT NUTR SURV JAP; Mohandas R, 2015, AM HEART J, V169, P412, DOI 10.1016/j.ahj.2014.12.010; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024	26	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137449	10.1371/journal.pone.0137449	http://dx.doi.org/10.1371/journal.pone.0137449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356235	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800048
J	Wang, J; Gong, L; Zhu, SJ; Zhu, Q; Yao, L; Han, XJ; Zhang, JR; Li, YH; Zhang, W				Wang, Jun; Gong, Li; Zhu, Shao-Jun; Zhu, Qiao; Yao, Li; Han, Xiu-Juan; Zhang, Jia-Rui; Li, Yan-Hong; Zhang, Wei			The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular Carcinoma	PLOS ONE			English	Article							PROTEIN; READTHROUGH; SCREEN; GENE	The molecular pathogenesis of hepatocellular carcinoma (HCC) is heterogeneous and extremely complex. Thus, for individual molecular targeted therapy, novel molecular markers are needed. The abnormal expression of the human homolog of Drosophila headcase (HECA homo) has been found in pancreatic, colorectal, and oral squamous cell carcinoma. Studies of oral squamous cell carcinoma have also demonstrated that the HECA homo protein can be negatively controlled by the Wnt-pathway and transcription factor 4 (TCF4) and can slow cell division by interacting with cyclins and CDKs. However, the role of HECA in HCC has not been reported elsewhere. Here, immunohistochemical analysis revealed that the downregulation of HECA homo protein occurred in 71.0%(66/93) of HCC cases and was positively correlated with a poorly differentiated grade, high serum AFP level, liver cirrhosis and large tumor size. The expression of HECA homo was detected in five live cell lines. In vitro, the overexpression of HECA homo in HepG2, Huh-7 and MHCC-97H cells could inhibit cell proliferation and colony formation and induce G1 phase arrest. In contrast, the downregulation of HECA homo could promote cell proliferation, colony formation and the cell cycle process. However, neither the overexpression nor downregulation of HECA homo in the three cell lines could affect cell migration or invasion. Collectively, HECA homo is regularly expressed in normal live cells, and the HECA homo protein level is heterogeneously altered in HCC, but the downregulation of HECA homo is more common and positively correlated with several malignant phenotypes. The HECA homo protein can slow cell proliferation to some extent primarily through its blocking effect on the cell cycle. Hence, the HECA homo protein may act as a tumor suppressor in HCC and might be a potential molecular marker for diagnostic classification and targeted therapy in HCC.	[Wang, Jun; Gong, Li; Zhu, Shao-Jun; Zhu, Qiao; Yao, Li; Han, Xiu-Juan; Zhang, Jia-Rui; Li, Yan-Hong; Zhang, Wei] Fourth Mil Med Univ, Dept Pathol, Tangdu Hosp, Helmholtz Sinogerman Lab Canc Res, Xian 710032, Shaanxi, Peoples R China; [Li, Yan-Hong] Fourth Mil Med Univ, Dept Gynecol & Obstet, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, YH (corresponding author), Fourth Mil Med Univ, Dept Pathol, Tangdu Hosp, Helmholtz Sinogerman Lab Canc Res, Xian 710032, Shaanxi, Peoples R China.	lyhzhw@fmmu.edu.cn; zhwlyh@fmmu.edu.cn			National Natural Science Foundation of China [81372226, 30672013, 30800417]; National Basic Research Program (973 Program) of China [2015CB553703]; Shaanxi Province Innovation Project [2011KTCL03-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Shaanxi Province Innovation Project	The study was supported by the National Natural Science Foundation of China (81372226 [WZ], 30672013 [WZ] and 30800417 [LG]) (URL: http://npd.nsfc.gov.cn/granttype1!index.action), the National Basic Research Program (973 Program) of China (2015CB553703 [WZ]) (URL: http://program.most.gov.cn/), and Shaanxi Province Innovation Project Co-ordinator (2011KTCL03-11 [WZ]) (URL: none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach EA, 2003, GENETICS, V165, P1149; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen WQ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.04.05; Chien CC, 2006, ONCOL REP, V15, P919; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dowejko A, 2012, EXP CELL RES, V318, P489, DOI 10.1016/j.yexcr.2011.11.004; Dowejko A, 2009, CARCINOGENESIS, V30, P1678, DOI 10.1093/carcin/bgp189; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Kudo M, 2012, WORLD J GASTROENTERO, V18, P6005, DOI 10.3748/wjg.v18.i42.6005; Loncle N, 2012, J NEUROSCI, V32, P17086, DOI 10.1523/JNEUROSCI.1391-12.2012; Makino N, 2001, DNA SEQUENCE, V11, P547, DOI 10.3109/10425170109041340; Nakagawa H, 2013, CANCER LETT, V340, P234, DOI 10.1016/j.canlet.2012.10.035; Nikolaou K, 2013, CLIN CANCER RES, V19, P2810, DOI 10.1158/1078-0432.CCR-12-1961; Resende LPF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068026; Shin JW, 2013, WORLD J GASTROENTERO, V19, P6144, DOI 10.3748/wjg.v19.i37.6144; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Weaver TA, 1995, DEVELOPMENT, V121, P4149; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	19	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137579	10.1371/journal.pone.0137579	http://dx.doi.org/10.1371/journal.pone.0137579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356417	gold, Green Published			2022-12-27	WOS:000360965800065
J	Johler, SM; Rejman, J; Guan, S; Rosenecker, J				Johler, Sarah M.; Rejman, Joanna; Guan, Shan; Rosenecker, Joseph			Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration	PLOS ONE			English	Article							GENE DELIVERY; AEROSOL DELIVERY; PULMONARY DELIVERY; PHYSICAL STABILITY; CYSTIC-FIBROSIS; PSEUDOURIDINE; EXPRESSION; EFFICIENCY; CAPACITY; THERAPY	During the last years the potential role of in vitro transcribed (IVT) mRNA as a vehicle to deliver genetic information has come into focus. IVT mRNA could be used for anti-cancer therapies, vaccination purposes, generation of pluripotent stem cells and also for genome engineering or protein replacement. However, the administration of IVT mRNA into the target organ is still challenging. The lung with its large surface area is not only of interest for delivery of genetic information for treatment of e.g. for cystic fibrosis or alpha-1-antitrypsin deficiency, but also for vaccination purposes. Administration of IVT mRNA to the lung can be performed by direct intratracheal instillation or by aerosol inhalation/nebulisation. The latter approach shows a non-invasive tool, although it is not known, if IVT mRNA is resistant during the process of nebulisation. Therefore, we investigated the transfection efficiency of non-nebulised and nebulised IVT mRNA polyplexes and lipoplexes in human bronchial epithelial cells (16HBE). A slight reduction in transfection efficiency was observed for lipoplexes (Lipofectamine 2000) in the nebulised part compared to the non-nebulised which can be overcome by increasing the amount of Lipofectamine. However, Lipofectamine was more than three times more efficient in transfecting 16HBE than DMRIE and linear PEI performed almost 10 times better than its branched derivative. By contrast, the nebulisation process did not affect the cationic polymer complexes. Furthermore, aerosolisation of IVT mRNA complexes did neither affect the protein duration nor the toxicity of the cationic complexes. Taken together, these data show that aerosolisation of cationic IVT mRNA complexes constitute a potentially powerful means to transfect cells in the lung with the purpose of protein replacement for genetic diseases such as cystic fibrosis or alpha-1-antitrypsin deficiency or for infectious disease vaccines, while bringing along the advantages of IVT mRNA as compared to pDNA as transfection agent.	[Johler, Sarah M.; Rejman, Joanna; Guan, Shan; Rosenecker, Joseph] Klinikum Univ Munchen, Dr von Haunerschen Kinderspital, Kinderklin & Kinderpoliklin, Munich, Germany	University of Munich	Rejman, J (corresponding author), Klinikum Univ Munchen, Dr von Haunerschen Kinderspital, Kinderklin & Kinderpoliklin, Munich, Germany.	Joanna.Rejman@med.uni-muenchen.de; Joseph.rosenecker@med.uni-muenchen.de	Rosenecker, Joseph/AAA-7330-2020		Bundesministerium fur Bildung und Forschung [01GM1106A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung, 01GM1106A.	Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Arulmuthu ER, 2007, BIOTECHNOL BIOENG, V98, P939, DOI 10.1002/bit.21493; Birchall J, 2007, EXPERT OPIN DRUG DEL, V4, P575, DOI 10.1517/17425247.4.6.575; Birchall JC, 2000, INT J PHARM, V197, P221, DOI 10.1016/S0378-5173(00)00339-2; Catanese DJ, 2012, GENE THER, V19, P94, DOI 10.1038/gt.2011.77; Davies LA, 2008, MOL THER, V16, P1283, DOI 10.1038/mt.2008.96; Davies LA, 2014, HUM GENE THER CL DEV, V25, P97, DOI 10.1089/humc.2014.019; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Huth S, 2006, J GENE MED, V8, P1416, DOI 10.1002/jgm.975; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Lentz YK, 2006, J PHARM SCI-US, V95, P607, DOI 10.1002/jps.20511; Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2; Pastor M, 2014, INT J PHARMACEUT, V477, P485, DOI 10.1016/j.ijpharm.2014.10.048; Rajapaksa AE, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-60; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Rudolph C, 2005, MOL THER, V12, P493, DOI 10.1016/j.ymthe.2005.03.002; Rudolph C, 2005, J GENE MED, V7, P59, DOI 10.1002/jgm.646; Rudolph C, 2002, J GENE MED, V4, P66, DOI 10.1002/jgm.225; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Yamamoto A, 2009, EUR J PHARM BIOPHARM, V71, P484, DOI 10.1016/j.ejpb.2008.09.016	23	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137504	10.1371/journal.pone.0137504	http://dx.doi.org/10.1371/journal.pone.0137504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352268	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800091
J	Kenyon, SG; Buerki, S; Hansson, C; Alvarez, N; Benrey, B				Kenyon, Sarah G.; Buerki, Sven; Hansson, Christer; Alvarez, Nadir; Benrey, Betty			Uncovering Cryptic Parasitoid Diversity in Horismenus (Chalcidoidea, Eulophidae)	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; ACANTHOSCELIDES-OBTECTUS SAY; HYMENOPTERA; PHYLOGENY; BEETLES; L.	Horismenus parasitoids are an abundant and understudied group of eulophid wasps found mainly in the New World. Recent surveys based on morphological analyses in Costa Rica have quadrupled the number of named taxa, with more than 400 species described so far. This recent revision suggests that there is still a vast number of unknown species to be identified. As Horismenus wasps have been widely described as parasitoids of insect pests associated with crop plants, it is of high importance to properly establish the extant diversity of the genus, in order to provide biological control practitioners with an exhaustive catalog of putative control agents. In this study, we first collected Horismenus wasps from wild Phaseolus bean seeds in Central Mexico and Arizona to assess the genetic relatedness of three morphologically distinct species with overlapping host and geographical ranges. Sequence data from two nuclear and two mitochondrial gene regions uncovered three cryptic species within each of the three focal species (i.e., H. missouriensis, H. depressus and H. butcheri). The monophyly of each cryptic group is statistically supported (except in two of them represented by one single tip in which monophyly cannot be tested). The phylogenetic reconstruction is discussed with respect to differences between gene regions as well as likely reasons for the differences in variability between species.	[Kenyon, Sarah G.; Benrey, Betty] Univ Neuchatel, Inst Biol, Lab Evolutionary Entomol, CH-2000 Neuchatel, Switzerland; [Buerki, Sven; Hansson, Christer] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Hansson, Christer] Lund Univ, Museum Biol Entomol, Lund, Sweden; [Alvarez, Nadir] Univ Lausanne, Dept Ecol & Evolut, Biophore Dorigny, Lausanne, Switzerland	University of Neuchatel; Natural History Museum London; Lund University; University of Lausanne	Benrey, B (corresponding author), Univ Neuchatel, Inst Biol, Lab Evolutionary Entomol, CH-2000 Neuchatel, Switzerland.	Betty.Benrey@unine.ch	Benrey, Betty/AAL-1374-2020; Alvarez, Nadir/AAM-2228-2021; Alvarez, Nadir/B-4318-2010	Benrey, Betty/0000-0002-3230-4450; Alvarez, Nadir/0000-0002-0729-166X; Alvarez, Nadir/0000-0002-0729-166X; Buerki, Sven/0000-0002-8299-6539	Swiss National Foundation [3100AO-10923]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Support was provided by the Swiss National Foundation (http://www.snf.ch), grant # 3100AO-10923, awarded to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI A, 2004, THESIS U NEUCHATEL S; Aebi A, 2008, BIOL CONTROL, V47, P289, DOI 10.1016/j.biocontrol.2008.07.019; Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Alvarez N, 2006, ECOL ENTOMOL, V31, P582, DOI 10.1111/j.1365-2311.2006.00817.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BORCHSENIUS F, 2009, FASTGAP 1 2; Campbell B, 2000, THE HYMENOPTERA EVOL, P57; Campbell B. C., 1993, Insect Molecular Biology, V2, P225, DOI 10.1111/j.1365-2583.1994.tb00142.x; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Chacon S MI, 2007, PLANT SYST EVOL, V266, P175, DOI 10.1007/s00606-007-0536-z; Cuignet M, 2007, MOL PHYLOGENET EVOL, V42, P573, DOI 10.1016/j.ympev.2006.09.005; Delgado-Salinas A, 2006, SYST BOT, V31, P779, DOI 10.1600/036364406779695960; Freytag G.F., 2002, TAXONOMY DISTRIBUTIO; Gauthier N, 2000, SYST ENTOMOL, V25, P521, DOI 10.1046/j.1365-3113.2000.00134.x; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Gepts P, 2000, WILD LEG P 7 MAFF IN; Gepts P., 2002, ENCY LIFE SCI, DOI [10.1038/npg.els.0003071, DOI 10.1038/NPG.ELS.0003071]; Hall T, 1999, BIOEDIT 5 0 6; Hansson C, 2004, ZOOTAXA, P1; Hansson Christer, 2009, Memoirs of the American Entomological Institute (Gainesville), V82, P1; Laurin-Lemay S, 2013, B ENTOMOL RES, V103, P182, DOI 10.1017/S000748531200051X; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pellissier L, 2012, ZOOL SCR, V41, P651, DOI 10.1111/j.1463-6409.2012.00556.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Sha ZL, 2006, BIOL CONTROL, V38, P380, DOI 10.1016/j.biocontrol.2006.04.008; Shlichta JG, 2014, J CHEM ECOL, V40, P468, DOI 10.1007/s10886-014-0434-0; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zaugg I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055317; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	35	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136063	10.1371/journal.pone.0136063	http://dx.doi.org/10.1371/journal.pone.0136063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352700	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800022
J	Kreuzinger-Janik, B; Schroeder, F; Majdi, N; Traunspurger, W				Kreuzinger-Janik, Bianca; Schroeder, Fabian; Majdi, Nabil; Traunspurger, Walter			Depth-Related Effects on a Meiofaunal Community Dwelling in the Periphyton of a Mesotrophic Lake	PLOS ONE			English	Article							EPILITHIC PERIPHYTON; BIOMASS; NEMATODES; PATTERNS; RIVER; BIOFILMS; ECOLOGY; LIGHT; HYDRODYNAMICS; ASSEMBLAGES	Periphyton is a complex assemblage of micro- and meiofauna embedded in the organic matrix that coats most submerged substrate in the littoral of lakes. The aim of this study was to better understand the consequences of depth-level fluctuation on a periphytic community. The effects of light and wave disturbance on the development of littoral periphyton were evaluated in Lake Erken (Sweden) using an experimental design that combined in situ shading with periphyton depth transfers. Free-living nematodes were a major contributor to the meiofaunal community. Their species composition was therefore used as a proxy to distinguish the contributions of light-and wave-related effects. The periphyton layer was much thicker at a depth of 30 cm than at 200 cm, as indicated by differences in the amounts of organic and phototrophic biomass and meiofaunal and nematode densities. A reduction of the depth-level of periphyton via a transfer from a deep to a shallow location induced rapid positive responses by its algal, meiofaunal, and nematode communities. The slower and weaker negative responses to the reverse transfer were attributed to the potentially higher resilience of periphytic communities to increases in the water level. In the shallow littoral of the lake, shading magnified the effects of phototrophic biomass erosion by waves, as the increased exposure to wave shear stress was not compensated for by an increase in photosynthesis. This finding suggests that benthic primary production will be strongly impeded in the shallow littoral zones of lakes artificially shaded by construction or embankments. However, regardless of the light constraints, an increased exposure to wave action had a generally positive short-term effect on meiofaunal density, by favoring the predominance of species able to anchor themselves to the substrate, especially the Chromadorid nematode Punctodora ratzeburgensis.	[Kreuzinger-Janik, Bianca; Schroeder, Fabian; Majdi, Nabil; Traunspurger, Walter] Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, Germany	University of Bielefeld	Kreuzinger-Janik, B (corresponding author), Univ Bielefeld, Anim Ecol, Konsequenz 45, D-33615 Bielefeld, Germany.	bianca.kreuzinger@gmx.de	Majdi, Nabil/J-8578-2016	Majdi, Nabil/0000-0001-7052-4297	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	Funding: The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Ask J, 2009, ECOLOGY, V90, P1923, DOI 10.1890/07-1855.1; Axler RP, 1996, LIMNOL OCEANOGR, V41, P659, DOI 10.4319/lo.1996.41.4.0659; Azim M. E., 2005, Periphyton: ecology, exploitation and management, P15, DOI 10.1079/9780851990965.0015; BARTON DR, 1982, CAN J ZOOL, V60, P984, DOI 10.1139/z82-137; Beier S, 2003, HYDROBIOLOGIA, V498, P107, DOI 10.1023/A:1026258607551; Bouletreau S, 2006, FRESHWATER BIOL, V51, P901, DOI 10.1111/j.1365-2427.2006.01541.x; Bourassa N, 2000, FRESHWATER BIOL, V44, P629, DOI 10.1046/j.1365-2427.2000.00610.x; CATTANEO A, 1990, HYDROBIOLOGIA, V206, P1, DOI 10.1007/BF00018964; CROLL NA, 1972, J NEMATOL, V4, P256; Eisendle-Flockner U, 2013, ECOL EVOL, V3, P2832, DOI 10.1002/ece3.679; Eriksson PG, 2001, BIOGEOCHEMISTRY, V55, P29, DOI 10.1023/A:1010679306361; Estifanos TK, 2013, NEMATOLOGY, V15, P1, DOI 10.1163/156854112X639900; EVANS WA, 1984, HYDROBIOLOGIA, V108, P105, DOI 10.1007/BF00014869; Gaudes A, 2006, NEMATOLOGY, V8, P909, DOI 10.1163/156854106779799169; Giere O., 1993, MEIOBENTHOLOGY; Graba M, 2014, FRESHWATER BIOL, V59, P1213, DOI 10.1111/fwb.12341; HAGERMAN G M JR, 1981, Marine Ecology, V2, P245, DOI 10.1111/j.1439-0485.1981.tb00099.x; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harrison SSC, 1998, FRESHWATER BIOL, V39, P477, DOI 10.1046/j.1365-2427.1998.00296.x; Hill Walter, 1996, P121, DOI 10.1016/B978-012668450-6/50034-5; Hillebrand H, 2001, LIMNOL OCEANOGR, V46, P1881, DOI 10.4319/lo.2001.46.8.1881; Hillebrand H, 2005, J ECOL, V93, P758, DOI 10.1111/j.1365-2745.2005.00978.x; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; Hillebrand H, 2002, J N AM BENTHOL SOC, V21, P349, DOI 10.2307/1468475; HOAGLAND KD, 1990, J PHYCOL, V26, P450, DOI 10.1111/j.0022-3646.1990.00450.x; Hoagland KD, 1986, ALGAL BIOFOULING; JENSEN P, 1982, NEMATOLOGICA, V28, P71, DOI 10.1163/187529282X00529; JONSSON GS, 1987, ARCH HYDROBIOL, V108, P531; Kairesalo T., 1983, PERIPHITON FRESHWATE, V17, P153; Kazemi-Dinan A, 2014, LIMNOLOGICA, V44, P49, DOI 10.1016/j.limno.2013.05.011; Larned ST, 2010, J N AM BENTHOL SOC, V29, P182, DOI 10.1899/08-063.1; Liu Y, 2015, HYDROBIOLOGIA, V744, P165, DOI 10.1007/s10750-014-2074-3; Majdi N, 2015, J NEMATOLOGY, V47; Majdi N, 2012, FRESHWATER BIOL, V57, P1180, DOI 10.1111/j.1365-2427.2012.02784.x; Majdi N, 2012, FRESHW SCI, V31, P38, DOI 10.1899/11-073.1; Majdi N, 2012, HYDROBIOLOGIA, V680, P219, DOI 10.1007/s10750-011-0920-0; Majdi N, 2011, HYDROBIOLOGIA, V673, P229, DOI 10.1007/s10750-011-0781-6; Mialet B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075352; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Peters L, 2005, NEMATOLOGY, V7, P267, DOI 10.1163/1568541054879520; Peters L, 2007, J N AM BENTHOL SOC, V26, P232, DOI 10.1899/0887-3593(2007)26[232:ECIALL]2.0.CO;2; Peters L, 2012, AQUAT ECOL, V46, P371, DOI 10.1007/s10452-012-9408-x; Peters L, 2012, AQUAT SCI, V74, P229, DOI 10.1007/s00027-011-0214-7; REUTER JE, 1986, LIMNOL OCEANOGR, V31, P149, DOI 10.4319/lo.1986.31.1.0149; Ricci C, 2000, FRESHWATER BIOL, V44, P15, DOI 10.1046/j.1365-2427.2000.00584.x; Schroeder F, 2013, INT REV HYDROBIOL, V98, P322, DOI 10.1002/iroh.201301652; Schroeder F, 2012, FUND APPL LIMNOL, V181, P143, DOI 10.1127/1863-9135/2012/0332; Schroeder F, 2012, J LIMNOL, V71, P216, DOI 10.4081/jlimnol.2012.e23; Seinhorst J. W., 1959, Nematologica, V4, P67; STEINMAN AD, 1987, CAN J FISH AQUAT SCI, V44, P1640, DOI 10.1139/f87-199; STEVENSON RJ, 1981, J PHYCOL, V17, P29, DOI 10.1111/j.0022-3646.1981.00029.x; Stich HB, 2005, ARCH HYDROBIOL, V162, P111, DOI 10.1127/0003-9136/2005/0162-0111; STRAYER D, 1986, ECOLOGY, V67, P303, DOI 10.2307/1938574; Tiekjen J.H., 1977, Belle W. Baruch Library in Marine Science, P21; Traunspurger W, 2000, FRESHWATER BIOL, V44, P29, DOI 10.1046/j.1365-2427.2000.00585.x; Traunspurger W, 1997, VIE MILIEU, V47, P1; Traunspurger Walter, 1992, Spixiana, V15, P233; Vadeboncoeur Y, 2000, J N AM BENTHOL SOC, V19, P68, DOI 10.2307/1468282; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vadeboncoeur Y, 2001, ECOLOGY, V82, P1065, DOI 10.1890/0012-9658(2001)082[1065:WLFEOD]2.0.CO;2; Vadeboncoeur Y, 2008, ECOLOGY, V89, P2542, DOI 10.1890/07-1058.1; van Dam AA, 2002, REV FISH BIOL FISHER, V12, P1, DOI 10.1023/A:1022639805031; Young Orson Whitney, 1945, TRANS AMER MICROSC SOC, V64, P1, DOI 10.2307/3223433	63	7	8	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137793	10.1371/journal.pone.0137793	http://dx.doi.org/10.1371/journal.pone.0137793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353016	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800114
J	Obakan, P; Barrero, C; Coker-Gurkan, A; Arisan, ED; Merali, S; Palavan-Unsal, N				Obakan, Pinar; Barrero, Carlos; Coker-Gurkan, Ajda; Arisan, Elif Damla; Merali, Salim; Palavan-Unsal, Narcin			SILAC-Based Mass Spectrometry Analysis Reveals That Epibrassinolide Induces Apoptosis via Activating Endoplasmic Reticulum Stress in Prostate Cancer Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; AMINO-ACIDS; CALRETICULIN; EXPRESSION; OVEREXPRESSION; CHAPERONE; ANDROGEN; SURVIVAL; CULTURE; BINDING	Epibrassinolide (EBR) is a polyhydroxylated sterol derivative and biologically active compound of the brassinosteroids. In addition to well-described roles in plant growth, EBR induces apoptosis in the LNCaP prostate cancer cells expressing functional androgen receptor (AR). Therefore, it is suggested that EBR might have an inhibitory potential on androgen receptor signaling pathway. However, the mechanism by which EBR exerts its effects on LNCaP is poorly understood. To address this gap in knowledge, we used an unbiased global proteomics approach, i.e., stable-isotope labeling by amino acids in cell culture (SILAC). In total, 964 unique proteins were identified, 160 of which were differentially expressed after 12 h of EBR treatment. The quantification of the differentially expressed proteins revealed that the expression of the unfolded protein response (UPR) chaperone protein, calreticulin (CALR), was dramatically downregulated. The decrease in CALR expression was also validated by immunoblotting. Because our data revealed the involvement of the UPR in response to EBR exposure, we evaluated the expression of the other UPR proteins. We demonstrated that EBR treatment downregulated calnexin and upregulated BiP and IRE1a expression levels and induced CHOP translocation from the cytoplasm to nucleus. The translocation of CHOP was associated with caspase-9 and caspase-3 activation after a 12 h EBR treatment. Co-treatment of EBR with rapamycin, an upstream mTOR pathway inhibitor, prevented EBR-induced cell viability loss and PARP cleavage in LNCaP prostate cancer cells, suggesting that EBR could induce ER stress in these cells. In addition, we observed similar results in DU145 cells with nonfunctional androgen receptor. When proteasomal degradation of proteins was blocked by MG132 co-treatment, EBR treatment further induced PARP cleavage relative to drug treatment alone. EBR also induced Ca2+ sequestration, which confirmed the alteration of the ER pathway due to drug treatment. Therefore, we suggest that EBR promotes ER stress and induces apoptosis.	[Obakan, Pinar; Coker-Gurkan, Ajda; Arisan, Elif Damla; Palavan-Unsal, Narcin] Istanbul Kultur Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Barrero, Carlos; Merali, Salim] Temple Univ, Sch Med, Fels Inst, Dept Biochem, Philadelphia, PA 19122 USA	Istanbul Kultur University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Obakan, P (corresponding author), Istanbul Kultur Univ, Dept Mol Biol & Genet, Atakoy Campus, Istanbul, Turkey.	p.obakan@iku.edu.tr	OBAKAN, PINAR/D-2836-2015; Arisan, Elif Damla/W-8682-2019	Arisan, Elif Damla/0000-0002-4844-6381; Barrero, Carlos/0000-0001-5779-6642; Unsal Palavan, Narcin/0000-0002-2945-540X; Gurkan, Ajda/0000-0003-1475-2417	Istanbul Kultur University Scientific Projects Support Center	Istanbul Kultur University Scientific Projects Support Center(Istanbul Kultur University)	This study was supported by the Istanbul Kultur University Scientific Projects Support Center and the Temple University Fels Institute of Cancer and Molecular Biology Department by using their own resources.	Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Duan XB, 2010, PROTEOMICS, V10, P2165, DOI 10.1002/pmic.201000020; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Ismaili J, 2012, STEROIDS, V77, P91, DOI 10.1016/j.steroids.2011.10.009; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Liu J, 2014, PLANT BIOLOGY, V16, P440, DOI 10.1111/plb.12052; Malikova J, 2008, PHYTOCHEMISTRY, V69, P418, DOI 10.1016/j.phytochem.2007.07.028; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Obakan P, 2014, AMINO ACIDS, V46, P553, DOI 10.1007/s00726-013-1574-1; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Quick QA, 2012, EXP THER MED, V3, P487, DOI 10.3892/etm.2011.422; Steigerova J, 2012, FOOD CHEM TOXICOL, V50, P4068, DOI 10.1016/j.fct.2012.08.031; Xu YH, 2009, BIOTECHNOL APPL BIOC, V54, P11, DOI 10.1042/BA20090007; Zhu N, 1999, CANCER RES, V59, P1896; Zhu N, 1998, ENDOCRINOLOGY, V139, P4337, DOI 10.1210/en.139.10.4337	26	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135788	10.1371/journal.pone.0135788	http://dx.doi.org/10.1371/journal.pone.0135788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353013	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800015
J	Yang, CY; Chen, FA; Chen, CF; Liu, WS; Shih, CJ; Ou, SM; Yang, WC; Lin, CC; Yang, AH				Yang, Chih-Yu; Chen, Fu-An; Chen, Chun-Fan; Liu, Wen-Sheng; Shih, Chia-Jen; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching; Yang, An-Hang			Diagnostic Accuracy of Urine Protein/Creatinine Ratio Is Influenced by Urine Concentration	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CREATININE EXCRETION; PROTEINURIA; GRAVITY	Background The usage of urine protein/creatinine ratio to estimate daily urine protein excretion is prevalent, but relatively little attention has been paid to the influence of urine concentration and its impact on test accuracy. We took advantage of 24-hour urine collection to examine both urine protein/creatinine ratio (UPCR) and daily urine protein excretion, with the latter as the reference standard. Specific gravity from a concomitant urinalysis of the same urine sample was used to indicate the urine concentration. Methods During 2010 to 2014, there were 540 adequately collected 24h urine samples with protein concentration, creatinine concentration, total volume, and a concomitant urinalysis of the same sample. Variables associated with an accurate UPCR estimation were determined by multivariate linear regression analysis. Receiver operating characteristic (ROC) curves were generated to determine the discriminant cut-off values of urine creatinine concentration for predicting an accurate UPCR estimation in either dilute or concentrated urine samples. Results Our findings indicated that for dilute urine, as indicated by a low urine specific gravity, UPCR is more likely to overestimate the actual daily urine protein excretion. On the contrary, UPCR of concentrated urine is more likely to result in an underestimation. By ROC curve analysis, the best cut-off value of urine creatinine concentration for predicting overestimation by UPCR of dilute urine (specific gravity <= 1.005) was <= 38.8 mg/dL, whereas the best cut-off values of urine creatinine for predicting underestimation by UPCR of thick urine were >= 63.6 mg/dL (specific gravity >= 1.015), >= 62.1 mg/dL (specific gravity >= 1.020), >= 61.5 mg/dL (specific gravity >= 1.025), respectively. We also compared distribution patterns of urine creatinine concentration of 24h urine cohort with a concurrent spot urine cohort and found that the underestimation might be more profound in single voided samples. Conclusions The UPCR in samples with low or high specific gravity is more likely to overestimate or underestimate actual daily urine protein amount, respectively, especially in a dilute urine sample with its creatinine below 38.8 mg/dL or a concentrated sample with its creatinine above 61.5 mg/dL. In particular, UPCR results should be interpreted with caution in cases that involve dilute urine samples because its overestimation may lead to an erroneous diagnosis of proteinuric renal disease or an incorrect staging of chronic kidney disease.	[Yang, Chih-Yu; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yang, Chih-Yu; Yang, An-Hang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Chih-Yu; Chen, Fu-An; Chen, Chun-Fan; Liu, Wen-Sheng; Shih, Chia-Jen; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching; Yang, An-Hang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Fu-An; Chen, Chun-Fan] Natl Yang Ming Univ Hosp, Div Nephrol, Dept Med, Yilan, Taiwan; [Liu, Wen-Sheng] Taipei City Hosp, Zhongxing Branch, Dept Med, Div Nephrol, Taipei, Taiwan; [Liu, Wen-Sheng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shih, Chia-Jen] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Med, Div Nephrol, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital	Lin, CC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.	lincc2@vghtpe.gov.tw; ahyang@vghtpe.gov.tw	Yang, Chih-Yu/AAR-6147-2020; liu, wen/HGE-3071-2022	Yang, Chih-Yu/0000-0001-9899-3159; Chen, Chun-Fan/0000-0003-1932-3590	Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program [103-V-B-024]	Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program	Funding: This study was supported by the Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program, No. 103-V-B-024 to CY.	Clark N, 2003, DIABETES CARE, V26, P3333; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Constantiner M, 2005, AM J KIDNEY DIS, V45, P833, DOI 10.1053/j.ajkd.2005.02.012; Cote AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.009; Drawz P, 2009, ANN INTERN MED, V150, pITC2; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; FORBES GB, 1976, AM J CLIN NUTR, V29, P1359, DOI 10.1093/ajcn/29.12.1359; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Kalantari K, 2013, CLIN J AM SOC NEPHRO, V8, P1847, DOI 10.2215/CJN.09770913; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Moore RR, 1997, KIDNEY INT, V52, P240, DOI 10.1038/ki.1997.326; Parikh CR, 2002, AM J NEPHROL, V22, P315, DOI 10.1159/000065220; PERRONE RD, 1992, CLIN CHEM, V38, P1933; WALSER M, 1987, JPEN-PARENTER ENTER, V11, pS73, DOI 10.1177/014860718701100510	18	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137460	10.1371/journal.pone.0137460	http://dx.doi.org/10.1371/journal.pone.0137460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353117	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800088
J	Hallsworth, M; Berry, D; Sanders, M; Sallis, A; King, D; Vlaev, I; Darzi, A				Hallsworth, Michael; Berry, Dan; Sanders, Michael; Sallis, Anna; King, Dominic; Vlaev, Ivo; Darzi, Ara			Stating Appointment Costs in SMS Reminders Reduces Missed Hospital Appointments: Findings from Two Randomised Controlled Trials	PLOS ONE			English	Article							TAX COMPLIANCE; ACCESS; INTERVENTION; ATTENDANCE; TELEPHONE; NORMS; CARE	Background Missed hospital appointments are a major cause of inefficiency worldwide. Healthcare providers are increasingly using Short Message Service reminders to reduce 'Did Not Attend' (DNA) rates. Systematic reviews show that sending such reminders is effective, but there is no evidence on whether their impact is affected by their content. Accordingly, we undertook two randomised controlled trials that tested the impact of rephrasing appointment reminders on DNA rates in the United Kingdom. Trial Methods Participants were outpatients with a valid mobile telephone number and an outpatient appointment between November 2013 and January 2014 (Trial One, 10,111 participants) or March and May 2014 (Trial Two, 9,848 participants). Appointments were randomly allocated to one of four reminder messages, which were issued five days in advance. Message assignment was then compared against appointment outcomes (appointment attendance, DNA, cancellation by patient). Results In Trial One, a message including the cost of a missed appointment to the health system produced a DNA rate of 8.4%, compared to 11.1% for the existing message (OR 0.74, 95% CI 0.61-0.89, P< 0.01). Trial Two replicated this effect (DNA rate 8.2%), but also found that expressing the same concept in general terms was significantly less effective (DNA rate 9.9%, OR 1.22, 95% CI 1.00-1.48, P< 0.05). Moving from the existing reminder to the more effective costs message would result in 5,800 fewer missed appointments per year in the National Health Service Trust in question, at no additional cost. The study's main limitations are that it took place in a single location in England, and that it required accurate phone records, which were only obtained for 20% of eligible patients. We conclude that missed appointments can be reduced, for no additional cost, by introducing persuasive messages to appointment reminders. Future studies could examine the impact of varying reminder messages in other health systems.	[Hallsworth, Michael; King, Dominic; Vlaev, Ivo; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England; [Hallsworth, Michael; Sanders, Michael] Behav Insights Team, London, England; [Berry, Dan] Dept Hlth, London SE1 6TE, England; [Sanders, Michael] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Sallis, Anna] Publ Hlth England, London, England	Imperial College London; Harvard University; Public Health England	Hallsworth, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England.	m.hallsworth11@imperial.ac.uk			Centre for Health Policy at Imperial College; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	Centre for Health Policy at Imperial College; National Institute for Health Research(National Institute for Health Research (NIHR))	The Centre for Health Policy at Imperial College provided funds to iPlato to permit the development of the randomization procedure. No other funds were received by the authors in connection with this trial. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Fogarty AW, 2013, JAMA INTERN MED, V173, P1654, DOI 10.1001/jamainternmed.2013.8211; Frederick S, 2009, J CONSUM RES, V36, P553, DOI 10.1086/599764; Gurol-Urganci I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub3; Guy R, 2012, HEALTH SERV RES, V47, P614, DOI 10.1111/j.1475-6773.2011.01342.x; Hallsworth M, 2014, 200420007 NBER, P20007; Hasvold PE, 2011, J TELEMED TELECARE, V17, P358, DOI 10.1258/jtt.2011.110707; Hawton K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f403; Haynes LC, 2013, J POLICY ANAL MANAG, V32, P718, DOI 10.1002/pam.21717; Health and Social Care Information Centre, 2014, NHSMALL US STAT; Health and Social Care Information Centre, 2013, NHSMALL US SURV RES; HSCIC, 2013, HOSP OUTP ACT 2012 1; Iyer GS, 2010, NATL TAX J, V63, P7, DOI 10.17310/ntj.2010.1.01; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; LaGanga LR, 2007, DECISION SCI, V38, P251, DOI 10.1111/j.1540-5915.2007.00158.x; Martin SJ, 2012, J ROY SOC MED, V105, P101, DOI 10.1258/jrsm.2011.110250; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Murdock A, 2002, J ROY SOC MED, V95, P284, DOI 10.1258/jrsm.95.6.284; Murray M, 2000, BRIT MED J, V320, P1594, DOI 10.1136/bmj.320.7249.1594; National Audit Office, 2014, NHS WAIT TIM EL CAR; Neal Richard D, 2005, BMC Fam Pract, V6, P47, DOI 10.1186/1471-2296-6-47; NHS England, 2014, Q HOSP ACT DAT; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Perron NJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-125; Petty R.E., 1995, ATTITUDE STRENGTH AN, P93; Slemrod J, 2013, TAXES INTERNET DETER; van Baar JD, 2006, QUAL SAF HEALTH CARE, V15, P191, DOI 10.1136/qshc.2004.013342; Wenzel M, 2005, J ECON PSYCHOL, V26, P862, DOI 10.1016/j.joep.2005.02.002	30	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137306	10.1371/journal.pone.0137306	http://dx.doi.org/10.1371/journal.pone.0137306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366885	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100064
J	Jagarlamudi, KK; Moreau, L; Westberg, S; Ronnberg, H; Eriksson, S				Jagarlamudi, Kiran Kumar; Moreau, Laura; Westberg, Sara; Ronnberg, Henrik; Eriksson, Staffan			A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CANINE LYMPHOMA; PROLIFERATION MARKER; LYMPHOCYTIC-LEUKEMIA; PROGNOSTIC VALUE; SOLID TUMORS; ASSAY; BIOMARKER; ANTIBODY; CANCER	Thymidine kinase 1 (TK1) is a DNA precursor enzyme whose expression is closely correlated with cell proliferation and cell turnover. Sensitive serum TK1 activity assays have been used for monitoring and prognosis of hematological malignancies in both humans and dogs. Here we describe the development of a specific sandwich TK1-ELISA for the quantification of TK1 protein levels in sera from dogs with different malignancies. A combination of rabbit polyclonal anti-dog TK1 antibody and a mouse monoclonal anti-human TK1 antibody was used. Different concentrations of recombinant canine TK1 was used as standard. Clinical evaluation of the ELISA was done by using sera from 42 healthy dogs, 43 dogs with hematological tumors and 55 with solid tumors. An established [H-3]-dThd phosphorylation assay was used to determine the TK1 activity levels in the same sera. The mean TK1 activities in dogs with hematological tumors were significantly higher than those found in healthy dogs. In agreement with earlier studies, no significant difference was observed in serum TK1 activities between healthy dogs and dogs with solid tumors. However, the mean TK1 protein levels determined by new TK1-ELISA were significantly higher not only in hematological tumors but also in solid tumors compared to healthy dogs (mean +/- SD = 1.30 +/- 1.16, 0.67 +/- 0.55 and 0.27 +/- 0.10 ng/mL, respectively). Moreover, TK1-ELISA had significantly higher ability to distinguish lymphoma cases from healthy based on receiver operating characteristic analyses (area under the curve, AUC, of 0.96) to that of the activity assay (AUC, 0.84). Furthermore, fluctuations in TK1 protein levels during the course of chemotherapy in dogs with lymphoma closely associated with clinical outcome. Overall, the TK1-ELISA showed significant linear correlation with the TK1 activity assay (r(s) = 0.6, p<0.0001). Thus, the new TK1-ELISA has sufficient sensitivity and specificity for routine clinical use in veterinary oncology.	[Jagarlamudi, Kiran Kumar; Moreau, Laura; Eriksson, Staffan] Swedish Univ Agr Sci, Vet Med & Anim Sci Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Westberg, Sara] Swedish Univ Agr Sci, Univ Anim Hosp, Uppsala, Sweden; [Ronnberg, Henrik] Swedish Univ Agr Sci, Dept Clin Sci, Ctr Clin Comparat Oncol C3O, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Jagarlamudi, KK (corresponding author), Swedish Univ Agr Sci, Vet Med & Anim Sci Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden.	kirankumar.j@slu.se	Jagarlamudi, Kiran Kumar/J-6075-2013; Ronnberg, HENRIK Paul Olof/AAP-9678-2021	Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Jagarlamudi, Kiran Kumar/0000-0003-1567-5863	Swedish Research Council; Thure. F and Karin Forsgrens Stiftelse; Faculty of Veterinary Medicine and Animal Science; Swedish University of Agricultural Sciences; companion animal insurance company AGRIA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Thure. F and Karin Forsgrens Stiftelse; Faculty of Veterinary Medicine and Animal Science; Swedish University of Agricultural Sciences; companion animal insurance company AGRIA	This study was partly supported by funds from The Swedish Research Council (S.E.), Thure. F and Karin Forsgrens Stiftelse, the Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, and the companion animal insurance company AGRIA (R.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZH, 2011, SENSORS-BASEL, V11, P11064, DOI 10.3390/s111211064; Chen ZH, 2008, ANTICANCER RES, V28, P3897; COTTER SM, 1983, J AM ANIM HOSP ASSOC, V19, P159; DORM CR, 1967, AM J VET RES, V28, P993; Elliott JW, 2013, VET COMP ONCOL, V11, P1, DOI 10.1111/j.1476-5829.2011.00296.x; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Hallek M, 1999, BLOOD, V93, P1732; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; Hanan S, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-12; He E, 2010, NUCLEOS NUCLEOT NUCL, V29, P352, DOI 10.1080/15257771003738535; He QM, 2005, ONCOL REP, V14, P1013; Jagarlamudi KK, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0228-1; Ke PY, 2003, BIOCHEM J, V370, P265, DOI 10.1042/BJ20021335; Kiupel M, 1998, J COMP PATHOL, V119, P407, DOI 10.1016/S0021-9975(98)80035-2; Kumar JK, 2013, VET J, V197, P854, DOI 10.1016/j.tvjl.2013.05.036; Li HX, 2005, ONCOL REP, V13, P145; Liu YP, 2011, EXP THER MED, V2, P1177, DOI 10.3892/etm.2011.338; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; O'Neill K L, 2001, Expert Rev Mol Diagn, V1, P428, DOI 10.1586/14737159.1.4.428; Piek CJ, 1999, VET QUART, V21, P44, DOI 10.1080/01652176.1999.9694990; Renwick MG, 2006, VET COMP ONCOL, V4, P141, DOI 10.1111/j.1476-5829.2006.00103.x; Sharif H, 2012, VET J, V194, P40, DOI 10.1016/j.tvjl.2012.03.006; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; TESKE E, 1994, VET QUART, V16, P209, DOI 10.1080/01652176.1994.9694451; Vail DM, 1997, VET CLIN PATH, V26, P66, DOI 10.1111/j.1939-165X.1997.tb00711.x; von Euler H, 2004, J VET INTERN MED, V18, P696, DOI 10.1892/0891-6640(2004)18&lt;696:STKAID&gt;2.0.CO;2; von Euler H, 2011, VET COMP ONCOL, V9, P1, DOI 10.1111/j.1476-5829.2010.00238.x; Von Euler HP, 2009, INT J ONCOL, V34, P505, DOI 10.3892/ijo_00000175; von Euler HP, 2006, RES VET SCI, V80, P17, DOI 10.1016/j.rvsc.2005.05.001; Wang NN, 2001, ANAL CELL PATHOL, V23, P11, DOI 10.1155/2001/658312; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102; Wu CJ, 2003, J IMMUNOL METHODS, V277, P157, DOI 10.1016/S0022-1759(03)00062-0; Zanatta R, 2003, VET RES COMMUN, V27, P449, DOI 10.1023/B:VERC.0000014201.82393.67	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137871	10.1371/journal.pone.0137871	http://dx.doi.org/10.1371/journal.pone.0137871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366881	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361601100162
J	Prevorovsky, M; Oravcova, M; Tvaruzkova, J; Zach, R; Folk, P; Puta, F; Bahler, J				Prevorovsky, Martin; Oravcova, Martina; Tvaruzkova, Jarmila; Zach, Robert; Folk, Petr; Puta, Frantisek; Baehler, Juerg			Fission Yeast CSL Transcription Factors: Mapping Their Target Genes and Biological Roles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRESS-ACTIVATED MAPK; CYCLE-REGULATED GENES; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL; EXPRESSION; PATHWAY; NOTCH	Background Cbf11 and Cbf12, the fission yeast CSL transcription factors, have been implicated in the regulation of cell-cycle progression, but no specific roles have been described and their target genes have been only partially mapped. Methodology/Principal Findings Using a combination of transcriptome profiling under various conditions and genome-wide analysis of CSL-DNA interactions, we identify genes regulated directly and indirectly by CSL proteins in fission yeast. We show that the expression of stress-response genes and genes that are expressed periodically during the cell cycle is deregulated upon genetic manipulation of cbf11 and/or cbf12. Accordingly, the coordination of mitosis and cytokinesis is perturbed in cells with genetically manipulated CSL protein levels, together with other specific defects in cell-cycle progression. Cbf11 activity is nutrient-dependent and Delta cbf11-associated defects are mitigated by inactivation of the protein kinase A (Pka1) and stress-activated MAP kinase (Sty1(p38)) pathways. Furthermore, Cbf11 directly regulates a set of lipid metabolism genes and Delta cbf11 cells feature a stark decrease in the number of storage lipid droplets. Conclusions/Significance Our results provide a framework for a more detailed understanding of the role of CSL proteins in the regulation of cell-cycle progression in fission yeast.	[Prevorovsky, Martin; Baehler, Juerg] UCL, Res Dept Genet Evolut & Environm, London, England; [Prevorovsky, Martin; Baehler, Juerg] UCL, UCL Canc Inst, London, England; [Prevorovsky, Martin; Oravcova, Martina; Tvaruzkova, Jarmila; Zach, Robert; Folk, Petr; Puta, Frantisek] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	University of London; University College London; University of London; University College London; Charles University Prague	Prevorovsky, M (corresponding author), UCL, Res Dept Genet Evolut & Environm, London, England.	prevorov@natur.cuni.cz	Převorovský, Martin/R-5191-2016; Bahler, Jurg/B-4572-2009; Princová, Jarmila/R-4583-2019; Folk, Petr/V-7545-2017; Půta, František/K-6731-2017	Převorovský, Martin/0000-0003-0277-8361; Bahler, Jurg/0000-0003-4036-1532; Princová, Jarmila/0000-0003-1656-9800; Folk, Petr/0000-0003-3813-7777; Půta, František/0000-0002-8313-878X; Zach, Robert/0000-0002-7604-1648	Wellcome Trust Senior Investigator Award [095598/Z/11/Z]; Czech Science Foundation [P305/12/P040]; Charles University Grant Agency [640413]; Charles University [SVV 260206, UNCE 204013]	Wellcome Trust Senior Investigator Award(Wellcome Trust); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University Grant Agency; Charles University	This work was funded by the Wellcome Trust Senior Investigator Award #095598/Z/11/Z to JB (www.wellcome.ac.uk), the Czech Science Foundation grant P305/12/P040 to MP (www.gacr.cz), grant no. 640413 of the Charles University Grant Agency to MO (www.cuni.cz), and Charles University grants SVV 260206 and UNCE 204013 (www.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beltraminelli N, 1999, J CELL SCI, V112, P3103; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; BYRNE SM, 1993, J CELL SCI, V105, P1095; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chua G, 2013, BIOCHEM SOC T, V41, P1696, DOI 10.1042/BST20130224; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Gould KL, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P27; Gregan J, 2006, NAT PROTOC, V1, P2457, DOI 10.1038/nprot.2006.385; Gupta DR, 2011, BIOSCI BIOTECH BIOCH, V75, P1456, DOI 10.1271/bbb.110125; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JIN M, 1995, GENETICS, V140, P457; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kwon EJG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MAEDA T, 1994, J BIOL CHEM, V269, P9632; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Navarro FJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r36; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Oravcova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059435; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023650; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Rostron KA, 2015, ANTON LEEUW INT J G, V108, P97, DOI 10.1007/s10482-015-0467-6; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; SAZER S, 1990, J CELL SCI, V97, P509; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vachon L, 2013, GENETICS, V194, P873, DOI 10.1534/genetics.113.150870; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	66	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137820	10.1371/journal.pone.0137820	http://dx.doi.org/10.1371/journal.pone.0137820			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366556	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100146
J	Saithong, T; Saerue, S; Kalapanulak, S; Sojikul, P; Narangajavana, J; Bhumiratana, S				Saithong, Treenut; Saerue, Samorn; Kalapanulak, Saowalak; Sojikul, Punchapat; Narangajavana, Jarunya; Bhumiratana, Sakarindr			Gene Co-Expression Analysis Inferring the Crosstalk of Ethylene and Gibberellin in Modulating the Transcriptional Acclimation of Cassava Root Growth in Different Seasons	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; DROUGHT STRESS; WATER-STRESS; PLANT HORMONES; GAS-EXCHANGE; RESPONSES; EXPRESSION; TOLERANCE; STARCH; COLD	Cassava is a crop of hope for the 21st century. Great advantages of cassava over other crops are not only the capacity of carbohydrates, but it is also an easily grown crop with fast development. As a plant which is highly tolerant to a poor environment, cassava has been believed to own an effective acclimation process, an intelligent mechanism behind its survival and sustainability in a wide range of climates. Herein, we aimed to investigate the transcriptional regulation underlying the adaptive development of a cassava root to different seasonal cultivation climates. Gene co-expression analysis suggests that AP2-EREBP transcription factor (ERF1) orthologue (D142) played a pivotal role in regulating the cellular response to exposing to wet and dry seasons. The ERF shows crosstalk with gibberellin, via ent-Kaurene synthase (D106), in the transcriptional regulatory network that was proposed to modulate the downstream regulatory system through a distinct signaling mechanism. While sulfur assimilation is likely to be a signaling regulation for dry crop growth response, calmodulin-binding protein is responsible for regulation in the wet crop. With our initiative study, we hope that our findings will pave the way towards sustainability of cassava production under various kinds of stress considering the future global climate change.	[Saithong, Treenut; Saerue, Samorn; Kalapanulak, Saowalak] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Saithong, Treenut; Kalapanulak, Saowalak; Bhumiratana, Sakarindr] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Sojikul, Punchapat; Narangajavana, Jarunya] Mahidol Univ, Fac Sci, Ctr Cassava Mol Biotechnol, Bangkok 10400, Thailand; [Sojikul, Punchapat; Narangajavana, Jarunya] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Bhumiratana, Sakarindr] King Mongkuts Univ Technol Thonburi, Dept Chem Engn, Fac Engn, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; Mahidol University; Mahidol University; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	treenut.sai@kmutt.ac.th	Saithong, Treenut/L-1395-2019	Saithong, Treenut/0000-0003-2888-6854	Thailand Research Fund [MRG5680110]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by Thailand Research Fund (MRG5680110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Ahmad N, 2013, IMPACT DROUGHT STRES; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alves AAC, 2000, CROP SCI, V40, P131, DOI 10.2135/cropsci2000.401131x; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; Bakayoko S, 2009, AFR J AGR RES, V4, P21; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chatakanonda P, 2003, CARBOHYD POLYM, V53, P233, DOI 10.1016/S0144-8617(03)00047-X; Chen QL, 2011, SCI CHINA EARTH SCI, V54, P1248, DOI 10.1007/s11430-011-4192-3; COCK JH, 1985, CROP SCI, V25, P265, DOI 10.2135/cropsci1985.0011183X002500020015x; CONNOR DJ, 1981, FIELD CROP RES, V4, P181, DOI 10.1016/0378-4290(81)90071-X; El-Sharkawy Mabrouk A., 2007, Braz. J. Plant Physiol., V19, P257, DOI 10.1590/S1677-04202007000400003; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; El-Sharkawy MA, 2012, OPEN J SOIL SCI, V2, P162, DOI [10.4236/ojss.2012.22022, DOI 10.4236/OJSS.2012.22022]; ELSHARKAWY MA, 1987, PLANT SOIL, V100, P345, DOI 10.1007/BF02370950; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hoeren FU, 1998, GENETICS, V149, P479; Iqbal N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22478; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; Larrainzar E, 2014, PLANT CELL ENVIRON, V37, P2051, DOI 10.1111/pce.12285; Licausi F, 2011, NEW PHYTOL, V190, P550, DOI 10.1111/j.1469-8137.2010.03562.x; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Liu J, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00116, 10.3389/fpls.2014.00392]; Lokko Y, 2007, PLANT CELL REP, V26, P1605, DOI 10.1007/s00299-007-0378-8; Lopez C, 2005, PLANT MOL BIOL, V57, P393, DOI 10.1007/s11103-004-7819-3; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maruyama K, 2014, PLANT PHYSIOL, V164, P1759, DOI 10.1104/pp.113.231720; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Moniuszko G, 2013, J EXP BOT, V64, P5173, DOI 10.1093/jxb/ert309; Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nuwamanya E., 2008, African Crop Science Journal, V16, P191; Nuwamanya E, 2012, AMBIO, V41, P262, DOI 10.1007/s13280-011-0183-z; PALTA JA, 1984, J EXP BOT, V35, P1441, DOI 10.1093/jxb/35.10.1441; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Ranola R. F., 2009, J ISSAAS, V15, P147; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Santisopasri V, 2001, IND CROP PROD, V13, P115, DOI 10.1016/S0926-6690(00)00058-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Sojikul P, 2010, PHYSIOL PLANTARUM, V140, P189, DOI 10.1111/j.1399-3054.2010.01389.x; Sriroth K, 2001, EUPHYTICA, V120, P95, DOI 10.1023/A:1017511806128; Sriroth K, 1999, CARBOHYD POLYM, V38, P161, DOI 10.1016/S0144-8617(98)00117-9; Turyagyenda LF, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt007; Verelst W, 2010, PLANT SIGNAL BEHAV, V5, P473, DOI 10.4161/psb.5.4.11421; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151	62	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137602	10.1371/journal.pone.0137602	http://dx.doi.org/10.1371/journal.pone.0137602			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366737	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100091
J	Shushimita, S; van der Pol, P; de Bruin, RWF; Ijzermans, JNM; van Kooten, C; Dor, FJMF				Shushimita, Shushimita; van der Pol, Pieter; de Bruin, Ron W. F.; Ijzermans, Jan N. M.; van Kooten, Cees; Dor, Frank J. M. F.			Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CALORIE RESTRICTION; COMPLEMENT-SYSTEM; LIFE-SPAN; MECHANISMS; PATHWAYS; ACTIVATION; RAPAMYCIN; STRESS	Preoperative fasting and dietary restriction offer robust protection against renal ischemia/reperfusion injury (I/RI) in mice. We recently showed that Mannan-binding lectin (MBL), the initiator of the lectin pathway of complement activation, plays a pivotal role in renal I/RI. Based on these findings, we investigated the effect of short-term DR (30% reduction of total food intake) or three days of water only fasting on MBL in 10-12 weeks old male C57/Bl6 mice. Both dietary regimens significantly reduce the circulating levels of MBL as well as its mRNA expression in liver, the sole production site of MBL. Reconstitution of MBL abolished the protection afforded by dietary restriction, whereas in the fasting group the protection persisted. These data show that modulation of MBL is involved in the protection against renal I/RI induced by dietary restriction, and suggest that the mechanisms of protection induced by dietary restriction and fasting may be different.	[Shushimita, Shushimita; de Bruin, Ron W. F.; Ijzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr, Div Transplant Surg, Dept Surg, Erasmus MC, Rotterdam, Netherlands; [van der Pol, Pieter; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dor, FJMF (corresponding author), Univ Med Ctr, Div Transplant Surg, Dept Surg, Erasmus MC, Rotterdam, Netherlands.	f.dor@erasmusmc.nl	van Kooten, Cees/E-5694-2018	van Kooten, Cees/0000-0002-6257-0899	Erasmus MC Fellowship	Erasmus MC Fellowship	This work was funded by an Erasmus MC Fellowship.	Alic N, 2011, CURR OPIN CELL BIOL, V23, P738, DOI 10.1016/j.ceb.2011.07.006; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Cefalu WT, 1997, J GERONTOL A-BIOL, V52, pB10, DOI 10.1093/gerona/52A.1.B10; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gorsuch WB, 2012, IMMUNOBIOLOGY, V217, P1026, DOI 10.1016/j.imbio.2012.07.024; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Ko GJ, 2010, IMMUNOL RES, V47, P78, DOI 10.1007/s12026-009-8140-7; Lameire N, 2005, LANCET, V365, P417; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Libert S, 2013, ANNU REV PHYSIOL, V75, P669, DOI 10.1146/annurev-physiol-030212-183800; Lutz J, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-27; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McCullough JW, 2013, SEMIN NEPHROL, V33, P543, DOI 10.1016/j.semnephrol.2013.08.005; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Morgan T. E., 2007, V35, P83; Morrison H, 2011, CURR NEUROVASC RES, V8, P52, DOI 10.2174/156720211794520260; Oroszlan M, 2007, MOL IMMUNOL, V44, P1150, DOI 10.1016/j.molimm.2006.06.015; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Owens W, 2003, ENVIRON HEALTH PERSP, V111, P1527, DOI 10.1289/ehp.6413; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Shushimita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087772; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; van Ginhoven TM, 2011, CLIN TRANSPLANT, V25, P486, DOI 10.1111/j.1399-0012.2010.01313.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541	43	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137795	10.1371/journal.pone.0137795	http://dx.doi.org/10.1371/journal.pone.0137795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367533	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100139
J	Tadesse, M; Abebe, G; Abdissa, K; Aragaw, D; Abdella, K; Bekele, A; Bezabih, M; Apers, L; de Jong, BC; Rigouts, L				Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Aragaw, Dossegnaw; Abdella, Kedir; Bekele, Alemayehu; Bezabih, Mesele; Apers, Ludwig; de Jong, Bouke C.; Rigouts, Leen			GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; XPERT MTB/RIF; SPECIMENS; CYTOLOGY; ETHIOPIA; BIOPSY	Introduction The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. Methods FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. Result Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0-94.5] and specificity 91.1% [95% CI: 82.8-99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. Conclusion Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates.	[Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Aragaw, Dossegnaw; Abdella, Kedir; Bekele, Alemayehu; Bezabih, Mesele] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Tadesse, Mulualem; Abebe, Gemeda; Aragaw, Dossegnaw; Abdella, Kedir] Jimma Univ, Biotechnol Res Inst, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Apers, Ludwig] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [de Jong, Bouke C.; Rigouts, Leen] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Tadesse, Mulualem; Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Jimma University; Jimma University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp	Abebe, G (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	gemeda.abebe@ju.edu.et	de Jong, Bouke/A-3636-2013; Abebe, Gemeda/AAB-8789-2019	de Jong, Bouke/0000-0002-1017-4675; Abebe, Gemeda/0000-0002-7172-9136; Abdulsemed, Kedir Abdella/0000-0002-1480-219X	Jimma University; Flemish Universities (VLIR-OUS project)	Jimma University; Flemish Universities (VLIR-OUS project)	Funding for this work was secured from interuniversity cooperation between Jimma University and Flemish Universities (VLIR-OUS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Ammari FF, 2003, OTOLARYNG HEAD NECK, V128, P576, DOI 10.1016/S0194-5998(03)00121-9; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2013, GLOB TUB CONTR; Biadglegne F, 2014, TUBERCULOSIS; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boeree M, 2014, MALAWI MED J, V11, P56; Das DK, 2000, LAB MED, V31, P625, DOI 10.1309/UJ0B-VDWV-U0LE-E0QQ; Denkinger C. M, 2014, EUROPEAN RESP J; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Kurabachew M, 2004, DIAGN MICR INFEC DIS, V49, P99, DOI 10.1016/j.diagmicrobio.2004.03.010; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Mistry Y, 2012, NJMR, V2, P77; Normung DIf, 1995, MED MICR DIAGN TU 32; Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262; Prevention CfDCa, 2003, AFB MICR CHAR STRAT; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2010, 10 M; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright CA, 2008, DIAGN CYTOPATHOL, V36, P245, DOI 10.1002/dc.20788	26	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137471	10.1371/journal.pone.0137471	http://dx.doi.org/10.1371/journal.pone.0137471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366871	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100078
J	Wilson, MC; Scior, K				Wilson, Michelle Clare; Scior, Katrina			Implicit Attitudes towards People with Intellectual Disabilities: Their Relationship with Explicit Attitudes, Social Distance, Emotions and Contact	PLOS ONE			English	Article							ASSOCIATION TEST; LEARNING-DISABILITIES; PHYSICAL-DISABILITIES; CHALLENGING BEHAVIOR; MENTAL-RETARDATION; PUBLIC-ATTITUDES; MINORITY-GROUPS; CARE STAFF; PREJUDICE; METAANALYSIS	Implicit attitude research has expanded rapidly over the last decade and is seen as very promising as it counters biases present in much attitude research such as social desirability. However, most research in the area of intellectual disabilities has focused on explicit attitudes alone. This study examined implicit attitudes to this population and also examined their association with emotional reactions and contact, which have previously been found to have a significant influence on attitudes and stigma. A web based survey consisting of a single target Implicit Association Test, measures of explicit attitudes, social distance, and emotional reactions towards and contact with individuals with intellectual disabilities was completed by 326 adult UK residents. Implicit attitudes were not significantly associated with explicit attitudes, social distance or emotional reactions. Instead there were small to moderate associations between emotional reactions and explicit attitudes and social distance. Implicit attitudes did not vary according to participants' level of contact with individuals with intellectual disabilities, type of the contact relationship (voluntary versus involuntary), gender or educational attainment. In contrast, these participant characteristics did affect explicit attitudes and social distance. Implicit attitudes towards individuals with intellectual disabilities were somewhat negative and, unlike explicit attitudes and stigma, did not vary according to participant demographics or contact. As they may have a negative impact on the lives of people with intellectual disabilities, implicit attitudes merit increased attention in research and interventions in the intellectual disabilities field.	[Wilson, Michelle Clare] Royal Free Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England; [Scior, Katrina] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Scior, K (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	k.scior@ucl.ac.uk		Scior, Katrina/0000-0002-4679-0090				Abbott S, 2006, J INTELLECT DISABILI, V10, P275, DOI 10.1177/1744629506067618; Akrami N, 2006, RES DEV DISABIL, V27, P605, DOI 10.1016/j.ridd.2005.07.003; Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2010, EPIDEMIOL PSICHIAT S, V19, P26, DOI 10.1017/S1121189X00001573; Angermeyer MC, 2003, SOC PSYCH PSYCH EPID, V38, P526, DOI 10.1007/s00127-003-0676-6; Antonak R.F., 1988, MEASUREMENT ATTITUDE; ANTONAK RF, 1995, J INTELL DISABIL RES, V39, P316, DOI 10.1111/j.1365-2788.1995.tb00523.x; Antonak RF, 2000, DISABIL REHABIL, V22, P211; Betsch T, 2004, CONTEMPORARY PERSPECTIVES ON THE PSYCHOLOGY OF ATTITUDES, P251; Binder J, 2009, J PERS SOC PSYCHOL, V96, P843, DOI 10.1037/a0013470; Blanton H, 2006, AM PSYCHOL, V61, P27, DOI 10.1037/0003-066X.61.1.27; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Bogardus Emory S., 1959, SOCIAL DISTANCE; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Brewer M., 1988, ADV SOCIAL COGNITION, P1; BROMLEY J, 1995, J INTELL DISABIL RES, V39, P341, DOI 10.1111/j.1365-2788.1995.tb00526.x; Burge P, 2007, J VOCAT REHABIL, V26, P29; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI 10.1176/appi.ps.201100529; Cummins RA, 2003, J APPL RES INTELLECT, V16, P145, DOI 10.1046/j.1468-3148.2003.00157.x; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; Deal M, 2007, DISABIL SOC, V22, P93, DOI 10.1080/09687590601056667; Dillenburger K, 2011, BRIT J LEARN DISABIL, V39, P29, DOI 10.1111/j.1468-3156.2010.00613.x; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Eagly A.H., 1998, HDB SOCIAL PSYCHOL; Emerson E, 2005, ADULTS LEARNING DIFF; Esterle M, 2008, SEX DISABIL, V26, P219, DOI 10.1007/s11195-008-9093-9; Forrester-Jones R, 2006, J APPL RES INTELLECT, V19, P285, DOI 10.1111/j.1468-3148.2006.00263.x; Gaebel W, 2008, SCHIZOPHR RES, V98, P184, DOI 10.1016/j.schres.2007.09.013; Gaertner S. L., 2000, REDUCING INTERGROUP; Gill F, 2002, PSYCHOL MED, V32, P1445, DOI 10.1017/S0033291702006608; Govan CL, 2004, J EXP SOC PSYCHOL, V40, P357, DOI 10.1016/j.jesp.2003.07.002; Greenwald A. G., 1998, J PERS SOC PSYCHOL, V74, P1646; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; HARTH R, 1971, EDUC TRAIN MENT RETA, V6, P142; Harwood J, 2005, PERS SOC PSYCHOL B, V31, P393, DOI 10.1177/0146167204271577; Hatton C, 1995, MENT HANDICAP RES, V8, P252; Henry D, 1996, MENT RETARD, V34, P149; Hergenrather K, 2007, REHABIL COUNS BULL, V50, P66, DOI 10.1177/00343552070500020501; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; ISLAM MR, 1993, PERS SOC PSYCHOL B, V19, P700, DOI 10.1177/0146167293196005; Jasinskaja-Lahti I, 2011, INT J INTERCULT REL, V35, P346, DOI 10.1016/j.ijintrel.2010.06.001; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Jones C, 2003, BRIT J CLIN PSYCHOL, V42, P189, DOI 10.1348/014466503321903599; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Karpinski A, 2005, PERS SOC PSYCHOL B, V31, P949, DOI 10.1177/0146167204273007; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kenny K., 2007, BRIT J LEARN DISABIL, V35, P221, DOI DOI 10.1111/J.1468-3156.2007.00445.X; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Morin D, 2013, J INTELL DISABIL RES, V57, P268, DOI 10.1111/j.1365-2788.2012.01559.x; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Ouellette-Kuntz H, 2010, J APPL RES INTELLECT, V23, P132, DOI 10.1111/j.1468-3148.2009.00514.x; Park JH, 2003, J NONVERBAL BEHAV, V27, P65, DOI 10.1023/A:1023910408854; Parmenter, 2004, J DISABIL POLICY STU, V15, P97, DOI DOI 10.1177/10442073040150020401; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Prestwich A, 2008, BRIT J SOC PSYCHOL, V47, P575, DOI 10.1348/014466607X267470; Quarmby K, 2008, GETTING AWAY MURDER; Quarmby K, 2011, SCAPEGOAT WHY WE ARE; Rojahn J, 2008, J DEV PHYS DISABIL, V20, P389, DOI 10.1007/s10882-008-9108-6; Rose D, 2004, J APPL RES INTELLECT, V17, P219, DOI 10.1111/j.1468-3148.2004.00194.x; Scior K, 2013, J INTELL DISABIL RES, V57, P1014, DOI 10.1111/j.1365-2788.2012.01597.x; Scior K, 2013, AJIDD-AM J INTELLECT, V118, P211, DOI 10.1352/1944-7558-118.3.211; Scior K, 2011, RES DEV DISABIL, V32, P1530, DOI 10.1016/j.ridd.2011.01.044; Scior K, 2010, INTELLECT DEV DISAB, V48, P278, DOI 10.1352/1934-9556-48.4.278; Sirlopu D, 2008, J APPL SOC PSYCHOL, V38, P2710, DOI 10.1111/j.1559-1816.2008.00411.x; Slevin E, 1996, J ADV NURS, V24, P1116, DOI 10.1111/j.1365-2648.1996.tb01016.x; Slevin E, 1995, Br J Nurs, V4, P761; Staniland L, 2011, PUBLIC PERCEPTIONS D; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Swain J., 1994, EQUAL TERMS WORKING, P87; Thomas A, 2007, J REHABIL, V73, P3; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Tumer RN, 2007, J PERS SOC PSYCHOL, V93, P369, DOI 10.1037/0022-3514.93.3.369; Turner RN, 2008, J PERS SOC PSYCHOL, V95, P846; White MJ, 2006, J REHABIL, V72, P33; Wigboldus D.H., 2004, SINGLE TARGET IUNPUB	77	38	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137902	10.1371/journal.pone.0137902	http://dx.doi.org/10.1371/journal.pone.0137902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366575	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100174
J	You, L; Simmons, DR; Bateman, CC; Short, DPG; Kasson, MT; Rabaglia, RJ; Hulcr, J				You, Li; Simmons, David Rabern; Bateman, Craig C.; Short, Dylan P. G.; Kasson, Matthew T.; Rabaglia, Robert J.; Hulcr, Jiri			New Fungus-Insect Symbiosis: Culturing, Molecular, and Histological Methods Determine Saprophytic Polyporales Mutualists of Ambrosiodmus Ambrosia Beetles	PLOS ONE			English	Article							RIBOSOMAL DNA; COLEOPTERA; EVOLUTION; IDENTIFICATION; EUWALLACEA; DIVERSITY	Ambrosia symbiosis is an obligate, farming-like mutualism between wood-boring beetles and fungi. It evolved at least 11 times and includes many notorious invasive pests. All ambrosia beetles studied to date cultivate ascomycotan fungi: early colonizers of recently killed trees with poor wood digestion. Beetles in the widespread genus Ambrosiodmus, however, colonize decayed wood. We characterized the mycosymbionts of three Ambrosiodmus species using quantitative culturing, high-throughput metabarcoding, and histology. We determined the fungi to be within the Polyporales, closely related to Flavodon flavus. Culture-independent sequencing of Ambrosiodmus minor mycangia revealed a single operational taxonomic unit identical to the sequences from the cultured Flavodon. Histological sectioning confirmed that Ambrosiodmus possessed preoral mycangia containing dimitic hyphae similar to cultured F. cf. flavus. The Ambrosiodmus-Flavodon symbiosis is unique in several aspects: it is the first reported association between an ambrosia beetle and a basidiomycotan fungus; the mycosymbiont grows as hyphae in the mycangia, not as budding pseudo-mycelium; and the mycosymbiont is a white-rot saprophyte rather than an early colonizer: a previously undocumented wood borer niche. Few fungi are capable of turning rotten wood into complete animal nutrition. Several thousand beetle-fungus symbioses remain unstudied and promise unknown and unexpected mycological diversity and enzymatic innovations.	[You, Li; Simmons, David Rabern; Hulcr, Jiri] Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Bateman, Craig C.; Hulcr, Jiri] Univ Florida, Inst Food & Agr Sci, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Short, Dylan P. G.; Kasson, Matthew T.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Rabaglia, Robert J.] ARS, Forest Hlth Protect State & Private Forestry, USDA, Washington, DC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; West Virginia University; United States Department of Agriculture (USDA)	Hulcr, J (corresponding author), Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	hulcr@ufl.edu	Hulcr, Jiri/AAE-4210-2019	Hulcr, Jiri/0000-0002-8706-4618; Simmons, D Rabern/0000-0002-7033-225X	USDA-FS-SRS [14-CA-11330130-032]; USDA-FS-FHP [12-CA-11420004-042]; USDA [14-8130-0377-CA]; NSF [DEB 1256968]; West Virginia Agricultural Experiment Station; University of Florida Opportunity Seed fund; Direct For Biological Sciences [1256968] Funding Source: National Science Foundation	USDA-FS-SRS; USDA-FS-FHP; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); West Virginia Agricultural Experiment Station; University of Florida Opportunity Seed fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by USDA-FS-SRS Coop agreement 14-CA-11330130-032, USDA-FS-FHP Coop agreement 12-CA-11420004-042, USDA Farm Bill agreement 14-8130-0377-CA, NSF DEB 1256968, the West Virginia Agricultural Experiment Station, and a University of Florida Opportunity Seed fund.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; BATRA LEKH R., 1963, TRANS KANAS ACAD SCI, V66, P213, DOI 10.2307/3626562; BATRA LR, 1967, MYCOLOGIA, V59, P976, DOI 10.2307/3757271; Beaver R.A., 1989, P121; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; BRIGHT DE, 1968, CAN ENTOMOL, V100, P1288, DOI 10.4039/Ent1001288-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Eichhoff WJ, 1875, SOC ENTOMOL BELGIQUE, P18195; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Freeman S, 2013, MYCOLOGIA, V105, P1595, DOI 10.3852/13-066; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAPP GM, 1976, INT J INSECT MORPHOL, V5, P381, DOI 10.1016/0020-7322(76)90012-X; Harrington Thomas C., 2005, P257; Hijii N., 1991, Journal of the Japanese Forestry Society, V73, P471; Hong Ki-Jeong, 2006, Korean Journal of Applied Entomology, V45, P113; Hopkins A. D., 1915, 99 USDA, V99, P1, DOI DOI 10.5962/BHL.TITLE.65905; Hsiau PTW, 2003, SYMBIOSIS, V34, P111; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Hulcr J, 2010, EVOLUTION, V64, P3205, DOI 10.1111/j.1558-5646.2010.01055.x; Hyodo F, 2000, SOIL BIOL BIOCHEM, V32, P653, DOI 10.1016/S0038-0717(99)00192-3; Kasson MT, 2013, FUNGAL GENET BIOL, V56, P147, DOI 10.1016/j.fgb.2013.04.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirkendall LR, 2015, BARK BEETLES BIOL EC, P85, DOI [DOI 10.1016/B978-0-12-417156-5.00003-4, 10.1016/B978-0-12-417156-5.00003-4]; Kolarik M, 2009, MYCOL RES, V113, P44, DOI 10.1016/j.mycres.2008.08.003; Kostovcik M, 2015, ISME J, V9, P126, DOI 10.1038/ismej.2014.115; Licht HHD, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-13; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rabaglia R.J., 2011, TRIOLOGY, V50, P6; Ranger CM, 2010, AGR FOREST ENTOMOL, V12, P177, DOI 10.1111/j.1461-9563.2009.00469.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYVARDEN L, 1973, Norwegian Journal of Botany, V20, P1; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Seltzer J.L., 2013, Midsouth Entomologist, V6, P119; Six DL, 2003, CONT T ENT, P97; Stebbing E.P., 1909, INDIAN FOREST MEMOIR, V1, P13; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tagaki K., 1967, JAPANESE SOC APPL EN, V2, P168, DOI [10.1303/aez.2.168, DOI 10.1303/AEZ.2.168]; TALBOT PHB, 1977, ANNU REV PHYTOPATHOL, V15, P41, DOI 10.1146/annurev.py.15.090177.000353; Tomsovsky M, 2010, FUNGAL BIOL-UK, V114, P350, DOI 10.1016/j.funbio.2010.02.004; Vega F.E., 2015, BARK BEETLES BIOL EC, V1st; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P1; Zhao CL, 2014, PHYTOTAXA, V164, P17; Zwickl D. J, 2006, GENETIC ALGORITHM AP	49	45	49	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137689	10.1371/journal.pone.0137689	http://dx.doi.org/10.1371/journal.pone.0137689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367271	Green Published, gold			2022-12-27	WOS:000361601100109
J	Conner, LM; Morris, G				Conner, L. Mike; Morris, Gail			Impacts of Mesopredator Control on Conservation of Mesopredators and Their Prey	PLOS ONE			English	Article							PREDATOR REMOVAL; PUBLICATION BIAS; MAMMALIAN CARNIVORES; POPULATION-DYNAMICS; BREEDING SUCCESS; COYOTE REMOVAL; RELEASE; ABUNDANCE; BIODIVERSITY; MANAGEMENT	Declining large carnivore populations, increased habitat fragmentation, declining interests in fur trapping, and other anthropogenic factors can all lead to increased mesopredator populations and these may negatively impact biodiversity. Lethal mesopredator control potentially mitigates some of these effects but can be controversial, largely because impacts on mesopredator populations have not been evaluated. Estimating these impacts may reduce controversies while increasing our understanding of when lethal control may be beneficial. Therefore, we analyzed published mesopredator removal data to determine if mesopredator removal rates changed over time. Removals of medium,(e.g., raccoons (Procyon lotor) or red foxes (Vulpes vulpes), and large, i.e., bobcats (Lynx rufus) or coyotes (Canis latrans), mesopredators were consistent from year to year and over the duration of study (i.e., number removed during the first and last years of studies were similar). In contrast, removals of small mesopredators, e.g., weasels (Mustela spp.) or spotted skunks (Spilogale putorius), declined over the duration of study. Study area size, number of species targeted for removal, and duration of removal effort were poor predictors of removal rates. Our analyses suggest that: (1) control, as typically implemented, is unlikely to cause negative long-term impacts on populations of medium and large mesopredators but may negatively impact small mesopredators, (2) if mesopredator control benefits prey, recurring removals will generally be needed to maintain benefits, and (3) timing of removals will be important to achieve management goals. We suggest that mesopredator control efforts are frequently spatially structured harvests from continuously distributed populations. This may explain (1) why removal of small mesopredators declined over time; whereas, medium and large mesopredator removals remained consistent, and (2) why some prey failed to respond to mesopredator control efforts.	[Conner, L. Mike; Morris, Gail] Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA		Conner, LM (corresponding author), Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA.	mconner@jonesctr.org			W. Jones Ecological Research Center	W. Jones Ecological Research Center	This study was entirely funded by the Joseph W. Jones Ecological Research Center.	Allen BL, 2014, ECOL MANAG RESTOR, V15, P191, DOI 10.1111/emr.12118; Allen BL, 2013, BIOL CONSERV, V159, P158, DOI 10.1016/j.biocon.2012.12.004; Beasley JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058982; BEASOM SL, 1974, J WILDLIFE MANAGE, V38, P854, DOI 10.2307/3800056; BEKOFF M, 1977, Mammalian Species, V79, P1; Bergstrom BJ, 2014, CONSERV LETT, V7, P131, DOI 10.1111/conl.12045; Bodey TW, 2011, BIOL INVASIONS, V13, P2817, DOI 10.1007/s10530-011-9965-2; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cypher Brian L., 1992, Proceedings of the Vertebrate Pest Conference, V15, P42; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fletcher K, 2010, J APPL ECOL, V47, P263, DOI 10.1111/j.1365-2664.2010.01793.x; Frey SN, 2007, J WILDLIFE MANAGE, V71, P303, DOI 10.2193/2005-417; Frey SN, 2003, WILDLIFE SOC B, V31, P727; Garrettson PR, 2001, J WILDLIFE MANAGE, V65, P398, DOI 10.2307/3803091; Gehrt SD, 2003, WILDLIFE SOC B, V31, P836; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gordon CE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2870; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Hola M, 2015, EUR J WILDLIFE RES, V61, P73, DOI 10.1007/s10344-014-0875-3; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; Imperio S, 2010, WILDLIFE BIOL, V16, P205, DOI 10.2981/08-051; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; Kauhala K, 2004, FOLIA ZOOL, V53, P367; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; King CM, 2009, BIOL CONSERV, V142, P806, DOI 10.1016/j.biocon.2008.12.010; King CM, 1989, NATURAL HIST WEASELS; Kirkwood R, 2014, WILDLIFE RES, V41, P222, DOI 10.1071/WR13196; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; LINT JR, 1995, WILDLIFE SOC B, V23, P164; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; McCullough DR, 1996, J WILDLIFE MANAGE, V60, P1, DOI 10.2307/3802033; Mills L. S., 2007, CONSERVATION WILDLIF; Morris G, 2011, OECOLOGIA, V167, P1005, DOI 10.1007/s00442-011-2053-6; Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258; Palmer WE, 2005, WILDLIFE SOC B, V33, P1398, DOI 10.2193/0091-7648(2005)33[1398:EOFBAN]2.0.CO;2; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Core Team, 2013, R LANG ENV STAT COMP; Reiter DK, 1999, WILDLIFE SOC B, V27, P746; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rogers CM, 1998, OECOLOGIA, V116, P227, DOI 10.1007/s004420050583; Rollins D, 2001, WILDLIFE SOC B, V29, P39; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Schmidt KA, 2008, BEHAV ECOL, V19, P759, DOI 10.1093/beheco/arn034; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; VanGilder Cory L., 2009, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V63, P11; WADE-SMITH J, 1982, Mammalian Species, P1, DOI 10.2307/3503883; Wallach AD, 2015, OIKOS, V124, P1453, DOI 10.1111/oik.01977; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	64	23	23	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137169	10.1371/journal.pone.0137169	http://dx.doi.org/10.1371/journal.pone.0137169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361211	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100024
J	Alves, LGA; Mendes, RS; Lenzi, EK; Ribeiro, HV				Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.; Ribeiro, Haroldo V.			Scale-Adjusted Metrics for Predicting the Evolution of Urban Indicators and Quantifying the Performance of Cities	PLOS ONE			English	Article							GROWTH; LAWS	More than a half of world population is now living in cities and this number is expected to be two-thirds by 2050. Fostered by the relevancy of a scientific characterization of cities and for the availability of an unprecedented amount of data, academics have recently immersed in this topic and one of the most striking and universal finding was the discovery of robust allometric scaling laws between several urban indicators and the population size. Despite that, most governmental reports and several academic works still ignore these nonlinearities by often analyzing the raw or the per capita value of urban indicators, a practice that actually makes the urban metrics biased towards small or large cities depending on whether we have super or sublinear allometries. By following the ideas of Bettencourt et al. [PLoS ONE 5 (2010) e13541], we account for this bias by evaluating the difference between the actual value of an urban indicator and the value expected by the allometry with the population size. We show that this scale-adjusted metric provides a more appropriate/informative summary of the evolution of urban indicators and reveals patterns that do not appear in the evolution of per capita values of indicators obtained from Brazilian cities. We also show that these scale-adjusted metrics are strongly correlated with their past values by a linear correspondence and that they also display crosscorrelations among themselves. Simple linear models account for 31%-97% of the observed variance in data and correctly reproduce the average of the scale-adjusted metric when grouping the cities in above and below the allometric laws. We further employ these models to forecast future values of urban indicators and, by visualizing the predicted changes, we verify the emergence of spatial clusters characterized by regions of the Brazilian territory where we expect an increase or a decrease in the values of urban indicators.	[Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.; Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, Parana, Brazil; [Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.] CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil; [Lenzi, Ervin K.] Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, PR, Brazil; [Ribeiro, Haroldo V.] Univ Tecnol Fed Parana, Dept Fis, BR-86812460 Apucarana, PR, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Ponta Grossa; Universidade Tecnologica Federal do Parana	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, Parana, Brazil.	hvr@dfi.uem.br	Mendes, Renio/F-9261-2017; Alves, Luiz G A/H-3389-2013; Lenzi, Ervin Kaminski/N-1767-2019; Ribeiro, Haroldo Valentin/C-8614-2012	Alves, Luiz G A/0000-0001-6204-5552; Lenzi, Ervin Kaminski/0000-0003-3853-1790; Ribeiro, Haroldo Valentin/0000-0002-9532-5195	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria (FA); CNPq [440650/2014-3]; RSM [263/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); RSM	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Araucaria (FA). HVR thanks the financial support of CNPq (grant 440650/2014-3) and RSM thanks FA (grant 263/2014) for partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2014, PHYSICA A, V409, P175, DOI 10.1016/j.physa.2014.04.046; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Angel S., 2005, DYNAMICS GLOBAL URBA; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bettencourt LMA, 2015, HYPOTHESIS URBAN SCA; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gordon MB, 2010, EUR J APPL MATH, V21, P283, DOI 10.1017/S0956792510000069; Hanley QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109004; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Jones E., 2001, SCIPY OPEN SOURCE SC; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Louf R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05561; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Podobnik B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00678; Pumain D, 2004, SCALING LAWS URBAN S; Pumain D, 2006, CYBERGEO, DOI 10.4000/cybergeo.2519; Rybski D, 2014, CITIES NUCL SUSTAINA; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; United Nations, 2014, WORLD FERT REP 2013, P1	34	42	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0134862	10.1371/journal.pone.0134862	http://dx.doi.org/10.1371/journal.pone.0134862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356081	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800002
J	Halstead, FD; Rauf, M; Moiemen, NS; Bamford, A; Wearn, CM; Fraise, AP; Lund, PA; Oppenheim, BA; Webber, MA				Halstead, Fenella D.; Rauf, Maryam; Moiemen, Naiem S.; Bamford, Amy; Wearn, Christopher M.; Fraise, Adam P.; Lund, Peter A.; Oppenheim, Beryl A.; Webber, Mark A.			The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SUPERFICIAL WOUNDS; PH HOMEOSTASIS; BACTERIA; INHIBITION	Introduction Localised infections, and burn wound sepsis are key concerns in the treatment of burns patients, and prevention of colonisation largely relies on biocides. Acetic acid has been shown to have good antibacterial activity against various planktonic organisms, however data is limited on efficacy, and few studies have been performed on biofilms. Objectives We sought to investigate the antibacterial activity of acetic acid against important burn wound colonising organisms growing planktonically and as biofilms. Methods Laboratory experiments were performed to test the ability of acetic acid to inhibit growth of pathogens, inhibit the formation of biofilms, and eradicate pre-formed biofilms. Results Twenty-nine isolates of common wound-infecting pathogens were tested. Acetic acid was antibacterial against planktonic growth, with an minimum inhibitory concentration of 0.16-0.31% for all isolates, and was also able to prevent formation of biofilms (at 0.31%). Eradication of mature biofilms was observed for all isolates after three hours of exposure. Conclusions This study provides evidence that acetic acid can inhibit growth of key burn wound pathogens when used at very dilute concentrations. Owing to current concerns of the reducing efficacy of systemic antibiotics, this novel biocide application offers great promise as a cheap and effective measure to treat infections in burns patients.	[Halstead, Fenella D.; Rauf, Maryam; Moiemen, Naiem S.; Bamford, Amy; Wearn, Christopher M.; Fraise, Adam P.; Oppenheim, Beryl A.] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Halstead, Fenella D.; Rauf, Maryam; Oppenheim, Beryl A.; Webber, Mark A.] Queen Elizabeth Hosp, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England; [Halstead, Fenella D.; Rauf, Maryam; Lund, Peter A.; Webber, Mark A.] Univ Birmingham, Coll Med & Dent Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Moiemen, Naiem S.] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Moiemen, Naiem S.; Bamford, Amy; Wearn, Christopher M.] Healing Fdn Burns Res Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Webber, MA (corresponding author), Queen Elizabeth Hosp, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England.	m.a.webber@bham.ac.uk	lund, peter a/N-9785-2018	Webber, Mark/0000-0001-9169-7592; Halstead, Fenella/0000-0002-2833-2926; Lund, Peter/0000-0002-6381-8526; Moiemen, Naiem/0000-0003-0836-5138	NIHR Surgical Reconstruction and Microbiology Research Centre; Institute of Microbiology at the University of Birmingham; Aston University; Healing Foundation Burns Research Centre	NIHR Surgical Reconstruction and Microbiology Research Centre; Institute of Microbiology at the University of Birmingham; Aston University; Healing Foundation Burns Research Centre	This work was supported by the NIHR Surgical Reconstruction and Microbiology Research Centre, the Institute of Microbiology at the University of Birmingham, Aston University (MR a student on secondment during the project), and the Healing Foundation Burns Research Centre.	Baugh S, 2012, J ANTIMICROB CHEMOTH, V67, P2409, DOI 10.1093/jac/dks228; Bjarnsholt T., 2014, ADV WOUND CARE, P1; Brown TPL, 2004, J TRAUMA, V56, P863, DOI 10.1097/01.TA.0000044565.69410.95; BSI Standards Publication, 2012, 13727 BS EN; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Cortesia C, 2014, MBIO, V5, DOI 10.1128/mBio.00013-14; CURRENCE WW, 1952, AMA AM J DIS CHILD, V83, P637, DOI 10.1001/archpedi.1952.02040090083008; Davies S, 2011, CHIEF MED OFFICER AN, V1; Entani E, 1998, J FOOD PROTECT, V61, P953, DOI 10.4315/0362-028X-61.8.953; Fraise AP, 2013, J HOSP INFECT, V84, P329, DOI 10.1016/j.jhin.2013.05.001; Fu Y, 2012, BURNS, V38, P90, DOI 10.1016/j.burns.2011.02.006; Gong YL, 2014, BURNS, V40, P402, DOI 10.1016/j.burns.2013.07.010; Guggenheim M, 2009, BURNS, V35, P553, DOI 10.1016/j.burns.2008.09.004; Hirshfield Irvin N., 2003, Science Progress, V86, P245, DOI 10.3184/003685003783238626; Johnston Carol S, 2006, MedGenMed, V8, P61; KASS EH, 1959, JAMA-J AM MED ASSOC, V169, P1181, DOI 10.1001/jama.1959.03000280033008; LAWRENCE JC, 1985, J HOSP INFECT, V6, P3, DOI 10.1016/S0195-6701(85)80081-5; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; McGuiness W, 2004, J Wound Care, V13, P383; MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601; MILNER SM, 1992, LANCET, V340, P61, DOI 10.1016/0140-6736(92)92483-V; PHILLIPS I, 1968, LANCET, V1, P11; Roe AJ, 1998, J BACTERIOL, V180, P767, DOI 10.1128/JB.180.4.767-772.1998; Ryssel H, 2009, BURNS, V35, P695, DOI 10.1016/j.burns.2008.11.009; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Sloss J M, 1993, J R Army Med Corps, V139, P49; Smith DT, 1924, JAMA PAEDIAT, V28, P1; STONE HH, 1966, ANN SURG, V163, P297, DOI 10.1097/00000658-196602000-00023; WALTER A, 1984, J MEMBRANE BIOL, V77, P255, DOI 10.1007/BF01870573; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Wright LL, 2015, J ANTIMICROB CHEMOTH, V70, P103, DOI 10.1093/jac/dku339	33	89	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136190	10.1371/journal.pone.0136190	http://dx.doi.org/10.1371/journal.pone.0136190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352256	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000360932800028
J	Matziridi, M; Brenner, E; Smeets, JBJ				Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.			The Role of Temporal Information in Perisaccadic Mislocalization	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; VISUAL-PERCEPTION; PSYCHOPHYSICS TOOLBOX; APPARENT POSITION; LOCALIZATION; STIMULI; COMPRESSION; SPACE; TIME; REPRESENTATION	In dynamic environments, it is crucial to accurately consider the timing of information. For instance, during saccades the eyes rotate so fast that even small temporal errors in relating retinal stimulation by flashed stimuli to extra-retinal information about the eyes' orientations will give rise to substantial errors in where the stimuli are judged to be. If spatial localization involves judging the eyes' orientations at the estimated time of the flash, we should be able to manipulate the pattern of mislocalization by altering the estimated time of the flash. We reasoned that if we presented a relevant flash within a short rapid sequence of irrelevant flashes, participants' estimates of when the relevant flash was presented might be shifted towards the centre of the sequence. In a first experiment, we presented five bars at different positions around the time of a saccade. Four of the bars were black. Either the second or the fourth bar in the sequence was red. The task was to localize the red bar. We found that when the red bar was presented second in the sequence, it was judged to be further in the direction of the saccade than when it was presented fourth in the sequence. Could this be because the red bar was processed faster when more black bars preceded it? In a second experiment, a red bar was either presented alone or followed by two black bars. When two black bars followed it, it was judged to be further in the direction of the saccade. We conclude that the spatial localization of flashed stimuli involves judging the eye orientation at the estimated time of the flash.	[Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Res Inst MOVE, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Matziridi, M (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Dept Human Movement Sci, Amsterdam, Netherlands.	mmatziridi@yahoo.gr	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Greek State Scholarships Foundation [10079]; Netherlands Organization for Scientific Research, NWO Vici [453-08-004]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); Netherlands Organization for Scientific Research, NWO Vici(Netherlands Organization for Scientific Research (NWO))	The research leading to these results has received funding from the Greek State Scholarships Foundation (www.iky.gr) under grant agreement number 10079 and the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Awater H, 2006, J NEUROSCI, V26, P12, DOI 10.1523/JNEUROSCI.2407-05.2006; Awater H, 2001, PERCEPTION, V30, P24; Awater H, 2004, J NEUROPHYSIOL, V91, P2457, DOI 10.1152/jn.00821.2003; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Binda P, 2007, J NEUROSCI, V27, P8525, DOI 10.1523/JNEUROSCI.0737-07.2007; Binda P, 2010, J VISION, V10, DOI 10.1167/10.2.7; BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brenner E, 2005, VISION RES, V45, P1587, DOI 10.1016/j.visres.2004.11.020; Brenner E, 2000, VISION RES, V40, P1645, DOI 10.1016/S0042-6989(00)00067-5; Brenner E, 2006, J EXP PSYCHOL HUMAN, V32, P811, DOI 10.1037/0096-1523.32.4.811; Brenner E, 2010, VISION RES, V50, P1101, DOI 10.1016/j.visres.2010.03.004; Brenner E, 2008, J VISION, V8, DOI 10.1167/8.2.7; Cicchini GM, 2013, J NEUROPHYSIOL, V109, P1117, DOI 10.1152/jn.00478.2012; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; HONDA H, 1990, PERCEPT PSYCHOPHYS, V48, P509, DOI 10.3758/BF03211595; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Lappe M, 2006, J VISION, V6, P1282, DOI 10.1167/6.11.11; Linares D, 2009, J VISION, V9, DOI 10.1167/9.13.9; Maij F, 2011, J NEUROSCI, V31, P3708, DOI 10.1523/JNEUROSCI.5097-10.2011; Maij F, 2011, VISION RES, V51, P154, DOI 10.1016/j.visres.2010.10.024; Maij F, 2010, J VISION, V10, DOI 10.1167/10.4.7; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; MATEEFF S, 1978, PERCEPT PSYCHOPHYS, V24, P215, DOI 10.3758/BF03206092; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MATIN L, 1970, PERCEPT PSYCHOPHYS, V8, P9, DOI 10.3758/BF03208921; Matziridi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062436; Morrone MC, 1997, J NEUROSCI, V17, P7941; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nava E, 2008, EXP BRAIN RES, V190, P179, DOI 10.1007/s00221-008-1459-9; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Ostendorf F, 2007, J NEUROSCI, V27, P7559, DOI 10.1523/JNEUROSCI.2074-07.2007; Pola J, 2004, VISION RES, V44, P2799, DOI 10.1016/j.visres.2004.06.008; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; van Mierlo CM, 2009, J VISION, V9, DOI 10.1167/9.3.25	45	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0134081	10.1371/journal.pone.0134081	http://dx.doi.org/10.1371/journal.pone.0134081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352603	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800003
J	Tamaki, N; Kurosaki, M; Higuchi, M; Takada, H; Nakakuki, N; Yasui, Y; Suzuki, S; Tsuchiya, K; Nakanishi, H; Itakura, J; Takahashi, Y; Ogawa, S; Tanaka, Y; Asahina, Y; Izumi, N				Tamaki, Nobuharu; Kurosaki, Masayuki; Higuchi, Mayu; Takada, Hitomi; Nakakuki, Natsuko; Yasui, Yutaka; Suzuki, Shoko; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Ogawa, Shintaro; Tanaka, Yasuhito; Asahina, Yasuhiro; Izumi, Namiki			Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; INTERFERON THERAPY; AMINOTRANSFERASE LEVELS; STEATOSIS; VIRUS; CLEARANCE; INFECTION; IMPACT	The assessment of individual risk of fibrosis progression in patients with chronic hepatitis C is an unmet clinical need. Recent genome-wide association studies have highlighted several genetic alterations as predictive risk factors of rapid fibrosis progression in chronic hepatitis C. However, most of these results require verification, and whether the combined use of these genetic predictors can assess the risk of fibrosis progression remains unclear. Therefore, genetic risk factors associated with fibrosis progression were analyzed in 176 chronic hepatitis C patients who did not achieve sustained virological response by interferon-based therapy and linked to the fibrosis progression rate (FPR). FPR was determined in all patients by paired liver biopsy performed before and after therapy (mean interval: 6.2 years). Mean FPR in patients with IL28B (rs8099917) TG/GG and PNPLA3 (rs738409) CG/GG were significantly higher than in those with IL28B TT (FPR: 0.144 vs. 0.034, P < 0.001) and PNPLA3 CC (FPR: 0.10 vs. 0.018, P = 0.005), respectively. IL28B TG/GG [hazard ratio (HR): 3.9, P = 0.001] and PNPLA3 CG/GG (HR: 3.1, P = 0.04) remained independent predictors of rapid fibrosis progression upon multivariate analysis together with average alanine aminotransferase after interferon therapy >= 40 IU/l (HR: 4.2, P = 0.002). Based on these data, we developed a new clinical score predicting the risk of fibrosis progression (FPR-score). The FPR-score identified subgroups of patients with a low (FPR: 0.005), intermediate (FPR: 0.103, P < 0.001), and high (FPR: 0.197, P < 0.001) risk of fibrosis progression. In conclusion, IL28B and PNPLA3 genotypes are associated with rapid fibrosis progression, and the FPR-score identifies patients who has a high risk of fibrosis progression and require urgent antiviral treatment.	[Tamaki, Nobuharu; Kurosaki, Masayuki; Higuchi, Mayu; Takada, Hitomi; Nakakuki, Natsuko; Yasui, Yutaka; Suzuki, Shoko; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Ogawa, Shintaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Ogawa, Shintaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Hepatitis Control, Tokyo, Japan	Nagoya City University; Nagoya City University; Tokyo Medical & Dental University (TMDU)	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Yasui, Yutaka/0000-0002-6117-4990; Tanaka, Yasuhito/0000-0002-2473-6966; Tamaki, Nobuharu/0000-0003-4634-6616	Japan Agency for Medical Research and Development [15fk0210007h0002]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors' financial disclosure is as follows: NI received a grant-in-aid from the Japan Agency for Medical Research and Development (grant number: 15fk0210007h0002, URL: http://www.amed.go.jp). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Asahina Y, 2013, J GASTROENTEROL, V17, P17; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Fartoux L, 2005, HEPATOLOGY, V41, P82, DOI 10.1002/hep.20519; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kitamoto T, 2014, J HUM GENET, V13, P17; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Kurosaki M, 2008, J HEPATOL, V48, P736, DOI 10.1016/j.jhep.2007.12.025; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Kyrlagkitsis L, 2003, AM J GASTROENTEROL, V98, P1588, DOI [10.1016/S0002-9270(03)00368-X, 10.1111/j.1572-0241.2003.07539.x]; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; LEFKOWITCH JH, 1993, GASTROENTEROLOGY, V104, P595, DOI 10.1016/0016-5085(93)90432-C; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622	37	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137351	10.1371/journal.pone.0137351	http://dx.doi.org/10.1371/journal.pone.0137351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352693	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800076
J	Brown, AS; Mohanty, BK; Howe, PH				Brown, Andrew S.; Mohanty, Bidyut K.; Howe, Philip H.			Computational Identification of Post Translational Modification Regulated RNA Binding Protein Motifs	PLOS ONE			English	Article							EUKARYOTIC MESSENGER-RNAS; 3' UNTRANSLATED REGIONS; EVOLUTIONARY CONSERVATION; SPECIALIZED DATABASES; FUNCTIONAL ELEMENTS; PHOSPHORYLATION; SEQUENCES; ALIGNMENT; UTRSITE; GENES	RNA and its associated RNA binding proteins (RBPs) mitigate a diverse array of cellular functions and phenotypes. The interactions between RNA and RBPs are implicated in many roles of biochemical processing by the cell such as localization, protein translation, and RNA stability. Recent discoveries of novel mechanisms that are of significant evolutionary advantage between RBPs and RNA include the interaction of the RBP with the 3' and 5' untranslated region (UTR) of target mRNA. These mechanisms are shown to function through interaction of a trans-factor (RBP) and a cis-regulatory element (3' or 5' UTR) by the binding of a RBP to a regulatory-consensus nucleic acid motif region that is conserved throughout evolution. Through signal transduction, regulatory RBPs are able to temporarily dissociate from their target sites on mRNAs and induce translation, typically through a posttranslational modification (PTM). These small, regulatory motifs located in the UTR of mRNAs are subject to a loss-of-function due to single polymorphisms or other mutations that disrupt the motif and inhibit the ability to associate into the complex with RBPs. The identification of a consensus motif for a given RBP is difficult, time consuming, and requires a significant degree of experimentation to identify each motif-containing gene on a genomic scale. We have developed a computational algorithm to analyze high-throughput genomic arrays that contain differential binding induced by a PTM for a RBP of interest-RBP-PTM Target Scan (RPTS). We demonstrate the ability of this application to accurately predict a PTM-specific binding motif to an RBP that has no antibody capable of distinguishing the PTM of interest, negating the use of in-vitro exonuclease digestion techniques.	[Brown, Andrew S.; Mohanty, Bidyut K.; Howe, Philip H.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Brown, Andrew S.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA	Medical University of South Carolina; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Howe, PH (corresponding author), Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA.	howep@musc.edu			National Cancer Institute [CA055536, CA154663, 5R01CA154663-06]; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA154663, R29CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA055536 and CA154663 from the National Cancer Institute, 5R01CA154663-06 [http://www.nih.gov] to PHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Rajewsky N, 2006, COLD SPRING HARBOR S; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Shi ZH, 2012, INT J GYNECOL CANCER, V22, P1125, DOI 10.1097/IGC.0b013e3182606ac3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Xue XY, 2014, TUMOR BIOL, V35, P7853, DOI 10.1007/s13277-014-1982-1	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137696	10.1371/journal.pone.0137696	http://dx.doi.org/10.1371/journal.pone.0137696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368004	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100112
J	Falloon, K; Juvvadi, PR; Richards, AD; Vargas-Muniz, JM; Renshaw, H; Steinbach, WJ				Falloon, Katie; Juvvadi, Praveen R.; Richards, Amber D.; Vargas-Muniz, Jose M.; Renshaw, Hilary; Steinbach, William J.			Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus	PLOS ONE			English	Article							FK506 BINDING-PROTEINS; EVOKED CA2+ RELEASE; INVASIVE ASPERGILLOSIS; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; CYCLOSPORINE-A; FKBP12-DEPENDENT INHIBITION; GALLERIA-MELLONELLA; HUMAN CALCINEURIN; SMOOTH-MUSCLE	Invasive aspergillosis, largely caused by Aspergillus fumigatus, is responsible for a growing number of deaths among immunosuppressed patients. Immunosuppressants such as FK506 (tacrolimus) that target calcineurin have shown promise for antifungal drug development. FK506-binding proteins (FKBPs) form a complex with calcineurin in the presence of FK506 (FKBP12-FK506) and inhibit calcineurin activity. Research on FKBPs in fungi is limited, and none of the FKBPs have been previously characterized in A. fumigatus. We identified four orthologous genes of FKBP12, the human FK506 binding partner, in A. fumigatus and designated them fkbp12-1, fkbp12-2, fkbp12-3, and fkbp12-4. Deletional analysis of the four genes revealed that the.fkbp12-1 strain was resistant to FK506, indicating FKBP12-1 as the key mediator of FK506-binding to calcineurin. The endogenously expressed FKBP12-1-EGFP fusion protein localized to the cytoplasm and nuclei under normal growth conditions but also to the hyphal septa following FK506 treatment, revealing its interaction with calcineurin. The FKBP12-1-EGFP fusion protein didn't localize at the septa in the presence of FK506 in the cnaA deletion background, confirming its interaction with calcineurin. Testing of all deletion strains in the Galleria mellonella model of aspergillosis suggested that these proteins don't play an important role in virulence. While the Delta fkbp12-2 and Delta fkbp12-3 strains didn't show any discernable phenotype, the Delta fkbp12-4 strain displayed slight growth defect under normal growth conditions and inhibition of the caspofungin-mediated "paradoxical growth effect" at higher concentrations of the antifungal caspofungin. Together, these results indicate that while only FKBP12-1 is the bona fide binding partner of FK506, leading to the inhibition of calcineurin in A. fumigatus, FKBP12-4 may play a role in basal growth and the caspofungin-mediated paradoxical growth response. Exploitation of differences between A. fumigatus FKBP12-1 and human FKBP12 will be critical for the generation of fungal-specific FK506 analogs to inhibit fungal calcineurin and treat invasive fungal disease.	[Falloon, Katie] Duke Univ, Sch Med, Durham, NC USA; [Juvvadi, Praveen R.; Richards, Amber D.; Steinbach, William J.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27710 USA; [Vargas-Muniz, Jose M.; Renshaw, Hilary; Steinbach, William J.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University; Duke University	Steinbach, WJ (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27710 USA.	bill.steinbach@duke.edu	Vargas-Muñiz, Jose/AAQ-7152-2020	Vargas-Muñiz, Jose/0000-0003-0138-8660; Juvvadi, Praveen/0000-0002-5112-7824	National Institutes of Health [1R01AI112595]; National Science Foundation Graduate Research Fellowship Program DGF [1106401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112595, P01AI104533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program DGF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PRJ and WJS are supported by the National Institutes of Health 1R01AI112595 (http://www.nih.gov/). JVM is supported by the National Science Foundation Graduate Research Fellowship Program DGF 1106401 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon CM, 1997, MOL CELL BIOL, V17, P5968, DOI 10.1128/MCB.17.10.5968; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Calo S, 2014, NATURE; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabol Y, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/821969; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Girgenrath T, 2013, J BIOL CHEM, V288, P16073, DOI 10.1074/jbc.M113.463299; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helbig JH, 2003, BIOL CHEM, V384, P125, DOI 10.1515/BC.2003.013; HEMENWAY C, 1993, ANN NY ACAD SCI, V696, P38; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; HOFFLIN JM, 1987, ANN INTERN MED, V106, P209, DOI 10.7326/0003-4819-106-2-209; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Juvvadi PR, 2014, MYCOPATHOLOGIA; Juvvadi PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003564; Juvvadi PR, 2008, EUKARYOT CELL, V7, P1606, DOI 10.1128/EC.00200-08; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Lewis RE, 2008, J ANTIMICROB CHEMOTH, V61, P1140, DOI 10.1093/jac/dkn069; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; MacMillan D, 2009, BRIT J PHARMACOL, V158, P1112, DOI 10.1111/j.1476-5381.2009.00369.x; MacMillan D, 2008, CELL CALCIUM, V43, P539, DOI 10.1016/j.ceca.2007.09.002; MacMillan D, 2013, EUR J PHARMACOL, V700, P181, DOI 10.1016/j.ejphar.2012.12.029; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; Melendez HG, 2009, FUNGAL GENET BIOL, V46, P308, DOI 10.1016/j.fgb.2008.11.011; Niu XW, 2013, GENE, V525, P77, DOI 10.1016/j.gene.2013.04.052; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Pemberton TJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-244; Pereira PJB, 2002, EMBO REP, V3, P88, DOI 10.1093/embo-reports/kvf009; Pinto D, 2008, FUNGAL GENET BIOL, V45, P1600, DOI 10.1016/j.fgb.2008.09.011; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Shimizu K, 2001, GENETICS, V157, P591; Singh N, 2003, CLIN INFECT DIS, V36, P46, DOI 10.1086/345441; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Steinbach WJ, 2012, J INFECTION, V65, P453, DOI 10.1016/j.jinf.2012.08.003; Steinbach WJ, 2011, MED MYCOL, V49, pS77, DOI 10.3109/13693786.2010.499374; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P4922, DOI 10.1128/AAC.48.12.4922-4925.2004; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Teichert S, 2006, EUKARYOT CELL, V5, P1807, DOI 10.1128/EC.00039-06; Wenzel R, 2005, J ANTIMICROB CHEMOTH, V55, P352, DOI 10.1093/jac/dkh535; Wiederhold NR, 2007, CURR OPIN INFECT DIS, V20, P574, DOI 10.1097/QCO.0b013e3282f1be7f; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Yao DY, 2000, J BIOL CHEM, V275, P13149, DOI 10.1074/jbc.275.17.13149	72	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137869	10.1371/journal.pone.0137869	http://dx.doi.org/10.1371/journal.pone.0137869			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366742	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100161
J	Huang, SH; Wu, SH; Lee, SS; Chang, KP; Chai, CY; Yeh, JL; Lin, SD; Kwan, AL; Wang, HMD; Lai, CS				Huang, Shu-Hung; Wu, Sheng-Hua; Lee, Su-Shin; Chang, Kao-Ping; Chai, Chee-Yin; Yeh, Jwu-Lai; Lin, Sin-Daw; Kwan, Aij-Lie; Wang, Hui-Min David; Lai, Chung-Sheng			Fat Grafting in Burn Scar Alleviates Neuropathic Pain via Anti-Inflammation Effect in Scar and Spinal Cord	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC CONSTRICTION INJURY; OXIDATIVE STRESS; STEM-CELLS; APOPTOSIS; RATS; AKT; RADIOTHERAPY; HYPERALGESIA; CONTRIBUTES	Burn-induced neuropathic pain is complex, and fat grafting has reportedly improved neuropathic pain. However, the mechanism of fat grafting in improving neuropathic pain is unclear. Previous investigations have found that neuroinflammation causes neuropathic pain, and anti-inflammatory targeting may provide potential therapeutic opportunities in neuropathic pain. We hypothesized that fat grafting in burn scars improves the neuropathic pain through anti-inflammation. Burn-induced scar pain was confirmed using a mechanical response test 4 weeks after burn injuries, and autologous fat grafting in the scar area was performed simultaneously. After 4 weeks, the animals were sacrificed, and specimens were collected for the inflammation test, including COX-2, iNOS, and nNOS in the injured skin and spinal cord dorsal horns through immunohistochemistry and Western assays. Furthermore, pro-inflammatory cytokines (IL-1 beta and TNF-alpha) in the spinal cord were collected. Double immunofluorescent staining images for measuring p-I kappa B, p-NF kappa B, p-JNK, and TUNEL as well as Western blots of AKT, Bax/Bcl-2 for the inflammatory process, and apoptosis were analyzed. Fat grafting significantly reduced COX2, nNOS, and iNOS in the skin and spinal cord dorsal horns, as well as IL-1 beta and TNF-alpha, compared with the burn group. Moreover, regarding the anti-inflammatory effect, the apoptosis cells in the spinal cord significantly decreased after the fat grafting in the burn injury group. Fat grafting was effective in treating burn-induced neuropathic pain through the alleviation of neuroinflammation and ameliorated spinal neuronal apoptosis.	[Huang, Shu-Hung; Wu, Sheng-Hua; Kwan, Aij-Lie; Lai, Chung-Sheng] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Kwan, Aij-Lie; Wang, Hui-Min David] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Chang, Kao-Ping; Lin, Sin-Daw; Lai, Chung-Sheng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Plast Surg, Dept Surg, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Chang, Kao-Ping; Lin, Sin-Daw; Lai, Chung-Sheng] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung 807, Taiwan; [Wu, Sheng-Hua] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesia, Kaohsiung 807, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Yeh, Jwu-Lai] Kaohsiung Med Univ, Dept & Grad Inst Pharmacol, Coll Med, Kaohsiung 807, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Wang, HMD (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan.	davidw@kmu.edu.tw; chshla@kmu.edu.tw	Lee, Su-Shin/D-4722-2009; Lai, Chung-Sheng/AAL-8778-2021; Huang, Shu-Hung/AAA-3445-2021	Lee, Su-Shin/0000-0001-8675-0870; Lai, Chung-Sheng/0000-0002-1298-9325; Huang, Shu-Hung/0000-0002-2903-1703; Wang, Hui-Min/0000-0002-4692-4917; Chai, Chee-Yin/0000-0003-0486-9742; lin, sindaw/0000-0002-2269-8484	Ministry of Science and Technology, Taiwan [NSC 102-2314-B-037-014-MY2, MOST 103-2221-E-037-004, MOST 104-2622-E-037-001]; Center for Stem Cell Research, Kaohsiung Medical University [KMU-TP103G00, KMU-TP103G02-05]; Kaohsiung Medical University Hospital [KMU-Q103002, KMUH103-3R22, KMUH103-3T04]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Center for Stem Cell Research, Kaohsiung Medical University; Kaohsiung Medical University Hospital	This work was supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2314-B-037-014-MY2, MOST 103-2221-E-037-004 and MOST 104-2622-E-037-001); Center for Stem Cell Research, Kaohsiung Medical University (KMU-TP103G00 and KMU-TP103G02-05); and Kaohsiung Medical University Hospital (KMU-Q103002, KMUH103-3R22, KMUH103-3T04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin B, 2014, AN ACAD BRAS CIENC, V86, P1821, DOI 10.1590/0001-3765201420140067; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Caviggioli F, 2011, PLAST RECONSTR SURG, V128, P349, DOI 10.1097/PRS.0b013e31821e70e7; Chen Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-13; Chung J, 2011, BIOL PHARM BULL, V34, P495, DOI 10.1248/bpb.34.495; Dai ZK, 2014, MOL PHARMACEUT, V11, P1621, DOI 10.1021/mp5000086; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Feng M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-98; Forbes-Duchart L, 2009, J BURN CARE RES, V30, P792, DOI 10.1097/BCR.0b013e3181b47cc2; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Huang SH, 2015, ANN PLAS SURG, V74, pS99, DOI 10.1097/SAP.0000000000000462; Huang SH, 2014, PLAST RECONSTR SURG, V133, P1396, DOI 10.1097/PRS.0000000000000169; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Keilhoff G, 2013, NEUROSCI RES, V77, P215, DOI 10.1016/j.neures.2013.08.008; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Klinger M, 2009, PLAST RECONSTR SURG, V124, P1727, DOI 10.1097/PRS.0b013e3181b98d6f; Klinger M, 2009, PLAST RECONSTR SURG, V124, P330, DOI 10.1097/PRS.0b013e3181a83842; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Ma DL, 2014, ANGEW CHEM INT EDIT, V53, P9178, DOI 10.1002/anie.201404686; Maione L, 2014, AESTHET PLAST SURG, V38, P528, DOI 10.1007/s00266-014-0311-9; Makuch W, 2013, NEUROPHARMACOLOGY, V75, P445, DOI 10.1016/j.neuropharm.2013.08.031; Melenfant A, 1998, PAIN, V77, P241, DOI 10.1016/S0304-3959(98)00096-7; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Mohamad O, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-51; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Payne JE, 2010, J MED CHEM, V53, P7739, DOI 10.1021/jm100828n; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Vaienti L, 2013, J HAND SURG-EUR VOL, V38E, P36, DOI 10.1177/1753193412441122; Wang HLS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055241, 10.1371/journal.pone.0056330]; Wang XX, 2014, NEUROPHARMACOLOGY, V79, P642, DOI 10.1016/j.neuropharm.2014.01.022; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819	44	32	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137563	10.1371/journal.pone.0137563	http://dx.doi.org/10.1371/journal.pone.0137563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368011	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100084
J	Lubaba, CH; Hidano, A; Welburn, SC; Revie, CW; Eisler, MC				Lubaba, Caesar H.; Hidano, Arata; Welburn, Susan C.; Revie, Crawford W.; Eisler, Mark C.			Movement Behaviour of Traditionally Managed Cattle in the Eastern Province of Zambia Captured Using Two-Dimensional Motion Sensors	PLOS ONE			English	Article							LYING BEHAVIOR; DAIRY-CATTLE; INFECTIONS; SYSTEMS; MONITOR; ANEMIA; ESTRUS; COWS	Two-dimensional motion sensors use electronic accelerometers to record the lying, standing and walking activity of cattle. Movement behaviour data collected automatically using these sensors over prolonged periods of time could be of use to stakeholders making management and disease control decisions in rural sub-Saharan Africa leading to potential improvements in animal health and production. Motion sensors were used in this study with the aim of monitoring and quantifying the movement behaviour of traditionally managed Angoni cattle in Petauke District in the Eastern Province of Zambia. This study was designed to assess whether motion sensors were suitable for use on traditionally managed cattle in two veterinary camps in Petauke District in the Eastern Province of Zambia. In each veterinary camp, twenty cattle were selected for study. Each animal had a motion sensor placed on its hind leg to continuously measure and record its movement behaviour over a two week period. Analysing the sensor data using principal components analysis (PCA) revealed that the majority of variability in behaviour among studied cattle could be attributed to their behaviour at night and in the morning. The behaviour at night was markedly different between veterinary camps; while differences in the morning appeared to reflect varying behaviour across all animals. The study results validate the use of such motion sensors in the chosen setting and highlight the importance of appropriate data summarisation techniques to adequately describe and compare animal movement behaviours if association to other factors, such as location, breed or health status are to be assessed.	[Lubaba, Caesar H.; Welburn, Susan C.] Univ Edinburgh, Div Infect & Pathway Med, Ctr Infect Dis, Sch Biomed Sci,Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Hidano, Arata; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Eisler, Mark C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Edinburgh; University of Prince Edward Island; University of Bristol	Hidano, A (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, EpiCtr, Palmerston North, New Zealand.	A.Hidano@massey.ac.nz	Hidano, Arata/S-1719-2019; Eisler, Mark/AAK-1119-2020; Revie, Crawford/B-5002-2011	Hidano, Arata/0000-0003-1707-5319; Eisler, Mark/0000-0001-6843-3345; Revie, Crawford/0000-0002-5018-0340	Department of Veterinary and Livestock Development, Zambia; Beit Trust	Department of Veterinary and Livestock Development, Zambia; Beit Trust	The authors acknowledge the considerable support of the Department of Veterinary and Livestock Development, Zambia for fieldwork costs. CHL acknowledges the support of the Beit Trust through a postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNEY DR, 1994, APPL ANIM BEHAV SCI, V40, P211, DOI 10.1016/0168-1591(94)90062-0; Billiouw M, 1999, TROP MED INT HEALTH, V4, pA28, DOI 10.1046/j.1365-3156.1999.00448.x; Blackie N, 2006, CATTLE PRACT, V14, P139; Blackie N, 2011, APPL ANIM BEHAV SCI, V134, P85, DOI 10.1016/j.applanim.2011.08.004; BUNDZA A, 1982, CAN VET J, V23, P337; Cook NB, 2005, J DAIRY SCI, V88, P3876, DOI 10.3168/jds.S0022-0302(05)73073-3; Edwards JL, 2004, J DAIRY SCI, V87, P524, DOI 10.3168/jds.S0022-0302(04)73192-6; Eisler M. C., 2004, The trypanosomiases, P253, DOI 10.1079/9780851994758.0253; Frost AR, 1997, COMPUT ELECTRON AGR, V17, P139, DOI 10.1016/S0168-1699(96)01301-4; IceRobotics, MOT SENS AN ACT AN I; Ito K, 2010, J DAIRY SCI, V93, P3553, DOI 10.3168/jds.2009-2951; KAUFMANN J, 1995, TROP ANIM HEALTH PRO, V27, P76, DOI 10.1007/BF02236314; KRZANOWSKI W. J., 2007, STAT PRINCIPLES TECH; Maule JP, REPORT TECHNICAL C D; Minjauw B., 2003, RES REPORT; Mitlohner FM, 2001, J ANIM SCI, V79, P1189; Mubanga J, 2009, THESIS U EDINBURGH; MURRAY M, 1988, ACTA TROP, V45, P389; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Robert B, 2009, COMPUT ELECTRON AGR, V67, P80, DOI 10.1016/j.compag.2009.03.002; Roelofs JB, 2005, THERIOGENOLOGY, V64, P1690, DOI 10.1016/j.theriogenology.2005.04.004; SEKONI VO, 1990, VET PARASITOL, V35, P11, DOI 10.1016/0304-4017(90)90112-O; SENGER PL, 1994, J DAIRY SCI, V77, P2745, DOI 10.3168/jds.S0022-0302(94)77217-9; Sinyangwe L, 2004, VET PARASITOL, V119, P125, DOI 10.1016/j.vetpar.2003.11.007; Tatchell R. J., 1981, Advances in the control of theileriosis. Proc. Internat. Conf., 9-13 Feb. 1981, Nairobi., P148; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; William R. D., 1984, MULTIVARIATE ANAL ME	28	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138125	10.1371/journal.pone.0138125	http://dx.doi.org/10.1371/journal.pone.0138125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366728	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000361601100231
J	Tenorio-Gomez, M; de Sena-Tomas, C; Perez-Martin, J				Tenorio-Gomez, Maria; de Sena-Tomas, Carmen; Perez-Martin, Jose			MRN- and 9-1-1-Independent Activation of the ATR-Chk1 Pathway during the Induction of the Virulence Program in the Phytopathogen Ustilago maydis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REPLICATION STRESS; REC1 GENE; CHECKPOINT; KINASE; PHOSPHORYLATION; MRC1	DNA damage response (DDR) leads to DNA repair, and depending on the extent of the damage, to further events, including cell death. Evidence suggests that cell differentiation may also be a consequence of the DDR. During the formation of the infective hypha in the phytopathogenic fungus Ustilago maydis, two DDR kinases, Atr1 and Chk1, are required to induce a G2 cell cycle arrest, which in turn is essential to display the virulence program. However, the triggering factor of DDR in this process has remained elusive. In this report we provide data suggesting that no DNA damage is associated with the activation of the DDR during the formation of the infective filament in U. maydis. We have analyzed bulk DNA replication during the formation of the infective filament, and we found no signs of impaired DNA replication. Furthermore, using RPA-GFP fusion as a surrogate marker of the presence of DNA damage, we were unable to detect any sign of DNA damage at the cellular level. In addition, neither MRN nor 9-1-1 complexes, both instrumental to transmit the DNA damage signal, are required for the induction of the above mentioned cell cycle arrest, as well as for virulence. In contrast, we have found that the claspin-like protein Mrc1, which in other systems serves as scaffold for Atr1 and Chk1, was required for both processes. We discuss possible alternative ways to trigger the DDR, independent of DNA damage, in U. maydis during virulence program activation.	[Tenorio-Gomez, Maria; de Sena-Tomas, Carmen; Perez-Martin, Jose] CSIC, Inst Biol Func & Genom, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG)	Perez-Martin, J (corresponding author), CSIC, Inst Biol Func & Genom, Salamanca, Spain.	jose.perez@csic.es	Perez-Martin, Jose/K-5117-2014	Perez-Martin, Jose/0000-0001-9849-7382; De Sena-Tomas, Carmen/0000-0002-0477-6135	Spanish government [BIO2011-27773, BIO2014-55398-R]	Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by grants from Spanish government (BIO2011-27773 and BIO2014-55398-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; Berens TJ, 2012, MOL BIOL CELL, V23, P1058, DOI 10.1091/mbc.E11-10-0852; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Budirahardja Y, 2009, DEVELOPMENT, V136, P2861, DOI 10.1242/dev.021931; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Castanheira S, 2014, PROGRAMMED CELL CYCL, DOI [10.1242/dev.113415, DOI 10.1242/DEV.113415]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; de Sena-Tomas C, 2015, NUCLEIC ACIDS RES, V43, P2138, DOI 10.1093/nar/gkv082; de Sena-Tomas C, 2011, PLANT CELL, V23, P1654, DOI 10.1105/tpc.110.082552; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Egel R, 2005, DNA REPAIR, V4, P525, DOI 10.1016/j.dnarep.2004.11.004; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Furuya K, 2010, MOL CELL BIOL, V30, P2909, DOI 10.1128/MCB.00049-10; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Garcia-Muse T, 2003, EUKARYOT CELL, V2, P494, DOI 10.1128/EC.2.3.494-500.2003; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Mielnichuk N, 2009, J CELL SCI, V122, P4130, DOI 10.1242/jcs.052233; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Onel K, 1996, GENETICS, V143, P165; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Perez-Martin J., 2012, MORPHOGENESIS PATHOG, V22, P97; Perez-Martin J, 2008, PLANT SIGNAL BEHAV, V3, P480, DOI 10.4161/psb.3.7.5680; Perez-Martin J, 2011, PLANT SIGNAL BEHAV, V6, P1574, DOI 10.4161/psb.6.10.17055; Perez-Martin J, 2009, DNA REPAIR, V8, P720, DOI 10.1016/j.dnarep.2009.01.023; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Sgarlata C, 2005, J CELL SCI, V118, P3607, DOI 10.1242/jcs.02499; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Steinberg G, 2012, J CELL BIOL, V198, P343, DOI 10.1083/jcb.201201087; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P2367, DOI 10.1271/bbb.100583; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; TSUKUDA T, 1989, GENE, V85, P335, DOI 10.1016/0378-1119(89)90426-5; Ullah Z, 2011, MOL CELL BIOL, V31, P4129, DOI 10.1128/MCB.05723-11	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137192	10.1371/journal.pone.0137192	http://dx.doi.org/10.1371/journal.pone.0137192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367864	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100056
J	Wang, T; Peng, SS; Krinner, G; Ryder, J; Li, Y; Dantec-Nedelec, S; Ottle, C				Wang, Tao; Peng, Shushi; Krinner, Gerhard; Ryder, James; Li, Yue; Dantec-Nedelec, Sarah; Ottle, Catherine			Impacts of Satellite-Based Snow Albedo Assimilation on Offline and Coupled Land Surface Model Simulations	PLOS ONE			English	Article							SPECTRAL ALBEDO; CLIMATE; COVER; VALIDATION; FEEDBACK; SENSITIVITY; SCHEME; AREA	Seasonal snow cover in the Northern Hemisphere is the largest component of the terrestrial cryosphere and plays a major role in the climate system through strong positive feedbacks related to albedo. The snow-albedo feedback is invoked as an important cause for the polar amplification of ongoing and projected climate change, and its parameterization across models is an important source of uncertainty in climate simulations. Here, instead of developing a physical snow albedo scheme, we use a direct insertion approach to assimilate satellite- based surface albedo during the snow season (hereafter as snow albedo assimilation) into the land surface model ORCHIDEE (ORganizing Carbon and Hydrology In Dynamic EcosystEms) and assess the influences of such assimilation on offline and coupled simulations. Our results have shown that snow albedo assimilation in both ORCHIDEE and ORCHIDEE-LMDZ (a general circulation model of Laboratoire de Meteorologie Dynamique) improve the simulation accuracy of mean seasonal (October throughout May) snow water equivalent over the region north of 40 degrees. The sensitivity of snow water equivalent to snow albedo assimilation is more pronounced in the coupled simulation than the offline simulation since the feedback of albedo on air temperature is allowed in ORCHIDEE-LMDZ. We have also shown that simulations of air temperature at 2 meters in ORCHIDEE-LMDZ due to snow albedo assimilation are significantly improved during the spring in particular over the eastern Siberia region. This is a result of the fact that high amounts of shortwave radiation during the spring can maximize its snow albedo feedback, which is also supported by the finding that the spatial sensitivity of temperature change to albedo change is much larger during the spring than during the autumn and winter. In addition, the radiative forcing at the top of the atmosphere induced by snow albedo assimilation during the spring is estimated to be -2.50 Wm(-2), the magnitude of which is almost comparable to that due to CO2 (2.83 Wm(-2)) increases since 1750. Our results thus highlight the necessity of realistic representation of snow albedo in the model and demonstrate the use of satellite-based snow albedo to improve model behaviors, which opens new avenues for constraining snow albedo feedback in earth system models.	[Wang, Tao; Peng, Shushi; Krinner, Gerhard] Univ Grenoble 1, CNRS, UMR5183, Lab Glaciol & Geophys Environm, Grenoble, France; [Wang, Tao] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100085, Peoples R China; [Ryder, James; Dantec-Nedelec, Sarah; Ottle, Catherine] CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Li, Yue] Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Peking University	Wang, T (corresponding author), Univ Grenoble 1, CNRS, UMR5183, Lab Glaciol & Geophys Environm, Grenoble, France.	twang@lsce.ipsl.fr	Wang, Tao/ABE-7107-2020; Krinner, Gerhard/A-6450-2011; Peng, Shushi/J-4779-2014; wang, tao/H-2830-2013; Li, Yue/M-8824-2019; OTTLE, Catherine/K-3895-2012; PENG, Shushi/AAS-2603-2020; Krinner, Gerhard/AAB-8837-2022	Krinner, Gerhard/0000-0002-2959-5920; Peng, Shushi/0000-0001-5098-726X; wang, tao/0000-0003-4792-5898; Li, Yue/0000-0003-2997-6368; OTTLE, Catherine/0000-0003-1304-6414; PENG, Shushi/0000-0001-5098-726X; Krinner, Gerhard/0000-0002-2959-5920	PAGE21 project - the European Commission FP7-ENV [282700]	PAGE21 project - the European Commission FP7-ENV	This study has been supported by the PAGE21 project, funded by the European Commission FP7-ENV-2011 (grant agreement NO. 282700).	Anderson EA, 1976, 19 NOAA NWS US DEP C; Aoki T, 2011, J GEOPHYS RES-ATMOS, V116, P22; Brown R, 2006, ATMOS OCEAN, V44, P223, DOI 10.3137/ao.440302; CHALITA S, 1994, CLIM DYNAM, V10, P231, DOI 10.1007/BF00208990; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Cohen JL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014007; De Lannoy GJM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010588; Dutra E, 2010, J HYDROMETEOROL, V11, P899, DOI 10.1175/2010JHM1249.1; Essery R, 2013, GEOPHYS RES LETT, V40, P5521, DOI 10.1002/grl.51008; Essery R, 2009, B AM METEOROL SOC, V90, P1120, DOI 10.1175/2009BAMS2629.1; Etchevers P, 2004, ANN GLACIOL-SER, V38, P150, DOI 10.3189/172756404781814825; Flanner MG, 2011, NAT GEOSCI, V4, P151, DOI 10.1038/NGEO1062; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Fletcher CG, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017724; Frei A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023394; He T, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021667; He T, 2014, IEEE T GEOSCI REMOTE, V52, P3428, DOI 10.1109/TGRS.2013.2272935; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Krinner G, 2006, CLIM DYNAM, V27, P613, DOI 10.1007/s00382-006-0159-z; Lehning M, 2002, COLD REG SCI TECHNOL, V35, P169, DOI 10.1016/S0165-232X(02)00072-1; Liston GE, 2004, J CLIMATE, V17, P1381, DOI 10.1175/1520-0442(2004)017<1381:RSSCHI>2.0.CO;2; Livneh B, 2010, J HYDROMETEOROL, V11, P721, DOI 10.1175/2009JHM1174.1; Loranty MM, 2014, GLOBAL CHANGE BIOL, V20, P594, DOI 10.1111/gcb.12391; Malik MJ, 2012, J HYDROMETEOROL, V13, P1119, DOI 10.1175/JHM-D-11-0125.1; MARSHALL S, 1994, CLIM DYNAM, V10, P21, DOI 10.1007/BF00210334; Molotch NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019063; Muller J. -P., 2012, IEEE GEOSC REM SENS; Muller J-P, 2013, GLOBALBEDO FINAL VAL; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Niu GY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008674; Pedersen CA, 2005, CLIM DYNAM, V25, P351, DOI 10.1007/s00382-005-0037-0; Pinty B, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009096; Qu X, 2014, CLIM DYNAM, V42, P69, DOI 10.1007/s00382-013-1774-0; Roman MO, 2010, REMOTE SENS ENVIRON, V114, P738, DOI 10.1016/j.rse.2009.11.014; Ryder J., 2014, GEOSCI MODEL DEV DIS, V7, P8649, DOI [10.5194/gmdd-7-8649-2014, DOI 10.5194/GMDD-7-8649-2014]; Su H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013035; Sun SF, 1999, J GEOPHYS RES-ATMOS, V104, P19587, DOI 10.1029/1999JD900305; Takala M, 2011, REMOTE SENS ENVIRON, V115, P3517, DOI 10.1016/j.rse.2011.08.014; Thirel G, 2013, REMOTE SENS-BASEL, V5, P5825, DOI 10.3390/rs5115825; USACE, 1956, SNOW HYDR SUMM REP S; Vionnet V, 2012, GEOSCI MODEL DEV, V5, P773, DOI 10.5194/gmd-5-773-2012; Wang T, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024018; Wang T, 2013, J GEOPHYS RES-ATMOS, V118, P6064, DOI 10.1002/jgrd.50395; Wang Z, 2010, J APPL METEOROL CLIM, V49, P363, DOI 10.1175/2009JAMC2134.1; WARREN SG, 1980, J ATMOS SCI, V37, P2734, DOI 10.1175/1520-0469(1980)037<2734:AMFTSA>2.0.CO;2; WISCOMBE WJ, 1980, J ATMOS SCI, V37, P2712, DOI 10.1175/1520-0469(1980)037<2712:AMFTSA>2.0.CO;2; Zaitchik BF, 2009, J HYDROMETEOROL, V10, P130, DOI 10.1175/2008JHM1042.1	48	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137275	10.1371/journal.pone.0137275	http://dx.doi.org/10.1371/journal.pone.0137275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366564	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100062
J	Cabrera, M; Gomez, N; Lenicov, FR; Echeverria, E; Shayo, C; Moglioni, A; Fernandez, N; Davio, C				Cabrera, Maia; Gomez, Natalia; Remes Lenicov, Federico; Echeverria, Emiliana; Shayo, Carina; Moglioni, Albertina; Fernandez, Natalia; Davio, Carlos			G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TAXOL-INDUCED APOPTOSIS; CATHEPSIN-L INHIBITORS; IRON CHELATORS; IN-VITRO; ANTITUMOR-ACTIVITY; MITOTIC ARREST; FUNCTIONALIZED BENZOPHENONE; RIBONUCLEOTIDE REDUCTASE; SPINDLE CHECKPOINT	Anti-mitotic therapies have been considered a hallmark in strategies against abnormally proliferating cells. Focusing on the extensively studied family of thiosemicarbazone (TSC) compounds, we have previously identified 4,4'-dimethoxybenzophenone thiosemicarbazone (T44Bf) as a promising pharmacological compound in a panel of human leukemia cell lines (HL60, U937, KG1a and Jurkat). Present findings indicate that T44Bf-mediated antiproliferative effects are associated with a reversible chronic mitotic arrest caused by defects in chromosome alignment, followed by induced programmed cell death. Furthermore, T44Bf selectively induces apoptosis in leukemia cell lines when compared to normal peripheral bloodmononuclear cells. The underlying mechanism of action involves the activation of the mitochondria signaling pathway, with loss of mitochondrial membrane potential and sustained phosphorylation of anti-apoptotic protein Bcl-xL as well as increased Bcl-2 (enhanced phosphorylated fraction) and pro-apoptotic protein Bad levels. In addition, ERK signaling pathway activation was found to be a requisite for T44Bf apoptotic activity. Our findings further describe a novel activity for a benzophenone thiosemicarbazone and propose T44Bf as a promising anti-mitotic prototype to develop chemotherapeutic agents to treat acute leukemia malignancies.	[Cabrera, Maia; Gomez, Natalia; Echeverria, Emiliana; Fernandez, Natalia; Davio, Carlos] UBA, CONICET, ININFA, Inst Invest Farmacol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Remes Lenicov, Federico] UBA, CONICET, INBIRS, Inst Invest Biomed Retrovirus,Fac Med, Buenos Aires, DF, Argentina; [Remes Lenicov, Federico] UBA, CONICET, INBIRS, SIDA,Fac Med, Buenos Aires, DF, Argentina; [Shayo, Carina] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, IBYME, RA-1033 Buenos Aires, DF, Argentina; [Moglioni, Albertina] UBA, CONICET, IQUIMEFA, Inst Quim & Metab Farm,Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Gomez, Natalia; Moglioni, Albertina; Fernandez, Natalia; Davio, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Cabrera, M (corresponding author), UBA, CONICET, ININFA, Inst Invest Farmacol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina.	cabrera.maia@gmail.com			Universidad de Buenos Aires UBACyT [20020100100601]; Agencia Nacional de Promocion Cientifica y Tecnologica [Prestamo BID-PICT-2013-2050]	Universidad de Buenos Aires UBACyT(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from the Universidad de Buenos Aires UBACyT 20020100100601 CD; Agencia Nacional de Promocion Cientifica y Tecnologica: Prestamo BID-PICT-2013-2050 CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 1996, DRUG SAFETY, V15, P406, DOI 10.2165/00002018-199615060-00005; Aguirre G, 2004, BIOORGAN MED CHEM, V12, P4885, DOI 10.1016/j.bmc.2004.07.003; Alho MA, 2000, ARKIVOC, Viv, P627; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; BAUER DJ, 1969, AM J EPIDEMIOL, V90, P130, DOI 10.1093/oxfordjournals.aje.a121057; Belaud-Rotureau MA, 2000, LEUKEMIA, V14, P1266, DOI 10.1038/sj.leu.2401803; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Berndtsson M, 2005, FEBS LETT, V579, P3090, DOI 10.1016/j.febslet.2005.04.067; Bharti N, 2004, BIOORGAN MED CHEM, V12, P4679, DOI 10.1016/j.bmc.2004.06.036; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buschini A, 2009, J INORG BIOCHEM, V103, P666, DOI 10.1016/j.jinorgbio.2008.12.016; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chao J, 2012, CANCER CHEMOTH PHARM, V69, P835, DOI 10.1007/s00280-011-1779-5; Chavarria GE, 2012, EUR J MED CHEM, V58, P568, DOI 10.1016/j.ejmech.2012.10.039; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cleveland DW, CANC CELL, V8, P7; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Elloumi-Mseddi J, 2014, J RECEPT SIG TRANSD, P1; Finkielsztein LM, 2008, EUR J MED CHEM, V43, P1767, DOI 10.1016/j.ejmech.2007.10.023; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; Gan CF, 2014, STEROIDS, V87, P99, DOI 10.1016/j.steroids.2014.05.026; HAIM N, 1994, CANCER, V73, P2515, DOI 10.1002/1097-0142(19940515)73:10<2515::AID-CNCR2820731011>3.0.CO;2-G; HAIM N, 1991, ACTA ONCOL, V30, P707, DOI 10.3109/02841869109092444; Han CR, 2012, BIOORG MED CHEM LETT, V22, P945, DOI 10.1016/j.bmcl.2011.12.023; HEINER GG, 1971, AM J EPIDEMIOL, V94, P435, DOI 10.1093/oxfordjournals.aje.a121340; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang H, 2010, J MED CHEM, V53, P3048, DOI 10.1021/jm9014394; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2009, FUTURE MED CHEM, V1, P1143, DOI [10.4155/fmc.09.80, 10.4155/FMC.09.80]; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kizilcikli I, 2007, FOLIA MICROBIOL, V52, P15, DOI 10.1007/BF02932132; Kumar GDK, 2010, BIOORG MED CHEM LETT, V20, P6610, DOI 10.1016/j.bmcl.2010.09.026; Kumar GDK, 2010, BIOORG MED CHEM LETT, V20, P1415, DOI 10.1016/j.bmcl.2009.12.090; Kunos CA, 2013, GYNECOL ONCOL, V130, P75, DOI 10.1016/j.ygyno.2013.04.019; Kunos CA, 2010, CLIN CANCER RES, V16, P1298, DOI 10.1158/1078-0432.CCR-09-2469; Ling YH, 1998, J BIOL CHEM, P273; Liu MY, 2014, ACTA PHARMACOL SIN, V35, P1302, DOI 10.1038/aps.2014.71; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; MCCULLOCH EA, 1983, BLOOD, V62, P1; Mendes IC, 2008, EUR J MED CHEM, V43, P1454, DOI 10.1016/j.ejmech.2007.09.016; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mortazavi A, 2013, INVEST NEW DRUG, V31, P685, DOI 10.1007/s10637-012-9863-1; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Otero L, 2006, J MED CHEM, V49, P3322, DOI 10.1021/jm0512241; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Pelosi G, 2010, OPEN CRYSTALLOGRAPHY; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rao VA, 2013, ANTIOXID REDOX SIGN, V18, P930, DOI 10.1089/ars.2012.4877; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; Schimmer AD, 2001, BLOOD, V98, P3541, DOI 10.1182/blood.V98.13.3541; Shao JM, 2006, MOL CANCER THER, V5, P586, DOI 10.1158/1535-7163.MCT-05-0384; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Stahnke K, 2003, LEUKEMIA, V17, P2130, DOI 10.1038/sj.leu.2403144; Su TT, 2001, CURR BIOL, V11, pR467, DOI 10.1016/S0960-9822(01)00283-4; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Thomadaki H, 2009, ANN NY ACAD SCI, V1171, P276, DOI 10.1111/j.1749-6632.2009.04912.x; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tyagi C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S10; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zeglis BM, 2011, J MED CHEM, V54, P2391, DOI 10.1021/jm101532u	77	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136878	10.1371/journal.pone.0136878	http://dx.doi.org/10.1371/journal.pone.0136878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360247	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100018
J	Espino, M; Font-Llitjos, M; Vilches, C; Salido, E; Prat, E; de Heredia, ML; Palacin, M; Nunes, V				Espino, Meritxell; Font-Llitjos, Mariona; Vilches, Clara; Salido, Eduardo; Prat, Esther; Lopez de Heredia, Miguel; Palacin, Manuel; Nunes, Virginia			Digenic Inheritance in Cystinuria Mouse Model	PLOS ONE			English	Article							MUTATIONS; SLC7A9; SLC3A1; REABSORPTION; MICE	Cystinuria is an aminoaciduria caused by mutations in the genes that encode the two subunits of the amino acid transport system b(0,+), responsible for the renal reabsorption of cystine and dibasic amino acids. The clinical symptoms of cystinuria relate to nephrolithiasis, due to the precipitation of cystine in urine. Mutations in SLC3A1, which codes for the heavy subunit rBAT, cause cystinuria type A, whereas mutations in SLC7A9, which encodes the light subunit b(0,+) AT, cause cystinuria type B. By crossing Slc3a(1-/-) with Slc7a9(-/-) mice we generated a type AB cystinuria mouse model to test digenic inheritance of cystinuria. The 9 genotypes obtained have been analyzed at early (2- and 5-months) and late stage (8-months) of the disease. Monitoring the lithiasic phenotype by X-ray, urine amino acid content analysis and protein expression studies have shown that double heterozygous mice (Slc7a9(+/-)Slc3a1(+/-)) present lower expression of system b(0,+) and higher hyperexcretion of cystine than single heterozygotes (Slc7a9(+/-)Slc3a1(+/+) and Slc7a9(+/+) Slc3a1(+/-)) and give rise to lithiasis in 4% of the mice, demonstrating that cystinuria has a digenic inheritance in this mouse model. Moreover in this study it has been demonstrated a genotype/phenotype correlation in type AB cystinuria mouse model providing new insights for further molecular and genetic studies of cystinuria patients.	[Espino, Meritxell; Font-Llitjos, Mariona; Vilches, Clara; Prat, Esther; Lopez de Heredia, Miguel; Nunes, Virginia] Bellvitge Biomed Res Inst IDIBELL, Mol Genet Lab, Barcelona, Spain; [Font-Llitjos, Mariona; Lopez de Heredia, Miguel; Nunes, Virginia] Ctr Biomed Network Res Rare Dis CIBERER, U730, Barcelona, Spain; [Salido, Eduardo] Canarias Univ Hosp La Laguna, Dept Pathol, Tenerife, Spain; [Salido, Eduardo] Ctr Biomed Network Res Rare Dis CIBERER, U740, Tenerife, Spain; [Palacin, Manuel] IRB, Barcelona, Spain; [Palacin, Manuel] Ctr Biomed Network Res Rare Dis CIBERER, U731, Barcelona, Spain; [Palacin, Manuel] Univ Barcelona, Biochem & Mol Biol Dept, Barcelona, Spain; [Nunes, Virginia] Univ Barcelona, Genet Sect, Physiol Sci Dept 2, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Nunes, V (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Mol Genet Lab, Barcelona, Spain.	vnunes@idibell.cat	Nunes, Virginia/AAD-1014-2019; Guarch, Meritxell Espino/AAR-4026-2020; López de Heredia, Miguel/A-7727-2008; Palacín, Manuel/G-9786-2015; Salido, Eduardo/I-2232-2015	Nunes, Virginia/0000-0002-5747-9310; Guarch, Meritxell Espino/0000-0002-7211-3229; López de Heredia, Miguel/0000-0003-2826-9565; Salido, Eduardo/0000-0001-9599-9854; Palacin, Manuel/0000-0002-8670-293X; Vilches, Clara/0000-0002-2695-2128	Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER) [PI13/00121]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR2009-1490, SGR2009-1355]; Ministerio de Economia y Competitividad [SAF2012-40080];  [SAF2011-23933]	Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Economia y Competitividad(Spanish Government); 	"Funding was provided by Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad" and "Fondo Europeo de Desarrollo Regional (FEDER)" reference: PI13/00121 to Virginia Nunes, http://gesdoc.isciii.es/?action=download?&id=14/11/2013-7e20e3561c; Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR2009-1490 to Virginia Nunes and SGR2009-1355 to Manuel Palacin, http://www10.gencat.cat/agaur_web/genera?dos/catala/home/recurs/doc/resolucio_3ju? l09_def.pdf; Ministerio de Economia y Competitividad SAF2012-40080 to Manuel Palacin, http://www.idi.mineco.gob.es/stfls/eSede?/Ficheros/2013/resolucion_concesion_pred?oc_2013completoFIRMADO.pdf; SAF2011-23933 to Eduardo Salido, https://sede.micinn.gob.es/stfls/eSede/F?icheros/2012/2012_resolucion%20concesion?_fpi_firmada.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; Dello Strologo L, 2002, J AM SOC NEPHROL, V13, P2547, DOI 10.1097/01.ASN.0000029586.17680.E5; Di Giacopo A, 2013, AM J PHYSIOL-RENAL, V305, pF1645, DOI 10.1152/ajprenal.00221.2013; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Gucev Z, 2011, J GENET, V90, P157, DOI 10.1007/s12041-011-0045-2; Kummer S, 2014, PEDIATR NEPHROL, V29, P155, DOI 10.1007/s00467-013-2617-2; Livrozet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102700; MCNAMARA PD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P101, DOI 10.1016/0005-2736(92)90062-Q; Palacin M, 2001, CURR OPIN GENET DEV, V11, P328, DOI 10.1016/S0959-437X(00)00198-2; Peters T, 2003, HUM MOL GENET, V12, P2109, DOI 10.1093/hmg/ddg189; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; Scriver C.R., 2001, METABOLIC MOL BASES; THIER S, 1964, SCIENCE, V143, P482, DOI 10.1126/science.143.3605.482	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137277	10.1371/journal.pone.0137277	http://dx.doi.org/10.1371/journal.pone.0137277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359869	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100028
J	Upadhyay, S; Hussain, A; Mishra, S; Maurya, AP; Bhattacharjee, A; Joshi, SR				Upadhyay, Supriya; Hussain, Abbas; Mishra, Shweta; Maurya, Anand Prakash; Bhattacharjee, Amitabha; Joshi, Santa Ram			Genetic Environment of Plasmid Mediated CTX-M-15 Extended Spectrum Beta-Lactamases from Clinical and Food Borne Bacteria in North-Eastern India	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BLA(CTX-M); DISSEMINATION; RESISTANT; OUTBREAK; ENTEROBACTERIACEAE; IDENTIFICATION; CARBAPENEMASE; EPIDEMIOLOGY	Background The study investigated the presence of CTX-M-15 type extended spectrum beta-lactamases (ESBL), compared their genetic arrangements and plasmid types in gram negative isolates of hospital and food origin in north-east India. From September 2013 to April 2014, a total of 252 consecutive, non-duplicate clinical isolates and 88 gram negative food isolates were selected. Phenotypic and molecular characterization of ESBL genes was performed. Presence of integrons and gene cassettes were analyzed by integrase and 59 base-element PCR respectively. The molecular environments surrounding bla(CTX-M) and plasmid types were investigated by PCR and PCR-based replicon typing respectively. Transformation was carried out to assess plasmid transfer. Southern blotting was conducted to localize the bla(CTX-M-15) genes. DNA fingerprinting was performed by ERIC-PCR. Results Prevalence of ESBL was found to be 40.8% (103/252) in clinical and 31.8%(28/88) in foodborne isolates. Molecular characterization revealed the presence of 56.3%(58/103) and 53.5% (15/28) bla(CTX-M-15) in clinical and food isolates respectively. Strains of clinical and food origin were non-clonal. Replicon typing revealed that IncI1 and IncFII plasmid were carrying bla(CTX-M-15) in clinical and food isolates and were horizontally transferable. The ISEcp1 element was associated with bla(CTX-M-15) in both clinical and food isolates. Conclusions The simultaneous presence of resistance determinants in non-clonal isolates of two different groups thus suggests that the microbiota of common food products consumed may serve as a reservoir for some of the drug resistance genes prevalent in human pathogens.	[Upadhyay, Supriya; Hussain, Abbas; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Mishra, Shweta] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India; [Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, Assam, India	North Eastern Hill University; Banaras Hindu University (BHU); Assam University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in	Joshi/F-2097-2015	Maurya, Anand Prakash/0000-0001-5231-8174; Joshi, Santa Ram/0000-0001-8080-484X	University Grants Commission (UGC) [F.4-2/2006(BSR)/13-927/2013(BSR)]	University Grants Commission (UGC)(University Grants Commission, India)	This work was supported by the University Grants Commission (UGC) under the Dr. D.S. Kothari Postdoctoral Fellowship Scheme (No. F.4-2/2006(BSR)/13-927/2013(BSR) to SU.	Akram M, 2007, ANN CLIN MICROB ANTI, V23, P6; Calbo E, 2011, CLIN INFECT DIS, V52, P743, DOI 10.1093/cid/ciq238; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cartelle M, 2004, ANTIMICROB AGENTS CH, V48, P2308, DOI 10.1128/AAC.48.6.2308-2313.2004; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Colee JG, 1996, MACKIE MCCARTNEY PRA; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; Ensor VM, 2006, J ANTIMICROB CHEMOTH, V58, P1260, DOI 10.1093/jac/dkl422; Gonullu N, 2008, J CLIN MICROBIOL, V46, P1110, DOI 10.1128/JCM.01974-07; Hussain A, 2012, ANTIMICROB AGENTS CH, V56, P6358, DOI 10.1128/AAC.01099-12; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Lartigue MF, 2004, FEMS MICROBIOL LETT, V234, P201, DOI 10.1016/j.femsle.2004.01.051; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P1244, DOI 10.1093/jac/dkn093; Lee S, 2005, J ANTIMICROB CHEMOTH, V56, P122, DOI 10.1093/jac/dki160; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Locke JB, 2012, ANTIMICROB AGENTS CH, V56, P332, DOI 10.1128/AAC.05420-11; Moore John E, 2010, Ulster Med J, V79, P85; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P75, DOI 10.1111/j.1469-0691.2007.01865.x; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P447, DOI 10.1128/AAC.49.1.447-450.2005; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Sambrook J., 1989, MOL CLONING LAB MANU, V2, P32; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Shahid M, 2009, J INFECT DEV COUNTR, V3, P593, DOI 10.3855/jidc.550; Stokes HW, 2002, APPL ENVIRON MICROB, V67, P5240; Tenover FC, 1999, J CLIN MICROBIOL, V37, P4065, DOI 10.1128/JCM.37.12.4065-4070.1999; Tsakris A, 2000, J CLIN MICROBIOL, V38, P1290, DOI 10.1128/JCM.38.3.1290-1292.2000; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; Woodford N, 2008, J ANTIMICROB CHEMOTH, V62, P1261, DOI 10.1093/jac/dkn396; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	36	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138056	10.1371/journal.pone.0138056	http://dx.doi.org/10.1371/journal.pone.0138056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361395	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100110
J	Watanabe, S; Takanashi, F; Ishida, K; Kobayashi, S; Kitamura, Y; Hamasaki, Y; Saito, M				Watanabe, Satoshi; Takanashi, Fumihito; Ishida, Kohei; Kobayashi, Suguru; Kitamura, Yoshiichiro; Hamasaki, Yuuta; Saito, Minoru			Nitric Oxide-Mediated Modulation of Central Network Dynamics during Olfactory Perception	PLOS ONE			English	Article							LONG-TERM-MEMORY; TERRESTRIAL SLUG; IN-VITRO; ODOR; OSCILLATIONS; SYNTHASE; INTERNEURONS; NEURONS; DISCRIMINATION; IMPAIRMENT	Nitric oxide (NO) modulates the dynamics of central olfactory networks and has been implicated in olfactory processing including learning. Land mollusks have a specialized olfactory lobe in the brain called the procerebral (PC) lobe. The PC lobe produces ongoing local field potential (LFP) oscillation, which is modulated by olfactory stimulation. We hypothesized that NO should be released in the PC lobe in response to olfactory stimulation, and to prove this, we applied an NO electrode to the PC lobe of the land slug Limax in an isolated tentacle-brain preparation. Olfactory stimulation applied to the olfactory epithelium transiently increased the NO concentration in the PC lobe, and this was blocked by the NO synthase inhibitor L-NAME at 3.7 mM. L-NAME at this concentration did not block the ongoing LFP oscillation, but did block the frequency increase during olfactory stimulation. Olfactory stimulation also enhanced spatial synchronicity of activity, and this response was also blocked by L-NAME. Single electrical stimulation of the superior tentacle nerve (STN) mimicked the effects of olfactory stimulation on LFP frequency and synchronicity, and both of these effects were blocked by L-NAME. L-NAME did not block synaptic transmission from the STN to the nonbursting (NB)-type PC lobe neurons, which presumably produce NO in an activity-dependent manner. Previous behavioral experiments have revealed impairment of olfactory discrimination after L-NAME injection. The recording conditions in the present work likely reproduce the in vivo brain state in those behavioral experiments. We speculate that the dynamical effects of NO released during olfactory perception underlie precise odor representation and memory formation in the brain, presumably through regulation of NB neuron activity.	[Watanabe, Satoshi] Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan; [Watanabe, Satoshi; Takanashi, Fumihito] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Ishida, Kohei; Hamasaki, Yuuta; Saito, Minoru] Nihon Univ, Grad Sch Integrated Basic Sci, Dept Correlat Study Phys & Chem, Tokyo, Japan; [Kobayashi, Suguru] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Kitamura, Yoshiichiro] Kanto Gakuin Univ, Coll Sci & Engn, Yokohama, Kanagawa, Japan	Tohoku University; University of Tokyo; Nihon University; Tokushima Bunri University; Kanto Gakuin University	Watanabe, S (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.	swatanabe@biomems.mech.tohoku.ac.jp	Kobayashi, Suguru/AAN-9001-2021		JSPS KAKENHI [17790032]; Nihon University Academic Research grant [14-002, 15-002]; Grants-in-Aid for Scientific Research [26440183] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon University Academic Research grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant Number 17790032 to S.W. and Nihon University Academic Research grant (Total Research 14-002 and 15-002) to M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; Aonuma H, 2008, NEUROSCIENCE, V157, P749, DOI 10.1016/j.neuroscience.2008.09.032; Barnes DC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00134; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fujie S, 2005, J NEUROBIOL, V62, P14, DOI 10.1002/neu.20046; Fujie S, 2002, ZOOL SCI, V19, P15, DOI 10.2108/zsj.19.15; Gage SL, 2013, J EXP BIOL, V216, P3294, DOI 10.1242/jeb.086694; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; Gelperin A, 2006, J NEUROSCI, V26, P1663, DOI 10.1523/JNEUROSCI.3737-05b.2006; GELPERIN A, 1994, NATURE, V369, P61, DOI 10.1038/369061a0; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Higgins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042556; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Inamura K, 1998, AM J PHYSIOL, P1201; Inoue T, 2000, J NEUROPHYSIOL, V84, P1112, DOI 10.1152/jn.2000.84.2.1112; Inoue T, 2004, J NEUROPHYSIOL, V91, P372, DOI 10.1152/jn.00247.2003; Inoue T, 2001, J NEUROPHYSIOL, V85, P2634, DOI 10.1152/jn.2001.85.6.2634; Inoue T, 2006, J NEUROPHYSIOL, V95, P3898, DOI 10.1152/jn.00853.2005; Ito E, 2013, NEUROSCI LETT, V541, P1, DOI 10.1016/j.neulet.2013.02.021; Katzoff A, 2002, J NEUROSCI, V22, P9581; Kemenes I, 2002, J NEUROSCI, V22, P1414, DOI 10.1523/JNEUROSCI.22-04-01414.2002; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Kitamura Y, 2001, NEUROSCI RES, V41, P129, DOI 10.1016/S0168-0102(01)00271-1; Kobayashi S, 2000, NEUROSCI RES, V38, P27, DOI 10.1016/S0168-0102(00)00136-X; Lowe G, 2008, NEUROSCIENCE, V153, P842, DOI 10.1016/j.neuroscience.2008.03.003; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Marine N, 2014, NEUROSCI BIOBEHAV R, V45, P262, DOI 10.1016/j.neubiorev.2014.06.016; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Matsuo R, 2008, GENE, V415, P74, DOI 10.1016/j.gene.2008.02.021; Matsuo R, 2009, BIOCHEM BIOPH RES CO, V386, P724, DOI 10.1016/j.bbrc.2009.06.112; Mochizuki S, 2005, HEART VESSELS, V20, P175, DOI 10.1007/s00380-005-0827-7; Muller U, 2002, J NEUROSCI, V22, P8739; Murakami M, 2004, J NEUROBIOL, V58, P369, DOI 10.1002/neu.10295; Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x; Pavesi E, 2013, LEARN MEMORY, V20, P482, DOI 10.1101/lm.031450.113; Pietrobon M, 2011, J NEUROSCI, V31, P8395, DOI 10.1523/JNEUROSCI.6722-10.2011; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sakura M, 2004, NEUROSCI LETT, V370, P257, DOI 10.1016/j.neulet.2004.08.025; Samama B, 1999, NEUROBIOL LEARN MEM, V71, P219, DOI 10.1006/nlme.1998.3869; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Watanabe S, 1999, J COMP PHYSIOL A, V184, P553, DOI 10.1007/s003590050355; Watanabe S, 2003, J NEUROSCI, V23, P2932; Watanabe S, 1998, J EXP BIOL, V201, P925; Watanabe S, 2008, LEARN MEMORY, V15, P633, DOI 10.1101/lm920908; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Yabumoto T, 2008, LEARN MEMORY, V15, P229, DOI 10.1101/lm.936508	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136846	10.1371/journal.pone.0136846	http://dx.doi.org/10.1371/journal.pone.0136846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360020	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100017
J	Watzlawick, R; Kenngott, EE; Liu, FDM; Schwab, JM; Hamann, A				Watzlawick, Ralf; Kenngott, Elisabeth E.; Liu, Francesca Diane M.; Schwab, Jan M.; Hamann, Alf			Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels	PLOS ONE			English	Article							CD4(+) T-CELLS; INFLAMMATION; INTERLEUKIN-27; MACROPHAGES; ACTIVATION; SUPPRESSION; MECHANISM; IMMUNITY; SYSTEM; P-28	Rapid activation of the innate immune system is critical for an efficient host response to invading pathogens. However, the inflammatory reaction has to be strictly controlled to minimize harmful immunopathology. A number of mediators including the cytokine interleukin-27 (IL-27) appear to be responsible for limitation and resolution of inflammation. Despite increasing knowledge of its suppressive effects on T cells, the influence on neutrophils and macrophages is poorly understood. To determine the role of IL-27 in innate immune responses we analysed the effect of IL-27 in a T cell independent model of zymosan-induced peritonitis. Early administration of recombinant IL-27 strongly reduced the number of neutrophils recruited to the peritoneal cavity after zymosan application as well as the neutrophil frequency in the blood. Simultaneously, IL-27 reduced the release of neutrophils from the bone marrow upon inflammation. Although cytokine levels were not affected by IL-27 treatment, the levels of the chemokines KC, MCP-1 and MIP-1 alpha in the peritoneal fluid were strongly decreased. These findings demonstrate that IL-27 is able to control mobilisation and recruitment of neutrophils into the peritoneal cavity and identify a novel mechanism to limit inflammation caused by innate immune cells.	[Watzlawick, Ralf; Schwab, Jan M.] Charite, Clin & Expt Spinal Cord Injury Res Lab Neuroparap, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Kenngott, Elisabeth E.; Liu, Francesca Diane M.; Hamann, Alf] Deutsch Rheuma Forschungszentrum, Dept Expt Rheumatol, Berlin, Germany; [Kenngott, Elisabeth E.; Hamann, Alf] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Spinal Cord Injury Div,Inst Neurosci, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Neurosci Inst, Dept Neurosci, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Neurosci Inst, Ctr Brain & Spinal Cord Repair,Dept Phys Med & Re, Columbus, OH 43210 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hamann, A (corresponding author), Deutsch Rheuma Forschungszentrum, Dept Expt Rheumatol, Berlin, Germany.	hamann@drfz.de		Schwab, Jan/0000-0001-6784-4919	Studienstiftung des deutschen Volkes [186392]; DAAD; Else-Kroehner-Fresenius Foundation; Wings-for-Life Spinal Cord Research Foundation [60-2012]; W.E. Hunt & C.M. Curtis Endowment; Deutsche Forschungsgemeinschaft [SFB633, SFB650]	Studienstiftung des deutschen Volkes; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Else-Kroehner-Fresenius Foundation; Wings-for-Life Spinal Cord Research Foundation; W.E. Hunt & C.M. Curtis Endowment; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	RWs work was supported by the Studienstiftung des deutschen Volkes (grant 186392, http://www.studienstiftung.de/) and FDL by the DAAD (http://www.daad.de/en/). JMS received funding from the Else-Kroehner-Fresenius Foundation (http://www.ekfs.de/de/start.html), the Wings-for-Life Spinal Cord Research Foundation (grant 60-2012, http://www.wingsforlife.com/en/) and by the W.E. Hunt & C.M. Curtis Endowment. AH received funding from the Deutsche Forschungsgemeinschaft (SFB633, SFB650, http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Gompertz S, 2000, Semin Respir Infect, V15, P14; Hause L, 2007, ANTIVIR RES, V76, P159, DOI 10.1016/j.antiviral.2007.06.013; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Li JP, 2010, SCAND J IMMUNOL, V72, P284, DOI 10.1111/j.1365-3083.2010.02422.x; Liu FDM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004110; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	24	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137651	10.1371/journal.pone.0137651	http://dx.doi.org/10.1371/journal.pone.0137651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360023	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100065
J	Asadzadeh, J; Neligan, N; Canabal-Alvear, JJ; Daly, AC; Kramer, SG; Labrador, JP				Asadzadeh, Jamshid; Neligan, Niamh; Canabal-Alvear, Judith J.; Daly, Amanda C.; Kramer, Sunita Gupta; Labrador, Juan-Pablo			The Unc-5 Receptor Is Directly Regulated by Tinman in the Developing Drosophila Dorsal Vessel	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NETRIN-RECEPTOR; HEART-DISEASE; GENES; SLIT; CELLS; EXPRESSION; REPULSION; MESODERM; GUIDANCE	During early heart morphogenesis cardiac cells migrate in two bilateral opposing rows, meet at the dorsal midline and fuse to form a hollow tube known as the primary heart field in vertebrates or dorsal vessel (DV) in Drosophila. Guidance receptors are thought to mediate this evolutionarily conserved process. A core of transcription factors from the NK2, GATA and T-box families are also believed to orchestrate this process in both vertebrates and invertebrates. Nevertheless, whether they accomplish their function, at least in part, through direct or indirect transcriptional regulation of guidance receptors is currently unknown. In our work, we demonstrate how Tinman (Tin), the Drosophila homolog of the Nkx-2.5 transcription factor, regulates the Unc-5 receptor during DV tube morphogenesis. We use genetics, expression analysis with single cell mRNA resolution and enhancer-reporter assays in vitro or in vivo to demonstrate that Tin is required for Unc-5 receptor expression specifically in cardioblasts. We show that Tin can bind to evolutionary conserved sites within an Unc-5 DV enhancer and that these sites are required for Tin-dependent transactivation both in vitro and in vivo.	[Asadzadeh, Jamshid; Neligan, Niamh; Daly, Amanda C.; Labrador, Juan-Pablo] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Asadzadeh, Jamshid; Daly, Amanda C.; Labrador, Juan-Pablo] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Canabal-Alvear, Judith J.; Kramer, Sunita Gupta] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Labrador, JP (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	labradoj@tcd.ie	Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Kramer, Sunita/0000-0001-8372-5928	Science Foundation Ireland [07/IN.1/B913, 08/RFP/NSC1617]; Irish Research Council New Foundations Award; Trinity Research Award from Trinity College Dublin; National Science Foundation [IOS-1123963]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council New Foundations Award(Irish Research Council for Science, Engineering and Technology); Trinity Research Award from Trinity College Dublin; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Science Foundation Ireland awards 07/IN.1/B913 and 08/RFP/NSC1617 (http://www.sfi.ie); Irish Research Council New Foundations Award 2012 (http://research.ie); Trinity Research Award 2009 from Trinity College Dublin (http://www.tcd.ie); and National Science Foundation, grant number IOS-1123963 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1990, DEVELOPMENT, V110, P661; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Harvey RP, 2002, COLD SPRING HARB SYM, V67, P107, DOI 10.1101/sqb.2002.67.107; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; LAI ZC, 1993, P NATL ACAD SCI USA, V90, P4122, DOI 10.1073/pnas.90.9.4122; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Macabenta FD, 2013, DEV BIOL, V380, P233, DOI 10.1016/j.ydbio.2013.05.007; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Medioni C, 2010, DEV DYNAM, V239, P3303, DOI 10.1002/dvdy.22449; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Rosenthal N., 2010, HEART DEV REGENERATI, P47, DOI DOI 10.1016/B978-0-12-381332-9.00002-5; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Su MT, 1999, DEVELOPMENT, V126, P3241; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; von Hilchen CM, 2010, DEVELOPMENT, V137, P1251, DOI 10.1242/dev.042853; Ward EJ, 2000, MECH DEVELOP, V96, P233, DOI 10.1016/S0925-4773(00)00389-0; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zarin AA, 2014, NEURON, V81, P1297, DOI 10.1016/j.neuron.2014.01.038; Zarin AA, 2014, CELL MOL LIFE SCI, V71, P419, DOI 10.1007/s00018-013-1434-x; Zarin AA, 2012, DEVELOPMENT, V139, P1798, DOI 10.1242/dev.070656	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137688	10.1371/journal.pone.0137688	http://dx.doi.org/10.1371/journal.pone.0137688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356221	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800078
J	Troester, N; Palfner, M; Schmidberger, E; Olschewski, H; Avian, A				Troester, Natascha; Palfner, Michael; Schmidberger, Erich; Olschewski, Horst; Avian, Alexander			Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR RISK; APNEA SYNDROME; ASSOCIATION; MARKERS; OBESITY; INTERLEUKIN-6; HYPOPNEA; DISEASE	Introduction Sleep related breathing disorders (SRBD) are associated with both obesity and systemic inflammation. While the relationship between obesity and SRBD is established, the causality between inflammation and SRBD remains unclear. In this study we investigated the relation between SRBD and C-reactive protein (CRP) as a parameter of inflammation and the influence of SRBD treatment on CRP with additional regard to changes in metabolic and cardiovascular parameters. Methods Polysomnography (PSG) and laboratory data of patients diagnosed with SRBD over a period of 5 years were prospectively collected in a database and retrospectively analysed regarding the association of SRBD (according to apnoea-hypopnoea-index (AHI), duration of events and extent of desaturation) to CRP, blood pressure, cholesterol, fasting plasma glucose, HbA1c, quality of life measured via a visual analogue scale (VAS 0-100%), and the effects of SRBD therapy on these parameters. Results 716 patients were included in the study, 171 withmild SRBD (AHI >= 5 to < 15/h), 209 with moderate SRBD (AHI 15 to < 30/h), 336 with severe SRBD (AHI >= 30/h). Results according to severity of SRBD. Severe SRBD was significantly associated with elevated levels of CRP (3.7 [1.8-7.0] mg/l, vs. moderate (p = 0.001), and mild SRBD (p< 0.001), and higher prevalence of hypertension as compared to moderate and mild SRBD (p< 0.001, respectively). Results in highly successful treatment. If SRBD treatment was highly successful (AHI <5/h), CRP and quality of life improved significantly (p = 0.001 and p = 0.002), as did blood pressure (p<0.001 for systolic and diastolic values), although BMI increased (p<0.001). Results in partially successful treatment. If success was defined as reduction of AHI of >= 50%, CRP also decreased (p<0.001), as did blood pressure (p<0.001). Again, BMI increased (p<0.001). Conclusion This is the first study to show an association of SRBD and CRP independently of BMI in a large cohort. The SRBD therapy-induced CRP decrease was not associated with BMI changes or metabolic changes but rather with the magnitude of AHI improvement.	[Troester, Natascha; Palfner, Michael; Olschewski, Horst] Med Univ, Div Pulmonol, Dept Internal Med, Graz, Austria; [Schmidberger, Erich; Avian, Alexander] Med Univ, Inst Med Informat Stat & Documentat, Graz, Austria; [Olschewski, Horst; Avian, Alexander] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute	Troester, N (corresponding author), Med Univ, Div Pulmonol, Dept Internal Med, Graz, Austria.	natascha.troester@klinikum-graz.at	Olschewski, Horst/L-3547-2019	Olschewski, Horst/0000-0002-2834-7466; Avian, Alexander/0000-0003-1084-5763				[Anonymous], 2014, INT CLASSIFICATION S; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Boudjeltia KZ, 2006, RESPIRATION, V73, P243, DOI 10.1159/000090201; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Can M, 2006, CHEST, V129, P233, DOI 10.1378/chest.129.2.233; Friedman M, 2012, OTOLARYNG HEAD NECK, V147, P423, DOI 10.1177/0194599812451840; Guilleminault C, 2004, SLEEP, V27, P1507, DOI 10.1093/sleep/27.8.1507; Guven SF, 2012, SLEEP BREATH, V16, P217, DOI 10.1007/s11325-011-0492-2; Hatipoglu U, 2003, RESPIRATION, V70, P665, DOI 10.1159/000075218; Hayashi M, 2006, RESPIROLOGY, V11, P24, DOI 10.1111/j.1440-1843.2006.00780.x; Iber C., 2007, AASM MANUAL SCORING; Ishida K, 2009, CHEST, V136, P125, DOI 10.1378/chest.08-1431; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kohler M, 2009, THORAX, V64, P67, DOI 10.1136/thx.2008.097931; Kokturk O, 2005, INT HEART J, V46, P801, DOI 10.1536/ihj.46.801; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lui MMS, 2009, CHEST, V135, P950, DOI 10.1378/chest.08-1798; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; Nural S, 2013, INFLAMMATION, V36, P66, DOI 10.1007/s10753-012-9520-z; Panoutsopoulos A, 2012, MED SCI MONITOR, V18, pCR747, DOI 10.12659/MSM.883603; Pasceri V, 2000, CIRCULATION, V102, P2165; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2007, SLEEP, V30, P29, DOI 10.1093/sleep/30.1.29; Quercioli A, 2010, SLEEP BREATH, V14, P261, DOI 10.1007/s11325-010-0338-3; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Saletu M, 2006, J NEUROL, V253, P746, DOI 10.1007/s00415-006-0110-6; Schiza SE, 2010, EUR J CLIN INVEST, V40, P968, DOI 10.1111/j.1365-2362.2010.02348.x; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Su MC, 2013, EUR ARCH OTO-RHINO-L, V270, P749, DOI 10.1007/s00405-012-2191-4; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Yao M, 2006, SLEEP, V29, P661; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Young Terry, 2009, WMJ, V108, P246; Zwaka TP, 2001, CIRCULATION, V103, P1194	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137594	10.1371/journal.pone.0137594	http://dx.doi.org/10.1371/journal.pone.0137594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356577	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800067
J	Boeddeker, N; Mertes, M; Dittmar, L; Egelhaaf, M				Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin			Bumblebee Homing: The Fine Structure of Head Turning Movements	PLOS ONE			English	Article							COLOR DISCRIMINATION; BLOWFLY FLIGHT; BEES; HONEYBEES; MOTION; INSECTS; DIRECTIONS; DISTANCE; VISION; ACUITY	Changes in flight direction in flying insects are largely due to roll, yaw and pitch rotations of their body. Head orientation is stabilized for most of the time by counter rotation. Here, we use high-speed video to analyse head-and body-movements of the bumblebee Bombus terrestris while approaching and departing from a food source located between three landmarks in an indoor flight-arena. The flight paths consist of almost straight flight segments that are interspersed with rapid turns. These short and fast yaw turns ("saccades") are usually accompanied by even faster head yaw turns that change gaze direction. Since a large part of image rotation is thereby reduced to brief instants of time, this behavioural pattern facilitates depth perception from visual motion parallax during the intersaccadic intervals. The detailed analysis of the fine structure of the bees' head turning movements shows that the time course of single head saccades is very stereotypical. We find a consistent relationship between the duration, peak velocity and amplitude of saccadic head movements, which in its main characteristics resembles the so-called "saccadic main sequence" in humans. The fact that bumblebee head saccades are highly stereotyped as in humans, may hint at a common principle, where fast and precise motor control is used to reliably reduce the time during which the retinal images moves.	[Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin] Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany; [Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin] Univ Bielefeld, CITEC, D-33615 Bielefeld, Germany; [Boeddeker, Norbert] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Boeddeker, N (corresponding author), Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany.	norbert.boeddeker@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270	Deutsche Forschungsgemeinschaft [EXC 277]; Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	The study was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de, EXC 277). L.D. was funded by the Studienstiftung des deutschen Volkes.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BOEDDEKER N, 2009, P ROY SOC LOND B BIO, V1685, P1209; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Bouguet J.-Y., 1999, THESIS CALTECH; Braun E, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00001; CARTWRIGHT BA, 1979, J EXP BIOL, V82, P367; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; CHENG K, 1986, J COMP PHYSIOL A, V159, P69, DOI 10.1007/BF00612497; Collett TS, 2013, J EXP BIOL, V216, P1105, DOI 10.1242/jeb.081463; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; COLLETT TS, 1975, J COMP PHYSIOL, V100, P59, DOI 10.1007/BF00623930; COLLETT TS, 1978, J EXP BIOL, V76, P237; de Ibarra NH, 2009, J EXP BIOL, V212, P3193, DOI 10.1242/jeb.029751; Dittmar L, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00020; Dittmar L, 2010, J EXP BIOL, V213, P2913, DOI 10.1242/jeb.043737; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Ellington CP, 1999, J EXP BIOL, V202, P3439; Fry SN, 2005, J EXP BIOL, V208, P3945, DOI 10.1242/jeb.01833; Gibson JJ, 1950, PERCEPTION VISUAL WO; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Harris CM, 2009, BIOL CYBERN, V95, P21; Hengstenberg Roland, 1993, Reviews of Oculomotor Research, V5, P285; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 2000, NEURONAL PROCESSING, V44; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; LEHRER M, 1994, J COMP PHYSIOL A, V175, P171, DOI 10.1007/BF00215113; LEHRER M, 1991, NATURWISSENSCHAFTEN, V78, P274, DOI 10.1007/BF01134357; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Macuda T, 2001, J EXP BIOL, V204, P559; Mertes M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00335; Morawetz L, 2012, J EXP BIOL, V215, P2515, DOI 10.1242/jeb.066399; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J NEUROSCI, V29, P9987, DOI 10.1523/JNEUROSCI.1325-09.2009; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pfeiffer K, 2011, J COMP NEUROL, V229, P212; Philippides A, 2013, J EXP BIOL, V216, P1093, DOI 10.1242/jeb.081455; Riabinina O, 2014, J EXP BIOL, V217, P2633, DOI 10.1242/jeb.102897; Riveros Andre J., 2009, Communicative & Integrative Biology, V2, P437; SANDEMAN DC, 1980, J EXP BIOL, V85, P43; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Sherman A, 2004, J EXP BIOL, V207, P133, DOI 10.1242/jeb.00731; Sherman A, 2003, J EXP BIOL, V206, P295, DOI 10.1242/jeb.00075; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; van Beers RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002070; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Warzecha AK, 2000, VISION RES, V40, P2973, DOI 10.1016/S0042-6989(00)00147-4; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zeil J, 2007, COLD SPRING HARB MON, V49, P381; Zeil J, 2008, CURR BIOL, V18, pR320, DOI 10.1016/j.cub.2008.02.017; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; Zeil J, 2009, FLYING INSECTS AND ROBOTS, P87, DOI 10.1007/978-3-540-89393-6_7	62	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135020	10.1371/journal.pone.0135020	http://dx.doi.org/10.1371/journal.pone.0135020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352836	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800005
J	Brunye, TT; Burte, H; Houck, LA; Taylor, HA				Brunye, Tad T.; Burte, Heather; Houck, Lindsay A.; Taylor, Holly A.			The Map in Our Head Is Not Oriented North: Evidence from a Real-World Environment	PLOS ONE			English	Article							SPATIAL KNOWLEDGE ACQUISITION; COGNITIVE MAPS; ORIENTATION; REPRESENTATIONS; STRATEGIES; NAVIGATION; MEMORY; FRAMES; ROUTES	Like most physical maps, recent research has suggested that cognitive maps of familiar environments may have a north-up orientation. We demonstrate that north orientation is not a necessary feature of cognitive maps and instead may arise due to coincidental alignment between cardinal directions and the built and natural environment. Experiment 1 demonstrated that pedestrians have difficulty pointing north while navigating a familiar real-world environment with roads, buildings, and green spaces oriented oblique to cardinal axes. Instead, north estimates tended to be parallel or perpendicular to roads. In Experiment 2, participants did not demonstrate privileged memory access when oriented toward north while making relative direction judgments. Instead, retrieval was fastest and most accurate when orientations were aligned with roads. In sum, cognitive maps are not always oriented north. Rather, in some real-world environments they can be oriented with respect to environment-specific features, serving as convenient reference systems for organizing and using spatial memory.	[Brunye, Tad T.; Houck, Lindsay A.; Taylor, Holly A.] Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA; [Brunye, Tad T.; Burte, Heather; Houck, Lindsay A.; Taylor, Holly A.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Brunye, Tad T.; Houck, Lindsay A.] US Army Natick Soldier Res Dev & Engn Ctr, Cognit Sci Team, Natick, MA USA	Tufts University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Brunye, TT (corresponding author), Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA.	Thaddeus.t.Brunye.civ@mail.mil	Burte, Heather/H-8341-2019	Burte, Heather/0000-0002-9623-4375; Brunye, Tad/0000-0002-8788-8764	U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC) [W911QY-13-C-0012]	U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC)	This work was funded by the U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC, Grant #W911QY-13-C-0012, PI: Holly A. Taylor). Permission was granted by the U.S. Army Natick Soldier Research, Development, and Engineering Center to publish this material. The views expressed in this article are solely those of the authors and do not reflect the official policies or positions of the Department of Army, the Department of Defense, or any other department or agency of the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Ekstrom AD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00803; EVANS GW, 1980, J EXP PSYCHOL-HUM L, V6, P13, DOI 10.1037/0278-7393.6.1.13; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Frankenstein J, 2012, PSYCHOL SCI, V23, P120, DOI 10.1177/0956797611429467; Gagnon SA, 2014, COGNITIVE SCI, V38, P275, DOI 10.1111/cogs.12055; Golledge R., 1999, WAYFINDING BEHAV COG; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Herman JF, 2013, B PSYCHONOMIC SOC, V13, P183, DOI [10.3758/BF03335054, DOI 10.3758/BFO3335054]; Iaria G, 2009, BEHAV BRAIN RES, V196, P187, DOI 10.1016/j.bbr.2008.08.040; Ishikawa T, 2006, COGNITIVE PSYCHOL, V52, P93, DOI 10.1016/j.cogpsych.2005.08.003; Janzen G, 2001, J ENVIRON PSYCHOL, V21, P149, DOI 10.1006/jevp.2000.0195; KOZLOWSKI LT, 1977, J EXP PSYCHOL HUMAN, V3, P590, DOI 10.1037/0096-1523.3.4.590; LEVINE M, 1984, ENVIRON BEHAV, V16, P139, DOI 10.1177/0013916584162001; Marchette SA, 2011, MEM COGNITION, V39, P1401, DOI 10.3758/s13421-011-0108-x; McNamara TP, 2003, PSYCHON B REV, V10, P589, DOI 10.3758/BF03196519; McNamara TP, 2003, TRENDS COGN SCI, V7, P333, DOI 10.1016/S1364-6613(03)00167-0; MCNAMARA TP, 1986, COGNITIVE PSYCHOL, V18, P87, DOI 10.1016/0010-0285(86)90016-2; Montello DR, 2010, SPAT COGN COMPUT, V10, P94, DOI 10.1080/13875860903585323; MONTELLO DR, 1991, ENVIRON BEHAV, V23, P47, DOI 10.1177/0013916591231003; Montello DR., 1998, SPATIAL TEMPORAL REA, P143; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; Pazzaglia F, 2001, EUR J COGN PSYCHOL, V13, P493, DOI 10.1080/09541440042000124; Richardson AE, 1999, MEM COGNITION, V27, P741, DOI 10.3758/BF03211566; Shelton AL, 2004, J EXP PSYCHOL LEARN, V30, P158, DOI 10.1037/0278-7393.30.1.158; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; SHOLL MJ, 1987, J EXP PSYCHOL LEARN, V13, P615, DOI 10.1037/0278-7393.13.4.615; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Taylor H., 2008, REV HUM FACT ERGON, V4, P1, DOI [10.1518/155723408X342835, DOI 10.1518/155723408X342835]; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tversky B., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P14; Werner S., 1999, SPAT COGN COMPUT, V1, P447, DOI DOI 10.1023/A:1010095831166; Zar JH, 1999, BIOSTATISTICAL ANAL	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135803	10.1371/journal.pone.0135803	http://dx.doi.org/10.1371/journal.pone.0135803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353119	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800016
J	Huberth, M; Chen, P; Tritz, J; McKay, TA				Huberth, Madeline; Chen, Patricia; Tritz, Jared; McKay, Timothy A.			Computer-Tailored Student Support in Introductory Physics	PLOS ONE			English	Article							ACADEMIC SELF-CONCEPT; MESSAGES	Large introductory courses are at a disadvantage in providing personalized guidance and advice for students during the semester. We introduce E(2)Coach (an Expert Electronic Coaching system), which allows instructors to personalize their communication with thousands of students. We describe the E(2)Coach system, the nature of the personalized support it provides, and the features of the students who did (and did not) opt-in to using it during the first three terms of its use in four introductory physics courses at the University of Michigan. Defining a 'better-than-expected' measure of performance, we compare outcomes for students who used E(2)Coach to those who did not. We found that moderate and high E(2)Coach usage was associated with improved performance. This performance boost was prominent among high users, who improved by 0.18 letter grades on average when compared to nonusers with similar incoming GPAs. This improvement in performance was comparable across both genders. E(2)Coach represents one way to use technology to personalize education at scale, contributing to the move towards individualized learning that is becoming more attainable in the 21st century.	[Huberth, Madeline] Stanford Univ, Dept Mus, Ctr Comp Res Mus & Acoust, Stanford, CA 94305 USA; [Chen, Patricia] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Tritz, Jared] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; [McKay, Timothy A.] Univ Michigan, Dept Phys, Dept Astron, Ann Arbor, MI 48109 USA; [McKay, Timothy A.] Univ Michigan, Sch Educ, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Huberth, M (corresponding author), Stanford Univ, Dept Mus, Ctr Comp Res Mus & Acoust, Stanford, CA 94305 USA.	mhuberth@ccrma.stanford.edu	McKay, Timothy/C-1501-2009	McKay, Timothy/0000-0001-9036-6150	Educause Next-Generation Learning Challenge Wave-I grant "Making the Course Fit: Customizing Introductory Science Courses with the Michigan Tailoring System"	Educause Next-Generation Learning Challenge Wave-I grant "Making the Course Fit: Customizing Introductory Science Courses with the Michigan Tailoring System"	This study was supported by an Educause Next-Generation Learning Challenge Wave-I grant "Making the Course Fit: Customizing Introductory Science Courses with the Michigan Tailoring System".	Adams WK, 2006, PHYS REV SPEC TOP-PH, V2, DOI 10.1103/PhysRevSTPER.2.010101; Adjoin AM, 1995, P 1995 FRONT ED C; Carrell SE, 2010, Q J ECON, V125, P1101, DOI 10.1162/qjec.2010.125.3.1101; de Vries H, 2008, AM J HEALTH PROMOT, V22, P417, DOI 10.4278/ajhp.22.6.417; Dijkstra A, 1998, HEALTH PSYCHOL, V17, P513, DOI 10.1037/0278-6133.17.6.513; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; GERARDI S, 1990, J COLL STUDENT DEV, V31, P402; Hazari Z, 2007, SCI EDUC, V91, P847, DOI 10.1002/sce.20223; Kost LE, 2009, PHYS REV SPEC TOP-PH, V5, DOI 10.1103/PhysRevSTPER.5.010101; Larkin-Hein T, 2001, IEEE T EDUC, V44, P276, DOI 10.1109/13.941000; Miller K., 2011, THESIS U MICHIGAN; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Oenema A, 2001, HEALTH EDUC RES, V16, P647, DOI 10.1093/her/16.6.647; REYNOLDS WM, 1988, J PERS ASSESS, V52, P223, DOI 10.1207/s15327752jpa5202_4; Smeets T, 2008, HEALTH EDUC RES, V23, P402, DOI 10.1093/her/cyl101; Strecher V, 2007, ANNU REV CLIN PSYCHO, V3, P53, DOI 10.1146/annurev.clinpsy.3.022806.091428; Strecher VJ, 2008, AM J PREV MED, V34, P373, DOI 10.1016/j.amepre.2007.12.024; STRECHER VJ, 1994, J FAM PRACTICE, V39, P262; Tseng JCR, 2008, COMPUT EDUC, V51, P776, DOI 10.1016/j.compedu.2007.08.002; Wright M, 2014, CHANGE MAGAZINE HIGH	20	30	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137001	10.1371/journal.pone.0137001	http://dx.doi.org/10.1371/journal.pone.0137001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352403	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800056
J	Pedro, S; Xavier, JC; Tavares, S; Trathan, PN; Ratcliffe, N; Paiva, VH; Medeiros, R; Pereira, E; Pardal, MA				Pedro, Sara; Xavier, Jose C.; Tavares, Silvia; Trathan, Phil N.; Ratcliffe, Norman; Paiva, Vitor H.; Medeiros, Renata; Pereira, Eduarda; Pardal, Miguel A.			Feathers as a Tool to Assess Mercury Contamination in Gentoo Penguins: Variations at the Individual Level	PLOS ONE			English	Article							BIRD FEATHERS; BODY FEATHERS; EXTERNAL CONTAMINATION; ORGANIC POLLUTANTS; MARINE-ENVIRONMENT; BIOMONITORING TOOL; PYGOSCELIS-PAPUA; STABLE-ISOTOPES; HEAVY-METALS; MOLT	Feathers have been widely used to assess mercury contamination in birds as they reflect metal concentrations accumulated between successive moult periods: they are also easy to sample and have minimum impact on the study birds. Moult is considered the major pathway for mercury excretion in seabirds. Penguins are widely believed to undergo a complete, annual moult during which they do not feed. As penguins lose all their feathers, they are expected to have a low individual-variability in feather mercury concentration as all feathers are formed simultaneously from the same somatic reserves. This assumption is central to penguin studies that use feathers to examine the annual or among-individual variation in mercury concentrations in penguins. To test this assumption, we measured the mercury concentrations in 3-5 body feathers of 52 gentoo penguins (Pygoscelis papua) breeding at Bird Island, South Georgia (54 degrees S 38 degrees W). Twenty-five percent of the penguins studied showed substantial within-individual variation in the amount of mercury in their feathers (Coefficient of Variation: 34.7-96.7%). This variation may be caused by differences in moult patterns among individuals within the population leading to different interpretations in the overall population. Further investigation is now needed to fully understand individual variation in penguins' moult.	[Pedro, Sara; Tavares, Silvia; Pardal, Miguel A.] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Xavier, Jose C.; Paiva, Vitor H.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, Coimbra, Portugal; [Xavier, Jose C.; Trathan, Phil N.; Ratcliffe, Norman] British Antarctic Survey, Cambridge CB3 0ET, England; [Medeiros, Renata] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Pereira, Eduarda] Univ Aveiro, Dept Chem, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal	Universidade de Coimbra; Universidade de Coimbra; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Cardiff University; Universidade de Aveiro	Pedro, S (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	sara.pedro@student.uc.pt	Paiva, Vitor H./J-1092-2019; Paiva, Vitor Hugo/GRX-9179-2022; Pardal, Miguel Ângelo/C-3984-2009; Medeiros, Renata/M-8616-2015	Paiva, Vitor H./0000-0001-6368-9579; Pardal, Miguel Ângelo/0000-0001-6048-7007; Medeiros, Renata/0000-0002-5833-309X; /0000-0002-9621-6660; Pereira, Eduarda/0000-0002-6046-5243	Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia); Tinker Foundation; British Antarctic Survey under CEPH; British Antarctic Survey under SCAR AnT-ERA; British Antarctic Survey under PROPOLAR; British Antarctic Survey under ICED; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia); Tinker Foundation; British Antarctic Survey under CEPH; British Antarctic Survey under SCAR AnT-ERA; British Antarctic Survey under PROPOLAR; British Antarctic Survey under ICED; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: This research was supported by the Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia, http://www.fct.pt/), the Tinker Foundation (http://www.tinker.org/) and the British Antarctic Survey (http://www.antarctica.ac.uk/), under the research programs CEPH, SCAR AnT-ERA, PROPOLAR and ICED. British Antarctic Survey plays an important role in data collection protocols.	Ancel A, 2013, CR BIOL, V336, P1, DOI 10.1016/j.crvi.2013.02.002; Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Bargagli R, 2008, SCI TOTAL ENVIRON, V400, P212, DOI 10.1016/j.scitotenv.2008.06.062; Bond AL, 2008, ENVIRON TOXICOL CHEM, V27, P2375, DOI 10.1897/08-163.1; Bond AL, 2010, ENVIRON POLLUT, V158, P1182, DOI 10.1016/j.envpol.2010.01.004; Brasso RL, 2013, ENVIRON TOXICOL CHEM, V32, P2331, DOI 10.1002/etc.2303; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Burger J, 2013, ENVIRON RES, V122, P11, DOI 10.1016/j.envres.2013.01.003; Carravieri A, 2014, MAR BIOL, V161, P963, DOI 10.1007/s00227-014-2394-x; CHEREL Y, 1994, AM J PHYSIOL, V266, pR1182, DOI 10.1152/ajpregu.1994.266.4.R1182; Cristol DA, 2012, ECOL INDIC, V18, P20, DOI 10.1016/j.ecolind.2011.10.007; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dauwe T, 2003, ENVIRON POLLUT, V124, P429, DOI 10.1016/S0269-7491(03)00044-7; DAVIS RW, 1989, J ANIM ECOL, V58, P59, DOI 10.2307/4986; Ek KH, 2004, ARCH ENVIRON CON TOX, V47, P259, DOI 10.1007/s00244-004-3138-6; FURNESS RW, 1986, MAR POLLUT BULL, V17, P27, DOI 10.1016/0025-326X(86)90801-5; GOEDE AA, 1986, ENVIRON MONIT ASSESS, V7, P249, DOI 10.1007/BF00418017; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Head JA, 2011, ECOTOXICOLOGY, V20, P1636, DOI 10.1007/s10646-011-0738-6; Jaeger A, 2009, MAR BIOL, V156, P1233, DOI 10.1007/s00227-009-1165-6; Jaspers VLB, 2007, ENVIRON INT, V33, P766, DOI 10.1016/j.envint.2007.02.013; Jaspers VLB, 2007, ENVIRON INT, V33, P328, DOI 10.1016/j.envint.2006.11.011; Jaspers VLB, 2011, ENVIRON INT, V37, P1349, DOI 10.1016/j.envint.2011.06.004; Jerez S, 2011, ENVIRON POLLUT, V159, P2412, DOI 10.1016/j.envpol.2011.06.036; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Martinez A, 2012, SCI TOTAL ENVIRON, V425, P254, DOI 10.1016/j.scitotenv.2012.03.017; MONTEIRO LR, 1995, WATER AIR SOIL POLL, V80, P851, DOI 10.1007/BF01189736; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pedro S, 2015, POLAR BIOL, V38, P1335, DOI 10.1007/s00300-015-1697-9; Tavares S, 2013, ENVIRON POLLUT, V181, P315, DOI 10.1016/j.envpol.2013.06.032; THOMPSON DR, 1993, POLAR BIOL, V13, P239	32	10	10	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137622	10.1371/journal.pone.0137622	http://dx.doi.org/10.1371/journal.pone.0137622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352664	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800103
J	Yao, H; Gao, M; Ma, JH; Zhang, MY; Li, SW; Wu, BS; Nie, XH; Jiao, J; Zhao, H; Wang, SS; Yang, YY; Zhang, YS; Sun, YL; Wicha, MS; Chang, AE; Gao, SR; Li, Q; Xu, RX				Yao, Hui; Gao, Mou; Ma, Jianhua; Zhang, Maoying; Li, Shaowu; Wu, Bingshan; Nie, Xiaohu; Jiao, Jiao; Zhao, Hao; Wang, Shanshan; Yang, Yuanyuan; Zhang, Yesen; Sun, Yilin; Wicha, Max S.; Chang, Alfred E.; Gao, Shaorong; Li, Qiao; Xu, Ruxiang			Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats	PLOS ONE			English	Article							DIRECT CONVERSION; MOUSE FIBROBLASTS; PROGENITOR CELLS; MODEL; TRANSPLANTATION; SPECTROSCOPY; GENERATION; IPSCS	Induced neural stem cells (iNSCs) can be directly transdifferentiated from somatic cells. One potential clinical application of the iNSCs is for nerve regeneration. However, it is unknown whether iNSCs function in disease models. We produced transdifferentiated iNSCs by conditional overexpressing Oct4, Sox2, Klf4, c-Mycin mouse embryonic fibroblasts. They expanded readily in vitro and expressed NSC mRNA profile and protein markers. These iNSCs differentiated into mature astrocytes, neurons and oligodendrocytes in vitro. Importantly, they reduced lesion size, promoted the recovery of motor and sensory function as well as metabolism status in middle cerebral artery stroke rats. These iNSCs secreted nerve growth factors, which was associated with observed protection of neurons from apoptosis. Furthermore, iNSCs migrated to and passed through the lesion in the cerebral cortex, where Tuj1+ neurons were detected. These findings have revealed the function of transdifferentiated iNSCs in vivo, and thus provide experimental evidence to support the development of personalized regenerative therapy for CNS diseases by using genetically engineered autologous somatic cells.	[Yao, Hui; Gao, Mou; Ma, Jianhua; Zhang, Maoying; Nie, Xiaohu; Zhao, Hao; Wang, Shanshan; Zhang, Yesen; Xu, Ruxiang] PLA, Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Yao, Hui; Zhao, Hao; Wang, Shanshan; Xu, Ruxiang] Neurosurg Inst Beijing Mil Reg, Beijing 100700, Peoples R China; [Gao, Mou] Third Mil Med Univ, Chongqing 400038, Peoples R China; [Ma, Jianhua; Wu, Bingshan; Zhang, Yesen] Anhui Med Univ, Hefei 230032, Peoples R China; [Zhang, Maoying; Nie, Xiaohu] So Med Univ, Guangzhou 510515, Guangdong, Peoples R China; [Li, Shaowu; Sun, Yilin] Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Jiao, Jiao; Yang, Yuanyuan; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wicha, Max S.; Chang, Alfred E.; Li, Qiao] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Seventh Medical Center of Chinese PLA General Hospital; Army Medical University; Anhui Medical University; Southern Medical University - China; Capital Medical University; National Institute of Biological Sciences, Beijing; University of Michigan System; University of Michigan	Xu, RX (corresponding author), PLA, Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	gaoshaorong@tongji.edu.cn; qiaoli@umich.edu; bjjzxuruxiang@163.com	Wicha, Max/AAE-7268-2019		China Postdoctoral Science Foundation [2013M532138]; Military Twelfth Five-Year Key Sci-Tech Research Projects [BWS11J002, BWS12J010]; Gillson Longenbaugh Foundation	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Military Twelfth Five-Year Key Sci-Tech Research Projects; Gillson Longenbaugh Foundation	This work was supported by the China Postdoctoral Science Foundation (2013M532138) and Military Twelfth Five-Year Key Sci-Tech Research Projects (Grant Nos. BWS11J002 and BWS12J010). This work was also supported in part by the Gillson Longenbaugh Foundation.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Di Tullio A, 2012, CELL CYCLE, V11, P2739, DOI 10.4161/cc.21119; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Fayed N, 2006, ACAD RADIOL, V13, P728, DOI 10.1016/j.acra.2006.01.047; Filippi CG, 2002, AM J NEURORADIOL, V23, P882; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hsu Yuan-Yu, 2004, Chang Gung Med J, V27, P399; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jiao J, 2013, HUM MOL GENET, V22, P4241, DOI 10.1093/hmg/ddt275; Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32; Kendall GS, 2014, RADIOLOGY, V271, P230, DOI 10.1148/radiol.13122679; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kubas B, 2007, Neuroradiol J, V19, P699; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Mueller SG, 2011, J NEUROL, V258, P603, DOI 10.1007/s00415-010-5799-6; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Shetty AK, 2012, NEURAL STEM CELL THE; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yang N, 2013, NAT MED, V19, P1580, DOI 10.1038/nm.3425	48	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137211	10.1371/journal.pone.0137211	http://dx.doi.org/10.1371/journal.pone.0137211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352672	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800067
J	Jenison, RL; Reale, RA; Armstrong, AL; Oya, H; Kawasaki, H; Howard, MA				Jenison, Rick L.; Reale, Richard A.; Armstrong, Amanda L.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III			Sparse Spectro-Temporal Receptive Fields Based on Multi-Unit and High-Gamma Responses in Human Auditory Cortex	PLOS ONE			English	Article							SINGLE NEURONS; REGRESSION SHRINKAGE; REVERSE-CORRELATION; GROUP-LASSO; FIRING RATE; POTENTIALS; SELECTION; REPRESENTATION; ORGANIZATION; LOCALIZATION	Spectro-Temporal Receptive Fields (STRFs) were estimated from both multi-unit sorted clusters and high-gamma power responses in human auditory cortex. Intracranial electrophysiological recordings were used to measure responses to a random chord sequence of Gammatone stimuli. Traditional methods for estimating STRFs from single-unit recordings, such as spike-triggered-averages, tend to be noisy and are less robust to other response signals such as local field potentials. We present an extension to recently advanced methods for estimating STRFs from generalized linear models (GLM). A new variant of regression using regularization that penalizes non-zero coefficients is described, which results in a sparse solution. The frequency-time structure of the STRF tends toward grouping in different areas of frequency-time and we demonstrate that group sparsity-inducing penalties applied to GLM estimates of STRFs reduces the background noise while preserving the complex internal structure. The contribution of local spiking activity to the high-gamma power signal was factored out of the STRF using the GLM method, and this contribution was significant in 85 percent of the cases. Although the GLM methods have been used to estimate STRFs in animals, this study examines the detailed structure directly from auditory cortex in the awake human brain. We used this approach to identify an abrupt change in the best frequency of estimated STRFs along posteromedial-to-anterolateral recording locations along the long axis of Heschl's gyrus. This change correlates well with a proposed transition from core to non-core auditory fields previously identified using the temporal response properties of Heschl's gyrus recordings elicited by click-train stimuli.	[Jenison, Rick L.; Reale, Richard A.; Armstrong, Amanda L.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Reale, Richard A.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III] Univ Iowa, Dept Neurosurg, Iowa City, IA USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Jenison, RL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	rjenison@wisc.edu	Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Kawasaki, Hiroto/0000-0002-7688-9171; Howard, Matthew/0000-0003-3935-8889; Jenison, Rick/0000-0002-3712-300X	National Institutes of Health (General Clinical Research Centers Program) [R01DC04290, M01RR59]; Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004290] Funding Source: NIH RePORTER	National Institutes of Health (General Clinical Research Centers Program); Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health grants R01DC04290, M01RR59 General Clinical Research Centers Program), the Hoover Fund, and the Carver Trust.	Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bach F, 2012, OPTIMIZATION SPARSIT; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; BINGHAM C, 1967, IEEE T ACOUST SPEECH, VAU15, P56, DOI 10.1109/TAU.1967.1161895; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; Brugge JF, 2009, J NEUROPHYSIOL, V102, P2358, DOI 10.1152/jn.91346.2008; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Clarke S, 2012, SPRINGER HANDB AUDIT, V43, P11, DOI 10.1007/978-1-4614-2314-0_2; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; de Boer E., 1973, T ASME             G, V95, P265; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Domany E, 1999, PHYSICA A, V263, P158, DOI 10.1016/S0378-4371(98)00494-4; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Eggermont JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020046; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; Escabi MA, 2003, BIOL CYBERN, V89, P350, DOI 10.1007/S00422-003-0440-8; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gaucher Q, 2012, J PHYSIOL-PARIS, V106, P93, DOI 10.1016/j.jphysparis.2011.09.006; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hackett Troy A, 2015, Handb Clin Neurol, V129, P27, DOI 10.1016/B978-0-444-62630-1.00002-0; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Howard MA, 1997, STEREOT FUNCT NEUROS, V68, P236, DOI 10.1159/000099931; Howard MA, 1996, J NEUROSURG, V84, P129, DOI 10.3171/jns.1996.84.1.0129; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; Howard MA, 2012, SPRINGER HANDB AUDIT, V43, P39, DOI 10.1007/978-1-4614-2314-0_3; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; KRAUSZ HI, 1975, BIOL CYBERN, V19, P217, DOI 10.1007/BF02281972; Kubanek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053398; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Linden JF, 2003, EVIDENCE OPTIMIZATIO; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mairal J., 2014, SPAMS SPARSE MODELIN, P1; Mairal J, 2012, FOUND TRENDS COMPUT, V8, DOI 10.1561/0600000058; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Mizrahi A, 2014, CURR OPIN NEUROBIOL, V24, P103, DOI 10.1016/j.conb.2013.09.007; Moerel M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00225; Mukamel R, 2011, HUM BRAIN MAPP, V32, P1181, DOI 10.1002/hbm.21100; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nourski KV, 2014, NEUROIMAGE, V101, P598, DOI 10.1016/j.neuroimage.2014.07.004; Nourski KV, 2014, CEREB CORTEX, V24, P340, DOI 10.1093/cercor/bhs314; Nourski KV, 2011, REV NEUROSCIENCE, V22, P187, DOI 10.1515/RNS.2011.016; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Pei XM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046028; Pei XM, 2011, NEUROIMAGE, V54, P2960, DOI 10.1016/j.neuroimage.2010.10.029; Prerau MJ, 2011, NEURAL COMPUT, V23, P2537, DOI 10.1162/NECO_a_00185; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reddy CG, 2010, J NEUROSURG, V112, P1301, DOI 10.3171/2009.7.JNS09404; Robinson K, 1992, AUDITORY PHYSL PERCE, P429, DOI DOI 10.1016/B978-0-08-041847-6.50054-X; Sabourin J, 2015, GENET EPIDEMIOL, V39, P77, DOI 10.1002/gepi.21869; Schonwiesner M, 2015, CEREB CORTEX, V25, P3278, DOI 10.1093/cercor/bhu124; Slaney M, 1993, EFFICIENT IMPLEMENTA; Srinivasan R, 2006, ELECT FIELDS BRAIN N, pxvi; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tibshirani RJ, 2011, ANN STAT, V39, P1335, DOI 10.1214/11-AOS878; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Valdar W, 2012, GENET EPIDEMIOL, V36, P451, DOI 10.1002/gepi.21639; Winer J. A., 2011, THE AUDITORY CORTEX; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	81	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137915	10.1371/journal.pone.0137915	http://dx.doi.org/10.1371/journal.pone.0137915			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367010	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100177
J	Spadoni, JL; Rucart, P; Le Clerc, S; van Manen, D; Coulonges, C; Ulveling, D; Laville, V; Labib, T; Taing, L; Delaneau, O; Montes, M; Schuitemaker, H; Noirel, J; Zagury, JF				Spadoni, Jean-Louis; Rucart, Pierre; Le Clerc, Sigrid; van Manen, Danielle; Coulonges, Cedric; Ulveling, Damien; Laville, Vincent; Labib, Taoufik; Taing, Lieng; Delaneau, Olivier; Montes, Matthieu; Schuitemaker, Hanneke; Noirel, Josselin; Zagury, Jean-Francois			Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIV-1 INFECTION; MISSING HERITABILITY; BIOLOGICAL PATHWAYS; HLA GENES; T-CELLS; REVEALS; DISEASE; MHC; NONPROGRESSION	Background Many genome-wide association studies have been performed on progression towards the acquired immune deficiency syndrome (AIDS) and they mainly identified associations within the HLA loci. In this study, we demonstrate that the integration of biological information, namely gene expression data, can enhance the sensitivity of genetic studies to unravel new genetic associations relevant to AIDS. Methods We collated the biological information compiled from three databases of expression quantitative trait loci (eQTLs) involved in cells of the immune system. We derived a list of single nucleotide polymorphisms (SNPs) that are functional in that they correlate with differential expression of genes in at least two of the databases. We tested the association of those SNPs with AIDS progression in two cohorts, GRIV and ACS. Tests on permuted phenotypes of the GRIV and ACS cohorts or on randomised sets of equivalent SNPs allowed us to assess the statistical robustness of this method and to estimate the true positive rate. Results Eight genes were identified with high confidence (p = 0.001, rate of true positives 75%). Some of those genes had previously been linked with HIV infection. Notably, ENTPD4 belongs to the same family as CD39, whose expression has already been associated with AIDS progression; while DNAJB12 is part of the HSP90 pathway, which is involved in mitochondrial ribosomal proteins and a zinc finger protein, ZFP57, which could be central to the effectiveness of HIV infection. Interestingly, for six out of those eight genes, down-regulation is associated with non-progression, which makes them appealing targets to develop drugs against HIV.	[Spadoni, Jean-Louis; Rucart, Pierre; Le Clerc, Sigrid; Coulonges, Cedric; Ulveling, Damien; Laville, Vincent; Labib, Taoufik; Taing, Lieng; Montes, Matthieu; Noirel, Josselin; Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Lab Genom Bioinformat & Applicat EA 4627, Paris, France; [Schuitemaker, Hanneke] Sanquin Res, Landsteiner Lab, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Schuitemaker, Hanneke] Crucell Holland BV, NL-2333 CN Leiden, Netherlands; [Delaneau, Olivier] Univ Geneva, Fac Med, Dept Genet & Dev, CH-1211 Geneva 4, Switzerland	heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Johnson & Johnson; University of Geneva	Zagury, JF (corresponding author), Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Lab Genom Bioinformat & Applicat EA 4627, Paris, France.	zagury@cnam.fr	/AAR-2792-2021; Montes, Matthieu/AAO-3578-2020	Montes, Matthieu/0000-0001-5921-460X; Delaneau, Olivier/0000-0002-3906-8446; Laville, Vincent/0000-0003-4946-698X	Agence Nationale de Recherche sur le SIDA et les Hepatites; Peptinov; Fondation pour la Recherche Medicale [ING20140129444]; Crucell Holland BV	Agence Nationale de Recherche sur le SIDA et les Hepatites; Peptinov; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Crucell Holland BV	The project was funded by Agence Nationale de Recherche sur le SIDA et les Hepatites (fellowship to PR) by Peptinov and by the Fondation pour la Recherche Medicale (to JN, grant number ING20140129444). The funder Crucell Holland BV provided support in the form of salaries for authors HS and DvM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Banerjee S, 2012, EXP NEUROL, V236, P298, DOI 10.1016/j.expneurol.2012.04.013; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fellay J, 2009, ANTIVIR THER, V14, P731, DOI 10.3851/IMP1253; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Guzman-Fulgencio M, 2013, JAIDS-J ACQ IMM DEF, V63, P178, DOI 10.1097/QAI.0b013e3182893f74; Hendel H, 1999, J IMMUNOL, V162, P6942; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Kang MG, 2015, BIOINFORMATICS, V31, P656, DOI 10.1093/bioinformatics/btu727; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Clerc S, 2011, JAIDS-J ACQ IMM DEF, V56, P279, DOI 10.1097/QAI.0b013e318204982b; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Limou S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00118; Limou S, 2012, J INFECT DIS, V205, P1155, DOI 10.1093/infdis/jis028; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Low JS, 2014, PARASITOLOGY, V141, P1192, DOI 10.1017/S0031182014000298; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Morou AK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-160; Nguyen DG, 2007, VIROLOGY, V362, P16, DOI 10.1016/j.virol.2006.11.036; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Plant K, 2014, EUR J HUM GENET, V22, P568, DOI 10.1038/ejhg.2013.244; Rappaport J, 1997, LANCET, V349, P922, DOI 10.1016/S0140-6736(05)62697-9; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Urano E, 2013, JAIDS-J ACQ IMM DEF, V64, P154, DOI 10.1097/QAI.0b013e31829a2ef8; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; van Manen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022208; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winkler CA, 2004, JAIDS-J ACQ IMM DEF, V37, P1534, DOI 10.1097/01.qai.0000127353.01578.63; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	54	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136989	10.1371/journal.pone.0136989	http://dx.doi.org/10.1371/journal.pone.0136989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367535	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100041
J	Berenson, CS; Kruzel, RL; Wrona, CT; Mammen, MJ; Sethi, S				Berenson, Charles S.; Kruzel, Ragina L.; Wrona, Catherine T.; Mammen, Manoj J.; Sethi, Sanjay			Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; SINGLE-NUCLEOTIDE POLYMORPHISMS; AIRWAY BACTERIAL LOAD; NF-KAPPA-B; 4 GENE; ASSOCIATION; DISEASE; SUSCEPTIBILITY; INFLAMMATION; HAPLOTYPES	Background Dysfunctional innate responses of alveolar macrophages to nontypeable Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae contribute to morbidity in chronic obstructive pulmonary disease (COPD). Our earlier studies discovered impaired COPD alveolar macrophage responses to Toll-like receptor (TLR) ligands of nontypeable H. influenzae and provide rationale for further evaluation of TLR signaling. While the role of TLR single nucleotide polymorphisms is increasingly recognized in inflammatory diseases, TLR single nucleotide polymorphisms in COPD have only recently been explored. We hypothesized that specific TLR polymorphisms are associated with dysfunctional innate immune COPD alveolar macrophage responses and investigated polymorphisms of TLR2 (Arg753Gln), TLR4(Thr399Ile; Asp299Gly), and TLR9(T1486C; T1237C). Methods DNA was purified from cells of 1) healthy nonsmokers (n = 20); 2) COPD ex-smokers (n = 83); 3) COPD active smokers (n = 93). DNA amplifications (polymerase chain reaction) were performed for each SNP. Alveolar macrophages from each group were incubated with nontypeable H. influenzae, M. catarrhalis and S. pneumoniae. Cytokine induction of macrophage supernatants was measured and the association with TLR single nucleotide polymorphism expression was determined. Results No significant inter-group differences in frequency of any TLR SNP existed. However both TLR9 single nucleotide polymorphisms were expressed in high frequency. Among COPD ex-smokers, diminished IL-8 responsiveness to nontypeable H. influenzae, M. catarrhalis and S. pneumoniae was strongly associated with carriage of TLR9(T1237C) (p = 0.02; p = 0.008; p = 0.02), but not TLR9(T1486C). Carriage of TLR9(T1237C), but not TLR9 (T1486C), correlated with diminished FEV1% predicted (p = 0.037). Conclusion Our results demonstrate a notable association of TLR9(T1237C) expression with dysfunctional innate alveolar macrophage responses to respiratory pathogens and with severity of COPD.	[Berenson, Charles S.; Kruzel, Ragina L.] SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Infect Dis, Buffalo, NY 14215 USA; [Wrona, Catherine T.; Mammen, Manoj J.; Sethi, Sanjay] SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14215 USA; [Mammen, Manoj J.] SUNY Buffalo, Sch Med, Dept Biomed Informat, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Berenson, CS (corresponding author), SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Infect Dis, Buffalo, NY 14215 USA.	berenson@buffalo.edu	Mammen, Manoj/AAH-8904-2020	Mammen, Manoj/0000-0003-0343-3234	National Institutes of Health [RO1HL082561-01]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grant RO1HL082561-01 (CSB, SS) from the National Institutes of Health and with support from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Berenson CS, 2013, J INFECT DIS, V208, P2036, DOI 10.1093/infdis/jit400; Berenson CS, 2005, INFECT IMMUN, V73, P2728, DOI 10.1128/IAI.73.5.2728-2735.2005; Berghofer B, 2005, CLIN EXP ALLERGY, V35, P1147, DOI 10.1111/j.1365-2222.2005.02325.x; Budulac SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043124; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Folwaczny M, 2004, CLIN EXP IMMUNOL, V135, P330, DOI 10.1111/j.1365-2249.2004.02383.x; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Graffelman J, 2015, J STAT SOFTW, V64, P1; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Hill AT, 2000, AM J MED, V109, P288, DOI 10.1016/S0002-9343(00)00507-6; Ito Michiko, 2012, BMC Res Notes, V5, P36, DOI 10.1186/1756-0500-5-36; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Mailaparambil B, 2008, DIS MARKERS, V25, P59, DOI 10.1155/2008/619595; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Pabst S, 2013, ADV EXP MED BIOL, V756, P239, DOI 10.1007/978-94-007-4549-0_30; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rohde G, 2006, RESP MED, V100, P892, DOI 10.1016/j.rmed.2005.08.018; Sabroe I, 2004, THORAX, V59, P81; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Vollmer J, 2006, INT REV IMMUNOL, V25, P155, DOI 10.1080/08830180600743107; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058444	40	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0134209	10.1371/journal.pone.0134209	http://dx.doi.org/10.1371/journal.pone.0134209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361369	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100002
J	Liu, SH; Yang, RS; Yen, YP; Chiu, CY; Tsai, KS; Lan, KC				Liu, Shing Hwa; Yang, Rong-Sen; Yen, Yuan-Peng; Chiu, Chen-Yuan; Tsai, Keh-Sung; Lan, Kuo-Cheng			Low-Concentration Arsenic Trioxide Inhibits Skeletal Myoblast Cell Proliferation via a Reactive Oxygen Species-Independent Pathway	PLOS ONE			English	Article							CYCLE ARREST; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; MUSCLE REGENERATION; DEPENDENT PATHWAY; C2C12 MYOBLASTS; CARCINOMA-CELLS; GROWTH-FACTORS; CANCER; DIFFERENTIATION	Myoblast proliferation and differentiation are essential for skeletal muscle regeneration. Myoblast proliferation is a critical step in the growth and maintenance of skeletal muscle. The precise action of inorganic arsenic on myoblast growth has not been investigated. Here, we investigated the in vitro effect of inorganic arsenic trioxide (As2O3) on the growth of C2C12 myoblasts. As2O3 decreased myoblast growth at submicromolar concentrations (0.25-1 mu M) after 72 h of treatment. Submicromolar concentrations of As2O3 did not induce the myoblast apoptosis. Low-concentration As2O3 (0.5 and 1 mu M) significantly suppressed the myoblast cell proliferative activity, which was accompanied by a small proportion of bromodeoxyuridine (BrdU) incorporation and decreased proliferating cell nuclear antigen (PCNA) protein expression. As2O3 (0.5 and 1 mu M) increased the intracellular arsenic content but did not affect the reactive oxygen species (ROS) levels in the myoblasts. Cell cycle analysis indicated that low-concentrations of As2O3 inhibited cell proliferation via cell cycle arrest in the G1 and G2/M phases. As2O3 also decreased the protein expressions of cyclin D1, cyclin E, cyclin B1, cyclin-dependent kinase (CDK) 2, and CDK4, but did not affect the protein expressions of p21 and p27. Furthermore, As2O3 inhibited the phosphorylation of Akt. Insulin-like growth factor-1 significantly reversed the inhibitory effect of As2O3 on Akt phosphorylation and cell proliferation in the myoblasts. These results suggest that submicromolar concentrations of As2O3 alter cell cycle progression and reduce myoblast proliferation, at least in part, through a ROS-independent Akt inhibition pathway.	[Liu, Shing Hwa; Yen, Yuan-Peng; Chiu, Chen-Yuan] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ, Dept Orthopaed, Coll Med & Hosp, Taipei 10764, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ, Dept Lab Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Lan, Kuo-Cheng] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan	National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Lan, KC (corresponding author), Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan.	d92447005@ntu.edu.tw		Chiu, Chen-Yuan/0000-0003-4378-993X; LIU, SHING-HWA/0000-0002-9976-1197; Yang, Rong-Sen/0000-0002-0553-4779; TSAI, KEH-SUNG/0000-0001-8528-1566	National Science Council of Taiwan [NSC100-2314-B-002-104]; Tri-Service General Hospital [TSGH-C104-060]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	Funding was provided by National Science Council of Taiwan (NSC100-2314-B-002-104) (SHL); Tri-Service General Hospital (TSGH-C104-060) (KCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZL, 2007, BIOCHEM BIOPH RES CO, V360, P684, DOI 10.1016/j.bbrc.2007.06.123; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Bobe P, 2006, BLOOD, V108, P3967, DOI 10.1182/blood-2006-04-020610; Brameld JM, 2000, J ENDOCRINOL, V167, P429, DOI 10.1677/joe.0.1670429; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen GQ, 1997, BLOOD, V89, P3345; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fahey AJ, 2005, J ANIM SCI, V83, P2564; Grabiec K, 2014, J ENDOCRINOL INVEST, V37, P233, DOI 10.1007/s40618-013-0007-z; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kligerman AD, 2007, TOXICOL APPL PHARM, V222, P281, DOI 10.1016/j.taap.2006.10.006; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Lin HJ, 2013, J HAZARD MATER, V262, P1132, DOI 10.1016/j.jhazmat.2012.12.049; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Miller WH, 2002, CANCER RES, V62, P3893; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Raghu KG, 2009, J TRACE ELEM MED BIO, V23, P61, DOI 10.1016/j.jtemb.2008.10.001; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Seol JG, 1999, BIOCHEM BIOPH RES CO, V265, P400, DOI 10.1006/bbrc.1999.1697; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Steffens AA, 2011, TOXICOL APPL PHARM, V250, P154, DOI 10.1016/j.taap.2010.10.006; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Vineetha VP, 2013, CARDIOVASC TOXICOL, V13, P123, DOI 10.1007/s12012-012-9191-x; Vineetha VP, 2015, EUR J PHARMACOL, V754, P174, DOI 10.1016/j.ejphar.2015.02.036; Vineetha VP, 2014, FOOD FUNCT, V5, P502, DOI 10.1039/c3fo60470e; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; Watcharasit P, 2012, ENVIRON TOXICOL PHAR, V33, P53, DOI 10.1016/j.etap.2011.10.005; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Wu CT, 2014, ENVIRON HEALTH PERSP, V122, P559, DOI 10.1289/ehp.1307832; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Yen YP, 2012, ARCH TOXICOL, V86, P923, DOI 10.1007/s00204-012-0864-9; Yen YP, 2010, ENVIRON HEALTH PERSP, V118, P949, DOI 10.1289/ehp.0901525; Yih LH, 2000, CANCER RES, V60, P6346; Zhang W, 1998, LEUKEMIA, V12, P1383, DOI 10.1038/sj.leu.2401112	55	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137907	10.1371/journal.pone.0137907	http://dx.doi.org/10.1371/journal.pone.0137907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359868	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100100
J	Schunk, M; Mekonnen, SK; Wondafrash, B; Mengele, C; Fleischmann, E; Herbinger, KH; Verweij, JJ; Geldmacher, C; Bretzel, G; Loscher, T; Zeynudin, A				Schunk, Mirjam; Mekonnen, Seleshi Kebede; Wondafrash, Beyene; Mengele, Carolin; Fleischmann, Erna; Herbinger, Karl-Heinz; Verweij, Jaco J.; Geldmacher, Christof; Bretzel, Gisela; Loscher, Thomas; Zeynudin, Ahmed			Use of Occult Blood Detection Cards for Real-Time PCR-Based Diagnosis of Schistosoma Mansoni Infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA PARASITES; REACTION ASSAY; URINE SAMPLES; FILTER-PAPER; DNA; HAEMATOBIUM; PREVALENCE; JAPONICUM; STORAGE	Background In Schistosoma mansoni infection, diagnosis and control after treatment mainly rely on parasitological stool investigations which are laborious and have limited sensitivity. PCR methods have shown equal or superior sensitivity but preservation and storage methods limit their use in the field. Therefore, the use of occult blood detection cards (fecal cards) for easy sampling and storage of fecal samples for further PCR testing was evaluated in a pilot study. Methodology Stool specimens were collected in a highly endemic area for S. mansoni in Ethiopia and submitted in an investigator-blinded fashion to microscopic examination by Kato-Katz thick smear as well as to real-time PCR using either fresh frozen stool samples or stool smears on fecal cards which have been stored at ambient temperature for up to ten months. Principal Findings Out of 55 stool samples, 35 were positive by microscopy, 33 and 32 were positive by PCR of frozen samples and of fecal card samples, respectively. When microscopy was used as diagnostic "gold standard", the sensitivity of PCR on fresh stool was 94.3%(95%-CI: 86.6; 100) and on fecal cards 91.4%(95%-CI: 82.2; 100). Conclusions The use of fecal cards proved to be a simple and useful method for stool collection and prolonged storage prior to PCR based diagnosis of S. mansoni infection. This technique may be a valuable approach for large scale surveillance and post treatment assessments	[Schunk, Mirjam; Mengele, Carolin; Fleischmann, Erna; Herbinger, Karl-Heinz; Geldmacher, Christof; Bretzel, Gisela; Loscher, Thomas] Univ Munich, Dept Infect Dis & Trop Med DITM, Munich, Germany; [Mekonnen, Seleshi Kebede; Wondafrash, Beyene; Zeynudin, Ahmed] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Fleischmann, Erna] Bundeswehr Inst Microbiol, Munich, Germany; [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilsburg, Netherlands	University of Munich; Jimma University; Bundeswehr Institute of Microbiology (IMB)	Schunk, M (corresponding author), Univ Munich, Dept Infect Dis & Trop Med DITM, Munich, Germany.	schunk@lrz.uni-muenchen.de	Löscher, Thomas/AAA-8399-2020; wonddafrash, beyene/J-6830-2016	Kasim, Ahmed Zeynudin/0000-0002-0552-1783; wonddafrash, beyene/0000-0001-9161-1509; Verweij, Jaco J./0000-0001-8553-931X	Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany	Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany	Funding: This work received financial support from the Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x; Basuni M, 2011, AM J TROP MED HYG, V84, P338, DOI 10.4269/ajtmh.2011.10-0499; Carnevale S, 2000, CLIN DIAGN LAB IMMUN, V7, P504, DOI 10.1128/CDLI.7.3.504-506.2000; Cesari IM, 2005, CLIN DIAGN LAB IMMUN, V12, P280, DOI 10.1128/CDLI.12.2.280-286.2005; Chaorattanakawee S, 2003, AM J TROP MED HYG, V69, P42, DOI 10.4269/ajtmh.2003.69.42; Cheesbrough M., 2001, MED LAB MANUAL TRO 1, P216; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109; Coulibaly JT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-29; Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021; Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319; Erko B, 2013, TROP MED INT HEALTH, V18, P1029, DOI 10.1111/tmi.12117; Farnert A, 1999, T ROY SOC TROP MED H, V93, P50, DOI 10.1016/S0035-9203(99)90177-3; Grimes KA, 2008, J CLIN MICROBIOL, V46, P2227, DOI 10.1128/JCM.00073-08; Gryseels B, 1996, PARASITOL TODAY, V12, P115, DOI 10.1016/0169-4758(96)80671-5; Hamburger J, 1998, AM J TROP MED HYG, V59, P872, DOI 10.4269/ajtmh.1998.59.872; HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R; Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lier T, 2009, AM J TROP MED HYG, V81, P428, DOI 10.4269/ajtmh.2009.81.428; Lin DD, 2008, PARASITOL INT, V57, P281, DOI 10.1016/j.parint.2008.04.005; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Sousa-Figueiredo JC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002008; Subrungruang I, 2004, J CLIN MICROBIOL, V42, P3490, DOI 10.1128/JCM.42.8.3490-3494.2004; Tansuphasiri Unchalee, 2001, Journal of the Medical Association of Thailand, V84, P1183; Tchuente LAT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001758; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Utzinger J, 2011, ACTA TROP, V120, pS121, DOI 10.1016/j.actatropica.2010.08.020; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422; Yu J, 1998, AM J TROP MED HYG, V59, P370, DOI 10.4269/ajtmh.1998.59.370	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137730	10.1371/journal.pone.0137730	http://dx.doi.org/10.1371/journal.pone.0137730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360049	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100077
J	Angelakis, E; Armougom, F; Carriere, F; Bachar, D; Laugier, R; Lagier, JC; Robert, C; Michelle, C; Henrissat, B; Raoult, D				Angelakis, Emmanouil; Armougom, Fabrice; Carriere, Frederic; Bachar, Dipankar; Laugier, Rene; Lagier, Jean-Christophe; Robert, Catherine; Michelle, Caroline; Henrissat, Bernard; Raoult, Didier			A Metagenomic Investigation of the Duodenal Microbiota Reveals Links with Obesity	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BACTERIAL COMMUNITY; PHOSPHOLIPASE-A; COLONIZATION; DIVERSITY; DIGESTION; TRACT; GENE; COLI; PLDA	Background Few studies have tested the small intestine microbiota in humans, where most nutrient digestion and absorption occur. Here, our objective was to examine the duodenal microbiota between obese and normal volunteers using metagenomic techniques. Methodology/Principal Findings We tested duodenal samples from five obese and five normal volunteers using 16S rDNA V6 pyrosequencing and Illumina MiSeq deep sequencing. The predominant phyla of the duodenal microbiota were Firmicutes and Actinobacteria, whereas Bacteroidetes were absent. Obese individuals had a significant increase in anaerobic genera (p < 0.001) and a higher abundance of genes encoding Acyl-CoA dehydrogenase (p = 0.0018) compared to the control group. Obese individuals also had a reduced abundance of genes encoding sucrose phosphorylase (p = 0.015) and 1,4-alpha-glucan branching enzyme (p = 0.05). Normal weight people had significantly increased FabK (p = 0.027), and the glycerophospholipid metabolism pathway revealed the presence of phospholipase A1 only in the control group (p = 0.05). Conclusions/Significance The duodenal microbiota of obese individuals exhibit alterations in the fatty acid and sucrose breakdown pathways, probably induced by diet imbalance.	[Angelakis, Emmanouil; Armougom, Fabrice; Bachar, Dipankar; Lagier, Jean-Christophe; Robert, Catherine; Michelle, Caroline; Raoult, Didier] Aix Marseille Univ, Fac Med, UMR 6236, URMITE CNRS IRD 198, F-13385 Marseille, France; [Carriere, Frederic] Aix Marseille Univ, CNRS, Enzymol Interfaces & Physiol Lipolysis, UMR7282, F-13009 Marseille, France; [Laugier, Rene] Hop La Timone, Hepatogastroenterol Dept, Marseille, France; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biolog, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Raoult, D (corresponding author), Aix Marseille Univ, Fac Med, UMR 6236, URMITE CNRS IRD 198, 27 Bd Jean Moulin, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Lagier, Jean-Christophe/AAY-3837-2021; Henrissat, Bernard/J-2475-2012; Carriere, Frederic/E-8408-2010; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Lagier, Jean-Christophe/0000-0003-0771-8245; Henrissat, Bernard/0000-0002-3434-8588; Carriere, Frederic/0000-0003-4848-9418; Michelle, Caroline/0000-0002-9235-074X; Angelakis, Emmanouil/0000-0001-7327-5441				Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Aron-Wisnewsky J, 2012, NAT REV GASTRO HEPAT, V9, P590, DOI 10.1038/nrgastro.2012.161; AUDET A, 1974, BIOCHIM BIOPHYS ACTA, V348, P334, DOI 10.1016/0005-2760(74)90213-6; Barrett E, 2013, MICROBIOLOGYOPEN, V2, P215, DOI 10.1002/mbo3.64; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carriere F, 2001, AM J PHYSIOL-GASTR L, V281, pG16, DOI 10.1152/ajpgi.2001.281.1.G16; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dorrell N, 1999, GASTROENTEROLOGY, V117, P1098, DOI 10.1016/S0016-5085(99)70394-X; Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P637, DOI 10.1007/s10096-012-1787-3; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Grant KA, 1997, INFECT IMMUN, V65, P1172, DOI 10.1128/IAI.65.4.1172-1180.1997; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Herieka M, 2014, MOL NUTR FOOD RES, V58, P136, DOI 10.1002/mnfr.201300104; Hildebrand P, 1998, GASTROENTEROLOGY, V114, P123, DOI 10.1016/S0016-5085(98)70640-7; Hugon P, 2013, J CLIN MICROBIOL, V51, P3286, DOI 10.1128/JCM.00473-13; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Laugerette F, 2014, MOL NUTR FOOD RES, V58, P1513, DOI 10.1002/mnfr.201400044; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; N'Goma JCB, 2012, THER DELIV, V3, P105, DOI 10.4155/TDE.11.138; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	42	70	74	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137784	10.1371/journal.pone.0137784	http://dx.doi.org/10.1371/journal.pone.0137784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356733	gold, Green Published			2022-12-27	WOS:000360965800083
J	Kamphee, H; Chaiprasert, A; Prammananan, T; Wiriyachaiporn, N; Kanchanatavee, A; Dharakul, T				Kamphee, Hatairat; Chaiprasert, Angkana; Prammananan, Therdsak; Wiriyachaiporn, Natpapas; Kanchanatavee, Airin; Dharakul, Tararaj			Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; RIFAMPIN-RESISTANT; DRUG-RESISTANCE; RPOB MUTATIONS; MONORESISTANT TUBERCULOSIS; GENOTYPIC DETECTION; KATG GENE; STRAINS; DIAGNOSIS	Several existing molecular tests for multidrug-resistant tuberculosis (MDR-TB) are limited by complexity and cost, hindering their widespread application. The objective of this proof of concept study was to develop a simple Nucleic Acid Lateral Flow (NALF) immunoassay as a potential diagnostic alternative, to complement conventional PCR, for the rapid molecular detection of MDR-TB. The NALF device was designed using antibodies for the indirect detection of labeled PCR amplification products. Multiplex PCR was optimized to permit the simultaneous detection of the drug resistant determining mutations in the 81-bp hot spot region of the rpoB gene (rifampicin resistance), while semi-nested PCR was optimized for the S315T mutation detection in the katG gene (isoniazid resistance). The amplification process additionally targeted a conserved region of the genes as Mycobacterium tuberculosis (Mtb) DNA control. The optimized conditions were validated with the H37Rv wild-type (WT) Mtb isolate and Mtb isolates with known mutations (MT) within the rpoB and katG genes. Results indicate the correct identification of WT (drug susceptible) and MT (drug resistant) Mtb isolates, with the least limit of detection (LOD) being 10(4) genomic copies per PCR reaction. NALF is a simple, rapid and low-cost device suitable for low resource settings where conventional PCR is already employed on a regular basis. Moreover, the use of antibody-based NALF to target primer-labels, without the requirement for DNA hybridization, renders the device generic, which could easily be adapted for the molecular diagnosis of other infectious and non-infectious diseases requiring nucleic acid detection.	[Kamphee, Hatairat; Kanchanatavee, Airin; Dharakul, Tararaj] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Chaiprasert, Angkana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Prammananan, Therdsak] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Dharakul, Tararaj] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr, Pathum Thani, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC)	Dharakul, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.	tararaj.dha@mahidol.ac.th			Cluster Program Management Office, National Science and Technology Development Agency, Thailand [P-12-01393]; Faculty of Graduate Studies, Mahidol University, Thailand	Cluster Program Management Office, National Science and Technology Development Agency, Thailand; Faculty of Graduate Studies, Mahidol University, Thailand	This study was supported by Cluster Program Management Office, National Science and Technology Development Agency, Thailand Grant number: P-12-01393 URL: (www.nstda.or.th/cpmo) to recipients: AC TD TP NW. HK was supported by a scholarship grant from the Faculty of Graduate Studies, Mahidol University, Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-4; Ahmad S, 2004, INT J ANTIMICROB AG, V23, P473, DOI 10.1016/j.ijantimicag.2003.10.004; Ando H, 2010, ANTIMICROB AGENTS CH, V54, P1793, DOI 10.1128/AAC.01691-09; [Anonymous], 2011, STAND MAN LAB TECHN; [Anonymous], 2010, RV1908C CATALASE PER; [Anonymous], 2010, RV0667 DNA DIRECTED; [Anonymous], TUBERCULOSIS MULTIDR; Avalos E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120470; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Bostanabad SZ, 2008, INDIAN J MED MICROBI, V26, P143, DOI 10.4103/0255-0857.40528; Bostanabad SZ, 2007, TUBERK TORAK, V55, P231; Bostanabad SZ, 2007, TUBERK TORAK, V55, P370; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Fasih N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050551; Fox L, 2011, EUR J CLIN MICROBIOL, V30, P863, DOI 10.1007/s10096-011-1167-4; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Hu SY, 2014, J CLIN MICROBIOL, V52, P1644, DOI 10.1128/JCM.03395-13; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Makadia JS, 2012, INDIAN J CLIN BIOCHE, V27, P370, DOI 10.1007/s12291-012-0228-5; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; Mens PF, 2008, DIAGN MICR INFEC DIS, V61, P421, DOI 10.1016/j.diagmicrobio.2008.03.009; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Negi SS, 2009, INDIAN J MED MICROBI, V27, P226, DOI 10.4103/0255-0857.45364; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; Pitaksajjakul Pannamthip, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P228; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Sajid M, 2015, J SAUDI CHEM SOC, V19, P689, DOI 10.1016/j.jscs.2014.09.001; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shi XD, 2013, GENE, V530, P95, DOI 10.1016/j.gene.2013.07.060; Singh OP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-154; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Tracevska T, 2002, J CLIN MICROBIOL, V40, P3789, DOI 10.1128/JCM.40.10.3789-3792.2002; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Varahram Mohammad, 2013, Open Microbiol J, V8, P1, DOI 10.2174/1874285801408010001; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Wang S, 2013, J TUBERC RES, V01, P1, DOI [10.4236/jtr.2013.11001, DOI 10.4236/JTR.2013.11001]; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; World Health Organization, 2013, WHO REC TUB DIAGN XP; World Health Organization, 2014, SUPPL GLOB TUB REP D; World Health Organization, 2008, EXP GROUP REP MOL LI; Yaku H, 2008, ELECTROPHORESIS, V29, P4130, DOI 10.1002/elps.200800097; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; Zaczek A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-10; Zakerbostanabad S, 2008, INFECT GENET EVOL, V8, P15, DOI 10.1016/j.meegid.2007.09.002	66	28	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137791	10.1371/journal.pone.0137791	http://dx.doi.org/10.1371/journal.pone.0137791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355296	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800085
J	Kato, H; Duarte, S; Liu, D; Busuttil, RW; Coito, AJ				Kato, Hiroyuki; Duarte, Sergio; Liu, Daniel; Busuttil, Ronald W.; Coito, Ana J.			Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice	PLOS ONE			English	Article							IN-VITRO; MYOCARDIAL INFLAMMATION; LIVER-TRANSPLANTATION; ENDOTHELIAL-CELLS; TUMOR PROGRESSION; POLYMERASE PARP; INHIBITION; EXPRESSION; FIBROSIS; PJ34	Hepatic ischemia and reperfusion injury (IRI) is an inflammatory condition and a significant cause of morbidity and mortality after surgery. Matrix metalloproteinases (MMPs) have been widely implicated in the pathogenesis of inflammatory diseases. Among the different MMPs, gelatinases (MMP-2 and MMP-9) are within the most prominent MMPs detected during liver IRI. While the role of MMP-9 in liver damage has been fairly documented, direct evidence of the role for MMP-2 activity in hepatic IRI remains to be established. Due to the lack of suitable inhibitors to target individual MMPs in vivo, gene manipulation is as an essential tool to assess MMP direct contribution to liver injury. Hence, we used MMP-2(-/-) deficient mice and MMP-2(+/+) wild-type littermates to examine the function of MMP-2 activity in hepatic IRI. MMP-2 expression was detected along the sinusoids of wild-type livers before and after surgery and in a small population of leukocytes post-IRI. Compared to MMP-2(+/+) mice, MMP-2 null (MMP-2(-/-)) mice showed exacerbated liver damage at 6, 24, and 48 hours post-reperfusion, which was fatal in some cases. MMP-2 deficiency resulted in upregulation of MMP-9 activity, spontaneous leukocyte infiltration in naive livers, and amplified MMP-9-dependent transmigration of leukocytes in vitro and after hepatic IRI. Moreover, complete loss of MMP-2 activity impaired the degradation of poly (ADP-ribose) polymerase (PARP-1) in extensively damaged livers post-reperfusion. However, the administration of a PARP-1 inhibitor to MMP-2 null mice restored liver preservation to almost comparable levels of MMP-2(+/+) mice post-IRI. Deficient PARP-1 degradation in MMP-2-null sinusoidal endothelial cells correlated with their increased cytotoxicity, evaluated by the measurement of LDH efflux in the medium. In conclusion, our results show for the first time that MMP-2 gene deletion exacerbates liver IRI. Moreover, they offer new insights into the MMP-2 modulation of inflammatory responses, which could be relevant for the design of new pharmacological MMP-targeted agents to treat hepatic IRI.	[Kato, Hiroyuki; Duarte, Sergio; Liu, Daniel; Busuttil, Ronald W.; Coito, Ana J.] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Coito, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA.	acoito@mednet.ucla.edu	Duarte, Sergio/AAH-2142-2021	Coito, Ana/0000-0003-1315-5661	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [R01AI057832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057832] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) R01AI057832 grant.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Braet F, 1996, J MICROSC-OXFORD, V181, P10, DOI 10.1046/j.1365-2818.1996.72348.x; Coito AJ, 2011, CURR OPIN ORGAN TRAN, V16, P34, DOI 10.1097/MOT.0b013e328342542e; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fiorillo C, 2006, CELL MOL LIFE SCI, V63, P3061, DOI 10.1007/s00018-006-6345-7; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Fares RCG, 2013, INFECT IMMUN, V81, P3600, DOI 10.1128/IAI.00153-13; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; HO MK, 1982, J IMMUNOL, V128, P2281; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Junior AM, 2008, BONE MARROW TRANSPL, V41, P95, DOI 10.1038/sj.bmt.1705883; Kato H, 2014, J HEPATOL; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kuyvenhoven JP, 2004, TRANSPLANTATION, V77, P1646, DOI 10.1097/01.TP.0000131170.67671.75; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Matsusaka H, 2005, AM J PHYSIOL-HEART C, V289, pH1858, DOI 10.1152/ajpheart.00216.2005; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Moore C, 2007, AM J PATHOL, V170, P567, DOI 10.2353/ajpath.2007.060456; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; OPDENAKKER G, 1991, LYMPHOKINE CYTOK RES, V10, P317; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Padrissa-Altes S, 2010, AM J TRANSPLANT, V10, P1167, DOI 10.1111/j.1600-6143.2010.03092.x; Panek AN, 2006, HYPERTENSION, V47, P640, DOI 10.1161/01.HYP.0000208603.97395.44; Pardridge William M, 2005, NeuroRx, V2, P3; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Sinha SK, 2014, AM J TRANSL RES, V6, P155; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Yadav SS, 1999, HEPATOLOGY, V30, P1223, DOI 10.1002/hep.510300513; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zimmerman MA, 2013, P NATL ACAD SCI USA, V110, P12012, DOI 10.1073/pnas.1221733110	45	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137642	10.1371/journal.pone.0137642	http://dx.doi.org/10.1371/journal.pone.0137642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355684	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800073
J	Korithoski, B; Kolaczkowski, O; Mukherjee, K; Kola, R; Earl, C; Kolaczkowski, B				Korithoski, Bryan; Kolaczkowski, Oralia; Mukherjee, Krishanu; Kola, Reema; Earl, Chandra; Kolaczkowski, Bryan			Evolution of a Novel Antiviral Immune-Signaling Interaction by Partial-Gene Duplication	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; BRANCH-SITE TEST; RIG-I; PHYLOGENETIC ANALYSIS; PROTEIN FAMILIES; STRUCTURAL BASIS; INNATE IMMUNITY; PREDICTION; PERFORMANCE	The RIG-like receptors (RLRs) are related proteins that identify viral RNA in the cytoplasm and activate cellular immune responses, primarily through direct protein-protein interactions with the signal transducer, IPS1. Although it has been well established that the RLRs, RIG-I and MDA5, activate IPS1 through binding between the twin caspase activation and recruitment domains (CARDs) on the RLR and a homologous CARD on IPS1, it is less clear which specific RLR CARD(s) are required for this interaction, and almost nothing is known about how the RLR-IPS1 interaction evolved. In contrast to what has been observed in the presence of immune-modulating K63-linked polyubiquitin, here we show that-in the absence of ubiquitin-it is the first CARD domain of human RIG-I and MDA5 (CARD1) that binds directly to IPS1 CARD, and not the second (CARD2). Although the RLRs originated in the earliest animals, both the IPS1 gene and the twin-CARD domain architecture of RIG-I and MDA5 arose much later in the deuterostome lineage, probably through a series of tandem partial-gene duplication events facilitated by tight clustering of RLRs and IPS1 in the ancestral deuterostome genome. Functional differentiation of RIG-I CARD1 and CARD2 appears to have occurred early during this proliferation of RLR and related CARDs, potentially driven by adaptive coevolution between RIG-I CARD domains and IPS1 CARD. However, functional differentiation of MDA5 CARD1 and CARD2 occurred later. These results fit a general model in which duplications of protein-protein interaction domains into novel gene contexts could facilitate the expansion of signaling networks and suggest a potentially important role for functionally-linked gene clusters in generating novel immune-signaling pathways.	[Korithoski, Bryan; Kolaczkowski, Oralia; Kola, Reema; Kolaczkowski, Bryan] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Mukherjee, Krishanu] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [Kola, Reema] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Earl, Chandra] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kolaczkowski, B (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	bryank@ufl.edu		Earl, Chandra/0000-0001-9850-882X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI101571]; USDA National Institute of Food and Agriculture [FLA-MCS-005262]; University of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101571] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Florida(University of Florida); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R21AI101571, grant number FLA-MCS-005262 from the USDA National Institute of Food and Agriculture, and by the University of Florida. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Falkhausen M, 1995, P EUR, P1487; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao X, 2009, P NATL ACAD SCI USA, V106, P20818, DOI 10.1073/pnas.0911093106; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu A, 2014, MOL BIOL EVOL, V31, P484, DOI 10.1093/molbev/mst198; Mansai SP, 2010, GENETICS, V184, P517, DOI 10.1534/genetics.109.111161; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mukherjee K, 2014, MOL BIOL EVOL, V31, P140, DOI 10.1093/molbev/mst184; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Susko E, 2013, SYST BIOL, V62, P330, DOI 10.1093/sysbio/sys075; Suzuki Y, 2008, GENES GENET SYST, V83, P331, DOI 10.1266/ggs.83.331; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137276	10.1371/journal.pone.0137276	http://dx.doi.org/10.1371/journal.pone.0137276			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356745	gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800038
J	Popova, B; Schubert, S; Bulla, I; Buchwald, D; Kramer, W				Popova, Blagovesta; Schubert, Steffen; Bulla, Ingo; Buchwald, Daniela; Kramer, Wilfried			A Robust and Versatile Method of Combinatorial Chemical Synthesis of Gene Libraries via Hierarchical Assembly of Partially Randomized Modules	PLOS ONE			English	Article							DESIGNING REPEAT PROTEINS; TRINUCLEOTIDE PHOSPHORAMIDITES; MIXED OLIGONUCLEOTIDES; CONVENIENT APPROACH; DIRECTED EVOLUTION; RANDOM MUTAGENESIS; GENERATION; ANTIBODIES; DIVERSITY; ENZYME	A major challenge in gene library generation is to guarantee a large functional size and diversity that significantly increases the chances of selecting different functional protein variants. The use of trinucleotides mixtures for controlled randomization results in superior library diversity and offers the ability to specify the type and distribution of the amino acids at each position. Here we describe the generation of a high diversity gene library using tHisF of the hyperthermophile Thermotoga maritima as a scaffold. Combining various rational criteria with contingency, we targeted 26 selected codons of the thisF gene sequence for randomization at a controlled level. We have developed a novel method of creating full-length gene libraries by combinatorial assembly of smaller sub-libraries. Full-length libraries of high diversity can easily be assembled on demand from smaller and much less diverse sublibraries, which circumvent the notoriously troublesome long-term archivation and repeated proliferation of high diversity ensembles of phages or plasmids. We developed a generally applicable software tool for sequence analysis of mutated gene sequences that provides efficient assistance for analysis of library diversity. Finally, practical utility of the library was demonstrated in principle by assessment of the conformational stability of library members and isolating protein variants with HisF activity from it. Our approach integrates a number of features of nucleic acids synthetic chemistry, biochemistry and molecular genetics to a coherent, flexible and robust method of combinatorial gene synthesis.	[Popova, Blagovesta] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany; [Popova, Blagovesta; Schubert, Steffen; Kramer, Wilfried] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Genet & Preparat Mol Biol, D-37073 Gottingen, Germany; [Schubert, Steffen] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Schubert, Steffen] Dept Dermatol IVDK, Informat Network, Gottingen, Germany; [Bulla, Ingo] Los Alamos Natl Lab, Theoret Biol & Biophys, Grp T 6, Los Alamos, NM USA; [Bulla, Ingo] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Greifswald, Germany; [Bulla, Ingo; Buchwald, Daniela] Univ Gottingen, Inst Microbiol & Genet, Dept Bioinformat, D-37073 Gottingen, Germany; [Buchwald, Daniela] German Primate Ctr GmbH, Neurobiol Lab, Gottingen, Germany; [Kramer, Wilfried] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Genet, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; United States Department of Energy (DOE); Los Alamos National Laboratory; Ernst Moritz Arndt Universitat Greifswald; University of Gottingen; Deutsches Primatenzentrum (DPZ); University of Gottingen	Popova, B (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany.	bpopova@gwdg.de	Buchwald, Daniela/X-1035-2019	Buchwald, Daniela/0000-0002-7840-641X; Popova, Blagovesta/0000-0001-6323-374X	German Research Foundation; Gottingen University; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	German Research Foundation(German Research Foundation (DFG)); Gottingen University; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. BP was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain.	Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Arunachalam TS, 2012, ORG BIOMOL CHEM, V10, P4641, DOI 10.1039/c2ob25328c; Ashraf M, 2013, BIOCHEM SOC T, V41, P1189, DOI 10.1042/BST20130123; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gaytan P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp602; He M, 2007, BIOCHEM SOC T, V35, P962, DOI 10.1042/BST0350962; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; Isalan M, 2006, NAT PROTOC, V1, P468, DOI 10.1038/nprot.2006.68; Janczyk M, 2012, ORG BIOMOL CHEM, V10, P1510, DOI 10.1039/c2ob06934b; Kayushin A, 2000, NUCLEOS NUCLEOT NUCL, V19, P1967, DOI 10.1080/15257770008045471; Kayushin AL, 1996, NUCLEIC ACIDS RES, V24, P3748, DOI 10.1093/nar/24.19.3748; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Krumpe LR, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-65; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Levy M, 2008, CHEM BIOL, V15, P979, DOI 10.1016/j.chembiol.2008.07.017; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Rauchenberger R, 2003, J BIOL CHEM, V278, P38194, DOI 10.1074/jbc.M303164200; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Stumpp MT, 2003, J MOL BIOL, V332, P471, DOI 10.1016/S0022-2836(03)00897-0; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Tee KL, 2013, BIOTECHNOL ADV, V31, P1707, DOI 10.1016/j.biotechadv.2013.08.021; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yanez J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh156; Zehl A, 1996, CHEM COMMUN, P2677, DOI 10.1039/cc9960002677	43	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136778	10.1371/journal.pone.0136778	http://dx.doi.org/10.1371/journal.pone.0136778			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355961	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800016
J	Ortega-Cisneros, K; Scharler, UM				Ortega-Cisneros, Kelly; Scharler, Ursula M.			Nutrient Dynamics of Estuarine Invertebrates Are Shaped by Feeding Guild Rather than Seasonal River Flow	PLOS ONE			English	Article							TEMPORARILY OPEN/CLOSED ESTUARIES; STABLE CARBON-ISOTOPE; SOUTH-AFRICAN ESTUARY; ECOLOGICAL STOICHIOMETRY; ELEMENTAL COMPOSITION; FOOD-WEB; PHOSPHORUS-CONTENT; NETWORK ANALYSIS; C-N; ZOOPLANKTON	This study aimed to determine the variability of carbon and nitrogen elemental content, stoichiometry and diet proportions of invertebrates in two sub-tropical estuaries in South Africa experiencing seasonal changes in rainfall and river inflow. The elemental ratios and stable isotopes of abiotic sources, zooplankton and macrozoobenthos taxa were analyzed over a dry/wet seasonal cycle. Nutrient content (C, N) and stoichiometry of suspended particulate matter exhibited significant spatio-temporal variations in both estuaries, which were explained by the variability in river inflow. Sediment particulate matter (%C, %N and C: N) was also influenced by the variability in river flow but to a lesser extent. The nutrient content and ratios of the analyzed invertebrates did not significantly vary among seasons with the exception of the copepod Pseudodiaptomus spp. (C:N) and the tanaid Apseudes digitalis (%N, C:N). These changes did not track the seasonal variations of the suspended or sediment particulate matter. Our results suggest that invertebrates managed to maintain their stoichiometry independent of the seasonality in river flow. A significant variability in nitrogen content among estuarine invertebrates was recorded, with highest %N recorded from predators and lowest %N from detritivores. Due to the otherwise general lack of seasonal differences in elemental content and stoichiometry, feeding guild was a major factor shaping the nutrient dynamics of the estuarine invertebrates. The nutrient richer suspended particulate matter was the preferred food source over sediment particulate matter for most invertebrate consumers in many, but not all seasons. The most distinct preference for suspended POM as a food source was apparent from the temporarily open/closed system after the estuary had breached, highlighting the importance of river flow as a driver of invertebrate nutrient dynamics under extreme events conditions. Moreover, our data showed that estuarine invertebrates concentrated C and N between 10-100 fold from trophic level I (POM) to trophic level II (detritivores/deposit feeders) and thus highlighted their importance not only as links to higher trophic level organisms in the food web, but also as providers of a stoichiometrically homeostatic food source for such consumers. As climate change scenarios for the east coast of South Africa predict increased rainfall as a higher number of rainy days and days with higher rainfall, our results suggest that future changes in rainfall and river inflow will have measurable effects on the nutrient content and stoichiometry of food sources and possibly also in estuarine consumers.	[Ortega-Cisneros, Kelly; Scharler, Ursula M.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Kwazulu Natal	Ortega-Cisneros, K (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa.	flypper5@hotmail.com	Ortega, Kelly/I-4520-2019	Ortega-Cisneros, Kelly/0000-0003-2511-5448; Scharler, Ursula/0000-0003-0493-2684	Kleinemonde SEAChange Project; South African Institute for Aquatic Biodiversity - National Research Foundation; Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding	Kleinemonde SEAChange Project; South African Institute for Aquatic Biodiversity - National Research Foundation; Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding	This work was supported by Kleinemonde SEAChange Project, South African Institute for Aquatic Biodiversity - National Research Foundation (KOC), Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding (UMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Janine, 1999, P91, DOI 10.1017/CBO9780511525490.005; Albuquerque ALS, 1997, WETLANDS, V17, P1, DOI 10.1007/BF03160713; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; BEERS JR, 1966, LIMNOL OCEANOGR, V11, P520; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; Carmichael RH, 2005, LIMNOL OCEANOGR, V50, P97, DOI 10.4319/lo.2005.50.1.0097; CAUWET G, 1993, MAR CHEM, V43, P235, DOI 10.1016/0304-4203(93)90229-H; Christian RR, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P25; Chrystal RA, 2014, ECOL INDIC, V38, P130, DOI 10.1016/j.ecolind.2013.10.025; Chrzanowski TH, 2008, LIMNOL OCEANOGR, V53, P1242, DOI 10.4319/lo.2008.53.4.1242; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; DAVIES B. R., 1998, VANISHING WATERS; DeMott WR, 2003, HYDROBIOLOGIA, V491, P177, DOI 10.1023/A:1024408430472; EKZNW, 2012, EST MAN PLAN MPENJ E; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; ELSER JJ, 1988, LIMNOL OCEANOGR, V33, P1, DOI 10.4319/lo.1988.33.1.0001; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1786, DOI 10.1111/j.1365-2427.2005.01455.x; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Froneman PW, 2002, ESTUAR COAST SHELF S, V55, P535, DOI 10.1006/ecss.2001.0921; Frost PC, 2003, J N AM BENTHOL SOC, V22, P51, DOI 10.2307/1467977; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; GAEDKE U, 1994, ECOL MODEL, V75, P435, DOI 10.1016/0304-3800(94)90038-8; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gismervik I, 1997, J PLANKTON RES, V19, P279, DOI 10.1093/plankt/19.2.279; Golz AL, 2015, J PLANKTON RES, V37, P293, DOI 10.1093/plankt/fbu109; Hessen DO, 1997, FRESHWATER BIOL, V38, P447, DOI 10.1046/j.1365-2427.1997.00224.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Kibirige I, 2002, J PLANKTON RES, V24, P1089, DOI 10.1093/plankt/24.10.1089; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; Martinson HM, 2008, ECOL RES, V23, P487, DOI 10.1007/s11284-008-0471-7; MATSON EA, 1990, LIMNOL OCEANOGR, V35, P1290, DOI 10.4319/lo.1990.35.6.1290; Montagna PA, 2002, ESTUARIES, V25, P1243, DOI 10.1007/BF02692221; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mulder K, 2007, ECOL MODEL, V202, P427, DOI 10.1016/j.ecolmodel.2006.11.007; Ortega-Cisneros K, 2014, ESTUAR COAST SHELF S, V136, P139, DOI 10.1016/j.ecss.2013.11.021; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Paterson AW, 1997, ESTUAR COAST SHELF S, V45, P705, DOI 10.1006/ecss.1997.0243; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Richoux NB, 2007, ESTUAR COAST SHELF S, V71, P545, DOI 10.1016/j.ecss.2006.09.007; Scharler UM, 2012, ESTUAR COAST SHELF S, V108, P119, DOI 10.1016/j.ecss.2011.08.003; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; STERNER RW, 2002, ECOLOGICAL STOICHIOM, P584; Trimmer M, 1998, MAR ECOL PROG SER, V163, P109, DOI 10.3354/meps163109; Turpie J. K, 2012, CSIRNREECOSER2011004, V3; Ventura M, 2005, LIMNOL OCEANOGR, V50, P2043, DOI 10.4319/lo.2005.50.6.2043; Walve J, 1999, J PLANKTON RES, V21, P2309, DOI 10.1093/plankt/21.12.2309; Wang H, 2012, ECOL MODEL, V243, P81, DOI 10.1016/j.ecolmodel.2012.06.003; Whitfield A.K., 2013, 7 SANCOR; Yu FL, 2010, ESTUAR COAST SHELF S, V87, P618, DOI 10.1016/j.ecss.2010.02.018; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]	57	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137417	10.1371/journal.pone.0137417	http://dx.doi.org/10.1371/journal.pone.0137417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352433	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800083
J	Thangavel, T; Tegg, RS; Wilson, CR				Thangavel, Tamilarasan; Tegg, Robert S.; Wilson, Calum R.			Monitoring Spongospora subterranea Development in Potato Roots Reveals Distinct Infection Patterns and Enables Efficient Assessment of Disease Control Methods	PLOS ONE			English	Article							F-SP SUBTERRANEA; POWDERY SCAB DISEASE; COMMON SCAB; SEED-TUBER; SUSCEPTIBILITY; PCR; QUANTIFICATION; RESISTANCE; INOCULUM; TIME	Spongospora subterranea is responsible for significant potato root and tuber disease globally. Study of this obligate (non-culturable) pathogen that infects below-ground plant parts is technically difficult. The capacity to measure the dynamics and patterns of root infections can greatly assist in determining the efficacy of control treatments on disease progression. This study used qPCR and histological analysis in time-course experiments to measure temporal patterns of pathogen multiplication and disease development in potato (and tomato) roots and tubers. Effects of delayed initiation of infection and fungicidal seed tuber and soil treatments were assessed. This study found roots at all plant developmental ages were susceptible to infection but that delaying infection significantly reduced pathogen content and resultant disease at final harvest. The pathogen was first detected in roots 15-20 days after inoculation (DAI) and the presence of zoosporangia noted 15-45 DAI. Following initial infection pathogen content in roots increased at a similar rate regardless of plant age at inoculation. All fungicide treatments (except soil-applied mancozeb which had a variable response) suppressed pathogen multiplication and root and tuber disease. In contrast to delayed inoculation, the fungicide treatments slowed disease progress (rate) rather than delaying onset of infection. Trials under suboptimal temperatures for disease expression provided valuable data on root infection rate, demonstrating the robustness of monitoring root infection. These results provide an early measure of the efficacy of control treatments and indicate two possible patterns of disease suppression by either delayed initiation of infection which then proceeds at a similar rate or diminished epidemic rate.	[Thangavel, Tamilarasan; Tegg, Robert S.; Wilson, Calum R.] Univ Tasmania, Tasmanian Inst Agr, Sch Land & Food, New Town Res Labs, Newtown, Tas 7008, Australia	University of Tasmania	Wilson, CR (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Sch Land & Food, New Town Res Labs, 13 St Johns Ave, Newtown, Tas 7008, Australia.	Calum.Wilson@utas.edu.au	Thangavel, Tamilarasan/P-8050-2019	Thangavel, Tamilarasan/0000-0002-8800-0990; Wilson, Calum/0000-0001-5434-3816	Simplot Australia Pty. Ltd.; McCain Foods Australia Pty. Ltd.; Federal Government through Horticulture Innovation Australia Limited [PT14002]	Simplot Australia Pty. Ltd.; McCain Foods Australia Pty. Ltd.; Federal Government through Horticulture Innovation Australia Limited	Funding: This study was supported by Simplot Australia Pty. Ltd. and McCain Foods Australia Pty. Ltd., with matched funds from the Federal Government through Horticulture Innovation Australia Limited: project number PT14002 (http://www.horticulture.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1975, ANN APPL BIOL, V79, P275, DOI 10.1111/j.1744-7348.1975.tb01583.x; ADAMS MJ, 1978, ANN APPL BIOL, V90, P335, DOI 10.1111/j.1744-7348.1978.tb02641.x; Bell KS, 1999, EUR J PLANT PATHOL, V105, P905, DOI 10.1023/A:1008782309333; BRAITHWAITE M, 1994, NEW ZEAL J CROP HORT, V22, P121, DOI 10.1080/01140671.1994.9513815; Falloon RE, 1996, NEW ZEAL J CROP HORT, V24, P341, DOI 10.1080/01140671.1996.9513971; Falloon RE, 2003, AUSTRALAS PLANT PATH, V32, P377, DOI 10.1071/AP03040; Falloon RE, 2004, P S 88 ANN M POT ASS, P253; Falloon RE, 2008, AM J POTATO RES, V85, P253, DOI 10.1007/s12230-008-9022-6; Harrison JG, 1997, PLANT PATHOL, V46, P1, DOI 10.1046/j.1365-3059.1997.d01-214.x; HUGHES IK, 1980, AUST J EXP AGR, V20, P625, DOI 10.1071/EA9800625; Khatri BB, 2011, PLANT PATHOL, V60, P776, DOI 10.1111/j.1365-3059.2011.02435.x; Khatri BB, 2010, J PHYTOPATHOL, V158, P453, DOI 10.1111/j.1439-0434.2009.01637.x; Maldonado M. L. H., 2013, Plant Pathology, V62, P1089, DOI 10.1111/ppa.12015; Merz U, 2009, POTATO RES, V52, P17, DOI 10.1007/s11540-008-9105-2; Merz U, 1989, EPPO B, V19, P585, DOI DOI 10.1111/J.1365-2338.1989.TB00436.X; Merz U, 2008, AM J POTATO RES, V85, P241, DOI 10.1007/s12230-008-9019-1; Nitzan N, 2008, PLANT DIS, V92, P1643, DOI 10.1094/PDIS-92-12-1643; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Qu XS, 2006, AM J POTATO RES, V83, P21, DOI 10.1007/BF02869606; Ramsay A, 2014, POT IND C 7 BIENN C; Shah FA, 2012, AUSTRALAS PLANT PATH, V41, P219, DOI 10.1007/s13313-011-0110-6; TAYLOR PA, 1986, AUST J EXP AGR, V26, P745, DOI 10.1071/EA9860745; Tegg RS, 2013, PLANT PATHOL, V62, P922, DOI 10.1111/j.1365-3059.2012.02698.x; Tegg RS, 2015, PLANT DIS, V99, P50, DOI 10.1094/PDIS-04-14-0337-RE; Tegg RS, 2014, EUR J PLANT PATHOL, V139, P353, DOI 10.1007/s10658-014-0392-y; van de Graaf P, 2007, PLANT PATHOL, V56, P1005, DOI 10.1111/j.1365-3059.2007.01686.x; van de Graaf P, 2005, PLANT PATHOL, V54, P22, DOI 10.1111/j.1365-3059.2005.01111.x; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Wilson CR, 1999, J PHYTOPATHOL, V147, P13, DOI 10.1111/j.1439-0434.1999.tb03801.x	29	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137647	10.1371/journal.pone.0137647	http://dx.doi.org/10.1371/journal.pone.0137647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352757	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800104
J	Erdman, LK; D'Acremont, V; Hayford, K; Rajwans, N; Kilowoko, M; Kyungu, E; Hongoa, P; Alamo, L; Streiner, DL; Genton, B; Kain, KC				Erdman, Laura K.; D'Acremont, Valerie; Hayford, Kyla; Rajwans, Nimerta; Kilowoko, Mary; Kyungu, Esther; Hongoa, Philipina; Alamo, Leonor; Streiner, David L.; Genton, Blaise; Kain, Kevin C.			Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; LOWER RESPIRATORY-TRACT; PUBLIC-HEALTH; DOUBLE-BLIND; BACTERIAL; PROCALCITONIN; DIAGNOSIS; EFFICACY	Background Diagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies. However, radiography requires expertise and is often inaccessible. We hypothesized that plasma biomarkers of inflammation and endothelial activation may be useful surrogates for end-point pneumonia, and may provide insight into its biological significance. Methods We studied children with WHO-defined clinical pneumonia (n = 155) within a prospective cohort of 1,005 consecutive febrile children presenting to Tanzanian outpatient clinics. Based on x-ray findings, participants were categorized as primary end-point pneumonia (n = 30), other infiltrates (n = 31), or normal chest x-ray (n = 94). Plasma levels of 7 host response biomarkers at presentation were measured by ELISA. Associations between biomarker levels and radiological findings were assessed by Kruskal-Wallis test and multivariable logistic regression. Biomarker ability to predict radiological findings was evaluated using receiver operating characteristic curve analysis and Classification and Regression Tree analysis. Results Compared to children with normal x-ray, children with end-point pneumonia had significantly higher C-reactive protein, procalcitonin and Chitinase 3-like-1, while those with other infiltrates had elevated procalcitonin and von Willebrand Factor and decreased soluble Tie-2 and endoglin. Clinical variables were not predictive of radiological findings. Classification and Regression Tree analysis generated multi-marker models with improved performance over single markers for discriminating between groups. A model based on C-reactive protein and Chitinase 3-like-1 discriminated between end-point pneumonia and non-end-point pneumonia with 93.3% sensitivity (95% confidence interval 76.5-98.8), 80.8% specificity (72.6-87.1), positive likelihood ratio 4.9 (3.4-7.1), negative likelihood ratio 0.083 (0.022-0.32), and misclassification rate 0.20 (standard error 0.038). Conclusions In Tanzanian children with WHO-defined clinical pneumonia, combinations of host biomarkers distinguished between end-point pneumonia, other infiltrates, and normal chest x-ray, whereas clinical variables did not. These findings generate pathophysiological hypotheses and may have potential research and clinical utility.	[Erdman, Laura K.; Hayford, Kyla; Rajwans, Nimerta; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Sandra Rotman Ctr Global Hlth,Dept Med, Toronto, ON M5G 1L7, Canada; [D'Acremont, Valerie; Genton, Blaise] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Kilowoko, Mary] Amana Reg Referral Hosp, Dar Es Salaam, Tanzania; [Kyungu, Esther; Hongoa, Philipina] St Francis Hosp, Ifakara, Tanzania; [Alamo, Leonor] Univ Hosp Lausanne CHUV, Dept Radiol, Lausanne, Switzerland; [Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Basel; Swiss Tropical & Public Health Institute; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kain, KC (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Sandra Rotman Ctr Global Hlth,Dept Med, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.ca	Erdman, Laura/ABB-6936-2021; Boillat-Blanco, Noémie/GLT-5579-2022; Streiner, David/E-6563-2011	Erdman, Laura/0000-0001-8142-825X; Streiner, David/0000-0003-0610-6271; Kain, Kevin/0000-0001-6068-1272; Hayford, Kyla/0000-0002-9872-2313	Bill and Melinda Gates Foundation [OPP1022128]; Canada Research Chair; Canadian Institutes of Health Research (CIHR) [MOP-13721, MOP-136813, MOP-115160]; Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023]; K-W Rotary International; Tesari Charitable Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); K-W Rotary International; Tesari Charitable Foundation	This work was supported by the Bill and Melinda Gates Foundation (OPP1022128 to KCK; www.gatesfoundation.org); a Canada Research Chair (to KCK; www.chairs-chaires.gc.ca); Canadian Institutes of Health Research (CIHR MOP-13721, MOP-136813 and MOP-115160 to KCK, and MD/PhD Studentship to LKE; www.cihr-irsc.gc.ca); the Swiss National Science Foundation (3270B0-109696 and IZ70Z0-124023 to VD and BG; www.snf.ch); K-W Rotary International (to KCK; www.rotarykw.ca); and the Tesari Charitable Foundation (to KCK; tesarifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronikou S, 2011, PEDIATR RADIOL, V41, P811, DOI 10.1007/s00247-011-2081-8; [Anonymous], 2001, STAND INT CHEST RAD; [Anonymous], 2005, EMERGENCY TRIAGE ASS; Arnold R, 2005, J IMMUNOL, V174, P7359, DOI 10.4049/jimmunol.174.11.7359; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Berg P, 2012, DAN MED J, V59; Breiman L., 1984, CLASSIFICATION REGRE; Chan CPY, 2013, ANNU REV ANAL CHEM, V6, P191, DOI 10.1146/annurev-anchem-062012-092641; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; COURTOY I, 1989, CLIN PEDIATR, V28, P261, DOI 10.1177/000992288902800604; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; de Wit M, 2013, CLIN BIOCHEM, V46, P466, DOI 10.1016/j.clinbiochem.2012.10.039; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Erdman LK, 2010, PLOS ONE, V6; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; FRIIS B, 1990, ACTA PAEDIATR SCAND, V79, P219, DOI 10.1111/j.1651-2227.1990.tb11442.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang HL, 2014, CLIN INFECT DIS, V58, P1707, DOI 10.1093/cid/ciu202; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Murray J, 2014, MMWR-MORBID MORTAL W, V63, P1159; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Oved K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120012; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pittet LF, 2012, CLIN MICROBIOL INFEC, V18, P25, DOI 10.1111/j.1469-0691.2012.03938.x; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Vernatter J, 2013, CURR OPIN INFECT DIS, V26, P277, DOI 10.1097/QCO.0b013e3283608419; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; Wilkins Tyler R, 2005, Radiol Technol, V77, P106; Woods CR, 2008, PEDIATR ANN, V37, P694, DOI 10.3928/00904481-20081001-11; World Health Organization, 1991, TECHN BAS WHO REC MA; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280	48	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137592	10.1371/journal.pone.0137592	http://dx.doi.org/10.1371/journal.pone.0137592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366571	gold, Green Published, Green Accepted			2022-12-27	WOS:000361601100090
J	Henry, L; Biquand, V; Craig, AJFK; Hausberger, M				Henry, Laurence; Biquand, Veronique; Craig, Adrian J. F. K.; Hausberger, Martine			Sexing Adult Pale-Winged Starlings Using Morphometric and Discriminant Function Analysis	PLOS ONE			English	Article							EXTERNAL MEASUREMENTS; SEXUAL-DIMORPHISM; BIRDS; DNA; PLUMAGE	Accurate sexing of birds is vital for behavioral studies but can be a real problem in the field, especially for monomorphic species. Our goal here was to characterize the morphology of male and female monomorphic pale-winged starlings (Onychognathus nabouroup), a South African sturnid whose plumage is sexually monomorphic. Morphological measurements of genetically sexed animals indicated that males were statistically larger than females for five measurements: Mass, tail length, tarsus length and wing length. By using a Discriminant Function Analysis based on the measurements taken by one ringer, we were able to predict correctly the sex of 81.10% of the birds of data collected in the field and 77.9% of museum skins independently of year of capture and ringer. The model developed here should be useful for further field studies of this species.	[Henry, Laurence; Biquand, Veronique; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Craig, Adrian J. F. K.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Rhodes University	Henry, L (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	Laurence.henry@univ-rennes1.fr			Centre National de la Recherche Scientifique (CNRS); National Research Foundation (NRF); Rhodes University; Rennes 1 University	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Research Foundation (NRF); Rhodes University; Rennes 1 University	Our studies were funded primarily by grants from the Centre National de la Recherche Scientifique (CNRS) to Martine Hausberger (France) and National Research Foundation (NRF) to Adrian Craig (South Africa) (through the CNRS PICS and LIA programs), with additional funding from Rhodes University and Rennes 1 University.	Cardoni DA, 2009, ORNITOL NEOTROP, V20, P347; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Brady RS, 2009, J FIELD ORNITHOL, V80, P198, DOI 10.1111/j.1557-9263.2009.00209.x; CLARK RG, 1991, J FIELD ORNITHOL, V62, P132; De Beer S.J., 2001, SAFRING BIRD RINGING; Dechaume-Moncharmont FX, 2011, AUK, V128, P78, DOI 10.1525/auk.2011.10129; Feare C.J., 2009, HDB BIRDS WORLD BUSH, V14, P654; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Houdelier C, 2012, NATURWISSENSCHAFTEN, V99, P1051, DOI 10.1007/s00114-012-0987-0; Kiss JB, 2005, RINGING MIGRATION, V22, P163; Miller RA, 1938, BEHAVIOUR, V120, P262; Nisbet ICT, 1999, IBIS, V141, P307, DOI 10.1111/j.1474-919X.1999.tb07553.x; Rajchard J, 2009, VET MED-CZECH, V54, P351, DOI 10.17221/110/2009-VETMED; Robertson BC, 2006, CONSERV GENET, V7, P267, DOI 10.1007/s10592-005-9105-6; Shealer DA, 2007, WATERBIRDS, V30, P180, DOI 10.1675/1524-4695(2007)30[180:SDOABT]2.0.CO;2; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SONTAG W A JR, 1990, Bonner Zoologische Beitraege, V41, P163; Van De Pol M, 2009, IBIS, V151, P171, DOI 10.1111/j.1474-919X.2008.00891.x; van Rooij EP, 2010, ETHOLOGY, V116, P929, DOI 10.1111/j.1439-0310.2010.01808.x; Weidinger K, 1998, J ZOOL, V245, P473, DOI 10.1017/S0952836998008115; Wellbrock AHJ, 2012, J ORNITHOL, V153, P991, DOI 10.1007/s10336-012-0843-1; Wilson RR, 1999, J FIELD ORNITHOL, V70, P514; Zavalaga CB, 1997, J FIELD ORNITHOL, V68, P102	25	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135628	10.1371/journal.pone.0135628	http://dx.doi.org/10.1371/journal.pone.0135628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367269	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100011
J	Liu, Z; Ueda, K; Kim, HJ; Sparrow, JR				Liu, Zhao; Ueda, Keiko; Kim, Hye Jin; Sparrow, Janet R.			Photobleaching and Fluorescence Recovery of RPE Bisretinoids	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SINGLET-OXYGEN; MACULAR DEGENERATION; PHOTOOXIDATION PRODUCTS; PHOTODYNAMIC THERAPY; A2E; LIPOFUSCIN; LIGHT; INVOLVEMENT; MECHANISMS	The autofluorescence of the retina that originates primarily from lipofuscin fluorophores in retinal pigment epithelial cells, is observed to undergo photobleaching during the acquisition of fundus autofluorescence images. Bisretinoid fluorophores isolated from retinal pigment epithelial cells have the spectral characteristics consistent with their being the source of fundus autofluorescence. Clinically relevant experiments were designed to better understand conditions in the micromilieu of bisretinoid fluorophores that can influence fluorescence efficiencies, photobleaching, and subsequent fluorescence recovery of this fluorophore. The consumption of the bisretinoid A2E due to photooxidation-induced degradation was quantified in solvent systems of variable relative permittivity (formerly called dielectric constant), in micelles, and in phospholipid vesicles of varying composition. Reorganization within biphasic systems was also examined. A2E content was measured by high performance liquid chromatography (HPLC) and fluorescence intensity was quantified spectroscopically. As solvent polarity was increased, A2E fluorescent spectra exhibited red-shifted maxima and reduced intensity. A2E was depleted by light irradiation and the loss was more pronounced in less polar solvents, lower concentrations of anionic surfactant, and in gel-versus fluid-ordered phospholipid liposomes. Conditions that permit A2E aggregation promoted photooxidation/photodegradation, while movement of A2E between bisphasic systems was associated with fluorescence recovery after photobleaching. The fluorescence characteristics of A2E are subject to environmental modulation. Photooxidation and photodegradation of bisretinoid can account for fundus autofluorescence photobleaching. Return of fluorescence intensity after photobleaching likely occurs due to redistribution of A2E fractions amongst co-existing heterogeneous microdomains of the lysosomal compartment.	[Liu, Zhao; Ueda, Keiko; Kim, Hye Jin; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Sparrow, Janet R.] Columbia Univ, Dept Cell Biol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA.	jrs88@cumc.columbia.edu			National Institutes of Health [EY004367, EY012951, P30EY019007]; Research to Prevent Blindness to the Department of Ophthalmology; NATIONAL EYE INSTITUTE [R01EY012951, R01EY004367, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknowledge support from National Institutes of Health grants EY004367, EY012951 and P30EY019007. A grant from Research to Prevent Blindness to the Department of Ophthalmology is gratefully acknowledged. The following authors received salary from the funders. Zhao Liu: EY004367 Keiko Ueda: EY012951 Hyejin Kim: EY012951 Janet Sparrow: EY004367, EY012951. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Bonnett R, 2001, TETRAHEDRON, V57, P9513, DOI 10.1016/S0040-4020(01)00952-8; Cano M, 2011, AM J PATHOL, V179, P850, DOI 10.1016/j.ajpath.2011.04.010; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dabkowska AP, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3658382; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V67, P612, DOI 10.1111/j.1751-1097.1998.tb09463.x; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Jarvi MT, 2012, BIOPHYS J, V102, P661, DOI 10.1016/j.bpj.2011.12.043; JOHANSSON LBA, 1987, J PHYS CHEM-US, V91, P5275, DOI 10.1021/j100304a028; Kanofsky JR, 2003, PHOTOCHEM PHOTOBIOL, V77, P235, DOI 10.1562/0031-8655(2003)077<0235:SOGFA>2.0.CO;2; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Lamb LE, 2001, J PHYS CHEM B, V105, P11507, DOI 10.1021/jp0123177; Mesquita RMRS, 2000, BIOPHYS J, V78, P3019, DOI 10.1016/S0006-3495(00)76840-8; MOAN J, 1988, J PHOTOCH PHOTOBIO B, V1, P429, DOI 10.1016/1011-1344(88)85003-6; Morgan JIW, 2008, INVEST OPHTH VIS SCI, V49, P3715, DOI 10.1167/iovs.07-1430; Morgan JIW, 2009, INVEST OPHTH VIS SCI, V50, P1350, DOI 10.1167/iovs.08-2618; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Ren RXF, 1997, J AM CHEM SOC, V119, P3619, DOI 10.1021/ja9700414; RODGERS MAJ, 1983, J AM CHEM SOC, V105, P6201, DOI 10.1021/ja00358a001; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; WILKINSON F, 1981, J PHYS CHEM REF DATA, V10, P809, DOI 10.1063/1.555655; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamamoto K, 2012, INVEST OPHTH VIS SCI, V53, P3536, DOI 10.1167/iovs.12-9535; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	32	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138081	10.1371/journal.pone.0138081	http://dx.doi.org/10.1371/journal.pone.0138081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366866	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100218
J	Nyasembe, VO; Cheseto, X; Kaplan, F; Foster, WA; Teal, PEA; Tumlinson, JH; Borgemeister, C; Torto, B				Nyasembe, Vincent O.; Cheseto, Xavier; Kaplan, Fatma; Foster, Woodbridge A.; Teal, Peter E. A.; Tumlinson, James H.; Borgemeister, Christian; Torto, Baldwyn			The Invasive American Weed Parthenium hysterophorus Can Negatively Impact Malaria Control in Africa	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; CLIMATE-CHANGE; WESTERN KENYA; BIDENS-PILOSA; FLORAL NECTAR; PLANTS; SURVIVAL; CULICIDAE; MOSQUITOS; DIPTERA	The direct negative effects of invasive plant species on agriculture and biodiversity are well known, but their indirect effects on human health, and particularly their interactions with disease-transmitting vectors, remains poorly explored. This study sought to investigate the impact of the invasive Neotropical weed Parthenium hysterophorus and its toxins on the survival and energy reserves of the malaria vector Anopheles gambiae. In this study, we compared the fitness of An. gambiae fed on three differentially attractive mosquito host plants and their major toxins; the highly aggressive invasive Neotropical weed Parthenium hysterophorus (Asteraceae) in East Africa and two other adapted weeds, Ricinus communis (Euphorbiaceae) and Bidens pilosa (Asteraceae). Our results showed that female An. gambiae fitness varied with host plants as females survived better and accumulated substantial energy reserves when fed on P. hysterophorus and R. communis compared to B. pilosa. Females tolerated parthenin and 1-phenylhepta-1, 3, 5-triyne, the toxins produced by P. hysterophorus and B. pilosa, respectively, but not ricinine produced by R. communis. Given that invasive plants like P. hysterophorus can suppress or even replace less competitive species that might be less suitable host-plants for arthropod disease vectors, the spread of invasive plants could lead to higher disease transmission. Parthenium hysterophorus represents a possible indirect effect of invasive plants on human health, which underpins the need to include an additional health dimension in risk-analysis modelling for invasive plants.	[Nyasembe, Vincent O.; Cheseto, Xavier; Borgemeister, Christian; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Kaplan, Fatma; Teal, Peter E. A.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA; [Kaplan, Fatma] Kaplan Schiller Res LLC, Gainesville, FL 32604 USA; [Foster, Woodbridge A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Tumlinson, James H.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Borgemeister, Christian] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany	International Centre of Insect Physiology & Ecology (ICIPE); United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bonn	Torto, B (corresponding author), Int Ctr Insect Physiol & Ecol, Box 30772, Nairobi, Kenya.	btorto@icipe.org	Kaplan, Fatma/AAJ-7666-2020	Kaplan, Fatma/0000-0002-9565-0211; Cheseto, Xavier/0000-0002-9779-0357	USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [RO1A1077722]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031637] Funding Source: NIH RePORTER	USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded in part by USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; and by the U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant RO1A1077722.	Adkins SW, 2011, SUSTAINABLE MANAGEME, pS238; Atella GC, 2002, J EXP BIOL, V205, P3623; Atella GC, 2009, ACTA TROP, V109, P159, DOI 10.1016/j.actatropica.2008.10.004; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Batish DR, 2002, ENVIRON EXP BOT, V47, P149, DOI 10.1016/S0098-8472(01)00122-8; Brandao MGL, 1997, J ETHNOPHARMACOL, V57, P131, DOI 10.1016/S0378-8741(97)00060-3; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; BRIGGS CJ, 1995, J ANIM ECOL, V64, P403, DOI 10.2307/5900; CHAN MS, 1993, EVOL ECOL, V7, P593, DOI 10.1007/BF01237823; Chang MH, 2000, J CHIN CHEM SOC-TAIP, V47, P1131, DOI 10.1002/jccs.200000152; Clements A.N., 1992, BIOL MOSQUITOES DEV, V1, P509; Das B, 2007, PHYTOCHEMISTRY, V68, P2029, DOI 10.1016/j.phytochem.2007.05.002; Dukes JS, 2009, CAN J FOREST RES, V39, P231, DOI 10.1139/X08-171; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gary RE, 2005, BIOL MALARIA VECTOR, P69; Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996; Ham OBA, 2007, PHARMAZIE, V62, P226, DOI 10.1691/ph.2007.3.6628; HERZ W, 1962, J AM CHEM SOC, V84, P2601, DOI 10.1021/ja00872a027; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Javaid A, 2007, PAK J BOT, V39, P2611; KANCHAN SD, 1975, CURR SCI INDIA, V44, P358; Kohl KD, 2014, ECOL LETT, V17, P1238, DOI 10.1111/ele.12329; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; McConnachie AJ, 2011, WEED RES, V51, P71, DOI 10.1111/j.1365-3180.2010.00820.x; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-262; Nikbakhtzadeh MR, 2014, J VECTOR ECOL, V39, P372, DOI 10.1111/jvec.12113; Nyasembe VO, 2014, CURR BIOL, V24, P217, DOI 10.1016/j.cub.2013.12.022; Nyasembe VO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-234; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; Orech FO, 2007, INT J FOOD SCI NUTR, V58, P522, DOI 10.1080/09637480701331163; Oudhia P., 1998, PARTHENIUM CURSE BIO, P30; PICMAN J, 1984, BIOCHEM SYST ECOL, V12, P287, DOI 10.1016/0305-1978(84)90051-6; R Development Team, 2010, R LANG ENV STAT COMP; Ramos-Lopez M, 2012, AFRIC J BIOTECH, P9; Rivero A, 1999, RES POPUL ECOL, V41, P39, DOI 10.1007/PL00011981; Shimoma F, 1998, J ORG CHEM, V63, P3758, DOI 10.1021/jo972077k; Singh HP, 2003, AGR ECOSYST ENVIRON, V95, P537, DOI 10.1016/S0167-8809(02)00202-5; Souza KMR, 2013, NAT PROD RES, V27, P364, DOI 10.1080/14786419.2012.695368; Stone CM, 2013, ECOL CONT VECTOR-BOR, V3, P35; Tamado T, 2000, WEED RES, V40, P507, DOI 10.1046/j.1365-3180.2000.00208.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; VANHANDE.E, 1972, MOSQ NEWS, V32, P458; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; Vitousek PM, 1996, AM SCI, V84, P468; Wachira SW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-312; WILLIAMS JD, 1980, WEED RES, V20, P47, DOI 10.1111/j.1365-3180.1980.tb00040.x; Witt A, 2010, IMPACTS INVASIVE PLA, P1102; Woodring Jennifer L., 1996, P51; Wu HP, 2008, BIOL CONTROL, V45, P353, DOI 10.1016/j.biocontrol.2008.01.017	55	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137836	10.1371/journal.pone.0137836	http://dx.doi.org/10.1371/journal.pone.0137836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367123	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100150
J	Ojelade, SA; Acevedo, SF; Kalahasti, G; Rodan, AR; Rothenfluh, A				Ojelade, Shamsideen A.; Acevedo, Summer F.; Kalahasti, Geetha; Rodan, Aylin R.; Rothenfluh, Adrian			RhoGAP18B Isoforms Act on Distinct Rho-Family GTPases and Regulate Behavioral Responses to Alcohol via Cofilin	PLOS ONE			English	Article							LOW-LEVEL; ETHANOL; DROSOPHILA; CYTOSKELETON; CONSUMPTION; DYNAMICS; CELLS; EPS8; RAC; MECHANISMS	Responses to the effects of ethanol are highly conserved across organisms, with reduced responses to the sedating effects of ethanol being predictive of increased risk for human alcohol dependence. Previously, we described that regulators of actin dynamics, such as the Rho-family GTPases Rac1, Rho1, and Cdc42, alter Drosophila's sensitivity to ethanol-induced sedation. The GTPase activating protein RhoGAP18B also affects sensitivity to ethanol. To better understand how different RhoGAP18B isoforms affect ethanol sedation, we examined them for their effects on cell shape, GTP-loading of Rho-family GTPase, activation of the actin-severing cofilin, and actin filamentation. Our results suggest that the RhoGAP18B-PA isoform acts on Cdc42, while PC and PD act via Rac1 and Rho1 to activate cofilin. In vivo, a loss-of-function mutation in the cofilin-encoding gene twinstar leads to reduced ethanol-sensitivity and acts in concert with RhoGAP18B. Different RhoGAP18B isoforms, therefore, act on distinct subsets of Rho-family GTPases to modulate cofilin activity, actin dynamics, and ethanol-induced behaviors.	[Ojelade, Shamsideen A.; Acevedo, Summer F.; Kalahasti, Geetha; Rothenfluh, Adrian] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ojelade, Shamsideen A.; Rothenfluh, Adrian] Univ Texas SW Med Ctr Dallas, Program Neurosci, Dallas, TX 75390 USA; [Rodan, Aylin R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rothenfluh, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Adrian.Rothenfluh@UTSouthwestern.edu		Acevedo, Summer/0000-0002-3206-6819; Rothenfluh, Adrian/0000-0002-3813-5723; Rodan, Aylin/0000-0001-9202-2378	National Institute of Health [DA007290, F31 AA021340, K08DK091316, R01AA019526]; Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK091316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019526, F31AA021340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (nib.gov) grants to S.A.O. (T32 fellowship DA007290 and F31 AA021340), A.R.R (K08DK091316), and A.R (R01AA019526). A.R. was also supported by an Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2015, J NEUROSCI; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Enoch MA, 1999, PSYCHIAT CLIN N AM, V22, P289, DOI 10.1016/S0193-953X(05)70077-0; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Knox S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000375; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Malliri Angeliki, 2002, Methods Mol Biol, V189, P99; Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Ojelade SA, 2015, P NATL ACAD SCI USA, V112, pE4085, DOI 10.1073/pnas.1417222112; Ojelade SA, 2013, REV NEUROSCIENCE, V24, P471, DOI 10.1515/revneuro-2013-0017; Peru y Colon de Portugal RL, 2013, ADDICT BIOL, DOI [10.1111/adb.12105, DOI 10.1111/ADB.12105]; Popp RL, 2008, ALCOHOL, V42, P525, DOI 10.1016/j.alcohol.2008.06.006; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shuai YC, 2010, PROTEIN CELL, V1, P503, DOI 10.1007/s13238-010-0077-z; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Wolf FW, 2002, J NEUROSCI, V22, P11035	35	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137465	10.1371/journal.pone.0137465	http://dx.doi.org/10.1371/journal.pone.0137465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366560	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100076
J	Subramanian, A; Jhawar, J; Sarkar, RR				Subramanian, Abhishek; Jhawar, Jitesh; Sarkar, Ram Rup			Dissecting Leishmania infantum Energy Metabolism - A Systems Perspective	PLOS ONE			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; PROCYCLIC TRYPANOSOMA-BRUCEI; CONSTRAINT-BASED MODELS; FLUX BALANCE ANALYSIS; CARBOHYDRATE-METABOLISM; ENZYME-ACTIVITIES; KREBS CYCLE; MEXICANA; PROTEINS; COMPARTMENTATION	Leishmania infantum, causative agent of visceral leishmaniasis in humans, illustrates a complex lifecycle pertaining to two extreme environments, namely, the gut of the sandfly vector and human macrophages. Leishmania is capable of dynamically adapting and tactically switching between these critically hostile situations. The possible metabolic routes ventured by the parasite to achieve this exceptional adaptation to its varying environments are still poorly understood. In this study, we present an extensively reconstructed energy metabolism network of Leishmania infantum as an attempt to identify certain strategic metabolic routes preferred by the parasite to optimize its survival in such dynamic environments. The reconstructed network consists of 142 genes encoding for enzymes performing 237 reactions distributed across five distinct model compartments. We annotated the subcellular locations of different enzymes and their reactions on the basis of strong literature evidence and sequence-based detection of cellular localization signal within a protein sequence. To explore the diverse features of parasite metabolism the metabolic network was implemented and analyzed as a constraint-based model. Using a systems-based approach, we also put forth an extensive set of lethal reaction knockouts; some of which were validated using published data on Leishmania species. Performing a robustness analysis, the model was rigorously validated and tested for the secretion of overflow metabolites specific to Leishmania under varying extracellular oxygen uptake rate. Further, the fate of important non-essential amino acids in L. infantum metabolism was investigated. Stage-specific scenarios of L. infantum energy metabolism were incorporated in the model and key metabolic differences were outlined. Analysis of the model revealed the essentiality of glucose uptake, succinate fermentation, glutamate biosynthesis and an active TCA cycle as driving forces for parasite energy metabolism and its optimal growth. Finally, through our in silico knockout analysis, we could identify possible therapeutic targets that provide experimentally testable hypotheses.	[Subramanian, Abhishek; Jhawar, Jitesh; Sarkar, Ram Rup] Natl Chem Lab, CSIR, Chem Engn & Proc Dev, Pune, Maharashtra, India; [Subramanian, Abhishek; Sarkar, Ram Rup] CSIR, Acad Sci & Innovat Res AcSIR, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Sarkar, RR (corresponding author), Natl Chem Lab, CSIR, Chem Engn & Proc Dev, Pune, Maharashtra, India.	rr.sarkar@ncl.res.in	Subramanian, Abhishek/AAN-1302-2020	Subramanian, Abhishek/0000-0002-4601-5991; SARKAR, RAM RUP/0000-0001-7115-163X	Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE" [BSC0114]	Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE"	RRS is supported by a grant from Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE" (BSC0114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; BORST P, 1986, BIOCHIM BIOPHYS ACTA, V866, P179, DOI 10.1016/0167-4781(86)90044-8; Bressi JC, 2000, J MED CHEM, V43, P4135, DOI 10.1021/jm000287a; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chavali AK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-27; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; COOMBS GH, 1982, MOL BIOCHEM PARASIT, V5, P199, DOI 10.1016/0166-6851(82)90021-4; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; El Fakhry Y, 2002, PROTEOMICS, V2, P1007, DOI 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Garami A, 2001, J BIOL CHEM, V276, P6566, DOI 10.1074/jbc.M009226200; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Gualdron-Lopez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034530; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Joyce Andrew R, 2007, Prog Drug Res, V64, P267; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KEEGAN F, 1990, MOL BIOCHEM PARASIT, V39, P235, DOI 10.1016/0166-6851(90)90062-Q; Lamerz AC, 2010, GLYCOBIOLOGY, V20, P872, DOI 10.1093/glycob/cwq045; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Louassini M, 1999, PARASITOL RES, V85, P300, DOI 10.1007/s004360050552; Louassini M, 1999, J PARASITOL, V85, P595, DOI 10.2307/3285729; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MEADE JC, 1984, J PROTOZOOL, V31, P156, DOI 10.1111/j.1550-7408.1984.tb04307.x; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; MICHELS PAM, 1988, BIOL CELL, V64, P157, DOI 10.1016/0248-4900(88)90075-5; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Opperdoes FR, 2001, INT J PARASITOL, V31, P482, DOI 10.1016/S0020-7519(01)00155-2; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Roberts SB, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-52; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Ter Kuile BH, 1999, J BACTERIOL, V181, P4863, DOI 10.1128/JB.181.16.4863-4872.1999; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Zar J.H., 2010, BIOSTAT ANAL; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	77	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137976	10.1371/journal.pone.0137976	http://dx.doi.org/10.1371/journal.pone.0137976			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367006	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100191
J	Wang, H; Shun, MC; Dickson, AK; Engelman, AN				Wang, Hao; Shun, Ming-Chieh; Dickson, Amy K.; Engelman, Alan N.			Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; HIV-1 INTEGRASE; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; CHROMATIN BINDING; CELL-ADHESION; KNOCKOUT MICE; LEDGF/P75; DOMAIN	Hepatoma-derived growth factor (HDGF) related protein 2 (HRP2) and lens epitheliumderived growth factor (LEDGF)/p75 are closely related members of the HRP2 protein family. LEDGF/p75 has been implicated in numerous human pathologies including cancer, autoimmunity, and infectious disease. Knockout of the Psip1 gene, which encodes for LEDGF/p75 and the shorter LEDGF/p52 isoform, was previously shown to cause perinatal lethality in mice. The function of HRP2 was by contrast largely unknown. To learn about the role of HRP2 in development, we knocked out the Hdgfrp2 gene, which encodes for HRP2, in both normal and Psip1 knockout mice. Hdgfrp2 knockout mice developed normally and were fertile. By contrast, the double deficient mice died at approximate embryonic day (E) 13.5. Histological examination revealed ventricular septal defect (VSD) associated with E14.5 double knockout embryos. To investigate the underlying molecular mechanism(s), RNA recovered from ventricular tissue was subjected to RNA-sequencing on the Illumina platform. Bioinformatic analysis revealed several genes and biological pathways that were significantly deregulated by the Psip1 knockout and/or Psip1/Hdgfrp2 double knockout. Among the dozen genes known to encode for LEDGF/p75 binding factors, only the expression of Nova1, which encodes an RNA splicing factor, was significantly deregulated by the knockouts. However the expression of other RNA splicing factors, including the LEDGF/p52-interacting protein ASF/SF2, was not significantly altered, indicating that deregulation of global RNA splicing was not a driving factor in the pathology of the VSD. Tumor growth factor (Tgf) beta-signaling, which plays a key role in cardiac morphogenesis during development, was the only pathway significantly deregulated by the double knockout as compared to control and Psip1 knockout samples. We accordingly speculate that deregulated Tgf-beta signaling was a contributing factor to the VSD and prenatal lethality of Psip1/Hdgfrp2 double-deficient mice.	[Engelman, Alan N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, AN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA.	alan_engelman@dfic.harvard.edu			US National Institutes of Health [R37 AI039394]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant R37 AI039394 to ANE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bao CH, 2014, FUTURE ONCOL, V10, P2675, DOI 10.2217/fon.14.194; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Briggs SF, 2014, CURR OPIN GENET DEV, V28, P78, DOI 10.1016/j.gde.2014.09.010; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194; Fassler R, 1996, J CELL SCI, V109, P2989; Gallitzendoerfer R, 2008, DEV DYNAM, V237, P1875, DOI 10.1002/dvdy.21589; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Gerard A, 2015, CELL HOST MICROBE, V17, P107, DOI 10.1016/j.chom.2014.12.002; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; HEINO J, 1989, J BIOL CHEM, V264, P21806; HEINO J, 1989, J BIOL CHEM, V264, P380; HINES KL, 1994, P NATL ACAD SCI USA, V91, P5187, DOI 10.1073/pnas.91.11.5187; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kirchhoff S, 2000, CIRC RES, V87, P399; KULKARNI AB, 1993, AM J PATHOL, V143, P3; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Li XL, 2006, EXP CELL RES, V312, P854, DOI 10.1016/j.yexcr.2005.12.002; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Morchikh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081217; Murai MJ, 2014, BLOOD, V124, P3730, DOI 10.1182/blood-2014-01-550079; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmon NA, 2006, GENESIS, V44, P515, DOI 10.1002/dvg.20241; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schrijvers R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-84; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takehara-Kasamatsu Yuka, 2007, J Med Invest, V54, P276, DOI 10.2152/jmi.54.276; Thakar K, 2012, FEBS J, V279, P737, DOI 10.1111/j.1742-4658.2011.08464.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	62	34	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137797	10.1371/journal.pone.0137797	http://dx.doi.org/10.1371/journal.pone.0137797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367869	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100140
J	Mosites, EM; Rabinowitz, PM; Thumbi, SM; Montgomery, JM; Palmer, GH; May, S; Rowhani-Rahbar, A; Neuhouser, ML; Walson, JL				Mosites, Emily M.; Rabinowitz, Peter M.; Thumbi, Samuel M.; Montgomery, Joel M.; Palmer, Guy H.; May, Susanne; Rowhani-Rahbar, Ali; Neuhouser, Marian L.; Walson, Judd L.			The Relationship between Livestock Ownership and Child Stunting in Three Countries in Eastern Africa Using National Survey Data	PLOS ONE			English	Article							UNDERNUTRITION; INCOME; DETERMINANTS; NUTRITION; GROWTH	Livestock ownership has the potential to improve child nutrition through various mechanisms, although direct evaluations of household livestock and child stunting status are uncommon. We conducted an analysis of Demographic and Health Survey (DHS) datasets from Ethiopia (2011), Kenya (2008- 2009), and Uganda (2010) among rural children under 5 years of age to compare stunting status across levels of livestock ownership. We classified livestock ownership by summing reported household numbers of goats, sheep, cattle and chickens, as well as calculating a weighted score to combine multiple species. The primary association was assessed separately by country using a log- binomial model adjusted for wealth and region, which was then stratified by child diarrheal illness, animal- source foods intake, sub- region, and wealth index. This analysis included n = 8079 children from Ethiopia, n = 3903 children from Kenya, and n = 1645 from Uganda. A ten- fold increase in household livestock ownership had significant association with lower stunting prevalence in Ethiopia (Prevalence Ratio [PR] 0.95, 95% CI 0.92- 0.98) and Uganda (PR 0.87, 95% CI 0.79- 0.97), but not Kenya (PR 1.01, 95% CI 0.96- 1.07). The weighted livestock score was only marginally associated with stunting status. The findings varied slightly by region, but not by wealth, diarrheal disease, or animal- source food intake. This analysis suggested a slightly beneficial effect of household livestock ownership on child stunting prevalence. The small effect size observed may be related to limitations of the DHS dataset or the potentially complicated relationship between malnutrition and livestock ownership, including livestock health and productivity.	[Mosites, Emily M.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rabinowitz, Peter M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Thumbi, Samuel M.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Montgomery, Joel M.] Ctr Dis Control & Prevent, Global Dis Detect, Nairobi, Kenya; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Neuhouser, Marian L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Walson, Judd L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Washington State University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mosites, EM (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	emily.mosites@gmail.com	Walson, Judd/R-7269-2019; Mwangi, Thumbi/L-2216-2019; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Mwangi, Thumbi/0000-0002-5754-0556; Mosites, Emily/0000-0002-2968-9564; Rowhani-Rahbar, Ali/0000-0002-2705-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007025] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2012, UG DEM HLTH SURV 201; Azzarri C., 2014, DOES LIVESTOCK OWNER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Ikeda N, 2013, B WORLD HEALTH ORGAN, V91, P341, DOI 10.2471/BLT.12.113381; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Kanyari PW, 2010, E AFR J PUBLIC HLTH, V7; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; MATA L, 1992, AM J TROP MED HYG, V47, P16, DOI 10.4269/ajtmh.1992.47.16; Neumann CG, 2013, BR J NUTR, V109; Nicholson C, 2003, AAEA ANN M MONTR QUE; Semba RD, 2008, LANCET, V371; USAID, DEM HLTH SURV DAT CO; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2006, CHILD GROWTH STAND T	25	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136686	10.1371/journal.pone.0136686	http://dx.doi.org/10.1371/journal.pone.0136686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26361393	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100014
J	Rifatbegovic, F; Abbasi, MR; Taschner-Mandl, S; Kauer, M; Weinhausel, A; Handgretinger, R; Ambros, PF				Rifatbegovic, Fikret; Abbasi, M. Reza; Taschner-Mandl, Sabine; Kauer, Maximilian; Weinhaeusel, Andreas; Handgretinger, Rupert; Ambros, Peter F.			Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RISK STRATIFICATION; MESSENGER-RNA; TUMOR-CELLS; IMPACT; TISSUE; CLASSIFICATION; SIGNATURE; BLOOD; BIOBANKING	Background Metastases in the bone marrow (BM) in form of disseminated tumor cells (DTCs) are frequent events at diagnosis and also at relapse in high-risk neuroblastoma patients. The frequently highly diluted occurrence of DTCs requires adequate enrichment strategies to enable their detailed characterization. However, to avoid methodical artifacts we tested whether pre-analytical processing steps-including transport duration, temperature and, importantly, tumor cell enrichment techniques-are confounding factors for gene expression analysis in DTCs. Methods LAN-1 neuroblastoma cells were spiked into tumor free BM and/or peripheral blood and: i) kept at room temperature or at 4 degrees C for 24, 48 and 72 hours; ii) frozen down at -80 degrees C and thawed; iii) enriched via magnetic beads. The effect on the gene expression signature of LAN-1 cells was analyzed by qPCR arrays and gene expression microarrays. Results Neither storage at -80 degrees C in DMSO and subsequent thawing nor enrichment of spiked-in neuroblastoma cells changed the expression of the analyzed genes significantly. Whereas storage at 4 degrees C altered the expression of analyzed genes (14.3%) only at the 72h-timepoint in comparison to the 0h-timepoint, storage at room temperature had a much more profound effect on gene expression by affecting 20% at 24h, 26% at 48h and 43% at 72h of the analyzed genes. Conclusion Using neuroblastoma as a model, we show that tumor cell enrichment by magnetic bead separation has virtually no effect on gene expression in DTCs. However, transport time and temperature can influence the expression profile remarkably. Thus, the expression profile of routinely collected BM samples can be analyzed without concern as long as the transport conditions are monitored.	[Rifatbegovic, Fikret; Abbasi, M. Reza; Taschner-Mandl, Sabine; Kauer, Maximilian; Ambros, Peter F.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Weinhaeusel, Andreas] AIT Austrian Inst Technol GmbH, Mol Diagnost Hlth & Environm Dept, Vienna, Austria; [Handgretinger, Rupert] Univ Tubingen, Childrens Univ Hosp, Tubingen, Germany; [Ambros, Peter F.] Med Univ Vienna, Dept Pediat, Vienna, Austria	Saint Anna Children's Hospital; Austrian Institute of Technology (AIT); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna	Rifatbegovic, F (corresponding author), St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria.	fikret.rifatbegovic@ccri.at; peter.ambros@ccri.at	Weinhaeusel, Andreas/A-7644-2018; Ambros, Peter/AAA-1266-2021	Ambros, Peter/0000-0002-5507-7211; Taschner-Mandl, Sabine/0000-0002-1439-5301; Weinhaeusel, Andreas/0000-0002-9318-1204	St. Anna Kinderkrebsforschung (Vienna, Austria); European Union's Seventh Framework Program (FP7) under the project ENCCA [HEALTH-F2-2011-261474]	St. Anna Kinderkrebsforschung (Vienna, Austria); European Union's Seventh Framework Program (FP7) under the project ENCCA	The research leading to these results has received funding from: St. Anna Kinderkrebsforschung (Vienna, Austria) and the European Union's Seventh Framework Program (FP7/2007-2013) under the project ENCCA, grant agreement HEALTH-F2-2011-261474.	Abbasi RM, 2014, MOL ONCOLOGY, DOI [http://dx.doi.org/10.1016/j.molonc.2014.10.010, DOI 10.1016/J.M0L0NC.2014.10.010]; Ambros IM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00202; Ambros PF, 2003, CANCER LETT, V197, P29, DOI 10.1016/S0304-3835(03)00078-8; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Barnes RO, 2008, CANCER EPIDEM BIOMAR, V17, P3344, DOI 10.1158/1055-9965.EPI-08-0622; Becker J, 2010, CLIN CANCER RES, V16, P1431, DOI 10.1158/1078-0432.CCR-09-1936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoy IH, 2006, CLIN CHEM LAB MED, V44, P1082, DOI 10.1515/CCLM.2006.210; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Brodeur GM, 2014, NAT REV CLIN ONCOL, V11, P704, DOI 10.1038/nrclinonc.2014.168; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Fischer M, 2006, CLIN CANCER RES, V12, P5118, DOI 10.1158/1078-0432.CCR-06-0985; Garcia I, 2012, CLIN CANCER RES, V18, P2012, DOI 10.1158/1078-0432.CCR-11-2483; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Halsall A, 2008, INT J EPIDEMIOL, V37, P7, DOI 10.1093/ije/dym278; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lee SY, 2008, FEBS LETT, V582, P2826, DOI 10.1016/j.febslet.2008.07.021; Letzkus M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0036-z; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Luchetti F, 2003, HISTOL HISTOPATHOL, V18, P1041, DOI 10.14670/HH-18.1041; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Moos PJ, 2002, CLIN CANCER RES, V8, P3118; Morandi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029922; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; Musella V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053406; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Pantel Klaus, 2014, Bonekey Rep, V3, P584, DOI 10.1038/bonekey.2014.79; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Seeger RC, 2000, J CLIN ONCOL, V18, P4067, DOI 10.1200/JCO.2000.18.24.4067; Segerstrom L, 2006, PEDIATR RES, V60, P576, DOI 10.1203/01.pdr.0000242494.94000.52; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Maldegem F, 2008, DIAGN MOL PATHOL, V17, P51, DOI 10.1097/PDM.0b013e31814b8866; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137995	10.1371/journal.pone.0137995	http://dx.doi.org/10.1371/journal.pone.0137995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360775	Green Submitted, gold, Green Published			2022-12-27	WOS:000361043100105
J	Song, YJ; Li, GL; He, JH; Guo, Y; Yang, L				Song, Yi-Jiang; Li, Guiling; He, Jian-Hua; Guo, Yao; Yang, Li			Bioinformatics-Based Identification of MicroRNA-Regulated and Rheumatoid Arthritis-Associated Genes	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; BLOOD MONONUCLEAR-CELLS; SYNOVIAL FIBROBLASTS; EXPRESSION ANALYSIS; DNA METHYLATION; ALTERED EXPRESSION; ROR2 EXPRESSION; UP-REGULATION; INFLAMMATION; PATHWAY	MicroRNAs (miRNAs) act as epigenetic markers and regulate the expression of their target genes, including those characterized as regulators in autoimmune diseases. Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. The potential roles of miRNA-regulated genes in RA pathogenesis have greatly aroused the interest of clinicians and researchers in recent years. In the current study, RA-related miRNAs records were obtained from PubMed through conditional literature retrieval. After analyzing the selected records, miRNA targeted genes were predicted. We identified 14 RA-associated miRNAs, and their sub-analysis in 5 microarray or RNA sequencing (RNA-seq) datasets was performed. The microarray and RNA-seq data of RA were also downloaded from NCBI Gene Expression Omnibus (GEO) and Sequence Read Archive (SRA), analyzed, and annotated. Using a bioinformatics approach, we identified a series of differentially expressed genes (DEGs) by comparing studies on RA and the controls. The RA-related gene expression profile was thus obtained and the expression of miRNA-regulated genes was analyzed. After functional annotation analysis, we found GO molecular function (MF) terms significantly enriched in calcium ion binding (GO: 0005509). Moreover, some novel dysregulated target genes were identified in RA through integrated analysis of miRNA/mRNA expression. The result revealed that the expression of a number of genes, including ROR2, ABI3BP, SMOC2, etc., was not only affected by dysregulated miRNAs, but also altered in RA. Our findings indicate that there is a close association between negatively correlated mRNA/miRNA pairs and RA. These findings may be applied to identify genetic markers for RA diagnosis and treatment in the future.	[Song, Yi-Jiang; He, Jian-Hua; Guo, Yao; Yang, Li] Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Bioengn Coll, Chongqing 630044, Peoples R China; [Li, Guiling] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China	Chongqing University; Wenzhou Medical University	Yang, L (corresponding author), Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Bioengn Coll, Chongqing 630044, Peoples R China.	yanglibme@cqu.edu.cn			National Innovation and Attracting Talents Project ("111" Project) [B06023]; National Natural Science Foundation of China [11032012, 10902130, 30870608, 31200976]	National Innovation and Attracting Talents Project ("111" Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Innovation and Attracting Talents Project ("111" Project) (B06023), National Natural Science Foundation of China (grant no. 11032012, 10902130, 30870608, 31200976).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; Birlea SA, 2010, J INVEST DERMATOL, V130, P798, DOI 10.1038/jid.2009.347; Bolzoni M, 2013, LEUKEMIA, V27, P451, DOI 10.1038/leu.2012.190; Bottini N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0372-9; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; Chatzikyriakidou A, 2012, AUTOIMMUN REV, V11, P636, DOI 10.1016/j.autrev.2011.11.004; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; CORVETTA A, 1991, J CHROMATOGR-BIOMED, V566, P481, DOI 10.1016/0378-4347(91)80265-E; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Del Rey MJ, 2012, ANN RHEUM DIS, V71, P275, DOI 10.1136/annrheumdis-2011-200281; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Glant TT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-35; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Heruth DP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-43; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Katoh Y, 2005, INT J ONCOL, V27, P275; Kaur P, 2012, TUMOR BIOL, V33, P325, DOI 10.1007/s13277-012-0331-5; Khurana R, 2008, J RHEUMATOL, V35, P1704; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimoto O, 2011, J RHEUMATOL, V38, P310, DOI 10.3899/jrheum.100486; Lai DM, 2012, INT J ONCOL, V41, P541, DOI 10.3892/ijo.2012.1475; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li XC, 2013, INT J MOL SCI, V14, P23910, DOI 10.3390/ijms141223910; Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; Lin JP, 2014, ARTHRITIS RHEUMATOL, V66, P49, DOI 10.1002/art.38142; Long L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296139; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Niederer F, 2012, ARTHRITIS RHEUM-US, V64, P1771, DOI 10.1002/art.34334; Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395; Pandis I, 2012, ANN RHEUM DIS, V71, P1716, DOI 10.1136/annrheumdis-2011-200803; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; PETTY RE, 1986, J RHEUMATOL, V13, P246; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Rasmussen NR, 2013, J BIOL CHEM, V288, P26301, DOI 10.1074/jbc.M113.466086; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Saito Y, 2014, CLIN REV ALLERG IMMU, V47, P128, DOI 10.1007/s12016-013-8401-z; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seki T, 1998, ARTHRITIS RHEUM-US, V41, P1356, DOI 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shibuya H, 2013, MOD RHEUMATOL, V23, P674, DOI 10.1007/s10165-012-0710-1; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Taylor PC, 2002, ARTHRITIS RES THER, V4, pS99, DOI 10.1186/ar582; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Trenkmann M, 2011, ANN RHEUM DIS, V70, P1482, DOI 10.1136/ard.2010.143040; Turesson C, 2013, CURR OPIN RHEUMATOL, V25, P360, DOI 10.1097/BOR.0b013e32835f693f; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YH, 2010, INFLAMM RES, V59, P1009, DOI 10.1007/s00011-010-0217-1; Worthington J, 2005, J AUTOIMMUN, V25, P16, DOI 10.1016/j.jaut.2005.09.011; Wright H. L., 2014, RHEUMATOLOGY; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; You S, 2014, P NATL ACAD SCI USA, V111, P550, DOI 10.1073/pnas.1311239111; Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Yuan FL, 2014, CELL BIOCHEM BIOPHYS, V70, P77, DOI 10.1007/s12013-014-9913-8; Zhang F, 2014, HUM GENET, V133, P793, DOI 10.1007/s00439-014-1418-4; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	91	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137551	10.1371/journal.pone.0137551	http://dx.doi.org/10.1371/journal.pone.0137551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359667	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100051
J	Bach, CC; Henriksen, TB; Bossi, R; Bech, BH; Fuglsang, J; Olsen, J; Nohr, EA				Bach, Cathrine Carlsen; Henriksen, Tine Brink; Bossi, Rossana; Bech, Bodil Hammer; Fuglsang, Jens; Olsen, Jorn; Nohr, Ellen Aagaard			Perfluoroalkyl Acid Concentrations in Blood Samples Subjected to Transportation and Processing Delay	PLOS ONE			English	Article							NATIONAL BIRTH COHORT; PERFLUORINATED CHEMICALS; PERFLUOROOCTANOATE PFOA; PRENATAL EXPOSURES; FETAL-GROWTH; HUMAN SERUM; DURATION	Background In studies of perfluoroalkyl acids, the validity and comparability of measured concentrations may be affected by differences in the handling of biospecimens. We aimed to investigate whether measured plasma levels of perfluoroalkyl acids differed between blood samples subjected to delay and transportation prior to processing and samples with immediate processing and freezing. Methods Pregnant women recruited at Aarhus University Hospital, Denmark, (n = 88) provided paired blood samples. For each pair of samples, one was immediately processed and plasma was frozen, and the other was delayed and transported as whole blood before processing and freezing of plasma (similar to the Danish National Birth Cohort). We measured 12 perfluoroalkyl acids and present results for compounds with more than 50% of samples above the lower limit of quantification. Results For samples taken in the winter, relative differences between the paired samples ranged between -77 and +38% for individual perfluoroalkyl acids. In most cases concentrations were lower in the delayed and transported samples, e.g. the relative difference was -29% (95% confidence interval -30; -27) for perfluorooctane sulfonate. For perfluorooctanoate there was no difference between the two setups [corresponding estimate 1% (0, 3)]. Differences were negligible in the summer for all compounds. Conclusions Transport of blood samples and processing delay, similar to conditions applied in some large, population-based studies, may affect measured perfluoroalkyl acid concentrations, mainly when outdoor temperatures are low. Attention to processing conditions is needed in studies of perfluoroalkyl acid exposure in humans.	[Bach, Cathrine Carlsen; Henriksen, Tine Brink] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Bossi, Rossana] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Bech, Bodil Hammer; Olsen, Jorn] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Fuglsang, Jens] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Nohr, Ellen Aagaard] Univ Southern Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, Odense, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles; University of Southern Denmark	Bach, CC (corresponding author), Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark.	ccbach@clin.au.dk	Bech, Bodil Hammer/B-9646-2016; Fuglsang, Jens/AAJ-4724-2020	Bech, Bodil Hammer/0000-0002-0287-3687; Fuglsang, Jens/0000-0002-0181-1986; Henriksen, Tine Brink/0000-0001-6933-8294	Danish Council for Strategic Research [10-092818]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The work was supported by The Danish Council for Strategic Research (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research), grant number 10-092818, and is part of the Fetotox project (fetotox.au.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CS, 2013, AM J EPIDEMIOL, V178, P921, DOI 10.1093/aje/kwt057; Andersen CS, 2010, AM J EPIDEMIOL, V172, P1230, DOI 10.1093/aje/kwq289; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Bach CC, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0040-9; Berger U, 2011, ANAL BIOANAL CHEM, V400, P1625, DOI 10.1007/s00216-011-4823-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Environment Canada, ENV PERF AGR AGR RES; European Parliament, 2006, OFFICIAL J EU   1227, V27; Fei CY, 2008, AM J EPIDEMIOL, V168, P66, DOI 10.1093/aje/kwn095; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Fei CY, 2010, SCAND J WORK ENV HEA, V36, P413, DOI 10.5271/sjweh.2908; Fei CY, 2009, HUM REPROD, V24, P1200, DOI 10.1093/humrep/den490; Flaherty JM, 2005, J CHROMATOGR B, V819, P329, DOI 10.1016/j.jchromb.2005.03.002; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kantiani L, 2010, ANAL BIOANAL CHEM, V398, P2413, DOI 10.1007/s00216-010-3944-9; Kato K, 2013, CHEMOSPHERE, V91, P115, DOI 10.1016/j.chemosphere.2012.11.013; Keller JM, 2010, ANAL BIOANAL CHEM, V397, P439, DOI 10.1007/s00216-009-3222-x; Nilsson H, 2013, ENVIRON INT, V51, P8, DOI 10.1016/j.envint.2012.09.001; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Shoeib M, 2011, ENVIRON SCI TECHNOL, V45, P7999, DOI 10.1021/es103562v; Thomas L., 1998, CLIN LAB DIAGNOSTICS, V1; U.S. Environmental Protection Agency, 2010 2015 PFOA STEW; US EPA, EPA 3M ANN PHAS OUT; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018	29	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137768	10.1371/journal.pone.0137768	http://dx.doi.org/10.1371/journal.pone.0137768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356420	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800080
J	Georgianos, PI; Agarwal, R				Georgianos, Panagiotis I.; Agarwal, Rajiv			Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; ARTERIAL STIFFNESS; HYPERTROPHY; HYPERTENSION; REDUCTION; IMPACT; REGRESSION; ATENOLOL	This study aimed to explore the relative contribution of aortic stiffness and volume in treatment- induced change of left ventricular mass in dialysis. Hypertension in Hemodialysis Patients Treated with Atenolol or Lisinopril trial compared the effect of lisinopril versus atenolol in reducing left ventricular mass index; 179 patients with echo measurements of aortic pulse wave velocity and left ventricular mass at baseline were included. In unadjusted analysis, overall reductions of 26.24 g/m(2) (95% CI: -49.20, -3.29) and 35.67 g/m(2) (95% CI: -63.70, -7.64) in left ventricular mass index were noted from baseline to 6 and 12 months respectively. Volume control emerged as an important determinant of regression of left ventricular mass index due to the following reasons: (i) additional control for change in ambulatory systolic blood pressure mitigated the reduction in left ventricular mass index in the statistical model above [6-month visit: -18.6 g/m(2) (95% CI: -43.7, 6.5); 12-month visit: -22.1 g/m(2) (95% CI: -52.2, 8.0)] (ii) regression of left ventricular hypertrophy was primarily due to reduction in left ventricular chamber and not wall thickness and (iii) adjustment for inferior vena cava diameter (as a proxy for volume) removed the effect of time on left ventricular mass index reduction [6-month visit: -6.6 g/m(2) (95% CI: (-41.6, 28.4); 12-month visit: 0.6 g/m(2) (95% CI: -39.5, 40.7)]. In contrast, aortic pulse wave velocity was neither a determinant of baseline left ventricular mass index nor predictor of its reduction. Among dialysis patients, ambulatory systolic pressure, a proxy for volume expansion, but not aortic stiffness is more important predictor of reduction in left ventricular mass index. Improving blood pressure control via adequate volume management appears as an effective strategy to improve left ventricular hypertrophy in dialysis.	[Agarwal, Rajiv] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Agarwal, R (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	ragarwal@iu.edu	Georgianos, Panagiotis/H-7498-2019; Agarwal, Rajiv/H-3454-2019	Agarwal, Rajiv/0000-0001-8355-7100; Georgianos, Panagiotis/0000-0001-7065-2096	NIH [2R01-DK062030-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH 2R01-DK062030-10. The sponsors or funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2014, NEPHROL DIAL TRANSPL, V29, P672, DOI 10.1093/ndt/gft515; Agarwal R, 2011, AM J NEPHROL, V33, P373, DOI 10.1159/000326235; Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1066, DOI 10.2215/CJN.09321010; Agarwal Rajiv, J AM SOC NEPHROL; Bossola M, 2008, SEMIN DIALYSIS, V21, P422, DOI 10.1111/j.1525-139X.2008.00471.x; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Devereux RB, 2004, CIRCULATION, V110, P1456, DOI 10.1161/01.CIR.0000141573.44737.5A; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drighil A, 2008, EUR J ECHOCARDIOGR, V9, P530, DOI 10.1093/ejechocard/jen125; Hashimoto J, 2008, J HYPERTENS, V26, P1017, DOI 10.1097/HJH.0b013e3282f62a9b; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Kayikcioglu M, 2009, NEPHROL DIAL TRANSPL, V24, P956, DOI 10.1093/ndt/gfn599; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lehmann ED, 1997, LANCET S1, V350, pSI14; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; LEVY D, 1991, J CARDIOVASC PHARM, V17, pS1, DOI 10.1097/00005344-199117002-00002; LIEBSON PR, 1995, CIRCULATION, V91, P698, DOI 10.1161/01.CIR.91.3.698; London G, 2011, KIDNEY INT SUPPL, V1, P10, DOI 10.1038/kisup.2011.5; London GM, 1996, KIDNEY INT, V50, P600, DOI 10.1038/ki.1996.355; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Palmieri V, 2008, AM J HYPERTENS, V21, P701, DOI 10.1038/ajh.2008.162; Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221; Sinha AD, 2009, AM J KIDNEY DIS, V54, P788, DOI 10.1053/j.ajkd.2009.07.004; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768; Zoccali C, 2011, AM J NEPHROL, V33, P370, DOI 10.1159/000326239	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135457	10.1371/journal.pone.0135457	http://dx.doi.org/10.1371/journal.pone.0135457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356419	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800005
J	Mueller, NH; Fogueri, U; Pedler, MG; Montana, K; Petrash, JM; Ammar, DA				Mueller, Niklaus H.; Fogueri, Uma; Pedler, Michelle G.; Montana, Kameron; Petrash, J. Mark; Ammar, David A.			Impact of Subunit Composition on the Uptake of alpha-Crystallin by Lens and Retina	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; A-CRYSTALLIN; INDUCED APOPTOSIS; CHAPERONE; CELLS; ACTIVATION; CASPASE-3; EXCHANGE; TRANSLOCATION	Misfolded protein aggregation, including cataract, cause a significant amount of blindness worldwide. alpha-Crystallin is reported to bind misfolded proteins and prevent their aggregation. We hypothesize that supplementing retina and lens with alpha-crystallin may help to delay disease onset. The purpose of this study was to determine if alpha B-crystallin subunits containing a cell penetration peptide (gC-tagged alpha B-crystallin) facilitate the uptake of wild type alpha Acrystallin (WT-alpha A) in lens and retina. Recombinant human alpha B-crystallin was modified by the addition of a novel cell penetration peptide derived from the gC gene product of herpes simplex virus (gC-alpha B). Recombinant gC-alpha B and wild-type alpha A-crystallin (WT-alpha A) were purified from E. coli over-expression cultures. After Alexa-labeling of WT-alpha A, these proteins were mixed at ratios of 1:2, 1:5 and 1:10, respectively, and incubated at 37 degrees C for 4 hours to allow for subunit exchange. Mixed oligomers were subsequently incubated with tissue culture cells or mouse organ cultures. Similarly, crystallin mixtures were injected into the vitreous of rat eyes. At various times after exposure, tissues were harvested and analyzed for protein uptake by confocal microscopy or flow cytometry. Chaperone-like activity assays were performed on alpha-crystallins ratios showing optimal uptake using chemically-induced or heat induced substrate aggregation assays. As determined by flow cytometry, a ratio of 1:5 for gC-alpha B to WT-alpha A was found to be optimal for uptake into retinal pigmented epithelial cells (ARPE-19). Chaperone-like activity assays demonstrated that hetero-oligomeric complex of gC-alpha B to WT-alpha A (in 1:5 ratio) retained protein aggregation protection. We observed a significant increase in protein uptake when optimized (gC-alpha B to WT-alpha A (1:5 ratio)) hetero-oligomers were used in mouse lens and retinal organ cultures. Increased levels of alpha-crystallin were found in lens and retina following intravitreal injection of homo-and hetero-oligomers in rats.	[Mueller, Niklaus H.; Pedler, Michelle G.; Montana, Kameron; Petrash, J. Mark; Ammar, David A.] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO 80045 USA; [Fogueri, Uma; Petrash, J. Mark] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mueller, NH (corresponding author), Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO 80045 USA.	Niklaus.Mueller@ucdenver.edu		Ammar, David A./0000-0002-7848-7192; Mueller, Niklaus/0000-0002-3201-7742	National Eye Institute [RC1 EY020361]; National Center Research Resources [UL1 RR025780];  [P30CA046934];  [P30AR057212]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC1EY020361] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center Research Resources; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JMP received grant RC1 EY020361 from the National Eye Institute. Institutional core grant for the Advance Light Microscopy facility was award by National Center Research Resources to the University of Colorado Grant number UL1 RR025780. Flow Cytometry core funding was awarded to the University of Colorado Canter Center Grant P30CA046934 and Skin Diseases Research Core Grant P30AR057212 (http://www.nih.gov/).	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Bloemendal H, 1981, LENS PROTEINS MOL CE, P1; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brzezinski JAt, 2011, DEVELOPMENT, V138, P3519, DOI [10.1242/dev.064006, DOI 10.1242/DEV.064006]; CAMMARATA PR, 1986, TISSUE CELL, V18, P83, DOI 10.1016/0040-8166(86)90009-1; Christopher KL, 2014, BBA-MOL CELL RES, V1843, P309, DOI 10.1016/j.bbamcr.2013.11.010; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; Danysh BP, 2010, MATRIX BIOL, V29, P228, DOI 10.1016/j.matbio.2009.12.004; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GOPALAKRISHNAN S, 1992, INVEST OPHTH VIS SCI, V33, P2936; HORWITZ J, 1992, CURR EYE RES, V11, P817, DOI 10.3109/02713689209000754; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Johnson LN, 2010, VISION RES, V50, P686, DOI 10.1016/j.visres.2009.08.028; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kastner C, 2013, CURR EYE RES, V38, P1057, DOI 10.3109/02713683.2013.803288; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Liu BF, 2008, EXP EYE RES, V87, P515, DOI 10.1016/j.exer.2008.08.021; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Mueller NH, 2013, INVEST OPHTH VIS SCI, V54, P2, DOI 10.1167/iovs.12-10947; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; Nahomi RB, 2013, J BIOL CHEM, V288, P13022, DOI 10.1074/jbc.M112.440214; Nahomi RB, 2013, BBA-MOL BASIS DIS, V1832, P195, DOI 10.1016/j.bbadis.2012.08.015; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Puppala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031399; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137659	10.1371/journal.pone.0137659	http://dx.doi.org/10.1371/journal.pone.0137659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355842	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800075
J	McCarthy, K; Cai, LB; Xu, FR; Wang, PG; Xue, HL; Ye, YL; Xiong, SZ; Liu, ZM; He, QQ				McCarthy, Kayne; Cai, Long-biao; Xu, Fang-rong; Wang, Pei-gang; Xue, Hong-liang; Ye, Yong-ling; Xiong, Shang-zhi; Liu, Zhao-min; He, Qi-qiang			Urban-Rural Differences in Cardiovascular Disease Risk Factors: A Cross-Sectional Study of Schoolchildren in Wuhan, China	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; CHILDREN; PREVALENCE; ADOLESCENTS; OBESITY	Background China's rapid population growth and urban migration has developed healthcare inequity across the urban-rural divide. Past studies comparing cardiovascular disease (CVD) risk factor prevalence amongst urban-rural Chinese children are sparse and conflicting. We examined the association between urban-rural residence and risk of offspring CVD in Chinese children. Methods A cross-sectional study was conducted in Wuhan, China, during May and June 2010. CVD risk factors include; waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), triglycerides (TG), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, body mass index (BMI), cardiorespiratory fitness (CRF), metabolic syndrome (MetS), and metabolic risk score (MRS). Analysis of covariance and multivariable logistic regression were used to estimate associations between urban-rural residence and offspring CVD risks. Findings A total of 579 Chinese children (338 boys and 241 girls) aged 9.6 (0.7) years participated in this study. Rural boys had significantly lower CRF and higher FBG, TG, and MRS, while urban boys had significantly higher LDL and DBP. Rural girls had significantly higher BMI, FBG, and TG, as well as lower CRF. Rural children were at increased risks for decreased CRF, elevated MRS, and TG, (OR: 2.04, 95% CI: 1.29-3.25), (OR: 2.33, 95% CI: 1.50-3.62), and (OR: 2.40, 95% CI: 1.62-3.57), respectively. Rural girls and mothers were at increased risks for overweight(OR: 7.19, 95% CI: 1.64-31.6)/obesity (OR: 1.683, 95% CI: 1.01-2.82). However, rural boys and fathers were less likely to have overweight(OR: 0.62, 95% CI: 0.34-1.12)/obesity (OR:0.68, 95% CI:0.48-0.97). Conclusions Rural residence was significantly associated with increased CVD risks amongst Chinese children. It is important to provide interventions aiming at China's urban-rural healthcare inequity and community-based approaches that reduce familial CVD risk.	[McCarthy, Kayne; Cai, Long-biao; Xu, Fang-rong; Wang, Pei-gang; Xue, Hong-liang; Ye, Yong-ling; Xiong, Shang-zhi; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [McCarthy, Kayne] Univ Hawaii, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Liu, Zhao-min] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China	Wuhan University; University of Hawaii System; Chinese University of Hong Kong; Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	Liu, Zhaomin/L-8685-2019; He, Qiqiang/A-7990-2012; LIU, Zhao-min/ABA-4413-2021					Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2011, NATL BUREAU STAT CHI; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Chen YY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-34; Chillon P, 2011, J SCI MED SPORT, V14, P417, DOI 10.1016/j.jsams.2011.04.004; China Salt Substitute Study Collaborative Group, 2007, CHINA SALT SUBSTITUT, V25, P2011; Davis AM, 2011, J PEDIATR PSYCHOL, V36, P669, DOI 10.1093/jpepsy/jsq117; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; He FJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003388; Hejazi N, 2009, Pak J Biol Sci, V12, P730, DOI 10.3923/pjbs.2009.730.733; Hodgkin E, 2010, RURAL REMOTE HEALTH, V10; Hofhuis W, 2003, ARCH DIS CHILD, V88, P1086, DOI 10.1136/adc.88.12.1086; Hu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-686; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Kim ES, 2004, DIABETIC MED, V21, P1141, DOI 10.1111/j.1464-5491.2004.01398.x; Kriemler S, 2008, DIABETOLOGIA, V51, P1408, DOI 10.1007/s00125-008-1067-z; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Mahoney C, 1992, Br J Sports Med, V26, P45; McCarthy K, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140384; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Sung RYT, 2007, INT J OBESITY, V31, P550, DOI 10.1038/sj.ijo.0803452; Tanner JM, 1962, GROWTH ADOLESCENCE G; Wang L., 2005, COMPREHENSIVE REPORT, P21; Wang PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027896; Wang SQ, 2015, ASIA-PAC J PUBLIC HE, V27, pNP674, DOI 10.1177/1010539513496137; Weng X, 2007, PUBLIC HEALTH NUTR, V10, P131, DOI 10.1017/S1368980007226023; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xu S, 2014, BMC PUBLIC HEALTH, V14, P1; Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195; Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949; Zhan YQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-921; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	40	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137615	10.1371/journal.pone.0137615	http://dx.doi.org/10.1371/journal.pone.0137615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352586	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800102
J	Schwartzbaum, J; Seweryn, M; Holloman, C; Harris, R; Handelman, SK; Rempala, GA; Huang, RP; Burkholder, B; Brandemihl, A; Kallberg, H; Johannesen, TB; Ahlbom, A; Feychting, M; Grimsrud, TK				Schwartzbaum, Judith; Seweryn, Michal; Holloman, Christopher; Harris, Randall; Handelman, Samuel K.; Rempala, Grzegorz A.; Huang, Ruo-Pan; Burkholder, Brett; Brandemihl, Adam; Kallberg, Henrik; Johannesen, Tom Borge; Ahlbom, Anders; Feychting, Maria; Grimsrud, Tom K.			Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma	PLOS ONE			English	Article							IL-4 RECEPTOR-ALPHA; CELLS; GLIOBLASTOMA; BRAIN; PATHOGENESIS; EXPRESSION; MEMBRANE; PATHWAYS; ASTHMA; CANCER	Allergy is inversely related to glioma risk. To determine whether prediagnostic allergy-related serum proteins are associated with glioma, we conducted a nested case-control study of seven cytokines (IL4, IL13, IL5, IL6, IL10, IFNG, TGFB2), two soluble cytokine receptors (sIL4RA, sIL13RA2) and three allergy-related transcription factors (FOXP3, STAT3, STAT6) using serum specimens from the Janus Serum Bank Cohort in Oslo, Norway. Blood donors subsequently diagnosed with glioma (n = 487) were matched to controls (n = 487) on age and date of blood draw and sex. We first estimated individual effects of the 12 serum proteins and then interactions between IL4 and IL13 and their receptors using conditional logistic regression. We next tested equality of case-control inter-correlations among the 12 serum proteins. We found that TGFB2 is inversely related to glioblastoma (Odds Ratio (OR) = 0.87, 95% Confidence Interval (CI)) = 0.76, 0.98). In addition, <= 5 years before diagnosis, we observed associations between IL4 (OR = 0.82, 95% CI = 0.66, 1.01), sIL4RA (OR = 0.80, 95% CI = 0.65, 1.00), their interaction (OR = 1.06, 95% CI = 1.01, 1.12) and glioblastoma. This interaction was apparent > 20 years before diagnosis (IL4-sIL4RA OR = 1.20, 95% CI = 1.05, 1.37). Findings for glioma were similar. Case correlations were different from control correlations stratified on time before diagnosis. Five years or less before diagnosis, correlations among case serum proteins were weaker than were those among controls. Our findings suggest that IL4 and sIL4RA reduce glioma risk long before diagnosis and early gliomagenesis affects circulating immune function proteins.	[Schwartzbaum, Judith; Harris, Randall] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA; [Schwartzbaum, Judith; Harris, Randall] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Math Biosci Inst, Columbus, OH USA; [Seweryn, Michal] Univ Lodz, Dept Math, PL-90131 Lodz, Poland; [Holloman, Christopher] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Handelman, Samuel K.] Ohio State Univ, Wexner Med Ctr, Ctr Pharmacogenet, Columbus, OH 43210 USA; [Huang, Ruo-Pan; Burkholder, Brett] RayBiotech Inc, Norcross, GA USA; [Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Brandemihl, Adam] Buckeye Psychiat, Columbus, OH USA; [Kallberg, Henrik; Ahlbom, Anders; Feychting, Maria] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Johannesen, Tom Borge] Canc Registry Norway, Dept Registrat, Oslo, Norway; [Grimsrud, Tom K.] Canc Registry Norway, Dept Res, Oslo, Norway	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Lodz; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Karolinska Institutet; University of Oslo; University of Oslo	Schwartzbaum, J (corresponding author), Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA.	ja.schwartzbaum@gmail.com	Schwartzbaum, Judith/A-9022-2016; Grimsrud, Tom K/M-6345-2015; Rempala, Grzegorz/C-3576-2013	Schwartzbaum, Judith/0000-0002-1523-9941; Grimsrud, Tom K/0000-0003-0425-043X; Handelman, Samuel/0000-0001-6970-2172; Seweryn, Michal/0000-0002-9090-3435	National Cancer Institute, National Institutes of Health [R01CA122163]; RayBiotech, Inc; Buckeye Psychiatry; NATIONAL CANCER INSTITUTE [R01CA122163] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RayBiotech, Inc; Buckeye Psychiatry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: National Cancer Institute, National Institutes of Health (grant number R01CA122163) to JS. RayBiotech, Inc and Buckeye Psychiatry provided support in the form of salaries for authors (RayBiotech, Inc.: Ruo-Pan Huang, Brett Burkholder; Buckeye Psychiatry: Adam Brandemihl), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Bartee E, 2009, CYTOKINE, V47, P199, DOI 10.1016/j.cyto.2009.06.006; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Besedovsky HO, 2011, NEUROCHEM RES, V36, P1, DOI 10.1007/s11064-010-0252-x; *CBTRUS, 2011, CBTRUS STAT REP PRIM; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; Chen WG, 2009, J IMMUNOL, V183, P7870, DOI 10.4049/jimmunol.0901028; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Hau P, 2011, CURR PHARM BIOTECHNO, V12, P2150, DOI 10.2174/138920111798808347; Helgesson G, 2007, NAT BIOTECHNOL, V25, P973, DOI 10.1038/nbt0907-973b; Holtzman MJ, 2003, AM J RESP CELL MOL, V29, P163, DOI 10.1165/rcmb.F276; JELLUM E, 1995, ENVIRON HEALTH PERSP, V103, P85, DOI 10.2307/3432566; JELLUM E, 1993, SCI TOTAL ENVIRON, V140, P527, DOI 10.1016/0048-9697(93)90049-C; Koshy M, 2012, J NEURO-ONCOL, V107, P207, DOI 10.1007/s11060-011-0738-7; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Ksendzovsky A, 2010, OPEN IMMUNOLOGY J, V3, P30; Langseth H, 2009, JANUS SERUM BANK FRO; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; McFarland BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078728; Nestor CE, 2014, ALLERGY, V69, P1564, DOI 10.1111/all.12505; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Schwartzbaum J, 2012, J NATL CANCER I, V104, P1251, DOI 10.1093/jnci/djs315; Schwartzbaum JA, 2010, NEURO-ONCOLOGY, V12, P320, DOI 10.1093/neuonc/nop035; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Turrin NP, 2000, BRAIN RES BULL, V51, P3, DOI 10.1016/S0361-9230(99)00203-8; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Williams CMM, 2012, TOXICOL PATHOL, V40, P205, DOI 10.1177/0192623311430694; Wu Y, 2012, INTEGR BIOL-UK, V4, P1478, DOI 10.1039/c2ib20044a; Zhao HY, 2014, TUMOR BIOL, V35, P3875, DOI 10.1007/s13277-013-1514-4; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001; Zisakis A, 2007, CYTOKINE	41	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137503	10.1371/journal.pone.0137503	http://dx.doi.org/10.1371/journal.pone.0137503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352148	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800090
J	Stupica, D; Lusa, L; Maraspin, V; Bogovic, P; Vidmar, D; O'Rourke, M; Traweger, A; Livey, I; Strle, F				Stupica, Dasa; Lusa, Lara; Maraspin, Vera; Bogovic, Petra; Vidmar, Darja; O'Rourke, Maria; Traweger, Andreas; Livey, Ian; Strle, Franc			Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings	PLOS ONE			English	Article							EARLY LYME-DISEASE; DOUBLE-BLIND; DOXYCYCLINE; MANIFESTATIONS; AZITHROMYCIN; AMOXICILLIN; PENICILLIN; SYMPTOMS	Background Limited data are available regarding the relationship of Borrelia burden in skin of patients with erythema migrans (EM) and the disease course and post-treatment outcome. Methods We studied 121 adult patients with EM in whom skin biopsy specimens were cultured and analyzed by quantitative PCR for the presence of Borreliae. Evaluation of clinical and microbiological findings were conducted at the baseline visit, and 14 days, 2, 6, and 12 months after treatment with either amoxicillin or cefuroxime axetil. Results In 94/121 (77.7%) patients Borrelia was detected in skin samples by PCR testing and 65/118 (55.1%) patients had positive skin culture result (96.8% B. afzelii, 3.2% B. garinii). Borrelia culture and PCR results correlated significantly with the presence of central clearing and EM size, while Borrelia burden correlated significantly with central clearing, EM size, and presence of newly developed or worsened symptoms since EM onset, with no other known medical explanation (new or increased symptoms, NOIS). In addition, the logistic regression model for repeated measurements adjusted for time from inclusion, indicated higher Borrelia burden was a risk factor for incomplete response (defined as NOIS and/or persistence of EM beyond 14 days and/or occurrence of new objective signs of Lyme borreliosis). The estimated association between PCR positivity and unfavorable outcome was large but not statistically significant, while no corresponding relationship was observed for culture positivity. Conclusions Higher Borrelia burden in EM skin samples was associated with more frequent central clearing and larger EM lesions at presentation, and with a higher chance of incomplete response.	[Stupica, Dasa; Maraspin, Vera; Bogovic, Petra; Vidmar, Darja; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Lusa, Lara] Inst Biostat & Med Informat, Fac Med, Ljubljana, Slovenia; [O'Rourke, Maria; Traweger, Andreas; Livey, Ian] Vaccine R&D Baxter Innovat, A-2304 Orth, Austria	University Medical Centre Ljubljana; Baxter International Inc; Baxter Innovations GmbH	Stupica, D (corresponding author), Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia.	dasa.stupica@kclj.si	Traweger, Andreas/M-1460-2015; Lusa, Lara/C-6692-2015	Traweger, Andreas/0000-0002-0220-4766; Lusa, Lara/0000-0002-8981-2421	Baxter; Slovenian Research Agency [P3-0296]	Baxter; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The microbiological analyses were funded by Baxter. The clinical part of the study was supported by the Slovenian Research Agency (grant number P3-0296). Baxter provided support in the form of salaries for authors MOR, AT and IL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; O'Rourke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063968; R Core Team, 2020, R LANG ENV STAT COMP; Ruzic-Sabljic E, 2001, J MED MICROBIOL, V50, P896, DOI 10.1099/0022-1317-50-10-896; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2014, CLIN INFECT DIS, V58, P372, DOI 10.1093/cid/cit735; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; WEBER K, 1986, ZBL BAKT-INT J MED M, V263, P209; WEBER K, 1993, INFECTION, V21, P367, DOI 10.1007/BF01728915; WEBER K, 1990, INFECTION, V18, P91, DOI 10.1007/BF01641422; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005	25	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136600	10.1371/journal.pone.0136600	http://dx.doi.org/10.1371/journal.pone.0136600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352832	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800041
J	Cui, B; Cui, LY; Gao, J; Liu, MS; Li, XG; Liu, CY; Ma, JF; Fang, J				Cui, Bo; Cui, Liying; Gao, Jing; Liu, Mingsheng; Li, Xiaoguang; Liu, Caiyan; Ma, Junfang; Fang, Jia			Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							STRUCTURED INTERVIEW GUIDE; RATING-SCALE; DYSFUNCTION; PREVALENCE; DIAGNOSIS; CONSENSUS; CRITERIA	Background It has reached a consensus that patients with amyotrophic lateral sclerosis (ALS) could display cognitive impairment characterized by executive dysfunction or even dementia, but cognitive spectrum of Chinese patients with ALS still waits to be documented. Methods A total of 106 incident patients with sporadic ALS were enrolled and comprehensive neuropsychological tests covering memory, executive function, attention, language, and visuo-spatial function were administered to them. Neuropsychological performances of 76 age- and education-matched healthy controls were used for the purpose of classification and comparison. Results 106 patients were categorized into 4 subtypes: 84 (79.2%) ALS with normal cognition (ALS-NC), 12 (11.3%) ALS with executive cognitive impairment (ALS-ECI), 5 (4.7%) ALS with non-executive cognitive impairment (ALS-NECI), and 5 (4.7%) ALS with frontotemporal lobe degeneration (ALS-FTLD). Under the same criteria, 2 (2.6%) and 1 (1.3%) healthy controls were diagnosed as ECI and NECI, respectively. The proportion of ECI was significantly higher in non-demented ALS than that in healthy controls, but it was not for NECI. Patients with ALS-FTLD had significantly severer bulbar function and older age than those with ALS-NC. Conclusion Comorbid FTLD occurred in around 5% of Chinese sporadic ALS cases. Different genetic background and unique age distribution of Chinese ALS patients might be the reasons for the relatively low rate of comorbid FTLD. Cognitive dysfunction, predominant but not exclusive in executive area, was present in around 16% of non-demented ALS patients.	[Cui, Bo; Cui, Liying; Gao, Jing; Liu, Mingsheng; Li, Xiaoguang; Liu, Caiyan; Ma, Junfang; Fang, Jia] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Cui, Liying] Chinese Acad Med Sci, Ctr Neurosci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Cui, LY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	pumchcuily@sina.com			Sino-Germany Science Research Foundation [GZ876]	Sino-Germany Science Research Foundation	This work was supported by Sino-Germany Science Research Foundation (GZ876, http://www.sinogermanscience.org.cn): BC, LC, ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cui F, 2014, ACTA NEUROL SCAND, V130, P111, DOI 10.1111/ane.12240; Gao Fei, 2009, Zhonghua Nei Ke Za Zhi, V48, P31; Gao S, 2006, APHASIA, P439; Gong Y.X., 1989, MANUAL MODIFIED WECH, P19; Gong YX, 1982, WECHSLER ADULT INTEL, p[52, 45]; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Jiao B, 2014, NEUROBIOL AGING, V35, P936, DOI DOI 10.1016/J.NEUR0BI0LAGING.2013.10.001; Liu MS, 2014, ACTA NEUROL SCAND, V129, P163, DOI 10.1111/ane.12157; Lomen-Hoerth C, 2011, J MOL NEUROSCI, V45, P656, DOI 10.1007/s12031-011-9636-x; McCluskey L, 2014, J NEUROL SCI, V345, P118, DOI 10.1016/j.jns.2014.07.022; Moberg PJ, 2001, AM J GERIAT PSYCHIAT, V9, P35, DOI 10.1176/appi.ajgp.9.1.35; Montuschi A, 2015, J NEUROL NEUROSUR PS, V86, P168, DOI 10.1136/jnnp-2013-307223; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nubling GS, 2014, AMYOTROPH LAT SCL FR, V15, P174, DOI 10.3109/21678421.2013.868001; Oh SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087163; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Shear MK, 2001, DEPRESS ANXIETY, V13, P166, DOI 10.1002/da.1033.abs; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; [史丽丽 SHI Li-Li], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P701; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Wei QQ, 2015, AMYOTROPH LAT SCL FR, V16, P40, DOI 10.3109/21678421.2014.966311; Wei QQ, 2014, J NEUROL, V261, P2393, DOI 10.1007/s00415-014-7508-3; Woollacott IOC, 2014, ACTA NEUROPATHOL, V127, P319, DOI 10.1007/s00401-014-1253-7; Xu S, 1986, ACTA PSYCHOL SIN, V18, P100; Zou ZY, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.11.018; 孟超, 2004, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V30, P452	35	19	24	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137921	10.1371/journal.pone.0137921	http://dx.doi.org/10.1371/journal.pone.0137921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367133	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100178
J	Howard, JT; O'Nan, AT; Maltecca, C; Baynes, RE; Ashwell, MS				Howard, Jeremy T.; O'Nan, Audrey T.; Maltecca, Christian; Baynes, Ronald E.; Ashwell, Melissa S.			Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine	PLOS ONE			English	Article							PHARMACOGENOMICS; CYTOCHROME-P450; POLYMORPHISM; PHARMACOKINETICS; METABOLISM; DISCOVERY; GENOMICS; ANIMALS; CLONING; TRAITS	Characterizing the variability in transcript levels across breeds and sex in swine for genes that play a role in drug metabolism may shed light on breed and sex differences in drug metabolism. The objective of the study is to determine if there is heterogeneity between swine breeds and sex in transcript levels for genes previously shown to play a role in drug metabolism for animals administered flunixin meglumine or fenbendazole. Crossbred nursery female and castrated male pigs (n = 169) spread across 5 groups were utilized. Sires (n = 15) of the pigs were purebred Duroc, Landrace, Yorkshire or Hampshire boars mated to a common sow population. Animals were randomly placed into the following treatments: no drug (control), flunixin meglumine, or fenbendazole. One hour after the second dosing, animals were sacrificed and liver samples collected. Quantitative Real-Time PCR was used to measure liver gene expression of the following genes: SULT1A1, ABCB1, CYP1A2, CYP2E1, CYP3A22 and CYP3A29. The control animals were used to investigate baseline transcript level differences across breed and sex. Post drug administration transcript differences across breed and sex were investigated by comparing animals administered the drug to the controls. Contrasts to determine fold change were constructed from a model that included fixed and random effects within each drug. Significant (P-value <0.007) basal transcript differences were found across breeds for SULT1A1, CYP3A29 and CYP3A22. Across drugs, significant (P-value <0.0038) transcript differences existed between animals given a drug and controls across breeds and sex for ABCB1, PS and CYP1A2. Significant (P <0.0038) transcript differences across breeds were found for CYP2E1 and SULT1A1 for flunixin meglumine and fenbendazole, respectively. The current analysis found transcript level differences across swine breeds and sex for multiple genes, which provides greater insight into the relationship between flunixin meglumine and fenbendazole and known drug metabolizing genes.	[Howard, Jeremy T.; O'Nan, Audrey T.; Maltecca, Christian; Ashwell, Melissa S.] N Carolina State Univ, Coll Agr & Life Sci, Dept Anim Sci, Raleigh, NC 27695 USA; [Baynes, Ronald E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Ctr Chem Toxicol & Res Pharmacokinet, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Ashwell, MS (corresponding author), N Carolina State Univ, Coll Agr & Life Sci, Dept Anim Sci, Raleigh, NC 27695 USA.	msashwel@ncsu.edu		maltecca, christian/0000-0002-9996-4680; Ashwell, Melissa/0000-0003-1732-1022	North Carolina Biotechnology Center [2012-MRG-1108]; Food Animal Residue Avoidance Databank (USDA) [2013-41480-21002]	North Carolina Biotechnology Center; Food Animal Residue Avoidance Databank (USDA)	Funding provided by North Carolina Biotechnology Center (grant #2012-MRG-1108) and Food Animal Residue Avoidance Databank (USDA #2013-41480-21002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerheiligen SRB, 2010, CLIN PHARMACOL THER, V88, P135, DOI 10.1038/clpt.2010.81; Bender JM, 2006, J ANIM SCI, V84, P1331, DOI 10.2527/2006.8461331x; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Blowe CD, 2006, J ANIM BREED GENET, V123, P389, DOI 10.1111/j.1439-0388.2006.00620.x; Ernst CW, 2013, TRENDS GENET, V29, P215, DOI 10.1016/j.tig.2013.02.002; Evans DAP, 2001, DRUG METAB DISPOS, V29, P606; Evans WE, 2003, GUT, V52, pII10, DOI 10.1136/gut.52.suppl_2.ii10; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fink-Gremmels J, 2008, EUR J PHARMACOL, V585, P502, DOI 10.1016/j.ejphar.2008.03.013; Franke RM, 2010, CURR PHARM DESIGN, V16, P220, DOI 10.2174/138161210790112683; Fry RS, 2012, J ANIM SCI, V90, P3112, DOI 10.2527/jas.2011-4403; Gardner CR, 2012, TOXICOL SCI, V125, P607, DOI 10.1093/toxsci/kfr301; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Ho RH, 2008, GENOMICS, V17, P647; Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371; Howard JT, 2014, J VET PHARMACOL THER, V37, P531, DOI 10.1111/jvp.12128; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012; Konigsson K, 2003, ACTA VET SCAND, V44, P153, DOI 10.1186/1751-0147-44-153; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Lin ZH, 2004, MAMM GENOME, V15, P218, DOI 10.1007/s00335-002-2318-4; Martinez M, 2008, J VET PHARMACOL THER, V31, P285, DOI 10.1111/j.1365-2885.2008.00964.x; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Mealey KL, 2008, XENOBIOTICA, V38, P1305, DOI 10.1080/00498250802446146 ; Mealey KL, 2008, JAVMA-J AM VET MED A, V233, P921, DOI 10.2460/javma.233.6.921; MURRAY M, 1992, CHEM RES TOXICOL, V5, P60, DOI 10.1021/tx00025a010; Pacifici GM, 2004, INT J CLIN PHARM TH, V42, P488; Pairis-Garcia MD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-165; Petersen MB, 2000, AM J VET RES, V61, P573, DOI 10.2460/ajvr.2000.61.573; Sakuma T, 2004, DRUG METAB DISPOS, V32, P376, DOI 10.1124/dmd.32.4.376; Shang HT, 2013, GENE, V524, P261, DOI 10.1016/j.gene.2013.04.007; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; STEPHENS EA, 1994, PHARMACOGENETICS, V4, P185, DOI 10.1097/00008571-199408000-00002; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666	37	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137830	10.1371/journal.pone.0137830	http://dx.doi.org/10.1371/journal.pone.0137830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366864	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100148
J	Su, CH; Chen, JH; Lan, JL; Wang, YC; Tseng, CH; Hsu, CY; Huang, LC				Su, Chia-Hsien; Chen, Jiunn-Horng; Lan, Joung-Liang; Wang, Yu-Chiao; Tseng, Chun-Hung; Hsu, Chung-Yi; Huang, Lichi			Increased Risk of Coronary Heart Disease in Patients with Primary Fibromyalgia and Those with Concomitant Comorbidity-A Taiwanese Population-Based Cohort Study	PLOS ONE			English	Article							2010 CLASSIFICATION CRITERIA; CHRONIC WIDESPREAD PAIN; OF-RHEUMATOLOGY 1990; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; SYMPTOM SEVERITY; PREVALENCE; DEPRESSION; DISORDER; EPIDEMIOLOGY	Objectives Fibromyalgia has seldom been associated with coronary heart disease (CHD). The aim of this study was to evaluate the risk of CHD in patients with fibromyalgia. Methods We used a dataset of one million participants, systemically scrambled from the Taiwanese national insurance beneficiaries, to identify 61,612 patients with incident fibromyalgia (ICD-9-CM 729.0-729.1) and 184,834 reference subjects matched by sex, age and index date of diagnosis in a 1: 3 ratio from 2000 to 2005, with a mean 8.86 +/- 2.68 years of follow-up until 2011. Risk of CHD was analyzed by Cox proportional hazard modeling. Results Patients with fibromyalgia had a mean age of 44.1 +/- 16.5 years. CHD events developed in fibromyalgia patients (n = 8,280; 15.2 per 103 person-years) and reference subjects (n = 15,162; 9.26 per 103 person-years) with a significant incidence rate ratio of 1.64 (95% confidence interval: 1.61-1.68). The adjusted hazard ratio for CHD in fibromyalgia patients relative to reference subjects was 1.47 (1.43-1.51), after adjusting for age, gender, occupation, monthly income, traditional cardiovascular comorbidities, depression and anxiety. We noted that fibromyalgia and cardiovascular comorbidities had a significant interaction effect on CHD risk (p for interaction < 0.01), which was markedly enhanced in fibromyalgia patients with concomitant comorbidities relative to patients with primary fibromyalgia and reference subjects (no fibromyalgia, no comorbidity). Conclusions Our report shows that fibromyalgia patients have an independent risk for CHD development. Fibromyalgia patients with concomitant comorbidities have markedly increased CHD risk relative to those with primary fibromyalgia.	[Su, Chia-Hsien] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Su, Chia-Hsien] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Chen, Jiunn-Horng; Lan, Joung-Liang; Wang, Yu-Chiao; Tseng, Chun-Hung; Hsu, Chung-Yi] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Jiunn-Horng; Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Dept Internal Med, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Hsu, Chung-Yi] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Huang, Lichi] China Med Univ, Sch Nursing, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Chen, JH (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	d91842001@ntu.edu.tw		Hsu, Chung Y./0000-0002-5632-2733	Department of Health, Executive Yuan, Taiwan [DOH 97-HP-1101, NSC97-2314-B-039-010-MY3, NSC100-2314-B-039-012, NSC101-2314-B-039-020, MOST103-2314-B-039-020]; China Medical University Hospital [1MS1, DMR-97-059, DMR-101-010, DMR-102-012]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Fund	Department of Health, Executive Yuan, Taiwan; China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Fund	This study was funded, in part, by the Department of Health, Executive Yuan, Taiwan (Grant DOH 97-HP-1101, 2008, Grant NSC97-2314-B-039-010-MY3, Grant NSC100-2314-B-039-012, Grant NSC101-2314-B-039-020, Grant MOST103-2314-B-039-020); China Medical University Hospital (Grant 1MS1, Grant DMR-97-059, Grant DMR-101-010, Grant DMR-102-012); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (Grant MOHW104-TDU-B-212-113002); Academia Sinica Taiwan Biobank, Stroke Biosignature Project (Grant BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Fund. None of the funders played a role in conducting the research.	Ablin Jacob N, 2009, Clin Cardiol, V32, pE7, DOI 10.1002/clc.20308; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Bureau of Health Promotion T, 2012, TAIW TOB CONTR ANN R; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Cao HJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/362831; Chen JH, 2008, MIDTAIWAN J MED, V13, P136; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho Kyoung Im, 2010, Korean Circ J, V40, P74, DOI 10.4070/kcj.2010.40.2.74; Clark P, 1998, J RHEUMATOL, V25, P2009; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; DELUZE C, 1992, BRIT MED J, V305, P1249, DOI 10.1136/bmj.305.6864.1249; Ding F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116441; Eisenlohr-Moul TA, 2015, J PAIN, V16, P247, DOI 10.1016/j.jpain.2014.12.005; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Golomb BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003208; Horvei LD, 2014, EUR J EPIDEMIOL, V29, P821, DOI 10.1007/s10654-014-9950-z; Huang CJ, 2013, INT J CARDIOL, V168, P4711, DOI 10.1016/j.ijcard.2013.07.173; Iannuccelli C, 2012, CLIN EXP RHEUMATOL, V30, pS112; Imbierowicz K, 2003, EUR J PAIN, V7, P113, DOI 10.1016/S1090-3801(02)00072-1; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kim C, 2012, RHEUMATOL INT, V32, P3435, DOI 10.1007/s00296-011-2195-1; Kim SC, 2013, ARTHRIT CARE RES, V65, P1813, DOI 10.1002/acr.22071; KRISHNAN KRR, 1985, PAIN, V22, P289, DOI 10.1016/0304-3959(85)90029-6; Lee CTC, 2013, ADDICT BEHAV, V38, P2619, DOI 10.1016/j.addbeh.2013.03.003; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; Martinez-Lavin M, 1998, ARTHRITIS RHEUM-US, V41, P1966, DOI 10.1002/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O; Martinez-Martinez LA, 2014, JCR-J CLIN RHEUMATOL, V20, P146, DOI 10.1097/RHU.0000000000000089; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Solano C, 2009, JCR-J CLIN RHEUMATOL, V15, P172, DOI 10.1097/RHU.0b013e3181a1083d; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P1378, DOI 10.1002/art.21887; Springer KW, 2003, J GEN INTERN MED, V18, P864, DOI 10.1046/j.1525-1497.2003.20918.x; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Tietjen GE, 2007, HEADACHE, V47, P857, DOI 10.1111/j.1526-4610.2007.00814.x; Toda K, 2007, SCAND J RHEUMATOL, V36, P140, DOI 10.1080/03009740600907949; Tsai PS, 2015, REGION ANESTH PAIN M, V40, P37, DOI 10.1097/AAP.0000000000000190; Vargas-Alarcon G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2316; Vincent A, 2013, ARTHRIT CARE RES, V65, P786, DOI 10.1002/acr.21896; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	46	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137137	10.1371/journal.pone.0137137	http://dx.doi.org/10.1371/journal.pone.0137137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366998	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100051
J	Joshi, L; Ponnana, M; Sivangala, R; Chelluri, LK; Nallari, P; Penmetsa, S; Valluri, V; Gaddam, S				Joshi, Lavanya; Ponnana, Meenakshi; Sivangala, Ramya; Chelluri, Lakshmi Kiran; Nallari, Prathiba; Penmetsa, Sitaramaraju; Valluri, Vijayalakshmi; Gaddam, Sumanlatha			Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DIAGNOSIS; RESPONSES; ANTIGENS; PATTERNS; GAMMA	Background Household contacts of diagnostically established tuberculosis (TB) patients are highly susceptible to disease development. It is surmised that cytokines perhaps play a synergistic and a prognostic role in the activation of the otherwise latent infection in these house hold contacts. Evaluation of the cytokines and any of their inherent polymorphisms might provide a useful diagnostic tool in evaluating the immune regulation and the progression of the disease. The cytokines thus released in a paracrine manner in serum may also provide an indirect measure of the cytokine function. Objective The present study was aimed to evaluate the levels of TNF-alpha, IL-10 & IL-6 cytokines and their correlation with genotype variants amongst tuberculosis patients and their household contacts. Methods The cytokine levels were estimated in serum by enzyme-linked immunosorbent assay (ELISA) and their polymorphisms were studied by amplification refractory mutation system polymerase chain reaction (ARMs PCR) in active pulmonary tuberculosis patients (APTB = 150), household contacts (HHC = 190), and healthy controls (HC = 150). Results The median values of TNF-a cytokine were significantly high among APTB and HHC compared to HCs (P<0.0001 and 0.0001). IL-6 levels also were elevated among APTB compared to HHC and HC, and a significant difference was observed between APTB and HHC at P<0.0001; APTB & HC at P<0.04; HHC & HC at P<0.01. The IL-10 levels were low in APTB compared to HHC and HCs and no significant difference was observed. TNF-alpha/IL-10 ratio was significant and indicated Th1 predominance in APTB and HHC. IL-6/IL-10 showed pronounced Th1 expression in APTB and Th2 in HHC and HC. The ROC analysis indicated that both IL-10 and IL-6 can be used to decide the risk of exposed individual to a disease. The results of multivariate analysis indicate that IL-10 (-1082) GA genotype was significantly associated with p<0.028 in APTB. No significant association was observed between genotypes, other serum cytokine levels and clinical characteristics between APTB, HHC and HCs. Conclusion Large sample size with follow-up at different time points may further illuminate the role of IL-10 and IL-6 cytokines as a prognostic marker in house hold contacts.	[Joshi, Lavanya; Ponnana, Meenakshi; Sivangala, Ramya; Penmetsa, Sitaramaraju; Gaddam, Sumanlatha] Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India; [Chelluri, Lakshmi Kiran] Global Hosp, Dept Transplant Biol & Stem Cell, Hyderabad, Andhra Pradesh, India; [Nallari, Prathiba; Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Valluri, Vijayalakshmi] Blue Peter Publ Hlth & Res Ctr, LEPRA India, Hyderabad, Andhra Pradesh, India	Osmania University	Gaddam, S (corresponding author), Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India.	sumanlathag@yahoo.com	Valluri, Vijaya Lakshmi/S-9219-2019		DBT-RGYI [102/IFD/PR/2029/2007-2008]; Department of Biotechnology (DBT) [BT/01/COE/07/02]	DBT-RGYI; Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	Financial support was provided by DBT-RGYI (rapid grants for young investigator) (Sanction no: 102/IFD/PR/2029/2007-2008 dated 18/01/2008); Department of Biotechnology (DBT), Sanction order no: BT/01/COE/07/02, dated 30/12/08, (COE-Center of excellence).	Abhimanyu, 2011, INFECT GENET EVOL, V11, P1015, DOI 10.1016/j.meegid.2011.03.017; Franceschi DSA, 2009, INT J INFECT DIS, V13, P493, DOI 10.1016/j.ijid.2008.08.019; Amanda M, 2009, INFLAMM ALLERGY DRUG, V8, P53; Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Biketov S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-146; Catriona HT, 2009, ANN NY ACAD SCI, V1182, P69, DOI [10.1111/j.1749-6632.2009.05069.x, DOI 10.1111/J.1749-6632.2009.05069.X]; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Ellertsen LK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-100; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Kart L, 2003, MEDIAT INFLAMM, V12, P9, DOI 10.1080/0962935031000096926; Karyadi E, 2007, ASIA PAC J CLIN NUTR, V16, P218; Kawaguchi H, 1996, Kekkaku, V71, P259; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Nakaya M, 1995, Kekkaku, V70, P461; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Salmaggi A, 1996, J NEUROL, V243, P13; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; Shu CC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-45; Tang S, 2013, PLOS ONE, V8; Tang Shenjie, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P325; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; WHO, GLOB TUB CONTR 2011	32	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137727	10.1371/journal.pone.0137727	http://dx.doi.org/10.1371/journal.pone.0137727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359865	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100076
J	Quan, LN; Chen, X; Liu, AC; Zhang, Y; Guo, XC; Yan, SJ; Liu, Y				Quan, Lina; Chen, Xue; Liu, Aichun; Zhang, Yan; Guo, Xiuchen; Yan, Shujie; Liu, Yue			PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; HPV-ASSOCIATED HEAD; DEATH-LIGAND 1; FOLLICULAR LYMPHOMA; PROGRAMMED DEATH-1; REGULATORY T; HEPATOCELLULAR-CARCINOMA; HODGKINS-LYMPHOMA; HIGH NUMBERS; IFN-GAMMA	Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is an aggressive malignancy that is largely resistant to current therapeutic regimens, and is an attractive target for immune-based therapies. Anti-programmed death-1 (PD-1) antibodies showed encouraging anti-tumor effects in both preclinical models and advanced solid and hematological malignancies, but its efficacy against EBV+DLBCL is unknown. Herein, we performed experiments using co-culture system with T cells and lymphoma cell lines including EBV+DLBCL and EBV-DLBCL [including germinal center B-cell like (GCB)-DLBCL and non-GCB-DLBCL] in vitro. We show that lymphoma cells augmented the expression of PD-1 on T cells, decreased the proliferation of T cells, and altered the secretion of multiple cytokines. However, through PD-1 blockade, these functions could be largely restored. Notbaly, the effect of PD-1 blockade on antitumor immunity was more effective in EBV+DLBCL than that in EBV-DLBCL in vitro. These results suggest that T-cell exhaustion and immune escape in microenvironment is one of the mechanisms underlying DLBCL; and PD-1 blockade could present as a efficacious immunotherapeutic treatment for EBV+DLBCL.	[Quan, Lina; Chen, Xue; Liu, Aichun; Guo, Xiuchen; Yan, Shujie; Liu, Yue] Harbin Med Univ, Canc Hosp, Dept Hematol, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Yan] Harbin Med Univ, Canc Hosp, Dept Radiotherapy, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liu, AC (corresponding author), Harbin Med Univ, Canc Hosp, Dept Hematol, Harbin, Heilongjiang Pr, Peoples R China.	aichun2002@hotmail.com	Liu, Yue/AAU-3811-2021	Quan, Lina/0000-0001-8995-7156	Harbin Medical University Cancer Hospital [JJZD2014-08]	Harbin Medical University Cancer Hospital	This research is funded by Harbin Medical University Cancer Hospital (award number JJZD2014-08).	Andorsky DJ, 2011, CLIN CANCER RES, V17, P4232, DOI 10.1158/1078-0432.CCR-10-2660; Ansell SM, 2009, CLIN CANCER RES, V15, P6446, DOI 10.1158/1078-0432.CCR-09-1339; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Badoual C, 2013, CANCER RES, V73, P128, DOI 10.1158/0008-5472.CAN-12-2606; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bryan LJ, 2015, BLOOD REV, V29, P25, DOI 10.1016/j.blre.2014.09.004; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; HAMILTONDUTOIT SJ, 1993, AM J PATHOL, V143, P1072; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Houot R, 2009, BLOOD, V113, P3546, DOI 10.1182/blood-2008-07-170274; Hui-Yuen J, 2011, JOVE-J VIS EXP, P8; IARC, 2008, WHO CLASSIFICATION T, V2; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Lu CH, 2014, JPN J CLIN ONCOL, V44, P1164, DOI 10.1093/jjco/hyu155; Lyford-Pike S, 2013, CANCER RES, V73, P1733, DOI 10.1158/0008-5472.CAN-12-2384; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Muenst S, 2009, HUM PATHOL, V40, P1715, DOI 10.1016/j.humpath.2009.03.025; Ok CY, 2013, BLOOD, V122, P328, DOI 10.1182/blood-2013-03-489708; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parish CR, 2010, JOVE-J VIS EXP, P12; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Wang BJ, 2011, WORLD J GASTROENTERO, V17, P3322, DOI 10.3748/wjg.v17.i28.3322; Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821	48	43	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136476	10.1371/journal.pone.0136476	http://dx.doi.org/10.1371/journal.pone.0136476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361042	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100011
J	Tomita, M; Kikuchi, E; Maeda, T; Kabeya, Y; Katsuki, T; Oikawa, Y; Kato, K; Ohashi, M; Nakamura, S; Oya, M; Shimada, A				Tomita, Masuomi; Kikuchi, Eiji; Maeda, Takahiro; Kabeya, Yusuke; Katsuki, Takeshi; Oikawa, Yoichi; Kato, Kiyoe; Ohashi, Masakazu; Nakamura, So; Oya, Mototsugu; Shimada, Akira			Clinical Background of Patients with Sperm in Their Urinary Sediment	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; RETROGRADE EJACULATION; SEXUAL DYSFUNCTION; SEMINAL EMISSION; DOUBLE-BLIND; MEN; ANEJACULATION; SILODOSIN	Introduction The detection rate and associated factors of at least one sperm in urinary sediment is not well-known in real clinical practice. Aims The aim of the present study was to evaluate the clinical features associated with the presence of sperm in urinary sediment in a large number of samples. Methods We conducted a cross-sectional study at Tokyo Saiseikai Central Hospital. We identified 5,005 males who were aged >= 20 years in whom urinary sedimentation had been performed at least twice between May 2011 and June 2012. The sperm group included patients in whom at least one urinary sediment test performed under a microscope had detected at least one sperm. We evaluated the associations between the presence of at least one sperm in urinary sediment and clinical parameters such as various diseases and the use of particular oral medicines. Main Outcomes In total, 1.6% (339/20,937) of urinary sediment samples contained at least one sperm. The sperm group consisted of 282 subjects (5.6%), and the no-sperm group included 4,723 subjects (94.3%). Results Multivariate analysis demonstrated that younger age (< 65) (odds ratio [OR]: 1.71, 95% confidence interval [CI]: 1.32-2.21), the total number of examinations (>= 4) (OR: 1.46, 95% CI: 1.11-1.92), diabetes (OR: 1.72, 95% CI: 1.31-2.25), a history of pelvic surgery for colon cancer (OR: 4.89, 95% CI: 2.38-10.02), alpha-1 blocker use (OR: 1.55, 95% CI: 1.16-2.08), a history of trans-urethral resection of the prostate (OR: 2.77, 95% CI: 1.46-5.13), and selective serotonin reuptake inhibitor use (OR: 2.12, 95% CI: 1.07-4.19) were independent predictors of the presence of at least one sperm in urinary sediment. Conclusion There is considerable overlap between the factors associated with the presence of at least one sperm in urinary sediment and those that are strongly associated with ejaculatory disorders.	[Tomita, Masuomi; Kabeya, Yusuke; Katsuki, Takeshi; Oikawa, Yoichi; Kato, Kiyoe; Shimada, Akira] Tokyo Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Kikuchi, Eiji; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Maeda, Takahiro; Nakamura, So] Tokyo Saiseikai Cent Hosp, Dept Urol, Tokyo, Japan; [Ohashi, Masakazu] Ogikubo Hosp, Dept Urol, Tokyo, Japan	Tokyo Saiseikai Central Hospital; Keio University; Tokyo Saiseikai Central Hospital	Kikuchi, E (corresponding author), 35 Shinano Machi,Shinjuku Ku, Tokyo, Japan.	eiji-k@kb3.so-net.ne.jp		Kikuchi, Eiji/0000-0002-1624-6676				Ariagno JI, 2005, ARCH ANDROLOGY, V51, P431, DOI 10.1080/014850190953294; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; Colpi G, 2004, EUR UROL, V46, P555, DOI 10.1016/j.eururo.2004.07.020; Ebiko M, 2006, JAPANESE J IMPOTENCE, P221; Examinaton of Urinary Sediment, 2010, GP1P4 JCCLS JAP ASS; Fedder J, 2013, ANDROLOGY-US, V1, P602, DOI 10.1111/j.2047-2927.2013.00083.x; Fode M, 2012, ASIAN J ANDROL, V14, P61, DOI 10.1038/aja.2011.70; Grimes DA, 2015, HUM REPROD, V30, P1749, DOI 10.1093/humrep/dev151; Hisasue S, 2006, INT J UROL, V13, P1311, DOI 10.1111/j.1442-2042.2006.01535.x; Jefferys A, 2012, FERTIL STERIL, V97, P306, DOI 10.1016/j.fertnstert.2011.11.019; Kawabe K, 2006, BJU INT, V98, P1019, DOI 10.1111/j.1464-410X.2006.06448.x; Kobayashi K, 2008, J SEX MED, V5, P2185, DOI 10.1111/j.1743-6109.2008.00779.x; Isidro ML, 2012, POSTGRAD MED J, V88, P152, DOI 10.1136/postgradmedj-2011-130069; Madersbacher S, 1999, BJU INT, V83, P227; Marks LS, 2009, J UROLOGY, V181, P2634, DOI 10.1016/j.juro.2009.02.034; Ohl DA, 2008, UROL CLIN N AM, V35, P211, DOI 10.1016/j.ucl.2008.01.014; Rosen RC, 2007, UROLOGY, V69, P805, DOI 10.1016/j.urology.2007.02.036; Schmidt HM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003546.pub3; Schulman CC, 2003, UROLOGY, V62, P24, DOI 10.1016/S0090-4295(03)00471-0; Sivananthan T, 2012, ASIAN J ANDROL, V14, P476, DOI 10.1038/aja.2012.2; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Yee CLS, 2012, UROL INT, V88, P165, DOI 10.1159/000333046	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136844	10.1371/journal.pone.0136844	http://dx.doi.org/10.1371/journal.pone.0136844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359862	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100016
J	Dreissig, S; Fuchs, J; Capal, P; Kettles, N; Byrne, E; Houben, A				Dreissig, Steven; Fuchs, Joerg; Capal, Petr; Kettles, Nicola; Byrne, Ed; Houben, Andreas			Measuring Meiotic Crossovers via Multi-Locus Genotyping of Single Pollen Grains in Barley	PLOS ONE			English	Article							RECOMBINATION LANDSCAPE	The detection of meiotic crossovers in crop plants currently relies on scoring DNA markers in a segregating population or cytological visualization. We investigated the feasibility of using flow-sorted haploid nuclei, Phi29 DNA polymerase-based whole-genome-amplification (WGA) and multi-locus KASP-genotyping to measure meiotic crossovers in individual barley pollen grains. To demonstrate the proof of concept, we used 24 gene-based physically mapped single nucleotide polymorphisms to genotype the WGA products of 50 single pollen nuclei. The number of crossovers per chromosome, recombination frequencies along chromosome 3H and segregation distortion were analysed and compared to a doubled haploid (DH) population of the same genotype. The number of crossovers and chromosome wide recombination frequencies show that this approach is able to produce results that resemble those obtained from other methods in a biologically meaningful way. Only the segregation distortion was found to be lower in the pollen population than in DH plants.	[Dreissig, Steven; Fuchs, Joerg; Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland, Germany; [Capal, Petr] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic; [Kettles, Nicola; Byrne, Ed] KWS UK Ltd, Thriplow SG8 7RE, Herts, England	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Houben, A (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Stadt Seeland, Germany.	houben@ipk-gatersleben.de	Houben, Andreas/I-1517-2015	Dreissig, Steven/0000-0002-4766-9698; Fuchs, Joerg/0000-0003-4171-5371; Houben, Andreas/0000-0003-3419-239X	IPK; Ministry of Education, Youth and Sports of the Czech Republic [LO1204]	IPK; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the IPK, P. Capal was supported by the Ministry of Education, Youth and Sports of the Czech Republic (grant LO1204 from the National Program of Sustainability I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz AN, 2008, MOL BREEDING, V21, P227, DOI 10.1007/s11032-007-9123-9; Baker K, 2014, PLANT J, V79, P981, DOI 10.1111/tpj.12600; Chen PH, 2008, J INTEGR PLANT BIOL, V50, P375, DOI 10.1111/j.1744-7909.2007.00624.x; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Copenhaver GP, 2000, PLANT PHYSIOL, V124, P7, DOI 10.1104/pp.124.1.7; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Higgins JD, 2012, PLANT CELL, V24, P4096, DOI 10.1105/tpc.112.102483; Kunzel G, 2000, GENETICS, V154, P397; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Petersen G, 1996, PLANT MOL BIOL, V31, P189, DOI 10.1007/BF00020620; Phillips D, 2013, J EXP BOT, V64, P2139, DOI 10.1093/jxb/ert079; Salome PA, 2012, HEREDITY, V108, P447, DOI 10.1038/hdy.2011.95; Sayed H, 2002, EUPHYTICA, V125, P265, DOI 10.1023/A:1015861610226; SYBENGA J, 1966, GENETICA, V37, P199, DOI 10.1007/BF01547131; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	22	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137677	10.1371/journal.pone.0137677	http://dx.doi.org/10.1371/journal.pone.0137677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356084	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800077
J	King, TL; Thornton, LE; Bentley, RJ; Kavanagh, AM				King, Tania L.; Thornton, Lukar E.; Bentley, Rebecca J.; Kavanagh, Anne M.			The Use of Kernel Density Estimation to Examine Associations between Neighborhood Destination Intensity and Walking and Physical Activity	PLOS ONE			English	Article							BODY-MASS INDEX; BUILT ENVIRONMENT; FOOD; BEHAVIOR; ACCESS; GIS; MULTILEVEL; MELBOURNE; PROXIMITY; TRANSPORT	Background Local destinations have previously been shown to be associated with higher levels of both physical activity and walking, but little is known about how the distribution of destinations is related to activity. Kernel density estimation is a spatial analysis technique that accounts for the location of features relative to each other. Using kernel density estimation, this study sought to investigate whether individuals who live near destinations (shops and service facilities) that are more intensely distributed rather than dispersed: 1) have higher odds of being sufficiently active; 2) engage in more frequent walking for transport and recreation. Methods The sample consisted of 2349 residents of 50 urban areas in metropolitan Melbourne, Australia. Destinations within these areas were geocoded and kernel density estimates of destination intensity were created using kernels of 400m (meters), 800m and 1200m. Using multilevel logistic regression, the association between destination intensity (classified in quintiles Q1(least)-Q5(most)) and likelihood of: 1) being sufficiently active (compared to insufficiently active); 2) walking >= 4/week (at least 4 times per week, compared to walking less), was estimated in models that were adjusted for potential confounders. Results For all kernel distances, there was a significantly greater likelihood of walking >= 4/week, among respondents living in areas of greatest destinations intensity compared to areas with least destination intensity: 400m (Q4 OR 1.41 95% CI 1.02-1.96; Q5 OR 1.49 95% CI 1.06-2.09), 800m (Q4 OR 1.55, 95% CI 1.09-2.21; Q5, OR 1.71, 95% CI 1.18-2.48) and 1200m (Q4, OR 1.7, 95% CI 1.18-2.45; Q5, OR 1.86 95% CI 1.28-2.71). There was also evidence of associations between destination intensity and sufficient physical activity, however these associations were markedly attenuated when walking was included in the models. Conclusions This study, conducted within urban Melbourne, found that those who lived in areas of greater destination intensity walked more frequently, and showed higher odds of being sufficiently physically active-an effect that was largely explained by levels of walking. The results suggest that increasing the intensity of destinations in areas where they are more dispersed; and or planning neighborhoods with greater destination intensity, may increase residents' likelihood of being sufficiently active for health.	[King, Tania L.; Bentley, Rebecca J.; Kavanagh, Anne M.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Hlth Equ, Gender & Womens Hlth, Melbourne, Vic, Australia; [Thornton, Lukar E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic, Australia	University of Melbourne; Deakin University	King, TL (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Hlth Equ, Gender & Womens Hlth, Melbourne, Vic, Australia.	tking@unimelb.edu.au	Kavenagh, Mellissa/S-7899-2018; Kavanagh, Anne/U-4826-2019; Thornton, Lukar E/C-9554-2014	King, Tania/0000-0002-1201-2485; Thornton, Lukar/0000-0001-8759-8671; Bentley, Rebecca/0000-0003-3334-7353; Kavanagh, Anne/0000-0002-1573-3464	Victorian Health Promotion Foundation PhD scholarship	Victorian Health Promotion Foundation PhD scholarship	TLK was supported by a Victorian Health Promotion Foundation PhD scholarship. The VicLANES project was funded by the Victorian Health Promotion Foundation.	Armstrong T, 2000, RESULTS 1999 NATL PH; Australian Bureau of Statistics, 2011, NAT HLTH SURV SUMM R; Australian Bureau of Statistics, 2014, AUSTR SOC TRENDS JUL; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; Australian Electoral Commission, 2005, MEAS ACC EL ROLLS TE; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Bader MDM, 2010, ECON GEOGR, V86, P409, DOI 10.1111/j.1944-8287.2010.01084.x; Bauman A F, 2001, TRENDS POPULATION LE; Buck C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-65; Centers for Disease Control and Prevention, 1996, PHYS ACT HLTH REP SU; Chaix B, 2009, SOC SCI MED, V69, P1306, DOI 10.1016/j.socscimed.2009.07.018; Charreire H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-59; Department of Health, 2004, LEAST 5 WEEK EV IMP; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 1; Frank L., 2003, HLTH COMMUNITY DESIG; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Halldin M, 2007, NUTR METAB CARDIOVAS, V17, P349, DOI 10.1016/j.numecd.2006.01.002; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Hoehner CM, 2005, AM J PREV MED, P28; Jones-Smith JC, 2013, DIABETES CARE, V36, P2697, DOI 10.2337/dc12-2190; Kavanagh AM, 2005, J EPIDEMIOL COMMUN H, V59, P934, DOI 10.1136/jech.2005.035931; Kavanagh AM, 2011, ADDICTION, V106, P1772, DOI 10.1111/j.1360-0443.2011.03510.x; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kloog I, 2009, COMPUT ENVIRON URBAN, V33, P55, DOI 10.1016/j.compenvurbsys.2008.09.006; Krizek KJ, 2006, J AM PLANN ASSOC, V72, P33, DOI 10.1080/01944360608976722; Lee C, 2006, TRANSPORT RES D-TR E, V11, P204, DOI 10.1016/j.trd.2006.02.003; Maroko AR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-34; Mbalilaki JA, 2007, NUTR METAB CARDIOVAS, V17, P344, DOI 10.1016/j.numecd.2006.03.003; McConville ME, 2011, AM J PREV MED, V40, P25, DOI 10.1016/j.amepre.2010.09.023; McCormack GR, 2008, PREV MED, V46, P33, DOI 10.1016/j.ypmed.2007.01.013; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Millward H, 2013, J TRANSP GEOGR, V28, P101, DOI 10.1016/j.jtrangeo.2012.11.012; Moore K, 2013, J EPIDEMIOL COMMUN H, V67, P846, DOI 10.1136/jech-2013-202682; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Nathan A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-133; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Owen N, 2010, J URBAN HEALTH, V87, P189, DOI 10.1007/s11524-009-9424-x; Roberts C. K., 2013, COMPREHENSIVE PHYSL; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Smiley MJ, 2010, HEALTH PLACE, V16, P885, DOI 10.1016/j.healthplace.2010.04.014; Sugiyama T, 2012, ASIA PACIFIC J PUBLI; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Sugiyama T, 2009, HEALTH PLACE, V15, P1058, DOI 10.1016/j.healthplace.2009.05.001; Suminski RR, 2005, AM J PREV MED, V28, P149, DOI 10.1016/j.amepre.2004.09.009; Thornton LE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-29; Thornton LE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-71; Thornton LE, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-28; Witten K, 2012, ENVIRON HEALTH PERSP, V120, P971, DOI 10.1289/ehp.1104584; Witten K, 2011, ENVIRON PLANN A, V43, P205, DOI 10.1068/a43219	55	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137402	10.1371/journal.pone.0137402	http://dx.doi.org/10.1371/journal.pone.0137402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355848	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800045
J	Mori, S; Usami, N; Fukumoto, K; Mizuno, T; Kuroda, H; Sakakura, N; Yokoi, K; Sakao, Y				Mori, Shunsuke; Usami, Noriyasu; Fukumoto, Koichi; Mizuno, Tetsuya; Kuroda, Hiroaki; Sakakura, Noriaki; Yokoi, Kohei; Sakao, Yukinori			The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							LYMPHOCYTE; PREDICTORS; SURVIVAL; CARCINOMA; SMOKING; COUNTS	Objectives Immunological parameters and nutritional status influence the outcome of patients with malignant tumors. A prognostic nutritional index, calculated using serum albumin levels and peripheral lymphocyte count, has been used to assess prognosis for various cancers. This study aimed to investigate whether this prognostic nutritional index affects overall survival and the incidence of postoperative complications in patients with completely resected nonsmall cell lung cancer. Methods We retrospectively reviewed the medical records of 409 patients with non-small cell lung cancer who underwent complete resection between 2005 and 2007 at the Aichi Cancer Center. Results The 5-year survival rates of patients with high (>= 50) and low (< 50) prognostic nutritional indices were 84.4% and 70.7%, respectively (p = 0.0011). Univariate analysis showed that gender, histology, pathological stage, smoking history, serum carcinoembryonic antigen levels, and prognostic nutritional index were significant prognostic factors. Multivariate analysis identified pathological stage and the prognostic nutritional index as independent prognostic factors. The frequency of postoperative complications tended to be higher in patients with a low prognostic nutritional index. Conclusions The prognostic nutritional index is an independent prognostic factor for survival of patients with completely resected non-small cell lung cancer.	[Mori, Shunsuke; Usami, Noriyasu; Mizuno, Tetsuya; Kuroda, Hiroaki; Sakakura, Noriaki; Sakao, Yukinori] Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Mori, Shunsuke; Usami, Noriyasu; Fukumoto, Koichi; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Aichi Cancer Center; Nagoya University	Sakao, Y (corresponding author), Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ysakao@aichi-cc.jp	Sakakura, Noriaki/HCI-9070-2022; Fukumoto, Koichi/M-4842-2014; Yokoi, Kohei/I-7261-2014	Sakao, Yukinori/0000-0002-6826-2280; Sakakura, Noriaki/0000-0002-9598-9629				Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Cerfolio RJ, 2009, ANN THORAC SURG, V88, P405, DOI 10.1016/j.athoracsur.2009.04.015; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hespanhol V, 1995, LUNG CANCER, V13, P253, DOI 10.1016/0169-5002(95)00497-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kobayashi N, 2012, LUNG CANCER, V75, P223, DOI 10.1016/j.lungcan.2011.06.009; Marugame T, 2005, CANCER SCI, V96, P120, DOI 10.1111/j.1349-7006.2005.00013.x; Muers MF, 1996, THORAX, V51, P894, DOI 10.1136/thx.51.9.894; Nozoe T, 2002, EUR J SURG ONCOL, V28, P396, DOI 10.1053/ejso.2002.1257; Nozoe T, 2010, SURG TODAY, V40, P440, DOI 10.1007/s00595-009-4065-y; Okada M, 2004, ANN THORAC SURG, V78, P216, DOI 10.1016/j.athoracsur.2004.02.009; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; OWNBY HE, 1983, CANCER, V52, P126, DOI 10.1002/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Suzuki K, 1999, CANCER-AM CANCER SOC, V86, P1976, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1976::AID-CNCR14>3.0.CO;2-I; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wakai K, 2006, JPN J CLIN ONCOL, V36, P309, DOI 10.1093/jjco/hyl025	23	69	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136897	10.1371/journal.pone.0136897	http://dx.doi.org/10.1371/journal.pone.0136897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356222	Green Submitted, gold, Green Published			2022-12-27	WOS:000360965800018
J	Riedelsberger, J; Dreyer, I; Gonzalez, W				Riedelsberger, Janin; Dreyer, Ingo; Gonzalez, Wendy			Outward Rectification of Voltage-Gated K+ Channels Evolved at Least Twice in Life History	PLOS ONE			English	Article							POTASSIUM CHANNEL; INWARD RECTIFICATION; S4-S5 LINKER; SENSOR; EXPRESSION; ACTIVATION; MECHANISM; TRANSPORT; REQUIRES; MODELS	Voltage-gated potassium (K+) channels are present in all living systems. Despite high structural similarities in the transmembrane domains (TMD), this K+ channel type segregates into at least two main functional categories-hyperpolarization-activated, inward-rectifying (Kin) and depolarization-activated, outward-rectifying (Kout) channels. Voltage-gated K+ channels sense the membrane voltage via a voltage-sensing domain that is connected to the conduction pathway of the channel. It has been shown that the voltage-sensing mechanism is the same in Kin and Kout channels, but its performance results in opposite pore conformations. It is not known how the different coupling of voltage-sensor and pore is implemented. Here, we studied sequence and structural data of voltage-gated K+ channels from animals and plants with emphasis on the property of opposite rectification. We identified structural hotspots that alone allow already the distinction between Kin and Kout channels. Among them is a loop between TMD S5 and the pore that is very short in animal Kout, longer in plant and animal Kin and the longest in plant Kout channels. In combination with further structural and phylogenetic analyses this finding suggests that outward-rectification evolved twice and independently in the animal and plant kingdom.	[Riedelsberger, Janin; Dreyer, Ingo; Gonzalez, Wendy] Univ Talca, CBSM, Talca, Chile; [Dreyer, Ingo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Universidad de Talca; Universidad Politecnica de Madrid; University of Potsdam	Riedelsberger, J (corresponding author), Univ Talca, CBSM, Talca, Chile.	jriedelsberger@utalca.cl; idreyer@utalca.cl	Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Riedelsberger, Janin/0000-0002-4687-7495; Gonzalez, Wendy/0000-0002-7535-6883	Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico [3150173, 1140624]; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica [Anillo ACT-1104]; Deutsche Forschungsgemeinschaft [DR430/8-1]; Marie Curie Career Integration Grant of the European Union [303674-Regopoc]	Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Career Integration Grant of the European Union	This work was supported by grants from the Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt) to JR (No. 3150173) and WG (No. 1140624), and by the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica (http://www.conicyt.cl) to JR and WG (Anillo ACT-1104). ID was supported by grants of the Deutsche Forschungsgemeinschaft (DR430/8-1) (http://www.dfg.de/) and Marie Curie Career Integration Grant of the European Union (FP7-PEOPLE-2011-CIG No. 303674-Regopoc) (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/cig/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Anselmi C, 2007, PROTEINS, V66, P136, DOI 10.1002/prot.21187; Bright J N, 2004, IEE Proc Nanobiotechnol, V151, P17, DOI 10.1049/ip-nbt:20040101; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; Gajdanowicz P, 2009, NEW PHYTOL, V182, P380, DOI 10.1111/j.1469-8137.2008.02749.x; Gonzalez C, 2012, COMPR PHYSIOL, V2, P2087, DOI 10.1002/cphy.c110047; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Gomez-Porras JL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00167; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Michard E, 2005, J GEN PHYSIOL, V126, P605, DOI 10.1085/jgp.200509413; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Nieves-Cordones M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.972892; Poree F, 2005, BIOCHEM BIOPH RES CO, V332, P465, DOI 10.1016/j.bbrc.2005.04.150; Riedelsberger J, 2010, MOL PLANT, V3, P236, DOI 10.1093/mp/ssp096; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Sharma T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00224; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Very AA, 2014, J PLANT PHYSIOL, V171, P748, DOI 10.1016/j.jplph.2014.01.011; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137600	10.1371/journal.pone.0137600	http://dx.doi.org/10.1371/journal.pone.0137600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356684	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000360965800068
J	Roper, AC; Orabi, J; Lutken, H; Christensen, B; Skou, AMT; Muller, R				Roper, Anna-Catharina; Orabi, Jihad; Lutken, Henrik; Christensen, Brian; Skou, Anne-Marie Thonning; Muller, Renate			Phenotypic and Genotypic Analysis of Newly Obtained Interspecific Hybrids in the Campanula Genus	PLOS ONE			English	Article							HYBRIDIZATION; POLYMORPHISMS; CONSTRUCTION; INHERITANCE; PHYLOGENY; MARKERS; AFLP	Interspecific hybridisation creates new phenotypes within several ornamental plant species including the Campanula genus. We have employed phenotypic and genotypic methods to analyse and evaluate interspecific hybridisation among cultivars of four Campanula species, i.e. C. cochleariifolia, C. isophylla, C. medium and C. formanekiana. Hybrids were analysed using amplified fragment length polymorphism (AFLP), flow cytometry and biometrical measurements. Results of correlation matrices demonstrated heterogeneous phenotypes for the parental species, which confirmed our basic premise for new phenotypes of interspecific hybrids. AFLP assays confirmed the hybridity and identified self-pollinated plants. Limitation of flow cytometry analysis detection was observed while detecting the hybridity status of two closely related parents, e.g. C. cochleariiafolia x C. isophylla. Phenotypic characteristics such as shoot habitus and flower colour were strongly influenced by one of the parental species in most crosses. Rooting analysis revealed that inferior rooting quality occurred more often in interspecific hybrids than in the parental species. Only interspecific hybrid lines of C. formanekiana 'White' x C. medium 'Pink' showed a high rooting level. Phenotype analyses demonstrated a separation from the interspecific hybrid lines of C. formanekiana 'White' x C. medium 'Pink' to the other clustered hybrids of C. formanekiana and C. medium. In our study we demonstrated that the use of correlation matrices is a suitable tool for identifying suitable cross material. This study presents a comprehensive overview for analysing newly obtained interspecific hybrids. The chosen methods can be used as guidance for analyses for further interspecific hybrids in Campanula, as well as in other ornamental species.	[Roper, Anna-Catharina; Lutken, Henrik; Muller, Renate] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Orabi, Jihad] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Christensen, Brian; Skou, Anne-Marie Thonning] AgroTech AS, Inst Agri Technol & Food Innovat, DK-2630 Taastrup, Denmark	University of Copenhagen; University of Copenhagen	Roper, AC (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Hojbakkegaard Alle 9-13, DK-2630 Taastrup, Denmark.	ac.roeper@gmail.com	Orabi, Jihad/ABB-1020-2020; Müller, Renate/F-8932-2014; Lutken, Henrik/F-9449-2014	Müller, Renate/0000-0003-4029-240X; Orabi, Jihad/0000-0001-9641-6657; Lutken, Henrik/0000-0003-3719-8324	Danish Agency for Science, Technology and Innovation; Copenhagen University; Nordic Seed A/S; AgroTech A/S	Danish Agency for Science, Technology and Innovation; Copenhagen University; Nordic Seed A/S; AgroTech A/S	Funding: This project has partly been funded by the Danish Agency for Science, Technology and Innovation and supported by Copenhagen University by co-funding of the PhD project of A-CR (http://ufm.dk/en/the-minister-and-the-ministry/organisation/the-danish-agency-for-science-technology-and-innovation). Nordic Seed A/S and AgroTech A/S provided support in the form of salaries for authors JO, BC and AMTS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alarcon M, 2013, MOL PHYLOGENET EVOL, V69, P828, DOI 10.1016/j.ympev.2013.06.021; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Banjanac T, 2014, TURK J BOT, V38, P68, DOI 10.3906/bot-1211-58; Bogdanova VS, 2007, THEOR APPL GENET, V114, P333, DOI 10.1007/s00122-006-0436-6; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Carl P., 2013, ECONOMETRIC TOOLS PE; Evgenidis G, 2011, HINDAWI PUBLISHING C, V2011, P1; Fedorov AA, 1957, CAMPANULACEAE, V24, P92; Floradania Marketing A/S, 2014, TOP 10 PROD PLANTS D; Fourar-Belaifa R, 2011, J STORED PROD RES, V47, P48, DOI 10.1016/j.jspr.2010.09.002; GESLOT A, 1980, PLANT SYST EVOL, V134, P193, DOI 10.1007/BF00986799; Haarman BCM, 2014, J BIOMEDICA IN PRESS; HOFINGER BJ, 2000, BIOTECHNOLOGICAL APP, P215; Husson F, 2014, MULTIVARIATE EXPLORA, P16; Ikeda Y, 2007, PLANT CELL PHYSIOL, V48, P205, DOI 10.1093/pcp/pcl061; Ishizaka H, 2008, PLANT BIOTECHNOL-NAR, V25, P511, DOI 10.5511/plantbiotechnology.25.511; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Kinoshita T, 2007, GENES GENET SYST, V82, P177, DOI 10.1266/ggs.82.177; Kovacic Sanja, 2004, Acta Botanica Croatica, V63, P171; Kradolfer D, 2013, DEV CELL, V26, P525, DOI 10.1016/j.devcel.2013.08.006; Kumari M, 2009, CRIT REV PLANT SCI, V28, P393, DOI 10.1080/07352680903133252; Lammers GL, 2007, WORLD CHECK LIST BIB, P144; Lammers Thomas G., 1996, SIDA Contributions to Botany, V17, P519; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; Meiners J, 2012, PLANT BIOLOGY, V14, P576, DOI 10.1111/j.1438-8677.2011.00542.x; Miyashita T, 2010, SCI HORTIC-AMSTERDAM, V125, P692, DOI 10.1016/j.scienta.2010.05.032; Munoz-Amatriain M, 2009, FUNCT INTEGR GENOMIC, V9, P311, DOI 10.1007/s10142-009-0113-3; Nicchols G, 2006, DWARF CAMPANULAS ASS; NYMAN Y, 1991, PLANT SYST EVOL, V177, P185, DOI 10.1007/BF00937956; Park JM, 2006, SYST BOT, V31, P862, DOI 10.1600/036364406779695924; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ronikier M, 2008, MOL ECOL, V17, P1763, DOI 10.1111/j.1365-294X.2008.03664.x; Roper A-C, EUPHYTICA IN PRESS; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schulte K, 2010, MOL PHYLOGENET EVOL, V57, P1105, DOI 10.1016/j.ympev.2010.09.001; Singh RJ., 2003, PLANT CYTOGENETICS; Strid A, 1985, CHROMOSOME NUMBERS G; Sujatha M, 2003, GENET RESOUR CROP EV, V50, P75, DOI 10.1023/A:1022961028064; Tornadore N, 1974, NUMERI CHROMOSMICI F; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walia H, 2009, CURR BIOL, V19, P1128, DOI 10.1016/j.cub.2009.05.068; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Ziems LA, 2014, THEOR APPL GENET, V127, P1199, DOI 10.1007/s00122-014-2291-1	46	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137537	10.1371/journal.pone.0137537	http://dx.doi.org/10.1371/journal.pone.0137537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352688	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800094
J	Aubin, K; Safoine, M; Proulx, M; Audet-Casgrain, MA; Cote, JF; Tetu, FA; Roy, A; Fradette, J				Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Audet-Casgrain, Marie-Alice; Cote, Jean-Francois; Tetu, Felix-Andre; Roy, Alphonse; Fradette, Julie			Characterization of In Vitro Engineered Human Adipose Tissues: Relevant Adipokine Secretion and Impact of TNF-alpha	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATION-RELATED ADIPOKINES; HEPATOCYTE GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; HUMAN ADIPOCYTES; CARDIOVASCULAR-DISEASE; REGENERATIVE MEDICINE; ORGANOTYPIC CULTURE; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Representative modelling of human adipose tissue functions is central to metabolic research. Tridimensional models able to recreate human adipogenesis in a physiological tissue-like context in vitro are still scarce. We describe the engineering of white adipose tissues reconstructed from their cultured adipose-derived stromal precursor cells. We hypothesize that these reconstructed tissues can recapitulate key functions of AT under basal and pro-inflammatory conditions. These tissues, featuring human adipocytes surrounded by stroma, were stable and metabolically active in long-term cultures (at least 11 weeks). Secretion of major adipokines and growth factors by the reconstructed tissues was determined and compared to media conditioned by human native fat explants. Interestingly, the secretory profiles of the reconstructed adipose tissues indicated an abundant production of leptin, PAI-1 and angiopoietin-1 proteins, while higher HGF levels were detected for the human fat explants. We next demonstrated the responsiveness of the tissues to the proinflammatory stimulus TNF-alpha, as reflected by modulation of MCP-1, NGF and HGF secretion, while VEGF and leptin protein expression did not vary. TNF-alpha exposure induced changes in gene expression for adipocyte metabolism-associated mRNAs such as SLC2A4, FASN and LIPE, as well as for genes implicated in NF-kappa B activation. Finally, this model was customized to feature adipocytes representative of progressive stages of differentiation, thereby allowing investigations using newly differentiated or more mature adipocytes. In conclusion, we produced tridimensional tissues engineered in vitro that are able to recapitulate key characteristics of subcutaneous white adipose tissue. These tissues are produced from human cells and their neo-synthesized matrix elements without exogenous or synthetic biomaterials. Therefore, they represent unique tools to investigate the effects of pharmacologically active products on human stromal cells, extracellular matrix and differentiated adipocytes, in addition to compounds modulating adipogenesis from precursor cells.	[Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Audet-Casgrain, Marie-Alice; Cote, Jean-Francois; Fradette, Julie] Univ Laval, Ctr Rech Organogenese Expt, LOEX, Quebec City, PQ, Canada; [Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Fradette, Julie] CHU Quebec, Res Ctr, Div Regenerat Med, Quebec City, PQ, Canada; [Tetu, Felix-Andre] Clin Chirurg Esthet Felix Andre Tetu, Quebec City, PQ, Canada; [Tetu, Felix-Andre; Roy, Alphonse] CHU Quebec, Quebec City, PQ, Canada; [Roy, Alphonse] Clin Chirurg Plast Alphonse Roy, Quebec City, PQ, Canada; [Fradette, Julie] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University	Fradette, J (corresponding author), Univ Laval, Ctr Rech Organogenese Expt, LOEX, Quebec City, PQ, Canada.	Julie.fradette@chg.ulaval.ca		Fradette, Julie/0000-0002-1851-5112	National Science and Engineering Research Council (NSERC) [326987]; Canadian Institutes of Health Research (CIHR) [111233]; Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S); Reseau TheCell du FRQ-S; Fonds de recherche du Quebec-Nature et technologies (FRQNT); CIHR; Laval University Faculty of Medicine; NSERC; FRQ-S; Canadian Federation of University Women (CFUW)	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S); Reseau TheCell du FRQ-S; Fonds de recherche du Quebec-Nature et technologies (FRQNT); CIHR(Canadian Institutes of Health Research (CIHR)); Laval University Faculty of Medicine; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQ-S; Canadian Federation of University Women (CFUW)	This work was supported by the National Science and Engineering Research Council (NSERC, grant #326987) and in part by the Canadian Institutes of Health Research (CIHR, grant #111233, Figs 3 and 4) awarded to JF. We acknowledge the support of the Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S) and of the Reseau TheCell du FRQ-S. The confocal imaging system was obtained through the Fonds des leaders program from Canada Foundation for Innovation (CFI) to JF. KA received a studentship from Fonds de recherche du Quebec-Nature et technologies (FRQNT). MS received studentships from CIHR and Laval University Faculty of Medicine. MP received studentships from NSERC, FRQ-S and the Canadian Federation of University Women (CFUW). JF is a FRQ-S career award scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin K, 2015, ACTA BIOMATER, V11, P333, DOI 10.1016/j.actbio.2014.09.044; Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003; Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]; Crandall DL, 2000, J CLIN ENDOCR METAB, V85, P2609, DOI 10.1210/jc.85.7.2609; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Finck BN, 2002, AM J PHYSIOL-REG I, V282, pR1429, DOI 10.1152/ajpregu.00569.2001; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Fortier GM, 2013, J TISSUE ENG REGEN M, V7, P292, DOI 10.1002/term.522; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Good Manuela, 2006, Diab Vasc Dis Res, V3, P26, DOI 10.3132/dvdr.2006.003; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hube F, 1999, EUR J CLIN INVEST, V29, P672, DOI 10.1046/j.1365-2362.1999.00520.x; Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469; Kirchgessner TG, 1997, J CLIN INVEST, V100, P2777, DOI 10.1172/JCI119824; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Labbe B, 2011, METHODS MOL BIOL, V702, P429, DOI 10.1007/978-1-61737-960-4_31; Lafontan M, 2012, AM J PHYSIOL-CELL PH, V302, pC327, DOI 10.1152/ajpcell.00168.2011; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Mahadik Sujata R, 2013, J Assoc Physicians India, V61, P244; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; NAKAMURA Y, 1995, BIOCHEM BIOPH RES CO, V215, P483, DOI 10.1006/bbrc.1995.2490; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Philips BJ, 2012, EXPERT OPIN BIOL TH, V12, P155, DOI 10.1517/14712598.2012.644533; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Toda S, 2009, ORGANOGENESIS, V5, P50, DOI 10.4161/org.5.2.8347; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Vallee M, 2009, PATHOL BIOL, V57, P309, DOI 10.1016/j.patbio.2008.04.010; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Wang BH, 2006, PFLUG ARCH EUR J PHY, V452, P418, DOI 10.1007/s00424-006-0055-8; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yao R, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045005; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	68	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137612	10.1371/journal.pone.0137612	http://dx.doi.org/10.1371/journal.pone.0137612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367137	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100094
J	Heuner, M; Silinski, A; Schoelynck, J; Bouma, TJ; Puijalon, S; Troch, P; Fuchs, E; Schroder, B; Schroder, U; Meire, P; Temmerman, S				Heuner, Maike; Silinski, Alexandra; Schoelynck, Jonas; Bouma, Tjeerd J.; Puijalon, Sara; Troch, Peter; Fuchs, Elmar; Schroeder, Boris; Schroeder, Uwe; Meire, Patrick; Temmerman, Stijn			Ecosystem Engineering by Plants on Wave-Exposed Intertidal Flats Is Governed by Relationships between Effect and Response Traits	PLOS ONE			English	Article							SALT-MARSH; SPECIES INTERACTIONS; VEGETATION; STRESS; LIGNIN; FLOW; MACROPHYTES; SERVICES; DRAG; BIODIVERSITY	In hydrodynamically stressful environments, some species-known as ecosystem engineers-are able to modify the environment for their own benefit. Little is known however, about the interaction between functional plant traits and ecosystem engineering. We studied the responses of Scirpus tabernaemontani and Scirpus maritimus to wave impact in full-scale flume experiments. Stem density and biomass were used to predict the ecosystem engineering effect of wave attenuation. Also the drag force on plants, their bending angle after wave impact and the stem biomechanical properties were quantified as both responses of stress experienced and effects on ecosystem engineering. We analyzed lignin, cellulose, and silica contents as traits likely effecting stress resistance (avoidance, tolerance). Stem density and biomass were strong predictors for wave attenuation, S. maritimus showing a higher effect than S. tabernaemontani. The drag force and drag force per wet frontal area both differed significantly between the species at shallow water depths (20 cm). At greater depths (35 cm), drag forces and bending angles were significantly higher for S. maritimus than for S. tabernaemontani. However, they do not differ in drag force per wet frontal area due to the larger plant surface of S. maritimus. Stem resistance to breaking and stem flexibility were significantly higher in S. tabernaemontani, having a higher cellulose concentration and a larger cross-section in its basal stem parts. S. maritimus had clearly more lignin and silica contents in the basal stem parts than S. tabernaemontani. We concluded that the effect of biomass seems more relevant for the engineering effect of emergent macrophytes with leaves than species morphology: S. tabernaemontani has avoiding traits with minor effects on wave attenuation; S. maritimus has tolerating traits with larger effects. This implies that ecosystem engineering effects are directly linked with traits affecting species stress resistance and responding to stress experienced.	[Heuner, Maike; Fuchs, Elmar] Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany; [Heuner, Maike] Tech Univ Berlin, Geoinformat Environm Planning Lab, Berlin, Germany; [Silinski, Alexandra; Schoelynck, Jonas; Meire, Patrick; Temmerman, Stijn] Univ Antwerp, Ecosyst Management Res Grp, Dept Biol, Antwerp, Belgium; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Puijalon, Sara] Univ Lyon 1, CNRS, UMR LEHNA 5023, ENTPE, F-69622 Villeurbanne, France; [Troch, Peter] Univ Ghent, Dept Civil Engn, B-9000 Ghent, Belgium; [Schroeder, Boris] Tech Univ Carolo Wilhelmina Braunschweig, Environm Syst Anal, Inst Geoecol, D-38106 Braunschweig, Germany; [Schroeder, Boris] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Schroeder, Uwe] Fed Inst Hydrol, Dept Vegetat Studies & Landscape Management, Koblenz, Germany	Technical University of Berlin; University of Antwerp; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ghent University; Braunschweig University of Technology	Heuner, M (corresponding author), Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany.	heuner@bafg.de	Troch, Peter/L-2463-2017; Schroder, Boris/B-7211-2009; Schröder, Boris/N-7250-2019; Puijalon, Sara/ABA-6520-2020; Temmerman, Stijn/C-5521-2009	Troch, Peter/0000-0003-3274-0874; Schroder, Boris/0000-0002-8577-7980; Schröder, Boris/0000-0002-8577-7980; Puijalon, Sara/0000-0002-1942-7958; Bouma, Tjeerd/0000-0001-7824-7546; Schoelynck, Jonas/0000-0003-0166-280X; Temmerman, Stijn/0000-0003-3346-9115	KLIWAS; FWO Scientific Research Community; Research Foundation Flanders (FWO); Port of Antwerp	KLIWAS; FWO Scientific Research Community; Research Foundation Flanders (FWO)(FWO); Port of Antwerp	This study was supprted by KLIWAS (Impacts of climate change on waterways and navigation - Searching for options of adaptation, (www.kliwas.de/KLIWAS/EN/)) - MH; FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions" - AS and MH Personal grant of Research Foundation Flanders (FWO, www.fwo.be/) - AS and JS; Port of Antwerp (www.portofantwerp.com) - AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2014, COAST ENG, V83, P82, DOI 10.1016/j.coastaleng.2013.10.004; Asaeda T, 2005, FRESHWATER BIOL, V50, P1991, DOI 10.1111/j.1365-2427.2005.01445.x; Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bertness MD, 2006, ATLANTIC SHORELINES; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bouma TJ, 2010, ECOLOGY, V91, P2696, DOI 10.1890/09-0690.1; Bouma TJ, 2009, MAR ECOL PROG SER, V388, P293, DOI 10.3354/meps08130; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Crain CM, 2005, ECOLOGY, V86, P2695, DOI 10.1890/04-1517; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cuddington K, 2009, AM NAT, V173, P488, DOI 10.1086/597216; DENNY MW, 1994, J EXP BIOL, V194, P97; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fittschen T, 2003, WELLENMESSUNGEN UNTE; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Gilad E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098105; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; Henry PY, 2013, COAST ENG, V78, P13, DOI 10.1016/j.coastaleng.2013.03.004; Jung HJG, 1999, J AGR FOOD CHEM, V47, P2005, DOI 10.1021/jf981250q; Kaufman PB, 1999, NATURAL PRODUCTS PLA, P343; Knutson PL, 1982, WAVE DAMPING SPARTIN; Koivisto M, 2011, MAR BIOL, V158, P945, DOI 10.1007/s00227-010-1621-3; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Levitt J, 1972, RESPONSES PLANTS ENV; MCLAUGHLIN EC, 1980, J MATER SCI, V15, P89, DOI 10.1007/BF00552431; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Moller I, 1999, ESTUAR COAST SHELF S, V49, P411, DOI 10.1006/ecss.1999.0509; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Paul M, 2012, MAR ECOL PROG SER, V444, P31, DOI 10.3354/meps09489; Pollen-Bankhead N, 2011, ECOL ENG, V37, P1779, DOI 10.1016/j.ecoleng.2011.06.027; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Schoelynck J, 2013, LIMNOLOGICA, V43, P371, DOI 10.1016/j.limno.2013.05.003; Schoelynck J, 2010, NEW PHYTOL, V186, P385, DOI 10.1111/j.1469-8137.2009.03176.x; Silinski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118687; TAYLOR GE, 1978, NEW PHYTOL, V80, P523, DOI 10.1111/j.1469-8137.1978.tb01584.x; Temmerman S, 2007, GEOLOGY, V35, P631, DOI 10.1130/G23502A.1; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Usherwood JR, 1997, J EXP BOT, V48, P1469, DOI 10.1093/jxb/48.7.1469; van Wesenbeeck BK, 2008, OIKOS, V117, P152, DOI 10.1111/j.2007.0030-1299.16245.x; Vandenbruwaene W, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001788; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; Vieira DAN, 2012, HYDROL PROCESS, V26, P2225, DOI 10.1002/hyp.8262; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Ysebaert T, 2011, WETLANDS, V31, P1043, DOI 10.1007/s13157-011-0240-1; Zhang CB, 2014, GEOMORPHOLOGY, V206, P196, DOI 10.1016/j.geomorph.2013.09.024	54	32	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138086	10.1371/journal.pone.0138086	http://dx.doi.org/10.1371/journal.pone.0138086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367004	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100219
J	Makino, Y; Konoshita, T; Omori, A; Maegawa, N; Nakaya, T; Ichikawa, M; Yamamoto, K; Wakahara, S; Ishizuka, T; Onoe, T; Nakamura, H				Makino, Yasukazu; Konoshita, Tadashi; Omori, Atsuhito; Maegawa, Nobuhiro; Nakaya, Takahiro; Ichikawa, Mai; Yamamoto, Katsushi; Wakahara, Shigeyuki; Ishizuka, Tamotsu; Onoe, Tamehito; Nakamura, Hiroyuki		Genomic Dis Outcome Consortium	A Genetic Variant in the Distal Enhancer Region of the Human Renin Gene Affects Renin Expression	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; PLASMA-RENIN; ESSENTIAL-HYPERTENSION; DELETION POLYMORPHISM; DIABETIC-NEPHROPATHY; RISK-FACTOR; SYSTEM; DETERMINANTS; MORTALITY; PRORENIN	Background The high heritability of plasma renin activity was confirmed in recent investigations. A variation located near the strong enhancer of the human renin gene (REN), C-5312T, has been shown to have different transcription activity levels depending on its allele: the 5312T allele shows transcription levels that are 45% greater than those of the 5312C allele. The purpose of this study was to confirm the hypothesis that variations in the enhancer region of the REN gene are involved in regulating renal expression of renin. Methods Sixty-four subjects with biopsy-proven renal diseases were included in this study (male/female: 35/29, age 41.9 +/- 20.9 years, SBP/DBP 123.1 +/- 23.7/73.4 +/- 14.8 mmHg, s-Cr 0.93 +/- 0.63 mg/dl). A genetic variant of REN, C-5312T, was assayed by PCR-RFLP and the Taq-Man method. Total RNAs from a small part of the renal cortex were reverse-transcribed and amplified for REN and GAPDH with a real-time PCR system. Results Logarithmically transformed expression values of the relative ratio of REN to GAPDH (10(-3)) were as follows (mean +/- SE): CC (26 cases), 0.016 +/- 0.005; CT (33 cases), 0.047 +/- 0.021 (p = 0.41 vs. CC); TT (5 cases), 0.198 +/- 0.194 (p = 0.011 vs. CC, p < 0.031 vs. CT). Thus, significant differences in REN expression were observed among the genetic variants. Conclusion The results suggest that variants in the enhancer region of the human renin gene have an effect on the expression levels of renin in renal tissue; this observation is in good accordance with the results of the transcriptional assay.	[Makino, Yasukazu; Konoshita, Tadashi; Omori, Atsuhito; Maegawa, Nobuhiro; Nakaya, Takahiro; Ichikawa, Mai; Yamamoto, Katsushi; Wakahara, Shigeyuki; Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan; [Onoe, Tamehito] Kanazawa Univ, Grad Sch Med Sci, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	University of Fukui; Kanazawa University; Kanazawa University	Konoshita, T (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan.	konosita@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [08770879, 09770843, 14571020, 22590909, 25461245]; National Research Foundation/Japan Science and Technology Agency (NRF/JST) [J110000349]; Strategic International Research Cooperative Program (SICP)	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Foundation/Japan Science and Technology Agency (NRF/JST); Strategic International Research Cooperative Program (SICP)	This work was supported by grant-in-aids 08770879, 09770843, 14571020, 22590909 and 25461245 from the Ministry of Education, Science and Culture of Japan and a grant from National Research Foundation/Japan Science and Technology Agency (NRF/JST) (Project number: J110000349) and Strategic International Research Cooperative Program (SICP).	BORENSZTEIN P, 1994, CIRC RES, V74, P764, DOI 10.1161/01.RES.74.5.764; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Corvol P, 1997, PATHOL BIOL, V45, P229; Daimon M, 2012, METABOLISM, V61, P504, DOI 10.1016/j.metabol.2011.08.004; Deinum J, 1999, NEPHROL DIAL TRANSPL, V14, P1904, DOI 10.1093/ndt/14.8.1904; Fogarty DG, 1996, DIABETES, V45, P1204, DOI 10.2337/diabetes.45.9.1204; Frossard PM, 1998, HYPERTENS RES-CLIN E, V21, P221, DOI 10.1291/hypres.21.221; Fuchs S, 2002, J HYPERTENS, V20, P2391, DOI 10.1097/00004872-200212000-00018; Germain S, 1996, BIOCHEM J, V316, P107, DOI 10.1042/bj3160107; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; HARDEN PN, 1995, LANCET, V345, P1540, DOI 10.1016/S0140-6736(95)91088-3; Hasimu B, 2003, HYPERTENSION, V41, P308, DOI 10.1161/01.HYP.0000049762.77830.89; Ichikawa M, 2014, ACTA DIABETOL, V51, P595, DOI 10.1007/s00592-014-0561-7; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; KLEMM SA, 1994, KIDNEY INT, V46, P1591, DOI 10.1038/ki.1994.455; Konoshita T, 2006, DIABETES CARE, V29, P848, DOI 10.2337/diacare.29.04.06.dc05-1873; Konoshita T, 2004, J CELL BIOCHEM, V93, P327, DOI 10.1002/jcb.20151; Konoshita T, 2001, AM J KIDNEY DIS, V37, P113, DOI 10.1053/ajkd.2001.20595; Konoshita T, 1996, KIDNEY INT, V50, P1515, DOI 10.1038/ki.1996.466; Konoshita T, 2007, J CELL BIOCHEM, V102, P1043, DOI 10.1002/jcb.21341; Konoshita T, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000354; Konoshita T, 2013, INT J CARDIOL, V166, P448, DOI 10.1016/j.ijcard.2011.10.133; Konoshita T, 2011, CURR HYPERTENS REP, V13, P356, DOI 10.1007/s11906-011-0212-0; Konoshita T, 2010, J HYPERTENS, V28, P2156, DOI 10.1097/HJH.0b013e32833d01dd; Konoshita T, 2009, DIABETES CARE, V32, P1485, DOI 10.2337/dc09-0348; Kotchen TA, 2000, HYPERTENSION, V36, P7, DOI 10.1161/01.HYP.36.1.7; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MERCURE C, 1995, J BIOL CHEM, V270, P16355, DOI 10.1074/jbc.270.27.16355; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SOUBRIER F, 1990, HYPERTENSION, V16, P712, DOI 10.1161/01.HYP.16.6.712; Tomaschitz A, 2011, EUR HEART J, V32, P2642, DOI 10.1093/eurheartj/ehr150; Waeber B, 1996, J CARDIOVASC PHARM, V27, pS36; Wakahara S, 2007, ENDOCRINOLOGY, V148, P2453, DOI 10.1210/en.2006-1287	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137469	10.1371/journal.pone.0137469	http://dx.doi.org/10.1371/journal.pone.0137469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366736	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100077
J	Miki, A; Ikuno, Y; Asai, T; Usui, S; Nishida, K				Miki, Atsuya; Ikuno, Yasushi; Asai, Tomoko; Usui, Shinich; Nishida, Kohji			Defects of the Lamina Cribrosa in High Myopia and Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE ELEVATION; NERVE HEAD; AXONAL-TRANSPORT; BEIJING EYE; THICKNESS; SUSCEPTIBILITY; MORPHOLOGY; MONKEY	Purpose We evaluated the prevalence and characteristics of the defects of the lamina cribrosa (LC) in high myopia and glaucoma, and compared them with control eyes using swept-source optical coherence tomography (SS-OCT). Methods One hundred fifty-nine eyes of 108 participants were divided into four subgroups; high myopia with glaucoma (MG, 67 eyes of 46 subjects), glaucoma without high myopia (G, 22 eyes of 13 subjects), high myopia without glaucoma (M, 35 eyes of 29 subjects), and a control group with neither glaucoma nor high myopia (C, 35 eyes of 20 subjects). The LC defects were identified and located using a standardized protocol in serial horizontal OCT scans. The prevalence rates of the defects were compared among the groups. Demographic and ocular factors were compared between eyes with and without defects. Results LC defects were observed in one eye (0.03%) in the C group, 8 eyes (22.9%) in the M group, 11 eyes (50%) in the G group, and 28 eyes (41.8%) in the MG group. The prevalence rates of the defects differed significantly among the groups (P = 0.0009). Most eyes with defects in the G and MG groups (79.5%) had damage in the corresponding visual hemi-fields. Other factors such as visual acuity, intraocular pressure, axial length, refractive error, disc ovality, or parapapillary atrophy area did not differ significantly between eyes with and without LC defects. Conclusions High myopia and glaucoma significantly increased the risk of LC damage. The LC damage in non-glaucomatous highly myopic eyes may at least partly explain the increased risk of developing glaucoma in myopic eyes.	[Miki, Atsuya; Ikuno, Yasushi; Asai, Tomoko; Usui, Shinich; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan	Osaka University	Miki, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan.	a.miki.md@gmail.com		Nishida, Kohji/0000-0001-9069-3610	Nidek Co; Santen Pharmaceutical; Pfizer Japan; Kowa Co Ltd.; Otsuka Pharmaceutical; Alcon Japan; Novartis; Bayer; TOMEY corp; Topcon; Abbott medical Optics Japan; National Institute of Biomedical Innovation Japan; Ministry of education, culture, sports, science and Technology, Japan; NEDO (new energy and industrial technology development organization); Ministry of Health, Labor, and Welfare, Japan; Japanese Society for the Promotion of Science; HOYA; Wacamoto; MSD; Pfizer; Menicon; JJ; Senju; Takeda	Nidek Co; Santen Pharmaceutical; Pfizer Japan(Pfizer); Kowa Co Ltd.; Otsuka Pharmaceutical(Otsuka Pharmaceutical); Alcon Japan(Novartis); Novartis(Novartis); Bayer(Bayer AG); TOMEY corp; Topcon; Abbott medical Optics Japan; National Institute of Biomedical Innovation Japan(National Institute of Biomedical Innovation); Ministry of education, culture, sports, science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO (new energy and industrial technology development organization)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HOYA; Wacamoto; MSD; Pfizer(Pfizer); Menicon; JJ; Senju; Takeda(Takeda Pharmaceutical Company Ltd)	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Miki reports personal fees from Nidek Co, personal fees from Santen Pharmaceutical, personal fees from Pfizer Japan, personal fees from Kowa Co Ltd., personal fees from Otsuka Pharmaceutical, personal fees from Alcon Japan, outside the submitted work; Dr. Ikuno reports personal fees from Novartis, personal fees from Bayer, grants from TOMEY corp, grants from Topcon, outside the submitted work; Dr. Nishida reports grants and personal fees from Otsuka Pharmaceutical, personal fees from Abbott medical Optics Japan, grants from National Institute of Biomedical Innovation Japan, grants from Ministry of education, culture, sports, science and Technology, Japan, grants from NEDO (new energy and industrial technology development organization, grants from Ministry of Health, Labor, and Welfare, Japan, grants from Japanese Society for the Promotion of Science, grants and personal fees from HOYA, grants and personal fees from Wacamoto, personal fees from MSD, grants and personal fees from Pfizer, grants and personal fees from Novartis, grants and personal fees from Santen Pharmaceutical, grants from Menicon, personal fees from J&J, personal fees from Senju, personal fees from Takeda, outside the submitted work. The authors declare that that competing interests do not alter their adherence to PLOS ONE policies on sharing data and materials.	Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; CAHANE M, 1992, OPHTHALMIC RES, V24, P280, DOI 10.1159/000267179; Faridi OS, 2014, OPHTHALMOLOGY, V121, P1524, DOI 10.1016/j.ophtha.2014.02.017; GREVE EL, 1980, A GRAEF ARCH KLIN EX, V213, P33, DOI 10.1007/BF02391209; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Ohno-Matsui K, 2012, OPHTHALMOLOGY, V119, P1685, DOI 10.1016/j.ophtha.2012.01.047; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2013, INVEST OPHTH VIS SCI, V54, P8401, DOI 10.1167/iovs.13-13014; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121	29	23	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137909	10.1371/journal.pone.0137909	http://dx.doi.org/10.1371/journal.pone.0137909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366870	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100176
J	Paul, D; Dasgupta, A; De, RK				Paul, Debjyoti; Dasgupta, Abhijit; De, Rajat K.			Exploring the Altered Dynamics of Mammalian Central Carbon Metabolic Pathway in Cancer Cells: A Classical Control Theoretic Approach	PLOS ONE			English	Article							PYRUVATE-KINASE M2; ISOFORM; PROMOTE; ENZYME; PKM2	Background In contrast with normal cells, most of the cancer cells depend on aerobic glycolysis for energy production in the form of adenosine triphosphate (ATP) bypassing mitochondrial oxidative phosphorylation. Moreover, compared to normal cells, cancer cells exhibit higher consumption of glucose with higher production of lactate. Again, higher rate of glycolysis provides the necessary glycolytic intermediary precursors for DNA, protein and lipid synthesis to maintain high active proliferation of the tumor cells. In this scenario, classical control theory based approach may be useful to explore the altered dynamics of the cancer cells. Since the dynamics of the cancer cells is different from that of the normal cells, understanding their dynamics may lead to development of novel therapeutic strategies. Method We have developed a model based on the state space equations of classical control theory along with an order reduction technique to mimic the actual dynamic behavior of mammalian central carbon metabolic (CCM) pathway in normal cells. Here, we have modified Michaelis Menten kinetic equation to incorporate feedback mechanism along with perturbations and cross talks associated with a metabolic pathway. Furthermore, we have perturbed the proposed model to reduce the mitochondrial oxidative phosphorylation. Thereafter, we have connected proportional-integral (PI) controller(s) with the model for tuning it to behave like the CCM pathway of a cancer cell. This methodology allows one to track the altered dynamics mediated by different enzymes. Results and Discussions The proposed model successfully mimics all the probable dynamics of the CCM pathway in normal cells. Moreover, experimental results demonstrate that in cancer cells, a coordination among enzymes catalyzing pentose phosphate pathway and intermediate glycolytic enzymes along with switching of pyruvate kinase (M2 isoform) plays an important role to maintain their altered dynamics.	[Paul, Debjyoti] Indian Stat Inst, Kolkata 700108, W Bengal, India; [Dasgupta, Abhijit; De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, 203 BT Rd, Kolkata 700108, W Bengal, India.	rajat@isical.ac.in	Dasgupta, Abhijit/W-7750-2019	Dasgupta, Abhijit/0000-0001-6062-9896; Dasgupta, Abhijit/0000-0002-6302-3512				ACERENZA L, 1989, J THEOR BIOL, V137, P423, DOI 10.1016/S0022-5193(89)80038-4; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chang R., 2005, PHYS CHEM BIOSCIENCE; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; De RK, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012500199; De RK, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-65; Famili I, 2003, BIOPHYS J, V85, P16, DOI 10.1016/S0006-3495(03)74450-6; Gerdtzen ZP, 2004, METAB ENG, V6, P140, DOI 10.1016/j.ymben.2003.11.003; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092949; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kholodenko BN, 1997, J PHYS CHEM B, V101, P2070, DOI 10.1021/jp962336u; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mazurek S, 2012, BIOMED RES-INDIA, V23, P133; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Morris K. A., 2000, INTRO FEEDBACK CONTR; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Panja S, 2013, IEEE ACM T COMPUT BI, V10, P858, DOI 10.1109/TCBB.2013.82; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Rao CV, 2004, 7 INT S DYN CONTR PR, V7; Resendis-Antonio O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012383; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wildermuth MC, 2000, GENOME BIOL, V1; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137728	10.1371/journal.pone.0137728	http://dx.doi.org/10.1371/journal.pone.0137728			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367460	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100124
J	Skryhan, K; Cuesta-Seijo, JA; Nielsen, MM; Marri, L; Mellor, SB; Glaring, MA; Jensen, PE; Palcic, MM; Blennow, A				Skryhan, Katsiaryna; Cuesta-Seijo, Jose A.; Nielsen, Morten M.; Marri, Lucia; Mellor, Silas B.; Glaring, Mikkel A.; Jensen, Poul E.; Palcic, Monica M.; Blennow, Andreas			The Role of Cysteine Residues in Redox Regulation and Protein Stability of Arabidopsis thaliana Starch Synthase 1	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; FERREDOXIN/THIOREDOXIN SYSTEM; THIOREDOXIN REDUCTASE; GLYCOGEN-SYNTHASE; ESCHERICHIA-COLI; BETA-AMYLASE; PLANT; LEAVES; METABOLISM; LIGHT	Starch biosynthesis in Arabidopsis thaliana is strictly regulated. In leaf extracts, starch synthase 1 (AtSS1) responds to the redox potential within a physiologically relevant range. This study presents data testing two main hypotheses: 1) that specific thiol-disulfide exchange in AtSS1 influences its catalytic function 2) that each conserved Cys residue has an impact on AtSS1 catalysis. Recombinant AtSS1 versions carrying combinations of cysteine-to-serine substitutions were generated and characterized in vitro. The results demonstrate that AtSS1 is activated and deactivated by the physiological redox transmitters thioredoxin f1 (Trxf1), thioredoxin m4 (Trxm4) and the bifunctional NADPH-dependent thioredoxin reductase C (NTRC). AtSS1 displayed an activity change within the physiologically relevant redox range, with a midpoint potential equal to -306 mV, suggesting that AtSS1 is in the reduced and active form during the day with active photosynthesis. Cys164 and Cys545 were the key cysteine residues involved in regulatory disulfide formation upon oxidation. A C164S_C545S double mutant had considerably decreased redox sensitivity as compared to wild type AtSS1 (30% vs 77%). Michaelis-Menten kinetics and molecular modeling suggest that both cysteines play important roles in enzyme catalysis, namely, Cys545 is involved in ADP-glucose binding and Cys164 is involved in acceptor binding. All the other single mutants had essentially complete redox sensitivity (98-99%). In addition of being part of a redox directed activity "light switch", reactivation tests and low heterologous expression levels indicate that specific cysteine residues might play additional roles. Specifically, Cys265 in combination with Cys164 can be involved in proper protein folding or/and stabilization of translated protein prior to its transport into the plastid. Cys442 can play an important role in enzyme stability upon oxidation. The physiological and phylogenetic relevance of these findings is discussed.	[Skryhan, Katsiaryna; Mellor, Silas B.; Glaring, Mikkel A.; Jensen, Poul E.; Blennow, Andreas] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Cuesta-Seijo, Jose A.; Nielsen, Morten M.; Marri, Lucia; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Palcic, Monica M.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Copenhagen; University of Victoria	Blennow, A (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	abl@plen.ku.dk	Jensen, Poul Erik/A-4862-2014; Mellor, Silas/D-8037-2015	Jensen, Poul Erik/0000-0001-6524-7723; Cuesta-Seijo, Jose Antonio/0000-0002-3755-9305; Mellor, Silas/0000-0002-3364-5804	University of Copenhagen; Carlsberg Foundation; VILLUM Center of Excellence "Plant Plasticity"; Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies [12-131834]	University of Copenhagen; Carlsberg Foundation(Carlsberg Foundation); VILLUM Center of Excellence "Plant Plasticity"; Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies	Funding was provided by a stipend from the University of Copenhagen, http://www.ku.dk/, providing a stipend for KS; Carlsberg Foundation, http://www.carlsbergfondet.dk/, funding salaries and materials for JAC-S MMN LM; the VILLUM Center of Excellence "Plant Plasticity", Salary and materials for SBM; "Plant Power: Light-Driven Synthesis of Complex Terpenoids Using Cytochrome P450s" (12-131834) funded by the Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies, salary and materials for SBM.	Antal TK, 2013, PHOTOSYNTH RES, V117, P1, DOI 10.1007/s11120-013-9945-8; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Balsera M, 2014, ANTIOXID REDOX SIGN, V21, P1327, DOI 10.1089/ars.2013.5817; Blennow A, 2013, CEREAL CHEM, V90, P274, DOI 10.1094/CCHEM-01-13-0010-FI; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Blennow A, 2010, BIOCATAL BIOTRANSFOR, V28, P3, DOI 10.3109/10242420903408211; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; Geigenberger P, 2014, ANTIOXID REDOX SIGN, V21, P1389, DOI 10.1089/ars.2014.6018; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Hadrich N, 2012, PLANT J, V70, P231, DOI 10.1111/j.1365-313X.2011.04860.x; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Onda Y., 2013, INT J CELL BIOL, V2013; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Reichmann D, 2013, CURR OPIN STRUC BIOL, V23, P436, DOI 10.1016/j.sbi.2013.02.006; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Sanz-Barrio R, 2013, PLANT BIOTECHNOL J, V11, P618, DOI 10.1111/pbi.12052; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Thormahlen I, 2013, PLANT CELL ENVIRON, V36, P16, DOI 10.1111/j.1365-3040.2012.02549.x; Toivola J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00389; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x	57	35	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136997	10.1371/journal.pone.0136997	http://dx.doi.org/10.1371/journal.pone.0136997			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367870	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100042
J	Hudson, MB; Smuder, AJ; Nelson, WB; Wiggs, MP; Shimkus, KL; Fluckey, JD; Szeto, HH; Powers, SK				Hudson, Matthew B.; Smuder, Ashley J.; Nelson, W. Bradley; Wiggs, Michael P.; Shimkus, Kevin L.; Fluckey, James D.; Szeto, Hazel H.; Powers, Scott K.			Partial Support Ventilation and Mitochondrial-Targeted Antioxidants Protect against Ventilator-Induced Decreases in Diaphragm Muscle Protein Synthesis	PLOS ONE			English	Article							PROLONGED MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; RAT DIAPHRAGM; MASS-SPECTROMETRY; KINASE-B; DYSFUNCTION; ATROPHY; WEAKNESS; ACTIVATION	Mechanical ventilation (MV) is a life-saving intervention in patients in respiratory failure. Unfortunately, prolonged MV results in the rapid development of diaphragm atrophy and weakness. MV-induced diaphragmatic weakness is significant because inspiratory muscle dysfunction is a risk factor for problematic weaning from MV. Therefore, developing a clinical intervention to prevent MV-induced diaphragm atrophy is important. In this regard, MV-induced diaphragmatic atrophy occurs due to both increased proteolysis and decreased protein synthesis. While efforts to impede MV-induced increased proteolysis in the diaphragm are well-documented, only one study has investigated methods of preserving diaphragmatic protein synthesis during prolonged MV. Therefore, we evaluated the efficacy of two therapeutic interventions that, conceptually, have the potential to sustain protein synthesis in the rat diaphragm during prolonged MV. Specifically, these experiments were designed to: 1) determine if partial-support MV will protect against the decrease in diaphragmatic protein synthesis that occurs during prolonged full-support MV; and 2) establish if treatment with a mitochondrial-targeted antioxidant will maintain diaphragm protein synthesis during full-support MV. Compared to spontaneously breathing animals, full support MV resulted in a significant decline in diaphragmatic protein synthesis during 12 hours of MV. In contrast, diaphragm protein synthesis rates were maintained during partial support MV at levels comparable to spontaneous breathing animals. Further, treatment of animals with a mitochondrial-targeted antioxidant prevented oxidative stress during full support MV and maintained diaphragm protein synthesis at the level of spontaneous breathing animals. We conclude that treatment with mitochondrial-targeted antioxidants or the use of partial-support MV are potential strategies to preserve diaphragm protein synthesis during prolonged MV.	[Hudson, Matthew B.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Smuder, Ashley J.; Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Ctr Exercise Sci, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Nelson, W. Bradley] Ohio Dominican Univ, Dept Nat Sci, Columbus, OH USA; [Shimkus, Kevin L.; Fluckey, James D.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Szeto, Hazel H.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida; Ohio Dominican University; Texas A&M University System; Texas A&M University College Station; Cornell University	Hudson, MB (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	mbhudson@temple.edu	Nelson, Brad/P-8771-2016	Nelson, Brad/0000-0003-0793-2006	National Institute of Health [R01AR064189]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064189] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institute of Health (grant #R01AR064189) awarded to SKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agten A, 2011, CRIT CARE MED, V39, P777, DOI 10.1097/CCM.0b013e318206cca9; Alirezaei M, 2001, J NEUROCHEM, V76, P1080, DOI 10.1046/j.1471-4159.2001.00105.x; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Bodine SC, 2006, MED SCI SPORT EXER, V38, P1950, DOI 10.1249/01.mss.0000233797.24035.35; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Bruells CS, 2013, ANESTHESIOLOGY, V119, P652, DOI 10.1097/ALN.0b013e31829b3692; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Eskandar N, 2007, CRIT CARE CLIN, V23, P263, DOI 10.1016/j.ccc.2006.12.002; Falk DJ, 2011, CHEST, V139, P816, DOI 10.1378/chest.09-2787; Futier E, 2008, CRIT CARE, V12, DOI 10.1186/cc7010; Gayan-Ramirez G, 2003, INTENS CARE MED, V29, P825, DOI 10.1007/s00134-003-1688-0; Hooijman PE, 2015, AM J RESP CRIT CARE, V191, P1126, DOI 10.1164/rccm.201412-2214OC; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Hudson MB, 2012, CRIT CARE MED, V40, P1254, DOI 10.1097/CCM.0b013e31823c8cc9; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Klawitter PF, 2004, J APPL PHYSIOL, V96, P89, DOI 10.1152/japplphysiol.00237.2003; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; McClung JM, 2009, CRIT CARE MED, V37, P1373, DOI 10.1097/CCM.0b013e31819cef63; MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250, DOI 10.1152/jappl.1983.55.1.250; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Rollier H, 1998, AM J RESP CRIT CARE, V157, P833, DOI 10.1164/ajrccm.157.3.9512103; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Smuder AJ, 2014, ANESTHESIOLOGY, V121, P115, DOI 10.1097/ALN.0000000000000245; Smuder AJ, 2012, CRIT CARE MED, V40, P927, DOI 10.1097/CCM.0b013e3182374a84; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Supinski GS, 2013, CRIT CARE, V17, DOI 10.1186/cc12792; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Vassilakopoulos T, 1996, Monaldi Arch Chest Dis, V51, P489; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	46	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137693	10.1371/journal.pone.0137693	http://dx.doi.org/10.1371/journal.pone.0137693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361212	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100072
J	Kang, J; Lee, HJ; Jun, SY; Park, ES; Maeng, LS				Kang, Jun; Lee, Hee Jin; Jun, Sun-Young; Park, Eun Su; Maeng, Lee-so			Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation	PLOS ONE			English	Article							GENOMIC CHARACTERIZATION; BREAST-CANCER; TUMOR-ANTIGEN; GENE; IMMUNOTHERAPY; MELANOMA; ABNORMALITIES; LYMPHOCYTES; ACTIVATION; RNA	Background Cancertestis antigens (CTAs) are potential targets for cancer immunotherapy. Many CTAs are located on the X chromosome and are epigenetically regulated. Loss of X chromosome inactivation (XCI) is observed in breast and ovarian cancers and is thought to be related to the overexpression of CTAs. We investigated the relation between expression of CTAs and loss of XCI in endometrial cancer. Materials and Methods We used data generated by The Cancer Genome Atlas Genome Data Analysis Centers and data for Xist knockout mice available at the Gene Expression Omnibus. Results The status of XCI was estimated by methylation status, and deletion or gain of the X chromosome. The endometrial cancers were classified into the following three groups: preserved inactivated X chromosome (Xi) (n = 281), partial reactivation of Xi (n = 52), and two copies of active X group (n = 38). Loss of XCI was more common in serous adenocarcinoma. Expression of CTAs increased in endometrial cancer with loss of XCI, which was accompanied by global hypomethylation. Expression of CTAs did not increase in Xist knockout mice. Conclusions Loss of XCI is common in serous adenocarcinoma. Global hypomethylation, and not loss of XCI, is the main mechanism of overexpression of CTAs.	[Kang, Jun; Jun, Sun-Young; Park, Eun Su; Maeng, Lee-so] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea; [Lee, Hee Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Catholic University of Korea; University of Ulsan; Asan Medical Center	Kang, J (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea.	jkang.alien@gmail.com		Jun, Sun-Young/0000-0002-3007-2094				Ahn J., 2008, NAT ED, V1, P24; [Anonymous], 2012, NATURE, V489, P519, DOI [DOI 10.1038/NATURE11404, 10.1038/nature11404]; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Chen ME, 1998, J BIOL CHEM, V273, P17618, DOI 10.1074/jbc.273.28.17618; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; De Backer O, 1999, CANCER RES, V59, P3157; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Jacobsen A, 2013, CGDSR R BASED API AC; Kang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118927; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Tureci O, 1996, CANCER RES, V56, P4766; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; WEBER J, 1994, CANCER RES, V54, P1766; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	27	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137476	10.1371/journal.pone.0137476	http://dx.doi.org/10.1371/journal.pone.0137476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360551	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100044
J	Kuling, IA; Smeets, JBJ; Lammertse, P; Onneweer, B; Mugge, W				Kuling, Irene A.; Smeets, Jeroen B. J.; Lammertse, Piet; Onneweer, Bram; Mugge, Winfred			Delays in Admittance-Controlled Haptic Devices Make Simulated Masses Feel Heavier	PLOS ONE			English	Article							PERCEPTION; WEIGHT	In an admittance-controlled haptic device, input forces are used to calculate the movement of the device. Although developers try to minimize delays, there will always be delays between the applied force and the corresponding movement in such systems, which might affect what the user of the device perceives. In this experiment we tested whether these delays in a haptic human-robot interaction influence the perception of mass. In the experiment an admittance-controlled manipulator was used to simulate various masses. In a staircase design subjects had to decide which of two virtual masses was heavier after gently pushing them leftward with the right hand in mid-air (no friction, no gravity). The manipulator responded as quickly as possible or with an additional delay (25 or 50 ms) to the forces exerted by the subject on the handle of the haptic device. The perceived mass was similar to 10% larger for a delay of 25 ms and similar to 20% larger for a delay of 50 ms. Based on these results, we estimated that the delays that are present in nowadays admittance-controlled haptic devices (up to 20ms) will give an increase in perceived mass which is smaller than the Weber fraction for mass (similar to 10% for inertial mass). Additional analyses showed that the subjects' decision on mass when the perceptual differences were small did not correlate with intuitive variables such as force, velocity or a combination of these, nor with any other measured variable, suggesting that subjects did not have a consistent strategy during guessing or used other sources of information, for example the efference copy of their pushes.	[Kuling, Irene A.; Smeets, Jeroen B. J.; Mugge, Winfred] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Lammertse, Piet] Moog BV, Nieuw Vennep, Netherlands; [Onneweer, Bram] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Vrije Universiteit Amsterdam; Delft University of Technology	Kuling, IA (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	i.a.kuling@vu.nl	Kuling, Irene/ABC-4022-2021; Smeets, Jeroen/B-4198-2008	Kuling, Irene/0000-0003-3556-0393; Smeets, Jeroen/0000-0002-3794-0579	Dutch Technology Foundation STW; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation; STW [12160]	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs, Agriculture and Innovation; STW(Technologiestichting STW)	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. STW grant 12160. Moog B.V. provided support in the form of salaries for author PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Bloch M. A. -M., 1885, CR HEBD ACAD SCI, V37, P493; Boessenkool H, 2013, IEEE T HAPTICS, V6, P2, DOI [10.1109/ToH.2012.22, 10.1109/TOH.2012.22]; Di Luca M, 2011, BRAIN RES BULL, V85, P245, DOI 10.1016/j.brainresbull.2010.02.009; Honda T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00760; Kahrimanovic M, 2011, IEEE T HAPTICS, V4, P316, DOI [10.1109/TOH.2011.22, 10.1109/ToH.2011.22]; Kambara H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00040; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Mulder M, 2012, HUMAN FACTORS J HUMA, V54, P681; Mulder M, 2008, IEEE SYS MAN CYBERN, P804, DOI 10.1109/ICSMC.2008.4811377; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Plaisier MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042518; Pressman A, 2007, INT J ROBOT RES, V26, P1191, DOI 10.1177/0278364907082611; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Tzafestas CS, 2013, PRESENCE-TELEOP VIRT, V22, P323, DOI 10.1162/PRES_a_00162; Wolfe H. K., 1898, PSYCHOL REV, V5, P25, DOI [DOI 10.1037/H0073342, 10.1037/h0073342]	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138023	10.1371/journal.pone.0138023	http://dx.doi.org/10.1371/journal.pone.0138023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361353	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100109
J	Liu, Y; Dun, BQ; Shi, PJ; Ma, R; Luo, HY; Bai, YG; Xie, XM; Yao, B				Liu, Yun; Dun, Baoqing; Shi, Pengjun; Ma, Rui; Luo, Huiying; Bai, Yingguo; Xie, Xiangming; Yao, Bin			A Novel GH7 Endo-beta-1,4-Glucanase from Neosartorya fischeri P1 with Good Thermostability, Broad Substrate Specificity and Potential Application in the Brewing Industry	PLOS ONE			English	Article							CLONING; ENDOGLUCANASES; PURIFICATION; DEGRADATION; CELLULOSE	An endo-beta-1,4-glucanase gene, cel7A, was cloned from the thermophilic cellulase-producing fungus Neosartorya fischeri P1 and expressed in Pichia pastoris. The 1,410-bp fulllength gene encodes a polypeptide of 469 amino acids consisting of a putative signal peptide at residues 1-20, a catalytic domain of glycoside hydrolase family 7 (GH7), a short Thr/Ser-rich linker and a family 1 carbohydrate-binding module (CBM 1). The purified recombinant Cel7A had pH and temperature optima of pH 5.0 and 60 degrees C, respectively, and showed broad pH adaptability (pH 3.0-6.0) and excellent stability at pH3.0-8.0 and 60 degrees C. Belonging to the group of nonspecific endoglucanases, Cel7A exhibited the highest activity on barley beta-glucan (2020 +/- 9 Umg(-1)), moderate on lichenan and CMC-Na, and weak on laminarin, locust bean galactomannan, Avicel, and filter paper. Under simulated mashing conditions, addition of Cel7A (99 mu g) reduced the mash viscosity by 9.1% and filtration time by 24.6%. These favorable enzymatic properties make Cel7A as a good candidate for applications in the brewing industry.	[Liu, Yun; Xie, Xiangming] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China; [Liu, Yun; Shi, Pengjun; Ma, Rui; Luo, Huiying; Bai, Yingguo; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Dun, Baoqing] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Xie, XM (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China.	xxm1005@126.com; binyao@caas.cn			National High Technology Research and Development Program of China [2012AA022208]; National Science Foundation for Distinguished Young Scholars of China [31225026]; National Natural Science Foundation of China [31101346, J1103516]; China Modern Agriculture Research System [CARS-42]; Fundamental Research Funds for the Central University of China [TD2012-03]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Modern Agriculture Research System; Fundamental Research Funds for the Central University of China	This research was supported by the National High Technology Research and Development Program of China (2012AA022208), the National Science Foundation for Distinguished Young Scholars of China (31225026), the National Natural Science Foundation of China (31101346, J1103516), the China Modern Agriculture Research System (CARS-42) and the Fundamental Research Funds for the Central University of China (TD2012-03).	Bai YG, 2010, APPL MICROBIOL BIOT, V87, P251, DOI 10.1007/s00253-010-2452-3; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Boyce A, 2007, APPL MICROBIOL BIOT, V76, P835, DOI 10.1007/s00253-007-1058-x; Brummell DA, 1997, P NATL ACAD SCI USA, V94, P4794, DOI 10.1073/pnas.94.9.4794; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Dimarogona M, 2012, BIORESOURCE TECHNOL, V110, P480, DOI 10.1016/j.biortech.2012.01.116; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Karlsson J, 2002, BIOPOLYMERS, V63, P32, DOI 10.1002/bip.1060; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Luo HY, 2010, APPL MICROBIOL BIOT, V85, P1015, DOI 10.1007/s00253-009-2119-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Silveira Celestino Klecius R., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-23; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang HM, 2014, BIORESOURCE TECHNOL, V153, P361, DOI 10.1016/j.biortech.2013.11.078; Wang K, 2014, PROCESS BIOCHEM, V49, P1448, DOI 10.1016/j.procbio.2014.06.003; Wei XM, 2010, J MICROBIOL BIOTECHN, V20, P265, DOI 10.4014/jmb.0904.04047; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106785; Zhao JQ, 2012, J BIOSCI BIOENG, V114, P379, DOI 10.1016/j.jbiosc.2012.04.021	28	14	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137485	10.1371/journal.pone.0137485	http://dx.doi.org/10.1371/journal.pone.0137485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360701	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100045
J	Menzel-Severing, J; Petsch, C; Tourtas, T; Polisetti, N; Klenke, J; Skerl, K; Wullner, C; Donitzky, C; Kruse, FE; Kremers, J; Hammer, CM				Menzel-Severing, Johannes; Petsch, Corinna; Tourtas, Theofilos; Polisetti, Naresh; Klenke, Joerg; Skerl, Katrin; Wuellner, Christian; Donitzky, Christof; Kruse, Friedrich E.; Kremers, Jan; Hammer, Christian M.			Evaluation of a 345 nm Femtosecond Laser for Corneal Surgery with Respect to Intraocular Radiation Hazard	PLOS ONE			English	Article							INCISION LENTICULE EXTRACTION; CLASSIFICATION-SYSTEM III; PHOTOCHEMICAL DAMAGE; LENS OPACITY; CROSS-LINKING; NUCLEAR; SAFETY; MYOPIA; OPACIFICATION; RIBOFLAVIN	Purpose We report our findings from a preclinical safety study designed to assess potential side effects of corneal ultraviolet femtosecond laser treatment on lens and retina. Methods Refractive lenticules (-5 dpt) with a diameter of 6 mm were created in the right cornea of eight Dutch Belted rabbits. Radiant exposure was 0.5 J/cm(2) in two animals and 18 J/cm(2) in six animals. The presence of lens opacities was assessed prior to and up to six months following laser application using Scheimpflug images (Pentacam, Oculus) and backscatter analysis (Opacity Lensmeter 702, Interzeag). Ganzfeld flash and flicker electroretinogram (ERG) recordings were obtained from both eyes prior to and up to six weeks following laser application. At the study endpoint, retinas were examined by light microscopy. Results Independent of energy dose applied, no cataract formation could be observed clinically or with either of the two objective methods used. No changes in ERG recordings over time and no difference between treated and untreated eye were detected. Histologically, retinal morphology was preserved and retinal pigment epithelium as well as photoreceptor inner and outer segments appeared undamaged. Quantitative digital image analysis did not reveal cell loss in inner or outer nuclear layers. Conclusions Our analysis confirms theoretical considerations suggesting that ultraviolet femtosecond laser treatment of the cornea is safe for intraocular tissues. Transmitted light including stray light induces no photochemical effects in lens or retina at energy levels much higher than required for the clinical purpose. These conclusions cannot be applied to eyes with preexisting retinal damage, as these may be more vulnerable to light.	[Menzel-Severing, Johannes; Petsch, Corinna; Tourtas, Theofilos; Polisetti, Naresh; Kruse, Friedrich E.; Kremers, Jan; Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Klenke, Joerg; Skerl, Katrin; Wuellner, Christian; Donitzky, Christof] WaveLight GmbH, Erlangen, Germany; [Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Anat 2, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Menzel-Severing, J (corresponding author), Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany.	johannes.menzel-severing@uk-erlangen.de	Kremers, Jan/X-3125-2019	Kremers, Jan/0000-0002-9293-7380; Polisetti, Naresh/0000-0001-8669-0388; Tourtas, Theofilos/0000-0002-3465-9837	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01EX1011B]; Wavelight GmbH	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Wavelight GmbH	This study was funded by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF), project grant no. 01EX1011B. The funder Wavelight GmbH provided support in the form of equipment (prototype femtosecond laser) and salaries for authors JoK, KS, CW and CD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ainsbury EA, 2009, RADIAT RES, V172, P1, DOI 10.1667/RR1688.1; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Cejka C, 2013, PHOTOCHEM PHOTOBIOL, V89, P474, DOI 10.1111/php.12010; Coroneo M, 2011, EYE CONTACT LENS, V37, P214, DOI 10.1097/ICL.0b013e318223394e; Gupta M, 2013, J CATARACT REFR SURG, V39, P1818, DOI 10.1016/j.jcrs.2013.05.052; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; Hammer CM, 2015, J CATARACT REFR SURG, V41, P1279, DOI 10.1016/j.jcrs.2014.11.046; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Hayashi LC, 2003, SCI TOTAL ENVIRON, V302, P53, DOI 10.1016/S0048-9697(02)00320-0; HOPPELER T, 1988, CURR EYE RES, V7, P849, DOI 10.3109/02713688808997242; Horn Folkert K., 2001, Documenta Ophthalmologica, V103, P105, DOI 10.1023/A:1012263922188; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Konig K, 2005, European Patent, Patent No. [1787607 A1, 1787607A1]; Kopf D, 2002, WO Patent, Patent No. [2,002,060,020, 2002060020]; LAWWILL T, 1973, INVEST OPHTH VISUAL, V12, P45; Le Harzic R, 2009, J REFRACT SURG, V25, P383, DOI 10.3928/1081597X-20090401-08; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; McKinlay AF, 2004, HEALTH PHYS, V87, P171; MIZUNO T, 1990, OPHTHALMIC RES, V22, P36, DOI 10.1159/000267062; Noell W K, 1966, Invest Ophthalmol, V5, P450; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Schumacher S, 2008, J REFRACT SURG, V24, P991, DOI 10.3928/1081597X-20081101-24; Seiler T, 2014, OPHTHALMOLOGE, V111, P539, DOI 10.1007/s00347-013-2993-9; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Sliney DH, 2002, INT J TOXICOL, V21, P501, DOI 10.1080/10915810290169927; Sliney DH, 2000, HDB OPTICS, VIII; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Sutton GL, 2010, CLIN EXP OPHTHALMOL, V38, P192, DOI 10.1111/j.1442-9071.2010.02227.x; Trost A, 2013, INVEST OPHTH VIS SCI, V54, P7854, DOI 10.1167/iovs.13-12580; TUFT SJ, 1990, BRIT J OPHTHALMOL, V74, P78, DOI 10.1136/bjo.74.2.78; Ullrich K, 2012, J CATARACT REFR SURG, V38, P2100, DOI 10.1016/j.jcrs.2012.07.033; Vestergaard A, 2012, J CATARACT REFR SURG, V38, P2003, DOI 10.1016/j.jcrs.2012.07.021; Wang MM, 2015, CLIN EXP OPHTHALMOL, V43, P156, DOI 10.1111/ceo.12392; Werner L, 2010, J CATARACT REFR SURG, V36, P1392, DOI 10.1016/j.jcrs.2010.02.018; Wu JM, 2006, SURV OPHTHALMOL, V51, P461, DOI 10.1016/j.survophthal.2006.06.009; ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137638	10.1371/journal.pone.0137638	http://dx.doi.org/10.1371/journal.pone.0137638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361228	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100060
J	Ghisleni, C; Bollmann, S; Biason-Lauber, A; Poil, SS; Brandeis, D; Martin, E; Michels, L; Hersberger, M; Suckling, J; Klaver, P; O'Gorman, RL				Ghisleni, Carmen; Bollmann, Steffen; Biason-Lauber, Anna; Poil, Simon-Shlomo; Brandeis, Daniel; Martin, Ernst; Michels, Lars; Hersberger, Martin; Suckling, John; Klaver, Peter; O'Gorman, Ruth L.			Effects of Steroid Hormones on Sex Differences in Cerebral Perfusion	PLOS ONE			English	Article							DEHYDROEPIANDROSTERONE-SULFATE LEVELS; BLOOD-FLOW; GENDER-DIFFERENCES; ENDOTHELIAL FUNCTION; REPLACEMENT THERAPY; BRAIN PERFUSION; POSTMENOPAUSAL WOMEN; MRI; ESTROGEN; AGE	Sex differences in the brain appear to play an important role in the prevalence and progression of various neuropsychiatric disorders, but to date little is known about the cerebral mechanisms underlying these differences. One widely reported finding is that women demonstrate higher cerebral perfusion than men, but the underlying cause of this difference in perfusion is not known. This study investigated the putative role of steroid hormones such as oestradiol, testosterone, and dehydroepiandrosterone sulphate (DHEAS) as underlying factors influencing cerebral perfusion. We acquired arterial spin labelling perfusion images of 36 healthy adult subjects (16 men, 20 women). Analyses on average whole brain perfusion levels included a multiple regression analysis to test for the relative impact of each hormone on the global perfusion. Additionally, voxel-based analyses were performed to investigate the sex difference in regional perfusion as well as the correlations between local perfusion and serum oestradiol, testosterone, and DHEAS concentrations. Our results replicated the known sex difference in perfusion, with women showing significantly higher global and regional perfusion. For the global perfusion, DHEAS was the only significant predictor amongst the steroid hormones, showing a strong negative correlation with cerebral perfusion. The voxel-based analyses revealed modest sex-dependent correlations between local perfusion and testosterone, in addition to a strong modulatory effect of DHEAS in cortical, subcortical, and cerebellar regions. We conclude that DHEAS in particular may play an important role as an underlying factor driving the difference in cerebral perfusion between men and women.	[Ghisleni, Carmen; Bollmann, Steffen; Poil, Simon-Shlomo; Martin, Ernst; Michels, Lars; Klaver, Peter; O'Gorman, Ruth L.] Univ Childrens Hosp Zurich, Ctr MR Res, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Poil, Simon-Shlomo; Brandeis, Daniel; Martin, Ernst; Klaver, Peter; O'Gorman, Ruth L.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Brandeis, Daniel; Martin, Ernst; Klaver, Peter] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Brandeis, Daniel; Martin, Ernst; Klaver, Peter] Swiss Fed Inst Technol, Zurich, Switzerland; [Biason-Lauber, Anna] Univ Fribourg, Dept Med, Endocrinol, CH-1700 Fribourg, Switzerland; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Michels, Lars] Univ Zurich Hosp, Klin Neuroradiol, CH-8091 Zurich, Switzerland; [Hersberger, Martin] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland; [Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England; [Klaver, Peter] Univ Zurich, Dept Psychol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Fribourg; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Cambridge; University of Zurich	O'Gorman, RL (corresponding author), Univ Childrens Hosp Zurich, Ctr MR Res, Zurich, Switzerland.	Ruth.OGorman@kispi.uzh.ch	Michels, Lars/X-6939-2018; Bollmann, Steffen/N-3413-2014; Klaver, Peter/G-7988-2011; Klaver, Peter/M-9506-2019; Suckling, John/ABD-7246-2021	Bollmann, Steffen/0000-0002-2909-0906; Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; Suckling, John/0000-0002-5098-1527; Hersberger, Martin/0000-0002-4472-329X; Michels, Lars/0000-0003-3750-1100; O'Gorman, Ruth/0000-0001-5932-7786	University Research Priority Program	University Research Priority Program	This work was supported by University Research Priority Program "Integrative Human Physiology": www.zihp.uzh.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2008, HYPERTENS RES, V31, P69, DOI 10.1291/hypres.31.69; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azad N, 2003, J CLIN ENDOCR METAB, V88, P3064, DOI 10.1210/jc.2002-020632; BAXTER LR, 1987, PSYCHIAT RES, V21, P237, DOI 10.1016/0165-1781(87)90028-X; Behringer V, 2012, J ENDOCRINOL, V214, P55, DOI 10.1530/JOE-12-0103; Carlson LE, 1999, HORM BEHAV, V35, P254, DOI 10.1006/hbeh.1999.1518; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Deegan BM, 2010, J APPL PHYSIOL, V109, P1424, DOI 10.1152/japplphysiol.01262.2009; Grasa MD, 2013, NEUROPSYCHOBIOLOGY, V67, P230, DOI 10.1159/000350473; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; DEVOUS MD, 1986, J CEREBR BLOOD F MET, V6, P95, DOI 10.1038/jcbfm.1986.12; Dong Y, 2012, J NEUROENDOCRINOL, V24, P215, DOI 10.1111/j.1365-2826.2011.02256.x; Elmlinger MW, 2002, CLIN CHEM LAB MED, V40, P1151, DOI 10.1515/CCLM.2002.202; Esposito G, 1996, J NUCL MED, V37, P559; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GUR RE, 1990, SCHIZOPHRENIA BULL, V16, P247, DOI 10.1093/schbul/16.2.247; HAFNER H, 1991, EUR ARCH PSY CLIN N, V241, P65, DOI 10.1007/BF02193758; Hofer A, 2006, NEUROIMAGE, V32, P854, DOI 10.1016/j.neuroimage.2006.03.053; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Jimenez MC, 2013, STROKE, V44, P1785, DOI 10.1161/STROKEAHA.111.000485; Kaya E, 2008, MATURITAS, V59, P72, DOI 10.1016/j.maturitas.2007.10.004; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Mazat L, 2001, P NATL ACAD SCI USA, V98, P8145, DOI 10.1073/pnas.121177998; Murialdo G, 2000, NEUROPSYCHOBIOLOGY, V42, P51, DOI 10.1159/000026672; Naruo T, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-2; Nevo O, 2007, AM J PHYSIOL-HEART C, V293, pH3265, DOI 10.1152/ajpheart.00633.2007; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Penotti M, 2001, FERTIL STERIL, V76, P235, DOI 10.1016/S0015-0282(01)01923-9; PODREKA I, 1989, STROKE, V20, P183, DOI 10.1161/01.STR.20.2.183; Savineau JP, 2013, BIOCHEM PHARMACOL, V85, P718, DOI 10.1016/j.bcp.2012.12.004; Silvestri A, 2005, MATURITAS, V50, P305, DOI 10.1016/j.maturitas.2004.07.012; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027; Sulcova J, 1997, J ENDOCRINOL, V154, P57, DOI 10.1677/joe.0.1540057; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Tannenbaum C, 2004, EUR J ENDOCRINOL, V151, P717, DOI 10.1530/eje.0.1510717; Tchernof A, 2004, EUR J ENDOCRINOL, V151, P1, DOI 10.1530/eje.0.1510001; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Williams MRI, 2004, J CLIN ENDOCR METAB, V89, P4708, DOI 10.1210/jc.2003-031560	59	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135827	10.1371/journal.pone.0135827	http://dx.doi.org/10.1371/journal.pone.0135827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356576	gold, Green Published, Green Accepted			2022-12-27	WOS:000360965800007
J	Hadchouel, A; Marchand-Martin, L; Franco-Montoya, ML; Peaudecerf, L; Ancel, PY; Delacourt, C				Hadchouel, Alice; Marchand-Martin, Laetitia; Franco-Montoya, Marie-Laure; Peaudecerf, Laetitia; Ancel, Pierre-Yves; Delacourt, Christophe		EPIPAGEADO Study Grp	Salivary Telomere Length and Lung Function in Adolescents Born Very Preterm: A Prospective Multicenter Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TOBACCO-SMOKE EXPOSURE; EXHALED NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; CIRCULATING LEUKOCYTES; OXIDATIVE STRESS; CHILDREN BORN; SCHOOL-AGE; CHILDHOOD; BIRTH	Preterm birth is associated with abnormal respiratory functions throughout life. The mechanisms underlying these long-term consequences are still unclear. Shortening of telomeres was associated with many conditions, such as chronic obstructive pulmonary disease. We aimed to search for an association between telomere length and lung function in adolescents born preterm. Lung function and telomere length were measured in 236 adolescents born preterm and 38 born full-term from the longitudinal EPIPAGE cohort. Associations between telomere length and spirometric indices were tested in univariate and multivariate models accounting for confounding factors in the study population. Airflows were significantly lower in adolescents born preterm than controls; forced expiratory volume in one second was 12% lower in the extremely preterm born group than controls (p< 0.001). Lower birth weight, bronchopulmonary dysplasia and postnatal sepsis were significantly associated with lower airflow values. Gender was the only factor that was significantly associated with telomere length. Telomere length correlated with forced expiratory flow 25-75 in the extremely preterm adolescent group in univariate and multivariate analyses (p = 0.01 and p = 0.02, respectively). We evidenced an association between telomere length and abnormal airflow in a population of adolescents born extremely preterm. There was no evident association with perinatal events. This suggests other involved factors, such as a continuing airway oxidative stress leading to persistent inflammation and altered lung function, ultimately increasing susceptibility to chronic obstructive pulmonary disease.	[Hadchouel, Alice; Delacourt, Christophe] Hop Univ Necker Enfants Malades, AP HP, Pneumol & Allergol Pediat, F-75015 Paris, France; [Hadchouel, Alice; Franco-Montoya, Marie-Laure; Delacourt, Christophe] INSERM, Equipe 4, U955, F-94000 Creteil, France; [Hadchouel, Alice; Ancel, Pierre-Yves; Delacourt, Christophe] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Marchand-Martin, Laetitia; Ancel, Pierre-Yves] INSERM, UMR 1153, F-75004 Paris, France; [Peaudecerf, Laetitia] AP HP, Unite Rech Clin Cochin Necker, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Hadchouel, A (corresponding author), Hop Univ Necker Enfants Malades, AP HP, Pneumol & Allergol Pediat, F-75015 Paris, France.	alice.hadchouel-duverge@aphp.fr	Delacourt, Christophe/K-6161-2019	ANCEL, pierre-yves/0000-0001-9632-7494; Marchand-Martin, Laetitia/0000-0002-8036-8387	Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et de Developpement); Programme Hospitalier de Recherche Clinique-PHRC (Ministere de la Sante) [AOM P100117]; l'Agence Nationale de la Recherche [ANR-12-BSV1-0004-01]	Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et de Developpement); Programme Hospitalier de Recherche Clinique-PHRC (Ministere de la Sante); l'Agence Nationale de la Recherche(French National Research Agency (ANR))	The present study was sponsored by Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et de Developpement). The study was funded by a grant from Programme Hospitalier de Recherche Clinique-PHRC 2010 (Ministere de la Sante, No AOM P100117). AH was funded by l'Agence Nationale de la Recherche (ANR-12-BSV1-0004-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Carraro S, 2015, J PEDIATR-US, V166, P234, DOI 10.1016/j.jpeds.2014.08.049; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Filippone M, 2012, EUR RESPIR J, V40, P1253, DOI 10.1183/09031936.00185511; Friedrich U, 2001, PEDIATR RES, V49, P252, DOI 10.1203/00006450-200102000-00020; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; Kajantie E, 2012, INT J EPIDEMIOL, V41, P1400, DOI 10.1093/ije/dys127; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Laganovic M, 2014, J HYPERTENS, V32, P1613, DOI 10.1097/HJH.0000000000000217; Landau LI, 2008, PAEDIATR RESPIR REV, V9, P39, DOI 10.1016/j.prrv.2007.11.002; Larroque B, 2000, Arch Pediatr, V7 Suppl 2, p339s, DOI 10.1016/S0929-693X(00)80094-9; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; LEBECQUE P, 1993, PEDIATR PULM, V16, P19, DOI 10.1002/ppul.1950160105; Lum S, 2011, EUR RESPIR J, V37, P1199, DOI 10.1183/09031936.00071110; Maritz GS, 2011, INT J ENV RES PUB HE, V8, P875, DOI 10.3390/ijerph8030875; Mieskonen ST, 2002, PEDIATR PULM, V33, P347, DOI 10.1002/ppul.10084; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montuschi P, 2010, METHODS MOL BIOL, V594, P73, DOI 10.1007/978-1-60761-411-1_5; Mui TSY, 2009, J AM GERIATR SOC, V57, P2372, DOI 10.1111/j.1532-5415.2009.02589.x; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Quanjer PH, 2010, EUR RESPIR J, V36, P1391, DOI 10.1183/09031936.00164109; Rode L, 2013, THORAX, V68, P429, DOI 10.1136/thoraxjnl-2012-202544; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Tarry-Adkins JL, 2011, AM J CLIN NUTR, V94, p1765S, DOI 10.3945/ajcn.110.000620; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; Theall KP, 2013, SOC SCI MED, V85, P50, DOI 10.1016/j.socscimed.2013.02.030; Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956; Vollsaeter M, 2013, THORAX, V68, P767, DOI 10.1136/thoraxjnl-2012-202980; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Zapletal A, 1987, LUNG FUNCTION CHILDR; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	46	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136123	10.1371/journal.pone.0136123	http://dx.doi.org/10.1371/journal.pone.0136123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355460	Green Submitted, gold, Green Published			2022-12-27	WOS:000360965800011
J	Burnett, SM; Mbonye, MK; Naikoba, S; Stella, ZM; Kinoti, SN; Ronald, A; Rubashembusya, T; Willis, KS; Colebunders, R; Manabe, YC; Weaver, MR				Burnett, Sarah M.; Mbonye, Martin K.; Naikoba, Sarah; Stella, Zawedde-Muyanja; Kinoti, Stephen N.; Ronald, Allan; Rubashembusya, Timothy; Willis, Kelly S.; Colebunders, Robert; Manabe, Yukari C.; Weaver, Marcia R.			Effect of Educational Outreach Timing and Duration on Facility Performance for Infectious Disease Care in Uganda: A Trial with Pre-Post and Cluster Randomized Controlled Components	PLOS ONE			English	Article							CONTINUOUS QUALITY IMPROVEMENT; CONTINUING MEDICAL-EDUCATION; MALARIA CASE-MANAGEMENT; INTEGRATED MANAGEMENT; HEALTH; ILLNESS; PROFESSIONALS; INTERVENTION; NURSES	Background Classroom-based learning is often insufficient to ensure high quality care and application of health care guidelines. Educational outreach is garnering attention as a supplemental method to enhance health care worker capacity, yet there is little information about the timing and duration required to improve facility performance. We sought to evaluate the effects of an infectious disease training program followed by either immediate or delayed on-site support (OSS), an educational outreach approach, on nine facility performance indicators for emergency triage, assessment, and treatment; malaria; and pneumonia. We also compared the effects of nine monthly OSS visits to extended OSS, with three additional visits over six months. Methods This study was conducted at 36 health facilities in Uganda, covering 1,275,960 outpatient visits over 23 months. From April 2010 to December 2010, 36 sites received infectious disease training; 18 randomly selected sites in arm A received nine monthly OSS visits (immediate OSS) and 18 sites in arm B did not. From March 2011 to September 2011, arm A sites received three additional visits every two months (extended OSS), while the arm B sites received eight monthly OSS visits (delayed OSS). We compared the combined effect of training and delayed OSS to training followed by immediate OSS to determine the effect of delaying OSS implementation by nine months. We also compared facility performance in arm A during the extended OSS to immediate OSS to examine the effect of additional, less frequent OSS. Results Delayed OSS, when combined with training, was associated with significant pre/post improvements in four indicators: outpatients triaged (44% vs. 87%, aRR = 1.54, 99% CI = 1.11, 2.15); emergency and priority patients admitted, detained, or referred (16% vs. 31%, aRR = 1.74, 99% CI = 1.10, 2.75); patients with a negative malaria test result prescribed an antimalarial (53% vs. 34%, aRR = 0.67, 99% CI = 0.55, 0.82); and pneumonia suspects assessed for pneumonia (6% vs. 27%, aRR = 2.97, 99% CI = 1.44, 6.17). Differences between the delayed OSS and immediate OSS arms were not statistically significant for any of the nine indicators (all adjusted relative RR (aRRR) between 0.76-1.44, all p > 0.06). Extended OSS was associated with significant improvement in two indicators (outpatients triaged: aRR = 1.09, 99% CI = 1.01; emergency and priority patients admitted, detained, or referred: aRR = 1.22, 99% CI = 1.01, 1.38) and decline in one (pneumonia suspects assessed for pneumonia: aRR: 0.93; 99% CI = 0.88, 0.98). Conclusions Educational outreach held up to nine months after training had similar effects on facility performance as educational outreach started within one month post-training. Six months of bimonthly educational outreach maintained facility performance gains, but incremental improvements were heterogeneous.	[Burnett, Sarah M.; Willis, Kelly S.] Accordia Global Hlth Fdn, Washington, DC USA; [Mbonye, Martin K.; Naikoba, Sarah; Stella, Zawedde-Muyanja; Rubashembusya, Timothy] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Kinoti, Stephen N.] Univ Res Co LLC, Ctr Human Serv, Bethesda, MD USA; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Colebunders, Robert] Univ Antwerp, Fac Med & Hlth Sci, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Weaver, Marcia R.] Univ Washington, I TECH, Dept Global Hlth, Seattle, WA 98195 USA	Makerere University; University of Manitoba; University of Antwerp; Institute of Tropical Medicine (ITM); Johns Hopkins University; University of Washington; University of Washington Seattle	Burnett, SM (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium.	sburnett@path.org		Colebunders, Robert/0000-0002-1919-1340; Zawedde-Muyanja, Stella/0000-0002-8823-7082	Bill & Melinda Gates Foundation [94298]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions contained within the manuscript are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation.	[Anonymous], QUAL ASS PROJ QAP 1; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bloom BS, 2005, INT J TECHNOL ASSESS, V21, P380, DOI 10.1017/S026646230505049X; Burlew R, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-20; Davis D, 2009, CHEST, V135, p42S, DOI 10.1378/chest.08-2517; Engels Y, 2006, BRIT J GEN PRACT, V56, P781; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Franco L. M., 2009, COLLABORATIVE EVALUA; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Government of Uganda Ministry of Health, 2004, HLTH SECT STRAT PLAN; Imani PD, BMC PEDIAT IN PRESS; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Mariam DH, 2014, ACAD MED, V89, pS50, DOI 10.1097/ACM.0000000000000330; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; Naikoba S, 2012, INT J CARE PATHWAYS, V16, P152, DOI DOI 10.1177/2040402613479342; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; O'Brien MA, 2008, COCHRANE LIB; O'Malley G, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-20; Rowe AK, 2012, TROP MED INT HEALTH, V17, P438, DOI 10.1111/j.1365-3156.2012.02976.x; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Rubenstein L, 2014, INT J QUAL HEALTH C, V26, P6, DOI 10.1093/intqhc/mzt085; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; The President's Emergency Plan for AIDS Relief, 2014, QUAL STRAT PHAS 1 I; Wayne W, 2013, SERVICE DELIVERY IND; Weaver MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051319; Weaver MR, PLOS ONE, V9; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	32	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136966	10.1371/journal.pone.0136966	http://dx.doi.org/10.1371/journal.pone.0136966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352257	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800055
J	Kim, SA; Jung, SK; Paik, JS; Yang, SW				Kim, Su Ah; Jung, Su Kyung; Paik, Ji Sun; Yang, Suk-Woo			Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy	PLOS ONE			English	Article							EXTRAOCULAR-MUSCLE SURGERY; GRAVES OPHTHALMOPATHY; ORBITOPATHY	Objective To evaluate changes in corneal astigmatism in patients undergoing orbital decompression surgery. Methods This retrospective, non randomized comparative study involved 42 eyes from 21 patients with thyroid ophthalmopathy who underwent orbital decompression surgery between September 2011 and September 2014. The 42 eyes were divided into three groups: control (9 eyes), two-wall decompression (25 eyes), and three-wall decompression (8 eyes). The control group was defined as the contralateral eyes of nine patients who underwent orbital decompression surgery in only one eye. Corneal topography (Orbscan II), Hertel exophthalmometry, and intraocular pressure were measured at 1 month before and 3 months after surgery. Corneal topographic parameters analyzed were total astigmatism (TA), steepest axis (SA), central corneal thickness (CCT), and anterior chamber depth (ACD). Results Exophthalmometry values and intraocular pressure decreased significantly after the decompression surgery. The change (absolute value (vertical bar x vertical bar) of the difference) in astigmatism at the 3 mm zone was significantly different between the decompression group and the controls (p = 0.025). There was also a significant change in the steepest axis at the 3 mm zone between the decompression group and the controls (p = 0.033). An analysis of relevant changes in astigmatism showed that there was a dominant tendency for incyclotorsion of the steepest axis in eyes that underwent decompression surgery. Using Astig PLOT, the mean surgically induced astigmatism (SIA) was 0.21 +/- 0.88 D with an axis of 46 +/- 22 degrees, suggesting that decompression surgery did change the corneal shape and induced incyclotorsion of the steepest axis. Conclusions There was a significant change in corneal astigmatism after orbital decompression surgery and this change was sufficient to affect the optical function of the cornea. Surgeons and patients should be aware of these changes.	[Kim, Su Ah; Jung, Su Kyung; Paik, Ji Sun; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Yang, SW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol, Seoul, South Korea.	yswoph@daum.net						Ben Simon GJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P1671, DOI 10.1001/archopht.123.12.1671; Hainsworth DP, 1999, J AAPOS, V3, P80, DOI 10.1016/S1091-8531(99)70074-1; Heufelder A E, 2000, Rev Endocr Metab Disord, V1, P87, DOI 10.1023/A:1010020621687; KWITKO S, 1991, ARCH OPHTHALMOL-CHIC, V109, P873, DOI 10.1001/archopht.1991.01080060137042; Lieberman DM, 2000, CORNEA, V19, P336, DOI 10.1097/00003226-200005000-00016; Mombaerts I, 2006, EYE, V20, P440, DOI 10.1038/sj.eye.6701898; Nardi M, 1997, J PEDIAT OPHTH STRAB, V34, P244; Norris JH, 2012, EYE, V26, P535, DOI 10.1038/eye.2011.362; Orbscan II, 2002, OPERATORS MANUAL SOF, P8; Paridaens D, 2006, EYE, V20, P154, DOI 10.1038/sj.eye.6701827; Wakelkamp IMMJ, 2005, CLIN ENDOCRINOL, V63, P323, DOI 10.1111/j.1365-2265.2005.02345.x; Yang DM, 1999, THYROID, V9, P305, DOI 10.1089/thy.1999.9.305; Zinkernagel MS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1610, DOI 10.1001/archopht.125.12.1610	13	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0133612	10.1371/journal.pone.0133612	http://dx.doi.org/10.1371/journal.pone.0133612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352432	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800002
J	Motawi, TK; Shaker, OG; El-Maraghy, SA; Senousy, MA				Motawi, Tarek K.; Shaker, Olfat G.; El-Maraghy, Shohda A.; Senousy, Mahmoud A.			Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; LIVER-DISEASE; RISK-FACTORS; EXPRESSION; CELLS; PROGRESSION; HEPATOCARCINOGENESIS; OVEREXPRESSION; IDENTIFICATION; TUMORIGENESIS	Circulating microRNAs are deregulated in liver fibrosis and hepatocellular carcinoma (HCC) and are candidate biomarkers. This study investigated the potential of serum microRNAs; miR-19a, miR-296, miR-130a, miR-195, miR-192, miR-34a, and miR-146a as early diagnostic biomarkers for hepatitis C virus (HCV)-related HCC. As how these microRNAs change during liver fibrosis progression is not clear, we explored their serum levels during fibrosis progression in HCV-associated chronic liver disease (CLD) and if they could serve as non-invasive biomarkers for fibrosis progression to HCC. 112 Egyptian HCV-HCC patients, 125 nonmalignant HCV-CLD patients, and 42 healthy controls were included. CLD patients were subdivided according to Metavir fibrosis-scoring. Serum microRNAs were measured by qRT-PCR customarray. Serum microRNAs were deregulated in HCC versus controls, and except miR-130a, they were differentially expressed between HCC and CLD or late fibrosis (F3-F4) subgroup. Serum microRNAs were not significantly different between individual fibrosis-stages or between F1-F2 (early/moderate fibrosis) and F3-F4. Only miR-19a was significantly downregulated from liver fibrosis (F1-F3) to cirrhosis (F4) to HCC. Individual microRNAs discriminated HCC from controls, and except miR-130a, they distinguished HCC from CLD or F3-F4 patients by receiver-operating-characteristic analysis. Multivariate logistic analysis revealed a panel of four microRNAs (miR-19a, miR-195, miR-192, and miR-146a) with high diagnostic accuracy for HCC (AUC = 0.946). The microRNA panel also discriminated HCC from controls (AUC = 0.949), CLD (AUC = 0.945), and F3-F4 (AUC = 0.955). Studied microRNAs were positively correlated in HCC group. miR-19a and miR-34a were correlated with portal vein thrombosis and HCC staging scores, respectively. In conclusion, studied microRNAs, but not miR-130a, could serve as potential early biomarkers for HCC in high-risk groups, with miR-19a as a biomarker for liver fibrosis progression to cirrhosis to HCC. We identified a panel of four serum microRNAs with high accuracy in HCC diagnosis. Additional studies are required to confirm this panel and test its prognostic significance.	[Motawi, Tarek K.; El-Maraghy, Shohda A.; Senousy, Mahmoud A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Senousy, MA (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	mohmoud.ali@pharma.cu.edu.eg	Issa, Randa @M.T/E-7144-2019; Senousy, Mahmoud Ahmed/AAB-6410-2022; Shaker, Olfat G/S-2010-2017; O, Shaker/Y-6125-2019	Issa, Randa @M.T/0000-0003-0619-1234; O, Shaker/0000-0002-3031-3599; Motawi, Tarek/0000-0001-8925-9702	Research Service of the Faculty of Pharmacy, Cairo University	Research Service of the Faculty of Pharmacy, Cairo University	Funding: This research was supported by the Research Service of the Faculty of Pharmacy, Cairo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Attallah AM, 2013, BRIT J CANCER, V109, P1657, DOI 10.1038/bjc.2013.481; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; El-Garem H, 2014, WORLD J HEPATOL, V6, P818, DOI 10.4254/wjh.v6.i11.818; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ElHefnawi Mahmoud, 2013, Genomics Proteomics & Bioinformatics, V11, P354, DOI 10.1016/j.gpb.2013.05.007; Freedman LS, 2006, CANC INCIDENCE 4 MEM; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Han ZB, 2012, MOL ONCOL, V6, P445, DOI 10.1016/j.molonc.2012.04.001; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Henrici A, 2013, MOL CARCINOG; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Jeong SW, 2012, CLIN MOL HEPATOL, V18, P347, DOI 10.3350/cmh.2012.18.4.347; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Matsumura H, 2013, WORLD J GASTROENTERO, V19, P4887, DOI 10.3748/wjg.v19.i30.4887; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Motawi TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120794; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pok S, 2013, J GASTROEN HEPATOL, V28, P1545, DOI 10.1111/jgh.12216; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Rong MH, 2014, UPSALA J MED SCI, V119, P19, DOI 10.3109/03009734.2013.856970; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Tan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107986; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Vaira V, 2012, ONCOGENE, V31, P27, DOI 10.1038/onc.2011.209; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Zhang Z, 2015, MOL CANCER, V14, DOI 10.1186/1476-4598-14-5; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	60	53	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137706	10.1371/journal.pone.0137706	http://dx.doi.org/10.1371/journal.pone.0137706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352740	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800112
J	Russell, BJ; Dierssen, HM				Russell, Brandon J.; Dierssen, Heidi M.			Use of Hyperspectral Imagery to Assess Cryptic Color Matching in Sargassum Associated Crabs	PLOS ONE			English	Article							GULF-OF-MEXICO; IN-SITU SPECTROMETRY; FIDDLER-CRAB; PELAGIC SARGASSUM; CALLINECTES-SAPIDUS; VISUAL PIGMENTS; MATE CHOICE; BLUE-CRAB; CAMOUFLAGE; ECOLOGY	Mats of the pelagic macroalgae Sargassum represent a complex environment for the study of marine camouflage at the air-sea interface. Endemic organisms have convergently evolved similar colors and patterns, but quantitative assessments of camouflage strategies are lacking. Here, spectral camouflage of two crab species (Portunus sayi and Planes minutus) was assessed using hyperspectral imagery (HSI). Crabs matched Sargassum reflectance across blue and green wavelengths (400-550 nm) and diverged at longer wavelengths. Maximum discrepancy was observed in the far-red (i.e., 675 nm) where Chlorophyll a absorption occurred in Sargassum and not the crabs. In a quantum catch color model, both crabs showed effective color matching against blue/green sensitive dichromat fish, but were still discernible to tetrachromat bird predators that have visual sensitivity to far red wavelengths. The two species showed opposing trends in background matching with relation to body size. Variation in model parameters revealed that discrimination of crab and background was impacted by distance from the predator, and the ratio of cone cell types for bird predators. This is one of the first studies to detail background color matching in this unique, challenging ecosystem at the air-sea interface.	[Russell, Brandon J.; Dierssen, Heidi M.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Dierssen, Heidi M.] Univ Connecticut, Dept Geog, Storrs, CT 06268 USA	University of Connecticut; University of Connecticut	Russell, BJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	Brandon.Russell@uconn.edu			Office of Naval Research, Multi-University Research Initiative [N000140911054]	Office of Naval Research, Multi-University Research Initiative	This work was funded by the Office of Naval Research (http://www.onr.navy.mil/) Multi-University Research Initiative (N000140911054). Ship time was donated by the Bermuda Alliance for the Sargasso Sea, and the Bermuda Aquarium, Museum, and Zoo.	Akkaynak D, 2013, J COMP PHYSIOL A, V199, P211, DOI 10.1007/s00359-012-0785-3; Baldwin J, 2012, J EXP BIOL, V215, P1184, DOI 10.1242/jeb.067512; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Barnard ME, 2012, INVERTEBR BIOL, V131, P52, DOI 10.1111/j.1744-7410.2011.00256.x; Brady PC, 2013, P NATL ACAD SCI USA, V110, P9764, DOI 10.1073/pnas.1222125110; Brooks W. Randy, 2007, Gulf of Mexico Science, V25, P144; Brown FA, 1939, AM NAT, V73, P564, DOI 10.1086/280866; BURSEY CR, 1984, CRUSTACEANA, V47, P278, DOI 10.1163/156854084X00531; Chang GC, 2004, J GEOPHYS RES, V109, P10; Cheney KL, 2009, P R SOC B, V276, P1565, DOI 10.1098/rspb.2008.1819; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chronin TW, 2014, VISUAL ECOLOGY, DOI [10.1186/1472-6785-14-14, DOI 10.1186/1472-6785-14-14]; Coston-Clements L., 1991, NMFSSEFSC296 NOAA; Cott H.B., 1940, ADAPTIVE COLORATION; Crozier WJ, 1918, AM NAT, V52, P262, DOI 10.1086/279666; Cummings ME, 2008, ANIM BEHAV, V75, P175, DOI 10.1016/j.anbehav.2007.04.016; Darnell MZ, 2012, J EXP MAR BIOL ECOL, V426, P39, DOI 10.1016/j.jembe.2012.05.014; Defrize J, 2010, J EXP BIOL, V213, P1425, DOI 10.1242/jeb.039743; Detto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001629; Detto T, 2007, P ROY SOC B-BIOL SCI, V274, P2785, DOI 10.1098/rspb.2007.1059; Dierssen HM, 2015, REMOTE SENS ENVIRON, V167, P247, DOI 10.1016/j.rse.2015.01.027; DOOLEY JK, 1972, CONTRIB MAR SCI, V16, P1; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; FINE ML, 1970, MAR BIOL, V7, P112, DOI 10.1007/BF00354914; Fritsches KA, 2000, PHILOS T ROY SOC B, V355, P1253, DOI 10.1098/rstb.2000.0678; Gilerson AA, 2013, APPL OPTICS, V52, P8685, DOI 10.1364/AO.52.008685; Gower J, 2006, IEEE T GEOSCI REMOTE, V44, P3619, DOI 10.1109/TGRS.2006.882258; Green JP, 1963, THESIS U MINNESOTA M; HACKER SD, 1991, MAR ECOL PROG SER, V70, P143, DOI 10.3354/meps070143; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon RT, 2013, BIOL J LINN SOC, V109, P535, DOI 10.1111/bij.12071; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2004, J EXP BIOL, V207, P1229, DOI 10.1242/jeb.00857; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HITCHCOCK HAROLD B., 1941, BIOL BULL, V80, P26, DOI 10.2307/1537704; Hultgren KM, 2012, ANIMAL CAMOUFLAGE ME; Hultgren KM, 2008, OECOLOGIA, V155, P519, DOI 10.1007/s00442-007-0926-5; Hurtado-Gonzales JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101497; HUTCHINSON KA, 2004, THESIS FLORIDA ATLAN; Hyatt GW, 1975, PHYSL ECOLOGY ESTUAR; Iampietro P., 1999, THESIS CALIFORNIA ST; Jobe CF, 2009, SYMBIOSIS, V49, P77, DOI 10.1007/s13199-009-0017-y; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Josef N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037579; Langmore NE, 2011, P ROY SOC B-BIOL SCI, V278, P2455, DOI 10.1098/rspb.2010.2391; Manolakis D., 2003, Lincoln Laboratory Journal, V14, P79; McPherson ML, 2011, ESTUAR COAST, V34, P1150, DOI 10.1007/s12237-011-9411-9; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; MONAHAN E, 1986, OCEANIC WHITECAPS TH; Morris BF, 1973, IDENTIFICATION MANUA; Moser ML, 2012, WILSON J ORNITHOL, V124, P66, DOI 10.1676/11-067.1; MUNZ FW, 1975, VISION RES, V15, P1045, DOI 10.1016/0042-6989(75)90001-2; Palko B. J., 1982, FAO FISHERIES SYNOPS, V130; PARR ALBERT EIDE, 1939, BULL BINGHAM OCEANOGR COLL PEABODY MUS NAT HIST, V6, P1; Peres JM, 1982, MARINE ECOLOGY 1, V5, P314; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Randolph K, 2014, J GEOPHYS RES-OCEANS, V119, P757, DOI 10.1002/2013JC009227; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; Russell BJ, 2012, OC OPT C 21 OCT 8 12; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Silbiger N, 2008, J EXP MAR BIOL ECOL, V355, P41, DOI 10.1016/j.jembe.2007.11.014; SMITH K L JR, 1973, Journal of Experimental Marine Biology and Ecology, V12, P219, DOI 10.1016/0022-0981(73)90055-5; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Troscianko J, 2015, METHODS ECOL EVOL; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; WEIS JS, 1968, AM MIDL NAT, V80, P554, DOI 10.2307/2423550; Wells RJD, 2009, J FISH BIOL, V75, P1719, DOI 10.1111/j.1095-8649.2009.02424.x; West L. E., 2012, THESIS FLORIDA ATLAN	74	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136260	10.1371/journal.pone.0136260	http://dx.doi.org/10.1371/journal.pone.0136260			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352667	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800031
J	Takeuchi, M; Sato, T; Tanaka, A; Muraoka, T; Taguchi, M; Sakurai, Y; Karasawa, Y; Ito, M				Takeuchi, Masaru; Sato, Tomohito; Tanaka, Atsushi; Muraoka, Tadashi; Taguchi, Manzo; Sakurai, Yutaka; Karasawa, Yoko; Ito, Masataka			Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients	PLOS ONE			English	Article							T-CELLS; ANGIOGENIC FACTORS; EXPRESSION; IL-31; IL-17; VEGF; INTERLEUKIN-31	Macrophages are involved in low-grade inflammation in diabetes, and play pathogenic roles in proliferative diabetic retinopathy (PDR) by producing proinflammatory cytokines. T cells as well as other cells are also activated by proinflammatory cytokines, and infiltration into the vitreous of patients with PDR has been shown. In this study, we measured helper T (Th) cell-related cytokines in the vitreous of PDR patients to define the characteristics of Th-mediated immune responses associated with PDR. The study group consisted of 25 type 2 diabetic patients (25 eyes) with PDR. The control group consisted of 27 patients with epiretinal membrane (ERM), 26 patients with idiopathic macular hole (MH), and 26 patients with uveitis associated with sarcoidosis. Vitreous fluid was obtained at the beginning of vitrectomy, and centrifuging for cellular removals was not performed. Serum was also collected from PDR patients. IL-1 beta, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, IFN-gamma, soluble sCD40L, and TNF alpha in the vitreous and serum samples were measured. Both percent detectable and levels of IL-4, IL-6, IL-17A, IL-21, IL-22, and TNF alpha in the vitreous were significantly higher than those in the serum in PDR patients. Vitreous levels of these cytokines and IL-31 were significantly higher in PDR than in ERM or MH patients. Vitreous levels of IL-4, IL-17A, IL-22, IL-31, and TNF alpha in PDR patients were also significantly higher than those of sarcoidosis patients. In PDR patients, vitreous IL-17A level correlated significantly with vitreous levels of IL-22 and IL-31, and especially with IL-4 and TNF alpha. Although it is unclear whether these cytokines play facilitative roles or inhibitory roles for the progression of PDR, the present study indicated that Th2- and Th17-related immune responses are involved in the pathogenesis of PDR.	[Takeuchi, Masaru; Sato, Tomohito; Tanaka, Atsushi; Muraoka, Tadashi; Taguchi, Manzo; Sakurai, Yutaka; Karasawa, Yoko] Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Saitama, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Takeuchi, M (corresponding author), Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan.	masatake@ndmc.ac.jp						Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Arimura N, 2009, OPHTHALMOLOGY, V116, P921, DOI 10.1016/j.ophtha.2008.12.024; Bromberg-White JL, 2013, INVEST OPHTH VIS SCI, V54, P6472, DOI 10.1167/iovs.13-12518; Canataroglu H, 2005, OCUL IMMUNOL INFLAMM, V13, P375, DOI 10.1080/09273940490518900; Canton A, 2004, ARCH OPHTHALMOL-CHIC, V122, P743, DOI 10.1001/archopht.122.5.743; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Kakehashi A, 2008, DIABETES RES CLIN PR, V79, P438, DOI 10.1016/j.diabres.2007.10.018; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Qu N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/968549; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Schuerwegh AJ, 2003, CYTOM PART B-CLIN CY, V55B, P52, DOI 10.1002/cyto.b.10041; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Urbancic M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/251528; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	29	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137358	10.1371/journal.pone.0137358	http://dx.doi.org/10.1371/journal.pone.0137358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352837	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800077
J	Zubrick, SR; Taylor, CL; Christensen, D				Zubrick, Stephen R.; Taylor, Catherine L.; Christensen, Daniel			Patterns and Predictors of Language and Literacy Abilities 4-10 Years in the Longitudinal Study of Australian Children	PLOS ONE			English	Article							VOCABULARY GROWTH; READING-ACHIEVEMENT; TEMPERAMENT; SKILLS; IMPAIRMENT; QUALITY; DIFFICULTIES; PRESCHOOL; AGE	Aims Oral language is the foundation of literacy. Naturally, policies and practices to promote children's literacy begin in early childhood and have a strong focus on developing children's oral language, especially for children with known risk factors for low language ability. The underlying assumption is that children's progress along the oral to literate continuum is stable and predictable, such that low language ability foretells low literacy ability. This study investigated patterns and predictors of children's oral language and literacy abilities at 4, 6, 8 and 10 years. The study sample comprised 2,316 to 2,792 children from the first nationally representative Longitudinal Study of Australian Children (LSAC). Six developmental patterns were observed, a stable middle-high pattern, a stable low pattern, an improving pattern, a declining pattern, a fluctuating low pattern, and a fluctuating middle-high pattern. Most children (69%) fit a stable middle-high pattern. By contrast, less than 1% of children fit a stable low pattern. These results challenged the view that children's progress along the oral to literate continuum is stable and predictable. Findings Multivariate logistic regression was used to investigate risks for low literacy ability at 10 years and sensitivity-specificity analysis was used to examine the predictive utility of the multivariate model. Predictors were modelled as risk variables with the lowest level of risk as the reference category. In the multivariate model, substantial risks for low literacy ability at 10 years, in order of descending magnitude, were: low school readiness, Aboriginal and/or Torres Strait Islander status and low language ability at 8 years. Moderate risks were high temperamental reactivity, low language ability at 4 years, and low language ability at 6 years. The following risk factors were not statistically significant in the multivariate model: Low maternal consistency, low family income, health care card, child not read to at home, maternal smoking, maternal education, family structure, temperamental persistence, and socio-economic area disadvantage. The results of the sensitivity-specificity analysis showed that a well-fitted multivariate model featuring risks of substantive magnitude did not do particularly well in predicting low literacy ability at 10 years.	[Zubrick, Stephen R.; Taylor, Catherine L.; Christensen, Daniel] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Zubrick, SR (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	steve@ichr.uwa.edu.au	Dhungana, Raja Ram/B-3673-2016; Zubrick, Stephen R/CAI-1970-2022; Christensen, Daniel/I-2018-2019	Dhungana, Raja Ram/0000-0002-9610-6306; Zubrick, Stephen R/0000-0002-6369-1713; Christensen, Daniel/0000-0002-9684-5782	Australian Research Council [CE140100027]	Australian Research Council(Australian Research Council)	SZ and DC are supported by a grant from the Australian Research Council (CE140100027).	[ABS Statistics ABo], 2003, INF PAP CENS POP HOU; Allen J, 2008, J EDUC BEHAV STAT, V33, P416, DOI 10.3102/1076998607306081; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2003, AUSTR VERSION ADAPTE; Australian Institute of Health and Welfare, 2011, HEADL IND CHILDR HLT; Baxter J., 2013, LSAC ANN STAT REPORT; Belsky J, 2005, DEV PSYCHOL, V41, P428, DOI 10.1037/0012-1649.41.2.428; Biemiller A, 2001, J EDUC PSYCHOL, V93, P498, DOI 10.1037/0022-0663.93.3.498; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Brinkman S., 2007, EARLY EDUC DEV, V18, P427, DOI [10.1080/10409280701610812, DOI 10.1080/10409280701610812]; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U, 2005, MAKING HUMAN BEINGS, P3; Brown Waesche JS, EXAMINING AGREEMENT, P296, DOI [10.1177/0022219410392048, DOI 10.1177/0022219410392048]; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Carson DK, 1998, INF MENTAL HLTH J, V19, P59, DOI 10.1002/(SICI)1097-0355(199821)19:1<59::AID-IMHJ4>3.0.CO;2-V; Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); CAULFIELD MB, 1989, J ABNORM CHILD PSYCH, V17, P187, DOI 10.1007/BF00913793; Christensen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101476; Coplan RJ, 1999, EARLY CHILD RES Q, V14, P537, DOI 10.1016/S0885-2006(99)00025-3; Dadey N, 2012, PRACTICA ASSESSMENT, V17; Dale E., 1981, LIVING WORD VOCABULA; de Lemos M., 1999, WHO AM I; Dickinson DK, 2011, HDB EARLY LITERACY R; Duckworth K., 2007, WIDER BENEFITS LEARN, V23; Duff FJ, 2015, J CHILD PSYCHOL PSYC, V56, P848, DOI 10.1111/jcpp.12378; Dunn L.M., 1981, PEABODY PICTURE VOCA; Feinstein L, 2004, OXFORD REV ECON POL, V20, P213, DOI 10.1093/oxrep/grh012; Feinstein L, 2006, DEV EARLY YEARS ITS; Gordon C, 2003, AM J MED GENET A, V120A, P199, DOI 10.1002/ajmg.a.20259; Gough P. B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Haddock CK, 1998, PSYCHOL METHODS, V3, P339, DOI 10.1037/1082-989X.3.3.339; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hattie J, VISIBLE LEARNING SYN; HOSMER DW, 1989, APPL LOGISTIC REGRES; Irwin JR, 2002, J AM ACAD CHILD PSY, V41, P1324, DOI 10.1097/00004583-200211000-00014; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Judge S, 2010, READ WRIT Q, V27, P153, DOI 10.1080/10573569.2011.532722; Kim S, 2014, LARGE SCALE ASSESSME, V2; Law J, 2009, J SPEECH LANG HEAR R, V52, P1401, DOI 10.1044/1092-4388(2009/08-0142); Lawrence D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-256; Leppanen U, 2004, READ RES QUART, V39, P72, DOI 10.1598/RRQ.39.1.5; Lesaux NK, 2007, J EDUC PSYCHOL, V99, P821, DOI 10.1037/0022-0663.99.4.821; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; MAZIADE M, 1986, J AM ACAD CHILD PSY, V25, P692, DOI 10.1016/S0002-7138(09)60296-X; Misson S, 2007, 5 AUSTR I FAM STUD; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; National Collaborating Centre for Determinants of Health, 2013, LETS TALK UN TARG AP; Parrila R, 2005, J EDUC PSYCHOL, V97, P299, DOI 10.1037/0022-0663.97.3.299; PAUL R, 1990, J AM ACAD CHILD PSY, V29, P669, DOI 10.1097/00004583-199007000-00030; Phillips LM, 2002, J EDUC PSYCHOL, V94, P3, DOI 10.1037//0022-0663.94.1.3; Pianta R., 2012, HDB EARLY CHILDHOOD, P194; Pianta RC, 2012, HDB EARLY CHILDHOOD; Pollack JM, 2005, 200562 NCES US DEP E; Prior M, 2013, ED PSYCHOL INT J EXP, V31, P3; Rescorla L, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/059); Rice ML, 2015, J SPEECH LANG HEAR R, V58, P345, DOI 10.1044/2015_JSLHR-L-14-0150; Rock D. A., 2002, 200205 NCES US DEP E; Rose Jim., 2006, INDEPENDENT REV TEAC; Rothman S., 2009, LSAC ACAD RATING SCA; Rothman S, 2005, 2 AUSTR COUNC ED RES; SANSON A, 1987, INFANT BEHAV DEV, V10, P97, DOI 10.1016/0163-6383(87)90009-9; SAS Institute Inc, 2002, SAS WIND VERS 9 3; Schoon I, 2010, PEDIATRICS, V125, pE459, DOI 10.1542/peds.2008-2111; Senechal M, 2002, CHILD DEV, V73, P445, DOI 10.1111/1467-8624.00417; Shepherd CCJ, 2012, AM J PUBLIC HEALTH, V102, P107, DOI 10.2105/AJPH.2011.300354; Soloff C, 2006, 3 AUSTR I FAM STUD; Soloff C, 2005, LONGITUDINAL STUDY A, P1; Strazdins L., 2007, AUSTR B LABOUR, V33, P202; Strazdins L, 2010, SOC SCI MED, V70, P2052, DOI 10.1016/j.socscimed.2010.02.041; Taylor CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073046; Thomas E.M., 2006, READINESS LEARN SCH; United Nations Educational Scientific and Cultural Organisation, ED ALL GLOB MON REP; Valentine J., 2003, EFFECT SIZE SUBSTANT; Verhoeven L, 2011, SCI STUD READ, V15, P8, DOI 10.1080/10888438.2011.536125; Vitiello VE, 2012, EARLY EDUC DEV, V23, P302, DOI 10.1080/10409289.2011.526415; WHITE TG, 1990, J EDUC PSYCHOL, V82, P281, DOI 10.1037/0022-0663.82.2.281; Zubrick S., 2014, PARENTING MEASURES L; Zubrick S. R., 2008, FAHCSIA SOCIAL POLIC, DOI [10.2139/ssrn.1703269, DOI 10.2139/SSRN.1703269]; Zubrick SR, 2008, CONTEXTS CHILD DEV C, P59; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	80	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135612	10.1371/journal.pone.0135612	http://dx.doi.org/10.1371/journal.pone.0135612			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352436	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800011
J	Boschloo, L; van Borkulo, CD; Rhemtulla, M; Keyes, KM; Borsboom, D; Schoevers, RA				Boschloo, Lynn; van Borkulo, Claudia D.; Rhemtulla, Mijke; Keyes, Katherine M.; Borsboom, Denny; Schoevers, Robert A.			The Network Structure of Symptoms of the Diagnostic and Statistical Manual of Mental Disorders	PLOS ONE			English	Article							DEPRESSION; COMORBIDITY; SELECTION; SUBTYPES	Although current classification systems have greatly contributed to the reliability of psychiatric diagnoses, they ignore the unique role of individual symptoms and, consequently, potentially important information is lost. The network approach, in contrast, assumes that psychopathology results from the causal interplay between psychiatric symptoms and focuses specifically on these symptoms and their complex associations. By using a sophisticated network analysis technique, this study constructed an empirically based network structure of 120 psychiatric symptoms of twelve major DSM-IV diagnoses using cross-sectional data of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, second wave; N = 34,653). The resulting network demonstrated that symptoms within the same diagnosis showed differential associations and indicated that the strategy of summing symptoms, as in current classification systems, leads to loss of information. In addition, some symptoms showed strong connections with symptoms of other diagnoses, and these specific symptom pairs, which both concerned overlapping and non-overlapping symptoms, may help to explain the comorbidity across diagnoses. Taken together, our findings indicated that psychopathology is very complex and can be more adequately captured by sophisticated network models than current classification systems. The network approach is, therefore, promising in improving our understanding of psychopathology and moving our field forward.	[Boschloo, Lynn; van Borkulo, Claudia D.; Schoevers, Robert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [van Borkulo, Claudia D.; Rhemtulla, Mijke; Borsboom, Denny] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Keyes, Katherine M.] Columbia Univ, Dept Psychiat, Dept Epidemiol, New York, NY USA	University of Groningen; University of Amsterdam; Columbia University	Boschloo, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	l.boschloo@umcg.nl		Schoevers, Robert A/0000-0003-0760-9866; Borsboom, Denny/0000-0001-9720-4162	National Institute on Alcohol Abuse and Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021511] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The National Epidemiologic Survey on Alcohol and Related Conditions is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) with supplemental support from the National Institute on Drug Abuse (NIDA). The authors received no specific funding for this work.	Borsboom D, 2008, J CLIN PSYCHOL, V64, P1089, DOI 10.1002/jclp.20503; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Cramer AOJ, 2012, BEHAV BRAIN SCI, V35, P146, DOI 10.1017/S0140525X11001488; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; de Wild-Hartmann JA, 2013, BRIT J PSYCHIAT, V202, P407, DOI 10.1192/bjp.bp.112.123794; Drton M, 11125635 ARXIV; Drton M, 14033374 ARXIV; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fried E., 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0090311, DOI 10.1371/JOURNAL.PONE.0090311, DOI 10.1371/J0URNAL.P0NE.0090311]; Fried EI, PSYCHOL MED; Fried EI, 2015, ACTA PSYCHIAT SCANDI; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Grant B. F., 2007, SOURCE ACCURACY STAT; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; Grant BF, 2003, SOURCE ACCURACY STAT; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kendler KS, 2012, MOL PSYCHIATR, V17, P11, DOI 10.1038/mp.2011.70; Kendler KS, 2011, PSYCHOL MED, V41, P1143, DOI 10.1017/S0033291710001844; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kramer I, 2014, SCHIZOPHRENIA BULL, V40, P278, DOI 10.1093/schbul/sbs194; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Lahey BB, 2005, ARCH GEN PSYCHIAT, V62, P896, DOI 10.1001/archpsyc.62.8.896; Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144; Lord F. M., 1968, STAT THEORIES MENTAL; Lux V, 2010, PSYCHOL MED, V40, P1679, DOI 10.1017/S0033291709992157; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	33	149	151	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137621	10.1371/journal.pone.0137621	http://dx.doi.org/10.1371/journal.pone.0137621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368008	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100098
J	Fan, B; Dun, SH; Gu, JQ; Guo, Y; Ikuyama, S				Fan, Bin; Dun, Sai-Hong; Gu, Jian-Qiu; Guo, Yang; Ikuyama, Shoichiro			Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-kappa B and AP-1 Activation	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADHESION MOLECULE EXPRESSION; NITRIC-OXIDE SYNTHASE; FRENCH MARITIME PINE; GENE-EXPRESSION; DOPAMINERGIC-NEURONS; TRANSCRIPTION FACTOR; LIPID-ACCUMULATION; CELLS; NEURODEGENERATION	Over activation of microglia results in the production of proinflammatory agents that have been implicated in various brain diseases. Pycnogenol is a patented extract from French maritime pine bark (Pinus pinaster Aiton) with strong antioxidant and anti-inflammatory potency. The present study investigated whether pycnogenol may be associated with the production of proinflammatory mediators in lipopolysaccharide-stimulated BV2 (mouse-derived) microglia. It was found that pycnogenol treatment was dose-dependently associated with significantly less release of nitricoxide (NO), TNF-alpha, IL-6 and IL-1 beta, and lower levels of intercellular adhesion molecule1 (ICAM-1) and perilipin 2 (PLIN2). Furthermore, this effect was replicated in primary brain microglia. Levels of inducible NO synthase mRNA and protein were attenuated, whereas there was no change in the production of the anti-inflammatory cytokine IL-10. Further evidence indicated that pycnogenol treatment led to the suppression of NF-kappa B activation through inhibition of p65 translocation into the nucleus and inhibited DNA binding of AP-1, suggesting that these proinflammatory factors are associated with NF-kappa B and AP-1. We conclude that pycnogenol exerts anti-inflammatory effects through inhibition of the NF-kappa B and AP-1pathway, and may be useful as a therapeutic agent in the prevention of diseases caused by over activation of microglia.	[Fan, Bin; Dun, Sai-Hong; Guo, Yang] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110004, Peoples R China; [Gu, Jian-Qiu] PR China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang 110001, Peoples R China; [Ikuyama, Shoichiro] Oita San Ai Med Ctr, Dept Clin Invest, Oita 8701151, Japan; [Ikuyama, Shoichiro] Oita San Ai Med Ctr, Dept Endocrine Metab & Rheumat Dis, Oita 8701151, Japan	China Medical University	Fan, B (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110004, Peoples R China.	fanbin@hotmail.co.jp			National Natural Science Foundation of China Youth Fund Project [81100216]; Scientific Research Foundation for the Returned Scholars, State Education Ministry [2013693]; Research Fund for the Doctoral Program of Higher Education of Liaoning Province [20131148]	National Natural Science Foundation of China Youth Fund Project; Scientific Research Foundation for the Returned Scholars, State Education Ministry; Research Fund for the Doctoral Program of Higher Education of Liaoning Province	This work is supported by Grant 81100216 from the National Natural Science Foundation of China Youth Fund Project; Grant 2013693 from the Scientific Research Foundation for the Returned Scholars, State Education Ministry; Grand 20131148 from Research Fund for the Doctoral Program of Higher Education of Liaoning Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Cho KJ, 2001, ANN NY ACAD SCI, V928, P141; Choi YH, 2009, PHYTOTHER RES, V23, P1691, DOI 10.1002/ptr.2812; Dang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102522; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; Fan B, 2013, METABOLISM, V62, P1168, DOI 10.1016/j.metabol.2013.02.013; Fan B, 2009, AM J PHYSIOL-ENDOC M, V297, pE112, DOI 10.1152/ajpendo.00119.2009; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Gu JQ, 2010, AM J PHYSIOL-ENDOC M, V299, pE593, DOI 10.1152/ajpendo.00159.2010; Gu JQ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1390, DOI 10.1152/ajpendo.90543.2008; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Jeong YH, 2013, BIOMOL THER, V21, P332, DOI 10.4062/biomolther.2013.069; Khan MM, 2013, NEUROCHEM INT, V62, P379, DOI 10.1016/j.neuint.2013.01.029; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Kim DH, 2006, EXP MOL MED, V38, P417, DOI 10.1038/emm.2006.49; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mukaida N, 1996, J LEUKOCYTE BIOL, V59, P145, DOI 10.1002/jlb.59.2.145; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Peng Q, 2000, CELL MOL LIFE SCI, V57, P834, DOI 10.1007/s000180050045; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Saliou C, 2001, FREE RADICAL BIO MED, V30, P154, DOI 10.1016/S0891-5849(00)00445-7; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; XIE QW, 1994, J BIOL CHEM, V269, P4705; Ye SM, 2001, J NEUROIMMUNOL, V117, P87, DOI 10.1016/S0165-5728(01)00316-2	48	24	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137837	10.1371/journal.pone.0137837	http://dx.doi.org/10.1371/journal.pone.0137837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367267	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100151
J	Miyake, S; Kim, S; Suda, W; Oshima, K; Nakamura, M; Matsuoka, T; Chihara, N; Tomita, A; Sato, W; Kim, SW; Morita, H; Hattori, M; Yamamura, T				Miyake, Sachiko; Kim, Sangwan; Suda, Wataru; Oshima, Kenshiro; Nakamura, Masakazu; Matsuoka, Takako; Chihara, Norio; Tomita, Atsuko; Sato, Wakiro; Kim, Seok-Won; Morita, Hidetoshi; Hattori, Masahira; Yamamura, Takashi			Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; METABOLITES; MECHANISMS; AUTOIMMUNE; INDUCTION; DIVERSITY; RISK	The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsingremitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.	[Miyake, Sachiko; Nakamura, Masakazu; Matsuoka, Takako; Chihara, Norio; Tomita, Atsuko; Sato, Wakiro; Yamamura, Takashi] Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo 1878502, Japan; [Miyake, Sachiko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Kim, Sangwan; Suda, Wataru; Oshima, Kenshiro; Kim, Seok-Won; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Ctr Omics & Bioinformat, Kashiwa, Chiba 2778561, Japan; [Kim, Seok-Won] RIKEN Ctr Integrat Med Sci, Lab Integrated Bioinformat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2298501, Japan	National Center for Neurology & Psychiatry - Japan; Juntendo University; University of Tokyo; RIKEN; Azabu University	Hattori, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Ctr Omics & Bioinformat, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778561, Japan.	hattori@k.u-tokyo.ac.jp; yamamura@ncnp.go.jp	Suda, Wataru/AAF-4469-2019; chihara, norio/GMX-0691-2022; Hattori, Masahira/AAD-3785-2019; Chihara, Norio/AAU-6956-2020; Chihara, Norio/AFW-3477-2022	chihara, norio/0000-0003-4499-0790; Katsumoto, Atsuko/0000-0002-5582-3050	Japan Society for the Promotion of Science (JSPS) [24229006]; Ministry of Health, Labour and Welfare of Japan (MHLW) [26293234]; Grants-in-Aid for Scientific Research [26293234] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan (MHLW)(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (S) (grant number: 24229006 https://kaken.nii.ac.jp/d/p/24229006.ja.html) from the Japan Society for the Promotion of Science (JSPS) to S.M., H.M., M.H., and T.Y., and a grant (grant number: 26293234 https://kaken.nii.ac.jp/d/p/26293234.ja.html) from the Ministry of Health, Labour and Welfare of Japan (MHLW) to S.M., M.H., and T.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clark RB, 2013, INFECT IMMUN, V81, P3479, DOI 10.1128/IAI.00803-13; Farrokhi V, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.11; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Houzen H, 2012, J NEUROL SCI, V323, P117, DOI 10.1016/j.jns.2012.08.032; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Osoegawa M, 2009, MULT SCLER J, V15, P159, DOI 10.1177/1352458508098372; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rehman A, 2015, GUT; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tindall BJ, 2014, INT J SYST EVOL MICR, V64, P3578, DOI 10.1099/ijs.0.069146-0; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Yamamura T, 2012, MULTIPLE SCLEROSIS I, P115; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686	39	415	432	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137429	10.1371/journal.pone.0137429	http://dx.doi.org/10.1371/journal.pone.0137429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367776	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100069
J	Philipson, CW; Bassaganya-Riera, J; Viladomiu, M; Kronsteiner, B; Abedi, V; Hoops, S; Michalak, P; Kang, L; Girardin, SE; Hontecillas, R				Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Michalak, Pawel; Kang, Lin; Girardin, Stephen E.; Hontecillas, Raquel			Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; INFLAMMATORY CASPASES; DENDRITIC CELLS; COMPLEX; GASTRITIS; STRAINS; HOST; GENE; MAVS	Helicobacter pylori colonizes half of the world's population as the dominant member of the gastric microbiota resulting in a lifelong chronic infection. Host responses toward the bacterium can result in asymptomatic, pathogenic or even favorable health outcomes; however, mechanisms underlying the dual role of H. pylori as a commensal versus pathogenic organism are not well characterized. Recent evidence suggests mononuclear phagocytes are largely involved in shaping dominant immunity during infection mediating the balance between host tolerance and succumbing to overt disease. We combined computational modeling, bioinformatics and experimental validation in order to investigate interactions between macrophages and intracellular H. pylori. Global transcriptomic analysis on bone marrow-derived macrophages (BMDM) in a gentamycin protection assay at six time points unveiled the presence of three sequential host response waves: an early transient regulatory gene module followed by sustained and late effector responses. Kinetic behaviors of pattern recognition receptors (PRRs) are linked to differential expression of spatiotemporal response waves and function to induce effector immunity through extracellular and intracellular detection of H. pylori. We report that bacterial interaction with the host intracellular environment caused significant suppression of regulatory NLRC3 and NLRX1 in a pattern inverse to early regulatory responses. To further delineate complex immune responses and pathway crosstalk between effector and regulatory PRRs, we built a computational model calibrated using time-series RNAseq data. Our validated computational hypotheses are that: 1) NLRX1 expression regulates bacterial burden in macrophages; and 2) early host response cytokines down-regulate NLRX1 expression through a negative feedback circuit. This paper applies modeling approaches to characterize the regulatory role of NLRX1 in mechanisms of host tolerance employed by macrophages to respond to and/or to co-exist with intracellular H. pylori.	[Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Michalak, Pawel; Kang, Lin; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA; [Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA USA; [Bassaganya-Riera, Josep] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Girardin, Stephen E.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Toronto	Hontecillas, R (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Kang, Lin/AAA-2260-2019; Viladomiu, Monica/GNM-6447-2022; Philipson, Casandra/AAY-5746-2021	Kang, Lin/0000-0002-9186-9574; Kronsteiner-Dobramysl, Barbara/0000-0003-0867-2867; Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases Contract [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases Contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract (www.niaid.nih.gov) No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; [Anonymous], 2007, GASTROENTEROLOGY, V133, P6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blaser MJ, 2008, CANCER PREV RES, V1, P308, DOI 10.1158/1940-6207.CAPR-08-0170; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 2008, GUT; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Chionh YT, 2015, MUCOSAL IMMUNOL, V8, P68, DOI 10.1038/mi.2014.43; Chow WH, 1998, CANCER RES, V58, P588; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; Deen NS, 2015, HELICOBACTER, V20, P449, DOI 10.1111/hel.12223; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Eftang LL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-9; Engler DB, 2014, P NATL ACAD SCI USA, V111, P11810, DOI 10.1073/pnas.1410579111; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gobert AP, 2014, J IMMUNOL, V193, P3013, DOI 10.4049/jimmunol.1401075; Hagar JA, 2015, CELL RES, V25, P149, DOI 10.1038/cr.2014.128; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Indramohan M, 2012, INFECT IMMUN, V80, P4099, DOI 10.1128/IAI.00589-12; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Kang MJ, 2015, J CLIN INVEST, V125, P2458, DOI 10.1172/JCI71747; Kronsteiner B, 2014, GUT MICROBES, V5, P357, DOI 10.4161/gmic.28899; Kronsteiner B, 2013, INFECT IMMUN, V81, P3803, DOI 10.1128/IAI.00660-13; Kurokawa K, 2012, J BIOL CHEM, V287, P13170, DOI 10.1074/jbc.M111.292235; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Lender N, 2014, ALIMENT PHARM THER, V40, P24, DOI 10.1111/apt.12790; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lord CA, 2009, J IMMUNOL, V182, P2948, DOI 10.4049/jimmunol.0801692; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McCune A, 2003, EUR J GASTROEN HEPAT, V15, P637, DOI 10.1097/00042737-200306000-00010; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muller A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-25; Mustapha P, 2014, INFECT IMMUN, V82, P2881, DOI 10.1128/IAI.01517-13; Nanda Shreeya, 2011, Nat Rev Gastroenterol Hepatol, V8, P299, DOI 10.1038/nrgastro.2011.77; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Pernitzsch SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00014; QIAGEN, INGENUITY PATHWAY AN; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074595; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; van Doorn NEM, 1999, INFECT IMMUN, V67, P3040, DOI 10.1128/IAI.67.6.3040-3046.1999; Vieth M, 2000, DIGESTION, V62, P225, DOI 10.1159/000007820; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	85	25	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137839	10.1371/journal.pone.0137839	http://dx.doi.org/10.1371/journal.pone.0137839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367386	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100152
J	Sahner, J; Budi, SW; Barus, H; Edy, N; Meyer, M; Corre, MD; Polle, A				Sahner, Josephine; Budi, Sri Wilarso; Barus, Henry; Edy, Nur; Meyer, Marike; Corre, Marife D.; Polle, Andrea			Degradation of Root Community Traits as Indicator for Transformation of Tropical Lowland Rain Forests into Oil Palm and Rubber Plantations	PLOS ONE			English	Article							ALUMINUM RESISTANCE; SOIL CARBON; LAND-USE; LITTER DECOMPOSITION; CENTRAL SULAWESI; ORGANIC-ACIDS; CONVERSION; TOLERANCE; PLANTS; CONSEQUENCES	Conversion of tropical forests into intensely managed plantations is a threat to ecosystem functions. On Sumatra, Indonesia, oil palm (Elaeis guineensis) plantations are rapidly expanding, displacing rain forests and extensively used rubber (Hevea brasiliensis) agroforests. Here, we tested the influence of land use systems on root traits including chemical traits (carbon, nitrogen, mineral nutrients, potentially toxic elements [aluminium, iron] and performance traits (root mass, vitality, mycorrhizal colonization). Traits were measured as root community-weighed traits (RCWTs) in lowland rain forests, in rubber agro-forests mixed with rain forest trees, in rubber and oil palm plantations in two landscapes (Bukit Duabelas and Harapan, Sumatra). We hypothesized that RCWTs vary with land use system indicating increasing transformation intensity and loss of ecosystem functions. The main factors found to be related to increasing transformation intensity were declining root vitality and root sulfur, nitrogen, carbon, manganese concentrations and increasing root aluminium and iron concentrations as well as increasing spore densities of arbuscular mycorrhizas. Mycorrhizal abundance was high for arbuscular and low for ectomycorrhizas and unrelated to changes in RCWTs. The decline in RCWTs showed significant correlations with soil nitrogen, soil pH and litter carbon. Thus, our study uncovered a relationship between deteriorating root community traits and loss of ecosystem functionality and showed that increasing transformation intensity resulted in decreasing root nutrition and health. Based on these results we suggest that land management that improves root vitality may enhance the ecological functions of intense tropical production systems.	[Sahner, Josephine; Edy, Nur; Polle, Andrea] Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, D-37073 Gottingen, Germany; [Budi, Sri Wilarso] IPB Darmaga, Fac Forestry, Dept Sylviculture, Bogor, Indonesia; [Barus, Henry; Edy, Nur] Tadulako Univ, Fac Agr, Dept Agrotechnol, Palu, Indonesia; [Meyer, Marike] Univ Gottingen, Inst Geog, D-37073 Gottingen, Germany; [Corre, Marife D.] Univ Gottingen, Dept Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany	University of Gottingen; Universitas Tadulako; University of Gottingen; University of Gottingen	Polle, A (corresponding author), Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, D-37073 Gottingen, Germany.	apolle@gwdg.de	Budi, Sri Wilarso/ABH-5213-2020; Edy, Nur/C-7648-2017	Edy, Nur/0000-0001-9013-5141; Barus, Henry/0000-0003-2351-2132; Budi, Sri Wilarso/0000-0002-3477-4261; Corre, Marife D./0000-0003-0359-2104; Polle, Andrea/0000-0001-8697-6394	Deutsche Forschungsgemeinschaft [CRC990]; Erasmus Mundus [EURASIA2]; Georg-August Universitat Gottingen [CRC990]; Deutsche Forschungsgemeinschaft; Georg-August Universitat Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Erasmus Mundus; Georg-August Universitat Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August Universitat Gottingen	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), CRC990: Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) project B07 (AP) and Project A05 (MDC); Erasmus Mundus, EURASIA2 (http://www.eurasia2.cz/page/erasmus-mundus) (NE); Georg-August Universitat Gottingen CRC990 internal research grants awarded to counterparts and stakeholders in the frame of Access and Benefit Sharing (ABS) of the Convention of Biological Diversity (CBD) (http://www.uni-goettingen.de/de/310995.html) (SWB); and Deutsche Forschungsgemeinschaft and Georg-August Universitat Gottingen open access publication fund (http://www.sub.uni-goettingen.de/en/electronicpublishing/open-access/open-access-publicationfunding/) (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118732; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; Carrasco LR, 2014, SCIENCE, V346, P38, DOI 10.1126/science.1256685; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cristancho R, 2007, PALMAS, P24; Cristancho RJA, 2011, PLANT BIOLOGY, V13, P333, DOI 10.1111/j.1438-8677.2010.00378.x; Dechert G, 2004, PLANT SOIL, V265, P197, DOI 10.1007/s11104-005-0885-8; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Erasmi S, 2010, ENVIRON SCI ENG, P269, DOI 10.1007/978-3-642-00493-3_12; Fankem H, 2006, AFR J BIOTECHNOL, V5, P2450; FAO, 2011, STAT WORLDS FOR; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finegan B, 2015, J ECOL, V103, P191, DOI 10.1111/1365-2745.12346; Fornara DA, 2009, J ECOL, V97, P48, DOI 10.1111/j.1365-2745.2008.01453.x; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; GOUYON A, 1993, AGROFOREST SYST, V22, P181, DOI 10.1007/BF00705233; Habib MT, 2013, PLANT ROOTS: THE HIDDEN HALF, 4TH EDITION; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; JANSEN S, 2004, EVOLUTION PLANT PHYS, P467; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Katabuchi M, 2012, J ECOL, V100, P643, DOI [10.1111/J.1365-2745.2011.01937.x, 10.1111/j.1365-2745.2011.01937.x]; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Leuschner C, 2013, AGROFOREST SYST, V87, P1173, DOI 10.1007/s10457-013-9628-7; Lovelock CE, 2003, OECOLOGIA, V135, P268, DOI 10.1007/s00442-002-1166-3; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Masunaga T, 1998, SOIL SCI PLANT NUTR, V44, P347, DOI 10.1080/00380768.1998.10414456; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Ministry of Agriculture, 2010, AR PROD CAT PROD OIL; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Murdiyarso D, 2002, J VEG SCI, V13, P429, DOI 10.1111/j.1654-1103.2002.tb02067.x; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; OHMS RE, 1957, PHYTOPATHOLOGY, V47, P751; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pena R, 2014, ISME J, V8, P321, DOI 10.1038/ismej.2013.158; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Prieto I, 2015, J ECOL, V103, P361, DOI 10.1111/1365-2745.12351; Rout GR, 2001, AGRONOMIE, V21, P3, DOI 10.1051/agro:2001105; Ryan PR, 2010, FUNCT PLANT BIOL, V37, P275, DOI 10.1071/FP09261; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Seguel A, 2013, MYCORRHIZA, V23, P167, DOI 10.1007/s00572-013-0479-x; Smiley GL, 2008, AGROFOREST SYST, V73, P219, DOI 10.1007/s10457-008-9144-3; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Squire G., 2005, EXP AGR, V41, P121, DOI [10.1017/S001447970422244X, DOI 10.1017/S001447970422244X]; Tata HL, 2008, P IND STUD SCI M 200; vanNoordwijk M, 1997, GEODERMA, V79, P187, DOI 10.1016/S0016-7061(97)00042-6; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wyatt TT, 2013, ADV APPL MICROBIOL, V85, P43, DOI 10.1016/B978-0-12-407672-3.00002-2	60	27	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138077	10.1371/journal.pone.0138077	http://dx.doi.org/10.1371/journal.pone.0138077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366576	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100216
J	Whitmore, LS; Ye, P				Whitmore, Leanne S.; Ye, Ping			Dissecting Germ Cell Metabolism through Network Modeling	PLOS ONE			English	Article							RETINOIC ACID METABOLISM; BINDING-PROTEIN-I; SERTOLI-CELLS; GLOBAL RECONSTRUCTION; TARGETED DISRUPTION; INSULIN-RESISTANCE; SPERMATOGENIC WAVE; MICE; DIFFERENTIATION; EXPRESSION	Metabolic pathways are increasingly postulated to be vital in programming cell fate, including stemness, differentiation, proliferation, and apoptosis. The commitment to meiosis is a critical fate decision for mammalian germ cells, and requires a metabolic derivative of vitamin A, retinoic acid (RA). Recent evidence showed that a pulse of RA is generated in the testis of male mice thereby triggering meiotic commitment. However, enzymes and reactions that regulate this RA pulse have yet to be identified. We developed a mouse germ cell-specific metabolic network with a curated vitamin A pathway. Using this network, we implemented flux balance analysis throughout the initial wave of spermatogenesis to elucidate important reactions and enzymes for the generation and degradation of RA. Our results indicate that primary RA sources in the germ cell include RA import from the extracellular region, release of RA from binding proteins, and metabolism of retinal to RA. Further, in silico knockouts of genes and reactions in the vitamin A pathway predict that deletion of Lipe, hormone-sensitive lipase, disrupts the RA pulse thereby causing spermatogenic defects. Examination of other metabolic pathways reveals that the citric acid cycle is the most active pathway. In addition, we discover that fatty acid synthesis/oxidation are the primary energy sources in the germ cell. In summary, this study predicts enzymes, reactions, and pathways important for germ cell commitment to meiosis. These findings enhance our understanding of the metabolic control of germ cell differentiation and will help guide future experiments to improve reproductive health.	[Whitmore, Leanne S.; Ye, Ping] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Ye, Ping] Avera Canc Inst, Dept Mol & Expt Med, Sioux Falls, SD 57105 USA	Washington State University	Ye, P (corresponding author), Washington State Univ, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA.	Ping.Ye@avera.org			National Institutes of Health (NIH) [R03HD079723]; NIH [T32GM008336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD079723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH) research grant R03HD079723 to PY. LSW was supported, in part, by NIH training grant T32GM008336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Anderson JE, 2009, FERTIL STERIL, V91, P2466, DOI 10.1016/j.fertnstert.2008.03.022; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Busada JT, 2015, DEV BIOL, V397, P140, DOI 10.1016/j.ydbio.2014.10.020; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chung SR, 2001, ENDOCRINOLOGY, V142, P4272, DOI 10.1210/en.142.10.4272; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DEBRUIJN DRH, 1994, DIFFERENTIATION, V58, P141; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Drumond AL, 2011, REPRODUCTION, V142, P145, DOI 10.1530/REP-10-0431; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Evans E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118034; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hermo L, 2008, MOL REPROD DEV, V75, P565, DOI 10.1002/mrd.20800; Hogarth CA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126326; Hogarth CA, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105346; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MORALES C, 1987, ENDOCRINOLOGY, V121, P432, DOI 10.1210/endo-121-1-432; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nogiec C, 2015, MOL METAB, V4, P151, DOI 10.1016/j.molmet.2014.12.012; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Singh K, 2013, REPROD SCI, V20, P622, DOI 10.1177/1933719112459232; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953	49	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137607	10.1371/journal.pone.0137607	http://dx.doi.org/10.1371/journal.pone.0137607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367011	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100093
J	Zeng, YH; Zhang, QW; Zhang, YJ; Lu, MX; Liu, Y; Zheng, TY; Feng, SJ; Hao, MQ; Shi, HS				Zeng, Yunhui; Zhang, Qiongwen; Zhang, Yujie; Lu, Minxun; Liu, Yang; Zheng, Tianying; Feng, Shijian; Hao, Meiqin; Shi, Huashan			MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies	PLOS ONE			English	Article							DEEPEST INVASIVE PORTION; CLINICAL-SIGNIFICANCE; BREAST-CANCER; KL-6 MUCIN; EXPRESSION; ADENOCARCINOMA; CARCINOMA; PROGNOSIS; PHOSPHORYLATION; TRANSCRIPTION	Objective To evaluate the predicting value of MUC1 expression in lymph node and distant metastasis of colorectal cancer (CRC). Methods Pubmed/MEDLINE and EMBASE were searched to identify eligible studies that evaluated the correlation between MUC1 and CRC. A meta-analysis was conducted to evaluate the impact of MUC1 expression on CRC metastasis. Results A total of 18 studies (n = 3271) met inclusion criteria and the mean Newcastle-Ottawa Scale (NOS) score was 6.3 with a range from 4 to 8. The pooled OR in the meta-analysis of 15 studies indicated that positive MUC1 expression correlated with more CRC node metastasis (OR = 2.32, 95% CI = 1.63-3.29). The data synthesis of 6 studies suggested that MUC1 expression predicted more possibility of CRC distant metastasis (OR = 2.22, 95% CI = 1.23-4.00). In addition, the combined OR of 7 studies showed that MUC1 expression indicated higher Duke's stage (OR = 3.02, 95% CI = 2.11-4.33). No publication bias was found in the mate-analysis by Begg's test or Egger's test with the exception of the meta-analysis of MUC1 with CRC node metastasis (Begg's test p = 0.729, Egger's test p = 0.000). Conclusions Despite of some modest bias, the pooled evidence suggested that MUC1 expression was significantly correlated with CRC metastasis.	[Zeng, Yunhui; Zhang, Qiongwen; Lu, Minxun; Liu, Yang; Zheng, Tianying; Feng, Shijian; Hao, Meiqin; Shi, Huashan] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Qiongwen; Shi, Huashan] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Qiongwen; Shi, Huashan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Head & Neck Oncol, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Yujie] Sichuan Univ, West China Med Sch, West China Hosp, Integrated Unit 2, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Zhang, QW (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	qiongwen2009@163.com; hx_natlife@163.com		Shi, Hua-shan/0000-0002-9958-9892; Zhang, Qiongwen/0000-0003-2033-6663				Ajioka Y, 1996, J CLIN PATHOL, V49, P560, DOI 10.1136/jcp.49.7.560; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Baldus SE, 2002, HISTOPATHOLOGY, V40, P440, DOI 10.1046/j.1365-2559.2002.01389.x; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI 10.2217/IMT.10.17; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109; Costa NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026970; DAVIDSON BR, 1989, GUT, V30, P1260, DOI 10.1136/gut.30.9.1260; DAVIDSON BR, 1988, INT J CANCER, P56; Duncan Timothy J, 2007, World J Surg Oncol, V5, P31, DOI 10.1186/1477-7819-5-31; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Guo Q, 2006, WORLD J GASTROENTERO, V12, P54, DOI 10.3748/wjg.v12.i1.54; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Hayashi T, 2001, DIGESTION, V63, P87, DOI 10.1159/000051917; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hiraga Y, 1998, ONCOLOGY-BASEL, V55, P307, DOI 10.1159/000011868; Huang MY, 2012, DNA CELL BIOL, V31, P43, DOI 10.1089/dna.2011.1264; HUANG W J, 2002, DECIDUOUS FRUITS, V1, P1; Jang KT, 2002, J KOREAN MED SCI, V17, P29, DOI 10.3346/jkms.2002.17.1.29; Kaneko I, 2007, WORLD J GASTROENTERO, V13, P3829; Karamitopoulou E, 2011, PATHOLOGY, V43, P133, DOI 10.1097/PAT.0b013e3283425b7f; Kashiwagi H, 2000, INT J ONCOL, V16, P455; Khalifa A, 2001, CANC MOL BIOL, V8, P1625; Kimura T, 2000, INT J ONCOL, V16, P55; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Kitamoto S, 2013, ONCOGENE, V32, P4614, DOI 10.1038/onc.2012.478; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Lugli A, 2007, J CLIN PATHOL, V60, P534, DOI 10.1136/jcp.2006.039552; Luttges J, 2002, AM J SURG PATHOL, V26, P466, DOI 10.1097/00000478-200204000-00008; Matsuda K, 2000, JPN J CLIN ONCOL, V30, P89, DOI 10.1093/jjco/hyd023; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mohr AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073306; Mulder WMC, 1996, CANCER IMMUNOL IMMUN, V42, P351, DOI 10.1007/s002620050293; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Nakamura H, 1998, J GASTROENTEROL, V33, P354, DOI 10.1007/s005350050096; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; Oshima T, 2007, PATHOL INT, V57, P82, DOI 10.1111/j.1440-1827.2006.02061.x; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Perez RO, 2008, INT J COLORECTAL DIS, V23, P757, DOI 10.1007/s00384-008-0486-0; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; SAFI F, 1991, CANCER-AM CANCER SOC, V68, P574, DOI 10.1002/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Wells G.A., NEWCASTLE OTTAWA SCA; World Health Organization, 2022, CANCER; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yu Xiu-Wen, 2007, Ai Zheng, V26, P1204; Zhang W, 2008, ONCOL REP, V20, P1013, DOI 10.3892/or_00000103; Zhang X. D., 2014, IMAGING, V1, P3	63	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138049	10.1371/journal.pone.0138049	http://dx.doi.org/10.1371/journal.pone.0138049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367866	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100210
J	Alkahyyat, F; Ni, M; Kim, SC; Yu, JH				Alkahyyat, Fahad; Ni, Min; Kim, Sun Chang; Yu, Jae-Hyuk			The WOPR Domain Protein OsaA Orchestrates Development in Aspergillus nidulans	PLOS ONE			English	Article							SEXUAL DEVELOPMENT; TRANSCRIPTION FACTOR; ASEXUAL SPORULATION; GENE ENCODES; MULTISPECIES CURATION; MASTER REGULATOR; EXPRESSION; FLUG; STERIGMATOCYSTIN; IDENTIFICATION	Orchestration of cellular growth and development occurs during the life cycle of Aspergillus nidulans. A multi-copy genetic screen intended to unveil novel regulators of development identified the AN6578 locus predicted to encode a protein with the WOPR domain, which is a broadly present fungi-specific DNA-binding motif. Multi-copy of AN6578 disrupted the normal life cycle of the fungus leading to enhanced proliferation of vegetative cells, whereas the deletion resulted in hyper-active sexual fruiting with reduced asexual development (conidiation), thus named as osaA (Orchestrator of Sex and Asex). Further genetic studies indicate that OsaA balances development mainly by repressing sexual development downstream of the velvet regulator VeA. The absence of osaA is sufficient to suppress the veA1 allele leading to the sporulation levels comparable to veA(+) wild type (WT). Genome-wide transcriptomic analyses of WT, veA1, and Delta osaA veA1 strains by RNA-Seq further corroborate that OsaA functions in repressing sexual development downstream of VeA. However, OsaA also plays additional roles in controlling development, as the Delta osaA veA1 mutant exhibits precocious and enhanced formation of Hulle cells compared to WT. The OsaA orthologue of Aspergillus flavus is able to complement the osaA null phenotype in A. nidulans, suggesting a conserved role of this group of WOPR domain proteins. In summary, OsaA is an upstream orchestrator of morphological and chemical development in Aspergillus that functions downstream of VeA.	[Alkahyyat, Fahad; Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Alkahyyat, Fahad] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Dae Jon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Yu, Jae-Hyuk/A-2343-2008; Kim, Sun/GSN-4867-2022	Yu, Jae-Hyuk/0000-0002-6530-8407	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]; Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology; Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology, 2011-0031955, SCK and JHY; and Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu, FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; AXELROD DE, 1972, J GEN MICROBIOL, V73, P181, DOI 10.1099/00221287-73-1-181; Barron G, 2013, EMERICELLA NIDULANS; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brown SH, 2008, APPL ENVIRON MICROB, V74, P5674, DOI 10.1128/AEM.00565-08; Cain CW, 2012, GENETICS, V190, P511, DOI 10.1534/genetics.111.134080; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Champe S, 1981, FUNGAL SPORE MORPHOG, P255; CHANG YC, 1993, GENETICS, V133, P29; CLUTTERBUCK AJ, 1990, J GEN MICROBIOL, V136, P1731, DOI 10.1099/00221287-136-9-1731; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Gerke J, 2012, APPL ENVIRON MICROB, V78, P8234, DOI 10.1128/AEM.01808-12; Gohari AM, 2014, MOL PLANT PATHOL, V15, P394, DOI 10.1111/mpp.12102; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Jonkers W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002724; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; KAFER E, 1965, GENETICS, V52, P217; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; KUNITOMO H, 1995, CURR GENET, V28, P32, DOI 10.1007/BF00311879; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; Lee MK, 2014, GENETICS, V197, P159, DOI 10.1534/genetics.114.161430; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lohse MB, 2014, P NATL ACAD SCI USA, V111, P10404, DOI 10.1073/pnas.1410110111; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; Michielse CB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r4; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Osherov N, 2000, FUNGAL GENET BIOL, V31, P181, DOI 10.1006/fgbi.2000.1236; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Seo JA, 2003, GENETICS, V165, P1083; Sohn K. T., 2002, Mycobiology, V30, P117; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Ugalde U, 2014, APPL MICROBIOL BIOT, V98, P8809, DOI 10.1007/s00253-014-6019-6; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x; Yager L N, 1992, Biotechnology, V23, P19; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	69	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137554	10.1371/journal.pone.0137554	http://dx.doi.org/10.1371/journal.pone.0137554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359867	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100052
J	Jia, L; Yarlagadda, R; Reed, CC				Jia, Lei; Yarlagadda, Ramya; Reed, Charles C.			Structure Based Thermostability Prediction Models for Protein Single Point Mutations with Machine Learning Tools	PLOS ONE			English	Article							THERMODYNAMIC DATABASE; STABILITY CHANGES; PROTHERM; CLASSIFICATION; PARAMETERS; REGRESSION; HYDRATION; MUTANTS; SERVER; QSAR	Thermostability issue of protein point mutations is a common occurrence in protein engineering. An application which predicts the thermostability of mutants can be helpful for guiding decision making process in protein design via mutagenesis. An in silico point mutation scanning method is frequently used to find "hot spots" in proteins for focused mutagenesis. ProTherm (http://gibk26.bio.kyutech.ac.jp/jouhou/Protherm/protherm.html) is a public database that consists of thousands of protein mutants' experimentally measured thermostability. Two data sets based on two differently measured thermostability properties of protein single point mutations, namely the unfolding free energy change (ddG) and melting temperature change (dTm) were obtained from this database. Folding free energy change calculation from Rosetta, structural information of the point mutations as well as amino acid physical properties were obtained for building thermostability prediction models with informatics modeling tools. Five supervised machine learning methods (support vector machine, random forests, artificial neural network, naive Bayes classifier, K nearest neighbor) and partial least squares regression are used for building the prediction models. Binary and ternary classifications as well as regression models were built and evaluated. Data set redundancy and balancing, the reverse mutations technique, feature selection, and comparison to other published methods were discussed. Rosetta calculated folding free energy change ranked as the most influential features in all prediction models. Other descriptors also made significant contributions to increasing the accuracy of the prediction models.	[Jia, Lei] Amgen Inc, Thousand Oaks, CA 91320 USA; [Yarlagadda, Ramya; Reed, Charles C.] Intrexon, Germantown, MD USA	Amgen	Jia, L (corresponding author), Amgen Inc, Thousand Oaks, CA 91320 USA.	ljia@amgen.com	Yarlagadda, Ramya/AAV-1625-2020		Intrexon Corp.; Intrexon; Amgen	Intrexon Corp.; Intrexon; Amgen(Amgen)	The authors received no specific funding from governments. Intrexon Corp. provided funding for licensing Rosetta software. Intrexon provided support in the form of salaries for authors LJ, RY, and CCR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amgen provided support in the form of salaries for author LJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Berliner N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107353; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burlingame AL, 2000, MASS SPECTROMETRY IN; Chen YW, 2008, ARCH BIOCHEM BIOPHYS, V469, P4, DOI 10.1016/j.abb.2007.05.014; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; Darby N.J., 1993, PROTEIN STRUCTURE; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gasser C, 2010, AMINO ACID PROPERTIE; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gromiha MM, 1999, NUCLEIC ACIDS RES, V27, P286, DOI 10.1093/nar/27.1.286; Gromiha MM, 2000, NUCLEIC ACIDS RES, V28, P283, DOI 10.1093/nar/28.1.283; Gromiha MM, 2002, NUCLEIC ACIDS RES, V30, P301, DOI 10.1093/nar/30.1.301; Hagan MT., 1997, NEURAL NETWORK DESIG; HANSCH C, 1964, J AM CHEM SOC, V86, P1616, DOI 10.1021/ja01062a035; HANSCH C, 1963, J AM CHEM SOC, V85, P2817, DOI 10.1021/ja00901a033; Hansch C, 1978, CORRELATION ANAL CHE; Huang LT, 2007, BIOPHYS CHEM, V125, P462, DOI 10.1016/j.bpc.2006.10.009; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kellogg GE, 2003, EXS, V93, P223; Ko GM, 2012, CURR COMPUT-AID DRUG, V8, P255; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047247; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Sarai A, 2001, BIOPOLYMERS, V61, P121, DOI 10.1002/1097-0282(2002)61:2<121::AID-BIP10077>3.0.CO;2-1; Thiltgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046084; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Wainreb G, 2011, BIOINFORMATICS, V27, P3286, DOI 10.1093/bioinformatics/btr576; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363	45	34	36	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138022	10.1371/journal.pone.0138022	http://dx.doi.org/10.1371/journal.pone.0138022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361227	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100108
J	Rodriguez, CE; Reidel, SI; Joffe, EDBD; Jasnis, MA; Fiszman, GL				Rodriguez, Cristina E.; Reidel, Sara I.; Bal de Kier Joffe, Elisa D.; Jasnis, Maria A.; Fiszman, Gabriel L.			Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids	PLOS ONE			English	Article							CANCER; RESISTANCE; APOPTOSIS; MICROENVIRONMENT; ASSOCIATION; PROGRESSION; INHIBITION; EFFICACY; THERAPY; HYPOXIA	Multicellular tumor spheroids represent a 3D in vitro model that mimics solid tumor essential properties including assembly and development of extracellular matrix and nutrient, oxygen and proliferation gradients. In the present study, we analyze the impact of 3D spatial organization of HER2-overexpressing breast cancer cells on the response to Trastuzumab. We cultured human mammary adenocarcinoma cell lines as spheroids with the hanging drop method and we observed a gradient of proliferating, quiescent, hypoxic, apoptotic and autophagic cells towards the inner core. This 3D organization decreased Trastuzumab sensitivity of HER2 over-expressing cells compared to monolayer cell cultures. We did not observe apoptosis induced by Trastuzumab but found cell arrest in G0/G1 phase. Moreover, the treatment downregulated the basal apoptosis only found in tumor spheroids, by eliciting protective autophagy. We were able to increase sensitivity to Trastuzumab by autophagy inhibition, thus exposing the interaction between apoptosis and autophagy. We confirmed this result by developing a resistant cell line that was more sensitive to autophagy inhibition than the parental BT474 cells. In summary, the development of Trastuzumab resistance relies on the balance between death and survival mechanisms, characteristic of 3D cell organization. We propose the use of spheroids to further improve the understanding of Trastuzumab antitumor activity and overcome resistance.	[Rodriguez, Cristina E.; Bal de Kier Joffe, Elisa D.; Jasnis, Maria A.; Fiszman, Gabriel L.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Reidel, Sara I.; Fiszman, Gabriel L.] Natl Inst Ind Technol, Ind Biotechnol Res & Dev Ctr, Buenos Aires, DF, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Industrial (INTI)	Fiszman, GL (corresponding author), Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina.	gfiszman@gmail.com		Reidel, Sara/0000-0003-1887-9538	University of Buenos Aires (UBACYT) [01/2366, 20020130100728BA]; Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT) [2010-01296]	University of Buenos Aires (UBACYT)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT)	This work was supported by University of Buenos Aires (UBACYT 01/2366) http://secinves.com.ar/guias/ubacyt (GF) and University of Buenos Aires (UBACYT 20020130100728BA). Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT: 2010-01296) http://www.agencia.mincyt.gob.ar/ (EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey Tameka A, 2011, J Carcinog, V10, P28, DOI 10.4103/1477-3163.90442; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Choi CH, 2010, MOL PHARMACOL, V78, P114, DOI 10.1124/mol.110.063495; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Esteve Juan M, 2011, World J Biol Chem, V2, P232, DOI 10.4331/wjbc.v2.i10.232; Feitelson MA, 2015, SEMIN CANCER BIOL, V35, pS25, DOI 10.1016/j.semcancer.2015.02.006; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hockel M, 1996, CANCER RES, V56, P4509; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kute T, 2004, CYTOM PART A, V57A, P86, DOI 10.1002/cyto.a.10095; Lee S, 2002, CANCER RES, V62, P5703; Liu QJ, 2014, MOL MED REP, V10, P625, DOI 10.3892/mmr.2014.2296; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moulder SL, 2001, CANCER RES, V61, P8887; Munoz L, 2010, TISSUE CELL, V42, P334, DOI 10.1016/j.tice.2010.07.006; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Negri T, 2010, GENE CHROMOSOME CANC, V49, P901, DOI 10.1002/gcc.20798; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vazquez Martin A, 2011, GENE CHROMOSOME CANC, V290, P284, DOI [10.1002/gcc, DOI 10.1002/GCC]; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774; Yakes FM, 2002, CANCER RES, V62, P4132; Zhu XM, 2013, J CELL BIOCHEM, V114, P2643, DOI 10.1002/jcb.24611	39	32	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137920	10.1371/journal.pone.0137920	http://dx.doi.org/10.1371/journal.pone.0137920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360292	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100102
J	Shin, B; Park, W				Shin, Bora; Park, Woojun			Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii	PLOS ONE			English	Article							URSOLIC ACID; PROTEOMIC ANALYSIS; TRITERPENOIDS; COMBINATION; EXPRESSION; RESISTANCE; PROTEINS; EFFLUX	Difficulties involved in treating drug-resistant pathogens have created a need for new therapies. In this study, we investigated the possibility of using oleanolic acid (OA), a natural pen-tacyclic triterpenoid, as a natural adjuvant for antibiotics against Acinetobacter baumannii. High concentrations of OA can kill cells, partly because it generates reactive oxygen species. Measurement of the fractional inhibitory concentration (FIC) for OA and time-kill experiments demonstrated that it only synergizes with aminoglycoside antibiotics (e.g., gentamicin, kanamycin). Other classes of antibiotics (e.g., ampicillin, rifampicin, norfloxacin, chloramphenicol, and tetracycline) have no interactions with OA. Microarray and quantitative reverse transcription-PCR analysis indicated that genes involved in ATP synthesis and cell membrane permeability, the gene encoding glycosyltransferase, peptidoglycan-related genes, phage-related genes, and DNA repair genes were upregulated under OA. OA highly induces the expression of adk, which encodes an adenylate kinase, and des6, which encodes a linoleoyl-CoA desaturase, and deletion of these genes increased FICs; these observations indicate that adk and des6 are involved in the synergism of OA with aminoglycosides. Data obtained using 8-anilino-1-naphthalenesulfonic acid, fluorescenceconjugated gentamicin, and membrane fatty acid analysis indicates that adk and des6 are involved in changes in membrane permeability. Proton-motive force and ATP synthesis tests show that those genes are also involved in energy metabolism. Taken together, our data show that OA boosts aminoglycoside uptake by changing membrane permeability and energy metabolism in A. baumannii.	[Shin, Bora; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea	Korea University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea.	wpark@korea.ac.kr			Mid-career Researcher Program through an NRF - Ministry of Science, ICT, and Future Planning (MSIP) [2014R1A2A2A05007010]	Mid-career Researcher Program through an NRF - Ministry of Science, ICT, and Future Planning (MSIP)	This work was supported by the Mid-career Researcher Program through an NRF grant (2014R1A2A2A05007010) funded by the Ministry of Science, ICT, and Future Planning (MSIP).	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; BALANEHRU S, 1991, BIOCHEM INT, V24, P981; Bassetti M, 2008, FUTURE MICROBIOL, V3, P649, DOI 10.2217/17460913.3.6.649; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Black PA, 2014, ANTIMICROB AGENTS CH, V58, P2491, DOI 10.1128/AAC.02293-13; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Dawis MA, 2003, J ANTIMICROB CHEMOTH, V51, P1203, DOI 10.1093/jac/dkg238; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Elkins CA, 2004, APPL ENVIRON MICROB, V70, P7200, DOI 10.1128/AEM.70.12.7200-7209.2004; Giamarellou H, 2001, MED CLIN N AM, V85, P19, DOI 10.1016/S0025-7125(05)70303-5; Gopal R, 2014, ANTIMICROB AGENTS CH, V58, P1622, DOI 10.1128/AAC.02473-13; Grudniak AM, 2011, CURR MICROBIOL, V62, P1331, DOI 10.1007/s00284-010-9866-0; He ZD, 2001, CHEM PHARM BULL, V49, P780, DOI 10.1248/cpb.49.780; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hong H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107716; Hong YY, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/761403; Hwang YY, 2013, ANTIMICROB AGENTS CH, V57, P3568, DOI 10.1128/AAC.02109-12; Jimenez-Arellanes A, 2007, J ETHNOPHARMACOL, V111, P202, DOI 10.1016/j.jep.2006.11.033; Jung J, 2013, APPL MICROBIOL BIOT, V97, P4511, DOI 10.1007/s00253-012-4669-9; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kim M, 2014, BIOMOL THER, V22, P254, DOI 10.4062/biomolther.2014.008; Kurek A, 2010, ANTON LEEUW INT J G, V97, P61, DOI 10.1007/s10482-009-9388-6; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; Lee KW, 2012, J MICROBIOL BIOTECHN, V22, P1432, DOI 10.4014/jmb.1203.03066; Lee SG, 2012, J MICROBIOL BIOTECHN, V22, P516, DOI 10.4014/jmb.1109.09012; Liu C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0084849; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Park J, 2011, CURR MICROBIOL, V62, P249, DOI 10.1007/s00284-010-9698-y; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; RAND KH, 1993, ANTIMICROB AGENTS CH, V37, P613, DOI 10.1128/AAC.37.3.613; REDDY AS, 1993, PLANT MOL BIOL, V22, P293, DOI 10.1007/BF00014936; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Sarkar C, 2014, FOOD CHEM TOXICOL, V66, P224, DOI 10.1016/j.fct.2014.01.020; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Tamburro A, 2004, FEMS MICROBIOL LETT, V241, P151, DOI 10.1016/j.femsle.2004.10.013; Toba FA, 2011, MICROBIOL-SGM, V157, P1640, DOI 10.1099/mic.0.045161-0; Wachter GA, 2001, J NAT PROD, V64, P37, DOI 10.1021/np000267b; Yeom J, 2012, RES MICROBIOL, V163, P258, DOI 10.1016/j.resmic.2012.01.008; Yin MC, 2007, J AGR FOOD CHEM, V55, P7177, DOI 10.1021/jf071242m; Yu F, 2013, J MED CHEM, V56, P4300, DOI 10.1021/jm301910a; Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6; Zhou L, 2013, ORAL DIS, V19, P494, DOI 10.1111/odi.12031	54	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137751	10.1371/journal.pone.0137751	http://dx.doi.org/10.1371/journal.pone.0137751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360766	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100081
J	Thrane, JE; Kyle, M; Striebel, M; Haande, S; Grung, M; Rohrlack, T; Andersen, T				Thrane, Jan-Erik; Kyle, Marcia; Striebel, Maren; Haande, Sigrid; Grung, Merete; Rohrlack, Thomas; Andersen, Tom			Spectrophotometric Analysis of Pigments: A Critical Assessment of a High-Throughput Method for Analysis of Algal Pigment Mixtures by Spectral Deconvolution	PLOS ONE			English	Article							NUTRIENT LIMITATION; CHLOROPHYLL-A; CAROTENOIDS; HPLC; PHYTOPLANKTON; LIGHT; QUANTIFICATION; ACCLIMATION; ABSORPTION; EQUATIONS	The Gauss-peak spectra (GPS) method represents individual pigment spectra as weighted sums of Gaussian functions, and uses these to model absorbance spectra of phytoplankton pigment mixtures. We here present several improvements for this type of methodology, including adaptation to plate reader technology and efficient model fitting by open source software. We use a one-step modeling of both pigment absorption and background attenuation with non-negative least squares, following a one-time instrument-specific calibration. The fitted background is shown to be higher than a solvent blank, with features reflecting contributions from both scatter and non-pigment absorption. We assessed pigment aliasing due to absorption spectra similarity by Monte Carlo simulation, and used this information to select a robust set of identifiable pigments that are also expected to be common in natural samples. To test the method's performance, we analyzed absorbance spectra of pigment extracts from sediment cores, 75 natural lake samples, and four phytoplankton cultures, and compared the estimated pigment concentrations with concentrations obtained using high performance liquid chromatography (HPLC). The deviance between observed and fitted spectra was generally very low, indicating that measured spectra could successfully be reconstructed as weighted sums of pigment and background components. Concentrations of total chlorophylls and total carotenoids could accurately be estimated for both sediment and lake samples, but individual pigment concentrations (especially carotenoids) proved difficult to resolve due to similarity between their absorbance spectra. In general, our modified-GPS method provides an improvement of the GPS method that is a fast, inexpensive, and high-throughput alternative for screening of pigment composition in samples of phytoplankton material.	[Thrane, Jan-Erik] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Kyle, Marcia; Rohrlack, Thomas] Norwegian Univ Life Sci NMBU, Dept Environm Sci, As, Norway; [Striebel, Maren] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Haande, Sigrid; Grung, Merete] Norwegian Inst Water Res NIVA, Oslo, Norway; [Thrane, Jan-Erik; Grung, Merete; Andersen, Tom] Univ Oslo, Sect Aquat Biol & Toxicol AQUA, Dept Biosci, Oslo, Norway	University of Oslo; Norwegian University of Life Sciences; Carl von Ossietzky Universitat Oldenburg; Norwegian Institute for Water Research (NIVA); University of Oslo	Thrane, JE (corresponding author), Univ Oslo, CEES, Dept Biosci, Oslo, Norway.	j.e.thrane@ibv.uio.no	Striebel, Maren/AAF-9996-2019	Striebel, Maren/0000-0003-2061-2154	Norwegian Institute for Water Research; University of Oslo; Norwegian University of Life Sciences	Norwegian Institute for Water Research; University of Oslo; Norwegian University of Life Sciences	This project was funded in part by internal grants from Norwegian Institute for Water Research for SH, MG, MK, and TR, and by internal grants from University of Oslo and Norwegian University of Life Sciences for JET, MK, and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEMOGLU M, 1988, HELV CHIM ACTA, V71, P931, DOI 10.1002/hlca.19880710502; Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; BAUMELER A, 1994, HELV CHIM ACTA, V77, P909, DOI 10.1002/hlca.19940770405; DAVIES AJ, 1984, J CHEM SOC PERK T 1, P2147, DOI 10.1039/p19840002147; Dogan M, 2009, B ENVIRON CONTAM TOX, V83, P249, DOI 10.1007/s00128-009-9733-5; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; ENGLERT G, 1991, HELV CHIM ACTA, V74, P969, DOI 10.1002/hlca.19910740507; GANGULY J, 1956, ARCH BIOCHEM BIOPHYS, V60, P345, DOI 10.1016/0003-9861(56)90436-2; HAGER A, 1966, PLANTA, V69, P198, DOI 10.1007/BF00384873; HAUGAN JA, 1989, PHYTOCHEMISTRY, V28, P2797; HEATH MR, 1990, J PLANKTON RES, V12, P381, DOI 10.1093/plankt/12.2.381; HERTZBERG S, 1969, PHYTOCHEMISTRY, V8, P1259, DOI 10.1016/S0031-9422(00)85566-1; Hobaek A, 2012, FRESHWATER BIOL, V57, P1998, DOI 10.1111/j.1365-2427.2012.02832.x; HYNNINEN PH, 1983, SYNTHESIS-STUTTGART, P705; ISLER O, 1956, HELV CHIM ACTA, V39, P249, DOI 10.1002/hlca.19560390128; Jeffrey S.W., 2011, MICROALGAL CLASSES T, DOI [10.1017/CBO9780511732263.004, DOI 10.1017/CBO9780511732263.004]; Jeffrey S.W, 1997, MONOGRAPHS OCEANOGRA, P10; JEFFREY SW, 1972, BIOCHIM BIOPHYS ACTA, V279, P15, DOI 10.1016/0304-4165(72)90238-3; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHANSEN JE, 1974, PHYTOCHEMISTRY, V13, P2261, DOI 10.1016/0031-9422(74)85038-7; KOBAYASHI M, 1993, APPL ENVIRON MICROB, V59, P867, DOI 10.1128/AEM.59.3.867-873.1993; Kupper H, 2000, ANAL BIOCHEM, V286, P247, DOI 10.1006/abio.2000.4794; Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.01148.x; Kupper H, 2007, ANAL CHEM, V79, P7611, DOI 10.1021/ac070236m; Latasa M, 1996, MAR CHEM, V51, P315, DOI 10.1016/0304-4203(95)00056-9; Lawson CL, 1974, SOLVING LEAST SQUARE; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; Naqvi KR, 2004, SPECTROCHIM ACTA A, V60, P2783, DOI 10.1016/j.saa.2004.01.017; Picazo A, 2013, LIMNETICA, V32, P139; Porra RJ, 2006, CHLOROPHYLLS BACTERI, DOI DOI 10.1007/1-4020-4516-6; R Core Team, 2012, R LANG ENV STAT COMP; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Roy S., 2011, PHYTOPLANKTON PIGMEN; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schagerl M, 2007, BIOLOGIA, V62, P270, DOI 10.2478/s11756-007-0048-x; Schagerl M, 2006, J PLANT PHYSIOL, V163, P709, DOI 10.1016/j.jplph.2005.09.015; Schneider SC, 2015, AQUAT BOT, V120, P121, DOI 10.1016/j.aquabot.2014.05.002; STRAIN HH, 1976, ACTA CHEM SCAND B, V30, P109, DOI 10.3891/acta.chem.scand.30b-0109; Strain HH, 1938, CARNEGIE I WASHINGTO, V490, P147; SURMATIS JD, 1970, HELV CHIM ACTA, V53, P974, DOI 10.1002/hlca.19700530513; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zscheile FP, 1942, PLANT PHYSIOL, V17, P331, DOI 10.1104/pp.17.3.331	50	57	57	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137645	10.1371/journal.pone.0137645	http://dx.doi.org/10.1371/journal.pone.0137645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359659	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361043100063
J	Chong, EW; Wang, YY; Robman, LD; Aung, KZ; Makeyeva, GA; Giles, GG; Graves, S; Cicuttini, FM; Guymer, RH				Chong, Elaine W.; Wang, Yuanyuan; Robman, Liubov D.; Aung, Khin Zaw; Makeyeva, Galina A.; Giles, Graham G.; Graves, Stephen; Cicuttini, Flavia M.; Guymer, Robyn H.			Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; VISUAL IMPAIRMENT; SYMPTOMATIC HIP; SYNOVIAL-FLUID; INFLAMMATION; OLDER; EPIDEMIOLOGY; AUSTRALIA; PEOPLE; DRUSEN	Osteoarthritis is the leading cause of total hip replacement, accounting for more than 80% of all total hip replacements. Emerging evidence suggests that osteoarthritis has a chronic inflammatory component to its pathogenesis similar to age-related macular degeneration. We evaluated the association between age-related macular degeneration and total hip replacement as proxy for severe osteoarthritis or fractured neck of femur in the Melbourne Collaborative Cohort Study. 20,744 participants had complete data on both age-related macular degeneration assessed from colour fundus photographs taken during 2003-2007 and total hip replacement. Total hip replacements due to hip osteoarthritis and fractured neck of femur during 2001-2011 were identified by linking the cohort records to the Australian Orthopedic Association National Joint Replacement Registry. Logistic regression was used to examine the association between age-related macular degeneration and risk of total hip replacement due to osteoarthritis and fracture separately, adjusted for confounders. There were 791 cases of total hip replacement for osteoarthritis and 102 cases of total hip replacement due to fractured neck of femur. After adjustment for age, sex, body mass index, smoking, and grouped country of birth, intermediate age-related macular degeneration was directly associated with total hip replacement for osteoarthritis (odds ratio 1.22, 95% CI 1.00-1.49). Late age-related macular degeneration was directly associated with total hip replacement due to fractured neck of femur (odds ratio 5.21, 95% CI2.25-12.02). The association between intermediate age-related macular degeneration and an increased 10-year incidence of total hip replacement due to osteoarthritis suggests the possibility of similar inflammatory processes underlying both chronic diseases. The association of late age-related macular degeneration with an increased 10-year incidence of total hip replacement due to fractured neck of femur may be due to an increased prevalence of fractures in those with poor central vision associated with the late complications of age-related macular degeneration.	[Chong, Elaine W.; Robman, Liubov D.; Aung, Khin Zaw; Makeyeva, Galina A.; Guymer, Robyn H.] Univ Melbourne, Ctr Eye Res Australia CERA, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Chong, Elaine W.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wang, Yuanyuan; Robman, Liubov D.; Cicuttini, Flavia M.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia; [Giles, Graham G.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Graves, Stephen] Repatriat Gen Hosp, Dept Orthopaed, Adelaide, SA, Australia; [Graves, Stephen] Univ Adelaide, Australian Orthopaed Assoc Natl Joint Replacement, Discipline Publ Hlth, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; Singapore National Eye Center; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Cancer Council Victoria; Flinders University South Australia; University of Adelaide	Chong, EW (corresponding author), Univ Melbourne, Ctr Eye Res Australia CERA, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia.	elainechongwt@alumni.unimelb.edu.au	Graves, Stephen E/A-9463-2016; Wang, Yuanyuan/AAC-1109-2019; Cicuttini, Flavia/H-4978-2014	Graves, Stephen E/0000-0002-1629-319X; Wang, Yuanyuan/0000-0002-7629-4178; Guymer, Robyn/0000-0002-9441-4356; Cicuttini, Flavia/0000-0002-8200-1618; Giles, Graham/0000-0003-4946-9099	Victoria Health, The Cancer Council Victoria; National Health & Medical Research Council of Australia (NHMRC) [209057, 251533, 396414]; Ophthalmic Research Institute of Australia; American Health Assistance Foundation [M2008-082]; NHMRC Centre for Clinical Research Excellence Grant [529923]; Commonwealth Department of Health	Victoria Health, The Cancer Council Victoria; National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; American Health Assistance Foundation; NHMRC Centre for Clinical Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Department of Health	Victoria Health, The Cancer Council Victoria and National Health & Medical Research Council of Australia (NHMRC) [Program Grant 209057, Capacity Building Grant 251533 and Enabling Grant 396414] funded the MCCS study. Ophthalmic component was funded by the Ophthalmic Research Institute of Australia and American Health Assistance Foundation # M2008-082. CERA is a recipient of the NHMRC Centre for Clinical Research Excellence Grant [529923] and Operational Infrastructure Support from the Victorian Government. The AOA NJRR is funded by the Commonwealth Department of Health. People support was provided through the NHMRC public health medical scholarship (EC), Novartis Medical Retinal Fellowship (EC), NHMRC Career Development Fellowship (YW, # 1065464), Wagstaff Fellowship (LR), NHMRC Career Development (RG, # 300052) and Practitioner (RG, # 529905) Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos E, 2006, AM J OPHTHALMOL, V142, P1081, DOI 10.1016/j.ajo.2006.06.058; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Aung KZ, 2009, OPHTHAL EPIDEMIOL, V16, P254, DOI [10.3109/09286580902864419, 10.1080/09286580902864419]; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; DEAN G, 1993, BRIT J RHEUMATOL, V32, P671; Deloitte Access Economics, 2011, EYES FUT CLEAR OUTL; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Giles G G, 2002, IARC Sci Publ, V156, P69; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Graves SE, 2004, MED J AUSTRALIA, V180, pS31; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hong T, 2014, INVEST OPHTH VIS SCI, V55, P7589, DOI 10.1167/iovs.14-14262; Legood R, 2002, INJ PREV, V8, P155, DOI 10.1136/ip.8.2.155; MAROTTOLI RA, 1992, J AM GERIATR SOC, V40, P861, DOI 10.1111/j.1532-5415.1992.tb01980.x; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Rahman N, 2007, IMP DIS ASS ARTHR OS; Registry AOANJR, 2013, ANN REPORT; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Spector TD, 1997, ARTHRITIS RHEUM, V40, P723, DOI 10.1002/art.1780400419; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Valdes AM, 2010, CURR OPIN RHEUMATOL, V22, P139, DOI 10.1097/BOR.0b013e3283367a6e; VanNewkirk MR, 2001, OPHTHALMOLOGY, V108, P960, DOI 10.1016/S0161-6420(01)00554-1; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wysong A, 2009, ARCH OPHTHALMOL-CHIC, V127, P320, DOI 10.1001/archophthalmol.2008.613	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137322	10.1371/journal.pone.0137322	http://dx.doi.org/10.1371/journal.pone.0137322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355683	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800043
J	Durbeej, N; Palmstierna, T; Rosendahl, I; Berman, AH; Kristiansson, M; Gumpert, CH				Durbeej, Natalie; Palmstierna, Tom; Rosendahl, Ingvar; Berman, Anne H.; Kristiansson, Marianne; Gumpert, Clara Hellner			Mental Health Services and Public Safety: Substance Abuse Outpatient Visits Were Associated with Reduced Crime Rates in a Swedish Cohort	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; ALCOHOL-USE; CRIMINAL RECIDIVISM; RISK-ASSESSMENT; TEST DUDIT; OFFENDERS; VIOLENT; PSYCHOPATHY; PREDICTION; COMMUNITY	Substance abuse is related to offending and substance abuse treatment has been associated with reductions in criminal behavior. This cohort study aimed to explore the relationship between participation in substance abuse interventions and general criminal recidivism among offenders with a combination of mental health problems and substance use problems. In total, 150 Swedish offenders with self-reported mental health and substance use problems were followed for approximately three years with regard to participation in substance abuse interventions and criminal recidivism. Participants with at least three planned visits to specialized outpatient substance abuse clinics had a substantially reduced risk of reoffending as compared to those with fewer than three such visits (HR = 0.47, 95% CI 0.29-0.77). For those with at least three planned visits, general criminal recidivism was reduced by 75% during periods of participation in outpatient visits, as compared to periods of non-participation (HR = 0.25, 95% CI 0.11-0.60). For offenders with mental health problems and substance use problems, outpatient substance abuse interventions could be regarded as important from a clinical risk management perspective, and be encouraged.	[Durbeej, Natalie; Palmstierna, Tom; Rosendahl, Ingvar; Berman, Anne H.; Kristiansson, Marianne; Gumpert, Clara Hellner] Karolinska Inst, Stockholm Cty Council, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Palmstierna, Tom] St Olavs Univ Hosp, Ctr Res & Educ Forens Psychiat, Forens Dept Broset, Div Psychiat, Trondheim, Norway; [Palmstierna, Tom] NTNU, Fac Med, Dept Neurosci, Trondheim, Norway; [Palmstierna, Tom; Berman, Anne H.] Stockholm Cty Council, Stockholm Ctr Dependency Disorders, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Stockholm County Council	Durbeej, N (corresponding author), Karolinska Inst, Stockholm Cty Council, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.	Natalie.Durbeej@ki.se	Berman, Anne H/C-4636-2011	Berman, Anne H/0000-0002-7709-0230; Rosendahl, Ingvar/0000-0002-1325-913X; Palmstierna, Tom/0000-0002-0490-7916; Kristiansson, Marianne/0000-0002-9448-7643	Swedish Council for Working Life and Social Research [2005/5:11]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The study was funded by the Swedish Council for Working Life and Social Research (Grant number: 2005/5:11, URL: http://www.forte.se/). TP, AHB, MK, and CHG received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abracen J, 2015, J ENVIRON PLANN MAN, V2, P1; Adam D, 2013, NATURE, V496, P416, DOI 10.1038/496416a; Agerholm J, 2013, SCAND J PUBLIC HEALT, V41, P318, DOI 10.1177/1403494812473205; Allebeck P, 2009, ACTA PSYCHIAT SCAND, V120, P386, DOI 10.1111/j.1600-0447.2009.01474.x; Allison PD, 2009, FIXED EFFECT REGRESS; Andrews DA, 2006, CRIME DELINQUENCY, V52, P7, DOI 10.1177/0011128705281756; Belfrage H, 1998, J FORENSIC PSYCHIATR, V9, P328, DOI 10.1080/09585189808402200; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Brunette MF, 2004, DRUG ALCOHOL REV, V23, P471, DOI 10.1080/09595230412331324590; Cacciola JS, 2011, ADDICTION, V106, P1588, DOI 10.1111/j.1360-0443.2011.03482.x; Campbell MA, 2009, CRIM JUSTICE BEHAV, V36, P567, DOI 10.1177/0093854809333610; Collins RE, 2010, J CRIM JUST, V38, P675, DOI 10.1016/j.jcrimjus.2010.04.041; Douglas KS, 2005, PSYCHOL PUBLIC POL L, V11, P347, DOI 10.1037/1076-8971.11.3.347; Durbeej N, 2014, J SUBST ABUSE TREAT, V46, P574, DOI 10.1016/j.jsat.2014.01.002; Durbeej N, 2010, J SUBST ABUSE TREAT, V39, P364, DOI 10.1016/j.jsat.2010.07.007; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Eriksson A, 2013, MENT HLTH SUBST USE, V6, P15; Gendreau P, 1996, CRIMINOLOGY, V34, P575, DOI 10.1111/j.1745-9125.1996.tb01220.x; Grann M, 1998, J PERS ASSESS, V70, P416, DOI 10.1207/s15327752jpa7003_2; Gray NS, 2008, BRIT J PSYCHIAT, V192, P384, DOI 10.1192/bjp.bp.107.044065; Gumpert C., 2010, INT J FORENSIC MENT, V9, P82, DOI [10.1080/14999013.2010.499557, DOI 10.1080/14999013.2010.499557]; Hakansson A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-111; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Hare RD, 2000, BEHAV SCI LAW, V18, P623, DOI 10.1002/1099-0798(200010)18:5<623::AID-BSL409>3.0.CO;2-W; Heilbrun K, 2012, CRIM JUSTICE BEHAV, V39, P351, DOI 10.1177/0093854811432421; Hemphill J., 1998, LEGAL CRIMINOL PSYCH, V3, P139, DOI DOI 10.1111/J.2044-8333.1998.TB00355.X; Hildebrand M, 2015, J SUBST ABUSE TREAT, V53, P52, DOI 10.1016/j.jsat.2015.01.008; Holloway KR, 2006, PSICOTHEMA, V18, P620; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Jaffe A, 2012, J SUBST ABUSE TREAT, V43, P244, DOI 10.1016/j.jsat.2011.12.002; Lindqvist Per, 2007, Crim Behav Ment Health, V17, P242, DOI 10.1002/cbm.658; Melnick G, 2008, BEHAV SCI LAW, V26, P457, DOI 10.1002/bsl.827; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Oberg D, 2006, SWEDISH VERSION ASI; Perry AE, 2014, COCHRANE DB SYST REV, V2, P1; Prendergast ML, 2002, DRUG ALCOHOL DEPEN, V67, P53, DOI 10.1016/S0376-8716(02)00014-5; Sacks S, 2012, J SUBST ABUSE TREAT, V42, P247, DOI 10.1016/j.jsat.2011.07.011; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Socialstyrelsen, 2007, 20071021 SOC; Storbjork J, 2008, ADDICT RES THEORY, V16, P67, DOI 10.1080/16066350701578136; Therneau T.M., 2000, MODELING SURVIVAL DA; Wallinius M, 2012, PSYCHIAT RES, V198, P279, DOI 10.1016/j.psychres.2012.01.005; Walters GD, 2010, ASSESSMENT, V17, P259, DOI 10.1177/1073191109356685; Webster C.D., 1997, HCR 20 ASSESSING RIS; Young D, 2004, J SUBST ABUSE TREAT, V27, P313, DOI 10.1016/j.jsat.2004.08.007	47	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137780	10.1371/journal.pone.0137780	http://dx.doi.org/10.1371/journal.pone.0137780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356604	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800082
J	Lal, S; Ndyomugenyi, R; Alexander, ND; Lagarde, M; Paintain, L; Magnussen, P; Chandramohan, D; Clarke, SE				Lal, Sham; Ndyomugenyi, Richard; Alexander, Neal D.; Lagarde, Mylene; Paintain, Lucy; Magnussen, Pascal; Chandramohan, Daniel; Clarke, Sian E.			Health Facility Utilisation Changes during the Introduction of Community Case Management of Malaria in South Western Uganda: An Interrupted Time Series Approach	PLOS ONE			English	Article							HOME-BASED MANAGEMENT; QUALITY; CARE; IMPLEMENTATION; MORBIDITY; ILLNESS; IMPACT; POLICY; DRUGS	Background Malaria endemic countries have scaled-up community health worker (CHW) interventions, to diagnose and treat malaria in communities with limited access to public health systems. The evaluations of these programmes have centred on CHW's compliance to guidelines, but the broader changes at public health centres including utilisation and diagnoses made, has received limited attention. Methods This analysis was conducted during a CHW-intervention for malaria in Rukungiri District, Western Uganda. Outpatient department (OPD) visit data were collected for children under-5 attending three health centres one year before the CHW-intervention started (pre-intervention period) and for 20 months during the intervention (intervention-period). An interrupted time series analysis with segmented regression models was used to compare the trends in malaria, non-malaria and overall OPD visits during the pre-intervention and intervention-period. Results The introduction of a CHW-intervention suggested the frequency of diagnoses of diarrhoeal diseases, pneumonia and helminths increased, whilst the frequency of malaria diagnoses declined at health centres. In May 2010 when the intervention began, overall health centre utilisation decreased by 63% compared to the pre-intervention period and the health centres saw 32 fewer overall visits per month compared to the pre-intervention period (p<0.001). Malaria visits also declined shortly after the intervention began and there were 27 fewer visits per month during the intervention-period compared with the pre-intervention period (p<0.05). The declines in overall and malaria visits were sustained for the entire intervention-period. In contrast, there were no observable changes in trends of non-malarial visits between the pre-intervention and intervention-period. Conclusions This analysis suggests introducing a CHW-intervention can reduce the number of child malaria visits and change the profile of cases presenting at health centres. The reduction in workload of health workers may allow them to spend more time with patients or undertake additional curative or preventative roles.	[Lal, Sham; Paintain, Lucy; Chandramohan, Daniel; Clarke, Sian E.] London Sch Hyg & Trop Med, Fac Infect Trop Dis, Dept Dis Control, London WC1, England; [Ndyomugenyi, Richard] Minist Hlth, Vector Control Div, Kampala, Uganda; [Alexander, Neal D.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1, England; [Lagarde, Mylene] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Magnussen, Pascal] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Magnussen, Pascal] Univ Copenhagen, Inst Vet Dis Biol, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; University of Copenhagen	Lal, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect Trop Dis, Dept Dis Control, London WC1, England.	sham.lal@lshtm.ac.uk	Clarke, Sian/AAF-5805-2019; Lagarde, Mylene/GVS-9289-2022	Magnussen, Pascal/0000-0001-7372-0250; Lal, Sham/0000-0002-3650-1398	ACT Consortium through Bill & Melinda Gates Foundation; United Kingdom Medical Research Council (MRC); Department for International Development (DFID) [MR/K012126/1]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	ACT Consortium through Bill & Melinda Gates Foundation; United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the ACT Consortium through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (www.actconsortium.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NDA receives support from the United Kingdom Medical Research Council (MRC) and Department for International Development (DFID) (MR/K012126/1).	Agresti A, 2007, INTRO CATEGORICAL DA; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2006, WORK TOG HLTH; [Anonymous], 2003, AFR MAL REP 2003; Dubois CA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-87; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Kallander Karin, 2006, BMC Int Health Hum Rights, V6, P2, DOI 10.1186/1472-698X-6-2; Kalyango JN, 2012, AM J TROP MED HYG, V87, P36, DOI 10.4269/ajtmh.2012.11-0733; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; McCleary R., 1980, APPL TIME SERIES ANA; Ministry of Health, 2014, HLTH SECT STRAT PLAN; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okwundu CI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009527.pub2; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rasanathan K, 2014, J GLOB HEALTH, V4, P48, DOI 10.7189/jogh.04.020401; Rukungiri District Local Government, 2009, HIGH LOC GOV STAT AB; Sievers AC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-167; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Steinhardt LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089050; Thomson A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-94; Tiono AB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-201; Uganda Ministry of Health, 2010, MIN HLTH STAT ABSTR; Uganda Ministry of Health, 2011, UG MAL PROGR REV REP; Uganda Ministry of Health, 2011, HLTH SYST 20 20; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wazny K, 2014, J GLOB HEALTH, V4, P193, DOI 10.7189/jogh.04.020413; WHO, 2006, AFR MAL REP 2006; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137448	10.1371/journal.pone.0137448	http://dx.doi.org/10.1371/journal.pone.0137448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356099	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800047
J	Markova, DN; Mason-Gamer, RJ				Markova, Dragomira N.; Mason-Gamer, Roberta J.			The Role of Vertical and Horizontal Transfer in the Evolutionary Dynamics of PIF-Like Transposable Elements in Triticeae	PLOS ONE			English	Article							NORTH-AMERICAN ELYMUS; SANT DOMAIN; DNA; GENOME; DROSOPHILA; MARINER; GENE; DIVERSITY; SELECTION; POACEAE	PIF-like transposable elements are members of the PIF/Harbinger superfamily of DNA transposons found in the genomes of many plants, animals, and fungi. The evolution of the gene that encodes the transposase responsible for mobilizing PIF-like elements has been studied in both plants and animals, but the elements' history in flowering plants remains poorly known. In this work, we describe the phylogenetic distribution and evolution of PIF-like elements in the genomes of 21 diploid species from the wheat tribe, Triticeae, and we present the first convincing evidence of horizontal transfer of PIF elements in plant genomes. A phylogenetic analysis of 240 PIF sequences based on the conserved region of the transposase domain revealed at least four main transposase lineages. Their complex evolutionary history can be best explained by a combination of vertical transmission with differential evolutionary success among lineages, and occasional horizontal transfer between phylogenetically distant Triticeae genera. In addition, we identified 127 potentially functional transposase sequences indicating possible recent activity of PIF.	[Markova, Dragomira N.; Mason-Gamer, Roberta J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Markova, DN (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	markova@ucdavis.edu			National Science Foundation [DEB-0426194]; University of Illinois at Chicago Graduate College; Department of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); University of Illinois at Chicago Graduate College; Department of Biological Sciences	This study was supported by a National Science Foundation grant (grant number DEB-0426194) to RJMG; Provost's Research Award from the University of Illinois at Chicago Graduate College and an Elmer Hadley award from the Department of Biological Sciences to DNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative A, 2000, 00280836 AR GEN IN; Arca B, 2000, GENETICA, V108, P263, DOI 10.1023/A:1004185024017; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Capy P, 1998, MOL B INT U, P1; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; Cm Gilbert, 2010, NATURE, V464, P1347, DOI [10.1038/ nature08939, DOI 10.1038/NATURE08939]; DANIELS SB, 1990, GENETICS, V124, P339; Dewey D, 1985, GENE MANIPULATION PL, P209; DEWEY DR, 1983, BRITTONIA, V35, P30, DOI 10.2307/2806044; DEWEY DR, 1983, CROP SCI, V23, P637, DOI 10.2135/cropsci1983.0011183X002300040009x; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Doyle J. J., 1987, PHYTOCHEM B, P11; El Baidouri M, 2014, GENOME RES, V24, P831, DOI 10.1101/gr.164400.113; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Grzebelus D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-409; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Loreto ELD, 2001, J HERED, V92, P375, DOI 10.1093/jhered/92.5.375; Love A., 1984, Feddes Repertorium, V95, P425; Maddison DR, 2005, ANAL PHYLOGENY CHARA; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Middleton CP, 2013, PLANT J, V73, P347, DOI 10.1111/tpj.12048; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; NEI M, 1986, MOL BIOL EVOL, V3, P418; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Shen ZC, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.24; Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomita M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-269; Wagner A, 1994, SYSTEMATIC BIOL, V43; Walker EL, 1997, GENETICS, V146, P681; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Witherspoon DJ, 1999, MOL BIOL EVOL, V16, P472, DOI 10.1093/oxfordjournals.molbev.a026129; Yu CM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-214; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971; Zhong H, 2010, BIOCHEM SYST ECOL, V38, P750, DOI 10.1016/j.bse.2010.06.010; Zhou MB, 2010, PLANT SCI, V179, P257, DOI 10.1016/j.plantsci.2010.05.012; Zwickl DJ., 2006, THESIS	67	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137648	10.1371/journal.pone.0137648	http://dx.doi.org/10.1371/journal.pone.0137648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355747	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800074
J	Ratovoson, R; Rasetarinera, OR; Andrianantenaina, I; Rogier, C; Piola, P; Pacaud, P				Ratovoson, Rila; Rasetarinera, Ony Rabarisoa; Andrianantenaina, Ionimalala; Rogier, Christophe; Piola, Patrice; Pacaud, Pierre			Hypertension, a Neglected Disease in Rural and Urban Areas in Moramanga, Madagascar	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; RISK-FACTORS; MARITAL-STATUS; GLOBAL BURDEN; PREVALENCE; AWARENESS; SEX; EPIDEMIOLOGY; TRANSITION	Background Hypertension is one of the main risk factors of cardiovascular diseases. In Madagascar, studies on hypertension in urban and rural communities are scarce. Objectives The aim of this study was to determine the prevalence of hypertension and identify associated risk factors in adults living in a health and demographic system in Moramanga, Madagascar. Methods The study included people aged 15 years old and above living in a health and demographic system in Moramanga. A household census was performed in 2012 to enumerate the population in 3 communities in Moramanga. In addition to the questionnaire used in the initial census, a standardized questionnaire and blood pressure were taken twice after 5 and 10 minutes of rest. In urban areas, heights and weights were also measured to calculate the body mass index. Results There were 3621 and 4010 participants respectively in rural and urban areas. Prevalence of hypertension in rural population was 27.0%(IC95%[25.6-28.5]) and 29.7% (IC95% [28.3-31.1]) in urban population. Among hypertensive subjects, 1.7% (17/979) and 5.3% (64/1191) were on antihypertensive treatment for at least 1 month before the survey in rural and urban population, respectively. In rural areas, increasing age (65 years and older vs 18-25 years OR = 11.81, IC95% [7.79-18.07]), giving more than 3 positive responses to the usual risks factors of hypertension (OR = 1.67, IC95% [1.14-2.42]) and singles in comparison with married people (OR = 1.61, IC95% [1.20-2.17]) were associated to hypertension in a logistic regression model. In urban areas, increasing age (65 years and older vs 18-25 years OR = 37.54, IC95% [24.81-57.92]), more than 3 positive responses to the usual risks of hypertension (OR = 3.47, IC95% [2.58-4.67]) and obesity (OR = 2.45, IC95% [1.56-3.87]) were found as risk factors. Conclusion Hypertension is highly prevalent in rural areas although it is significantly less treated. As a result, a major epidemic of cardiovascular diseases is at risk in Madagascar's progressively aging society.	[Ratovoson, Rila; Andrianantenaina, Ionimalala; Rogier, Christophe; Piola, Patrice] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Rasetarinera, Ony Rabarisoa] Antananarivo Univ, Fac Med, Antananarivo, Madagascar; [Rogier, Christophe] URMITE, UMR 6236, F-13385 Marseille 05, France; [Rogier, Christophe] French Armed Forces IRBA, Inst Biomed Res, F-91223 Bretigny Sur Orge, France; [Pacaud, Pierre] Univ Nantes, INSERM, UMR S1087, CHU Nantes,Inst Thorax, F-44000 Nantes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Ratovoson, R (corresponding author), Inst Pasteur Madagascar, POB 1274 Ambatofotsikely, Antananarivo, Madagascar.	rila@pasteur.mg	Pacaud, Pierre/D-6392-2015	Ratovoson, Rila/0000-0002-3867-6343	University of Nantes; Institut Pasteur de Madagascar	University of Nantes; Institut Pasteur de Madagascar	This study was supported by University of Nantes: This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Institut Pasteur de Madagascar: This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2014, AM J HYPERTENS, V27, P1511, DOI 10.1093/ajh/hpu081; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Balla Siham Ahmed, 2014, Glob J Health Sci, V6, P206, DOI 10.5539/gjhs.v6n3p206; Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choukem SP, 2007, DIABETES RES CLIN PR, V77, P293, DOI 10.1016/j.diabres.2006.11.007; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Fourcade L, 2007, Med Trop (Mars), V67, P559; Institut National de la Statistique (INSTAT) ICF Macro, 2010, ENQ DEM SANT MAD 200; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Kuller LH, 2007, HYPERTENSION, V50, P1004, DOI 10.1161/HYPERTENSIONAHA.107.095620; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Maselko J, 2009, J AM GERIATR SOC, V57, P2293, DOI 10.1111/j.1532-5415.2009.02555.x; Masquelier B, 2014, GLOBAL HEALTH ACTION, V7, P110, DOI 10.3402/gha.v7.23237; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Organisation Mondiale de la Sante, STAT SAN MOND 2013; Peck RN, 2013, J HYPERTENS, V31, P1806, DOI 10.1097/HJH.0b013e328362bad7; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; R Core Team, 2021, R LANGUAGE ENV STAT; Rabarijaona L, 2009, REV ANESTHESIE REANI, V1, P24; Rakotoarimanana S, 2005, MED AFR NOIRE, V52, P135; Tibazarwa KB, 2014, CAN J CARDIOL, V30, P527, DOI 10.1016/j.cjca.2014.02.020; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7	37	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137408	10.1371/journal.pone.0137408	http://dx.doi.org/10.1371/journal.pone.0137408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355997	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800046
J	Green, JP; Foster, R; Wilkins, L; Osorio, D; Hartley, SE				Green, Jonathan P.; Foster, Rosie; Wilkins, Lucas; Osorio, Daniel; Hartley, Susan E.			Leaf Colour as a Signal of Chemical Defence to Insect Herbivores in Wild Cabbage (Brassica oleracea)	PLOS ONE			English	Article							AUTUMN TREE COLORS; PIERIS-RAPAE; GLUCOSINOLATE POLYMORPHISM; SPECIALIST HERBIVORE; HOST-PLANT; RESPONSES; APHID; PREFERENCE; POPULATIONS; RED	Leaf colour has been proposed to signal levels of host defence to insect herbivores, but we lack data on herbivory, leaf colour and levels of defence for wild host populations necessary to test this hypothesis. Such a test requires measurements of leaf spectra as they would be sensed by herbivore visual systems, as well as simultaneous measurements of chemical defences and herbivore responses to leaf colour in natural host-herbivore populations. In a large-scale field survey of wild cabbage (Brassica oleracea) populations, we show that variation in leaf colour and brightness, measured according to herbivore spectral sensitivities, predicts both levels of chemical defences (glucosinolates) and abundance of specialist lepidopteran (Pieris rapae) and hemipteran (Brevicoryne brassicae) herbivores. In subsequent experiments, P. rapae larvae achieved faster growth and greater pupal mass when feeding on plants with bluer leaves, which contained lower levels of aliphatic glucosinolates. Glucosinolate-mediated effects on larval performance may thus contribute to the association between P. rapae herbivory and leaf colour observed in the field. However, preference tests found no evidence that adult butterflies selected host plants based on leaf coloration. In the field, B. brassicae abundance varied with leaf brightness but greenhouse experiments were unable to identify any effects of brightness on aphid preference or performance. Our findings suggest that although leaf colour reflects both levels of host defences and herbivore abundance in the field, the ability of herbivores to respond to colour signals may be limited, even in species where performance is correlated with leaf colour.	[Green, Jonathan P.; Hartley, Susan E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Foster, Rosie; Wilkins, Lucas; Osorio, Daniel] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of York - UK; University of Sussex	Hartley, SE (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	sue.hartley@york.ac.uk		Osorio, Daniel/0000-0002-5856-527X; Hartley, Sue/0000-0002-5117-687X	Biotechnology and Biological Sciences PhD studentship; University of York; University of Sussex	Biotechnology and Biological Sciences PhD studentship; University of York(European Commission); University of Sussex	The work was funded by a Biotechnology and Biological Sciences PhD studentship and by the University of York and the University of Sussex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; [Anonymous], 2014, R LANG ENV STAT COMP; Archetti M, 2005, OIKOS, V110, P339, DOI 10.1111/j.0030-1299.2005.13656.x; Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Arikawa K., 2014, INSECT PHOTOPIGMENTS, P137; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; Courtney S.P., 1990, P161; Doring TF, 2007, ENTOMOL GEN, V30, P233; Doring TF, 2014, ANN APPL BIOL, V165, P3, DOI 10.1111/aab.12142; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Ewald NC, 2011, ECOL ENTOMOL, V36, P596, DOI 10.1111/j.1365-2311.2011.01304.x; Frentiu FD, 2008, BIOESSAYS, V30, P1151, DOI 10.1002/bies.20828; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hamilton WD, 2001, P ROY SOC B-BIOL SCI, V268, P1489, DOI 10.1098/rspb.2001.1672; Hare JD, 2012, SCIENCE, V338, P50, DOI 10.1126/science.1228893; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hoagland DR, 1950, CIRC; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; HUANG XP, 1994, J CHEM ECOL, V20, P1025, DOI 10.1007/BF02059739; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 1999, J EXP BIOL, V202, P2619; Kirchner SM, 2005, J INSECT PHYSIOL, V51, P1255, DOI 10.1016/j.jinsphys.2005.07.002; Kos M, 2012, PHYTOCHEMISTRY, V77, P162, DOI 10.1016/j.phytochem.2012.01.005; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; LEATHER SR, 1988, OIKOS, V51, P386, DOI 10.2307/3565323; Li YH, 2014, OECOLOGIA, V174, P853, DOI 10.1007/s00442-013-2805-6; LOADER C, 1991, ECOLOGY, V72, P1586, DOI 10.2307/1940958; MacDonald JH, 2014, HDB BIOL STAT, DOI DOI 10.1016/j.aquatox.2007.10.001; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Miles CI, 2005, J COMP PHYSIOL A, V191, P147, DOI 10.1007/s00359-004-0580-x; MITCHELL ND, 1979, J ECOL, V67, P1087, DOI 10.2307/2259229; MITHEN R, 1995, HEREDITY, V75, P472, DOI 10.1038/hdy.1995.164; Moyes CL, 2000, J CHEM ECOL, V26, P2625, DOI 10.1023/A:1005549115751; Mumm R, 2008, J CHEM ECOL, V34, P1311, DOI 10.1007/s10886-008-9534-z; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newton E, 2010, OECOLOGIA, V164, P689, DOI 10.1007/s00442-010-1702-5; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; NOTTINGHAM SF, 1991, J CHEM ECOL, V17, P1231, DOI 10.1007/BF01402946; Pirih P, 2010, J COMP PHYSIOL A, V196, P501, DOI 10.1007/s00359-010-0538-0; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Poelman EH, 2009, ECOLOGY, V90, P1863, DOI 10.1890/08-0977.1; PROKOPY RJ, 1983, SCIENCE, V221, P190, DOI 10.1126/science.221.4606.190; Qiu XD, 2003, J EXP BIOL, V206, P2787, DOI 10.1242/jeb.00493; Ramirez CC, 2008, J EVOLUTION BIOL, V21, P49, DOI 10.1111/j.1420-9101.2007.01469.x; Reeves JL, 2011, ENVIRON ENTOMOL, V40, P855, DOI 10.1603/EN10212; Rolshausen G, 2007, PLANT ECOL, V191, P77, DOI 10.1007/s11258-006-9215-3; Santolamazza-Carbone S, 2014, OECOLOGIA, V174, P893, DOI 10.1007/s00442-013-2817-2; Schaefer HM, 2006, BIOESSAYS, V28, P65, DOI 10.1002/bies.20340; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schwarzkopf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075298; Sinkkonen A, 2012, NEW PHYTOL, V195, P461, DOI 10.1111/j.1469-8137.2012.04156.x; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; Stavenga DG, 2011, J COMP PHYSIOL A, V197, P373, DOI 10.1007/s00359-010-0622-5; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; TRAYNIER RMM, 1979, PHYSIOL ENTOMOL, V4, P87, DOI 10.1111/j.1365-3032.1979.tb00181.x; TRAYNIER RMM, 1986, ENTOMOL EXP APPL, V40, P25, DOI 10.1007/BF00187019; van Dam NM, 2004, NEW PHYTOL, V161, P801, DOI 10.1111/j.1469-8137.2004.00984.x; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	70	13	13	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136884	10.1371/journal.pone.0136884	http://dx.doi.org/10.1371/journal.pone.0136884			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353086	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000360932800052
J	Netzahuatl-Munoz, AR; Cristiani-Urbina, MD; Cristiani-Urbina, E				Rosa Netzahuatl-Munoz, Alma; del Carmen Cristiani-Urbina, Maria; Cristiani-Urbina, Eliseo			Chromium Biosorption from Cr(VI) Aqueous Solutions by Cupressus lusitanica Bark: Kinetics, Equilibrium and Thermodynamic Studies	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; WASTE-WATER; HEAVY-METALS; NICKEL(II) BIOSORPTION; ACTIVATED CARBONS; REMOVAL MECHANISM; FUNGAL BIOMASS; ADSORPTION; SORPTION; BIOSORBENT	The present study investigated the kinetics, equilibrium and thermodynamics of chromium (Cr) ion biosorption from Cr(VI) aqueous solutions by Cupressus lusitanica bark (CLB). CLB total Cr biosorption capacity strongly depended on operating variables such as initial Cr(VI) concentration and contact time: as these variables rose, total Cr biosorption capacity increased significantly. Total Cr biosorption rate also increased with rising solution temperature. The pseudo-second-order model described the total Cr biosorption kinetic data best. Langmuir ' s model fitted the experimental equilibrium biosorption data of total Cr best and predicted a maximum total Cr biosorption capacity of 305.4 mg g(-1). Total Cr biosorption by CLB is an endothermic and non-spontaneous process as indicated by the thermodynamic parameters. Results from the present kinetic, equilibrium and thermodynamic studies suggest that CLB biosorbs Cr ions from Cr(VI) aqueous solutions pre-dominantly by a chemical sorption phenomenon. Low cost, availability, renewable nature, and effective total Cr biosorption make CLB a highly attractive and efficient method to remediate Cr(VI)-contaminated water and wastewater.	[Rosa Netzahuatl-Munoz, Alma; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Rosa Netzahuatl-Munoz, Alma] Univ Politecn Tlaxcala, Tepeyanco, Tlaxcala, Mexico; [del Carmen Cristiani-Urbina, Maria] Univ Autonoma Chiapas, Tuxtla Gutierrez, Chiapas, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Chiapas	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.	ecristia@encb.ipn.mx	Muñoz, Alma Rosa Netzahuatl/ABC-9252-2020	Muñoz, Alma Rosa Netzahuatl/0000-0003-1963-8357; Cristiani-Urbina, Eliseo/0000-0002-8470-0711				Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1; Altundogan HS, 2005, PROCESS BIOCHEM, V40, P1443, DOI 10.1016/j.procbio.2004.06.027; Aranda-Garcia E, 2014, ENVIRON MONIT ASSESS, V186, P6207, DOI 10.1007/s10661-014-3849-8; Aravindhan R, 2012, CLEAN TECHNOL ENVIR, V14, P727, DOI 10.1007/s10098-011-0440-7; Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008; Bayramoglu G, 2008, CHEM ENG J, V139, P20, DOI 10.1016/j.cej.2007.07.068; Benavente M, 2011, J TAIWAN INST CHEM E, V42, P976, DOI 10.1016/j.jtice.2011.05.003; Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575; Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005; Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8; Company Hach, 2008, HACH WAT AN HDB; Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u; Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155; Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345; Eisler R, 1986, US FISH WILDLIFE SER, V85; Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067; Fathy NA, 2015, J ENVIRON CHEM ENG, V3, P1137, DOI 10.1016/j.jece.2015.04.011; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6; Gaggelli E, 2002, ENVIRON HEALTH PERSP, V110, P733, DOI 10.1289/ehp.02110s5733; Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0; Ghodbane I, 2008, J HAZARD MATER, V160, P301, DOI 10.1016/j.jhazmat.2008.02.116; GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5; Bermudez YG, 2012, CHEM ENG J, V183, P68, DOI 10.1016/j.cej.2011.12.022; Flores-Garnica JG, 2013, BIORESOURCE TECHNOL, V136, P635, DOI 10.1016/j.biortech.2013.02.059; Guerrero-Coronilla I, 2015, J ENVIRON MANAGE, V152, P99, DOI 10.1016/j.jenvman.2015.01.026; Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; Hasan SH, 2008, J HAZARD MATER, V152, P356, DOI 10.1016/j.jhazmat.2007.07.006; Hernandez-Estevez A, 2014, ENVIRON MONIT ASSESS, V186, P7987, DOI 10.1007/s10661-014-3981-5; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2002, ADSORPT SCI TECHNOL, V20, P797, DOI 10.1260/026361702321104282; Puentes-Cardenas IJ, 2012, ENVIRON ENG MANAG J, V11, P1741; Kalyani G., 2009, ARPN J ENG APPL SCI, V4, P39; Khambhaty Y, 2009, CHEM ENG J, V145, P489, DOI 10.1016/j.cej.2008.05.002; Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012; Kim EJ, 2011, BIORESOURCE TECHNOL, V102, P11155, DOI 10.1016/j.biortech.2011.09.107; Kumar NS, 2012, COLLOID SURFACE B, V94, P125, DOI 10.1016/j.colsurfb.2012.01.048; Kumar R, 2008, CHEM ENG J, V135, P202, DOI 10.1016/j.cej.2007.03.004; Leon-Torres A, 2012, J COLLOID INTERF SCI, V386, P325, DOI 10.1016/j.jcis.2012.07.038; Liang FB, 2013, J ENVIRON CHEM ENG, V1, P1301, DOI 10.1016/j.jece.2013.09.025; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Lin CJ, 2002, WATER AIR SOIL POLL, V139, P137, DOI 10.1023/A:1015870907389; Deng LP, 2007, J HAZARD MATER, V143, P220, DOI 10.1016/j.jhazmat.2006.09.009; Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q; Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006; Ma W, 2015, BIORESOURCE TECHNOL, V186, P356, DOI 10.1016/j.biortech.2015.03.133; Malkoc E, 2007, CHEM ENG PROCESS, V46, P1020, DOI 10.1016/j.cep.2007.05.007; Masaki Y, 2015, EXTREMOPHILES, V19, P495, DOI 10.1007/s00792-015-0733-6; Matouq M, 2015, J ENVIRON CHEM ENG, V3, P775, DOI 10.1016/j.jece.2015.03.027; Mauguet MC, 2005, J MATER SCI, V40, P747, DOI 10.1007/s10853-005-6316-7; Miretzky P, 2006, CHEMOSPHERE, V62, P247, DOI 10.1016/j.chemosphere.2005.05.010; Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060; Morales-Barrera L, 2008, BIOCHEM ENG J, V40, P284, DOI 10.1016/j.bej.2007.12.014; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Nakajima A, 2004, WATER RES, V38, P2859, DOI 10.1016/j.watres.2004.04.005; Niu HC, 2006, HYDROMETALLURGY, V84, P28, DOI 10.1016/j.hydromet.2006.03.057; Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026; Padmavathy V, 2008, BIORESOURCE TECHNOL, V99, P3100, DOI 10.1016/j.biortech.2007.05.070; Pagnanelli F, 2011, MICROBIAL BIOSORPTIO, P59; Pandey PK, 2010, INT J ENVIRON SCI TE, V7, P395, DOI 10.1007/BF03326149; Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Rakhunde R, 2012, CRIT REV ENV SCI TEC, V42, P776, DOI 10.1080/10643389.2010.534029; Netzahuatl-Munoz AR, 2012, FRESEN ENVIRON BULL, V21, P1793; Netzahuatl-Munoz AR, 2012, WATER AIR SOIL POLL, V223, P625, DOI 10.1007/s11270-011-0888-4; Netzahuatl-Munoz AR, 2010, FRESEN ENVIRON BULL, V19, P2911; Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005; Samuel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116884; Samuel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118999; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Stasinakis AS, 2003, CHEMOSPHERE, V52, P1059, DOI 10.1016/S0045-6535(03)00309-6; Suazo-Madrid A, 2011, J IND MICROBIOL BIOT, V38, P51, DOI 10.1007/s10295-010-0828-0; Uysal M, 2007, J HAZARD MATER, V149, P482, DOI 10.1016/j.jhazmat.2007.04.019; Vaghetti JCP, 2008, BIOCHEM ENG J, V42, P67, DOI 10.1016/j.bej.2008.05.021; Viamajala S, 2004, BIOTECHNOL PROGR, V20, P87, DOI 10.1021/bp034131q; Lopez-Nunez PV, 2014, ENVIRON ENG MANAG J, V13, P1927; Vijayaraghavan K, 2006, PROCESS BIOCHEM, V41, P853, DOI 10.1016/j.procbio.2005.10.028; Vinod VTP, 2010, J HAZARD MATER, V178, P851, DOI 10.1016/j.jhazmat.2010.02.016; VOLESKY B, 2003, SORPTION BIOSORPTION, P233; Weng CH, 2008, J HAZARD MATER, V155, P65, DOI 10.1016/j.jhazmat.2007.11.029; Xu LH, 2015, MINER PETROL, V109, P309, DOI 10.1007/s00710-014-0332-8; Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021; Zhao JQ, 2015, J MATER CHEM A, V3, P14703, DOI 10.1039/c5ta03089g; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+	85	47	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137086	10.1371/journal.pone.0137086	http://dx.doi.org/10.1371/journal.pone.0137086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352933	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800060
J	Song, JH; Zhu, CX; Zhang, X; Wen, X; Liu, LL; Peng, JY; Guo, HW; Yi, CQ				Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi			Biochemical and Structural Insights into the Mechanism of DNA Recognition by Arabidopsis ETHYLENE INSENSITIVE3	PLOS ONE			English	Article							RECEPTOR GENE FAMILY; SIGNALING PATHWAY; RESPONSE PATHWAY; EIN3; TRANSCRIPTION; BINDING; ETHYLENE-INSENSITIVE3; EXPRESSION; REGULATOR; JASMONATE	Gaseous hormone ethylene regulates numerous stress responses and developmental adaptations in plants by controlling gene expression via transcription factors ETHYLENE INSENSITIVE3 (EIN3) and EIN3-Like1 (EIL1). However, our knowledge regarding to the accurate definition of DNA-binding domains (DBDs) within EIN3 and also the mechanism of specific DNA recognition by EIN3 is limited. Here, we identify EIN3 82-352 and 174-306 as the optimal and core DBDs, respectively. Results from systematic biochemical analyses reveal that both the number of EIN3-binding sites (EBSs) and the spacing length between two EBSs affect the binding affinity of EIN3; accordingly, a new DNA probe which has higher affinity with EIN3 than ERF1 is also designed. Furthermore, we show that palindromic repeat sequences in ERF1 promoter are not necessary for EIN3 binding. Finally, we provide, to our knowledge, the first crystal structure of EIN3 core DBD, which contains amino acid residues essential for DNA binding and signaling. Collectively, these data suggest the detailed mechanism of DNA recognition by EIN3 and provide an in-depth view at molecular level for the transcriptional regulation mediated by EIN3.	[Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Dept Biol Chem, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Synthet & Funct Biomol Ctr, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Guo, HW (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	hongweig@pku.edu.cn; chengqi.yi@pku.edu.cn	Zhu, Chenxu/ABC-4679-2021; Wen, Xing/ABI-5408-2020	Zhu, Chenxu/0000-0003-4216-6562; Wen, Xing/0000-0002-9322-2272; Yi, Chengqi/0000-0003-2540-9729	National Basic Research Foundation of China [2014CB964900]; National Natural Science Foundation of China [31270838, 21472009]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Foundation of China (http://www.most.gov.cn/; 2014CB964900 to C.Y.), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; 31270838 to C.Y., 21472009 to C.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen HM, 2009, PLANT CELL, V21, P2527, DOI 10.1105/tpc.108.065193; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Kosugi S, 2000, NUCLEIC ACIDS RES, V28, P960, DOI 10.1093/nar/28.4.960; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SS, 2014, PLANT CELL, V26, P263, DOI 10.1105/tpc.113.120394; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wuriyanghan H, 2009, PLANT CELL, V21, P1473, DOI 10.1105/tpc.108.065391; Yamasaki K, 2005, J MOL BIOL, V348, P253, DOI 10.1016/j.jmb.2005.02.065; Yin CC, 2015, PLANT CELL; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang LX, 2011, PLANT PHYSIOL, V157, P854, DOI 10.1104/pp.111.179028; Zhang X, 2014, PLANT CELL, V26, P1105, DOI 10.1105/tpc.113.122002; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhong SW, 2010, PLANT SIGNAL BEHAV, V5, P739, DOI 10.4161/psb.5.6.11698; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	55	18	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137439	10.1371/journal.pone.0137439	http://dx.doi.org/10.1371/journal.pone.0137439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352699	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800085
J	Contreras-Bolton, C; Parada, V				Contreras-Bolton, Carlos; Parada, Victor			Automatic Combination of Operators in a Genetic Algorithm to Solve the Traveling Salesman Problem	PLOS ONE			English	Article							INVER-OVER OPERATOR; LOCAL SEARCH; MUTATION OPERATORS; PARAMETER CONTROL; EVOLUTIONARY; CROSSOVER; OPTIMIZATION	Genetic algorithms are powerful search methods inspired by Darwinian evolution. To date, they have been applied to the solution of many optimization problems because of the easy use of their properties and their robustness in finding good solutions to difficult problems. The good operation of genetic algorithms is due in part to its two main variation operators, namely, crossover and mutation operators. Typically, in the literature, we find the use of a single crossover and mutation operator. However, there are studies that have shown that using multi-operators produces synergy and that the operators are mutually complementary. Using multi-operators is not a simple task because which operators to use and how to combine them must be determined, which in itself is an optimization problem. In this paper, it is proposed that the task of exploring the different combinations of the crossover and mutation operators can be carried out by evolutionary computing. The crossover and mutation operators used are those typically used for solving the traveling salesman problem. The process of searching for good combinations was effective, yielding appropriate and synergic combinations of the crossover and mutation operators. The numerical results show that the use of the combination of operators obtained by evolutionary computing is better than the use of a single operator and the use of multi-operators combined in the standard way. The results were also better than those of the last operators reported in the literature.	[Contreras-Bolton, Carlos; Parada, Victor] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	Universidad de Santiago de Chile	Parada, V (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	victor.parada@usach.cl	Parada, Victor/M-5840-2014; Contreras-Bolton, Carlos/D-9624-2016; Parada, Victor/AHD-6455-2022	Contreras-Bolton, Carlos/0000-0001-9549-4143; Parada, Victor/0000-0002-8649-5694	Complex Engineering Systems Institute [P-05-004-F]; CONICYT [FBO16]; ECOS/CONICYT [C13E04]	Complex Engineering Systems Institute; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ECOS/CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The authors would like to thank the Complex Engineering Systems Institute: P-05-004-F, CONICYT: FBO16, ECOS/CONICYT: C13E04.	Acan A, 2003, IEEE C EVOL COMPUTAT, P256, DOI 10.1109/CEC.2003.1299583; Albayrak M, 2011, EXPERT SYST APPL, V38, P1313, DOI 10.1016/j.eswa.2010.07.006; [Anonymous], 1991, HDB GENETIC ALGORITH; Applegate D.L., 2007, TRAVELING SALESMAN P, DOI DOI 10.1515/9781400841103; BANZHAF W, 1990, BIOL CYBERN, V64, P7, DOI 10.1007/BF00203625; Bolton CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058551; Davis L, 1985, P IJCAI, V85, P162; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Eiben AE, 2007, STUD COMPUT INTELL, V54, P19; Eiben A. E., 2010, 2010 Fourth IEEE International Conference on Self-Adaptive and Self-Organizing Systems Workshop (SASOW), P147, DOI 10.1109/SASOW.2010.31; Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Elaoud S., 2010, ELECT NOTES DISCRETE, V36, P939, DOI DOI 10.1016/J.ENDM.2010.05.119; Elsayed SM, 2011, COMPUT OPER RES, V38, P1877, DOI 10.1016/j.cor.2011.03.003; Esquivel SC, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P103, DOI 10.1109/ICEC.1997.592277; FLOOD MM, 1956, OPER RES, V4, P61, DOI 10.1287/opre.4.1.61; Fogel D. B., 1990, Proceedings of the Fourth Annual Parallel Processing Symposium, P318; FOGEL DB, 1993, CYBERNET SYST, V24, P27, DOI 10.1080/01969729308961697; FOGEL DB, 1988, BIOL CYBERN, V60, P139, DOI 10.1007/BF00202901; Freisleben B, 1996, IEEE C EVOL COMPUTAT, P616, DOI 10.1109/ICEC.1996.542671; Garcia S, 2009, J HEURISTICS, V15, P617, DOI 10.1007/s10732-008-9080-4; Gen M., 1997, GENETIC ALGORITHMS E; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goldberg D. E, 1985, P 1 INT C GEN ALG TH; Grefenstette J., 1985, PROC 1 INT C GENET A, V160, P160; Grefenstette J.J., 1987, INCORPORATING PROBLE, P42; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; Holland J.H., 1975, ADAPTATION NATURAL A; Hong I, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION, VOLS 1 AND 2, P245, DOI 10.1109/ICEC.1995.489153; Hong TP, 2001, APPL INTELL, V16, P7, DOI 10.1023/A:1012815625611; Hong TP, 1998, J INF SCI ENG, V14, P369; Hong TP, 2000, J HEURISTICS, V6, P439, DOI 10.1023/A:1009642825198; Jong D., 1975, ANAL BEHAV CLASS GEN; Karp R. M., 1972, P COMPL COMP COMP, P85; Koza JR, 1992, GENETIC PROGRAMMING; Larranaga P, 1999, ARTIF INTELL REV, V13, P129, DOI 10.1023/A:1006529012972; LIN S, 1965, AT&T TECH J, V44, P2245, DOI 10.1002/j.1538-7305.1965.tb04146.x; Louis SJ, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P385; Martin O., 1991, Complex Systems, V5, P299; MARTIN O, 1992, OPER RES LETT, V11, P219, DOI 10.1016/0167-6377(92)90028-2; Michalewicz Z., 1994, GENETIC ALGORITHMS D; MORTON G, 1955, J ROY STAT SOC B, V17, P185; MUHLENBEIN H, 1988, PARALLEL COMPUT, V7, P65, DOI 10.1016/0167-8191(88)90098-1; MUHLENBEIN H, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P416; MUHLENBEIN H, 1991, LECT NOTES ARTIF INT, V565, P398; Murata T, 1996, IEEE C EVOL COMPUTAT, P170, DOI 10.1109/ICEC.1996.542355; Ngyen H. D., 2002, IPSJ T MATH MODELING, V43, P165; Oliver I. M., 1987, Genetic Algorithms and their Applications: Proceedings of the Second International Conference on Genetic Algorithms, P224; Osaba E, 2014, STUD COMPUT INTELL, V512, P113, DOI 10.1007/978-3-319-01692-4_9; Osaba E, 2013, 2013 IEEE 8TH INTERNATIONAL SYMPOSIUM ON APPLIED COMPUTATIONAL INTELLIGENCE AND INFORMATICS (SACI 2013), P17, DOI 10.1109/SACI.2013.6608960; Poli R., 2008, FIELD GUIDE GENETIC; Ray SS, 2004, INT C PATT RECOG, P497, DOI 10.1109/ICPR.2004.1334276; Reinelt G., 1991, ORSA Journal on Computing, V3, P376, DOI 10.1287/ijoc.3.4.376; Reinelt G., 1994, TRAVELING SALESMAN C; Schaffer J. D., 1987, Genetic Algorithms and their Applications: Proceedings of the Second International Conference on Genetic Algorithms, P36; Sengoku Y. I. H., 1998, PROC AROB 3, P283; SYSWERDA G, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P2; Syswerda G., 1991, HDB GENETIC ALGORITH, P332; Tao G, 1998, LECT NOTES COMPUT SC, V1498, P803, DOI 10.1007/BFb0056922; Tasgetiren MF, 2013, LECT NOTES COMPUT SC, V8297, P1, DOI 10.1007/978-3-319-03753-0_1; Tsai HK, 2002, IEEE C EVOL COMPUTAT, P1290, DOI 10.1109/CEC.2002.1004429; Wang CX, 2005, LECT NOTES COMPUT SC, V3611, P1269; Wang YT, 2011, COMPUT MATH APPL, V62, P2743, DOI 10.1016/j.camwa.2011.06.063; Wang YT, 2012, LECT NOTES ARTIF INT, V6839, P17; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P133; Yoon HS, 2002, IEEE T EVOLUT COMPUT, V6, P212, DOI 10.1109/4235.996022; Zhang L, 2006, INT J ADV MANUF TECH, V27, P580, DOI 10.1007/s00170-004-2223-3	67	27	27	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137724	10.1371/journal.pone.0137724	http://dx.doi.org/10.1371/journal.pone.0137724			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367182	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100122
J	Feldblum, PJ; Okech, J; Ochieng, R; Hart, C; Kiyuka, G; Lai, JJ; Veena, V				Feldblum, Paul J.; Okech, Jairus; Ochieng, Rolex; Hart, Catherine; Kiyuka, Grace; Lai, Jaim Jou; Veena, Valentine			Longer-Term Follow-Up of Kenyan Men Circumcised Using the ShangRing Device	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV PREVENTION	Objectives To ascertain clinical sequelae, client satisfaction and sexual behavior 2+ years after male circumcision using the ShangRing device. Methods We enrolled 199 men from the Kenya sites (Homa Bay district) participating in a 2012 study of the ShangRing device used in routine male circumcision services (N = 552). We enrolled men who had had the ShangRing placed successfully, and over-sampled men who had had an adverse event and/or were HIV-positive during the field study. In the present study, each participant was examined and interviewed by a study clinician, and penile photographs were taken to document longer-term cosmetic results and any abnormal findings. Results 194 men were included in the analysis. The mean and median times between circumcision and the longer-term follow-up visit in this study were 31.8 and 32 months, respectively. Four men (2.1%) had signs/symptoms of a sexually transmitted infection (STI). Virtually all (99.5%) of the men were very satisfied with the appearance of their circumcised penis, and all would recommend a ShangRing circumcision to friends or family members. The most prevalent reported advantage of the circumcision was the ease of bathing and enhanced cleanliness of the penis (75.8%). 94.3% of the men did not cite a single negative feature of their circumcision. 87.5% of men reported more sexual pleasure post-MC, the most common reason being more prolonged intercourse. The majority of men (52.6%) reported one sexual partner post-MC, but more than a quarter of the men (28.1%) reported an increased number of partners post-MC. Less than half of the men (44.3%) reported using condoms half of the time or more, but the great majority of condom users stated that condom use was much easier post-MC, and 76.9% of users said they used condoms more after circumcision than before. Conclusions This study supports the safety and acceptability of ShangRing male circumcision during 2-3 years of follow-up. It should allay worries that the ShangRing procedure could lead to delayed complications later than the observation period of most clinical studies.	[Feldblum, Paul J.; Hart, Catherine; Lai, Jaim Jou] FHI 360, Durham, NC 27701 USA; [Okech, Jairus; Ochieng, Rolex; Kiyuka, Grace] Homa Bay Dist Hosp, Homa Bay, Kenya; [Veena, Valentine] FHI 360, Nairobi, Kenya	FHI 360	Feldblum, PJ (corresponding author), FHI 360, Durham, NC 27701 USA.	pfeldblum@fhi360.org			Bill and Melinda Gates Foundation [OPPGH5166]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Grant OPPGH5166, Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Barone MA, 2014, TRANSL ANDROL UROL, V3, P113, DOI 10.3978/j.issn.2223-4683.2014.01.09; Cao DH, 2015, UROLOGY, V85, P799, DOI 10.1016/j.urology.2014.12.007; Cheng Y, 2014, CHINESE MED J-PEKING, V127, P1879, DOI 10.3760/cma.j.issn.0366-6999.20133135; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Samuelson J, 2013, JAIDS-J ACQ IMM DEF, V64, P127, DOI 10.1097/QAI.0b013e3182a61dd3; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V67, P430, DOI 10.1097/QAI.0000000000000321; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO, 2013, GUID US DEV AD MAL C; WHO, 2015, WHO PREQ MAL CIRC DE; World Health Organization, 2013, WHO PREQ MAL CIRC DE	14	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137510	10.1371/journal.pone.0137510	http://dx.doi.org/10.1371/journal.pone.0137510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367141	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100080
J	Korsa, MG; Browning, GF; Coppo, MJC; Legione, AR; Gilkerson, JR; Noormohammadi, AH; Vaz, PK; Lee, SW; Devlin, JM; Hartley, CA				Korsa, Mesula G.; Browning, Glenn F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Gilkerson, James R.; Noormohammadi, Amir H.; Vaz, Paola K.; Lee, Sang-Won; Devlin, Joanne M.; Hartley, Carol A.			Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; UNITED-STATES; EYE-DROP; VACCINATION; STRAIN; RESTRICTION; REPLICATION; VIRULENCE; POULTRY	Infectious laryngotracheitis virus (ILTV) causes acute upper respiratory tract disease in chickens. Attenuated live ILTV vaccines are often used to help control disease, but these vaccines have well documented limitations, including retention of residual virulence, incomplete protection, transmission of vaccine virus to unvaccinated birds and reversion to high levels of virulence following bird-to-bird passage. Recently, two novel ILTV field strains (class 8 and 9 ILTV viruses) emerged in Australia due to natural recombination between two genotypically distinct commercial ILTV vaccines. These recombinant field strains became dominant field strains in important poultry producing areas. In Victoria, Australia, the recombinant class 9 virus largely displaced the previously predominant class 2 ILTV strain. The ability of ILTV vaccines to protect against challenge with the novel class 9 ILTV strain has not been studied. Here, the protection induced by direct (drinking-water) and indirect (contact) exposure to four different ILTV vaccines against challenge with class 9 ILTV in commercial broilers was studied. The vaccines significantly reduced, but did not prevent, challenge virus replication in vaccinated chickens. Only one vaccine significantly reduced the severity of tracheal pathology after direct drinking-water vaccination. The results indicate that the current vaccines can be used to help control class 9 ILTV, but also indicate that these vaccines have limitations that should be considered when designing and implementing disease control programs.	[Korsa, Mesula G.; Browning, Glenn F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Gilkerson, James R.; Noormohammadi, Amir H.; Vaz, Paola K.; Lee, Sang-Won; Devlin, Joanne M.; Hartley, Carol A.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Lee, Sang-Won] Konkuk Univ, Coll Vet Med, Seoul, South Korea	University of Melbourne; Konkuk University	Devlin, JM (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	devlinj@unimelb.edu.au	Legione, Alistair/L-9102-2015; Browning, Glenn Francis/P-4459-2014; Vaz, Paola K./D-8713-2015; Legione, Alistair/AAX-6064-2020	Legione, Alistair/0000-0003-2407-4496; Browning, Glenn Francis/0000-0002-0903-2469; Vaz, Paola K./0000-0001-6877-7383; Legione, Alistair/0000-0003-2407-4496; Devlin, Joanne/0000-0003-0400-9670; Korsa, Mesula G/0000-0001-9334-4790; Hartley, Carol/0000-0001-6174-7341; Gilkerson, James/0000-0003-1801-4817; Coppo, Mauricio/0000-0002-4344-9532; NOORMOHAMMADI, AMIR/0000-0003-3459-2692	Rural Industries Research and Development Corporation (RIRDC) [PRJ-008792]; Australian Research Council (ARC) [DP130103991]; ARC Future Fellowship [FT140101287]	Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp); Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council)	This work was supported by the Rural Industries Research and Development Corporation (RIRDC, PRJ-008792) and by the Australian Research Council (ARC, DP130103991). JMD is supported by an ARC Future Fellowship (FT140101287). The ARC had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The RIRDC contributed to the study design and approved the manuscript for publication, but had no role in data collection and analysis or preparation of the manuscript.	BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2012, AVIAN PATHOL, V41, P99, DOI 10.1080/03079457.2011.643222; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; Cover M.S., 1960, AVIAN DIS, V4, P467; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; Fulton RM, 2000, AVIAN DIS, V44, P8, DOI 10.2307/1592502; Gharaibeh S, 2013, POULTRY SCI, V92, P2333, DOI 10.3382/ps.2013-03249; GUY JS, 1990, AVIAN DIS, V34, P106, DOI 10.2307/1591340; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Ingram DR, 2000, J APPL POULTRY RES, V9, P501, DOI 10.1093/japr/9.4.501; Jones RC, 2010, BRIT POULTRY SCI, V51, P1, DOI 10.1080/00071660903541378; Koenen ME, 2002, VET IMMUNOL IMMUNOP, V89, P47, DOI 10.1016/S0165-2427(02)00169-1; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2014, AVIAN DIS, V58, P147, DOI 10.1637/10508-013113-ResNote.1; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Mutinda WU, 2014, TROP ANIM HEALTH PRO, V46, P603, DOI 10.1007/s11250-013-0533-x; Neff C, 2008, AVIAN DIS, V52, P278, DOI 10.1637/8168-110107-Reg.1; Oldoni I, 2008, AVIAN DIS, V52, P59, DOI 10.1637/8054-070607-Reg; Oldoni I, 2009, AVIAN PATHOL, V38, P47, DOI 10.1080/03079450802632031; PURCELL DA, 1974, AUST VET J, V50, P419, DOI 10.1111/j.1751-0813.1974.tb05357.x; ROBERTSON GM, 1981, AUST VET J, V57, P119, DOI 10.1111/j.1751-0813.1981.tb00472.x; Rodriguez-Avila A, 2008, AVIAN PATHOL, V37, P287, DOI 10.1080/03079450802043742	28	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137719	10.1371/journal.pone.0137719	http://dx.doi.org/10.1371/journal.pone.0137719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366738	Green Published, gold			2022-12-27	WOS:000361601100119
J	Li, XL; Menade, M; Kozlov, G; Hu, ZP; Dai, Z; McPherson, PS; Brais, B; Gehring, K				Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; McPherson, Peter S.; Brais, Bernard; Gehring, Kalle			High-Throughput Screening for Ligands of the HEPN Domain of Sacsin	PLOS ONE			English	Article							RECESSIVE SPASTIC ATAXIA; CHARLEVOIX-SAGUENAY ARSACS; FLUORESCENCE POLARIZATION; PROTEIN SACSIN; BINDING SITES; MUTATIONS; CHAPERONE; DEFECTS; COMMON	Sacsin is a large protein implicated in the neurodevelopmental and neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), which features the loss of Purkinje neurons in the cerebellum. Although the domain architecture of sacsin suggests that it is a neuronal chaperone assisting in protein quality control, the precise function of sacsin remains elusive. Using fluorescence polarization (FP) assays, we confirmed that the HEPN domain of sacsin binds to nucleotides with low micromolar affinities. FP competition assays with a variety of nucleotides and nucleotide analogs revealed that the binding is primarily mediated by the phosphate groups of nucleotides. A highthroughput screen subsequently identified novel small molecule ligands of HEPN, providing new chemical probes for cell culture studies and drug development. Together, the results are consistent with the HEPN domain contributing to the functional activity of sacsin by binding to nucleotides or other multiply charged anionic compounds in neurons.	[Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; Gehring, Kalle] Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [McPherson, Peter S.; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; Brais, Bernard/Y-3910-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; 	Bionanomachines NSERC CREATE scholarship; Fondation de l'Ataxie de Charlevoix-Saguenay; Marcelle and Jean Coutu Foundation; Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases [126526]	Bionanomachines NSERC CREATE scholarship; Fondation de l'Ataxie de Charlevoix-Saguenay; Marcelle and Jean Coutu Foundation; Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases	XL is a recipient of a Bionanomachines NSERC CREATE scholarship. This research was supported by the Fondation de l'Ataxie de Charlevoix-Saguenay (www.arsacs.com), the Marcelle and Jean Coutu Foundation, and a Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases (126526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; BLACK CB, 1994, COORDIN CHEM REV, V135, P165, DOI 10.1016/0010-8545(94)80068-5; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Erlandsen H, 2004, PROTEINS, V54, P806, DOI 10.1002/prot.10631; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Synofzik M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-41; Turek-Etienne TC, 2003, J BIOMOL SCREEN, V8, P176, DOI 10.1177/1087057103252304	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137298	10.1371/journal.pone.0137298	http://dx.doi.org/10.1371/journal.pone.0137298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366743	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100063
J	Saccenti, E; Nieuwenhuijse, D; Koehorst, JJ; dos Santos, VAPM; Schaap, PJ				Saccenti, Edoardo; Nieuwenhuijse, David; Koehorst, Jasper J.; dos Santos, Vitor A. P. Martins; Schaap, Peter J.			Assessing the Metabolic Diversity of Streptococcus from a Protein Domain Point of View	PLOS ONE			English	Article							EVOLUTION; GENES; MODEL	Understanding the diversity and robustness of the metabolism of bacteria is fundamental for understanding how bacteria evolve and adapt to different environments. In this study, we characterised 121 Streptococcus strains and studied metabolic diversity from a protein domain perspective. Metabolic pathways were described in terms of the promiscuity of domains participating in metabolic pathways that were inferred to be functional. Promiscuity was defined by adapting existing measures based on domain abundance and versatility. The approach proved to be successful in capturing bacterial metabolic flexibility and species diversity, indicating that it can be described in terms of reuse and sharing functional domains in different proteins involved in metabolic activity. Additionally, we showed striking differences among metabolic organisation of the pathogenic serotype 2 Streptococcus suis and other strains.	[Saccenti, Edoardo; Nieuwenhuijse, David; Koehorst, Jasper J.; dos Santos, Vitor A. P. Martins; Schaap, Peter J.] Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands	Wageningen University & Research	Saccenti, E (corresponding author), Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands.	esaccenti@gmail.com; peter.schaap@wur.nl	Koehorst, Jasper Jan/Z-1697-2019	Koehorst, Jasper Jan/0000-0001-8172-8981; Schaap, Peter/0000-0002-4346-6084; Saccenti, Edoardo/0000-0001-8284-4829; martins dos santos, vitor/0000-0002-2352-9017	European Commission-funded FP7 project INFECT [305340]	European Commission-funded FP7 project INFECT	This work was supported by the European Commission-funded FP7 project INFECT (Contract No. 305340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2012, PRINTS DATABASE FINE; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; Caspi R, 2014, NUCLEIC ACIDS RES, V42; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Cochrane G, 2012, NUCL ACIDS RES; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; De Leeuw J., 2011, MULTIDIMENSIONAL SCA; De Lima Morais DA, 2011, NUCLEIC ACIDS RES, V39; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Eddy Sean R, 2009, Genome Inform, V23, P205; Fiebig A, INT J MED MICROBIOL; Finn RD, 2014, PFAM PROTIEN FAMILIE; Graham K., 2004, W3C RECOMMENDATION, V10, P1; Guzman GI, 2015, P NATL ACAD SCI USA, V112, P929, DOI 10.1073/pnas.1414218112; Haft DH, 2013, NUCLEIC ACIDS RES, V41; Harris S., 2013, SPARQL 1 1 QUERY LAN; Hunter S, 2012, NUCLEIC ACIDS RES, V40; Husson F, 2006, COMPUT STAT DATA AN, V50, P358, DOI 10.1016/j.csda.2004.08.005; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim J, 2007, BIOCHEMISTRY-US, V46, P12501, DOI 10.1021/bi7014629; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lee B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S5; Lees J, 2012, NUCLEIC ACIDS RES, V40; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Letunic I., 2012, NUCLEIC ACIDS RES, P40; Levering J, 2011, SYSTEMS BIOL CENTRAL; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Mi H, 2013, NUCLEIC ACIDS RES, V41; Mohanty S, 2013, MOL BIOSYST, V9, P1708, DOI 10.1039/c3mb25481j; Morgat A, 2012, NUCLEIC ACIDS RES, V40; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Notebaart RA, 2014, P NATL ACAD SCI USA, V111, P11762, DOI 10.1073/pnas.1406102111; Pedruzzi I, 2013, NUCLEIC ACIDS RES, V41; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; Weiner J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-285; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137908	10.1371/journal.pone.0137908	http://dx.doi.org/10.1371/journal.pone.0137908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366735	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100175
J	van der Kooi, ALLF; Snijder, MB; Peters, RJG; van Valkengoed, IGM				van der Kooi, Anne-Lotte L. F.; Snijder, Marieke B.; Peters, Ron J. G.; van Valkengoed, Irene G. M.			The Association of Handgrip Strength and Type 2 Diabetes Mellitus in Six Ethnic Groups: An Analysis of the HELIUS Study	PLOS ONE			English	Article							GRIP STRENGTH; BODY-FAT; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; MUSCLE STRENGTH; OLDER-ADULTS; HEALTH; MORTALITY; RISK; EPIDEMIOLOGY	We investigated whether ethnic differences in handgrip strength, a marker of poor muscle strength and quality, is a potential cause of ethnic disparities in type 2 diabetes mellitus. We included 2086 Dutch, 2216 South Asian Surinamese, 2084 African Surinamese, 1786 Ghanaian, 2223 Turkish and 2199 Moroccan origin participants from the HELIUS study. We analyzed ethnic differences in handgrip strength, and its association with type 2 diabetes mellitus using logistic regression analyses adjusted for socio-demographic factors, body composition and lifestyle factors. Additionally, we investigated whether handgrip strength explained the ethnic differences in type 2 diabetes mellitus. We found that handgrip strength differed significantly across ethnic groups. After full adjustment, we found an inverse association with type 2 diabetes mellitus (OR 0.95; 95% CI 0.92-0.97) that did not differ substantially between ethnic groups, men and among women, and lean and overweight individuals. The association was not affected by the measure used to define type 2 diabetes mellitus, but was attenuated by exclusion of people with known diabetes. The ethnic differences in type 2 diabetes mellitus were not explained by handgrip strength (e.g. the OR for the South Asian Surinamese vs. Dutch changed from 5.03; 3.69-6.68 to 4.87; 3.57-6.65). In conclusion, we found large ethnic differences in handgrip strength and a consistent association of low handgrip strength with prevalent type 2 diabetes mellitus. This suggests that handgrip strength may be investigated as a target for intervention or a marker to identify people at risk of type 2 diabetes mellitus.	[van der Kooi, Anne-Lotte L. F.; Snijder, Marieke B.; van Valkengoed, Irene G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Peters, Ron J. G.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Valkengoed, IGM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.g.vanvalkengoed@amc.nl	van Valkengoed, Irene G.M./B-2974-2013; van Valkengoed, Irene/ABA-1551-2021	van Valkengoed, Irene G.M./0000-0002-9306-7831; van Valkengoed, Irene/0000-0002-9306-7831	Dutch Heart Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union(European Commission)	The author(s) received no specific funding for this work. The HELIUS study is conducted by the Academic Medical Center (AMC) Amsterdam and the Public Health Service (GGD) of Amsterdam. Both organizations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), and the European Union (FP-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Baldi JC, 2003, INT J SPORTS MED, V24, P419, DOI 10.1055/s-2003-41173; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; de Munter JSL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-223; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; FRIEDL KE, 1994, J APPL PHYSIOL, V77, P933, DOI 10.1152/jappl.1994.77.2.933; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Haas SA, 2012, J GERONTOL B-PSYCHOL, V67, P238, DOI 10.1093/geronb/gbr155; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Lopez-Jaramillo P, 2014, INT J CARDIOL, V174, P458, DOI 10.1016/j.ijcard.2014.04.013; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; SOBOL W, 1991, INT J OBESITY, V15, P589; Stewart Kerry J, 2003, J Cardiopulm Rehabil, V23, P109, DOI 10.1097/00008483-200303000-00008; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Timpka S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-62; TOKUNAGA K, 1983, INT J OBESITY, V7, P437; Tresierras MA, 2009, J CARDIOPULM REHABIL, V29, P67, DOI 10.1097/HCR.0b013e318199ff69; Vlaar EMA, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-8; Wander PL, 2011, DIABETES RES CLIN PR, V92, P261, DOI 10.1016/j.diabres.2011.01.007; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2006, DEFINITION AND DIAGN; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	40	36	37	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137739	10.1371/journal.pone.0137739	http://dx.doi.org/10.1371/journal.pone.0137739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368020	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100126
J	Jawin, V; Ang, HL; Omar, A; Thong, MK				Jawin, Vida; Ang, Hak-Lee; Omar, Asma; Thong, Meow-Keong			Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country	PLOS ONE			English	Article							DEFECTS; INFECTION; ACCURACY; INFANCY	Background Studies on pulse oximetry screening for neonatal sepsis and respiratory disease in a middle-income country are lacking. Newborn screening for critical congenital heart disease (CCHD) using pulse oximetry is an effective and life-saving strategy in developed countries. While most studies have reported false-positive results during CCHD screening, they have not elaborated on the detected disease types. We studied the effectiveness and outcomes of pulse oximetry newborn screening for non-cardiac hypoxemic diseases such as neonatal sepsis, respiratory diseases, and CCHD in a middle-income country. Methods and Findings In a pilot study performed at the University Malaya Medical Centre (UMMC), Malaysia, all apparently healthy term newborns, delivered at UMMC were screened pre-discharge using pulse oximetry. Echocardiography was performed for newborns that had positive screening results on two separate occasions, 1-h apart. Newborns with normal echocardiograms were evaluated and treated for other non-cardiac diseases. Fifteen of 5247 term newborns had positive screening results. The median age at screening was 20 h. Thirteen newborns (0.24%) had significant non-cardiac diseases: sepsis (n = 2) and respiratory diseases (n = 11) that required hospitalization and treatment. The remaining two newborns with normal antenatal ultrasonograms had positive screening test and confirmed to have CCHD. Another 18 newborns with negative screening test were later admitted for treatment of sepsis (n = 16) and penumonia (n = 2). All newborns were treated and alive at the end of the study. The sensitivity and specificity of pulse oximetry screening for non-cardiac diseases were 42% and 99.9% respectively, and 100% and 99.7% for CCHD, respectively. Conclusions Routine pulse oximetry screening test was effective in identifying newborns with CCHD and other hypoxemia illnesses, which may led to potential life-threatening condition. This study showed that the expanded use of pulse oximetry has immediate implications for low- and middle-income countries contemplating strategies to reduce neonatal mortality and morbidity.	[Jawin, Vida; Ang, Hak-Lee; Omar, Asma; Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia	Universiti Malaya	Thong, MK (corresponding author), Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia.	thongmk@um.edu.my	Thong, Meow-Keong/B-9960-2010; Ang, Hak Lee/G-4150-2015	Thong, Meow-Keong/0000-0002-7288-7910; Ang, Hak Lee/0000-0001-5492-9091	University of Malaya [RG435/12HTM]; Malaysian Rare Disorders Society	University of Malaya(Universiti Malaya); Malaysian Rare Disorders Society	H-LA received funding for clinical research from the University of Malaya. This research was funded by the University of Malaya Research Grant (RG435/12HTM), URL: umresearch.um.edu.my. VJ received a fund from The Malaysian Rare Disorders Society. This is a personal private fund. URL: www.mrds.org.my. The funders have played a role in the data collection and analysis by providing the material needed for the study.	Ainsworth SB, 1999, ARCH DIS CHILD-FETAL, V80, pF43, DOI 10.1136/fn.80.1.F43; Al-Taiar A, 2013, ARCH DIS CHILD-FETAL, V98, pF249, DOI 10.1136/archdischild-2012-301767; Andrews JP, 2014, CLIN PEDIATR, V53, P173, DOI 10.1177/0009922813502850; [Anonymous], 2010, LEVEL TRENDS CHILD M; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Ewer AK, 2014, LANCET, V384, P725, DOI 10.1016/S0140-6736(14)60575-4; Fink M, 1997, Acta Anaesthesiol Scand Suppl, V110, P87; Hunter S, 2000, HEART, V84, P294, DOI 10.1136/heart.84.3.294; King E. M., 2014, British Journal of Medicine and Medical Research, V4, P1115; Klein SK, 1999, PRENATAL DIAG, V19, P318, DOI 10.1002/(SICI)1097-0223(199904)19:4<318::AID-PD538>3.0.CO;2-X; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Koh IHJ, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181e7e80c; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Mik EG, 1985, J APPL PHYSL, P2015; PAYNE RM, 1995, CIRCULATION, V91, P494, DOI 10.1161/01.CIR.91.2.494; Randall P, 2005, BJOG-INT J OBSTET GY, V112, P24, DOI 10.1111/j.1471-0528.2004.00295.x; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Ruangritmachai C, 2007, PEDIAT CARDIOL, V9, P10; Schultz AH, 2008, PEDIATRICS, V121, P751, DOI 10.1542/peds.2007-0421; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Seale AC, 2012, EARLY HUM DEV, V88, P957, DOI 10.1016/j.earlhumdev.2012.09.005; Sebelius K, 2011, HHS SECRETARY ADOPTS; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Talner NS, 1998, PEDIATRICS, V102, P258; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49; Wright J, 2014, PEDIATRICS, V133, pE561, DOI 10.1542/peds.2013-3284; Zhao QM, 2014, LANCET, V384, P747, DOI 10.1016/S0140-6736(14)60198-7	31	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137580	10.1371/journal.pone.0137580	http://dx.doi.org/10.1371/journal.pone.0137580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360420	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100055
J	Shen, W; Xiao, YY; Ying, XH; Li, ST; Zhai, YJ; Shang, XP; Li, FD; Wang, XY; He, F; Lin, JF				Shen, Wei; Xiao, Yuanyuan; Ying, Xuhua; Li, Songtao; Zhai, Yujia; Shang, Xiaopeng; Li, Fudong; Wang, Xiyi; He, Fan; Lin, Junfen			Tea Consumption and Cognitive Impairment: A Cross-Sectional Study among Chinese Elderly	PLOS ONE			English	Article							GREEN TEA; BLACK TEA; REACTIVE OXYGEN; OLDER CHINESE; POLYPHENOL; CATECHINS; EXTRACT; DEMENTIA; ISCHEMIA; DECLINE	Background Laboratorial and epidemiological researches suggested that tea exhibited potential neuroprotective effect which may prevent cognitive impairment, but there were few data among the elderly aged 60 years and above in China. Objective The objective was to explore the relationship between characteristics of tea consumption and cognitive impairment. Design We analyzed the baseline data from Zhejiang Major Public Health Surveillance Program (ZPHS) which was conducted in 2014. Totally 9,375 residents aged 60 years and above were recruited in this study. Face-to-face interview based on a self-developed questionnaire was performed for each participant. Detailed tea consumption habits were included in the questionnaire. Cognitive impairment screening was performed by using Mini-Mental State Examination (MMSE). Education-specific cut-off points for Chinese were applied to determine the status of cognitive impairment. Logistic regression analysis was used to calculate odds ratios (ORs) of cognitive impairment associated with tea consumption. Results The means (SD) of MMSE scores for the subjects who did not consume tea and consumed <2 cups/d, 2-4 cups/d, >= 4 cups/d were 23.3 (SD = 5.61), 23.8 (SD = 5.60), 24.5 (SD = 5.63) and 25.0 (SD = 5.08), respectively. An inverse correlation was found between tea consumption (of all types) and prevalence of cognitive impairment. Volume of tea consumption was significantly associated with cognitive impairment: compared with non-consumption participants, those who consumed <2 cups/d, 2-4 cups/d, and >= 4 cups/d were observed ORs of 0.77 (95% CI: 0.56, 1.07), 0.62 (95% CI: 0.47, 0.81), and 0.49 (95% CI: 0.36, 0.66), respectively. Compared with non-consumption, black tea presented a positive correlation with cognitive function after controlling for potential confounders (OR = 0.52, 95% CI: 0.28, 0.95), while green tea showed no significant difference (OR = 1.04, 95% CI: 0.72, 1.51). Participants who consumed weak tea, moderate tea or strong tea more often were observed a better cognitive status when compared with those who did not have tea, with an OR of 0.51 (95% CI: 0.28, 0.92), 0.32 (95% CI: 0.19, 0.56) and 0.42 (95% CI: 0.22, 0.78) after adjusting for the potential confounders. But there was no statistically significant difference between any two of these ORs. Conclusion Black tea consumption was association with better cognitive performance among the elderly aged 60 years and above in China, while green tea presented no correlation. The positive association of cognitive status with tea consumption was not limited to particular type of concentration.	[Shen, Wei; Xiao, Yuanyuan; Zhai, Yujia; Shang, Xiaopeng; Li, Fudong; Wang, Xiyi; He, Fan; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance, Hangzhou, Zhejiang, Peoples R China; [Ying, Xuhua; Li, Songtao] Yuhuan Ctr Dis Control & Prevent, Dept Chron Dis Prevent & Control, Taizhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance, Hangzhou, Zhejiang, Peoples R China.	jflin@cdc.zj.cn		Schooling, Mary/0000-0001-9933-5887				Bastianetto S, 2006, EUR J NEUROSCI, V23, P55, DOI 10.1111/j.1460-9568.2005.04532.x; Bhattacharjee S, 2014, FRONT AGING NEUROSCI, V6; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chaturvedi RK, 2006, NEUROBIOL DIS, V22, P421, DOI 10.1016/j.nbd.2005.12.008; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cheng ST, 2014, AM J GERIAT PSYCHIAT, V22, P63, DOI 10.1016/j.jagp.2013.01.060; Ciz M, 2008, PHYSIOL RES, V57, P393, DOI 10.33549/physiolres.931088; Du Y, 2007, J AGR FOOD CHEM, V55, P1695, DOI 10.1021/jf063071b; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Feng L, 2015, J Prev Alzheimers Dis, V2, P136, DOI 10.14283/jpad.2015.57; Feng L, 2012, J NUTR HEALTH AGING, V16, P754, DOI 10.1007/s12603-012-0077-1; Feng L, 2010, J NUTR HEALTH AGING, V14, P433; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao Y, 2013, INT J GERIATR PSYCH, V28, P441, DOI 10.1002/gps.3845; Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043; Hayden KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130419; Henning SM, 2004, AM J CLIN NUTR, V80, P1558; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8; Ide K, 2014, NUTRIENTS, V6, P4032, DOI 10.3390/nu6104032; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Luczaj W, 2005, PREV MED, V40, P910, DOI 10.1016/j.ypmed.2004.10.014; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Modica CM, 2015, AM J NEURORADIOL, V36, P57, DOI 10.3174/ajnr.A3998; Morgen K, 2014, ALZHEIMERS DEMENT, V10, pS269, DOI 10.1016/j.jalz.2013.11.001; Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224; Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013; Park YH, 2003, CELL BIOL TOXICOL, V19, P325, DOI 10.1023/B:CBTO.0000004986.51081.c5; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Sherwin BB, 2012, BEHAV NEUROSCI, V126, P123, DOI 10.1037/a0025539; Spitzer RL, INSTRUCTIONS PATIENT; Verdelho A, 2012, STROKE, V43, P3331, DOI 10.1161/STROKEAHA.112.661793; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xu Y, 2010, J NUTR BIOCHEM, V21, P741, DOI 10.1016/j.jnutbio.2009.05.002; Yongjun W, 2005, RATING SCALES NEUROL; Zeng Y, 2014, J GERONTOLOGY A; Zhai G., 1989, SHANGHAI ARCH PSYCHI, V7, P108; Zhen Y. S., 2002, TEA BIOACTIVITY THER, P243	43	24	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137781	10.1371/journal.pone.0137781	http://dx.doi.org/10.1371/journal.pone.0137781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359663	Green Published, gold			2022-12-27	WOS:000361043100087
J	Terry, CM; Zhuplatov, I; He, YX; Wun, TC; Kim, SE; Cheung, AK				Terry, Christi M.; Zhuplatov, Ilya; He, Yuxia; Wun, Tze-Chein; Kim, Seong-Eun; Cheung, Alfred K.			Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft	PLOS ONE			English	Article							COMPRISING ANNEXIN-V; NEOINTIMAL HYPERPLASIA; INTIMAL HYPERPLASIA; ATTENUATES STENOSIS; ARTERIAL INJURY; PLUS ASPIRIN; HEMODIALYSIS; PATENCY; THROMBIN; FAILURE	Background Hemodialysis arteriovenous synthetic grafts (AVG) provide high volumetric blood flow rates shortly after surgical placement. However, stenosis often develops at the vein-graft anastomosis contributing to thrombosis and early graft failure. Two novel fusion proteins, ANV-6L15 and TAP-ANV, inhibit the tissue factor/factor VIIa coagulation complex and the factor Xa/factor Va complex, respectively. Each inhibitor domain is fused to an annexin V domain that targets the inhibitor activity to sites of vascular injury to locally inhibit thrombosis. This study's objective was to determine if these antithrombotic proteins are safe and effective in inhibiting AVG stenosis. Methods A bolus of either TAP-ANV or ANV-6L15 fusion protein was administered intravenously immediately prior to surgical placement of a synthetic graft between the external jugular vein and common carotid artery in a porcine model. At surgery, the vein and artery were irrigated with the anti-thrombotic fusion protein. Control animals received intravenous heparin. At 4 weeks, MRI was performed to evaluate graft patency, the pigs were then euthanized and grafts and attached vessels were explanted for histomorphometric assessment of neointimal hyperplasia at the vein-graft anastomosis. Blood was collected at surgery, immediately after surgery and at euthanasia for serum metabolic panels and coagulation chemistries. Results No acute thrombosis occurred in the control group or in either experimental group. No abnormal serum chemistries, activated clotting times or PT, PTT values were observed after treatment in experimental or control animals. However, at the vein-graft anastomosis, there was no difference between the control and experimental groups in cross-sectional lumen areas, as measured on MRI, and no difference in hyperplasia areas as determined by histomorphometry. These results suggest that local irrigation of TAP-ANV or ANV-6L15 intra-operatively was as effective in inhibiting acute graft thrombosis as intravenous administration of heparin, but failed to inhibit hyperplasia development and stenosis in AVG.	[Terry, Christi M.; Zhuplatov, Ilya; He, Yuxia; Cheung, Alfred K.] Univ Utah, Div Nephrol & Hypertens, Salt Lake City, UT 84132 USA; [Wun, Tze-Chein] EVAS Therapeut LLC, Ballwin, MO USA; [Kim, Seong-Eun] Univ Utah, Dept Radiol, Utah Ctr Adv Imaging Res, Salt Lake City, UT 84132 USA; [Cheung, Alfred K.] Vet Affairs Salt Lake City Healthcare Syst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Terry, CM (corresponding author), Univ Utah, Div Nephrol & Hypertens, Salt Lake City, UT 84132 USA.	christi.terry@hsc.utah.edu			SBIR [R44HL093848]; National Heart Lung Blood Institute at the National Institutes of Health; University of Utah Study Design and Biostatistics Center; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [5UL1TR001067-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000105, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL093848] Funding Source: NIH RePORTER	SBIR; National Heart Lung Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Utah Study Design and Biostatistics Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an SBIR (R44HL093848), awarded by the National Heart Lung Blood Institute at the National Institutes of Health to TCW, and by the University of Utah Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 5UL1TR001067-02 (formerly 8UL1TR000105 and UL1RR025764). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abendschein DR, 1996, J AM COLL CARDIOL, V28, P1849, DOI 10.1016/S0735-1097(96)00362-2; Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; Allemang MT, 2014, ANN VASC SURG, V28, P28, DOI 10.1016/j.avsg.2013.08.001; Brown DM, 1996, ARCH SURG-CHICAGO, V131, P1086; Chen HH, 2005, BLOOD, V105, P3902, DOI 10.1182/blood-2004-11-4435; Coleman CI, 2010, INT J CLIN PRACT, V64, P1239, DOI 10.1111/j.1742-1241.2009.02329.x; Crowther MA, 2002, J AM SOC NEPHROL, V13, P2331, DOI 10.1097/01.ASN.0000027356.16598.99; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Dixon BS, 2011, J AM SOC NEPHROL, V22, P773, DOI 10.1681/ASN.2010060582; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; FAGER G, 1995, CIRC RES, V77, P645, DOI 10.1161/01.RES.77.4.645; Guomundsdottir IJ, 2008, J AM COLL CARDIOL, V51, P1749, DOI 10.1016/j.jacc.2007.12.047; He Y, 2013, J BIOMECH, V46, P165, DOI 10.1016/j.jbiomech.2012.09.005; Hung YN, 2010, CLIN J AM SOC NEPHRO, V5, P1029, DOI 10.2215/CJN.08181109; Huynh TTT, 2001, J VASC SURG, V33, P400, DOI 10.1067/mva.2001.111989; Kaufman JS, 2003, J AM SOC NEPHROL, V14, P2313, DOI 10.1097/01.ASN.0000081661.10246.33; Kim SE, 2004, MAGNET RESON MED, V52, P1379, DOI 10.1002/mrm.20296; KOSTERING H, 1983, LAB ANIM, V17, P346, DOI 10.1258/002367783781062262; Li L, 2007, NEPHROL DIAL TRANSPL, V22, P3139, DOI 10.1093/ndt/gfm415; Liao MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/675701; Lindholt JS, 2011, EUR J VASC ENDOVASC, V41, P668, DOI 10.1016/j.ejvs.2011.01.021; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P810, DOI 10.2215/CJN.00730112; Lok CE, 2012, JAMA-J AM MED ASSOC, V307, P1809, DOI 10.1001/jama.2012.3473; Masaki T, 2004, KIDNEY INT, V66, P2061, DOI 10.1111/j.1523-1755.2004.00985.x; Mehta RI, 2011, CARDIOVASC PATHOL, V20, P213, DOI 10.1016/j.carpath.2010.06.005; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Oltrona L, 1997, CIRCULATION, V96, P646; Osborn G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub2; Palmer SC, 2013, AM J KIDNEY DIS, V61, P112, DOI 10.1053/j.ajkd.2012.08.031; Roque M, 2000, J AM COLL CARDIOL, V36, P2303, DOI 10.1016/S0735-1097(00)01018-4; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Sanders WG, 2012, AM J PHYSIOL-CELL PH, V303, pC278, DOI 10.1152/ajpcell.00386.2011; SAREMBOCK IJ, 1991, CIRCULATION, V84, P232, DOI 10.1161/01.CIR.84.1.232; Schwartz RS, 1996, CIRCULATION, V93, P1542, DOI 10.1161/01.CIR.93.8.1542; Stouffer GA, 1998, SEMIN THROMB HEMOST, V24, P145, DOI 10.1055/s-2007-995833; Terry CM, 2006, NEPHROL DIAL TRANSPL, V21, P3172, DOI 10.1093/ndt/gfl366; Terry CM, 2012, J CONTROL RELEASE, V160, P459, DOI 10.1016/j.jconrel.2012.03.011; Terry CM, 2009, ACAD RADIOL, V16, P96, DOI 10.1016/j.acra.2008.05.019; Thome LM, 1998, CIRCULATION, V98, P2301, DOI 10.1161/01.CIR.98.21.2301; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025; Yeh CH, 2013, J THROMB HAEMOST, V11, P1454, DOI 10.1111/jth.12314; Yin XH, 2002, CARDIOVASC RES, V56, P454, DOI 10.1016/S0008-6363(02)00595-3; Zhou J, 2010, ULTRASOUND MED BIOL, V36, P1876, DOI 10.1016/j.ultrasmedbio.2010.08.013	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137381	10.1371/journal.pone.0137381	http://dx.doi.org/10.1371/journal.pone.0137381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360605	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100032
J	Wollebo, HS; Bellizzi, A; Kaminski, R; Hu, WH; White, MK; Khalili, K				Wollebo, Hassen S.; Bellizzi, Anna; Kaminski, Rafal; Hu, Wenhui; White, Martyn K.; Khalili, Kamel			CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HEPATITIS-B-VIRUS; INACTIVATING LENTIVIRUS VECTOR; RNA-GUIDED ENDONUCLEASE; EPSTEIN-BARR-VIRUS; FETAL GLIAL-CELLS; IN-VIVO; PRIMATE POLYOMAVIRUSES; HIV-1 INFECTION; GENE-EXPRESSION	Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system (CNS) caused by reactivation of the human polyomavirus JCV gene expression and its replication in oligodendrocytes, the myelin producing cells in the brain. Once a rare disease seen in patients with lymphotproliferative and myeloproliferative disorders, PML has been seen more frequently in HIV-1 positive/AIDS patients as well as patients undergoing immunomodulatory therapy due for autoimmune disorders including multiple sclerosis, rheumatoid arthritis, and others. As of now there is no cure for PML and in most cases disease progression leads to death within two years. Similar to other polyomaviruses, the JCV genome is small circular double stranded DNA that includes coding sequences for the viral early protein, T-antigen, which is critical for directing viral reactivation and lytic infection. Here, we employ a newly developed gene editing strategy, CRISPR/Cas9, to introduce mutations in the viral genome and, by inactivating the gene encoding T-antigen, inhibit viral replication. We first used bioinformatics screening and identified several potential targets within the JCV T-antigen gene that can serve as sites for the creation of guide RNAs (gRNAs) for positioning the Cas9 nuclease on the designated area of the viral genome for editing. Results from a series of integrated genetic and functional studies showed that transient or conditional expression of Cas9 and gRNAs specifically targets the DNA sequences corresponding to the N-terminal region of T-antigen, and by introducing mutation, interferes with expression and function of of the viral protein, hence suppressing viral replication in permissive cells. Results from SURVEYOR assay revealed no off-target effects of the JCV-specific CRISPR/Cas9 editing apparatus. These observations provide the first evidence for the employment of a gene editing strategy as a promising tool for the elimination of the JCV genome and a potential cure for PML.	[Wollebo, Hassen S.; Bellizzi, Anna; Kaminski, Rafal; Hu, Wenhui; White, Martyn K.; Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Kaminski, Rafal/V-3516-2018	Kaminski, Rafal/0000-0001-8827-6658; Wollebo, Hassen/0000-0003-2285-3496	National Institutes of Health [R01NS087971, R01MH086358, P30 MH092177, R01AI077460]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093271, R01MH086358, P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Grants awarded by the National Institutes of Health to: KK (R01NS087971, R01MH086358 and P30 MH092177- please note that this grant did not directly support this research; however, the services provided by this center grant were utilized in the experiments presented in the manuscript) MKW (R01AI077460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei G, 1997, ANTIMICROB AGENTS CH, V41, P587, DOI 10.1128/AAC.41.3.587; ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Berger Joseph R, 2011, Cleve Clin J Med, V78 Suppl 2, pS8, DOI 10.3949/ccjm.78.s2.03; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Chalkley JJ, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0408-6; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Chapagain ML, 2008, J NEUROVIROL, V14, P448, DOI 10.1080/13550280802235916; Clifford DB, 2011, ARCH NEUROL-CHICAGO, V68, P1156, DOI 10.1001/archneurol.2011.103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; DeCaprio J. A., 2013, FIELDS VIROLOGY, P1633; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Hou J, 1998, J NEUROVIROL, V4, P451, DOI 10.3109/13550289809114545; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hu Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/612823; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266; Khalili K, 2015, J NEUROVIRO IN PRESS; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagayama S, 2013, CLIN NEUROL NEUROSUR, V115, P1482, DOI 10.1016/j.clineuro.2012.11.016; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Radhakrishnan S, 2004, J VIROL, V78, P7264, DOI 10.1128/JVI.78.13.7264-7269.2004; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; RAJ GV, 1995, INT J ONCOL, V7, P801; ROBINSON WS, 1974, J VIROL, V14, P384, DOI 10.1128/JVI.14.2.384-391.1974; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Tavazzi E, 2012, REV MED VIROL, V22, P18, DOI 10.1002/rmv.710; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2014, CLIN MICROBIOL REV, V27, P463, DOI 10.1128/CMR.00124-13; White MK, 2011, J INFECT DIS, V203, P578, DOI 10.1093/infdis/jiq097; White MK, 2004, VIROLOGY, V324, P1, DOI 10.1016/j.virol.2004.03.025; Wollebo HS, 2013, METHODS MOL BIOL, V1078, P141, DOI 10.1007/978-1-62703-640-5_12; Wollebo HS, 2012, VIROLOGY, V432, P146, DOI 10.1016/j.virol.2012.06.010; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhen S, 2015, GENE THER IN PRESS; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	56	60	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136046	10.1371/journal.pone.0136046	http://dx.doi.org/10.1371/journal.pone.0136046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360417	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100007
J	Tvete, IF; Natvig, B; Gasemyr, J; Meland, N; Roine, M; Klemp, M				Tvete, Ingunn Fride; Natvig, Bent; Gasemyr, Jorund; Meland, Nils; Roine, Marianne; Klemp, Marianne			Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTITUMOR NECROSIS FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; ADALIMUMAB PLUS METHOTREXATE; ALPHA MONOCLONAL-ANTIBODY; RECEIVING CONCOMITANT METHOTREXATE; INTERLEUKIN-6 RECEPTOR INHIBITION; RANDOMIZED CONTROLLED-TRIAL; PHASE-III TRIAL; EVERY 4 WEEKS	Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs (DMARDs) and the newer biologic drugs. We sought to compare and rank the biologics with respect to efficacy. We performed a literature search identifying 54 publications encompassing 9 biologics. We conducted a multiple treatment comparison regression analysis letting the number experiencing a 50% improvement on the ACR score be dependent upon dose level and disease duration for assessing the comparable relative effect between biologics and placebo or DMARD. The analysis embraced all treatment and comparator arms over all publications. Hence, all measured effects of any biologic agent contributed to the comparison of all biologic agents relative to each other either given alone or combined with DMARD. We found the drug effect to be dependent on dose level, but not on disease duration, and the impact of a high versus low dose level was the same for all drugs (higher doses indicated a higher frequency of ACR50 scores). The ranking of the drugs when given without DMARD was certolizumab (ranked highest), etanercept, tocilizumab/abatacept and adalimumab. The ranking of the drugs when given with DMARD was certolizumab (ranked highest), tocilizumab, anakinra, rituximab, golimumab/infliximab/abatacept, adalimumab/ etanercept. Still, all drugs were effective. All biologic agents were effective compared to placebo, with certolizumab the most effective and adalimumab (without DMARD treatment) and adalimumab/etanercept (combined with DMARD treatment) the least effective. The drugs were in general more effective, except for etanercept, when given together with DMARDs.	[Tvete, Ingunn Fride] Norwegian Comp Ctr, Oslo, Norway; [Natvig, Bent; Gasemyr, Jorund] Univ Oslo, Dept Math, Oslo, Norway; [Meland, Nils; Roine, Marianne] Smerud Med Res Int AS, Oslo, Norway; [Klemp, Marianne] Univ Oslo, Dept Pharmacol, Oslo, Norway; [Klemp, Marianne] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Knowledge Centre for Health Services	Tvete, IF (corresponding author), Norwegian Comp Ctr, Oslo, Norway.	ingunn.fride.tvete@nr.no	Klemp, Marianne/AAQ-5652-2021	Klemp, Marianne/0000-0002-9530-8344	Norwegian Center for Research [970141669]	Norwegian Center for Research	This work was financed by the Norwegian Center for Research-based Innovation 'Statistics for innovation', Project Number 970141669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J RHEUMATOL, V33, P37; [Anonymous], ARTHRITIS CARE RES H, DOI DOI 10.1002/ACR.21641; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chen DY, 2009, J FORMOS MED ASS, V108; Choy E, 2012, RHEUMATOLOGY, V51, P1226, DOI 10.1093/rheumatology/ker519; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; Cohen SB, 2004, ANN RHEUM DIS, V63, P1062, DOI 10.1136/ard.2003.016014; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Divine EB, 2011, PHARMACOTHERAPY, V31; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Emery P, 2002, J RHEUMATOL, V29, P3; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Furst DE, 2003, J RHEUMATOL, V30, P2563; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; KIM HY, 2007, APLAR J RHEUMATOL, V10, P9, DOI DOI 10.1111/J.1479-8077.2007.00248.X; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Klemp M, 2011, J CLIN PSYCHOPHARM, V31, P698, DOI 10.1097/JCP.0b013e31823657d9; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer J, 2010, ARTHRITIS RHEUM-US, V62, P917, DOI 10.1002/art.27348; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mandema JW, 2011, CLIN PHARMACOL THER, V90, P828, DOI 10.1038/clpt.2011.256; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; R Core Team, R LANG ENV STAT COMP; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Tak PP, 2011, ANN RHEUM DIS, V70, P39, DOI 10.1136/ard.2010.137703; Tanaka Y, 2012, ANN RHEUM DIS, V71, P817, DOI 10.1136/ard.2011.200317; Thomas A, 1994, RTA BCS MODULAR LANG, V2, P36; Thorlund K, 2013, ANN RHEUM DIS, V72, P1524, DOI 10.1136/annrheumdis-2012-201574; Turkstra E, 2011, CURR MED RES OPIN, V27, P1885, DOI 10.1185/03007995.2011.608655; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van de Putte L. B., 2003, ANN RHEUM DIS, V62, P1168, DOI DOI 10.1136/ard.2003.009563; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Yazici Y, 2012, ANN RHEUM DIS, V71, P198, DOI 10.1136/ard.2010.148700; Zhang F, 2006, APLAR J RHEUMATOL, V9, P127, DOI DOI 10.1111/J.1479-8077.2006.00186.X	67	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137258	10.1371/journal.pone.0137258	http://dx.doi.org/10.1371/journal.pone.0137258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356639	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800037
J	Kim, HK; Konishi, M; Takahashi, M; Tabata, H; Endo, N; Numao, S; Lee, SK; Kim, YH; Suzuki, K; Sakamoto, S				Kim, Hyeon-Ki; Konishi, Masayuki; Takahashi, Masaki; Tabata, Hiroki; Endo, Naoya; Numao, Shigeharu; Lee, Sun-Kyoung; Kim, Young-Hak; Suzuki, Katsuhiko; Sakamoto, Shizuo			Effects of Acute Endurance Exercise Performed in the Morning and Evening on Inflammatory Cytokine and Metabolic Hormone Responses	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; SKELETAL-MUSCLE; INTERLEUKIN-6; IL-6; CORTISOL; LIPOPOLYSACCHARIDE; DETERMINES; EXPRESSION; INTENSITY; PLASMA	Purpose To compare the effects of endurance exercise performed in the morning and evening on inflammatory cytokine responses in young men. Methods Fourteen healthy male participants aged 24.3 +/- 0.8 years (mean +/- standard error) performed endurance exercise in the morning (0900-1000 h) on one day and then in the evening (1700-1800 h) on another day with an interval of at least 1 week between each trial. In both the morning and evening trials, the participants walked for 60 minutes at approximately 60% of the maximal oxygen uptake ((V) over dotO(2max)) on a treadmill. Blood samples were collected to determine hormones and inflammatory cytokines at pre-exercise, immediately post exercise, and 2 h post exercise. Results Plasma interleukin (IL)-6 and adrenaline concentrations were significantly higher immediately after exercise in the evening trial than in the morning trial (P < 0.01, both). Serum free fatty acids concentrations were significantly higher in the evening trial than in the morning trial at 2 h after exercise (P < 0.05). Furthermore, a significant correlation was observed between the levels of IL-6 immediately post-exercise and free fatty acids 2 h post-exercise in the evening (r = 0.68, P < 0.01). Conclusions These findings suggest that the effect of acute endurance exercise in the evening enhances the plasma IL-6 and adrenaline concentrations compared to that in the morning. In addition, IL-6 was involved in increasing free fatty acids, suggesting that the evening is more effective for exercise-induced lipolysis compared with the morning.	[Kim, Hyeon-Ki; Tabata, Hiroki] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Kim, Hyeon-Ki] Japan Soc Promot Sci, Tokyo, Japan; [Konishi, Masayuki; Suzuki, Katsuhiko; Sakamoto, Shizuo] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Takahashi, Masaki] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Endo, Naoya] Japan Inst Sports Sci, Tokyo, Japan; [Numao, Shigeharu] Kyoto Pharmaceut Univ, Dept Hlth & Sports Sci, Kyoto 607, Japan; [Numao, Shigeharu] Waseda Univ, Waseda Inst Sport Sci, Tokyo, Japan; [Lee, Sun-Kyoung] Myongji Univ, Dept Sports & Phys Arts, Seoul, South Korea; [Kim, Young-Hak] Yongin Univ, Dept Oriental Martial Arts, Yongin, South Korea	Waseda University; Japan Society for the Promotion of Science; Waseda University; Waseda University; Kyoto Pharmaceutical University; Waseda University; Myongji University; Yongin University	Kim, HK (corresponding author), Waseda Univ, Grad Sch Sport Sci, Saitama, Japan.	gusrl82@ruri.waseda.jp	Endo, Naoya/GOJ-7466-2022; Suzuki, Katsuhiko/AAI-2197-2019	Suzuki, Katsuhiko/0000-0002-6572-5809; Takahashi, Masaki/0000-0002-4038-8164; Tabata, Hiroki/0000-0001-9396-5247; Konishi, Masayuki/0000-0003-1512-3014	Ministry of Education, Culture, Sports Science, and Technology of Japan;  [24300238]	Ministry of Education, Culture, Sports Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	Funding: This study was supported by grants from the Ministry of Education, Culture, Sports Science, and Technology of Japan; and a Grant-in-Aid for the Global COE Program "Sport Science for the Promotion of Active Life" (2011-2012) and Scientific Research (B) 24300238.	Born J, 1997, J IMMUNOL, V158, P4454; BRANDENBERGER G, 1982, J CLIN ENDOCR METAB, V54, P592, DOI 10.1210/jcem-54-3-592; DAVIES CTM, 1973, J APPL PHYSIOL, V35, P887, DOI 10.1152/jappl.1973.35.6.887; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dimitriou L, 2002, BRIT J SPORT MED, V36, P260, DOI 10.1136/bjsm.36.4.260; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Gagnon DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110774; Giraldo E, 2009, NEUROIMMUNOMODULAT, V16, P237, DOI 10.1159/000212384; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; Hermann C, 2006, EUR J IMMUNOL, V36, P371, DOI 10.1002/eji.200535470; Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014; Keller P, 2004, J APPL PHYSIOL, V97, P1309, DOI 10.1152/japplphysiol.00284.2004; Kim HK, 2014, JAPANESE SOC CLIN SP, V22, P497; Martin-Cordero L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-42; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Papanicolaou DA, 1996, AM J PHYSIOL-ENDOC M, V271, pE601; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, PFLUG ARCH EUR J PHY, V446, P9, DOI 10.1007/s00424-002-0981-z; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Ploeger HE, 2009, EXERC IMMUNOL REV, V15, P6; Rahman SA, 2015, BRAIN BEHAV IMMUN, V47, P4, DOI 10.1016/j.bbi.2014.11.003; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Shephard RJ, 1997, CAN J APPL PHYSIOL, V22, P95, DOI 10.1139/h97-009; Stallknecht B, 1995, AM J PHYSIOL-ENDOC M, V269, pE1059, DOI 10.1152/ajpendo.1995.269.6.E1059; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Takagi S, 2014, J SPORT SCI, V32, P175, DOI 10.1080/02640414.2013.815360; TRINE MR, 1995, SPORTS MED, V20, P328, DOI 10.2165/00007256-199520050-00004; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Zelazowska EB, 1997, MED SCI SPORT EXER, V29, P467, DOI 10.1097/00005768-199704000-00007	33	24	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137567	10.1371/journal.pone.0137567	http://dx.doi.org/10.1371/journal.pone.0137567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352938	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800096
J	Luo, YG; Liu, P; Shi, L; Luo, YS; Yi, L; Li, A; Qin, J; Heng, PA; Wang, DF				Luo, Yun-gang; Liu, Ping; Shi, Lin; Luo, Yishan; Yi, Lei; Li, Ang; Qin, Jing; Heng, Pheng-Ann; Wang, Defeng			Accelerating Neuroimage Registration through Parallel Computation of Similarity Metric	PLOS ONE			English	Article							IMAGE REGISTRATION; OPTIMIZATION; ROBUST	Neuroimage registration is crucial for brain morphometric analysis and treatment efficacy evaluation. However, existing advanced registration algorithms such as FLIRT and ANTs are not efficient enough for clinical use. In this paper, a GPU implementation of FLIRT with the correlation ratio (CR) as the similarity metric and a GPU accelerated correlation coefficient (CC) calculation for the symmetric diffeomorphic registration of ANTs have been developed. The comparison with their corresponding original tools shows that our accelerated algorithms can greatly outperform the original algorithm in terms of computational efficiency. This paper demonstrates the great potential of applying these registration tools in clinical applications.	[Luo, Yun-gang] Jilin Univ, Dept Stomatol, Hosp 2, Changchun 130041, Jilin, Peoples R China; [Liu, Ping; Qin, Jing; Heng, Pheng-Ann] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Chow Yuk Ho Technol Ctr Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Yishan; Li, Ang; Wang, Defeng] Chinese Univ Hong Kong, Res Ctr Med Image Comp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Yi, Lei] Second Peoples Hosp Shenzhen, Dept Radiol, Shenzhen, Peoples R China; [Heng, Pheng-Ann] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Hong Kong, Hong Kong, Peoples R China	Jilin University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Second People's Hospital of Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Luo, YG (corresponding author), Jilin Univ, Dept Stomatol, Hosp 2, Changchun 130041, Jilin, Peoples R China.	luoyungang@sohu.com; shilin@cuhk.edu.hk	Shi, Lin/K-5241-2014	Shi, Lin/0000-0003-2318-4669; Heng, Pheng Ann/0000-0003-3055-5034	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 475711, CUHK 416712, CUHK 473012, CUHK 14113214]; Ministry of Science and Technology of the People's Republic of China [2013DFG12900]; National Natural Science Foundation of China [61233012, 81201157]; Science, Technology and Innovation Commission of Shenzhen Municipality [CXZZ20140606164105361, JCYJZ20130401112102666]; Shenzhen Basic Research Project [CYJ20130402113127511]; Natural Science Foundation of Guangdong [S2013010014973]; Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong [BME-p2-13/BME-CUHK]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science, Technology and Innovation Commission of Shenzhen Municipality; Shenzhen Basic Research Project; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong(Chinese University of Hong Kong)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 475711, CUHK 416712, CUHK 473012, CUHK 14113214), a grant from Ministry of Science and Technology of the People's Republic of China (Project No.: 2013DFG12900), and grants from the National Natural Science Foundation of China (Project No. 61233012, and 81201157), and grants from The Science, Technology and Innovation Commission of Shenzhen Municipality (No. CXZZ20140606164105361, JCYJZ20130401112102666), a grant of Shenzhen Basic Research Project (No. CYJ20130402113127511), a grant from Natural Science Foundation of Guangdong (No. S2013010014973) and by project BME-p2-13/BME-CUHK of the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong.	Ang L, DIG SYST DES DSD 201, P82; Avants B, 2009, INSIGHT J; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Chen SF, 2009, 2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009), P544, DOI 10.1109/FBIE.2009.5405778; Chen SF, 2009, LECT NOTES COMPUT SC, V5574, P281, DOI 10.1007/978-3-642-03095-6_28; Chou CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050540; Eklund A, 2013, MED IMAGE ANAL, V17, P1073, DOI 10.1016/j.media.2013.05.008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Muyan-Ozcelik P, 2008, INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCES AND ITS APPLICATIONS, PROCEEDINGS, P223, DOI 10.1109/ICCSA.2008.22; Podlozhnyuk V., 2007, TECHNICAL REPORT; Roche A, 1998, LECT NOTES COMPUT SC, V1496, P1115, DOI 10.1007/BFb0056301; Satish N, 2009, INT PARALL DISTRIB P, P257; Shackleford J., 2013, HIGH PERFORMANCE DEF; Shams R., 2007, P INT C SIGN PROC CO, P418; Shams R, 2010, COMPUT METH PROG BIO, V99, P133, DOI 10.1016/j.cmpb.2009.11.004; Shams R, 2010, IEEE SIGNAL PROC MAG, V27, P50, DOI 10.1109/MSP.2009.935387; Vetter C, 2011, I S BIOMED IMAGING, P1227, DOI 10.1109/ISBI.2011.5872623	20	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136718	10.1371/journal.pone.0136718	http://dx.doi.org/10.1371/journal.pone.0136718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352412	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800047
J	Tornero-Esteban, P; Peralta-Sastre, A; Herranz, E; Rodriguez-Rodriguez, L; Mucientes, A; Abasolo, L; Marco, F; Fernandez-Gutierrez, B; Lamas, JR				Tornero-Esteban, Pilar; Peralta-Sastre, Ascension; Herranz, Eva; Rodriguez-Rodriguez, Luis; Mucientes, Arkaitz; Abasolo, Lydia; Marco, Fernando; Fernandez-Gutierrez, Benjamin; Ramon Lamas, Jose			Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients	PLOS ONE			English	Article							HIGH BONE MASS; BETA-CATENIN; STROMAL CELLS; DKK1-MEDIATED INHIBITION; SUBCHONDRAL BONE; LRP5 GENE; OSTEOBLASTS; MUTATIONS; PROTEIN; DENSITY	Introduction Osteoarthritis (OA) is characterized by altered homeostasis of joint cartilage and bone, whose functional properties rely on chondrocytes and osteoblasts, belonging to mesenchymal stem cells (MSCs). WNT signaling acts as a hub integrating and crosstalking with other signaling pathways leading to the regulation of MSC functions. The aim of this study was to evaluate the existence of a differential signaling between Healthy and OA-MSCs during osteogenesis. Methods MSCs of seven OA patients and six healthy controls were isolated, characterised and expanded. During in vitro osteogenesis, cells were recovered at days 1, 10 and 21. RNA and protein content was obtained. Expression of WNT pathway genes was evaluated using RT-qPCR. Functional studies were also performed to study the MSC osteogenic commitment and functional and post-traslational status of beta-catenin and several receptor tyrosine kinases. Results Several genes were downregulated in OA-MSCs during osteogenesis in vitro. These included soluble Wnts, inhibitors, receptors, co-receptors, several kinases and transcription factors. Basal levels of beta-catenin were higher in OA-MSCs, but calcium deposition and expression of osteogenic genes was similar between Healthy and OA-MSCs. Interestingly an increased phosphorylation of p44/42 MAPK (ERK1/2) signaling node was present in OA-MSCs. Conclusion Our results point to the existence in OA-MSCs of alterations in expression of Wnt pathway components during in vitro osteogenesis that are partially compensated by post-translational mechanisms modulating the function of other pathways. We also point the relevance of other signaling pathways in OA pathophysiology suggesting their role in the maintenance of joint homeostasis through modulation of MSC osteogenic potential.	[Tornero-Esteban, Pilar; Peralta-Sastre, Ascension; Herranz, Eva; Rodriguez-Rodriguez, Luis; Mucientes, Arkaitz; Abasolo, Lydia; Fernandez-Gutierrez, Benjamin; Ramon Lamas, Jose] Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, Madrid 28040, Spain; [Marco, Fernando] Hosp Clin San Carlos, UGC Traumatol, Inst Invest Sanitaria, Madrid 28040, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos	Lamas, JR (corresponding author), Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, 4a Planta,C Prof Martin Lagos S-N, Madrid 28040, Spain.	jrlamas@gmail.com	Rodriguez-Rodriguez, Luis/H-5880-2013; Mucientes, Arkaitz/AAJ-4567-2021; Mucientes, Arkaitz/AAE-4162-2022; Lamas, José Ramón/C-8318-2012; Fernandez-Gutierrez, Benjamin/AAM-9063-2020	Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Mucientes, Arkaitz/0000-0002-7431-7225; Mucientes, Arkaitz/0000-0002-7431-7225; Lamas, José Ramón/0000-0003-1913-7261; TORNERO, PILAR/0000-0003-3565-2722	ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); RETICS Program (RIER) from Instituto de Salud Carlos III (ISCIII) [RD08/0075];  [CP10/00346]	ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); RETICS Program (RIER) from Instituto de Salud Carlos III (ISCIII); 	This work was supported by project CP10/00346 included in the Plan Nacional de I+D+I (AES 2010) and co-financed by ISCIII-Subdireccion General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER). PT is supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII).	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5; Chapman K, 2012, BONE, V51, P258, DOI 10.1016/j.bone.2011.11.026; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Hardcastle SA, 2013, RHEUMATOLOGY, V52, P1042, DOI 10.1093/rheumatology/kes411; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kawaguchi H, 2009, J BONE MINER RES, V24, P8, DOI 10.1359/JBMR.081115; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lories RJU, 2008, BEST PRACT RES CL RH, V22, P209, DOI 10.1016/j.berh.2007.12.001; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; MacFarlane RJ, 2013, EXPERT OPIN THER TAR, V17, P243, DOI 10.1517/14728222.2013.746954; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Pangrazio A, 2011, BONE, V49, P568, DOI 10.1016/j.bone.2011.05.006; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Stagg J, 2013, CURR MOL MED, V13, P856, DOI 10.2174/1566524011313050016; Suda T, 2008, CELL, V132, P729, DOI 10.1016/j.cell.2008.02.017; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377	48	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137170	10.1371/journal.pone.0137170	http://dx.doi.org/10.1371/journal.pone.0137170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352263	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800064
J	Urrutia-Jalabert, R; Malhi, Y; Lara, A				Urrutia-Jalabert, Rocio; Malhi, Yadvinder; Lara, Antonio			The Oldest, Slowest Rainforests in the World? Massive Biomass and Slow Carbon Dynamics of Fitzroya cupressoides Temperate Forests in Southern Chile	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; NEW-ZEALAND; STORAGE; PRODUCTIVITY; CORDILLERA; ALLOCATION; BALANCE; PIUCHUE; RANGE; PINE	Old-growth temperate rainforests are, per unit area, the largest and most long-lived stores of carbon in the terrestrial biosphere, but their carbon dynamics have rarely been described. The endangered Fitzroya cupressoides forests of southern South America include stands that are probably the oldest dense forest stands in the world, with long-lived trees and high standing biomass. We assess and compare aboveground biomass, and provide the first estimates of net primary productivity (NPP), carbon allocation and mean wood residence time in medium-age stands in the Alerce Costero National Park (AC) in the Coastal Range and in old-growth forests in the Alerce Andino National Park (AA) in the Andean Cordillera. Aboveground live biomass was 113-114 Mg C ha(-1) and 448-517 Mg C ha(-1) in AC and AA, respectively. Aboveground productivity was 3.35-3.36 Mg C ha(-1) year(-1) in AC and 2.22-2.54 Mg C ha(-1) year(-1) in AA, values generally lower than others reported for temperate wet forests worldwide, mainly due to the low woody growth of Fitzroya. NPP was 4.21-4.24 and 3.78-4.10 Mg C ha(-1) year(-1) in AC and AA, respectively. Estimated mean wood residence time was a minimum of 539-640 years for the whole forest in the Andes and 1368-1393 years for only Fitzroya in this site. Our biomass estimates for the Andes place these ecosystems among the most massive forests in the world. Differences in biomass production between sites seem mostly apparent as differences in allocation rather than productivity. Residence time estimates for Fitzroya are the highest reported for any species and carbon dynamics in these forests are the slowest reported for wet forests worldwide. Although primary productivity is low in Fitzroya forests, they probably act as ongoing biomass carbon sinks on long-term timescales due to their low mortality rates and exceptionally long residence times that allow biomass to be accumulated for millennia.	[Urrutia-Jalabert, Rocio; Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Urrutia-Jalabert, Rocio; Lara, Antonio] Univ Austral Chile, Lab Dendrocronol & Cambio Global, Inst Conservac Biodiversidad & Terr, Fac Ciencias Forestales & Recursos Nat, Valdivia, Chile; [Lara, Antonio] Univ Chile, Fac Ciencias Fis & Matemat, Ctr Climate & Resilience Res CR2, Santiago, Chile; [Lara, Antonio] Fdn Ctr Ios Bosques Nativos FORECOS, Valdivia, Chile	University of Oxford; Universidad Austral de Chile; Universidad de Chile	Urrutia-Jalabert, R (corresponding author), Univ Oxford, Environm Change Inst, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	rocio.urrutia@ouce.ox.ac.uk		Lara, Antonio/0000-0003-4998-4584	FONDECYT [1130410]; CRNII2047 project of the Inter-American Institute for Global Change Research by NSF [GEO-0452325]; Gordon and Betty Moore Foundation; Center for Climate and Resilience Research (CR)2 - CONICYT/FONDAP [15110009]; Rufford Small Grants for Nature Conservation [11371-1]; Royal Geographical Society under Monica Cole Research Grant; Jackson Foundation; European Research Council	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CRNII2047 project of the Inter-American Institute for Global Change Research by NSF; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Climate and Resilience Research (CR)2 - CONICYT/FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Rufford Small Grants for Nature Conservation; Royal Geographical Society under Monica Cole Research Grant; Jackson Foundation; European Research Council(European Research Council (ERC)European Commission)	Funding: This work was supported by the FONDECYT Project No. 1130410 (RU-J, www.conicyt.cl/fondecyt), the CRNII2047 project of the Inter-American Institute for Global Change Research supported by NSF (Grant GEO-0452325, RU-J, http://www.iai.int/), the Gordon and Betty Moore Foundation grant (YM, http://www.moore.org/), the Center for Climate and Resilience Research (CR)2 funded by CONICYT/FONDAP/15110009 (AL, http://www.cr2.cl/), the Rufford Small Grants for Nature Conservation (Project 11371-1, RU-J, http://www.rufford.org/) and the Royal Geographical Society under the Monica Cole Research Grant (RU-J, http://www.rgs.org/HomePage.htm). YM is supported by the Jackson Foundation and an European Research Council Advanced Investigator Award, GEM-TRAITS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker SA, 2002, TREE PHYSIOL, V22, P213, DOI 10.1093/treephys/22.2-3.213; [Anonymous], [No title captured]; Barichivich J, 2005, THESIS U AUSTRAL CHI; Battles JJ, 2002, PLANT ECOL, V158, P5, DOI 10.1023/A:1014741821292; Binkley D, 2003, FOREST ECOL MANAG, V172, P271, DOI 10.1016/S0378-1127(01)00794-0; Busing RT, 2005, PLANT ECOL, V177, P177, DOI 10.1007/s11258-005-2322-8; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clement Joel P., 2001, Selbyana, V22, P76; Clinton PW, 2002, CAN J FOREST RES, V32, P344, DOI 10.1139/X01-188; CONAF, 1985, 1 CONAF; CONAF, 2011, CAT REC VEG NAT CHIL; DGA, 2011, EST PREC MENS EST VE; Donoso C., 1990, Bosque, V11, P21; DONOSO C, 1993, J VEG SCI, V4, P303, DOI 10.2307/3235588; DONOSO C, 1993, REV CHIL HIST NAT, V66, P53; Donoso C., 2006, ESPECIES ARB REAS BO, P68; Donoso C, 1984, MEDIO AMBIENTE, V7, P9; Eggleston S., 2006, 2006 IPCC GUIDELINES, V5; Enright N., 1995, ECOLOGY SO CONIFERS, P271; Fenn K, 2015, ECOSYSTEMS, V18, P1, DOI 10.1007/s10021-014-9793-1; Ferrando J, 2001, REV FACULTAD AGRONOM, V103, P139; Fujimori T., 1976, Journal of the Japanese Forestry Society, V58, P360; Galbraith D, 2013, PLANT ECOL DIVERS, V6, P139, DOI 10.1080/17550874.2013.770578; GAYOSO A JORGE, 2005, Bosque (Valdivia), V26, P33; Gayoso J, 2002, D98I1076 FONDEF U AU; Gerding V, 2013, COMMUNICATION; GHOLZ HL, 1982, ECOLOGY, V63, P469, DOI 10.2307/1938964; Godoy R., 1989, Bosque, V10, P89; GODOY R, 1994, REV CHIL HIST NAT, V67, P209; Gower S. T., 1994, ECOL BULL, P115; Gower ST, 1997, J GEOPHYS RES-ATMOS, V102, P29029, DOI [10.1029/97JD02317, 10.1029/97JD01440]; GOWER ST, 1995, RESOURCE PHYSL CONIF, P217; Gutiurrez E., 1991, OECOLOGIA AQUATICA, V10, P351; Harmon ME, 2004, ECOSYSTEMS, V7, P498, DOI 10.1007/s10021-004-0140-9; Hessl A.E., 2004, ECOPHYSIOLOGICAL PAR; Huston MA, 2009, ECOL MONOGR, V79, P343, DOI 10.1890/08-0588.1; IUCN, 2013, IUCN RED LIST THREAT; Johnson CM, 1999, THESIS U PENNSYLVANI; Joshi AB, 2006, SOIL SCI SOC AM J, V70, P153, DOI 10.2136/sssaj2004.0173; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; LARA A, 1993, SCIENCE, V260, P1104, DOI 10.1126/science.260.5111.1104; Lara A, 1999, ECOSCIENCE, V6, P100, DOI 10.1080/11956860.1999.11952199; Lara A., 1991, THESIS U COLORADO BO; Lara A, 2002, ENZYKLOPADIE HOLZGEW, P1; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Lusk CH, 2000, J BIOGEOGR, V27, P1011, DOI 10.1046/j.1365-2699.2000.00449.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Malhi Y, 2014, PLANT ECOL DIVERS, V7, P85, DOI 10.1080/17550874.2013.820805; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Marthews T., 2012, MEASURING TROPICAL F; Pan Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200004; Peralta M., 1982, CIENCIAS FORESTALES, V2, P39; Perez CA, 2003, AUSTRAL ECOL, V28, P591, DOI 10.1046/j.1442-9993.2003.01315.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Prodan M., 1997, MENSURA FORESTAL; RUNYON J, 1994, ECOL APPL, V4, P226, DOI 10.2307/1941929; Schlegel BC, 2008, FOREST ECOL MANAG, V255, P1906, DOI 10.1016/j.foreco.2007.12.013; SCHULMAN E, 1954, SCIENCE, V119, P396, DOI 10.1126/science.119.3091.396; Silvester WB, 1999, NEW ZEAL J BOT, V37, P553, DOI 10.1080/0028825X.1999.9512653; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Teobaldelli M, 2009, FOREST ECOL MANAG, V257, P1004, DOI 10.1016/j.foreco.2008.11.002; Urrutia-Jalabert R, ECOSPHERE UNPUB; Van Tuyl S, 2005, FOREST ECOL MANAG, V209, P273, DOI 10.1016/j.foreco.2005.02.002; Vann DR, 2002, BIOGEOCHEMISTRY, V60, P25, DOI 10.1023/A:1016550027991; Vann DR, 1998, FOREST ECOL MANAG, V106, P55, DOI 10.1016/S0378-1127(97)00215-6; Vann DR, 2013, COMMUNICATION; VEBLEN T T, 1976, Environmental Conservation, V3, P291; Veblen T.T., 2005, ECOSYSTEMS WORLD CON, P701; VEBLEN TT, 1982, BIOL CONSERV, V23, P141, DOI 10.1016/0006-3207(82)90036-2; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; Waring RH, 1998, TREE PHYSIOL, V18, P129; WESTMAN WE, 1975, J ECOL, V63, P493, DOI 10.2307/2258732; Wolodarsky-Franke Alexia, 2005, Dendrochronologia, V22, P235, DOI 10.1016/j.dendro.2005.05.008	78	19	20	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137569	10.1371/journal.pone.0137569	http://dx.doi.org/10.1371/journal.pone.0137569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353111	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800097
J	Brito, MO; Lerebours, L; Volquez, C; Basora, E; Khosla, S; Lantigua, F; Flete, R; Rosario, R; Rodriguez, LA; Fernandez, M; Donastorg, Y; Bailey, RC				Brito, Maximo O.; Lerebours, Leonel; Volquez, Claudio; Basora, Emmanuel; Khosla, Shaveta; Lantigua, Flavia; Flete, Roberto; Rosario, Riqui; Rodriguez, Luis A.; Fernandez, Mathius; Donastorg, Yeycy; Bailey, Robert C.			A Clinical Trial to Introduce Voluntary Medical Male Circumcision for HIV Prevention in Areas of High Prevalence in the Dominican Republic	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADULT MALE CIRCUMCISION; PROSPECTIVE COHORT; KENYA; MEN; KISUMU; RISK; ACCEPTABILITY; PROVINCE; UGANDA	Background Voluntary Medical Male Circumcision (VMMC) is an effective strategy to reduce the risk of HIV infection. Studies conducted in the Dominican Republic (DR) suggest that acceptability of VMMC among men may be as high as 67%. The goal of this clinical trial was to assess the acceptability, uptake and safety for VMMC services in two areas of high HIV prevalence in the country. Methods This was a single-arm, non-randomized, pragmatic clinical trial. Study personnel received background information about the risks and benefits of VMMC and practical training on the surgical technique. A native speaking research assistant administered a questionnaire of demographics, sexual practices and knowledge about VMMC. One week after the surgery, participants returned for wound inspection and to answer questions about their post-surgical experience. Results 539 men consented for the study. Fifty seven were excluded from participation for medical or anatomical reasons and 28 decided not to have the procedure after providing consent. A total of 454 men were circumcised using the Forceps Guided Method Under Local Anesthesia. The rate of adverse events (AE) was 4.4% (20% moderate, 80% mild). There were no serious AEs and all complications resolved promptly with treatment. Eighty eight percent of clients reported being "very satisfied" and 12% were "somewhat satisfied" with the outcome at the one-week postoperative visit. Conclusions Recruitment and uptake were satisfactory. Client satisfaction with VMMC was high and the rate of AEs was low. Roll out of VMMC in targeted areas of the DR is feasible and should be considered.	[Brito, Maximo O.; Khosla, Shaveta; Bailey, Robert C.] Univ Illinois, Chicago, IL 60637 USA; [Lerebours, Leonel; Basora, Emmanuel; Rosario, Riqui] Clin Familia, La Romana, Dominican Rep; [Volquez, Claudio; Lantigua, Flavia; Flete, Roberto; Rodriguez, Luis A.; Fernandez, Mathius; Donastorg, Yeycy] Inst Dermatol & Cirugia Piel, HIV Vaccine Trials Unit, Santo Domingo, Dominican Rep	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Brito, MO (corresponding author), Univ Illinois, Chicago, IL 60637 USA.	mbrito@uic.edu	Brito, Maximo O./AAI-4905-2021	Brito, Maximo O./0000-0003-4463-514X	National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000050]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000050. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brito MO, 2010, AIDS CARE, V22, P1530, DOI 10.1080/09540121.2010.484455; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; CESDEM, 2014, ENC SOC VIH SIDA BAT; CESDEM, 2014, ENC DEM SAL REP DOM; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kiggundu V, 2009, BJU INT, V104, P529, DOI 10.1111/j.1464-410X.2009.08420.x; Krieger JN, 2005, BJU INT, V96, P1109, DOI 10.1111/j.1464-410X.2005.05810.x; Krieger JN, 2007, UROL INT, V78, P235, DOI 10.1159/000099344; Madhivanan P, 2011, SEX TRANSM DIS, V38, P571, DOI 10.1097/OLQ.0b013e318219c930; Mehta SD, 2010, J UROLOGY, V184, P203, DOI 10.1016/j.juro.2010.03.015; Seretse MD, 2013, MMWR-MORBID MORTAL W, V62, P953; UNAIDS, 2010, REP GLOB AIDS EP 201; Walcott MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075074; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; *WHO UNAIDS, NEW DAT MAL CIRC HIV; World Health Organization, 2009, MAN MAL CIRC LOC AN; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137376	10.1371/journal.pone.0137376	http://dx.doi.org/10.1371/journal.pone.0137376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367187	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100066
J	Galan-Cobo, A; Ramirez-Lorca, R; Serna, A; Echevarria, M				Galan-Cobo, Ana; Ramirez-Lorca, Reposo; Serna, Ana; Echevarria, Miriam			Overexpression of AQP3 Modifies the Cell Cycle and the Proliferation Rate of Mammalian Cells in Culture	PLOS ONE			English	Article							PLASMA-MEMBRANE; WATER CHANNELS; AQUAPORIN 5; EXPRESSION; APOPTOSIS; PROMOTES; HYPOXIA; GROWTH; ADAPTATION; ESOPHAGEAL	Abnormal AQP3 overexpression in tumor cells of different origins has been reported and a role for this enhanced AQP3 expression in cell proliferation and tumor processess has been indicated. To further understand the role AQP3 plays in cell proliferation we explore the effect that stable over expression of AQP3 produces over the proliferation rate and cell cycle of mammalian cells. The cell cycle was analyzed by flow cytometry with propidium iodide (PI) and the cell proliferation rate measured through cell counting and BrdU staining. Cells with overexpression of AQP3 (AQP3-o) showed higher proliferation rate and larger percentage of cells in phases S and G2/M, than wild type cells (wt). Evaluation of the cell response against arresting the cell cycle with Nocodazole showed that AQP3-o exhibited a less modified cell cycle pattern and lower Annexin V specific staining than wt, consistently with a higher resistance to apoptosis of AQP3-overexpressing cells. The cell volume and complexity were also larger in AQP3-o compared to wt cells. After transcriptomic analysis, RT-qPCR was performed to highlight key molecules implicated in cell proliferation which expression may be altered by overexpression of AQP3 and the comparative analysis between both type of cells showed significant changes in the expression of Zeb2, Jun, JunB, NF-k beta, Cxcl9, Cxcl10, TNF, and TNF receptors. We conclude that the role of AQP3 in cell proliferation seems to be connected to increments in the cell cycle turnover and changes in the expression levels of relevant genes for this process. Larger expression of AQP3 may confer to the cell a more tumor like phenotype and contributes to explain the presence of this protein in many different tumors.	[Galan-Cobo, Ana; Ramirez-Lorca, Reposo; Serna, Ana; Echevarria, Miriam] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS,Dept Fisiol Med & Biofis, Seville, Spain; [Echevarria, Miriam] Inst Salud Carlos III, CIBERES, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Echevarria, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS,Dept Fisiol Med & Biofis, Seville, Spain.	irusta@us.es	IBIS, TERAPIA CELULA/P-3297-2015; Reposo, Ramirez-Lorca/D-7907-2014; Echevarría, Miriam/E-6682-2010; Serna Gallego, Ana/M-3379-2014	Echevarría, Miriam/0000-0002-4758-9428; Ramirez Lorca, Reposo/0000-0002-1594-0404; Serna Gallego, Ana/0000-0002-7142-0315; Galan Cobo, Ana/0000-0002-0988-1823	Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa; Red de Terapia Celular; Instituto de Salud Carlos III [Exp. PI12/01882, Exp. PS09/00605]; La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa [P08-CTS-03574]; Consejeria de Salud [PI0018-2014, PI0298-2010]	Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa(Junta de Andalucia); Red de Terapia Celular; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa(Junta de Andalucia); Consejeria de Salud	The authors thank "Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa" for the postdoctoral contract that supported AGC and "Red de Terapia Celular" for the postdoctoral contract that supported RRL. This work was funded by grants from the "Instituto de Salud Carlos III" (Exp. PI12/01882 and Exp. PS09/00605), and by grants from "La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa" (P08-CTS-03574) and Consejeria de Salud (PI0018-2014) to RRL and (PI0298-2010) to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghouleh I, 2013, CARDIOVASC RES, V97, P134, DOI 10.1093/cvr/cvs295; Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Beswick RW, 2006, LEUKEMIA RES, V30, P427, DOI 10.1016/j.leukres.2005.08.009; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Di Giusto G, 2012, J CELL BIOCHEM, V113, P3721, DOI 10.1002/jcb.24246; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Flamenco P, 2009, BIOL CELL, V101, P237, DOI 10.1042/BC20080050; Galan-Cobo A, 2016, J CELL PHYSIOL, V231, P243, DOI 10.1002/jcp.25078; Galan-Cobo A, 2013, GENE, V522, P18, DOI 10.1016/j.gene.2013.03.075; Gao L, 2004, FEBS LETT, V569, P256, DOI 10.1016/j.febslet.2004.06.004; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Huang YM, 2010, CANCER BIOL THER, V9, P1000, DOI 10.4161/cbt.9.12.11705; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Ko SBH, 2002, AM J PHYSIOL-GASTR L, V282, pG324, DOI 10.1152/ajpgi.00198.2001; Kusayama M, 2011, CANCER SCI, V102, P1128, DOI 10.1111/j.1349-7006.2011.01927.x; Lee M, 2012, MOL ENDOCRINOL, V26, P1394, DOI 10.1210/me.2012-1055; Liu YL, 2007, HUM PATHOL, V38, P171, DOI 10.1016/j.humpath.2006.07.015; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Onori P, 2010, INT J CANCER, V127, P43, DOI 10.1002/ijc.25028; Papadopoulos MC, 2015, BBA-BIOMEMBRANES, V1848, P2576, DOI 10.1016/j.bbamem.2014.09.001; Pedersen SF, 2013, FRONT PHYSIOL, V4; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rivarola V, 2010, J CELL PHYSIOL, V224, P405, DOI 10.1002/jcp.22136; Serna A, 2014, J CELL PHYSIOL, V229, P1787, DOI 10.1002/jcp.24632; Shimizu H, 2014, J GASTROENTEROL, V49, P655, DOI 10.1007/s00535-013-0827-9; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137692	10.1371/journal.pone.0137692	http://dx.doi.org/10.1371/journal.pone.0137692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367709	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100111
J	Langos, D; Kulik, L; Ruiz-Lambides, A; Widdig, A				Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja			Does Male Care, Provided to Immature Individuals, Influence Immature Fitness in Rhesus Macaques?	PLOS ONE			English	Article							LIFETIME REPRODUCTIVE SUCCESS; MONKEYS MACACA-MULATTA; PATERNAL CARE; SOCIAL RELATIONSHIPS; BARBARY MACAQUES; DOMINANCE RANK; ADAPTIVE VALUE; ENERGY-INTAKE; BODY-FAT; PRIMATE	Among many mammals, maternal care strongly impacts infant survival; however, less is known about whether adult males also affect infant fitness. Paternal care is expected when providing care enhances offspring survival and reproduction, which likewise increases fathers' fitness. Males might also care for unrelated immature individuals to increase their mating probability with the immature individuals' mothers. Studies in multimale primate groups showed that sires enhance food access for offspring and provide protection in conflicts. Furthermore, fathers' presence during infancy has been suggested to accelerate offspring sexual maturation. However, no study has yet directly linked the degree of father-offspring bonds to offspring fitness in primates. We previously reported father-offspring affiliation in rhesus macaques, pronounced during early infancy and independent of mothers' presence. The present study aims at investigating whether affiliation with fathers or other males affects proxies of immature fitness (body mass gain, body fat and testis size). First, we combined behavioral, genetic and morphometric data from 55 subjects of one group. Second, using demographic and genetic data, we investigated for 92 individuals of the population whether mother-and father-offspring co-residence during immaturity influenced offspring lifetime reproductive success (LRS). Our results show that focal rank and higher amounts of affiliation with high-ranking males during infancy tend to positively impact body mass gain of female, but not male focal animals. In contrast, body mass gain of male focal individuals, but not females', appeared to be higher when affiliation of male immature individuals was evenly distributed across their adult male partners. Moreover, we found mothers', but not fathers', presence during immaturity to predict offspring LRS. Our results suggest that male-immature affiliation, but not father-offspring co-residence, potentially impacts proxies of immature fitness. However, future studies should investigate the underlying mechanisms of male-immature relationships and their impact on immature fitness in more detail.	[Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, D-04103 Leipzig, Germany; [Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja] Univ Leipzig, Inst Biol, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Ruiz-Lambides, Angelina] Univ Puerto Rico, Caribbean Primate Res Ctr, Punta Santiago, PR 00741 USA	Max Planck Society; Leipzig University; University of Puerto Rico; University of Puerto Rico Mayaguez	Widdig, A (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Deutsch Pl 6, D-04103 Leipzig, Germany.	anja.widdig@eva.mpg.de			German Research Foundation (DFG) [WI 1801/1-1, 1-2, 2-1, 3-1]; KKGS Stiftung; Elsa-Neumann Stiftung; DAAD; Research Academy of Leipzig; National Center for Research Resources (NCRR) [8 P40 OD012217-25]; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; Medical Sciences Campus of the University of Puerto Rico; University of Leipzig; KKGS; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); KKGS Stiftung; Elsa-Neumann Stiftung; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Research Academy of Leipzig; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Sciences Campus of the University of Puerto Rico; University of Leipzig; KKGS; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The following funding was awarded to AW: German Research Foundation (DFG) (grant numbers WI 1801/1-1, 1-2, 2-1, 3-1) (http://www.dfg.de/en/index.jsp). The following funding was awarded to DL: 1. KKGS Stiftung (http://www.kkgs-stiftung.de/index.html), 2. Elsa-Neumann Stiftung (http://www.hu-berlin.de/forschung/szf/wiss_nachwuchs/wn_nafoeg_html), 3. DAAD (https://www.daad.de/en/index.html), and 4. Research Academy of Leipzig (http://www.zv.unileipzig.de/en/research/ral/information-about-researchacademy-leipzig/funding-opportunities. html). The population of Cayo Santiago was supported by grant number 8 P40 OD012217-25 from the National Center for Research Resources (NCRR), the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health and the Medical Sciences Campus of the University of Puerto Rico. Additionally, funding was received through a PhD grant of the University of Leipzig (awarded to LK and DL), as well as from the KKGS, Elsa-Neumann Stiftung and the DAAD (awarded to DL). The authors thank the Max-Planck Institute for Evolutionary Anthropology, Leipzig, for hosting of the Jr. Research Group of Primate Kin Selection and for their logistic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1996, ANIM BEHAV, V51, P733, DOI 10.1006/anbe.1996.0077; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; ALBERTS SC, 1995, BEHAV ECOL SOCIOBIOL, V36, P397, DOI 10.1007/BF00177335; Alberts SC, 2012, BEHAV ECOL, V23, P699, DOI 10.1093/beheco/ars052; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J, 1980, BABOON MOTHERS AND I; Alvergne A, 2009, ANIM BEHAV, V78, P61, DOI 10.1016/j.anbehav.2009.03.019; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Asher GW, 2013, ANIM REPROD SCI, V143, P79, DOI 10.1016/j.anireprosci.2013.10.013; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bates D, 2011, R PACKAGE VERSION 0; Belachew T, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-125; Berard J, 1999, PRIMATES, V40, P159, DOI 10.1007/BF02557708; BERCOVITCH FB, 1993, BEHAV ECOL SOCIOBIOL, V33, P313; Bercovitch FB, 1998, AM J PRIMATOL, V46, P135, DOI 10.1002/(SICI)1098-2345(1998)46:2<135::AID-AJP3>3.3.CO;2-A; BERCOVITCH FB, 1993, AM J PRIMATOL, V30, P163, DOI 10.1002/ajp.1350300208; Bercovitch FB, 2003, NATURWISSENSCHAFTEN, V90, P309, DOI 10.1007/s00114-003-0436-1; BERCOVITCH FB, 1990, MG PRIMATOL, V13, P59; BERCOVITCH FB, 1992, PATERNITY IN PRIMATES : GENETIC TESTS AND THEORIES, P225; Bercovitch FB, 1997, PRIMATES, V38, P247, DOI 10.1007/BF02381613; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Blomquist GE, 2013, AM J PRIMATOL, V75, P238, DOI 10.1002/ajp.22117; Blumstein DT, 2001, ETHOLOGY, V107, P655, DOI 10.1046/j.1439-0310.2001.00699.x; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966; Cawthon Lang KA, 2005, PRIMATE FACTSHEETS R; Chapais Bernard, 1992, P29; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Colvin J, 1983, PRIMATE SOCIAL RELAT, P190; Crean AJ, 2014, TRENDS ECOL EVOL, V29, P554, DOI 10.1016/j.tree.2014.07.009; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; Diaz-Munoz SL, 2011, ANIM BEHAV, V82, P563, DOI 10.1016/j.anbehav.2011.06.013; Dixson AF, 1997, HORM BEHAV, V31, P126, DOI 10.1006/hbeh.1997.1374; Dobson AJ, 2002, AN INTRODUCTION TO G; DRICKAMER LC, 1974, FOLIA PRIMATOL, V21, P61, DOI 10.1159/000155596; Dubuc C, 2014, BEHAV ECOL, V25, P878, DOI 10.1093/beheco/aru052; Dubuc C, 2012, HORM BEHAV, V61, P696, DOI 10.1016/j.yhbeh.2012.03.003; Elo AE, 1978, THE RATING OF CHESS; FEDIGAN LM, 1986, FOLIA PRIMATOL, V47, P143, DOI 10.1159/000156271; Fernandez-Duque E, 2009, ANNU REV ANTHROPOL, V38, P115, DOI 10.1146/annurev-anthro-091908-164334; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; Foster EA, 2012, SCIENCE, V337, P1313, DOI 10.1126/science.1224198; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gende SM, 2004, CAN J ZOOL, V82, P75, DOI 10.1139/Z03-226; Goodall J, 1986, THE CHIMPANZEES OF G; Gouzoules S., 1987, P299; GRAFEN A, 1980, ANIM BEHAV, V28, P967, DOI 10.1016/S0003-3472(80)80160-6; Griffin AS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001520; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hastie TJ, 1991, STATISTICAL MODELS I; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; HILL DA, 1986, PRIMATES, V27, P425, DOI 10.1007/BF02381888; Hinde RA, 1983, PRIMATE SOCIAL RELAT, P160; HOOGLAND JL, 1982, BEHAV ECOL SOCIOBIOL, V11, P155, DOI 10.1007/BF00300058; Hrdy SB, 1999, MOTHER NATURE A HIST; Hrdy SB, 1981, THE WOMAN THAT NEVER; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Jolly CJ, 2003, INT J PRIMATOL, V24, P125, DOI 10.1023/A:1021402730111; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kaar P, 1996, P ROY SOC B-BIOL SCI, V263, P1475, DOI 10.1098/rspb.1996.0215; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KEDDYHECTOR AC, 1992, AM ZOOL, V32, P62; Kessler MJ, 2015, AM J PRIMATOL, V77, P211, DOI 10.1002/ajp.22323; Kessler MJ, 1986, THE CAYO SANTIAGO MA; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Kleiman D.G., 1981, P347; Kulik L, 2015, INT J PRIMATOL, V36, P353, DOI 10.1007/s10764-015-9826-4; Kulik L, 2012, MOL ECOL, V21, P699, DOI 10.1111/j.1365-294X.2011.05250.x; Langos D, 2013, MOL ECOL, V22, P3638, DOI 10.1111/mec.12328; Le Boeuf BJ, 1990, REPROD SUCCESS, P344; LINDBURG DG, 1969, SCIENCE, V166, P1176, DOI 10.1126/science.166.3909.1176; Lindburg DG, 1971, PRIMATE BEHAVIOR DEV, P1, DOI Academic Press; Lukas D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0418; MAESTRIPIERI D, 1994, PRIMATES, V35, P443, DOI 10.1007/BF02381953; Maestripieri Dario, 2009, P256; Manly BFJ, 1997, RANDOMIZATION BOOTST; MANSON JH, 1992, ANIM BEHAV, V44, P405, DOI 10.1016/0003-3472(92)90051-A; Marriott B.M., 1988, Bulletin de la Societe Herpetologique de France, V11, P125; Marriott B.M., 1989, Puerto Rico Health Sciences Journal, V8, P87; Mateo JM, 2009, MATERNAL EFFECTS IN; MATSUBAYASHI K, 1983, Primates, V24, P521, DOI 10.1007/BF02381685; Meelis E, 1994, STAT ANAL; Menard N, 2001, CR ACAD SCI III-VIE, V324, P601, DOI 10.1016/S0764-4469(01)01339-7; Mitani JC, 2012, THE EVOLUTION OF PRI; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Moscovice LR, 2009, BEHAV ECOL SOCIOBIOL, V63, P1471, DOI 10.1007/s00265-009-0781-y; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Onyango PO, 2013, HORM BEHAV, V63, P430, DOI 10.1016/j.yhbeh.2012.11.014; Ostner J, 2013, ANIM BEHAV, V86, P623, DOI 10.1016/j.anbehav.2013.07.004; Packer C, 1990, REPROD SUCCESS, P363; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Palombit Ryne, 2009, P377; Palombit Ryne A., 2000, P239, DOI 10.1017/CBO9780511542312.013; Palombit Ryne A., 2000, P123, DOI 10.1017/CBO9780511542312.008; Pan Y, 2008, EPIDEMIOL INFECT, V136, P421, DOI 10.1017/S095026880700831X; Paul A, 1996, ANIM BEHAV, V51, P155, DOI 10.1006/anbe.1996.0013; Paul A, 1999, PRIMATES, V40, P33, DOI 10.1007/BF02557700; Pereira M.E., 1985, Monographs in Primatology, P217; PEREIRA ME, 1995, AM J PRIMATOL, V37, P143, DOI 10.1002/ajp.1350370207; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Potter DM, 2006, J BIOPHARM STAT, V16, P327, DOI 10.1080/10543400600609585; Price TA, 2012, CURR BIOL, V22, pR135, DOI 10.1016/j.cub.2012.01.020; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Quinn GP, 2002, EXPERIMENTAL DESIGN; Reinhold K, 2002, J HERED, V93, P400, DOI 10.1093/jhered/93.6.400; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; Rogerson PA, 2001, STAT METHODS; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schwartz S.M., 1989, Puerto Rico Health Sciences Journal, V8, P103; Setchell JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P474, DOI 10.1007/s00265-005-0946-2; Sheppard P, 2012, BIOL LETTERS, V8, P237, DOI 10.1098/rsbl.2011.0747; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2014, EVOL ANTHROPOL, V23, P83, DOI 10.1002/evan.21402; Smuts BB, 1992, FATHER CHILD RELATIO; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Stearns SC, 1992, THE EVOLUTION OF LIF; Stoehr Andrew M., 1999, Animal Behaviour Forum, V57, pF22, DOI 10.1006/anbe.1998.1016; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Swedell L., 2011, PRIMATES PERSPECTIVE, V2, P241; Swedell L, DOMINANCE IN BABOONS; Trivers R., 1972, SEXUAL SELECTION DES, P139; TRIVERS RL, 1974, AM ZOOL, V14, P249; TURNQUIST JE, 1989, AM J PRIMATOL, V19, P1, DOI 10.1002/ajp.1350190102; van Schaik Carel, 1996, Evolutionary Anthropology, V5, P152, DOI 10.1002/(SICI)1520-6505(1996)5:5<152::AID-EVAN3>3.3.CO;2-9; Vancata V, 2000, VAR EVO, V8, P83; Vessey SH, 1973, PRIMATES, V14, P359, DOI [10.1007/BF01731357, DOI 10.1007/BF01731357]; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; WALKER ML, 1984, AM J PHYS ANTHROPOL, V63, P323, DOI 10.1002/ajpa.1330630309; WESTNEAT DF, 1993, BEHAV ECOL, V4, P66, DOI 10.1093/beheco/4.1.66; Whitten P.L., 1987, P343; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2015, AM J PRIMATOL, DOI DOI 10.1002/AJP.22401/ABSTRACT; WILSON ME, 1983, AM J PHYS ANTHROPOL, V61, P103, DOI 10.1002/ajpa.1330610111; Wittig RM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0118695, DOI 10.1371/J0URNAL.P0NE.0118695]; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; WRIGHT PC, 1990, INT J PRIMATOL, V11, P89, DOI 10.1007/BF02192783; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zehr JL, 2005, BIOL REPROD, V72, P1087, DOI 10.1095/biolreprod.104.027755	155	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137841	10.1371/journal.pone.0137841	http://dx.doi.org/10.1371/journal.pone.0137841			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367536	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100153
J	Li, TY; Chen, Y; Li, J; Yang, XB; Zhang, HY; Qin, X; Hu, YL; Mo, ZN				Li, Tianyu; Chen, Yang; Li, Jie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Hu, Yanling; Mo, Zengnan			Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; RHEUMATOID-ARTHRITIS; ENDOTHELIAL FUNCTION; C4; C3; ATHEROSCLEROSIS; INFLAMMATION; IMMUNOLOGY; EXPRESSION; BIOMARKERS	Recent studies suggest that serum homocysteine (HCY) level is correlated to inflammatory/immune factors that influence the development and progression of many diseases, such as cardiovascular disease. However, the association between serum HCY level and inflammatory/immune factors in healthy populations has not been systematically investigated. This study was conducted based on the Fangchenggang Area Male Health and Examination Survey (FAMHES) project. After comprehensive baseline analysis, we could not find any significant association between HCY level and inflammatory/immune factors. However, in the next linear regression analysis, serum C4 [age-adjusted: Beta = -0.053, 95% CI = (-3.798, -0.050), P = 0.044; multivariate adjusted: Beta = -0.064, 95% CI = (-4.271, -0.378), P = 0.019] and C-reactive protein (CRP) concentration [unadjusted: Beta = 0.056, 95% CI = (0.037, 0.740), P = 0.030] were positively related with HCY. In further binary regression analysis, a significant correlation was confirmed for C4 and HCY [age-adjusted: OR = 0.572, 95% CI = (0.359, 0.911); multivariate adjusted: OR = 0.558, 95% CI = (0.344, 0.905)]. In order to discover more potential associations, multivariate logistic regression analysis was applied and suggested that HCY and C4 were significantly correlated [age-adjusted: OR = 0.703, 95% CI = (0.519, 0.951); multivariate adjusted: OR = 0.696, 95% CI = (0.509, 0.951)]. In addition, immunoglobulin M (IgM) may influence the HCY level to some extent [unadjusted: OR = 1.427, 95% CI = (1.052, 1.936); age-adjusted: OR = 1.446, 95% CI = (1.061, 1.970); multivariate adjusted: OR = 1.447, 95% CI = (1.062, 1.973)]. Combining our results with recent studies, we propose that C4, CRP, and IgM in serum are significantly associated with HCY concentration. Further studies are needed on the mechanism of the interaction, especially among cardiovascular disease subjects.	[Li, Tianyu; Chen, Yang; Li, Jie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Hu, Yanling; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi Zhuang, Peoples R China; [Li, Tianyu; Chen, Yang; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Li, Tianyu; Chen, Yang; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Hu, Yanling; Mo, Zengnan] Guangxi Collaborat Innovat Ctr Genom & Personaliz, Guangxi Key Lab Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Li, Jie] Guangxi Med Univ, Affiliated Hosp 1, Res Ctr Guangxi Reprod Med, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Hu, YL (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	ylhupost@163.com; zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016	mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [81472414, 81272853, 81370857]; National Key Basic Research Program of China [2012CB518303]; Key Program and University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Chairman Science and Technology Fund; Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Natural Science Foundation [2012GXNSFDA053016, 2012GXNSFAA053152]; Guangxi Graduate Education Innovation Program [2010105981002M175, 2011105981002M202]; Guangxi Medical University Future Scholar Training Program [02304001012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Key Program and University Talents Highland Innovation Team of Guangxi; Chairman Science and Technology Fund; Tackle Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Graduate Education Innovation Program; Guangxi Medical University Future Scholar Training Program	This study was supported by grants from the National Natural Science Foundation of China (81472414, 81272853, 81370857), National Key Basic Research Program of China(2012CB518303), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Natural Science Foundation (2012GXNSFDA053016), Guangxi Graduate Education Innovation Program (2010105981002M175 and 2011105981002M202), Guangxi Natural Science Foundation (2012GXNSFAA053152), and Guangxi Medical University Future Scholar Training Program (02304001012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakulski KM, 2014, ENVIRON HEALTH PERSP, V122, P1066, DOI 10.1289/ehp.1306931; Chang L, 2007, BIOCHEM BIOPH RES CO, V357, P772, DOI 10.1016/j.bbrc.2007.04.016; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111269; Chen Y, 2012, IMMUNOGENETICS, V64, P747, DOI 10.1007/s00251-012-0636-y; Das M, 2010, INDIAN J CLIN BIOCHE, V25, P295, DOI 10.1007/s12291-010-0044-8; Dawson H, 2004, MECH AGEING DEV, V125, P107, DOI 10.1016/j.mad.2003.11.013; FALK E, 1989, AM J CARDIOL, V63, pE114, DOI 10.1016/0002-9149(89)90242-7; Foucher C, 2010, CURR VASC PHARMACOL, V8, P589, DOI 10.2174/157016110792006987; Giasuddin A S M, 2007, Bangladesh Med Res Counc Bull, V33, P98; Guo HY, 2009, INDIAN J MED RES, V129, P279; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; Holven KB, 2006, SCAND J CLIN LAB INV, V66, P45, DOI 10.1080/00335510500429821; Holven KB, 2003, EUR J CLIN INVEST, V33, P555, DOI 10.1046/j.1365-2362.2003.01189.x; Kerekes G, 2008, J RHEUMATOL, V35, P398; KERR SJ, 1972, J BIOL CHEM, V247, P4248; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Li WH, 2013, EXP THER MED, V6, P1271, DOI 10.3892/etm.2013.1304; Liu CC, 2005, ARTHRITIS RHEUM-US, V52, P3087, DOI 10.1002/art.21305; Mansoor MA, 2004, CLIN BIOCHEM, V37, P408, DOI 10.1016/j.clinbiochem.2004.01.003; McCully KS, 2007, AM J CLIN NUTR, V86, p1563S, DOI 10.1093/ajcn/86.5.1563S; Mosca T, 2011, J PEDIAT-BRAZIL, V87, P512, DOI [10.2223/JPED.2135, 10.1590/S0021-75572011000600009]; MUSCARI A, 1988, ATHEROSCLEROSIS, V74, P179, DOI 10.1016/0021-9150(88)90204-3; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Owczarek Danuta, 2014, Przegl Lek, V71, P189; Pastore A, 2014, J NEPHROL; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schroecksnadel K, 2010, THROMB HAEMOSTASIS, V103, P926, DOI 10.1160/TH09-07-0422; SEIFERT PS, 1989, ARTERIOSCLEROSIS, V9, P802, DOI 10.1161/01.ATV.9.6.802; Shenoy V, 2014, INDIAN J CLIN BIOCHE, V29, P339, DOI 10.1007/s12291-013-0373-5; Shields KJ, 2011, CTS-CLIN TRANSL SCI, V4, P146, DOI 10.1111/j.1752-8062.2011.00304.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang CY, 2014, EUR J INTERN MED, V25, P538, DOI 10.1016/j.ejim.2014.04.011; XU QB, 1990, CLIN IMMUNOL IMMUNOP, V56, P344, DOI 10.1016/0090-1229(90)90155-J; Yang XB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002916; Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atherosclerosis.2004.04.027; Zhang Q, 2001, CARDIOVASC RES, V52, P328, DOI 10.1016/S0008-6363(01)00376-5	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138099	10.1371/journal.pone.0138099	http://dx.doi.org/10.1371/journal.pone.0138099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367537	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100223
J	Macedo, AA; Silva, APC; Mol, JPS; Costa, LF; Garcia, LNN; Araujo, MS; Martins, OA; Paixao, TA; Santos, RL				Macedo, Auricelio A.; Silva, Ana P. C.; Mol, Juliana P. S.; Costa, Luciana F.; Garcia, Luize N. N.; Araujo, Marcio S.; Martins Filho, Olindo A.; Paixao, Tatiane A.; Santos, Renato L.			The abcEDCBA-Encoded ABC Transporter and the virB Operon-Encoded Type IV Secretion System of Brucella ovis Are Critical for Intracellular Trafficking and Survival in Ovine Monocyte-Derived Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; MURINE MACROPHAGES; ABORTUS; AGROBACTERIUM; REPLICATION; INFECTION; HOMOLOG	Brucella ovis infection is associated with epididymitis, orchitis and infertility in rams. Most of the information available on B. ovis and host cell interaction has been generated using murine macrophages or epithelial cell lines, but the interaction between B. ovis and primary ovine macrophages has not been studied. The aim of this study was to evaluate the role of the B. ovis abcEDCBA-encoded ABC transporter and the virB operon-encoded Type IV Secretion System (T4SS) during intracellular survival of B. ovis in ovine peripheral blood monocyte-derived macrophages. Delta abcBA and Delta virB2 mutant strains were unable to survive in the intracellular environment when compared to the WT B. ovis at 48 hours post infection (hpi). In addition, these mutant strains cannot exclude the lysosomal marker LAMP1 from its vacuolar membrane, and their vacuoles do not acquire the endoplasmic reticulum marker calreticulin, which takes place in the WT B. ovis containing vacuole. Higher levels of nitric oxide production were observed in macrophages infected with WT B. ovis at 48 hpi when compared to macrophages infected with the Delta abcBA or Delta virB2 mutant strains. Conversely, higher levels of reactive oxygen species were detected in macrophages infected with the Delta abcBA or Delta virB2 mutant strains at 48 hpi when compared to macrophages infected with the WT strain. Our results demonstrate that B. ovis is able to persist and multiply in ovine macrophages, while Delta abcBA and Delta virB2 mutations prevent intracellular multiplication, favor phagolysosome fusion, and impair maturation of the B. ovis vacuole towards an endoplasmic reticulum-derived compartment.	[Macedo, Auricelio A.; Silva, Ana P. C.; Mol, Juliana P. S.; Garcia, Luize N. N.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Costa, Luciana F.; Paixao, Tatiane A.] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Araujo, Marcio S.; Martins Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	Araujo, Marcio Sobreira Silva/ABE-7105-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; de Lima Santos, Renato/A-1134-2008	Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Lima Santos, Renato/0000-0002-4830-0470; Mol, Juliana/0000-0002-6946-8213	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil). AAM, OAMF, and RLS have fellowships from CNPq (Brazil).	ADAMS LB, 1991, J IMMUNOL, V147, P1642; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blasco J. M., 1990, Animal brucellosis., P351; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; BURGESS GW, 1982, VET MICROBIOL, V7, P551, DOI 10.1016/0378-1135(82)90049-9; CARPENTER TE, 1987, J AM VET MED ASSOC, V190, P977; Carvalho CA, 2012, SMALL RUMINANT RES, V102, P213, DOI 10.1016/j.smallrumres.2011.08.004; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Celli J, 2015, CELL MICROBIOL, V17, P951, DOI 10.1111/cmi.12452; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gross A, 1998, INFECT IMMUN, V66, P1309, DOI 10.1128/IAI.66.4.1309-1316.1998; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Kikuchi H, 2006, FEMS MICROBIOL LETT, V259, P120, DOI 10.1111/j.1574-6968.2006.00253.x; Lewis AM, 2015, MOL MICROBIOL, V96, P651, DOI 10.1111/mmi.12962; LIEW FY, 1990, J IMMUNOL, V144, P4794; Macedo AA, 2013, VET IMMUNOL IMMUNOP, V151, P294, DOI 10.1016/j.vetimm.2012.12.001; MAUEL J, 1991, J LEUKOCYTE BIOL, V49, P73, DOI 10.1002/jlb.49.1.73; Mol JPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108606; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rocco NM, 2011, INFECT IMMUN, V79, P2385, DOI 10.1128/IAI.01249-10; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; SORENSEN AL, 1994, APMIS, V102, P265, DOI 10.1111/j.1699-0463.1994.tb04874.x; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; STEINER M, 1994, HISTOCHEM J, V26, P934; SUMMERSGILL JT, 1992, J LEUKOCYTE BIOL, V52, P625, DOI 10.1002/jlb.52.6.625; Sun YH, 2002, INFECT IMMUN, V70, P4826, DOI 10.1128/IAI.70.9.4826-4832.2002; Thoen C. O., 1993, P236; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Wang M, 2001, MICROB PATHOGENESIS, V31, P221, DOI 10.1006/mpat.2001.0463; Xavier MN, 2010, VET MICROBIOL, V145, P158, DOI 10.1016/j.vetmic.2010.02.037; Xavier MN, 2009, CIENC RURAL, V39, P2252, DOI 10.1590/S0103-84782009005000167	51	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138131	10.1371/journal.pone.0138131	http://dx.doi.org/10.1371/journal.pone.0138131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366863	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100232
J	Schultz, ST; Kruschel, C; Bakran-Petricioli, T; Petricioli, D				Schultz, Stewart T.; Kruschel, Claudia; Bakran-Petricioli, Tatjana; Petricioli, Donat			Error, Power, and Blind Sentinels: The Statistics of Seagrass Monitoring	PLOS ONE			English	Article							POSIDONIA-OCEANICA MEADOWS; BENTHIC HABITATS; UNDERWATER VIDEOGRAPHY; MANAGEMENT; VIDEO; COVER; TOOL; SEA; BAY; BIODIVERSITY	We derive statistical properties of standard methods for monitoring of habitat cover worldwide, and criticize them in the context of mandated seagrass monitoring programs, as exemplified by Posidonia oceanica in the Mediterranean Sea. We report the novel result that cartographic methods with non-trivial classification errors are generally incapable of reliably detecting habitat cover losses less than about 30 to 50%, and the field labor required to increase their precision can be orders of magnitude higher than that required to estimate habitat loss directly in a field campaign. We derive a universal utility threshold of classification error in habitat maps that represents the minimum habitat map accuracy above which direct methods are superior. Widespread government reliance on blind-sentinel methods for monitoring seafloor can obscure the gradual and currently ongoing losses of benthic resources until the time has long passed for meaningful management intervention. We find two classes of methods with very high statistical power for detecting small habitat cover losses: 1) fixed-plot direct methods, which are over 100 times as efficient as direct random-plot methods in a variable habitat mosaic; and 2) remote methods with very low classification error such as geospatial underwater videography, which is an emerging, lowcost, non-destructive method for documenting small changes at millimeter visual resolution. General adoption of these methods and their further development will require a fundamental cultural change in conservation and management bodies towards the recognition and promotion of requirements of minimal statistical power and precision in the development of international goals for monitoring these valuable resources and the ecological services they provide.	[Schultz, Stewart T.; Kruschel, Claudia] Univ Zadar, Dept Ecol Agr & Aquaculture, Zadar 23000, Croatia; [Bakran-Petricioli, Tatjana] Univ Zagreb, Dept Biol, Fac Sci, Zagreb 10000, Croatia; [Petricioli, Donat] DIIV Ltd, Sali 23281, Croatia	University of Zadar; University of Zagreb	Schultz, ST (corresponding author), Univ Zadar, Dept Ecol Agr & Aquaculture, Zadar 23000, Croatia.	sschultz@unizd.hr	Kruschel, Claudia/AAX-1772-2020; Bakran-Petricioli, Tatjana/AAU-3594-2020	Bakran-Petricioli, Tatjana/0000-0002-3368-4248	Croatian Science Foundation; COREBIO; European Commission grant COCONET	Croatian Science Foundation; COREBIO; European Commission grant COCONET	This work was funded by the Croatian Science Foundation, grant COREBIO (SS), and the European Commission grant COCONET (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coauthor DP donated his expertise for this project, and is director of the commercial firm D.I.I.V., which had no role in the funding of this project.	[Anonymous], 2000, BIOL MAR MEDITERR; Ardizzone G, 2006, MAR ECOL-EVOL PERSP, V27, P299, DOI 10.1111/j.1439-0485.2006.00128.x; Baggett LP, 2014, OYSTER REEF HABITAT; Bakran-Petricioli T, 2006, ECOL MODEL, V191, P96, DOI 10.1016/j.ecolmodel.2005.08.014; Ball David, 2007, Parks Victoria Technical Series, V37, pi; Bonacorsi M, 2013, MEDITERR MAR SCI, V14, P193, DOI 10.12681/mms.334; Borfecchia F, 2013, INT J REMOTE SENS, V34, P4680, DOI 10.1080/01431161.2013.781701; Borg JA, 2009, MEDITERR MAR SCI, V10, P45, DOI 10.12681/mms.108; Borg JA, 2006, MAR ECOL-EVOL PERSP, V27, P320, DOI 10.1111/j.1439-0485.2006.00085.x; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Calvo S, 2003, INT J REMOTE SENS, V24, P2703, DOI 10.1080/0143116031000066882; Coles RG, 2001, GLOBAL SEAGRASS RESE; De Falco G, 2000, GEO-MAR LETT, V20, P50, DOI 10.1007/s003670000030; De Falco G, 2010, CONT SHELF RES, V30, P1941, DOI 10.1016/j.csr.2010.09.006; Dekker AG, 2005, REMOTE SENS ENVIRON, V97, P415, DOI 10.1016/j.rse.2005.02.017; Di Maida G, 2011, ICES J MAR SCI, V68, P12, DOI 10.1093/icesjms/fsq130; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Durell SEALD, 2005, BIOL CONSERV, V121, P289, DOI 10.1016/j.biocon.2004.05.005; Ehrhold A, 2006, ICES J MAR SCI, V63, P1604, DOI 10.1016/j.icesjms.2006.06.010; FAIRWEATHER PG, 1991, AUST J MAR FRESH RES, V42, P555, DOI 10.1071/MF9910555; Ferguson RL, 1997, AQUAT BOT, V58, P241, DOI 10.1016/S0304-3770(97)00038-7; Field SA, 2004, ECOL LETT, V7, P669, DOI 10.1111/j.1461-0248.2004.00625.x; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Fonseca M.S., 1998, GUIDELINES CONSERVAT; Foody GM, 2010, REMOTE SENS ENVIRON, V114, P2271, DOI 10.1016/j.rse.2010.05.003; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fox DR, 2001, ENVIRONMETRICS, V12, P437, DOI 10.1002/env.470; Gaeckle J., 2011, PUGET SOUND SUBMERGE; Gardner T., 2010, MONITORING FOREST BI; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Gerrodette T, 2002, B MAR SCI, V70, P657; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; Gladstone W, 2014, ESTUAR COAST SHELF S, V136, P53, DOI 10.1016/j.ecss.2013.10.023; GREEN RH, 1993, AUST J ECOL, V18, P81, DOI 10.1111/j.1442-9993.1993.tb00436.x; Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1; Guala I., 2014, MONITORING PROTOCOL; Guala I, 2012, MONITORING POSIDONIA; Guala I, 2014, MONITORING ACTIVITES; Holmer M, 2003, MAR POLLUT BULL, V46, P1372, DOI 10.1016/S0025-326X(03)00396-5; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Irving AD, 2013, MAR POLLUT BULL, V66, P176, DOI 10.1016/j.marpolbul.2012.10.017; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kendall MS, 2005, J COASTAL RES, V21, P1154, DOI 10.2112/03-0101R.1; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; Kiparissis S, 2011, BIOL INVASIONS, V13, P669, DOI 10.1007/s10530-010-9858-9; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Leriche A, 2004, ESTUAR COAST SHELF S, V59, P353, DOI 10.1016/j.ecss.2003.09.007; Lindenmayer D.B., 2003, FOREST SUSTAINABILIT; Lindenmayer D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P193; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lirman D, 2008, J COASTAL RES, V24, P135, DOI 10.2112/04-0428.1; Royo CLY, 2010, ENVIRON MONIT ASSESS, V171, P365, DOI 10.1007/s10661-009-1284-z; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V133, P203, DOI 10.3354/meps133203; Marba N, 2014, BIOL CONSERV, V176, P183, DOI 10.1016/j.biocon.2014.05.024; Marba N, 2013, HYDROBIOLOGIA, V704, P265, DOI 10.1007/s10750-012-1403-7; March D, 2013, AQUAT BOT, V106, P14, DOI 10.1016/j.aquabot.2012.12.005; Matta E, 2014, INT GEOSCI REMOTE SE, P5152, DOI 10.1109/IGARSS.2014.6947658; McDonald JI, 2006, J ENVIRON MANAGE, V80, P148, DOI 10.1016/j.jenvman.2005.08.021; McKenzie LJ, SEAGRASS WATCH MANUL; McKenzie LJ, 2010, REEF RESCUE MARINE M; McKenzie LJ, 2014, DEV WET TOPICS WQIP; Meehan AJ, 2005, ESTUARIES, V28, P462, DOI 10.1007/BF02693927; Montefalcone M, 2013, AQUAT BOT, V104, P204, DOI 10.1016/j.aquabot.2011.05.009; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Norris JG, 1997, AQUAT BOT, V58, P269, DOI 10.1016/S0304-3770(97)00040-5; Ooi JLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086782; Pergent G., 1995, M SOG E MARSEILLE, V54, P3; Pergent-Martini C, 2005, ECOL INDIC, V5, P213, DOI 10.1016/j.ecolind.2005.02.004; Pierre D, 2011, MAR POLLUT BULL, V62, P284, DOI 10.1016/j.marpolbul.2010.10.012; Puhr K, 2014, SCI TOTAL ENVIRON, V470, P364, DOI 10.1016/j.scitotenv.2013.09.103; R Core Team, 2021, R LANGUAGE ENV STAT; Sabol BM, 2002, ESTUARIES, V25, P133, DOI 10.1007/BF02696057; Sanchez-Carnero N, 2012, ESTUAR COAST SHELF S, V115, P334, DOI 10.1016/j.ecss.2012.09.015; Sandulli R., 1998, Oebalia, P3; Santos RO, 2012, CAN J FISH AQUAT SCI, V69, P1380, DOI [10.1139/f2012-018, 10.1139/F2012-018]; Schultz ST, 2008, AQUAT BOT, V88, P228, DOI 10.1016/j.aquabot.2007.10.009; Schultz ST, 2011, AQUAT BOT, V95, P117, DOI 10.1016/j.aquabot.2011.04.004; SFWMD, 2007, ENV MON REP GUID; Short FT, 2014, MAR POLLUT BULL, V83, P408, DOI 10.1016/j.marpolbul.2014.03.036; Somaschini A, 1998, SCI MAR, V62, P27; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Stuart A, 1998, KENDALLS ADV THEORY, V1; USACE, 2015, 2013 REG COMP MIT MO; Vandermeulen H, 2014, HELGOLAND MAR RES, V68, P559, DOI 10.1007/s10152-014-0412-5; Vassallo P, 2013, MAR POLLUT BULL, V75, P157, DOI 10.1016/j.marpolbul.2013.07.044; Vlachopoulou EI, 2013, OCEAN COAST MANAGE, V76, P105, DOI 10.1016/j.ocecoaman.2013.02.008; Vos P, 2000, ENVIRON MONIT ASSESS, V61, P317, DOI 10.1023/A:1006139412372; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Zampoukas N, 2012, MONITORING MARINE ST; Zampoukas N, 2011, REV METHODOLOGICAL S; Zapata-Ramirez PA, 2013, ADV OCEANOGR LIMNOL, V4, P102, DOI DOI 10.1080/19475721.2013.849758; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zawada DG, 2008, REV BIOL TROP, V56, P51	99	5	5	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138378	10.1371/journal.pone.0138378	http://dx.doi.org/10.1371/journal.pone.0138378			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367863	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100252
J	Sigdel, TK; Bestard, O; Tran, TQ; Hsieh, SC; Roedder, S; Damm, I; Vincenti, F; Sarwal, MM				Sigdel, Tara K.; Bestard, Oriol; Tran, Tim Q.; Hsieh, Szu-Chuan; Roedder, Silke; Damm, Izabella; Vincenti, Flavio; Sarwal, Minnie M.			A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts	PLOS ONE			English	Article							TRANSPLANT REJECTION; MESSENGER-RNA; NONINVASIVE DETECTION; IFN-GAMMA; IDENTIFICATION; BIOMARKERS; RECIPIENTS; PROTEOMICS; URINE; NEPHROPATHY	Background Whole genome microarray meta-analyses of 1030 kidney, heart, lung and liver allograft biopsies identified a common immune response module (CRM) of 11 genes that define acute rejection (AR) across different engrafted tissues. We evaluated if the CRM genes can provide a molecular microscope to quantify graft injury in acute rejection (AR) and predict risk of progressive interstitial fibrosis and tubular atrophy (IFTA) in histologically normal kidney biopsies. Methods Computational modeling was done on tissue qPCR based gene expression measurements for the 11 CRM genes in 146 independent renal allografts from 122 unique patients with AR (n = 54) and no-AR (n = 92). 24 demographically matched patients with no-AR had 6 and 24 month paired protocol biopsies; all had histologically normal 6 month biopsies, and 12 had evidence of progressive IFTA (pIFTA) on their 24 month biopsies. Results were correlated with demographic, clinical and pathology variables. Results The 11 gene qPCR based tissue CRM score (tCRM) was significantly increased in AR (5.68 +/- 0.91) when compared to STA (1.29 +/- 0.28; p < 0.001) and pIFTA (7.94 +/- 2.278 versus 2.28 +/- 0.66; p = 0.04), with greatest significance for CXCL9 and CXCL10 in AR (p < 0.001) and CD6 (p < 0.01), CXCL9 (p < 0.05), and LCK (p < 0.01) in pIFTA. tCRM was a significant independent correlate of biopsy confirmed AR (p < 0.001; AUC of 0.900; 95% CI = 0.705-903). Gene expression modeling of 6 month biopsies across 7/11 genes (CD6, INPP5D, ISG20, NKG7, PSMB9, RUNX3, and TAP1) significantly (p = 0.037) predicted the development of pIFTA at 24 months. Conclusions Genome-wide tissue gene expression data mining has supported the development of a tCRM-qPCR based assay for evaluating graft immune inflammation. The tCRM score quantifies injury in AR and stratifies patients at increased risk of future pIFTA prior to any perturbation of graft function or histology.	[Sigdel, Tara K.; Bestard, Oriol; Tran, Tim Q.; Hsieh, Szu-Chuan; Roedder, Silke; Damm, Izabella; Vincenti, Flavio; Sarwal, Minnie M.] Univ Calif San Francisco, Div Transplant Surg, Dept Surg, San Francisco, CA 94017 USA; [Bestard, Oriol] UB, Bellvitge Univ Hosp, Kidney Transplant Unit, Barcelona, Spain	University of California System; University of California San Francisco; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Sarwal, MM (corresponding author), Univ Calif San Francisco, Div Transplant Surg, Dept Surg, San Francisco, CA 94017 USA.	Minnie.sarwal@ucsf.edu	Sigdel, Tara/AAV-5886-2020	Sigdel, Tara/0000-0001-8448-0328	NIDDK [R01 DK083447]; UCSF internal grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083447, P30DK063720] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCSF internal grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK083447 (NIDDK) and UCSF internal grant to Minnie Sarwal.	Chen R, 2010, PLOS COMPUTATIONAL B, V6, DOI [10.1371/journal.pcbi.1000940, DOI 10.1371/J0URNAL.PCBI.1000940]; Dadhania D, 2010, TRANSPLANTATION, V90, P189, DOI 10.1097/TP.0b013e3181e2a932; Davis ID, 1998, PEDIATR NEPHROL, V12, P96, DOI 10.1007/s004670050412; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900; Fairchild RL, 2015, J AM SOC NEPHROL, V26, P2607, DOI 10.1681/ASN.2015040353; Girmanova E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/972102; Hauser IA, 2005, J AM SOC NEPHROL, V16, P1849, DOI 10.1681/ASN.2004100836; Hu HZ, 2009, TRANSPLANTATION, V87, P1814, DOI 10.1097/TP.0b013e3181a66b3e; Jackson JA, 2011, AM J TRANSPLANT, V11, P2228, DOI 10.1111/j.1600-6143.2011.03680.x; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kuznetsov VA, 2007, GENOME INFORM SER, V19, P83; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lee JR, 2014, IMMUNOL REV, V258, P218, DOI 10.1111/imr.12159; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo DJ, 2014, NAT REV NEPHROL, V10, P215, DOI 10.1038/nrneph.2013.281; Lodhi SA, 2011, AM J TRANSPLANT, V11, P2264, DOI 10.1111/j.1600-6143.2011.03713.x; Lubetzky M, 2014, TRANSPLANTATION, V97, P451, DOI 10.1097/01.TP.0000437432.35227.3e; Mannon RB, 2005, AM J TRANSPLANT, V5, P2883, DOI 10.1111/j.1600-6143.2005.01096.x; Muthukumar T, 2014, TRANSPLANT REV-ORLAN, V28, P145, DOI 10.1016/j.trre.2014.05.003; Naesens M, 2011, KIDNEY INT, V80, P1364, DOI 10.1038/ki.2011.245; Pape L, 2004, TRANSPLANTATION, V77, P1191, DOI 10.1097/01.TP.0000120099.92220.7A; PROVOOST AP, 1984, J PEDIATR SURG, V19, P63, DOI 10.1016/S0022-3468(84)80018-4; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roedder S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001759; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schaub S, 2004, J AM SOC NEPHROL, V15, P219, DOI 10.1097/01.ASN.0000101031.52826.BE; Schaub S, 2009, AM J TRANSPLANT, V9, P1347, DOI 10.1111/j.1600-6143.2009.02645.x; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Sigdel TK, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00057; Sigdel TK, 2014, MOL CELL PROTEOMICS, V13, P621, DOI 10.1074/mcp.M113.030577; Sigdel TK, 2011, EXPERT REV PROTEOMIC, V8, P705, DOI [10.1586/EPR.11.66, 10.1586/epr.11.66]; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Tatapudi RR, 2004, KIDNEY INT, V65, P2390, DOI 10.1111/j.1523-1755.2004.00663.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zhuang JW, 2014, EXP THER MED, V8, P237, DOI 10.3892/etm.2014.1714	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138133	10.1371/journal.pone.0138133	http://dx.doi.org/10.1371/journal.pone.0138133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367000	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100233
J	Sun, HZ; Ge, WJ; Gao, X; Wang, SS; Jiang, SJ; Hu, Y; Yu, M; Hu, SS				Sun, Haizhu; Ge, Wenjie; Gao, Xin; Wang, Shaoshan; Jiang, Shijian; Hu, Ying; Yu, Miao; Hu, Shaoshan			Apoptosis-Promoting Effects of Hematoporphyrin Monomethyl Ether-Sonodynamic Therapy (HMME-SDT) on Endometrial Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; CELL-DEATH; ULTRASOUND; CALCIUM; MITOCHONDRIA; INDUCTION	Objective The aim of the present study was to examine the apoptosis-promoting effects and mechanisms of hematoporphyrin monomethyl ether (HMME)-sonodynamic therapy (SDT) on endometrial cancer cells in vitro. Methods Endometrial cancer cell samples were divided into four groups: 1) untreated control group, 2) HMME group, 3) pure ultrasound group, and 4) HMME combined with ultrasound, i.e. SDT group. CCK-8 method was utilized to assess the inhibiting effect of SDT on the proliferation of endometrial cancer cells. Optical microscope and field emission transmission electron microscopy were used to characterize the morphology changes of the cancer cells induced by the treatments. Apoptosis rate, reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were examined by flow cytometer. Fluorescence intensity measured by laser scanning confocal microscopy was used to explore the variation of intracellular calcium ion (Ca2+) concentration. Apoptosis-related proteins involved in both intrinsic and extrinsic apoptosis signallings were analyzed by western blot. Results SDT can effectively induce the apoptosis of endometrial cancer cells. Compared with ultrasound which is known as an effective anti-tumor method, SDT leads to a significant improvement on suppression of cell viability and induction of apoptosis, together with more remarkable modifications on the morphology and substructure in both ultrasound sensitive and resistant endometrial cancer cells. Further studies reveals that SDT promotes ROS production, induces loss of MMP and increases intracellular Ca2+ concentration more efficiently than HMME or ultrasound alone. SDT groups also show a rather high expression of apoptosis- promoting proteins, including Bax, Fas and Fas-L, and a significant low expression of apoptosis- suspending proteins including Bcl-2 and Survivin. Meanwhile, both cleaved caspse-3 and caspase-8 are dramatically enhanced in SDT groups. Multiple pathways has been proposed in the process, including the intrinsic activation by excessive ROS and overloaded Ca2+, silencing survivin gene, and the extrinsic pathway mediated by the death receptor. Conclusion Given its considerable effectivity in both ultrasound sensitive and resistant cells, SDT may therefore be a promising therapeutic method for treating endometrial cancers.	[Sun, Haizhu; Gao, Xin; Hu, Shaoshan] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150001, Peoples R China; [Wang, Shaoshan; Yu, Miao] Harbin Inst Technol, Sch Chem Engn & Technol, State Key Lab Urban Water Resource & Environm, Harbin 150001, Peoples R China; [Sun, Haizhu] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin 150001, Peoples R China; [Ge, Wenjie; Jiang, Shijian; Hu, Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Institute of Technology	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	shaoshanhu@126.com; huying@hit.edu.cn; miaoyu_che@hit.edu.cn	Hu, Ying/ABG-2935-2021	Hu, Ying/0000-0003-2469-5604; Yu, Miao/0000-0001-8820-9594	National Natural Science Foundation of China [30872650]; Program for New Century Excellent Talents in University of China [NCET-09-0131]; Recruitment Program of Global Young Experts, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Recruitment Program of Global Young Experts, China	This work was financially supported by the National Natural Science Foundation of China (Grant No. 30872650); Program for New Century Excellent Talents in University of China (Grant No. NCET-09-0131); MY acknowledges financial support from the Recruitment Program of Global Young Experts, China.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Ando H, 2006, CANCER LETT, V242, P37, DOI 10.1016/j.canlet.2005.10.032; Ashush H, 2000, CANCER RES, V60, P1014; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Chen HJ, 2014, DRUG DISCOV TODAY, V19, P502, DOI 10.1016/j.drudis.2014.01.010; Dellinger TH, 2009, EXPERT REV ANTICANC, V9, P905, DOI [10.1586/era.09.54, 10.1586/ERA.09.54]; Ding XM, 2004, CANCER LETT, V216, P43, DOI 10.1016/j.canlet.2004.07.005; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Guan HT, 2006, WORLD J GASTROENTERO, V12, P2901, DOI 10.3748/wjg.v12.i18.2901; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kumar B, 2012, BIOCHEM BIOPH RES CO, V417, P903, DOI 10.1016/j.bbrc.2011.12.072; Lei TC, 2012, PHOTODIAGN PHOTODYN, V9, P232, DOI 10.1016/j.pdpdt.2012.01.003; Li YC, 2009, NEUROCHEM RES, V34, P418, DOI 10.1007/s11064-008-9799-1; Masgras I, 2012, J BIOL CHEM, V287, P9845, DOI 10.1074/jbc.M111.250357; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Tarkowski R, 2003, INT J GYNECOLOGICAL, V13, P72; Vyssokikh MY, 2002, MOL BIOL REP, V29, P93, DOI 10.1023/A:1020383108620; Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173; Wang HY, 2010, BIOMATERIALS, V31, P413, DOI 10.1016/j.biomaterials.2009.09.066; Wood AKW, 2015, ULTRASOUND MED BIOL, V41, P905, DOI 10.1016/j.ultrasmedbio.2014.11.019; YUMITA N, 1989, JPN J CANCER RES, V80, P219, DOI 10.1111/j.1349-7006.1989.tb02295.x; Zhang L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/696107; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009	28	20	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137980	10.1371/journal.pone.0137980	http://dx.doi.org/10.1371/journal.pone.0137980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367393	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100194
J	Zhang, P; Liu, KP; Zhao, B; Li, YC				Zhang, Peng; Liu, Keping; Zhao, Bo; Li, Yuanchun			A Computationally Inexpensive Optimal Guidance via Radial-Basis-Function Neural Network for Autonomous Soft Landing on Asteroids	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; INDIRECT OPTIMIZATION; REGRESSION; APPROXIMATION; NAVIGATION; SYSTEMS	Optimal guidance is essential for the soft landing task. However, due to its high computational complexities, it is hardly applied to the autonomous guidance. In this paper, a computationally inexpensive optimal guidance algorithm based on the radial basis function neural network (RBFNN) is proposed. The optimization problem of the trajectory for soft landing on asteroids is formulated and transformed into a two-point boundary value problem (TPBVP). Combining the database of initial states with the relative initial co-states, an RBFNN is trained offline. The optimal trajectory of the soft landing is determined rapidly by applying the trained network in the online guidance. The Monte Carlo simulations of soft landing on the Eros433 are performed to demonstrate the effectiveness of the proposed guidance algorithm.	[Zhang, Peng; Li, Yuanchun] Jilin Univ, Dept Control Sci & Engn, Changchun 130023, Jilin, Peoples R China; [Liu, Keping; Li, Yuanchun] Changchun Univ Technol, Dept Control Engn, Changchun, Jilin, Peoples R China; [Zhao, Bo] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China	Jilin University; Changchun University of Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Li, YC (corresponding author), Jilin Univ, Dept Control Sci & Engn, Changchun 130023, Jilin, Peoples R China.	liyc@ccut.edu.cn	Li, Yuan/GXV-1310-2022		National Basic Research Program of China (973 Program) [2012CB720000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB720000.	Bencherif MA, 2015, IEEE GEOSCI REMOTE S, V12, P527, DOI 10.1109/LGRS.2014.2349538; Broomhead D. S., 1988, Complex Systems, V2, P321; Cheng T, 2007, AUTOMATICA, V43, P482, DOI 10.1016/j.automatica.2006.09.021; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Furfaro R, 2013, J GUID CONTROL DYNAM, V36, P1075, DOI 10.2514/1.58246; GIROSI F, 1990, BIOL CYBERN, V63, P169, DOI 10.1007/BF00195855; GUELMAN M, 1994, J GUID CONTROL DYNAM, V17, P15, DOI 10.2514/3.21153; Guibout VM, 2004, J GUID CONTROL DYNAM, V27, P693, DOI 10.2514/1.11164; He YL, 2015, ENG APPL ARTIF INTEL, V41, P65, DOI 10.1016/j.engappai.2015.02.001; Hossain MA, 2013, ENG APPL ARTIF INTEL, V26, P1230, DOI 10.1016/j.engappai.2012.10.007; Huang GB, 2005, IEEE T NEURAL NETWOR, V16, P57, DOI 10.1109/TNN.2004.836241; Huang XY, 2004, ACTA ASTRONAUT, V54, P763, DOI 10.1016/j.actaastro.2003.09.001; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Lantoine G, 2008, ADV ASTRONAUT SCI, V129, P447; Li S, 2006, AEROSP SCI TECHNOL, V10, P239, DOI 10.1016/j.ast.2005.12.003; Liu KP, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/510618; Mai-Duy N, 2003, APPL MATH MODEL, V27, P197, DOI 10.1016/S0307-904X(02)00101-4; Medagam PV, 2009, P AMER CONTR CONF, P355, DOI 10.1109/ACC.2009.5160105; Miller JK, 2002, ICARUS, V155, P3, DOI 10.1006/icar.2001.6753; Ranieri CL, 2006, J GUID CONTROL DYNAM, V29, P1360, DOI 10.2514/1.19539; Ranieri CL, 2009, J GUID CONTROL DYNAM, V32, P445, DOI 10.2514/1.38170; Romain G, 2001, CELEST MECH DYN ASTR, V79, P235, DOI 10.1023/A:1017555515763; Scheeres Daniel J., 2014, 2014 American Control Conference, P1584, DOI 10.1109/ACC.2014.6858821; Scheeres DJ, 2000, J GUID CONTROL DYNAM, V23, P466, DOI 10.2514/2.4552; Wang H, 2014, RESEARCH OF ASTEROID, P26; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511; Zhang P, 2013, CHIN CONTR CONF, P5000; Zhang ZX, 2012, J FRANKLIN I, V349, P493, DOI 10.1016/j.jfranklin.2011.07.007	29	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137792	10.1371/journal.pone.0137792	http://dx.doi.org/10.1371/journal.pone.0137792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367382	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100138
J	Doijad, SP; Barbuddhe, SB; Garg, S; Poharkar, KV; Kalorey, DR; Kurkure, NV; Rawool, DB; Chakraborty, T				Doijad, Swapnil P.; Barbuddhe, Sukhadeo B.; Garg, Sandeep; Poharkar, Krupali V.; Kalorey, Dewanand R.; Kurkure, Nitin V.; Rawool, Deepak B.; Chakraborty, Trinad			Biofilm-Forming Abilities of Listeria monocytogenes Serotypes Isolated from Different Sources	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BENZALKONIUM CHLORIDE; GROWTH; STRAINS; EPIDEMIOLOGY; TEMPERATURE; RESISTANCE; HYDROPHOBICITY; DIVERSITY; VIRULENCE	A total of 98 previously characterized and serotyped L. monocytogenes strains, comprising 32 of 1/2a; 20 of 1/2b and 46 of 4b serotype, from clinical and food sources were studied for their capability to form a biofilm. The microtiter plate assay revealed 62 (63.26%) strains as weak, 27 (27.55%) strains as moderate, and 9 (9.18%) strains as strong biofilm formers. Among the strong biofilm formers, 6 strains were of serotype 1/2a and 3 strains were of serotype 1/2b. None of the strain from 4b serotype exhibited strong biofilm formation. No firm correlation (p = 0.015) was noticed between any serotype and respective biofilm formation ability. Electron microscopic studies showed that strong biofilm forming isolates could synthesize a biofilm within 24 h on surfaces important in food industries such as stainless steel, ceramic tiles, high-density polyethylene plastics, polyvinyl chloride pipes, and glass. Cell enumeration of strong, moderate, and weak biofilm was performed to determine if the number of cells correlated with the biofilm-forming capabilities of the isolates. Strong, moderate, and weak biofilm showed 570 +/- 127x 10(3) cells/cm(2), 33 +/- 26x 10(3) cells/cm2, 5 +/- 3x 10(3) cells/cm2, respectively, indicating that the number of cells was directly proportional to the strength of the biofilm. The hydrophobicity index (HI) analysis revealed higher hydrophobicity with an increased biofilm formation. Fatty acid methyl esterase analysis revealed the amount of certain fatty acids such as iso-C15:0, anteiso-C15:0, and anteiso-C17:0 fatty acids correlated with the biofilm-forming capability of L. monocytogenes. This study showed that different strains of L. monocytogenes form biofilm of different intensities which did not completely correlate with their serotype; however, it correlated with the number of cells, hydrophobicity, and amount of certain fatty acids.	[Doijad, Swapnil P.; Barbuddhe, Sukhadeo B.; Poharkar, Krupali V.] ICAR Res Complex Goa, Old Goa 403402, India; [Garg, Sandeep] Goa Univ, Dept Microbiol, Taleigaon Plateau 403206, Goa, India; [Kalorey, Dewanand R.; Kurkure, Nitin V.] Maharashtra Anim & Fishery Sci Univ, Nagpur Vet Coll, Dept Microbiol & Anim Biotechnol, Nagpur 440006, Maharashtra, India; [Rawool, Deepak B.] Indian Vet Res Inst, Div Vet Publ Hlth, Izatnagar 243122, Uttar Pradesh, India; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Barbuddhe, Sukhadeo B.] Natl Inst Biot Stress Management, Raipur 492012, Chhattisgarh, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Coastal Agricultural Research Institute; Goa University; Maharashtra Animal & Fishery Sciences University; Nagpur Veterinary College; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Justus Liebig University Giessen; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Biotic Stresses Management	Barbuddhe, SB (corresponding author), ICAR Res Complex Goa, Old Goa 403402, India.	barbuddhesb@gmail.com; Trinad.Chakraborty@mikrobio.med.uni-giessen.de	Rawool, Deepak/AAS-9197-2020; Doijad, Swapnil/C-4848-2013; Garg, Sandeep/E-9780-2019; Barbuddhe, Sukhadeo/AAI-8477-2020	Rawool, Deepak/0000-0002-6173-4708; Doijad, Swapnil/0000-0002-0932-8542; 	Department of Biotechnology, Government of India [BT/IN/FRG/01/SBB/2008, BT/01/CEIB/11/VI/13]; German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme	The research work is supported by grants from Department of Biotechnology, Government of India (BT/IN/FRG/01/SBB/2008; BT/01/CEIB/11/VI/13) and the German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme to SBB and TC.	Adzitey F., 2010, African Journal of Microbiology Research, V4, P2848; Alonso AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113696; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Barbuddhe SB, 2012, INT J FOOD MICROBIOL, V154, P113, DOI 10.1016/j.ijfoodmicro.2011.08.030; Barbuddhe SB, 2009, CURR TOP MICROBIOL, V337, P173, DOI 10.1007/978-3-642-01846-6_6; Bertsch D, 2013, PLASMID, V70, P284, DOI 10.1016/j.plasmid.2013.06.001; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Bujdakova H, 2013, CENT EUR J BIOL, V8, P259, DOI 10.2478/s11535-013-0136-y; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chao J, 2010, CAN J MICROBIOL, V56, P1028, DOI 10.1139/W10-093; Chavant P, 2004, FEMS MICROBIOL LETT, V236, P241, DOI 10.1111/j.1574-6968.2004.tb09653.x; Chen Yi, 2008, P203, DOI 10.1201/9781420051414.ch7; Chihib NE, 2003, FEMS MICROBIOL LETT, V218, P155, DOI 10.1111/j.1574-6968.2003.tb11512.x; da Silva EP, 2013, APPL MICROBIOL BIOT, V97, P957, DOI 10.1007/s00253-012-4611-1; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Gianotti A, 2008, INT J FOOD MICROBIOL, V123, P9, DOI 10.1016/j.ijfoodmicro.2007.11.039; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Jensen AK, 2010, EUROSURVEILLANCE, V15, P12; Jeyasekaran G, 2011, IND J FISH, P211; Kadam SR, 2013, INT J FOOD MICROBIOL, V165, P259, DOI 10.1016/j.ijfoodmicro.2013.05.025; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kathariou S, 2003, FOOD BORNE OUTBREAKS; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; Li J, 2011, INFLUENCE ENV CONDIT; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014; Mirani ZA, 2013, PAK J PHARM SCI, V26, P383; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; Norwood DE, 2001, LETT APPL MICROBIOL, V33, P320, DOI 10.1046/j.1472-765X.2001.01004.x; Perez LJ, 2012, J MED CHEM, V55, P9669, DOI 10.1021/jm300908t; PUTTMANN M, 1993, RES MICROBIOL, V144, P279, DOI 10.1016/0923-2508(93)90012-Q; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Ratti RP, 2010, CIENCIA TECNOL ALIME, V30, P1011, DOI 10.1590/S0101-20612010000400027; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Ruckerl I, 2014, INT J FOOD MICROBIOL, V189, P98, DOI 10.1016/j.ijfoodmicro.2014.08.001; Saa Ibusquiza P, 2011, BIOFILM FORMATION LI; Skovager A, 2013, INT J FOOD MICROBIOL, V165, P35, DOI 10.1016/j.ijfoodmicro.2013.04.014; Somers EB, 2004, J FOOD PROTECT, V67, P2218, DOI 10.4315/0362-028X-67.10.2218; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202; Weiler C, 2013, INT J FOOD MICROBIOL, V161, P61, DOI 10.1016/j.ijfoodmicro.2012.11.027; Wen J, 2009, APPL ENVIRON MICROB, V75, P1581, DOI 10.1128/AEM.01942-08; Whittaker P, 2003, J MICROBIOL METH, V55, P709, DOI 10.1016/j.mimet.2003.07.005	52	93	93	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137046	10.1371/journal.pone.0137046	http://dx.doi.org/10.1371/journal.pone.0137046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360831	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100022
J	Guyot, V; Castagneyrol, B; Vialatte, A; Deconchat, M; Selvi, F; Bussotti, F; Jactel, H				Guyot, Virginie; Castagneyrol, Bastien; Vialatte, Aude; Deconchat, Marc; Selvi, Federico; Bussotti, Filippo; Jactel, Herve			Tree Diversity Limits the Impact of an Invasive Forest Pest	PLOS ONE			English	Article							CHESTNUT GALL WASP; DRYOCOSMUS-KURIPHILUS; VEGETATIONAL DIVERSITY; ASSOCIATIONAL SUSCEPTIBILITY; PHYLOGENETIC DIVERSITY; BIOLOGICAL-CONTROL; TORYMUS-SINENSIS; PLANT INVASIONS; VOLATILES; RELEASE	The impact of invasive herbivore species may be lower in more diverse plant communities due to mechanisms of associational resistance. According to the "resource concentration hypothesis" the amount and accessibility of host plants is reduced in diverse plant communities, thus limiting the exploitation of resources by consumers. In addition, the "natural enemy hypothesis" suggests that richer plant assemblages provide natural enemies with more complementary resources and habitats, thus promoting top down regulation of herbivores. We tested these two hypotheses by comparing crown damage by the invasive Asian chestnut gall wasp (Dryocosmus kuriphilus) on chestnut trees (Castanea sativa) in pure and mixed stands in Italy. We estimated the defoliation on 70 chestnut trees in 15 mature stands sampled in the same region along a gradient of tree species richness ranging from one species (chestnut monocultures) to four species (mixtures of chestnut and three broadleaved species). Chestnut defoliation was significantly lower in stands with higher tree diversity. Damage on individual chestnut trees decreased with increasing height of neighboring, heterospecific trees. These results suggest that conservation biological control method based on tree species mixtures might help to reduce the impact of the Asian chestnut gall.	[Guyot, Virginie; Vialatte, Aude; Deconchat, Marc] INRA, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France; [Vialatte, Aude] Univ Toulouse, INPT ENSAT, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France; [Castagneyrol, Bastien; Jactel, Herve] Univ Bordeaux, BIOGECO, UMR 1202, F-33405 Talence, France; [Guyot, Virginie; Castagneyrol, Bastien; Jactel, Herve] INRA, BIOGECO, UMR 1202, F-33610 Cestas, France; [Selvi, Federico; Bussotti, Filippo] Univ Florence, DISPAA, Lab Bot, I-50144 Florence, Italy	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; UDICE-French Research Universities; Universite de Bordeaux; INRAE; University of Florence	Guyot, V (corresponding author), INRA, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France.	virginie.guyot@ensat.fr	Deconchat, Marc/N-7383-2013	Deconchat, Marc/0000-0002-4638-3858; Castagneyrol, Bastien/0000-0001-8795-7806	European Union Seventh Framework Programme (FP7) [265171]; EFPA department of INRA; Aquitaine French region	European Union Seventh Framework Programme (FP7); EFPA department of INRA; Aquitaine French region	The study design and data collection leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013), grant agreement no265171: HJ. EFPA department of INRA and Aquitaine French region: VG PhD.	Acs Z, 2007, SYST ENTOMOL, V32, P70, DOI 10.1111/j.1365-3113.2006.00351.x; Aebi A., 2007, Bulletin OEPP, V37, P166, DOI 10.1111/j.1365-2338.2007.01099.x; Aebi A, 2006, GALLING ARTHROPODS AND THEIR ASSOCIATES: ECOLOGY AND EVOLUTION, P103, DOI 10.1007/4-431-32185-3_9; ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2005, Bulletin OEPP/EPPO Bulletin, V35, P422; [Anonymous], 2014, R LANG ENV STAT COMP; Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Baeten L, 2013, PERSPECT PLANT ECOL, V15, P281, DOI 10.1016/j.ppees.2013.07.002; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Battisti A, 2014, AGR FOREST ENTOMOL, V16, P75, DOI 10.1111/afe.12036; Borden JH, 1997, J CHEM ECOL, V23, P2479, DOI 10.1023/B:JOEC.0000006661.99953.26; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, ECOLOGY, V93, P2115, DOI 10.1890/11-1300.1; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Cooper WR, 2007, ANN ENTOMOL SOC AM, V100, P236, DOI 10.1603/0013-8746(2007)100[236:CAOAEG]2.0.CO;2; Cooper WR, 2011, BIOCONTROL, V56, P725, DOI 10.1007/s10526-011-9350-1; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dulaurent AM, 2012, AGR FOREST ENTOMOL, V14, P19, DOI 10.1111/j.1461-9563.2011.00549.x; Eichhorn J, 2010, MANUAL ON METHODS AN; Elton C S., 1958, THE ECOLOGY OF INVAS; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; ESRI, 2012, US ARCGIS DESKT VERS; European and Mediterranean Plant Protection Organization, 2013, FIRST REPORT OF DRYO; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Floater GJ, 2000, J APPL ECOL, V37, P87, DOI 10.1046/j.1365-2664.2000.00468.x; Forster B, 2011, NEW DIS REPORTS, V23, P2044; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Gibbs M, 2011, BIOCONTROL, V56, P527, DOI 10.1007/s10526-011-9364-8; Giraudoux P., 2014, PGIRMESS DATA ANAL E; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Iverson AL, 2014, J APPL ECOL, V51, P1593, DOI 10.1111/1365-2664.12334; Jactel H, 2006, CAN J FOREST RES, V36, P314, DOI 10.1139/x05-251; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Liebhold AM, 2013, DIVERS DISTRIB, V19, P1208, DOI 10.1111/ddi.12112; Maltoni A, 2012, IFOREST, V5, P50, DOI 10.3832/ifor0598-008; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moriya S, 2003, PROCEEDINGS OF THE F, P14; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Panzavolta T, 2013, B INSECTOL, V66, P195; Pearse IS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1841; Quacchia A, 2008, BIOCONTROL, V53, P829, DOI 10.1007/s10526-007-9139-4; Quacchia A, 2013, INSECT CONSERV DIVER, V6, P114, DOI 10.1111/j.1752-4598.2012.00192.x; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Santi F, 2011, B INSECTOL, V64, P275; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuldt A, 2014, NEW PHYTOL, V202, P864, DOI 10.1111/nph.12695; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Zhang AJ, 1999, J CHEM ECOL, V25, P1221, DOI 10.1023/A:1020910305873; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	81	35	39	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136469	10.1371/journal.pone.0136469	http://dx.doi.org/10.1371/journal.pone.0136469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360881	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100010
J	Huang, SC; Wong, MK; Lin, PJ; Tsai, FC; Wen, MS; Kuo, CT; Hsu, CC; Wang, JS				Huang, Shu-Chun; Wong, May-Kuen; Lin, Pyng-Jing; Tsai, Feng-Chun; Wen, Ming-Shien; Kuo, Chi-Tai; Hsu, Chih-Chin; Wang, Jong-Shyan			Passive Leg Raising Correlates with Future Exercise Capacity after Coronary Revascularization	PLOS ONE			English	Article							HEART-FAILURE; CARDIAC-OUTPUT; STROKE VOLUME; REHABILITATION; METAANALYSIS; ASSOCIATION; DIAGNOSIS; DISEASE; HUMANS; GUIDE	Hemodynamic properties affected by the passive leg raise test (PLRT) reflect cardiac pumping efficiency. In the present study, we aimed to further explore whether PLRT predicts exercise intolerance/capacity following coronary revascularization. Following coronary bypass/percutaneous coronary intervention, 120 inpatients underwent a PLRT and a cardiopulmonary exercise test (CPET) 2-12 days during post-surgery hospitalization and 3-5 weeks after hospital discharge. The PLRT included head-up, leg raise, and supine rest postures. The end point of the first CPET during admission was the supra-ventilatory anaerobic threshold, whereas that during the second CPET in the outpatient stage was maximal performance. Bio-reactance-based non-invasive cardiac output monitoring was employed during PLRT to measure real-time stroke volume and cardiac output. A correlation matrix showed that stroke volume during leg raise (SVLR) during the first PLRT was positively correlated (R = 0.653) with the anaerobic threshold during the first CPET. When exercise intolerance was defined as an anaerobic threshold < 3 metabolic equivalents, SVLR/body weight had an area under curve value of 0.822, with sensitivity of 0.954, specificity of 0.593, and cut-off value of 1504.10(-3)mL/kg (positive predictive value 0.72; negative predictive value 0.92). Additionally, cardiac output during leg raise (COLR) during the first PLRT was related to peak oxygen consumption during the second CPET (R = 0.678). When poor aerobic fitness was defined as peak oxygen consumption < 5 metabolic equivalents, COLR/body weight had an area under curve value of 0.814, with sensitivity of 0.781, specificity of 0.773, and a cut-off value of 68.3 mL/min/kg (positive predictive value 0.83; negative predictive value 0.71). Therefore, we conclude that PLRT during hospitalization has a good screening and predictive power for exercise intolerance/capacity in inpatients and early outpatients following coronary revascularization, which has clinical significance.	[Huang, Shu-Chun; Wong, May-Kuen] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Lin, Pyng-Jing; Tsai, Feng-Chun] Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Taoyuan, Taiwan; [Wen, Ming-Shien] Chang Gung Mem Hosp, Dept Med, Sect Cardiol 2, Taoyuan, Taiwan; [Kuo, Chi-Tai] Chang Gung Mem Hosp, Dept Cardiol, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsu, Chih-Chin] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Keelung, Taiwan; [Wang, Jong-Shyan] Chang Gung Univ, Hlth Aging Res Ctr, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Wang, JS (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan.	s5492@mail.cgu.edu.tw	Wong, Alice M. K./ABI-1000-2020	Wong, Alice M. K./0000-0003-3586-1292	Chang Gung Medical Research Program [CMRPG 3C1441, CMRPG 391201-3, CMRPG 1A0302, CMRPG 190173]	Chang Gung Medical Research Program	This work was supported by Chang Gung Medical Research Program CMRPG 3C1441: HSC; CMRPG 391201-3: HSC; CMRPG 1A0302: WJS; CMRPG 190173: WJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MOJ, 2003, HEART FAILURE CONGES; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Bertolissi M, 2003, CRIT CARE, V7, P164, DOI 10.1186/cc1882; Boulain T, 2002, CHEST, V121, P1245, DOI 10.1378/chest.121.4.1245; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Chemla D, 1998, AM J PHYSIOL-HEART C, V274, pH500, DOI 10.1152/ajpheart.1998.274.2.H500; Choi EY, 2010, J AM SOC ECHOCARDIOG, V23, P523, DOI 10.1016/j.echo.2010.02.004; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; DUBOIS D, 1989, NUTRITION, V5, P303; Fisher JP, 2012, AUTON NEUROSCI-BASIC, V172, P13, DOI 10.1016/j.autneu.2012.10.013; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281; Keren H, 2007, AM J PHYSIOL-HEART C, V293, pH583, DOI 10.1152/ajpheart.00195.2007; KYRIAKIDES ZS, 1994, INT J CARDIOL, V44, P288, DOI 10.1016/0167-5273(94)90294-1; Maizel J, 2007, INTENS CARE MED, V33, P1133, DOI 10.1007/s00134-007-0642-y; Marik PE, 2011, ANN INTENSIVE CARE, V1, DOI [10.1186/2110-5820-1-1, 10.1186/2110-5820-1-17]; Maurer MM, 2009, J CARD FAIL, V15, P689, DOI 10.1016/j.cardfail.2009.04.005; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Monnet X, 2008, INTENS CARE MED, V34, P659, DOI 10.1007/s00134-008-0994-y; Myers J, 2007, J CARD FAIL, V13, P629, DOI 10.1016/j.cardfail.2007.05.009; Pescatello SL, 2014, ACSMS GUIDELINES FOR, P237; Rosenblum Hannah, 2010, Congest Heart Fail, V16, P254, DOI 10.1111/j.1751-7133.2010.00187.x; RUTLEN DL, 1981, CIRCULATION, V64, P146, DOI 10.1161/01.CIR.64.1.146; Schmid JP, 2013, EUR J PREV CARDIOL, V20, P585, DOI 10.1177/2047487312444368; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wilson JR, 1996, CIRCULATION, V94, P1567, DOI 10.1161/01.CIR.94.7.1567	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137846	10.1371/journal.pone.0137846	http://dx.doi.org/10.1371/journal.pone.0137846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360736	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100093
J	Kalda, M; Peterson, P; Vendelin, M				Kalda, Mari; Peterson, Pearu; Vendelin, Marko			Cross-Bridge Group Ensembles Describing Cooperativity in Thermodynamically Consistent Way	PLOS ONE			English	Article							CARDIAC-MUSCLE; ACTIVATION; MODEL; TROPOMYOSIN; FORCE; ATP; CONTRACTION; CONSUMPTION; FILAMENTS; STRESS	The aim of this work is to incorporate cooperativity into Huxley-type cross-bridge model in thermodynamically consistent way. While the Huxley-type models assume that cross-bridges act independently from each other, we take into account that each cross-bridge is influenced by its neighbors and cooperativity is induced by tropomyosin movement. For that, we introduce ensembles of cross-bridge groups connected by elastic tropomyosin. By taking into account that the mechanical displacement of tropomyosin induces free energy change of the cross-bridge group ensemble, we develop the formalism for thermodynamically consistent description of the cooperativity in muscle contraction. An example model was composed to test the approach. The model parameters were found by optimization from the linear relation between oxygen consumption and stress-strain area as well as experimentally measured stress dynamics of rat trabecula. We have found a good agreement between the optimized model solution and experimental data. Simulations also showed that it is possible to study cooperativity with the approach developed in this work.	[Kalda, Mari; Peterson, Pearu; Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia	Tallinn University of Technology	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad Tee 21, EE-12618 Tallinn, Estonia.	markov@sysbio.ioc.ee	Kalda, Mari/AAF-1693-2020; Vendelin, Marko/AAE-7137-2020	Kalda, Mari/0000-0002-4705-7237; Vendelin, Marko/0000-0002-6459-0391; Peterson, Pearu/0000-0001-7328-4305	European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research)	European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research)	This research was supported by the European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Campbell SG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002156; Campbell SG, 2010, BIOPHYS J, V98, P2254, DOI 10.1016/j.bpj.2010.02.010; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; DELHAAS T, 1994, J PHYSIOL-LONDON, V477, P481, DOI 10.1113/jphysiol.1994.sp020209; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; Gibbs CL, 1995, CARDIOVASC RES, V30, P627, DOI 10.1016/S0008-6363(95)00161-1; Hill T L, 1975, Prog Biophys Mol Biol, V29, P105; Hill T.L., 1974, Progress Biophys Molec Biol, V28, P267, DOI 10.1016/0079-6107(74)90020-0; HISANO R, 1987, CIRC RES, V61, P318, DOI 10.1161/01.RES.61.3.318; JANSSEN PML, 1995, AM J PHYSIOL-HEART C, V269, pH676, DOI 10.1152/ajpheart.1995.269.2.H676; Kalda M, 2013, COMPUTER MODELS BIOM, P91; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Mansson A, 2010, BIOPHYS J, V98, P1237, DOI 10.1016/j.bpj.2009.12.4285; More J. J., 1984, SOURCES DEV MATH SOF; PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809; Peterson P, 2009, INT J COMPUT SCI ENG, V4, P296, DOI 10.1504/IJCSE.2009.029165; Powell M.J.D., 1970, NUMERICAL METHODS NO, P87; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Rice JJ, 2004, PROG BIOPHYS MOL BIO, V85, P179, DOI 10.1016/j.pbiomolbio.2004.01.011; Rice JJ, 2003, BIOPHYS J, V84, P897, DOI 10.1016/S0006-3495(03)74907-8; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; SUGA H, 1990, PHYSIOL REV, V70, P247, DOI 10.1152/physrev.1990.70.2.247; Tanner BCW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002506; TAYLOR TW, 1993, AM J PHYSIOL, V264, pH994, DOI 10.1152/ajpheart.1993.264.3.H994; TAYLOR TW, 1993, J BIOMECH, V26, P1217, DOI 10.1016/0021-9290(93)90069-Q; van der Velden J, 1998, J PHYSIOL-LONDON, V507, P497, DOI 10.1111/j.1469-7793.1998.497bt.x; Vendelin M, 2000, ANN BIOMED ENG, V28, P629, DOI 10.1114/1.1305910; Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; ZAHALAK GI, 1990, J BIOMECH ENG-T ASME, V112, P52, DOI 10.1115/1.2891126; ZOU GZ, 1994, BIOPHYS J, V67, P11, DOI 10.1016/S0006-3495(94)80475-8	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137438	10.1371/journal.pone.0137438	http://dx.doi.org/10.1371/journal.pone.0137438			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361396	Green Published, gold			2022-12-27	WOS:000361043100038
J	Kiddee, W; Montriwet, M				Kiddee, Weerawat; Montriwet, Mayuree			Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents	PLOS ONE			English	Article							RANIBIZUMAB LUCENTIS; MACULAR DEGENERATION; SUSTAINED ELEVATION; BEVACIZUMAB; INJECTION	Purpose To study the prevalence of sustained intraocular pressure (IOP) elevation associated with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents. Methods Prospective comparative study. Non-glaucomatous patients scheduled to receive intravitreal injection of anti-VEGF therapy were recruited from an outpatient eye clinic, Songklanagarind Hospital between April 2013 and March 2014. The IOP was measured by Goldmann applanation tonometer before and at 1 hour, 1 week, 1 month, 3 months, and 6 months after injection. The IOP was compared using the repeated measures analysis. Sustained IOP elevation was defined as either an IOP > 21 mmHg or an increase from baseline >= 5mmHg on two consecutive visits. Results Seventy eyes of 54 patients met the inclusion criteria. The most common diagnosis was diabetic macular edema (48%). The mean IOP +/- standard deviation (SD) before treatment was 13.7 +/- 2.8 mmHg. The means +/- SDs after treatment at 1 hour, 1 week, 1 month, 3 months, and 6 months were 11.3 +/- 2.6, 13.7 +/- 3.6, 14.1 +/- 3.3, 14.0 +/- 2.3, and 13.7 +/- 2.4 mmHg, respectively. A mean of IOP difference at 1 hour postinjection and at baseline was -2.36 +/- 2.5 mmHg (P < 0.001). Four of 70 treated eyes (5.7%) developed sustained IOP elevation (IOP >= 5 mmHg from baseline on two consecutive visits). The IOP returned to baseline levels after 1 month, in three eyes. One eye had sustained IOP elevation at 3 and 6 months follow-up. Thereafter, IOP returned to baseline level. There was no need of anti-glaucoma medication. Conclusions After receiving intravitreal injection of anti-VEGF agent, a small proportion of non-glaucomatous eyes developed a sustained IOP elevation without requiring IOP-lowering treatment. At 1 hour postinjection, there was a significant reduction of the mean IOP compared with the baseline level.	[Kiddee, Weerawat; Montriwet, Mayuree] Prince Songkla Univ, Dept Ophthalmol, Fac Med, Hat Yai, Songkhla Provin, Thailand	Prince of Songkla University	Kiddee, W (corresponding author), Prince Songkla Univ, Dept Ophthalmol, Fac Med, Hat Yai, Songkhla Provin, Thailand.	kweerawat@hotmail.com	Kiddee, Weerawat/ABH-3241-2020	Kiddee, Weerawat/0000-0002-0055-8210	Faculty of Medicine, Prince of Songkla University [EC-56-168-02-4-2]	Faculty of Medicine, Prince of Songkla University	WK; the Faculty of Medicine, Prince of Songkla University funded this study (EC-56-168-02-4-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman RA, 2010, J OCUL PHARMACOL TH, V26, P105, DOI 10.1089/jop.2009.0076; Aref AA, 2012, CURR OPIN OPHTHALMOL, V23, P105, DOI 10.1097/ICU.0b013e32834ff41d; Axer-Siegel R, 2012, RETINA-J RET VIT DIS, V32, P1811, DOI 10.1097/IAE.0b013e31825db771; Bakri SJ, 2008, GRAEF ARCH CLIN EXP, V246, P955, DOI 10.1007/s00417-008-0819-2; Choi DY, 2011, RETINA-J RET VIT DIS, V31, P1028, DOI 10.1097/IAE.0b013e318217ffde; Falkenstein IA, 2007, RETINA-J RET VIT DIS, V27, P1044, DOI 10.1097/IAE.0b013e3180592ba6; Gismondi M, 2009, J GLAUCOMA, V18, P658, DOI 10.1097/IJG.0b013e31819c4893; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Hoang QV, 2013, RETINA-J RET VIT DIS, V33, P179, DOI 10.1097/IAE.0b013e318261a6f7; Hoang QV, 2012, OPHTHALMOLOGY, V119, P321, DOI 10.1016/j.ophtha.2011.08.011; Hollands H, 2007, CAN J OPHTHALMOL, V42, P807, DOI 10.3129/i07-172; Kahook MY, 2009, OPHTHAL SURG LAS IM, V40, P293, DOI 10.3928/15428877-20090430-12; Kernt M, 2007, OPHTHALMOLOGE, V104, P965, DOI 10.1007/s00347-007-1569-y; Kim JE, 2008, AM J OPHTHALMOL, V146, P930, DOI 10.1016/j.ajo.2008.07.007; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mathalone N, 2012, GRAEF ARCH CLIN EXP, V250, P1435, DOI 10.1007/s00417-012-1981-0; Schmucker C, 2010, CURR OPIN OPHTHALMOL, V21, P218, DOI 10.1097/ICU.0b013e3283386783; Sniegowski M, 2010, OPEN OPHTHALMOL J, V4, P28, DOI 10.2174/1874364101004010028; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; Tseng JJ, 2012, J GLAUCOMA, V21, P241, DOI 10.1097/IJG.0b013e31820d7d19; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Wehrli SJ, 2012, RETINA-J RET VIT DIS, V32, P1295, DOI 10.1097/IAE.0b013e31823f0c95	22	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137833	10.1371/journal.pone.0137833	http://dx.doi.org/10.1371/journal.pone.0137833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360382	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100091
J	Kono, Y; Kohn, JR				Kono, Yoshiaki; Kohn, Joshua R.			Range and Frequency of Africanized Honey Bees in California (USA)	PLOS ONE			English	Article							APIS-MELLIFERA L.; MITOCHONDRIAL-DNA; EUROPEAN HONEYBEES; GENETIC-STRUCTURE; TROPICAL YUCATAN; UNITED-STATES; HYBRIDIZATION; POPULATIONS; IDENTIFICATION; HYMENOPTERA	Africanized honey bees entered California in 1994 but few accounts of their northward expansion or their frequency relative to European honey bees have been published. We used mitochondrial markers and morphometric analyses to determine the prevalence of Africanized honeybees in San Diego County and their current northward progress in California west of the Sierra Nevada crest. The northernmost African mitotypes detected were approximately 40 km south of Sacramento in California's central valley. In San Diego County, 65% of foraging honey bee workers carry African mitochondria and the estimated percentage of Africanized workers using morphological measurements is similar (61%). There was no correlation between mitotype and morphology in San Diego County suggesting Africanized bees result from bidirectional hybridization. Seventy percent of feral hives, but only 13% of managed hives, sampled in San Diego County carried the African mitotype indicating that a large fraction of foraging workers in both urban and rural San Diego County are feral. We also found a single nucleotide polymorphism at the DNA barcode locus COI that distinguishes European and African mitotypes. The utility of this marker was confirmed using 401 georeferenced honey bee sequences from the worldwide Barcode of Life Database. Future censuses can determine whether the current range of the Africanized form is stable, patterns of introgression at nuclear loci, and the environmental factors that may limit the northern range of the Africanized honey bee.	[Kono, Yoshiaki; Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kohn, JR (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	jkohn@ucsd.edu			Agouron Foundation; UCSD; Direct For Education and Human Resources [1140640, 1446563] Funding Source: National Science Foundation	Agouron Foundation; UCSD; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	Y.K. was partially supported by a grant from the Agouron Foundation. JRK received support from UCSD. No additional funding sources for this study.	Balling SS, 1978, J KANSAS ENTOMOL SYS, V51, P857; Chapman NC, 2015, MOL ECOL RESOUR, V15, P1346, DOI 10.1111/1755-0998.12411; Clarke KE, 2002, EVOLUTION, V56, P1462; CROZIER RH, 1993, GENETICS, V133, P97; CROZIER YC, 1991, EXPERIENTIA, V47, P968, DOI 10.1007/BF01929894; DALY HV, 1991, APIDOLOGIE, V22, P591, DOI 10.1051/apido:19910603; Diniz NM, 2003, GENET MOL BIOL, V26, P47, DOI 10.1590/S1415-47572003000100008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRANCA FOS, 1994, Q J MED, V87, P269; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Galindo-Cardona A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-65; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Harrison JF, 2006, INTEGR COMP BIOL, V46, P1110, DOI 10.1093/icb/icl046; Kerr W.E., 1967, S AFR BEE J, V39, P3; Lazaneo V, 2002, U CALIFORNIA AGR NAT, V8068; MICHENER CD, 1975, ANNU REV ENTOMOL, V20, P399, DOI 10.1146/annurev.en.20.010175.002151; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Pinto MA, 2007, ANN ENTOMOL SOC AM, V100, P289, DOI 10.1603/0013-8746(2007)100[289:HBHAOA]2.0.CO;2; Pinto MA, 2005, GENETICS, V170, P1653, DOI 10.1534/genetics.104.035030; Pinto MA, 2004, EVOLUTION, V58, P1047, DOI 10.1111/j.0014-3820.2004.tb00438.x; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Quezada-Euan JJG, 2000, APIDOLOGIE, V31, P443, DOI 10.1051/apido:2000135; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RINDERER T E, 1986, Bulletin of the Entomological Society of America, V32, P226; RINDERER TE, 1993, APIDOLOGIE, V24, P569, DOI 10.1051/apido:19930605; RINDERER TE, 1991, SCIENCE, V253, P309, DOI 10.1126/science.253.5017.309; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Rivera-Marchand B, 2008, CARIBB J SCI, V44, P264; Rivera-Marchand B, 2012, EVOL APPL, V5, P746, DOI 10.1111/j.1752-4571.2012.00252.x; Ruttner F., 1988, Biogeography and taxonomy of honeybees.; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Segura JAL, 2000, GENET MOL BIOL, V23, P317; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; SMITH DR, 1989, NATURE, V339, P213, DOI 10.1038/339213a0; SOUTHWICK EE, 1990, COMP BIOCHEM PHYS A, V97, P1, DOI 10.1016/0300-9629(90)90713-3; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Szalanski AL, 2010, J APICULT RES, V49, P177, DOI 10.3896/IBRA.1.49.2.06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133	43	29	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137407	10.1371/journal.pone.0137407	http://dx.doi.org/10.1371/journal.pone.0137407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361047	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100035
J	Murakami, M; Ono, K; Tsubokura, M; Nomura, S; Oikawa, T; Oka, T; Kami, M; Oki, T				Murakami, Michio; Ono, Kyoko; Tsubokura, Masaharu; Nomura, Shuhei; Oikawa, Tomoyoshi; Oka, Tosihiro; Kami, Masahiro; Oki, Taikan			Was the Risk from Nursing-Home Evacuation after the Fukushima Accident Higher than the Radiation Risk?	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; CANCER INCIDENCE; JAPAN; RESIDENTS; MORTALITY; RATES	After the 2011 accident at the Fukushima Daiichi nuclear power plant, nursing-home residents and staff were evacuated voluntarily from damaged areas to avoid radiation exposure. Unfortunately, the evacuation resulted in increased mortalities among nursing home residents. We assessed the risk trade-off between evacuation and radiation for 191 residents and 184 staff at three nursing homes by using the same detriment indicator, namely loss of life expectancy (LLE), under four scenarios, i.e. "rapid evacuation (in accordance with the actual situation; i.e. evacuation on 22 March)," "deliberate evacuation (i.e. evacuation on 20 June)," " 20-mSv exposure," and "100-mSv exposure." The LLE from evacuation-related mortality among nursing home residents was assessed with survival probability data from nursing homes in the city of Minamisoma and the city of Soma. The LLE from radiation mortality was calculated from the estimated age-specific mortality rates from leukemia and all solid cancers based on the additional effective doses and the survival probabilities. The total LLE of residents due to evacuation-related risks in rapid evacuation was 11,000 persons-d-much higher than the total LLEs of residents and staff due to radiation in the other scenarios (27, 1100, and 5800 persons-d for deliberate evacuation, 20 mSv-exposure, and 100 mSv-exposure, respectively). The latitude for reducing evacuation risks among nursing home residents is surprisingly large. Evacuation regulation and planning should therefore be well balanced with the trade-offs against radiation risks. This is the first quantitative assessment of the risk trade-off between radiation exposure and evacuation after a nuclear power plant accident.	[Murakami, Michio; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Ono, Kyoko] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki 3058569, Japan; [Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo 1088639, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Oikawa, Tomoyoshi] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima 9750033, Japan; [Oka, Tosihiro] Fukui Prefectural Univ, Fac Econ, Fukui 9101195, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Imperial College London; Fukui Prefectural University	Murakami, M (corresponding author), Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	michio@fmu.ac.jp	Tsubokura, Masaharu/AAV-4364-2021; Oki, Taikan/E-5778-2010; Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/D-7300-2017; Ono, Kyoko/J-4346-2018	Tsubokura, Masaharu/0000-0001-8027-202X; Oki, Taikan/0000-0003-4067-4678; Tsubokura, Masaharu/0000-0001-8027-202X; Ono, Kyoko/0000-0001-8100-3905; Nomura, Shuhei/0000-0002-2963-7297	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html. MM and TOki receive the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2006, CHERNOBYL FORUM 2003; Gamo M, 2003, CHEMOSPHERE, V53, P277, DOI 10.1016/S0045-6535(03)00053-5; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; ICRP, 1991, ANN ICRP; Journy N, 2014, RADIAT ENVIRON BIOPH, V53, P39, DOI 10.1007/s00411-013-0491-8; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kodama Y, 2014, DISASTER MED PUBLIC, V8, P471, DOI 10.1017/dmp.2014.112; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Ministry of Health and Welfare, 2012, 21 LIF TABL; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; [National Cancer Center Japan Center for Cancer Control and Information Services], 2013, CANC INC 1975 2008; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; R Development Core Team, 2011, R 2 1 3 0 R LANG ENV; Reconstruction Agency, 2014, EARTHQ REL DEATH GRE; Royal Society, 1983, RISK ASS REP ROYAL S; Statistics Bureau of Japan, 2011, GEN MORT 2010; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, REP UN SCI COMM EFF; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, ANN A EP STUD RAD CA, V1; World Health Organization, 2012, PREL DOS EST NUCL AC; World Health Organization, 2013, HLTH RISK ASS NUCL A; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	29	47	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137906	10.1371/journal.pone.0137906	http://dx.doi.org/10.1371/journal.pone.0137906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359666	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100099
J	Nogueira-Paiva, NC; Vieira, PMD; Oliveri, LMR; Fonseca, KD; Pound-Lana, G; de Oliveira, MT; de Lana, M; Veloso, VM; Reis, AB; Tafuri, WL; Carneiro, CM				Nogueira-Paiva, Nivia Carolina; de Abreu Vieira, Paula Melo; Rezende Oliveri, Larissa Maris; Fonseca, Katia da Silva; Pound-Lana, Gwenaelle; de Oliveira, Maykon Tavares; de Lana, Marta; Veloso, Vanja Maria; Reis, Alexandre Barbosa; Tafuri, Washington Luiz; Carneiro, Claudia Martins			Host-Parasite Interactions in Chagas Disease: Genetically Unidentical Isolates of a Single Trypanosoma cruzi Strain Identified In Vitro via LSSP-PCR	PLOS ONE			English	Article							DIFFERENTIAL TISSUE DISTRIBUTION; LONG-TERM INFECTION; PATHOGENESIS; VARIABILITY; DIVERSITY; ISOENZYME; PATTERNS; BE-78; DOGS; DNA	The present study aims at establishing whether the diversity in pathogenesis within a genetically diverse host population infected with a single polyclonal strain of Trypanosoma cruzi is due to selection of specific subpopulations within the strain. For this purpose we infected Swiss mice, a genetically diverse population, with the polyclonal strain of Trypanosoma cruzi Berenice-78 and characterized via LSSP-PCR the kinetoplast DNA of subpopulations isolated from blood samples collected from the animals at various times after inoculation (3, 6 and 12 months after inoculation). We examined the biological behavior of the isolates in acellular medium and in vitro profiles of infectivity in Vero cell medium. We compared the characteristics of the isolates with the inoculating strain and with another strain, Berenice 62, isolated from the same patient 16 years earlier. We found that one of the isolates had intermediate behavior in comparison with Berenice-78 and Berenice-62 and a significantly different genetic profile by LSSP-PCR in comparison with the inoculating strain. We hereby demonstrate that genetically distinct Trypanosoma cruzi isolates may be obtained upon experimental murine infection with a single polyclonal Trypanosoma cruzi strain.	[Nogueira-Paiva, Nivia Carolina; de Abreu Vieira, Paula Melo; Rezende Oliveri, Larissa Maris; Fonseca, Katia da Silva; Pound-Lana, Gwenaelle; Reis, Alexandre Barbosa; Tafuri, Washington Luiz; Carneiro, Claudia Martins] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Imunopatol, Ouro Preto, MG, Brazil; [de Oliveira, Maykon Tavares; de Lana, Marta] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Doenca Chagas, Ouro Preto, MG, Brazil; [de Abreu Vieira, Paula Melo] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Dept Ciencias Biol, Ouro Preto, MG, Brazil; [Veloso, Vanja Maria] Univ Fed Ouro Preto, Dept Farm, Escola Farm, Ouro Preto, MG, Brazil; [Reis, Alexandre Barbosa; Carneiro, Claudia Martins] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	Carneiro, CM (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Imunopatol, Ouro Preto, MG, Brazil.	claudiamartinscarneiro@gmail.com	Pound-Lana, Gwenaelle E N/C-5835-2015; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; carneiro, claudia m/B-6205-2013; Tavares, Maykon/Q-4801-2019	Pound-Lana, Gwenaelle E N/0000-0003-0569-0242; Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Lana, Marta/0000-0002-1565-4707; Tavares de Oliveira, Maykon/0000-0002-7652-3225; Nogueira-Paiva, Nivia Carolina/0000-0002-2048-9400	Universidade Federal de Ouro Preto (UFOP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq	Universidade Federal de Ouro Preto (UFOP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Universidade Federal de Ouro Preto (UFOP), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and research fellowships from CNPq (Carneiro CM, Reis AB, Lana M, Oliveri LMR), CAPES (Fonseca KS, Nogueira-Paiva NC) and FAPEMIG (Pound-Lana G, Oliveira MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Andrade LO, 2010, MEM I OSWALDO CRUZ, V105, P834, DOI 10.1590/S0074-02762010000600018; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; BRENER Z, 1965, ANN TROP MED PARASIT, V59, P19, DOI 10.1080/00034983.1965.11686277; Brito CMM, 2008, PARASITOL RES, V103, P1111, DOI 10.1007/s00436-008-1102-5; Carneiro CM, 2007, ACTA TROP, V101, P120, DOI 10.1016/j.actatropica.2006.12.009; CARNEIRO M, 1990, ACTA TROP, V47, P35, DOI 10.1016/0001-706X(90)90005-K; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Cruz RE, 2006, ACTA TROP, V97, P239, DOI 10.1016/j.actatropica.2005.03.011; D'Avila DA, 2009, J CLIN MICROBIOL, V47, P1718, DOI 10.1128/JCM.01658-08; Vieira PMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032912; Vieira PMD, 2009, EXP PARASITOL, V121, P76, DOI 10.1016/j.exppara.2008.09.023; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Guedes PMM, 2007, MEM I OSWALDO CRUZ, V102, P141, DOI 10.1590/S0074-02762007005000003; LANA M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P247, DOI 10.1590/S0074-02761986000300001; Lana M, 1981, THESIS U FEDERAL MIN; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; Nogueira-Paiva NC, 2014, MEM I OSWALDO CRUZ, V109, P51, DOI 10.1590/0074-0276130216; Oliveira LT, 2011, J PHARMACEUT BIOMED, V56, P70, DOI 10.1016/j.jpba.2011.04.016; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; Rimoldi A, 2012, PARASITOLOGY, V139, P37, DOI 10.1017/S0031182011001697; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2; SALGADO JOAO AMILCAR, 1962, REV INST MED TROP SSB PAULO, V4, P330; Valadares HMS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001722; Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Veloso VM, 2012, INFECT GENET EVOL, V12, P1128, DOI 10.1016/j.meegid.2012.03.019; Veloso VM, 2005, PARASITOL RES, V96, P382, DOI 10.1007/s00436-005-1373-z; Villarreal D, 2004, EXP PARASITOL, V108, P24, DOI 10.1016/j.exppara.2004.07.001; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137788	10.1371/journal.pone.0137788	http://dx.doi.org/10.1371/journal.pone.0137788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359864	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100088
J	Yilmaz, O; Bahcekapili, HG				Yilmaz, Onurcan; Bahcekapili, Hasan G.			When Science Replaces Religion: Science as a Secular Authority Bolsters Moral Sensitivity	PLOS ONE			English	Article							ANALYTIC THINKING; EVOLUTION; GOD; BELIEF	Scientific and religious thinking compete with each other on several levels. For example, activating one generally weakens the other. Since priming religion is known to increase moral behaviour and moral sensitivity, priming science might be expected to have the opposite effect. However, it was recently demonstrated that, on the contrary, science priming increases moral sensitivity as well. The present set of studies sought to replicate this effect and test two explanations for it. Study 1 used a sentence unscrambling task for implicitly priming the concept of science but failed to replicate its effect on moral sensitivity, presumably due to a ceiling effect. Study 2 replicated the effect with a new measure of moral sensitivity. Study 3 tested whether science-related words create this effect by activating the idea of secular authority or by activating analytic thinking. It was demonstrated that words related to secular authority, but not words related to analytic thinking, produced a similar increase in moral sensitivity. Religiosity level of the participants did not influence this basic finding. The results are consistent with the hypothesis that science as a secular institution has overtaken some of the functions of religion in modern societies.	[Yilmaz, Onurcan; Bahcekapili, Hasan G.] Dogus Univ, Dept Psychol, TR-34722 Istanbul, Turkey	Dogus University	Yilmaz, O (corresponding author), Dogus Univ, Dept Psychol, TR-34722 Istanbul, Turkey.	oyilmaz@dogus.edu.tr	Yilmaz, Onurcan/I-3839-2019	Yilmaz, Onurcan/0000-0002-6094-7162				Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Aveyard ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099447; Bering J., 2011, GOD INSTINCT PSYCHOL, DOI DOI 10.24204/EJPR.V5I3.229; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Kay AC, 2010, J PERS SOC PSYCHOL, V99, P725, DOI 10.1037/a0021140; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kvaran T, 2013, PROG BRAIN RES, V202, P187, DOI 10.1016/B978-0-444-62604-2.00011-3; Ma-Kellams C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057989; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Norenzayan A, 2013, BIG GODS RELIG TRANS; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Pennycook G, 2014, THINK REASONING, V20, P188, DOI 10.1080/13546783.2013.865000; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Yilmaz O, 2015, J EXP SOC PSYCHOL, V58, P95, DOI 10.1016/j.jesp.2015.01.003	22	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137499	10.1371/journal.pone.0137499	http://dx.doi.org/10.1371/journal.pone.0137499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR0WB	26360826	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100046
J	Lin, YK; Yang, SH; Chen, CC; Kao, HC; Fang, JY				Lin, Yin-Ku; Yang, Sien-Hung; Chen, Chin-Chuan; Kao, Hsiao-Ching; Fang, Jia-You			Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID DELIVERY; NANOSTRUCTURED LIPID CARRIERS; PROTOPORPHYRIN-IX; BETA-CATENIN; INDIGO NATURALIS; STRATUM-CORNEUM; ABSORPTION; PERMEATION; EXPRESSION; BARRIER	Objective Psoriasis is a chronic inflammatory skin disease and topical therapy remains a key role for treatment. The aim of this study is to evaluate the influence of psoriasis-like lesions on the cutaneous permeation of anti-psoriatic drugs. Methods We first set up imiquimod-induced dermatitis in mice that closely resembles human psoriasis lesions. The development of the lesions is based on the IL-23/IL17A axis for phenotypical and histological characteristics. Four drugs, 5-aminolevulinic acid (ALA), tacrolimus, calcipotriol, and retinoic acid, were used to evaluate percutaneous absorption. Results The most hydrophilic molecule, ALA, revealed the greatest enhancement on skin absorption after imiquimod treatment. Imiquimod increased the skin deposition and flux of ALA by 5.6 to 14.4-fold, respectively, compared to normal skin. The follicular accumulation of ALA was also increased 3.8-fold. The extremely lipophilic drug retinoic acid showed a 1.7-and 3.8-fold increase in skin deposition and flux, respectively. Tacrolimus flux was enhanced from 2 to 21 mu g/cm(2)/h by imiquimod intervention. However, imiquimod did not promote skin deposition of this macrolide. The lipophilicity, but not the molecular size, dominated drug permeation enhancement by psoriatic lesions. The in vivo percutaneous absorption of ALA and rhodamine B examined by confocal microscopy confirmed the deficient resistance of epidermal barrier for facilitating cutaneous delivery of drugs via psoriasis-like skin. Conclusion We established the topical delivery profiles of anti-psoriatic drugs via imiquimod-treated psoriasis-like skin.	[Lin, Yin-Ku; Yang, Sien-Hung] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Lin, Yin-Ku] Chang Gung Mem Hosp Keelung, Dept Tradit Chinese Med, Keelung, Taiwan; [Yang, Sien-Hung] Chang Gung Mem Hosp Linkou, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Univ, Grad Inst Nat Prod, Mol Genet Lab, Taoyuan, Taiwan; [Kao, Hsiao-Ching; Fang, Jia-You] Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan, Taiwan; [Fang, Jia-You] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology	Fang, JY (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan, Taiwan.	fajy@mail.cgu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209	Chang Gung Memorial Hospital [CMRPG3D1191]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Jia-You Fang received the financial support from Chang Gung Memorial Hospital (grant number: CMRPG3D1191).	Akazawa Y, 2013, SKIN PHARMACOL PHYS, V26, P15, DOI 10.1159/000343173; Andrews SN, 2013, PHARM RES-DORDR, V30, P1099, DOI 10.1007/s11095-012-0946-7; Antoniou C, 2010, AM J CLIN DERMATOL, V11, P95, DOI 10.2165/11530210-000000000-00000; Ben-Shabat S, 2005, PHARM RES-DORDR, V22, P50, DOI 10.1007/s11095-004-9008-0; Boehncke WH, 2013, AM J CLIN DERMATOL, V14, P377, DOI 10.1007/s40257-013-0032-x; Brune A, 2007, PEDIATR DERMATOL, V24, P76, DOI 10.1111/j.1525-1470.2007.00341.x; Chang HN, 2010, MOLECULES, V15, P6423, DOI 10.3390/molecules15096423; Chen WY, 2013, LASER MED SCI, V28, P1363, DOI 10.1007/s10103-012-1257-2; Chiang A, 2012, J APPL TOXICOL, V32, P537, DOI 10.1002/jat.1773; de Bruijn HS, 2008, J PHOTOCH PHOTOBIO B, V92, P91, DOI 10.1016/j.jphotobiol.2008.05.005; Donnelly RF, 2008, J CONTROL RELEASE, V129, P154, DOI 10.1016/j.jconrel.2008.05.002; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fang JY, 2008, EUR J PHARM BIOPHARM, V70, P633, DOI 10.1016/j.ejpb.2008.05.008; Fang JY, 2004, BRIT J DERMATOL, V151, P132, DOI 10.1111/j.1365-2133.2004.06051.x; Frum Y, 2007, EUR J PHARM SCI, V30, P280, DOI 10.1016/j.ejps.2006.11.014; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gaber MAE, 2015, INDIAN DERMATOL ONLI, V6, P13, DOI [10.4103/2229-5178.148923, DOI 10.4103/2229-5178.148923]; Gattu S, 2010, SKIN PHARMACOL PHYS, V23, P171, DOI 10.1159/000288163; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Hung CF, 2012, J DERMATOL SCI, V68, P135, DOI 10.1016/j.jdermsci.2012.09.005; Jiang WW, 2013, J INVEST DERMATOL, V133, P1777, DOI 10.1038/jid.2013.57; Kasting GB, 2013, SKIN PHARMACOL PHYS, V26, P295, DOI 10.1159/000351956; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Kono F, 2014, BRIT J DERMATOL, V170, P1048, DOI 10.1111/bjd.12812; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Levin AA, 2014, J AM ACAD DERMATOL, V70, P555, DOI 10.1016/j.jaad.2013.10.043; Li M, 2007, CANCER LETT, V248, P58, DOI 10.1016/j.canlet.2006.05.019; Li ZX, 2008, INT J DERMATOL, V47, P207, DOI 10.1111/j.1365-4632.2007.03318.x; Lin YK, 2010, INT J NANOMED, V5, P117; Lin YK, 2009, J DERMATOL SCI, V54, P168, DOI 10.1016/j.jdermsci.2009.02.007; Liu X, 2011, BRIT J CLIN PHARMACO, V72, P768, DOI 10.1111/j.1365-2125.2011.04022.x; McCarron PA, 2008, PHARM RES, V25, P812, DOI 10.1007/s11095-007-9352-y; McCormack PL, 2011, DRUGS, V71, P709, DOI 10.2165/11207300-000000000-00000; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; Monteleone G, 2011, CLIN SCI, V120, P1, DOI 10.1042/CS20100163; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nielsen JB, 2005, ARCH DERMATOL RES, V296, P560, DOI 10.1007/s00403-005-0555-y; O'goshi K, 2000, ARCH DERMATOL RES, V292, P605, DOI 10.1007/s004030000185; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; Ray S, 2013, J CELL BIOL, V202, P45, DOI 10.1083/jcb.201212140; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Shah PP, 2012, BIOMATERIALS, V33, P1607, DOI 10.1016/j.biomaterials.2011.11.011; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Smits T, 2005, J INVEST DERMATOL, V125, P833, DOI 10.1111/j.0022-202X.2005.23843.x; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Teichmann A, 2005, J INVEST DERMATOL, V125, P264, DOI 10.1111/j.0022-202X.2005.23779.x; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Zhang LW, 2011, DERMATOL SIN, V29, P1, DOI 10.1016/j.dsi.2011.02.002; Zhang LW, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S17524	55	124	124	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137890	10.1371/journal.pone.0137890	http://dx.doi.org/10.1371/journal.pone.0137890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355594	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800087
J	Palao, T; Sward, K; Jongejan, A; Moerland, PD; de Vos, J; van Weert, A; Arribas, SM; Groma, G; vanBavel, E; Bakker, ENTP				Palao, Teresa; Sward, Karl; Jongejan, Aldo; Moerland, Perry D.; de Vos, Judith; van Weert, Angela; Arribas, Silvia M.; Groma, Gergely; vanBavel, Ed; Bakker, Erik N. T. P.			Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; WISTAR-KYOTO RATS; RESISTANCE ARTERIES; PROTEIN; THROMBOSPONDIN-4; CONTRACTILITY; HETEROGENEITY; PRESSURE; TORSINA; GROWTH	Small arteries are known to develop functional and structural alterations in hypertension. However, the mechanisms of this remodeling are not fully understood. We hypothesized that altered gene expression is associated with the development of hypertension in mesenteric arteries of spontaneously hypertensive rats (SHR). Three sublines of SHR and normotensive Wistar Kyoto rats (WKY) were studied at 6 weeks and 5 months of age. MiRNA and mRNA microarray experiments were performed and analyzed with bioinformatical tools, including Ingenuity Pathway Analysis (IPA). Principal component analysis showed a clear separation in both miRNA and mRNA expression levels between both ages studied, demonstrating strong age-related changes in expression. At the miRNA level, IPA identified differences between SHR and WKY related to metabolic diseases, cellular growth, and proliferation. The mRNAs differentially expressed between SHR and WKY were related to metabolism, cellular movement and proliferation. The most strongly upregulated gene (9.2-fold) was thrombospondin 4 (Thbs4), a protein involved in the endoplasmic reticulum (ER) stress response that activates transcription factor 6 alpha (ATF6 alpha). ATF6 alpha downstream targets were also differentially expressed in SHR vs. WKY. Differential expression of THBS4, the cleaved form of ATF6a, and two of its targets were further confirmed at the protein level by western blot. In summary, these data revealed a number of genes (n = 202) and miRNAs (n = 3) in mesenteric arteries of SHR that had not been related to hypertension previously. The most prominent of these, Thbs4, is related to vascular ER stress that is associated with hypertension.	[Palao, Teresa; de Vos, Judith; van Weert, Angela; Groma, Gergely; vanBavel, Ed; Bakker, Erik N. T. P.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Jongejan, Aldo; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Arribas, Silvia M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain	University of Amsterdam; Academic Medical Center Amsterdam; Lund University; University of Amsterdam; Academic Medical Center Amsterdam; Autonomous University of Madrid	Bakker, ENTP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.t.bakker@amc.uva.nl	Moerland, Perry/AAG-1425-2020	Moerland, Perry/0000-0002-2357-3659; Groma, Gergely/0000-0001-8487-0465; van Bavel, Ed/0000-0001-8654-986X; de Vos, Judith/0000-0003-0736-7449; Bakker, Erik/0000-0003-2819-5818; Sward, Karl/0000-0002-7255-5510; Palao, Teresa/0000-0002-1291-7153; Arribas, Silvia M/0000-0001-7103-6105	European Union, Marie Curie ITN [606998, 235711]	European Union, Marie Curie ITN	This work was supported by the European Union, Marie Curie ITN number 606998 and 235711. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ashenagar MS, 2010, MOL MED REP, V3, P213, DOI 10.3892/mmr_00000242; Bakker ENTP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107998; Balta S, 2014, ANGIOLOGY, V65, P773, DOI 10.1177/0003319713513492; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Christensen KL, 2001, J VASC RES, V38, P1, DOI 10.1159/000051024; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Grayson TH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-404; Hadoke PWF, 2000, GEN PHARMACOL-VASC S, V35, P119, DOI 10.1016/S0306-3623(01)00085-4; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hu WY, 2002, J HYPERTENS, V20, P1323, DOI 10.1097/00004872-200207000-00019; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jin W, 2012, J BIOL CHEM, V287, P15672, DOI 10.1074/jbc.M111.322669; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; Liang B, 2013, ARTERIOSCL THROM VAS, V33, P595, DOI 10.1161/ATVBAHA.112.300606; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; O'Farrell C, 2004, MOL BRAIN RES, V127, P1, DOI 10.1016/j.molbrainres.2004.05.005; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okuda T, 2002, HYPERTENS RES, V25, P249, DOI 10.1291/hypres.25.249; Okuda T, 2002, BIOCHEM BIOPH RES CO, V296, P537, DOI 10.1016/S0006-291X(02)00902-6; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rose AE, 2014, J BIOL CHEM, V289, P552, DOI 10.1074/jbc.M113.515791; Schiffrin EL, 2004, AM J HYPERTENS, V17, P1192, DOI 10.1016/j.amjhyper.2004.05.023; Spitler KM, 2014, HYPERTENSION, V63, pE40, DOI 10.1161/HYPERTENSIONAHA.113.02558; Spitler KM, 2013, AM J PHYSIOL-HEART C, V305, pH344, DOI 10.1152/ajpheart.00952.2012; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; Unthank JL, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.5; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zwaveling J, 1997, FUNDAM CLIN PHARM, V11, P41, DOI 10.1111/j.1472-8206.1997.tb00167.x	38	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137027	10.1371/journal.pone.0137027	http://dx.doi.org/10.1371/journal.pone.0137027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356734	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800023
J	Talukdar, P; Douglas, A; Price, AH; Norton, GJ				Talukdar, Partha; Douglas, Alex; Price, Adam H.; Norton, Gareth J.			Biallelic and Genome Wide Association Mapping of Germanium Tolerant Loci in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARSENIC ACCUMULATION; SILICON UPTAKE; GENETIC DISSECTION; ROOT MORPHOLOGY; TRANSPORTER; METABOLISM; GRAIN; QTLS; DIVERSITY	Rice plants accumulate high concentrations of silicon. Silicon has been shown to be involved in plant growth, high yield, and mitigating biotic and abiotic stresses. However, it has been demonstrated that inorganic arsenic is taken up by rice through silicon transporters under anaerobic conditions, thus the ability to efficiently take up silicon may be considered either a positive or a negative trait in rice. Germanium is an analogue of silicon that produces brown lesions in shoots and leaves, and germanium toxicity has been used to identify mutants in silicon and arsenic transport. In this study, two different genetic mapping methods were performed to determine the loci involved in germanium sensitivity in rice. Genetic mapping in the biparental cross of Bala x Azucena (an F-6 population) and a genome wide association (GWA) study with 350 accessions from the Rice Diversity Panel 1 were conducted using 15 mu M of germanic acid. This identified a number of germanium sensitive loci: some co-localised with previously identified quantitative trait loci (QTL) for tissue silicon or arsenic concentration, none co-localised with Lsi1 or Lsi6, while one single nucleotide polymorphism (SNP) was detected within 200 kb of Lsi2 (these are genes known to transport silicon, whose identity was discovered using germanium toxicity). However, examining candidate genes that are within the genomic region of the loci detected above reveals genes homologous to both Lsi1 and Lsi2, as well as a number of other candidate genes, which are discussed.	[Talukdar, Partha; Douglas, Alex; Price, Adam H.; Norton, Gareth J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland	University of Aberdeen	Norton, GJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland.	g.norton@abdn.ac.uk	Talukdar, Partha/AAI-4040-2020	Talukdar, Partha/0000-0001-8825-589X; Douglas, Alex/0000-0001-6606-1058; Price, Adam/0000-0003-3094-0485; Norton, Gareth/0000-0003-4560-170X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J003336/1]; Biotechnology and Biological Sciences Research Council [BB/J003336/1] Funding Source: researchfish; BBSRC [BB/J003336/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was partially funded by a Biotechnology and Biological Sciences Research Council (BBSRC) grant (BB/J003336/1) awarded to AHP. The work was also supported by a self-funded studentship (PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2002, ENVIRON SCI TECHNOL, V36, P962, DOI 10.1021/es0101678; Basten JC, 2001, QTL CARTOGRAPHER VER; Bryant R, 2011, GENETICA, V139, P1383, DOI 10.1007/s10709-012-9637-x; Dai WM, 2008, EUPHYTICA, V160, P317, DOI 10.1007/s10681-007-9501-8; Dai WM, 2005, CROP SCI, V45, P1345, DOI 10.2135/cropsci2004.0505; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Eizenga GC, 2014, J PLANT REGIST, V8, P109, DOI 10.3198/jpr2013.03.0013crmp; Hayes JE, 2013, FUNCT PLANT BIOL, V40, P618, DOI 10.1071/FP12329; Jia Y, 2012, ENVIRON SCI TECHNOL, V46, P8090, DOI 10.1021/es300499a; Li RY, 2009, PLANT PHYSIOL, V150, P2071, DOI 10.1104/pp.109.140350; Lomax C, 2012, NEW PHYTOL, V193, P665, DOI 10.1111/j.1469-8137.2011.03956.x; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Mitani N, 2005, J EXP BOT, V56, P1255, DOI 10.1093/jxb/eri121; Norton GJ, 2012, ANN APPL BIOL, V161, P46, DOI 10.1111/j.1744-7348.2012.00549.x; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Norton GJ, 2009, EUPHYTICA, V166, P229, DOI 10.1007/s10681-008-9833-z; Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Rains DW, 2006, PLANT SOIL, V280, P223, DOI 10.1007/s11104-005-3082-x; Sakurai G, 2015, PLANT CELL PHYSIOL, V56, P631, DOI 10.1093/pcp/pcv017; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Sparks JP, 2011, BIOGEOCHEMISTRY, V104, P237, DOI 10.1007/s10533-010-9498-2; Sun GX, 2009, ENVIRON INT, V35, P473, DOI 10.1016/j.envint.2008.07.020; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P191; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P183; Wang D.L., 1999, USER MANUAL QTLMAPPE; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wu QS, 2006, PLANT SCI, V171, P441, DOI 10.1016/j.plantsci.2006.05.001; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yoshida S., 1981, FUNDAMENTAL RICE CRO; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	45	6	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137577	10.1371/journal.pone.0137577	http://dx.doi.org/10.1371/journal.pone.0137577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356220	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800063
J	Tong, DY; Jin, Y; Xue, TY; Ma, XY; Zhang, JX; Ou, XL; Cheng, JD; Sun, HY				Tong, Dayue; Jin, Yi; Xue, Tianyu; Ma, Xiaoyan; Zhang, Jinxiang; Ou, Xueling; Cheng, Jianding; Sun, Hongyu			Investigation of the Application of miR10b and miR135b in the Identification of Semen Stains	PLOS ONE			English	Article							BODY-FLUID IDENTIFICATION; MICRORNA BIOGENESIS; MARKERS; PCR	To evaluate the identification method using the microRNA markers miR10b and miR135b to distinguish semen stains from menstrual blood, peripheral blood, vaginal fluid and so on body fluid stains. The expression levels of miR10b and miR35b in semen stains and menstrual blood and so on were detected utilizing a real-time quantitative PCR technique with a specific fluorescence-labeled TaqMan probe. RNU6b was used as the internal reference gene; the difference in their expression was analyzed, and the specificity, sensitivity, and detection capability of the techniques were evaluated. The expression of miR10b and miR135b in semen stains was significantly higher than that of other body fluid stains, with a mean value of Delta C-T from-6 to-7. However, it ranged from-2 to-4 for other body fluid stains. The initial criteria for judging which semen stains can be identified were determined by analyzing the research results. When the threshold value was set to 0.04, the C-T value could be detected in the target genes miR10b, miR135b and in the internal reference gene RNU6b, and C-T values are< 40, Delta C-T[10b-U6]<-5.5, and Delta C-T[135b-U6]<-6, respectively, and the semen stain could be identified. The expression levels of miR10b and miR135b are higher in semen with strong tissue specificity; thus, they can be used to differentiate semen stains from other body fluid stains in forensic science.	[Tong, Dayue; Xue, Tianyu; Ma, Xiaoyan; Zhang, Jinxiang; Ou, Xueling; Cheng, Jianding; Sun, Hongyu] Sun Yat Sen Univ, Zhongshan Schoool Med, Forens Biol Sect, Guangzhou 510080, Guangdong, Peoples R China; [Jin, Yi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510630, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Sun, HY (corresponding author), Sun Yat Sen Univ, Zhongshan Schoool Med, Forens Biol Sect, Guangzhou 510080, Guangdong, Peoples R China.	sunhongyu125678@21cn.com	Ou, Xueling/W-9964-2019; MA, XIAO/HHN-5611-2022; Sun, 宏钰/H-7885-2018	Ou, Xueling/0000-0003-2345-4980; Sun, 宏钰/0000-0002-5926-4495	National Natural Science Foundation [30400519]; Scientific Research Foundation of Ministry of Education [2008-890]; Ministry of Public Security [2007YYCXGDST079]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Ministry of Education; Ministry of Public Security	This research is supported by the National Natural Science Foundation (30400519), the Scientific Research Foundation of Ministry of Education (2008-890), and the application innovation program of the Ministry of Public Security (2007YYCXGDST079).	An JH, 2012, BMB REP, V45, P545, DOI 10.5483/BMBRep.2012.45.10.206; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Gao Lin-Lin, 2011, Fa Yi Xue Za Zhi, V27, P455; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanson Erin K, 2013, Methods Mol Biol, V1024, P221, DOI 10.1007/978-1-62703-453-1_18; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Uchimoto ML, 2013, FORENSIC SCI INT-GEN, V7, P418, DOI 10.1016/j.fsigen.2013.04.006; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Wang Z, 2013, FORENSIC SCI INT-GEN, V7, P116, DOI 10.1016/j.fsigen.2012.07.006; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069856; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	14	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137067	10.1371/journal.pone.0137067	http://dx.doi.org/10.1371/journal.pone.0137067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355456	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800026
J	Tully, T; Potapov, M				Tully, Thomas; Potapov, Mikhail			Intraspecific Phenotypic Variation and Morphological Divergence of Strains of Folsomia candida (Willem) (Collembola: Isotomidae), the "Standard" Test Springtaill	PLOS ONE			English	Article							BRISTLE PATTERNS; EVOLUTION; VARIABILITY; CHAETOTAXY	We describe and compare the external morphology of eleven clonal strains and one sexual lineage of the globally distributed Folsomia candida, known as "standard" test Collembola. Of the 18 morphological characters studied, we measured 14 to have significant between-strains genetic variations, 9 of these had high heritabilities (> 78%). The quantified morphological polymorphism was used to analyse the within-species relationships between strains by using both a parsimony analysis and a distance tree. These two detailed morphological phylogenies have revealed that the parthenogenetic strains grouped themselves into two major clades. However the exact position of the sexual strain remains unclear and further analysis is needed to confirm its exact relationship with the parthenogenetic ones. The two morphologically based clades were found to be the same as the ones previously described using molecular analysis. This shows that despite large within-strain variations, morphological characters can be used to differentiate some strains that have diverged within a single morphospecies. We discuss the potential evolutionary interpretations and consequences of these different levels of phenotypic variability.	[Tully, Thomas] Sorbonne Univ, Univ Paris 06, CNRS, iEES Paris,UMR 7618, Paris, France; [Tully, Thomas] Univ Paris 04, ESPE Paris, Paris, France; [Potapov, Mikhail] Moscow State Pedag Univ, Dept Zool & Ecol, Moscow 119435, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite; Moscow State University of Education	Tully, T (corresponding author), Sorbonne Univ, Univ Paris 06, CNRS, iEES Paris,UMR 7618, Paris, France.	thomas.tully@upmc.fr		Tully, Thomas/0000-0003-1847-7504; Potapov, Mikhail/0000-0002-6111-3354	Ministry of Education and Science of the Russian Federation [6.632.2014/K]; Angence Nationale de la Recherche [ANR-09-PEXT-011]; UPMC; CNRS (France)	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Angence Nationale de la Recherche; UPMC(University of Pittsburgh); CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This study received financial support of the Ministry of Education and Science of the Russian Federation (Project No 6.632.2014/K) and of the Angence Nationale de la Recherche ANR-09-PEXT-011 and from UPMC and CNRS (France).	Barateiro Diogo J, 2007, J SOIL SEDIMENT, V7, P388, DOI 10.1065/jss2007.09.252; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bruce Walsh., 1998, GENETICS ANAL QUANTI; Bur T, 2012, SCI TOTAL ENVIRON, V414, P187, DOI 10.1016/j.scitotenv.2011.10.029; Chenon P, 2000, APPL SOIL ECOL, V14, P103, DOI 10.1016/S0929-1393(00)00047-0; Chernova NM., 2010, ENTOMOL REV, V90, P23, DOI DOI 10.1134/S0013873810010033; CHRISTIANSEN K, 1968, EVOLUTION, V22, P237, DOI 10.1111/j.1558-5646.1968.tb05891.x; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; Cicconardi F, 2013, MOL ECOL, V22, P5382, DOI 10.1111/mec.12472; Crouau Y, 1999, APPL SOIL ECOL, V12, P103, DOI 10.1016/S0929-1393(99)00002-5; Crouau Y, 2003, APPL SOIL ECOL, V22, P175, DOI 10.1016/S0929-1393(02)00128-2; de Boer TE, 2011, MOL ECOL, V20, P1144, DOI 10.1111/j.1365-294X.2010.04985.x; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Environnement Canada, 2007, METH ESS BIOL ESS ME; Faddeeva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130600; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Gibert JM, 2005, DEV BIOL, V288, P194, DOI 10.1016/j.ydbio.2005.09.032; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Goto H. E., 1961, Entomologist London, V94, P105; Gough HJ, 1973, ENTOMOLOGISTS MONTHL, V108, P205; Grens A, 1995, DEVELOPMENT, V121, P4027; GROW A, 1976, REV ECOL BIOL SOL, V13, P611; GROW AB, 1974, REV ECOL BIOL SOL, V11, P377; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Hopkin Steve P., 1998, Antenna, V22, P117; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; ISO (International Organization for Standardization), 2014, 11267 ISO; Krogh P.H., 2009, TOXICITY TESTING COL; LAWRENCE PN, 1978, REV ECOL BIOL SOL, V15, P265; Lawrence PN, 1961, ENTOMOLOGIST, V94, P151; Le Bourlot V, 2014, AM NAT, V184, P609, DOI 10.1086/678083; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Mendonca M.C., 1992, B MUSEU NACL NOVA Z, V351, P1; MUTT JAM, 1984, INT J ENTOMOL, V26, P369; Paradis E., 2012, ANAL PHYLOGENETICS E; PETERSEN H, 1978, 1ST INT SEM APT SIEN, P19; Pfeffer SP, 2010, PEDOBIOLOGIA, V54, P19, DOI 10.1016/j.pedobi.2010.08.003; PITKIN BR, 1980, SYST ENTOMOL, V5, P405, DOI 10.1111/j.1365-3113.1980.tb00425.x; Porco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046056; Potapov M, 2001, ISOTOMIDAE SYNOPSES, V3; Potapov M.B., 1984, P26; Potapov MB, 2000, PEDOBIOLOGIA, V44, P234, DOI 10.1078/S0031-4056(04)70043-8; Potapov M, 2012, ANN SOC ENTOMOL FR, V48, P51, DOI 10.1080/00379271.2012.10697750; PRABHOO NR, 1976, ENTOMON, V1, P67; RAPOPORT E. H., 1962, ANN AND MAG NAT HIST, V5, P205; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; RUSEK JOSEF, 1964, VESTNIK CESK SPOLECNOSTI ZOOL, V28, P44; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schneider C, 2013, INVERTEBR SYST, V27, P317, DOI 10.1071/IS13002; Schneider Clement, 2011, Soil Organisms, V83, P383; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Simpson P, 1999, DEVELOPMENT, V126, P1349; Simpson P, 2007, TRENDS GENET, V23, P350, DOI 10.1016/j.tig.2007.04.006; Stach J., 1947, APTERYGOTAN FAUNA PO; Stam EM, 1996, OECOLOGIA, V107, P283, DOI 10.1007/BF00328444; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Tully T, 2011, EVOLUTION, V65, P3013, DOI 10.1111/j.1558-5646.2011.01347.x; Tully T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003207; Waagner D, 2010, COMP BIOCHEM PHYS A, V157, P177, DOI 10.1016/j.cbpa.2010.06.171; WETTON MN, 1987, SYST ENTOMOL, V12, P257, DOI 10.1111/j.1365-3113.1987.tb00201.x; WHALLEY P, 1981, NATURE, V291, P317, DOI 10.1038/291317a0; Willem V., 1902, Annales de la Societe Entomologique de Belgique, Vxlvi, P275; Yoshii R., 1994, ANN SPEL I JAPAN, V12, P1; Zhang F, 2014, ZOOL SCR, V43, P393, DOI 10.1111/zsc.12056	70	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136047	10.1371/journal.pone.0136047	http://dx.doi.org/10.1371/journal.pone.0136047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355293	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800010
J	Dorneles, EMS; Lima, GK; Teixeira-Carvalho, A; Araujo, MSS; Martins, OA; Sriranganathan, N; Al Qublan, H; Heinemann, MB; Lage, AP				Dorneles, Elaine M. S.; Lima, Graciela K.; Teixeira-Carvalho, Andrea; Araujo, Marcio S. S.; Martins-Filho, Olindo A.; Sriranganathan, Nammalwar; Al Qublan, Hamzeh; Heinemann, Marcos B.; Lage, Andrey P.			Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51	PLOS ONE			English	Article							STRAIN RB51; BALB/C MICE; PROTECTIVE IMMUNITY; NEOSPORA-CANINUM; T-CELLS; INTRACELLULAR BACTERIA; CYTOTOXIC LYMPHOCYTES; ERADICATION PROGRAMS; BOVINE BRUCELLOSIS; C57BL/6 MICE	Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6-1.2 x 10(11) CFU) or RB51 (1.3 x 10(10) CFU) on day 0, and revaccinated with RB51 (1.3 x 10(10) CFU) on day 365 of the experiment. Characterization of the immune response was performed using serum and peripheral blood mononuclear cells. Blood samples were collected on days 0, 28, 210, 365, 393 and 575 post-immunization. Results showed that S19 and RB51 vaccination induced an immune response characterized by proliferation of CD4(+) and CD8(+) T-cells; IFN-gamma and IL-17A production by CD4(+) T-cells; cytotoxic CD8(+) T-cells; IL-6 secretion; CD4(+) and CD8(+) memory cells; antibodies of IgG1 class; and expression of the phenotypes of activation in T-cells. However, the immune response stimulated by S19 compared to RB51 showed higher persistency of IFN-. and CD4(+) memory cells, induction of CD21(+) memory cells and higher secretion of IL-6. After RB51 revaccination, the immune response was chiefly characterized by increase in IFN-. expression, proliferation of antigen-specific CD4(+) and CD8(+) T-cells, cytotoxic CD8(+) T-cells and decrease of IL-6 production in both groups. Nevertheless, a different polarization of the immune response, CD4(+)or CD8(+)-dominant, was observed after the booster with RB51 for S19 and RB51 prime-vaccinated animals, respectively. Our results indicate that after prime vaccination both vaccine strains induce a strong and complex Th1 immune response, although after RB51 revaccination the differences between immune profiles induced by prime-vaccination become accentuated.	[Dorneles, Elaine M. S.; Lima, Graciela K.; Lage, Andrey P.] Univ Fed Minas Gerais, Lab Bacteriol Aplicada, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil; [Teixeira-Carvalho, Andrea; Araujo, Marcio S. S.; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Sriranganathan, Nammalwar; Al Qublan, Hamzeh] Virginia Polytech Inst & State Univ, Ctr Mol Med & Infect Dis, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll,Vet Med, Blacksburg, VA 24061 USA; [Heinemann, Marcos B.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Med Vet & Zootecnia, Sao Paulo, SP, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Virginia Polytechnic Institute & State University; Universidade de Sao Paulo	Lage, AP (corresponding author), Univ Fed Minas Gerais, Lab Bacteriol Aplicada, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Dorneles, Elaine/J-1115-2016; Martins-Filho, Olindo Assis/ABE-6278-2021; Araujo, Marcio Sobreira Silva/ABE-7105-2021; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos B/G-2780-2015; Heinemann, Marcos Bryan/AAI-9390-2020	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos B/0000-0001-6444-9788; Heinemann, Marcos Bryan/0000-0001-6444-9788	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig); FEP - MVZ Coordenacao Preventiva; CNPq; Capes (Ciencia Sem Fronteiras) [8808-13]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FEP - MVZ Coordenacao Preventiva; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes (Ciencia Sem Fronteiras)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) and FEP - MVZ Coordenacao Preventiva. ATC, OAMF, MBH and APL thank CNPq for their fellowships. EMSD thanks CNPq and Capes (Ciencia Sem Fronteiras 8808-13) for her fellowship as well.	Andrews E, 2006, MICROBIOL IMMUNOL, V50, P389, DOI 10.1111/j.1348-0421.2006.tb03805.x; ARAYA LN, 1990, INFECT IMMUN, V58, P254, DOI 10.1128/IAI.58.1.254-256.1990; ARAYA LN, 1989, J IMMUNOL, V143, P3330; Banks HT, 2011, B MATH BIOL, V73, P116, DOI 10.1007/s11538-010-9524-5; Bernues A, 1997, PREV VET MED, V30, P137, DOI 10.1016/S0167-5877(96)01103-8; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Brasil, 2007, EST COND VAC FEM BOV, P6; Brasil, 2004, REG TECN PROGR NAC C, P6; Brasil, 2006, MAN TECN PROGR NAC C; CHEVILLE NF, 1993, AM J VET RES, V54, P1591; Cheville NF, 1996, AM J VET RES, V57, P1153; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Colby LA, 2002, J WILDLIFE DIS, V38, P752, DOI 10.7589/0090-3558-38.4.752; CONFER AW, 1985, VET MICROBIOL, V10, P561, DOI 10.1016/0378-1135(85)90065-3; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; DIAZ R, 1968, J BACTERIOL, V96, P893, DOI 10.1128/JB.96.4.893-901.1968; Dorneles EMS, 2015, GENET MOL RES, V14, P940, DOI 10.4238/2015.February.3.1; Dorneles EMS, 2015, VACCINE, V33, P3659, DOI 10.1016/j.vaccine.2015.05.057; Dorneles EMS, 2014, VACCINE, V32, P6034, DOI 10.1016/j.vaccine.2014.08.060; Dorneles EMS, 2015, VET RES IN PRESS; Estes DM, 2002, VET IMMUNOL IMMUNOP, V90, P1, DOI 10.1016/S0165-2427(02)00201-5; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hersperger AR, 2008, CYTOM PART A, V73A, P1050, DOI 10.1002/cyto.a.20596; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Hoek A, 2009, VET RES, V40, DOI 10.1051/vetres:2008044; Hu XD, 2009, DNA CELL BIOL, V28, P191, DOI 10.1089/dna.2008.0790; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; LASALLE JM, 1991, J IMMUNOL, V147, P774; Luo D, 2006, INFECT IMMUN, V74, P2734, DOI 10.1128/IAI.74.5.2734-2741.2006; Manthei CA, 1959, SUMMARY CONTROLLED R, V19, P91; McDiarmid A., 1960, Veterinary Record, V72, P917; MCDIARMID A., 1957, Veterinary Record, V69, P877; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Miranda KL, 2015, VACCINE, V33, P507, DOI 10.1016/j.vaccine.2014.11.056; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; MYERS DM, 1972, APPL MICROBIOL, V23, P894, DOI 10.1128/AEM.23.5.894-902.1972; OIE, 2009, MANUAL DIAGNOSTIC TE; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Olsen S C, 2000, Vet Ther, V1, P183; Olsen SC, 2005, EXPERT REV VACCINES, V4, P915, DOI 10.1586/14760584.4.6.915; Palmer MV, 1997, AM J VET RES, V58, P472; Pasquali P, 2001, INFECT IMMUN, V69, P6541, DOI 10.1128/IAI.69.10.6541-6544.2001; Pasquevich KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016203; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Polci A, 2006, Vet Ital, V42, P147; R RCT, 2013, LANG ENV STAT COMP; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1531, DOI 10.1016/j.ijpara.2007.04.021; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1521, DOI 10.1016/j.ijpara.2007.04.020; REDMAN DR, 1967, J AM VET MED ASSOC, V150, P403; Rosinha GMS, 2002, J MED MICROBIOL, V51, P661, DOI 10.1099/0022-1317-51-8-661; Garcia JVSY, 2008, MICROBES INFECT, V10, P635, DOI 10.1016/j.micinf.2008.02.010; Garcia JVSY, 2010, MICROBES INFECT, V12, P1236, DOI 10.1016/j.micinf.2010.09.009; Sampaio IBM, 2002, ESTATISTICA APLICADA; Sanakkayala N, 2005, CLIN DIAGN LAB IMMUN, V12, P1429, DOI 10.1128/CDLI.12.12.1429-1436.2005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Siegrist C-A, 2013, VACCINES, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5; Singh R, 2012, INDIAN J EXP BIOL, V50, P239; SMITH R, 1990, VET IMMUNOL IMMUNOP, V25, P83, DOI 10.1016/0165-2427(90)90112-6; Splitter G, 1996, VET IMMUNOL IMMUNOP, V54, P309, DOI 10.1016/S0165-2427(96)05703-0; Srisuradetchai P, 2013, SKILLINGS MACK SKILL; STEVENS MG, 1994, INFECT IMMUN, V62, P3206, DOI 10.1128/IAI.62.8.3206-3212.1994; STEVENS MG, 1995, VET IMMUNOL IMMUNOP, V44, P223, DOI 10.1016/0165-2427(94)05311-F; STEVENS MG, 1994, INFECT IMMUN, V62, P4646, DOI 10.1128/IAI.62.10.4646-4649.1994; TOBIAS L, 1992, RES VET SCI, V53, P179, DOI 10.1016/0034-5288(92)90107-D; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vemulapalli R, 2002, VET MICROBIOL, V90, P521, DOI 10.1016/S0378-1135(02)00232-8; Vemulapalli R, 2000, CLIN DIAGN LAB IMMUN, V7, P114, DOI 10.1128/CDLI.7.1.114-118.2000; Vemulapalli R, 2007, VET PARASITOL, V148, P219, DOI 10.1016/j.vetpar.2007.06.029; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; WYCKOFF JH, 1993, VET IMMUNOL IMMUNOP, V36, P45, DOI 10.1016/0165-2427(93)90005-O; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yu DH, 2007, VACCINE, V25, P6744, DOI 10.1016/j.vaccine.2007.06.061; Yu DH, 2007, DNA CELL BIOL, V26, P435, DOI 10.1089/dna.2006.0552; ZHAN YF, 1993, INFECT IMMUN, V61, P2841, DOI 10.1128/IAI.61.7.2841-2847.1993; ZHAN YF, 1995, INFECT IMMUN, V63, P720, DOI 10.1128/IAI.63.2.720-723.1995	82	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136696	10.1371/journal.pone.0136696	http://dx.doi.org/10.1371/journal.pone.0136696			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352261	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800046
J	Kauhl, B; Heil, J; Hoebe, CJPA; Schweikart, J; Krafft, T; Dukers-Muijrers, NHTM				Kauhl, Boris; Heil, Jeanne; Hoebe, Christian J. P. A.; Schweikart, Juergen; Krafft, Thomas; Dukers-Muijrers, Nicole H. T. M.			The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants-An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots	PLOS ONE			English	Article							GENERAL-POPULATION; COST-EFFECTIVENESS; HCV INFECTION; UNITED-STATES; RISK-FACTORS; PREVALENCE; DISEASE; SEROPREVALENCE; IDENTIFICATION; EPIDEMIOLOGY	Background Hepatitis C Virus (HCV) infections are a major cause for liver diseases. A large proportion of these infections remain hidden to care due to its mostly asymptomatic nature. Population-based screening and screening targeted on behavioural risk groups had not proven to be effective in revealing these hidden infections. Therefore, more practically applicable approaches to target screenings are necessary. Geographic Information Systems (GIS) and spatial epidemiological methods may provide a more feasible basis for screening interventions through the identification of hotspots as well as demographic and socio-economic determinants. Methods Analysed data included all HCV tests (n = 23,800) performed in the southern area of the Netherlands between 2002-2008. HCV positivity was defined as a positive immunoblot or polymerase chain reaction test. Population data were matched to the geocoded HCV test data. The spatial scan statistic was applied to detect areas with elevated HCV risk. We applied global regression models to determine associations between population-based determinants and HCV risk. Geographically weighted Poisson regression models were then constructed to determine local differences of the association between HCV risk and population-based determinants. Results HCV prevalence varied geographically and clustered in urban areas. The main population at risk were middle-aged males, non-western immigrants and divorced persons. Socio-economic determinants consisted of one-person households, persons with low income and mean property value. However, the association between HCV risk and demographic as well as socio-economic determinants displayed strong regional and intra-urban differences. Discussion The detection of local hotspots in our study may serve as a basis for prioritization of areas for future targeted interventions. Demographic and socio-economic determinants associated with HCV risk show regional differences underlining that a one-size-fits-all approach even within small geographic areas may not be appropriate. Future screening interventions need to consider the spatially varying association between HCV risk and associated demographic and socio-economic determinants.	[Kauhl, Boris; Krafft, Thomas] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Schweikart, Juergen] Beuth Univ Appl Sci, Dept Civil Engn & Geoinformat 3, Berlin, Germany	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kauhl, B (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands.	boris.kauhl@maastrichtuniversity.nl	Dukers-Muijrers, Nicole/M-7178-2014	Heil, Jeanne/0000-0002-0057-9599; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Krafft, Thomas/0000-0002-6164-7815; Hoebe, Christian/0000-0003-1815-0974				Alencar CH, 2012, TROP MED INT HEALTH, V17, P518, DOI 10.1111/j.1365-3156.2011.02945.x; Alter M. J., 1998, MMWR MORB MORTAL WKL, V47; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Anselin L, 2005, EXPLORING SPATIAL DA; Bao YP, 2012, JAIDS-J ACQ IMM DEF, V60, P438, DOI 10.1097/QAI.0b013e31825694f2; Berke O, 2003, J VET MED B, V50, P322, DOI 10.1046/j.1439-0450.2003.00689.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bush KR, 2008, SEX TRANSM DIS, V35, P291, DOI 10.1097/OLQ.0b013e31815c1edb; Cavlek TV, 2009, J MED VIROL, V81, P1348, DOI 10.1002/jmv.21530; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Culver DH, 2000, TRANSFUSION, V40, P1176, DOI 10.1046/j.1537-2995.2000.40101176.x; Desenclos J-C, 2003, Euro Surveill, V8, P99; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Dore GJ, 2011, CURR OPIN HIV AIDS, V6, P508, DOI 10.1097/COH.0b013e32834b87f8; Du P, 2010, CANCER CAUSE CONTROL, V21, P1669, DOI 10.1007/s10552-010-9596-4; ESRI, 2013, EXPL REGR WORKS; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gebo KA, 2002, HOPKINS HIV REP S, V14, pi; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181; Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Jones RC, 2006, PUBLIC HEALTH REP, V121, P133, DOI 10.1177/003335490612100206; Kauhl B, 2015, HEALTH PLACE, V31, P111, DOI 10.1016/j.healthplace.2014.11.002; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2013, SATSCANTM USER GUIDE; Lawson AB, 2000, STAT MED, V19, P2217; Lin CH, 2011, INT J ENV RES PUB HE, V8, P2798, DOI 10.3390/ijerph8072798; LOVETT A, 1989, PROF GEOGR, V41, P190, DOI 10.1111/j.0033-0124.1989.00190.x; LOVETT AA, 1986, SOC SCI MED, V23, P935, DOI 10.1016/0277-9536(86)90251-0; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mujeeb SA, 2000, PUBLIC HEALTH, V114, P413, DOI 10.1016/S0033-3506(00)00375-9; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Nakaya T., 2012, GWR4 USER MANUAL; OECD, 2013, DEM CHANG NETH STRAT; Paez A, 2011, ENVIRON PLANN A, V43, P2992, DOI 10.1068/a44111; Perz JF, 2004, ESTIMATED GLOBAL PRE; POOLE MA, 1971, T I BRIT GEOGR, P145, DOI 10.2307/621706; Rodrigues Neto Joao, 2012, Rev Bras Epidemiol, V15, P627; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shoff C, 2012, DEMOGR RES, V27, P377; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Slavenburg S, 2008, NETH J MED, V66, P13; Smith BD, 2014, AM J PREV MED, V47, P233, DOI 10.1016/j.amepre.2014.05.011; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Statistics Netherlands, 2015, STATL; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tsai PJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-191; Tsai Pui-Jen, 2013, Glob J Health Sci, V5, P101, DOI 10.5539/gjhs.v5n3p101; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Veldhuijzen Irene K, 2009, Int J Infect Dis, V13, pe9, DOI 10.1016/j.ijid.2008.05.1224; Vermeiren APA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051194; Vriend HJ, 2013, EPIDEMIOL INFECT, V141, P1310, DOI 10.1017/S0950268812001884; Vriend HJ, 2012, EUR J PUBLIC HEALTH, V22, P819, DOI 10.1093/eurpub/cks013; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110861; Weisent J, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-45; WHO, 2014, GUID SCREEN CAR TREA; Zheng S, 2014, EPIDEMIOL INFECT, V142, P1751, DOI 10.1017/S0950268813002586; Zuure FR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-66	67	36	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135656	10.1371/journal.pone.0135656	http://dx.doi.org/10.1371/journal.pone.0135656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352611	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800012
J	Aravindhan, V; Mohan, V; Arunkumar, N; Sandhya, S; Babu, S				Aravindhan, Vivekanandhan; Mohan, Viswanathan; Arunkumar, Namasivayam; Sandhya, Sreedharan; Babu, Subash			Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; URBAN-RURAL EPIDEMIOLOGY; BINDING PROTEIN; ENVIRONMENTAL-FACTORS; GUT PERMEABILITY; DISEASE; SERUM; LPS; NEPHROPATHY; PROGRESSION	Background Lipopolysaccharide (LPS)/Endotoxin is hypothesized to play an important role in chronic inflammation associated with Type-1 diabetes (T1DM) and its complications. Endotoxin core antibodies (EndoCAb), LPS binding protein (LBP) and soluble CD14 (sCD14) act as modulators of LPS induced activation of innate immune system in vivo. For the present study we estimated the levels of LPS and its translocation markers in T1DM subjects with and without microvascular complications (MVC) and correlate them with clinical parameters of T1DM and serum inflammatory cytokine levels (TNF-alpha, IL-6, IL-1 beta and GM-CSF). Methods A total of 197 subjects (64 normal glucose tolerance (NGT) subjects, 97 T1DM subjects without MVC and 36 with MVC) were included in this study and the levels of serum LPS, its translocation markers and cytokines measured by immunoassays. Results Compared to NGT, T1DM subjects (both with and without MVC) had significantly higher levels of LPS, reduced levels of LBP and EndoCAb along with significant increase in the levels of IL-1 beta, IL-6, TNF-alpha and GM-CSF (p<0.05). No significant change was seen in the levels of these biomarkers between T1DM subjects with and without MVC. Conclusions Decreased levels of EndoCAb and LBP suggest sustained endotoxin activity in T1DM subjects even before the onset of microvascular complications.	[Aravindhan, Vivekanandhan; Sandhya, Sreedharan] Anna Univ, AU KBC Res Ctr, Chennai 600025, Tamil Nadu, India; [Aravindhan, Vivekanandhan] Univ Madras, Dept Genet, Dr ALM PG IBMS, Chennai 600113, Tamil Nadu, India; [Mohan, Viswanathan] Int Diabet Federat IDF Ctr Educ, Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Mohan, Viswanathan] Int Diabet Federat IDF Ctr Educ, Dr Mohans Diabet Specialties Ctr, WHO Collaborating Ctr Noncommunicable Dis Prevent, Chennai, Tamil Nadu, India; [Arunkumar, Namasivayam] Algorithm Inc, Biostat & Programming, Bengaluru, India; [Babu, Subash] Natl Inst Res TB, Natl Inst Hlth, Int Ctr Excellence Res, Chennai, Tamil Nadu, India	Anna University; Anna University Chennai; University of Madras; Madras Diabetes Research Foundation; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Aravindhan, V (corresponding author), Anna Univ, AU KBC Res Ctr, MIT Campus, Chennai 600025, Tamil Nadu, India.	cvaravindhan@gmail.com	Babu, Subash/GXG-4746-2022	Aravindhan, Vivekanandhan/0000-0002-5639-4948	DST FAST TRACK [SR/FT/LS-105/2009]; DST-FIST program; UGC-SAP program; Intramural Research Program of the Division of Intramural Research, NIAID, NIH, US	DST FAST TRACK; DST-FIST program(Department of Science & Technology (India)); UGC-SAP program; Intramural Research Program of the Division of Intramural Research, NIAID, NIH, US	The project was partially funded by DST FAST TRACK (http://www.serb.gov.in/home.php) grant obtained by VA (SR/FT/LS-105/2009). This study was also supported by the Intramural Research Program of the Division of Intramural Research, NIAID, NIH, US. The Dept of Genetics, University of Madras has received funds for infrastructural support from DST-FIST and UGC-SAP programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkanani AK, 2012, DIABETES, V61, P2525, DOI 10.2337/db12-0099; Amutha A, 2011, PRIM CARE DIABETES, V5, P223, DOI 10.1016/j.pcd.2011.04.003; Anuradha R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002749; Aravindhan V, 2013, J CLIN EXPT CARDIOLO, V4, P1; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Eshcol J, 2014, J DIABETES COMPLICAT, V28, P627, DOI 10.1016/j.jdiacomp.2014.04.013; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; Kumar NP, 2013, CLIN VACCINE IMMUNOL, V20, P704, DOI 10.1128/CVI.00038-13; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Mohan Viswanathan, 2013, J Assoc Physicians India, V61, P12; Monte SV, 2012, SURGERY, V151, P587, DOI 10.1016/j.surg.2011.09.038; Moretti EW, 2006, ARCH SURG-CHICAGO, V141, P637, DOI 10.1001/archsurg.141.7.637; Mussap M, J MATERN FETAL NE S2, V24, P12; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Nistico L, 2012, J CLIN ENDOCR METAB, V97, pE1483, DOI 10.1210/jc.2011-3457; Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200; Nymark M, 2009, DIABETES CARE, V32, P1689, DOI 10.2337/dc09-0467; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Pradeepa R, 2015, DIABETES TECHNOL THE, V17, P112, DOI 10.1089/dia.2014.0141; Ruiz AG, 2007, OBES SURG, V17, P1374; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Surendar J, 2012, DIABETES TECHNOL THE, V14, P344, DOI 10.1089/dia.2011.0182; Unnikrishnan R, 2007, DIABETES CARE, V30, P2019, DOI 10.2337/dc06-2554; Vaarala O, 2008, CURR OPIN GASTROEN, V24, P701, DOI 10.1097/MOG.0b013e32830e6d98; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	32	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137618	10.1371/journal.pone.0137618	http://dx.doi.org/10.1371/journal.pone.0137618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367738	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100097
J	Dou, WB; Zhang, MY; Zhang, XJ; Li, Y; Chen, HY; Li, SW; Lu, M; Dai, JP; Constans, JM				Dou, Weibei; Zhang, Mingyu; Zhang, Xiaojie; Li, Yuan; Chen, Hongyan; Li, Shaowu; Lu, Min; Dai, Jianping; Constans, Jean-Marc			Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel H-1-MRS Applied to Brain Tumor Analysis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; CEREBRAL GLIOMA GRADE; NONINVASIVE EVALUATION; PREDICTIVE VALUES; DIFFUSION; TIME; QUANTIFICATION; SPECIFICITY; SENSITIVITY	Background Magnetic Resonance Spectroscopy (MRS) can measure in vivo brain tissue metabolism that exhibits unique biochemical characteristics in brain tumors. For clinical application, an efficient and versatile quantification method of MRS would be an important tool for medical research, particularly for exploring the scientific problem of tumor monitoring. The objective of our study is to propose an automated MRS quantitative approach and assess the feasibility of this approach for glioma grading, prognosis and boundary detection. Methods An automated quantitative approach based on a convex envelope (AQoCE) is proposed in this paper, including preprocessing, convex-envelope based baseline fitting, bias correction, sectional baseline removal, and peak detection, in a total of 5 steps. Some metabolic ratios acquired by this quantification are selected for statistical analysis. An independent sample t-test and the Kruskal-Wallis test are used for distinguishing low-grade gliomas (LGG) and high-grade gliomas (HGG) and for detecting the tumor, peritumoral and contralateral areas, respectively. Seventy-eight cases of pre-operative brain gliomas with pathological reports are included in this study. Results Cho/NAA, Cho/Cr and Lip-Lac/Cr (LL/Cr) calculated by AQoCE in the tumor area differ significantly between LGG and HGG, with p <= 0.005. Using logistic regression combining Cho/NAA, Cho/Cr and LL/Cr to generate a ROC curve, AQoCE achieves a sensitivity of 92.9%, a specificity of 72.2%, and an area under ROC curve (AUC) of 0.860. Moreover, both Cho/NAA and Cho/Cr in the AQoCE approach show a significant difference (p <= 0.019) between tumoral, peritumoral, and contralateral areas. The comparison between the results of AQoCE and Siemens MRS processing software are also discussed in this paper. Conclusions The AQoCE approach is an automated method of residual water removal and metabolite quantification. It can be applied to multi-voxel H-1-MRS for evaluating brain glioma grading and demonstrating characteristics of brain glioma metabolism. It can also detect infiltration in the peritumoral area. Under the limited clinical data used, AQoCE is significantly more versatile and efficient compared to the reference approach of Siemens.	[Dou, Weibei; Zhang, Xiaojie; Li, Yuan; Lu, Min] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Zhang, Mingyu; Chen, Hongyan; Dai, Jianping] Capital Med Univ, Beijing Tian Tan Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Mingyu; Li, Shaowu; Dai, Jianping] Beijing Neurosurg Inst, Beijing, Peoples R China; [Constans, Jean-Marc] Univ Hosp, Serv Neuroradiol, Amiens, France	Tsinghua University; Capital Medical University; Beijing Neurosurgical Institute; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Dou, WB (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.	douwb@tsinghua.edu.cn; daijianping_2008@126.com	Zhang, mingyu/HGB-1069-2022; Dou, Weibei/K-6044-2012	Dou, Weibei/0000-0001-8555-2776; Constans, Jean-Marc/0000-0002-6751-4378	Natural Science Foundation of China [NSFC-61171002, NSFC-60372023]; Tsinghua University Initiative Scientific Research Program [20131089382]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work was supported by the Natural Science Foundation of China (NSFC-61171002 and NSFC-60372023) and Tsinghua University Initiative Scientific Research Program (Grant No. 20131089382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Brandao LA, 2004, MR SPECTROSCOPY BRAI, P91; Caseiras GB, 2010, EUR J RADIOL, V73, P215, DOI 10.1016/j.ejrad.2008.11.005; Chi P., 2011, BIOINF BIOM ENG ICBB, P1; Cudalbu C, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104034; De Edeleny FS, 2000, NAT MED, V6, P1287, DOI 10.1038/81401; Di Costanzo A, 2008, EUR RADIOL, V18, P1727, DOI 10.1007/s00330-008-0938-5; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Grams AE, 2014, OPEN J RADIOLOGY, V4, P182, DOI DOI 10.4236/0JRAD.2014.42024; Guillevin R, 2011, BRIT J CANCER, V104, P1854, DOI 10.1038/bjc.2011.174; Guillevin R, 2008, J NEURO-ONCOL, V87, P181, DOI 10.1007/s11060-007-9508-y; Guzman-De-Villoria JA, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0035-8; Hlaihel C, 2010, J NEURO-ONCOL, V97, P73, DOI 10.1007/s11060-009-9991-4; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Kwock L, 2006, LANCET ONCOL, V7, P859, DOI 10.1016/S1470-2045(06)70905-6; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Liu ZL, 2012, J INT MED RES, V40, P76, DOI 10.1177/147323001204000108; Majos C, 2009, EUR RADIOL, V19, P2049, DOI 10.1007/s00330-009-1357-y; McKnight TR, 2002, J NEUROSURG, V97, P794, DOI 10.3171/jns.2002.97.4.0794; Metwally LIA, 2014, EGYPT J RADIOL NUC M, V45, P211, DOI 10.1016/j.ejrnm.2013.07.004; Mierisova S, 2001, NMR BIOMED, V14, P247, DOI 10.1002/nbm.697; Nakajima T, 2009, NEUROL MED-CHIR, V49, P394, DOI 10.2176/nmc.49.394; Pedersen CL, 2013, CLIN NEUROL NEUROSUR, V115, P1, DOI 10.1016/j.clineuro.2012.07.002; Pijnappel W, 1992, J MAGN RESON, V97, P97, DOI DOI 10.1016/0022-2364(92)90241-X; Preul MC, 1996, NAT MED, V2, P323, DOI 10.1038/nm0396-323; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Ratiney H, 2004, MAGN RESON MATER PHY, V16, P284, DOI 10.1007/s10334-004-0037-9; Sahin N, 2013, NEURORADIOL J, V26, P531, DOI 10.1177/197140091302600506; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Server A, 2011, EUR J RADIOL, V80, P462, DOI 10.1016/j.ejrad.2010.07.017; Server A, 2010, ACTA RADIOL, V51, P316, DOI 10.3109/02841850903482901; Stadlbauer A, 2006, RADIOLOGY, V238, P958, DOI 10.1148/radiol.2382041896; van den Boogaart A, 1997, MAGN RESON CHEM, V35, pS146, DOI 10.1002/(SICI)1097-458X(199712)35:13<S146::AID-OMR196>3.0.CO;2-X; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VanHuffel S, 1997, SIAM PROC S, P307; Wang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112577; Zeng QS, 2011, MAGN RESON IMAGING, V29, P25, DOI 10.1016/j.mri.2010.07.017	39	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137850	10.1371/journal.pone.0137850	http://dx.doi.org/10.1371/journal.pone.0137850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367871	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100154
J	Lee, YN; Kim, MC; Lee, YT; Hwang, HS; Lee, J; Kim, C; Kang, SM				Lee, Yu-Na; Kim, Min-Chul; Lee, Young-Tae; Hwang, Hye Suk; Lee, Jongsang; Kim, Cheol; Kang, Sang-Moo			Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CONJUGATE VACCINES; MATRIX PROTEIN-2; FC-RECEPTOR; IMMUNOGENICITY; VACCINATION; IMMUNITY; DOMAIN; ECTODOMAIN; PARTICLES	The influenza M2 ectodomain (M2e) is well conserved across human influenza A subtypes, but there are few residue changes among avian and swine origin influenza A viruses. We expressed a tandem repeat construct of heterologous M2e sequences (M2e5x) derived from human, swine, and avian origin influenza A viruses using the yeast expression system. Intramuscular immunization of mice with AS04-adjuvanted M2e5x protein vaccines was effective in inducing M2e-specific antibodies reactive to M2e peptide and native M2 proteins on the infected cells with human, swine, or avian influenza virus, mucosal and systemic memory cellular immune responses, and cross-protection against H3N2 virus. Importantly, M2e5x immune sera were found to confer protection against different subtypes of H1N1 and H5N1 influenza A viruses in naive mice. Also, M2e5x-immune complexes of virus-infected cells stimulated macrophages to secrete cytokines via Fc receptors, indicating a possible mechanism of protection. The present study provides evidence that M2e5x proteins produced in yeast cells could be developed as a potential universal influenza vaccine.	[Lee, Yu-Na; Kim, Min-Chul; Lee, Young-Tae; Hwang, Hye Suk; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Kim, Min-Chul] Anim & Plant Quarantine Agcy, Anyang, Gyeonggi Do, South Korea; [Lee, Jongsang; Kim, Cheol] BEAMS Biotechnol Co Ltd, Seongnam, Gyeonggi Do, South Korea	University System of Georgia; Georgia State University; Animal & Plant Quarantine Agency	Kang, SM (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	skang24@gsu.edu			NIH/NIAID [AI105170, AI093772, AI119366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R01AI093772, R21AI119366] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants AI105170 (SMK), AI093772 (SMK), and AI119366 (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BEAMS Biotechnology Co. Ltd. provided support in the form of salaries for authors JL and CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andersson AMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046395; Boland G, 2004, VACCINE, V23, P316, DOI 10.1016/j.vaccine.2004.06.006; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Hilleman MR, 2000, VACCINE, V18, P1436, DOI 10.1016/S0264-410X(99)00434-X; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Husain M, 2014, INFECT GENET EVOL, V28, P304, DOI 10.1016/j.meegid.2014.10.016; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kim EH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-104; Kim MC, 2014, MOL THER, V22, P1364, DOI 10.1038/mt.2014.33; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Krammer F, 2010, TRENDS MOL MED, V16, P313, DOI 10.1016/j.molmed.2010.05.002; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Lee YN, 2014, IMMUNOLOGY, V143, P300, DOI 10.1111/imm.12310; Lee YN, 2014, VACCINE, V32, P4578, DOI 10.1016/j.vaccine.2014.06.040; Lee YN, 2011, VIROLOGY, V417, P57, DOI 10.1016/j.virol.2011.05.005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Margine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051559; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park JW, 2014, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2014-1; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Sivakumar SM, 2011, SAUDI PHARM J, V19, P197, DOI 10.1016/j.jsps.2011.06.003; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Wong KK, 2012, J INFECT DIS, V206, pS68, DOI 10.1093/infdis/jis585; ZEBEDEE SL, 1989, NUCLEIC ACIDS RES, V17, P2870, DOI 10.1093/nar/17.7.2870; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005	62	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137822	10.1371/journal.pone.0137822	http://dx.doi.org/10.1371/journal.pone.0137822			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366729	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100147
J	Phay, M; Welzel, AT; Williams, AD; McWilliams-Koeppen, HP; Blinder, V; O'Malley, TT; Solomon, A; Walsh, DM; O'Nuallain, B				Phay, Monichan; Welzel, Alfred T.; Williams, Angela D.; McWilliams-Koeppen, Helen P.; Blinder, Veronika; O'Malley, Tiernan T.; Solomon, Alan; Walsh, Dominic M.; O'Nuallain, Brian			IgG Conformer's Binding to Amyloidogenic Aggregates	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; ALZHEIMERS-DISEASE; BETA-PROTEIN; MOUSE MODEL; HUMAN PLASMA; ANTIBODIES; PEPTIDE; RECEPTOR; VIRUS; RAGE	Amyloid-reactive IgGs isolated from pooled blood of normal individuals (pAbs) have demonstrated clinical utility for amyloid diseases by in vivo targeting and clearing amyloidogenic proteins and peptides. We now report the following three novel findings on pAb conformer's binding to amyloidogenic aggregates: 1) pAb aggregates have greater activity than monomers (HMW species > dimers > monomers), 2) pAbs interactions with amyloidogenic aggregates at least partially involves unconventional (non-CDR) interactions of F(ab) regions, and 3) pAb's activity can be easily modulated by trace aggregates generated during sample processing. Specifically, we show that HMW aggregates and dimeric pAbs present in commercial preparations of pAbs, intravenous immunoglobulin (IVIg), had up to similar to 200-and similar to 7-fold stronger binding to aggregates of A beta and transthyretin (TTR) than the monomeric antibody. Notably, HMW aggregates were primarily responsible for the enhanced anti-amyloid activities of A beta- and Cibacron blue-isolated IVIg IgGs. Human pAb conformer's binding to amyloidogenic aggregates was retained in normal human sera, and mimicked by murine pAbs isolated from normal pooled plasmas. An unconventional (non-CDR) component to pAb's activity was indicated from control human mAbs, generated against non-amyloid targets, binding to aggregated A beta and TTR. Similar to pAbs, HMW and dimeric mAb conformers bound stronger than their monomeric forms to amyloidogenic aggregates. However, mAbs had lower maximum binding signals, indicating that pAbs were required to saturate a diverse collection of binding sites. Taken together, our findings strongly support further investigations on the physiological function and clinical utility of the inherent anti-amyloid activities of monomeric but not aggregated IgGs.	[Phay, Monichan; Blinder, Veronika; O'Malley, Tiernan T.; Walsh, Dominic M.; O'Nuallain, Brian] Brigham & Womens Hosp, Harvard Inst Med, Lab Neurodegenerat Res, Boston, MA 02115 USA; [Welzel, Alfred T.; O'Nuallain, Brian] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Williams, Angela D.; McWilliams-Koeppen, Helen P.; Solomon, Alan; O'Nuallain, Brian] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University College Dublin; University of Tennessee System; University of Tennessee Health Science Center	O'Nuallain, B (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Lab Neurodegenerat Res, 75 Francis St, Boston, MA 02115 USA.	briano_nuallain@hotmail.com			Baxter BioScience (Baxter International Inc., Deerfield, IL); SENS Research Foundation	Baxter BioScience (Baxter International Inc., Deerfield, IL); SENS Research Foundation	These studies were funded by an investigator initiated research grant (IIRG) from Baxter BioScience (Baxter International Inc., Deerfield, IL) (BO), and by a research grant from the SENS Research Foundation (BO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis PW, 2014, J BIOL CHEM, V289, P7200, DOI 10.1074/jbc.M113.492215; Ahmadi M, 2015, PHARM RES-DORDR, V32, P1383, DOI 10.1007/s11095-014-1541-x; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Ballow M, 2014, CURR OPIN ALLERGY CL, V14, P509, DOI 10.1097/ACI.0000000000000116; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bevacizumab, 2005, DRUGS IN R D, V3, P28; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; BURTON DR, 1990, TRENDS BIOCHEM SCI, V15, P64, DOI 10.1016/0968-0004(90)90178-E; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeVincenzo JP, 2004, J INFECT DIS, V190, P975, DOI 10.1086/423213; DODEL R, 2010, 2010 DRUGS, V70, P513, DOI DOI 10.2165/11533070-000000000-00000; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gever J, 2013, ALZHEIMERS DISEASE I; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Golde TE, 2009, CNS NEUROL DISORD-DR, V8, P31, DOI 10.2174/187152709787601830; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; HUANG D, 1993, J NEUROIMMUNOL, V48, P199, DOI 10.1016/0165-5728(93)90192-2; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Loeffler DA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-70; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Maftei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068996; Maftei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044516; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; MCCARTHY D, 1981, J IMMUNOL METHODS, V41, P63, DOI 10.1016/0022-1759(81)90274-X; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; NEEPER M, 1992, J BIOL CHEM, V267, P14998; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2010, J CLIN IMMUNOL, V30, pS43, DOI 10.1007/s10875-010-9414-5; Phay M, 2014, REJUV RES, V17, P97, DOI 10.1089/rej.2013.1524; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Rahman MM, 2015, ACS CHEM BIOL, V10, P766, DOI 10.1021/cb5008663; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; REEVES JP, 1995, HYBRIDOMA, V14, P235, DOI 10.1089/hyb.1995.14.235; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Seite JF, 2008, AUTOIMMUN REV, V7, P435, DOI 10.1016/j.autrev.2008.04.012; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; SILVERMAN GJ, 1995, J CLIN INVEST, V96, P417, DOI 10.1172/JCI118051; Solomon A, 2003, CANCER BIOTHER RADIO, V18, P853, DOI 10.1089/108497803322702824; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; St-Amour I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-54; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; VIDAL MA, 1980, J IMMUNOL METHODS, V35, P169, DOI 10.1016/0022-1759(80)90161-1; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Welzel AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050317; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yu Z, 2013, J PHARM SCI-US, V102, P4284, DOI 10.1002/jps.23746; Zilka N, 2008, J ALZHEIMERS DIS, V15, P169	91	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137344	10.1371/journal.pone.0137344	http://dx.doi.org/10.1371/journal.pone.0137344			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367058	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100065
J	Rout, SP; Charles, CJ; Doulgeris, C; McCarthy, AJ; Rooks, DJ; Loughnane, JP; Laws, AP; Humphreys, PN				Rout, Simon P.; Charles, Christopher J.; Doulgeris, Charalampos; McCarthy, Alan J.; Rooks, Dave J.; Loughnane, J. Paul; Laws, Andrew P.; Humphreys, Paul N.			Anoxic Biodegradation of Isosaccharinic Acids at Alkaline pH by Natural Microbial Communities	PLOS ONE			English	Article							GEN. NOV.; GLUCOISOSACCHARINIC ACID; BLACK LIQUOR; FERMENTATION; DEGRADATION; REPOSITORY; COMPLEXATION; METHANOGENS; STABILITY; CELLULOSE	One design concept for the long-term management of the UK's intermediate level radioactive wastes (ILW) is disposal to a cementitious geological disposal facility (GDF). Under the alkaline (10.0 < pH > 13.0) anoxic conditions expected within a GDF, cellulosic wastes will undergo chemical hydrolysis. The resulting cellulose degradation products (CDP) are dominated by alpha- and beta-isosaccharinic acids (ISA), which present an organic carbon source that may enable subsequent microbial colonisation of a GDF. Microcosms established from neutral, near-surface sediments demonstrated complete ISA degradation under methanogenic conditions up to pH 10.0. Degradation decreased as pH increased, with beta-ISA fermentation more heavily influenced than alpha-ISA. This reduction in degradation rate was accompanied by a shift in microbial population away from organisms related to Clostridium sporosphaeroides to a more diverse Clostridial community. The increase in pH to 10.0 saw an increase in detection of Alcaligenes aquatilis and a dominance of hydrogenotrophic methanogens within the Archaeal population. Methane was generated up to pH 10.0 with acetate accumulation at higher pH values reflecting a reduced detection of acetoclastic methanogens. An increase in pH to 11.0 resulted in the accumulation of ISA, the absence of methanogenesis and the loss of biomass from the system. This study is the first to demonstrate methanogenesis from ISA by near surface microbial communities not previously exposed to these compounds up to and including pH 10.0.	[Rout, Simon P.; Charles, Christopher J.; Doulgeris, Charalampos; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [McCarthy, Alan J.; Rooks, Dave J.; Loughnane, J. Paul] Univ Liverpool, Inst Integrat Biol, Microbiol Res Grp, Liverpool L69 3BX, Merseyside, England	University of Huddersfield; University of Liverpool	Humphreys, PN (corresponding author), Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England.	p.n.humphreys@hud.ac.uk	Doulgeris, Charalampos/K-5363-2019; Doulgeris, Charalampos/Q-5016-2019	Humphreys, Paul/0000-0003-3431-7930; Rout, Simon/0000-0001-5778-6145; Doulgeris, Charalampos/0000-0002-4825-2296	EPSRC [EP/I036354/1]; Radioactive Waste Management (RWM); Natural Environment Research Council (NERC); NERC [NE/H007563/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; Natural Environment Research Council [NE/H007563/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management (RWM); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PH was funded by the EPSRC under grant EP/I036354/1 https://www.epsrc.ac.uk and Radioactive Waste Management (RWM) as part of the C14-BIG project. Further information regarding the C14-BIG project can be found at: www.hud.ac.uk/c14-big. The molecular ecology components of this research were supported by the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2006, J SOLUTION CHEM, V35, P1173, DOI 10.1007/s10953-006-9048-7; Almond M, 2012, CARBOHYD RES, V363, P51, DOI 10.1016/j.carres.2012.09.019; [Anonymous], 1999, 576681999 BSI; [Anonymous], 2005, 148532005 BSI ISO; Askarieh MM, 2000, WASTE MANAGE, V20, P93, DOI 10.1016/S0956-053X(99)00275-5; Avis J, 2014, NUCL TECHNOL, V187, P175, DOI 10.13182/NT13-83; BAILEY MJ, 1986, APPL MICROBIOL BIOT, V24, P493; Bassil NM, 2015, ISME J, V9, P310, DOI 10.1038/ismej.2014.125; Bracke G, 2008, J CONTAM HYDROL, V102, P210, DOI 10.1016/j.jconhyd.2008.09.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choung S, 2014, ANN NUCL ENERGY, V71, P6, DOI 10.1016/j.anucene.2014.03.021; Cowper M, SERCO CONTRACTORS RE; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duro L, 2014, APPL GEOCHEM, V49, P192, DOI 10.1016/j.apgeochem.2014.04.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Elberson MA, 1997, INT J SYST BACTERIOL, V47, P1258, DOI 10.1099/00207713-47-4-1258; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Garnova ES, 2004, EXTREMOPHILES, V8, P309, DOI 10.1007/s00792-004-0390-7; Grant WD, 2002, AEATERRA0301 U LEIC; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hsiao CL, 2009, INT J HYDROGEN ENERG, V34, P7173, DOI 10.1016/j.ijhydene.2009.06.028; Huang L, 2014, BIORESOURCE TECHNOL, V153, P87, DOI 10.1016/j.biortech.2013.11.049; Humphreys P. N., 2010, SERCOTAS002274001; Jeon BS, 2010, APPL MICROBIOL BIOT, V88, P1161, DOI 10.1007/s00253-010-2827-5; Keith-Roach MJ, 2008, SCI TOTAL ENVIRON, V396, P1, DOI 10.1016/j.scitotenv.2008.02.030; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Lawson PA, 2014, INT J SYST EVOL MICR, V64, P198, DOI 10.1099/ijs.0.053728-0; Libert M, 2011, PHYS CHEM EARTH, V36, P1616, DOI 10.1016/j.pce.2011.10.010; MAESTROJUAN GM, 1991, INT J SYST BACTERIOL, V41, P267, DOI 10.1099/00207713-41-2-267; Milodowski A., 2013, HARPUR HILL SITE ITS; NDA, 2010, NEAR FIELD EV STAT R; NDA, 2011, 2010 UK RAD WAST INV; NDA, 2012, CARBON 14 PROJECT PH; NIEMELA K, 1990, J CHEM TECHNOL BIOT, V48, P17; Nolla-Ardevol V, 2012, J BIOTECHNOL, V161, P167, DOI 10.1016/j.jbiotec.2012.04.003; PEKAROVICOVA A, 1991, J CHEM TECHNOL BIOT, V52, P539; Rizk S, 1963, JOURNAL OF APPLIED B, V26, P20; Rizoulis A, 2012, MINERAL MAG, V76, P3261, DOI 10.1180/minmag.2012.076.8.39; Rizoulis A, 2016, GEOMICROBIOL J, V33, P73, DOI 10.1080/01490451.2014.961107; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, PLOS ONE, V10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw PB, 2012, CARBOHYD RES, V349, P6, DOI 10.1016/j.carres.2011.11.022; STAMS AJM, 1984, ARCH MICROBIOL, V137, P329, DOI 10.1007/BF00410730; STRAND SE, 1984, APPL ENVIRON MICROB, V47, P268, DOI 10.1128/AEM.47.2.268-271.1984; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Van Soest PJ, 1970, ARS USDA HDB, V379; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; WANG SH, 1993, HOLZFORSCHUNG, V47, P141, DOI 10.1515/hfsg.1993.47.2.141; Warwick P, 2003, RADIOCHIM ACTA, V91, P233, DOI 10.1524/ract.91.4.233.19971; Wilkins MJ, 2007, GEOBIOLOGY, V5, P293, DOI 10.1111/j.1472-4669.2007.00101.x; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380; WU WM, 1992, APPL MICROBIOL BIOT, V38, P282, DOI 10.1007/BF00174484; Xing DF, 2006, INT J SYST EVOL MICR, V56, P755, DOI 10.1099/ijs.0.63926-0; Zhu JX, 2011, INT J SYST EVOL MICR, V61, P2974, DOI 10.1099/ijs.0.027540-0	57	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137682	10.1371/journal.pone.0137682	http://dx.doi.org/10.1371/journal.pone.0137682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367005	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000361601100107
J	Shibasaki, M; Wang, JG; Figueiredo, JL; New, SEP; Quillard, T; Goettsch, C; Koga, J; Sonoki, H; Matsumoto, J; Aikawa, M; Aikawa, E				Shibasaki, Manabu; Wang, Jian-Guo; Figueiredo, Jose-Luiz; New, Sophie E. P.; Quillard, Thibaut; Goettsch, Claudia; Koga, Jun-ichiro; Sonoki, Hiroyuki; Matsumoto, Jiro; Aikawa, Masanori; Aikawa, Elena			Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COA REDUCTASE INHIBITOR; VASCULAR CALCIFICATION; OSTEOPONTIN EXPRESSION; IN-VIVO; STATINS; CHOLESTEROL; MACROPHAGES; SIMVASTATIN; PHOSPHATE	Objectives Chronic renal disease (CRD) accelerates atherosclerosis and cardiovascular calcification. Statins reduce low-density lipoprotein-cholesterol levels in patients with CRD, however, the benefits of statins on cardiovascular disease in CRD remain unclear. This study has determined the effects of pitavastatin, the newest statin, on arterial inflammation and calcification in atherogenic mice with CRD. Methods and Results CRD was induced by 5/6 nephrectomy in cholesterol-fed apolipoprotein E-deficient mice. Mice were randomized into three groups: control mice, CRD mice, and CRD mice treated with pitavastatin. Ultrasonography showed that pitavastatin treatment significantly attenuated luminal stenosis in brachiocephalic arteries of CRD mice. Near-infrared molecular imaging and correlative Mac3 immunostaining demonstrated a significant reduction in macrophage accumulation in pitavastatin-treated CRD mice. Pitavastatin treatment reduced levels of osteopontin in plasma and atherosclerotic lesions in CRD mice, but did not produce a significant reduction in calcification in atherosclerotic plaques as assesses by histology. CRD mice had significantly higher levels of phosphate in plasma than did control mice, which did not change by pitavastatin. In vitro, pitavastatin suppressed the expression of osteopontin in peritoneal macrophages stimulated with phosphate or calcium/phosphate in concentrations similar to those found in human patients with CRD. Conclusion Our study provides in vivo evidence that pitavastatin reduces inflammation within atherosclerotic lesions in CRD mice.	[Shibasaki, Manabu; Wang, Jian-Guo; Figueiredo, Jose-Luiz; New, Sophie E. P.; Goettsch, Claudia; Sonoki, Hiroyuki; Matsumoto, Jiro; Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,CICS, Boston, MA 02115 USA; [Quillard, Thibaut; Koga, Jun-ichiro; Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,Ctr Excellence Vasc Biol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Aikawa, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,CICS, Boston, MA 02115 USA.	eaikawa@partners.org	Goettsch, Claudia/AAD-9658-2019; Aikawa, Elena/L-6173-2019; Quillard, Thibaut/K-8150-2015	Quillard, Thibaut/0000-0002-8096-2597; Goettsch, Claudia/0000-0002-7973-1329; Aikawa, Masanori/0000-0002-9275-2079; Aikawa, Elena/0000-0001-7835-2135	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health [R01HL107550, R01HL114805, R01HL109506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109506, R01HL114805, R01HL107550] Funding Source: NIH RePORTER	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a research grant from Kowa Company, Ltd. (Tokyo, Japan, to M.A.) and the National Institutes of Health grants (R01HL107550 to M.A. and R01HL114805; R01HL109506 to E.A.). Kowa had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Aikawa M, 2001, CIRCULATION, V103, P276; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Cheng XW, 2011, J HYPERTENS, V29, P542, DOI 10.1097/HJH.0b013e328341cedf; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Fatherazi S, 2009, J DENT RES, V88, P39, DOI 10.1177/0022034508328072; Fujii M, 2007, KIDNEY INT, V72, P473, DOI 10.1038/sj.ki.5002366; Fukumoto Y, 2001, CIRCULATION, V103, P993; Haynes R, 2014, J AM SOC NEPHROL, V25, P1825, DOI 10.1681/ASN.2013090965; HIROTA S, 1993, AM J PATHOL, V143, P1003; Ivanovski O, 2008, J UROLOGY, V179, P1631, DOI 10.1016/j.juro.2007.11.042; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kadoglou NPE, 2014, CLIN DRUG INVEST, V34, P165, DOI 10.1007/s40261-013-0157-y; Kalaitzidis RG, 2011, AM J NEPHROL, V34, P195, DOI 10.1159/000330355; Kimata H, 1998, XENOBIO METABOL DISP, V13, P484, DOI DOI 10.2133/DMPK.13.484; Koga J, 2009, ARTERIOSCL THROM VAS, V29, P458, DOI 10.1161/ATVBAHA.109.183772; Kon V, 2011, NAT REV NEPHROL, V7, P45, DOI 10.1038/nrneph.2010.157; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Levin A, 2012, NAT REV NEPHROL, V8, P70, DOI 10.1038/nrneph.2011.195; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Matter CM, 2009, EUR HEART J, V30, P2566, DOI 10.1093/eurheartj/ehp419; Mazhar AR, 2001, KIDNEY INT, V60, P324, DOI 10.1046/j.1523-1755.2001.00803.x; Moody WE, 2012, ATHEROSCLEROSIS, V223, P86, DOI 10.1016/j.atherosclerosis.2012.01.043; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Saito Y, 2009, VASC HEALTH RISK MAN, V5, P921; Sata M, 2004, HYPERTENSION, V43, P1214, DOI 10.1161/01.HYP.0000126186.29571.41; Scalia R, 2001, CIRCULATION, V103, P2598; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Swaminathan S, 2011, KIDNEY INT, V80, P453, DOI 10.1038/ki.2011.178; Takemoto M, 2001, BRIT J PHARMACOL, V133, P83, DOI 10.1038/sj.bjp.0704046; Thukkani AK, 2013, AM J NUCL MED MOLEC, V3, P217; Towler DA, 2008, IBMS BONEKEY, V5, P41, DOI DOI 10.1138/20080298; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138047	10.1371/journal.pone.0138047	http://dx.doi.org/10.1371/journal.pone.0138047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367531	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100209
J	Brennan, MD; Rexius-Hall, ML; Eddington, DT				Brennan, Martin D.; Rexius-Hall, Megan L.; Eddington, David T.			A 3D-Printed Oxygen Control Insert for a 24-Well Plate	PLOS ONE			English	Article							MICROFLUIDIC DEVICES; CHEMICAL-SYNTHESIS; HYPOXIA; REACTIONWARE; POLY(DIMETHYLSILOXANE); NETWORKS; PLATFORM; LAB	3D printing has emerged as a method for directly printing complete microfluidic devices, although printing materials have been limited to oxygen-impermeable materials. We demonstrate the addition of gas permeable PDMS (Polydimethylsiloxane) membranes to 3D-printed microfluidic devices as a means to enable oxygen control cell culture studies. The incorporation of a 3D-printed device and gas-permeable membranes was demonstrated on a 24-well oxygen control device for standard multiwell plates. The direct printing allows integrated distribution channels and device geometries not possible with traditional planar lithography. With this device, four different oxygen conditions were able to be controlled, and six wells were maintained under each oxygen condition. We demonstrate enhanced transcription of the gene VEGFA (vascular endothelial growth factor A) with decreasing oxygen levels in human lung adenocarcinoma cells. This is the first 3D-printed device incorporating gas permeable membranes to facilitate oxygen control in cell culture.	[Brennan, Martin D.; Rexius-Hall, Megan L.; Eddington, David T.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Eddington, DT (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	dte@uic.edu	, Martin/R-3672-2018	, Martin/0000-0002-1118-0911	National Science Foundation [1253060]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation 1253060, DTE (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1253060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Bley CR, 2011, LUNG CANCER, V73, P294, DOI 10.1016/j.lungcan.2011.01.010; Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007; Causier A, 2015, LAB CHIP, V15, P2049, DOI 10.1039/c5lc00193e; Chen CP, 2014, ANALYST, V139, P3219, DOI 10.1039/c3an02357e; Chi A, 2014, DRUG DELIV TRANSL RE, V4, P320, DOI 10.1007/s13346-014-0198-7; Chisholm G, 2014, ENERG ENVIRON SCI, V7, P3026, DOI 10.1039/c4ee01426j; Comina G, 2014, LAB CHIP, V14, P2978, DOI 10.1039/c4lc00394b; Comina G, 2014, LAB CHIP, V14, P424, DOI 10.1039/c3lc50956g; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Femmer T, 2014, LAB CHIP, V14, P2610, DOI 10.1039/c4lc00320a; Gelber MK, 2015, LAB CHIP, V15, P1736, DOI 10.1039/c4lc01392a; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gregory C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082307; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Kamei K, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9928-y; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; King PH, 2014, LAB CHIP, V14, P722, DOI 10.1039/c3lc51072g; Kitson PJ, 2013, CHEM SCI, V4, P3099, DOI 10.1039/c3sc51253c; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Kitson PJ, 2014, ANGEW CHEM INT EDIT, P1; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep07717; Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; McDonald JC, 2002, ANAL CHEM, V74, P1537, DOI 10.1021/ac010938q; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Oppegard SC, 2010, LAB CHIP, V10, P2366, DOI 10.1039/c004856a; Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891; Rexius-Hall ML, 2014, LAB CHIP, V14, P4688, DOI 10.1039/c4lc01168f; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Shallan AI, 2014, ANAL CHEM, V86, P3124, DOI 10.1021/ac4041857; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Sinkala E, 2010, LAB CHIP, V10, P3291, DOI 10.1039/c0lc00244e; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Tek P, 2008, J NEUROSCI METH, V172, P263, DOI 10.1016/j.jneumeth.2008.03.011; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e; Wang XD, 2014, CHEM SOC REV, V43, P3666, DOI 10.1039/c4cs00039k; Yuen PK, 2008, LAB CHIP, V8, P1374, DOI 10.1039/b805086d	49	28	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137631	10.1371/journal.pone.0137631	http://dx.doi.org/10.1371/journal.pone.0137631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360882	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100058
J	Langhagen, T; Albers, L; Heinen, F; Straube, A; Filippopulos, F; Landgraf, MN; Gerstl, L; Jahn, K; von Kries, R				Langhagen, Thyra; Albers, Lucia; Heinen, Florian; Straube, Andreas; Filippopulos, Filipp; Landgraf, Mirjam N.; Gerstl, Lucia; Jahn, Klaus; von Kries, Ruediger			Period Prevalence of Dizziness and Vertigo in Adolescents	PLOS ONE			English	Article							MIGRAINE; COMMUNITY; SYMPTOMS; CLASSIFICATION; EPIDEMIOLOGY; CHILDREN	Objectives To assess the period prevalence and severity of dizziness and vertigo in adolescents. Methods In 1661 students in 8th-10th grade in twelve grammar schools in Munich, Germany information on vertigo/dizziness was assessed by a questionnaire in the class room setting. Three month prevalence of dizziness/vertigo was estimated; symptoms were categorized as orthostatic dizziness, spinning vertigo, swaying vertigo or unspecified dizziness. Duration of symptoms and impact on daily life activities were assessed. Results 72.0% (95%-CI = [69.8-74.2]; N = 1196) of the students (mean age 14.5 +/- 1.1) reported to suffer fromat least one episode of dizziness or vertigo in the last three months. Most adolescents ticked to have symptoms of orthostatic dizziness (52.0%, 95%-CI = [49.5-54.4], N = 863). The period prevalence for the other types of vertigo were spinning vertigo: 11.6%, 95%-CI = [10.1-13.3], N = 193; swaying vertigo: 12.2%, 95%-CI = [10.6-13.8], N = 202; and unspecified dizziness: 15.2%, 95%-CI = [13.5-17.1], N = 253. About 50% of students with spinning vertigo and swaying vertigo also report to have orthostatic dizziness. Most vertigo/dizziness types were confined to less than one minute on average. The proportion of students with any dizziness/vertigo accounting for failure attending school, leisure activities or obliging them to stay in bed were more pronounced for spinning or swaying vertigo. Conclusion Dizziness and vertigo in grammar school students appear to be as common as in adults. In face of the high period prevalence and clinical relevance of dizziness/vertigo in adolescents there is a need for prevention strategies. Risk factors for dizziness/vertigo need to be assessed to allow for conception of an intervention programme.	[Langhagen, Thyra; Heinen, Florian; Landgraf, Mirjam N.; Gerstl, Lucia] Univ Munich, Hauner Childrens Hosp, Dept Paediat Neurol & Dev Med, Munich, Germany; [Langhagen, Thyra; Heinen, Florian; Straube, Andreas; Filippopulos, Filipp; Landgraf, Mirjam N.; Gerstl, Lucia; Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Albers, Lucia; von Kries, Ruediger] Univ Munich, Div Epidemiol, Inst Social Paediat & Adolescents Med, Munich, Germany; [Straube, Andreas; Filippopulos, Filipp; Jahn, Klaus] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Jahn, Klaus] Schon Klin Bad Aibling, Bad Aibling, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Langhagen, T (corresponding author), Univ Munich, Hauner Childrens Hosp, Dept Paediat Neurol & Dev Med, Munich, Germany.	Thyra.Langhagen@med.uni-muenchen.de	Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010; Heinen, Florian/B-6594-2015	Jahn, Klaus/0000-0002-1669-3652; Heinen, Florian/0000-0002-3872-6136	DMKG (German Headache Society); German Federal Ministry of Education and Research [01 EO1401]	DMKG (German Headache Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by an unrestricted fund of the DMKG (German Headache Society) and by the German Federal Ministry of Education and Research (Grant code 01 EO1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers L, 2014, EUR J NEUROL; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Best C, 2009, J NEUROL, V256, P58, DOI 10.1007/s00415-009-0038-8; Bisdorff A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00029; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Kizlauskas M, 2009, DIE ENTWICKLUNG DER; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Lempert T, 2014, REV NEUROL-FRANCE, V170, P401, DOI 10.1016/j.neurol.2013.05.010; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Niemensivu R, 2006, INT J PEDIATR OTORHI, V70, P259, DOI 10.1016/j.ijporl.2005.06.015; Radtke A, 2002, NEUROLOGY, V59, P1700, DOI 10.1212/01.WNL.0000036903.22461.39; Radtke A, 2011, CLIN AUTON RES, V21, P161, DOI 10.1007/s10286-010-0114-2; Russell G, 1999, INT J PEDIATR OTORHI, V49, pS105, DOI 10.1016/S0165-5876(99)00143-3; Thijs RD, 2006, NEUROLOGY, V66, P1034, DOI 10.1212/01.wnl.0000204186.43597.66; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wiltink J, 2009, J PSYCHOSOM RES, V66, P417, DOI 10.1016/j.jpsychores.2008.09.012; Wu JS, 2008, HYPERTENS RES, V31, P897, DOI 10.1291/hypres.31.897; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	22	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136512	10.1371/journal.pone.0136512	http://dx.doi.org/10.1371/journal.pone.0136512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361225	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100012
J	Prince, SA; Reed, JL; Mark, AE; Blanchard, CM; Grace, SL; Reid, RD				Prince, Stephanie A.; Reed, Jennifer L.; Mark, Amy E.; Blanchard, Christopher M.; Grace, Sherry L.; Reid, Robert D.			A Comparison of Accelerometer Cut-Points among Individuals with Coronary Artery Disease	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; CARDIORESPIRATORY FITNESS; SECONDARY PREVENTION; FUNCTIONAL-CAPACITY; AEROBIC CAPACITY; HEART-DISEASE; EXERCISE; VALIDATION; GUIDELINES	Background Accurate assessment of physical activity among coronary artery disease patients is important for assessing adherence to interventions. The study compared moderate-to-vigorous physical intensity activity and relationships with cardiometabolic health/fitness indicators using accelerometer cut-points developed for coronary artery disease patients versus those developed in younger and middle-aged adults. Methods A total of 231 adults with coronary artery disease wore an Actigraph GT3X accelerometer for >= 4 days (>= 10 hours/day). Moderate-to-vigorous intensity physical activity between cut-points was compared using Bland-Altman analyses. Partial spearman correlations assessed relationships between moderate-to-vigorous intensity physical activity from each cut-point with markers of cardiometabolic health and fitness while controlling for age and sex. Results Average time spent in bouts of moderate-to-vigorous intensity physical activity using coronary artery disease cut-points was significantly higher than the young (mean difference: 13.0 +/- 12.8 minutes/day) or middle-aged (17.0 +/- 15.2 minutes/day) cut-points. Young and middle-aged cut-points were more strongly correlated with body mass index, waist circumference and systolic blood pressure, while coronary artery disease cut-points had stronger relationships with triglycerides, high-density and low-density lipoproteins. All were similarly correlated with measures of fitness. Conclusion Researchers need to exert caution when deciding on which cut-points to apply to their population. Further work is needed to validate which cut-points provide a true reflection of moderate-to-vigorous intensity physical activity and to examine relationships among patients with varying fitness.	[Prince, Stephanie A.; Reed, Jennifer L.; Reid, Robert D.] Univ Ottawa, Inst Heart, Div Prevent & Rehabil, Ottawa, ON, Canada; [Mark, Amy E.] Inst Clin Evaluat Serv, Ottawa, ON, Canada; [Blanchard, Christopher M.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Grace, Sherry L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Grace, Sherry L.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; Dalhousie University; York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Prince, SA (corresponding author), Univ Ottawa, Inst Heart, Div Prevent & Rehabil, Ottawa, ON, Canada.	sprinceware@ottawaheart.ca	Reed, Jennifer/J-8086-2019; Grace, Sherry L/H-1388-2013; Prince, Stephanie A./J-9361-2019	Reed, Jennifer/0000-0001-8006-8555; Grace, Sherry L/0000-0001-7063-3610; Prince, Stephanie A./0000-0001-6729-5649	Gordon E. Allen Post-Doctoral Fellowship; Strategic Endowed Research Fellowship from the UOHI Foundation; Canadian Institutes of Health Research Fellowship; UOHI; Heart and Stroke Foundation of Ontario [6838, 000109]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Gordon E. Allen Post-Doctoral Fellowship; Strategic Endowed Research Fellowship from the UOHI Foundation; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); UOHI; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SAP was funded by a Gordon E. Allen Post-Doctoral Fellowship and is currently funded by a Strategic Endowed Research Fellowship from the UOHI Foundation and a Canadian Institutes of Health Research Fellowship. JLR held a Jan and Ian Craig Endowed Fellowship from the UOHI. AEM held a Health Services/Population Health Post-Doctoral Research Fellowship Award from the Heart and Stroke Foundation of Ontario (grant FPDL # 6838). The ECO-PCR study was funded by the Heart and Stroke Foundation of Ontario (Grant # 000109).	Ades PA, 2006, CIRCULATION, V113, P2706, DOI 10.1161/CIRCULATIONAHA.105.606624; American College of Sports Medicine, 2009, ACSMS GUID EX TEST P; BUSKIRK ER, 1987, FASEB J, V46, P1824; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Colley RC, 2011, HLTH REP, V22, P7; Davidson MH, 2004, PROG CARDIOVASC DIS, V47, P73, DOI 10.1016/j.pcad.2004.04.007; DeFina LF, 2015, PROG CARDIOVASC DIS, V57, P324, DOI 10.1016/j.pcad.2014.09.008; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Grace SL, 2014, PROG CARDIOVASC DIS, V56, P530, DOI 10.1016/j.pcad.2013.09.010; HARTUNG GH, 1981, AM HEART J, V101, P181, DOI 10.1016/0002-8703(81)90664-5; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Humphrey R, 2014, PROG CARDIOVASC DIS, V56, P551, DOI 10.1016/j.pcad.2013.08.004; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lavie CJ, 2009, MAYO CLIN PROC, V84, P373, DOI [10.4065/84.4.373, 10.1016/S0025-6196(11)60548-X]; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Menezes AR, 2014, PROG CARDIOVASC DIS, V56, P522, DOI 10.1016/j.pcad.2013.09.018; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Ozemek C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-53; Parker BA, 2010, EUR J APPL PHYSIOL, V110, P235, DOI 10.1007/s00421-010-1506-7; PATTERSON JA, 1972, AM J CARDIOL, V30, P757, DOI 10.1016/0002-9149(72)90151-8; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Statistics Canada, PHYS ACT LEIS TIM 20; Stone JA, 2009, CANADIAN GUIDELINES, P1; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WEBER KT, 1987, CIRCULATION, V76, P40; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2011, GLOB STAT REP ALC HL	36	20	20	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137759	10.1371/journal.pone.0137759	http://dx.doi.org/10.1371/journal.pone.0137759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361345	gold, Green Submitted, Green Published			2022-12-27	WOS:000361043100085
J	Song, W; Jiang, KJ; Zhang, FY; Lin, Y; Ma, LB				Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo			Transcriptome Sequencing, De Novo Assembly and Differential Gene Expression Analysis of the Early Development of Acipenser baeri	PLOS ONE			English	Article							SIBERIAN STURGEON; EARLY ONTOGENY; IDENTIFICATION; ANNOTATION; FULVESCENS; GENERATION; ZEBRAFISH; DISCOVERY; RIBOSOME; GONADS	The molecular mechanisms that drive the development of the endangered fossil fish species Acipenser baeri are difficult to study due to the lack of genomic data. Recent advances in sequencing technologies and the reducing cost of sequencing offer exclusive opportunities for exploring important molecular mechanisms underlying specific biological processes. This manuscript describes the large scale sequencing and analyses of mRNA from Acipenser baeri collected at five development time points using the Illumina Hiseq2000 platform. The sequencing reads were de novo assembled and clustered into 278167 unigenes, of which 57346 (20.62%) had 45837 known homologues proteins in Uniprot protein databases while 11509 proteins matched with at least one sequence of assembled unigenes. The remaining 79.38% of unigenes could stand for non-coding unigenes or unigenes specific to A. baeri. A number of 43062 unigenes were annotated into functional categories via Gene Ontology (GO) annotation whereas 29526 unigenes were associated with 329 pathways by mapping to KEGG database. Subsequently, 3479 differentially expressed genes were scanned within developmental stages and clustered into 50 gene expression profiles. Genes preferentially expressed at each stage were also identified. Through GO and KEGG pathway enrichment analysis, relevant physiological variations during the early development of A. baeri could be better cognized. Accordingly, the present study gives insights into the transcriptome profile of the early development of A. baeri, and the information contained in this large scale transcriptome will provide substantial references for A. baeri developmental biology and promote its aquaculture research.	[Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Ma, LB (corresponding author), Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China.	malingbo@vip.sina.com	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013; Jiang, keji/F-1519-2010	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; 	National Natural Science Foundation of China [31302161]; National Infrastructure of Fishery Germplasm Resources	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Fishery Germplasm Resources	This work was supported by the National Natural Science Foundation of China (No. 31302161) and the National Infrastructure of Fishery Germplasm Resources.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BROWN DD, 1962, DEV BIOL, V5, P412, DOI 10.1016/0012-1606(62)90022-2; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Docan Angelica, 2011, AACL Bioflux, V4, P180; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Gisbert E, 1998, AQUACULTURE, V167, P195, DOI 10.1016/S0044-8486(98)00312-3; Gisbert E, 1999, J FISH BIOL, V54, P852, DOI 10.1111/j.1095-8649.1999.tb02037.x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hagihara S, 2014, J APPL ICHTHYOL, V30, P1557, DOI 10.1111/jai.12588; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; King TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102784; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Rajkov J, 2014, J HERED, V105, P521, DOI 10.1093/jhered/esu027; Raymakers C, 2006, J APPL ICHTHYOL, V22, P53, DOI 10.1111/j.1439-0426.2007.00929.x; Rodriguez A, 2002, J APPL ICHTHYOL, V18, P280, DOI 10.1046/j.1439-0426.2002.00406.x; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Yuan LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115251; Zhu L, 2014, DEV COMP IMMUNOL, V42, P138, DOI 10.1016/j.dci.2013.08.020	26	10	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137450	10.1371/journal.pone.0137450	http://dx.doi.org/10.1371/journal.pone.0137450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359664	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100039
J	Altwasser, R; Baldin, C; Weber, J; Guthke, R; Kniemeyer, O; Brakhage, AA; Linde, J; Valiante, V				Altwasser, Robert; Baldin, Clara; Weber, Jakob; Guthke, Reinhard; Kniemeyer, Olaf; Brakhage, Axel A.; Linde, Joerg; Valiante, Vito			Network Modeling Reveals Cross Talk of MAP Kinases during Adaptation to Caspofungin Stress in Aspergillus fumigatus	PLOS ONE			English	Article							CELL-WALL STRESS; TRANSCRIPTION FACTOR; PATHWAYS; IDENTIFICATION; RESISTANCE; SURVIVAL; SYSTEM; DRUGS; GENE; TOOL	Mitogen activated protein kinases (MAPKs) are highly conserved in eukaryotic organisms. In pathogenic fungi, their activities were assigned to different physiological functions including drug adaptation and resistance. Aspergillus fumigatus is a human pathogenic fungus, which causes life-threatening invasive infections. Therapeutic options against invasive mycoses are still limited. One of the clinically used drugs is caspofungin, which specifically targets the fungal cell wall biosynthesis. A systems biology approach, based on comprehensive transcriptome data sets and mathematical modeling, was employed to infer a regulatory network and identify key interactions during adaptation to caspofungin stress in A. fumigatus. Mathematical modeling and experimental validations confirmed an intimate cross talk occurring between the cell wall-integrity and the high osmolarity-glycerol signaling pathways. Specifically, increased concentrations of caspofungin promoted activation of these signalings. Moreover, caspofungin affected the intracellular transport, which caused an additional osmotic stress that is independent of glucan inhibition. High concentrations of caspofungin reduced this osmotic stress, and thus decreased its toxic activity. Our results demonstrated that MAPK signaling pathways play a key role during caspofungin adaptation and are contributing to the paradoxical effect exerted by this drug.	[Altwasser, Robert; Guthke, Reinhard; Linde, Joerg] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol Bioinformat, D-07745 Jena, Germany; [Baldin, Clara; Weber, Jakob; Kniemeyer, Olaf; Brakhage, Axel A.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Baldin, Clara; Weber, Jakob; Kniemeyer, Olaf; Brakhage, Axel A.] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, D-07745 Jena, Germany; [Kniemeyer, Olaf] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, D-07747 Jena, Germany; [Valiante, Vito] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Leibniz Jr Res Grp Biobricks Microbial Nat Prod S, D-07745 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Linde, J (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol Bioinformat, Adolf Reichwein Str 23, D-07745 Jena, Germany.	joerg.linde@leibniz-hki.de; vito.valiante@leibniz-hki.de	Baldin, Clara/L-7703-2019; Kniemeyer, Olaf/K-1253-2013; Valiante, Vito/E-5640-2016	Kniemeyer, Olaf/0000-0002-9493-6402; Valiante, Vito/0000-0002-4405-169X	ERA-NET PathoGenoMics programme ANTIFUN [BFU2008-04709-E/BMC]; German Federal Ministry of Education and Research [BMBF FKZ 0315439]; DFG; "ARIADNE" Marie Curie Training Network	ERA-NET PathoGenoMics programme ANTIFUN; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); "ARIADNE" Marie Curie Training Network	This work was supported by the ERA-NET PathoGenoMics programme ANTIFUN (The cell wall as a target to improve antifungal therapy against Aspergillosis), BFU2008-04709-E/BMC, (German Federal Ministry of Education and Research: BMBF FKZ 0315439). R.A. was supported by the DFG-founded excellence graduate school Jena School for Microbial Communication (JSMC). J.L. was supported by the DFG-founded CRC/Transregio 124 "FungiNet". C.B. was supported by the "ARIADNE" Marie Curie Training Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Butte A J, 2000, Pac Symp Biocomput, P418; Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen SCA, 2011, DRUGS, V71, P11, DOI 10.2165/11585270-000000000-00000; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dichtl K, 2015, MOL MICROBIOL, V95, P458, DOI 10.1111/mmi.12877; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Forster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033253; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gilsenan JM, 2012, NUCLEIC ACIDS RES, V40, pD660, DOI 10.1093/nar/gkr971; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Juvvadi PR, 2015, ANTIMICROB AGENTS CH, V8; Karthaus M, 2011, EUR J MED RES, V16, P145, DOI 10.1186/2047-783X-16-4-145; Konig CC, 2013, CHEMBIOCHEM, V14, P938, DOI 10.1002/cbic.201300070; Kovacs Z, 2013, FUNGAL GENET BIOL, V54, P1, DOI 10.1016/j.fgb.2013.02.004; Lamoth F, 2014, ANTIMICROB AGENTS CH, V58, P1889, DOI 10.1128/AAC.02286-13; Linde J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-6; Linde J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-148; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Rodriguez-Pena JM, 2010, YEAST, V27, P495, DOI 10.1002/yea.1792; May GS, 2005, MED MYCOL, V43, pS83, DOI 10.1080/13693780400024784; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Muller Sebastian, 2012, BMC Genomics, V13, P519, DOI 10.1186/1471-2164-13-519; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rocha EMF, 2007, ANTIMICROB AGENTS CH, V51, P4174, DOI 10.1128/AAC.00917-07; Samantaray S, 2013, EUKARYOT CELL, V12, P288, DOI 10.1128/EC.00246-12; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valiante V, 2015, ANTIMICROB AGENTS CH, V8; Valiante V, 2015, FRONT MICROBIOL, V6; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Vlaic S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-147; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-1; Winkelstroter LK, 2015, G3-GENES GENOM GENET, V5, P1525, DOI 10.1534/g3.115.016766; Zadra I, 2000, APPL ENVIRON MICROB, V66, P4810, DOI 10.1128/AEM.66.11.4810-4816.2000	51	49	50	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136932	10.1371/journal.pone.0136932	http://dx.doi.org/10.1371/journal.pone.0136932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356475	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800020
J	Dong, HL; Pi, FH; Ding, Z; Chen, W; Pang, SJ; Dong, WY; Zhang, QY				Dong, Hongli; Pi, Fuhua; Ding, Zan; Chen, Wei; Pang, Shaojie; Dong, Wenya; Zhang, Qingying			Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; TRANSIENT ISCHEMIC ATTACK; CARDIOVASCULAR-DISEASE; PLASMA HOMOCYSTEINE; HEART-DISEASE; RISK-FACTOR; MORTALITY; PLACEBO; EVENTS; THERAPY	Background Supplementation with B vitamins for stroke prevention has been evaluated over the years, but which combination of B vitamins is optimal for stroke prevention is unclear. We performed a network meta-analysis to assess the impact of different combinations of B vitamins on risk of stroke. Methods A total of 17 trials (86 393 patients) comparing 7 treatment strategies and placebo were included. A network meta-analysis combined all available direct and indirect treatment comparisons to evaluate the efficacy of B vitamin supplementation for all interventions. Results B vitamin supplementation was associated with reduced risk of stroke and cerebral hemorrhage. The risk of stroke was lower with folic acid plus vitamin B6 as compared with folic acid plus vitamin B12 and was lower with folic acid plus vitamin B6 plus vitamin B12 as compared with placebo or folic acid plus vitamin B12. The treatments ranked in order of efficacy for stroke, from higher to lower, were folic acid plus vitamin B6 > folic acid > folic acid plus vitamin B6 plus vitamin B12 > vitamin B6 plus vitamin B12 > niacin > vitamin B6 > placebo > folic acid plus vitamin B12. Conclusions B vitamin supplementation was associated with reduced risk of stroke; different B vitamins and their combined treatments had different efficacy on stroke prevention. Folic acid plus vitamin B6 might be the optimal therapy for stroke prevention. Folic acid and vitamin B6 were both valuable for stroke prevention. The efficacy of vitamin B12 remains to be studied.	[Dong, Hongli; Ding, Zan; Pang, Shaojie; Dong, Wenya; Zhang, Qingying] Shantou Univ, Coll Med, Dept Prevent Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Pi, Fuhua] Shantou Univ, Coll Med, Dept Sports, Shantou, Guangdong, Peoples R China; [Chen, Wei] Shantou Univ, Coll Med, Dept Neurol, Affiliated Hosp 2, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Zhang, QY (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	qyzhang@stu.edu.cn			Science and Technology Plans of Guangdong Province [2013B021800264]; Natural Science Foundation of Guangdong Province [2014A030313472]	Science and Technology Plans of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the Science and Technology Plans of Guangdong Province (2013B021800264) and the Natural Science Foundation of Guangdong Province (2014A030313472).	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bos MJ, 2005, J NEUROL, V252, P332, DOI 10.1007/s00415-005-0647-9; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Ebbing M, 2010, J INTERN MED, V268, P367, DOI 10.1111/j.1365-2796.2010.02259.x; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Huang T, 2012, CLIN NUTR, V31, P448, DOI 10.1016/j.clnu.2011.01.003; Imasa Marcelo Severino B, 2009, Asian Cardiovasc Thorac Ann, V17, P13, DOI 10.1177/0218492309102494; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Saposnik G, 2009, STROKE, V40, P1365, DOI 10.1161/STROKEAHA.108.529503; Selhub J, 1999, ANN INTERN MED, V131, P331, DOI 10.7326/0003-4819-131-5-199909070-00003; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Towfighi A, 2010, J NEUROL SCI, V298, P153, DOI 10.1016/j.jns.2010.07.013; Van Guelpen B, 2005, STROKE, V36, P1426, DOI 10.1161/01.STR.0000169934.96354.3a; Virtanen JK, 2005, EUR J CARDIOV PREV R, V12, P369, DOI 10.1097/01.hjr.0000160834.75466.b0; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081577; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	41	34	34	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137533	10.1371/journal.pone.0137533	http://dx.doi.org/10.1371/journal.pone.0137533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355679	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800058
J	Sun, HZ; Peng, T; Zhao, YF; Du, YX; Zhang, J; Li, JZ; Xin, ZY; Zhao, QZ				Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi			Dynamic Analysis of Gene Expression in Rice Superior and Inferior Grains by RNA-Seq	PLOS ONE			English	Article							ORYZA-SATIVA L.; DIFFERENT POSITIONS; SUCROSE SYNTHASE; ABSCISIC-ACID; HYBRID RICE; MAJOR QTL; STARCH; YIELD; SPIKELETS; SIZE	Poor grain filling of inferior grains located on lower secondary panicle branch causes great drop in rice yield and quality. Dynamic gene expression patterns between superior and inferior grains were examined from the view of the whole transcriptome by using RNA-Seq method. In total, 19,442 genes were detected during rice grain development. Genes involved in starch synthesis, grain storage and grain development were interrogated in particular in superior and inferior grains. Of the genes involved in sucrose to starch transformation process, most were expressed at lower level in inferior grains at early filling stage compared to that of superior grains. But at late filling stage, the expression of those genes was higher in inferior grains and lower in superior grains. The same trends were observed in the expression of grain storage protein genes. While, evidence that genes involved in cell cycle showed higher expression in inferior grains during whole period of grain filling indicated that cell proliferation was active till the late filling stage. In conclusion, delayed expression of most starch synthesis genes in inferior grains and low capacity of sink organ might be two important factors causing low filling rate of inferior grain at early filling stage, and shortage of carbohydrate supply was a limiting factor at late filling stage.	[Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Collaberat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Rice Engn Ctr, Zhengzhou, Peoples R China; [Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Xin, ZY (corresponding author), Henan Agr Univ, Collaberat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China.	mrxxtz@163.com; qzzhaoh@126.com			National Natural Science Foundation of China [31200973, 30471018]; Program for New Century Excellent Talents in University [NCET-08-0663]; University of Henan Province [2010IRTSTHN005]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [94200510003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); University of Henan Province; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work was supported by the National Natural Science Foundation of China (grant No. 31200973to H.Z.S.), National Natural Science Foundation of China (grant No. 30471018 to Q.-Z.Z.), Program for New Century Excellent Talents in University (grant No. NCET-08-0663 to Q.-Z.Z.), Supported Program for Innovative Research Team (in Science and Technology) in University of Henan Province (grant No 2010IRTSTHN005 to Q.-Z.Z.) and Innovation Scientists and Technicians Troop Construction Projects of Henan Province (grant No. 94200510003 to Q.-Z.Z.).	Abu-Zaitoon YM, 2012, PHYSIOL PLANTARUM, V146, P487, DOI 10.1111/j.1399-3054.2012.01649.x; Bahaji A, 2013, BIOTECHNOL ADV; Baroja-Fernandez E, 2003, PLANT CELL PHYSIOL, V44, P500, DOI 10.1093/pcp/pcg062; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dong MH, 2014, J PROTEOMICS, V109, P382, DOI 10.1016/j.jprot.2014.07.001; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ezquer I, 2010, PLANT CELL PHYSIOL, V51, P1674, DOI 10.1093/pcp/pcq126; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flugge UI, 2011, J EXP BOT, V62, P2381, DOI 10.1093/jxb/erq361; Geiger D, 2011, MOL PLANT, V4, P395, DOI 10.1093/mp/ssr029; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Kawakatsu T, 2008, J EXP BOT, V59, P4233, DOI 10.1093/jxb/ern265; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Peng T, 2015, J INTEGR AGR, V14, P847, DOI 10.1016/S2095-3119(14)60858-3; Peng T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0196-4; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; SINGH R, 1977, PLANT PHYSIOL, V59, P417, DOI 10.1104/pp.59.3.417; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Toyota K, 2006, PLANTA, V223, P248, DOI 10.1007/s00425-005-0128-5; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xu F, 2015, PLANT CELL ENVIRON, V38, P800, DOI 10.1111/pce.12452; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhai H, 2002, SCI CHINA SER C, V45, P637, DOI 10.1007/BF02879752; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	44	21	22	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137168	10.1371/journal.pone.0137168	http://dx.doi.org/10.1371/journal.pone.0137168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355995	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800031
J	Chhibber, AV; Hill, PC; Jafali, J; Jasseh, M; Hossain, MI; Ndiaye, M; Pathirana, JC; Greenwood, B; Mackenzie, GA				Chhibber, Aakash Varun; Hill, Philip C.; Jafali, James; Jasseh, Momodou; Hossain, Mohammad Ilias; Ndiaye, Malick; Pathirana, Jayani C.; Greenwood, Brian; Mackenzie, Grant A.			Child Mortality after Discharge from a Health Facility following Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort Study	PLOS ONE			English	Article							MANAGEMENT; INFECTION	Objective To measure mortality and its risk factors among children discharged from a health centre in rural Gambia. Methods We conducted a cohort study between 12 May 2008 and 11 May 2012. Children aged 2-59 months, admitted with suspected pneumonia, sepsis, or meningitis after presenting to primary and secondary care facilities, were followed for 180 days after discharge. We developed models associating post-discharge mortality with clinical syndrome on admission and clinical risk factors. Findings One hundred and five of 3755 (2.8%) children died, 80% within 3 months of discharge. Among children aged 2-11 and 12-59 months, there were 30 and 29 deaths per 1000 children per 180 days respectively, compared to 11 and 5 respectively in the resident population. Children with suspected pneumonia unaccompanied by clinically severe malnutrition (CSM) had the lowest risk of post-discharge mortality. Mortality increased in children with suspected meningitis or septicaemia without CSM (hazard ratio [HR] 2.6 and 2.2 respectively). The risk of mortality greatly increased with CSM on admission: CSM with suspected pneumonia (HR 8.1; 95% confidence interval (CI) 4.4 to 15), suspected sepsis (HR 18.4; 95% CI 11.3 to 30), or suspected meningitis (HR 13.7; 95% CI 4.2 to 45). Independent associations with mortality were: mid-upper arm circumference (MUAC) of 11.5-13.0 cm compared to > 13.0 cm (HR 7.2; 95% CI 3.0 to 17.0), MUAC 10.5-11.4 cm (HR 24; 95% CI 9.4 to 62), and MUAC <10.5 cm (HR 44; 95% CI 18 to 108), neck stiffness (HR 10.4; 95% CI 3.1 to 34.8), non-medical discharge (HR 4.7; 95% CI 2.0 to 10.9), dry season discharge (HR 2.0; 95% CI 1.2 to 3.3), while greater haemoglobin (HR 0.82; 0.73 to 0.91), axillary temperature (HR 0.71; 95% CI 0.58 to 0.87), and oxygen saturation (HR 0.96; 95% CI 0.93 to 0.99) were associated with reduced mortality. Conclusion Gambian children experience increased mortality after discharge from primary and secondary care. Interventions should target both moderately and severely malnourished children.	[Chhibber, Aakash Varun; Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Jafali, James; Jasseh, Momodou; Hossain, Mohammad Ilias; Ndiaye, Malick; Pathirana, Jayani C.; Mackenzie, Grant A.] Med Res Council UK, Gambia Unit, Fajara, Gambia; [Greenwood, Brian; Mackenzie, Grant A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Mackenzie, Grant A.] Murdoch Childrens Res Inst, Infect & Immun Theme, Melbourne, Vic, Australia	University of Otago; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Murdoch Children's Research Institute	Mackenzie, GA (corresponding author), Med Res Council UK, Gambia Unit, Fajara, Gambia.	gmackenzie@mrc.gm	Jasseh, Momodou/AAB-6071-2022	Mackenzie, Grant/0000-0002-4994-2627; Hossain, Ilias/0000-0002-0571-4702	Global Alliance for Vaccines and Immunisation's PneumoADIP; Bill & Melinda Gates Foundation; MRC (UK); University of Otago; Medical Research Council [MC_UP_1003/1] Funding Source: researchfish; MRC [MC_UP_1003/1] Funding Source: UKRI	Global Alliance for Vaccines and Immunisation's PneumoADIP; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Otago; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Global Alliance for Vaccines and Immunisation's PneumoADIP (http://www.gavi.org/), Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/, MRC (UK) (http://www.mrc.ac.uk/), and the University of Otago (http://www.otago.ac.nz/) funded the work. The funding bodies did not influence the design or implementation of the study or the decision to publish, and the authors alone are responsible for the content of this paper.	Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Burkart KA, 2014, T ROY SOC TROP MED H, V108, P393, DOI 10.1093/trstmh/tru055; Chang RKR, 2006, AM HEART J, V152, P386, DOI 10.1016/j.ahj.2005.12.016; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107663; Cooper S, 2004, INTENS CARE MED, V30, P113, DOI 10.1007/s00134-003-2074-7; Garenne M, 2013, PUBLIC HEALTH NUTR, V16, P1533, DOI 10.1017/S136898001200448X; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; HANLON P, 1987, ANN TROP PAEDIATR, V7, P238, DOI 10.1080/02724936.1987.11748515; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235; National AIDS Control Programme, 2012, HIV SENT SURV REP 20; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; ROY SK, 1983, BRIT MED J, V287, P1097, DOI 10.1136/bmj.287.6399.1097; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; Stark AR, 2008, PEDIATRICS, V121, P627, DOI 10.1542/peds.2007-3282; UNICEF, 2012, ACC PROGR CHILD SURV; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698	25	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137095	10.1371/journal.pone.0137095	http://dx.doi.org/10.1371/journal.pone.0137095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353110	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000360932800061
J	Mei, QM; Dvornyk, V				Mei, Qiming; Dvornyk, Volodymyr			Evolutionary History of the Photolyase/Cryptochrome Superfamily in Eukaryotes	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; BLUE-LIGHT PHOTORECEPTORS; AMINO-ACID SITES; CIRCADIAN CLOCK; DNA PHOTOLYASE; FUNCTIONAL DIVERGENCE; ARABIDOPSIS-THALIANA; MOLECULAR EVOLUTION; GENOME DUPLICATION; CRYSTAL-STRUCTURE	Background Photolyases and cryptochromes are evolutionarily related flavoproteins, which however perform distinct physiological functions. Photolyases (PHR) are evolutionarily ancient enzymes. They are activated by light and repair DNA damage caused by UV radiation. Although cryptochromes share structural similarity with DNA photolyases, they lack DNA repair activity. Cryptochrome (CRY) is one of the key elements of the circadian system in animals. In plants, CRY acts as a blue light receptor to entrain circadian rhythms, and mediates a variety of light responses, such as the regulation of flowering and seedling growth. Results We performed a comprehensive evolutionary analysis of the CRY/PHR superfamily. The superfamily consists of 7 major subfamilies: CPD class I and CPD class II photolyases, (6-4) photolyases, CRY-DASH, plant PHR2, plant CRY and animal CRY. Although the whole superfamily evolved primarily under strong purifying selection (average omega = 0.0168), some subfamilies did experience strong episodic positive selection during their evolution. Photolyases were lost in higher animals that suggests natural selection apparently became weaker in the late stage of evolutionary history. The evolutionary time estimates suggested that plant and animal CRYs evolved in the Neoproterozoic Era (similar to 1000-541 Mya), which might be a result of adaptation to the major climate and global light regime changes occurred in that period of the Earth's geological history.	[Mei, Qiming] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Dvornyk, Volodymyr] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Dvornyk, Volodymyr] Alfaisal Univ, Coll Sci & Gen Studies, Dept Life Sci, Riyadh, Saudi Arabia	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Hong Kong; Alfaisal University	Dvornyk, V (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	dvornyk@hku.hk	Dvornyk, Volodymyr/X-6072-2019; Dvornyk, Volodymyr/C-6031-2008	Dvornyk, Volodymyr/0000-0002-2535-103X; 	University of Hong Kong PhD Fellowship	University of Hong Kong PhD Fellowship(University of Hong Kong)	This study was supported by The University of Hong Kong PhD Fellowship to Mr. Qiming Mei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Akaike H, 1981, ENG TECHNOLOGY APPL, V19, P716; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baca I, 2010, J MOL EVOL, V70, P453, DOI 10.1007/s00239-010-9344-0; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BellPedersen D, 1996, J GENET, V75, P387, DOI 10.1007/BF02966317; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cadar D, 2013, MOL PHYLOGENET EVOL, V66, P243, DOI 10.1016/j.ympev.2012.09.030; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chaves I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023447; Chen JJ, 1996, PLANT PHYSIOL, V111, P19, DOI 10.1104/pp.111.1.19; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvornyk Volodymyr, 2009, P241, DOI 10.1007/978-3-540-88431-6_14; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lau SKP, 2012, J VIROL, V86, P11906, DOI 10.1128/JVI.01305-12; Layeghifard M, 2008, GENE, V426, P65, DOI 10.1016/j.gene.2008.08.014; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08113; Lu A, 2014, MOL BIOL EVOL, V31, P484, DOI 10.1093/molbev/mst198; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mei QM, 2014, CHROMOSOMA, V123, P385, DOI 10.1007/s00412-014-0457-x; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nielsen R, 1998, GENETICS, V148, P929; Nybakken J W, 2001, MARINE BIOL ECOLOGIC; Oliveri P, 2014, MAR GENOM, V14, P23, DOI 10.1016/j.margen.2014.02.001; Paranjpe Dhanashree A, 2005, J Circadian Rhythms, V3, P7, DOI 10.1186/1740-3391-3-7; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Petersen JL, 1999, PLANT MOL BIOL, V40, P1063, DOI 10.1023/A:1006279720960; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; SCHMIDT PW, 1995, EARTH PLANET SC LETT, V134, P107, DOI 10.1016/0012-821X(95)00106-M; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Schopf JW, 1983, EVOLUTION OF THE EAR; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shirai H, 2006, BIOCHEM BIOPH RES CO, V351, P387, DOI 10.1016/j.bbrc.2006.10.031; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sonett CP, 1996, SCIENCE, V273, P100, DOI 10.1126/science.273.5271.100; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Takahashi M, 2011, PLANT J, V66, P433, DOI 10.1111/j.1365-313X.2011.04500.x; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Wade HK, 2001, PLANT J, V25, P675, DOI 10.1046/j.1365-313x.2001.01001.x; Wenderoth N, 1999, BIOL CYBERN, V80, P285, DOI 10.1007/s004220050525; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; ZAHNLE K, 1987, PRECAMBRIAN RES, V37, P95, DOI 10.1016/0301-9268(87)90073-8; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	107	45	49	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135940	10.1371/journal.pone.0135940	http://dx.doi.org/10.1371/journal.pone.0135940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352435	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800020
J	Di Giacomo, G; Campello, S; Corrado, M; Di Giambattista, L; Cirotti, C; Filomeni, G; Gentile, G				Di Giacomo, Giuseppina; Campello, Silvia; Corrado, Mauro; Di Giambattista, Livia; Cirotti, Claudia; Filomeni, Giuseppe; Gentile, Gabriele			Mature Erythrocytes of Iguana iguana (Squamata, Iguanidae) Possess Functional Mitochondria	PLOS ONE			English	Article							RED-BLOOD-CELLS; ELECTRON-MICROSCOPE; OXYGEN-BINDING; HEMOGLOBIN; METABOLISM; CROCODYLUS; EVOLUTION	Electron microscopy analyses of Iguana iguana blood preparations revealed the presence of mitochondria within erythrocytes with well-structured cristae. Fluorescence microscopy analyses upon incubation with phalloidin-FITC, Hoechst 33342 and mitochondrial transmembrane potential (Delta psi(m))-sensitive probe MitoTracker Red indicated that mitochondria i) widely occur in erythrocytes, ii) are polarized, and iii) seem to be preferentially confined at a "perinuclear" region, as confirmed by electron microscopy. The analysis of NADH-dependent oxygen consumption showed that red blood cells retain the capability to consume oxygen, thereby providing compelling evidence that mitochondria of Iguana erythrocytes are functional and capable to perform oxidative phosphorylation.	[Di Giacomo, Giuseppina; Campello, Silvia; Di Giambattista, Livia; Cirotti, Claudia; Filomeni, Giuseppe; Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy; [Campello, Silvia; Corrado, Mauro] IRCCS Fdn Santa Lucia, Rome, Italy; [Corrado, Mauro] Ist Veneto Med Mol, Ist Telethon Dulbecco, Padua, Italy; [Filomeni, Giuseppe] Danish Canc Soc, Res Ctr, Cell Stress & Survival Unit, Copenhagen, Denmark	University of Rome Tor Vergata; IRCCS Santa Lucia; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Danish Cancer Society	Filomeni, G (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy.	filomeni@bio.uniroma2.it; gabriele.gentile@uniroma2.it	cirotti, claudia/AAN-7789-2020; Gentile, Gabriele/E-8945-2013; Campello, Silvia/AAB-3399-2019	cirotti, claudia/0000-0001-6267-8034; Gentile, Gabriele/0000-0002-1045-6816; Filomeni, Giuseppe/0000-0002-2719-1412; campello, silvia/0000-0003-0536-2484				BARTLETT GR, 1980, AM ZOOL, V20, P103; BEAM KG, 1979, J CELL BIOL, V83, P1, DOI 10.1083/jcb.83.1.1; BOUTILIER RG, 1989, CAN J ZOOL, V67, P2986, DOI 10.1139/z89-421; BRASCH K, 1974, J CELL SCI, V15, P659; Bratosin D, 2004, BIOCHIMIE, V86, P183, DOI 10.1016/j.biochi.2004.03.003; Damsgaard C, 2013, AM J PHYSIOL-REG I, V305, pR961, DOI 10.1152/ajpregu.00284.2013; DAVIES HG, 1961, J BIOPHYS BIOCHEM CY, V9, P671, DOI 10.1083/jcb.9.3.671; EDDY FB, 1977, J FISH BIOL, V10, P87, DOI 10.1111/j.1095-8649.1977.tb04044.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GRIGG GC, 1993, J EXP BIOL, V175, P15; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRIS JR, 1971, J ULTRA MOL STRUCT R, V36, P8, DOI 10.1016/S0022-5320(71)80085-0; Herman JK, 1996, J EXP BIOL, V199, P2061; HUNTER AS, 1957, J CELL COMPAR PHYSL, V49, P479, DOI 10.1002/jcp.1030490307; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; LESSLER MA, 1962, RADIAT RES, V17, P111, DOI 10.2307/3571300; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Nikinmaa M., 1990, VERTEBRATE RED BLOOD; OGO SH, 1993, J COMP PHYSIOL B, V163, P614, DOI 10.1007/BF00302122; Olsson M, 2008, BIOL LETTERS, V4, P186, DOI 10.1098/rsbl.2007.0611; Phillips MCL, 2000, J EXP BIOL, V203, P1039; Pica A, 2001, COMP BIOCHEM PHYS B, V128, P213, DOI 10.1016/S1096-4959(00)00312-2; Rozas J, 2009, BIOINFORMATICS; RUCKNAGEL KP, 1988, BIOL CHEM H-S, V369, P1143, DOI 10.1515/bchm3.1988.369.2.1143; Snyder GK, 1999, AM ZOOL, V39, P189; Stier A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-33; Thrall M. A., 2012, Veterinary hematology and clinical chemistry, P61; TIIHONEN K, 1991, J EXP BIOL, V161, P509; TOOZE J, 1967, J CELL SCI, V2, P617; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; YASUZUMI G, 1960, Z ZELLFORSCH MIK ANA, V51, P325; ZENTGRAF H, 1971, J BIOL CHEM, V246, P2986; Zhang ZW, 2011, IUBMB LIFE, V63, P560, DOI 10.1002/iub.490	35	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136770	10.1371/journal.pone.0136770	http://dx.doi.org/10.1371/journal.pone.0136770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367118	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100024
J	Lai, YJ; Chang, GJ; Yeh, YH; Pang, JHS; Huang, CC; Chen, WJ				Lai, Ying-Ju; Chang, Gwo-Jyh; Yeh, Yung-Hsin; Pang, Jong-Hwei S.; Huang, Chung-Chi; Chen, Wei-Jan			Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase	PLOS ONE			English	Article							INHALED ILOPROST; SILDENAFIL; EXPRESSION; PRESENILIN; NOTCH; HYPERTHYROIDISM; VASODILATATION; OVEREXPRESSION; NICASTRIN; INDUCTION	Gamma-secretase-mediated Notch3 signaling is involved in smooth muscle cell (SMC) hyper-activity and proliferation leading to pulmonary arterial hypertension (PAH). In addition, Propylthiouracil (PTU), beyond its anti-thyroid action, has suppressive effects on atherosclerosis and PAH. Here, we investigated the possible involvement of gammasecretase- mediated Notch3 signaling in PTU-inhibited PAH. In rats with monocrotalineinduced PAH, PTU therapy improved pulmonary arterial hypertrophy and hemodynamics. In vitro, treatment of PASMCs from monocrotaline-treated rats with PTU inhibited their proliferation and migration. Immunocyto, histochemistry, and western blot showed that PTU treatment attenuated the activation of Notch3 signaling in PASMCs from monocrotalinetreated rats, which was mediated via inhibition of gamma-secretase expression especially its presenilin enhancer 2 (Pen-2) subunit. Furthermore, over-expression of Pen-2 in PASMCs from control rats increased the capacity of migration, whereas knockdown of Pen2 with its respective siRNA in PASMCs from monocrotaline-treated rats had an opposite effect. Transfection of PASMCs from monocrotaline-treated rats with Pen-2 siRNA blocked the inhibitory effect of PTU on PASMC proliferation and migration, reflecting the crucial role of Pen-2 in PTU effect. We present a novel cell-signaling paradigm in which overexpression of Pen-2 is essential for experimental pulmonary arterial hypertension to promote motility and growth of smooth muscle cells. Propylthiouracil attenuates experimental PAH via suppression of the gamma-secretase-mediated Notch3 signaling especially its presenilin enhancer 2 (Pen-2) subunit. These findings provide a deep insight into the pathogenesis of PAH and a novel therapeutic strategy.	[Lai, Ying-Ju; Huang, Chung-Chi] Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan; [Chang, Gwo-Jyh; Pang, Jong-Hwei S.] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Yeh, Yung-Hsin; Chen, Wei-Jan] Chang Gung Mem Hosp, Cardiovasc Div, Tao Yuan, Taiwan; [Huang, Chung-Chi] Chang Gung Mem Hosp, Div Thorac Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, WJ (corresponding author), Chang Gung Mem Hosp, Cardiovasc Div, Tao Yuan, Taiwan.	wjchen@adm.cgmh.org.tw	Yeh, Yung-Hsin/ABD-9351-2021	Lai, Ying-Ju/0000-0001-9750-7649	Chang Gung Medical Research Program [CMRPD1B001-3, CMRPG3A0571-3]; National Science Council, Taiwan [NSC 101-2314-B-182-076-MY3]	Chang Gung Medical Research Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants from Chang Gung Medical Research Program [CMRPD1B001-3 (to YJL) and CMRPG3A0571-3 (to YHY)] and National Science Council, Taiwan [NSC 101-2314-B-182-076-MY3 (to YJL)]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2010, ARTERIOSCL THROM VAS, V30, P667, DOI 10.1161/ATVBAHA.109.202713; Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Campbell WA, 2006, J NEUROCHEM, V96, P1423, DOI 10.1111/j.1471-4159.2006.03648.x; Chen WJ, 2008, ATHEROSCLEROSIS, V196, P383, DOI 10.1016/j.atherosclerosis.2006.11.018; Chen WJ, 2010, BASIC RES CARDIOL, V105, P19, DOI 10.1007/s00395-009-0045-z; Chen WJ, 2009, BASIC RES CARDIOL, V104, P60, DOI 10.1007/s00395-008-0746-8; Chen WJ, 2004, CIRCULATION, V110, P1313, DOI 10.1161/01.CIR.0000140764.15398.F3; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Garcia-Mayor RV, 2010, MED CHEM, V6, P239, DOI 10.2174/1573406411006040239; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; HICKS M, 1992, BIOCHEM PHARMACOL, V43, P439, DOI 10.1016/0006-2952(92)90561-V; Holmes O, J NEUROCHEM IN PRESS; Humbert M, 1998, EUR RESPIR J, V11, P554; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Mao GZ, 2012, J NEUROCHEM, V123, P837, DOI 10.1111/jnc.12016; Marvisi M, 2006, EUR J INTERN MED, V17, P267, DOI 10.1016/j.ejim.2005.11.023; Mechanick JI, 1997, THYROID DIS, P253; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Montani D, 2010, EUR HEART J, V31, P1898, DOI 10.1093/eurheartj/ehq170; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nam SH, 2011, INT J MOL MED, V28, P961, DOI 10.3892/ijmm.2011.767; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; OPPENHEIMER JH, 1985, J CLIN INVEST, V75, P147, DOI 10.1172/JCI111667; Ozdem S, 2000, PHARMACOLOGY, V61, P31, DOI 10.1159/000028377; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; RICH S, 1991, J AM COLL CARDIOL, V18, P1323, DOI 10.1016/0735-1097(91)90556-O; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Sun CK, 2009, CIRC J, V73, P1722, DOI 10.1253/circj.CJ-09-0074; Tomita T, 2013, J BIOL CHEM, V288, P14673, DOI 10.1074/jbc.R113.463281; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Wight JL, 1992, NATL I HEART NOCTURN, V170, P109; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137426	10.1371/journal.pone.0137426	http://dx.doi.org/10.1371/journal.pone.0137426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367462	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100068
J	Lim, SM; Choi, J; Chang, JH; Sohn, J; Jacobson, K; Policht, F; Schulz, J; Cho, BC; Kim, SH				Lim, Sun Min; Choi, Junjeong; Chang, Jong Hee; Sohn, Jinyoung; Jacobson, Kristine; Policht, Frank; Schulz, John; Cho, Byoung Chul; Kim, Se Hoon			Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme	PLOS ONE			English	Article							TARGETING ROS1; TEMOZOLOMIDE; IDENTIFICATION; INACTIVATION; BEVACIZUMAB; LANDSCAPE; FUSIONS; TUMORS; MGMT; FIG	Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor, and the prognosis remains poor. Rearrangement of ROS1 gene, which was shown to have an oncogenic potential, was previously discovered in GBM cell lines. In this pilot study, we aimed to identify the incidence of ROS1 rearrangement in GBM patient tissues to explore novel biomarkers for therapeutic strategy. Formalin-fixed and paraffin-embedded (FFPE) tissue sections from 109 patients with GBM were screened for ROS1 rearrangement by anti-ROS immunohistochemistry (IHC) and ROS1 break-apart fluorescent in situ hybridization (FISH) assays. O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation and Isocitrate dehydrogenase 1 (IDH1) mutation status were also assessed. All samples were interpreted by two experienced pathologists who were blinded to the clinical data. A total of 109 samples were collected and all samples were examined for ROS1 rearrangement by IHC and FISH assays, and none was found to harbor ROS1 rearrangement. MGMT gene methylation was found in 42 (39.2%) cases, and IDH1 mutation was found in 6 (5.5%) cases. In this study, ROS1 rearrangement was not identified in GBM patients, and thus it is difficult to classify ROS1 rearrangement as a novel molecular subset in GBM patients for now.	[Lim, Sun Min; Cho, Byoung Chul] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea; [Choi, Junjeong] Yonsei Univ, Coll Pharm, Dept Pharm, Seoul 120749, South Korea; [Chang, Jong Hee] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Sohn, Jinyoung] JEUK Co Ltd, JE UK Inst Canc Res, Gumi, Kyungbuk, South Korea; [Jacobson, Kristine; Policht, Frank; Schulz, John] Abbott Mol Diagnost, Des Plaines, IL USA; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, BC (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea.	cbc1971@yuhs.ac; PAXCO70@yuhs.ac		Kim, Se Hoon/0000-0001-7516-7372; Cho, Byoung Chul/0000-0002-5562-270X; Chang, Jong Hee/0000-0003-1509-9800	Novartis Pharmaceuticals; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C1186]; JEUK Co., Ltd; Abbott Molecular Diagnostics	Novartis Pharmaceuticals(Novartis); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; JEUK Co., Ltd; Abbott Molecular Diagnostics	This work was funded by the Novartis Pharmaceuticals and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C1186 to BCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jinyoung Sohn is employed by JEUK Co., Ltd. John Schulz is employed by Abbott Molecular Diagnostics. JEUK Co., Ltd and Abbott Molecular Diagnostics provided support in the form of salaries for authors Jinyoung Sohn and John Schulz respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; BIRCHMEIER C, 1987, P NATL ACAD SCI USA, V84, P9270, DOI 10.1073/pnas.84.24.9270; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin LP, 2012, J THORAC ONCOL, V7, P1625, DOI 10.1097/JTO.0b013e31826baf83; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Horbinski C, 2009, J NEUROPATH EXP NEUR, V68, P1319, DOI 10.1097/NEN.0b013e3181c391be; Kim HR, 2013, ANN ONCOL, V24, P2364, DOI 10.1093/annonc/mdt220; Kim YS, 2012, INT J RADIAT ONCOL, V84, P661, DOI 10.1016/j.ijrobp.2011.12.086; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Ou SHI, 2012, EXPERT REV ANTICANC, V12, P447, DOI [10.1586/ERA.12.17, 10.1586/era.12.17]; Ou SH, 2013, 15 WORLD C LUNG CANC; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Saborowski A, 2013, P NATL ACAD SCI USA, V110, P19513, DOI 10.1073/pnas.1311707110; SHARMA S, 1989, ONCOGENE RES, V5, P91; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020	30	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137678	10.1371/journal.pone.0137678	http://dx.doi.org/10.1371/journal.pone.0137678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366867	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100106
J	Ribeiro, R; Otte, J; Madeira, S; Hutchings, GH; Boinas, F				Ribeiro, Rita; Otte, Joachim; Madeira, Sara; Hutchings, Geoff H.; Boinas, Fernando			Experimental Infection of Ornithodoros erraticus sensu stricto with Two Portuguese African Swine Fever Virus Strains. Study of Factors Involved in the Dynamics of Infection in Ticks	PLOS ONE			English	Article							EXPERIMENTAL TRANSMISSION; MOUBATA-PORCINUS; DOMESTIC PIGS; ARGASID TICK; BONE-MARROW; ACARI; VECTOR; MODEL	African swine fever (ASF) is a frequently devastating hemorrhagic disease of domestic pigs and wild boar and Ornithodoros erraticus sensu stricto argasid ticks are the only biological vectors of African swine fever virus (ASFV) known to occur in Europe. Recently this disease emerged in Eastern Europe and Russian Federation, showing a huge potential for a rapid spread between countries. There is some risk of re-emergence of ASF in the countries where these ticks exist, that can contribute for the persistence of infection and compromise control measures. In this study we aimed to identify factors that determine the probability of infection and its dynamics in the tick vector Ornithodoros erraticus sensu stricto, with two Portuguese strains of ASFV. Our results suggest that these ticks have a high likelihood of excreting the two haemadsorbing ASF viruses of different host origins and that, in field surveys, the analysis of adults and 5th nymphal stage can provide the best chance of detecting virus infection. The results also indicate that infection of pigs with highly virulent ASF viruses will promote higher rates of infection and a higher likelihood for virus excretion by ticks. Nevertheless, there is also a risk, although lower, that ticks can become infected on pigs that have overcome the acute phase of infection, which was simulated in our study by membrane feeding ticks with low titres of virus. We believe these results can be valuable in designing and interpreting the results of ASF control programmes, and future work can also be undertaken as our dataset is released under open access, to perform studies in risk assessment for ASFV persistence in a region where O. erraticus sensu stricto ticks are present.	[Ribeiro, Rita; Madeira, Sara; Boinas, Fernando] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Otte, Joachim] FAO Reg Off Asia & Pacific, Bangkok 10200, Thailand; [Hutchings, Geoff H.] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England	Universidade de Lisboa; Food & Agriculture Organization of the United Nations (FAO); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Boinas, F (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	fboinas@fmv.ulisboa.pt	Boinas, Fernando/AAD-9779-2022	Boinas, Fernando/0000-0001-6259-4404; Madeira, Sara/0000-0001-5804-9745; Ribeiro, Rita/0000-0002-9976-3731	Commission of the Economic Communities -Directorate General VI project [ATS/4]; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship [PO/86/00]	Commission of the Economic Communities -Directorate General VI project; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship	Fernando Boinas was funded by Commission of the Economic Communities -Directorate General VI project ATS/4 and by a Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship (ref PO/86/00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OFFICIAL J EUROPEAN, V31; Arias M, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P133; Arnot LF, 2009, ONDERSTEPOORT J VET, V76, P385; Basto AP, 2006, J GEN VIROL, V87, P1863, DOI 10.1099/vir.0.81765-0; Bastos ADS, 2009, MED VET ENTOMOL, V23, P399, DOI 10.1111/j.1365-2915.2009.00828.x; Bastos ADS, 2003, ARCH VIROL, V148, P693, DOI 10.1007/s00705-002-0946-8; Boinas F, 2014, J VECTOR ECOL, V39, P238, DOI 10.1111/jvec.12098; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boinas FJS, 1994, THESIS U READING REA; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Boorman J, 1975, Lab Pract, V24, P90; Boshoff CI, 2007, VET MICROBIOL, V121, P45, DOI 10.1016/j.vetmic.2006.11.007; Burrage TG, 2013, VIRUS RES, V173, P131, DOI 10.1016/j.virusres.2012.10.010; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Diaz AV, 2012, EMERG INFECT DIS, V18, P1026, DOI 10.3201/eid1806.111728; ENDRIS RG, 1994, J MED ENTOMOL, V31, P373, DOI 10.1093/jmedent/31.3.373; ENDRIS RG, 1991, J MED ENTOMOL, V28, P854, DOI 10.1093/jmedent/28.6.854; Goddard J, 2008, INFECT DIS ARTHROPOD, DOI DOI 10.1007/978-1-60327-400-5; GomezVillamandos JC, 1997, VET PATHOL, V34, P97, DOI 10.1177/030098589703400202; GREIG A, 1972, ARCH GES VIRUSFORSCH, V39, P240, DOI 10.1007/BF01241546; GROOCOCK CM, 1980, AM J VET RES, V41, P591; Guglielmone AA, 2010, ARGASIDAE LXODIDAE N; HARESNAPE JM, 1989, EPIDEMIOL INFECT, V102, P507, DOI 10.1017/S0950268800030223; HELMY N, 1983, J PARASITOL, V69, P229, DOI 10.2307/3281305; HESS WR, 1989, J MED ENTOMOL, V26, P314, DOI 10.1093/jmedent/26.4.314; HESS WR, 1987, VET PARASITOL, V26, P145, DOI 10.1016/0304-4017(87)90084-7; Jori F, 2009, ECOHEALTH, V6, P296, DOI 10.1007/s10393-009-0248-7; Kleiboeker SB, 1999, J VIROL, V73, P8587, DOI 10.1128/JVI.73.10.8587-8598.1999; Kleiboeker Steven B., 2001, Animal Health Research Reviews, V2, P121; Leitao A, 2001, J GEN VIROL, V82, P513, DOI 10.1099/0022-1317-82-3-513; MALMQUIST WA, 1960, AM J VET RES, V21, P104; MELLOR PS, 1985, RES VET SCI, V39, P353, DOI 10.1016/S0034-5288(18)31726-0; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; OLEAGA A, 1990, J PARASITOL, V76, P874, DOI 10.2307/3282808; OSBORNE RW, 1985, TROP ANIM HEALTH PRO, V17, P31, DOI 10.1007/BF02356130; PLOWRIGH.W, 1974, RES VET SCI, V17, P106, DOI 10.1016/S0034-5288(18)33716-0; PLOWRIGHT W, 1968, J HYG-CAMB, V66, P117, DOI 10.1017/S0022172400040997; Plowright W, 1970, Res Vet Sci, V11, P582; PLOWRIGHT W, 1970, ARCH GES VIRUSFORSCH, V31, P33, DOI 10.1007/BF01241664; Plowright W, 1977, VECTOR TRANSMISSION, P575; PLOWRIGHT W, 1994, INFECT DIS LIVESTOCK, P567; Plowright W, 1968, J HYG LOND, V1, P117; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rennie L, 2000, MED VET ENTOMOL, V14, P355, DOI 10.1046/j.1365-2915.2000.00251.x; Rowlands RJ, 2009, VIROLOGY, V393, P319, DOI 10.1016/j.virol.2009.07.040; SANCHEZBOTIJA A, 1963, B OFF INT EPIZOOT, V60, P895; Sonenshine D. E., 1993, ECOLOGY NIDICOLOUS T, V2; Tendeiro J., 1962, Bol Pecuario Lisboa, V30, P1; Thomson G, 1983, RELATIONSHIP AFRICAN, P85; Trape JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078473; Travassos Santos Dias JA, 1994, I INVESTIG CIENTIFIC, P128; WALTON GA, 1979, RECENT ADV ACAROL, V11, P491; Wilkinson PJ, 1989, P M HELD U EX EX, P80; Wilkinson PJ, 1983, AGR AFR SWIN FEV P C, P74; Wilson AJ, 2013, PREV VET MED, V110, P45, DOI 10.1016/j.prevetmed.2013.02.006; 2010, EFSA J, V8	56	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137718	10.1371/journal.pone.0137718	http://dx.doi.org/10.1371/journal.pone.0137718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366570	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100118
J	Wang, ZH; Liu, NC; Shi, TG; Zhou, G; Wang, ZZ; Gan, JJ; Guo, T; Qian, HB; Bao, NR; Zhao, JN				Wang, Zhenheng; Liu, Naicheng; Shi, Tongguo; Zhou, Gang; Wang, Zhenzhen; Gan, Jingjing; Guo, Ting; Qian, Hongbo; Bao, Nirong; Zhao, Jianning			ER Stress Mediates TiAl6V4 Particle-Induced Peri-Implant Osteolysis by Promoting RANKL Expression in Fibroblasts	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMISSION ELECTRON-MICROSCOPY; NF-KAPPA-B; WEAR DEBRIS; PERIPROSTHETIC OSTEOLYSIS; OSTEOCLAST DIFFERENTIATION; OXIDATIVE STRESS; HIP; TISSUE; NANOPARTICLES	Wear particle-induced osteolysis is a major cause of aseptic loosening, which is one of the most common reasons for total hip arthroplasty (THA) failure. Previous studies have shown that the synovial fibroblasts present in the periprosthetic membrane are important targets of wear debris during osteolysis. However, the interaction mechanisms between the wear debris and fibroblasts remain largely unknown. In the present study, we investigated the effect of ER (endoplasmic reticulum) stress induced by TiAl6V4 particles (TiPs) in human synovial fibroblasts and calvarial resorption animal models. The expression of ER stress markers, including IRE1-alpha, GRP78/Bip and CHOP, were determined by western blot in fibroblasts that had been treated with TiPs for various times and concentration. To address whether ER stress was involved in the expression of RANKL, the effects of ER stress blockers (including 4-PBA and TUDCA) on the expression of RANKL in TiPs-treated fibroblasts were examined by real-time PCR, western blot and ELISA. Osteoclastogenesis was assessed by tartrate resistant acid phosphatase (TRAP) staining. Our study demonstrated that ER stress markers were markedly upregulated in TiPs-treated fibroblasts. Blocking ER stress significantly reduced the TiPs-induced expression of RANKL both in vitro and in vivo. Moreover, the inhibition of ER stress ameliorated wear particle-induced osteolysis in animal models. Taken together, these results suggested that the expression of RANKL induced by TiPs was mediated by ER stress in fibroblasts. Therefore, down regulating the ER stress of fibroblasts represents a potential therapeutic approach for wear particle-induced periprosthetic osteolysis.	[Qian, Hongbo] Nanjing Univ, Sch Med, Dept Orthopaed, Jinling Hosp, Nanjing 210093, Jiangsu, Peoples R China; Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Qian, HB (corresponding author), Nanjing Univ, Sch Med, Dept Orthopaed, Jinling Hosp, Nanjing 210093, Jiangsu, Peoples R China.	qianrenyang@vip.163.com; bnrbnr@sina.com; zhaojianning.0207@163.com	Shi, Tongguo/AAS-3460-2021	Shi, Tongguo/0000-0002-5382-2775	Department of Orthopedics Clinical Research Center of Jiangsu Province, China [BL2012002]	Department of Orthopedics Clinical Research Center of Jiangsu Province, China	This work was supported by the Department of Orthopedics Clinical Research Center of Jiangsu Province, China (BL2012002) (Jianning Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz EB, 2001, BIOMATERIALS, V22, P2835, DOI 10.1016/S0142-9612(01)00027-8; Brown C, 2007, J MATER SCI-MATER M, V18, P819, DOI 10.1007/s10856-006-0015-z; Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057; Chen R, 2014, ACS NANO, V8, P2562, DOI 10.1021/nn406184r; Dong L, 2008, J ORTHOP RES, V26, P1114, DOI 10.1002/jor.20607; Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.3.CO;2-D; Fujii J, 2011, HIP INT, V21, P231, DOI 10.5301/HIP.2011.7977; Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779; Horiki M, 2004, J BONE MINER METAB, V22, P346, DOI 10.1007/s00774-003-0493-8; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hou CC, 2013, INT J NANOMED, V8, P2689, DOI 10.2147/IJN.S47208; Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134; Landgraeber S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185150; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778; Mediero A, 2015, ARTHRITIS RHEUMATOL, V67, P849, DOI 10.1002/art.38971; Nine MJ, 2014, MATERIALS, V7, P980, DOI 10.3390/ma7020980; O'Neill SC, 2013, BONE JOINT J, V95B, P1022, DOI 10.1302/0301-620X.95B8.31229; Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034; Ramage SC, 2007, J BONE JOINT SURG AM, V89A, P841, DOI 10.2106/JBJS.F.00655; Ren WP, 2003, BIOMATERIALS, V24, P4819, DOI 10.1016/S0142-9612(03)00384-3; Sakai H, 2002, ANN RHEUM DIS, V61, P103, DOI 10.1136/ard.61.2.103; Sheng L, 2015, J BIOMED MATER RES A, V103, P1141, DOI 10.1002/jbm.a.35263; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tsai YY, 2011, ACS NANO, V5, P9354, DOI 10.1021/nn2027775; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3; Visentin M, 2004, BIOMATERIALS, V25, P5531, DOI 10.1016/j.biomaterials.2004.01.001; Wang H, 2013, GENE THER, V20, P128, DOI 10.1038/gt.2012.1; Wang KK, 2011, J MOL CELL BIOL, V3, P360, DOI 10.1093/jmcb/mjr021; Wang L, 2014, METHODS, V67, P394, DOI 10.1016/j.ymeth.2014.01.007; Wang R, 2013, BIOMATERIALS, V34, P2611, DOI 10.1016/j.biomaterials.2013.01.025; Wei XC, 2005, J BONE MINER RES, V20, P1136, DOI 10.1359/JBMR.050206; Xu J, 2012, EXP DIABETES RES; Yang SY, 2002, ARTHRITIS RHEUM, V46, P2514, DOI 10.1002/art.10527; Yang X, 2015, TOXICOL LETT, V234, P40, DOI 10.1016/j.toxlet.2015.02.004; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Zhai ZJ, 2014, BIOMATERIALS, V35, P6299, DOI 10.1016/j.biomaterials.2014.04.044; Zhang T, 2009, BIOMATERIALS, V30, P6102, DOI 10.1016/j.biomaterials.2009.07.032; Zijlstra WP, 2012, J ORTHOP RES, V30, P740, DOI 10.1002/jor.21581	45	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137774	10.1371/journal.pone.0137774	http://dx.doi.org/10.1371/journal.pone.0137774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366858	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100134
J	Zhang, GX; Jin, LQ; Hu, JL; Rodemer, W; Selzer, ME				Zhang, Guixin; Jin, Li-qing; Hu, Jianli; Rodemer, William; Selzer, Michael E.			Antisense Morpholino Oligonucleotides Reduce Neurofilament Synthesis and Inhibit Axon Regeneration in Lamprey Reticulospinal Neurons	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LARVAL SEA LAMPREY; GROWTH CONES; IN-VIVO; FUNCTIONAL REGENERATION; BEHAVIORAL RECOVERY; TRANSECTED LAMPREY; LOCOMOTOR RECOVERY; PROJECTION NEURONS; XENOPUS-LAEVIS	The sea lamprey has been used as a model for the study of axonal regeneration after spinal cord injury. Previous studies have suggested that, unlike developing axons in mammal, the tips of regenerating axons in lamprey spinal cord are simple in shape, packed with neurofilaments (NFs), and contain very little F-actin. Thus it has been proposed that regeneration of axons in the central nervous system of mature vertebrates is not based on the canonical actin-dependent pulling mechanism of growth cones, but involves an internal protrusive force, perhaps generated by the transport or assembly of NFs in the distal axon. In order to assess this hypothesis, expression of NFs was manipulated by antisense morpholino oligonucleotides (MO). A standard, company-supplied MO was used as control. Axon retraction and regeneration were assessed at 2, 4 and 9 weeks after MOs were applied to a spinal cord transection (TX) site. Antisense MO inhibited NF180 expression compared to control MO. The effect of inhibiting NF expression on axon retraction and regeneration was studied by measuring the distance of axon tips from the TX site at 2 and 4 weeks post-TX, and counting the number of reticulospinal neurons (RNs) retrogradely labeled by fluorescently-tagged dextran injected caudal to the injury at 9 weeks post-TX. There was no statistically significant effect of MO on axon retraction at 2 weeks post-TX. However, at both 4 and 9 weeks post-TX, inhibition of NF expression inhibited axon regeneration.	[Zhang, Guixin; Jin, Li-qing; Hu, Jianli; Rodemer, William; Selzer, Michael E.] Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil, Philadelphia, PA 19140 USA; [Selzer, Michael E.] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA	Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Selzer, ME (corresponding author), Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil, 3500 North Broad St, Philadelphia, PA 19140 USA.	mselzer@temple.edu		Hu, Jianli/0000-0002-3022-1950; Rodemer, William/0000-0001-5091-4343	National Institutes of Health [R01 NS14837, R01 NS38537]; Shriners Research Foundation [SHC-85220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038537, R01NS014837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, R01 NS14837 and R01 NS38537 to MES (http://www.nih.gov) and Shriners Research Foundation, SHC-85220 to MES (http://www.mheresearchfoundation.org/MHE_Shriners_Hospital_Directory.html).	Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Chan WKH, 2003, CELL MOTIL CYTOSKEL, V54, P195, DOI 10.1002/cm.10084; Chen E, 2004, CURR PHARM BIOTECHNO, V5, P409, DOI 10.2174/1389201043376652; COHEN AH, 1988, TRENDS NEUROSCI, V11, P227, DOI 10.1016/0166-2236(88)90131-2; COHEN AH, 1986, P NATL ACAD SCI USA, V83, P2763, DOI 10.1073/pnas.83.8.2763; DAVIS GR, 1993, BRAIN RES, V602, P131, DOI 10.1016/0006-8993(93)90252-I; DAVIS GR, 1994, EXP NEUROL, V127, P94, DOI 10.1006/exnr.1994.1083; DAVIS GR, 1993, EXP BRAIN RES, V97, P83; GORGELS TGMF, 1991, J COMP NEUROL, V306, P95, DOI 10.1002/cne.903060108; Hall GF, 1997, J NEUROCYTOL, V26, P733, DOI 10.1023/A:1018562331003; Hall GF, 2000, CELL MOTIL CYTOSKEL, V46, P166, DOI 10.1002/1097-0169(200007)46:3<166::AID-CM2>3.0.CO;2-8; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; JACOBS AJ, 1995, MOL BRAIN RES, V29, P43, DOI 10.1016/0169-328X(94)00227-6; Jacobs AJ, 1996, J COMP NEUROL, V364, P383; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jin LQ, 2011, BRAIN RES, V1370, P16, DOI 10.1016/j.brainres.2010.11.037; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Jin LQ, 2005, J COMP NEUROL, V483, P403, DOI 10.1002/cne.20459; Jones SL, 2006, J NEUROBIOL, V66, P1630, DOI 10.1002/neu.20309; LANNERS HN, 1980, J NEUROCYTOL, V9, P733, DOI 10.1007/BF01205016; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; LASEK RJ, 1985, ANN NY ACAD SCI, V455, P462, DOI 10.1111/j.1749-6632.1985.tb50429.x; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Lin WC, 1996, DEV BIOL, V179, P197, DOI 10.1006/dbio.1996.0251; Lin WC, 1995, J NEUROSCI, V15, P8331; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCKERRACHER L, 1990, J NEUROSCI, V10, P641; NORDLANDER RH, 1987, J COMP NEUROL, V263, P485, DOI 10.1002/cne.902630403; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Pijak DS, 1996, J COMP NEUROL, V368, P569; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; SCALIA F, 1985, J COMP NEUROL, V231, P323, DOI 10.1002/cne.902310304; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; SWAIN GP, 1994, EXP NEUROL, V126, P256, DOI 10.1006/exnr.1994.1063; SWAIN GP, 1993, J COMP NEUROL, V336, P194, DOI 10.1002/cne.903360204; WOOD MR, 1979, SCIENCE, V206, P344, DOI 10.1126/science.482943; Yuan AD, 2003, J NEUROSCI, V23, P9452; Zhang GX, 2011, J COMP NEUROL, V519, P3657, DOI 10.1002/cne.22673; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Zhang GX, 2004, J COMP NEUROL, V471, P188, DOI 10.1002/cne.20026; Zhang L, 1999, J COMP NEUROL, V410, P612, DOI 10.1002/(SICI)1096-9861(19990809)410:4<612::AID-CNE8>3.0.CO;2-R; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	51	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137670	10.1371/journal.pone.0137670	http://dx.doi.org/10.1371/journal.pone.0137670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366578	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100104
J	Bakker, PJ; Scantlebery, AM; Butter, LM; Claessen, N; Teske, GJD; van der Poll, T; Florquin, S; Leemans, JC				Bakker, Pieter J.; Scantlebery, Angelique M.; Butter, Loes M.; Claessen, Nike; Teske, Gwendoline J. D.; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSES; KIDNEY INJURY; ACTIVATION; TOLL-LIKE-RECEPTOR-9; PROGRESSION; INHIBITION; EXPRESSION; INNATE	Ischemia reperfusion injury is a common cause of acute kidney injury and is characterized by tubular damage. Mitochondrial DNA is released upon severe tissue injury and can act as a damage-associated molecular pattern via the innate immune receptor TLR9. Here, we investigated the role of TLR9 in the context of moderate or severe renal ischemia reperfusion injury using wild-type C57BL/6 mice or TLR9KO mice. Moderate renal ischemia induced renal dysfunction but did not decrease animal well-being and was not regulated by TLR9. In contrast, severe renal ischemia decreased animal well-being and survival in wildtype mice after respectively one or five days of reperfusion. TLR9 deficiency improved animal well-being and survival. TLR9 deficiency did not reduce renal inflammation or tubular necrosis. Rather, severe renal ischemia induced hepatic injury as seen by increased plasma ALAT and ASAT levels and focal hepatic necrosis which was prevented by TLR9 deficiency and correlated with reduced circulating mitochondrial DNA levels and plasma LDH. We conclude that TLR9 does not mediate renal dysfunction following either moderate or severe renal ischemia. In contrast, our data indicates that TLR9 is an important mediator of hepatic injury secondary to ischemic acute kidney injury.	[Bakker, Pieter J.; Scantlebery, Angelique M.; Butter, Loes M.; Claessen, Nike; Teske, Gwendoline J. D.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Bakker, PJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	pieterjeroenbakker@gmail.com	Leemans, Jaklien/AAM-4958-2020	Florquin, Sandrine/0000-0002-9676-1722; Scantlebery, Angelique/0000-0001-9303-6042	Dutch Kidney Foundation [C06.6023]; Netherlands Organization for Scientific Research [91712386]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by grants from the Dutch Kidney Foundation to author PJB (C06.6023) and the Netherlands Organization for Scientific Research to authors LMB and JCL (91712386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Anders HJ, 2003, J AM SOC NEPHROL, V14, P317, DOI 10.1097/01.ASN.0000042169.23931.73; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Benigni A, 2007, ARTHRITIS RHEUM, V56, P1569, DOI 10.1002/art.22524; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Hekimoglu AT, 2013, KOREAN J PHYSIOL PHA, V17, P169, DOI 10.4196/kjpp.2013.17.2.169; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Kadkhodaee M, 2009, WORLD J GASTROENTERO, V15, P1113, DOI 10.3748/wjg.15.1113; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li XZ, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.016; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Papadimitraki ED, 2009, LUPUS, V18, P831, DOI 10.1177/0961203309103054; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; van Loo PLP, 1997, LAB ANIM, V31, P318, DOI 10.1258/002367797780596211; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	35	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137511	10.1371/journal.pone.0137511	http://dx.doi.org/10.1371/journal.pone.0137511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361210	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100048
J	dos Reis, IC; Honorio, NA; de Barros, FSM; Barcellos, C; Kitron, U; Camara, DCP; Pereira, GR; Keppeler, EC; da Silva-Nunes, M; Codeco, CT				dos Reis, Izabel Cristina; Honorio, Nildimar Alves; Monteiro de Barros, Fabio Saito; Barcellos, Christovam; Kitron, Uriel; Portela Camara, Daniel Cardoso; Pereira, Glaucio Rocha; Keppeler, Erlei Cassiano; da Silva-Nunes, Monica; Codeco, Claudia Torres			Epidemic and Endemic Malaria Transmission Related to Fish Farming Ponds in the Amazon Frontier	PLOS ONE			English	Article							ANOPHELES-DARLINGI; BRAZILIAN AMAZON; DEFORESTATION; HABITAT; VECTOR	Fish farming in the Amazon has been stimulated as a solution to increase economic development. However, poorly managed fish ponds have been sometimes associated with the presence of Anopheles spp. and consequently, with malaria transmission. In this study, we analyzed the spatial and temporal dynamics of malaria in the state of Acre (and more closely within a single county) to investigate the potential links between aquaculture and malaria transmission in this region. At the state level, we classified the 22 counties into three malaria endemicity patterns, based on the correlation between notification time series. Furthermore, the study period (2003-2013) was divided into two phases (epidemic and post-epidemic). Higher fish pond construction coincided both spatially and temporally with increased rate of malaria notification. Within one malaria endemic county, we investigated the relationship between the geolocation of malaria cases (2011-2012) and their distance to fish ponds. Entomological surveys carried out in these ponds provided measurements of anopheline abundance that were significantly associated with the abundance of malaria cases within 100 m of the ponds (P < 0.005; r = 0.39). These results taken together suggest that fish farming contributes to the maintenance of high transmission levels of malaria in this region.	[dos Reis, Izabel Cristina; Codeco, Claudia Torres] Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, RJ, Brazil; [dos Reis, Izabel Cristina; Honorio, Nildimar Alves; Portela Camara, Daniel Cardoso] Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-20001 Rio De Janeiro, RJ, Brazil; [Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil; [Barcellos, Christovam] Fiocruz MS, Inst Comunicacao & Informacao Cient & Tecnol Saud, Lab Informacao Saude, BR-21045900 Rio De Janeiro, RJ, Brazil; [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Keppeler, Erlei Cassiano] Univ Floresta, Ctr Multidiscipinar Campus Floresta, Univ Fed Acre, Cruzeiro Do Sul, Acre, Brazil; [Honorio, Nildimar Alves; Pereira, Glaucio Rocha] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores, DIRAC, VPAAPS,IOC, BR-21045900 Rio De Janeiro, RJ, Brazil; [da Silva-Nunes, Monica] Univ Fed Acre, Ctr Ciencias Saude & Desporto, Rio Branco, Acre, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Emory University; Fundacao Oswaldo Cruz; Universidade Federal do Acre (UFAC)	dos Reis, IC (corresponding author), Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, RJ, Brazil.	izabio2005@gmail.com	Câmara, Daniel C. P./S-3504-2018; Barcellos, Christovam/G-6856-2012; da Silva-Nunes, Monica/A-1885-2008; Barcellos, Christovam/GQA-5106-2022	Câmara, Daniel C. P./0000-0002-5439-4477; Barcellos, Christovam/0000-0002-1161-2753; Barcellos, Christovam/0000-0002-1161-2753	Brazilian Council for Scientific and Technological Development [484027/2012-3, 479977/2008-9, 471295/2011-6, 552746/2011-8]; Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro [E-26/111.500/2011]; Agency for Support and Evaluation of Graduate Education (Science without Borders program) [3341-13-5]; Universidade Federal do Acre; Fundacao de tecnologia do estado do Acre [04/2012]; Fundacao de Amparo a pesquisa no estado do Acre [14/2013]	Brazilian Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro; Agency for Support and Evaluation of Graduate Education (Science without Borders program); Universidade Federal do Acre; Fundacao de tecnologia do estado do Acre; Fundacao de Amparo a pesquisa no estado do Acre	Funding was provided by Brazilian Council for Scientific and Technological Development (Grants 484027/2012-3 to NAH, 479977/2008-9 to CTC, 471295/2011-6 to MdSN and Climate and Health Observatory 552746/2011-8 to CB), Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro (Grants E-26/111.500/2011 to CTC); Agency for Support and Evaluation of Graduate Education (Grants 3341-13-5 from Science without Borders program to ICdR); Universidade Federal do Acre, Fundacao de tecnologia do estado do Acre (Grant n. 04/2012 to MdSN), and Fundacao de Amparo a pesquisa no estado do Acre Grant n. 14/2013 to MdSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2006, J VECTOR ECOL, V31, P145, DOI 10.3376/1081-1710(2006)31[145:EEOOBI]2.0.CO;2; ACRE. Secretaria de Estado de Meio Ambiente-SEMA, 2012, PROGR ARB URB EST AC; Anjos LHCS, 2013, 9 REUN BRAS CLASS CO; Barreto P, 2005, I HOMEM MEIO AMBIENT, V3, P1; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Braz Rui Moreira, 2014, Rev. bras. epidemiol., V17, P615, DOI 10.1590/1809-4503201400030004; Brochero Helena, 2006, Biomed., V26, P269; Chavent M, 2012, J STAT SOFTW, V50, P1; Cohen J, 2010, MALARIA J, V9, P1, DOI [10.1186/1475-2875-9-S1-S1, DOI 10.1186/1475-2875-9-S1-S1.PUBMED:20043863]; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Costa KMD, 2010, REV PANAM SALUD PUBL, V28, P353, DOI 10.1590/S1020-49892010001100005; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; Duarte RBA, 2007, HIST SUCESSO AGRONEG; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Minitry of Health Brazil, 2006, TECHN REP SIVEP MAL; Minitry of Health Brazil, 2010, SIST INF VIG EP MAL; Monteiro de Barros Fabio Saito, 2007, Memorias do Instituto Oswaldo Cruz, V102, P299; Oliveira- Ferreira J, 2010, MAL J, V9, P2; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; OpenStreetMap, 2012, OPENSTREETMAP FREE W; Pan American Health Organization and World Health Organization, 2011, MAL CHAMP AM 2011 FI, V11; Pan American Health Organization and World Health Organization, 2013, EST ACR HOM COM CAMP, V11; R Development Core Team, 2014, R LANG ENV STAT COMP; REZENDE F. J. W., 2008, AMAZONIA CIENCIA DES, V4, P167; Rodrigues I. B., 2008, Revista de Patologia Tropical, V37, P161; Sawyer DR, 1988, FRONTIER MALARIA AMA; Service M, 1993, MOSQUITO ECOLOGY FIE; Simpson JM, 2006, THESIS COLUMBIA U; Stefani A, 2013, MALARIA J, V12, P1; Suarez-Mutis MC, 2007, CAD SAUDE PUBLICA, V23, P795, DOI 10.1590/S0102-311X2007000400007; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137521	10.1371/journal.pone.0137521	http://dx.doi.org/10.1371/journal.pone.0137521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361330	Green Published, gold			2022-12-27	WOS:000361043100049
J	Shi, DW; Shen, S; Fan, XL; Chen, SH; Wang, DY; Li, CG; Wu, X; Li, LL; Bai, DT; Zhang, CT; Wang, JZ				Shi, Dawei; Shen, Shu; Fan, Xingliang; Chen, Suhong; Wang, Dayan; Li, Changgui; Wu, Xing; Li, Lili; Bai, Dongting; Zhang, Chuntao; Wang, Junzhi			Evaluation of Commercial Diagnostic Assays for the Specific Detection of Avian Influenza A (H7N9) Virus RNA Using a Quality-Control Panel and Clinical Specimens in China	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; HUMAN INFECTION; A(H7N9) VIRUS; FERRETS; ORIGIN; PCR	A novel avian influenza A H7N9-subtype virus emerged in China in 2013 and threatened global public health. Commercial kits that specifically detect avian influenza A (H7N9) virus RNA are urgently required to prepare for the emergence and potential pandemic of this novel influenza virus. The safety and effectiveness of three commercial molecular diagnostic assays were evaluated using a quality-control panel and clinical specimens collected from over 90 patients with confirmed avian influenza A (H7N9) virus infections. The analytical performance evaluation showed that diverse influenza H7N9 viruses can be detected with high within-and between-lot reproducibility and without cross-reactivity to other influenza viruses (H1N1 pdm09, seasonal H1N1, H3N2, H5N1 and influenza B). The detection limit of all the commercial assays was 2.83 Log(10) copies/mu l [0.7 Log(10)T-CID50/mL of avian influenza A (H7N9) virus strain A/Zhejiang/DTID-ZJU01/2013], which is comparable to the method recommended by the World Health Organization (WHO). In addition, using a WHO-Chinese National Influenza Center (CNIC) method as a reference for clinical evaluation, positive agreement of more than 98% was determined for all of the commercial kits, while negative agreement of more than 99% was observed. In conclusion, our findings provide comprehensive evidence for the high performance of three commercial diagnostic assays and suggest the application of these assays as rapid and effective diagnostic tools for avian influenza A (H7N9) virus in the routine clinical practice of medical laboratories.	[Shi, Dawei; Shen, Shu; Fan, Xingliang; Li, Changgui; Wu, Xing; Li, Lili; Bai, Dongting; Zhang, Chuntao; Wang, Junzhi] Natl Inst Food & Drug Control, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China; [Fan, Xingliang; Li, Changgui; Wu, Xing; Wang, Junzhi] WHO Collaborating Ctr Standardizat & Evaluat Biol, Beijing, Peoples R China; [Chen, Suhong] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Dayan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, Beijing, Peoples R China; [Wang, Dayan] WHO Collaborating Ctr Reference & Res Influenza, Beijing, Peoples R China	National Institute of Food & Drug Control - China; Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, CT (corresponding author), Natl Inst Food & Drug Control, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China.	zhangct2@126.com; wangjunzhi2013@126.com			Ministry of Science and Technology of the People's Republic of China [KJYJ-2013-01-03]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work is supported by the grant (KJYJ-2013-01-03) from Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to BDT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Chantratita W, 2008, MOL CELL PROBE, V22, P287, DOI 10.1016/j.mcp.2008.06.005; Chen E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.43.20616; Chen Y, 2014, EMERG INFECT DIS, V21; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Corman VM, 2013, EUROSURVEILLANCE, V18, P10; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ge YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069941; Hatchette TF, 2013, J CLIN MICROBIOL, V51, P3835, DOI 10.1128/JCM.01808-13; Kalthoff D, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.10.20731; Kang KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092306; Kang XP, 2014, J VIROL METHODS, V206, P140, DOI 10.1016/j.jviromet.2014.01.026; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li Y, 2013, J VIROL METHODS, V194, P194, DOI 10.1016/j.jviromet.2013.08.021; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0271-x; Lu J, 2014, EMERG INFECT DIS, V20, P1582, DOI 10.3201/eid2009.140250; Meng Z, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.6.20699; Nie K, 2013, CLIN MICROBIOL INFEC, V19, pE372, DOI 10.1111/1469-0691.12263; Quidel Corpoation, 2013, QUID LYR INFL A SUBT; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; The National Food Drug Administration of China, 2013, NOT NATL FOOD DRUG A; US Food and Drug Administration, 2014, LETT EM US AUTH EUA; Wang D, 2014, EUROSURVEILLANCE, V2013, P19, DOI DOI 10.2807/1560-7917.ES2014.19.25.20836; Wang SQ, 2002, ANAL BIOCHEM, V309, P206, DOI 10.1016/S0003-2697(02)00317-2; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; WHO, 2013, REAL TIM RT PCR PROT; World Health Organization, 2014, HUM INF AV INFL A H7; World Health Organization, 2013, LAB PROC SER DET AV; World Health Organization, 2013, SER DET AV INFL A H7; Xiao XC, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.25.20837; Zhang JH, 2013, J CLIN MICROBIOL, V51, P3760, DOI 10.1128/JCM.01907-13; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137862	10.1371/journal.pone.0137862	http://dx.doi.org/10.1371/journal.pone.0137862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361351	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100097
J	Teteloshvili, N; Kluiver, J; van der Geest, KSM; van der Lei, RJ; Jellema, P; Pawelec, G; Brouwer, E; Kroesen, BJ; Boots, AMH; van den Berg, A				Teteloshvili, Nato; Kluiver, Joost; van der Geest, Kornelis S. M.; van der Lei, Roelof Jan; Jellema, Pytrick; Pawelec, Graham; Brouwer, Elisabeth; Kroesen, Bart-Jan; Boots, Annemieke M. H.; van den Berg, Anke			Age-Associated Differences in MiRNA Signatures Are Restricted to CD45RO Negative T Cells and Are Associated with Changes in the Cellular Composition, Activation and Cellular Ageing	PLOS ONE			English	Article							LIFE-SPAN; 2 SUBSETS; SENESCENCE; NAIVE; MICRORNA-21; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; REPERTOIRE; INCREASES	MicroRNAs (miRNAs) have emerged as important players in the regulation of T-cell functionality. However, comprehensive insight into the extent of age-related miRNA changes in T cells is lacking. We established miRNA expression patterns of CD45RO- naive and CD45RO+ memory T-cell subsets isolated from peripheral blood cells from young and elderly individuals. Unsupervised clustering of the miRNA expression data revealed an age-related clustering in the CD45RO- T cells, while CD45RO+ T cells clustered based on expression of CD4 and CD8. Seventeen miRNAs showed an at least 2-fold up-or downregulation in CD45RO- T cells obtained from young as compared to old donors. Validation on the same and independent samples revealed a statistically significant age-related upregulation of miR-21, miR-223 and miR-15a. In a T-cell subset analysis focusing on known age-related phenotypic changes, we showed significantly higher miR-21 and miR-223 levels in CD8+CD45RO-CCR7- T-EMRA compared to CD45RO-CCR7+ T-NAIVE-cells. Moreover, miR21 but not miR-223 levels were significantly increased in CD45RO-CD31-post-thymic T-NAIVE cells as compared to thymic CD45RO-CD31+ T-NAIVE cells. Upon activation of CD45RO-T-NAIVE cells we observed a significant induction of miR-21 especially in CD4+ T cells, while miR-223 levels significantly decreased only in CD4+ T cells. Besides composition and activation-induced changes, we showed a borderline significant increase in miR-21 levels upon an increasing number of population doublings in CD4+ T-cell clones. Together, our results show that ageing related changes in miRNA expression are dominant in the CD45RO- T-cell compartment. The differential expression patterns can be explained by age related changes in T-cell composition, i.e. accumulation of CD8+ T-EMRA and CD4+ post-thymic expanded CD31-T cells and by cellular ageing, as demonstrated in a longitudinal clonal culture model.	[Teteloshvili, Nato; Kluiver, Joost; van der Lei, Roelof Jan; Jellema, Pytrick; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van der Geest, Kornelis S. M.; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Teteloshvili, Nato; van der Geest, Kornelis S. M.; Brouwer, Elisabeth; Kroesen, Bart-Jan; Boots, Annemieke M. H.; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Hlth Ageing & Immune Longev, Groningen, Netherlands; [Pawelec, Graham] Univ Tubingen, Med Res Ctr, Dept Internal Med 2, Tubingen, Germany; [Pawelec, Graham] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Eberhard Karls University of Tubingen; Nottingham Trent University	van den Berg, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	Kluiver, Joost/G-6406-2014; Brouwer, Elisabeth/A-3198-2015; Pawelec, Graham/H-2713-2019; Brouwer, Elisabeth/AAL-9029-2020; Teteloshvili, Nato/G-5288-2019; van den Berg, Anke/H-1718-2011	Kluiver, Joost/0000-0001-7650-2937; Brouwer, Elisabeth/0000-0002-5652-4423; Pawelec, Graham/0000-0002-3600-0163; Brouwer, Elisabeth/0000-0002-5652-4423; van den Berg, Anke/0000-0002-8894-2638; van der Geest, Kornelis/0000-0003-2798-6765	Abbot; Jan Kornelis de Cock Foundation; Graduate School of Medical Sciences	Abbot; Jan Kornelis de Cock Foundation; Graduate School of Medical Sciences	This study was supported by unrestricted funds from Abbot, Jan Kornelis de Cock Foundation and the Graduate School of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brunner S, 2012, AGING CELL, V11, P579, DOI 10.1111/j.1474-9726.2012.00819.x; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Effros RB, 2003, CURR HIV RES, V1, P153, DOI 10.2174/1570162033485348; Effros Rita B, 2005, Discov Med, V5, P293; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fornasa G, 2010, J IMMUNOL, V184, P5485, DOI 10.4049/jimmunol.0902219; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kluiver Joost, 2013, Methods Mol Biol, V971, P265, DOI 10.1007/978-1-62703-269-8_15; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; LIGTHART GJ, 1984, MECH AGEING DEV, V28, P47, DOI 10.1016/0047-6374(84)90152-0; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Ohyashiki M, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-11; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Park S, 2013, IMMUNOL INVEST, V42, P179, DOI 10.3109/08820139.2012.717328; Pawelec G, 2002, EXP GERONTOL, V37, P265, DOI 10.1016/S0531-5565(01)00192-9; Pawelec G, 1997, IMMUNOL REV, V160, P31, DOI 10.1111/j.1600-065X.1997.tb01025.x; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Smigielska-Czepiel K, 2014, GENES IMMUN, V15, P115, DOI 10.1038/gene.2013.69; Smigielska-Czepiel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076217; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Geest KSM, 2015, RHEUMATOLOGY, V54, P950, DOI 10.1093/rheumatology/keu407; Wang L, 2014, MOL IMMUNOL, V59, P163, DOI 10.1016/j.molimm.2014.02.004; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137556	10.1371/journal.pone.0137556	http://dx.doi.org/10.1371/journal.pone.0137556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360056	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100053
J	Hocking, DR; Reeve, J; Porter, MA				Hocking, Darren R.; Reeve, Jessica; Porter, Melanie A.			Characterising the Profile of Everyday Executive Functioning and Relation to IQ in Adults with Williams Syndrome: Is the BRIEF Adult Version a Valid Rating Scale?	PLOS ONE			English	Article							YOUNG-CHILDREN; IMPAIRMENTS; INHIBITION; INVENTORY; INTERVENTION; INTELLIGENCE; DISABILITIES; INDIVIDUALS; EXPLORATION; DYSFUNCTION	Although there is evidence of a distinct profile of executive dysfunction in Williams syndrome (WS), a rare genetically based neurodevelopmental disorder, the utility of informant reports of everyday executive function (EF) impairments and their relation to intelligence is not yet clear. Here we aimed to evaluate the functional impact of executive dysfunction in adults with WS and to establish the validity of child and adult versions of the most commonly used rating scale for EF assessment, the Behaviour Rating Inventory of Executive Function (BRIEF). We were also interested in whether distinct components of everyday EF relate to intelligence in WS. Parent report child (BRIEF-C) and adult (BRIEF-A) ratings were collected on 20 adults with WS (aged 18.5 to 53 years), with a mean IQ of 60.95 (SD = 17.67). Neuropsychological measures of EF included: The Shape School Test (Espy, 2007); select subdomains of EF from the Woodcock-Johnson III Tests of Cognitive Abilities, Australian Adaptation (WJ III COG); and select subdomains from the Vineland Adaptive Behaviour Scales, Second Edition-Parent Survey (Vineland-II). Results showed that the BRIEF-A, but not the BRIEF-C, was the most highly correlated with neuropsychological measures of EF, suggesting that it was a valid measure of the profile of EF impairments in adults with WS. The profile of everyday EF dysfunction revealed relative impairments in monitoring, working memory, planning and organisation in WS. In addition, both neuropsychological and rating scale measures showed an association between the shifting component of EF and intelligence. These findings indicate that the BRIEF-A is a valid measure of the multidimensional nature of real-world impairments in EF, and highlight its utility as a less labor intensive and low-cost screening tool for measuring specific EF impairments that could become the focus of targeted intervention in adults with WS.	[Hocking, Darren R.] La Trobe Univ, Sch Psychol & Publ Hlth, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia; [Reeve, Jessica; Porter, Melanie A.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Porter, Melanie A.] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia	La Trobe University; Macquarie University; Macquarie University	Hocking, DR (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia.	D.Hocking@latrobe.edu.au		Porter, Melanie/0000-0003-3281-1732; Hocking, Darren/0000-0003-1143-8190	Apex Foundation for Research Into Intellectual Disability	Apex Foundation for Research Into Intellectual Disability	Apex Foundation for Research Into Intellectual Disability awarded to DH and MP, (http://www.afrid.com.au). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Ardila A, 1998, NEUROPSYCHOL REV, V8, P171, DOI 10.1023/A:1021618218943; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Baddeley A. D, 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bellugi U, 2001, CLIN NEUROSCI RES, V1, P217, DOI 10.1016/S1566-2772(01)00008-1; Blijd-Hoogewys EMA, 2014, J AUTISM DEV DISORD, V44, P3089, DOI 10.1007/s10803-014-2176-9; Carney DPJ, 2013, RES DEV DISABIL, V34, P46, DOI 10.1016/j.ridd.2012.07.013; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Daunhauer LA, 2014, AJIDD-AM J INTELLECT, V119, P303, DOI 10.1352/1944-7558-119.4.303; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2009, DEV PSYCHOL, V45, P130, DOI 10.1037/a0014025; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Duncan, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00752-2; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Emslie H., 2003, BEHAV ASSESSMENT DYS; Espy KA, 2006, PSYCHOL ASSESSMENT, V18, P373, DOI 10.1037/1040-3590.18.4.373; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2000, BEHAV RATING INVENTO; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Greer J, 2013, RES DEV DISABIL, V34, P4170, DOI 10.1016/j.ridd.2013.08.041; Hocking DR, 2008, NEUROSCI BIOBEHAV R, V32, P497, DOI 10.1016/j.neubiorev.2007.09.003; Hocking DR, 2014, RES DEV DISABIL, V35, P203, DOI 10.1016/j.ridd.2013.10.005; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Kenworthy L, 2014, J CHILD PSYCHOL PSYC, V55, P374, DOI 10.1111/jcpp.12161; Kenworthy LE, 2005, DEV NEUROPSYCHOL, V28, P809, DOI 10.1207/s15326942dn2803_4; Lawson RA, 2015, NEUROPSYCHOLOGY, V29, P445, DOI 10.1037/neu0000145; Lee NR, 2011, AJIDD-AM J INTELLECT, V116, P290, DOI 10.1352/1944-7558-116.4.290; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Maehler C, 2009, J INTELL DISABIL RES, V53, P3, DOI 10.1111/j.1365-2788.2008.01105.x; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Mather N., 2001, EXAMINERS MANUAL WOO; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Mervis CB, 2010, AM J MED GENET C, V154C, P229, DOI 10.1002/ajmg.c.30263; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Porter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047457; Porter MA, 2009, CHILD NEUROPSYCHOL, V15, P359, DOI 10.1080/09297040802577881; Rhodes SM, 2011, BRAIN COGNITION, V77, P208, DOI 10.1016/j.bandc.2011.08.009; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Rosenthal M, 2013, NEUROPSYCHOLOGY, V27, P13, DOI 10.1037/a0031299; Roth RM., 2005, BRIEF A BEHAV RATING; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Russell J, 1999, Cogn Neuropsychiatry, V4, P303; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, Vsecond; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Vicari S, 2006, DEV MED CHILD NEUROL, V48, P126, DOI 10.1017/S0012162206000272; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	65	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137628	10.1371/journal.pone.0137628	http://dx.doi.org/10.1371/journal.pone.0137628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355600	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800072
J	Liu, YB; Li, XR; Chen, GX; Li, MM; Liu, ML; Liu, D				Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan			Epidermal Micromorphology and Mesophyll Structure of Populus euphratica Heteromorphic Leaves at Different Development Stages	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CALCIUM-OXALATE; LOWER REACHES; LEAF HAIRS; PLANTS; PHOTOSYNTHESIS; RESPONSES; CRYSTALS; GENE; FOG	Leaf epidermal micromorphology and mesophyll structure during the development of Populus euphratica heteromorphic leaves, including linear, lanceolate, ovate, dentate ovate, dentate rhombic, dentate broad-ovate and dentate fan-shaped leaves, were studied by using electron and light microscopy. During development of heteromorphic leaves, epidermal appendages (wax crystals and trichomes) and special cells (mucilage cells and crystal idioblasts) increased in all leaf types while chloroplast ultrastructure and stomatal characters show maximum photosynthetic activity in dentate ovate and rhombic leaves. Also, functional analysis by subordinate function values shows that the maximum adaptability to adverse stress was exhibited in the broad type of mature leaves. The 12 heteromorphic leaf types are classified into three major groups by hierarchical cluster analysis: young, developing and mature leaves. Mature leaves can effectively obtain the highest stress resistance by combining the protection of xerophytic anatomy from drought stress, regulation of water uptake in micro-environment by mucilage and crystal idioblasts, and assistant defense of transpiration reduction through leaf epidermal appendages, which improves photosynthetic activity under arid desert conditions. Our data confirms that the main leaf function is differentiated during the developing process of heteromorphic leaves.	[Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan] Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China; [Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Liu, YB (corresponding author), Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China.	ybliu13@163.com	Liu, Yubing/AFR-0289-2022	Liu, Yubing/0000-0002-2338-097X	State Key Development Program for Basic Research of China (973 Program) [2013CB429904]; National Natural Science Foundation of China [91125029]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the State Key Development Program for Basic Research of China (973 Program, Grant No. 2013CB429904) and the National Natural Science Foundation of China (Grant No. 91125029).	Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; BAMBER RK, 1978, AUST J BOT, V26, P177, DOI 10.1071/BT9780177; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; [王金山 Jinshan Wang], 2008, [植物学通报, Chinese Bulletin of Botany], V25, P728; Brown HT, 1900, PHILOS T R SOC LON B, V193, P223, DOI 10.1098/rstb.1900.0014; Brown SL, 2013, PLANT PHYSIOL BIOCH, V73, P219, DOI 10.1016/j.plaphy.2013.10.006; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Cao SK, 2011, ENVIRON EARTH SCI, V62, P1597, DOI 10.1007/s12665-010-0643-y; Chen JH, 2011, GENE, V483, P36, DOI 10.1016/j.gene.2011.05.010; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen YP, 2011, ENVIRON EARTH SCI, V62, P119, DOI 10.1007/s12665-010-0502-x; Chen YN, 2004, ACTA BOT SIN, V46, P1393; Cutler DF, 2008, PLANT ANATOMY APPL A; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; DRIESSCHE TV, 1966, EXP CELL RES, V42, P18, DOI 10.1016/0014-4827(66)90315-6; EHLERINGER J, 1976, SCIENCE, V192, P376, DOI 10.1126/science.192.4237.376; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Fahmy GM, 1997, J ARID ENVIRON, V36, P499, DOI 10.1006/jare.1996.0217; Fahn A, 1992, ENCY PLANT ANATOMY 3; Feng Q, 2001, ENVIRON GEOL, V41, P229, DOI 10.1007/s002540100387; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Fu AH, 2011, PHOTOSYNTHETICA, V49, P295, DOI 10.1007/s11099-011-0036-9; Hao JianQing, 2011, Forestry Studies in China, V13, P52, DOI 10.1007/s11632-011-0102-1; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; Klich MG, 2000, ENVIRON EXP BOT, V44, P171, DOI 10.1016/S0098-8472(00)00056-3; Knight CA, 2003, NEW PHYTOL, V160, P337, DOI 10.1046/j.1469-8137.2003.00880.x; Li ZhaoXia, 2005, Forestry Studies in China, V7, P11, DOI 10.1007/s11632-005-0050-8; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ottow EA, 2005, PLANT MOL BIOL, V58, P75, DOI 10.1007/s11103-005-4525-8; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; Roth-Nebelsick A, 2007, ANN BOT-LONDON, V100, P23, DOI 10.1093/aob/mcm075; Sayer JD, 1926, OHIO J SCI, V26, P233; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Si JH, 2014, ENVIRON MONIT ASSESS, V186, P5469, DOI 10.1007/s10661-014-3796-4; [苏培玺 Su pei xi], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P34; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Maarseveen C, 2009, PHYTOCHEMISTRY, V70, P899, DOI 10.1016/j.phytochem.2009.04.011; Wang XZ, 2004, ENVIRON EXP BOT, V51, P21, DOI 10.1016/S0098-8472(03)00057-1; WOOLLEY JOSEPH T., 1964, AGRON J, V56, P569; WUENSCHER JE, 1970, NEW PHYTOL, V69, P65, DOI 10.1111/j.1469-8137.1970.tb04050.x; [严巧娣 YAN QiaoDi], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P761; Yue Ning, 2010, Agricultural Science & Technology - Hunan, V11, P41; Zheng C., 2007, FRONTIERS FORESTRY C, V2, P87; Zhuang L, 2011, J ARID LAND, V3, P261, DOI 10.3724/SP.J.1227.2011.00261; Zimmermann D, 2007, PROTOPLASMA, V232, P10, DOI 10.1007/s00709-007-0279-2; Zimmermann U, 2004, NEW PHYTOL, V162, P575, DOI 10.1111/j.1469-8137.2004.01083.x	50	23	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137701	10.1371/journal.pone.0137701	http://dx.doi.org/10.1371/journal.pone.0137701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356300	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800079
J	Maekawa, T; Kaneko, H				Maekawa, Toru; Kaneko, Hirohiko			Does Changing Vertical Disparity Induce Horizontal Head Movement?	PLOS ONE			English	Article							PERCEPTION; DIRECTION; MOTION	Theoretically, one can estimate the direction of an object that is relative to the head using vertical disparity if the distance from the head to the object is known. However, several reports describe vertical disparity as having little or no effect on the perception of visual direction. It has been suggested, however, that the visual processes involved in action are different from those involved in perception, and the effect of visual disparity on action has not been investigated in previous studies. This study investigated the influence of vertical disparity on the stability of head direction as a motor response to visual information. We presented a stimulus consisting of horizontal lines with vertical size-disparity oscillation, and examined whether the stimulus affected the subject's head movement. The results showed that the head movement in the condition of vertical size-disparity oscillation was not significantly different from that in the condition of no disparity oscillation. Our results suggest that, despite theoretical validity, vertical disparity is not used for controlling head movement.	[Maekawa, Toru] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Maekawa, Toru; Kaneko, Hirohiko] Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Tokyo Institute of Technology	Maekawa, T (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	torumaekawa@nict.go.jp			Japan Society for the Promotion of Science [24500236]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (no. 24500236) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; Banks MS, 2002, VISION RES, V42, P801, DOI 10.1016/S0042-6989(01)00283-8; Berends EM, 2002, PERCEPTION, V31, P1323, DOI 10.1068/p3440; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; GILLAM B, 1983, PERCEPT PSYCHOPHYS, V34, P121, DOI 10.3758/BF03211336; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hering E., 1942, SPATIAL SENSE MOVEME; Ishii M, 2009, VISION RES, V49, P1563, DOI 10.1016/j.visres.2009.03.012; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Maekawa T, 2014, VISION, V26, P109; MAYHEW JEW, 1982, NATURE, V297, P376, DOI 10.1038/297376a0; NAKAMIZO S, 1994, PERCEPTION, V23, P1037, DOI 10.1068/p231037; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; ONO H, 1995, PERCEPTION, V24, P237, DOI 10.1068/p240237; ROGERS BJ, 1993, NATURE, V361, P253, DOI 10.1038/361253a0; Uwa N, 1998, PERCEPTION, V27, P49; Uwa N, 1999, J I IMAGE INFORM TEL, V53, P1300; Wade N., 2003, ESSAY SINGLE VISION, P71	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137483	10.1371/journal.pone.0137483	http://dx.doi.org/10.1371/journal.pone.0137483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356478	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800050
J	Li, JS; Chen, X; Peng, L; Wei, SY; Zhao, SL; Diao, TT; He, YX; Liu, F; Wei, QJ; Zhang, QF; Li, B				Li, Jian-Si; Chen, Xiao; Peng, Lei; Wei, Shi-Yao; Zhao, Shi-Lei; Diao, Tian-Tian; He, Yi-Xin; Liu, Fang; Wei, Qiu-Ju; Zhang, Qing-Fang; Li, Bing			Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease	PLOS ONE			English	Article							RESISTANT NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; KIDNEY REPAIR; CYCLOSPORINE; NEPHROPATHY; INHIBITOR; CELLS; GENE; PROTEINURIA; EXPRESSION	Podocyte injury plays central roles in proteinuria and kidney dysfunction, therefore, identifying specific biomarker to evaluate earlier podocyte injury is highly desirable. Podocytesecreted angiopoietin-like-4 (Angptl4) mediates proteinuria in different types of podocytopathy. In the present study, we established an experimental minimal change disease (MCD) rat model, induced by adriamycin (ADR) and resulted in definite podocyte injury, to identify the dynamic changes in Angptl4 expression. We also investigated the direct effects of tacrolimus on Angptl4 and podocyte repair. We determined that the glomerular Angptl4 expression was rapidly upregulated and reached a peak earlier than desmin, an injured podocyte marker, in the ADR rats. Furthermore, this upregulation occurred prior to heavy proteinuria and was accompanied by increased urinary Angptl4. We observed that the Angptl4 upregulation occurred only when podocyte was mainly damaged since we didn't observe little Angptl4 upregulation in MsPGN patients. In addition, we observed the glomerular Angptl4 mainly located in injured podocytes rather than normal podocytes. Moreover, we found that tacrolimus treatment significantly promoted podocyte repair and reduced glomerular and urinary Angptl4 expression at an earlier stage with a significant serum Angptl4 upregulation. And similar results were confirmed in MCD patients. In conclusion, this study represents the first investigation to demonstrate that Angptl4 can predict podocyte injury at earlier stages in MCD and the identification of earlier podocyte injury biomarkers could facilitate the prompt diagnosis and treatment of patients with podocytopathy, as well as determination of the prognosis and treatment efficacy in these diseases.	[Li, Jian-Si; Chen, Xiao; Peng, Lei; Wei, Shi-Yao; Zhao, Shi-Lei; Diao, Tian-Tian; He, Yi-Xin; Liu, Fang; Wei, Qiu-Ju; Zhang, Qing-Fang; Li, Bing] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Peoples R China; [Peng, Lei] Sichuan Acad Med Sci, Chengdu, Peoples R China; [Peng, Lei] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Harbin Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, B (corresponding author), Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Peoples R China.	zqfhlj@aliyun.com; icecreamlee@hotmail.com		Zhao, Shilei/0000-0002-8168-8112	National Basic Research Program of China 973 Program [2012CB517602]; National Natural Science Foundation of China [81370812]; research fund for the Doctoral Program of Ministry of Education of China [20122307110018]; Special Grade of China Postdoctoral Science Foundation [201003463]; Heilongjiang Postdoctoral Science Research Foundation [LBHQ10028]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Special Grade of China Postdoctoral Science Foundation; Heilongjiang Postdoctoral Science Research Foundation	This study was supported by research grants from the National Basic Research Program of China 973 Program (No. 2012CB517602), the National Natural Science Foundation of China (81370812), research fund for the Doctoral Program of Ministry of Education of China (20122307110018), the Special Grade of China Postdoctoral Science Foundation (No. 201003463), and the Heilongjiang Postdoctoral Science Research Foundation (No. LBHQ10028).	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; BERTANI T, 1982, LAB INVEST, V46, P16; Brenner BM, 2008, BRENNER RECTORS KIDN; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Fan L, 2013, INT UROL NEPHROL, V45, P459, DOI 10.1007/s11255-012-0205-1; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Gulati A, 2012, KIDNEY INT, V82, P1130, DOI 10.1038/ki.2012.238; Habashy D, 2003, PEDIATR NEPHROL, V18, P906, DOI 10.1007/s00467-003-1207-0; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Hoshi S, 2002, LAB INVEST, V82, P25, DOI 10.1038/labinvest.3780392; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XY, 2009, AM J KIDNEY DIS, V54, P51, DOI 10.1053/j.ajkd.2009.02.018; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Ma J, 2015, ENDOCRINE, V49, P373, DOI 10.1007/s12020-014-0486-5; Massella L, 2010, PEDIATR NEPHROL, V25, P1269, DOI 10.1007/s00467-010-1484-3; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Ozbay LA, 2012, BRIT J CLIN PHARMACO, V73, P536, DOI 10.1111/j.1365-2125.2011.04118.x; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Presser D, 2009, KIDNEY INT, V76, P557, DOI 10.1038/ki.2009.198; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; YAOITA E, 1990, AM J PATHOL, V136, P899; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Zhang QX, 2012, AM J NEPHROL, V35, P312, DOI 10.1159/000337175	37	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137049	10.1371/journal.pone.0137049	http://dx.doi.org/10.1371/journal.pone.0137049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352670	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800058
J	Austin, E; Novosselov, I; Seto, E; Yost, MG				Austin, Elena; Novosselov, Igor; Seto, Edmund; Yost, Michael G.			Laboratory Evaluation of the Shinyei PPD42NS Low-Cost Particulate Matter Sensor	PLOS ONE			English	Article							AIR-POLLUTION; CARDIOVASCULAR-DISEASE; MORTALITY; POPULATION; STATEMENT; EXPOSURE; QUALITY; PM2.5	Objective Finely resolved PM2.5 exposure measurements at the level of individual participants or over a targeted geographic area can be challenging due to the cost, size and weight of the monitoring equipment. We propose re-purposing the low-cost, portable and lightweight Shinyei PPD42NS particle counter as a particle counting device. Previous field deployment of this sensor suggests that it captures trends in ambient PM2.5 concentrations, but important characteristics of the sensor response have yet to be determined. Laboratory testing was undertaken in order to characterize performance. Methods The Shinyei sensors, in-line with a TSI Aerosol Particle Sizer (APS) model 3321, tracked particle decay within an aerosol exposure chamber. Test atmospheres were composed of monodisperse polystyrene spheres with diameters of 0.75, 1, 2 3 and 6 um as well as a polydisperse atmosphere of ASHRAE test dust #1. Results Two-minute block averages of the sensor response provide a measurement with low random error, within sensor, for particles in the 0.75-6 mu m range with a limit of detection of 1 mu g/m(3). The response slope of the sensors is idiomatic, and each sensor requires a unique response curve. A linear model captures the sensor response for concentrations below 50 mu g/m(3) and for concentrations above 50 mu g/m(3) a non-linear function captures the response and saturates at 800 mu g/m(3). The Limit of Detection (LOD) is 1 mu g/m(3). The response time is on the order of minutes, making it appropriate for tracking short-term changes in concentration. Conclusions When paired with prior evaluation, these sensors are appropriate for use as ambient particle counters for low and medium concentrations of respirable particles (< 100 ug/m(3)). Multiple sensors deployed over a spatial grid would provide valuable spatio-temporal variability in PM2.5 and could be used to validate exposure models. When paired with GPS tracking, these devices have the potential to provide time and space resolved exposure measurements for a large number of participants, thus increasing the power of a study.	[Austin, Elena; Seto, Edmund; Yost, Michael G.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Novosselov, Igor] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Austin, E (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	elaustin@uw.edu	Novosselov, Igor/ABA-1810-2020; Austin, Elena/AAX-7013-2021	Novosselov, Igor/0000-0002-6347-7450; Austin, Elena/0000-0002-4724-1042	Department of Environmental and Occupational Health Sciences at the University of Washington; National Institute of Environmental Health Sciences of the National Institutes of Health [T32ES015459, R21ES024715]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R33ES024715, T32ES015459, R21ES024715] Funding Source: NIH RePORTER	Department of Environmental and Occupational Health Sciences at the University of Washington(University of Washington); National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors would like to thank the Department of Environmental and Occupational Health Sciences at the University of Washington for its support of this project. Research reported in this article was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under award number T32ES015459 and award number R21ES024715. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; California Environmental Protection Agency, 2005, AIR QUAL LAND US HDB; Clougherty JE, 2013, J EXPO SCI ENV EPID, V23, P232, DOI 10.1038/jes.2012.125; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Evans J, 2013, ENVIRON RES, V120, P33, DOI 10.1016/j.envres.2012.08.005; Gao ML, 2015, ENVIRON POLLUT, V199, P56, DOI 10.1016/j.envpol.2015.01.013; Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Krewski D., 2000, REANALYSIS HARVARD 6, P295; Krewski D, 2009, EXTENDED FOLLOW UP S; Lipfert FW, 2006, ATMOS ENVIRON, V40, P154, DOI 10.1016/j.atmosenv.2005.09.027; Osman LM, 2007, AM J RESP CRIT CARE, V176, P465, DOI 10.1164/rccm.200605-589OC; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Seto E., 2014, ATMOS MEAS TECH DISC, V7, P605, DOI DOI 10.5194/amtd-7-605-2014; Siddiqui AR, 2009, INDOOR AIR, V19, P75, DOI 10.1111/j.1600-0668.2008.00563.x; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Stein SW, 2003, J AEROSOL MED, V16, P107, DOI 10.1089/089426803321919870; US EPA, 2013, FIN PART PM2 5 DES; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Volckens J, 2005, J AEROSOL SCI, V36, P1400, DOI 10.1016/j.jaerosci.2005.03.009; Zeger SL, 2008, ENVIRON HEALTH PERSP, V116, P1614, DOI 10.1289/ehp.11449	26	84	85	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137789	10.1371/journal.pone.0137789	http://dx.doi.org/10.1371/journal.pone.0137789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367264	gold, Green Published			2022-12-27	WOS:000361601100137
J	Ichijo, M; Ishibashi, S; Li, FY; Yui, DS; Miki, K; Mizusawa, H; Yokota, T				Ichijo, Masahiko; Ishibashi, Satoru; Li, Fuying; Yui, Daishi; Miki, Kazunori; Mizusawa, Hidehiro; Yokota, Takanori			Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE ISCHEMIC-STROKE; FLUID SHEAR-STRESS; SPHINGOSINE 1-PHOSPHATE; CEREBRAL-ISCHEMIA; ACTIVATION; MICE; FTY720; EDG-1; FATE	Background and Purpose Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear stress in preexisting collateral pathways. Recently, sphingosine-1-phosphate receptor-1 (S1PR1) on endothelial cells was reported to be essential in sensing fluid shear stress. Here, we evaluated the expression of S1PR1 in the hypoperfused mouse brain and investigated the effect of a selective S1PR1 agonist on leptomeningeal collateral growth and subsequent ischemic damage after focal ischemia. Methods In C57Bl/6 mice (n = 133) subjected to unilateral common carotid occlusion (CCAO) and sham surgery. The first series examined the time course of collateral growth, cell proliferation, and S1PR1 expression in the leptomeningeal arteries after CCAO. The second series examined the relationship between pharmacological regulation of S1PR1 and collateral growth of leptomeningeal anastomoses. Animals were randomly assigned to one of the following groups: LtCCAO and daily intraperitoneal (ip) injection for 7 days of an S1PR1 selective agonist (SEW2871, 5 mg/kg/day); sham surgery and daily ip injection for 7 days of SEW2871 after surgery; LtCCAO and daily ip injection for 7 days of SEW2871 and an S1PR1 inverse agonist (VPC23019, 0.5 mg/kg); LtCCAO and daily ip injection of DMSO for 7 days after surgery; and sham surgery and daily ip injection of DMSO for 7 days. Leptomeningeal anastomoses were visualized 14 days after LtCCAO by latex perfusion method, and a set of animals underwent subsequent permanent middle cerebral artery occlusion (pMCAO) 7days after the treatment termination. Neurological functions 1hour, 1, 4, and 7days and infarction volume 7days after pMCAO were evaluated. Results In parallel with the increase in S1PR1 mRNA levels, S1PR1 expression colocalized with endothelial cellmarkers in the leptomeningeal arteries, increased markedly on the side of the CCAO, and peaked 7 days after CCAO. Mitotic cell numbers in the leptomeningeal arteries increased after CCAO. Administration of the S1PR1 selective agonist significantly increased cerebral blood flow (CBF) and the diameter of leptomeningeal collateral vessels (42.9 +/- 2.6 mu m) compared with the controls (27.6 +/- 5.7 mu m; P < 0.01). S1PR1 inverse agonist administration diminished the effect of the S1PR1 agonist (P < 0.001). After pMCAO, S1PR1 agonist pretreated animals showed significantly smaller infarct volume (17.5% +/- 4.0% vs. 7.7% +/- 4.0%, P < 0.01) and better functional recovery than vehicle-treated controls. Conclusions These results suggest that S1PR1 is one of the principal regulators of leptomeningeal collateral recruitment at the site of increased shear stress and provide evidence that an S1PR1 selective agonist has a role in promoting collateral growth and preventing of ischemic damage and neurological dysfunction after subsequent stroke in patients with intracranial major artery stenosis or occlusion.	[Ichijo, Masahiko; Ishibashi, Satoru; Li, Fuying; Yui, Daishi; Yokota, Takanori] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo, Japan; [Miki, Kazunori] Tokyo Med & Dent Univ, Dept Endovasc Surg, Tokyo, Japan; [Mizusawa, Hidehiro] Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Yokota, Takanori] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Neurology & Psychiatry - Japan; Tokyo Medical & Dental University (TMDU)	Ishibashi, S (corresponding author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo, Japan.	t-ishibashi.nuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263				Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gu YJ, 2000, ARTIF ORGANS, V24, P43, DOI 10.1046/j.1525-1594.2000.06351.x; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hecht N, 2012, STROKE, V43, P3052, DOI 10.1161/STROKEAHA.112.653204; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kitagawa K, 2005, STROKE, V36, P2270, DOI 10.1161/01.STR.0000181075.77897.0e; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Montrose DC, 2013, J LIPID RES, V54, P843, DOI 10.1194/jlr.M034108; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Samarska IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097196; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Sugiyama Y, 2011, STROKE, V42, P770, DOI 10.1161/STROKEAHA.110.597799; Tarbell JM, 2014, ANNU REV BIOMED ENG, V16, P505, DOI 10.1146/annurev-bioeng-071813-104908; Todo K, 2008, STROKE, V39, P1875, DOI 10.1161/STROKEAHA.107.503433; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138029	10.1371/journal.pone.0138029	http://dx.doi.org/10.1371/journal.pone.0138029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367258	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100207
J	Ishizuka, M; Miyazaki, Y; Masuo, M; Suhara, K; Tateishi, T; Yasui, M; Inase, N				Ishizuka, Masahiro; Miyazaki, Yasunari; Masuo, Masahiro; Suhara, Kozo; Tateishi, Tomoya; Yasui, Makito; Inase, Naohiko			Interleukin-17A and Neutrophils in a Murine Model of Bird-Related Hypersensitivity Pneumonitis	PLOS ONE			English	Article							PIGEON-BREEDERS LUNG; SIGLEC-F; ALLERGIC ALVEOLITIS; CYCLOSPORINE-A; FANCIERS LUNG; T-CELLS; INNATE; INFLAMMATION; FIBROSIS; MICE	Hypersensitivity pneumonitis (HP) is an immune mediated lung disease induced by the repeated inhalation of a wide variety of antigens. Bird-related hypersensitivity pneumonitis (BRHP) is one of the most common forms of HP in human and results from the inhalation of avian antigens. The findings of a recent clinical analysis suggest that in addition to Th1 factors, the levels of interleukin(IL)-17 and IL-17-associated transcripts are increased in the setting of HP, and that both IL-17A and neutrophils are crucial for the development of pulmonary inflammation in murine models of HP. Our objectives were to investigate the roles of IL-17A and neutrophils in granuloma-forming inflammation in an acute HP model. We developed a mouse model of acute BRHP using pigeon dropping extract. We evaluated the process of granuloma formation and the roles of both IL-17A and neutrophils in a model. We found that the neutralization of IL-17A by the antibody attenuated granuloma formation and the recruitment of neutrophils, and also decreased the expression level of chemokine(C-XC motif) ligand 5 (CXCL5) in the acute HP model. We confirmed that most of the neutrophils in the acute HP model exhibited immunoreactivity to the anti-IL-17 antibody. We have identified the central roles of both IL-17A and neutrophils in the pathogenesis of granuloma formation in acute HP. We have also assumed that neutrophils are an important source of IL-17A in an acute HP model, and that the IL-17A-CXCL5 pathway may be responsible for the recruitment of neutrophils.	[Ishizuka, Masahiro; Miyazaki, Yasunari; Masuo, Masahiro; Suhara, Kozo; Tateishi, Tomoya; Yasui, Makito; Inase, Naohiko] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	Miyazaki, Yasunari/B-7847-2015	Miyazaki, Yasunari/0000-0002-9073-9815; Tateishi, Tomoya/0000-0001-5402-3185	Ministry of Health, Labor and Welfare, Japan; Japan Agency for Medical Research and development, AMED; Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This project was supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labor and Welfare, Japan (N.I.). This research is partially supported by the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and development, AMED. This study is partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases.	Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Butler NS, 2002, J IMMUNOL, V169, P3700, DOI 10.4049/jimmunol.169.7.3700; COLEMAN A, 1988, AM J SURG PATHOL, V12, P514, DOI 10.1097/00000478-198807000-00002; Costabel U, 2012, CLIN CHEST MED, V33, P151, DOI 10.1016/j.ccm.2011.12.004; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DENIS M, 1992, AM J RESP CELL MOL, V6, P68, DOI 10.1165/ajrcmb/6.1.68; DENIS M, 1992, AM J RESP CELL MOL, V6, P183, DOI 10.1165/ajrcmb/6.2.183; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; FINK JN, 1984, J ALLERGY CLIN IMMUN, V74, P1, DOI 10.1016/0091-6749(84)90077-0; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; Gudmundsson G, 1998, J IMMUNOL, V161, P991; Hasan SA, 2013, J ALLERGY CLIN IMMUN, V131, P1663, DOI 10.1016/j.jaci.2013.01.015; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Joshi AD, 2009, AM J RESP CRIT CARE, V179, P705, DOI 10.1164/rccm.200811-1700OC; Lacasse Y, 2009, INT ARCH ALLERGY IMM, V149, P161, DOI 10.1159/000189200; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Mitaka K, 2011, INT ARCH ALLERGY IMM, V154, P264, DOI 10.1159/000321114; Nance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762; Ohtani Y, 2000, CHEST, V118, P1382, DOI 10.1378/chest.118.5.1382; Ohtani Y, 1999, INTERNAL MED, V38, P896, DOI 10.2169/internalmedicine.38.896; Pardo A, 2000, AM J RESP CRIT CARE, V161, P1698, DOI 10.1164/ajrccm.161.5.9907065; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Pickens SR, 2011, ANGIOGENESIS, V14, P443, DOI 10.1007/s10456-011-9227-z; SALVAGGIO JE, 1993, RESP MED, V87, P495, DOI 10.1016/0954-6111(93)90004-J; Schuyler M, 2000, J LAB CLIN MED, V136, P29, DOI 10.1067/mlc.2000.107694; Schuyler M, 1997, CELL IMMUNOL, V177, P169, DOI 10.1006/cimm.1997.1107; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; SELMAN M, 1987, CLIN IMMUNOL IMMUNOP, V44, P63, DOI 10.1016/0090-1229(87)90052-3; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Suzukawa M, 2013, J IMMUNOL, V190, P5939, DOI 10.4049/jimmunol.1203455; TAKIZAWA H, 1988, J ALLERGY CLIN IMMUN, V81, P391, DOI 10.1016/0091-6749(88)90907-4; TAKIZAWA H, 1992, AM REV RESPIR DIS, V146, P479, DOI 10.1164/ajrccm/146.2.479; TODD A, 1991, CLIN EXP IMMUNOL, V85, P453; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	42	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137978	10.1371/journal.pone.0137978	http://dx.doi.org/10.1371/journal.pone.0137978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367130	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100192
J	Kindgren, P; Dubreuil, C; Strand, A				Kindgren, Peter; Dubreuil, Carole; Strand, Asa			The Recovery of Plastid Function Is Required for Optimal Response to Low Temperatures in Arabidopsis	PLOS ONE			English	Article							CHELATASE H-SUBUNIT; MG-PROTOPORPHYRIN IX; COLD-REGULATED GENES; ABSCISIC-ACID; CHLOROPLAST DEVELOPMENT; FREEZING TOLERANCE; NUCLEUS COMMUNICATION; MAGNESIUM-CHELATASE; SIGNAL-TRANSDUCTION; PROTEIN-SYNTHESIS	Cold acclimation is an essential response in higher plants to survive freezing temperatures. Here, we report that two independent mutant alleles of the H-subunit of Mg-chelatase, CHLH, gun5-1 and cch in Arabidopsis are sensitive to low temperatures. Plants were grown in photoperiodic conditions and exposed to low temperatures for short-and long-term periods. Tetrapyrrole biosynthesis was initially significantly inhibited in response to low temperature but recovered in wild type (Col-0), although the tetrapyrrole levels were lower in cold compared to control conditions. The gun5-1 and cch alleles showed an inability to recover chlorophyll biosynthesis in addition to a significant decrease in freezing tolerance. We found that the impaired plastid function in the CHLH mutant plants resulted in compromised de novo protein synthesis at low temperatures. The expression of the transcription factors CBF1-3 was super-induced in gun5-1 and cch mutant alleles but expression levels of their target genes, COR15a, COR47 and COR78 were similar or even lower compared to Col-0. In addition, the protein levels of COR15a were lower in gun5-1 and cch and a general defect in protein synthesis could be seen in the gun5-1 mutant following a 35S labelling experiment performed at low temperature. Taken together, our results demonstrate the importance of a functional chloroplast for the cold acclimation process and further suggest that impaired plastid function could result in inhibition of protein synthesis at low temperature.	[Kindgren, Peter; Dubreuil, Carole; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Kindgren, P (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, Frederiksberg C, Denmark.	peter.kindgren@plen.ku.dk	Kindgren, Peter/ABF-7599-2020; Kindgren, Peter/H-4649-2015	Kindgren, Peter/0000-0003-0947-2648	Swedish research foundation, VR	Swedish research foundation, VR(Swedish Research Council)	This work was supported by a grant from the Swedish research foundation, VR, www.vr.se (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Baldi P, 2001, J PLANT PHYSIOL, V158, P1541, DOI 10.1078/0176-1617-00591; Barajas-Lopez JD, 2013, BBA-MOL CELL RES, V1833, P425, DOI 10.1016/j.bbamcr.2012.06.020; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Crosatti C, 2013, PHYSIOL PLANTARUM, V147, P55, DOI 10.1111/j.1399-3054.2012.01689.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dal Bosco C, 2003, PLANT PHYSIOL, V131, P793, DOI 10.1104/pp.014530; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kindgren P, 2012, PLANT J, V70, P279, DOI 10.1111/j.1365-313X.2011.04865.x; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; KRISHNA P, 1995, PLANT PHYSIOL, V107, P915, DOI 10.1104/pp.107.3.915; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; Maibam P, 2013, INT J MOL SCI, V14, P11527, DOI 10.3390/ijms140611527; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mei C, 2014, J EXPT BOT; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nakayama K, 2007, PLANT PHYSIOL, V144, P513, DOI 10.1104/pp.106.094581; Nelson CJ, 2014, PLANT PHYSIOL, V166, P91, DOI 10.1104/pp.114.243014; Pesaresi P, 2006, PLANT CELL, V18, P970, DOI 10.1105/tpc.105.039073; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; STITT M, 1989, METHOD ENZYMOL, V174, P518; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Thalhammer A, 2014, PLANT PHYSIOL, V166, P190, DOI 10.1104/pp.114.245399; Thomashow MF, 1997, ACTA PHYSIOL PLANT, V19, P497, DOI 10.1007/s11738-997-0046-1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tokuhisa JG, 1998, PLANT CELL, V10, P699, DOI 10.1105/tpc.10.5.699; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731	61	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138010	10.1371/journal.pone.0138010	http://dx.doi.org/10.1371/journal.pone.0138010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366569	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100202
J	Ziaei, M; von Hippel, W; Henry, JD; Becker, SI				Ziaei, Maryam; von Hippel, William; Henry, Julie D.; Becker, Stefanie I.			Are Age Effects in Positivity Influenced by the Valence of Distractors?	PLOS ONE			English	Article							OLDER-ADULTS; EMOTION REGULATION; SOCIAL INAPPROPRIATENESS; INDIVIDUAL-DIFFERENCES; PUPILLARY RESPONSE; COGNITIVE CONTROL; NEGATIVE IMAGES; VISUAL FIXATION; MEMORY; ATTENTION	An age-related 'positivity' effect has been identified, in which older adults show an information-processing bias towards positive emotional items in attention and memory. In the present study, we examined this positivity bias by using a novel paradigm in which emotional and neutral distractors were presented along with emotionally valenced targets. Thirty-five older and 37 younger adults were asked during encoding to attend to emotional targets paired with distractors that were either neutral or opposite in valence to the target. Pupillary responses were recorded during initial encoding as well as a later incidental recognition task. Memory and pupillary responses for negative items were not affected by the valence of distractors, suggesting that positive distractors did not automatically attract older adults' attention while they were encoding negative targets. Additionally, the pupil dilation to negative items mediated the relation between age and positivity in memory. Overall, memory and pupillary responses provide converging support for a cognitive control account of positivity effects in late adulthood and suggest a link between attentional processes and the memory positivity effect.	[Ziaei, Maryam; von Hippel, William; Henry, Julie D.; Becker, Stefanie I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Ziaei, M (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	maryam.ziaei@uqconnect.edu.au	Von Hippel, Bill/L-4729-2019; Ziaei, Maryam/AAC-2587-2021; Ziaei, Maryam/B-2382-2017	Ziaei, Maryam/0000-0003-2758-8038; Ziaei, Maryam/0000-0003-2758-8038; VON HIPPEL, William/0000-0001-9900-0868; Henry, Julie/0000-0002-2081-3717; Becker, Stefanie/0000-0003-4198-5056	Australian Research Council [DP1093234]	Australian Research Council(Australian Research Council)	This work has been supported by Australian Research Council DP1093234 to JDH and BVH.	Allard ES, 2010, AGING NEUROPSYCHOL C, V17, P296, DOI 10.1080/13825580903265681; Allard E, 2008, AGING NEUROPSYCHOL C, V15, P725, DOI 10.1080/13825580802348562; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Cacioppo JT., 2011, SOCIAL NEUROSCIENCE, P249, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.003.0017, 10.1093/acprof:oso/9780195316872.003.0017]; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Clapp WC, 2012, NEUROBIOL AGING, V33, P134, DOI 10.1016/j.neurobiolaging.2010.01.012; Ebner NC, 2010, COGNITION EMOTION, V24, P1095, DOI 10.1080/02699930903128395; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A., 2012, PRINCIPLES FRONTAL L; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Goeleven E, 2010, AGING MENT HEALTH, V14, P129, DOI 10.1080/13607860903228754; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Henry JD, 2009, PSYCHOL AGING, V24, P239, DOI 10.1037/a0013423; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; Isaacowitz DM, 2009, PSYCHOL AGING, V24, P989, DOI 10.1037/a0017706; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kalokerinos EK, 2014, PSYCHOL AGING, V29, P636, DOI 10.1037/a0037452; Knight M, 2007, EMOTION, V7, P705, DOI 10.1037/1528-3542.7.4.705; Lang PJ, 2008, INT AFFECTIVE PICTUR; Larcom MJ, 2009, J GERONTOL B-PSYCHOL, V64, P733, DOI 10.1093/geronb/gbp077; Lockenhoff CE, 2007, PSYCHOL AGING, V22, P134, DOI 10.1037/0882-7974.22.1.134; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Manor BR, 2003, J NEUROSCI METH, V128, P85, DOI 10.1016/S0165-0270(03)00151-1; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M., 2012, ANN N Y ACAD SCI; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Phillips LH, 2008, J GERONTOL B-PSYCHOL, V63, pP138, DOI 10.1093/geronb/63.3.P138; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rosler A, 2005, J NEUROL SCI, V229, P109, DOI 10.1016/j.jns.2004.11.007; Samanez-Larkin GR, 2009, PSYCHOL AGING, V24, P519, DOI 10.1037/a0016952; St Jacques PL, 2009, J INT NEUROPSYCH SOC, V15, P819, DOI 10.1017/S1355617709990439; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; TAYLOR JS, 1981, PERCEPT MOTOR SKILL, V52, P425, DOI 10.2466/pms.1981.52.2.425; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; von Hippel W, 2005, PSYCHOL AGING, V20, P519, DOI 10.1037/0882-7974.20.3.519; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Ziaei M, 2014, NEUROIMAGE, V87, P276, DOI 10.1016/j.neuroimage.2013.10.048	54	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137604	10.1371/journal.pone.0137604	http://dx.doi.org/10.1371/journal.pone.0137604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366872	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100092
J	Cooney, S; Dignam, H; Brady, N				Cooney, Sarah; Dignam, Holly; Brady, Nuala			Heads First: Visual Aftereffects Reveal Hierarchical Integration of Cues to Social Attention	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; GAZE DIRECTION; ORIENTATION; ADAPTATION; PERCEPTION; SIZE; REPRESENTATION; MECHANISMS; RESPONSES	Determining where another person is attending is an important skill for social interaction that relies on various visual cues, including the turning direction of the head and body. This study reports a novel high-level visual aftereffect that addresses the important question of how these sources of information are combined in gauging social attention. We show that adapting to images of heads turned 25 degrees to the right or left produces a perceptual bias in judging the turning direction of subsequently presented bodies. In contrast, little to no change in the judgment of head orientation occurs after adapting to extremely oriented bodies. The unidirectional nature of the aftereffect suggests that cues from the human body signaling social attention are combined in a hierarchical fashion and is consistent with evidence from single-cell recording studies in nonhuman primates showing that information about head orientation can override information about body posture when both are visible.	[Cooney, Sarah; Brady, Nuala] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland; [Dignam, Holly] Univ Coll Dublin, Sch Bimol & Biomed Sci, Dublin 2, Ireland	University College Dublin; University College Dublin	Brady, N (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland.	nuala.brady@ucd.ie			Irish Research Council (IRC) [GOIPD/2013/83]	Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology)	The research described in the authors' manuscript - Cooney, Dignam & Brady, 'Heads First: Visual Aftereffects Reveal Hierarchical Integration of Cues to Social Attention' - is funded by a postgraduate research scholarship to the first author, Sarah Cooney, from the Irish Research Council (IRC: Funding Agency Reference Number: Ref: GOIPD/2013/83). Dr. Nuala Brady is a senior lecturer in Psychology at University College Dublin (UCD), Sarah Cooney is a postgraduate researcher working under the supervision of Dr Nuala Brady, and Holly Dignam is a former undergraduate student from UCD who worked on this project as part of her final year project in Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2001, INVEST OPHTH VIS SCI, V42, P1411; [Anonymous], 2010, R LANG ENV STAT COMP; Ashbridge E, 2000, COGN NEUROPSYCHOL, V17, P13, DOI 10.1080/026432900380463; Ashwin C, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-5; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bayliss AP, 2011, J EXP PSYCHOL HUMAN, V37, P634, DOI 10.1037/a0020559; Calder AJ, 2007, CURR BIOL, V17, P20, DOI 10.1016/j.cub.2006.10.052; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Ghuman AS, 2010, CURR BIOL, V20, P32, DOI 10.1016/j.cub.2009.10.077; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Hietanen JK, 2002, PSYCHOL RES-PSYCH FO, V66, P174, DOI 10.1007/s00426-002-0091-8; Hietanen JK, 1999, NEUROREPORT, V10, P3443, DOI 10.1097/00001756-199911080-00033; Hudson M, 2009, COGNITION, V112, P423, DOI 10.1016/j.cognition.2009.06.011; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046079; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Kessler E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00413; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Langton SRH, 2000, Q J EXP PSYCHOL-A, V53, P825, DOI 10.1080/027249800410562; Laube I, 2011, NEUROIMAGE, V54, P1643, DOI 10.1016/j.neuroimage.2010.08.074; Lawson RP, 2011, J VISION, V11, DOI 10.1167/11.9.17; Lawson RP, 2009, PSYCHOL SCI, V20, P363, DOI 10.1111/j.1467-9280.2009.02301.x; Mareschal I, 2013, CURR BIOL, V23, P717, DOI 10.1016/j.cub.2013.03.030; Palumbo R, 2004, PSYCHOL RES, P1; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Re DE, 2011, J EVOLUTIONARY PSYCH, V9, P295, DOI DOI 10.1556/JEP.9.2011.4.2; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Vangeneugden J, 2014, J NEUROSCI, V34, P574, DOI 10.1523/JNEUROSCI.4032-13.2014; Webster M. A., 2005, ADV VISUAL COGNITION, V2, P241, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0010; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135742	10.1371/journal.pone.0135742	http://dx.doi.org/10.1371/journal.pone.0135742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26359866	Green Submitted, gold, Green Published			2022-12-27	WOS:000361043100004
J	Kong, Y; Liang, XJ; Liu, L; Zhang, DD; Wan, C; Gan, ZJ; Yuan, LD				Kong, Yan; Liang, Xijun; Liu, Lin; Zhang, Dongdong; Wan, Chao; Gan, Zhenji; Yuan, Liudi			High Throughput Sequencing Identifies MicroRNAs Mediating alpha-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model	PLOS ONE			English	Article							PROTECTS DOPAMINERGIC-NEURONS; DIETARY SUPPLEMENTATION; CLIMBING ABILITY; GABA(B) RECEPTOR; LEAF EXTRACT; OVEREXPRESSION; EXPRESSION; NEUROTOXICITY; DYSFUNCTION; MIR-137	Parkinson's disease (PD) is a prevalent neurodegenerative disorder with pathological features including death of dopaminergic neurons in the substantia nigra and intraneuronal accumulations of Lewy bodies. As the main component of Lewy bodies, alpha-synuclein is implicated in PD pathogenesis by aggregation into insoluble filaments. However, the detailed mechanisms underlying alpha-synuclein induced neurotoxicity in PD are still elusive. MicroRNAs are similar to 20nt small RNA molecules that fine-tune gene expression at posttranscriptional level. A plethora of miRNAs have been found to be dysregulated in the brain and blood cells of PD patients. Nevertheless, the detailed mechanisms and their in vivo functions in PD still need further investigation. By using Drosophila PD model expressing alpha-synuclein A30P, we examined brain miRNA expression with high-throughput small RNA sequencing technology. We found that five miRNAs (dme-miR-133-3p, dme-miR-137-3p, dme-miR-13b-3p, dme-miR-932-5p, dme-miR-1008-5p) were upregulated in PD flies. Among them, miR-13b, miR-133, miR-137 are brain enriched and highly conserved from Drosophila to humans. KEGG pathway analysis using DIANA miR-Path demonstrated that neuroactive-ligand receptor interaction pathway was most likely affected by these miRNAs. Interestingly, miR-137 was predicted to regulate most of the identified targets in this pathway, including dopamine receptor (DopR, D2R), gamma-aminobutyric acid (GABA) receptor (GABA-B-R1, GABA-B-R3) and N-methyl-D-aspartate (NMDA) receptor (Nmdar2). The validation experiments showed that the expression of miR-137 and its targets was negatively correlated in PD flies. Further experiments using luciferase reporter assay confirmed that miR-137 could act on specific sites in 3' UTR region of D2R, Nmdar2 and GABA-B-R3, which downregulated significantly in PD flies. Collectively, our findings indicate that a-synuclein could induce the dysregulation of miRNAs, which target neuroactive ligand-receptor interaction pathway in vivo. We believe it will help us further understand the contribution of miRNAs to alpha-synuclein neurotoxicity and provide new insights into the pathogenesis driving PD.	[Kong, Yan; Yuan, Liudi] Southeast Univ, Sch Med, Dept Biochem & Mol Biol, Nanjing 210009, Jiangsu, Peoples R China; [Liang, Xijun; Liu, Lin; Gan, Zhenji] Nanjing Univ, MOE, Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Dongdong; Wan, Chao; Yuan, Liudi] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Nanjing University; Southeast University - China	Kong, Y (corresponding author), Southeast Univ, Sch Med, Dept Biochem & Mol Biol, Nanjing 210009, Jiangsu, Peoples R China.	kongyancn@163.com; yld@seu.edu.cn	KONG, YAN/AGT-7798-2022	Jiang, Bing-Hua/0000-0003-4526-2031; Gan, Zhenji/0000-0001-5940-207X	Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China [20120092120065]; National Natural Science Foundation of China [31200804]; Jiangsu Natural Science Foundation [BK20140600]	Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was funded by the Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China (20120092120065), www.sdns.cutech.edu.cn; the National Natural Science Foundation of China (31200804), www.nsfc.gov.cn; and the Jiangsu Natural Science Foundation (BK20140600), www.jstd.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002425; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barkholt P, 2012, NEUROSCIENCE, V208, P85, DOI 10.1016/j.neuroscience.2012.02.004; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Botella JA, 2008, NEUROBIOL DIS, V30, P65, DOI 10.1016/j.nbd.2007.11.013; Bouleau S, 2015, J ALZHEIMERS DIS, V45, P1015, DOI 10.3233/JAD-142802; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Cardo LF, 2013, J NEUROL, V260, P1420, DOI 10.1007/s00415-013-6900-8; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Czapski GA, 2013, FEBS LETT, V587, P3135, DOI 10.1016/j.febslet.2013.07.053; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Desplats P, 2012, J BIOL CHEM, V287, P31691, DOI 10.1074/jbc.M112.354522; Devine MJ, 2012, J NEUROSCI, V32, P16071, DOI 10.1523/JNEUROSCI.4224-12.2012; Dorval V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085510; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gao SS, 2015, INT J BIOCHEM CELL B, V64, P25, DOI 10.1016/j.biocel.2015.03.006; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Gispert S, 2015, MOL NEUROBIOL, V52, P57, DOI 10.1007/s12035-014-8844-0; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hillman R, 2012, NEUROSCI LETT, V516, P167, DOI 10.1016/j.neulet.2012.03.034; Huang AH, 2014, GENET EPIDEMIOL, V38, P300, DOI 10.1002/gepi.21803; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Johnston T, 2003, BRIT J PHARMACOL, V139, P1480, DOI 10.1038/sj.bjp.0705372; Kabaria S, 2015, FEBS LETT, V589, P319, DOI 10.1016/j.febslet.2014.12.014; Khan S, 2012, INT J NEUROSCI, V122, P704, DOI 10.3109/00207454.2012.709893; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kohno R, 2004, BIOCHEM BIOPH RES CO, V318, P113, DOI 10.1016/j.bbrc.2004.04.012; Kong Y, 2014, CURR ALZHEIMER RES, V11, P882; Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x; Liu SM, 2007, EUR J NEUROSCI, V25, P3583, DOI 10.1111/j.1460-9568.2007.05569.x; Long JG, 2009, REJUV RES, V12, P321, DOI 10.1089/rej.2009.0877; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Luo J, 2014, HUM MOL GENET, V23, P6567, DOI 10.1093/hmg/ddu377; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Maheshwari M, 2014, HUM MOL GENET, V23, P2737, DOI 10.1093/hmg/ddt667; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Musgrove REJ, 2013, NEUROTOX RES, V23, P358, DOI 10.1007/s12640-012-9352-5; Nalls MA, 2014, HUM MOL GENET, V23, P831, DOI 10.1093/hmg/ddt465; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pendleton RG, 2002, J PHARMACOL EXP THER, V300, P91, DOI 10.1124/jpet.300.1.91; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Price DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014020; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Shaltiel-Karyo R, 2013, J BIOL CHEM, V288, P17579, DOI 10.1074/jbc.M112.434787; Shaltiel-Karyo R, 2012, BBA-GEN SUBJECTS, V1820, P1628, DOI 10.1016/j.bbagen.2012.04.021; Siddique YH, 2014, CHIN J NAT MEDICINES, V12, P777, DOI 10.1016/S1875-5364(14)60118-7; Siddique YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606928; Siddique Yasir Hasan, 2014, Journal of Dietary Supplements, V11, P121, DOI 10.3109/19390211.2013.859207; Siddique YH, 2013, FOOD CHEM TOXICOL, V55, P29, DOI 10.1016/j.fct.2012.12.028; Siddique Yasir Hasan, 2012, Journal of Dietary Supplements, V9, P1, DOI 10.3109/19390211.2011.630716; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Laurent R, 2013, NEUROSCIENCE, V246, P382, DOI 10.1016/j.neuroscience.2013.04.037; Strazisar M, 2015, MOL PSYCHIATR, V20, P472, DOI 10.1038/mp.2014.53; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Valles A, 2014, J PSYCHIATR NEUROSCI, V39, P312, DOI 10.1503/jpn.130269; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1559, DOI 10.1016/j.neurobiolaging.2015.01.014; Verma P, 2015, NAT NEUROSCI, V18, P379, DOI 10.1038/nn.3935; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang B, 2015, BIOCHEM CELL BIOL, V93, P351, DOI 10.1139/bcb-2015-0015; Wang SX, 2014, P NATL ACAD SCI USA, V111, pE3976, DOI 10.1073/pnas.1411694111; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wright Carrie, 2013, Frontiers in Genetics, V4, P58, DOI 10.3389/fgene.2013.00058; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Yin JW, 2014, INT J MOL SCI, V15, P3262, DOI 10.3390/ijms15023262; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhao LX, 2013, NEURAL REGEN RES, V8, P2441, DOI 10.3969/j.issn.1673-5374.2013.26.005	94	81	85	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137432	10.1371/journal.pone.0137432	http://dx.doi.org/10.1371/journal.pone.0137432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361355	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100037
J	Nishizawa, M; Matsuda, M; Hattori, J; Shiino, T; Matano, T; Heneine, W; Johnson, JA; Sugiura, W				Nishizawa, Masako; Matsuda, Masakazu; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru			Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; SINGLE-DOSE NEVIRAPINE; TREATMENT-NAIVE; VIROLOGICAL FAILURE; INFECTED PATIENTS; TYPE-1 POL; VARIANTS; MUTATIONS; TRANSMISSION; PCR	Background Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequencing due to the ability to detect low-frequency variants. To clarify a clinical benefit to monitoring minority-level drug resistance populations as a guide to select active drugs for salvage therapy, we retrospectively analyzed the dynamics of low-frequency drug-resistant population in antiretroviral (ARV)-exposed drug resistant individuals. Materials and Methods Six HIV-infected individuals treated with ARV for more than five years were analyzed. These individuals had difficulty in controlling viremia, and treatment regimens were switched multiple times guided by standard drug resistance testing using bulk sequencing. To detect minority variant populations with drug resistance, we used a highly sensitive allele-specific PCR (AS-PCR) with detection thresholds of 0.3-2%. According to ARV used in these individuals, we focused on the following seven reverse transcriptase inhibitor-resistant mutations: M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y. Results of AS-PCR were compared with bulk sequencing data for concordance and presence of additional mutations. To clarify the genetic relationship between low-frequency and high-frequency populations, AS-PCR amplicon sequences were compared with bulk sequences in phylogenetic analysis. Results The use of AS-PCR enabled detection of the drug-resistant mutations, M41L, K103N, Y181C, M184V and T215Y, present as low-frequency populations in five of the six individuals. These drug resistant variants persisted for several years without ARV pressure. Phylogenetic analysis indicated that pre-existing K103N and T215I variants had close genetic relationships with high-frequency K103N and T215I observed during treatment. Discussion and Conclusion Our results demonstrate the long-term persistence of drug-resistant viruses in the absence of drug pressure. The rapid virologic failures with pre-existing mutant viruses detectable by AS-PCR highlight the clinical importance of low-frequency drug-resistant viruses. Thus, our results highlight the usefulness of AS-PCR and support its expanded evaluation in ART clinical management.	[Nishizawa, Masako; Matano, Tetsuro; Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Matsuda, Masakazu; Hattori, Junko; Sugiura, Wataru] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Heneine, Walid; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; National Institute of Infectious Diseases (NIID); Centers for Disease Control & Prevention - USA; Nagoya University	Sugiura, W (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	taru1600@me.com			Ministry of Health, Labour, and Welfare of Japan [H25-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan (H25-AIDS-004) http://www.mhlw.go.jp/ to WS.	Albrecht D, 2002, J CLIN VIROL, V24, P93, DOI 10.1016/S1386-6532(01)00231-1; Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Boltz VF, 2010, J VIROL METHODS, V164, P122, DOI 10.1016/j.jviromet.2009.11.025; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Edelstein RE, 1998, J CLIN MICROBIOL, V36, P569, DOI 10.1128/JCM.36.2.569-572.1998; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halfon P, 2003, AIDS, V17, P1351, DOI 10.1097/00002030-200306130-00009; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Katlama C, 2012, EXPERT OPIN INV DRUG, V21, P523, DOI 10.1517/13543784.2012.661713; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021734; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mohamed S, 2014, AIDS; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083150; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES FOR THE U; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Stelzl E, 2011, J VIROL METHODS, V178, P94, DOI 10.1016/j.jviromet.2011.08.020; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Wainberg MA, 2011, J ANTIMICROB CHEMOTH, V66, P2346, DOI 10.1093/jac/dkr291	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135941	10.1371/journal.pone.0135941	http://dx.doi.org/10.1371/journal.pone.0135941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360259	Green Published, gold, Green Submitted			2022-12-27	WOS:000361043100006
J	Grant, JF; Chittleborough, CR; Taylor, AW				Grant, Janet F.; Chittleborough, Catherine R.; Taylor, Anne W.			Parental Midlife Body Shape and Association with Multiple Adult Offspring Obesity Measures: North West Adelaide Health Study	PLOS ONE			English	Article							BRITISH BIRTH COHORT; TO-HEIGHT RATIO; WAIST-HIP RATIO; MASS INDEX; CARDIOVASCULAR-DISEASE; FAT DISTRIBUTION; SCREENING TOOL; RISK-FACTORS; CIRCUMFERENCE; WEIGHT	There is compelling evidence that parental weight is a strong determinant of offspring weight status. The study used cross-sectional self-reported and measured data from a longitudinal cohort of Australian adults (n = 2128) from Stage 3 (2008-10) of the North West Adelaide Health Study (1999-2003, baseline n = 4056) to investigate the association between midlife parental body shape and four indicators of obesity and fat distribution. The analysis used measured body mass index (BMI), waist circumference (WC), waist hip ratio (WHR) and waist height ratio (WHtR) of adult offspring, together with pictograms for recall of parental body shape. Compared to both parents being a healthy weight, offspring were more likely to be overweight or obese if both parents were an unhealthy weight at age 40 (OR 2.14, 95% CI 1.67-2.76) and further, those participants whose mother was an unhealthy weight were more likely to be overweight or obese themselves (OR 1.50, 95% CI 1.14-1.98). There were similar but lower results for those with an overweight/obese father (OR 1.44, 95% CI 1.08-1.93). The effect of one or both parents being overweight or obese tended to be stronger for daughters than for sons across BMI, WC and WHtR. BMI showed the strongest association with parental body shape (OR 2.14), followed by WC (OR 1.78), WHtR (OR 1.71) and WHR (OR 1.45). WHtR (42-45%) and BMI (35-36%) provided the highest positive predictive values for overweight/obesity from parental body shape. Parental obesity increases the risk of obesity for adult offspring, both for overall body shape and central adiposity, particularly for daughters. Pictograms could potentially be used as a screening tool in primary care settings to promote healthy weight among young adults.	[Grant, Janet F.; Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Chittleborough, Catherine R.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Grant, JF (corresponding author), Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	janet.grant@adelaide.edu.au	Grant, Janet F/B-9577-2011; Taylor, Anne w/F-5708-2010; Chittleborough, Catherine/A-7436-2011	Taylor, Anne w/0000-0002-4422-7974; Chittleborough, Catherine/0000-0003-3196-7137; Grant, Janet/0000-0002-3421-5603	South Australian Department of Human Services	South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA))	The research was internally funded by the South Australian Department of Human Services, including an allocation from the SA Health Human Services Research Initiatives (Large) Projects (HSRIP) fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2008, OBESITY, V16, P1388, DOI 10.1038/oby.2008.211; [Anonymous], 2005, ENCY HUMAN NUTR, P392; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Australian Bureau of Statistics, 2012, PROF HLTH AUSTR 2011; Australian Bureau of Statistics, 2006, AUSTR NZ STAND CLASS; Bhuiyan AR, 2003, AM J EPIDEMIOL, V158, P792, DOI 10.1093/aje/kwg218; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Choi BCK, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/875253; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Flood V, 1998, RECOMMENDATIONS MONI; Fontaine KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027692; Frayling TM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5844; Gardner RM, 1998, PERCEPT MOTOR SKILL, V86, P387, DOI 10.2466/pms.1998.86.2.387; GARN SM, 1989, AM J CLIN NUTR, V50, P1308, DOI 10.1093/ajcn/50.6.1308; Gill T, 2003, SOZ PRAVENTIV MED, V48, P191, DOI 10.1007/s00038-003-2055-1; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Johnson PCD, 2012, EUR J EPIDEMIOL, V27, P53, DOI 10.1007/s10654-011-9639-5; Katzmarzyk PT, 1999, AM J EPIDEMIOL, V149, P933, DOI 10.1093/oxfordjournals.aje.a009737; Keshtkar AA, 2010, J CLIN EPIDEMIOL, V63, P655, DOI 10.1016/j.jclinepi.2009.08.014; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Murrin CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-81; Overgaard D, 2006, OBESITY, V14, P458, DOI 10.1038/oby.2006.60; Power C, 2011, ANN HUM BIOL, V38, P390, DOI 10.3109/03014460.2011.591827; SORENSEN TIA, 1992, INT J OBESITY, V16, P705; SORENSEN TIA, 1983, INT J OBESITY, V7, P115; SORENSEN TIA, 1993, ACTA PSYCHIAT SCAND, V87, P67, DOI 10.1111/j.1600-0447.1993.tb05363.x; STUNKARD AJ, 1982, RES PUBL ASSOC RES N, V60, P115; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Taylor AW, 2013, J CLIN EPIDEMIOL, V66, P461, DOI 10.1016/j.jclinepi.2012.06.021; Turner LR, 2015, MED J AUSTRALIA, V202, P370, DOI 10.5694/mja14.00998; Vanltallie TB, 1998, NUTR REV, V56, P300, DOI 10.1111/j.1753-4887.1998.tb01663.x; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; Wilding J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5843; World Health Organization, 2013, BMI CLASS GEN; World Health Organization, WAIST CIRC WAIST HIP	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137534	10.1371/journal.pone.0137534	http://dx.doi.org/10.1371/journal.pone.0137534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355742	Green Published, Green Submitted, gold			2022-12-27	WOS:000360965800059
J	Cieza, A; Anczewska, M; Ayuso-Mateos, JL; Baker, M; Bickenbach, J; Chatterji, S; Hartley, S; Leonardi, M; Pitkanen, T				Cieza, Alarcos; Anczewska, Marta; Ayuso-Mateos, Jose Luis; Baker, Mary; Bickenbach, Jerome; Chatterji, Somnath; Hartley, Sally; Leonardi, Matilde; Pitkanen, Tuuli		PARADISE Consortium	Understanding the Impact of Brain Disorders: Towards a 'Horizontal Epidemiology' of Psychosocial Difficulties and Their Determinants	PLOS ONE			English	Article							QUALITY-OF-LIFE; ALCOHOL DEPENDENCE; HEALTH; DEPRESSION; VERSION; SCHIZOPHRENIA; DISABILITY; OUTCOMES; ANXIETY; PROFILE	Objective To test the hypothesis of 'horizontal epidemiology', i.e. that psychosocial difficulties (PSDs), such as sleep disturbances, emotional instability and difficulties in personal interactions, and their environmental determinants are experienced in common across neurological and psychiatric disorders, together called brain disorders. Study Design A multi-method study involving systematic literature reviews, content analysis of patient-reported outcomes and outcome instruments, clinical input and a qualitative study was carried out to generate a pool of PSD and environmental determinants relevant for nine different brain disorders, namely epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke, dementia, depression, schizophrenia and substance dependency. Information from these sources was harmonized and compiled, and after feedback from external experts, a data collection protocol including PSD and determinants common across these nine disorders was developed. This protocol was implemented as an interview in a cross-sectional study including a convenience sample of persons with one of the nine brain disorders. PSDs endorsed by at least 25% of patients with a brain disorder were considered associated with the disorder. PSD were considered common across disorders if associated to 5 out of the 9 brain disorders and if among the 5 both neurological and psychiatric conditions were represented. Setting The data collection protocol with 64 PSDs and 20 determinants was used to collect data from a convenience sample of 722 persons in four specialized health care facilities in Europe. Results 57 of the PSDs and 16 of the determinants included in the protocol were found to be experienced across brain disorders. Conclusion This is the first evidence that supports the hypothesis of horizontal epidemiology in brain disorders. This result challenges the brain disorder-specific or vertical approach in which clinical and epidemiological research about psychosocial difficulties experienced in daily life is commonly carried in neurology and psychiatry and the way in which the corresponding health care delivery is practiced in many countries of the world.	[Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England; [Cieza, Alarcos] Univ Munich, Res Unit Biopsychosocial Hlth, Chair Publ Hlth & Hlth Serv Res, Dept Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Cieza, Alarcos; Bickenbach, Jerome] Swiss Parapleg Res, Nottwil, Switzerland; [Anczewska, Marta] Inst Psychiat & Neurol, Dept Psychiat, Warsaw, Poland; [Ayuso-Mateos, Jose Luis] Univ Autonoma Madrid, Dept Psychiat, Inst Salud Carlos III,Psychiat Serv, Ctr Invest Biomed Red Salud Mental CIBERSAM,Inst, Madrid, Spain; [Baker, Mary] European Brain Council, Brussels, Belgium; [Chatterji, Somnath] WHO, Dept Measurement & Hlth Informat Syst, Multicountry Studies, CH-1211 Geneva, Switzerland; [Hartley, Sally] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Hartley, Sally] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Hartley, Sally] London Sch Hyg & Trop Med, London WC1, England; [Leonardi, Matilde] Neurol Inst Carlo Besta IRCCS Fdn, Sci Directorate, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Pitkanen, Tuuli] A Clin Fdn, Helsinki, Finland	University of Southampton; University of Munich; Swiss Paraplegic Research; Institute of Psychiatry & Neurology; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; World Health Organization; University of East Anglia; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; IRCCS Istituto Neurologico Besta	Cieza, A (corresponding author), Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England.	a.cieza@soton.ac.uk	Schiavolin, Silvia/K-6595-2016; leonardi, matilde/J-9997-2018; Cerniauskaite, Milda/AAS-2802-2021; CHATTERJI, Somnath/ABE-6832-2020; Pitkänen, Tuuli/AAH-2204-2020; Cabello, Maria/R-5665-2019; Quintas, Rui/AAJ-6630-2021; Raggi, Alberto/K-5787-2016	Schiavolin, Silvia/0000-0002-5391-7539; leonardi, matilde/0000-0003-0552-8923; Cerniauskaite, Milda/0000-0003-1871-3650; Cabello, Maria/0000-0003-2362-6092; Quintas, Rui/0000-0002-9985-334X; Raggi, Alberto/0000-0002-7433-7779; Pitkanen, Tuuli/0000-0002-2381-9436; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Giovannetti, Ambra Mara/0000-0002-7496-6727; Anczewska, Marta/0000-0001-8816-930X	Coordination Theme 1 (Health) of the European Community's FP7 [HEALTH-F2-2009-241572]	Coordination Theme 1 (Health) of the European Community's FP7	The PARADISE project is supported by the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement No. HEALTH-F2-2009-241572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbaju DA, 2013, SOC PSYCH PSYCH EPID, V48, P1405, DOI 10.1007/s00127-013-0654-6; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brazier J, 2010, BRIT J PSYCHIAT, V197, P348, DOI 10.1192/bjp.bp.110.082453; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132410; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; Cieza A, 2010, DISABIL REHABIL, V32, pS85, DOI 10.3109/09638288.2010.515702; Coenen M, 2016, DISABIL REHABIL, V38, P1134, DOI 10.3109/09638288.2015.1074729; Cohen A, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-1; Colman I, 2010, CAN J PSYCHIAT, V55, P622, DOI 10.1177/070674371005501002; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Finsterer J, 2013, AM J HOSPICE PALLIAT; Habermann Barbara, 2005, J Gerontol Nurs, V31, P49; Hamedani AG, 2001, STROKE, V32, P687, DOI 10.1161/01.STR.32.3.687; Hartley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096890; Iosifescu DV, 2012, EUR NEUROPSYCHOPHARM, V22, pS499, DOI 10.1016/j.euroneuro.2012.08.002; Leonardi M, 2009, DISABIL REHABIL, V31, pS88, DOI 10.3109/09638280903317732; Levola J, 2014, DISABIL REHABIL, V36, P1227, DOI 10.3109/09638288.2013.837104; Levola J, 2014, NORD J PSYCHIAT, V68, P369, DOI 10.3109/08039488.2013.852242; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Matsubayashi T, 2011, SOC SCI MED, V73, P1395, DOI 10.1016/j.socscimed.2011.08.022; McKenzie K, 2004, BRIT MED J, V329, P1138, DOI 10.1136/bmj.329.7475.1138; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nandi PR, 2012, CURR OPIN SUPPORT PA, V6, P194, DOI 10.1097/SPC.0b013e328352edff; National Institute for Health and Care Excellence, 2011, 136 NICE; National Institutes of Health N, BRAIN RES ADV INN NE; Papaioannou D, 2011, VALUE HEALTH, V14, P907, DOI 10.1016/j.jval.2011.04.006; Payne Krista A, 2010, Healthc Policy, V5, pe173; Quintas R, 2012, EPILEPSY BEHAV, V25, P60, DOI 10.1016/j.yebeh.2012.05.016; Raggi A, 2012, J HEADACHE PAIN, V13, P595, DOI 10.1007/s10194-012-0482-1; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Reed GM, 2009, ALTER, V3, P340, DOI 10.1016/j.alter.2008.11.003; Sabariego C, DETERMINANT IN PRESS; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schauenburg H, 1998, PSYCHOTHER PSYCH MED, V48, P257; Scott KM, 2010, J AFFECT DISORDERS, V125, P207, DOI 10.1016/j.jad.2010.06.022; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Switaj P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-193; Tacchini G, 1994, Minerva Psichiatr, V35, P63; vanStraten A, 1997, STROKE, V28, P2155, DOI 10.1161/01.STR.28.11.2155; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2001, WHO INT CLASS FUNCT; WHO, 1998, PSYCHOL MED, V28, P551; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018; World Health Organization (WHO), 2010, MEAS HLTH DIS MAN WH	50	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136271	10.1371/journal.pone.0136271	http://dx.doi.org/10.1371/journal.pone.0136271			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352911	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800033
J	Goodall, LJ; Ovecka, M; Rycroft, D; Friel, SL; Sanderson, A; Mistry, P; Davies, ML; Stoop, AA				Goodall, Laura J.; Ovecka, Milan; Rycroft, Daniel; Friel, Sarah L.; Sanderson, Andrew; Mistry, Prafull; Davies, Marie L.; Stoop, A. Allart			Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODIES; AUTOIMMUNE-DISEASES; KAPPA-B; ARTHRITIS; LIGAND; ACTIVATION; INFECTION; RESPONSES; MICE	Tumour Necrosis Factor-alpha (TNF-alpha) inhibition has been transformational in the treatment of patients with inflammatory disease, e.g. rheumatoid arthritis. Intriguingly, TNF-alpha signals through two receptors, TNFR1 and TNFR2, which have been associated with detrimental inflammatory and beneficial immune-regulatory processes, respectively. To investigate if selective TNFR1 inhibition might provide benefits over pan TNF-alpha inhibition, tools to investigate the potential impact of pharmacological intervention are needed. Receptor-deficient mice have been very insightful, but are not reversible and could distort receptor cross-talk, while inhibitory anti-TNFR1 monoclonal antibodies have a propensity to induce receptor agonism. Therefore, we set out to characterise a monovalent anti-TNFR1 domain antibody (dAb) formatted for in vivo use. The mouse TNFR1 antagonist (DMS5540) is a genetic fusion product of an anti-TNFR1 dAb with an albumin-binding dAb (AlbudAb). It bound mouse TNFR1, but not human TNFR1, and was an antagonist of TNF-alpha-mediated cytotoxicity in a L929 cell assay. Surprisingly, the dAb did not compete with TNF-alpha for TNFR1-binding. This was supported by additional data showing the anti-TNFR1 epitope mapped to a single residue in the first domain of TNFR1. Pharmacokinetic studies of DMS5540 in mice over three doses (0.1, 1.0 and 10 mg/kg) confirmed extended in vivo half-life, mediated by the AlbudAb, and demonstrated non-linear clearance of DMS5540. Target engagement was further confirmed by dose-dependent increases in total soluble TNFR1 levels. Functional in vivo activity was demonstrated in a mouse challenge study, where DMS5540 provided dose-dependent inhibition of serum IL-6 increases in response to bolus mouse TNF-alpha injections. Hence, DMS5540 is a potent mouse TNFR1 antagonist with in vivo pharmacokinetic and pharmacodynamic properties compatible with use in pre-clinical disease models and could provide a useful tool to dissect the individual contributions of TNFR1 and TNFR2 in homeostasis and disease.	[Goodall, Laura J.; Ovecka, Milan; Rycroft, Daniel; Friel, Sarah L.; Sanderson, Andrew; Davies, Marie L.; Stoop, A. Allart] GlaxoSmithKline, Biopharm Innovat Unit, Biopharm R&D, Stevenage, Herts, England; [Mistry, Prafull] GlaxoSmithKline, R&D Projects, Clin Platforms & Sci, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline	Davies, ML (corresponding author), GlaxoSmithKline, Biopharm Innovat Unit, Biopharm R&D, Stevenage, Herts, England.	marie.l.davies@gsk.com			GlaxoSmithkline	GlaxoSmithkline(GlaxoSmithKline)	The work described was funded by GlaxoSmithkline. The funder provided support in the form of salaries for authors LG, MO, DR, SF, PM, AS, MD and AAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Aggarwal BB, 2014, ARTHRITIS RHEUMATOL, V66, P2657, DOI 10.1002/art.38753; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Dostalek M, 2013, CLIN PHARMACOKINET, V52, P83, DOI 10.1007/s40262-012-0027-4; Doyle ML, 2003, J BIOL CHEM, V278, P9426, DOI 10.1074/jbc.M209220200; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Evans TJ, 2000, MOL BIOTECHNOL, V15, P243, DOI 10.1385/MB:15:3:243; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; McCann FE, 2014, ARTHRITIS RHEUMATOL, V66, P2728, DOI 10.1002/art.38755; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872	32	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137065	10.1371/journal.pone.0137065	http://dx.doi.org/10.1371/journal.pone.0137065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352810	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800059
J	McClune, DW; Kostka, B; Delahay, RJ; Montgomery, WI; Marks, NJ; Scantlebury, DM				McClune, David W.; Kostka, Berit; Delahay, Richard J.; Montgomery, W. Ian; Marks, Nikki J.; Scantlebury, David M.			Winter Is Coming: Seasonal Variation in Resting Metabolic Rate of the European Badger (Meles meles)	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; ENERGY-METABOLISM; BODY-SIZE; FAT MASS; ENERGETICS; TEMPERATURE; COSTS; MOLT; AGE; HIBERNATION	Resting metabolic rate (RMR) is a measure of the minimum energy requirements of an animal at rest, and can give an indication of the costs of somatic maintenance. We measured RMR of free-ranging European badgers (Meles meles) to determine whether differences were related to sex, age and season. Badgers were captured in live-traps and placed individually within a metabolic chamber maintained at 20 +/- 1 degrees C. Resting metabolic rate was determined using an open-circuit respirometry system. Season was significantly correlated with RMR, but no effects of age or sex were detected. Summer RMR values were significantly higher than winter values (mass-adjusted mean +/- standard error: 2366 +/- 70 kJ.d(-1); 1845 +/- 109 kJ.d(-1), respectively), with the percentage difference being 24.7%. While under the influence of anaesthesia, RMR was estimated to be 25.5% lower than the combined average value before administration, and after recovery from anaesthesia. Resting metabolic rate during the autumn and winter was not significantly different to allometric predictions of basal metabolic rate for mustelid species weighing 1 kg or greater, but badgers measured in the summer had values that were higher than predicted. Results suggest that a seasonal reduction in RMR coincides with apparent reductions in physical activity and body temperature as part of the overwintering strategy ('winter lethargy') in badgers. This study contributes to an expanding dataset on the ecophysiology of medium-sized carnivores, and emphasises the importance of considering season when making predictions of metabolic rate.	[McClune, David W.; Kostka, Berit; Montgomery, W. Ian; Marks, Nikki J.; Scantlebury, David M.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Delahay, Richard J.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Stonehouse GL10 3UJ, Glos, England	Queens University Belfast; Animal & Plant Health Agency UK	Marks, NJ (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland.	n.marks@qub.ac.uk; m.scantlebury@qub.ac.uk	Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022	McClune, David/0000-0001-9629-0249	Department of Employment and Learning (DEL) NI	Department of Employment and Learning (DEL) NI	David W. McClune was supported by a PhD studentship from the Department of Employment and Learning (DEL) NI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiglbock C, 2003, J WILDLIFE DIS, V39, P665, DOI 10.7589/0090-3558-39.3.665; Bevanger K, 1998, WILDLIFE BIOL, V4, P97, DOI 10.2981/wlb.1998.006; Bracco D, 1996, OBES RES, V4, P213, DOI 10.1002/j.1550-8528.1996.tb00539.x; BROWN JH, 1972, ECOLOGY, V53, P939, DOI 10.2307/1934312; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Chamane SC, 2009, J THERM BIOL, V34, P337, DOI 10.1016/j.jtherbio.2009.06.005; CHRAIBI F, 1982, J PHYSIOL-PARIS, V78, P207; Corp N, 1997, J COMP PHYSIOL B, V167, P229, DOI 10.1007/s003600050069; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; DEPOCAS F, 1957, J APPL PHYSIOL, V10, P388, DOI 10.1152/jappl.1957.10.3.388; Elliott KH, 2015, FUNCT ECOL, V29, P219, DOI 10.1111/1365-2435.12316; FOWLER PA, 1988, J REPROD FERTIL, V84, P259; FOWLER PA, 1988, J ZOOL, V214, P635, DOI 10.1111/j.1469-7998.1988.tb03763.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Goszczynski J, 2005, MAMM BIOL, V70, P1, DOI 10.1078/1616-5047-00171; HARLOW HJ, 1985, COMP BIOCHEM PHYS A, V82, P885, DOI 10.1016/0300-9629(85)90501-8; Harrington LA, 2003, J MAMMAL, V84, P497, DOI 10.1644/1545-1542(2003)084<0497:BMOTBF>2.0.CO;2; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; HINDELL MA, 1994, POLAR BIOL, V14, P275; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IVERSEN J A, 1972, Norwegian Journal of Zoology, V20, P317; IVERSEN JA, 1972, J COMP PHYSIOL, V81, P341, DOI 10.1007/BF00697754; Iversen JA, 1970, STOFFSKIFTE KROPSSTO; Johannsen DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040837; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KRUUK H, 1983, Z SAUGETIERKD, V48, P45; Kruuk H., 1978, BEHAV ECOL SOCIOBIOL, V4, P75, DOI [10.1007/BF00302562, DOI 10.1007/BF00302562]; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Luhrmann PM, 2001, METABOLISM, V50, P972, DOI 10.1053/meta.2001.24871; MAUREL D, 1987, GEN COMP ENDOCR, V65, P317, DOI 10.1016/0016-6480(87)90179-1; MAUREL D, 1979, GEN COMP ENDOCR, V38, P207, DOI 10.1016/0016-6480(79)90208-9; MAUREL D, 1983, J INTERDISCIPL CYCLE, V14, P285, DOI 10.1080/09291018309359823; McKay WP, 2009, EUR J APPL PHYSIOL, V106, P583, DOI 10.1007/s00421-009-1054-1; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; McNab BK, 2002, J THERM BIOL, V27, P459, DOI 10.1016/S0306-4565(02)00016-5; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Moore JAH, 2003, MAMMAL REV, V33, P308, DOI 10.1046/j.1365-2907.2003.00021.x; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Neal E., 1996, BADGERS; Noonan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083156; PEREL'DIK M. N., 1950, Karakulevodstvo i Zverovodstvo, V3, P29; Pinheiro J., 2015, NLME LINEAR NONLINEA, P1; POCZOPKO P, 1979, ACTA THERIOL, V24, P125, DOI 10.4098/AT.arch.79-16; R Core Team, 2013, R LANG ENV STAT COMP; Roper T, 2010, BADGER; Roper TJ, 2001, BEHAVIOUR, V138, P173, DOI 10.1163/15685390151074366; Scantlebury M, 2005, PHYSIOL BEHAV, V84, P739, DOI 10.1016/j.physbeh.2005.02.022; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Schutz KE, 2006, J WILDLIFE MANAGE, V70, P884, DOI 10.2193/0022-541X(2006)70[884:BAPROT]2.0.CO;2; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Speakman JR, 2000, ADV ECOL RES, V30, P177; Stearns S.C., 1992, pi; Stewart PD, 1997, J ZOOL, V241, P543, DOI 10.1111/j.1469-7998.1997.tb04846.x; Tanaka H, 2006, ZOOL SCI, V23, P991, DOI 10.2108/zsj.23.991; Thompson LJ, 2015, J THERM BIOL, V51, P119, DOI 10.1016/j.jtherbio.2015.04.003; TOMASI T, 1984, COMP BIOCHEM PHYS A, V78, P431, DOI 10.1016/0300-9629(84)90572-3; Tomasi TE, 1998, GEN COMP ENDOCR, V109, P192, DOI 10.1006/gcen.1997.7018; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; Trewby ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095477; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; WOODROFFE R, 1995, J ZOOL, V235, P237; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008	75	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135920	10.1371/journal.pone.0135920	http://dx.doi.org/10.1371/journal.pone.0135920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352150	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800018
J	Tang, X; Zhao, LN; Chen, HQ; Chen, YQ; Chen, W; Song, YD; Ratledge, C				Tang, Xin; Zhao, Lina; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Song, Yuanda; Ratledge, Colin			Complete Genome Sequence of a High Lipid-Producing Strain of Mucor circinelloides WJ11 and Comparative Genome Analysis with a Low Lipid-Producing Strain CBS 277.49	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; MALIC ENZYME; OLEAGINOUS MICROORGANISMS; OVER-EXPRESSION; ACCUMULATION; ANNOTATION; NADPH; TRIACYLGLYCEROL; OVEREXPRESSION; IDENTIFICATION	The genome of a high lipid-producing fungus Mucor circinelloides WJ11 (36% w/w lipid, cell dry weight, CDW) was sequenced and compared with that of the low lipid-producing strain, CBS 277.49 (15% w/w lipid, CDW), which had been sequenced by Joint Genome Institute. The WJ11 genome assembly size was 35.4 Mb with a G+C content of 39.7%. The general features of WJ11 and CBS 277.49 indicated that they have close similarity at the level of gene order and gene identity. Whole genome alignments with MAUVE revealed the presence of numerous blocks of homologous regions and MUMmer analysis showed that the genomes of these two strains were mostly co-linear. The central carbon and lipid metabolism pathways of these two strains were reconstructed and the numbers of genes encoding the enzymes related to lipid accumulation were compared. Many unique genes coding for proteins involved in cell growth, carbohydrate metabolism and lipid metabolism were identified for each strain. In conclusion, our study on the genome sequence of WJ11 and the comparative genomic analysis between WJ11 and CBS 277.49 elucidated the general features of the genome and the potential mechanism of high lipid accumulation in strain WJ11 at the genomic level. The different numbers of genes and unique genes involved in lipid accumulation may play a role in the high oleaginicity of strain WJ11.	[Tang, Xin; Zhao, Lina; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Song, Yuanda] Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China; [Chen, Haiqin; Chen, Yong Q.; Chen, Wei] Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Ratledge, Colin] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Jiangnan University; University of Hull	Song, YD (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China.	ysong@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Natural Science Foundation of China [31271812, 81071685, 21276108]; National High Technology Research and Development Program of China [2012AA022105C]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1249]; Program for New Century Excellent Talents [NCET-13-0831]; Strategic Merieux Research Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Strategic Merieux Research Grant	Funding: This work was supported by the National Natural Science Foundation of China (31271812, 81071685, 21276108), the National High Technology Research and Development Program of China (2012AA022105C), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1249), the Program for New Century Excellent Talents (NCET-13-0831), and the Strategic Merieux Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Rodriguez-Frometa RA, 2013, APPL MICROBIOL BIOT, V97, P3063, DOI 10.1007/s00253-012-4432-2; ArisanAtac I, 1996, FEMS MICROBIOL LETT, V140, P77, DOI 10.1016/0378-1097(96)00164-4; BOTHAM PA, 1979, J GEN MICROBIOL, V114, P361, DOI 10.1099/00221287-114-2-361; BOULTON CA, 1981, J GEN MICROBIOL, V127, P169; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Csernetics A, 2011, FUNGAL GENET BIOL, V48, P696, DOI 10.1016/j.fgb.2011.03.006; Delcher AL, 2003, CURR PROTOC BIOINF, DOI DOI 10.13.11-10.13.18; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; HOSAKA K, 1979, EUR J BIOCHEM, V93, P197, DOI 10.1111/j.1432-1033.1979.tb12811.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KENDRICK A, 1992, EUR J BIOCHEM, V209, P667, DOI 10.1111/j.1432-1033.1992.tb17334.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Z, 2013, APPL MICROBIOL BIOT, V97, P4927, DOI 10.1007/s00253-012-4571-5; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Lim H, 2009, J MICROBIOL, V47, P225, DOI 10.1007/s12275-008-0247-3; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Navarro E, 2000, EUR J BIOCHEM, V267, P800, DOI 10.1046/j.1432-1327.2000.01058.x; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C., 2005, HDB FUNCTIONAL LIPID, P19, DOI [10.1201/9781420039184.ch2, DOI 10.1201/9781420039184.CH2]; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Tang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128396; Tang X, 2014, CURR MICROBIOL, V69, P899, DOI 10.1007/s00284-014-0671-z; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Vongsangnak W, 2012, BIOTECHNOL LETT, V34, P941, DOI 10.1007/s10529-012-0859-x; Wanasundara UN, 2005, HDB FUNCTIONAL LIPID, P47; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319; Wasylenko TM, 2015, METAB ENG, V30, P27, DOI 10.1016/j.ymben.2015.02.007; Wynn JP, 1999, MICROBIOL-UK, V145, P1911, DOI 10.1099/13500872-145-8-1911; Wynn JP, 1997, MICROBIOL-SGM, V143, P253, DOI 10.1099/00221287-143-1-253; Wynn JP, 2001, MICROBIOL-SGM, V147, P2857, DOI 10.1099/00221287-147-10-2857; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Yang WL, 2012, PLANT PHYSIOL, V160, P638, DOI 10.1104/pp.112.201996; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang HY, 2014, J BIOTECHNOL, V192, P78, DOI 10.1016/j.jbiotec.2014.10.004; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0; Zhao GZ, 2013, J AGR FOOD CHEM, V61, P7805, DOI 10.1021/jf400080g	49	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137543	10.1371/journal.pone.0137543	http://dx.doi.org/10.1371/journal.pone.0137543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352831	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800095
J	Juratli, MA; Siegel, ER; Nedosekin, DA; Sarimollaoglu, M; Jamshidi-Parsian, A; Cai, CZ; Menyaev, YA; Suen, JY; Galanzha, EI; Zharov, VP				Juratli, Mazen A.; Siegel, Eric R.; Nedosekin, Dmitry A.; Sarimollaoglu, Mustafa; Jamshidi-Parsian, Azemat; Cai, Chengzhong; Menyaev, Yulian A.; Suen, James Y.; Galanzha, Ekaterina I.; Zharov, Vladimir P.			In Vivo Long-Term Monitoring of Circulating Tumor Cells Fluctuation during Medical Interventions	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BREAST-CANCER; BLOOD; BIOPSY; DISSEMINATION; MAMMOGRAPHY; RESECTION; SURGERY; GROWTH	The goal of this research was to study the long-term impact of medical interventions on circulating tumor cell (CTC) dynamics. We have explored whether tumor compression, punch biopsy or tumor resection cause dissemination of CTCs into peripheral blood circulation using in vivo fluorescent flow cytometry and breast cancer-bearing mouse model inoculated with MDA-MB-231-Luc2-GFP cells in the mammary gland. Two weeks after tumor inoculation, three groups of mice were the subject of the following interventions: (1) tumor compression for 15 minutes using 400 g weight to approximate the pressure during mammography; (2) punch biopsy; or (3) surgery. The CTC dynamics were determined before, during and six weeks after these interventions. An additional group of tumor-bearing mice was used as control and did not receive an intervention. The CTC dynamics in all mice were monitored weekly for eight weeks after tumor inoculation. We determined that tumor compression did not significantly affect CTC dynamics, either during the procedure itself (P = 0.28), or during the 6-week follow-up. In the punch biopsy group, we observed a significant increase in CTC immediately after the biopsy (P = 0.02), and the rate stayed elevated up to six weeks after the procedure in comparison to the tumor control group. The CTCs in the group of mice that received a tumor resection disappeared immediately after the surgery (P = 0.03). However, CTC recurrence in small numbers was detected during six weeks after the surgery. In the future, to prevent these side effects of medical interventions, the defined dynamics of intervention-induced CTCs may be used as a basis for initiation of aggressive anti-CTC therapy at time-points of increasing CTC number.	[Juratli, Mazen A.; Nedosekin, Dmitry A.; Sarimollaoglu, Mustafa; Jamshidi-Parsian, Azemat; Cai, Chengzhong; Menyaev, Yulian A.; Galanzha, Ekaterina I.; Zharov, Vladimir P.] UAMS, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA; [Juratli, Mazen A.] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Suen, James Y.; Zharov, Vladimir P.] Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Little Rock; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Juratli, MA (corresponding author), UAMS, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA.	mjuratli@uams.edu	Juratli, Mazen/ABH-2883-2021; Juratli, Mazen/AAJ-3277-2021; Juratli, Mazen/AAH-7970-2019	Juratli, Mazen/0000-0002-1793-0672; Zharov, Vladimir/0000-0003-4773-0548; Siegel, Eric/0000-0001-9824-6612; Menyaev, Yulian/0000-0001-5861-3641; Sarimollaoglu, Mustafa/0000-0003-0246-9702	National Institutes of Health [R01 EB017217, R01 CA131164]; FDA [HHSF223201400079C]; EPSCOR from the NSF [1457888]; Translational Reserach Institute (TRI) at UAMS; Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant) [JU 2814/1-1]; Arkansas Breast Cancer Research Program Grant [ABCRP-FY13]; NATIONAL CANCER INSTITUTE [R01CA131164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); EPSCOR from the NSF; Translational Reserach Institute (TRI) at UAMS; Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant)(German Research Foundation (DFG)); Arkansas Breast Cancer Research Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants R01 EB017217 and R01 CA131164 from the National Institutes of Health, HHSF223201400079C from the FDA, 1457888 EPSCOR from the NSF, from the Translational Reserach Institute (TRI) at UAMS, Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant, JU 2814/1-1), and by the Arkansas Breast Cancer Research Program Grant ABCRP-FY13.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Bonadonna G, 2005, BRIT MED J, V330, P217, DOI 10.1136/bmj.38314.622095.8F; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Fornvik D, 2013, BREAST CANCER RES TR, V141, P187, DOI 10.1007/s10549-013-2674-z; Georgakoudi I, 2004, CANCER RES, V64, P5044, DOI 10.1158/0008-5472.CAN-04-1058; HANSEN E, 1995, ARCH SURG-CHICAGO, V130, P387; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Hayashi N, 1999, SURGERY, V125, P369, DOI 10.1067/msy.1999.96536; Hogg P, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120222; Hu XC, 2000, ONCOLOGY-BASEL, V59, P217, DOI 10.1159/000012164; Juratli MA, 2014, CANCERS, V6, P128, DOI 10.3390/cancers6010128; Juratli MA, 2014, HEAD NECK-J SCI SPEC, V36, P1207, DOI 10.1002/hed.23439; Katharina Pachmann, 2011, Cancers (Basel), V3, P2540, DOI 10.3390/cancers3022540; Louha M, 1999, HEPATOLOGY, V29, P879, DOI 10.1002/hep.510290348; Menyaev YA, 2013, BIOMED OPT EXPRESS, V4, P3030, DOI 10.1364/BOE.4.003030; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P425, DOI 10.1002/jbio.201200047; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Sarimollaoglu M, 2014, PHOTOACOUSTICS, V2, P1, DOI 10.1016/j.pacs.2013.11.002; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Tyzzer EE, 1913, J MED RES, V28, P309; WATMOUGH DJ, 1993, J BIOMED ENG, V15, P121, DOI 10.1016/0141-5425(93)90040-6; WATMOUGH DJ, 1992, LANCET, V340, P122, DOI 10.1016/0140-6736(92)90451-8; Weitz J, 1998, CLIN CANCER RES, V4, P343; Yamaguchi K, 2000, ANN SURG, V232, P58, DOI 10.1097/00000658-200007000-00009	26	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137613	10.1371/journal.pone.0137613	http://dx.doi.org/10.1371/journal.pone.0137613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367280	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100095
J	Lee, SH; Hayano, K; Zhu, AX; Sahani, DV; Yoshida, H				Lee, Sang Ho; Hayano, Koichi; Zhu, Andrew X.; Sahani, Dushyant V.; Yoshida, Hiroyuki			Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy	PLOS ONE			English	Article							TRACER KINETICS; BLOOD-VOLUME; HEPATIC METASTASES; T-1-WEIGHTED MRI; SHUTTER-SPEED; PERFUSION; HYPOXIA; BRAIN; CT; QUANTIFICATION	Background To find prognostic biomarkers in pretreatment dynamic contrast-enhanced MRI (DCE-MRI) water-exchange-modified (WX) kinetic parameters for advanced hepatocellular carcinoma (HCC) treated with antiangiogenic monotherapy. Methods Twenty patients with advanced HCC underwent DCE-MRI and were subsequently treated with sunitinib. Pretreatment DCE-MRI data on advanced HCC were analyzed using five different WX kinetic models: the Tofts-Kety (WX-TK), extended TK (WX-ETK), two compartment exchange, adiabatic approximation to tissue homogeneity (WX-AATH), and distributed parameter (WX-DP) models. The total hepatic blood flow, arterial flow fraction (gamma), arterial blood flow (BFA), portal blood flow, blood volume, mean transit time, permeability-surface area product, fractional interstitial volume (v(I)), extraction fraction, mean intracellular water molecule lifetime (tau(C)), and fractional intracellular volume (v(C)) were calculated. After receiver operating characteristic analysis with leave-one-out cross-validation, individual parameters for each model were assessed in terms of 1-year-survival (1YS) discrimination using Kaplan-Meier analysis, and association with overall survival (OS) using univariate Cox regression analysis with permutation testing. Results The WX-TK-model-derived. (P = 0.022) and v(I) (P = 0.010), and WX-ETK-model-derived tC (P = 0.023) and v(C) (P = 0.042) were statistically significant prognostic biomarkers for 1YS. Increase in the WX-DP-model-derived BFA (P = 0.025) and decrease in the WX-TK, WX-ETK, WX-AATH, and WX-DP-model-derived v(C) (P = 0.034, P = 0.038, P = 0.028, P = 0.041, respectively) were significantly associated with an increase in OS. Conclusions The WX-ETK-model-derived v(C) was an effective prognostic biomarker for advanced HCC treated with sunitinib.	[Lee, Sang Ho; Yoshida, Hiroyuki] Massachusetts Gen Hosp, Dept Radiol, Imaging Res 3D, Boston, MA 02114 USA; [Lee, Sang Ho; Yoshida, Hiroyuki] Harvard Univ, Sch Med, Boston, MA USA; [Hayano, Koichi; Sahani, Dushyant V.] Massachusetts Gen Hosp, Dept Radiol, Div Abdominal Imaging & Intervent, Boston, MA USA; [Zhu, Andrew X.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Yoshida, H (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Imaging Res 3D, Boston, MA 02114 USA.	yoshida.hiro@mgh.harvard.edu	Hayano, Koichi/Z-2895-2019; Lee, Sang Ho/B-9149-2017	Hayano, Koichi/0000-0003-4733-8220; Lee, Sang Ho/0000-0002-4634-4904	National Institutes of Health [R21CA187877]; NATIONAL CANCER INSTITUTE [R21CA187877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Part of this work was supported by the National Institutes of Health grant (http://grants.nih.gov/grants/oer.htm) of R21CA187877 (PI: Yoshida). National Institutes of Health had a role in supporting, through the above grant, the development of the software that implemented kinetic models used for the analysis of the DCE-MRI data in this study. The majority of the study presented in manuscript was done under the "work made for hire" by the affiliated institution (MGH), which is, by nature, not an explicit funding dedicated to the study. Thus, there is no explicit funding other than what was stated.	Bains LJ, 2010, MAGN RESON MED, V64, P595, DOI 10.1002/mrm.22430; Barsky D, 1997, MAGNET RESON MED, V37, P666, DOI 10.1002/mrm.1910370507; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Brix G, 1999, RADIOLOGY, V210, P269, DOI 10.1148/radiology.210.1.r99ja46269; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; Buckley DL., 2005, MEASURING CONTRAST A, P69, DOI [10.1007/3-540-26420-5_5, DOI 10.1007/3-540-26420-5_5]; Bultman EM, 2014, J MAGN RESON IMAGING, V39, P853, DOI 10.1002/jmri.24238; Cunningham SD., 2011, LONGITUDINAL DATA AN, P43; Czabanka M, 2009, INT J CANCER, V124, P1293, DOI 10.1002/ijc.24019; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Gordon MJ, 1999, BIOTECHNOL BIOENG, V65, P459, DOI 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O; Haider MA, 2005, INT J RADIAT ONCOL, V62, P1100, DOI 10.1016/j.ijrobp.2004.12.064; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang W, 2011, RADIOLOGY, V261, P394, DOI 10.1148/radiol.11102413; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Kim YR, 2002, MAGNET RESON MED, V47, P1110, DOI 10.1002/mrm.10175; Koh T S, 2008, IEEE Trans Biomed Eng, V55, P340, DOI 10.1109/TBME.2007.910682; Koh TS, 2011, MAGN RESON MED, V66, P886, DOI 10.1002/mrm.22868; Koh TS, 2011, MAGN RESON MED, V65, P250, DOI 10.1002/mrm.22596; Koh TS, 2008, RADIOLOGY, V249, P307, DOI 10.1148/radiol.2483071958; Koh TS, 2011, J MAGN RESON IMAGING, V34, P1262, DOI 10.1002/jmri.22795; Landis CS, 2000, MAGNET RESON MED, V44, P563, DOI 10.1002/1522-2594(200010)44:4<563::AID-MRM10>3.0.CO;2-#; Landis CS, 1999, MAGNET RESON MED, V42, P467, DOI 10.1002/(SICI)1522-2594(199909)42:3<467::AID-MRM9>3.0.CO;2-0; Larsson HBW, 2001, MAGNET RESON MED, V46, P272, DOI 10.1002/mrm.1188; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Li X, 2005, MAGN RESON MED, V54, P1351, DOI [10.1002/mrm.20684, 10.1002/mrm.20864]; Li X, 2010, J MAGN RESON, V206, P190, DOI 10.1016/j.jmr.2010.07.004; Markwardt CB, 2009, ASTR SOC P, V411, P251; Miyazaki K, 2012, RADIOLOGY, V263, P139, DOI 10.1148/radiol.12110770; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; More JJ, 1980, USER GUIDE FOR MINPA; Orton MR, 2008, PHYS MED BIOL, V53, P1225, DOI 10.1088/0031-9155/53/5/005; Osawa Y, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P547, DOI 10.1007/978-1-60327-381-7_24; Paudyal R, 2013, J MAGN RESON IMAGING, V37, P435, DOI 10.1002/jmri.23837; R Core Team, 2013, R A LANGUAGE AND ENV; Sahani DV, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-51; Simon R, 2007, CANCER INFORM, V3, P11; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sourbron S, 2007, PHYS MED BIOL, V52, P6761, DOI 10.1088/0031-9155/52/22/014; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Springer CS, 2014, NMR BIOMED, V27, P760, DOI 10.1002/nbm.3111; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1365, DOI 10.1097/00004647-199812000-00011; Taouli B, 2013, AM J ROENTGENOL, V201, P795, DOI 10.2214/AJR.12.9798; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Turetschek K, 2004, J MAGN RESON IMAGING, V20, P138, DOI 10.1002/jmri.20049; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Yankeelov TE, 2003, MAGNET RESON MED, V50, P1151, DOI 10.1002/mrm.10624; Yopp AC, 2011, ANN SURG ONCOL, V18, P2192, DOI 10.1245/s10434-011-1570-1; Zhang J, 2014, MAGN RESON MED, V72, P534, DOI 10.1002/mrm.24927; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136725	10.1371/journal.pone.0136725	http://dx.doi.org/10.1371/journal.pone.0136725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366997	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100023
J	Shivalli, S; Srivastava, RK; Singh, GP				Shivalli, Siddharudha; Srivastava, Ratan Kumar; Singh, Gyan Prakash			Trials of Improved Practices (TIPs) to Enhance the Dietary and Iron-Folate Intake during Pregnancy-A Quasi Experimental Study among Rural Pregnant Women of Varanasi, India	PLOS ONE			English	Article							ADHERENCE; SERVICES; BELIEFS; CARE	Background Behavior Change Communications (BCC) play a decisive role in modifying socio-cultural norms affecting the perception and nutritional practices during pregnancy. Objective To examine the effectiveness of 'Trials of Improved Practices' (TIPs) on dietary and iron-folate intake during pregnancy. Design Community based quasi experimental study with a control group Setting Four villages of Chiraigaon Community Development Block of Varanasi, India from May 2010 and recruited from August 2010. End line assessment, after 12 weeks of intervention, was completed in April 2011. Participants Pregnant women in 13-28 weeks of gestation Intervention TIPs was implemented in addition to ongoing essential obstetric care services in two villages through 3 home (assessment, negotiation and evaluation) visits and only assessmentand evaluation visits in the other two control villages. Interpersonal communication, endorsing the active participation of family members and home based reminder materials were the TIPs based strategies. The effect of TIPs was assessed by comparing key outcome variables at baseline and after 12 weeks of intervention. Outcome Measures Hemoglobin%, anemia prevalence, weight gain, compliance for iron-folate supplementation and dietary intake of calorie, protein, calcium and iron. Results A total of 86 participants completed the study. At the end, mean hemoglobin levels were 11.5 +/- 1.24 g/dl and 10.37 +/- 1.38 g/dl in the TIPs and control groups, respectively. The prevalence of anemia reduced by half in TIPs group and increased by 2.4% in the control group. Weight gain (grams/week) was significantly (p<0.01) higher in TIPs group (326.9 +/- 91.8 vs. 244.6 +/- 97.4). More than 85% of the PW in TIPs group were compliant for Iron-folate and only 38% were compliant among controls. The mean intake of protein increased by 1.78gm in intervention group and decreased by 1.81 gm in controls (p<0.05). More than two thirds of PW in TIPs group were taking one extra meal and only one third of controls were doing the same. Conclusion TIPs found to be an effective approach to improve the nutritional status of pregnant women in the study area. TIPs strategy could be further explored on larger sample representing different socio-cultural and geographical areas.	[Shivalli, Siddharudha] Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangalore, Karnataka, India; [Srivastava, Ratan Kumar] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi 221005, Uttar Pradesh, India; [Singh, Gyan Prakash] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Div Biostat, Varanasi 221005, Uttar Pradesh, India	Yenepoya (Deemed to be University); Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Shivalli, S (corresponding author), Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangalore, Karnataka, India.	shivalli.bhu@gmail.com	Shivalli, Siddharudha/AAU-3907-2020					Ahlqvist M, 2000, SCAND J CARING SCI, V14, P105, DOI 10.1080/02839310050162334; [Anonymous], 2014, CENSUS INDIA 2011PRO; [Anonymous], 2014, GUIDELINES ANTENATAL; [Anonymous], 2001, WHO TECHN REP SER; Bhalwar R, 2009, TXB PUBLIC HLTH COMM, P751; Boeni F, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-29; Boland MV, 2014, JAMA OPHTHALMOL, V132, P845, DOI 10.1001/jamaophthalmol.2014.857; Chow S, 2008, SAMPLE SIZE CALCULAT, P89; Dupclay Leon, 2012, Patient Prefer Adherence, V6, P499, DOI 10.2147/PPA.S31417; FAO WHO, 1992, INT C NUTR ROM FOOD; Golay Alain, 2011, J Med Econ, V14, P594, DOI 10.3111/13696998.2011.597808; Grewal SK, 2008, JOGNN-J OBST GYN NEO, V37, P290, DOI 10.1111/j.1552-6909.2008.00234.x; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; IIPS, 2010, DISTR LEV HOUS FAC S; IIPS & ORC Macro, 2007, NATL FAMILY HLTH SUR; JONES SRG, 1992, AM J SOCIOL, V98, P451, DOI 10.1086/230046; Malik Geeta, 2009, Nurs J India, V100, P88; Martin LT, 2007, MATERN CHILD HLTH J, V11, P595, DOI 10.1007/s10995-007-0209-0; Mayo E, 1993, HUMAN PROBLEMS IND C, V3, P55; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moni Nag, 1994, EC POLITICAL WE 0910, V10, P2427; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Nayar D, 1998, Indian Pediatr, V35, P287; Oriji Vaduneme K, 2011, Niger J Med, V20, P131; Pathak P, 2008, ASIA PAC J CLIN NUTR, V17, P276; Pena-Robichaux V, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/894258; Sachar RK, 2000, INDIAN J COMMUNITY M, V25, P166; Sanghvi TG, 2010, FOOD NUTR BULL, V31, pS100, DOI 10.1177/15648265100312S202; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Shahid A., 2011, PROF MED J, V18, P189; Sookhoo D., 2009, SOCIAL CONTEXT BIRTH, P85; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization (WHO), 2014, ADHERENCE LONG TERM	36	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137735	10.1371/journal.pone.0137735	http://dx.doi.org/10.1371/journal.pone.0137735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367775	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100125
J	Bennink, E; Oosterbroek, J; Horsch, AD; Dankbaar, JW; Velthuis, BK; Viergever, MA; de Jong, HWAM				Bennink, Edwin; Oosterbroek, Jaap; Horsch, Alexander D.; Dankbaar, Jan Willem; Velthuis, Birgitta K.; Viergever, Max A.; de Jong, Hugo W. A. M.			Influence of Thin Slice Reconstruction on CT Brain Perfusion Analysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY; THRESHOLDS VARY; VENOUS OUTPUT; INFARCT CORE; PENUMBRA; VOLUME; MAPS; PERMEABILITY	Objectives Although CT scanners generally allow dynamic acquisition of thin slices (1 mm), thick slice (>= 5 mm) reconstruction is commonly used for stroke imaging to reduce data, processing time, and noise level. Thin slice CT perfusion (CTP) reconstruction may suffer less from partial volume effects, and thus yield more accurate quantitative results with increased resolution. Before thin slice protocols are to be introduced clinically, it needs to be ensured that this does not affect overall CTP constancy. We studied the influence of thin slice reconstruction on average perfusion values by comparing it with standard thick slice reconstruction. Materials and Methods From 50 patient studies, absolute and relative hemisphere averaged estimates of cerebral blood volume (CBV), cerebral blood flow (CBF), mean transit time (MTT), and permeability-surface area product (PS) were analyzed using 0.8, 2.4, 4.8, and 9.6 mm slice reconstructions. Specifically, the influence of Gaussian and bilateral filtering, the arterial input function (AIF), and motion correction on the perfusion values was investigated. Results Bilateral filtering gave noise levels comparable to isotropic Gaussian filtering, with less partial volume effects. Absolute CBF, CBV and PS were 22%, 14% and 46% lower with 0.8 mm than with 4.8 mm slices. If the AIF and motion correction were based on thin slices prior to reconstruction of thicker slices, these differences reduced to 3%, 4% and 3%. The effect of slice thickness on relative values was very small. Conclusions This study shows that thin slice reconstruction for CTP with unaltered acquisition protocol gives relative perfusion values without clinically relevant bias. It does however affect absolute perfusion values, of which CBF and CBV are most sensitive. Partial volume effects in large arteries and veins lead to overestimation of these values. The effects of reconstruction slice thickness should be taken into account when absolute perfusion values are used for clinical decision making.	[Bennink, Edwin; Oosterbroek, Jaap; Horsch, Alexander D.; Dankbaar, Jan Willem; Velthuis, Birgitta K.; de Jong, Hugo W. A. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Bennink, Edwin; Oosterbroek, Jaap; Viergever, Max A.; de Jong, Hugo W. A. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bennink, E (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	H.E.Bennink@umcutrecht.nl	Horsch, Alexander D./U-3330-2019; Viergever, Max A/J-1215-2014	baron, jean-claude/0000-0002-5264-2588; Horsch, Alexander/0000-0001-8213-2784; Bennink, Edwin/0000-0002-3689-8532	Dutch Technology Foundation STW (AIRSPACE) [11632]; Philips Healthcare; LifeTec Group; University Medical Center Utrecht; Netherlands Heart Foundation [2008T034, 2012T61]; NutsOhra Foundation [0903-012]	Dutch Technology Foundation STW (AIRSPACE); Philips Healthcare; LifeTec Group; University Medical Center Utrecht; Netherlands Heart Foundation(Netherlands Heart Foundation); NutsOhra Foundation	This work was supported by a research grant from the Dutch Technology Foundation STW (AIRSPACE, 11632). The project AIRSPACE received in-kind funding from Philips Healthcare and the LifeTec Group. The CTP data was collected under the Dutch acute Stroke Trial (DUST), details of which can be found at https://clinicaltrials.gov/ct2/ show/NCT00880113. The DUST study was funded by the University Medical Center Utrecht, the Netherlands Heart Foundation (2008T034), the NutsOhra Foundation (0903-012), and in-kind by Philips Healthcare. Jan Willem Dankbaar was funded by the Netherlands Heart Foundation (2012T61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axel L, 1981, Adv Neurol, V30, P67; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bennink E, 2013, J CEREBR BLOOD F MET, V33, P1743, DOI 10.1038/jcbfm.2013.122; Bisdas S, 2007, J NEURORADIOLOGY, V34, P101, DOI 10.1016/j.neurad.2007.02.003; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Burton KR, 2015, RADIOLOGY, V274, P103, DOI 10.1148/radiol.14140728; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Fiorella D, 2004, AM J NEURORADIOL, V25, P97; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7; MULLER HR, 1991, NEURORADIOLOGY, V33, P212; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Murphy BD, 2008, RADIOLOGY, V247, P818, DOI 10.1148/radiol.2473070551; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Riordan AJ, 2013, AM J NEURORADIOL, V34, P1353, DOI 10.3174/ajnr.A3397; Sacco S, 2006, NEUROLOGY, V66, P1335, DOI 10.1212/01.wnl.0000210457.89798.0e; SAWADA Y, 1989, AM J PHYSIOL, V256, pH794, DOI 10.1152/ajpheart.1989.256.3.H794; Schaefer PW, 2006, AM J NEURORADIOL, V27, P20; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; van der Schaaf I, 2006, AM J NEURORADIOL, V27, P46; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137766	10.1371/journal.pone.0137766	http://dx.doi.org/10.1371/journal.pone.0137766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361391	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100086
J	Chen, JG; Yang, HQ; Zhang, DD; Xu, D; Luo, J; Wang, JF				Chen, Jingan; Yang, Haiquan; Zhang, David Dian; Xu, Dan; Luo, Jing; Wang, Jingfu			A Particular River-Whiting Phenomenon Caused by Discharge of Hypolimnetic Water from a Stratified Reservoir	PLOS ONE			English	Article								A particular river-whiting phenomenon occurred in the early 2000s in the Xiaoche River and since then it has been reoccurring from June to November each year. Residents were surprised by this phenomenon and worried about it. This study was designed to reveal the forming mechanism of the river-whiting phenomenon. A comparison of T, EC, ORP, DO, TDS and delta S-34 in the culvert water and discharge pipe water with that in the water column of Aha Reservoir strongly indicated that the culvert water and discharge pipe water derived primarily from the hypolimnetic reservoir water. When the hypolimnetic water enriched in SO42- and H2S, through seepage from the penstock, flows into the Xiaoche River, the water's supersaturation degree with respect to CaSO4 is increased as a result of increased temperature and DO, thus colloid CaSO4 can be formed. This is the essential cause of the river-whiting phenomenon. The sources of high concentrations of SO42- and H2S in hypolimnetic water include not only direct SO42- and H2S input of acid mine drainage as a result of irrational coal mining in the watershed, but also the sulfur-enriched surface sediments which may release H2S through the sulfate reduction processes. The contaminated sediment has acted as an important contamination source for sulfur to the overlying water in Aha Reservoir. There are more than 50,000 large dams in the world until now. With the increase of reservoir age and the persistent accumulation of pollutants within the reservoir system, discharged hypolimnetic water may contain high levels of pollutants and lead to unpredicted disasters. More investigations are needed to illuminate the water quality condition of discharge water from reservoirs and estimate its impacts on the downstream ecoenvironment.	[Chen, Jingan; Yang, Haiquan; Xu, Dan; Wang, Jingfu] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang 550002, Peoples R China; [Zhang, David Dian] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Luo, Jing] Guizhou Univ, Coll Resources & Environm Engn, Guiyang 550025, Peoples R China	Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; University of Hong Kong; Guizhou University	Chen, JG (corresponding author), Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang 550002, Peoples R China.	chenjingan@vip.skleg.cn		Yang, Haiquan/0000-0003-4826-8199	Natural Science Foundation of China [U1302231, 41173125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (Grant Nos. U1302231, 41173125) for data collection and analysis.	Canavan CM, 2000, SCI TOTAL ENVIRON, V260, P159, DOI 10.1016/S0048-9697(00)00560-X; Chen J, 2013, INVESTIGATION REPORT; Chen ZL, 1996, CHINESE SCI BULL, V41, P1359; Cibils Martina L, 2013, J LIMNOL, V72, P79, DOI 10.4081/jlimnol.2013.e7; Feng XB, 2011, APPL GEOCHEM, V26, P213, DOI 10.1016/j.apgeochem.2010.11.021; Guizhou Normal University, 2009, INV REP WHIT TURB WA; Li KF, 2013, ENVIRON REV, V21, P127, DOI 10.1139/er-2012-0051; Luo S, 2003, THESIS CHINESE ACAD; Nichols S, 2006, HYDROBIOLOGIA, V572, P255, DOI 10.1007/s10750-005-0995-6; Petts G.E., 1984, IMPOUNDED RIVERS PER, DOI [10.1177/030913338601000116., DOI 10.1016/0006-3207(85)90110-7]; Qianzhong Morning Post, 2011, QIANZHONG MORNING PO; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Song LT, 2011, ACTA GEOCHIM, V30, P444, DOI 10.1007/s11631-011-0530-6; Song LT, 2011, CHEM GEOL, V280, P170, DOI 10.1016/j.chemgeo.2010.11.006; Wan G. J., 2001, EARTH SCI FRONTIERS, V8, P353; Wan X, 1997, LAKE SCI, V9, P129; Wang F, 2003, THESIS CHINESE ACAD; Wang Fu-shun, 2005, Huanjing Kexue, V26, P135; Wang Y C, 1998, GEOLOGY GEOCHEMISTRY, V1, p94 ; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Wu N, 2010, AQUAT SCI, V72, P117, DOI 10.1007/s00027-009-0121-3	21	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137860	10.1371/journal.pone.0137860	http://dx.doi.org/10.1371/journal.pone.0137860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361219	gold, Green Published, Green Submitted			2022-12-27	WOS:000361043100096
J	Miller, EV; Grandi, LN; Giannini, JA; Robinson, JD; Powell, JR				Miller, Elizabeth V.; Grandi, Leah N.; Giannini, Jennifer A.; Robinson, Joseph D.; Powell, Jennifer R.			The Conserved G-Protein Coupled Receptor FSHR-1 Regulates Protective Host Responses to Infection and Oxidative Stress	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; CAENORHABDITIS-ELEGANS; PATHOGENIC BACTERIA; CHEMOSENSORY CELLS; HYDROGEN-PEROXIDE; IMMUNE-RESPONSE; AVOIDANCE; GENES; EXPRESSION; COMPLEX	The innate immune system's ability to sense an infection is critical so that it can rapidly respond if pathogenic microorganisms threaten the host, but otherwise maintain a quiescent baseline state to avoid causing damage to the host or to commensal microorganisms. One important mechanism for discriminating between pathogenic and non-pathogenic bacteria is the recognition of cellular damage caused by a pathogen during the course of infection. In Caenorhabditis elegans, the conserved G-protein coupled receptor FSHR-1 is an important constituent of the innate immune response. FSHR-1 activates the expression of antimicrobial infection response genes in infected worms and delays accumulation of the ingested pathogen Pseudomonas aeruginosa. FSHR-1 is central not only to the worm's survival of infection by multiple pathogens, but also to the worm's survival of xenobiotic cadmium and oxidative stresses. Infected worms produce reactive oxygen species to fight off the pathogens; FSHR-1 is required at the site of infection for the expression of detoxifying genes that protect the host from collateral damage caused by this defense response. Finally, the FSHR-1 pathway is important for the ability of worms to discriminate pathogenic from benign bacteria and subsequently initiate an aversive learning program that promotes selective pathogen avoidance.	[Miller, Elizabeth V.; Grandi, Leah N.; Giannini, Jennifer A.; Robinson, Joseph D.; Powell, Jennifer R.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	Gettysburg College	Powell, JR (corresponding author), Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA.	jpowell@gettysburg.edu	Powell, Jennifer/HFZ-8254-2022	Giannini, Jennifer/0000-0003-0034-9328; Miller, Elizabeth/0000-0001-5087-3713	Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program	Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program	This work was supported in part by a grant to Gettysburg College from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program.	Bolm M, 2004, INFECT IMMUN, V72, P1192, DOI 10.1128/IAI.72.2.1192-1194.2004; BRENNER S, 1974, GENETICS, V77, P71; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chmielowska-Bak J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00245; Darby Creg, 2005, WormBook, P1; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GINSBURG I, 1993, FREE RADICAL BIO MED, V14, P495, DOI 10.1016/0891-5849(93)90106-5; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Kirienko NV, 2014, METHODS MOL BIOL, V1149, P653, DOI 10.1007/978-1-4939-0473-0_50; Kudo M, 2000, MOL ENDOCRINOL, V14, P272, DOI 10.1210/me.14.2.272; Lee KA, 2015, CELL HOST MICROBE, V17, P191, DOI 10.1016/j.chom.2014.12.012; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meisel JD, 2014, TRENDS IMMUNOL, V35, P465, DOI 10.1016/j.it.2014.08.008; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Sem X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045417; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Der Hoeven R, 2015, PLOS ONE, V10; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zugasti O, 2014, NAT IMMUNOL, V15, P833, DOI 10.1038/ni.2957	42	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137403	10.1371/journal.pone.0137403	http://dx.doi.org/10.1371/journal.pone.0137403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360906	Green Published, gold			2022-12-27	WOS:000361043100034
J	Paredes, M; Quiles, MJ				Paredes, Miriam; Quiles, Maria Jose			The Effects of Cold Stress on Photosynthesis in Hibiscus Plants	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHLOROPLASTIC NAD(P)H DEHYDROGENASE; HIGH LIGHT-INTENSITY; PLASTID TERMINAL OXIDASE; HIGH ROOT TEMPERATURE; PHOTOSYSTEM-I; HIGH ILLUMINATION; CHILLING STRESS; NDH COMPLEX; C-3 PLANTS	The present work studies the effects of cold on photosynthesis, as well as the involvement in the chilling stress of chlororespiratory enzymes and ferredoxin-mediated cyclic electron flow, in illuminated plants of Hibiscus rosa-sinensis. Plants were sensitive to cold stress, as indicated by a reduction in the photochemistry efficiency of PSII and in the capacity for electron transport. However, the susceptibility of leaves to cold may be modified by root temperature. When the stem, but not roots, was chilled, the quantum yield of PSII and the relative electron transport rates were much lower than when the whole plant, root and stem, was chilled at 10 degrees C. Additionally, when the whole plant was cooled, both the activity of electron donation by NADPH and ferredoxin to plastoquinone and the amount of PGR5 polypeptide, an essential component of the cyclic electron flow around PSI, increased, suggesting that in these conditions cyclic electron flow helps protect photosystems. However, when the stem, but not the root, was cooled cyclic electron flow did not increase and PSII was damaged as a result of insufficient dissipation of the excess light energy. In contrast, the chlororespiratory enzymes (NDH complex and PTOX) remained similar to control when the whole plant was cooled, but increased when only the stem was cooled, suggesting the involvement of chlororespiration in the response to chilling stress when other pathways, such as cyclic electron flow around PSI, are insufficient to protect PSII.	[Paredes, Miriam; Quiles, Maria Jose] Univ Murcia, Fac Biol, Dept Biol Vegetal, Murcia, Spain	University of Murcia	Quiles, MJ (corresponding author), Univ Murcia, Fac Biol, Dept Biol Vegetal, Murcia, Spain.	mjquiles@um.es			Spanish Ministry of Education and Science [BFU2009-00331]; University of Murcia (Spain) [E005-03]	Spanish Ministry of Education and Science(Spanish Government); University of Murcia (Spain)	This work was supported by the Spanish Ministry of Education and Science (grant BFU2009-00331) and the University of Murcia (Spain) (grant E005-03).	Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Aluru MR, 2004, PHYSIOL PLANTARUM, V120, P4, DOI 10.1111/j.0031-9317.2004.0217.x; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Bernhard Teicher H, 2000, PHOTOSYNTH RES, V64, P53, DOI 10.1023/A:1026524302191; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Catala R, 1997, PLANT CELL PHYSIOL, V38, P1382, DOI 10.1093/oxfordjournals.pcp.a029133; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; Gamboa J, 2009, PLANT SCI, V177, P643, DOI 10.1016/j.plantsci.2009.09.004; Golding AJ, 2004, PLANTA, V220, P356, DOI 10.1007/s00425-004-1345-z; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; Havaux M, 2005, BBA-BIOENERGETICS, V1709, P203, DOI 10.1016/j.bbabio.2005.07.010; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; Herbert SK, 1995, PHOTOSYNTH RES, V46, P277, DOI 10.1007/BF00020441; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Ibanez H, 2010, J PLANT PHYSIOL, V167, P732, DOI 10.1016/j.jplph.2009.12.013; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Ivanov AG, 2012, PHOTOSYNTH RES, V113, P191, DOI 10.1007/s11120-012-9769-y; Joet T, 2002, PLANT PHYSIOL, V128, P760, DOI 10.1104/pp.010775; Joet T, 2001, PLANT PHYSIOL, V125, P1919, DOI 10.1104/pp.125.4.1919; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Joliot P, 2011, P NATL ACAD SCI USA, V108, P13317, DOI 10.1073/pnas.1110189108; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; Laureau C, 2011, PHYSIOL PLANTARUM, V143, P246, DOI 10.1111/j.1399-3054.2011.01505.x; Li XG, 2004, PLANT CELL PHYSIOL, V45, P103, DOI 10.1093/pcp/pch011; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Martin M, 1996, PLANT CELL PHYSIOL, V37, P293, DOI 10.1093/oxfordjournals.pcp.a028945; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Munoz R, 2013, INT J MOL SCI, V14, P5432, DOI 10.3390/ijms14035432; Paredes M, 2013, J PLANT PHYSIOL, V170, P165, DOI 10.1016/j.jplph.2012.09.010; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Quiles MJ, 2006, PLANT CELL ENVIRON, V29, P1463, DOI 10.1111/j.1365-3040.2006.01510.x; Quiles MJ, 1998, PLANT PHYSIOL, V117, P235, DOI 10.1104/pp.117.1.235; Quiles MJ, 2005, PLANT SCI, V168, P1561, DOI 10.1016/j.plantsci.2005.02.005; Quiles MJ, 2004, PLANT SCI, V166, P815, DOI 10.1016/j.plantsci.2003.11.025; Quiles MJ, 2003, PLANT SCI, V164, P541, DOI 10.1016/S0168-9452(03)00003-7; Quiles MJ, 2000, PLANT PHYSIOL BIOCH, V38, P225, DOI 10.1016/S0981-9428(00)00740-3; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Saura P., 2009, Open Plant Science Journal, V3, P7, DOI 10.2174/1874294700903010007; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Segura MV, 2015, PLANT CELL ENVIRON, V38, P525, DOI 10.1111/pce.12406; Sonoike K, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2217; Streb P, 2005, PLANT CELL ENVIRON, V28, P1123, DOI 10.1111/j.1365-3040.2005.01350.x; Sun X, 2011, J BIOSCIENCES, V36, P951, DOI 10.1007/s12038-011-9161-7; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Suzuki K, 2013, PLANT CELL PHYSIOL, V54, P1769, DOI 10.1093/pcp/pct120; Suzuki K, 2011, PLANT CELL PHYSIOL, V52, P1697, DOI 10.1093/pcp/pcr104; Tallon C, 2007, PLANT SCI, V173, P438, DOI 10.1016/j.plantsci.2007.07.001; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490	63	27	30	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137472	10.1371/journal.pone.0137472	http://dx.doi.org/10.1371/journal.pone.0137472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360248	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100042
J	Dai, XF; Guo, WW; Zhan, CJ; Liu, XX; Bai, ZH; Yang, YK				Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun			WDR5 Expression Is Prognostic of Breast Cancer Outcome	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; GENE-EXPRESSION; CHROMATIN; PROSTATE; MUTATION; IDENTIFICATION; TRANSCRIPTION; METHYLATION	WDR5 is a core component of the human mixed lineage leukemia-2 complex, which plays central roles in ER positive tumour cells and is a major driver of androgen-dependent prostate cancer cell proliferation. Given the similarities between breast and prostate cancers, we explore the potential prognostic value of WDR5 gene expression on breast cancer survival. Our findings reveal that WDR5 over-expression is associated with poor breast cancer clinical outcome in three gene expression data sets and BreastMark. The eQTL analysis reveals 130 trans-eQTL SNPs whose genes mapped with statistical significance are significantly associated with patient survival. These genes together with WDR5 are enriched with "cellular development, gene expression, cell cycle" signallings. Knocking down WDR5 in MCF7 dramatically decreases cell viability, but does not alter tumour cell response to doxorubicin. Our study reveals the prognostic value of WDR5 expression in breast cancer which is under long-range regulation of genes involved in cell cycle, and anthracycline could be coupled with treatments targeting WDR5 once such a regimen is available.	[Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Dai, XF (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China.	xiaofeng.dai@me.com; yangyankun@jiangnan.edu.cn	Bai, Zhihui/O-5303-2019; Yang, Yankun/AAJ-3032-2020	Bai, Zhihui/0000-0002-3818-527X; Yang, Yankun/0000-0003-4815-6832	National Natural Science Foundation of China [31471251]; Jiangnan University Research Support Foundation for Young Scientists [5922050205150370]; National High Technology Research and Development Program of China, 863 Program [2015AA020802]; National Basic Research Program of China, 973 Program [2013CB733602]; Fundamental Research Funds for the Central Universities [JUSRP51401A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangnan University Research Support Foundation for Young Scientists; National High Technology Research and Development Program of China, 863 Program(National High Technology Research and Development Program of China); National Basic Research Program of China, 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 31471251, http://www.nsfc.gov.cn/ to XFD), the Jiangnan University Research Support Foundation for Young Scientists (Grant No. 5922050205150370, http://kjc.jiangnan.edu.cn/ to XFD), the National High Technology Research and Development Program of China, 863 Program (Grant No. 2015AA020802, http://www.863.gov.cn/ to ZHB), the National Basic Research Program of China, 973 Program (Grant No. 2013CB733602, http://www.973.gov.cn/ to ZHB) and the Fundamental Research Funds for the Central Universities (Grant No. JUSRP51401A, http://kjc.jiangnan.edu.cn/ to YKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix I, 2008, AFF GEN WID HUM SNP; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coffey DS, 2001, UROLOGY, V57, P31, DOI 10.1016/S0090-4295(00)00938-9; Day TK, 2013, ENDOCR-RELAT CANCER, V20, pR215, DOI 10.1530/ERC-13-0204; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Frommolt P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-475; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kilpivaara O, 2005, INT J CANCER, V113, P575, DOI 10.1002/ijc.20638; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mungamuri SK, 2013, CELL REP, V5, P302, DOI 10.1016/j.celrep.2013.09.009; Natarajan TG, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-13; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tan SK, 2011, EMBO J, V30, P2569, DOI 10.1038/emboj.2011.151; Team RDC, 2009, R LANG ENV STAT COMP; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	48	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0124964	10.1371/journal.pone.0124964	http://dx.doi.org/10.1371/journal.pone.0124964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355959	gold, Green Published, Green Submitted			2022-12-27	WOS:000360965800001
J	Woodfield, R; Sudlow, CLM				Woodfield, Rebecca; Sudlow, Cathie L. M.		UK Biobank Stroke Outcomes Grp; UK Biobank Follow-up Outcomes	Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group	PLOS ONE			English	Review							TRANSIENT ISCHEMIC ATTACK; MEDICAL-RECORDS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-ATTACK; RISK-FACTORS; VALIDATION; QUESTIONNAIRE; AGREEMENT; VALIDITY	Objective We performed a systematic review of the accuracy of patient self-report of stroke to inform approaches to ascertaining and confirming stroke cases in large prospective studies. Methods We sought studies comparing patient self-report against a reference standard for stroke. We extracted data on survey method(s), response rates, participant characteristics, the reference standard used, and the positive predictive value (PPV) of self-report. Where possible we also calculated sensitivity, specificity, negative predictive value (NPV), and stroke prevalence. Study-level risk of bias was assessed using the Quality Assessment of Diagnostic Studies tool (QUADAS-2). Results From > 1500 identified articles, we included 17 studies. Most asked patients to report a lifetime history of stroke but a few limited recall time to <= 5 years. Some included questions for transient ischaemic attack (TIA) or stroke synonyms. No study was free of risk of bias in the QUADAS-2 assessment, the most frequent causes of bias being incomplete reference standard data, absence of blinding of adjudicators to self-report status, and participant response rates (<80%). PPV of self-report ranged from 22-87% (17 studies), sensitivity from 36-98% (10 studies), specificity from 96-99.6% (10 studies), and NPV from 88.2-99.9% (10 studies). PPV increased with stroke prevalence as expected. Among six studies with available relevant data, if confirmed TIAs were considered to be true rather than false positive strokes, PPV of self-report was > 75% in all but one study. It was not possible to assess the influence of recall time or of the question(s) asked on PPV or sensitivity. Conclusions Characteristics of the study population strongly influence self-report accuracy. In population-based studies with low stroke prevalence, a large proportion of self-reported strokes may be false positives. Self-report is therefore unlikely to be helpful for identifying cases without subsequent confirmation, but may be useful for case ascertainment in combination with other data sources.	[Woodfield, Rebecca; Sudlow, Cathie L. M.] Univ Edinburgh, Clin Ctr Brain Sci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.] UK Biobank, Stockport, Lancs, England	University of Edinburgh	Sudlow, CLM (corresponding author), Univ Edinburgh, Clin Ctr Brain Sci, Edinburgh, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk	Sullivan, Frank/L-8286-2019; de Lusignan, Smion/S-7838-2019; Hemingway, Harry/C-1219-2009	Sullivan, Frank/0000-0002-6623-4964; de Lusignan, Smion/0000-0002-8553-2641; Eastwood, Sophie/0000-0002-1883-8771; Hotopf, Matthew/0000-0002-3980-4466; Sudlow, Cathie/0000-0002-7725-7520; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Lewington, Sarah/0000-0002-4496-4771; Moller, Henrik/0000-0001-8200-5929; Brophy, Sinead/0000-0001-7417-2858; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624	UK Biobank; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/K006584/1, G1002605, G0800270, MR/L003120/1, MR/L023784/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [G1002605, MR/L023784/2, MR/L003120/1, G0800270] Funding Source: UKRI	UK Biobank; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by UK Biobank (www.ukbiobank.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Barr ELM, 2009, INTERN MED J, V39, P49, DOI 10.1111/j.1445-5994.2008.01864.x; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bots ML, 1996, STROKE, V27, P1499, DOI 10.1161/01.STR.27.9.1499; Britton A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-83; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brown M, 2003, NEW ENGL J MED, V348, P16; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; de Vet HCW EA, 2008, COCHRANE HDB SYSTEMA; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Ferro JM, 1996, STROKE, V27, P2225, DOI 10.1161/01.STR.27.12.2225; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Fourrier-Reglat A, 2010, PHARMACOEPIDEM DR S, V19, P474, DOI 10.1002/pds.1951; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Health and Social Care Information Centre, 2009, PREV COR HEART DIS S; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Jackson CA, 2010, STROKE, V41, P624, DOI 10.1161/STROKEAHA.109.558809; Jin YP, 2010, NEUROEPIDEMIOLOGY, V35, P215, DOI 10.1159/000315484; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Machon M, 2013, J EPIDEMIOL COMMUN H, V67, P71, DOI 10.1136/jech-2011-200104; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; OMAHONY PG, 1995, STROKE, V26, P1334, DOI 10.1161/01.STR.26.8.1334; PAGANINIHILL A, 1993, AM J EPIDEMIOL, V138, P101, DOI 10.1093/oxfordjournals.aje.a116832; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Teh R, 2013, J CLIN EPIDEMIOL, V66, P1135, DOI 10.1016/j.jclinepi.2013.05.001; Walker MK, 1998, AM J EPIDEMIOL, V148, P355; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; Whiting P, 2008, J CLIN EPIDEMIOL, V61, P357, DOI 10.1016/j.jclinepi.2007.05.013; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yamagishi K, 2009, J CLIN EPIDEMIOL, V62, P667, DOI 10.1016/j.jclinepi.2008.07.016	37	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137538	10.1371/journal.pone.0137538	http://dx.doi.org/10.1371/journal.pone.0137538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355837	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800060
J	Newkirk, GS; Hoon, M; Wong, RO; Detwiler, PB				Newkirk, G. S.; Hoon, M.; Wong, R. O.; Detwiler, P. B.			Response Properties of a Newly Identified Tristratified Narrow Field Amacrine Cell in the Mouse Retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; MAMMALIAN RETINA; GANGLION-CELLS; BIPOLAR CELLS; KAINATE-RECEPTORS; CAT RETINA; LIGHT; PATHWAYS; SIGNALS; VISION	Amacrine cells were targeted for whole cell recording using two-photon fluorescence microscopy in a transgenic mouse line in which the promoter for dopamine receptor 2 drove expression of green fluorescent protein in a narrow field tristratified amacrine cell (TNAC) that had not been studied previously. Light evoked a multiphasic response that was the sum of hyperpolarizing and depolarization synaptic inputs consistent with distinct dendritic ramifications in the off and on sublamina of the inner plexiform layer. The amplitude and waveform of the response, which consisted of an initial brief hyperpolarization at light onset followed by recovery to a plateau potential close to dark resting potential and a hyperpolarizing response at the light offset varied little over an intensity range from 0.4 to similar to 10(boolean AND)6 Rh*/rod/s. This suggests that the cell functions as a differentiator that generates an output signal (a transient reduction in inhibitory input to downstream retina neurons) that is proportional to the derivative of light input independent of its intensity. The underlying circuitry appears to consist of rod and cone driven on and off bipolar cells that provide direct excitatory input to the cell as well as to GABAergic amacrine cells that are synaptically coupled to TNAC. Canonical reagents that blocked excitatory (glutamatergic) and inhibitory (GABA and glycine) synaptic transmission had effects on responses to scotopic stimuli consistent with the rod driven component of the proposed circuit. However, responses evoked by photopic stimuli were paradoxical and could not be interpreted on the basis of conventional thinking about the neuropharmacology of synaptic interactions in the retina.	[Newkirk, G. S.; Detwiler, P. B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Newkirk, G. S.; Detwiler, P. B.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Hoon, M.; Wong, R. O.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Newkirk, GS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	gnewkirk@uw.edu; detwiler@uw.edu			National Eye Institute [EY02048, EY10699]; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R01EY010699, R01EY002048] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: The work was supported by the following: National Eye Institute EY02048 and EY10699, https://www.nei.nih.gov; and Knights Templar Eye Foundation, http://www.knightstemplar.org/ktef/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Baden T, 2013, TRENDS NEUROSCI, V36, P480, DOI 10.1016/j.tins.2013.04.006; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FAMIGLIETTI EV, 1983, VISION RES, V23, P1265, DOI 10.1016/0042-6989(83)90102-5; Grimes WN, 2010, NEURON, V65, P873, DOI 10.1016/j.neuron.2010.02.028; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Majumdar S, 2009, J PHYSIOL-LONDON, V587, P3831, DOI 10.1113/jphysiol.2009.171207; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Menger N, 2000, VISUAL NEUROSCI, V17, P769, DOI 10.1017/S0952523800175108; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; Newkirk GS, 2013, J NEUROPHYSIOL, V110, P536, DOI 10.1152/jn.00118.2013; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Russell TL, 2010, J NEUROPHYSIOL, V103, P2757, DOI 10.1152/jn.00987.2009; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; VERSAUXBOTTERI C, 1984, BRAIN RES, V301, P192, DOI 10.1016/0006-8993(84)90423-2; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; Wilding TJ, 1996, MOL PHARMACOL, V49, P540; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137702	10.1371/journal.pone.0137702	http://dx.doi.org/10.1371/journal.pone.0137702			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352594	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800111
J	Basang, ZM; Wang, BY; Li, L; Yang, L; Liu, L; Cui, CY; Lanzi, GG; Yuzhen, NM; Duo, J; Zheng, HX; Wang, Y; Xu, SH; Jin, L; Wang, XF				Basang, Zhuoma; Wang, Boyang; Li, Lei; Yang, La; Liu, Lan; Cui, Chaoying; Lanzi, Gongga; Yuzhen, Nima; Duo, Ji; Zheng, Hongxiang; Wang, Yi; Xu, Shuhua; Jin, Li; Wang, Xiaofeng			HIF2A Variants Were Associated with Different Levels of High-Altitude Hypoxia among Native Tibetans	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ADAPTATION; GENE; HIF-1; POLYMORPHISMS; POPULATION; RESIDENTS; SELECTION; INSIGHTS; PLATEAU	Hypoxia inducible factors, including HIF1A and HIF2A, play central roles in response to high-altitude hypoxia and genetic variants of HIF1A or HIF2A were associated with high-altitude sickness or adaptation. However, it remains to determine whether they are associated with tolerance to different levels of high-altitude selection pressure among native Tibetans. We recruited 189 Tibetan subjects living at 2,700 meters (Low level of high altitude, LHA), 197 at 3,200 meters (Middle level of high altitude of high altitude, MHA), 249 at 3,700 meters (High level of high altitude, HHA) and 269 at 4,700 meters (Very high level of high altitude, VHA) and performed association analysis of twelve tSNPs (tagging SNPs) in HIF1A and HIF2A with high-altitude. We found (1) a increasing trend of HIF2A rs5621780-C(18.4%, 15.9%, 32.8% and 31.1%, respectively, in LHA, MHA, HHA and VHA)(P = 3.56E-9); (2) increasing trends of HIF2A rs6756667-A(68.7%, 73.4%, 79.9% and 89.6%), rs7589621-G( 74.6%, 77.9%, 83.7%, and 92.1%) and rs1868092-A(64.1%, 67.3%, 75.1% and 84.4%) (P = 3.56E-9, 4.68E-16, 1.17E-13 and 7.09E-14, respectively); (3) a increasing trend of haplotype AG (68.7%, 73.1%, 79.9% and 89.6%) (P = 2.22E-7) which was constructed by rs6756667 and rs7589621; (4) a strong linear correlation between major alleles of rs6756667-A (R-2 = 0.997, P = 0.002), rs7589621-G (R-2 = 0.994, P = 0.003), rs1868092-A (R-2 = 0.985, P = 0.008) and altitude by linear correlation test. The associations between HIF2A variants and different level of high altitude support that extremely high-altitude hypoxia challenge imposes selective effects on HIF2A variants among native Tibetans.	[Basang, Zhuoma; Yang, La; Liu, Lan; Cui, Chaoying; Lanzi, Gongga] Tibet Univ, Coll Med, Tibet Autonomous Region 850002, Peoples R China; [Wang, Boyang; Li, Lei; Zheng, Hongxiang; Wang, Yi; Jin, Li; Wang, Xiaofeng] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yuzhen, Nima] Peoples Hosp Tibet Autonomous Reg, Tibet Autonomous Region 850000, Peoples R China; [Duo, Ji] Shigatse Ctr Dis Control, Tibet Autonomous Region 850000, Peoples R China; [Xu, Shuhua] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China	Tibet University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Jin, L (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com; xiaofengautomatic@gmail.com	Xu, Shuhua/AAH-7620-2020; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Xu, Shuhua/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; 	National Natural Science Foundation of China [31330038, 30760274, 81060161]; National Basic Research Program [2012CB944600]; Shanghai Western Cooperation Project [11495801700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Shanghai Western Cooperation Project	This research was supported by grants from, the National Natural Science Foundation of China (no. 31330038, 30760274, 81060161, http://www.nsfc.gov.cn/), and grant from the National Basic Research Program (2012CB944600, http://www.973.gov.cn/), and grants from Shanghai Western Cooperation Project (no. 11495801700, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan A, 2005, ANN HUM GENET, V69, P260, DOI 10.1046/j.1529-8817.2005.00158.x; Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; [Anonymous], 1995, HIGH ALTITUDE MED PH; [Anonymous], 1991, CHINAS 4 NATL CENSUS; BAKER PT, 1969, SCIENCE, V163, P1149, DOI 10.1126/science.163.3872.1149; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; CURRAN LS, 1995, RESP PHYSIOL, V100, P223, DOI 10.1016/0034-5687(94)00110-L; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Droma Y, 2006, HIGH ALT MED BIOL, V7, P209, DOI 10.1089/ham.2006.7.209; GARRUTO RM, 1983, AM J PHYS ANTHROPOL, V61, P355, DOI 10.1002/ajpa.1330610310; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hochachka PW, 1998, P NATL ACAD SCI USA, V95, P1915, DOI 10.1073/pnas.95.4.1915; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Lio D, 2003, J MED GENET, V40, P296, DOI 10.1136/jmg.40.4.296; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Moore LG, 2002, HIGH ALT MED BIOL, V3, P39, DOI 10.1089/152702902753639531; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Rupert JL, 2006, HIGH ALT MED BIOL, V7, P150, DOI 10.1089/ham.2006.7.150; Rupert JL, 2003, ANN HUM GENET, V67, P17, DOI 10.1046/j.1469-1809.2003.00004.x; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Ward MP, 2003, HIGH ALT MED BIOL, V4, P27, DOI 10.1089/152702903321488951; Wu TY, 2001, HIGH ALT MED BIOL, V2, P489, DOI 10.1089/152702901753397054; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Zhang T, 1994, Soc Sci China, V15, P46; ZHUANG JG, 1993, J APPL PHYSIOL, V75, P1968, DOI 10.1152/jappl.1993.75.5.1968	49	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137956	10.1371/journal.pone.0137956	http://dx.doi.org/10.1371/journal.pone.0137956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368009	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100182
J	Brenneman, EC; Kuntz, AB; Wiebenga, EG; Maly, MR				Brenneman, Elora C.; Kuntz, Alexander B.; Wiebenga, Emily G.; Maly, Monica R.			A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PHYSICAL FUNCTION; OARSI RECOMMENDATIONS; CARTILAGE LOSS; OUTCOME SCORE; IYENGAR YOGA; BASE-LINE; EXERCISE; HIP; MANAGEMENT	People with knee osteoarthritis may benefit from exercise prescriptions that minimize knee loads in the frontal plane. The primary objective of this study was to determine whether a novel 12-week strengthening program designed to minimize exposure to the knee adduction moment (KAM) could improve symptoms and knee strength in women with symptomatic knee osteoarthritis. A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. The tertiary objective was to evaluate the biomechanical characteristics of this yoga program. In particular, we compared the peak KAM during gait with that during yoga postures at baseline. We also compared lower limb normalized mean electromyography (EMG) amplitudes during yoga postures between baseline and follow-up. Primary measures included self-reported pain and physical function (Knee injury and Osteoarthritis Outcome Score) and knee strength (extensor and flexor torques). Secondary measures included mobility (six-minute walk, 30-second chair stand, stair climbing), fitness (submaximal cycle ergometer test), and clinical gait analysis using motion capture synchronized with electromyography and force measurement. Also, KAM and normalized mean EMG amplitudes were collected during yoga postures. Forty-five women over age 50 with symptomatic knee osteoarthritis, consistent with the American College of Rheumatology criteria, enrolled in our 12-week (3 sessions per week) program. Data from 38 were analyzed (six drop-outs; one lost to co-intervention). Participants experienced reduced pain (mean improvement 10.1-20.1 normalized to 100; p < 0.001), increased knee extensor strength (mean improvement 0.01 Nm/kg; p = 0.004), and increased flexor strength (mean improvement 0.01 Nm/kg; p = 0.001) at follow-up compared to baseline. Participants improved mobility on the six-minute walk (mean improvement 37.7 m; p < 0.001) and 30-second chair stand (mean improvement 1.3; p = 0.006) at follow-up compared to baseline. Fitness and peak KAM during gait were unchanged between baseline and follow-up. Average KAM during the yoga postures were lower than that of normal gait. Normalized mean EMG amplitudes during yoga postures were up to 31.0% of maximum but did not change between baseline and follow-up. In this cohort study, the yoga-based strengthening postures that elicit low KAMs improved knee symptoms and strength in women with knee OA following a 12 week program (3 sessions per week). The program also improved mobility, but did not improve fitness or reduce peak KAM during gait. The KAM during the yoga postures were lower than that of normal gait. Overall, the proposed program may be useful in improving pain, strength, and mobility in women with knee osteoarthritis. Clinical efficacy needs to be assessed using a randomized controlled trial design.	[Brenneman, Elora C.; Wiebenga, Emily G.; Maly, Monica R.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Kuntz, Alexander B.; Maly, Monica R.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University; McMaster University	Maly, MR (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.	mmaly@mcmaster.ca			Labarge Optimal Aging Initiative-Opportunities Fund; Natural Sciences and Engineering Research Council of Canada [353715]; Canadian Foundation of Innovation; Ontario Ministry of Research and Innovation [27501]	Labarge Optimal Aging Initiative-Opportunities Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation of Innovation(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was funded by Labarge Optimal Aging Initiative-Opportunities Fund (MRM) (http://optimalaging.mcmaster.ca/opportunities_fund.html), Natural Sciences and Engineering Research Council of Canada-Discovery (#353715; MRM) (http://www.nserc-crsng.gc.ca/Professors-Professeurs/GrantsSubs/DGIGP-PSIGP_eng.asp) and Canadian Foundation of Innovation and Ontario Ministry of Research and Innovation-Leaders Opportunities Fund (#27501; MRM) (http://roads.mcmaster.ca/funding/initiatives/cfi-lof). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005; Ageberg E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-232; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Alviar MJ, 2011, J REHABIL MED, V43, P374, DOI 10.2340/16501977-0801; Andriacchi TP, 2013, ARTHRITIS RHEUM-US, V65, P310, DOI 10.1002/art.37724; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; [Anonymous], 2014, WAIT TIMES PRIORITY, P1; Australian Institute of Health and Welfare, 2014, HIP KNEE ARTHR, P1; Beekley MD, 2004, RES Q EXERCISE SPORT, V75, P337, DOI 10.1080/02701367.2004.10609165; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Bennell KL, 2008, RHEUM DIS CLIN N AM, V34, P731, DOI 10.1016/j.rdc.2008.05.005; Bennell KL, 2015, CURR OPIN RHEUMATOL, V27, P304, DOI 10.1097/BOR.0000000000000160; Bennell KL, 2013, RHEUM DIS CLIN N AM, V39, P145, DOI 10.1016/j.rdc.2012.11.003; Bennell KL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-276; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Bombardier C, 2011, ARTHRITIS ALLIANCE C, V606, P1; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bukowski EL, 2006, INT Q COMMUNITY HEAL, V26, P287, DOI 10.2190/IQ.26.3.f; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Chang A, 2007, ANN RHEUM DIS, V66, P1271, DOI 10.1136/ard.2006.062927; Chehab EF, 2014, OSTEOARTHR CARTILAGE, V22, P1833, DOI 10.1016/j.joca.2014.08.009; Cheung C, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-160; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; Creaby MW, 2010, OSTEOARTHR CARTILAGE, V18, P1380, DOI 10.1016/j.joca.2010.08.013; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Foroughi N, 2011, CLIN BIOMECH, V26, P167, DOI 10.1016/j.clinbiomech.2010.08.011; Franciozi CES, 2013, OSTEOARTHR CARTILAGE, V21, P965, DOI 10.1016/j.joca.2013.04.007; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Horisberger M, 2013, CLIN BIOMECH, V28, P536, DOI 10.1016/j.clinbiomech.2013.04.009; Hunt MA, 2008, OSTEOARTHR CARTILAGE, V16, P591, DOI 10.1016/j.joca.2007.10.017; Kean CO, 2010, ARCH PHYS MED REHAB, V91, P1447, DOI 10.1016/j.apmr.2010.06.002; Keenan GS, 2011, GAIT POSTURE, V33, P350, DOI 10.1016/j.gaitpost.2010.09.019; Kelley GA, 2001, AM J PHYS MED REHAB, V80, P65, DOI 10.1097/00002060-200101000-00017; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Kolasinski SL, 2005, J ALTERN COMPLEM MED, V11, P689, DOI 10.1089/acm.2005.11.689; KOOS, 2012, KOOS SCOR 2012; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lange AK, 2008, ARTHRIT RHEUM-ARTHR, V59, P1488, DOI 10.1002/art.24118; Larose J, 2013, APPL PHYSIOL NUTR ME, V38, P886, DOI 10.1139/apnm-2012-0487; Lim BW, 2008, ARTHRIT RHEUM-ARTHR, V59, P943, DOI 10.1002/art.23823; Longpre HS, CLIN BIOMECH; Longpre HS, 2015, THESIS MCMASTER U; Messier SP, 2000, J AM GERIATR SOC, V48, P131, DOI 10.1111/j.1532-5415.2000.tb03903.x; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Messier SP, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-208; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Moisio KC, 2003, J BIOMECH, V36, P599, DOI 10.1016/S0021-9290(02)00433-5; Monticone M, 2013, AM J PHYS MED REHAB, V92, P864, DOI 10.1097/PHM.0b013e31829f19d8; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Mundermann A, 2004, ARTHRITIS RHEUM-US, V50, P1172, DOI 10.1002/art.20132; Robbins SM, 2011, ARTHRIT CARE RES, V63, P991, DOI 10.1002/acr.20476; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Roos EM, 2005, ARTHRITIS RHEUM-US, V52, P3507, DOI 10.1002/art.21415; Runhaar J, 2015, OSTEOARTHRITIS CARTI; Rutherford DJ, 2008, OSTEOARTHR CARTILAGE, V16, P883, DOI 10.1016/j.joca.2007.11.012; RUUSKANEN JM, 1995, AGE AGEING, V24, P292, DOI 10.1093/ageing/24.4.292; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; Sled EA, 2010, PHYS THER, V90, P895, DOI 10.2522/ptj.20090294; The NJR Editorial Board, 2013, 10 NJR ED BOARD, P1; Thorstensson CA, 2007, OSTEOARTHR CARTILAGE, V15, P1163, DOI 10.1016/j.joca.2007.03.012; van Baar ME, 2001, ANN RHEUM DIS, V60, P1123, DOI 10.1136/ard.60.12.1123; Wang MY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-8; Winter D. A, 2009, BIOMECHANICS MOTOR C; Wluka A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1962; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	71	15	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136854	10.1371/journal.pone.0136854	http://dx.doi.org/10.1371/journal.pone.0136854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367862	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100028
J	Chen, WL; Sheu, JR; Chen, RJ; Hsiao, SH; Hsiao, CJ; Chou, YC; Chung, CL; Hsiao, G				Chen, Wei-Lin; Sheu, Joen-Rong; Chen, Ray-Jade; Hsiao, Shih-Hsin; Hsiao, Che-Jen; Chou, Yung-Chen; Chung, Chi-Li; Hsiao, George			Mycobacterium tuberculosis Upregulates TNF-alpha Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROINFLAMMATORY CYTOKINES; MATRIX METALLOPROTEINASES; FIBRINOLYTIC ENZYMES; TISSUE INHIBITORS; GRANULOMA; MATRIX-METALLOPROTEINASE-9; ACTIVATION; PROTEIN	Background Tumor necrosis factor (TNF)-alpha and matrix metalloproteinases (MMPs) are elevated in pleural fluids of tuberculous pleuritis (TBP) where pleural mesothelial cells (PMCs) conduct the first-line defense against Mycobacterium tuberculosis (MTB). However, the clinical implication of TNF-alpha and MMPs in TBP and the response of PMCs to MTB infection remain unclear. Methods We measured pleural fluid levels of TNF-alpha and MMPs in patients with TBP (n = 18) or heart failure (n = 18) as controls. Radiological scores for initial effusion amount and residual pleural fibrosis at 6-month follow-up were assessed. In vitro human PMC experiments were performed to assess the effect of heat-killed M. tuberculosis H37Ra (MTBRa) on the expression of TNF-alpha and MMPs. Results As compared with controls, the effusion levels of TNF-alpha, MMP-1 and MMP-9 were significantly higher and correlated positively with initial effusion amount in patients with TBP, while TNF-alpha and MMP-1, but not MMP-9, were positively associated with residual pleural fibrosis of TBP. Moreover, effusion levels of TNF-alpha had positive correlation with those of MMP-1 and MMP-9 in TBP. In cultured PMCs, MTBRa enhanced TLR2 and TLR4 expression, activated ERK signaling, and upregulated TNF-alpha mRNA and protein expression. Furthermore, knockdown of TLR2, but not TLR4, significantly inhibited ERK phosphorylation and TNF-alpha expression. Additionally, both MTBRa and TNF-alpha markedly induced MMP-1 and MMP-9 synthesis in human PMCs, and TNF-alpha neutralization substantially reduced the production of MMP-1, but not MMP-9, in response to MTBRa stimulation. Conclusion MTBRa activates TLR2/ERK signalings to induce TNF-alpha and elicit MMP-1 and MMP-9 in human PMCs, which are associated with effusion volume and pleural fibrosis and may contribute to pathogenesis of TBP. Further investigation of manipulation of TNF-alpha and MMP expression in pleural mesothelium may provide new insights into the mechanisms and rational treatment strategies for TBP.	[Chen, Wei-Lin; Sheu, Joen-Rong; Chou, Yung-Chen; Hsiao, George] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Wei-Lin; Sheu, Joen-Rong; Chou, Yung-Chen; Hsiao, George] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hsiao, Shih-Hsin; Chung, Chi-Li] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Hsiao, Che-Jen; Chung, Chi-Li] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Hsiao, G (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	geohsiao@tmu.edu.tw	Chen, Ray/GRJ-6736-2022		National Science Council of Taiwan [NSC 101-2314-B-038-044-MY3, NSC 102-2628-B-038-009-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC 101-2314-B-038-044-MY3 and NSC 102-2628-B-038-009-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231012; Chou YC, 2011, BBA-GEN SUBJECTS, V1810, P475, DOI 10.1016/j.bbagen.2011.01.004; Chung CL, 2012, AM J RESP CELL MOL, V46, P437, DOI 10.1165/rcmb.2011-0118OC; Chung CL, 2009, AM J RESP CELL MOL, V40, P692, DOI 10.1165/rcmb.2008-0087OC; Chung CL, 2005, CHEST, V128, P690, DOI 10.1016/S0012-3692(15)50413-3; dePablo A, 1997, CHEST, V112, P1293, DOI 10.1378/chest.112.5.1293; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Hua CC, 1999, CHEST, V116, P1292, DOI 10.1378/chest.116.5.1292; Iglesias D, 2005, EUR RESPIR J, V25, P104, DOI 10.1183/09031936.04.00010504; Means TK, 1999, J IMMUNOL, V163, P3920; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; Park KJ, 2005, RESPIRATION, V72, P166, DOI 10.1159/000084048; Petrikin JE, 2010, PEDIATR RES, V68, P335, DOI 10.1203/00006450-201011001-00656; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Sheen P, 2009, EUR RESPIR J, V33, P134, DOI 10.1183/09031936.00127807; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; Tchou-Wong KM, 1999, AM J RESP CRIT CARE, V159, P1323, DOI 10.1164/ajrccm.159.4.9710105; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wang CH, 2010, INT J TUBERC LUNG D, V14, P627	31	77	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137979	10.1371/journal.pone.0137979	http://dx.doi.org/10.1371/journal.pone.0137979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367274	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100193
J	Li, JJ; Ding, Q; Wang, FD; Zhang, YH; Li, HY; Gao, JW				Li, Jingjuan; Ding, Qian; Wang, Fengde; Zhang, Yihui; Li, Huayin; Gao, Jianwei			Integrative Analysis of mRNA and miRNA Expression Profiles of the Tuberous Root Development at Seedling Stages in Turnips	PLOS ONE			English	Article							POTATO IPOMOEA-BATATAS; DIGITAL GENE-EXPRESSION; BRASSICA-RAPA L.; SWEET-POTATO; STORAGE ROOT; TRANSCRIPTOME ANALYSIS; THICKENING GROWTH; DOWN-REGULATION; FOLDING LEAVES; MICRORNAS	The tuberous root of Brassica rapa L. (turnip) is an important modified organ for nutrition storage. A better understanding of the molecular mechanisms involved in the process of tuberous root development is of great value in both economic and biological context. In this study, we analyzed the expression profiles of both mRNAs and miRNAs in tuberous roots at an early stage before cortex splitting (ES), cortex splitting stage (CSS), and secondary root thickening stage (RTS) in turnip based on high-throughput sequencing technology. A large number of differentially expressed genes (DEGs) and several differentially expressed miRNAs (DEMs) were identified. Based on the DEG analysis, we propose that metabolism is the dominant pathway in both tuberous root initiation and secondary thickening process. The plant hormone signal transduction pathway may play a predominant role in regulating tuberous root initiation, while the starch and sucrose metabolism may be more important for the secondary thickening process. These hypotheses were partially supported by sequential DEM analyses. Of all DEMs, miR156a, miR157a, and miR172a exhibited relatively high expression levels, and were differentially expressed in both tuberous root initiation and the secondary thickening process with the expression profiles negatively correlated with those of their target genes. Our results suggest that these miRNAs play important roles in tuberous root development in turnips.	[Li, Jingjuan; Ding, Qian; Wang, Fengde; Zhang, Yihui; Li, Huayin; Gao, Jianwei] Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Gao, JW (corresponding author), Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Shandong, Peoples R China.	jianweigao3@yahoo.com	Wang, Fengde/HCI-6590-2022		Modern Agriculture Industrial Technology System Funding of Shandong Province, China [SDAIT-02-022-04]; National Natural Science Foundation of China [31401869]; China Postdoctoral Science Foundation [2013M541948]; Shandong Postdoctoral Science Foundation Funded Project, China [201303030]	Modern Agriculture Industrial Technology System Funding of Shandong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Postdoctoral Science Foundation Funded Project, China	This study was supported by Modern Agriculture Industrial Technology System Funding of Shandong Province, China (SDAIT-02-022-04, http://cyjstx.sdny.gov.cn/). The role of funder: study design, decision to publish, and preparation of the manuscript. National Natural Science Foundation of China (31401869, http://www.nsfc.gov.cn/). The role of funder: study design, data collection and analysis, and preparation of the manuscript. China Postdoctoral Science Foundation Funded Project (2013M541948, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx). The role of funder: study design, data collection and analysis, and preparation of the manuscript. Shandong Postdoctoral Science Foundation Funded Project, China (201303030, http://www.sdhrss.gov.cn/cm/). The role of funder: study design, data collection and analysis, and preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bari A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/307145; Bhogale S, 2014, PLANT PHYSIOL, V164, P1011, DOI 10.1104/pp.113.230714; Choi SR, 2007, THEOR APPL GENET, V115, P777, DOI 10.1007/s00122-007-0608-z; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Curtis IS, 2003, TRENDS PLANT SCI, V8, P305, DOI 10.1016/S1360-1385(03)00127-4; Dini I, 2009, FOOD CHEM, V113, P411, DOI 10.1016/j.foodchem.2008.07.053; Eguchi Toshihiko, 2011, Environmental Control in Biology, V49, P47; Fan MX, 2011, J PLANT GROWTH REGUL, V30, P11, DOI 10.1007/s00344-010-9163-y; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gupta AK, 2001, ACTA PHYSIOL PLANT, V23, P31, DOI 10.1007/s11738-001-0019-8; Jiang JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-72; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Kim B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-218; Kim SH, 2005, J PLANT BIOL, V48, P387, DOI 10.1007/BF03030580; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ku AT, 2008, ANN BOT-LONDON, V102, P57, DOI 10.1093/aob/mcn067; Legnani G, 2001, NEW PHYTOL, V149, P449, DOI 10.1046/j.1469-8137.2001.00055.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005436; Luo XingLu, 2011, Journal of Agricultural Science (Toronto), V3, P64; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noh SA, 2013, J EXP BOT, V64, P129, DOI 10.1093/jxb/ers236; Noh SA, 2010, J EXP BOT, V61, P1337, DOI 10.1093/jxb/erp399; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rouhier H, 2001, PLANT CELL PHYSIOL, V42, P583, DOI 10.1093/pcp/pce071; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Solis J, 2014, J AM SOC HORTIC SCI, V139, P317, DOI 10.21273/JASHS.139.3.317; Song XM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-71; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Sun P, 2010, MOL BIOL REP, V37, P1069, DOI 10.1007/s11033-009-9834-6; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tanaka M, 2005, J PLANT PHYSIOL, V162, P91, DOI 10.1016/j.jplph.2004.06.003; Tanaka M, 2008, J PLANT PHYSIOL, V165, P1726, DOI 10.1016/j.jplph.2007.11.009; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wang FD, 2013, GENE, V532, P222, DOI 10.1016/j.gene.2013.09.039; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang FD, 2012, GENOMICS, V99, P299, DOI 10.1016/j.ygeno.2012.02.005; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/G11-069, 10.1139/g11-069]; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang QingMei, 2006, Agricultural Sciences in China, V5, P919, DOI 10.1016/S1671-2927(07)60005-4; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang J, 2011, J INTEGR PLANT BIOL, V53, P193, DOI 10.1111/j.1744-7909.2010.01018.x; Yao Y, 2013, ADV MATER RES-SWITZ, V726-731, P4529, DOI 10.4028/www.scientific.net/AMR.726-731.4529; Yasunori K, 2001, PLANT PROD SCI, V4, P131; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337	55	20	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137983	10.1371/journal.pone.0137983	http://dx.doi.org/10.1371/journal.pone.0137983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367742	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100195
J	Soltysiak, KA; van Schaik, EJ; Samuel, JE				Soltysiak, Kelly A.; van Schaik, Erin J.; Samuel, James E.			Surfactant Protein D Binds to Coxiella burnetii and Results in a Decrease in Interactions with Murine Alveolar Macrophages	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LEGIONELLA-PNEUMOPHILA; MYCOBACTERIUM-TUBERCULOSIS; KLEBSIELLA-PNEUMONIAE; PULMONARY COLLECTINS; LUNG COLLECTINS; CELL-LINE; Q-FEVER; MH-S	Coxiella burnetii is a Gram-negative, obligate intracellular bacterium and the causative agent of Q fever. Infections are usually acquired after inhalation of contaminated particles, where C. burnetii infects its cellular target cells, alveolar macrophages. Respiratory pathogens encounter the C-type lectin surfactant protein D (SP-D) during the course of natural infection. SP-D is a component of the innate immune response in the lungs and other mucosal surfaces. Many Gram-negative pulmonary pathogens interact with SP-D, which can cause aggregation, bactericidal effects and aid in bacterial clearance. Here we show that SP-D binds to C. burnetii in a calcium-dependent manner with no detectable bacterial aggregation or bactericidal effects. Since SP-D interactions with bacteria often alter macrophage interactions, it was determined that SP-D treatment resulted in a significant decrease in C. burnetii interactions to a mouse alveolar macrophage model cell line MH-S indicating SP-D causes a significant decrease in phagocytosis. The ability of SP-D to modulate macrophage activation by C. burnetii was tested and it was determined that SP-D does not alter the correlates measured for macrophage activation. Taken together these studies support those demonstrating limited activation of alveolar macrophages with C. burnetii and demonstrate interactions with SP-D participate in reduction of phagocyte attachment and phagocytosis.	[Soltysiak, Kelly A.; van Schaik, Erin J.; Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Samuel, JE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA.	jsamuel@medicine.tamhsc.edu			National Institutes of Health [AI088430, AI090142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088430, R01AI090142, R56AI090142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health AI088430 awarded to JS; and by National Institutes of Health AI090142 awarded to JS [http://grants.nih.gov/grants/oer.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen C, 2013, NAT REV MICROADVANCE; Ferguson JS, 2002, J IMMUNOL, V168, P1309, DOI 10.4049/jimmunol.168.3.1309; Ferguson JS, 1999, J IMMUNOL, V163, P312; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; Griese M, 2005, PEDIATR PULM, V40, P378, DOI 10.1002/ppul.20295; Hogenkamp A, 2007, MOL IMMUNOL, V44, P3517, DOI 10.1016/j.molimm.2007.03.013; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Jounblat R, 2004, INFECT IMMUN, V72, P709, DOI 10.1128/IAI.72.2.709-716.2004; Keisari Y, 2001, J LEUKOCYTE BIOL, V70, P135; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kurimura Y, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380287; LIM BL, 1994, BIOCHEM BIOPH RES CO, V202, P1674, DOI 10.1006/bbrc.1994.2127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsunaga K, 2001, AM J RESP CELL MOL, V24, P326, DOI 10.1165/ajrcmb.24.3.4359; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Oberley RE, 2004, LUNG CELLULAR MOL PH, V287, P296; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; ORIORDAN DM, 1995, J CLIN INVEST, V95, P2699, DOI 10.1172/JCI117972; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Samuel JE, 2009, CURRENT PROTOCOLS MI; Sano H, 2006, RESPIROLOGY, V11, pS46, DOI 10.1111/j.1440-1843.2006.00808.x; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Schaeffer LM, 2004, INFECT IMMUN, V72, P7124, DOI 10.1128/IAI.72.12.7124-7130.2004; Wu HFM, 2005, AM J PHYSIOL-LUNG C, V288, pL585, DOI 10.1152/ajplung.00305.2004; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yan L, 2004, FEMS MICROBIOL LETT, V230, P147, DOI 10.1016/S0378-1097(03)00883-8; Yokota S, 2012, INFECT IMMUN, V80, P2956, DOI 10.1128/IAI.00345-12	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136699	10.1371/journal.pone.0136699	http://dx.doi.org/10.1371/journal.pone.0136699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366725	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100021
J	Wack, M; Puymirat, E; Ranque, B; Georgin-Lavialle, S; Pierre, I; Tanguy, A; Ackermann, F; Mallet, C; Pavie, J; Boultache, H; Durieux, P; Avillach, P				Wack, Maxime; Puymirat, Etienne; Ranque, Brigitte; Georgin-Lavialle, Sophie; Pierre, Isabelle; Tanguy, Aurelia; Ackermann, Felix; Mallet, Celine; Pavie, Juliette; Boultache, Hakima; Durieux, Pierre; Avillach, Paul			Evaluating the Impact of Computerized Provider Order Entry on Medical Students Training at Bedside: A Randomized Controlled Trial	PLOS ONE			English	Article							PRESCRIBING ERRORS; EDUCATION; PREVENTION; SYSTEM	Objective To evaluate the impact of computerized provider order entry (CPOE) at the bedside on medical students training. Materials and Methods We conducted a randomized cross-controlled educational trial on medical students during two clerkship rotations in three departments, assessing the impact of the use of CPOE on their ability to place adequate monitoring and therapeutic orders using a written test before and after each rotation. Students' satisfaction with their practice and the order placement system was surveyed. A multivariate mixed model was used to take individual students and chief resident (CR) effects into account. Factorial analysis was applied on the satisfaction questionnaire to identify dimensions, and scores were compared on these dimensions. Results Thirty-six students show no better progress (beginning and final test means = 69.87 and 80.98 points out of 176 for the control group, 64.60 and 78.11 for the CPOE group, p = 0.556) during their rotation in either group, even after adjusting for each student and CR, but show a better satisfaction with patient care and greater involvement in the medical team in the CPOE group (p = 0.035*). Both groups have a favorable opinion regarding CPOE as an educational tool, especially because of the order reviewing by the supervisor. Conclusion This is the first randomized controlled trial assessing the performance of CPOE in both the progress in prescriptions ability and satisfaction of the students. The absence of effect on the medical skills must be weighted by the small time scale and low sample size. However, students are more satisfied when using CPOE rather than usual training.	[Wack, Maxime; Boultache, Hakima; Durieux, Pierre; Avillach, Paul] Paris Descartes Univ, HEGP, AP HP, Biomed Informat & Publ Hlth Dept, Paris, France; [Wack, Maxime; Boultache, Hakima; Durieux, Pierre; Avillach, Paul] Paris Descartes Univ, Fac Med, INSERM UMR S Team 22 872, Paris, France; [Puymirat, Etienne; Tanguy, Aurelia] Paris Descartes Univ, HEGP, AP HP, Dept Cardiol, Paris, France; [Puymirat, Etienne; Ranque, Brigitte] Paris Descartes Univ, Fac Med, INSERM U970, Paris, France; [Ranque, Brigitte; Georgin-Lavialle, Sophie; Ackermann, Felix; Mallet, Celine] Paris Descartes Univ, HEGP, AP HP, Dept Internal Med, Paris, France; [Pierre, Isabelle] Paris Descartes Univ, HEGP, AP HP, Dept Clin Immunol, Paris, France; [Pavie, Juliette] Paris Diderot Univ, St Louis Hosp, Dept Infect Dis, Paris, France; [Durieux, Pierre] Paris Descartes Univ, Fac Med, INSERM, Ctr Invest Epidemiol 4, Paris, France; [Avillach, Paul] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Avillach, Paul] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Avillach, P (corresponding author), Paris Descartes Univ, HEGP, AP HP, Biomed Informat & Publ Hlth Dept, Paris, France.	paul_avillach@hms.harvard.edu	Puymirat, Etienne/AAP-8895-2021; ranque, brigitte/B-7298-2014	ranque, brigitte/0000-0001-8549-2275	Universite Paris Descartes Innovative Grant in Education	Universite Paris Descartes Innovative Grant in Education	This work was supported by Universite Paris Descartes Innovative Grant in Education.	Anderson MB, 1999, ACAD MED, V74, P13; Barber N, 2003, QUAL SAF HEALTH CARE, V12, pI29, DOI 10.1136/qhc.12.suppl_1.i29; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bobb A, 2004, ARCH INTERN MED, V164, P785, DOI 10.1001/archinte.164.7.785; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Chi J, 2014, JAMA-J AM MED ASSOC, V312, P2331, DOI 10.1001/jama.2014.12820; Ghahramani N, 2009, J MED SYST, V33, P199, DOI 10.1007/s10916-008-9180-6; Hier DB, 2005, INT J MED INFORM, V74, P657, DOI 10.1016/j.ijmedinf.2005.03.006; Knight AM, 2005, J AM MED INFORM ASSN, V12, P554, DOI 10.1197/jamia.M1839; Knight AM, 2012, TEACH LEARN MED, V24, P63, DOI 10.1080/10401334.2012.641490; Larsen DP, 2013, ADV HEALTH SCI EDUC, V18, P409, DOI 10.1007/s10459-012-9379-7; Lesar TS, 2002, J GEN INTERN MED, V17, P579, DOI 10.1046/j.1525-1497.2002.11056.x; MASSARO TA, 1993, ACAD MED, V68, P25, DOI 10.1097/00001888-199301000-00004; Oliven A, 2005, INT J MED INFORM, V74, P377, DOI 10.1016/j.ijmedinf.2005.03.010; Patterson R, 2001, J AM MED INFORM ASSN, V8, P111, DOI 10.1136/jamia.2001.0080111; Schectman JM, 2005, INT J MED INFORM, V74, P711, DOI 10.1016/j.ijmedinf.2005.05.011; STAIR TO, 1995, ACAD MED, V70, P543, DOI 10.1097/00001888-199506000-00019; TIERNEY WM, 1994, ACAD MED, V69, P386, DOI 10.1097/00001888-199405000-00013; Whelan A, 2004, AM J MED, V116, P576, DOI 10.1016/j.amjmed.2004.02.001	21	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138094	10.1371/journal.pone.0138094	http://dx.doi.org/10.1371/journal.pone.0138094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367388	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100222
J	Wu, LN; Ci, YS; Chu, JW; Zhang, HS				Wu, Lina; Ci, Yusheng; Chu, Jiangwei; Zhang, Hongsheng			The Influence of Intersections on Fuel Consumption in Urban Arterial Road Traffic: A Single Vehicle Test in Harbin, China	PLOS ONE			English	Article							HYBRID ELECTRIC BUS; ENERGY EFFICIENCY; POWER MANAGEMENT; PREDICTION; STOPS	The calculating method for fuel consumption (FC) was put forward and calibrated and the characteristics of the fuel consumption on intersections were analyzed based on 18 groups of vehicular operating data which were acquired from the test experiment of a single vehicle along the urban arterial roads in Harbin, China. The results obtained show that 50.36% of the fuel consumption for the test vehicle was used at the area of intersections compared with 28.9% of the influencing distance and 68.5% of the running time; and 78.4% of them was burnt at the stages of acceleration and idling. Meanwhile, the type (c) of the vehicular operating status was illustrated to be the worst way of reducing fuel consumption, the causes were analyzed and four improvement strategies were put forward.	[Wu, Lina] Heilongjiang Inst Technol, Coll Automobile & Traff Engn, Harbin, Heilongjiang, Peoples R China; [Wu, Lina; Chu, Jiangwei] Northeast forestry Univ, Coll Traff, Harbin, Heilongjiang, Peoples R China; [Ci, Yusheng] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China; [Zhang, Hongsheng] Harbin Inst Technol, Sch Mechatron Engn, Harbin 150006, Heilongjiang, Peoples R China	Heilongjiang Institute of Technology; Northeast Forestry University - China; Harbin Institute of Technology; Harbin Institute of Technology	Ci, YS (corresponding author), Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China.	ciyusheng1999@126.com			Scientific Research Fund of Heilongjiang Provincial Education Department of China [12541650]	Scientific Research Fund of Heilongjiang Provincial Education Department of China	This work was financially supported by the Scientific Research Fund of Heilongjiang Provincial Education Department of China (No. 12541650).	Ahn K, 2002, J TRANSP ENG, V128, P182, DOI 10.1061/(ASCE)0733-947X(2002)128:2(182); Asadi B, 2011, IEEE T CONTR SYST T, V19, P707, DOI 10.1109/TCST.2010.2047860; Bie YM, 2012, J TRANSP ENG, V138, P12, DOI 10.1061/(ASCE)TE.1943-5436.0000310; Evans LE, 1976, TRANSPORT SCI, V10, P213; Feng YQ, 2011, J HARBIN I TECHNOLOG, V18, P79; HERMAN R, 1985, TRANSPORT SCI, V19, P1, DOI 10.1287/trsc.19.1.1; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2015, APPL ENERG, V137, P913, DOI 10.1016/j.apenergy.2014.05.013; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, APPL ENERG, V111, P1001, DOI 10.1016/j.apenergy.2013.06.056; Lai WT, 2015, TRANSPORT RES D-TR E, V34, P155, DOI 10.1016/j.trd.2014.10.003; Li L, 2006, IEEE T VEH TECHNOL, V55, P1712, DOI 10.1109/TVT.2006.878730; Li L, 2015, IEEE T VEH TECHNOL, V64, P2792, DOI 10.1109/TVT.2014.2352357; Li Zhenlei, 2010, China Mechanical Engineering, V21, P110; Luo XH, 1997, J BEIJING I CIVIL EN, V13, P25; Mahler G, 2014, IEEE T INTELL TRANSP, V15, P2516, DOI 10.1109/TITS.2014.2319306; McIlroy RC, 2015, ERGONOMICS, V58, P866, DOI 10.1080/00140139.2014.997807; Rakha H, 2003, J TRANSP ENG, V129, P23, DOI 10.1061/(ASCE)0733-947X(2003)129:1(23); Staubach M, 2014, TRANSPORT RES F-TRAF, V27, P11, DOI 10.1016/j.trf.2014.09.006; Sun C, 2015, IEEE T CONTR SYST T, V23, P1075, DOI 10.1109/TCST.2014.2361294; Xia HT, 2013, J INTELL TRANSPORT S, V17, P31, DOI 10.1080/15472450.2012.712494; Xiang QJ, 2004, J HIGHWAY TRANSPORTA, V21, P100; Yang C, 2015, IET CONTROL THEORY A, V9, P270, DOI 10.1049/iet-cta.2014.0321; Zhang R, 2015, IET INTELL TRANSP SY, V9, P488, DOI 10.1049/iet-its.2014.0145; [张卫华 Zhang Weihua], 2002, [东南大学学报. 自然科学版, Journal of southeast university], V32, P249; Zheng CH, 2013, INT J HYDROGEN ENERG, V38, P5192, DOI 10.1016/j.ijhydene.2013.02.048	26	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137477	10.1371/journal.pone.0137477	http://dx.doi.org/10.1371/journal.pone.0137477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367012	Green Published, gold			2022-12-27	WOS:000361601100079
J	Dickson, TL; Gross, KL				Dickson, Timothy L.; Gross, Katherine L.			Can the Results of Biodiversity-Ecosystem Productivity Studies Be Translated to Bioenergy Production?	PLOS ONE			English	Article							BIOMASS PRODUCTION; PLANT DIVERSITY; LOW-INPUT; GRASSLAND; CONSERVATION; RESTORATION; SWITCHGRASS; EVENNESS; NITROGEN; HISTORY	Biodiversity experiments show that increases in plant diversity can lead to greater biomass production, and some researchers suggest that high diversity plantings should be used for bioenergy production. However, many methods used in past biodiversity experiments are impractical for bioenergy plantings. For example, biodiversity experiments often use intensive management such as hand weeding to maintain low diversity plantings and exclude unplanted species, but this would not be done for bioenergy plantings. Also, biodiversity experiments generally use high seeding densities that would be too expensive for bioenergy plantings. Here we report the effects of biodiversity on biomass production from two studies of more realistic bioenergy crop plantings in southern Michigan, USA. One study involved comparing production between switchgrass (Panicum virgatum) monocultures and species-rich prairie plantings on private farm fields that were managed similarly to bioenergy plantings. The other study was an experiment where switchgrass was planted in monoculture and in combination with increasingly species-rich native prairie mixtures. Overall, we found that bioenergy plantings with higher species richness did not produce more biomass than switchgrass monocultures. The lack of a positive relationship between planted species richness and production in our studies may be due to several factors. Non-planted species (weeds) were not removed from our studies and these non-planted species may have competed with planted species and also prevented realized species richness from equaling planted species richness. Also, we found that low seeding density of individual species limited the biomass production of these individual species. Production in future bioenergy plantings with high species richness may be increased by using a high density of inexpensive seed from switchgrass and other highly productive species, and future efforts to translate the results of biodiversity experiments to bioenergy plantings should consider the role of seeding density.	[Dickson, Timothy L.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Gross, Katherine L.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Gross, Katherine L.] Michigan State Univ, Dept Plant Biol, Hickory Corners, MI USA	University of Nebraska System; Michigan State University; Michigan State University	Dickson, TL (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	tdickson@unomaha.edu			University of Nebraska-Omaha Office of Research and Creative Activity; Department of Energy Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; National Science Foundation [DEB 1027253]; Michigan State University; Direct For Biological Sciences [1027253] Funding Source: National Science Foundation	University of Nebraska-Omaha Office of Research and Creative Activity; Department of Energy Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Michigan State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the University of Nebraska-Omaha Office of Research and Creative Activity to TLD, the Department of Energy Great Lakes Bioenergy Research Center (DE-FC02-07ER64494) to KLG, the Department of Energy Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830) to KLG, the National Science Foundation (DEB 1027253) to KLG, and Michigan State University to KLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Baer SG, 2005, RESTOR ECOL, V13, P413, DOI 10.1111/j.1526-100X.2005.00051.x; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Bullock JM, 2001, ECOL LETT, V4, P185, DOI 10.1046/j.1461-0248.2001.00215.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Dickson TL, 2009, RESTOR ECOL, V17, P597, DOI 10.1111/j.1526-100X.2008.00427.x; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Henschell MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125758; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jungers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061209; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x; McCoy TD, 2001, AM MIDL NAT, V145, P1, DOI 10.1674/0003-0031(2001)145[0001:GBCCVC]2.0.CO;2; Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006; Natural Resources Conservation Service, 2013, NAT GRASS PLANT MICH; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2013, BASIC APPL ECOL, V14, P187, DOI 10.1016/j.baae.2013.01.003; Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VOGEL KP, 1987, AGRON J, V79, P509, DOI 10.2134/agronj1987.00021962007900030021x; Wallander S., 2011, EC INFORM B; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2003, ECOLOGY, V84, P920, DOI 10.1890/0012-9658(2003)084[0920:EOSAAG]2.0.CO;2; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wullschleger SD, 2010, AGRON J, V102, P1158, DOI 10.2134/agronj2010.0087	41	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135253	10.1371/journal.pone.0135253	http://dx.doi.org/10.1371/journal.pone.0135253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359662	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100003
J	George, AA; Paz, H; Fei, F; Kirzner, J; Kim, YM; Heisterkamp, N; Abdel-Azim, H				George, Aswathi A.; Paz, Helicia; Fei, Fei; Kirzner, Jonathan; Kim, Yong-Mi; Heisterkamp, Nora; Abdel-Azim, Hisham			Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							RAS PATHWAY; RAS/RAF/MEK/ERK; PHOSPHORYLATION; SENSITIVITY; ACTIVATION; MUTATIONS; THERAPY; BCL6; AML	Upstream mutations that lead to constitutive activation of Erk in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) are relatively common. In the era of personalized medicine, flow cytometry could be used as a rapid method for selection of optimal therapies, which may include drugs that target the Erk pathway. Here, we evaluated the utility of phosphoflow, compared to Western blotting, to monitor Erk pathway activation and its inhibition by targeted Mek kinase inhibitors in human BCP ALL. Because the Erk pathway is not only activated endogenously, by mutations, but also by normal extracellular stimulation through stromal contact and serum growth factors, we compared Erk activation ex vivo in ALL cells in the presence and absence of stroma and serum. Phospho-flow was able to readily detect changes in the pool of pErk1/2 that had been generated by normal microenvironmental stimuli in patient-derived BCP-ALL cells passaged in NSG mice, in viably frozen primary patient samples, and in fresh patient samples. Treatment with the Mek1/2 inhibitor selumetinib resulted in a rapid, complete and persistent reduction of microenvironment-generated pErk1/2. Imaging flow cytometry confirmed reduction of nuclear pErk1/2 upon selumetinib treatment. An ALL relapsing with an activating KRasG12V mutation contained higher endogenous as well as serum/stromal-stimulated levels of pErk1/2 than the matched diagnosis sample which lacked the mutation, but selumetinib treatment reduced pErk1/2 to the same level in both samples. Selumetinib and trametinib as Mek inhibitors were mainly cytostatic, but combined treatment with the PI3K@ inhibitor CAL101 increased cytotoxicity. Thus phospho-flow cytometry could be used as a platform for rapid, individualized in vitro drug sensitivity assessment for leukemia patients at the time of diagnosis.	[George, Aswathi A.; Paz, Helicia; Fei, Fei; Kirzner, Jonathan; Kim, Yong-Mi; Heisterkamp, Nora; Abdel-Azim, Hisham] Childrens Hosp Los Angeles, Saban Res Inst, Div Hematol Oncol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA; [Paz, Helicia; Fei, Fei; Heisterkamp, Nora] Childrens Hosp Los Angeles, Saban Res Inst, Sect Mol Carcinogenesis, Dept Pediat, Los Angeles, CA 90027 USA; [Heisterkamp, Nora] Univ So Calif, Norris Comprehens Canc Ctr, Leukemia & Lymphoma Program, Los Angeles, CA USA; [Heisterkamp, Nora] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Heisterkamp, N (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Div Hematol Oncol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu; HAbdelAzim@chla.usc.edu	kim, y/AAR-6095-2020; Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273; Kim, Yong-Mi/0000-0003-3793-6438	Alex's Lemonade Stand Foundation; Leukemia & Lymphoma Society; V-Foundation; National Institutes of Health Public Health Service [CA174020, CA172896]; NATIONAL CANCER INSTITUTE [R01CA172040, R01CA172896] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); V-Foundation; National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from Alex's Lemonade Stand Foundation [www.alexslemonade.org] (NH), the Leukemia & Lymphoma Society [http://www.lls.org/] (NH), the V-Foundation [http://www.jimmyv.org/] (NH), and National Institutes of Health Public Health Service grants CA174020 (NH) and CA172896 (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown R, 2015, LEUKEMIA, V29, P483, DOI 10.1038/leu.2014.204; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Fei F, 2010, LEUKEMIA, V24, P813, DOI 10.1038/leu.2009.302; Fei F, 2010, MOL CANCER THER, V9, P1318, DOI 10.1158/1535-7163.MCT-10-0069; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Gregorj C, 2007, BLOOD, V109, P5473, DOI 10.1182/blood-2006-05-021071; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Knight T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00160; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Perl AE, 2012, CLIN CANCER RES, V18, P1716, DOI 10.1158/1078-0432.CCR-11-2346; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; Shojaee S, 2015, CANCER CELL, V28, P114, DOI 10.1016/j.ccell.2015.05.008; Wang X, 2014, ONCOTARGET, V5, P10732, DOI 10.18632/oncotarget.2533	19	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137917	10.1371/journal.pone.0137917	http://dx.doi.org/10.1371/journal.pone.0137917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360058	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100101
J	Komaba, S; Coluccio, LM				Komaba, Shigeru; Coluccio, Lynne M.			Myosin 1b Regulates Amino Acid Transport by Associating Transporters with the Apical Plasma Membrane of Kidney Cells	PLOS ONE			English	Article							MOLECULAR-CLONING; HARTNUP DISORDER; RAT-LIVER; L-CYSTINE; I-ALPHA; ACTIN; SYSTEM; GENE; IDENTIFICATION; COLLECTRIN	Amino acid transporters (AATers) in the brush border of the apical plasma membrane (APM) of renal proximal tubule (PT) cells mediate amino acid transport (AAT). We found that the membrane-associated class I myosin myosin 1b (Myo1b) localized at the apical brush border membrane of PTs. In opossum kidney (OK) 3B/2 epithelial cells, which are derived from PTs, expressed rat Myo1b-GFP colocalized in patched microvilli with expressed mouse V5-tagged SIT1 (SIT1-V5), which mediates neutral amino acid transport in OK cells. Lentivirus-mediated delivery of opossum Myo1b-specific shRNA resulted in knockdown (kd) of Myo1b expression, less SIT1-V5 at the APM as determined by localization studies, and a decrease in neutral AAT as determined by radioactive uptake assays. Myo1b kd had no effect on Pi transport or noticeable change in microvilli structure as determined by rhodamine phalloidin staining. The studies are the first to define a physiological role for Myo1b, that of regulating renal AAT by modulating the association of AATers with the APM.	[Komaba, Shigeru; Coluccio, Lynne M.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Coluccio, LM (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	coluccio@bu.eduj			National Institutes of Health [1R01 DC 08793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by National Institutes of Health Grant 1R01 DC 08793 to LMC (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Bacic D, 2001, PFLUG ARCH EUR J PHY, V443, P306, DOI 10.1007/s004240100695; Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bohmer C, 2005, BIOCHEM J, V389, P745; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer S, 2008, PHYSIOLOGY, V23, P95, DOI 10.1152/physiol.00045.2007; Broer S, 2009, IUBMB LIFE, V61, P591, DOI 10.1002/iub.210; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cechova S, 2013, CIRCULATION, V128, P1770, DOI 10.1161/CIRCULATIONAHA.113.003301; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; COLUCCIO LM, 2008, PROTEINS CELL REGULA, V7, P95; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Fernandez E, 2003, J AM SOC NEPHROL, V14, P837, DOI 10.1097/01.ASN.0000057852.35075.AC; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GSTRAUNTHALER G, 1985, AM J PHYSIOL, V248, pF536, DOI 10.1152/ajprenal.1985.248.4.F536; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Herve JC, 2014, BBA-BIOMEMBRANES, V1838, P511, DOI 10.1016/j.bbamem.2013.10.014; HOSHIMARU M, 1987, J BIOL CHEM, V262, P14625; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Ito M, 2010, AM J PHYSIOL-RENAL, V299, pF243, DOI 10.1152/ajprenal.00189.2009; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Kowalczuk S, 2005, BIOCHEM J, V386, P417, DOI 10.1042/BJ20050100; KOYAMA H, 1978, IN VITRO CELL DEV B, V14, P239; Kravtsov DV, 2012, TRAFFIC, V13, P1072, DOI 10.1111/j.1600-0854.2012.01368.x; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Liang MY, 1999, KIDNEY INT, V56, P2304, DOI 10.1046/j.1523-1755.1999.00787.x; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; MALMSTROM K, 1986, AM J PHYSIOL, V251, pC23, DOI 10.1152/ajpcell.1986.251.1.C23; MALSTROM K, 1987, BIOCHIM BIOPHYS ACTA, V902, P269, DOI 10.1016/0005-2736(87)90305-1; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; Mora C, 1996, J BIOL CHEM, V271, P10569, DOI 10.1074/jbc.271.18.10569; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nickel A, 2010, AMINO ACIDS, V38, P753, DOI 10.1007/s00726-009-0280-5; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; RUPPERT C, 1995, J CELL SCI, V108, P3775; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; STATES B, 1991, AM J PHYSIOL, V261, pC8, DOI 10.1152/ajpcell.1991.261.1.C8; STATES B, 1990, J CELL PHYSIOL, V143, P555, DOI 10.1002/jcp.1041430321; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; TEITELBAUM AP, 1984, ENDOCRINOLOGY, V114, P980, DOI 10.1210/endo-114-3-980; Tokuo H, 2013, MOL BIOL CELL, V24, P2820, DOI 10.1091/mbc.E12-12-0884; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Verrey F, 2009, PFLUG ARCH EUR J PHY, V458, P53, DOI 10.1007/s00424-009-0638-2; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; Zhang YL, 2007, BIOCHEM BIOPH RES CO, V363, P1, DOI 10.1016/j.bbrc.2007.08.136	77	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138012	10.1371/journal.pone.0138012	http://dx.doi.org/10.1371/journal.pone.0138012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361046	Green Published, Green Submitted, gold			2022-12-27	WOS:000361043100107
J	Alameddine, M; Mourad, Y; Dimassi, H				Alameddine, Mohamad; Mourad, Yara; Dimassi, Hani			A National Study on Nurses' Exposure to Occupational Violence in Lebanon: Prevalence, Consequences and Associated Factors	PLOS ONE			English	Article							HEALTH-CARE WORKERS; JORDANIAN HOSPITAL NURSES; WORKPLACE VIOLENCE; VERBAL ABUSE; EMERGENCY-DEPARTMENTS; QUESTIONNAIRE SURVEY; PSYCHOLOGICAL VIOLENCE; AGGRESSION; STAFF; PHYSICIANS	Background Healthcare institutions have commonly reported exposure of employees, particularly nurses, to high levels of occupational violence. Despite such evidence in the Middle East Region, there is a dearth of national studies that have systematically investigated this phenomenon. This study investigates the prevalence, characteristics, consequences and factors associated with nurses' exposure to occupational violence in Lebanon. Methods A cross-sectional design was utilized to survey a nationally representative sample of 915 nurses registered with the Order of Nurses in Lebanon. Stratified random sampling by governorate was utilized. Individually-mailed questionnaires collected information on exposure to violence, degree of burnout and demographic/professional background. The main outcome variables were exposure to verbal abuse (never, 1-3, 4-9 and 10+ times) and physical violence (never, ever) over the past 12-months. Descriptive statistics were used to estimate prevalence of violence. Multivariable, binomial and multinomial regression models were carried out to investigate the correlates of exposure to verbal abuse and physical violence, respectively. Results Response rate was 64.8%. Over the last year, prevalence of nurses' exposure to verbal abuse was 62%, (CI: 58-65%) and physical violence was 10%, (CI: 8-13%). Among respondents, 31.7% of nurses indicated likelihood to quit their jobs and 22.3% were undetermined. Furthermore, 54.1% reported high levels of emotional exhaustion and 28.8% reported high levels of depersonalization. Compared to nurses with no exposure to verbal abuse, nurses reporting high exposure had high levels of emotional exhaustion (OR: 6.4; CI: 1.76-23.32), depersonalization (OR: 6.8; CI: 3-15) and intention to quit job (OR: 3.9; CI: 1.8-8.3). They further reported absence of anti-violence policies at their institutions (OR: 3; CI: 1.5-6.3). Nurses that were ever exposed to physical violence were more likely to bemales (OR: 2.2; CI: 1.1-4.3), working day and night shifts (OR: 2.8; CI: 1.4-5.5) and subject to ten or more incidents of verbal abuse per year (OR: 46.7; CI: 10.1-214). Conclusions An alarming two-thirds of respondents reported exposure to verbal abuse which was found to be a significant predictor of the three subscales of burnout, intention to quit and exposure to physical violence. The prevalence of exposure to physical violence is disconcerting due to its severe consequences. Policy and decision-makers are urged to use study findings for policy and practice interventions to create safe work environments conducive to nurses' productivity and retention.	[Alameddine, Mohamad; Mourad, Yara] Amer Univ Beirut, Fac Hlth Sci, Dept Hlth Management & Policy, Beirut, Lebanon; [Dimassi, Hani] Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon	American University of Beirut; Lebanese American University	Alameddine, M (corresponding author), Amer Univ Beirut, Fac Hlth Sci, Dept Hlth Management & Policy, Beirut, Lebanon.	ma164@aub.edu.lb	Dimassi, Hani/AAH-5334-2019; Alameddine, Mohamad/AAN-1624-2020	Dimassi, Hani/0000-0003-1827-2453; Alameddine, Mohamad/0000-0002-2299-1242	University Research Board at the American University of Beirut [115050-288502]; WHO office in Lebanon [100344-20323]	University Research Board at the American University of Beirut; WHO office in Lebanon	The study was co-funded by the University Research Board at the American University of Beirut, award number 115050-288502 and the WHO office in Lebanon, award number 100344-20323.	Abualrub RF, 2007, J NURS SCHOLARSHIP, V39, P281, DOI 10.1111/j.1547-5069.2007.00181.x; AbuAlRub RF, 2014, J TRANSCULT NURS, V25, P6, DOI 10.1177/1043659613493330; AbuAlRub RF, 2011, J TRANSCULT NURS, V22, P157, DOI 10.1177/1043659610395769; Adib SM, 2002, INT J NURS STUD, V39, P469, DOI 10.1016/S0020-7489(01)00050-5; Al-Sahlawi K S, 1999, Eur J Emerg Med, V6, P301; Alameddine M, 2013, J HOSP ADM, V2, P31; Alameddine M, 2011, J OCCUP HEALTH, V53, P455, DOI 10.1539/joh.11-0102-OA; ALBashtawy M, 2013, INT NURS REV, V60, P550, DOI 10.1111/inr.12059; Anderson Cheryl, 2003, J Transcult Nurs, V14, P237, DOI 10.1177/1043659603014003010; Arnetz JE, 2000, J ADV NURS, V31, P668, DOI 10.1046/j.1365-2648.2000.01322.x; Atan SU, 2013, J PSYCHIATR MENT HLT, V20, P882, DOI 10.1111/jpm.12027; Beecroft PC, 2001, J NURS ADMIN, V31, P575, DOI 10.1097/00005110-200112000-00008; Behnam M, 2011, J EMERG MED, V40, P565, DOI 10.1016/j.jemermed.2009.11.007; Boyle M, 2007, EMERG MED J, V24, P760, DOI 10.1136/emj.2007.046789; Carter R, 1999, Nurs Manag (Harrow), V6, P5; Celik SS, 2007, INT NURS REV, V54, P359, DOI 10.1111/j.1466-7657.2007.00548.x; Chapman Rose, 2009, Br J Nurs, V18, P1256; Chen WC, 2008, J OCCUP HEALTH, V50, P288, DOI 10.1539/joh.L7132; Christmas K, 2007, NURS ECON, V25, P365; Clements PT, 2005, NURS ECON, V23, P119; Crilly Julia, 2004, Accid Emerg Nurs, V12, P67, DOI 10.1016/j.aaen.2003.11.003; Deeb Mary, 2003, WORKPLACE VIOLENCE H; El-Gilany AH, 2010, J INTERPERS VIOLENCE, V25, P716, DOI 10.1177/0886260509334395; El-Jardali F, 2008, INT J NURS STUD, V45, P1490, DOI 10.1016/j.ijnurstu.2007.10.012; El-Jardali F, 2009, BMC NURS, V8, DOI 10.1186/1472-6955-8-3; Embree JL, 2010, NURS FORUM, V45, P166, DOI 10.1111/j.1744-6198.2010.00185.x; Erickson L, 2000, J Emerg Nurs, V26, P210, DOI 10.1067/men.2000.106979; Farrell GA, 2001, J ADV NURS, V35, P26, DOI 10.1046/j.1365-2648.2001.01802.x; Farrell GA, 2006, J ADV NURS, V55, P778, DOI 10.1111/j.1365-2648.2006.03956.x; Gacki-Smith Jessica, 2010, J Healthc Prot Manage, V26, P81; Gallant-Roman MA, 2008, AAOHN J, V56, P51; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; Hahn S, 2012, J ADV NURS, V68, P2685, DOI 10.1111/j.1365-2648.2012.05967.x; Hegney Desley, 2006, Int J Nurs Pract, V12, P220, DOI 10.1111/j.1440-172X.2006.00571.x; Hegney Desley, 2003, Int J Nurs Pract, V9, P261, DOI 10.1046/j.1440-172X.2003.00431.x; Hesketh KL, 2003, HEALTH POLICY, V63, P311, DOI 10.1016/S0168-8510(02)00142-2; Hinchberger PA, 2009, NURS FORUM, V44, P37, DOI 10.1111/j.1744-6198.2009.00125.x; International Council of Nurses, 2001, NURS ALW THER YOU UN; Jackson M, 2005, REV PANAM SALUD PUBL, V18, P114, DOI 10.1590/S1020-49892005000700006; Jenkins MG, 1998, J ACCID EMERG MED, V15, P262; Kamchuchat C, 2008, J OCCUP HEALTH, V50, P201, DOI 10.1539/joh.O7001; Kennedy M, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.663; Koritsas S, 2007, BRIT J GEN PRACT, V57, P967, DOI 10.3399/096016407782604848; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010; Kwok R. P. W., 2006, Hong Kong Medical Journal, V12, P6; Levin P F, 1998, Image J Nurs Sch, V30, P249, DOI 10.1111/j.1547-5069.1998.tb01300.x; Lipscomb JA, 2013, NEW SOLUT, V23, P297, DOI 10.2190/NS.23.2.f; Longo Joy, 2007, Nurs Manage, V38, P34, DOI 10.1097/01.NUMA.0000262925.77680.e0; Maslach C., 1996, MASLACH BURNOUT INVE; McKenna BG, 2003, J ADV NURS, V42, P90, DOI 10.1046/j.1365-2648.2003.02583.x; McPhaul Kathleen M, 2004, Online J Issues Nurs, V9, P7; Merecz D, 2006, EUR PSYCHIAT, V21, P442, DOI 10.1016/j.eurpsy.2006.01.001; Moustafa M. S., 2013, The Journal of American Science, V9, P243; O'Connell B, 2000, J CLIN NURS, V9, P602, DOI 10.1046/j.1365-2702.2000.00401.x; Oweis A, 2005, INT J NURS STUD, V42, P881, DOI 10.1016/j.ijnurstu.2004.11.005; Oztunc G, 2006, J NURS CARE QUAL, V21, P360; Phillips Susan, 2007, Nurs Adm Q, V31, P209; Randle J, 2003, J ADV NURS, V43, P395, DOI 10.1046/j.1365-2648.2003.02728.x; Rippon TJ, 2000, J ADV NURS, V31, P452, DOI 10.1046/j.1365-2648.2000.01284.x; Shoghil M, 2008, WORKPLACE VIOLENCE A, P184; Spector PE, 2014, INT J NURS STUD, V51, P72, DOI 10.1016/j.ijnurstu.2013.01.010; Taylor JL, 2011, J CLIN NURS, V20, P1072, DOI 10.1111/j.1365-2702.2010.03342.x; Taylor JL, 2010, J CLIN NURS; Trossman Susan, 2008, Am Nurse, V40, P8; Uzun O, 2003, J NURS SCHOLARSHIP, V35, P81, DOI 10.1111/j.1547-5069.2003.00081.x; Whelan T, 2008, J EMERG NURS, V34, P130, DOI 10.1016/j.jen.2007.05.018; Winstanley S, 2004, J CLIN NURS, V13, P3, DOI 10.1111/j.1365-2702.2004.00807.x; Winstanley S, 2002, WORK STRESS, V16, P302, DOI 10.1080/0267837021000058650; Zahid M A, 1999, Eur J Emerg Med, V6, P305; Zampieron A, 2010, J CLIN NURS, V19, P2329, DOI 10.1111/j.1365-2702.2009.03118.x	70	60	61	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137105	10.1371/journal.pone.0137105	http://dx.doi.org/10.1371/journal.pone.0137105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355686	Green Published, gold, Green Submitted			2022-12-27	WOS:000360965800028
J	Balas, B; Conlin, C				Balas, Benjamin; Conlin, Catherine			The Visual N1 Is Sensitive to Deviations from Natural Texture Appearance	PLOS ONE			English	Article							IMAGE STATISTICS; PERCEPTION; DISCRIMINATION; RECOGNITION; REVERSAL; FACES; SHAPE	Disruptions of natural texture appearance are known to negatively impact performance in texture discrimination tasks, for example, such that contrast-negated textures, synthetic textures, and textures depicting abstract art are processed less efficiently than natural textures. Presently, we examined how visual ERP responses (the P1 and the N1 in particular) were affected by violations of natural texture appearance. We presented participants with images depicting either natural textures or synthetic textures made from the original stimuli. Both stimulus types were additionally rendered either in positive or negative contrast. These appearance manipulations (negation and texture synthesis) preserve a range of low-level features, but also disrupt higher-order aspects of texture appearance. We recorded continuous EEG while participants completed a same/different image discrimination task using these images and measured both the P1 and N1 components over occipital recording sites. While the P1 exhibited no sensitivity to either contrast polarity or real/synthetic appearance, the N1 was sensitive to both deviations from natural appearance. Polarity reversal and synthetic appearance affected the N1 latency differently, however, suggesting a differential impact on processing. Our results suggest that stages of visual processing indexed by the P1 and N1 are sensitive to high-order statistical regularities in natural textures and also suggest that distinct violations of natural appearance impact neural responses differently.	[Balas, Benjamin; Conlin, Catherine] N Dakota State Univ, Dept Psychol, Fargo, ND 58105 USA; [Balas, Benjamin] N Dakota State Univ, Ctr Visual & Cognit Neurosci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo	Balas, B (corresponding author), N Dakota State Univ, Dept Psychol, Fargo, ND 58105 USA.	Benjamin.Balas@ndsu.edu	Balas, Ben/R-4003-2019		National Institutes of Health [R15 EY024375, GM103505]; NATIONAL EYE INSTITUTE [R15EY024375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant R15 EY024375 awarded to BB, and the National Institutes of Health grant GM103505 awarded to Mark McCourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balas B, 2015, P SPIE; Balas B, 2014, INFANCY, V19, P262, DOI 10.1111/infa.12050; Balas B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00515; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Balas BJ, 2006, VISION RES, V46, P299, DOI 10.1016/j.visres.2005.04.013; Bulthoff H. H., 2004, P 1 S APPL PERC GRAP, P127; CALLAWAY E, 1982, PSYCHIAT RES, V7, P299, DOI 10.1016/0165-1781(82)90066-X; Ellemberg D, 2012, VISION RES, V67, P1, DOI 10.1016/j.visres.2012.06.018; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Fleming RW, 2011, P NATL ACAD SCI USA, V108, P20438, DOI 10.1073/pnas.1114619109; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Fleming RW., 2005, ACM T APPL PERCEPT, V2, P346, DOI [10.1145/1077399.1077409, DOI 10.1145/1077399.1077409]; Freeman J, 2013, NAT NEUROSCI, V16, P974, DOI 10.1038/nn.3402; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Gerhard HE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002873; Geusebroek JM, 2005, INT J COMPUT VISION, V62, P7, DOI 10.1007/s11263-005-4632-7; Ghebreab S, 2009, ADV NEURAL INFORM PR, P629; Groen IIA, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00034; Hansen BC, 2006, J VISION, V6, P696, DOI 10.1167/6.7.3; Heeger D. J., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P229, DOI 10.1145/218380.218446; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacobs RHAH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00146; JOHNSTON A, 1994, PERCEPTION, V23, P169, DOI 10.1068/p230169; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; Luck S.J., 2005, INTRO EVENT RELATED; MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Nederhouser M, 2007, VISION RES, V47, P2134, DOI 10.1016/j.visres.2007.04.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Proverbio AM, 2002, NEUROPSYCHOLOGIA, V40, P479, DOI 10.1016/S0028-3932(01)00135-X; Rosenholtz R, 2011, P SPIE HVEI; Schubo A, 2001, COGNITIVE BRAIN RES, V11, P341, DOI 10.1016/S0926-6410(01)00008-8; Sharan L, 2008, J OPT SOC AM A, V25, P846, DOI 10.1364/JOSAA.25.000846; Tyler CW, 2004, VISION RES, V44, P2187, DOI 10.1016/j.visres.2004.03.032	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136471	10.1371/journal.pone.0136471	http://dx.doi.org/10.1371/journal.pone.0136471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355681	gold, Green Submitted, Green Published			2022-12-27	WOS:000360965800013
J	Cheng, SL; Lin, WH; Phoa, FKH; Hwang, JS; Liu, WC				Cheng, Shu-li; Lin, Wen-hsien; Phoa, Frederick Kin Hing; Hwang, Jing-shiang; Liu, Wei-chung			Analysing the Unequal Effects of Positive and Negative Information on the Behaviour of Users of a Taiwanese On-Line Bulletin Board	PLOS ONE			English	Article							SOCIAL-INFLUENCE; BIAS; COMMUNICATION; MODELS	The impact of social influence causes people to adopt the behaviour of others when interacting with other individuals. The effects of social influence can be direct or indirect. Direct social influence is the result of an individual directly influencing the opinion of another, while indirect social influence is a process taking place when an individual's opinion and behaviour is affected by the availability of information about others' actions. Such indirect effect may exhibit a more significant impact in the on-line community because the internet records not only positive but also negative information, for example on-line written text comments. This study focuses on indirect social influence and examines the effect of preceding information on subsequent users' opinions by fitting statistical models to data collected from an on-line bulletin board. Specifically, the different impacts of information on approval and disapproval comments on subsequent opinions were investigated. Although in an anonymous situation where social influence is assumed to be at minimum, our results demonstrate the tendency of on-line users to adopt both positive and negative information to conform to the neighbouring trend when expressing opinions. Moreover, our results suggest unequal effects of the local approval and disapproval comments in affecting the likelihood of expressing opinions. The impact of neighbouring disapproval densities was stronger than that of neighbouring approval densities on inducing subsequent disapproval relative to approval comments. However, our results suggest no effects of global social influence on subsequent opinion expression.	[Cheng, Shu-li; Lin, Wen-hsien; Phoa, Frederick Kin Hing; Hwang, Jing-shiang; Liu, Wei-chung] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Liu, WC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	wliu56@gate.sinica.edu.tw	Hwang, Jing-Shiang/AAP-2835-2021; Phoa, Frederick Kin Hing/AAP-4913-2021; Liu, Wei-chung/AAP-3893-2021	Hwang, Jing-Shiang/0000-0002-5807-7583; Liu, Wei-chung/0000-0001-8041-8789				Agresti A, 2007, INTRO CATEGORICAL DA; An M. Y., 1995, J EVOLUTIONARY EC, V5, P103; [Anonymous], 2014, PTT B BOARD SYST; Asch S.E., 1951, GROUPS LEADERSHIP ME, P177, DOI DOI 10.1037/10025-01; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Chiang YS, 2007, J MATH SOCIOL, V31, P47, DOI 10.1080/00222500601013536; Denrell J, 2008, SCIENCE, V321, P47, DOI 10.1126/science.1157667; Denrell J, 2007, PSYCHOL REV, V114, P398, DOI 10.1037/0033-295X.114.2.398; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Dong GH, 2011, J PSYCHOPHYSIOL, V25, P9, DOI 10.1027/0269-8803/a000027; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Granovetter M., 1988, SOCIOL METHODOL, V18, P69, DOI [10.2307/271045, DOI 10.2307/271045]; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; KRASSA MA, 1988, SOC NETWORKS, V10, P109, DOI 10.1016/0378-8733(88)90018-4; Lee J, 2008, ELECTRON COMMER R A, V7, P341, DOI 10.1016/j.elerap.2007.05.004; Lin Y. H., 2014, NANOMEDICINE, V1, P1, DOI DOI 10.1186/2045-3701-4-67; Lopez MV, 2010, CHOICE NONCOORDINATI; Lopez-Pintado D, 2008, RATION SOC, V20, P399, DOI 10.1177/1043463108096787; Mavrodiev P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01360; Metzger MJ, 2007, J AM SOC INF SCI TEC, V58, P2078, DOI 10.1002/asi.20672; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Phan D, 2006, LECT NOTES ECON MATH, V584, P203; Postmes T, 2001, PERS SOC PSYCHOL B, V27, P1243, DOI 10.1177/01461672012710001; Postmes T, 2002, PERS SOC PSYCHOL B, V28, P1073, DOI 10.1177/01461672022811006; Rashotte L. S., 2006, BLACKWELL ENCY SOCIO, VIX, P4426; Reicher S. D., 1995, EUROPEAN REV SOCIAL, V6, P161, DOI [10.1080/14792779443000049, DOI 10.1080/14792779443000049]; Roberts LD, 2013, AUSTRALAS J EDUC TEC, V29, P612; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Valente T, 1995, NETWORK MODELS DIFFU; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137842	10.1371/journal.pone.0137842	http://dx.doi.org/10.1371/journal.pone.0137842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355455	Green Submitted, Green Published, gold			2022-12-27	WOS:000360965800086
J	Schmidt, EM; Wiek, C; Parkinson, OT; Roellecke, K; Freund, M; Gombert, M; Lottmann, N; Steward, CA; Kramm, CM; Yarov-Yarovoy, V; Rettie, AE; Hanenberg, H				Schmidt, Eva M.; Wiek, Constanze; Parkinson, Oliver T.; Roellecke, Katharina; Freund, Marcel; Gombert, Michael; Lottmann, Nadine; Steward, Charles A.; Kramm, Christof M.; Yarov-Yarovoy, Vladimir; Rettie, Allan E.; Hanenberg, Helmut			Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution	PLOS ONE			English	Article							POTATOES IPOMOEA-BATATAS; TARGET ORGAN ALKYLATION; DAMAGED SWEET-POTATOES; LUNG-CANCER; FIBRONECTIN FRAGMENTS; DOSE SCHEDULE; GENE-TRANSFER; PHASE-I; 4-IPOMEANOL; CYTOCHROME-P450	CYP4B1 belongs to the cytochrome P450 family 4, one of the oldest P450 families whose members have been highly conserved throughout evolution. The CYP4 monooxygenases typically oxidize fatty acids to both inactive and active lipid mediators, although the endogenous ligand(s) is largely unknown. During evolution, at the transition of great apes to humanoids, the CYP4B1 protein acquired a serine instead of a proline at the canonical position 427 in the meander region. Although this alteration impairs P450 function related to the processing of naturally occurring lung toxins, a study in transgenic mice suggested that an additional serine insertion at position 207 in human CYP4B1 can rescue the enzyme stability and activity. Here, we report that the genomic insertion of a CAG triplet at the intron 5-exon 6 boundary in human CYP4B1 introduced an additional splice acceptor site in frame. During evolution, this change occurred presumably at the stage of Hominoidae and leads to two major isoforms of the CYP4B1 enzymes of humans and great apes, either with or without a serine 207 insertion (insSer207). We further demonstrated that the CYP4B1 enzyme with insSer207 is the dominant isoform (76%) in humans. Importantly, this amino acid insertion did not affect the 4-ipomeanol metabolizing activities or stabilities of the native rabbit or human CYP4B1 enzymes, when introduced as transgenes in human primary cells and cell lines. In our 3D modeling, this functional neutrality of insSer207 is compatible with its predicted location on the exterior surface of CYP4B1 in a flexible side chain. Therefore, the Ser207 insertion does not rescue the P450 functional activity of human CYP4B1 that has been lost during evolution.	[Schmidt, Eva M.; Gombert, Michael] Univ Dusseldorf, Childrens Hosp, Dept Pediat Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Wiek, Constanze; Roellecke, Katharina; Freund, Marcel; Lottmann, Nadine; Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany; [Parkinson, Oliver T.; Rettie, Allan E.] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA; [Steward, Charles A.] Wellcome Trust Sanger Inst, Cambridge, England; [Kramm, Christof M.] Univ Gottingen, Dept Child & Adolescent Hlth, Div Pediat Hematol & Oncol, D-37099 Gottingen, Germany; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Membrane Biol, Davis, CA 95616 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediat 3, D-45122 Essen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; University of Gottingen; University of California System; University of California Davis; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of Duisburg Essen	Hanenberg, H (corresponding author), Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany.	Helmut.Hanenberg@uni-due.de	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Steward, Charles/0000-0001-8829-5349; Wiek, Constanze/0000-0003-2214-8148	Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany); Deutsche Krebshilfe e. V.; NIH [R01 GM49054, R01 CA155294]; Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany; UW School of Pharmacy Brady Fund for Natural Products Research; Lilly Foundation Physician/Scientist initiative; NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049054] Funding Source: NIH RePORTER	Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany); Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany; UW School of Pharmacy Brady Fund for Natural Products Research; Lilly Foundation Physician/Scientist initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was initially supported by the Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany), the Deutsche Krebshilfe e. V. (to CMK and HH) and the NIH grant R01 GM49054 (AER). Later support was from the Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany (to CW), the UW School of Pharmacy Brady Fund for Natural Products Research (to AER), and NIH R01 CA155294 (to HH). HH is supported by the Lilly Foundation Physician/Scientist initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer BR, 2005, CHEM RES TOXICOL, V18, P855, DOI 10.1021/tx0496993; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; BOYD MR, 1976, ENVIRON HEALTH PERSP, V16, P127, DOI 10.2307/3428593; BOYD MR, 1978, J PHARMACOL EXP THER, V207, P687; BOYD MR, 1972, J AGR FOOD CHEM, V20, P428, DOI 10.1021/jf60180a066; BOYD MR, 1975, TOXICOL APPL PHARM, V32, P147, DOI 10.1016/0041-008X(75)90205-7; BOYD MR, 1972, NATURE-NEW BIOL, V236, P158, DOI 10.1038/newbio236158a0; Bylund J, 1999, BIOCHEM BIOPH RES CO, V261, P169, DOI 10.1006/bbrc.1999.1011; Carr BA, 2003, MOL PHARMACOL, V63, P1137, DOI 10.1124/mol.63.5.1137; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; CHRISTIAN MC, 1989, J NATL CANCER I, V81, P1133, DOI 10.1093/jnci/81.15.1133; CZERWINSKI M, 1991, CANCER RES, V51, P4636; DOSTER AR, 1978, VET PATHOL, V15, P367, DOI 10.1177/030098587801500312; DUTCHER JS, 1979, BIOCHEM PHARMACOL, V28, P3367, DOI 10.1016/0006-2952(79)90074-1; Gotoh O, 2012, BIOL PHARM BULL, V35, P812; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hiratsuka Masahiro, 2004, Drug Metab Pharmacokinet, V19, P114, DOI 10.2133/dmpk.19.114; Imaoka S, 2001, BIOCHEM BIOPH RES CO, V284, P757, DOI 10.1006/bbrc.2001.5055; Kasturi VK, 1998, CLIN CANCER RES, V4, P2095; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lakhanpal S, 2001, INVEST NEW DRUG, V19, P69, DOI 10.1023/A:1006408803734; Lo-Guidice JM, 2002, PHARMACOGENETICS, V12, P367, DOI 10.1097/00008571-200207000-00004; Nakano M, 2012, MOL PHARMACOL, V82, P679, DOI 10.1124/mol.112.080085; Nelson David R., 2009, Human Genomics, V4, P59; NHAMBURO PT, 1989, BIOCHEMISTRY-US, V28, P8060, DOI 10.1021/bi00446a014; Omura T, 2013, BIOTECHNOL APPL BIOC, V60, P4, DOI 10.1002/bab.1099; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; ROBERTSON IGC, 1983, MOL PHARMACOL, V24, P156; ROWINSKY EK, 1993, CANCER RES, V53, P1794; SERABJITSINGH CJ, 1979, J BIOL CHEM, V254, P9901; SERABJITSINGH CJ, 1980, SCIENCE, V207, P1469, DOI 10.1126/science.6767272; SMITH PB, 1995, BIOCHEM PHARMACOL, V50, P1567, DOI 10.1016/0006-2952(95)02029-2; VERSCHOYLE RD, 1993, TOXICOL APPL PHARM, V123, P193, DOI 10.1006/taap.1993.1237; Wiek C, 2015, BIOCHEM J, V465, P103, DOI 10.1042/BJ20140813; WILSON BJ, 1970, NATURE, V227, P521, DOI 10.1038/227521a0; WILSON BJ, 1971, NATURE, V231, P52, DOI 10.1038/231052a0; WOLF CR, 1982, MOL PHARMACOL, V22, P738; YOKOTANI N, 1990, EUR J BIOCHEM, V187, P23, DOI 10.1111/j.1432-1033.1990.tb15273.x; YOST GS, 1989, TOXICOL APPL PHARM, V101, P179, DOI 10.1016/0041-008X(89)90268-8; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074; Zheng YM, 1998, BIOCHEMISTRY-US, V37, P12847, DOI 10.1021/bi981280m	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137110	10.1371/journal.pone.0137110	http://dx.doi.org/10.1371/journal.pone.0137110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355749	Green Published, gold			2022-12-27	WOS:000360965800029
J	Bartholome, R; Salden, B; Vrolijk, MF; Troost, FJ; Masclee, A; Bast, A; Haenen, GR				Bartholome, R.; Salden, B.; Vrolijk, M. F.; Troost, F. J.; Masclee, A.; Bast, A.; Haenen, G. R.			Paracetamol as a Post Prandial Marker for Gastric Emptying, A Food-Drug Interaction on Absorption	PLOS ONE			English	Article								The use of paracetamol as tool to determine gastric emptying was evaluated in a cross over study. Twelve healthy volunteers were included and each of them consumed two low and two high caloric meals. Paracetamol was mixed with a liquid meal and administered by a nasogastric feeding tube. The post prandial paracetamol plasma concentration time curve in all participants and the paracetamol concentration in the stomach content in six participants were determined. It was found that after paracetamol has left the stomach, based on analysis of the stomach content, there was still a substantial rise in the plasma paracetamol concentration time curve. Moreover, the difference in gastric emptying between high and low caloric meals was missed using the plasma paracetamol concentration time curve. The latter curves indicate that (i) part of the paracetamol may leave the stomach much quicker than the meal and (ii) part of the paracetamol may be relatively slowly absorbed in the duodenum. This can be explained by the partition of the homogenous paracetamol-meal mixture in the stomach in an aqueous phase and a solid bolus. The aqueous phase leaves the stomach quickly and the paracetamol in this phase is quickly absorbed in the duodenum, giving rise to the relatively steep increase of the paracetamol concentration in the plasma. The bolus leaves the stomach relatively slowly, and encapsulation by the bolus results in relatively slow uptake of paracetamol from the bolus in the duodenum. These findings implicate that paracetamol is not an accurate post prandial marker for gastric emptying. The paracetamol concentration time curve rather illustrates the food-drug interaction on absorption, which is not only governed by gastric emptying.	[Bartholome, R.; Vrolijk, M. F.; Bast, A.; Haenen, G. R.] Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Salden, B.; Troost, F. J.; Masclee, A.] Maastricht Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	Haenen, GR (corresponding author), Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	g.haenen@maastrichtuniversity.nl	Bast, Aalt/I-7809-2013	Vrolijk, Misha/0000-0002-2751-8972; Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789				Anson NM, 2011, J NUTR, V141, P137, DOI 10.3945/jn.110.127720; Cvijic S, 2014, EUR J PHARM SCI, V61, P40, DOI 10.1016/j.ejps.2014.04.008; DiPietra AM, 1996, J CHROMATOGR A, V729, P355, DOI 10.1016/0021-9673(95)01037-8; Gonzalez A, 2000, EUR J NUTR, V39, P224, DOI 10.1007/s003940070015; HEADING RC, 1973, BRIT J PHARMACOL, V47, P415, DOI 10.1111/j.1476-5381.1973.tb08339.x; Henderson HRJRRFG, 2011, RANG DALES PHARM; HOLT S, 1979, LANCET, V1, P636; HUNT JN, 1980, AM J PHYSIOL, V239, pG1, DOI 10.1152/ajpgi.1980.239.1.G1; Lentz KA, 2008, AAPS J, V10, P282, DOI 10.1208/s12248-008-9025-8; Medhus AW, 2001, NEUROGASTROENT MOTIL, V13, P179, DOI 10.1046/j.1365-2982.2001.00249.x; Parojcic J, 2008, INT J PHARM, V355, P93, DOI 10.1016/j.ijpharm.2007.11.058; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Welling PG, 1996, ANNU REV NUTR, V16, P383, DOI 10.1146/annurev.nu.16.070196.002123; Willems M, 2001, DIGEST DIS SCI, V46, P2256, DOI 10.1023/A:1011935603893	14	84	85	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136618	10.1371/journal.pone.0136618	http://dx.doi.org/10.1371/journal.pone.0136618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352940	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800042
J	Pilgrim, T; Heg, D; Tal, K; Erne, P; Radovanovic, D; Windecker, S; Juni, P				Pilgrim, Thomas; Heg, Dik; Tal, Kali; Erne, Paul; Radovanovic, Dragana; Windecker, Stephan; Jueni, Peter		AMIS Plus Investigators	Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; UNCONSCIOUS BIAS; DECISION-MAKING; DISEASE; CARE; QUALITY; GUIDELINES; WOMEN; MANAGEMENT; PHYSICIANS	Background Previous analyses reported age-and gender-related differences in the provision of cardiac care. The objective of the study was to compare circadian disparities in the delivery of primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) according to the patient's age and gender. Methods We investigated patients included into the Acute Myocardial Infarction in Switzerland (AMIS) registry presenting to one of 11 centers in Switzerland providing primary PCI around the clock, and stratified patients according to gender and age. Findings A total of 4723 patients presented with AMI between 2005 and 2010; 1319 (28%) were women and 2172 (54%) were >= 65 years of age. More than 90% of patients <65 years of age underwent primary PCI without differences between gender. Elderly patients and particularly women were at increased risk of being withheld primary PCI (males adj. HR 4.91, 95% CI 3.93-6.13; females adj. HR 9.31, 95% CI 7.37-11.75) as compared to males <65 years of age. An increased risk of a delay in door-to-balloon time >90 minutes was found in elderly males (adj HR 1.66 (95% CI 1.40-1.95), p < 0.001) and females (adj HR 1.57 (95% CI 1.27-1.93), p < 0.001), as well as in females <65 years (adj HR 1.47 (95% CI 1.13-1.91), p = 0.004) as compared to males <65 years of age, with significant differences in circadian patterns during on- and off-duty hours. Conclusions In a cohort of patients with AMI in Switzerland, we observed discrimination of elderly patients and females in the circadian provision of primary PCI.	[Pilgrim, Thomas; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Heg, Dik; Tal, Kali] Univ Bern, Dept Clin Res, ISPM, Bern, Switzerland; [Heg, Dik; Tal, Kali] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Radovanovic, Dragana] Univ Zurich, Inst Social & Prevent Med, AMIS Plus Data Ctr, CH-8006 Zurich, Switzerland; [Jueni, Peter] Univ Bern, Inst Primary Care & Clin Epidemiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Zurich; University of Bern	Juni, P (corresponding author), Univ Bern, Inst Primary Care & Clin Epidemiol, Bern, Switzerland.	peter.juni@biham.unibe.ch	Pilgrim, Thomas/AAS-9120-2021; Jeger, Raban/ABG-1678-2021; Radovanovic, Dragana I/F-7908-2013; Puhan, Milo/ABE-6298-2020; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Jeger, Raban/0000-0003-1290-5491; Radovanovic, Dragana I/0000-0002-9507-6272; Puhan, Milo/0000-0003-4721-1879; Juni, Peter/0000-0002-5985-0670; Heg, Dik/0000-0002-8766-7945; Maggiorini, Marco/0000-0001-8180-2117; Tal, Kali/0000-0003-2454-2560				AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Berger A, 2008, AM J CARDIOL, V101, P422, DOI 10.1016/j.amjcard.2007.09.092; Blair Irene V, 2011, Perm J, V15, P71; Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x; Cabana MD, 2003, WOMEN HEALTH ISS, V13, P142, DOI 10.1016/S1049-3867(03)00034-3; Chiaramonte GR, 2006, HEALTH PSYCHOL, V25, P255, DOI 10.1037/0278-6133.25.3.255; CLARKE KW, 1994, BMJ-BRIT MED J, V309, P563, DOI 10.1136/bmj.309.6954.563; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Hannah SD, 2013, CULT MED PSYCHIAT, V37, P314, DOI 10.1007/s11013-013-9320-4; Hebert K, 2010, J HEALTH CARE POOR U, V21, P264, DOI 10.1353/hpu.0.0243; ject, 2003, EUR HEART J, V24, P987, DOI [DOI 10.1016/S0195-668X(02)00618-8, 10.1016/s0195-668x(03)00114-3, DOI 10.1016/S0195-668X(03)00114-3]; Kudenchuk PJ, 1996, AM J CARDIOL, V78, P9, DOI 10.1016/S0002-9149(96)00218-4; Medina HM, 2011, AM HEART J, V162, P283, DOI 10.1016/j.ahj.2011.04.017; Mejhert M, 1999, EUR J HEART FAIL, V1, P407, DOI 10.1016/S1388-9842(99)00053-7; Milcent C, 2007, CIRCULATION, V115, P833, DOI 10.1161/CIRCULATIONAHA.106.664979; Moretti C, 2015, INT J CARDIOL, V179, P552, DOI 10.1016/j.ijcard.2014.10.035; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Stepanikova I, 2012, J HEALTH SOC BEHAV, V53, P329, DOI 10.1177/0022146512445807; Stock EO, 2012, CURR PROB CARDIOLOGY, V37, P450, DOI 10.1016/j.cpcardiol.2012.07.001; Stone J, 2011, MED EDUC, V45, P768, DOI 10.1111/j.1365-2923.2011.04026.x; Teal CR, 2012, MED EDUC, V46, P80, DOI 10.1111/j.1365-2923.2011.04101.x; Travis CB, 2012, WOMEN THER, V35, P207, DOI 10.1080/02703149.2012.684589; Wang TY, 2011, J AM COLL CARDIOL, V58, P637, DOI 10.1016/j.jacc.2011.05.012	29	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137047	10.1371/journal.pone.0137047	http://dx.doi.org/10.1371/journal.pone.0137047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352574	Green Published, gold			2022-12-27	WOS:000360932800057
J	Vincens, N; Stafstrom, M				Vincens, Natalia; Stafstrom, Martin			Income Inequality, Economic Growth and Stroke Mortality in Brazil: Longitudinal and Regional Analysis 2002-2009	PLOS ONE			English	Article							SELF-RATED HEALTH; NONCOMMUNICABLE DISEASES; SOCIOECONOMIC-STATUS; POPULATION HEALTH; LIFE EXPECTANCY; PUBLIC-HEALTH; NEIGHBORHOOD; PATTERNS; IMPACT; LEVEL	Background and Purpose Stroke accounts for more than 10% of all deaths globally and most of it occurs in low-and middle-income countries (LMIC). Income inequality and gross domestic product (GDP) per capita has been associated to stroke mortality in developed countries. In LMIC, GDP per capita is considered to be a more relevant health determinant than income inequality. This study aims to investigate if income inequality is associated to stroke mortality in Brazil at large, but also on regional and state levels, and whether GDP per capita modulates the impact of this association. Methods Stroke mortality rates, Gini index and GDP per capita data were pooled for the 2002 to 2009 period from public available databases. Random effects models were fitted, controlling for GDP per capita and other covariates. Results Income inequality was independently associated to stroke mortality rates, even after controlling for GDP per capita and other covariates. GDP per capita reduced only partially the impact of income inequality on stroke mortality. A decrease in 10 points in the Gini index was associated with 18% decrease in the stroke mortality rate in Brazil. Conclusions Income inequality was independently associated to stroke mortality in Brazil.	[Vincens, Natalia; Stafstrom, Martin] Lund Univ, Social Med & Global Hlth, Dept Clin Sci Malmo, Malmo, Sweden; [Vincens, Natalia] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil	Lund University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Vincens, N (corresponding author), Lund Univ, Social Med & Global Hlth, Dept Clin Sci Malmo, Malmo, Sweden.	natalia.vincens@med.lu.se			Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Ministry of Education of Brazil, Brasilia - DF, Brazil [13122/13-4]	Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Ministry of Education of Brazil, Brasilia - DF, Brazil	This study was supported by Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Ministry of Education of Brazil, Brasilia - DF, Brazil [http://www.capes.gov.br], scholarship process number 13122/13-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL; Azzoni CR, 2001, ANN REGIONAL SCI, V35, P133, DOI 10.1007/s001680000038; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Baltagi B. H., 2005, ECONOMETRIC ANAL PAN; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bell A, 2015, POLIT SCI RES METH, V3, P133, DOI 10.1017/psrm.2014.7; Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; BROWN MC, 1994, SOC SCI MED, V38, P1243, DOI 10.1016/0277-9536(94)90189-9; Cabral NL, 2011, NEUROEPIDEMIOLOGY, V36, P258, DOI 10.1159/000328865; Cameron A.C., 2009, MICROECONOMETRICS US; Cin C.B., 2013, INT J ADV SCI TECHNO, V53, P95; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dieleman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110257; Elias PEM, 2003, AM J PUBLIC HEALTH, V93, P44, DOI 10.2105/AJPH.93.1.44; Goulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x; Howard VJ, 2012, STROKE, V43, P2033, DOI 10.1161/STROKEAHA.112.663237; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P197, DOI 10.1590/S1415-790X2002000200007; Kakwani N, 2010, WORLD DEV, V38, P881, DOI 10.1016/j.worlddev.2010.02.015; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Lamarca GA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-1; Lotufo PA, 2013, INT J STROKE, V8, P155, DOI 10.1111/j.1747-4949.2011.00757.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macinko JA, 2003, MED CARE RES REV, V60, P407, DOI 10.1177/1077558703257169; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Messias E, 2003, AM J PUBLIC HEALTH, V93, P1294, DOI 10.2105/AJPH.93.8.1294; Ministerio da Saude, 2013, IND DE SAUD; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Muntaner C, 1999, INT J HEALTH SERV, V29, P59, DOI 10.2190/G8QW-TT09-67PL-QTNC; Naing N N, 2000, Malays J Med Sci, V7, P10; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pattussi Marcos Pascoal, 2006, Cad. Saúde Pública, V22, P1525, DOI 10.1590/S0102-311X2006000800002; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; PEARSON TA, 1993, DIS CONTROL PRIORITI, P577; Pop IA, 2013, SOC INDIC RES, V113, P1025, DOI 10.1007/s11205-012-0125-6; Rasella D, 2013, J EPIDEMIOL COMMUN H, V67, P661, DOI 10.1136/jech-2012-201426; Remler DK, 2011, RES METHODS PRACTICE, P427; Schramm Joyce Mendes de Andrade, 2004, Ciênc. saúde coletiva, V9, P897, DOI 10.1590/S1413-81232004000400011; Shi LY, 2003, STROKE, V34, P1958, DOI 10.1161/01.STR.0000082380.80444.A9; Siddiqi A, 2015, SOC SCI MED, V131, P82, DOI 10.1016/j.socscimed.2015.03.010; Sposato LA, 2012, STROKE, V43, P170, DOI 10.1161/STROKEAHA.111.632158; STATA, 2011, LONG DAT PAN DAT REF; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; United nations Development Programme (UNDP), 2007, NAT HUM DEV REP RUSS; Uphoff EP, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-54; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Wooldrige J., 2009, INTRO ECONOMETRICS M	54	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137332	10.1371/journal.pone.0137332	http://dx.doi.org/10.1371/journal.pone.0137332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352415	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800074
J	Yang, XJ; Wu, QP; Zhang, JM; Huang, JH; Guo, WP; Cai, SZ				Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen			Prevalence and Characterization of Monophasic Salmonella Serovar (1) under bar,4,[5], 12: i:-of Food Origin in China	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; MOLECULAR CHARACTERIZATION; PHENOTYPIC CHARACTERISTICS; INFECTIONS; RESISTANCE; STRAINS; VARIANT; SURVEILLANCE; EMERGENCE; EVOLUTION	Salmonella enterica subsp. enterica serovar (1) under bar,4,[5], 12:i:-is a monophasic variant of Salmonella Typhimurium, which has recently been recognized as an emerging cause of infection worldwide. This bacterium has also ranked among the four most frequent serovars causing human salmonellosis in China. However, there are no reports on its contamination in Chinese food. Serotyping, polymerase chain reaction, antibiotic resistance, virulotyping, and multilocus sequence typing (MLST) assays were used to investigate the prevalence of this serological variant in food products in China, and to determine phenotypic and genotypic difference of monophasic isolates and Salmonella Typhimurium isolated over the same period. Salmonella (1) under bar,4,[5], 12:i:-was prevalent in various food sources, including beef, pork, chicken, and pigeon. The study also confirmed the high prevalence (53.8%) of resistance to ampicillin, streptomycin, sulfonamides, and tetracycline in Salmonella (1) under bar,4,[5], 12:i:-, which was higher than that in Salmonella Typhimurium. Moreover, Salmonella (1) under bar,4,[5], 12:i:-isolates in our study were different from Salmonella Typhimurium isolates by the absence of three plasmid-borne genes (spvC, pefA, and rck) and the presence of gipA in all isolates. All Salmonella (1) under bar,4,[5], 12:i:-isolates demonstrated MLST pattern ST34. Genomic deletions within the fljBA operon and surrounding genes were only found in Salmonella (1) under bar,4,[5], 12:i:isolates, with all isolates containing a deletion of fljB. However, hin and iroB were identified in all Salmonella (1) under bar,4,[5], 12:i:-isolates. Three different deletion profiles were observed and two of them were different from the reported Salmonella (1) under bar,4,[5], 12:i:-clones from Spain, America, and Italy, which provided some new evidence on the independent evolution of the multiple successful monophasic clones from Salmonella Typhimurium ancestors. This study is the first report of Salmonella (1) under bar,4,[5], 12:i:-in food products from China. The data are more comprehensive and representative, providing valuable information for epidemiological studies, risk management, and public health strategies.	[Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Open Lab Appl Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wu, QP (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.	wuqp203@163.com	Gu, Yan/AFQ-1163-2022		Science and Technology Projects of Guangdong [2013B050800026, 2014A040401055]; Science and Technology Projects of Guangzhou [201300000074]	Science and Technology Projects of Guangdong; Science and Technology Projects of Guangzhou	The authors' study was supported by the Science and Technology Projects of Guangdong (2013B050800026, JMZ; 2014A040401055, XJY) and the Science and Technology Projects of Guangzhou (201300000074, JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amavisit P, 2005, J CLIN MICROBIOL, V43, P2736, DOI 10.1128/JCM.43.6.2736-2740.2005; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Barco L, 2012, ZOONOSES PUBLIC HLTH, V59, P505, DOI 10.1111/j.1863-2378.2012.01487.x; Barco L, 2014, FOODBORNE PATHOG DIS, V11, P138, DOI 10.1089/fpd.2013.1626; Boland C, 2014, VET MICROBIOL, V168, P447, DOI 10.1016/j.vetmic.2013.11.040; Bone A, 2010, EUROSURVEILLANCE, V15, P2; Capuano F, 2013, FOODBORNE PATHOG DIS, V10, P963, DOI 10.1089/fpd.2013.1511; Centers for Disease Control and Prevention [CDC], 2006, EM ANT RES SALM SER; Chiou CS, 2006, DIAGN MICR INFEC DIS, V54, P315, DOI 10.1016/j.diagmicrobio.2005.10.009; Clinical and Laboratory Standards Institute, 2014, CLSI DOC; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Grimont PAD, 2007, ANTIGENIC FORMULAE F; Guerra B, 2000, FEMS MICROBIOL LETT, V190, P341, DOI 10.1016/S0378-1097(00)00359-1; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hopkins K L, 2010, Euro Surveill, V15, P19580; Hopkins KL, 2010, 2 ANT RES ZOON BACT, P13; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; Kurosawa A, 2012, VET MICROBIOL, V160, P264, DOI 10.1016/j.vetmic.2012.05.023; Laorden L, 2010, J CLIN MICROBIOL, V48, P4563, DOI 10.1128/JCM.00337-10; Liang ZM, 2013, S CHINA J PREVENTIVE, V39, P27; Lucarelli C, 2012, J ANTIMICROB CHEMOTH, V67, P111, DOI 10.1093/jac/dkr391; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mossong J, 2007, Euro Surveill, V12, pE11; Mulvey MR, 2013, J ANTIMICROB CHEMOTH, V68, P1982, DOI 10.1093/jac/dkt149; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Wasyl D, 2012, FOODBORNE PATHOG DIS, V9, P1037, DOI 10.1089/fpd.2012.1154; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	36	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137967	10.1371/journal.pone.0137967	http://dx.doi.org/10.1371/journal.pone.0137967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360603	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100104
J	Yang, X; Zhu, CF; Gu, Y				Yang, Xue; Zhu, Chenfang; Gu, Yan			The Prognosis of Breast Cancer Patients after Mastectomy and Immediate Breast Reconstruction: A Meta-Analysis	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; POSTMASTECTOMY RECONSTRUCTION; ONCOLOGICAL SAFETY; ADJUVANT CHEMOTHERAPY; LOCAL RECURRENCE; FOLLOW-UP; SURVIVAL; IMPACT; CONSERVATION; REVIEWS	Background An increasing number of patients with breast cancer are being offered immediate breast reconstruction (IBR). The aim of this study was to analyze the impact of IBR on the prognosis of patients with breast cancer. Methods We searched the electronic databases of Medline (Pubmed), ISI Web of Knowledge, Embase, and Google Scholar databases for studies reporting the overall recurrence, disease- free survival (DFS), and overall survival (OS) of patients after mastectomy only and mastectomy with IBR. With these data, we conducted a meta-analysis of the clinical outcomes. Results Fourteen studies, including 3641 cases and 9462 controls, matched our criteria. Relevant information was extracted from these 14 studies. There was no significant heterogeneity (P for Q-statistic > 0.10 and I-2 < 25%). Patients who underwent IBR showed no increased risk of overall recurrence of breast cancer (RR = 0.89; 95% confidence interval [CI]: 0.75, 1.04; P = 0.14). Furthermore, patients receiving IBR had similar DFS (RR = 1.04; 95% CI: 0.99, 1.08); P = 0.10) and OS (RR = 1.02; 95% CI: 0.99, 1.05; P = 0.24)) as those of control patients. Conclusion This meta-analysis provides evidence that IBR does not have an adverse effect on prognosis. These data suggest that IBR is an appropriate and safe choice for patients with breast cancer.	[Yang, Xue; Zhu, Chenfang; Gu, Yan] Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Gu, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China.	guyan_8@hotmail.com	Gu, Yan/AFQ-1163-2022					Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x; Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Barry PN, 2014, AM J CLIN ONCOL-CANC, V37, P575, DOI 10.1097/COC.0b013e318280d79f; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen C, 2011, BREAST CANCER RES TR, V127, P439, DOI 10.1007/s10549-011-1437-y; Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f; Gieni M, 2012, BREAST, V21, P230, DOI 10.1016/j.breast.2011.12.013; Goktas SB, 2011, TURK KLIN TIP BILIM, V31, P664, DOI 10.5336/medsci.2009-15488; Gomez SL, 2010, J CLIN ONCOL, V28, pE155, DOI 10.1200/JCO.2009.26.1032; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Hoshaw SJ, 2001, PLAST RECONSTR SURG, V107, P1393, DOI 10.1097/00006534-200105000-00012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson A, 2000, BREAST CANCER RES TR, V60, P201, DOI 10.1023/A:1006441018271; Joslyn SA, 2005, PLAST RECONSTR SURG, V115, P1289, DOI 10.1097/01.PRS.0000156974.69184.5E; Kim MK, 2014, EUROPEAN J SURG ONCO; Kontos M, 2010, EJSO-EUR J SURG ONC, V36, P745, DOI 10.1016/j.ejso.2010.06.013; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee TJ, 2012, ARCH PLAST SURG-APS, V39, P376, DOI 10.5999/aps.2012.39.4.376; Lim W, 2010, J SURG ONCOL, V102, P39, DOI 10.1002/jso.21573; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; McCarthy CM, 2008, PLAST RECONSTR SURG, V121, P381, DOI 10.1097/01.prs.0000298316.74743.dd; McGuire KP, 2009, ANN SURG ONCOL, V16, P2682, DOI 10.1245/s10434-009-0635-x; Min SY, 2010, BREAST J, V16, P356, DOI 10.1111/j.1524-4741.2010.00941.x; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Murphy RX, 2003, ANN PLAS SURG, V50, P333, DOI 10.1097/01.SAP.0000041488.88950.A2; Nedumpara T, 2011, BREAST, V20, P437, DOI 10.1016/j.breast.2011.04.006; Neyt MJ, 2005, BRIT J PLAST SURG, V58, P493, DOI 10.1016/j.bjps.2004.12.002; Nguyen TJ, 2012, ANN SURG, V256, P326, DOI 10.1097/SLA.0b013e3182602bb7; NOGUCHI M, 1992, J SURG ONCOL, V50, P241, DOI 10.1002/jso.2930500409; Ota D, 2014, CLIN BREAST CANCER, V14, P339, DOI 10.1016/j.clbc.2013.12.014; Petit JY, 2008, BREAST CANCER RES TR, V112, P545, DOI 10.1007/s10549-008-9891-x; Reddy S, 2011, ANN PLAS SURG, V66, P466, DOI 10.1097/SAP.0b013e318214e575; Roder D, 2013, BREAST, V22, P1220, DOI 10.1016/j.breast.2013.09.011; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ueda S, 2008, SURGERY, V143, P414, DOI 10.1016/j.surg.2007.10.006; Viera AJ, 2005, FAM MED, V37, P360; Yoshimura, 1996, Breast Cancer, V3, P47, DOI 10.1007/BF02966962	43	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125655	10.1371/journal.pone.0125655	http://dx.doi.org/10.1371/journal.pone.0125655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26360603	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400008
